PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gallazzini, M; Yu, MJ; Gunaratne, R; Burg, MB; Ferraris, JD				Gallazzini, Morgan; Yu, Ming-Jiun; Gunaratne, Ruwan; Burg, Maurice B.; Ferraris, Joan D.			c-Abl mediates high NaCl-induced phosphorylation and activation of the transcription factor TonEBP/OREBP	FASEB JOURNAL			English	Article						hypertonicity; kinase; NFAT5; signaling	ENHANCER-BINDING PROTEIN; OSMOTIC RESPONSE ELEMENT; DAMAGE-INDUCIBLE KINASE; TYROSINE KINASE; NUCLEAR-LOCALIZATION; PHOSPHOLIPASE C-GAMMA-1; ATM; CONTRIBUTES; GENE; AUTOPHOSPHORYLATION	The transcription factor TonEBP/OREBP promotes cell survival during osmotic stress. High NaCl-induced phosphorylation of TonEBP/OREBP at tyrosine-143 was known to be an important factor in increasing its activity in cell culture. We now find that TonEBP/OREBP also is phosphorylated at tyrosine-143 in rat renal inner medulla, dependent on the interstitial osmolality. c-Abl seemed likely to be the kinase that phosphorylates TonEBP/OREBP because Y143 is in a consensus c-Abl phosphorylation site. We now confirm that, as follows. High NaCl increases c-Abl activity. Specific inhibition of c-Abl by imatinib, siRNA, or c-Abl kinase dead drastically reduces high NaCl-induced TonEBP/OREBP activity by reducing its nuclear location and transactivating activity. c-Abl associates with TonEBP/OREBP (coimmunoprecipitation) and phosphorylates TonEBP/OREBP-Y143 both in cell and in vitro. High NaCl-induced activation of ataxia telangiectasia mutated, previously known to contribute to activation of TonEBP/OREBP, depends on c-Abl activity. Thus, c-Abl is the kinase responsible for high NaCl-induced phosphorylation of TonEBP/OREBPY143, which contributes to its increased activity.-Gallazzini, M., Yu, M.-J., Gunaratne, R., Burg, M. B., Ferraris, J. D. c-Abl mediates high NaCl-induced phosphorylation and activation of the transcription factor TonEBP/OREBP. FASEB J. 24, 4325-4335 (2010). www.fasebj.org	[Gallazzini, Morgan; Yu, Ming-Jiun; Gunaratne, Ruwan; Burg, Maurice B.; Ferraris, Joan D.] NHLBI, Kidney & Electrolyte Metab Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gallazzini, M (corresponding author), 9000 Rockville Pike, Bethesda, MD 20892 USA.	gallazzinim@gmail.com	Gallazzini, Morgan/E-5465-2011	Gallazzini, Morgan/0000-0002-7185-7162; YU, MING-JIUN/0000-0003-0393-4696	NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006133, ZIAHL006134, ZICHL006019, ZIAHL001283] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Martin Playford for suggestions on experimental design and Dr. Chris Combs and Dr. Daniela Malide of the National Heart, Lung, and Blood Institute (NHLBI) Light Microscopy Core Facility for help with microscopy. This research was supported by the Intramural Research Program of NHLBI.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 1996, J BIOL CHEM, V271, P18318, DOI 10.1074/jbc.271.31.18318; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Ferraris JD, 2007, METHOD ENZYMOL, V428, P279, DOI 10.1016/S0076-6879(07)28016-4; Gu JJ, 2009, IMMUNOL REV, V228, P170, DOI 10.1111/j.1600-065X.2008.00751.x; Irarrazabal CE, 2008, J BIOL CHEM, V283, P2554, DOI 10.1074/jbc.M703490200; Irarrazabal CE, 2006, P NATL ACAD SCI USA, V103, P8882, DOI 10.1073/pnas.0602911103; Irarrazabal CE, 2010, P NATL ACAD SCI USA, V107, P906, DOI 10.1073/pnas.0913415107; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Sheikh-Hamad D, 1998, J BIOL CHEM, V273, P1832, DOI 10.1074/jbc.273.3.1832; Smith JM, 2002, FRONT BIOSCI, V7, pD31; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; VALTIN H, 1962, NATURE, V196, P1109, DOI 10.1038/1961109a0; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Yu MJ, 2006, MOL CELL PROTEOMICS, V5, P2131, DOI 10.1074/mcp.M600177-MCP200; Zhang Z, 2005, AM J PHYSIOL-RENAL, V289, pF506, DOI 10.1152/ajprenal.00417.2004	31	26	26	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4325	4335		10.1096/fj.10-157362	http://dx.doi.org/10.1096/fj.10-157362			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20585028	Green Published			2022-12-25	WOS:000283861100020
J	Du, JX; McConnell, BB; Yang, VW				Du, James X.; McConnell, Beth B.; Yang, Vincent W.			A Small Ubiquitin-related Modifier-interacting Motif Functions as the Transcriptional Activation Domain of Kruppel-like Factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; SUMO-BINDING MOTIF; SUBNUCLEAR LOCALIZATION; TRANSACTIVATION DOMAIN; GENE-EXPRESSION; NUCLEAR-BODIES; P53 ACTIVITY; FACTOR KLF4; PROTEIN; ALPHA	The zinc finger transcription factor, Kruppel-like factor 4 (KLF4), regulates numerous biological processes, including proliferation, differentiation, and embryonic stem cell self-renewal. Although the DNA sequence to which KLF4 binds is established, the mechanism by which KLF4 controls transcription is not well defined. Small ubiquitin-related modifier (SUMO) is an important regulator of transcription. Here we show that KLF4 is both SUMOylated at a single lysine residue and physically interacts with SUMO-1 in a region that matches an acidic and hydrophobic residue-rich SUMO-interacting motif (SIM) consensus. The SIM in KLF4 is required for transactivation of target promoters in a SUMO-1-dependent manner. Mutation of either the acidic or hydrophobic residues in the SIM significantly impairs the ability of KLF4 to interact with SUMO-1, activate transcription, and inhibit cell proliferation. Our study provides direct evidence that SIM in KLF4 functions as a transcriptional activation domain. A survey of transcription factor sequences reveals that established transactivation domains of many transcription factors contain sequences highly related to SIM. These results, therefore, illustrate a novel mechanism by which SUMO interaction modulates the activity of transcription factors.	[Du, James X.; McConnell, Beth B.; Yang, Vincent W.] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Yang, Vincent W.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University	Yang, VW (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, 615 Michael St, Atlanta, GA 30322 USA.	vyang@emory.edu			National Institutes of Health [DK52230, DK64399, DK76742, DK77381, CA84197]; NATIONAL CANCER INSTITUTE [R01CA084197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064399, K01DK076742, R03DK089131, R01DK052230, F32DK077381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52230, DK64399, DK76742, DK77381, and CA84197.	Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Breiding DE, 1996, VIROLOGY, V221, P34, DOI 10.1006/viro.1996.0350; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; CHANG J, 1995, J BIOL CHEM, V270, P25014, DOI 10.1074/jbc.270.42.25014; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Cho G, 2009, J BIOL CHEM, V284, P19592, DOI 10.1074/jbc.M109.010181; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; Defossez PA, 1997, NUCLEIC ACIDS RES, V25, P4455, DOI 10.1093/nar/25.22.4455; DONALDSON L, 1992, J BIOL CHEM, V267, P1411; Drysdale CM, 1998, MOL CELL BIOL, V18, P1711, DOI 10.1128/MCB.18.3.1711; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2008, CURR COLORECT CANC R, V4, P59, DOI 10.1007/s11888-008-0011-4; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; Hagos EG, 2009, ONCOGENE, V28, P1197, DOI 10.1038/onc.2008.465; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Hi R, 1999, J BIOL CHEM, V274, P35152, DOI 10.1074/jbc.274.49.35152; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Jonker HRA, 2005, BIOCHEMISTRY-US, V44, P827, DOI 10.1021/bi0482912; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kim DH, 2009, BMB REP, V42, P411, DOI 10.5483/BMBRep.2009.42.7.411; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; LEUTHER KK, 1993, CELL, V72, P575, DOI 10.1016/0092-8674(93)90076-3; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu R, 2009, J BIOL CHEM, V284, P16791, DOI 10.1074/jbc.M808919200; McAndrew PC, 1998, MOL CELL BIOL, V18, P5818, DOI 10.1128/MCB.18.10.5818; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; OHARE P, 1992, BIOCHEMISTRY-US, V31, P4150, DOI 10.1021/bi00131a035; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Pountney DL, 2003, EXP NEUROL, V184, P436, DOI 10.1016/j.expneurol.2003.07.004; Rajagopalan S, 2009, J BIOL CHEM, V284, P21728, DOI 10.1074/jbc.M109.006429; Remacle JE, 1997, EMBO J, V16, P5722, DOI 10.1093/emboj/16.18.5722; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sainz MB, 1997, MOL CELL BIOL, V17, P115, DOI 10.1128/MCB.17.1.115; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; SEIPEL K, 1994, BIOL CHEM H-S, V375, P463, DOI 10.1515/bchm3.1994.375.7.463; Sekiyama N, 2008, J BIOL CHEM, V283, P35966, DOI 10.1074/jbc.M802528200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Subang MC, 2009, SCIENCE, V326, P238, DOI 10.1126/science.1181038; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tell G, 1998, BIOCHEM J, V329, P395, DOI 10.1042/bj3290395; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; VANHOY M, 1993, CELL, V72, P587, DOI 10.1016/0092-8674(93)90077-4; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wang DM, 2002, ONCOGENE, V21, P1611, DOI 10.1038/sj.onc.1205236; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; XIAO H, 1994, MOL CELL BIOL, V14, P7507, DOI 10.1128/MCB.14.11.7507; Yamanaka S, 2008, CELL PROLIFERAT, V41, P51, DOI 10.1111/j.1365-2184.2008.00493.x; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	83	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28298	28308		10.1074/jbc.M110.101717	http://dx.doi.org/10.1074/jbc.M110.101717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20584900	Green Published, hybrid			2022-12-25	WOS:000281404100072
J	Gao, ZB; Zhang, TZ; Wu, M; Xiong, QJ; Sun, HY; Zhang, YA; Zu, LS; Wang, W; Li, M				Gao, Zhaobing; Zhang, Tangzhi; Wu, Meng; Xiong, Qiaojie; Sun, Haiyan; Zhang, Yinan; Zu, Liansuo; Wang, Wei; Li, Min			Isoform-specific Prolongation of Kv7 (KCNQ) Potassium Channel Opening Mediated by New Molecular Determinants for Drug-Channel Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KCNQ2/KCNQ3 K+ CHANNELS; I-KS; ANTICONVULSANT RETIGABINE; ION CHANNELS; ACTIVATION; ICA-27243; BINDING; ASSAY; N-(6-CHLORO-PYRIDIN-3-YL)-3,4-DIFLUORO-BENZAMIDE; SENSITIVITY	Kv7 channels, especially Kv7.2 (KCNQ2) and Kv7.3 (KCNQ3), are key determinants for membrane excitability in the brain. Some chemical modulators of KCNQ channels are in development for use as anti-epileptic drugs, such as retigabine (D-23129, N-(2-amino-4-(4-fluorobenzylamino)-phenyl)), which was recently approved for clinical use. In addition, several other compounds were also reported to potentiate activity of the Kv7 channels. It is therefore of interest to investigate compound-channel interactions, so that more insights may be gained to aid future development of therapeutics. We have conducted a screen of 20,000 compounds for KCNQ2 potentiators using rubidium flux combined with atomic absorption spectrometry. Here, we report the characterization of a series of new structures that display isoform specificity and induce a marked reduction of deactivation distinct from that of retigabine. Furthermore, KCNQ2(W236L), a previously reported mutation that abolishes sensitivity to retigabine, remains fully sensitive to these compounds. This result, together with mutagenesis and other studies, suggests that the reported compounds confer a unique mode of action and involve new molecular determinants on the channel protein, consistent with the idea of recognizing a new site on channel protein.	[Zhang, Tangzhi; Zhang, Yinan; Zu, Liansuo; Wang, Wei] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA; [Gao, Zhaobing; Wu, Meng; Xiong, Qiaojie; Sun, Haiyan; Li, Min] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Dept Neurosci, Baltimore, MD 21205 USA; [Gao, Zhaobing; Wu, Meng; Xiong, Qiaojie; Sun, Haiyan; Li, Min] Johns Hopkins Univ, Sch Med, Johns Hopkins Ion Channel Ctr, Baltimore, MD 21205 USA	University of New Mexico; Johns Hopkins University; Johns Hopkins University	Wang, W (corresponding author), Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA.	wwang@unm.edu; minli@jhmi.edu	Wu, Meng/F-3958-2010	Wu, Meng/0000-0003-2222-0736	National Institutes of Health [GM078579, MH084691]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078579 and MH084691 (to M. L.). This work was also supported by a postdoctoral fellowship award from the American Heart Association (to Z. G.).	Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BEZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819, DOI 10.1146/annurev.bb.23.060194.004131; Brown DA, 2008, J PHYSIOL-LONDON, V586, P1781, DOI 10.1113/jphysiol.2008.153007; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lange W, 2009, MOL PHARMACOL, V75, P272, DOI 10.1124/mol.108.052282; Lawson K, 2006, CURR PHARM DESIGN, V12, P459, DOI 10.2174/138161206775474477; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Padilla K, 2009, NEUROSCI LETT, V465, P138, DOI 10.1016/j.neulet.2009.08.071; RAE JL, 1990, CURR EYE RES, V9, P847, DOI 10.3109/02713689008999557; Redrobe JP, 2009, BEHAV BRAIN RES, V198, P481, DOI 10.1016/j.bbr.2008.12.027; Roeloffs R, 2008, J PHARMACOL EXP THER, V326, P818, DOI 10.1124/jpet.108.137794; Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Seebohm G, 2003, CIRC RES, V93, P941, DOI 10.1161/01.RES.0000102866.67863.2B; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Shapiro MS, 2000, J NEUROSCI, V20, P1710; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Sun HY, 2006, J BIOL CHEM, V281, P5877, DOI 10.1074/jbc.M600072200; Sun HY, 2004, P NATL ACAD SCI USA, V101, P16964, DOI 10.1073/pnas.0404178101; Surti Toral S, 2005, Curr Opin Investig Drugs, V6, P704; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Terstappen GC, 1999, ANAL BIOCHEM, V272, P149, DOI 10.1006/abio.1999.4179; TOPLISS JG, 1977, J MED CHEM, V20, P463, DOI 10.1021/jm00214a001; TOPLISS JG, 1972, J MED CHEM, V15, P1006, DOI 10.1021/jm00280a002; Wang HS, 2000, MOL PHARMACOL, V57, P1218; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Weaver CD, 2004, J BIOMOL SCREEN, V9, P671, DOI 10.1177/1087057104268749; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Wickenden AD, 2008, MOL PHARMACOL, V73, P977, DOI 10.1124/mol.107.043216; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874; Xu J, 2001, DRUG DISCOV TODAY, V6, P1278, DOI 10.1016/S1359-6446(01)02095-5	43	46	48	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28322	28332		10.1074/jbc.M110.116392	http://dx.doi.org/10.1074/jbc.M110.116392			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20584905	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000281404100074
J	Jastrebova, N; Vanwildemeersch, M; Lindahl, U; Spillmann, D				Jastrebova, Nadja; Vanwildemeersch, Maarten; Lindahl, Ulf; Spillmann, Dorothe			Heparan Sulfate Domain Organization and Sulfation Modulate FGF-induced Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; CRYSTAL-STRUCTURE; BASIC FGF; BINDING; SEQUENCE; OLIGOSACCHARIDES; IDENTIFICATION; CHONDROITIN; DEPOLYMERIZATION; GROWTH-FACTOR-1	Heparan sulfates (HSs) modulate various developmental and homeostatic processes by binding to protein ligands. We have evaluated the structural characteristics of porcine HS in cellular signaling induced by basic fibroblast growth factor (FGF2), using CHO745 cells devoid of endogenous glycosaminoglycans as target. Markedly enhanced stimulation of cell signaling, measured as phosphorylation of ERK1/2 and protein kinase B, was only observed with the shortest HS chains isolated from liver, whereas the longer chains from either liver or intestine essentially prolonged duration of signals induced by FGF2 in the absence of polysaccharide. Structural analysis showed that contiguous sulfated domains were most abundant in the shortest HS chains and were more heavily sulfated in HS from liver than in HS from intestine. Moreover, the shortest chains from either source entered into ternary complexes with FGF2 and FGF receptor-1c more efficiently than the corresponding longer chains. In addition to authentic HSs, decasaccharide libraries generated by chemo-enzymatic modification of heparin were probed for effect on FGF2 signaling. Only the most highly sulfated decamers, previously found most efficient in ternary complex formation (Jastrebova, N., Vanwildemeersch, M., Rapraeger, A. C., Gimenez-Gallego, G., Lindahl, U., and Spillmann, D. (2006) J. Biol. Chem. 281, 26884-26892), promoted FGF2 cellular signaling as efficiently as short HS chains from liver. Together these results suggest that the effects of HS on FGF2 signaling are determined by both the structure of the highly sulfated domains and by the organization/availability of such domains within the HS chain. These findings underpin the need for regulation of HS biosynthesis in relation to control of growth factor-induced signaling pathways.	[Spillmann, Dorothe] Uppsala Univ, BMC, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University	Spillmann, D (corresponding author), Uppsala Univ, BMC, Dept Med Biochem & Microbiol, POB 582, SE-75123 Uppsala, Sweden.	Dorothe.Spillmann@imbim.uu.se			Swedish Research Council [150223]; Swedish Cancer Society; Swedish Foundation for Strategic Research [A303: 156e]; Polysackaridforskning AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Polysackaridforskning AB	This work was supported by Swedish Research Council Grant 150223, Swedish Cancer Society, Swedish Foundation for Strategic Research Grant A303: 156e, and Polysackaridforskning AB.	Allen BL, 2001, J CELL BIOL, V155, P845, DOI 10.1083/jcb.200106075; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Boilly B, 2000, CYTOKINE GROWTH F R, V11, P295, DOI 10.1016/S1359-6101(00)00014-9; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442; HOOK M, 1982, ANAL BIOCHEM, V119, P236, DOI 10.1016/0003-2697(82)90580-2; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Jemth P, 2002, J BIOL CHEM, V277, P30567, DOI 10.1074/jbc.M203404200; Kariya Y, 2000, J BIOL CHEM, V275, P25949, DOI 10.1074/jbc.M004140200; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 1999, GLYCOBIOLOGY, V9, P723, DOI 10.1093/glycob/9.7.723; Kreuger J, 2002, EMBO J, V21, P6303, DOI 10.1093/emboj/cdf638; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; LINKER A, 1973, CARBOHYD RES, V29, P41, DOI 10.1016/S0008-6215(00)82069-8; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; LYON M, 1987, BIOCHEM J, V242, P493, DOI 10.1042/bj2420493; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Ornitz DM, 2001, GENOME BIOL, V2; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; PEJLER G, 1987, J BIOL CHEM, V262, P5036; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; REILAND J, 1993, J CELL SCI, V105, P1085; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Sperinde GV, 1998, BIOCHEMISTRY-US, V37, P13153, DOI 10.1021/bi980600z; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	65	54	54	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26842	26851		10.1074/jbc.M109.093542	http://dx.doi.org/10.1074/jbc.M109.093542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576609	Green Published, hybrid			2022-12-25	WOS:000281172700015
J	Kuhn, FJP; Witschas, K; Kuhn, C; Luckhoff, A				Kuehn, Frank J. P.; Witschas, Katja; Kuehn, Cornelia; Lueckhoff, Andreas			Contribution of the S5-Pore-S6 Domain to the Gating Characteristics of the Cation Channels TRPM2 and TRPM8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD RECEPTOR TRPM8; INTRACELLULAR CALCIUM; VOLTAGE SENSOR; MENTHOL; ACTIVATION; ICILIN; DESENSITIZATION; SELECTIVITY; MECHANISM; STIMULI	The closely related cation channels TRPM2 and TRPM8 show completely different requirements for stimulation and are regulated by Ca2+ in an opposite manner. TRPM8 is basically gated in a voltage-dependent process enhanced by cold temperatures and cooling compounds such as menthol and icilin. The putative S4 voltage sensor of TRPM8 is closely similar to that of TRPM2, which, however, is mostly devoid of voltage sensitivity. To gain insight into principal interactions of critical channel domains during the gating process, we created chimeras in which the entire S5-pore-S6 domains were reciprocally exchanged. The chimera M2-M8P (i.e. TRPM2 with the pore of TRPM8) responded to ADP-ribose and hydrogen peroxide and was regulated by extracellular and intracellular Ca2+ as was wild-type TRPM2. Single-channel recordings revealed the characteristic pattern of TRPM2 with extremely long open times. Only at far-negative membrane potentials (-120 to -140 mV) did differences become apparent because currents were reduced by hyperpolarization in M2-M8P but not in TRPM2. The reciprocal chimera, M8-M2P, showed currents after stimulation with high concentrations of menthol and icilin, but these currents were only slightly larger than in controls. The transfer of the NUDT9 domain to the C terminus of TRPM8 produced a channel sensitive to cold, menthol, or icilin but insensitive to ADPribose or hydrogen peroxide. We conclude that the gating processes in TRPM2 and TRPM8 differ in their requirements for specific structures within the pore. Moreover, the regulation by extracellular and intracellular Ca2+ and the single-channel properties in TRPM2 are not determined by the S5-pore-S6 region.	[Kuehn, Frank J. P.; Witschas, Katja; Kuehn, Cornelia; Lueckhoff, Andreas] Rhein Westfal TH Aachen, Fac Med, Inst Physiol, D-52057 Aachen, Germany	RWTH Aachen University	Kuhn, FJP (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Physiol, D-52057 Aachen, Germany.	fkuehn@physiology.rwth-aachen.de	Kuehn, Frank JP/H-5889-2018; Witschas, Katja/AAJ-3431-2020	Witschas, Katja/0000-0002-0960-683X	Deutsche Forschungsgemeinschaft [DFG KU 2271/11]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DFG KU 2271/11.	Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Heiner I, 2006, BIOCHEM J, V398, P225, DOI 10.1042/BJ20060183; Hui KY, 2005, BIOCHEM BIOPH RES CO, V333, P374, DOI 10.1016/j.bbrc.2005.05.123; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kuhn FJP, 2007, J BIOL CHEM, V282, P27598, DOI 10.1074/jbc.M702247200; Kuhn FJP, 2009, J BIOL CHEM, V284, P4102, DOI 10.1074/jbc.M806651200; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mahieu F, 2010, J PHYSIOL-LONDON, V588, P315, DOI 10.1113/jphysiol.2009.183582; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Schnitzler MMY, 2008, FASEB J, V22, P1540, DOI 10.1096/fj.07-9694com; Starkus J, 2007, J GEN PHYSIOL, V130, P427, DOI 10.1085/jgp.200709836; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862	30	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26806	26814		10.1074/jbc.M110.109975	http://dx.doi.org/10.1074/jbc.M110.109975			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20587417	Green Published, hybrid			2022-12-25	WOS:000281172700011
J	Wang, B; Ardura, JA; Romero, G; Yang, YM; Hall, RA; Friedman, PA				Wang, Bin; Ardura, Juan A.; Romero, Guillermo; Yang, Yanmei; Hall, Randy A.; Friedman, Peter A.			Na/H Exchanger Regulatory Factors Control Parathyroid Hormone Receptor Signaling by Facilitating Differential Activation of G alpha Protein Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; OSTEOBLAST-LIKE CELLS; OPOSSUM KIDNEY-CELLS; SMOOTH-MUSCLE-CELLS; (PTH)/PTH-RELATED PEPTIDE; PHOSPHOLIPASE-C; CYCLIC-AMP; KINASE-C; CA2+-DEPENDENT INHIBITION; PHOSPHATE-TRANSPORT	The Na/H exchanger regulatory factors, NHERF1 and NHERF2, are adapter proteins involved in targeting and assembly of protein complexes. The parathyroid hormone receptor (PTHR) interacts with both NHERF1 and NHERF2. The NHERF proteins toggle PTHR signaling from predominantly activation of adenylyl cyclase in the absence of NHERF to principally stimulation of phospholipase C when the NHERF proteins are expressed. We hypothesized that this signaling switch occurs at the level of the G protein. We measured G protein activation by [S-35]GTP gamma S binding and G alpha subtype-specific immunoprecipitation using three different cellular models of PTHR signaling. These studies revealed that PTHR interactions with NHERF1 enhance receptor-mediated stimulation of G alpha(q) but have no effect on stimulation of G alpha(i) or G alpha(s). In contrast, PTHR associations with NHERF2 enhance receptor-mediated stimulation of both G alpha(q) and G alpha(i) but decrease stimulation of G alpha(s). Consistent with these functional data, NHERF2 formed cellular complexes with both G alpha(q) and G alpha(i), whereas NHERF1 was found to interact only with G alpha(q). These findings demonstrate that NHERF interactions regulate PTHR signaling at the level of G proteins and that NHERF1 and NHERF2 exhibit isotype-specific effects on G protein activation.	[Wang, Bin; Ardura, Juan A.; Romero, Guillermo; Yang, Yanmei; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab G Prot Coupled Receptor Biol, Pittsburgh, PA 15261 USA; [Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab G Prot Coupled Receptor Biol, W-1340 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Ardura, Juan/L-8139-2014; Ardura, Juan Antonio/F-3378-2017	Ardura, Juan/0000-0002-8881-4775; Ardura, Juan Antonio/0000-0002-2827-3364; Hall, Randy/0000-0002-8318-8728; Wang, Bin/0000-0002-5396-6111	National Institutes of Health [R01DK69998, R01NS055179]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054171, R01DK069998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK69998 (to P. A. F.) and R01NS055179 (to R. A. H.).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Akam EC, 2001, BRIT J PHARMACOL, V132, P950, DOI 10.1038/sj.bjp.0703892; ATKINSON MJ, 1987, J BONE MINER RES, V2, P303; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Friedman PA, 1996, ENDOCRINOLOGY, V137, P13, DOI 10.1210/en.137.1.13; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; HRUSKA KA, 1987, J CLIN INVEST, V79, P230, DOI 10.1172/JCI112788; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; IIDAKLEIN A, 1995, J BIOL CHEM, V270, P8458, DOI 10.1074/jbc.270.15.8458; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; KLINGER M, 1990, KIDNEY INT, V37, P1543, DOI 10.1038/ki.1990.147; Kunkel MT, 2009, J BIOL CHEM, V284, P24653, DOI 10.1074/jbc.M109.024547; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Maeda S, 1996, ENDOCRINOLOGY, V137, P3154, DOI 10.1210/en.137.8.3154; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Offermanns S, 1996, MOL ENDOCRINOL, V10, P566, DOI 10.1210/me.10.5.566; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; ORLOFF JJ, 1995, ENDOCRINOLOGY, V136, P3016, DOI 10.1210/en.136.7.3016; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; RAMPE D, 1991, AM J PHYSIOL, V261, pH1945, DOI 10.1152/ajpheart.1991.261.6.H1945; Rochdi MD, 2002, J BIOL CHEM, V277, P40751, DOI 10.1074/jbc.M207910200; SCHLUTER KD, 1995, BIOCHEM J, V310, P439, DOI 10.1042/bj3100439; Schwindinger WF, 1998, ENDOCRINE, V8, P201, DOI 10.1385/ENDO:8:2:201; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Wheeler D, 2008, MOL ENDOCRINOL, V22, P1163, DOI 10.1210/me.2007-0461; WHITFIELD JF, 1971, J CELL PHYSIOL, V78, P355, DOI 10.1002/jcp.1040780305; WHITFIELD JF, 1992, J CELL PHYSIOL, V150, P299, DOI 10.1002/jcp.1041500212; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; WU SX, 1993, ENDOCRINOLOGY, V133, P2437, DOI 10.1210/en.133.6.2437; YAMAMOTO I, 1988, ENDOCRINOLOGY, V122, P1208, DOI 10.1210/endo-122-4-1208	53	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26976	26986		10.1074/jbc.M110.147785	http://dx.doi.org/10.1074/jbc.M110.147785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562104	hybrid, Green Published			2022-12-25	WOS:000281172700029
J	Duke, AM; Hopkins, PM; Calaghan, SC; Halsall, JP; Steele, DS				Duke, Adrian M.; Hopkins, Philip M.; Calaghan, Sarah C.; Halsall, Jane P.; Steele, Derek S.			Store-operated Ca2+ Entry in Malignant Hyperthermia-susceptible Human Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED CALCIUM-ENTRY; SARCOPLASMIC-RETICULUM; PLASMA-MEMBRANE; RYANODINE RECEPTOR; FIBERS; STIM1; ACTIVATION; DEPLETION; RELEASE; RYR1	In malignant hyperthermia (MH), mutations in RyR1 underlie direct activation of the channel by volatile anesthetics, leading to muscle contracture and a life-threatening increase in core body temperature. The aim of the present study was to establish whether the associated depletion of sarcoplasmic reticulum (SR) Ca2+ triggers sarcolemmal Ca2+ influx via store-operated Ca2+ entry (SOCE). Samples of vastus medialis muscle were obtained from patients undergoing assessment for MH susceptibility using the in vitro contracture test. Single fibers were mechanically skinned, and confocal microscopy was used to detect changes in [Ca2+] either within the resealed t-system ([Ca2+](t-sys)) or within the cytosol. In normal fibers, halothane (0.5 mM) failed to initiate SR Ca2+ release or Ca-t-sys(2+) depletion. However, in MH-susceptible (MHS) fibers, halothane induced both SR Ca2+ release and Ca-t-sys(2+) depletion, consistent with SOCE. In some MHS fibers, halothane-induced SR Ca2+ release took the form of a propagated wave, which was temporally coupled to a wave of Ca(t-sys)(2+)depletion. SOCE was potently inhibited by "extracellular" application of a STIM1 antibody trapped within the t-system but not when the antibody was denatured by heating. In conclusion, (i) in human MHS muscle, SR Ca2+ depletion induced by a level of volatile anesthetic within the clinical range is sufficient to induce SOCE, which is tightly coupled to SR Ca2+ release; (ii) sarcolemmal STIM1 has an important role in regulating SOCE; and (iii) sustained SOCE from an effectively infinite extracellular Ca2+ pool may contribute to the maintained rise in cytosolic [Ca2+] that underlies MH.	Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Hopkins, Philip M.; Halsall, Jane P.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; Saint James's University Hospital; University of Leeds		d.steele@leeds.ac.uk	Hopkins, Philip/ABE-5970-2020	Hopkins, Philip/0000-0002-8127-1739; Calaghan, Sarah/0000-0002-9145-2576; Steele, Derek/0000-0002-1339-784X	Medical Research Council; MRC [G0601243] Funding Source: UKRI; Medical Research Council [G0601243] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a grant from the Medical Research Council.	ADNET PJ, 1991, ANESTHESIOLOGY, V75, P413, DOI 10.1097/00000542-199109000-00006; Allard B, 2006, J PHYSIOL-LONDON, V575, P69, DOI 10.1113/jphysiol.2006.112367; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; BRUM G, 1988, J PHYSIOL-LONDON, V398, P441, DOI 10.1113/jphysiol.1988.sp017052; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; DAVIES DN, 1972, BRIT J ANAESTH, V44, P548, DOI 10.1093/bja/44.6.548; Duke AM, 1998, PFLUG ARCH EUR J PHY, V436, P104, DOI 10.1007/s004240050610; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Edwards JN, 2010, CELL CALCIUM, V47, P458, DOI 10.1016/j.ceca.2010.04.001; FLETCHER JE, 1990, CAN J ANAESTH, V37, P695, DOI 10.1007/BF03006495; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hopkins PM, 2000, BRIT J ANAESTH, V85, P118, DOI 10.1093/bja/85.1.118; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Kabbara AA, 2001, J PHYSIOL-LONDON, V534, P87, DOI 10.1111/j.1469-7793.2001.00087.x; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; Launikonis BS, 2009, J PHYSIOL-LONDON, V587, P2299, DOI 10.1113/jphysiol.2009.168682; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; Launikonis BS, 2003, P NATL ACAD SCI USA, V100, P2941, DOI 10.1073/pnas.0536227100; Launikonis BS, 2002, CELL BIOL INT, V26, P921, DOI 10.1006/cbir.2002.0942; Li J, 2008, CIRC RES, V103, pE97, DOI 10.1161/CIRCRESAHA.108.182931; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; LYNCH GS, 1995, J MUSCLE RES CELL M, V16, P65, DOI 10.1007/BF00125311; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; Ording H, 1997, ACTA ANAESTH SCAND, V41, P955, DOI 10.1111/j.1399-6576.1997.tb04820.x; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Posterino GS, 2003, J PHYSIOL-LONDON, V551, P219, DOI 10.1113/jphysiol.2003.040022; REICHELT S, 2001, MICROSC ANAL, V86, P9; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Steele DS, 2007, ARCH BIOCHEM BIOPHYS, V458, P57, DOI 10.1016/j.abb.2006.03.001; Steele DS, 2003, ACTA PHYSIOL SCAND, V179, P39, DOI 10.1046/j.1365-201X.2003.01169.x; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; WESTERBLAD H, 1992, J PHYSIOL-LONDON, V453, P413, DOI 10.1113/jphysiol.1992.sp019236; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhao XL, 2008, AGING CELL, V7, P561, DOI 10.1111/j.1474-9726.2008.00408.x; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005; ZIMINA OA, 2008, DOKL AKAD NAUK, V420, P214	45	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25645	25653		10.1074/jbc.M110.104976	http://dx.doi.org/10.1074/jbc.M110.104976			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20566647	Green Published, hybrid			2022-12-25	WOS:000280682400058
J	Mitra, A; Radha, V				Mitra, A.; Radha, V.			F-actin-binding domain of c-Abl regulates localized phosphorylation of C3G: role of C3G in c-Abl-mediated cell death	ONCOGENE			English	Article						guanine nucleotide exchange factor; tyrosine kinase; apoptosis; c-Abl	NUCLEOTIDE EXCHANGE FACTOR; PROTEIN-TYROSINE-PHOSPHATASE; SRC HOMOLOGY-3 DOMAIN; FAMILY KINASES; INDUCED APOPTOSIS; BCR-ABL; ACTIVATION; RAP1; CRK; OVEREXPRESSION	The c-Abl tyrosine kinase maintains cellular homeostasis through its ability to regulate apoptosis and actin dynamics. In vivo, c-Abl activity is stringently regulated and mechanisms involved are not fully understood. Here, we identified the Rap1 guanine nucleotide exchange factor, C3G (RapGEF1), as a substrate and an effector of c-Abl-mediated functions. Ectopic expression of c-Abl in mammalian cell lines, known to induce apoptosis, resulted in phosphorylation of endogenous C3G on Y504 coincident with cell detachment and chromatin condensation. Phosphorylation of C3G coincided with restricted c-Abl activation in regions rich in actin, and was dependent on cellular F-actin dynamics. Unlike C3G or c-Abl, p-C3G was resistant to detergent extraction, suggesting its enhanced affinity for the cytoskeleton. Localized C3G phosphorylation and coincidence with cells undergoing cell death was dependent on F-actin-binding domain (FABD) of c-Abl. Activation of endogenous c-Abl by oxidative stress was associated with phosphorylation of cellular C3G on Y504. Inhibition of C3G expression and function using RNAi or dominant-negative approaches inhibited c-Abl-mediated cell death. These findings identify C3G as a novel target of c-Abl and also show that FABD of c-Abl is essential for regulation of its restricted activation to induce apoptosis. Oncogene (2010) 29, 4528-4542; doi: 10.1038/onc.2010.113; published online 28 June 2010	[Mitra, A.; Radha, V.] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Radha, V (corresponding author), Ctr Cellular & Mol Biol, CSIR, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	vradha@ccmb.res.in			Council for Scientific and Industrial Research; Department of Science and Technology, Government of India	Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	We thank Drs PJS Stork (Oregon Health and Science University), Richard Van Etten (Tufts University), Patrick Casey (Duke University), S Tanaka (Hokkaido University School of Medicine), Bruce Mayer (University of Connecticut Health Center) for gifts of various constructs. We thank Dr Ghanshyam Swarup for support extended and for critically reading the paper. Assistance received from Ms Nandini Rangaraj during use of confocal microscopes is gratefully acknowledged. AM was supported by a fellowship from the Council for Scientific and Industrial Research. This work was supported by the Department of Science and Technology, Government of India through a grant awarded to VR.	Agami R, 1999, NATURE, V399, P809; Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; Ba XQ, 2005, J CELL BIOCHEM, V94, P365, DOI 10.1002/jcb.20213; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Chen CX, 2006, J BIOCHEM, V140, P229, DOI 10.1093/jb/mvj149; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Cho YJ, 2005, BIOCHEM BIOPH RES CO, V333, P1276, DOI 10.1016/j.bbrc.2005.06.030; Cipres A, 2007, CELL SIGNAL, V19, P1662, DOI 10.1016/j.cellsig.2007.02.011; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cong F, 1999, P NATL ACAD SCI USA, V96, P13819, DOI 10.1073/pnas.96.24.13819; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Gotoh T, 1997, J BIOL CHEM, V272, P18602, DOI 10.1074/jbc.272.30.18602; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Grevengoed EE, 2003, J CELL BIOL, V163, P1267, DOI 10.1083/jcb.200307026; Guerrero C, 2004, ONCOGENE, V23, P4885, DOI 10.1038/sj.onc.1207622; Gutierrez-Berzal J, 2006, EXP CELL RES, V312, P938, DOI 10.1016/j.yexcr.2005.12.007; Halle M, 2007, MOL CELL BIOL, V27, P1172, DOI 10.1128/MCB.02462-05; Hernandez SE, 2004, TRENDS CELL BIOL, V14, P36, DOI 10.1016/j.tcb.2003.11.003; Holcomb M, 2006, J BIOL CHEM, V281, P2430, DOI 10.1074/jbc.M508454200; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; Huang YP, 2008, BLOOD, V112, P111, DOI 10.1182/blood-2007-10-118232; Huang YY, 1997, ONCOGENE, V15, P1947, DOI 10.1038/sj.onc.1201376; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Kain KH, 2003, ONCOGENE, V22, P6071, DOI 10.1038/sj.onc.1206930; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kobayashi Y, 2006, ONCOGENE, V25, P512, DOI 10.1038/sj.onc.1209072; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Machuy N, 2004, CELL DEATH DIFFER, V11, P290, DOI 10.1038/sj.cdd.4401336; Maia V, 2009, CELL SIGNAL, V21, P1229, DOI 10.1016/j.cellsig.2009.03.015; Martin-Encabo S, 2007, EXP CELL RES, V313, P3881, DOI 10.1016/j.yexcr.2007.07.036; Mochizuki N, 2000, J BIOL CHEM, V275, P12667, DOI 10.1074/jbc.275.17.12667; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Radha V, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-31; Radha V, 1999, FEBS LETT, V453, P308, DOI 10.1016/S0014-5793(99)00734-6; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; Radha V, 2008, J NEUROCHEM, V107, P1424, DOI 10.1111/j.1471-4159.2008.05710.x; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Shishido T, 2001, GENES CELLS, V6, P431, DOI 10.1046/j.1365-2443.2001.00431.x; Shivakrupa R, 2003, J BIOL CHEM, V278, P52188, DOI 10.1074/jbc.M310656200; Skourides PA, 1999, ONCOGENE, V18, P1165, DOI 10.1038/sj.onc.1202407; SMITH JM, 2002, FRONT BIOSCI, V7, P131; Stevens TL, 2008, MOL BIOL CELL, V19, P378, DOI 10.1091/mbc.E07-01-0008; SUBHASH T, 2006, FEBS J, V273, P2766; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Theis S, 1998, ONCOGENE, V17, P557, DOI 10.1038/sj.onc.1201973; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Wang JYJ, 2004, NAT CELL BIOL, V6, P3, DOI 10.1038/ncb0104-3; Woodring PJ, 2005, J BIOL CHEM, V280, P10318, DOI 10.1074/jbc.M410658200; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5	64	23	27	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 12	2010	29	32					4528	4542		10.1038/onc.2010.113	http://dx.doi.org/10.1038/onc.2010.113			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	638AQ	20581864				2022-12-25	WOS:000280862300004
J	Cree, BAC; Rioux, JD; McCauley, JL; Gourraud, PAFD; Goyette, P; McElroy, J; De Jager, P; Santaniello, A; Vyse, TJ; Gregersen, PK; Mirel, D; Hafler, DA; Haines, JL; Pericak-Vance, MA; Compston, A; Sawcer, SJ; Oksenberg, JR; Hauser, SL				Cree, Bruce A. C.; Rioux, John D.; McCauley, Jacob L.; Gourraud, Pierre-Antoine F. D.; Goyette, Philippe; McElroy, Joseph; De Jager, Philip; Santaniello, Adam; Vyse, Timothy J.; Gregersen, Peter K.; Mirel, Daniel; Hafler, David A.; Haines, Jonathan L.; Pericak-Vance, Margaret A.; Compston, Alastair; Sawcer, Stephen J.; Oksenberg, Jorge R.; Hauser, Stephen L.		IMAGEN; IMSGC	A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; EXTENDED HUMAN MHC; HLA-G MOLECULES; LINKAGE-DISEQUILIBRIUM; ASSOCIATION; EXPRESSION; REGION; DISEASE; COMPLEX; GENES	Background: In Northern European descended populations, genetic susceptibility for multiple sclerosis (MS) is associated with alleles of the human leukocyte antigen (HLA) Class II gene DRB1. Whether other major histocompatibility complex (MHC) genes contribute to MS susceptibility is controversial. Methodology/Principal Findings: A case control analysis was performed using 958 single nucleotide polymorphisms (SNPs) spanning the MHC assayed in two independent datasets. The discovery dataset consisted of 1,018 cases and 1,795 controls and the replication dataset was composed of 1,343 cases and 1,379 controls. The most significantly MS-associated SNP in the discovery dataset was rs3135391, a Class II SNP known to tag the HLA-DRB1*15:01 allele, the primary MS susceptibility allele in the MHC (O.R. = 3.04, p<1 x 10(-78)). To control for the effects of the HLA-DRB1*15:01 haplotype, case control analysis was performed adjusting for this HLA-DRB1*15: 01 tagging SNP. After correction for multiple comparisons (false discovery rate =.05) 52 SNPs in the Class I, II and III regions were significantly associated with MS susceptibility in both datasets using the Cochran Armitage trend test. The discovery and replication datasets were merged and subjects carrying the HLA-DRB1*15:01 tagging SNP were excluded. Association tests showed that 48 of the 52 replicated SNPs retained significant associations with MS susceptibility independently of the HLA-DRB1*15:01 as defined by the tagging SNP. 20 Class I SNPs were associated with MS susceptibility with p-values <= 1 x 10(-8). The most significantly associated SNP was rs4959039, a SNP in the downstream un-translated region of the non-classical HLA-G gene (Odds ratio 1.59, 95% CI 1.40, 1.81, p = 8.45 x 10(-13)) and is in linkage disequilibrium with several nearby SNPs. Logistic regression modeling showed that this SNP's contribution to MS susceptibility was independent of the Class II and Class III SNPs identified in this screen. Conclusions: A MHC Class I locus contributes to MS susceptibility independently of the HLA-DRB1*15:01 haplotype.	[Cree, Bruce A. C.; Gourraud, Pierre-Antoine F. D.; McElroy, Joseph; Santaniello, Adam; Oksenberg, Jorge R.; Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Rioux, John D.; Goyette, Philippe] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [McCauley, Jacob L.] Miami Univ, Sch Med, Dept Human Genet, Dr John T MacDonald Fdn, Miami, FL USA; [De Jager, Philip] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [De Jager, Philip] Harvard Univ, Sch Med, Partners Healthcare Ctr Genet & Genom, Cambridge, MA 02138 USA; [Vyse, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Rheumatol, London, England; [Gregersen, Peter K.] Robert S Boas Ctr Genom & Human Genet, Feinstein Inst Med Res, Manhasset, NY USA; [Mirel, Daniel] MIT & Harvard, Broad Inst, Cambridge, MA USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Hafler, David A.; Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN USA; [Pericak-Vance, Margaret A.] Miami Univ, Sch Med, Hussman Inst Human Genom, Miami, FL USA; [Compston, Alastair; Sawcer, Stephen J.] Univ Cambridge, Neurol Unit, Dept Clin Neurosci, Cambridge, England	University of California System; University of California San Francisco; Universite de Montreal; Harvard University; Brigham & Women's Hospital; Harvard University; Partners Healthcare System; Imperial College London; Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Vanderbilt University; University of Cambridge	Cree, BAC (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	bruce.cree@ucsf.edu	Hauser, Stephen L/J-2978-2016; de Bakker, Paul IW/B-8730-2009; Haines, Jonathan/C-3374-2012; Rioux, John D/A-9599-2015; Gourraud, Pierre-Antoine FD/O-3024-2015; Cree, Bruce C/AAV-6109-2020	de Bakker, Paul IW/0000-0001-7735-7858; Haines, Jonathan/0000-0002-4351-4728; Rioux, John D/0000-0001-7560-8326; Cree, Bruce C/0000-0001-7689-2533; Klareskog, Lars/0000-0001-9601-6186; Gourraud, Pierre-Antoine/0000-0003-1131-9554; Alfredsson, Lars/0000-0003-1688-6697	National Institutes of Allergy and Infectious Diseases [AI067152]; National Institute of Neurological Disease and Stroke [NS21799, K23 NS048869]; National Multiple Sclerosis Society (NMSS); Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; National Center for Research Resources [U54 RR020278];  [RO1NS049477]; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS048869, R01NS049477, R01NS046297] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported primarily by a grant from the National Institutes of Allergy and Infectious Diseases (AI067152). Additional support was received from the National Institute of Neurological Disease and Stroke (NS21799) to SLH and (K23 NS048869) to BACC. PLD was supported by a Harry Weaver Neuroscience Scholar Award of the National Multiple Sclerosis Society (NMSS). The IMSGC is supported by RO1NS049477. The authors also thank the NMSS and Nancy Davis Foundation for support of DNA collections. They acknowledge use of DNA from the British 1958 Birth Cohort collection (D. Strachan, S. Ring, W. McArdle and M. Pembrey), funded by the Medical Research Council grant G0000934 and Wellcome Trust grant 068545/Z/02. The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation in the manuscript.	Apps R, 2008, TRENDS IMMUNOL, V29, P313, DOI 10.1016/j.it.2008.02.012; Bainbridge D, 2001, TRENDS IMMUNOL, V22, P548, DOI 10.1016/S1471-4906(01)02031-2; Barcellos LF, 2002, BRAIN, V125, P150; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Burfoot RK, 2008, TISSUE ANTIGENS, V71, P42, DOI 10.1111/j.1399-0039.2007.00962.x; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chao MJ, 2007, HUM MOL GENET, V16, P1951, DOI 10.1093/hmg/ddm142; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Fainardi E, 2006, MULT SCLER J, V12, P2, DOI 10.1191/1352458506ms1241oa; Fainardi E, 2003, J NEUROIMMUNOL, V142, P149, DOI 10.1016/S0165-5728(03)00266-2; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Goris A, 2009, J NEUROIMMUNOL, V210, P113, DOI 10.1016/j.jneuroim.2009.03.001; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huang YH, 2009, ANN NEUROL, V66, P171, DOI 10.1002/ana.21705; Hunt JS, 2006, IMMUNOL REV, V213, P36, DOI 10.1111/j.1600-065X.2006.00436.x; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Kroner A, 2007, HUM IMMUNOL, V68, P422, DOI 10.1016/j.humimm.2007.01.012; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Marrosu MG, 1997, AM J HUM GENET, V61, P454; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Pazmany L, 1996, SCIENCE, V274, P792, DOI 10.1126/science.274.5288.792; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Rouas-Freiss N, 2007, SEMIN CANCER BIOL, V17, P413, DOI 10.1016/j.semcancer.2007.07.003; Sawcer S, 2005, AM J HUM GENET, V77, P454; Urosevic M, 2007, SEMIN CANCER BIOL, V17, P480, DOI 10.1016/j.semcancer.2007.09.001; Wiendl H, 2000, ANN NEUROL, V48, P679, DOI 10.1002/1531-8249(200010)48:4<679::AID-ANA19>3.3.CO;2-M; Wiendl H, 2005, BRAIN, V128, P2689, DOI 10.1093/brain/awh609; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063	38	40	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11296	10.1371/journal.pone.0011296	http://dx.doi.org/10.1371/journal.pone.0011296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593013	Green Published, gold, Green Submitted			2022-12-25	WOS:000279140800007
J	Mizuno, N; Hosogi, N; Park, P; Takumi, S				Mizuno, Nobuyuki; Hosogi, Naoki; Park, Pyoyun; Takumi, Shigeo			Hypersensitive Response-Like Reaction Is Associated with Hybrid Necrosis in Interspecific Crosses between Tetraploid Wheat and Aegilops tauschii Coss	PLOS ONE			English	Article							COMMON WHEAT; WILD WHEAT; ALTERNATIVE OXIDASE; HEXAPLOID WHEAT; F-1 HYBRID; RESPIRATION CAPACITY; NICOTIANA-TABACUM; NATURAL VARIATION; DURUM-WHEAT; GENES	Background: Hybrid speciation is classified into homoploid and polyploid based on ploidy level. Common wheat is an allohexaploid species that originated from a naturally occurring interploidy cross between tetraploid wheat and diploid wild wheat Aegilops tauschii Coss. Aegilops tauschii provides wide naturally occurring genetic variation. Sometimes its triploid hybrids with tetraploid wheat show the following four types of hybrid growth abnormalities: types II and III hybrid necrosis, hybrid chlorosis, and severe growth abortion. The growth abnormalities in the triploid hybrids could act as postzygotic hybridization barriers to prevent formation of hexaploid wheat. Methodology/Principal Findings: Here, we report on the geographical and phylogenetic distribution of Ae. tauschii accessions inducing the hybrid growth abnormalities and showed that they are widely distributed across growth habitats in Ae. tauschii. Molecular and cytological characterization of the type III necrosis phenotype was performed. The hybrid abnormality causing accessions were widely distributed across growth habitats in Ae. tauschii. Transcriptome analysis showed that a number of defense-related genes such as pathogenesis-related genes were highly up-regulated in the type III necrosis lines. Transmission electron microscope observation revealed that cell death occurred accompanied by generation of reactive oxygen species in leaves undergoing type III necrosis. The reduction of photosynthetic activity occurred prior to the appearance of necrotic symptoms on the leaves exhibiting hybrid necrosis. Conclusions/Significance: Taking these results together strongly suggests that an autoimmune response might be triggered by intergenomic incompatibility between the tetraploid wheat and Ae. tauschii genomes in type III necrosis, and that genetically programmed cell death could be regarded as a hypersensitive response-like cell death similar to that observed in Arabidopsis intraspecific and Nicotiana interspecific hybrids. Only Ae. tauschii accessions without such inhibiting factors could be candidates for the D-genome donor for the present hexaploid wheat.	[Mizuno, Nobuyuki; Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Kobe, Hyogo 657, Japan; [Hosogi, Naoki; Park, Pyoyun] Kobe Univ, Grad Sch Agr Sci, Lab Stress Cytol, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Mizuno, N (corresponding author), Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Kobe, Hyogo 657, Japan.	takumi@kobe-u.ac.jp		Hosogi, Naoki/0000-0001-6662-1940	Ministry of Education, Culture, Sports, Science and Technology of Japan [21380005]; Ministry of Agriculture, Forestry and Fisheries of Japan [TRC-1003)]; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Basic Research B, No. 21380005) and from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, TRC-1003) to ST, and by a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, MOL PLANT, V2, P32, DOI 10.1093/mp/ssn075; Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; Bestwick CS, 1997, PLANT CELL, V9, P209, DOI 10.1105/tpc.9.2.209; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Chu CG, 2006, THEOR APPL GENET, V112, P1374, DOI 10.1007/s00122-006-0239-9; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; DHALIWAL H S, 1986, Wheat Information Service, P27; Dilkes BP, 2008, PLOS BIOL, V6, P2707, DOI 10.1371/journal.pbio.0060308; DIXON WJ, 1990, BMDP STATISTICAL SOF, V1, P339; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; HERMSEN JGT, 1972, EUPHYTICA, V21, P204, DOI 10.1007/BF00036760; Hori K, 2003, THEOR APPL GENET, V107, P806, DOI 10.1007/s00122-003-1342-9; Jeuken MJW, 2009, PLANT CELL, V21, P3368, DOI 10.1105/tpc.109.070334; Jwa NS, 2006, PLANT PHYSIOL BIOCH, V44, P261, DOI 10.1016/j.plaphy.2006.06.010; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; KIHARA H, 1949, P 8 INT C GEN HER S, P307; Kihara H, 1944, AGR HORTIC, V19, P889; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LIN BY, 1984, GENETICS, V107, P103; Masuda Y, 2007, PLANT CELL REP, V26, P1595, DOI 10.1007/s00299-007-0352-5; Matsuoka Y, 2004, THEOR APPL GENET, V109, P1710, DOI 10.1007/s00122-004-1806-6; Matsuoka Y, 2007, THEOR APPL GENET, V115, P509, DOI 10.1007/s00122-007-0584-3; Matsuoka Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003138; Matsuoka Y, 2009, PLANT SYST EVOL, V279, P233, DOI 10.1007/s00606-009-0159-7; McFadden E.S., 1944, REC GENET SOC AM, V13, P26; Mino M, 2002, PLANT PHYSIOL, V130, P1776, DOI 10.1104/pp.006023; Mizuno N, 2010, MOL ECOL, V19, P999, DOI 10.1111/j.1365-294X.2010.04537.x; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Murray JW, 2006, TRENDS PLANT SCI, V11, P152, DOI 10.1016/j.tplants.2006.01.007; NISHIKAWA K, 1962, JPN J GENET, V37, P227, DOI 10.1266/jjg.37.227; NISHIKAWA K., 1962, SEIKEN ZIHO, V14, P45; NISHIKAWA KOZO, 1960, SEIKEN ZIHO, V11, P21; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; Shinogi Takeshi, 2003, Journal of General Plant Pathology, V69, P7, DOI 10.1007/s10327-002-0013-z; Sugie A, 2007, GENES GENET SYST, V82, P231, DOI 10.1266/ggs.82.231; Sugie A, 2006, GENES GENET SYST, V81, P349, DOI 10.1266/ggs.81.349; Takumi S, 2002, GENES GENET SYST, V77, P81, DOI 10.1266/ggs.77.81; Takumi S, 2009, PLANT BREEDING, V128, P585, DOI 10.1111/j.1439-0523.2009.01630.x; Takumi S, 2009, BREEDING SCI, V59, P579, DOI 10.1270/jsbbs.59.579; Tsunewaki K., 1970, Seiken Ziho, P67; TSUNEWAKI K, 1992, GENOME, V35, P594, DOI 10.1139/g92-089; TSUNEWAKI K, 1966, JPN J BOT, V19, P175; TSUNEWAKI K, 1961, WHEAT INFORM SERV, V12, P1; TSUNEWAKI KOICHIRO, 1960, JAPANESE JOUR GENETICS, V35, P71, DOI 10.1266/jjg.35.71; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681	50	54	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11326	10.1371/journal.pone.0011326	http://dx.doi.org/10.1371/journal.pone.0011326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593003	Green Submitted, Green Published, gold			2022-12-25	WOS:000279140800023
J	Polato, NR; Voolstra, CR; Schnetzer, J; DeSalvo, MK; Randall, CJ; Szmant, AM; Medina, M; Baums, IB				Polato, Nicholas R.; Voolstra, Christian R.; Schnetzer, Julia; DeSalvo, Michael K.; Randall, Carly J.; Szmant, Alina M.; Medina, Monica; Baums, Iliana B.			Location-Specific Responses to Thermal Stress in Larvae of the Reef-Building Coral Montastraea faveolata	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENE-EXPRESSION; ELEVATED-TEMPERATURE; SCLERACTINIAN CORAL; CARIBBEAN CORAL; OXIDATIVE STRESS; ACROPORA-PALMATA; CLIMATE-CHANGE; ELKHORN CORAL; SETTLEMENT	Background: The potential to adapt to a changing climate depends in part upon the standing genetic variation present in wild populations. In corals, the dispersive larval phase is particularly vulnerable to the effects of environmental stress. Larval survival and response to stress during dispersal and settlement will play a key role in the persistence of coral populations. Methodology/Principal Findings: To test the hypothesis that larval transcription profiles reflect location-specific responses to thermal stress, symbiont-free gametes from three to four colonies of the scleractinian coral Montastraea faveolata were collected from Florida and Mexico, fertilized, and raised under mean and elevated (up 1 to 2 degrees C above summer mean) temperatures. These locations have been shown to exchange larvae frequently enough to prevent significant differentiation of neutral loci. Differences among 1,310 unigenes were simultaneously characterized using custom cDNA microarrays, allowing investigation of gene expression patterns among larvae generated from wild populations under stress. Results show both conserved and location-specific variation in key processes including apoptosis, cell structuring, adhesion and development, energy and protein metabolism, and response to stress, in embryos of a reef-building coral. Conclusions/Significance: These results provide first insights into location-specific variation in gene expression in the face of gene flow, and support the hypothesis that coral host genomes may house adaptive potential needed to deal with changing environmental conditions.	[Polato, Nicholas R.; Baums, Iliana B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Voolstra, Christian R.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Schnetzer, Julia] Max Planck Inst Marine Microbiol, Bremen, Germany; [DeSalvo, Michael K.; Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Randall, Carly J.; Szmant, Alina M.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; King Abdullah University of Science & Technology; Max Planck Society; University of California System; University of California Merced; University of North Carolina; University of North Carolina Wilmington	Polato, NR (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	baums@psu.edu	Randall, Carly J./H-4195-2019; Baums, Iliana Brigitta/G-6435-2010; Voolstra, Christian R/H-7158-2014	Randall, Carly J./0000-0001-8112-3552; Baums, Iliana Brigitta/0000-0001-6463-7308; Voolstra, Christian R/0000-0003-4555-3795	National Science Foundation (NSF) [0313708]; NSF Division of Ocean Sciences [0825979]; NSF Division of Intagrative Organismal Systems (IOS) [0644438]; University of California; NOAA; World Bank; University of North Carolina Wilmington Academic Affairs; Division Of Integrative Organismal Systems [1402065] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Division of Ocean Sciences(National Science Foundation (NSF)); NSF Division of Intagrative Organismal Systems (IOS); University of California(University of California System); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); World Bank(The World Bank India); University of North Carolina Wilmington Academic Affairs; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by a National Science Foundation (NSF) Graduate Research Fellowship Program award to N.R.P.; NSF Division of Ocean Sciences (OCE) grant 0825979 to I.B.B.; NSF Division of Intagrative Organismal Systems (IOS) grant 0644438, NSF OCE grant 0313708, and University of California Mexus grant to M.M.; the NOAA coral reef grant conservation program supporting M. Miller; and the World Bank Coral Reef Targeted Research and University of North Carolina Wilmington Academic Affairs grants to A.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Baird A.H., 2006, P 10 INT COR REEF S, P38; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BLACK NA, 1995, BIOL BULL, V188, P234, DOI 10.2307/1542301; BOSCH TCG, 1988, P NATL ACAD SCI USA, V85, P7927, DOI 10.1073/pnas.85.21.7927; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown BE, 1997, ADV MAR BIOL, V31, P221, DOI 10.1016/S0065-2881(08)60224-2; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; BUDDEMEIER RW, 2004, ADAPTIVE HYPOTHESIS, P427, DOI DOI 10.1007/978-3-662-06414-6_24; CLAUSEN CD, 1975, MAR BIOL, V33, P93, DOI 10.1007/BF00390713; Coles S.L., 1976, THERMAL TOLERANCE TR; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DESALVO MK, MOL ECOLOGY IN PRESS; Done TJ, 1999, AM ZOOL, V39, P66; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Dorion S, 2002, J BIOL CHEM, V277, P30792, DOI 10.1074/jbc.M203642200; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Edmunds PJ, 2004, MAR ECOL PROG SER, V269, P111, DOI 10.3354/meps269111; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Feldman AL, 2002, BIOTECHNIQUES, V33, P906, DOI 10.2144/02334mt04; Gates RD, 1999, AM ZOOL, V39, P30; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; GLYNN PW, 1984, ENVIRON CONSERV, V11, P133, DOI 10.1017/S0376892900013825; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; HARRIOTT VJ, 1985, MAR ECOL PROG SER, V21, P81, DOI 10.3354/meps021081; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoover CA, 2008, BIOL BULL-US, V214, P319, DOI 10.2307/25470673; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Jacobs MW, 2006, INTEGR COMP BIOL, V46, P760, DOI 10.1093/icb/icl015; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kammenga JE, 2007, TRENDS ECOL EVOL, V22, P273, DOI 10.1016/j.tree.2007.01.013; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Knapen D, 2009, TRENDS BIOTECHNOL, V27, P406, DOI 10.1016/j.tibtech.2009.03.007; Krebs RA, 1997, EVOLUTION, V51, P173, DOI 10.1111/j.1558-5646.1997.tb02398.x; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Marsh AG, 2005, J EXP ZOOL PART B, V304B, P238, DOI 10.1002/jez.b.21037; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Miller MW, 2009, MAR ECOL PROG SER, V387, P147, DOI 10.3354/meps08097; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; PERRET E, 1995, J CELL SCI, V108, P711; Petersen D, 2008, CORAL REEFS, V27, P715, DOI 10.1007/s00338-008-0385-4; R Core Team, 2022, R LANG ENV STAT COMP; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Randall CJ, 2009, CORAL REEFS, V28, P537, DOI 10.1007/s00338-009-0482-z; Randall CJ, 2009, BIOL BULL-US, V217, P269, DOI 10.1086/BBLv217n3p269; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Severance EG, 2004, MOL ECOL NOTES, V4, P74, DOI 10.1046/j.1471-8286.2003.00573.x; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Sharp VA, 1997, J THERM BIOL, V22, P11, DOI 10.1016/S0306-4565(96)00029-0; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sunagawa S, 2008, COMP BIOCHEM PHYS B, V151, P133, DOI 10.1016/j.cbpb.2008.06.007; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; SZMANT AM, 1991, MAR ECOL PROG SER, V74, P13, DOI 10.3354/meps074013; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; WERNER I, 1997, ENV TOXICOLOGY CHEM, V16; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Williams EA, 2009, MOL ECOL, V18, P1006, DOI 10.1111/j.1365-294X.2008.04078.x; Wray GA, 2006, INTEGR COMP BIOL, V46, P233, DOI 10.1093/icb/icj030; Yang YH, 2003, INST MATH S, V40, P403	91	82	83	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11221	10.1371/journal.pone.0011221	http://dx.doi.org/10.1371/journal.pone.0011221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585643	Green Accepted, Green Published, gold			2022-12-25	WOS:000279135400010
J	Glauche, I; Herberg, M; Roeder, I				Glauche, Ingmar; Herberg, Maria; Roeder, Ingo			Nanog Variability and Pluripotency Regulation of Embryonic Stem Cells - Insights from a Mathematical Model Analysis	PLOS ONE			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; MOUSE EMBRYOS; ES CELLS; OCT4; DIFFERENTIATION; NETWORKS; STATE; TERATOCARCINOMA; FIBROBLASTS	The expression of the transcription factors Oct4, Sox2, and Nanog is commonly associated with pluripotency of mouse embryonic stem (ES) cells. However, recent observations suggest that ES cell populations are heterogeneous with respect to the expression of Nanog and that individual ES cells reversibly change their Nanog expression level. Furthermore, it has been shown that cells exhibiting a low Nanog level are more likely to undergo differentiation. Applying a novel mathematical transcription factor network model we explore mechanisms and feedback regulations to describe the observed variation of the Nanog levels in mouse ES cells. In particular we show that these variations can occur under different assumptions yielding similar experimental characteristics. Based on model predictions we propose experimental strategies to distinguish between these explanations. Concluding from our results we argue that the heterogeneity with respect to the Nanog concentrations is most likely a functional element to control the differentiation propensity of an ES cell population. Furthermore, we provide a conceptual framework that consistently explains Nanog variability and a potential "gate-keeper'' function of Nanog expression with respect to the control of ES cell differentiation.	[Glauche, Ingmar; Herberg, Maria; Roeder, Ingo] Univ Leipzig, Fac Med, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Glauche, Ingmar; Roeder, Ingo] Tech Univ Dresden, Inst Med Informat & Biometry, Fac Med Carl Gustav Carus, D-8027 Dresden, Germany	Leipzig University; Technische Universitat Dresden	Glauche, I (corresponding author), Univ Leipzig, Fac Med, Inst Med Informat Stat & Epidemiol, Leipzig, Germany.	ingo.roeder@tu-dresden.de			European Commission [200270]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission project EuroSyStem (200270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944	42	69	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11238	10.1371/journal.pone.0011238	http://dx.doi.org/10.1371/journal.pone.0011238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574542	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058300022
J	Domitrovic, T; Kozlov, G; Freire, JCG; Masuda, CA; Almeida, MD; Montero-Lomeli, M; Atella, GC; Matta-Camacho, E; Gehring, K; Kurtenbach, E				Domitrovic, Tatiana; Kozlov, Guennadi; Goncalves Freire, Joao Claudio; Masuda, Claudio Akio; Almeida, Marcius da Silva; Montero-Lomeli, Monica; Atella, Georgia Correa; Matta-Camacho, Edna; Gehring, Kalle; Kurtenbach, Eleonora			Structural and Functional Study of Yer067w, a New Protein Involved in Yeast Metabolism Control and Drug Resistance	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; AZOLE RESISTANCE; EVOLUTION; ALIGNMENT; HOMOLOGY; TRANSCRIPTOME; REFINEMENT; GLYCOGEN; HISTORY	The genome of Saccharomyces cerevisiae is arguably the best studied eukaryotic genome, and yet, it contains approximately 1000 genes that are still relatively uncharacterized. As the majority of these ORFs have no homologs with characterized sequence or protein structure, traditional sequence-based approaches cannot be applied to deduce their biological function. Here, we characterize YER067W, a conserved gene of unknown function that is strongly induced in response to many stress conditions and repressed in drug resistant yeast strains. Gene expression patterns of YER067W and its paralog YIL057C suggest an involvement in energy metabolism. We show that yeast lacking YER067W display altered levels of reserve carbohydrates and a growth deficiency in media that requires aerobic metabolism. Impaired mitochondrial function and overall reduction of ergosterol content in the YER067W deleted strain explained the observed 2- and 4-fold increase in resistance to the drugs fluconazole and amphotericin B, respectively. Cell fractionation and immunofluorescence microscopy revealed that Yer067w is associated with cellular membranes despite the absence of a transmembrane domain in the protein. Finally, the 1.7 angstrom resolution crystal structure of Yer067w shows an alpha-beta fold with low similarity to known structures and a putative functional site. YER067W's involvement with aerobic energetic metabolism suggests the assignment of the gene name RGI1, standing for respiratory growth induced 1. Altogether, the results shed light on a previously uncharacterized protein family and provide basis for further studies of its apparent role in energy metabolism control and drug resistance.	[Domitrovic, Tatiana; Goncalves Freire, Joao Claudio; Kurtenbach, Eleonora] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Biol Mol & Estrutural, BR-21941 Rio De Janeiro, Brazil; [Domitrovic, Tatiana; Masuda, Claudio Akio; Almeida, Marcius da Silva; Montero-Lomeli, Monica; Atella, Georgia Correa] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, BR-21941 Rio De Janeiro, Brazil; [Kozlov, Guennadi; Matta-Camacho, Edna; Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ, Canada; [Almeida, Marcius da Silva] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet Nucl, BR-21941 Rio De Janeiro, Brazil; [Atella, Georgia Correa] Conselho Nacl Desenvolvimento Cient & Tecnolol MC, Inst Nacl Entomol, Rio De Janeiro, Brazil; [Kurtenbach, Eleonora] Conselho Nacl Desenvolvimento Cient & Tecnolol MC, Inst Nacl Pesquisa Translac Saude & Ambiente Regi, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; McGill University; Universidade Federal do Rio de Janeiro	Domitrovic, T (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Programa Biol Mol & Estrutural, BR-21941 Rio De Janeiro, Brazil.	domitrovic@biof.ufrj.br	Gehring, Kalle/N-2945-2019; Domitrovic, Tatiana/AAX-1142-2021; Gehring, Kalle/I-4403-2013; Kurtenbach, Eleonora/L-4148-2016; Masuda, Claudio A/F-7214-2014; Atella, Georgia/AAK-7897-2020; Montero-Lomeli, Monica/D-9885-2013	Gehring, Kalle/0000-0001-6500-1184; Domitrovic, Tatiana/0000-0001-9196-9412; Gehring, Kalle/0000-0001-6500-1184; Kurtenbach, Eleonora/0000-0002-2141-518X; Masuda, Claudio A/0000-0002-0310-7108; almeida, marcius/0000-0003-4921-8185	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Financiadora de Estudos e Projetos (FINEP); Canadian Institutes of Health Research [GSP-48370]; National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Brazilian grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Financiadora de Estudos e Projetos (FINEP). Operating grant GSP-48370 (to M. Cygler) from the Canadian Institutes of Health Research. K. G is a Chercheur National of the Fonds de la recherche en sante de Quebec (FRSQ). Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS) was supported by the National Science Foundation award DMR 0225180 and the National Institutes of Health award RR-01646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JB, 2009, ANTIMICROB AGENTS CH, V53, P1931, DOI 10.1128/AAC.01315-08; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Bammert GF, 2000, ANTIMICROB AGENTS CH, V44, P1255, DOI 10.1128/AAC.44.5.1255-1265.2000; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Brun S, 2004, ANTIMICROB AGENTS CH, V48, P1788, DOI 10.1128/AAC.48.5.1788-1796.2004; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cuff AL, 2009, NUCLEIC ACIDS RES, V37, pD310, DOI 10.1093/nar/gkn877; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Fernandes PMB, 2004, FEBS LETT, V556, P153, DOI 10.1016/S0014-5793(03)01396-6; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1111/j.1574-6976.2001.tb00574.x; Fribourg S, 2003, EMBO REP, V4, P699, DOI 10.1038/sj.embor.embor883; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gulshan K, 2007, EUKARYOT CELL, V6, P1933, DOI 10.1128/EC.00254-07; Hasek Jiri, 2006, Methods Mol Biol, V313, P85; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kontoyiannis DP, 2000, J ANTIMICROB CHEMOTH, V46, P191, DOI 10.1093/jac/46.2.191; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Masuda CA, 2000, BIOCHEM CELL BIOL, V78, P51, DOI 10.1139/bcb-78-1-51; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nishida H, 2006, BIOSCI BIOTECH BIOCH, V70, P2646, DOI 10.1271/bbb.60251; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Rogers PD, 2003, ANTIMICROB AGENTS CH, V47, P1220, DOI 10.1128/AAC.47.4.1220-1227.2003; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Schneiter R, 2007, BIOCHIMIE, V89, P255, DOI 10.1016/j.biochi.2006.07.022; Seo HY, 2008, J MICROBIOL BIOTECHN, V18, P1368; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Siew N, 2004, J MOL BIOL, V342, P369, DOI 10.1016/j.jmb.2004.06.073; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wilson WA, 2002, MOL CELL PROTEOMICS, V1, P232, DOI 10.1074/mcp.M100024-MCP200; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	61	8	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11163	10.1371/journal.pone.0011163	http://dx.doi.org/10.1371/journal.pone.0011163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567505	gold, Green Published			2022-12-25	WOS:000278886300009
J	Matthews, B; Harmon, LJ; M'Gonigle, L; Marchinko, KB; Schaschl, H				Matthews, Blake; Harmon, Luke J.; M'Gonigle, Leithen; Marchinko, Kerry B.; Schaschl, Helmut			Sympatric and Allopatric Divergence of MHC Genes in Threespine Stickleback	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GASTEROSTEUS-ACULEATUS L.; 3-SPINED STICKLEBACK; ADAPTIVE RADIATION; FRESH-WATER; MATE CHOICE; CLASS-I; ECOLOGICAL IMMUNOLOGY; DISRUPTIVE SELECTION; SEXUAL SELECTION	Parasites can strongly affect the evolution of their hosts, but their effects on host diversification are less clear. In theory, contrasting parasite communities in different foraging habitats could generate divergent selection on hosts and promote ecological speciation. Immune systems are costly to maintain, adaptable, and an important component of individual fitness. As a result, immune system genes, such as those of the Major Histocompatability Complex (MHC), can change rapidly in response to parasite-mediated selection. In threespine stickleback (Gasterosteus aculeatus), as well as in other vertebrates, MHC genes have been linked with female mating preference, suggesting that divergent selection acting on MHC genes might influence speciation. Here, we examined genetic variation at MHC Class II loci of sticklebacks from two lakes with a limnetic and benthic species pair, and two lakes with a single species. In both lakes with species pairs, limnetics and benthics differed in their composition of MHC alleles, and limnetics had fewer MHC alleles per individual than benthics. Similar to the limnetics, the allopatric population with a pelagic phenotype had few MHC alleles per individual, suggesting a correlation between MHC genotype and foraging habitat. Using a simulation model we show that the diversity and composition of MHC alleles in a sympatric species pair depends on the amount of assortative mating and on the strength of parasite-mediated selection in adjacent foraging habitats. Our results indicate parallel divergence in the number of MHC alleles between sympatric stickleback species, possibly resulting from the contrasting parasite communities in littoral and pelagic habitats of lakes.	[Matthews, Blake] Swiss Fed Inst Aquat Sci & Technol EAWAG, Dept Aquat Ecol, Kastanienbaum, Switzerland; [Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [M'Gonigle, Leithen] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Marchinko, Kerry B.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Schaschl, Helmut] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Idaho; University of Idaho; University of British Columbia; Fred Hutchinson Cancer Center; University of Veterinary Medicine Vienna	Matthews, B (corresponding author), Swiss Fed Inst Aquat Sci & Technol EAWAG, Dept Aquat Ecol, Kastanienbaum, Switzerland.	blake.matthews@eawag.ch	Matthews, Blake/B-5608-2009; Harmon, Luke/A-8225-2012	Matthews, Blake/0000-0001-9089-704X; Schaschl, Helmut/0000-0003-2826-8773; Harmon, Luke/0000-0002-4985-5750	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) graduate scholarships to BM, KBM, and LM. Financial support was provided by an NSERC Industrial Research Chair (IRC) grant to Asit Mazumder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Binz T, 2001, J FISH BIOL, V58, P887, DOI 10.1006/jfbi.2000.1485; Blais J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000734; Bolnick DI, 2008, AM NAT, V172, P1, DOI 10.1086/587805; Borghans JAM, 2003, EUR J IMMUNOL, V33, P3353, DOI 10.1002/eji.200324365; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Duffy MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-80; Eizaguirre C, 2009, MOL ECOL, V18, P3316, DOI 10.1111/j.1365-294X.2009.04243.x; Eizaguirre C, 2009, ECOL LETT, V12, P5, DOI 10.1111/j.1461-0248.2008.01247.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frank SA, 2000, J THEOR BIOL, V202, P283, DOI 10.1006/jtbi.1999.1054; Gavrilets S, 2004, FITNESS LANDSCAPES O; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Heckel G, 2002, CONSERV GENET, V3, P79, DOI 10.1023/A:1014255027870; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Jokela J, 2000, OIKOS, V89, P267, DOI 10.1034/j.1600-0706.2000.890207.x; Kalbe M, 2006, PARASITOLOGY, V132, P105, DOI 10.1017/S0031182005008681; Knudsen R, 2010, J ANIM ECOL, V79, P161, DOI 10.1111/j.1365-2656.2009.01625.x; Koskella B, 2009, EVOLUTION, V63, P2213, DOI 10.1111/j.1558-5646.2009.00711.x; Largiader CR, 1999, MOL ECOL, V8, P342; LAVIN PA, 1986, CAN J FISH AQUAT SCI, V43, P2455, DOI 10.1139/f86-305; MacColl ADC, 2009, ECOGRAPHY, V32, P153, DOI 10.1111/j.1600-0587.2008.05486.x; MacColl ADC, 2009, BIOL J LINN SOC, V96, P425, DOI 10.1111/j.1095-8312.2008.01123.x; Matthews B, 2010, ECOLOGY, V91, P1025, DOI 10.1890/09-0235.1; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Milinski M, 2005, P NATL ACAD SCI USA, V102, P4414, DOI 10.1073/pnas.0408264102; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Nuismer SL, 2008, ECOL LETT, V11, P937, DOI 10.1111/j.1461-0248.2008.01207.x; Poulin R, 1999, PARASITOL TODAY, V15, P28, DOI 10.1016/S0169-4758(98)01357-X; *RDEVELOPMENTTEA, 2008, R LANG ENV STAT COMP; Reimchen TE, 2001, BIOL J LINN SOC, V73, P51, DOI 10.1006/bijl.2001.0523; Reimchen TE, 2001, J EVOLUTION BIOL, V14, P632, DOI 10.1046/j.1420-9101.2001.00305.x; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Reusch TBH, 2005, J MOL EVOL, V61, P531, DOI 10.1007/s00239-004-0340-0; Reusch TBH, 2004, IMMUNOGENETICS, V56, P427, DOI 10.1007/s00251-004-0704-z; Robinson BW, 2000, BEHAVIOUR, V137, P865, DOI 10.1163/156853900502501; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Sato A, 2000, IMMUNOGENETICS, V51, P108, DOI 10.1007/s002510050019; Scharsack JP, 2007, P ROY SOC B-BIOL SCI, V274, P1523, DOI 10.1098/rspb.2007.0210; Schaschl H, 2006, J FISH BIOL, V69, P177, DOI 10.1111/j.1095-8649.2006.01223.x; Schaschl H, 2007, IMMUNOGENETICS, V59, P295, DOI 10.1007/s00251-007-0192-z; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Snowberg LK, 2008, AM NAT, V172, P733, DOI 10.1086/591692; Summers K, 2003, BIOL REV, V78, P639, DOI 10.1017/S146479310300616X; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wegner KM, 2008, J FISH BIOL, V73, P2110, DOI 10.1111/j.1095-8649.2008.02051.x; Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Woelfing B, 2009, PHILOS T R SOC B, V364, P117, DOI 10.1098/rstb.2008.0174	62	41	41	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e10948	10.1371/journal.pone.0010948	http://dx.doi.org/10.1371/journal.pone.0010948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585386	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886100002
J	Falcone, T; Fazio, V; Lee, C; Simon, B; Franco, K; Marchi, N; Janigro, D				Falcone, Tatiana; Fazio, Vincent; Lee, Catherine; Simon, Barry; Franco, Kathleen; Marchi, Nicola; Janigro, Damir			Serum S100B: A Potential Biomarker for Suicidality in Adolescents?	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MINOR HEAD TRAUMA; CHRONIC-SCHIZOPHRENICS; MAJOR DEPRESSION; PERIPHERAL MARKERS; TEMPORAL-LOBES; PROTEIN S100B; CSF BARRIER; DAMAGE; DISRUPTION	Background: Studies have shown that patients suffering from depression or schizophrenia often have immunological alterations that can be detected in the blood. Others reported a possible link between inflammation, a microgliosis and the blood-brain barrier (BBB) in suicidal patients. Serum S100B is a marker of BBB function commonly used to study cerebrovascular wall function. Methods: We measured levels of S100B in serum of 40 adolescents with acute psychosis, 24 adolescents with mood disorders and 20 healthy controls. Patients were diagnosed according to DSM-IV TR criteria. We evaluated suicidal ideation using the suicidality subscale of the Brief Psychiatric Rating Scale for Children (BPRS-C). Results: Serum S100B levels were significantly higher (p<0.05) and correlated to severity of suicidal ideation in patients with psychosis or mood disorders, independent of psychiatric diagnosis. Patients with a BPRS-C suicidality subscores of 1-4 (low suicidality) had mean serum S100B values +/2 SEM of 0.152+/20.020 ng/mL (n = 34) compared to those with BPRS-C suicidality subscores of 5-7 (high suicidality) with a mean of 0.354+/20.044 ng/mL (n = 30). This difference was statistically significant (p<0.05). Conclusion: Our data support the use of S100B as an adjunctive biomarker to assess suicidal risk in patients with mood disorders or schizophrenia.	[Falcone, Tatiana; Fazio, Vincent; Lee, Catherine; Simon, Barry; Franco, Kathleen; Marchi, Nicola; Janigro, Damir] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation	Falcone, T (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	janigrd@ccf.org	Marchi, Nicola/J-8607-2016	Marchi, Nicola/0000-0001-9124-0226; Janigro, Damir/0000-0003-2165-5826; Falcone, Tatiana/0000-0002-4431-6782	National Institutes of Health (NIH) [R01]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Damir Janigro is funded by an R01 National Institutes of Health (NIH) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BayardBurfield L, 1996, EUR NEUROPSYCHOPHARM, V6, P195, DOI 10.1016/0924-977X(96)00020-X; Bayer TA, 1999, NEUROSCI LETT, V271, P126, DOI 10.1016/S0304-3940(99)00545-5; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; FIELDS JH, 1994, AM J PSYCHIAT, V151, P249; Hetzel G, 2005, PSYCHOPHARMACOLOGY, V178, P161, DOI 10.1007/s00213-004-1999-z; Hohoff C, 2010, AM J MED GENET B, V153B, P291, DOI 10.1002/ajmg.b.30950; Hughes CW, 2001, J CHILD ADOL PSYCHOP, V11, P77, DOI 10.1089/104454601750143500; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kim YK, 2008, PROG NEURO-PSYCHOPH, V32, P356, DOI 10.1016/j.pnpbp.2007.08.041; Kim YK, 2006, PROG NEURO-PSYCHOPH, V30, P1091, DOI 10.1016/j.pnpbp.2006.04.008; Kowalski J, 2001, SCHIZOPHR RES, V50, P169, DOI 10.1016/S0920-9964(00)00156-0; Lindqvist D, 2008, PSYCHONEUROENDOCRINO, V33, P1061, DOI 10.1016/j.psyneuen.2008.05.012; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI 10.1089/neu.2008-0753; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2009, NEUROBIOL DIS, V33, P171, DOI 10.1016/j.nbd.2008.10.002; Mendlovic S, 1999, IMMUNOL LETT, V67, P105, DOI 10.1016/S0165-2478(98)00145-X; Meyer JM, 2009, BIOL PSYCHIAT, V66, P1013, DOI 10.1016/j.biopsych.2009.06.005; Mora GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005759; Mussack T, 2000, ACT NEUR S, V76, P393; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Radewicz K, 2000, J NEUROPATH EXP NEUR, V59, P137, DOI 10.1093/jnen/59.2.137; Rothermundt M, 2001, MOL PSYCHIATR, V6, P445, DOI 10.1038/sj.mp.4000889; Rothermundt M, 2004, INT REV NEUROBIOL, V59, P445; Schroeter ML, 2009, MOL PSYCHIATR, V14, P235, DOI 10.1038/mp.2008.85; Schroeter ML, 2009, PSYCHIAT RES, V167, P66, DOI 10.1016/j.psychres.2008.01.002; Schroeter ML, 2008, J AFFECT DISORDERS, V111, P271, DOI 10.1016/j.jad.2008.03.005; Sisask M, 2008, NORD J PSYCHIAT, V62, P431, DOI 10.1080/08039480801959273; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Steiner J, 2008, J PSYCHIATR RES, V42, P151, DOI 10.1016/j.jpsychires.2006.10.013; Steiner J, 2006, ACTA NEUROPATHOL, V112, P305, DOI 10.1007/s00401-006-0090-8; Tonelli LH, 2008, ACTA PSYCHIAT SCAND, V117, P198, DOI 10.1111/j.1600-0447.2007.01128.x; TRASKMANBENDZ L, 1992, J CLIN PSYCHOPHARM, V12, pS21; van Heeringen K, 2003, CAN J PSYCHIAT, V48, P292, DOI 10.1177/070674370304800504; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; WESTLIN S, 2009, NEUROLOGY PSYCHIAT S, V1; Wierzba-Bobrowicz T, 2004, FOLIA NEUROPATHOL, V42, P157; Wierzba-Bobrowicz T, 2005, FOLIA NEUROPATHOL, V43, P81	47	51	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11089	10.1371/journal.pone.0011089	http://dx.doi.org/10.1371/journal.pone.0011089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559426	Green Published, gold			2022-12-25	WOS:000278741100006
J	Brier, S; Pflieger, D; Le Mignon, M; Bally, I; Gaboriaud, C; Arlaud, GJ; Daniel, R				Brier, Sebastien; Pflieger, Delphine; Le Mignon, Maxime; Bally, Isabelle; Gaboriaud, Christine; Arlaud, Gerard J.; Daniel, Regis			Mapping Surface Accessibility of the C1r/C1s Tetramer by Chemical Modification and Mass Spectrometry Provides New Insights into Assembly of the Human C1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST COMPONENT; PROTEASE C1R; CATALYTIC DOMAIN; HYDROGEN/DEUTERIUM-EXCHANGE; NEUTRON-SCATTERING; CRYSTAL-STRUCTURE; SERINE PROTEASES; FUNCTIONAL-MODEL; LECTIN PATHWAYS; SUB-COMPONENTS	C1, the complex that triggers the classic pathway of complement, is a 790-kDa assembly resulting from association of a recognition protein C1q with a Ca2+-dependent tetramer comprising two copies of the proteases C1r and C1s. Early structural investigations have shown that the extended C1s-C1r-C1r-C1s tetramer folds into a compact conformation in C1. Recent site-directed mutagenesis studies have identified the C1q-binding sites in C1r and C1s and led to a three-dimensional model of the C1 complex (Bally, I., Rossi, V., Lunardi, T., Thielens, N. M., Gaboriaud, C., and Arlaud, G. J. (2009) J. Biol. Chem. 284, 19340-19348). In this study, we have used a mass spectrometry-based strategy involving a label-free semi-quantitative analysis of protein samples to gain new structural insights into C1 assembly. Using a stable chemical modification, we have compared the accessibility of the lysine residues in the isolated tetramer and in C1. The labeling data account for 51 of the 73 lysine residues of C1r and C1s. They strongly support the hypothesis that both C1s CUB1-EGF-CUB2 interaction domains, which are distant in the free tetramer, associate with each other in the C1 complex. This analysis also provides the first experimental evidence that, in the proenzyme form of C1, the C1s serine protease domain is partly positioned inside the C1q cone and yields precise information about its orientation in the complex. These results provide further structural insights into the architecture of the C1 complex, allowing significant improvement of our current C1 model.	[Brier, Sebastien; Pflieger, Delphine; Le Mignon, Maxime; Daniel, Regis] Univ Evry Val dEssonne, Lab Anal & Modelisat Biol & Environm, CNRS, UMR 8587, F-91025 Evry, France; [Bally, Isabelle; Gaboriaud, Christine; Arlaud, Gerard J.] CEA CNRS UJF, Inst Biol Struct JP Ebel, Lab Enzymol Mol, UMR 5075, F-38027 Grenoble, France; [Bally, Isabelle; Gaboriaud, Christine; Arlaud, Gerard J.] CEA CNRS UJF, Inst Biol Struct JP Ebel, Lab Cristallog & Cristallogenese Prot, UMR 5075, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Brier, S (corresponding author), Univ Evry Val dEssonne, Lab Anal & Modelisat Biol & Environm, CNRS, UMR 8587, Blvd Francois Mitterrand, F-91025 Evry, France.	sebastien.brier@novartis.com; regis.daniel@univ-evry.fr	Daniel, Regis/S-7890-2016; Brier, Sebastien/L-7787-2019; Pflieger, Delphine/ABD-1496-2021; Brier, Sébastien/E-8558-2019	Daniel, Regis/0000-0003-0725-5439; Brier, Sebastien/0000-0003-1758-8237; 	CNRS; Genopole-France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Genopole-France	This work was supported by CNRS and by Genopole-France.	ARLAUD GJ, 1993, METHOD ENZYMOL, V223, P61; ARLAUD GJ, 1987, IMMUNOL TODAY, V8, P106, DOI 10.1016/0167-5699(87)90860-7; ARLAUD GJ, 1986, BIOCHEMISTRY-US, V25, P5177, DOI 10.1021/bi00366a029; Arlaud GJ, 2002, BIOCHEM SOC T, V30, P1001, DOI 10.1042/bst0301001; ARLAUD GJ, 1979, MOL IMMUNOL, V16, P445, DOI 10.1016/0161-5890(79)90069-5; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; Bally I, 2008, MOL IMMUNOL, V45, P4097, DOI 10.1016/j.molimm.2008.08.008; Bersch B, 1998, BIOCHEMISTRY-US, V37, P1204, DOI 10.1021/bi971851v; Botto M, 2002, IMMUNOBIOLOGY, V205, P395, DOI 10.1078/0171-2985-00141; BOYD J, 1983, P NATL ACAD SCI-BIOL, V80, P3769, DOI 10.1073/pnas.80.12.3769; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Chen YJ, 2008, ANTI-CANCER DRUG, V19, P55, DOI 10.1097/CAD.0b013e3282f18826; Cutalo JM, 2006, BIOCHEMISTRY-US, V45, P15458, DOI 10.1021/bi061392a; Duncan RC, 2008, BIOCHIMIE, V90, P387, DOI 10.1016/j.biochi.2007.07.023; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; Gabant G, 2008, J MASS SPECTROM, V43, P360, DOI 10.1002/jms.1328; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Gaboriaud C, 2007, IMMUNOBIOLOGY, V212, P279, DOI 10.1016/j.imbio.2006.11.007; Gal P, 2007, IMMUNOBIOLOGY, V212, P267, DOI 10.1016/j.imbio.2006.11.002; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; ILLY C, 1993, J PROTEIN CHEM, V12, P771, DOI 10.1007/BF01024936; Janecki DJ, 2005, ANAL CHEM, V77, P7274, DOI 10.1021/ac050891z; Kardos J, 2008, MOL IMMUNOL, V45, P1752, DOI 10.1016/j.molimm.2007.09.031; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; PERKINS SJ, 1984, J MOL BIOL, V179, P547, DOI 10.1016/0022-2836(84)90079-2; Pflieger D, 2006, PROTEOMICS, V6, P5868, DOI 10.1002/pmic.200402040; Pflieger D, 2010, MOL CELL PROTEOMICS, V9, P593, DOI 10.1074/mcp.M900350-MCP200; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; Scholten A, 2006, J AM SOC MASS SPECTR, V17, P983, DOI 10.1016/j.jasms.2006.03.005; SCHUMAKER VN, 1986, MOL IMMUNOL, V23, P557, DOI 10.1016/0161-5890(86)90119-7; STRANG CJ, 1982, P NATL ACAD SCI-BIOL, V79, P586, DOI 10.1073/pnas.79.2.586; SUCKAU D, 1992, P NATL ACAD SCI USA, V89, P5630, DOI 10.1073/pnas.89.12.5630; Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374; THIELENS NM, 1994, BIOCHEM J, V301, P509, DOI 10.1042/bj3010509; Tissot B, 2005, BIOCHEMISTRY-US, V44, P2602, DOI 10.1021/bi047802h; TSCHOPP J, 1980, P NATL ACAD SCI-BIOL, V77, P7014, DOI 10.1073/pnas.77.12.7014; VILLIERS CL, 1985, P NATL ACAD SCI USA, V82, P4477, DOI 10.1073/pnas.82.13.4477; WEISS V, 1986, J MOL BIOL, V189, P573, DOI 10.1016/0022-2836(86)90325-6; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Yan XG, 2002, PROTEIN SCI, V11, P2113, DOI 10.1110/ps.0204402; ZICCARDI RJ, 1982, J IMMUNOL, V128, P2500	44	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32251	32263		10.1074/jbc.M110.149112	http://dx.doi.org/10.1074/jbc.M110.149112			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20592021	Green Published, hybrid			2022-12-25	WOS:000282683000038
J	Chang, YP; Tsai, CC; Huang, WC; Wang, CY; Chen, CL; Lin, YS; Kai, JI; Hsieh, CY; Cheng, YL; Choi, PC; Chen, SH; Chang, SP; Liu, HS; Lin, CF				Chang, Yu-Ping; Tsai, Cheng-Chieh; Huang, Wei-Ching; Wang, Chi-Yun; Chen, Chia-Ling; Lin, Yee-Shin; Kai, Jui-In; Hsieh, Chia-Yuan; Cheng, Yi-Lin; Choi, Pui-Ching; Chen, Shun-Hua; Chang, Shih-Ping; Liu, Hsiao-Sheng; Lin, Chiou-Feng			Autophagy Facilitates IFN-gamma-induced Jak2-STAT1 Activation and Cellular Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-GAMMA; DENDRITIC CELLS; PHOSPHATASE 2; STAT1; MACROPHAGES; SURVIVAL; CANCER; ROLES; BCG	Autophagy is regulated for IFN-gamma-mediated antimicrobial efficacy; however, its molecular effects for IFN-gamma signaling are largely unknown. Here, we show that autophagy facilitates IFN-gamma-activated Jak2-STAT1. IFN-gamma induces autophagy in wild-type but not in autophagy protein 5 (Atg5(-/-))-deficient mouse embryonic fibroblasts (MEFs), and, autophagy-dependently, IFN-gamma induces IFN regulatory factor 1 and cellular inflammatory responses. Pharmacologically inhibiting autophagy using 3-methyladenine, a known inhibitor of class III phosphatidylinositol 3-kinase, confirms these effects. Either Atg5(-/-) or Atg7(-/-) MEFs are, independent of changes in IFN-gamma receptor expression, resistant to IFN-gamma-activated Jak2-STAT1, which suggests that autophagy is important for IFN-gamma signal transduction. Lentivirus-based short hairpin RNA for Atg5 knockdown confirmed the importance of autophagy for IFN-gamma-activated STAT1. Without autophagy, reactive oxygen species increase and cause SHP2 (Src homology-2 domain-containing phosphatase 2)-regulated STAT1 inactivation. Inhibiting SHP2 reversed both cellular inflammation and the IFN-gamma-induced activation of STAT1 in Atg5(-/-) MEFs. Our study provides evidence that there is a link between autophagy and both IFN-gamma signaling and cellular inflammation and that autophagy, because it inhibits the expression of reactive oxygen species and SHP2, is pivotal for Jak2-STAT1 activation.	[Kai, Jui-In; Hsieh, Chia-Yuan; Cheng, Yi-Lin; Choi, Pui-Ching; Lin, Chiou-Feng] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 701, Taiwan; [Tsai, Cheng-Chieh; Huang, Wei-Ching; Wang, Chi-Yun; Lin, Yee-Shin; Chen, Shun-Hua; Liu, Hsiao-Sheng; Lin, Chiou-Feng] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan; [Chang, Yu-Ping; Chen, Chia-Ling; Lin, Yee-Shin; Chen, Shun-Hua; Chang, Shih-Ping; Liu, Hsiao-Sheng; Lin, Chiou-Feng] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 701, Taiwan; [Cheng, Yi-Lin] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Coll Med, Tainan 701, Taiwan; [Tsai, Cheng-Chieh] Chung Hwa Univ Med Technol, Dept Nursing, Tainan 717, Taiwan; [Lin, Yee-Shin] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chung Hua University; National Cheng Kung University	Lin, CF (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan 701, Taiwan.	cflin@mail.ncku.edu.tw		Liu, Hsiao-Sheng/0000-0003-0576-7203; Wang, Chi-Yun/0000-0003-0317-5378	National Health Research Institutes, Taiwan [NHRI-EX99-9917NC]; National Science Council, Taiwan [NSC 96-2320-B-006-018-MY3]; National Cheng Kung University, Taiwan [C020]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University, Taiwan	This work was supported by Grants NHRI-EX99-9917NC and NSC 96-2320-B-006-018-MY3 from the National Health Research Institutes and the National Science Council, respectively, Taiwan, and Landmark Project C020 of National Cheng Kung University, Taiwan.	Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Fielhaber JA, 2009, J BIOL CHEM, V284, P24341, DOI 10.1074/jbc.M109.033530; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Kaur N, 2005, J NEUROCHEM, V92, P1521, DOI 10.1111/j.1471-4159.2004.02990.x; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee L, 2006, GENE CHROMOSOME CANC, V45, P933, DOI 10.1002/gcc.20357; Lehtonen A, 1997, J IMMUNOL, V159, P794; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Orvedahl A, 2008, AUTOPHAGY, V4, P280, DOI 10.4161/auto.5289; Park SJ, 2009, FREE RADICAL BIO MED, V46, P1694, DOI 10.1016/j.freeradbiomed.2009.03.026; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tsai CC, 2009, J IMMUNOL, V183, P856, DOI 10.4049/jimmunol.0804033; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416	30	70	74	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28715	28722		10.1074/jbc.M110.133355	http://dx.doi.org/10.1074/jbc.M110.133355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20592027	Green Published, hybrid			2022-12-25	WOS:000281594000037
J	Hoshino, A; Iimura, T; Ueha, S; Hanada, S; Maruoka, Y; Mayahara, M; Suzuki, K; Imai, T; Ito, M; Manome, Y; Yasuhara, M; Kirino, T; Yamaguchi, A; Matsushima, K; Yamamoto, K				Hoshino, Akiyoshi; Iimura, Tadahiro; Ueha, Satoshi; Hanada, Sanshiro; Maruoka, Yutaka; Mayahara, Mitsuori; Suzuki, Keiko; Imai, Toshio; Ito, Masako; Manome, Yoshinobu; Yasuhara, Masato; Kirino, Takaaki; Yamaguchi, Akira; Matsushima, Kouji; Yamamoto, Kenji			Deficiency of Chemokine Receptor CCR1 Causes Osteopenia Due to Impaired Functions of Osteoclasts and Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; BIOCHEMICAL MARKERS; OSTEOLYTIC LESIONS; MULTIPLE-MYELOMA; BONE-FORMATION; CELLS; EXPRESSION; ACTIVATOR; RANKL; DIFFERENTIATION	Chemokines are characterized by the homing activity of leukocytes to targeted inflammation sites. Recent research indicates that chemokines play more divergent roles in various phases of pathogenesis as well as immune reactions. The chemokine receptor, CCR1, and its ligands are thought to be involved in inflammatory bone destruction, but their physiological roles in the bone metabolism in vivo have not yet been elucidated. In the present study, we investigated the roles of CCR1 in bone metabolism using CCR1-deficient mice. Ccr1(-/-) mice have fewer and thinner trabecular bones and low mineral bone density in cancellous bones. The lack of CCR1 affects the differentiation and function of osteoblasts. Runx2, Atf4, Osteopontin, and Osteonectin were significantly up-regulated in Ccr1(-/-) mice despite sustained expression of Osterix and reduced expression of Osteocalcin, suggesting a lower potential for differentiation into mature osteoblasts. In addition, mineralized nodule formation was markedly disrupted in cultured osteoblastic cells isolated from Ccr1(-/-) mice. Osteoclastogenesis induced from cultured Ccr1(-/-) bone marrow cells yielded fewer and smaller osteoclasts due to the abrogated cell-fusion. Ccr1(-/-) osteoclasts exerted no osteolytic activity concomitant with reduced expressions of Rank and its downstream targets, implying that the defective osteoclastogenesis is involved in the bone phenotype in Ccr1(-/-) mice. The co-culture of wild-type osteoclast precursors with Ccr1(-/-) osteoblasts failed to facilitate osteoclastogenesis. This finding is most likely due to a reduction in Rankl expression. These observations suggest that the axis of CCR1 and its ligands are likely to be involved in crosstalk between osteoclasts and osteoblasts by modulating the RANK-RANKL-mediated interaction.	[Yamamoto, Kenji] Int Med Ctr Japan, Int Clin Res Ctr, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan; [Ueha, Satoshi; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo 1130033, Japan; [Hoshino, Akiyoshi; Manome, Yoshinobu] Tokyo Med & Dent Univ, Dept Pharmacokinet & Pharmacodynam Hosp Pharm, Tokyo 1138519, Japan; [Iimura, Tadahiro; Yamaguchi, Akira] Tokyo Med & Dent Univ, Dept Oral Pathol, Global Ctr Excellence, Tokyo 1138519, Japan; [Hoshino, Akiyoshi; Manome, Yoshinobu] Jikei Univ, Dept Mol Cell Biol, Inst DNA Med, Res Ctr Med Sci,Sch Med, Tokyo 1058461, Japan; [Maruoka, Yutaka] Toyama Natl Hosp, Int Med Ctr Japan, Dept Dent & Oral Surg, Tokyo 1628655, Japan; [Mayahara, Mitsuori] Showa Univ, Dept Oral Histol, Sch Dent, Tokyo 1428555, Japan; [Suzuki, Keiko] Showa Univ, Dept Pharmacol, Sch Dent, Tokyo 1428555, Japan; [Imai, Toshio] Kan Res Inst Inc, Kobe, Hyogo 6500047, Japan; [Ito, Masako] Nagasaki Univ, Dept Radiol, Sch Med, Nagasaki 8528501, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Jikei University; National Center for Global Health & Medicine - Japan; Showa University; Showa University; KAN Research Institute; Nagasaki University	Yamamoto, K (corresponding author), Int Med Ctr Japan, Int Clin Res Ctr, Res Inst, Shinjuku Ku, Toyama 1-21-1, Tokyo 1628655, Japan.	backen@ri.ncgm.go.jp	Hanada, Sanshiro/I-6525-2013; YAMAMOTO, Kenji/I-1758-2013; Iimura, Tadahiro/P-3550-2018	Hanada, Sanshiro/0000-0003-2933-3522; Iimura, Tadahiro/0000-0002-1431-0689; Manome, Yoshinobu/0000-0002-8755-8976; Ueha, Satoshi/0000-0002-3871-9921	Ministry of Health, Labor and Welfare [H19-nano-012, H21-nanchi-097, H22-nanchi-ippan157]; Japan Society for the Promotion of Science [21659426]; Japan Foundation of Cardiovascular Research; Naito Foundation; Japanese Ministry of Education; Global Center of Excellence Program; International Research Center for Molecular Science in Tooth and Bone Diseases; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Solution Oriented Research for Science and Technology; Japan Science and Technology Corp	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation of Cardiovascular Research; Naito Foundation(Naito Memorial Foundation); Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Research Center for Molecular Science in Tooth and Bone Diseases; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Solution Oriented Research for Science and Technology; Japan Science and Technology Corp(Japan Science & Technology Agency (JST))	This work was supported in part by Grant H19-nano-012 from the Ministry of Health, Labor and Welfare (to K. Y.) and by a research fellowship from the Japan Society for the Promotion of Science for Young Scientists (2007-2009) (to A. H.).; Supported by grants from the Japan Foundation of Cardiovascular Research (2006) and from the Naito Foundation (2005).; Supported by a grant from the Japanese Ministry of Education, Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases.; Supported by The Takeda Science Foundation, The Mochida Memorial Foundation for Medical and Pharmaceutical Research, and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (21659426).; Supported by Grants H21-nanchi-097 and H22-nanchi-ippan157 from the Ministry of Health, Labor and Welfare. Supported by Solution Oriented Research for Science and Technology and by Japan Science and Technology Corp.	Abe M, 2002, BLOOD, V100, P2195, DOI 10.1182/blood.V100.6.2195.h81802002195_2195_2202; Anders HJ, 2003, J IMMUNOL, V170, P5658, DOI 10.4049/jimmunol.170.11.5658; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Chintalacharuvu SR, 2005, IMMUNOL LETT, V100, P202, DOI 10.1016/j.imlet.2005.03.012; Choi SJ, 2000, BLOOD, V96, P671; Coates PTH, 2004, KIDNEY INT, V66, P1907, DOI 10.1111/j.1523-1755.2004.00965.x; DELMAS PD, 1993, J BONE MINER RES, V8, pS549; Doi M, 2002, BIOCHEM BIOPH RES CO, V290, P381, DOI 10.1006/bbrc.2001.6196; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Furuichi K, 2008, J IMMUNOL, V181, P8670, DOI 10.4049/jimmunol.181.12.8670; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Hoshino A, 2007, J IMMUNOL, V178, P5296, DOI 10.4049/jimmunol.178.8.5296; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ito M, 2005, J BONE MINER RES, V20, P1828, DOI 10.1359/JBMR.050610; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; Kim MS, 2006, J CELL BIOCHEM, V97, P512, DOI 10.1002/jcb.20649; Kitazawa R, 2008, J CELL BIOCHEM, V105, P1289, DOI 10.1002/jcb.21929; Kominsky SL, 2008, CANCER RES, V68, P1261, DOI 10.1158/0008-5472.CAN-07-6122; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lean JM, 2002, J CELL BIOCHEM, V87, P386, DOI 10.1002/jcb.10319; Liotta L A, 1990, Semin Cancer Biol, V1, P99; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Ma B, 2004, J IMMUNOL, V172, P1872, DOI 10.4049/jimmunol.172.3.1872; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Menu E, 2006, CLIN EXP METASTAS, V23, P291, DOI 10.1007/s10585-006-9038-6; Murphy PM, 2000, PHARMACOL REV, V52, P145; Oba Y, 2005, EXP HEMATOL, V33, P272, DOI 10.1016/j.exphem.2004.11.015; Okamatsu Y, 2004, J IMMUNOL, V173, P2084, DOI 10.4049/jimmunol.173.3.2084; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Rioja I, 2008, ARTHRITIS RHEUM-US, V58, P2257, DOI 10.1002/art.23667; Saitoh Y, 2007, BIOCHEM BIOPH RES CO, V364, P417, DOI 10.1016/j.bbrc.2007.09.137; Sakai N, 2006, J LEUKOCYTE BIOL, V79, P555, DOI 10.1189/jlb.0305127; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Schneider DL, 1997, ARCH INTERN MED, V157, P1241, DOI 10.1001/archinte.157.11.1241; Shang XZ, 2000, AM J PATHOL, V157, P2055, DOI 10.1016/S0002-9440(10)64844-4; Takahashi M, 1997, J ENDOCRINOL INVEST, V20, P112, DOI 10.1007/BF03346887; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Vallet S, 2007, BLOOD, V110, P3744, DOI 10.1182/blood-2007-05-093294; Votta BJ, 2000, J CELL PHYSIOL, V183, P196, DOI 10.1002/(SICI)1097-4652(200005)183:2<196::AID-JCP6>3.3.CO;2-#; WILSON MJ, 1991, BIOL REPROD, V44, P776, DOI 10.1095/biolreprod44.5.776; Yang MH, 2006, BLOOD, V107, P2262, DOI 10.1182/blood-2005-08-3365; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910	46	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28826	28837		10.1074/jbc.M109.099424	http://dx.doi.org/10.1074/jbc.M109.099424			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20571024	Green Published, hybrid			2022-12-25	WOS:000281594000048
J	Hanelt, I; Wunnicke, D; Muller-Trimbusch, M; Vor der Bruggen, M; Kraus, I; Bakker, EP; Steinhoff, HJ				Haenelt, Inga; Wunnicke, Dorith; Mueller-Trimbusch, Meike; Vor der Brueggen, Marc; Kraus, Inga; Bakker, Evert P.; Steinhoff, Heinz-Juergen			Membrane Region M-2C2 in Subunit KtrB of the K+ Uptake System KtrAB from Vibrio alginolyticus Forms a Flexible Gate Controlling K+ Flux AN ELECTRON PARAMAGNETIC RESONANCE STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; ESCHERICHIA-COLI K-12; FULL-LENGTH KCSA; POTASSIUM-TRANSPORT; DISTANCE MEASUREMENTS; CRYSTAL-STRUCTURE; GLYCINE RESIDUES; KDPFABC COMPLEX; HIGH-AFFINITY; ION CHANNEL	Transmembrane stretch M-2C from the bacterial K+-translocating protein KtrB is unusually long. In its middle part, termed M-2C2, it contains several small and polar amino acids. This region is flanked by the two alpha-helices M-2C1 and M-2C3 and may form a flexible gate at the cytoplasmic side of the membrane controlling K+ translocation. In this study, we provide experimental evidence for this notion by using continuous wave and pulse EPR measurements of single and double spin-labeled cysteine variants of KtrB. Most of the spin-labeled residues in M-2C2 were shown to be immobile, pointing to a compact structure. However, the high polarity revealed for the microenvironment of residue positions 317, 318, and 327 indicated the existence of a water-accessible cavity. Upon the addition of K+ ions, M2C2 residue Thr-318R1 (R1 indicates the bound spin label) moved with respect to M-2B residue Asp-222R1 and M2C3 residue Val-331R1 but not with respect to M2C1 residue Met-311R1. Based on distances determined between spin-labeled residues of double-labeled variants of KtrB in the presence and absence of K+ ions, structural models of the open and closed conformations were developed.	[Bakker, Evert P.] Univ Osnabruck, Dept Microbiol, D-49076 Osnabruck, Germany; [Wunnicke, Dorith; Mueller-Trimbusch, Meike; Steinhoff, Heinz-Juergen] Univ Osnabruck, Dept Phys, D-49076 Osnabruck, Germany	University Osnabruck; University Osnabruck	Hanelt, I (corresponding author), Univ Groningen, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	i.haenelt@rug.nl	Steinhoff, Heinz-Juergen/H-3791-2014; Hänelt, Inga/N-2982-2016	Steinhoff, Heinz-Juergen/0000-0002-5888-0157; Hänelt, Inga/0000-0003-1495-3163	Deutsche Forschungsgemeinschaft [SFB431]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB431 (projects P6 and P18).	Albright RA, 2007, J BIOL CHEM, V282, P35046, DOI 10.1074/jbc.M704260200; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; Bertrand J, 2004, J BACTERIOL, V186, P5519, DOI 10.1128/JB.186.16.5519-5522.2004; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DRIESSEN AJM, 1993, METHOD ENZYMOL, V221, P394, DOI 10.1016/0076-6879(93)21032-4; Durell SR, 2000, BIOPHYS J, V78, P188, DOI 10.1016/S0006-3495(00)76584-2; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Durell SR, 1999, BIOPHYS J, V77, P789, DOI 10.1016/S0006-3495(99)76932-8; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; EPSTEIN W, 1986, FEMS MICROBIOL LETT, V39, P73; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P475; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Hanelt I, 2010, J BIOL CHEM, V285, P10318, DOI 10.1074/jbc.M109.089870; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2004, J MAGN RESON, V169, P1, DOI 10.1016/j.jmr.2004.03.024; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Kato N, 2007, CHANNELS, V1, P161, DOI 10.4161/chan.4374; Kawano M, 2000, J BACTERIOL, V182, P2507, DOI 10.1128/JB.182.9.2507-2512.2000; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kroning N, 2007, J BIOL CHEM, V282, P14018, DOI 10.1074/jbc.M609084200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Nimigean CM, 2006, NAT PROTOC, V1, P1207, DOI 10.1038/nprot.2006.166; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Savitsky A, 2004, J PHYS CHEM B, V108, P9541, DOI 10.1021/jp036397l; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; STUMPE S, 1996, HDB BIOL PHYS, V2, P473; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; van der Laan M, 2002, J BACTERIOL, V184, P5491, DOI 10.1128/JB.184.19.5491-5494.2002; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	50	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28210	28219		10.1074/jbc.M110.139311	http://dx.doi.org/10.1074/jbc.M110.139311			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573964	Green Published, hybrid			2022-12-25	WOS:000281404100064
J	Park, KH; Kurokawa, K; Zheng, L; Jung, DJ; Tateishi, K; Jin, JO; Ha, NC; Kang, HJ; Matsushita, M; Kwak, JY; Takahashi, K; Lee, BL				Park, Keun-Hwa; Kurokawa, Kenji; Zheng, Lili; Jung, Dong-Jun; Tateishi, Koichiro; Jin, Jun-O; Ha, Nam-Chul; Kang, Hee Jung; Matsushita, Misao; Kwak, Jong-Young; Takahashi, Kazue; Lee, Bok Luel			Human Serum Mannose-binding Lectin Senses Wall Teichoic Acid Glycopolymer of Staphylococcus aureus, Which Is Restricted in Infancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; LIPOTEICHOIC ACID; SERINE-PROTEASE; COMPLEMENT ACTIVATION; INNATE IMMUNITY; ASSOCIATION; INFECTION; RESISTANCE; PATHWAY; GENE	Innate immunity is the first line of host defense against invading pathogens, and it is recognized by a variety of pattern recognition molecules, including mannose-binding lectin (MBL). MBL binds to mannose and N-acetylglucosamine residues present on the glycopolymers of microorganisms. Human serum MBL functions as an opsonin and activates the lectin complement pathway. However, which glycopolymer of microorganism is recognized by MBL is still uncertain. Here, we show that wall teichoic acid of Staphylococcus aureus, a bacterial cell surface glycopolymer containing N-acetylglucosamine residue, is a functional ligand of MBL. Whereas serum MBL in adults did not bind to wall teichoic acid because of an inhibitory effect of anti-wall teichoic acid antibodies, MBL in infants who had not yet fully developed their adaptive immunity could bind to S. aureus wall teichoic acid and then induced complement C4 deposition. Our data explain the molecular reasons of why MBL-deficient infants are susceptible to S. aureus infection.	[Park, Keun-Hwa; Kurokawa, Kenji; Zheng, Lili; Jung, Dong-Jun; Ha, Nam-Chul; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Tateishi, Koichiro; Matsushita, Misao] Tokai Univ, Dept Appl Biochem, Kanagawa 2591292, Japan; [Jin, Jun-O; Kwak, Jong-Young] Dong A Univ, Dept Biochem, Pusan 602714, South Korea; [Kang, Hee Jung] Hallym Univ, Coll Med, Dept Lab Med, Anyang Si 431070, South Korea; [Takahashi, Kazue] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Programs Dev Immunol, Boston, MA 02114 USA	Pusan National University; Tokai University; Dong A University; Hallym University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Jin, Jun-O/G-2998-2014	Jin, Jun-O/0000-0003-4216-8111	National Research Foundation of Korea [M10400000028-04J0000-02, 2009-032-2000, 2008-8057-6001, BK21]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Programs M10400000028-04J0000-02, 2009-032-2000, 2008-8057-6001, and BK21 of the National Research Foundation of Korea.	Archer GL, 2001, NEW ENGL J MED, V344, P55, DOI 10.1056/NEJM200101043440110; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; CHATTERJEE AN, 1969, J BACTERIOL, V98, P519, DOI 10.1128/JB.98.2.519-527.1969; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; Fattom AI, 2004, VACCINE, V22, P880, DOI 10.1016/j.vaccine.2003.11.034; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Jo EJ, 2004, J IMMUNOL, V173, P6433, DOI 10.4049/jimmunol.173.10.6433; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kang HJ, 2007, IMMUNOLOGY, V122, P335, DOI 10.1111/j.1365-2567.2007.02644.x; Kiriukhin MY, 2001, J BACTERIOL, V183, P3506, DOI 10.1128/JB.183.11.3506-3514.2001; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Oku Y, 2009, J BACTERIOL, V191, P141, DOI 10.1128/JB.01221-08; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Polotsky VY, 1996, INFECT IMMUN, V64, P380, DOI 10.1128/IAI.64.1.380-383.1996; Santos IKFD, 2001, INFECT IMMUN, V69, P5212, DOI 10.1128/IAI.69.8.5212-5215.2001; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; SUPER M, 1989, LANCET, V2, P1236; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weisman LE, 2007, ARCH PEDIATRIE, V14, pS31, DOI 10.1016/S0929-693X(07)80008-X; Yamagishi JI, 1996, ANTIMICROB AGENTS CH, V40, P1157, DOI 10.1128/AAC.40.5.1157	47	50	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27167	27175		10.1074/jbc.M110.141309	http://dx.doi.org/10.1074/jbc.M110.141309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592033	Green Published, hybrid			2022-12-25	WOS:000281172700047
J	Vinogradov, E; King, JD; Pathak, AK; Harvill, ET; Preston, A				Vinogradov, Evgeny; King, Jerry D.; Pathak, Ashutosh K.; Harvill, Eric T.; Preston, Andrew			Antigenic Variation among Bordetella BORDETELLA BRONCHISEPTICA STRAIN MO149 EXPRESSES A NOVEL O CHAIN THAT IS POORLY IMMUNOGENIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE O-ANTIGENS; RESPIRATORY-TRACT INFECTION; BORDETELLA-BRONCHISEPTICA; GENE-CLUSTER; PERTUSSIS; POLYSACCHARIDE; PARAPERTUSSIS; BIOSYNTHESIS; BINDING; CHAIN	The O chain polysaccharide (O PS) of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharide is a homopolymer of 2,3-diacetamido-2,3-dideoxygalacturonic acid (GalNAc3NAcA) in which some of the sugars are present as uronamides. The terminal residue contains several unusual modifications. To date, two types of modification have been characterized, and a survey of numerous strains demonstrated that each contained one of these two modification types. Host antibody responses against the O PS are directed against the terminal residue modifications, and there is little cross-reactivity between the two types. This suggests that Bordetella O PS modifications represent a means of antigenic variation. Here we report the characterization of the O PS of B. bronchiseptica strain MO149. It consists of a novel two-sugar repeating unit and a novel terminal residue modification, with the structure Me-4-alpha-L-Ga1NAc3NAcA-(4-beta-D-G1cNAc3NAcA-4-alpha-L-Ga1NAc3NAcA-) (5-6)-, which we propose be defined as the B. bronchiseptica O3 PS. We show that the O3 PS is very poorly immunogenic and that the MO149 strain contains a novel wbm (O PS biosynthesis) locus. Thus, there is greater diversity among Bordetella O PSs than previously recognized, which is likely to be a result of selection pressure from host immunity. We also determine experimentally, for the first time, the absolute configuration of the diacetimido-uronic acid sugars in Bordetella O PS.	[Preston, Andrew] Univ Bristol, Dept Vet Clin Sci, Langford BS40 5DU, North Somerset, England; CNR, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [King, Jerry D.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Pathak, Ashutosh K.; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	University of Bristol; National Research Council Canada; University of Guelph; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Preston, A (corresponding author), Univ Bristol, Dept Vet Clin Sci, Langford BS40 5DU, North Somerset, England.	a.preston@bristol.ac.uk		Preston, Andrew/0000-0002-1489-280X; Harvill, Eric/0000-0001-8893-2133; Vinogradov, Evgeny/0000-0002-5364-1376	National Institutes of Health [GM083113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM083113 (to E. T. H.).	Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Buboltz AM, 2009, INFECT IMMUN, V77, P3249, DOI 10.1128/IAI.01448-08; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; Caroff M, 2000, FEBS LETT, V477, P8, DOI 10.1016/S0014-5793(00)01720-8; Cherry JD, 1996, J INFECT DIS, V174, pS259, DOI 10.1093/infdis/174.Supplement_3.S259; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; DIFABIO JL, 1992, FEMS MICROBIOL LETT, V97, P275, DOI 10.1111/j.1574-6968.1992.tb05475.x; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; GUEIRARD P, 1995, J CLIN MICROBIOL, V33, P2002, DOI 10.1128/JCM.33.8.2002-2006.1995; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; HEININGER U, 1994, PEDIATR INFECT DIS J, V13, P306, DOI 10.1097/00006454-199404000-00011; Kido N, 1998, MOL MICROBIOL, V27, P1213, DOI 10.1046/j.1365-2958.1998.00765.x; King JD, 2007, J MOL BIOL, V374, P749, DOI 10.1016/j.jmb.2007.09.055; Merino S, 2000, INFECT IMMUN, V68, P2435, DOI 10.1128/IAI.68.5.2435-2440.2000; PEPPLER MS, 1984, INFECT IMMUN, V43, P224, DOI 10.1128/IAI.43.1.224-232.1984; Pilione MR, 2004, INFECT IMMUN, V72, P2837, DOI 10.1128/IAI.72.5.2837-2842.2004; PORTER JF, 1994, MICROBIOL-SGM, V140, P255, DOI 10.1099/13500872-140-2-255; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Preston A, 1996, J BACTERIOL, V178, P396, DOI 10.1128/jb.178.2.396-402.1996; Preston A, 2006, J BIOL CHEM, V281, P18135, DOI 10.1074/jbc.M513904200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Vinogradov E, 2002, CARBOHYD RES, V337, P961; Vinogradov E, 2000, EUR J BIOCHEM, V267, P7230, DOI 10.1046/j.1432-1327.2000.01835.x; Vinogradov E, 2008, CARBOHYD RES, V343, P3079, DOI 10.1016/j.carres.2008.09.015; Vinogradov E, 2007, CARBOHYD RES, V342, P638, DOI 10.1016/j.carres.2006.10.025; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Zhang XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006989; Zhang XQ, 2009, INFECT IMMUN, V77, P5050, DOI 10.1128/IAI.00667-09	33	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26869	26877		10.1074/jbc.M110.115121	http://dx.doi.org/10.1074/jbc.M110.115121			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592026	hybrid, Green Published			2022-12-25	WOS:000281172700018
J	Nakatsumi, H; Yonehara, S				Nakatsumi, Hirokazu; Yonehara, Shin			Identification of Functional Regions Defining Different Activity in Caspase-3 and Caspase-7 within Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; KEY MEDIATORS; ACTIVATION; APOPTOSIS; SUBSTRATE; MECHANISMS; CLEAVAGE; SPECIFICITIES; PROCASPASE-7; INHIBITION	Caspases are central to apoptosis, and the principal executioner caspases, caspase-3 and -7, were reported to be similar in activity, primary structure, and three-dimensional structure. Here, we identified different activity in caspase-3 and -7 within cells and examined the relationship between their structure and function using human cells expressing almost equal amounts of exogenous caspase-3, caspase-7, and/or chimeric constructs after down-regulation of endogenous caspase-3 and -7 expression. Caspase-3 (produced in human cells) showed much stronger cleaving activity than caspase-7 against a low molecular weight substrate in vitro dependent on four specific amino acid regions. Within cells, however, an additional three regions were required for caspase-3 to exert much stronger protease activity than caspase-7 against cellular substrates. Three of the former four regions and the latter three regions were shown to form two different three-dimensional structures that were located at the interface of the homodimer of procaspase-7 on opposite sides. In addition, procaspase-3 and -7 revealed specific homodimer-forming activity within cells dependent on five amino acid regions, which were included in the regions critical to the cleaving activity within cells. Thus, human caspase-3 and -7 exhibit differences in protease activity, specific homodimer-forming activity, and three-dimensional structural features, all of which are closely interrelated.	[Yonehara, Shin] Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Dept Anim Dev & Physiol,Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Yonehara, S (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Dept Anim Dev & Physiol,Sakyo Ku, SCRB Bldg G,Konoe Cho, Kyoto 6068501, Japan.	yonehara@lif.kyoto-u.ac.jp	Nakatsumi, Hirokazu/AFQ-3000-2022	Nakatsumi, Hirokazu/0000-0003-0944-6319				Agniswamy J, 2007, FEBS J, V274, P4752, DOI 10.1111/j.1742-4658.2007.05994.x; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Denault JB, 2006, MOL CELL, V23, P523, DOI 10.1016/j.molcel.2006.06.020; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fu GX, 2008, APOPTOSIS, V13, P1291, DOI 10.1007/s10495-008-0259-9; Gyobu H, 2004, CANCER RES, V64, P1490, DOI 10.1158/0008-5472.CAN-03-2780; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lippke JA, 1996, J BIOL CHEM, V271, P1825, DOI 10.1074/jbc.271.4.1825; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; Morita A, 2000, BIOCHEM BIOPH RES CO, V278, P627, DOI 10.1006/bbrc.2000.3860; Piana S, 2003, BIOCHEMISTRY-US, V42, P8720, DOI 10.1021/bi034032l; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Tahara-Hanaoka S, 2002, EXP HEMATOL, V30, P11, DOI 10.1016/S0301-472X(01)00761-5; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wei YY, 2000, CHEM BIOL, V7, P423, DOI 10.1016/S1074-5521(00)00123-X; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	28	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25418	25425		10.1074/jbc.M110.126573	http://dx.doi.org/10.1074/jbc.M110.126573			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20566630	Green Published, hybrid			2022-12-25	WOS:000280682400035
J	Bernardo, BL; Wachtmann, TS; Cosgrove, PG; Kuhn, M; Opsahl, AC; Judkins, KM; Freeman, TB; Hadcock, JR; LeBrasseur, NK				Bernardo, Barbara L.; Wachtmann, Timothy S.; Cosgrove, Patricia G.; Kuhn, Max; Opsahl, Alan C.; Judkins, Kyle M.; Freeman, Thomas B.; Hadcock, John R.; LeBrasseur, Nathan K.			Postnatal PPAR delta Activation and Myostatin Inhibition Exert Distinct yet Complimentary Effects on the Metabolic Profile of Obese Insulin-Resistant Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; TRAINING IMPROVES; FAT MASS; GLUCOSE-HOMEOSTASIS; WEIGHT-LOSS; ADULT MICE; EXPRESSION; RECEPTOR; SENSITIVITY; EXERCISE	Background: Interventions for T2DM have in part aimed to mimic exercise. Here, we have compared the independent and combined effects of a PPAR delta agonist and endurance training mimetic (GW501516) and a myostatin antibody and resistance training mimetic (PF-879) on metabolic and performance outcomes in obese insulin resistant mice. Methodology/Principal Findings: Male ob/ob mice were treated for 6 weeks with vehicle, GW501516, PF-879, or GW501516 in combination with PF-879. The effects of the interventions on body composition, glucose homeostasis, glucose tolerance, energy expenditure, exercise capacity and metabolic gene expression were compared at the end of study. GW501516 attenuated body weight and fat mass accumulation and increased the expression of genes of oxidative metabolism. In contrast, PF-879 increased body weight by driving muscle growth and altered the expression of genes involved in insulin signaling and glucose metabolism. Despite their differences, both interventions alone improved glucose homeostasis. Moreover, GW501516 more effectively improved serum lipids, and PF-879 uniquely increased energy expenditure, exercise capacity and adiponectin levels. When combined the robust effects of GW501516 and/or PF-879 on body weight, adiposity, muscle mass, glycemia, serum lipids, energy expenditure and exercise capacity were highly conserved. Conclusions/Significance: The data, for the first time, demonstrate postnatal inhibition of myostatin not only promotes gains in muscle mass similar to resistance training, but improves metabolic homeostasis. In several instances, these effects were either distinct from or complimentary to those of GW501516. The data further suggest that strategies to increase muscle mass, and not necessarily oxidative capacity, may effectively counter insulin resistance and T2DM.	[Bernardo, Barbara L.; Wachtmann, Timothy S.; Cosgrove, Patricia G.; Judkins, Kyle M.; Freeman, Thomas B.; Hadcock, John R.; LeBrasseur, Nathan K.] Pfizer Global Res & Dev, Cardiovasc Metab & Endocrine Dis, Groton, CT USA; [Kuhn, Max] Pfizer Global Res & Dev, Preclin Stat, Groton, CT USA; [Opsahl, Alan C.] Pfizer Global Res & Dev, Investigat Pathol Lab, Groton, CT USA	Pfizer; Pfizer; Pfizer	Bernardo, BL (corresponding author), Pfizer Global Res & Dev, Cardiovasc Metab & Endocrine Dis, Groton, CT USA.	lebrasseur.nathan@mayo.edu	Bernardo, Barbara/N-7101-2019	LeBrasseur, Nathan/0000-0002-2002-0418	Pfizer, Inc	Pfizer, Inc(Pfizer)	This study was funded by Pfizer, Inc. All authors were employees of Pfizer, Inc. and were paid as such, therefore Pfizer had a role in the study design, data collection and analysis and decision to publish.	Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Dunstan DW, 2002, DIABETES CARE, V25, P1729, DOI 10.2337/diacare.25.10.1729; Efron B., 1994, INTRO BOOTSTRAP; Fujii N, 2007, DIABETES RES CLIN PR, V77, pS92, DOI 10.1016/j.diabres.2007.01.040; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; HASSID WA, 1957, METHODS ENZYMOLOGY; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Honkola A, 1997, ACTA DIABETOL, V34, P245, DOI 10.1007/s005920050082; Ishii T, 1998, DIABETES CARE, V21, P1353, DOI 10.2337/diacare.21.8.1353; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; LEBRASSEUR NK, 2009, J GERONTOL A; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE657, DOI 10.1152/ajpendo.00186.2009; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Milan G, 2004, J CLIN ENDOCR METAB, V89, P2724, DOI 10.1210/jc.2003-032047; MURPHY KT, 2010, AM J PATHOL; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Stolz LE, 2008, DIABETES OBES METAB, V10, P135, DOI 10.1111/j.1463-1326.2006.00672.x; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wilkes JJ, 2009, DIABETES, V58, P1133, DOI 10.2337/db08-0245; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044	39	49	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11307	10.1371/journal.pone.0011307	http://dx.doi.org/10.1371/journal.pone.0011307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593012	gold, Green Published, Green Submitted			2022-12-25	WOS:000279140800009
J	Guo, R; Scott, GI; Ren, J				Guo, Rui; Scott, Glenda I.; Ren, Jun			Involvement of AMPK in Alcohol Dehydrogenase Accentuated Myocardial Dysfunction Following Acute Ethanol Challenge in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CARDIAC CONTRACTILE DYSFUNCTION; ENERGY-METABOLISM; OXIDATIVE STRESS; ISCHEMIC-HEART; FATTY-ACID; OVEREXPRESSION; INSULIN; PHOSPHORYLATION; ACETALDEHYDE	Objectives: Binge alcohol drinking often triggers myocardial contractile dysfunction although the underlying mechanism is not fully clear. This study was designed to examine the impact of cardiac-specific overexpression of alcohol dehydrogenase (ADH) on ethanol-induced change in cardiac contractile function, intracellular Ca(2+) homeostasis, insulin and AMP-dependent kinase (AMPK) signaling. Methods: ADH transgenic and wild-type FVB mice were acutely challenged with ethanol (3 g/kg/d, i.p.) for 3 days. Oral glucose tolerance test, cardiac AMP/ATP levels, cardiac contractile function, intracellular Ca(2+) handling and AMPK signaling (including ACC and LKB1) were examined. Results: Ethanol exposure led to glucose intolerance, elevated plasma insulin, compromised cardiac contractile and intracellular Ca(2+) properties, downregulated protein phosphatase PP2A subunit and PPAR-gamma, as well as phosphorylation of AMPK, ACC and LKB1, all of which except plasma insulin were overtly accentuated by ADH transgene. Interestingly, myocardium from ethanol-treated FVB mice displayed enhanced expression of PP2C alpha and PGC-1 alpha, decreased insulin receptor expression as well as unchanged expression of Glut4, the response of which was unaffected by ADH. Cardiac AMP-to-ATP ratio was significantly enhanced by ethanol exposure with a more pronounced increase in ADH mice. In addition, the AMPK inhibitor compound C (10 mu M) abrogated acute ethanol exposure-elicited cardiomyocyte mechanical dysfunction. Conclusions: In summary, these data suggest that the ADH transgene exacerbated acute ethanol toxicity-induced myocardial contractile dysfunction, intracellular Ca(2+) mishandling and glucose intolerance, indicating a role of ADH in acute ethanol toxicity-induced cardiac dysfunction possibly related to altered cellular fuel AMPK signaling cascade.	[Guo, Rui; Scott, Glenda I.; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA	University of Wyoming	Guo, R (corresponding author), Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.	jren@uwyo.edu	Guo, Rui/ACH-5568-2022; Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism [1R01 AA013412]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013412] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism 1R01 AA013412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergheim I, 2006, GASTROENTEROLOGY, V130, P2099, DOI 10.1053/j.gastro.2006.03.020; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Ceylan-Isik AF, 2010, J MOL CELL CARDIOL, V48, P367, DOI 10.1016/j.yjmcc.2009.11.003; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Duan JH, 2002, AM J PHYSIOL-HEART C, V282, pH1216, DOI 10.1152/ajpheart.00780.2001; FENG L, 2004, ACTA PHARMACOL SIN, V31, P329; Seiva FRF, 2009, ALCOHOL, V43, P649, DOI 10.1016/j.alcohol.2009.09.028; Gaidhu MP, 2006, J BIOL CHEM, V281, P25956, DOI 10.1074/jbc.M602992200; Guo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008757; Hintz KK, 2003, ALCOHOL CLIN EXP RES, V27, P1090, DOI 10.1097/01.ALC.0000075823.73536.DD; Hong-Brown LQ, 2007, J BIOL CHEM, V282, P3702, DOI 10.1074/jbc.M606593200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; KOPIC S, CELL PHYSL BIOCH, V25, P195; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Li SY, 2008, J MOL CELL CARDIOL, V44, P992, DOI 10.1016/j.yjmcc.2008.02.276; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liangpunsakul S, 2008, AM J PHYSIOL-GASTR L, V295, pG1173, DOI 10.1152/ajpgi.90349.2008; Ma H, 2009, J AM COLL CARDIOL, V54, P2187, DOI 10.1016/j.jacc.2009.04.100; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Pan JS, 2008, WORLD J GASTROENTERO, V14, P5857, DOI 10.3748/wjg.14.5857; Patel VB, 1997, ADVERSE DRUG REACT T, V16, P15; RAMNANAN CJ, MOL CELL BIOCH, V335, P91; RAMNANAN CJ, 2009, MOL CELL BIOCH; Ren J, 1997, CELL MOL BIOL, V43, P825; Ren J, 2002, PHARMACOL RES, V45, P195, DOI 10.1006/phrs.2002.0947; Ren Jun, 2008, Ther Adv Cardiovasc Dis, V2, P497, DOI 10.1177/1753944708095137; Rodriguez A, 2008, LIFE SCI, V83, P540, DOI 10.1016/j.lfs.2008.07.022; Ryu JH, 2008, BIOCHEM BIOPH RES CO, V366, P438, DOI 10.1016/j.bbrc.2007.11.134; SALASPURO MP, 1977, EUR J CLIN INVEST, V7, P487, DOI 10.1111/j.1365-2362.1977.tb01640.x; Sambandam N, 2003, PROG LIPID RES, V42, P238, DOI 10.1016/S0163-7827(02)00065-6; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; SARDESAI VM, 1978, J NUTR, V108, P1907, DOI 10.1093/jn/108.12.1907; Stolle M, 2009, DTSCH ARZTEBL INT, V106, P323, DOI 10.3238/arztebl.2009.0323; Tian R, 2006, CIRC RES, V99, P3, DOI 10.1161/01.RES.0000233142.26369.f6; Verma SK, 2005, BASIC CLIN PHARMACOL, V96, P475, DOI 10.1111/j.1742-7843.2005.pto_96611.x; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Zhang XC, 2004, ALCOHOL, V32, P175, DOI 10.1016/j.alcohol.2004.01.005	39	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11268	10.1371/journal.pone.0011268	http://dx.doi.org/10.1371/journal.pone.0011268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585647	Green Published, gold, Green Submitted			2022-12-25	WOS:000279135400014
J	Henaux, V; Samuel, MD; Bunck, CM				Henaux, Viviane; Samuel, Michael D.; Bunck, Christine M.			Model-Based Evaluation of Highly and Low Pathogenic Avian Influenza Dynamics in Wild Birds	PLOS ONE			English	Article							A VIRUS; NORTH-AMERICA; MIGRATORY BIRDS; SOUTH-KOREA; HONG-KONG; DUCKS; H5N1; WATERFOWL; SUSCEPTIBILITY; TRANSMISSION	There is growing interest in avian influenza (AI) epidemiology to predict disease risk in wild and domestic birds, and prevent transmission to humans. However, understanding the epidemic dynamics of highly pathogenic (HPAI) viruses remains challenging because they have rarely been detected in wild birds. We used modeling to integrate available scientific information from laboratory and field studies, evaluate AI dynamics in individual hosts and waterfowl populations, and identify key areas for future research. We developed a Susceptible-Exposed-Infectious-Recovered (SEIR) model and used published laboratory challenge studies to estimate epidemiological parameters (rate of infection, latency period, recovery and mortality rates), considering the importance of age classes, and virus pathogenicity. Infectious contact leads to infection and virus shedding within 1-2 days, followed by relatively slower period for recovery or mortality. We found a shorter infectious period for HPAI than low pathogenic (LP) AI, which may explain that HPAI has been much harder to detect than LPAI during surveillance programs. Our model predicted a rapid LPAI epidemic curve, with a median duration of infection of 50-60 days and no fatalities. In contrast, HPAI dynamics had lower prevalence and higher mortality, especially in young birds. Based on field data from LPAI studies, our model suggests to increase surveillance for HPAI in post-breeding areas, because the presence of immunologically naive young birds is predicted to cause higher HPAI prevalence and bird losses during this season. Our results indicate a better understanding of the transmission, infection, and immunity-related processes is required to refine predictions of AI risk and spread, improve surveillance for HPAI in wild birds, and develop disease control strategies to reduce potential transmission to domestic birds and/or humans.	[Henaux, Viviane] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Samuel, Michael D.] US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA; [Bunck, Christine M.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Henaux, V (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	henaux@wisc.edu			United States Geological Survey (USGS) [MSN105937, 1434-03HQRU1511/105]	United States Geological Survey (USGS)(United States Geological Survey)	This work was funded by the United States Geological Survey (USGS) to University of Wisconsin - Madison, under grant ID: MSN105937, number: 1434-03HQRU1511/105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron J, 1982, POPULATION DYNAMICS, P139; Bellrose F, 1980, DUCKS GEESE SWANS N; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Burnham K. P., 1998, MODEL SELECTION INFE; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Gaidet N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000127; Grenfell B. T., 1995, P362, DOI 10.1017/CBO9780511629396.014; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Guberti V, 2007, AVIAN DIS, V51, P275, DOI 10.1637/7633-042806R1.1; HIGGINS DA, 1987, IMMUNOLOGY, V62, P499; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; HINSHAW VS, 1978, J GEN VIROL, V41, P115, DOI 10.1099/0022-1317-41-1-115; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Jilbert AR, 1998, VIROLOGY, V244, P273, DOI 10.1006/viro.1998.9095; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Lee CW, 2005, J VIROL, V79, P3692, DOI 10.1128/JVI.79.6.3692-3702.2005; Lee YJ, 2008, EMERG INFECT DIS, V14, P487, DOI 10.3201/eid1403.070767; Manache G, 2004, J WATER RES PL-ASCE, V130, P232, DOI 10.1061/(ASCE)0733-9496(2004)130:3(232); MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pantin-Jackwood MJ, 2007, VIRUS RES, V130, P151, DOI 10.1016/j.virusres.2007.06.006; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P250, DOI 10.1637/7710-090606R.1; Parmley EJ, 2008, EMERG INFECT DIS, V14, P84, DOI 10.3201/eid1401.061562; Pasick J, 2007, EMERG INFECT DIS, V13, P1821, DOI 10.3201/eid1312.070502; Perdue ML, 2000, AVIAN POULT BIOL REV, V11, P1; Pillai SPS, 2008, VET MICROBIOL, V129, P48, DOI 10.1016/j.vetmic.2007.11.003; Pinheiro J. C., 2005, NLME LINEAR NONLINEA; R Development Core Team, 2005, R LANG ENV STAT COMP; Rappole JH, 2006, EMERG INFECT DIS, V12, P1486, DOI 10.3201/eid1210.051577; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Spackman E, 2007, J VIROL, V81, P11612, DOI 10.1128/JVI.01368-07; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; Stallknecht D. E., 2008, AVIAN INFLUENZA, V1, P43, DOI DOI 10.1002/9780813818634.ch3; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Swayne D. E., 2008, AVIAN INFLUENZA, P287; THERNEAU T, 2007, SURVIVAL SURVIVAL AN; Tian GB, 2005, VIROLOGY, V341, P153, DOI 10.1016/j.virol.2005.07.011; Tumpey TM, 2002, J VIROL, V76, P6344, DOI 10.1128/JVI.76.12.6344-6355.2002; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; van der Goot JA, 2007, VACCINE, V25, P8318, DOI 10.1016/j.vaccine.2007.09.048; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; Webster RG, 2002, J VIROL, V76, P118, DOI 10.1128/JVI.76.1.118-126.2002; WESTBURY HA, 1979, VET MICROBIOL, V4, P223, DOI 10.1016/0378-1135(79)90058-0	59	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e10997	10.1371/journal.pone.0010997	http://dx.doi.org/10.1371/journal.pone.0010997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585637	Green Published, gold			2022-12-25	WOS:000279135400001
J	Zhang, WD; Savelieva, KV; Suwanichkul, A; Small, DL; Kirkpatrick, LL; Xu, NH; Lanthorn, TH; Ye, GL				Zhang, Wandong; Savelieva, Katerina V.; Suwanichkul, Adisak; Small, Daniel L.; Kirkpatrick, Laura L.; Xu, Nianhua; Lanthorn, Thomas H.; Ye, Gui-Lan			Transmembrane and Ubiquitin-Like Domain Containing 1 (Tmub1) Regulates Locomotor Activity and Wakefulness in Mice and Interacts with CAMLG	PLOS ONE			English	Article							MODULATING CYCLOPHILIN LIGAND; GABA(A) RECEPTORS; GENE-EXPRESSION; PROTEIN; MEMBRANE; BINDING; SLEEP; BRAIN; CELLS; IDENTIFICATION	Tmub1 (C7orf21/HOPS) encodes a protein containing a ubiquitin-like domain. Tmub1 is highly expressed in the nervous system. To study its physiological function, we generated mice with Tmub1 deleted by homologous recombination. The knockout mice were grossly normal and viable. In a comprehensive behavioral testing battery, the only knockout phenotype displayed was a strong increase in home cage locomotor activity during the dark phase (subjective day) of the light;dark (L;D) cycle. There were no changes in activity during the light period. There were no changes in locomotor activity observed in other assays, e. g. novel open-field. The increase in dark phase locomotor activity persisted during a seven day D;D (complete darkness) challenge, and remained largely confined to the normally dark period. Telemetric recording in freely moving subjects for one 24 hr L;D cycle, revealed the same increase in locomotor activity in the dark phase. In addition, EEG analysis showed that the knockout mice exhibited increased waking and decreased NREM & REM times during the dark phase, but the EEG was otherwise normal. Using lacZ as a reporter we found Tmub1 expression prominent in a few brain structures including the thalamus, a region known to drive wakefulness and arousal via its projections to the cortex. We identified calcium modulating cyclophilin ligand CAMLG/CAML as a binding partner by a yeast two-hybrid screen of a brain library. The interaction of Tmub1 and CAMLG was confirmed by co-immunoprecipitation assays in HEK cells. The two proteins were also found to be co-localized to the cytoplasm when expressed in HEK cells. Both Tmub1 and CAMLG have been recently described in the regulation of membrane trafficking of specific receptors. Taken together our results implicate Tmub1 in the regulation of locomotor activity and wakefulness and suggest that Tmub1 binds to and functions together with CAMLG.	[Zhang, Wandong; Savelieva, Katerina V.; Suwanichkul, Adisak; Small, Daniel L.; Kirkpatrick, Laura L.; Xu, Nianhua; Lanthorn, Thomas H.; Ye, Gui-Lan] Lexicon Pharmaceut Inc, Neurosci Res, The Woodlands, TX USA	Lexicon Pharmaceuticals	Zhang, WD (corresponding author), Lexicon Pharmaceut Inc, Neurosci Res, The Woodlands, TX USA.	gye@lexpharma.com			Lexicon Pharmaceuticals	Lexicon Pharmaceuticals	The study was conducted at and financially supported by Lexicon Pharmaceuticals. All authors were employees of Lexicon Pharmaceuticals when conducting the research of this manuscript. Authors designed the study, conducted data collection and analysis, and prepared the manuscript. Lexicon Pharmaceuticals approved the decision to publish this manuscript.	Abuin A, 2002, TRENDS BIOTECHNOL, V20, P36, DOI 10.1016/S0167-7799(01)01843-1; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Della Fazia MA, 2005, J CELL SCI, V118, P3185, DOI 10.1242/jcs.02452; Feng PH, 2002, J VIROL, V76, P11491, DOI 10.1128/JVI.76.22.11491-11504.2002; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guang W, 2009, INT J BIOCHEM CELL B, V41, P1354, DOI 10.1016/j.biocel.2008.12.004; Guo SD, 2005, J BIOL CHEM, V280, P12536, DOI 10.1074/jbc.M500296200; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim JY, 2008, KOREAN J PARASITOL, V46, P209, DOI 10.3347/kjp.2008.46.4.209; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Liu GY, 2009, CELL MOL IMMUNOL, V6, P27, DOI 10.1038/cmi.2009.4; Madsen L, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S1; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Nagano J, 2005, BIOCHEM BIOPH RES CO, V338, P880, DOI 10.1016/j.bbrc.2005.10.022; Pieroni S, 2008, CELL CYCLE, V7, P1462, DOI 10.4161/cc.7.10.5882; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; TINUPER P, 1989, ELECTROEN CLIN NEURO, V73, P117, DOI 10.1016/0013-4694(89)90190-9; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Varthakavi V, 2008, NAT MED, V14, P641, DOI 10.1038/nm1778; Villablanca JR, 2004, J SLEEP RES, V13, P179, DOI 10.1111/j.1365-2869.2004.00412.x; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yang HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002809; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002	32	10	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11261	10.1371/journal.pone.0011261	http://dx.doi.org/10.1371/journal.pone.0011261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582322	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058500013
J	Bull, JJ; Jessop, TS; Whiteley, M				Bull, J. J.; Jessop, Tim S.; Whiteley, Marvin			Deathly Drool: Evolutionary and Ecological Basis of Septic Bacteria in Komodo Dragon Mouths	PLOS ONE			English	Article							FLORA; POPULATIONS; BITES; VENOM; SIZE	Komodo dragons, the world's largest lizard, dispatch their large ungulate prey by biting and tearing flesh. If a prey escapes, oral bacteria inoculated into the wound reputedly induce a sepsis that augments later prey capture by the same or other lizards. However, the ecological and evolutionary basis of sepsis in Komodo prey acquisition is controversial. Two models have been proposed. The "bacteria as venom'' model postulates that the oral flora directly benefits the lizard in prey capture irrespective of any benefit to the bacteria. The "passive acquisition'' model is that the oral flora of lizards reflects the bacteria found in carrion and sick prey, with no relevance to the ability to induce sepsis in subsequent prey. A third model is proposed and analyzed here, the "lizard-lizard epidemic'' model. In this model, bacteria are spread indirectly from one lizard mouth to another. Prey escaping an initial attack act as vectors in infecting new lizards. This model requires specific life history characteristics and ways to refute the model based on these characteristics are proposed and tested. Dragon life histories (some details of which are reported here) prove remarkably consistent with the model, especially that multiple, unrelated lizards feed communally on large carcasses and that escaping, wounded prey are ultimately fed on by other lizards. The identities and evolutionary histories of bacteria in the oral flora may yield the most useful additional insights for further testing the epidemic model and can now be obtained with new technologies.	[Bull, J. J.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Whiteley, Marvin] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Bull, J. J.; Whiteley, Marvin] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Bull, J. J.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Jessop, Tim S.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Melbourne	Bull, JJ (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	bull@mail.utexas.edu	Jessop, Tim/I-6647-2012; Jessop, Tim/Q-2473-2019	Jessop, Tim S./0000-0002-7712-4373	National Institutes of Health (NIH) [GM57756, AI075068]; University of Texas; Zoological Society of San Diego; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057756] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas; Zoological Society of San Diego; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health (NIH) GM57756 and the University of Texas Miescher Regents Professorship to JJB and NIH AI075068 to MW. TSJ was supported by a Conservation Research Fellowship from the Zoological Society of San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUFFENBERG W, 1981, BEHAV ECOLOGY KOMODO, V10, P40; BAILIE WE, 1978, J CLIN MICROBIOL, V7, P223; Barer MR, 1999, ADV MICROB PHYSIOL, V41, P93, DOI 10.1016/S0065-2911(08)60166-6; BREDY JP, 1989, J WILDLIFE DIS, V25, P232, DOI 10.7589/0090-3558-25.2.232; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; GOLDSTEIN EJC, 1981, J CLIN MICROBIOL, V13, P954, DOI 10.1128/JCM.13.5.954-956.1981; GOLDSTEIN EJC, 1979, J INFECT DIS, V140, P818, DOI 10.1093/infdis/140.5.818; HUBBERT WT, 1970, AM J PUBLIC HEALTH N, V60, P1103, DOI 10.2105/AJPH.60.6.1103; Jessop TS, 2007, BIOL CONSERV, V135, P247, DOI 10.1016/j.biocon.2006.10.025; Jessop TS, 2006, OIKOS, V112, P422, DOI 10.1111/j.0030-1299.2006.14371.x; LENNETTE EH, 1985, MANUAL CLIN MICROBIO, V16, P1149; Montgomery JM, 2002, J WILDLIFE DIS, V38, P545, DOI 10.7589/0090-3558-38.3.545; OWEN C R, 1968, Rocky Mountain Medical Journal, V65, P45; PURWANDANA D, 2007, THESIS U KEBANGSAAN; RAFFI F, 1987, SCAND J INFECT DIS, V19, P385, DOI 10.3109/00365548709021670; Rosen M. N., 1969, Bulletin of the Wildlife Disease Association, V5, P195; SAPHIR DA, 1976, J CLIN MICROBIOL, V3, P344; Shine R., 1988, BIOL REPTILIA, P275; SMITH J. E., 1958, JOUR COMP PATH AND THERAP, V68, P315, DOI 10.1016/S0368-1742(58)80033-8; TITCHE AR, 1979, CALIFORNIA DEP FISH, V79, P49	20	25	26	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11097	10.1371/journal.pone.0011097	http://dx.doi.org/10.1371/journal.pone.0011097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574514	Green Published, gold			2022-12-25	WOS:000279058300003
J	Kozak, LP; Newman, S; Chao, PM; Mendoza, T; Koza, RA				Kozak, Leslie P.; Newman, Susan; Chao, Pei-Min; Mendoza, Tamra; Koza, Robert A.			The Early Nutritional Environment of Mice Determines the Capacity for Adipose Tissue Expansion by Modulating Genes of Caveolae Structure	PLOS ONE			English	Article							DIET-INDUCED OBESITY; WHITE FAT; REGULATES CAVEOLIN-1; GLUCOSE-INTOLERANCE; DIABETES-MELLITUS; 3T3-L1 ADIPOCYTES; ENERGY-BALANCE; LEPTIN SURGE; ANNEXIN-II; IN-UTERO	While the phenomenon linking the early nutritional environment to disease susceptibility exists in many mammalian species, the underlying mechanisms are unknown. We hypothesized that nutritional programming is a variable quantitative state of gene expression, fixed by the state of energy balance in the neonate, that waxes and wanes in the adult animal in response to changes in energy balance. We tested this hypothesis with an experiment, based upon global gene expression, to identify networks of genes in which expression patterns in inguinal fat of mice have been altered by the nutritional environment during early post-natal development. The effects of over-and under-nutrition on adiposity and gene expression phenotypes were assessed at 5, 10, 21 days of age and in adult C57Bl/6J mice fed chow followed by high fat diet for 8 weeks. Under-nutrition severely suppressed plasma insulin and leptin during lactation and diet-induced obesity in adult mice, whereas over-nourished mice were phenotypically indistinguishable from those on a control diet. Food intake was not affected by under-or over-nutrition. Microarray gene expression data revealed a major class of genes encoding proteins of the caveolae and cytoskeleton, including Cav1, Cav2, Ptrf (Cavin1), Ldlr, Vldlr and Mest, that were highly associated with adipose tissue expansion in 10 day-old mice during the dynamic phase of inguinal fat development and in adult animals exposed to an obesogenic environment. In conclusion gene expression profiles, fat mass and adipocyte size in 10 day old mice predicted similar phenotypes in adult mice with variable diet-induced obesity. These results are supported by phenotypes of KO mice and suggest that when an animal enters a state of positive energy balance adipose tissue expansion is initiated by coordinate changes in mRNA levels for proteins required for modulating the structure of the caveolae to maximize the capacity of the adipocyte for lipid storage.	[Kozak, Leslie P.; Newman, Susan; Mendoza, Tamra; Koza, Robert A.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Chao, Pei-Min] China Med Univ, Dept Nutr, Taichung, Taiwan	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; China Medical University Taiwan	Kozak, LP (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA USA.	Kozaklp@pbrc.edu	Chao, Pei-Min/L-8157-2013; chao, P/GSD-8001-2022	Chao, Pei-Min/0000-0002-4846-3245; 	Center of Biomedical Research Excellence COBRE (National Institutes of Health (NIH)) [P20-RR021945]; Clinical Nutrition Research Unit CNRU [NIH 1P30-DK072476]; Health Excellent Fund of the State of Louisiana; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	Center of Biomedical Research Excellence COBRE (National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit CNRU; Health Excellent Fund of the State of Louisiana; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research was supported by grants from Center of Biomedical Research Excellence COBRE (National Institutes of Health (NIH) P20-RR021945), Clinical Nutrition Research Unit CNRU (NIH 1P30-DK072476) and the Health Excellent Fund of the State of Louisiana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Allison DB, 1996, INT J OBESITY, V20, P501; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1986, LANCET, V1, P1077; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Boullu-Ciocca S, 2008, DIABETES, V57, P669, DOI 10.2337/db07-1316; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Drake AJ, 2007, CLIN SCI, V113, P219, DOI 10.1042/CS20070107; Engelman JA, 1999, J BIOL CHEM, V274, P32333, DOI 10.1074/jbc.274.45.32333; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004; Hales CN, 2003, DIABETOLOGIA, V46, P1013, DOI 10.1007/s00125-003-1131-7; Hayes M, 2005, INT J OBESITY, V29, P151, DOI 10.1038/sj.ijo.0802842; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Huang J, 2004, ENDOCRINOLOGY, V145, P1579, DOI 10.1210/en.2003-1197; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; MCCANCE RA, 1962, LANCET, V2, P671; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Patel MS, 2002, J BIOL CHEM, V277, P1629, DOI 10.1074/jbc.R100017200; Plagemann A, 2006, HORM RES, V65, P83, DOI 10.1159/000091511; Poussin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003385; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Riachi M, 2004, CAN J PHYSIOL PHARM, V82, P1075, DOI [10.1139/y04-117, 10.1139/Y04-117]; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Srinivasan M, 2003, EXP BIOL MED, V228, P15, DOI 10.1177/153537020322800102; Takahashi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE117, DOI 10.1152/ajpendo.00244.2004; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; TeichertKuliszewska K, 1996, INT J OBESITY, V20, pS108; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zhang YY, 2002, AM J PHYSIOL-REG I, V282, pR226, DOI 10.1152/ajpregu.00392.2001	62	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11015	10.1371/journal.pone.0011015	http://dx.doi.org/10.1371/journal.pone.0011015			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574519	gold, Green Published, Green Submitted			2022-12-25	WOS:000279058300002
J	Nachman, J; Gish, G; Virag, C; Pawson, T; Pomes, R; Pai, E				Nachman, Joseph; Gish, Gerry; Virag, Cristina; Pawson, Tony; Pomes, Regis; Pai, Emil			Conformational Determinants of Phosphotyrosine Peptides Complexed with the Src SH2 Domain	PLOS ONE			English	Article							SECONDARY STRUCTURE; STRUCTURAL BASIS; BINDING; SPECIFICITY; INHIBITORS; PP60(C-SRC); MODEL	The inhibition of specific SH2 domain mediated protein-protein interactions as an effective chemotherapeutic approach in the treatment of diseases remains a challenge. That different conformations of peptide-ligands are preferred by different SH2 domains is an underappreciated observation from the structural analysis of phosphotyrosine peptide binding to SH2 domains that may aid in future drug design. To explore the nature of ligand binding, we use simulated annealing (SA) to sample the conformational space of phosphotyrosine-containing peptides complexed with the Src SH2 domain. While in good agreement with the crystallographic and NMR studies of high-affinity phosphopeptide-SH2 domain complexes, the results suggest that the structural basis for phopsphopeptide-Src SH2 interactions is more complex than the "two-pronged plug two-hole socket'' model. A systematic study of peptides of type pYEEX, where pY is phosphotyrosine and X is a hydrophobic residue, indicates that these peptides can assume two conformations, one extended and one helical, representing the balance between the interaction of residue X with the hydrophobic hole on the surface of the Src SH2 domain, and its contribution to the inherent tendency of the two glutamic acids to form an a-helix. In contrast, a beta-turn conformation, almost identical to that observed in the crystal structure of pYVNV bound to the Grb2 SH2 domain, predominates for pYXNX peptides, even in the presence of isoleucine at the third position. While peptide binding affinities, as measured by fluorescence polarization, correlate with the relative proportion of extended peptide conformation, these results suggest a model where all three residues C-terminal to the phosphotyrosine determine the conformation of the bound phosphopeptide. The information obtained in this work can be used in the design of specific SH2 domain inhibitors.	[Nachman, Joseph; Pomes, Regis; Pai, Emil] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Gish, Gerry; Virag, Cristina; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Div Mol & Dev Biol, Toronto, ON M5G 1X5, Canada; [Pomes, Regis] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Pai, Emil] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Pai, Emil] Univ Toronto, Dept Mol Biol, Toronto, ON, Canada; [Pai, Emil] Ontario Canc Inst, Div Genom & Prote, Toronto, ON M4X 1K9, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Nachman, J (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	nachman@hera.med.utoronto.ca	Pawson, Tony J/E-4578-2013; Pai, Emil/R-8908-2019; Gish, Gerald D/C-7228-2017; Pai, Emil F/D-2526-2013	Pai, Emil/0000-0002-1162-7242; 	PrioNet, National Centre of Excellence, Canada; Canada Research Chairs Program	PrioNet, National Centre of Excellence, Canada; Canada Research Chairs Program(Canada Research Chairs)	This research was supported by a grant from PrioNet, National Centre of Excellence, Canada, and the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P9083, DOI 10.1021/bi973147k; CASE DA, 1999, AMBER6; CHOU KC, 1991, PROTEIN ENG, V4, P661, DOI 10.1093/protein/4.6.661; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Davidson JP, 2002, J AM CHEM SOC, V124, P205, DOI 10.1021/ja011746f; FRISCH MJ, 1995, GAUSSIAN 94; Gay B, 1997, BIOCHEMISTRY-US, V36, P5712, DOI 10.1021/bi962642y; GILMER T, 1994, J BIOL CHEM, V269, P31711; GUARNIERI F, 1995, J COMPUT CHEM, V16, P648, DOI 10.1002/jcc.540160512; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Hassan SA, 2001, INT J QUANTUM CHEM, V83, P193, DOI 10.1002/qua.1210; Jojart B, 2006, J MOL MODEL, V12, P823, DOI 10.1007/s00894-006-0104-4; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kimber MS, 2000, MOL CELL, V5, P1043, DOI 10.1016/S1097-2765(00)80269-5; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Lynch BA, 1997, ANAL BIOCHEM, V247, P77, DOI 10.1006/abio.1997.2042; Malkov SN, 2008, J MOL MODEL, V14, P769, DOI 10.1007/s00894-008-0313-0; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; Nam NH, 2004, J MED CHEM, V47, P3131, DOI 10.1021/jm040008+; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Rahuel J, 1996, NAT STRUCT BIOL, V3, P586, DOI 10.1038/nsb0796-586; Schaefer M, 1999, THEOR CHEM ACC, V101, P194, DOI 10.1007/s002140050429; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Steinbach PJ, 2004, PROTEINS, V57, P665, DOI 10.1002/prot.20247; Verkhivker GM, 2002, J MED CHEM, V45, P72, DOI 10.1021/jm0101141; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; XU RX, 1995, BIOCHEMISTRY-US, V34, P2107, DOI 10.1021/bi00007a003; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	34	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11215	10.1371/journal.pone.0011215	http://dx.doi.org/10.1371/journal.pone.0011215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574521	Green Published, gold, Green Submitted			2022-12-25	WOS:000279058300010
J	Venkataraman, S; Alimova, I; Fan, R; Harris, P; Foreman, N; Vibhakar, R				Venkataraman, Sujatha; Alimova, Irina; Fan, Rong; Harris, Peter; Foreman, Nicholas; Vibhakar, Rajeev			MicroRNA 128a Increases Intracellular ROS Level by Targeting Bmi-1 and Inhibits Medulloblastoma Cancer Cell Growth by Promoting Senescence	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; DEVELOPMENTAL BIOLOGY; PROLIFERATION; EXPRESSION; DIFFERENTIATION; POLYCISTRON; ONCOGENE; PROFILES; PATHWAY	Background: MicroRNAs (miRNAs) are a class of short non-coding RNAs that regulate cell homeostasis by inhibiting translation or degrading mRNA of target genes, and thereby can act as tumor suppressor genes or oncogenes. The role of microRNAs in medulloblastoma has only recently been addressed. We hypothesized that microRNAs differentially expressed during normal CNS development might be abnormally regulated in medulloblastoma and are functionally important for medulloblastoma cell growth. Methodology and Principal Findings: We examined the expression of microRNAs in medulloblastoma and then investigated the functional role of one specific one, miR-128a, in regulating medulloblastoma cell growth. We found that many microRNAs associated with normal neuronal differentiation are significantly down regulated in medulloblastoma. One of these, miR-128a, inhibits growth of medulloblastoma cells by targeting the Bmi-1 oncogene. In addition, miR-128a alters the intracellular redox state of the tumor cells and promotes cellular senescence. Conclusions and Significance: Here we report the novel regulation of reactive oxygen species (ROS) by microRNA 128a via the specific inhibition of the Bmi-1 oncogene. We demonstrate that miR-128a has growth suppressive activity in medulloblastoma and that this activity is partially mediated by targeting Bmi-1. This data has implications for the modulation of redox states in cancer stem cells, which are thought to be resistant to therapy due to their low ROS states.	[Venkataraman, Sujatha; Alimova, Irina; Harris, Peter; Foreman, Nicholas; Vibhakar, Rajeev] Univ Colorado, Dept Pediat, Denver, CO 80202 USA; [Foreman, Nicholas; Vibhakar, Rajeev] Childrens Hosp, Aurora, CO USA; [Fan, Rong; Vibhakar, Rajeev] Univ Iowa, Dept Pediat, Childrens Hosp, Iowa City, IA 52242 USA	University of Colorado System; University of Colorado Denver; Children's Hospital Colorado; University of Iowa	Venkataraman, S (corresponding author), Univ Colorado, Dept Pediat, Denver, CO 80202 USA.	Rajeev.Vibhakar@ucdenver.edu		Foreman, Nicholas/0000-0003-4848-4801	Pediatric Brain Tumor Foundation; Bear Necessities Pediatric Cancer Foundation; National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) [K08NS059790]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS059790] Funding Source: NIH RePORTER	Pediatric Brain Tumor Foundation; Bear Necessities Pediatric Cancer Foundation; National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Pediatric Brain Tumor Foundation (http://www.pbtfus.org/), the Bear Necessities Pediatric Cancer Foundation (http://www.bearnecessities.org), and National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) grant K08NS059790. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hara E, 1996, MOL CELL BIOL, V16, P859; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; Rubin JB, 2002, CANCER CELL, V2, P7, DOI 10.1016/S1535-6108(02)00090-9; Rutka James T, 2004, Expert Rev Neurother, V4, P879, DOI 10.1586/14737175.4.5.879; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song YS, 2005, MECH AGEING DEV, V126, P580, DOI 10.1016/j.mad.2004.11.008; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Vibhakar R, 2007, NEURO-ONCOLOGY, V9, P135, DOI 10.1215/15228517-2006-038; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385	38	137	142	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e10748	10.1371/journal.pone.0010748	http://dx.doi.org/10.1371/journal.pone.0010748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574517	gold, Green Published, Green Submitted			2022-12-25	WOS:000279058300001
J	Nakamura, S; Kinoshita, S; Yokoi, N; Ogawa, Y; Shibuya, M; Nakashima, H; Hisamura, R; Imada, T; Imagawa, T; Uehara, M; Shibuya, I; Dogru, M; Ward, S; Tsubota, K				Nakamura, Shigeru; Kinoshita, Shigeru; Yokoi, Norihiko; Ogawa, Yoko; Shibuya, Michiko; Nakashima, Hideo; Hisamura, Ryuji; Imada, Toshihiro; Imagawa, Tomohiro; Uehara, Masato; Shibuya, Izumi; Dogru, Murat; Ward, Samantha; Tsubota, Kazuo			Lacrimal Hypofunction as a New Mechanism of Dry Eye in Visual Display Terminal Users	PLOS ONE			English	Article							TEAR DYNAMICS; EXOCYTOSIS; GLAND; BLINKING; PILOCARPINE; DISORDERS; SECRETION; SYMPTOMS; DISEASE; CELLS	Background: Dry eye has shown a marked increase due to visual display terminal (VDT) use. It remains unclear whether reduced blinking while focusing can have a direct deleterious impact on the lacrimal gland function. To address this issue that potentially affects the life quality, we conducted a large-scale epidemiological study of VDT users and an animal study. Methodology/Principal Findings: Cross sectional survey carried out in Japan. A total of 1025 office workers who use VDT were enrolled. The association between VDT work duration and changes in tear film status, precorneal tear stability, lipid layer status and tear secretion were analyzed. For the animal model study, the rat VDT user model, placing rats onto a balance swing in combination with exposure to an evaporative environment was used to analyze lacrimal gland function. There was no positive relationship between VDT working duration and change in tear film stability and lipid layer status. The odds ratio for decrease in Schirmer score, index of tear secretion, were significantly increased with VDT working year (P = 0.012) and time (P = 0.005). The rat VDT user model, showed chronic reduction of tear secretion and was accompanied by an impairment of the lacrimal gland function and morphology. This dysfunction was recovered when rats were moved to resting conditions without the swing. Conclusions/Significance: These data suggest that lacrimal gland hypofunction is associated with VDT use and may be a critical mechanism for VDT-associated dry eye. We believe this to be the first mechanistic link to the pathogenesis of dry eye in office workers.	[Nakamura, Shigeru; Ogawa, Yoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Nakamura, Shigeru; Shibuya, Michiko; Nakashima, Hideo; Hisamura, Ryuji; Imada, Toshihiro] Ophtecs Corp, Res Ctr, Toyooka, Japan; [Kinoshita, Shigeru; Yokoi, Norihiko] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Nakashima, Hideo; Imagawa, Tomohiro; Uehara, Masato] Tottori Univ, Fac Agr, Dept Vet Anat, Tottori 680, Japan; [Shibuya, Izumi] Tottori Univ, Fac Agr, Dept Vet Physiol, Tottori 680, Japan; [Dogru, Murat; Ward, Samantha] Keio Univ, Sch Med, Johnson & Johnson Ocular Surface Visual Opt Dept, Tokyo, Japan	Keio University; Kyoto Prefectural University of Medicine; Tottori University; Tottori University; Keio University	Nakamura, S (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	tsubota@sc.itc.keio.ac.jp	Ogawa, Yoko/AAV-1932-2021	Ogawa, Yoko/0000-0002-2906-9621; Shibuya, Izumi/0000-0003-4137-5856	Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	Grant funding was received from the Japanese Ministry of Health, Labour and Welfare. 1) Principal investigator: Kazuo Tsubota, "Establishment of a world consensus of dry eye diagnostic criteria and implementation into Japanese dry eye diagnostic criteria''. 2) Principal investigator: Kazuo Tsubota, "Development of new treatment methods for lacrimal gland destruction resulting from treatment-refractory disorders''. 3) Principal investigator: Shigeru Kinoshita, "Preparation method of GNP-based cultivated epithelia sheet for transplantation''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson MB, 2002, ADV EXP MED BIOL, V506, P1121; Acosta MC, 1999, EXP EYE RES, V68, P663, DOI 10.1006/exer.1998.0656; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; HALL HD, 1964, P SOC EXP BIOL MED, V117, P789, DOI 10.3181/00379727-117-29699; Hodges RR, 2003, INT REV CYTOL, V231, P129, DOI 10.1016/S0074-7696(03)31004-6; HOLLY FJ, 1977, SURV OPHTHALMOL, V22, P69, DOI 10.1016/0039-6257(77)90087-X; *INT CORP, PERS COMP TURNS 25 N; JORDAN A, 1980, OPHTHALMOLOGY, V87, P920; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; Lemp MA, 2008, AM J OPHTHALMOL, V146, P350, DOI 10.1016/j.ajo.2008.05.016; Lemp Michael A., 1995, CLAO Journal, V21, P221; Matsumoto M, 2004, P NATL ACAD SCI USA, V101, P8313, DOI 10.1073/pnas.0306709101; *MIN LAB JAP, 1985, GUID OCC HLTH VDT WO; Nakamura S, 2005, INVEST OPHTH VIS SCI, V46, P2379, DOI 10.1167/iovs.04-1344; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Nguyen DH, 2004, PHYSIOL GENOMICS, V18, P108, DOI 10.1152/physiolgenomics.00011.2004; OBATA H, 1995, OPHTHALMOLOGY, V102, P678, DOI 10.1016/S0161-6420(95)30971-2; Papas AS, 2004, JCR-J CLIN RHEUMATOL, V10, P169, DOI 10.1097/01.rhu.0000135553.08057.21; Pflugfelder SC, 1998, CORNEA, V17, P38, DOI 10.1097/00003226-199801000-00007; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; SAKAMOTO R, 1993, INVEST OPHTH VIS SCI, V34, P3510; SCOTT J, 1994, J DENT RES, V73, P1180, DOI 10.1177/00220345940730060901; Toshida H, 2007, INVEST OPHTH VIS SCI, V48, P4468, DOI 10.1167/iovs.06-1486; Tsubota K, 1998, PROG RETIN EYE RES, V17, P565, DOI 10.1016/S1350-9462(98)00004-4; Tsubota K, 1996, LANCET, V347, P768, DOI 10.1016/S0140-6736(96)90122-1; TSUBOTA K, 1995, ARCH OPHTHALMOL-CHIC, V113, P155, DOI 10.1001/archopht.1995.01100020037025; TSUBOTA K, 1993, NEW ENGL J MED, V328, P584, DOI 10.1056/NEJM199302253280817; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Vivino FB, 1999, ARCH INTERN MED, V159, P174, DOI 10.1001/archinte.159.2.174; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; *WHO, 1987, OFFS PUBL WHO, V99; Wolkoff P, 2005, OCCUP ENVIRON MED, V62, P4, DOI 10.1136/oem.2004.016030; Wu KJ, 2006, EXP EYE RES, V83, P84, DOI 10.1016/j.exer.2005.11.009; Yokoi N, 1996, AM J OPHTHALMOL, V122, P818, DOI 10.1016/S0002-9394(14)70378-2	36	84	87	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11119	10.1371/journal.pone.0011119	http://dx.doi.org/10.1371/journal.pone.0011119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559543	Green Published, gold, Green Submitted			2022-12-25	WOS:000278775900010
J	Heinisch, JJ; Dupres, V; Wilk, S; Jendretzki, A; Dufrene, YF				Heinisch, Juergen J.; Dupres, Vincent; Wilk, Sabrina; Jendretzki, Arne; Dufrene, Yves F.			Single-Molecule Atomic Force Microscopy Reveals Clustering of the Yeast Plasma-Membrane Sensor Wsc1	PLOS ONE			English	Article							CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; LIPID RAFTS; ESCHERICHIA-COLI; STRESS-RESPONSE; RECEPTOR; MAINTENANCE; ACTIVATION; MECHANISMS; PROTEINS	Signalling is a key feature of living cells which frequently involves the local clustering of specific proteins in the plasma membrane. How such protein clustering is achieved within membrane microdomains ("rafts'') is an important, yet largely unsolved problem in cell biology. The plasma membrane of yeast cells represents a good model to address this issue, since it features protein domains that are sufficiently large and stable to be observed by fluorescence microscopy. Here, we demonstrate the ability of single-molecule atomic force microscopy to resolve lateral clustering of the cell integrity sensor Wsc1 in living Saccharomyces cerevisiae cells. We first localize individual wild-type sensors on the cell surface, revealing that they form clusters of similar to 200 nm size. Analyses of three different mutants indicate that the cysteine-rich domain of Wsc1 has a crucial, not yet anticipated function in sensor clustering and signalling. Clustering of Wsc1 is strongly enhanced in deionized water or at elevated temperature, suggesting its relevance in proper stress response. Using in vivo GFP-localization, we also find that non-clustering mutant sensors accumulate in the vacuole, indicating that clustering may prevent endocytosis and sensor turnover. This study represents the first in vivo single-molecule demonstration for clustering of a transmembrane protein in S. cerevisiae. Our findings indicate that in yeast, like in higher eukaryotes, signalling is coupled to the localized enrichment of sensors and receptors within membrane patches.	[Heinisch, Juergen J.; Wilk, Sabrina; Jendretzki, Arne] Univ Osnabruck, Fachbereich Biol Chem AG Genet, Osnabruck, Germany; [Dupres, Vincent; Dufrene, Yves F.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium	University Osnabruck; Universite Catholique Louvain	Heinisch, JJ (corresponding author), Univ Osnabruck, Fachbereich Biol Chem AG Genet, Osnabruck, Germany.	Juergen.Heinisch@Biologie.Uni-Osnabrueck.DE; Yves.Dufrene@uclouvain.be	Dupres, Vincent/GLQ-5321-2022; Heinisch, Juergen J./G-3801-2017	Dupres, Vincent/0000-0002-1970-3633; Dufrene, Yves/0000-0002-7289-4248	National Foundation for Scientific Research (FNRS); Universite Catholique de Louvain (Fonds Speciaux de Recherche); Region Wallonne; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute Francaise de Belgique; Deutsche Forschungsgemeinschaft (DFG) [SFB431]	National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Catholique de Louvain (Fonds Speciaux de Recherche); Region Wallonne; Federal Office for Scientific, Technical and Cultural Affairs; Research Department of the Communaute Francaise de Belgique; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the National Foundation for Scientific Research (FNRS), the Universite Catholique de Louvain (Fonds Speciaux de Recherche), the Region Wallonne, the Federal Office for Scientific, Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), the Research Department of the Communaute Francaise de Belgique (Concerted Research Action) and the Deutsche Forschungsgemeinschaft (DFG) within the framework of the SFB431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahimou FO, 2003, YEAST, V20, P25, DOI 10.1002/yea.923; Alonso MA, 2001, J CELL SCI, V114, P3957; ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911; Besschetnova TY, 2008, P NATL ACAD SCI USA, V105, P12289, DOI 10.1073/pnas.0802868105; Dupres V, 2009, NAT CHEM BIOL, V5, P857, DOI 10.1038/nchembio.220; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; HEINISCH JJ, 1993, YEAST, V9, P1103, DOI 10.1002/yea.320091010; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Heinisch JJ, 2010, NAT PROTOC, V5, P670, DOI 10.1038/nprot.2010.19; Huk KH, 2002, MOL NEUROBIOL, V25, P79; Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0; Kenworthy AK, 2008, EMBO REP, V9, P531, DOI 10.1038/embor.2008.92; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lodder AL, 1999, GENETICS, V152, P1487; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Ponting CP, 1999, CURR BIOL, V9, pR585, DOI 10.1016/S0960-9822(99)80379-0; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Qian F, 2005, J BIOL CHEM, V280, P40723, DOI 10.1074/jbc.M509650200; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Rodicio R, 2008, FUNGAL GENET BIOL, V45, P422, DOI 10.1016/j.fgb.2007.07.009; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Straede A, 2007, YEAST, V24, P321, DOI 10.1002/yea.1478; Straede A, 2007, FEBS LETT, V581, P4495, DOI 10.1016/j.febslet.2007.08.027; Vay HA, 2004, MICROBIOL-SGM, V150, P3281, DOI 10.1099/mic.0.27264-0; Verbelen C, 2007, J MOL RECOGNIT, V20, P490, DOI 10.1002/jmr.833; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	42	71	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11104	10.1371/journal.pone.0011104	http://dx.doi.org/10.1371/journal.pone.0011104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559440	Green Published, Green Submitted, gold			2022-12-25	WOS:000278741100017
J	Meissner, M; Hrgovic, I; Doll, M; Naidenow, J; Reichenbach, G; Hailemariam-Jahn, T; Michailidou, D; Gille, J; Kaufmann, R				Meissner, Markus; Hrgovic, Igor; Doll, Monika; Naidenow, Julia; Reichenbach, Gabi; Hailemariam-Jahn, Tsige; Michailidou, Despina; Gille, Jens; Kaufmann, Roland			Peroxisome Proliferator-activated Receptor delta Activators Induce IL-8 Expression in Nonstimulated Endothelial Cells in a Transcriptional and Posttranscriptional Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA/DELTA PPAR-BETA/DELTA; NF-KAPPA-B; EPITHELIAL-CELLS; GENE-EXPRESSION; LIGAND ACTIVATION; PROTEIN-KINASE; MESSENGER-RNA; GROWTH-FACTOR; ALPHA; INTERLEUKIN-8	Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are implicated in the regulation of lipid and glucose homeostasis. PPAR agonists have been shown to control inflammatory processes, in part by inhibiting distinct proinflammatory genes (e.g. Il-1 beta and IFN-gamma). IL-8 is a member of the proinflammatory chemokine family that is important for various functions, such as mediating the adhesion of eosinophilic granulocytes onto endothelial cells. The influence of PPAR delta activators on the expression of IL-8 in noninduced quiescent endothelial cells is unclear. Therefore, we explored the influence of PPAR delta activators on the expression of IL-8 in nonstimulated endothelial cells. PPAR delta agonists induce IL-8 expression in human umbilical vein endothelial cells. This induction is demonstrated at the level of both protein and mRNA expression. Transcriptional activation studies using IL-8 reporter gene constructs and DNA binding assays revealed that PPAR delta agonists mediated their effects via an NF kappa B binding site. It is well known that IL-8 is also regulated by mRNA stability. To provide further evidence for this concept, we performed mRNA stability assays and found that PPAR delta agonists induce the mRNA stability of IL-8. In addition, we showed that PPAR delta agonists induce the phosphorylation of ERK1/2 and p38, which are known to be involved in the increase of mRNA stability. The inhibition of these MAPK signaling pathways resulted in a significant suppression of the induced IL-8 expression and the reduced mRNA stability. Therefore, our data provide the first evidence that PAR delta induces IL-8 expression in nonstimulated endothelial cells via transcriptional as well as posttranscriptional mechanisms.	[Meissner, Markus; Hrgovic, Igor; Doll, Monika; Naidenow, Julia; Reichenbach, Gabi; Hailemariam-Jahn, Tsige; Michailidou, Despina; Gille, Jens; Kaufmann, Roland] Goethe Univ Frankfurt, Dept Dermatol, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Meissner, M (corresponding author), Klinikum JW Goethe Univ, Zentrum Dermatol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	markus.meissner@kgu.de	Meissner, Markus/AAP-8179-2020; Meissner, Markus/F-9125-2014	Meissner, Markus/0000-0002-5630-587X	Wilhelm Sander Stiftung	Wilhelm Sander Stiftung	This work was supported by the Wilhelm Sander Stiftung (M.M.).	Balakathiresan NS, 2009, AM J PHYSIOL-LUNG C, V296, pL1012, DOI 10.1152/ajplung.90601.2008; Bartels M, 2007, J IMMUNOL, V179, P7605, DOI 10.4049/jimmunol.179.11.7605; Bility MT, 2008, CARCINOGENESIS, V29, P2406, DOI 10.1093/carcin/bgn219; Chen WZ, 2000, EXP LUNG RES, V26, P13, DOI 10.1080/019021400269934; Clifton DR, 2005, INT J MED MICROBIOL, V295, P267, DOI 10.1016/j.ijmm.2005.05.006; Duan SZ, 2009, CURR OPIN NEPHROL HY, V18, P128, DOI 10.1097/MNH.0b013e328325803b; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Gross B, 2007, BEST PRACT RES CL EN, V21, P687, DOI 10.1016/j.beem.2007.09.004; Han SW, 2009, AM J RESP CELL MOL, V40, P325, DOI 10.1165/rcmb.2008-0197OC; Hansen MK, 2008, CURR OPIN INVEST DR, V9, P247; He PF, 2008, TOXICOLOGY, V254, P112, DOI 10.1016/j.tox.2008.09.023; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Kim DJ, 2006, CARCINOGENESIS, V27, P1105, DOI 10.1093/carcin/bgi346; Lee JW, 2008, J IMMUNOL, V181, P6536, DOI 10.4049/jimmunol.181.9.6536; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Liang YJ, 2010, INT J CARDIOL, V143, P361, DOI 10.1016/j.ijcard.2009.03.100; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; Meissner M, 2008, J INVEST DERMATOL, V128, P2084, DOI 10.1038/jid.2008.37; Meissner M, 2009, CANCER RES, V69, P1976, DOI 10.1158/0008-5472.CAN-08-3150; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; Piqueras L, 2009, J LEUKOCYTE BIOL, V86, P115, DOI [10.1189/jlb.0508284, 10.1189/JLB.0508284]; Reilly SM, 2008, FEBS LETT, V582, P26, DOI 10.1016/j.febslet.2007.11.040; Ren SY, 2005, BIOCHEM BIOPH RES CO, V338, P1818, DOI 10.1016/j.bbrc.2005.10.158; Rival Y, 2002, EUR J PHARMACOL, V435, P143, DOI 10.1016/S0014-2999(01)01589-8; Robinson E, 2009, PHARMACOL THERAPEUT, V122, P246, DOI 10.1016/j.pharmthera.2009.03.003; Rochelson B, 2007, J REPROD IMMUNOL, V73, P101, DOI 10.1016/j.jri.2006.06.004; Rodriguez-Calvo R, 2008, DIABETES, V57, P2149, DOI 10.2337/db08-0176; Seedorf U, 2007, BBA-MOL CELL BIOL L, V1771, P1125, DOI 10.1016/j.bbalip.2007.04.017; Subramaniam D, 2008, GASTROENTEROLOGY, V134, P1070, DOI 10.1053/j.gastro.2008.01.040; Suzuki M, 2000, FEBS LETT, V465, P23, DOI 10.1016/S0014-5793(99)01717-2; Torra IP, 2001, CURR OPIN LIPIDOL, V12, P245, DOI 10.1097/00041433-200106000-00002; Wang NP, 2008, PPAR RES, V2008, DOI 10.1155/2008/164163; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015	37	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33797	33804		10.1074/jbc.M110.137943	http://dx.doi.org/10.1074/jbc.M110.137943			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20592029	Green Published, hybrid			2022-12-25	WOS:000283354000026
J	Weber, B; Kimhi, S; Howard, G; Eden, A; Lyko, F				Weber, B.; Kimhi, S.; Howard, G.; Eden, A.; Lyko, F.			Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription	ONCOGENE			English	Article						DNA methylation; LINE element; cMet; azacytidine; decitabine	DNA METHYLTRANSFERASE INHIBITORS; METHYLATION; CANCER; GENE; 5-AZA-2'-DEOXYCYTIDINE; HYPOMETHYLATION; ELEMENTS; EPIGENOMICS; MECHANISMS; RESISTANCE	The cytosine analogues 5-azacytidine and 5-aza-2'-deoxycytidine are currently the most advanced drugs for epigenetic cancer therapy. Both drugs function as DNA methyltransferase (DNMT) inhibitors and lead to the reactivation of epigenetically silenced tumour suppressor genes. However, not much is known about their target sequence specificity and their possible side effects on normally methylated sequences such as long interspersed nuclear element (LINE)-1 retroelements. It has been shown that demethylation and activation of the LINE-1 antisense promoter can drive the transcription of neighbouring sequences. In this study, we show that demethylation of the colon carcinoma cell line HCT116, either by treatment with DNMT inhibitors or by genetic disruption of the major DNMTs, induces the expression of an illegitimate fusion transcript between an intronic LINE-1 element and the proto-oncogene cMet (L1-cMet). Similar findings were also obtained with myeloid leukaemia cells, an established cellular model for the approved indication of azacytidine and decitabine. Interestingly, upregulation of L1-cMet transcription resulted in reduced cMet expression, which in turn led to decreased cMet receptor signalling. Our results thus provide an important paradigm for demethylation-dependent modulation of gene expression, even if the promoter of the corresponding gene is unmethylated. Oncogene (2010) 29, 5775-5784; doi: 10.1038/onc.2010.227; published online 21 June 2010	[Kimhi, S.; Howard, G.; Eden, A.] Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel; [Weber, B.; Lyko, F.] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Epigenet, D-6900 Heidelberg, Germany	Hebrew University of Jerusalem; Helmholtz Association; German Cancer Research Center (DKFZ)	Eden, A (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel.	eden@vms.huji.ac.il; f.lyko@dkfz.de			Deutsches Krebsforschungszentrum (DKFZ); Israeli Ministry of Science and Technology (MOST)	Deutsches Krebsforschungszentrum (DKFZ)(Helmholtz Association); Israeli Ministry of Science and Technology (MOST)	We thank Achim Breiling and Azeemudeen Hussain for their advice and support in chromatin immunoprecipitation and cMet signalling analysis. This work was supported by the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and by the Israeli Ministry of Science and Technology (MOST).	Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Chuang JC, 2005, MOL CANCER THER, V4, P1515, DOI 10.1158/1535-7163.MCT-05-0172; Cruickshanks HA, 2009, GENOMICS, V94, P397, DOI 10.1016/j.ygeno.2009.08.013; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Mund C, 2005, CANCER RES, V65, P7086, DOI 10.1158/0008-5472.CAN-05-0695; Mund C, 2006, EPIGENETICS-US, V1, P7; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Schulz WA, 2006, CURR TOP MICROBIOL, V310, P211; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Stresemann C, 2008, MOL CANCER THER, V7, P2998, DOI 10.1158/1535-7163.MCT-08-0411; VESELY J, 1967, INT J CANCER, V2, P639, DOI 10.1002/ijc.2910020625; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	40	68	73	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2010	29	43					5775	5784		10.1038/onc.2010.227	http://dx.doi.org/10.1038/onc.2010.227			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	672LY	20562909				2022-12-25	WOS:000283586200003
J	Soriani, M; Petit, P; Grifantini, R; Petracca, R; Gancitano, G; Frigimelica, E; Nardelli, F; Garcia, C; Spinelli, S; Scarabelli, G; Fiorucci, S; Affentranger, R; Ferrer-Navarro, M; Zacharias, M; Colombo, G; Vuillard, L; Daura, X; Grandi, G				Soriani, Marco; Petit, Pierre; Grifantini, Renata; Petracca, Roberto; Gancitano, Giovanni; Frigimelica, Elisabetta; Nardelli, Filomena; Garcia, Christel; Spinelli, Silvia; Scarabelli, Guido; Fiorucci, Sebastien; Affentranger, Roman; Ferrer-Navarro, Mario; Zacharias, Martin; Colombo, Giorgio; Vuillard, Laurent; Daura, Xavier; Grandi, Guido			Exploiting Antigenic Diversity for Vaccine Design THE CHLAMYDIA ArtJ PARADIGM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTION SITES; PROTEINS; IDENTIFICATION; SIMULATIONS; PNEUMONIAE; CANDIDATES; ENERGETICS; STABILITY; EXTENSION; BINDING	Wepresent an interdisciplinary approach that, by incorporating a range of experimental and computational techniques, allows the identification and characterization of functional/ immunogenic domains. This approach has been applied to ArtJ, an arginine-binding protein whose orthologs in Chlamydiae trachomatis (CT ArtJ) and pneumoniae (CPn ArtJ) are shown to have different immunogenic properties despite a high sequence similarity (60% identity). We have solved the crystallographic structures of CT ArtJ and CPn ArtJ, which are found to display a type II transporter fold organized in two alpha-beta domains with the arginine-binding region at their interface. Although ArtJ is considered to belong to the periplasm, we found that both domains contain regions exposed on the bacterial surface. Moreover, we show that recombinant ArtJ binds to epithelial cells in vitro, suggesting a role for ArtJ in host-cell adhesion during Chlamydia infection. Experimental epitope mapping and computational analysis of physicochemical determinants of antibody recognition revealed that immunogenic epitopes reside mainly in the terminal (D1) domain of both CPn and CT ArtJ, whereas the surface properties of the respective binding-prone regions appear sufficiently different to assume divergent immunogenic behavior. Neutralization assays revealed that sera raised against CPn ArtJ D1 partially reduce both CPn and CT infectivity in vitro, suggesting that functional antibodies directed against this domain may potentially impair chlamydial infectivity. These findings suggest that the approach presented here, combining functional and structure-based analyses of evolutionary-related antigens can be a valuable tool for the identification of cross-species immunogenic epitopes for vaccine development.	[Soriani, Marco; Grifantini, Renata; Petracca, Roberto; Gancitano, Giovanni; Frigimelica, Elisabetta; Nardelli, Filomena; Grandi, Guido] Novartis Vaccines, I-53100 Siena, Italy; [Petit, Pierre; Garcia, Christel; Vuillard, Laurent] Univ Aix Marseille 1, BioXtal Struct Biol Unit, F-13288 Marseille 09, France; [Spinelli, Silvia] Univ Aix Marseille 1, AFMB, CNRS, UMR 6098, F-13288 Marseille 09, France; [Spinelli, Silvia] Univ Aix Marseille 2, AFMB, CNRS, UMR 6098, F-13288 Marseille 09, France; [Petit, Pierre; Garcia, Christel; Vuillard, Laurent] Univ Aix Marseille 2, BioXtal Struct Biol Unit, F-13288 Marseille 09, France; [Fiorucci, Sebastien; Zacharias, Martin] Jacobs Univ Bremen, D-28759 Bremen, Germany; [Affentranger, Roman; Ferrer-Navarro, Mario; Daura, Xavier] Univ Autonoma Barcelona, IBB, Bellaterra 08193, Spain; [Daura, Xavier] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain	Novartis; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Jacobs University; Autonomous University of Barcelona; ICREA	Grandi, G (corresponding author), Novartis Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	guido.grandi@novartis.com	Colombo, Giorgio/A-2730-2012; Fiorucci, Sebastien/A-2060-2010; Daura, Xavier/C-9275-2009; Renata, Grifantini/AAB-9969-2022; Fiorucci, Stefano/I-1251-2012	Colombo, Giorgio/0000-0002-1318-668X; Fiorucci, Sebastien/0000-0003-2245-0478; Daura, Xavier/0000-0001-9235-6730; Renata, Grifantini/0000-0003-0024-3355; Grandi, Guido/0000-0001-9724-2185; SORIANI, Marco/0000-0002-9752-5844; Ferrer-Navarro, Mario/0000-0001-9990-914X	European Union [LSHB-CT-2006-037325]; ICREA Funding Source: Custom	European Union(European Commission); ICREA(ICREA)	This work was supported by Sixth Research Framework Programme of the European Union Ref. LSHB-CT-2006-037325, BacAbs.	Affentranger R, 2006, J CHEM THEORY COMPUT, V2, P217, DOI 10.1021/ct050250b; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Daura X, 1999, PROTEINS, V34, P269, DOI 10.1002/(SICI)1097-0134(19990215)34:3<269::AID-PROT1>3.0.CO;2-3; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; ESWAR N, 2000, CURRENT PROTOCOLS S, V15; Finco O, 2005, VACCINE, V23, P1178, DOI 10.1016/j.vaccine.2004.07.045; Fiorucci S, 2010, BIOPHYS J, V98, P1921, DOI 10.1016/j.bpj.2009.12.4332; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; GOURLAY LJ, 2009, HUM VACCIN, V5, P1; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Klock Heath E., 2005, Journal of Structural and Functional Genomics, V6, P89, DOI 10.1007/s10969-005-3084-1; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Makarova KS, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-9-RESEARCH0033; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meoni E, 2009, INFECT IMMUN, V77, P4168, DOI 10.1128/IAI.00344-09; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Morra G, 2008, PROTEINS, V72, P660, DOI 10.1002/prot.21963; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scarabelli G, 2010, BIOPHYS J, V98, P1966, DOI 10.1016/j.bpj.2010.01.014; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tiana G, 2004, PROTEIN SCI, V13, P113, DOI 10.1110/ps.03223804; Vahedi-Faridi A, 2008, J MOL BIOL, V375, P448, DOI 10.1016/j.jmb.2007.10.049; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	32	34	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30126	30138		10.1074/jbc.M110.118513	http://dx.doi.org/10.1074/jbc.M110.118513			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20592031	Green Published, hybrid			2022-12-25	WOS:000281984300050
J	Ding, WX; Ni, HM; Li, M; Liao, Y; Chen, XY; Stolz, DB; Dorn, GW; Yin, XM				Ding, Wen-Xing; Ni, Hong-Min; Li, Min; Liao, Yong; Chen, Xiaoyun; Stolz, Donna B.; Dorn, Gerald W., II; Yin, Xiao-Ming			Nix Is Critical to Two Distinct Phases of Mitophagy, Reactive Oxygen Species-mediated Autophagy Induction and Parkin-Ubiquitin-p62-mediated Mitochondrial Priming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ORGANELLE DEGRADATION; SELECTIVE AUTOPHAGY; SPERM MITOCHONDRIA; CELL-DEATH; MATURATION; BNIP3; CLEARANCE; UBIQUITIN; PROTEIN	Damaged mitochondria can be eliminated by autophagy, i.e. mitophagy, which is important for cellular homeostasis and cell survival. Despite the fact that a number of factors have been found to be important for mitophagy in mammalian cells, their individual roles in the process had not been clearly defined. Parkin is a ubiquitin-protein isopeptide ligase able to translocate to the mitochondria that are to be removed. We showed here in a chemical hypoxia model of mitophagy induced by an uncoupler, carbonyl cyanide m-chlorophenylhydrazone (CCCP) that Parkin translocation resulted in mitochondrial ubiquitination and p62 recruitment to the mitochondria. Small inhibitory RNA-mediated knockdown of p62 significantly diminished mitochondrial recognition by the autophagy machinery and the subsequent elimination. Thus Parkin, ubiquitin, and p62 function in preparing mitochondria for mitophagy, here referred to as mitochondrial priming. However, these molecules were not required for the induction of autophagy machinery. Neither Parkin nor p62 seemed to affect autophagy induction by CCCP. Instead, we found that Nix was required for the autophagy induction. Nix promoted CCCP-induced mitochondrial depolarization and reactive oxygen species generation, which inhibited mTOR signaling and activated autophagy. Nix also contributed to mitochondrial priming by controlling the mitochondrial translocation of Parkin, although reactive oxygen species generation was not involved in this step. Deletion of the C-terminal membrane targeting sequence but not mutations in the BH3 domain disabled Nix for these functions. Our work thus distinguished the molecular events responsible for the different phases of mitophagy and placed Nix upstream of the events.	[Ding, Wen-Xing; Ni, Hong-Min; Li, Min; Liao, Yong; Chen, Xiaoyun; Yin, Xiao-Ming] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Ding, Wen-Xing; Ni, Hong-Min] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Dorn, Gerald W., II] Washington Univ, Ctr Pharmacogenom, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Kansas; University of Kansas Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Yin, XM (corresponding author), Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	xmyin@iupui.edu	Chen, Xiaoyun/K-4786-2019; Li, Min/B-1281-2011		National Institutes of Health [R01 CA83817, R01 CA111456, R21-AA017421, P20 RR021940, P20 RR016475]; NATIONAL CANCER INSTITUTE [R01CA083817, R01CA111456] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940, P20RR016475] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA83817 and R01 CA111456 (to X.-M. Y.) and R21-AA017421, P20 RR021940, and P20 RR016475 (to W.-X. D.).	Bassnett S, 2002, EXP EYE RES, V74, P1, DOI 10.1006/exer.2001.1111; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Sutovsky P, 2000, BIOL REPROD, V63, P582, DOI 10.1095/biolreprod63.2.582; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	40	442	454	3	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27879	27890		10.1074/jbc.M110.119537	http://dx.doi.org/10.1074/jbc.M110.119537			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573959	hybrid, Green Published			2022-12-25	WOS:000281404100043
J	Lucana, DOD; Roscher, M; Honigmann, A; Schwarz, J				Lucana, Dario Ortiz de Orue; Roscher, Mareike; Honigmann, Alf; Schwarz, Julia			Iron-mediated Oxidation Induces Conformational Changes within the Redox-sensing Protein HbpS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING CHARACTERISTICS; RESONANCE ENERGY-TRANSFER; CATALASE-PEROXIDASE CPEB; STREPTOMYCES-RETICULI; CIRCULAR-DICHROISM; OXYGEN RADICALS; HEME; DITYROSINE; STRESS; FLUORESCENCE	HbpS is an extracellular oligomeric protein, which has been shown to act in concert with the two-component system SenS-SenR during the sensing of redox stress. HbpS can bind and degrade heme under oxidative stress conditions, leading to a free iron ion. The liberated iron is subsequently coordinated on the protein surface. Furthermore, HbpS has been shown to modulate the phosphorylation state of the sensor kinase SenS as, in the absence of oxidative stress conditions, HbpS inhibits SenS autophosphorylation whereas the presence of heme or iron ions and redox-stressing agents enhances it. Using HbpS wild type and mutants as well as different biochemical and biophysical approaches, we show that iron-mediated oxidative stress induces both secondary structure and overall intrinsic conformational changes within HbpS. We demonstrate in addition that HbpS is oxidatively modified, leading to the generation of highly reactive carbonyl groups and tyrosine-tyrosine bonds. Further examination of the crystal structure and subsequent mutational analyses allowed the identification of the tyrosine residue participating in dityrosine formation, which occurs between two monomers within the octomeric assembly. Therefore, it is proposed that oxidative modifications causing structural and conformational changes are responsible for the control of SenS and hence of the HbpS-SenS-SenR signaling cascade.	Univ Osnabruck, Fac Biol Chem, Dept Appl Genet Microorganisms, D-49069 Osnabruck, Germany; [Honigmann, Alf] Univ Osnabruck, Fac Biol Chem, Dept Biophys, D-49069 Osnabruck, Germany	University Osnabruck; University Osnabruck	Lucana, DOD (corresponding author), Barbarastr 13, D-49069 Osnabruck, Germany.	ortiz@biologie.uni-osnabrueck.de	; Honigmann, Alf/C-4832-2017	Schwarz, Julia/0000-0002-7227-6730; Honigmann, Alf/0000-0003-0475-3790	Deutsche Forschungsgemeinschaft (DFG) [OR 224/1-3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Grant OR 224/1-3 from the Deutsche Forschungsgemeinschaft (DFG).	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bogel G, 2007, FEBS J, V274, P3900, DOI 10.1111/j.1742-4658.2007.05923.x; Bogel G, 2009, AMINO ACIDS, V37, P681, DOI 10.1007/s00726-008-0188-5; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; DiMarco T, 2007, MASS SPECTROM REV, V26, P108, DOI 10.1002/mas.20109; Ding F, 2003, PROTEINS, V53, P220, DOI 10.1002/prot.10468; Ding F, 2002, J MOL BIOL, V324, P851, DOI 10.1016/S0022-2836(02)01112-9; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Giulivi C, 2001, J BIOL CHEM, V276, P24129, DOI 10.1074/jbc.M010697200; Hagelueken G., 2009, ANGEW CHEM INT EDIT, V121, P2948, DOI DOI 10.1002/ange.200805758; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Hopwood D. A., 1985, GENETIC MANIPULATION; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; KIM K, 1985, J BIOL CHEM, V260, P5394; KUNGL AJ, 1994, BIOPHYS J, V67, P309, DOI 10.1016/S0006-3495(94)80482-5; Lardinois OM, 2008, BIOCHEMISTRY-US, V47, P10440, DOI 10.1021/bi800771k; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Lucana DODO, 2009, J MOL BIOL, V386, P1108, DOI 10.1016/j.jmb.2009.01.017; Lucana DOD, 2000, MOL GEN GENET, V264, P341; Lucana DOD, 2005, MICROBIOL-SGM, V151, P3603, DOI 10.1099/mic.0.28298-0; Lucana DOD, 2004, MICROBIOL-SGM, V150, P2575, DOI 10.1099/mic.0.27091-0; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; Nishimura C, 2000, J MOL BIOL, V299, P1133, DOI 10.1006/jmbi.2000.3804; Richardson LGL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-35; Rintala H, 2001, MOL CELL PROBE, V15, P337, DOI 10.1006/mcpr.2001.0379; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Sambrook J., 2006, CONDENSED PROTOCOLS; Sambrook J, 1989, MOL CLONING LABORATO; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Severance S, 2004, BIOCHEM J, V380, P487, DOI 10.1042/BJ20031921; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; SREEREMA N, 2000, ANAL BIOCHEM, V287, P52; SREEREMA N, 2003, SCIENCE, V12, P384; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Steinhoff HJ, 2004, BIOL CHEM, V385, P913, DOI 10.1515/BC.2004.119; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; VILLAREJO M, 1972, J BIOL CHEM, V247, P2212; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Zou P, 2008, ACTA CRYSTALLOGR E, V64, pO2215, DOI 10.1107/S160053680803465X	49	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28086	28096		10.1074/jbc.M110.127506	http://dx.doi.org/10.1074/jbc.M110.127506			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20571030	Green Published, hybrid			2022-12-25	WOS:000288742300007
J	Mandapathil, M; Szczepanski, MJ; Szajnik, M; Ren, J; Jackson, EK; Johnson, JT; Gorelik, E; Lang, S; Whiteside, TL				Mandapathil, Magis; Szczepanski, Miroslaw J.; Szajnik, Marta; Ren, Jin; Jackson, Edwin K.; Johnson, Jonas T.; Gorelik, Elieser; Lang, Stephan; Whiteside, Theresa L.			Adenosine and Prostaglandin E-2 Cooperate in the Suppression of Immune Responses Mediated by Adaptive Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PERIPHERAL-BLOOD; TYPE-1 CELLS; EXPRESSION; RECEPTORS; CANCER; HEAD; NECK; CYCLOOXYGENASE-2; CARCINOMA	Adaptive regulatory T cells (Tr1) are induced in the periphery upon encountering cognate antigens. In cancer, their frequency is increased; however, Tr1-mediated suppression mechanisms are not yet defined. Here, we evaluate the simultaneous involvement of ectonucleotidases (CD39/CD73) and cyclooxygenase 2 (COX-2) in Tr1-mediated suppression. Human Tr1 cells were generated from peripheral blood mononuclear cell-derived, sorted CD4(+)CD25(-) T cells and incubated with autologous immature dendritic cells, irradiated COX-2(+) or COX-2(-) tumor cells, and IL-2, IL-10, and IL-15 (each at 10-15 IU/ml) for 10 days as described (Bergmann, C., Strauss, L., Zeidler, R., Lang, S., and Whiteside, T. L. (2007) Cancer Immunol. Immunother. 56, 1429-1442). Tr1 were phenotyped by multicolor flow cytometry, and suppression of proliferating responder cells was assessed in carboxyfluorescein diacetate succinimidyl ester-based assays. ATP hydrolysis was measured using a luciferase detection assay, and levels of adenosine or prostaglandin E-2 (PGE(2)) in cell supernatants were analyzed by mass spectrometry or ELISA, respectively. Intracellular cAMP levels were measured by enzyme immunoassay. The COX-2(+) tumor induced a greater number of Tr1 than COX-2(-) tumor (p < 0.05). Tr1 induced by COX-2(+) tumor were more suppressive, hydrolyzed more exogenous ATP (p < 0.05), and produced higher levels of adenosine and PGE(2) (p < 0.05) than Tr1 induced by COX-2(-) tumor. Inhibitors of ectonucleotidase activity, A(2A) and EP2 receptor antagonists, or an inhibitor of the PKA type I decreased Tr1-mediated suppression (p < 0.05), whereas rolipram, a PDE4 inhibitor, increased the intracellular cAMP level in responder cells and their susceptibility to Tr1-mediated suppression. Tr1 present in tumors or the peripheral blood of head and neck squamous cell carcinoma patients co-expressed COX-2, CD39, and CD73. A concomitant inhibition of PGE(2) and adenosine via the common intracellular cAMP pathway might be a novel approach for improving results of immune therapies for cancer.	[Whiteside, Theresa L.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Ren, Jin; Jackson, Edwin K.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15219 USA; [Johnson, Jonas T.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Mandapathil, Magis; Lang, Stephan] Univ Duisburg Essen, Dept Otorhinolaryngol, D-45127 Essen, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Duisburg Essen	Whiteside, TL (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavilion 5117 Ctr Ave,Suite 1-27, Pittsburgh, PA 15213 USA.	whitesidetl@upmc.edu	Mandapathil, Magis/AFL-3260-2022	Jackson, Edwin/0000-0002-8101-6009	National Institutes of Health [PO1 CA109688]; Philip Morris International; Interdisziplinare Forschungsforderung der Universitat Essen (IFORES) Program; United States Department of Defense IDEA [W81XWH-06-1-0498]; Hillman Foundation; NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris International; Interdisziplinare Forschungsforderung der Universitat Essen (IFORES) Program; United States Department of Defense IDEA(United States Department of Defense); Hillman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 CA109688 (to T. L. W.). This work was also supported by Philip Morris International and the Interdisziplinare Forschungsforderung der Universitat Essen (IFORES) Program (to M. M.) and by United States Department of Defense IDEA Award W81XWH-06-1-0498 and Hillman Foundation grants (to E. G.).	Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Bergmann C, 2008, CLIN CANCER RES, V14, P3706, DOI 10.1158/1078-0432.CCR-07-5126; Bergmann C, 2007, CANCER IMMUNOL IMMUN, V56, P1429, DOI 10.1007/s00262-007-0280-9; Bergmann C, 2007, CANCER RES, V67, P8865, DOI 10.1158/0008-5472.CAN-07-0767; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Czystowska M, 2010, J MOL MED, V88, P577, DOI 10.1007/s00109-010-0602-9; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Denkert Carsten, 2004, Clin Breast Cancer, V4, P428, DOI 10.3816/CBC.2004.n.006; Desai S, 2000, MOL PHARMACOL, V58, P1279, DOI 10.1124/mol.58.6.1279; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Duarte MMF, 2007, FEBS J, V274, P2707, DOI 10.1111/j.1742-4658.2007.05805.x; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Harris Randall E, 2007, Subcell Biochem, V42, P93; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; HEO DS, 1989, CANCER RES, V49, P5167; JOHNSON KW, 1988, P NATL ACAD SCI USA, V85, P6072, DOI 10.1073/pnas.85.16.6072; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Mahic M, 2006, J IMMUNOL, V177, P246, DOI 10.4049/jimmunol.177.1.246; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; Mandapathil M, 2009, CLIN CANCER RES, V15, P6348, DOI 10.1158/1078-0432.CCR-09-1143; Mandapathil M, 2009, J IMMUNOL METHODS, V346, P55, DOI 10.1016/j.jim.2009.05.004; Marra LE, 2004, J IMMUNOL, V172, P1028, DOI 10.4049/jimmunol.172.2.1028; Mocellin S, 2005, J LEUKOCYTE BIOL, V78, P1043, DOI 10.1189/jlb.0705358; Mrena J, 2005, CLIN CANCER RES, V11, P7362, DOI 10.1158/1078-0432.CCR-05-0764; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Raskovalova T, 2007, CANCER RES, V67, P5949, DOI 10.1158/0008-5472.CAN-06-4249; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; Schaefer U, 2007, J PHARMACOL EXP THER, V322, P1269, DOI 10.1124/jpet.107.125328; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Sitkovsky M, 2008, BRIT J PHARMACOL, V153, pS457, DOI 10.1038/bjp.2008.23; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Su YY, 2008, CANCER IMMUNOL IMMUN, V57, P1611, DOI 10.1007/s00262-008-0494-5; TAKAYAMA H, 1989, J PHARM SCI, V78, P8, DOI 10.1002/jps.2600780104; Torgersen KM, 1997, J BIOL CHEM, V272, P5495, DOI 10.1074/jbc.272.9.5495; Vila J, 2009, CURR OPIN HEMATOL, V16, P274, DOI 10.1097/MOH.0b013e32832a9a01; Wolf AM, 2003, CLIN CANCER RES, V9, P606	44	117	128	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27571	27580		10.1074/jbc.M110.127100	http://dx.doi.org/10.1074/jbc.M110.127100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20558731	hybrid, Green Published			2022-12-25	WOS:000281404100012
J	Melillo, AA; Bakshi, CS; Melendez, JA				Melillo, Amanda A.; Bakshi, Chandra Shekhar; Melendez, J. Andres			Francisella tularensis Antioxidants Harness Reactive Oxygen Species to Restrict Macrophage Signaling and Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; FACTOR-KAPPA-B; REVERSIBLE OXIDATION; REDOX REGULATION; IMMUNE-RESPONSE; DOWN-REGULATION; IFN-GAMMA; TNF-ALPHA; INACTIVATION; VIRULENCE	Francisella tularensis is the etiologic agent of the highly infectious animal and human disease tularemia. Its extreme infectivity and virulence are associated with its ability to evade immune detection, which we now link to its robust reactive oxygen species-scavenging capacity. Infection of primary human monocyte-derived macrophages with virulent F. tularensis SchuS4 prevented proinflammatory cytokine production in the presence or absence of IFN-gamma compared with infection with the attenuated live vaccine strain. SchuS4 infection also blocked signals required for macrophage cytokine production, including Akt phosphorylation, I kappa B alpha degradation, and NF-kappa B nuclear localization and activation. Concomitant with SchuS4-mediated suppression of Akt phosphorylation was an increase in the levels of the Akt antagonist PTEN. Moreover, SchuS4 prevented the H2O2-dependent oxidative inactivation of PTEN compared with a virulent live vaccine strain. Mutation of catalase (katG) sensitized F. tularensis to H2O2 and enhanced PTEN oxidation, Akt phosphorylation, NF-kappa B activation, and inflammatory cytokine production. Together, these findings suggest a novel role for bacterial antioxidants in restricting macrophage activation through their ability to preserve phosphatases that temper kinase signaling and proinflammatory cytokine production.	[Melillo, Amanda A.; Bakshi, Chandra Shekhar; Melendez, J. Andres] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	Melendez, JA (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Mail Code 151,47 New Scotland Ave, Albany, NY 12208 USA.	melenda@mail.amc.edu		Melendez, Juan/0000-0001-8021-3097	National Institutes of Health [2P01AI056320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 2P01AI056320.	ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200; Claiborne A, 1985, CRC HDB METHODS OXYG, P283; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Dasgupta J, 2006, ANTIOXID REDOX SIGN, V8, P1295, DOI 10.1089/ars.2006.8.1295; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Flaherty DM, 2006, J BIOL CHEM, V281, P5058, DOI 10.1074/jbc.M508997200; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Ganster RW, 2005, J INTERF CYTOK RES, V25, P707, DOI 10.1089/jir.2005.25.707; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Hrstka R, 2007, FOLIA MICROBIOL, V52, P631, DOI 10.1007/BF02932193; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Kim JH, 2009, EUR J PHARMACOL, V602, P422, DOI 10.1016/j.ejphar.2008.10.062; Kim S, 2004, J BIOL CHEM, V279, P4285, DOI 10.1074/jbc.M308383200; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Meibom KL, 2009, FUTURE MICROBIOL, V4, P713, DOI 10.2217/FMB.09.37; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Ojeda SS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-215; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	39	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27553	27560		10.1074/jbc.M110.144394	http://dx.doi.org/10.1074/jbc.M110.144394			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20558723	Green Published, hybrid			2022-12-25	WOS:000281404100010
J	Caron, C; Lestrat, C; Marsal, S; Escoffier, E; Curtet, S; Virolle, V; Barbry, P; Debernardi, A; Brambilla, C; Brambilla, E; Rousseaux, S; Khochbin, S				Caron, C.; Lestrat, C.; Marsal, S.; Escoffier, E.; Curtet, S.; Virolle, V.; Barbry, P.; Debernardi, A.; Brambilla, C.; Brambilla, E.; Rousseaux, S.; Khochbin, S.			Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers	ONCOGENE			English	Article						H4 K5ac; proteasome; chromatin; histone; epigenetics	GENE-EXPRESSION; HISTONE CODE; PROTEIN; BOUNDARY; COACTIVATOR; ATPASE; ROLES; ANCCA	Cancer cells frequently express genes normally active in male germ cells. ATAD2 is one of them encoding a conserved factor harbouring an AAA type ATPase domain and a bromodomain. We show here that ATAD2 is highly expressed in testis as well as in many cancers of different origins and that its high expression is a strong predictor of rapid mortality in lung and breast cancers. These observations suggest that ATAD2 acts on upstream and basic cellular processes to enhance oncogenesis in a variety of unrelated cell types. Accordingly, our functional studies show that ATAD2 controls chromatin dynamics, genome transcriptional activities and apoptotic cell response. We could also highlight some of the important intrinsic properties of its two regulatory domains, including a functional cross-talk between the AAA ATPase domain and the bromodomain. Altogether, these data indicate that ATAD2 overexpression in somatic cells, by acting on basic properties of chromatin, may contribute to malignant transformation. Oncogene (2010) 29, 5171-5181; doi:10.1038/onc.2010.259; published online 28 June 2010	[Caron, C.; Lestrat, C.; Marsal, S.; Escoffier, E.; Curtet, S.; Debernardi, A.; Brambilla, C.; Brambilla, E.; Rousseaux, S.; Khochbin, S.] Univ Grenoble 1, INSERM, U823, Inst Albert Bonniot, Grenoble, France; [Virolle, V.; Barbry, P.] CNRS, Sophia Antipolis, France; [Virolle, V.; Barbry, P.] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Caron, C (corresponding author), INSERM, Inst Albert Bonniot, F-38706 La Tronche, Isere, France.	cecile.caron@ujf-grenoble.fr; khochbin@ujf-grenoble.fr	CURTET, Sandrine/E-8217-2019; Khochbin, Saadi/M-8090-2013; CURTET, Sandrine/N-3517-2013; Barbry, Pascal/O-5021-2016; Rousseaux, Sophie/G-1697-2013; debernardi, alexandra/N-4220-2013	CURTET, Sandrine/0000-0002-9419-8868; Khochbin, Saadi/0000-0002-0455-0857; Barbry, Pascal/0000-0001-9632-6483; Rousseaux, Sophie/0000-0001-5246-5350; 	ANR blanc-Episperm; INCa-DHOS; ARC-ARECA; Region Rhone-Alpes; INCa [AO 2006]; Nice-Sophia Antipolis Transcriptome Platform of the Marseille-Nice Genopole; Albert Bonniot Institute; Grenoble	ANR blanc-Episperm(French National Research Agency (ANR)); INCa-DHOS; ARC-ARECA; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); INCa(Institut National du Cancer (INCA) France); Nice-Sophia Antipolis Transcriptome Platform of the Marseille-Nice Genopole; Albert Bonniot Institute; Grenoble(Region Auvergne-Rhone-Alpes)	This work was supported by the 'ANR blanc-Episperm', INCa-DHOS' and 'ARC-ARECA' research programs. CL and SM are supported by the PhD fellowship program of Region Rhone-Alpes and the post-doc fellowship program of INCa (AO 2006), respectively. AD salary is paid by the INCa-DHOS funds. Transcriptomic analyses of lung cancer patients were obtained thanks to the Ligue Contre le Cancer 'Carte d'identite des Tumeurs' (CIT) program. We acknowledge the support of the Nice-Sophia Antipolis Transcriptome Platform of the Marseille-Nice Genopole, in which the microarray experiments were carried out. Special thanks are due to Geraldine Rios for microarray production. We also acknowledge the support of the microscopy platform, Albert Bonniot Institute, Grenoble, and thank Catherine Souchier for her precious help in the FRAP experiments.	Boussouar F, 2008, CELL CYCLE, V7, P3499, DOI 10.4161/cc.7.22.6975; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Col E, 2005, EMBO J, V24, P2634, DOI 10.1038/sj.emboj.7600734; De Koning L, 2009, EMBO MOL MED, V1, P178, DOI 10.1002/emmm.200900022; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Gradolatto A, 2008, GENETICS, V179, P291, DOI 10.1534/genetics.107.086520; Hartman HB, 2005, EMBO REP, V6, P445, DOI 10.1038/sj.embor.7400391; Jambunathan N, 2005, GENETICS, V171, P913, DOI 10.1534/genetics.105.046938; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Rousseaux S, 2009, EPIGENOMICS-UK, V1, P153, DOI 10.2217/EPI.09.1; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Tackett AJ, 2005, J CELL BIOL, V169, P35, DOI 10.1083/jcb.200502104; Tseng RJ, 2007, MOL GENET GENOMICS, V278, P507, DOI 10.1007/s00438-007-0265-6; Yu JJ, 2003, EMBO J, V22, P3403, DOI 10.1093/emboj/cdg326; Zou JX, 2007, P NATL ACAD SCI USA, V104, P18067, DOI 10.1073/pnas.0705814104; Zou JX, 2009, CANCER RES, V69, P3339, DOI 10.1158/0008-5472.CAN-08-3440	21	120	128	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	37					5171	5181		10.1038/onc.2010.259	http://dx.doi.org/10.1038/onc.2010.259			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	650QZ	20581866				2022-12-25	WOS:000281867200006
J	Lee, SH; Bahn, JH; Whitlock, NC; Baek, SJ				Lee, S-H; Bahn, J. H.; Whitlock, N. C.; Baek, S. J.			Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways	ONCOGENE			English	Article						Tolfenamic acid; ATF2; ATF3; apoptosis; colorectal cancer	COLORECTAL-CANCER CELLS; STRESS-INDUCIBLE GENE; RESPONSE GENE; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; MAMMARY-TUMORS; BREAST-CANCER; APOPTOSIS; GROWTH; NAG-1	Tolfenamic acid (TA) is a non-steroidal anti-inflammatory drug associated with anti-tumorigenic and pro-apoptotic properties in animal and in vitro models of cancer. However, the underlying cellular mechanisms by which TA exerts its effects are only partially understood. Activating transcription factor 3 (ATF3) is a member of the ATF/CREB subfamily of the basic region-leucine zipper family and has been known as a tumor suppressor in human colorectal cancer cells. The present study was performed to observe whether ATF3 mediates TA-induced apoptosis and to elucidate the molecular mechanism of ATF3 transcription induced by TA. TA treatment and ectopic expression of ATF3 increased apoptosis, whereas knockdown of ATF3 resulted in significant repression of TA-activated apoptosis. The TA treatment also induced ATF3 promoter activity. Internal deletion and point mutation of the predicted ATF/C/EBP binding site in ATF3 promoter abolished luciferase activation by TA. Overexpression of ATF2 resulted in significant increase in ATF3 promoter activity, and electrophoretic mobility shift assay identified this region as a core sequence to which ATF2 binds. TA treatment resulted in an increase in ATF2 phosphorylation, which was followed by a subsequent increase in ATF3 transcription. Knock down of ATF2 abolished TA-induced ATF3 expression. We further provide evidence that TA leads to increases in phospho-p38 MAPK, JNK and ERK levels. Inhibition of these pathways using selective inhibitors and dominant negative constructs ameliorated TA-induced ATF3 expression and promoter activities. The current study shows that TA stimulates ATF3 expression and subsequently induces apoptosis. These pathways are mediated through phosphorylation of ATF2, which is mediated by p38 MAPK-, JNK- and ERK-dependent pathways. Oncogene (2010) 29, 5182-5192; doi:10.1038/onc.2010.251; published online 28 June 2010	[Lee, S-H; Bahn, J. H.; Whitlock, N. C.; Baek, S. J.] Univ Tennessee, Dept Pathobiol, Lab Environm Carcinogenesis, Coll Vet Med, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Baek, SJ (corresponding author), Univ Tennessee, Dept Pathobiol, Lab Environm Carcinogenesis, Coll Vet Med, 2407 River Dr, Knoxville, TN 37996 USA.	sbaek2@utk.edu	Bahn, Jae Hoon/G-7686-2016; Bahn, Jae Hoon/AAP-2672-2020; Bahn, Jae Hoon/AAA-9612-2019	Bahn, Jae Hoon/0000-0002-0365-1728; 	National Institutes of Health [R01CA108975]; University of Tennessee, Center of Excellence in Livestock Diseases and Human Health; American Cancer Society [CNE-111611]; NATIONAL CANCER INSTITUTE [R01CA108975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tennessee, Center of Excellence in Livestock Diseases and Human Health; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr T Hai (Ohio State University, Columbus, OH, USA) and Dr S Kitajima (Tokyo Medical and Dental University, Tokyo, Japan) for providing the pCG-ATF3 construct and ATF3 promoter, respectively. We thank Dr Philip Cohen (University of Dundee, Scotland, UK) and Dr Joo-Heon Yoon (Yonsei University, Seoul, Korea) for providing pEBG2T-GST-ATF2-6His- and CREB-expression vector, respectively. We thank Dr Melanie Cobb (University of Texas Southwestern Medical Center, Dallas, TX, USA) for providing wild type and dominant negative ERK2-expression vector. We also thank Misty Bailey for her critical reading of the paper. This work was supported by Grants from the American Cancer Society (CNE-111611), National Institutes of Health (R01CA108975) and the University of Tennessee, Center of Excellence in Livestock Diseases and Human Health to SJB.	Abdelrahim M, 2007, CANCER RES, V67, P3286, DOI 10.1158/0008-5472.CAN-06-3831; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Allan AL, 2001, J BIOL CHEM, V276, P27272, DOI 10.1074/jbc.M103196200; Baek SJ, 2004, CARCINOGENESIS, V25, P2425, DOI 10.1093/carcin/bgh255; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337; Bottone FG, 2004, CARCINOGENESIS, V25, P349, DOI 10.1093/carcin/bgh016; Brown SL, 2008, CANCER RES, V68, P364, DOI 10.1158/0008-5472.CAN-07-2170; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chen HH, 2004, MOL PHARMACOL, V65, P1130, DOI 10.1124/mol.65.5.1130; Cho KN, 2007, EUR J CANCER, V43, P2404, DOI 10.1016/j.ejca.2007.07.020; Deng XH, 2008, CANCER RES, V68, P9663, DOI 10.1158/0008-5472.CAN-08-2229; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; HAI T, 1988, GENE DEV, V2, P1216, DOI 10.1101/gad.2.10.1216; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HANSEN PE, 1994, PHARMACOL TOXICOL, V75, P81, DOI 10.1111/j.1600-0773.1994.tb02005.x; Hao F, 2007, BBA-MOL CELL BIOL L, V1771, P883, DOI 10.1016/j.bbalip.2007.04.010; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kashiwakura Y, 2008, CANCER RES, V68, P8333, DOI 10.1158/0008-5472.CAN-08-0080; Lee SH, 2008, MOL CANCER THER, V7, P3739, DOI 10.1158/1535-7163.MCT-08-0548; Lee SH, 2006, CARCINOGENESIS, V27, P972, DOI 10.1093/carcin/bgi268; Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Maekawa T, 2008, ONCOGENE, V27, P1045, DOI 10.1038/sj.onc.1210727; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Oh YK, 2008, MOL CANCER RES, V6, P1232, DOI 10.1158/1541-7786.MCR-07-0297; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piyanuch R, 2007, CANCER LETT, V258, P230, DOI 10.1016/j.canlet.2007.09.007; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Woo IS, 2002, INT J ONCOL, V20, P527; Xue L, 2005, ONCOGENE, V24, P2343, DOI 10.1038/sj.onc.1208434; Yamaguchi K, 2006, CANCER RES, V66, P2376, DOI 10.1158/0008-5472.CAN-05-1987; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861	45	65	68	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	37					5182	5192		10.1038/onc.2010.251	http://dx.doi.org/10.1038/onc.2010.251			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	650QZ	20581861	Green Accepted			2022-12-25	WOS:000281867200007
J	Cho, SJ; Chen, XB				Cho, Seong Jun; Chen, Xinbin			Myosin VI Is Differentially Regulated by DNA Damage in p53-and Cell Type-dependent Manners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II; MOTOR PROPERTIES; PROSTATE-CANCER; IN-VIVO; P53; MIGRATION; INVASION; GOLGI; PHOSPHORYLATION; TRANSCRIPTION	Myosin VI is an unconventional motor protein and functions in a variety of intracellular processes such as cell migration, vesicular trafficking, and homeostasis of the Golgi complex. Previously, we found that myosin VI is up-regulated in RKO, LS174T, and H1299 cells by DNA damage in a p53-dependent manner and mediates the pro-survival function of p53. Here, we showed that the levels of myosin VI protein were markedly inhibited in MCF7 and LNCaP cells by topoisomerase I-II inhibitors. However, the levels of myosin VI transcript were decreased only by topoisomerase I inhibitors. We also found that the levels of myosin VI protein were markedly inhibited in MCF7 cells by wild-type p53 but not tumor-derived mutant p53. Surprisingly, we found that the level of myosin VI transcript was slightly increased instead of decreased in MCF7 cells by p53, suggesting that a mechanism other than transcriptional repression is involved. Additionally, we found that on the myosin VI promoter, the level of acetylated histone H3 was markedly decreased, whereas that of p53 and acetylated histone H4 was slightly increased in MCF7 cells upon treatment with topoisomerase I-II inhibitors. Finally, we showed that overexpression of myosin VI enhances, whereas knockdown of myosin VI decreases, DNA damage-induced stabilization of p53, and consequently, knockdown of myosin VI de-sensitizes MCF7 cells to DNA damage-induced apoptosis. Taken together, as a mediator of the p53 pro-survival pathway and a marker of malignancy in some tumors, differential regulation of myosin VI in various tumor cells by topoisomerase inhibitors dictates whether knockdown of myosin VI inhibits, rather than enhances, the susceptibility of tumor cells to some therapeutic agents, which might be explored for designing a proper therapeutic strategy.	[Cho, Seong Jun; Chen, Xinbin] Univ Calif Davis, Dept Surg & Radiol Sci, Comparat Canc Ctr, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Dept Surg & Radiol Sci, Comparat Canc Ctr, Davis, CA 95616 USA.	xbchen@ucdavis.edu	Cho, Seong-Jun/P-2491-2019		National Institutes of Health [CA121137, CA076069]; NATIONAL CANCER INSTITUTE [R01CA121137, R29CA076069, R01CA076069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA121137 and CA076069.	Andoh T, 1998, BBA-GENE STRUCT EXPR, V1400, P155, DOI 10.1016/S0167-4781(98)00133-X; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2002, TRAFFIC, V3, P851, DOI 10.1034/j.1600-0854.2002.31201.x; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; CUMMINGS J, 1993, ANN ONCOL, V4, P533, DOI 10.1093/oxfordjournals.annonc.a058584; Dong P, 2007, CLIN EXP METASTAS, V24, P471, DOI 10.1007/s10585-007-9084-8; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; Frank DJ, 2004, CURR OPIN CELL BIOL, V16, P189, DOI 10.1016/j.ceb.2004.02.001; Gadea G, 2004, J CELL SCI, V117, P6355, DOI 10.1242/jcs.01566; Gadea G, 2002, EMBO J, V21, P2373, DOI 10.1093/emboj/21.10.2373; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hodge T, 2000, J CELL SCI, V113, P3353; Jung EJ, 2006, MOL CELL BIOL, V26, P2175, DOI 10.1128/MCB.26.6.2175-2186.2006; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Morris CA, 2003, J BIOL CHEM, V278, P23324, DOI 10.1074/jbc.M208957200; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Yves, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P429, DOI 10.2174/1568011043352777; Rene B, 2007, BIOCHIMIE, V89, P508, DOI 10.1016/j.biochi.2007.02.011; Roberts R, 2004, PHILOS T R SOC B, V359, P1931, DOI 10.1098/rstb.2004.1563; Roger L, 2006, BIOL CELL, V98, P141, DOI 10.1042/BC20050058; Tamaki K, 2008, NEUROSCI LETT, V433, P183, DOI 10.1016/j.neulet.2007.12.062; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; Warner CL, 2003, EMBO J, V22, P569, DOI 10.1093/emboj/cdg055; Wei SZ, 2008, PROSTATE, V68, P1387, DOI 10.1002/pros.20806; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yoshida H, 2004, P NATL ACAD SCI USA, V101, P8144, DOI 10.1073/pnas.0400400101; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200; Zhu JH, 1998, CANCER RES, V58, P5061	42	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27159	27166		10.1074/jbc.M110.142117	http://dx.doi.org/10.1074/jbc.M110.142117			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576604	Green Published, hybrid			2022-12-25	WOS:000281172700046
J	Pastrana-Mena, R; Dinglasan, RR; Franke-Fayard, B; Vega-Rodriguez, J; Fuentes-Caraballo, M; Baerga-Ortiz, A; Coppens, I; Jacobs-Lorena, M; Janse, CJ; Serrano, AE				Pastrana-Mena, Rebecca; Dinglasan, Rhoel R.; Franke-Fayard, Blandine; Vega-Rodriguez, Joel; Fuentes-Caraballo, Mariela; Baerga-Ortiz, Abel; Coppens, Isabelle; Jacobs-Lorena, Marcelo; Janse, Chris J.; Serrano, Adelfa E.			Glutathione Reductase-null Malaria Parasites Have Normal Blood Stage Growth but Arrest during Development in the Mosquito	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT PLASMODIUM-FALCIPARUM; HIGH-EFFICIENCY TRANSFECTION; METHYLENE-BLUE; INFECTED ERYTHROCYTES; IN-VIVO; THIOREDOXIN SYSTEM; OXIDATIVE STRESS; INTRACELLULAR GLUTATHIONE; DIHYDROFOLATE-REDUCTASE; DISULFIDE REDUCTASES	Malaria parasites contain a complete glutathione (GSH) redox system, and several enzymes of this system are considered potential targets for antimalarial drugs. Through generation of a gamma-glutamylcysteine synthetase (gamma-GCS)-null mutant of the rodent parasite Plasmodium berghei, we previously showed that de novo GSH synthesis is not critical for blood stage multiplication but is essential for oocyst development. In this study, phenotype analyses of mutant parasites lacking expression of glutathione reductase (GR) confirmed that GSH metabolism is critical for the mosquito oocyst stage. Similar to what was found for gamma-GCS, GR is not essential for blood stage growth. GR-null parasites showed the same sensitivity to methylene blue and eosin B as wild type parasites, demonstrating that these compounds target molecules other than GR in Plasmodium. Attempts to generate parasites lacking both GR and gamma-GCS by simultaneous disruption of gr and gamma-gcs were unsuccessful. This demonstrates that the maintenance of total GSH levels required for blood stage survival is dependent on either de novo GSH synthesis or glutathione disulfide (GSSG) reduction by Plasmodium GR. Our studies provide new insights into the role of the GSH system in malaria parasites with implications for the development of drugs targeting GSH metabolism.	[Pastrana-Mena, Rebecca; Vega-Rodriguez, Joel; Fuentes-Caraballo, Mariela; Serrano, Adelfa E.] Univ Puerto Rico, Sch Med, Dept Microbiol, San Juan, PR 00936 USA; [Baerga-Ortiz, Abel] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Dinglasan, Rhoel R.; Coppens, Isabelle; Jacobs-Lorena, Marcelo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Franke-Fayard, Blandine; Janse, Chris J.] Leiden Univ Med Ctr, Ctr Infect Dis, Dept Parasitol, Leiden Malaria Res Grp, NL-2333 ZA Leiden, Netherlands	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Leiden University; Leiden University Medical Center (LUMC)	Serrano, AE (corresponding author), Univ Puerto Rico, Sch Med, Dept Microbiol, POB 365067, San Juan, PR 00936 USA.	adelfa.serrano@upr.edu		, Blandine/0000-0001-6041-4182; Janse, Chris J/0000-0002-6410-6205; Dinglasan, Rhoel/0000-0001-6563-1506; Dinglasan, Rhoel/0000-0001-5433-8179	National Institutes of Health NIGMS/Minority Biomedical Research Support (MBRS) [GM08224]; National Center for Research Resources Research Centers in Minority Institutions [G12RR03051]; MBRS/Research Initiative for Scientific Enhancement [R25GM061838]; National Institutes of Health [9 T37 MD001477-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [T37MD001477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, S06GM008224] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health NIGMS/Minority Biomedical Research Support (MBRS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MBRS/Research Initiative for Scientific Enhancement; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health NIGMS/Minority Biomedical Research Support (MBRS) Grant GM08224 and National Center for Research Resources Research Centers in Minority Institutions Grant G12RR03051.; Supported in part by MBRS/Research Initiative for Scientific Enhancement Grant R25GM061838.; Supported in part by National Institutes of Health MHIRT Award 9 T37 MD001477-05.	Abu Bakar N, 2010, J CELL SCI, V123, P441, DOI 10.1242/jcs.061499; Arora K, 2005, PARASITOL RES, V97, P521, DOI 10.1007/s00436-005-1478-4; Atamna H, 1997, EUR J BIOCHEM, V250, P670, DOI 10.1111/j.1432-1033.1997.00670.x; ATAMNA H, 1995, J BIOL CHEM, V270, P24876, DOI 10.1074/jbc.270.42.24876; Atreya CE, 2003, J BIOL CHEM, V278, P14092, DOI 10.1074/jbc.M212690200; Ayi K, 1998, FEBS LETT, V424, P257, DOI 10.1016/S0014-5793(98)00185-9; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Becker K, 2003, EUR J BIOCHEM, V270, P1057, DOI 10.1046/j.1432-1033.2003.03495.x; Becker K, 2003, BIOL CHEM, V384, P551, DOI 10.1515/BC.2003.063; Birago C, 1999, MOL BIOCHEM PARASIT, V99, P33, DOI 10.1016/S0166-6851(98)00179-0; Bozdech Z, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-23; Braks JAM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj033; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; de Koning-Ward TF, 2000, MOL BIOCHEM PARASIT, V106, P199, DOI 10.1016/S0166-6851(99)00189-9; Deharo E, 2003, BIOCHEM PHARMACOL, V66, P809, DOI 10.1016/S0006-2952(03)00396-4; DUBOIS VL, 1995, EXP PARASITOL, V81, P117, DOI 10.1006/expr.1995.1099; ELFERINK RPJO, 1990, AM J PHYSIOL, V258, pG699, DOI 10.1152/ajpgi.1990.258.5.G699; ENEA V, 1984, P NATL ACAD SCI-BIOL, V81, P7520, DOI 10.1073/pnas.81.23.7520; Farber PM, 1998, FEBS LETT, V422, P311, DOI 10.1016/S0014-5793(98)00031-3; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Friebolin W, 2008, J MED CHEM, V51, P1260, DOI 10.1021/jm7009292; Gallo V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007303; Garavito G, 2007, PARASITE, V14, P135, DOI 10.1051/parasite/2007142135; Gilberger TW, 2000, MOL BIOCHEM PARASIT, V107, P169, DOI 10.1016/S0166-6851(00)00188-2; Grellier P, 2001, ARCH BIOCHEM BIOPHYS, V393, P199, DOI 10.1006/abbi.2001.2487; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Homolya L, 2003, BIOFACTORS, V17, P103, DOI 10.1002/biof.5520170111; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; JANSE CJ, 1994, METHOD CELL BIOL, V42, P295; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Janse CJ, 2003, MOL MICROBIOL, V50, P1539, DOI 10.1046/j.1365-2958.2003.03820.x; JANSE CJ, 1994, INT J PARASITOL, V24, P589, DOI 10.1016/0020-7519(94)90150-3; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; KELNER MJ, 1985, J BIOL CHEM, V260, P5168; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Koncarevic S, 2009, P NATL ACAD SCI USA, V106, P13323, DOI 10.1073/pnas.0905387106; KRAUTHSIEGEL RL, 1989, BIOCHEM SOC T, V17, P315, DOI 10.1042/bst0170315; Krungkrai J, 2000, PARASITE, V7, P19, DOI 10.1051/parasite/2000071019; Kumar S, 2003, MOL PHARMACOL, V63, P276, DOI 10.1124/mol.63.2.276; Lash LH, 2006, CHEM-BIOL INTERACT, V163, P54, DOI 10.1016/j.cbi.2006.03.001; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Luersen K, 2000, BIOCHEM J, V346, P545, DOI 10.1042/0264-6021:3460545; MANSOOR MA, 1992, ANAL BIOCHEM, V200, P218, DOI 10.1016/0003-2697(92)90456-H; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Massimine KM, 2006, ANTIMICROB AGENTS CH, V50, P3132, DOI 10.1128/AAC.00621-06; Meierjohann S, 2002, BIOCHEM J, V368, P761, DOI 10.1042/BJ20020962; Meierjohann S, 2002, BIOCHEM J, V363, P833, DOI 10.1042/0264-6021:3630833; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Muller S, 2001, PROTOPLASMA, V217, P43, DOI 10.1007/BF01289412; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Platel DFN, 1999, MOL BIOCHEM PARASIT, V98, P215, DOI 10.1016/S0166-6851(98)00170-4; Ponzi M, 2009, CELL MICROBIOL, V11, P1272, DOI 10.1111/j.1462-5822.2009.01331.x; Quittnat F, 2004, MOL BIOCHEM PARASIT, V138, P107, DOI 10.1016/j.molbiopara.2004.08.004; Rodrigues JR, 2009, PARASITOL RES, V104, P1491, DOI 10.1007/s00436-009-1355-7; Rodriguez JF, 1998, PEDIATR INFECT DIS J, V17, P236, DOI 10.1097/00006454-199803000-00012; ROSNER B, 2000, FUNDAMENTALS BIOSTAT, P32; Sarma GN, 2003, J MOL BIOL, V328, P893, DOI 10.1016/S0022-2836(03)00347-4; Schirmer RH, 2003, REDOX REP, V8, P272, DOI 10.1179/135100003225002899; SINDEN RE, 1997, MOL BIOL INSECT DIS, P261; SINDEN RE, 1978, RODENT MALARIA, P1; Spaccapelo R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/ajpath.2010.090504; Srinivasan P, 2008, CELL MICROBIOL, V10, P1304, DOI 10.1111/j.1462-5822.2008.01127.x; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Taraschi TF, 2001, INT J PARASITOL, V31, P1381, DOI 10.1016/S0020-7519(01)00256-9; TUGGLE CK, 1985, J BACTERIOL, V162, P448, DOI 10.1128/JB.162.1.448-450.1985; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Wiser MF, 1996, MOL BIOCHEM PARASIT, V83, P25, DOI 10.1016/S0166-6851(96)02743-0; WORTHINGTON DJ, 1976, EUR J BIOCHEM, V67, P231, DOI 10.1111/j.1432-1033.1976.tb10654.x; WORTHINGTON DJ, 1974, EUR J BIOCHEM, V48, P167, DOI 10.1111/j.1432-1033.1974.tb03754.x; Zhang JM, 1999, MOL BIOCHEM PARASIT, V99, P129, DOI 10.1016/S0166-6851(99)00008-0; Zuluaga L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-47	81	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27045	27056		10.1074/jbc.M110.122275	http://dx.doi.org/10.1074/jbc.M110.122275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573956	hybrid, Green Published			2022-12-25	WOS:000281172700036
J	Winarski, KL; Sheng, N; Chen, JX; Kleyman, TR; Sheng, SH				Winarski, Katie L.; Sheng, Nan; Chen, Jingxin; Kleyman, Thomas R.; Sheng, Shaohu			Extracellular Allosteric Regulatory Subdomain within the gamma Subunit of the Epithelial Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; SELF-INHIBITION; HISTIDINE-RESIDUES; ENAC; ACTIVATION; SITES; FURIN; SELECTIVITY; TRANSPORT; PROTEASES	The activity of the epithelial Na+ channel (ENaC) is modulated by Na+ self-inhibition, a down-regulation of the open probability of ENaC by extracellular Na+. A His residue within the extracellular domain of gamma ENaC (gamma His(239)) was found to have a critical role in Na+ self-inhibition. We investigated the functional roles of residues in the vicinity of this His by mutagenesis and analyses of Na+ self-inhibition responses in Xenopus oocytes. Significant changes in the speed and magnitude of Na+ self-inhibition were observed in 16 of the 47 mutants analyzed. These 16 mutants were distributed within a 22-residue tract. We further characterized this scanned region by examining the accessibility of introduced Cys residues to the sulfhydryl reagent MTSET. External MTSET irreversibly increased or decreased currents in 13 of 47 mutants. The distribution patterns of the residues where substitutions significantly altered Na+ self-inhibition or/and conferred sensitivity to MTSET were consistent with the existence of two helices within this region. In addition, single channel recordings of the gamma H239F mutant showed that, in the absence of Na+ self-inhibition and with an increased open probability, ENaCs still undergo transitions between open and closed states. We conclude that gamma His(239) functions within an extracellular allosteric regulatory subdomain of the gamma subunit that has an important role in conferring the response of the channel to external Na+.	[Winarski, Katie L.; Sheng, Nan; Chen, Jingxin; Kleyman, Thomas R.; Sheng, Shaohu] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	National Institutes of Health [R01 DK054354, R01 ES014701, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054354, P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK054354, R01 ES014701, and P30 DK079307.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF1249, DOI 10.1152/ajprenal.00401.2009; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Ma CL, 2007, J BIOL CHEM, V282, P17210, DOI 10.1074/jbc.M611268200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Palmer LG, 1996, J GEN PHYSIOL, V107, P35, DOI 10.1085/jgp.107.1.35; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHENG S, 2007, SELDIN GIEBISCHS KID, P743; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF236, DOI 10.1152/ajprenal.00002.2007	39	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26088	26096		10.1074/jbc.M110.149963	http://dx.doi.org/10.1074/jbc.M110.149963			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20587418	Green Published, hybrid			2022-12-25	WOS:000280921000025
J	Keutgens, A; Zhang, X; Shostak, K; Robert, I; Olivier, S; Vanderplasschen, A; Chapelle, JP; Viatour, P; Merville, MP; Bex, F; Gothot, A; Chariot, A				Keutgens, Aurore; Zhang, Xin; Shostak, Kateryna; Robert, Isabelle; Olivier, Sabine; Vanderplasschen, Alain; Chapelle, Jean-Paul; Viatour, Patrick; Merville, Marie-Paule; Bex, Francoise; Gothot, Andre; Chariot, Alain			BCL-3 Degradation Involves Its Polyubiquitination through a FBW7-independent Pathway and Its Binding to the Proteasome Subunit PSMB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FBW7 UBIQUITIN LIGASE; ANAPLASTIC LARGE-CELL; CYCLIN-E DEGRADATION; PROTOONCOGENE BCL-3; ONCOPROTEIN BCL-3; TUMOR-SUPPRESSOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION	The oncogenic protein BCL-3 activates or represses gene transcription through binding with the NF-kappa B proteins p50 and p52 and is degraded through a phospho-and GSK3-dependent pathway. However, the mechanisms underlying its degradation remain poorly understood. Yeast two-hybrid analysis led to the identification of the proteasome subunit PSMB1 as a BCL-3-associated protein. The binding of BCL-3 to PSMB1 is required for its degradation through the proteasome. Indeed, PSMB1-depleted cells are defective in degrading polyubiquitinated BCL-3. The N-terminal part of BCL-3 includes lysines 13 and 26 required for the Lys(48)-linked polyubiquitination of BCL-3. Moreover, the E3 ligase FBW7, known to polyubiquitinate a variety of substrates phosphorylated by GSK3, is dispensable for BCL-3 degradation. Thus, our data defined a unique motif of BCL-3 that is needed for its recruitment to the proteasome and identified PSMB1 as a key protein required for the proteasome-mediated degradation of a nuclear and oncogenic I kappa B protein.	[Keutgens, Aurore; Zhang, Xin; Shostak, Kateryna; Robert, Isabelle; Olivier, Sabine; Chapelle, Jean-Paul; Viatour, Patrick; Merville, Marie-Paule; Gothot, Andre; Chariot, Alain] Univ Liege, Fac Vet Med, Interdisciplinary Cluster Appl Genoprote GIGA Res, B-4000 Liege, Belgium; [Keutgens, Aurore; Zhang, Xin; Shostak, Kateryna; Robert, Isabelle; Olivier, Sabine; Chapelle, Jean-Paul; Viatour, Patrick; Merville, Marie-Paule; Chariot, Alain] Univ Liege, Fac Vet Med, Unit Med Chem, B-4000 Liege, Belgium; [Keutgens, Aurore; Zhang, Xin; Shostak, Kateryna; Robert, Isabelle; Olivier, Sabine; Chapelle, Jean-Paul; Viatour, Patrick; Merville, Marie-Paule; Chariot, Alain] Univ Liege, Fac Vet Med, GIGA Signal Transduct, B-4000 Liege, Belgium; [Vanderplasschen, Alain] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, B-4000 Liege, Belgium; [Bex, Francoise] Univ Brussels, Inst Microbiol Res JM Wiame, B-1070 Brussels, Belgium; [Bex, Francoise] Univ Brussels, Microbiol Lab, B-1070 Brussels, Belgium; [Gothot, Andre] Univ Liege, Dept Med Hematol, B-4000 Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege	Chariot, A (corresponding author), Univ Liege, GIGA R, Med Chem Lab, Tour GIGA, 2 B34, B-4000 Liege, Belgium.	Alain.chariot@ulg.ac.be		Chariot, Alain/0000-0002-1691-4347	Fonds de la Recherche Scientifique (FNRS); TELEVIE; Belgian Federation Against Cancer; University of Liege [04/09-323]; Federal Ministry of Science; Centre Anti-Cancereux; Leon Fredericq Foundation (ULg); King Baudouin Foundation (Brussels, Belgium)	Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); TELEVIE; Belgian Federation Against Cancer; University of Liege(University of Liege); Federal Ministry of Science; Centre Anti-Cancereux; Leon Fredericq Foundation (ULg); King Baudouin Foundation (Brussels, Belgium)	This work was supported by grants from the Fonds de la Recherche Scientifique (FNRS), TELEVIE, the Belgian Federation Against Cancer, the Concerted Research Action Program (04/09-323, University of Liege), the Inter-University Attraction Pole 6/12 (Federal Ministry of Science), the Centre Anti-Cancereux, the Leon Fredericq Foundation (ULg), and the King Baudouin Foundation (Brussels, Belgium).	An J, 2008, CANCER CELL, V14, P394, DOI 10.1016/j.ccr.2008.10.007; Arsura M, 2000, MOL CELL BIOL, V20, P5381, DOI 10.1128/MCB.20.15.5381-5391.2000; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Brenne AT, 2009, EUR J HAEMATOL, V82, P354, DOI 10.1111/j.1600-0609.2009.01225.x; Canoz O, 2004, MODERN PATHOL, V17, P911, DOI 10.1038/modpathol.3800140; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Hanson JL, 2004, CANCER RES, V64, P7248, DOI 10.1158/0008-5472.CAN-03-3898; Hanson JL, 2003, J BIOL CHEM, V278, P34910, DOI 10.1074/jbc.M304189200; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Mathas S, 2005, BLOOD, V106, P4287, DOI 10.1182/blood-2004-09-3620; MCKEITHAN TW, 1987, P NATL ACAD SCI USA, V84, P9257, DOI 10.1073/pnas.84.24.9257; Minella AC, 2005, P NATL ACAD SCI USA, V102, P9649, DOI 10.1073/pnas.0503677102; Nishikori M, 2003, BLOOD, V101, P2789, DOI 10.1182/blood-2002-08-2464; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; O'Neil BH, 2007, ONCOLOGY-BASEL, V72, P97, DOI 10.1159/000111116; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Ong ST, 1998, ONCOGENE, V16, P2333, DOI 10.1038/sj.onc.1201771; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Viatour P, 2003, J BIOL CHEM, V278, P46541, DOI 10.1074/jbc.M306381200; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	32	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25831	25840		10.1074/jbc.M110.112128	http://dx.doi.org/10.1074/jbc.M110.112128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558726	Green Published, hybrid			2022-12-25	WOS:000280682400075
J	Yu, FX; Chai, TF; He, HP; Hagen, T; Luo, Y				Yu, Fa-Xing; Chai, Tin Fan; He, Hongpeng; Hagen, Thilo; Luo, Yan			Thioredoxin-interacting Protein (Txnip) Gene Expression SENSING OXIDATIVE PHOSPHORYLATION STATUS AND GLYCOLYTIC RATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-CONTAINING MOLECULES; CARBOHYDRATE RESPONSE ELEMENT; BETA-CELL APOPTOSIS; GLUCOSE; ACTIVATION; STIMULATION; KINASE; GROWTH; VDUP1; 6-PHOSPHOFRUCTO-2-KINASE	Thioredoxin-interacting protein (Txnip) has important functions in regulating cellular metabolism including glucose utilization; the expression of the Txnip gene is sensitive to the availability of glucose and other fuels. Here, we show that Txnip expression is down-regulated at the transcriptional level by diverse inhibitors of mitochondrial oxidative phosphorylation (OXPHOS). The effect of these OXPHOS inhibitors is mediated by earlier identified carbohydrate-response elements (ChoREs) on the Txnip promoter and the ChoRE-associated transcription factors Max-like protein X (MLX) and MondoA (or carbohydrate-response element-binding protein (ChREBP)) involved in glucose-induced Txnip expression, suggesting that inhibited oxidative phosphorylation compromises glucose-induced effects on Txnip expression. We also show that the OXPHOS inhibitors repress the Txnip transcription most likely by inducing the glycolytic rate, and increased glycolytic flux decreases the levels of glycolytic intermediates important for the function of MLX and MondoA (or ChREBP). Our findings suggest that the Txnip expression is tightly correlated with glycolytic flux, which is regulated by oxidative phosphorylation status. The identified link between the Txnip expression and glycolytic activity implies a mechanism by which the cellular glucose uptake/homeostasis is regulated in response to various metabolic cues, oxidative phosphorylation status, and other physiological signals, and this may facilitate our efforts toward understanding metabolism in normal or cancer cells.	[Chai, Tin Fan; Hagen, Thilo; Luo, Yan] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Yu, Fa-Xing; He, Hongpeng; Luo, Yan] Inst Mol & Cell Biol, Singapore 138673, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hagen, T (corresponding author), Natl Univ Singapore, Dept Biochem, 8 Med Dr, Singapore 117597, Singapore.	thilo_hagen@nuhs.edu.sg; yluo@imcb.a-star.edu.sg		Yu, Fa-Xing/0000-0003-4834-9335	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by grants from the Agency for Science, Technology and Research (A*STAR), Singapore.	APARICIO O, 2005, CURRENT PROTOCOLS MO; Bertrand L, 1999, J BIOL CHEM, V274, P30927, DOI 10.1074/jbc.274.43.30927; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; Donnelly KL, 2004, J NUTR, V134, P1475, DOI 10.1093/jn/134.6.1475; Fan X, 2003, J BIOL CHEM, V278, P10232, DOI 10.1074/jbc.M209911200; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jeon JH, 2005, CANCER RES, V65, P4485, DOI 10.1158/0008-5472.CAN-04-2271; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; LANKS KW, 1986, J CELL PHYSIOL, V126, P319, DOI 10.1002/jcp.1041260224; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Schulze PC, 2006, ARTERIOSCL THROM VAS, V26, P2666, DOI 10.1161/01.ATV.0000248914.21018.f1; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Shaked M, 2009, DIABETOLOGIA, V52, P636, DOI 10.1007/s00125-009-1274-2; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; Yu FX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008397; Yu FX, 2009, MOL ENDOCRINOL, V23, P932, DOI 10.1210/me.2008-0383; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321	36	56	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25822	25830		10.1074/jbc.M110.108290	http://dx.doi.org/10.1074/jbc.M110.108290			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558747	Green Published, hybrid			2022-12-25	WOS:000280682400074
J	Darling, AE; Mau, B; Perna, NT				Darling, Aaron E.; Mau, Bob; Perna, Nicole T.			progressiveMauve: Multiple Genome Alignment with Gene Gain, Loss and Rearrangement	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; ESCHERICHIA-COLI; TREE RECONSTRUCTION; LOCAL ALIGNMENT; EVOLUTION; HOMOLOGY; INVERSION; INFERENCE; REPEATS; VIEW	Background: Multiple genome alignment remains a challenging problem. Effects of recombination including rearrangement, segmental duplication, gain, and loss can create a mosaic pattern of homology even among closely related organisms. Methodology/Principal Findings: We describe a new method to align two or more genomes that have undergone rearrangements due to recombination and substantial amounts of segmental gain and loss ( flux). We demonstrate that the new method can accurately align regions conserved in some, but not all, of the genomes, an important case not handled by our previous work. The method uses a novel alignment objective score called a sum-of-pairs breakpoint score, which facilitates accurate detection of rearrangement breakpoints when genomes have unequal gene content. We also apply a probabilistic alignment filtering method to remove erroneous alignments of unrelated sequences, which are commonly observed in other genome alignment methods. We describe new metrics for quantifying genome alignment accuracy which measure the quality of rearrangement breakpoint predictions and indel predictions. The new genome alignment algorithm demonstrates high accuracy in situations where genomes have undergone biologically feasible amounts of genome rearrangement, segmental gain and loss. We apply the new algorithm to a set of 23 genomes from the genera Escherichia, Shigella, and Salmonella. Analysis of whole-genome multiple alignments allows us to extend the previously defined concepts of core- and pan-genomes to include not only annotated genes, but also non-coding regions with potential regulatory roles. The 23 enterobacteria have an estimated core- genome of 2.46Mbp conserved among all taxa and a pan-genome of 15.2Mbp. We document substantial population-level variability among these organisms driven by segmental gain and loss. Interestingly, much variability lies in intergenic regions, suggesting that the Enterobacteriacae may exhibit regulatory divergence. Conclusions: The multiple genome alignments generated by our software provide a platform for comparative genomic and population genomic studies. Free, open-source software implementing the described genome alignment approach is available from http://gel.ahabs.wisc.edu/mauve.	[Darling, Aaron E.; Perna, Nicole T.] Univ Wisconsin, Genome Ctr, Madison, WI USA; [Darling, Aaron E.] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Mau, Bob] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA; [Mau, Bob] Univ Wisconsin, Dept Oncol, Madison, WI USA; [Perna, Nicole T.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Darling, AE (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	aarondarling@ucdavis.edu	Weinstock, George M/C-6314-2013; Darling, Aaron/G-8119-2017	Weinstock, George M/0000-0002-2997-4592; Perna, Nicole/0000-0001-8208-0929; Darling, Aaron/0000-0003-2397-7925	National Institutes of Health (NIH) [R01-GM62994]; National Science Foundation (NSF) [DBI-0630765]; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services [HHSN266200400040C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062994] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) grant R01-GM62994 to N.T.P. and National Science Foundation (NSF) grant DBI-0630765 to A.E.D. This project has also been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, under Contract No. HHSN266200400040C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2003, GENETICS, V164, P1279; Akerborg O, 2009, P NATL ACAD SCI USA, V106, P5714, DOI 10.1073/pnas.0806251106; Alekseyev MA, 2008, J COMPUT BIOL, V15, P1117, DOI 10.1089/cmb.2008.0080; Bergeron A, 2006, LECT NOTES COMPUT SC, V4175, P163; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Blanchette, 1997, Genome Inform Ser Workshop Genome Inform, V8, P25; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Bray N, 2003, NUCLEIC ACIDS RES, V31, P3525, DOI 10.1093/nar/gkg623; Brudno M, 2004, NUCLEIC ACIDS RES, V32, pW41, DOI 10.1093/nar/gkh361; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; CHAO KM, 1995, COMPUT APPL BIOSCI, V11, P147; Chiaromonte F, 2002, Pac Symp Biocomput, P115; Darling AE, 2006, LECT NOTES COMPUT SC, V4175, P126; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darling AE, 2004, BIOINFORMATICS, V20, P122, DOI 10.1093/bioinformatics/btg378; DARLING AE, 2006, THESIS U WISCONSIN M; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; DEWEY CN, 2006, HUM MOL GENET S1, V15; Dewey Colin N., 2007, V395, P221; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2009, GENOME RES, V19, P306, DOI 10.1101/gr.082263.108; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dubchak I, 2009, GENOME RES, V19, P682, DOI 10.1101/gr.081778.108; DURBIN R, 1998, BIOL SEQUENCE ANAL P, P80; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; Fu Z, 2007, J COMPUT BIOL, V14, P1160, DOI 10.1089/cmb.2007.0048; Hannenhalli S, 1995, AN S FDN CO, P581, DOI 10.1109/SFCS.1995.492588; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hohl Michael, 2002, Bioinformatics, V18 Suppl 1, pS312; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kucherov G, 2005, IEEE ACM T COMPUT BI, V2, P51, DOI 10.1109/TCBB.2005.12; Kumar S, 2007, GENOME RES, V17, P127, DOI 10.1101/gr.5232407; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langille MGI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010071; Larget B, 2002, J R STAT SOC B, V64, P681, DOI 10.1111/1467-9868.00356; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LIPPERT RA, 2004, RECOMB, P233; LUNTER G, 2007, BIOINFORMATICS, V23; Lunter G, 2008, GENOME RES, V18, P298, DOI 10.1101/gr.6725608; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Ma J, 2008, P NATL ACAD SCI USA, V105, P14254, DOI 10.1073/pnas.0805217105; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; MILLER W, 2007, GENOME RES; Ogurtsov AY, 2002, BIOINFORMATICS, V18, P1703, DOI 10.1093/bioinformatics/18.12.1703; OPPENHEIM AB, 1993, MOL MICROBIOL, V10, P113, DOI 10.1111/j.1365-2958.1993.tb00908.x; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Phuong TM, 2006, NUCLEIC ACIDS RES, V34, P5932, DOI 10.1093/nar/gkl511; Prakash A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r124; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Raphael B, 2004, GENOME RES, V14, P2336, DOI 10.1101/gr.2657504; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Swidan F, 2006, PLOS COMPUT BIOL, V2, P870, DOI 10.1371/journal.pcbi.0020075; Swidan F, 2006, J COMPUT BIOL, V13, P1397, DOI 10.1089/cmb.2006.13.1397; Tang JJ, 2003, BIOINFORMATICS, V19, pi305, DOI 10.1093/bioinformatics/btg1042; Tannier E, 2004, LECT NOTES COMPUT SC, V3109, P1; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Treangen TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-433; Treangen TJ, 2009, IEEE ACM T COMPUT BI, V6, P180, DOI 10.1109/TCBB.2009.9; Vernikos GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r100; Vinh L., 2006, GENOME INFORM, V17, P141; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Yancopoulos S, 2005, BIOINFORMATICS, V21, P3340, DOI 10.1093/bioinformatics/bti535; Yang J, 2007, J MOL EVOL, V64, P71, DOI 10.1007/s00239-006-0052-8; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1285, DOI 10.1073/pnas.0409240102	75	2543	2564	6	195	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11147	10.1371/journal.pone.0011147	http://dx.doi.org/10.1371/journal.pone.0011147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593022	Green Submitted, Green Published, gold			2022-12-25	WOS:000279140800001
J	Panosa, A; Roca, I; Gibert, I				Panosa, Anais; Roca, Ignasi; Gibert, Isidre			Ribonucleotide Reductases of Salmonella Typhimurium: Transcriptional Regulation and Differential Role in Pathogenesis	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NITRIC-OXIDE SYNTHASE; CELL-CYCLE REGULATION; COLI-NRD OPERON; ESCHERICHIA-COLI; EXPRESSION ANALYSIS; DIPHOSPHATE REDUCTASE; NATURAL-RESISTANCE; HYDROGEN-PEROXIDE; DNA-REPLICATION	Ribonucleotide reductases (RNRs) are essential enzymes that carry out the de novo synthesis of deoxyribonucleotides by reducing ribonucleotides. There are three different classes of RNRs (I, II and III), all having different oxygen dependency and biochemical characteristics. Salmonella enterica serovar Typhimurium (S. Typhimurium) harbors class Ia, class Ib and class III RNRs in its genome. We have studied the transcriptional regulation of these three RNR classes in S. Typhimurium as well as their differential function during infection of macrophage and epithelial cells. Deletion of both NrdR and Fur, two main transcriptional regulators, indicates that Fur specifically represses the class Ib enzyme and that NrdR acts as a global repressor of all three classes. A Fur recognition sequence within the nrdHIEF promoter has also been described and confirmed by electrophoretic mobility shift assays (EMSA). In order to elucidate the role of each RNR class during infection, S. Typhimurium single and double RNR mutants (as well as Fur and NrdR mutants) were used in infection assays with macrophage and epithelial cell lines. Our results indicate class Ia to be mainly responsible for deoxyribonucleotide production during invasion and proliferation inside macrophages and epithelial cells. Neither class Ib nor class III seem to be essential for growth under these conditions. However, class Ib is able to maintain certain growth in an nrdAB mutant during the first hours of macrophage infection. Our results suggest that, during the early stages of macrophage infection, class Ib may contribute to deoxyribonucleotide synthesis by means of both an NrdR and a Fur-dependent derepression of nrdHIEF due to hydrogen peroxide production and DNA damage associated with the oxidative burst, thus helping to overcome the host defenses.	Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Panosa, A (corresponding author), Hosp Arnau Vilanova, Labs Invest IRBLleida, Lleida, Spain.	IGROCA@clinic.ub.es; Isidre.Gibert@uab.cat	Panosa, Anais/A-1402-2013; Gibert, Isidre/L-9834-2014; Roca, Ignasi/M-4509-2014	Panosa, Anais/0000-0001-7686-9237; Gibert, Isidre/0000-0003-1442-2258; Roca, Ignasi/0000-0002-1800-1576	Ministerio de Educacion y Ciencia [BFU2004-03383]; (Generalitat de Catalunya), Spain [2005SGR-00956, 2009SGR-00108]; Universitat Autonoma de Barcelona	Ministerio de Educacion y Ciencia(Spanish Government); (Generalitat de Catalunya), Spain(Generalitat de Catalunya); Universitat Autonoma de Barcelona	This work was supported by grants BFU2004-03383 (Ministerio de Educacion y Ciencia), 2005SGR- 00956 and 2009SGR-00108 (Generalitat de Catalunya), Spain. A. P. was recipient of a fellowship from the Universitat Autonoma de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, J MOL MICROB BIOTECH, V2, P191; AUGUSTIN LB, 1994, J BACTERIOL, V176, P378, DOI 10.1128/JB.176.2.378-387.1994; Borovok I, 2004, MOL MICROBIOL, V54, P1022, DOI 10.1111/j.1365-2958.2004.04325.x; Borovok I, 2002, MICROBIOL-SGM, V148, P391, DOI 10.1099/00221287-148-2-391; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY DJ, 1979, CLIN EXP IMMUNOL, V37, P7; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DELORENZO V, 1988, EUR J BIOCHEM, V173, P537; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; FILPULA D, 1977, J BACTERIOL, V130, P107, DOI 10.1128/JB.130.1.107-113.1977; FILPULA D, 1978, J BACTERIOL, V135, P429, DOI 10.1128/JB.135.2.429-435.1978; Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; GROS P, 1981, J IMMUNOL, V127, P2417; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Han JS, 1998, MOL GEN GENET, V259, P610, DOI 10.1007/s004380050854; HANTKE K, 1988, ARCH MICROBIOL, V149, P344, DOI 10.1007/BF00411654; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Ikeda JS, 2005, J BACTERIOL, V187, P912, DOI 10.1128/JB.187.3.912-922.2005; Jacobson BA, 1998, MOL MICROBIOL, V28, P1307, DOI 10.1046/j.1365-2958.1998.00896.x; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; JORDAN A, 1994, J BACTERIOL, V176, P3420, DOI 10.1128/jb.176.11.3420-3427.1994; Jordan A, 1996, MOL MICROBIOL, V19, P777, DOI 10.1046/j.1365-2958.1996.424950.x; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; PLANT J, 1976, J INFECT DIS, V133, P72, DOI 10.1093/infdis/133.1.72; Roca I, 2008, INT MICROBIOL, V11, P49, DOI 10.2436/20.1501.01.44; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Sambrook D.J., 1989, MOL CLONING LAB MANU; Smalley D, 2002, J BACTERIOL, V184, P895, DOI 10.1128/jb.184.4.895-903.2002; SUN L, 1994, J BACTERIOL, V176, P2415, DOI 10.1128/JB.176.8.2415-2426.1994; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Torrents E, 2003, MICROBIOL-SGM, V149, P1011, DOI 10.1099/mic.0.26133-0; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Williams SM, 1998, FEMS MICROBIOL LETT, V163, P203, DOI 10.1111/j.1574-6968.1998.tb13046.x; Wyllie S, 2002, MICROBES INFECT, V4, P351, DOI 10.1016/S1286-4579(02)01548-4; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	55	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11328	10.1371/journal.pone.0011328	http://dx.doi.org/10.1371/journal.pone.0011328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593029	Green Published, gold, Green Submitted			2022-12-25	WOS:000279140800025
J	Xue, Y; Liu, ZX; Gao, XJ; Jin, CJ; Wen, LP; Yao, XB; Ren, JA				Xue, Yu; Liu, Zexian; Gao, Xinjiao; Jin, Changjiang; Wen, Longping; Yao, Xuebiao; Ren, Jian			GPS-SNO: Computational Prediction of Protein S-Nitrosylation Sites with a Modified GPS Algorithm	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; IDENTIFICATION; DENITROSYLATION	As one of the most important and ubiquitous post-translational modifications (PTMs) of proteins, S-nitrosylation plays important roles in a variety of biological processes, including the regulation of cellular dynamics and plasticity. Identification of S-nitrosylated substrates with their exact sites is crucial for understanding the molecular mechanisms of S-nitrosylation. In contrast with labor-intensive and time-consuming experimental approaches, prediction of S-nitrosylation sites using computational methods could provide convenience and increased speed. In this work, we developed a novel software of GPS-SNO 1.0 for the prediction of S-nitrosylation sites. We greatly improved our previously developed algorithm and released the GPS 3.0 algorithm for GPS-SNO. By comparison, the prediction performance of GPS 3.0 algorithm was better than other methods, with an accuracy of 75.80%, a sensitivity of 53.57% and a specificity of 80.14%. As an application of GPS-SNO 1.0, we predicted putative S-nitrosylation sites for hundreds of potentially S-nitrosylated substrates for which the exact S-nitrosylation sites had not been experimentally determined. In this regard, GPS-SNO 1.0 should prove to be a useful tool for experimentalists. The online service and local packages of GPS-SNO were implemented in JAVA and are freely available at: http://sno.biocuckoo.org/.	[Xue, Yu] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Dept Syst Biol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Liu, Zexian; Gao, Xinjiao; Jin, Changjiang; Wen, Longping; Yao, Xuebiao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Liu, Zexian; Gao, Xinjiao; Jin, Changjiang; Wen, Longping; Yao, Xuebiao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Ren, Jian] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University	Xue, Y (corresponding author), Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Dept Syst Biol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	xueyu@mail.hust.edu.cn; renjian.sysu@gmail.com	Liu, Zexian/D-1153-2011; Xue, Yu/G-5929-2011; Ren, Jian/D-3270-2011; Yao, Xuebiao/P-5771-2014	Liu, Zexian/0000-0001-9698-0610; Xue, Yu/0000-0002-9403-6869; Ren, Jian/0000-0002-4161-1292; Wen, Longping/0000-0003-0384-4578	National Basic Research Program [2006CB933300, 2007CB947401, 2007CB914503, 2010CB945400]; National Natural Science Foundation of China [90919001, 30700138, 30900835, 30830036, 30721002]; Chinese Academy of Sciences [KSCX2-YW-R-139, INFO-115-C01-SDB4-36]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program (973 project) (2006CB933300, 2007CB947401, 2007CB914503, 2010CB945400), National Natural Science Foundation of China (90919001, 30700138, 30900835, 30830036, 30721002), and Chinese Academy of Sciences (KSCX2-YW-R-139, INFO-115-C01-SDB4-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Derakhshan B, 2007, NAT PROTOC, V2, P1685, DOI 10.1038/nprot.2007.210; DHAWAN AP, 1991, IEEE ENG MED BIOL, V10, P30, DOI 10.1109/51.107166; Filzmoser P, 1999, MAGN RESON IMAGING, V17, P817, DOI 10.1016/S0730-725X(99)00014-4; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Han P, 2008, RAPID COMMUN MASS SP, V22, P1137, DOI 10.1002/rcm.3476; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hernlund E, 2009, FREE RADICAL BIO MED, V46, P1607, DOI 10.1016/j.freeradbiomed.2009.03.015; Herwig R, 1999, GENOME RES, V9, P1093, DOI 10.1101/gr.9.11.1093; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hess DT, 2001, NAT CELL BIOL, V3, pE46, DOI 10.1038/35055152; Huang B, 2009, CARDIOVASC RES, V83, P536, DOI 10.1093/cvr/cvp154; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kuncewicz T, 2003, MOL CELL PROTEOMICS, V2, P156, DOI 10.1074/mcp.M300003-MCP200; Lai TS, 2001, BIOCHEMISTRY-US, V40, P4904, DOI 10.1021/bi002321t; Lefievre L, 2007, PROTEOMICS, V7, P3066, DOI 10.1002/pmic.200700254; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li H, 2009, MOL CELL PROTEOMICS, V8, P1839, DOI 10.1074/mcp.M900030-MCP200; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Murphy JP, 2010, PROTEOMICS, V10, P1847, DOI 10.1002/pmic.200900711; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Soukas A, 2000, GENE DEV, V14, P963; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Tannenbaum SR, 2006, ACS CHEM BIOL, V1, P615, DOI 10.1021/cb600439h; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yoon S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S10; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	41	174	177	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11290	10.1371/journal.pone.0011290	http://dx.doi.org/10.1371/journal.pone.0011290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585580	Green Submitted, gold, Green Published			2022-12-25	WOS:000279135800004
J	Hatano, E; Kunert, G; Weisser, WW				Hatano, Eduardo; Kunert, Grit; Weisser, Wolfgang W.			Aphid Wing Induction and Ecological Costs of Alarm Pheromone Emission under Field Conditions	PLOS ONE			English	Article							GREEN PEACH APHID; ACYRTHOSIPHON-PISUM; 2 STRAINS; (E)-BETA-FARNESENE; BEHAVIOR; PREDATORS; RESPONSES; LADYBIRD; FORMS	The pea aphid, Acyrthosiphon pisum Harris, (Homoptera: Aphididae) releases the volatile sesquiterpene (E)-beta-farnesene (EBF) when attacked by a predator, triggering escape responses in the aphid colony. Recently, it was shown that this alarm pheromone also mediates the production of the winged dispersal morph under laboratory conditions. The present work tested the wing-inducing effect of EBF under field conditions. Aphid colonies were exposed to two treatments (control and EBF) and tested in two different environmental conditions (field and laboratory). As in previous experiments aphids produced higher proportion of winged morphs among their offspring when exposed to EBF in the laboratory but even under field conditions the proportion of winged offspring was higher after EBF application (6.84 +/- 0.98%) compared to the hexane control (1.54 +/- 0.25%). In the field, the proportion of adult aphids found on the plant at the end of the experiment was lower in the EBF treatment (58.1 +/- 5.5%) than in the control (66.9 +/- 4.6%), in contrast to the climate chamber test where the numbers of adult aphids found on the plant at the end of the experiment were, in both treatments, similar to the numbers put on the plant initially. Our results show that the role of EBF in aphid wing induction is also apparent under field conditions and they may indicate a potential cost of EBF emission. They also emphasize the importance of investigating the ecological role of induced defences under field conditions.	[Hatano, Eduardo; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany; [Hatano, Eduardo; Kunert, Grit] Max Planck Inst Chem Ecol, Jena, Germany	Friedrich Schiller University of Jena; Max Planck Society	Hatano, E (corresponding author), Univ Jena, Inst Ecol, Jena, Germany.	wolfgang.weisser@uni-jena.de	Hatano, Eduardo/AAE-3430-2020; Hatano, Eduardo/AAK-1381-2020; Weisser, Wolfgang W/B-9718-2014; Kunert, Grit/H-4271-2014	Hatano, Eduardo/0000-0002-2575-244X; Weisser, Wolfgang W/0000-0002-2757-8959; Kunert, Grit/0000-0002-9969-8044	Deutsche Forschungsgemeinschaft (DFG); International Max Planck Research School (IMPRS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); International Max Planck Research School (IMPRS)	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) and the International Max Planck Research School (IMPRS) for the "Exploration of Ecological Interactions with Molecular and Chemical Techniques''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar EB, 2001, CAN ENTOMOL, V133, P389, DOI 10.4039/Ent133389-3; Al Abassi S, 2000, J CHEM ECOL, V26, P1765, DOI 10.1023/A:1005555300476; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; Boo KS, 1998, J CHEM ECOL, V24, P631, DOI 10.1023/A:1022386001722; BOWERS WS, 1972, SCIENCE, V177, P1121, DOI 10.1126/science.177.4054.1121; Bruce TJA, 2005, PEST MANAG SCI, V61, P1115, DOI 10.1002/ps.1102; Crawley M.J., 2007, J CHEM INF MODEL, DOI DOI 10.1002/9780470515075; Crawley M. J., 2007, R BOOK, DOI [10.1002/9780470515075, DOI 10.1002/9780470515075]; CRAWLEY MJ, 2002, STAT COMPUTING; DILL LM, 1990, OECOLOGIA, V83, P473, DOI 10.1007/BF00317197; DIXON A. F. G., 1958, TRANS ROY ENTOMOL SOC LONDON, V110, P319; Dixon AF G, 1998, APHID ECOLOGY; Dixon AFG, 1999, P ROY SOC B-BIOL SCI, V266, P1549, DOI 10.1098/rspb.1999.0814; EDWARDS LJ, 1973, NATURE, V241, P126, DOI 10.1038/241126b0; FOLDIHOPE C, 1990, INT J INSECT MORPHOL, V19, P25, DOI 10.1016/0020-7322(90)90028-N; Francis FD, 2005, EUR J ENTOMOL, V102, P431, DOI 10.14411/eje.2005.061; Hatano E, 2008, J CHEM ECOL, V34, P1149, DOI 10.1007/s10886-008-9527-y; Katis NI, 2007, APHIDS AS CROP PESTS, P353, DOI 10.1079/9780851998190.0353; KISLOW CJ, 1972, NATURE, V235, P108, DOI 10.1038/235108a0; Kunert G, 2005, ECOL LETT, V8, P596, DOI 10.1111/j.1461-0248.2005.00754.x; Kunert G, 2003, OECOLOGIA, V135, P304, DOI 10.1007/s00442-003-1185-8; Kunert G, 2007, EUR J ENTOMOL, V104, P47, DOI 10.14411/eje.2007.007; LEES AD, 1966, NATURE, V210, P986, DOI 10.1038/210986a0; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; Micha SG, 1996, CHEMOECOLOGY, V7, P132, DOI 10.1007/BF01245965; Mondor EB, 2007, BIOL INVASIONS, V9, P623, DOI 10.1007/s10530-006-9062-0; MONTGOMERY ME, 1977, ENTOMOL EXP APPL, V22, P236, DOI 10.1007/BF00302860; Muller CB, 2001, ECOL ENTOMOL, V26, P330, DOI 10.1046/j.1365-2311.2001.00321.x; NAULT L R, 1973, Environmental Entomology, V2, P101, DOI 10.1093/ee/2.1.101; NAULT LR, 1976, SCIENCE, V192, P1349, DOI 10.1126/science.1273595; PICKETT JA, 1980, J CHEM ECOL, V6, P349, DOI 10.1007/BF01402913; Podjasek JO, 2005, CAN J ZOOL, V83, P1138, DOI [10.1139/Z05-108, 10.1139/z05-108]; Quisenberry SS, 2007, APHIDS AS CROP PESTS, P331, DOI 10.1079/9780851998190.0331; ROITBERG BD, 1979, J ANIM ECOL, V48, P111, DOI 10.2307/4104; ROITBERG BD, 1978, CAN J ZOOL, V56, P103, DOI 10.1139/z78-014; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Schwartzberg EG, 2008, J CHEM ECOL, V34, P76, DOI 10.1007/s10886-007-9397-8; Sloggett JJ, 2004, SCI UPDATE, P79; Sloggett JJ, 2002, OIKOS, V98, P323, DOI 10.1034/j.1600-0706.2002.980213.x; SUTHERLA.OR, 1967, NATURE, V216, P387, DOI 10.1038/216387a0; SUTHERLAND OR, 1969, J INSECT PHYSIOL, V15, P1385, DOI 10.1016/0022-1910(69)90199-1; SUTHERLAND OR, 1970, J INSECT PHYSIOL, V16, P1349, DOI 10.1016/0022-1910(70)90134-4; Verheggen FJ, 2009, BEHAV ECOL, V20, P283, DOI 10.1093/beheco/arp009; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; WOHLERS P, 1980, ENTOMOL EXP APPL, V27, P156, DOI 10.1007/BF00573890; WOHLERS P, 1981, ENTOMOL EXP APPL, V29, P117, DOI 10.1007/BF00300757; Xiangyu JG, 2002, PHYSIOL ENTOMOL, V27, P307, DOI 10.1046/j.1365-3032.2002.00302.x	47	33	35	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11188	10.1371/journal.pone.0011188	http://dx.doi.org/10.1371/journal.pone.0011188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585639	Green Submitted, Green Published, gold			2022-12-25	WOS:000279135400005
J	Wu, CH; Sercu, B; Van de Werfhorst, LC; Wong, J; DeSantis, TZ; Brodie, EL; Hazen, TC; Holden, PA; Andersen, GL				Wu, Cindy H.; Sercu, Bram; Van de Werfhorst, Laurie C.; Wong, Jakk; DeSantis, Todd Z.; Brodie, Eoin L.; Hazen, Terry C.; Holden, Patricia A.; Andersen, Gary L.			Characterization of Coastal Urban Watershed Bacterial Communities Leads to Alternative Community-Based Indicators	PLOS ONE			English	Article							MICROBIAL COMMUNITY; PHYLOGENETIC DIVERSITY; MICROARRAY ANALYSIS; ESCHERICHIA-COLI; FECAL POLLUTION; GENETIC-MARKERS; TREATMENT-PLANT; CLONE LIBRARY; LAKE; SLUDGE	Background: Microbial communities in aquatic environments are spatially and temporally dynamic due to environmental fluctuations and varied external input sources. A large percentage of the urban watersheds in the United States are affected by fecal pollution, including human pathogens, thus warranting comprehensive monitoring. Methodology/Principal Findings: Using a high-density microarray (PhyloChip), we examined water column bacterial community DNA extracted from two connecting urban watersheds, elucidating variable and stable bacterial subpopulations over a 3-day period and community composition profiles that were distinct to fecal and non-fecal sources. Two approaches were used for indication of fecal influence. The first approach utilized similarity of 503 operational taxonomic units (OTUs) common to all fecal samples analyzed in this study with the watershed samples as an index of fecal pollution. A majority of the 503 OTUs were found in the phyla Firmicutes, Proteobacteria, Bacteroidetes, and Actinobacteria. The second approach incorporated relative richness of 4 bacterial classes (Bacilli, Bacteroidetes, Clostridia and alpha-proteobacteria) found to have the highest variance in fecal and non-fecal samples. The ratio of these 4 classes (BBC: A) from the watershed samples demonstrated a trend where bacterial communities from gut and sewage sources had higher ratios than from sources not impacted by fecal material. This trend was also observed in the 124 bacterial communities from previously published and unpublished sequencing or PhyloChip-analyzed studies. Conclusions/Significance: This study provided a detailed characterization of bacterial community variability during dry weather across a 3-day period in two urban watersheds. The comparative analysis of watershed community composition resulted in alternative community-based indicators that could be useful for assessing ecosystem health.	[Wu, Cindy H.; Wong, Jakk; DeSantis, Todd Z.; Brodie, Eoin L.; Hazen, Terry C.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA; [Sercu, Bram; Van de Werfhorst, Laurie C.; Holden, Patricia A.] Univ Calif Santa Barbara, Donald Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara	Wu, CH (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA.	GLAndersen@lbl.gov	Hazen, Terry C/C-1076-2012; Brodie, Eoin L/A-7853-2008; Andersen, Gary/G-2792-2015	Hazen, Terry C/0000-0002-2536-9993; Brodie, Eoin L/0000-0002-8453-8435; Andersen, Gary/0000-0002-1618-9827	Department of Energy [DE-AC02-05CH11231]; Rathmann Family Foundation; California State Water Resources Control Board; Department of Public Health, Marin County California; City of Santa Barbara; Switzer Foundation; NSF [OCE 9982105, OCE 0620276]	Department of Energy(United States Department of Energy (DOE)); Rathmann Family Foundation; California State Water Resources Control Board; Department of Public Health, Marin County California; City of Santa Barbara; Switzer Foundation; NSF(National Science Foundation (NSF))	Part of this work was performed at Lawrence Berkeley National Laboratory under Department of Energy contract number DE-AC02-05CH11231 and funded by the Rathmann Family Foundation and the California State Water Resources Control Board Prop. 50 Clean Beaches Initiative grant with additional assistance by the Department of Public Health, Marin County California (CHW, JW, TZD, ELB, TCH, GLA). Additional funding was provided by the City of Santa Barbara through Measure B funding, the California State Water Resources Control Board Prop. 50 Clean Beaches Initiative grant and by the Switzer Foundation through a Leadership Grant. Flow data were provided through the NSF-funded Santa Barbara Long Term Ecological Research project, NSF OCE 9982105 and OCE 0620276 (BS, LCVDW, PAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Andersen GL, 2010, ENVIRONMENTAL MOLECULAR MICROBIOLOGY, P87; Benlloch S, 1995, FEMS MICROBIOL ECOL, V18, P267; Black LE, 2007, APPL ENVIRON MICROB, V73, P3965, DOI 10.1128/AEM.02780-06; Bodtker G, 2008, J IND MICROBIOL BIOT, V35, P1625, DOI 10.1007/s10295-008-0406-x; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; Chauhan A, 2009, P NATL ACAD SCI USA, V106, P4301, DOI 10.1073/pnas.0809671106; Chouari R, 2005, ENVIRON MICROBIOL, V7, P1104, DOI 10.1111/j.1462-2920.2005.00795.x; Chouari R, 2005, APPL ENVIRON MICROB, V71, P2145, DOI 10.1128/AEM.71.4.2145-2153.2005; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; Cruz-Martinez K, 2009, ISME J, V3, P738, DOI 10.1038/ismej.2009.16; Daffonchio D, 2006, NATURE, V440, P203, DOI 10.1038/nature04418; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; DOWD SE, 2008, BMC MICROBIOL, V8; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Field KG, 2003, ENVIRON MONIT ASSESS, V81, P313, DOI 10.1023/A:1021349629950; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Fogarty LR, 2005, APPL ENVIRON MICROB, V71, P5999, DOI 10.1128/AEM.71.10.5999-6007.2005; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franklin MP, 2005, ENVIRON MICROBIOL, V7, P723, DOI 10.1111/j.1462-2920.2004.00736.x; FUHRMAN JA, 1993, APPL ENVIRON MICROB, V59, P1294, DOI 10.1128/AEM.59.5.1294-1302.1993; GELDREICH EE, 1976, CRIT REV ENV CONTR, V6, P349, DOI 10.1080/10643387609381645; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Graneli E, 2008, HARMFUL ALGAE, V8, P94, DOI 10.1016/j.hal.2008.08.011; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Harwood VJ, 2005, APPL ENVIRON MICROB, V71, P3163, DOI 10.1128/AEM.71.6.3163-3170.2005; Hirayama H, 2005, EXTREMOPHILES, V9, P169, DOI 10.1007/s00792-005-0433-8; Humayoun SB, 2003, APPL ENVIRON MICROB, V69, P1030, DOI 10.1128/AEM.69.2.1030-1042.2003; Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Juretschko S, 2002, SYST APPL MICROBIOL, V25, P84, DOI 10.1078/0723-2020-00093; Juteau P, 2004, APPL MICROBIOL BIOT, V66, P115, DOI 10.1007/s00253-004-1692-5; Kaartokallio H, 2005, APPL ENVIRON MICROB, V71, P4364, DOI 10.1128/AEM.71.8.4364-4371.2005; La Duc MT, 2007, APPL ENVIRON MICROB, V73, P2600, DOI 10.1128/AEM.03007-06; LaPara TM, 2000, APPL ENVIRON MICROB, V66, P3951, DOI 10.1128/AEM.66.9.3951-3959.2000; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lu JR, 2007, WATER RES, V41, P3561, DOI 10.1016/j.watres.2007.05.033; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; McCune B., 2006, PC ORD MULTIVARIATE; Mei R, 2003, P NATL ACAD SCI USA, V100, P11237, DOI 10.1073/pnas.1534744100; MIELKE PW, 1994, J EDUC BEHAV STAT, V19, P217, DOI 10.2307/1165295; Mosier AC, 2007, FEMS MICROBIOL ECOL, V59, P274, DOI 10.1111/j.1574-6941.2006.00220.x; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Nelson CE, 2009, ISME J, V3, P13, DOI 10.1038/ismej.2008.81; Nelson KE, 2010, ENVIRONMENTAL MOLECULAR MICROBIOLOGY, P21; Paerl HW, 2003, FEMS MICROBIOL ECOL, V46, P233, DOI 10.1016/S0168-6496(03)00200-9; Petersen TM, 2005, J ENVIRON ENG, V131, P1414, DOI 10.1061/(ASCE)0733-9372(2005)131:10(1414); Platt RH, 2006, ENVIRONMENT, V48, P38; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Roest K, 2005, SYST APPL MICROBIOL, V28, P175, DOI 10.1016/j.syapm.2004.10.006; Sagaram US, 2009, APPL ENVIRON MICROB, V75, P1566, DOI 10.1128/AEM.02404-08; Savichtcheva O, 2007, WATER RES, V41, P3615, DOI 10.1016/j.watres.2007.03.028; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; Scupham AJ, 2008, MICROB ECOL, V56, P322, DOI 10.1007/s00248-007-9349-4; Sercu B, 2009, ENVIRON SCI TECHNOL, V43, P293, DOI 10.1021/es801505p; Shibata T, 2004, WATER RES, V38, P3119, DOI 10.1016/j.watres.2004.04.044; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; Sun HY, 2004, APPL ENVIRON MICROB, V70, P5868, DOI 10.1128/AEM.70.10.5868-5874.2004; Troussellier M, 2002, AQUAT MICROB ECOL, V28, P13, DOI 10.3354/ame028013; Urbach E, 2001, LIMNOL OCEANOGR, V46, P557, DOI 10.4319/lo.2001.46.3.0557; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; WASSEL RA, 1983, MICROB ECOL, V9, P155, DOI 10.1007/BF02015128; Wery N, 2008, WATER RES, V42, P53, DOI 10.1016/j.watres.2007.06.048; West NJ, 2008, ENVIRON MICROBIOL, V10, P738, DOI 10.1111/j.1462-2920.2007.01497.x; Williams MM, 2004, J APPL MICROBIOL, V96, P954, DOI 10.1111/j.1365-2672.2004.02229.x; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Wrighton KC, 2008, ISME J, V2, P1146, DOI 10.1038/ismej.2008.48; Zaballos M, 2006, FEMS MICROBIOL ECOL, V56, P389, DOI 10.1111/j.1574-6941.2006.00060.x; Zrafi-Nouira I, 2009, BIODEGRADATION, V20, P467, DOI 10.1007/s10532-008-9235-x; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	94	56	60	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11285	10.1371/journal.pone.0011285	http://dx.doi.org/10.1371/journal.pone.0011285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585654	gold, Green Submitted, Green Published			2022-12-25	WOS:000279135400027
J	Gertsenstein, M; Nutter, LMJ; Reid, T; Pereira, M; Stanford, WL; Rossant, J; Nagy, A				Gertsenstein, Marina; Nutter, Lauryl M. J.; Reid, Tammy; Pereira, Monica; Stanford, William L.; Rossant, Janet; Nagy, Andras			Efficient Generation of Germ Line Transmitting Chimeras from C57BL/6N ES Cells by Aggregation with Outbred Host Embryos	PLOS ONE			English	Article							INBRED MOUSE STRAINS; STEM-CELLS; BALB/C BLASTOCYSTS; RAT BLASTOCYSTS; SELF-RENEWAL; MICE; GENE; ESTABLISHMENT; KNOCKOUT; DERIVATION	Genetically modified mouse strains derived from embryonic stem (ES) cells have become essential tools for functional genomics and biomedical research. Large scale mutagenesis projects are producing libraries of mutant C57BL/6 (B6) ES cells to enable the functional annotation of every gene of the mouse genome. To realize the utility of these resources, efficient and accessible methods of generating mutant mice from these ES cells are necessary. Here, we describe a combination of ICR morula aggregation and a chemically-defined culture medium with widely available and accessible components for the high efficiency generation of germline transmitting chimeras from C57BL/6N ES cells. Together these methods will ease the access of the broader biomedical research community to the publicly available B6 ES cell resources.	[Gertsenstein, Marina; Pereira, Monica; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gertsenstein, Marina; Pereira, Monica] Toronto Ctr Phenogen, Toronto, ON, Canada; [Nutter, Lauryl M. J.; Rossant, Janet] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Reid, Tammy; Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Rossant, Janet; Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rossant, Janet] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Gertsenstein, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	nagy@mshri.on.ca	Nagy, Andras/G-6465-2013	Nagy, Andras/0000-0003-4311-0413; Nutter, Lauryl/0000-0001-9619-146X; Stanford, William/0000-0002-5813-8016	Genome Prairie; Genome Canada; National Institutes of Health [1U01DA23284, 5U01DA023284-2]; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA023284] Funding Source: NIH RePORTER	Genome Prairie; Genome Canada(Genome Canada); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported with NorCOMM grant funding provided by Genome Prairie (http://www.genomeprairie.ca/) and Genome Canada (http://www.genomecanada.ca/) to WS, JR, and AN; and National Institutes of Health KOMP funding (grant 1U01DA23284 and 5U01DA023284-2; http://www.nih.gov/science/models/mouse/knockout/) to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chen SB, 2006, MOL BIOSYST, V2, P18, DOI 10.1039/b512000b; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Collins FS, 2007, CELL, V129, P235, DOI 10.1016/j.cell.2007.04.007; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Huang JJ, 2008, STEM CELLS, V26, P1883, DOI 10.1634/stemcells.2008-0164; Hughes ED, 2007, MAMM GENOME, V18, P549, DOI 10.1007/s00335-007-9054-0; KAWASE E, 1994, INT J DEV BIOL, V38, P385; KIYONARI H, 2010, GENESIS; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; LALLEMAND Y, 1990, DEVELOPMENT, V110, P1241; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; Lemckert FA, 1997, NUCLEIC ACIDS RES, V25, P917, DOI 10.1093/nar/25.4.917; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; MEREAU A, 1993, J CELL BIOL, V122, P713, DOI 10.1083/jcb.122.3.713; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NAGY A, 2003, MANIPULATING MOUSE E, pR10; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Pacholczyk G, 2008, BIOTECHNIQUES, V44, P413, DOI 10.2144/000112706; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Sato H, 2009, GENESIS, V47, P414, DOI 10.1002/dvg.20514; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; Schuster-Gossler K, 2001, BIOTECHNIQUES, V31, P1022, DOI 10.2144/01315st01; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Sharova LV, 2007, DEV BIOL, V307, P446, DOI 10.1016/j.ydbio.2007.05.004; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; TOKUNAGA T, 1992, DEV GROWTH DIFFER, V34, P561; Ward CM, 2004, EXP CELL RES, V293, P229, DOI 10.1016/j.yexcr.2003.10.017; Ware CB, 2003, TRANSGENIC RES, V12, P743, DOI 10.1023/B:TRAG.0000005246.35812.c8; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	46	78	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11260	10.1371/journal.pone.0011260	http://dx.doi.org/10.1371/journal.pone.0011260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582321	Green Published, Green Submitted, gold			2022-12-25	WOS:000279058500012
J	Evangelista, AM; Rao, VS; Filo, AR; Marozkina, NV; Doctor, A; Jones, DR; Gaston, B; Guilford, WH				Evangelista, Alicia M.; Rao, Vijay S.; Filo, Ashley R.; Marozkina, Nadzeya V.; Doctor, Allan; Jones, David R.; Gaston, Benjamin; Guilford, William H.			Direct Regulation of Striated Muscle Myosins by Nitric Oxide and Endogenous Nitrosothiols	PLOS ONE			English	Article							SKELETAL-MUSCLE; IN-VITRO; ACTIN-FILAMENTS; FORCE; MOTILITY; PURIFICATION; PROTEINS; ASSAY	Background: Nitric oxide (NO) has long been recognized to affect muscle contraction [1], both through activation of guanylyl cyclase and through modification of cysteines in proteins to yield S-nitrosothiols. While NO affects the contractile apparatus directly, the identities of the target myofibrillar proteins remain unknown. Here we report that nitrogen oxides directly regulate striated muscle myosins. Principal Findings: Exposure of skeletal and cardiac myosins to physiological concentrations of nitrogen oxides, including the endogenous nitrosothiol S-nitroso-L-cysteine, reduced the velocity of actin filaments over myosin in a dose-dependent and oxygen-dependent manner, caused a doubling of force as measured in a laser trap transducer, and caused S-nitrosylation of cysteines in the myosin heavy chain. These biomechanical effects were not observed in response to S-nitroso-D-cysteine, demonstrating specificity for the naturally occurring isomer. Both myosin heavy chain isoforms in rats and cardiac myosin heavy chain from human were S-nitrosylated in vivo. Significance: These data show that nitrosylation signaling acts as a molecular "gear shift'' for myosin-an altogether novel mechanism by which striated muscle and cellular biomechanics may be regulated.	[Evangelista, Alicia M.; Rao, Vijay S.; Filo, Ashley R.; Guilford, William H.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA; [Marozkina, Nadzeya V.; Gaston, Benjamin] Univ Virginia, Dept Pediat, Charlottesville, VA USA; [Doctor, Allan] Washington Univ, Dept Pediat, St Louis, MO 63130 USA	University of Virginia; University of Virginia; Washington University (WUSTL)	Evangelista, AM (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	guilford@virginia.edu		Guilford, William/0000-0002-6543-5713; Doctor, Allan/0000-0002-6096-6400	National Institutes of Health [EB002185, CA136705, HL059337]; National Science Foundation [MCB0718430]; NATIONAL CANCER INSTITUTE [R01CA136705] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL059337, R01HL059337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the National Institutes of Health (EB002185 to WHG, CA136705 to DRJ, and HL059337 to BMG) and the National Science Foundation (MCB0718430 to WHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P577, DOI 10.1111/j.1469-7793.1998.577bn.x; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P21, DOI 10.1016/S0968-0004(00)01698-4; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; Galler S, 1997, PFLUG ARCH EUR J PHY, V434, P242, DOI 10.1007/s004240050391; Gow A, 2007, J CHROMATOGR B, V851, P140, DOI 10.1016/j.jchromb.2007.01.052; GRUETTER CA, 1979, J CYCLIC NUCL PROT, V5, P211; Guilford WH, 2004, ANAL BIOCHEM, V326, P153, DOI 10.1016/j.ab.2003.11.025; Guo B, 2004, CELL MOTIL CYTOSKEL, V59, P264, DOI 10.1002/cm.20040; Han PW, 2008, ANAL BIOCHEM, V377, P150, DOI 10.1016/j.ab.2008.03.023; HARADA Y, 1987, NATURE, V326, P805, DOI 10.1038/326805a0; HARRIS DE, 1991, AM J PHYSIOL, V260, pC1104; HARRIS DE, 1994, J MUSCLE RES CELL M, V15, P11, DOI 10.1007/BF00123828; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kanai AJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1371, DOI 10.1152/ajpcell.1997.273.4.C1371; KIELLEY WW, 1961, BIOCHIM BIOPHYS ACTA, V51, P591; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; MALAVIA NK, 2007, AM J RESP CRIT CARE, V175, pA522; Marechal G, 1999, CELL MOL LIFE SCI, V55, P1088, DOI 10.1007/s000180050359; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARINO SM, 2009, J MOL BIOL; Nogueira L, 2009, BIOCHEM J, V424, P221, DOI 10.1042/BJ20091144; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pearce LL, 2002, J BIOL CHEM, V277, P13556, DOI 10.1074/jbc.M109838200; Perkins WJ, 1997, J APPL PHYSIOL, V83, P1326, DOI 10.1152/jappl.1997.83.4.1326; Peterson J, 2004, AM J PHYSIOL-HEART C, V286, pH55, DOI 10.1152/ajpheart.00744.2003; Pinsky DJ, 1997, CIRC RES, V81, P372, DOI 10.1161/01.RES.81.3.372; Rao VS, 2009, CELL MOTIL CYTOSKEL, V66, P10, DOI 10.1002/cm.20321; Roberts CK, 1999, AM J PHYSIOL-ENDOC M, V277, pE390, DOI 10.1152/ajpendo.1999.277.2.E390; Rodriguez J, 2003, P NATL ACAD SCI USA, V100, P336, DOI 10.1073/pnas.0234600100; SHIVERICK KT, 1975, BIOCHIM BIOPHYS ACTA, V393, P124, DOI 10.1016/0005-2795(75)90222-6; Snook JH, 2008, FREE RADICAL BIO MED, V44, P14, DOI 10.1016/j.freeradbiomed.2007.09.004; Takahashi S, 1999, FREE RADICAL BIO MED, V27, pS87, DOI 10.1016/S0891-5849(99)90801-8; Umar S, 2010, MOL CELL BIOCHEM, V333, P191, DOI 10.1007/s11010-009-0219-x	35	53	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11209	10.1371/journal.pone.0011209	http://dx.doi.org/10.1371/journal.pone.0011209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585450	Green Submitted, Green Published, gold			2022-12-25	WOS:000278977200012
J	Hsieh, STT				Hsieh, Shi-Tong Tonia			A Locomotor Innovation Enables Water-Land Transition in a Marine Fish	PLOS ONE			English	Article							EEL ANGUILLA-ROSTRATA; EVOLUTIONARY INNOVATIONS; ALTICUS-MONOCHRUS; ESCAPE RESPONSES; MUSCLE-ACTIVITY; INDIAN-OCEAN; PECTORAL FIN; ORIGIN; KINEMATICS; MACROEVOLUTION	Background: Morphological innovations that significantly enhance performance capacity may enable exploitation of new resources and invasion of new ecological niches. The invasion of land from the aquatic realm requires dramatic structural and physiological modifications to permit survival in a gravity-dominated, aerial environment. Most fishes are obligatorily aquatic, with amphibious fishes typically making slow-moving and short forays on to land. Methodology/Principal Findings: Here I describe the behaviors and movements of a little known marine fish that moves extraordinarily rapidly on land. I found that the Pacific leaping blenny, Alticus arnoldorum, employs a tail-twisting movement on land, previously unreported in fishes. Focal point behavioral observations of Alticus show that they have largely abandoned the marine realm, feed and reproduce on land, and even defend terrestrial territories. Comparisons of these blennies' terrestrial kinematic and kinetic (i.e., force) measurements with those of less terrestrial sister genera show A. arnoldorum move with greater stability and locomotor control, and can move away more rapidly from impending threats. Conclusions/Significance: My results demonstrate that axial tail twisting serves as a key innovation enabling invasion of a novel marine niche. This paper highlights the potential of using this system to address general evolutionary questions about water-land transitions and niche invasions.	[Hsieh, Shi-Tong Tonia] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Hsieh, STT (corresponding author), Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.	sthsieh@temple.edu		Hsieh, Shi-Tong/0000-0003-2233-3327	National Geographic Society; Society of Integrative and Comparative Biology; Museum of Comparative Zoology at Harvard University	National Geographic Society(National Geographic Society); Society of Integrative and Comparative Biology; Museum of Comparative Zoology at Harvard University	This study was funded by the National Geographic Society Research and Exploration Grant (http://www.nationalgeographic.com/field/grants-programs/cre.html), a Student Travel Fellowship from the Society of Integrative and Comparative Biology (http://www.sicb.org/grants/fgst/), and the Putnam Expedition Fund from the Museum of Comparative Zoology at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1990, PHILOS T ROY SOC B, V329, P3, DOI 10.1098/rstb.1990.0144; Anker A, 2006, EVOLUTION, V60, P2507, DOI 10.1111/j.0014-3820.2006.tb01886.x; Aubret F, 2008, FUNCT ECOL, V22, P317, DOI 10.1111/j.1365-2435.2007.01359.x; Bhikajee M, 2006, AFR ZOOL, V41, P1, DOI 10.3377/1562-7020(2006)41[1:LHCOAM]2.0.CO;2; Bhikajee M, 2002, AFR ZOOL, V37, P221; BROWN CR, 1992, COPEIA, P1007; BURKE AC, 1989, J MORPHOL, V199, P363, DOI 10.1002/jmor.1051990310; CARSTENS T, 1968, Sarsia, V34, P37; COATES MI, 1994, DEVELOPMENT, P169; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; DENNY MW, 1985, LIMNOL OCEANOGR, V30, P1171, DOI 10.4319/lo.1985.30.6.1171; Domenici P, 1997, J EXP BIOL, V200, P1165; Eckhart L, 2008, P NATL ACAD SCI USA, V105, P18419, DOI 10.1073/pnas.0805154105; Gilbert SF, 2001, EVOL DEV, V3, P47, DOI 10.1046/j.1525-142x.2001.003002047.x; Gillis GB, 2000, J EXP BIOL, V203, P471; Gillis GB, 1998, J EXP BIOL, V201, P949; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Hale ME, 2002, J EXP BIOL, V205, P2005; HARRIS VERNON A., 1960, PROC ZOOL SOC LONDON, V134, P107; Hoso M, 2007, BIOL LETTERS, V3, P169, DOI 10.1098/rsbl.2006.0600; Hsieh ST, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2202910; Huberty CJ, 2003, J EXP EDUC, V71, P177, DOI 10.1080/00220970309602062; Hunter JP, 1998, TRENDS ECOL EVOL, V13, P31, DOI 10.1016/S0169-5347(97)01273-1; JENSSEN TA, 1977, AM ZOOL, V17, P203; Jindrich DL, 2002, J EXP BIOL, V205, P2803; Lee M, 2009, HUM MOVEMENT SCI, V28, P226, DOI 10.1016/j.humov.2008.10.008; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; Love AC, 2003, BIOL PHILOS, V18, P309, DOI 10.1023/A:1023940220348; MARSH RL, 1994, J EXP BIOL, V188, P131; MARTIN KLM, 1989, COPEIA, P723; Miller A.H., 1949, ORNITHOLOGIE ALS BIO, V28, P84; Nelson JS, 1994, FISHES WORLD, DOI 10.1002/9781119174844; Pace CM, 2009, J EXP BIOL, V212, P2279, DOI 10.1242/jeb.029041; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 1997, AM NAT, V149, P668, DOI 10.1086/286014; Rao H. S., 1938, Records of the Indian Museum, V40, P377; RITTER D, 1995, J EXP BIOL, V198, P2477; Sazima Ivan, 2003, Ichthyological Exploration of Freshwaters, V14, P175; Schmitt J, 2000, BIOL CYBERN, V83, P501, DOI 10.1007/s004220000181; Schoenfuss HL, 2003, J ZOOL, V261, P191, DOI 10.1017/S0952836903004102; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Springer V. G., 1994, INDOWEST PACIFIC BLE; Swanson BO, 2004, J EXP BIOL, V207, P4037, DOI 10.1242/jeb.01237; Tytell ED, 2002, J EXP BIOL, V205, P2591; Vermeij GJ, 2006, P NATL ACAD SCI USA, V103, P1804, DOI 10.1073/pnas.0508724103; Wainwright PC, 2007, ANNU REV ECOL EVOL S, V38, P381, DOI 10.1146/annurev.ecolsys.38.091206.095706	47	51	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11197	10.1371/journal.pone.0011197	http://dx.doi.org/10.1371/journal.pone.0011197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585564	Green Published, Green Submitted, gold			2022-12-25	WOS:000278977200004
J	Fischer, AJ; Zelinka, C; Scott, MA				Fischer, Andy J.; Zelinka, Christopher; Scott, Melissa A.			Heterogeneity of Glia in the Retina and Optic Nerve of Birds and Mammals	PLOS ONE			English	Article							TRANSFERRIN-BINDING PROTEIN; CHOLINERGIC AMACRINE CELLS; FIBRILLARY ACIDIC PROTEIN; MULLER GLIA; CHICKEN RETINA; PROGENITOR CELLS; PRIMATE RETINA; GANGLION-CELLS; OLIGODENDROCYTE DIFFERENTIATION; INTERMEDIATE-FILAMENT	We have recently described a novel type of glial cell that is scattered across the inner layers of the avian retina [1]. These cells are stimulated by insulin-like growth factor 1 (IGF1) to proliferate, migrate distally into the retina, and up-regulate the nestin-related intermediate filament transitin. These changes in glial activity correspond with increased susceptibility of neurons to excitotoxic damage. This novel cell-type has been termed the Non-astrocytic Inner Retinal Glia-like (NIRG) cells. The purpose of the study was to investigate whether the retinas of non-avian species contain cells that resemble NIRG cells. We assayed for NIRG cells by probing for the expression of Sox2, Sox9, Nkx2.2, vimentin and nestin. NIRG cells were distinguished from astrocytes by a lack of expression for Glial Fibrilliary Acidic Protein (GFAP). We examined the retinas of adult mice, guinea pigs, dogs and monkeys (Macaca fasicularis). In the mouse retina and optic nerve head, we identified numerous astrocytes that expressed GFAP, S100 beta, Sox2 and Sox9; however, we found no evidence for NIRG-like cells that were positive for Nkx2.2, nestin, and negative for GFAP. In the guinea pig retina, we did not find astrocytes or NIRG cells in the retina, whereas we identified astrocytes in the optic nerve. In the eyes of dogs and monkeys, we found astrocytes and NIRG-like cells scattered across inner layers of the retina and within the optic nerve. We conclude that NIRG-like cells are present in the retinas of canines and non-human primates, whereas the retinas of mice and guinea pigs do not contain NIRG cells.	[Fischer, Andy J.; Zelinka, Christopher; Scott, Melissa A.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Fischer, AJ (corresponding author), Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA.	fischer.412@osu.edu	Fischer, Andy J./AFF-1827-2022; Fischer, Andrew J/E-3061-2011; Fischer, Andy J./AAE-9817-2022	Fischer, Andy J./0000-0001-6123-7405; Fischer, Andy J./0000-0001-6123-7405	National Institutes of Health, National Eye Institute [RO1 EY016043-04]; NICHD; NATIONAL EYE INSTITUTE [R01EY016043] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health, National Eye Institute RO1 EY016043-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. John Buford (the Ohio State University) for providing primate tissues, Dr. Simon Petersen-Jones (Michigan State University) for providing canine tissues, Dr. Karl Obrietan (the Ohio State University) for providing murine tissues, and Dr. Jackie Wood (the Ohio State University) for providing guinea pig tissues. We thank Drs. P. Henion and J.J. Lucas for providing antibodies to transitin and transferrin binding protein, respectively. Confocal microscopy was performed at the Hunt-Curtis Imaging Facility at the Department of Neuroscience of The Ohio State University. The Islet1, Nkx2.2 (developed by Dr. T. M Jessell) and vimentin (developed by Dr. A. Alvarez-Buylla) antibodies were obtained from the Developmental Studies Hybridoma Bank developed under auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	ALVAREZBUYLLA A, 1987, J COMP NEUROL, V264, P159, DOI 10.1002/cne.902640203; Bhat RV, 1996, GLIA, V17, P169; Cai J, 2010, GLIA, V58, P458, DOI 10.1002/glia.20937; Cho SS, 1999, BRAIN RES, V816, P229, DOI 10.1016/S0006-8993(98)01117-2; CHO SS, 1995, BRAIN RES, V674, P15, DOI 10.1016/0006-8993(94)01398-2; Cho SS, 1997, J COMP NEUROL, V382, P260; Close JL, 2005, DEVELOPMENT, V132, P3015, DOI 10.1242/dev.01882; CLOSE JL, 2000, SOC NEUR ABSTR, V26, P1603; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; Dacey DM, 1996, P NATL ACAD SCI USA, V93, P582, DOI 10.1073/pnas.93.2.582; Dakubo GD, 2003, DEVELOPMENT, V130, P2967, DOI 10.1242/dev.00515; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fischer AJ, 2005, J COMP NEUROL, V484, P1, DOI 10.1002/cne.20406; Fischer AJ, 2001, INVEST OPHTH VIS SCI, V42, P3256; Fischer AJ, 2004, MOL CELL NEUROSCI, V27, P531, DOI 10.1016/j.mcn.2004.08.007; FISCHER AJ, 2010, MULLER GLIA GLIA, V58, P633; Fischer AJ, 2008, J COMP NEUROL, V506, P584, DOI 10.1002/cne.21578; Fischer AJ, 2009, GLIA, V57, P1538, DOI 10.1002/glia.20868; Fischer AJ, 2009, GLIA, V57, P166, DOI 10.1002/glia.20743; Friedlander Martin, 2007, Angiogenesis, V10, P89, DOI 10.1007/s10456-007-9070-4; Fu H, 2001, DEV BRAIN RES, V129, P115, DOI 10.1016/S0165-3806(01)00178-X; GalliResta L, 1997, J NEUROSCI, V17, P7831; Gao LM, 2006, J NEUROSCI, V26, P7619, DOI 10.1523/JNEUROSCI.0855-06.2006; Gao LM, 2006, DEV BIOL, V290, P277, DOI 10.1016/j.ydbio.2005.11.007; Ghai K, 2010, J NEUROSCI, V30, P3101, DOI 10.1523/JNEUROSCI.4919-09.2010; KOHSAKA S, 1980, J NEUROCHEM, V34, P662, DOI 10.1111/j.1471-4159.1980.tb11195.x; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Marquardt T, 2003, PROG RETIN EYE RES, V22, P567, DOI 10.1016/S1350-9462(03)00036-3; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; MARSHAK DR, 1990, PROG BRAIN RES, V86, P169; Messam CA, 2000, EXP NEUROL, V161, P585, DOI 10.1006/exnr.1999.7319; Messam CA, 2002, DEV BRAIN RES, V134, P87, DOI 10.1016/S0165-3806(01)00325-X; Moshiri A, 2008, DEV BIOL, V316, P214, DOI 10.1016/j.ydbio.2008.01.015; NARANG HK, 1977, NATURE, V266, P858, DOI 10.1038/266855a0; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; POOLA I, 1988, J BIOL CHEM, V263, P19137; Qi YC, 2001, DEVELOPMENT, V128, P2723; Raff MC, 1987, PROG BRAIN RES <D>, V71, P435; Rompani SB, 2010, J NEUROSCI, V30, P4970, DOI 10.1523/JNEUROSCI.3456-09.2010; SCHNITZER J, 1988, GLIA, V1, P74, DOI 10.1002/glia.440010109; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; SELINFREUND RH, 1990, J CELL BIOL, V111, P2021, DOI 10.1083/jcb.111.5.2021; SHAW G, 1984, EUR J CELL BIOL, V33, P95; Soula C, 2001, DEVELOPMENT, V128, P1369; Stanke J, 2010, J COMP NEUROL, V518, P2316, DOI 10.1002/cne.22335; Stanke JJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-13; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; Tsai HH, 2002, TRENDS NEUROSCI, V25, P173, DOI 10.1016/S0166-2236(00)02096-8; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; Wang YP, 2002, NAT NEUROSCI, V5, P831, DOI 10.1038/nn911; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Won MH, 2000, MICROSC RES TECHNIQ, V50, P151, DOI 10.1002/1097-0029(20000715)50:2<151::AID-JEMT7>3.0.CO;2-5; WYSE JPH, 1981, ACTA NEUROPATHOL, V54, P203, DOI 10.1007/BF00687743; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	62	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e10774	10.1371/journal.pone.0010774	http://dx.doi.org/10.1371/journal.pone.0010774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567503	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886300001
J	King, J; Keim, M; Teo, R; Weening, KE; Kapur, M; McQuillan, K; Ryves, J; Rogers, B; Dalton, E; Williams, RSB; Harwood, AJ				King, Jason; Keim, Melanie; Teo, Regina; Weening, Karin E.; Kapur, Mridu; McQuillan, Karina; Ryves, Jonathan; Rogers, Ben; Dalton, Emma; Williams, Robin S. B.; Harwood, Adrian J.			Genetic Control of Lithium Sensitivity and Regulation of Inositol Biosynthetic Genes	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; MANIC-DEPRESSIVE PATIENTS; DIPEPTIDYL PEPTIDASE-IV; BIPOLAR DISORDER; DICTYOSTELIUM-DISCOIDEUM; PROLYL ENDOPEPTIDASE; ANTIPSYCHOTIC-DRUGS; MONOPHOSPHATASE; POLYPHOSPHATES; CELLS	Lithium (Li+) is a common treatment for bipolar mood disorder, a major psychiatric illness with a lifetime prevalence of more than 1%. Risk of bipolar disorder is heavily influenced by genetic predisposition, but is a complex genetic trait and, to date, genetic studies have provided little insight into its molecular origins. An alternative approach is to investigate the genetics of Li+ sensitivity. Using the social amoeba Dictyostelium, we previously identified prolyl oligopeptidase (PO) as a modulator of Li+ sensitivity. In a link to the clinic, PO enzyme activity is altered in bipolar disorder patients. Further studies demonstrated that PO is a negative regulator of inositol(1,4,5) trisphosphate (IP3) synthesis, a Li+ sensitive intracellular signal. However, it was unclear how PO could influence either Li+ sensitivity or risk of bipolar disorder. Here we show that in both Dictyostelium and cultured human cells PO acts via Multiple Inositol Polyphosphate Phosphatase (Mipp1) to control gene expression. This reveals a novel, gene regulatory network that modulates inositol metabolism and Li+ sensitivity. Among its targets is the inositol monophosphatase gene IMPA2, which has also been associated with risk of bipolar disorder in some family studies, and our observations offer a cellular signalling pathway in which PO activity and IMPA2 gene expression converge.	[King, Jason; Keim, Melanie; Teo, Regina; Weening, Karin E.; Kapur, Mridu; McQuillan, Karina; Ryves, Jonathan; Rogers, Ben; Dalton, Emma; Harwood, Adrian J.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Williams, Robin S. B.] Univ London, Sch Biol Sci, Egham, Surrey, England	Cardiff University; University of London; Royal Holloway University London	Harwood, AJ (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	harwoodaj@cf.ac.uk	Harwood, Adrian/A-4350-2010; Williams, Robin/G-6807-2011; Kapur, Mridu/M-2669-2019; King, Jason/D-6228-2011	Kapur, Mridu/0000-0002-3313-5038; King, Jason/0000-0003-0596-4506; Dalton, Emma/0000-0002-3517-0742; Harwood, Adrian/0000-0003-3124-5169	Wellcome Trust [74540]; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Programme Grant to AJH (74540) and a BBSRC committee studentship to JSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam G, 2003, J PSYCHIAT RES, V37, P433, DOI 10.1016/S0022-3956(03)00044-X; Alloy LB, 2005, CLIN PSYCHOL REV, V25, P1043, DOI 10.1016/j.cpr.2005.06.006; ATACK JR, 1995, FEBS LETT, V361, P1, DOI 10.1016/0014-5793(95)00063-F; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Breen G, 2004, BIPOLAR DISORD, V6, P156, DOI 10.1111/j.1399-5618.2004.00100.x; Burgess S.S.A., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003013, DOI 10.1002/14651858.CD003013]; Casals I, 2002, ANAL BIOCHEM, V300, P69, DOI 10.1006/abio.2001.5449; Cho J, 2008, P NATL ACAD SCI USA, V105, P5998, DOI 10.1073/pnas.0710980105; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; Eickholt BJ, 2005, MOL PHARMACOL, V67, P1426, DOI 10.1124/mol.104.009308; Fischbach A, 2006, BIOCHEM J, V397, P509, DOI 10.1042/BJ20060277; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Gao Y, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702106200; GEE NS, 1988, BIOCHEM J, V253, P777, DOI 10.1042/bj2530777; GUSE AH, 1995, J CHROMATOGR B, V672, P189, DOI 10.1016/0378-4347(95)00219-9; INHORN RC, 1988, J BIOL CHEM, V263, P14559; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; King JS, 2009, DIS MODEL MECH, V2, P306, DOI 10.1242/dmm.001271; LAX AJ, 1979, J CELL SCI, V36, P311; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loovers HM, 2003, J BIOL CHEM, V278, P5652, DOI 10.1074/jbc.M208396200; Maes M, 1996, ACTA PSYCHIAT SCAND, V93, P1, DOI 10.1111/j.1600-0447.1996.tb10612.x; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; Mamdani F, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-9; MAYR GW, 1988, BIOCHEM J, V254, P585, DOI 10.1042/bj2540585; Nalaskowski MM, 2002, BIOCHEM J, V366, P549, DOI 10.1042/BJ20020327; Ohnishi T, 2007, NEUROPSYCHOPHARMACOL, V32, P1727, DOI 10.1038/sj.npp.1301307; Otto JC, 2007, P NATL ACAD SCI USA, V104, P15653, DOI 10.1073/pnas.0705729104; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Padmos RC, 2009, ARCH GEN PSYCHIAT, V66, P957, DOI 10.1001/archgenpsychiatry.2009.116; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schulz I, 2002, EUR J BIOCHEM, V269, P5813, DOI 10.1046/j.1432-1033.2002.03297.x; Shaltiel G, 2001, World J Biol Psychiatry, V2, P95; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Sjoholt G, 2000, MOL PSYCHIATR, V5, P172, DOI 10.1038/sj.mp.4000681; Soll DR, 2001, METH MOL B, V161, P45; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Taylor Levi, 2002, Curr Psychiatry Rep, V4, P130, DOI 10.1007/s11920-002-0046-1; Van Gool AR, 2004, J INTERF CYTOK RES, V24, P411, DOI 10.1089/1079990041535629; VANDIJKEN P, 1995, J BIOL CHEM, V270, P29724; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Wilson MP, 1996, J BIOL CHEM, V271, P11904, DOI 10.1074/jbc.271.20.11904; Yang XN, 2000, BIOCHEM J, V351, P551, DOI 10.1042/0264-6021:3510551; ZIGMOND SH, 1988, METHOD ENZYMOL, V162, P65	47	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11151	10.1371/journal.pone.0011151	http://dx.doi.org/10.1371/journal.pone.0011151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567601	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000278886300005
J	Prescott, J; Hall, P; Acuna-Retamar, M; Ye, CY; Wathelet, MG; Ebihara, H; Feldmann, H; Hjelle, B				Prescott, Joseph; Hall, Pamela; Acuna-Retamar, Mariana; Ye, Chunyan; Wathelet, Marc G.; Ebihara, Hideki; Feldmann, Heinz; Hjelle, Brian			New World Hantaviruses Activate IFN lambda Production in Type I IFN-Deficient Vero E6 Cells	PLOS ONE			English	Article							SIN-NOMBRE HANTAVIRUS; MOUSE PEROMYSCUS-MANICULATUS; INNATE IMMUNE-RESPONSES; PULMONARY SYNDROME; INTERFERON ANTAGONIST; VIRUS-INFECTION; UNITED-STATES; T-CELLS; REPLICATION; EXPRESSION	Background: Hantaviruses indigenous to the New World are the etiologic agents of hantavirus cardiopulmonary syndrome (HCPS). These viruses induce a strong interferon-stimulated gene (ISG) response in human endothelial cells. African green monkey-derived Vero E6 cells are used to propagate hantaviruses as well as many other viruses. The utility of the Vero E6 cell line for virus production is thought to owe to their lack of genes encoding type I interferons (IFN), rendering them unable to mount an efficient innate immune response to virus infection. Interferon lambda, a more recently characterized type III IFN, is transcriptionally controlled much like the type I IFNs, and activates the innate immune system in a similar manner. Methodology/Principal Findings: We show that Vero E6 cells respond to hantavirus infection by secreting abundant IFN lambda. Three New World hantaviruses were similarly able to induce IFN lambda expression in this cell line. The IFN lambda contained within virus preparations generated with Vero E6 cells independently activates ISGs when used to infect several non-endothelial cell lines, whereas innate immune responses by endothelial cells are specifically due to viral infection. We show further that Sin Nombre virus replicates to high titer in human hepatoma cells (Huh7) without inducing ISGs. Conclusions/Significance: Herein we report that Vero E6 cells respond to viral infection with a highly active antiviral response, including secretion of abundant IFN lambda. This cytokine is biologically active, and when contained within viral preparations and presented to human epithelioid cell lines, results in the robust activation of innate immune responses. We also show that both Huh7 and A549 cell lines do not respond to hantavirus infection, confirming that the cytoplasmic RNA helicase pathways possessed by these cells are not involved in hantavirus recognition. We demonstrate that Vero E6 actively respond to virus infection and inhibiting IFN lambda production in these cells might increase their utility for virus propagation.	[Prescott, Joseph; Ebihara, Hideki; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA; [Hall, Pamela] New Mexico Vet Affairs Hlth Care Syst, Res Serv 151, Albuquerque, NM USA; [Acuna-Retamar, Mariana; Ye, Chunyan; Wathelet, Marc G.; Hjelle, Brian] Univ New Mexico, Sch Med, Dept Pathol, Ctr Infect Dis & Immun, Albuquerque, NM 87131 USA; [Hjelle, Brian] Univ New Mexico, Dept Biol, Sch Med, Ctr Infect Dis & Immun, Albuquerque, NM 87131 USA; [Hjelle, Brian] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Ctr Infect Dis & Immun, Albuquerque, NM 87131 USA; [Wathelet, Marc G.] Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of New Mexico; University of New Mexico; University of New Mexico; Lovelace Respiratory Research Institute	Feldmann, H (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA.	feldmannh@niaid.nih.gov	Hall, Pamela/O-5402-2016	Hall, Pamela/0000-0003-2367-3382; Prescott, Joseph/0000-0001-5718-5155; Ebihara, Hideki/0000-0002-2576-9735	U.S Public Services [U01 AI56618]; Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI074246, U01AI056618, ZIAAI001089] Funding Source: NIH RePORTER	U.S Public Services; Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S Public Services grants U01 AI56618 (BH) and Division of Intramural Research (DIR) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alff PJ, 2008, J VIROL, V82, P9115, DOI 10.1128/JVI.00290-08; Alff PJ, 2006, J VIROL, V80, P9676, DOI 10.1128/JVI.00508-06; Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; CHANG KC, 1991, ARCH VIROL, V117, P1, DOI 10.1007/BF01310488; Chew T, 2009, MOL IMMUNOL, V46, P393, DOI 10.1016/j.molimm.2008.10.010; CHILDS JE, 1994, J INFECT DIS, V169, P1271, DOI 10.1093/infdis/169.6.1271; ELLIOTT LH, 1994, AM J TROP MED HYG, V51, P102, DOI 10.4269/ajtmh.1994.51.102; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Gavrilovskaya I, 1999, J CLIN MICROBIOL, V37, P122, DOI 10.1128/JCM.37.1.122-126.1999; Geimonen E, 2002, P NATL ACAD SCI USA, V99, P13837, DOI 10.1073/pnas.192298899; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Handke W, 2009, J IMMUNOL, V182, P2849, DOI 10.4049/jimmunol.0802893; Hartman AL, 2008, J VIROL, V82, P2699, DOI 10.1128/JVI.02344-07; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; KITAMURA T, 1983, JPN J MED SCI BIOL, V36, P17, DOI 10.7883/yoken1952.36.17; Kotenko SV, 2002, CYTOKINE GROWTH F R, V13, P223, DOI 10.1016/S1359-6101(02)00012-6; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Li Z D, 1983, Zhonghua Liu Xing Bing Xue Za Zhi, V4, P198; Mennechet FJD, 2006, BLOOD, V107, P4417, DOI 10.1182/blood-2005-10-4129; Mertz GJ, 1997, ADV INTERNAL MED, V42, P369; Mori M, 1999, J INFECT DIS, V179, P295, DOI 10.1086/314597; Nam JH, 2003, VIRUS GENES, V26, P31, DOI 10.1023/A:1022373904357; NOLTE KB, 1995, HUM PATHOL, V26, P110, DOI 10.1016/0046-8177(95)90123-X; Oelschlegel R, 2007, VIRUS RES, V127, P100, DOI 10.1016/j.virusres.2007.03.027; Perrone LA, 2007, J VIROL, V81, P884, DOI 10.1128/JVI.01074-06; Pober JS, 2001, ANN NY ACAD SCI, V941, P12; Prescott J, 2005, J VIROL, V79, P15007, DOI 10.1128/JVI.79.24.15007-15015.2005; Prescott JB, 2007, J IMMUNOL, V179, P1796, DOI 10.4049/jimmunol.179.3.1796; PUTHAVATHANA P, 1992, VIRUS RES, V26, P1, DOI 10.1016/0168-1702(92)90142-V; Ronni T, 1998, J INTERF CYTOK RES, V18, P773, DOI 10.1089/jir.1998.18.773; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Song JW, 2009, J VIROL, V83, P6184, DOI 10.1128/JVI.00371-09; Song JW, 1996, VIRUS GENES, V12, P249; Spiropoulou CF, 2007, J VIROL, V81, P2769, DOI 10.1128/JVI.02402-06; Stoltz M, 2007, J VIROL, V81, P8685, DOI 10.1128/JVI.00415-07; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; ZAKI SR, 1995, AM J PATHOL, V146, P552; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	43	39	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11159	10.1371/journal.pone.0011159	http://dx.doi.org/10.1371/journal.pone.0011159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567522	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886300006
J	Squeri, V; Masia, L; Casadio, M; Morasso, P; Vergaro, E				Squeri, Valentina; Masia, Lorenzo; Casadio, Maura; Morasso, Pietro; Vergaro, Elena			Force-Field Compensation in a Manual Tracking Task	PLOS ONE			English	Article							NERVOUS-SYSTEM; TRAJECTORY FORMATION; STEADY POSTURE; NEURAL-CONTROL; DYNAMICS; MOVEMENTS; REPRESENTATION; INTERMITTENCY; MAINTENANCE; IMPEDANCE	This study addresses force/movement control in a dynamic "hybrid'' task: the master sub-task is continuous manual tracking of a target moving along an eight-shaped Lissajous figure, with the tracking error as the primary performance index; the slave sub-task is compensation of a disturbing curl viscous field, compatibly with the primary performance index. The two sub-tasks are correlated because the lateral force the subject must exert on the eight-shape must be proportional to the longitudinal movement speed in order to perform a good tracking. The results confirm that visuo-manual tracking is characterized by an intermittent control mechanism, in agreement with previous work; the novel finding is that the overall control patterns are not altered by the presence of a large deviating force field, if compared with the undisturbed condition. It is also found that the control of interaction-forces is achieved by a combination of arm stiffness properties and direct force control, as suggested by the systematic lateral deviation of the trajectories from the nominal path and the comparison between perturbed trials and catch trials. The coordination of the two sub-tasks is quickly learnt after the activation of the deviating force field and is achieved by a combination of force and the stiffness components (about 80% vs. 20%), which is a function of the implicit accuracy of the tracking task.	[Squeri, Valentina; Masia, Lorenzo; Casadio, Maura; Morasso, Pietro] Italian Inst Technol, RBCS Dept, Genoa, Italy; [Casadio, Maura] Northwestern Univ, Chicago, IL 60611 USA; [Casadio, Maura; Morasso, Pietro; Vergaro, Elena] Univ Genoa, DIST Dept, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Northwestern University; University of Genoa	Squeri, V (corresponding author), Italian Inst Technol, RBCS Dept, Genoa, Italy.	valentina.squeri@iit.it	MASIA, LORENZO/D-9385-2014; Casadio, Maura/AAH-2861-2022; Casadio, Maura/AFM-0496-2022		RBCS dept. of the Italian Institute of Technology; EU [FP7]	RBCS dept. of the Italian Institute of Technology; EU(European Commission)	This work was partly supported by the RBCS dept. of the Italian Institute of Technology and the EU-funded FP7 project HUMOUR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL RW, 1972, J EXP PSYCHOL, V96, P92, DOI 10.1037/h0033457; BIZZI E, 1976, J NEUROPHYSIOL, V39, P435, DOI 10.1152/jn.1976.39.2.435; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Casadio Maura, 2006, Technol Health Care, V14, P123; Chib VS, 2009, J NEUROSCI, V29, P3939, DOI 10.1523/JNEUROSCI.5856-08.2009; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; FAVILLA M, 1989, EXP BRAIN RES, V75, P280; FELDMAN AG, 1966, BIOPHYS-USSR, V11, P766; FELDMAN AG, 1966, BIOPHYS-USSR, V11, P565; Hanneton S, 1997, BIOL CYBERN, V77, P381, DOI 10.1007/s004220050398; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Hogan N., 1985, ASME, V107, P1, DOI DOI 10.1115/1.3140702; KEARNEY RE, 1982, J BIOMECH, V15, P753, DOI 10.1016/0021-9290(82)90090-2; MCINTYRE J, 1995, J NEUROPHYSIOL, V73, P1201, DOI 10.1152/jn.1995.73.3.1201; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; MORASSO P, 1981, EXP BRAIN RES, V42, P223; MORASSO P, 1982, BIOL CYBERN, V45, P131, DOI 10.1007/BF00335240; Mugge W, 2010, EXP BRAIN RES, V200, P325, DOI 10.1007/s00221-009-1985-0; Mugge W, 2009, J NEUROSCI, V29, P5476, DOI 10.1523/JNEUROSCI.0116-09.2009; NAVAS F, 1968, BIOPHYS J, V8, P252, DOI 10.1016/S0006-3495(68)86488-4; Nisky I, 2008, IEEE T HAPTICS, V1, P73, DOI [10.1109/TOH.2008.17, 10.1109/ToH.2008.17]; Ohta K, 2004, BIOL CYBERN, V91, P23, DOI 10.1007/s00422-004-0491-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Poulton EC., 1974, TRACKING SKILL MANUA; RAIBERT MH, 1981, T ASME, V102, P126; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; RUSSELL D, 1989, P IEEE ENG MED BIOL, P892; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; STEINBACH MJ, 1969, J EXP PSYCHOL, V82, P366, DOI 10.1037/h0028115; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; Venkadesan M, 2008, J NEUROSCI, V28, P1366, DOI 10.1523/JNEUROSCI.4993-07.2008; VIVIANI P, 1982, NEUROSCIENCE, V7, P431, DOI 10.1016/0306-4522(82)90277-9; WOLPERT DM, 1992, J MOTOR BEHAV, V24, P299, DOI 10.1080/00222895.1992.9941626	34	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11189	10.1371/journal.pone.0011189	http://dx.doi.org/10.1371/journal.pone.0011189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567516	Green Submitted, Green Published, gold			2022-12-25	WOS:000278886300029
J	Stevens, VM; Pavoine, S; Baguette, M				Stevens, Virginie M.; Pavoine, Sandrine; Baguette, Michel			Variation within and between Closely Related Species Uncovers High Intra-Specific Variability in Dispersal	PLOS ONE			English	Article							DENSITY-DEPENDENT DISPERSAL; HABITAT FRAGMENTATION; CLIMATE-CHANGE; QUADRATIC ENTROPY; PARARGE-AEGERIA; WOLF SPIDER; DYNAMICS; LEPIDOPTERA; SELECTION; BEHAVIOR	Mounting evidence shows that contrasting selection pressures generate variability in dispersal patterns among individuals or populations of the same species, with potential impacts on both species dynamics and evolution. However, this variability is hardly considered in empirical works, where a single dispersal function is considered to adequately reflect the species-specific dispersal ability, suggesting thereby that within-species variation is negligible as regard to inter-specific differences in dispersal abilities. We propose here an original method to make the comparison of intra- and inter-specific variability in dispersal, by decomposing the diversity of that trait along a phylogeny of closely related species. We used as test group European butterflies that are classic study organisms in spatial ecology. We apply the analysis separately to eight metrics that reflect the dispersal propensity, the dispersal ability or the dispersal efficiency of populations and species. At the inter-specific level, only the dispersal ability showed the signature of a phylogenetic signal while neither the dispersal propensity nor the dispersal efficiency did. At the within-species level, the partitioning of dispersal diversity showed that dispersal was variable or highly variable among populations: intra- specific variability represented from 11% to 133% of inter-specific variability in dispersal metrics. This finding shows that dispersal variation is far from negligible in the wild. Understanding the processes behind this high within-species variation should allow us to properly account for dispersal in demographic models. Accordingly, to encompass the within species variability in life histories the use of more than one value per trait per species should be encouraged in the construction of databases aiming at being sources for modelling purposes.	[Stevens, Virginie M.] FRS FNRS, Liege, Belgium; [Stevens, Virginie M.] Univ Liege, Unite Biol Comportement, Liege, Belgium; [Stevens, Virginie M.; Baguette, Michel] Museum Natl Hist Nat, UMR CNRS MNHN 7179, Brunoy, France; [Pavoine, Sandrine] Museum Natl Hist Nat, UMR CNRS MNHN 7204, Dept Ecol & Gest Biodivers Paris, F-75231 Paris, France; [Baguette, Michel] CNRS Moulis, USR CNRS Stn Ecol Expt 2936, St Girons, France	Fonds de la Recherche Scientifique - FNRS; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS)	Stevens, VM (corresponding author), FRS FNRS, Liege, Belgium.	stevens@mnhn.fr	Baguette, Michel/HHZ-3609-2022; Baguette, Michel/E-4754-2011		CNRS-MNHN [7179]; EU [226852]	CNRS-MNHN(Centre National de la Recherche Scientifique (CNRS)); EU(European Commission)	This study was funded by the mixed CNRS-MNHN research unit 7179. MB was partly funded by the EU FP7 SCALES project (Securing the conservations of biodiversity across Administrative levels and spatial, temporal and Ecological Scales; project #226852). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; [Anonymous], 2004, WINGS CHECKERSPOTS M, DOI DOI 10.1086/431079; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; Bonte D, 2007, BEHAV ECOL, V18, P438, DOI 10.1093/beheco/arl103; Bonte D, 2006, ANIM BEHAV, V72, P655, DOI 10.1016/j.anbehav.2005.11.026; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bowler DE, 2009, J ANIM ECOL, V78, P1234, DOI 10.1111/j.1365-2656.2009.01580.x; Cizek L, 2006, ECOL ENTOMOL, V31, P337, DOI 10.1111/j.1365-2311.2006.00783.x; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Dytham C, 2006, OIKOS, V113, P530, DOI 10.1111/j.2006.0030-1299.14395.x; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; GOULSON D, 1993, HEREDITY, V71, P386, DOI 10.1038/hdy.1993.153; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I., 1999, METAPOPULATION ECOLO; Hanski Ilkka, 1995, P149, DOI 10.1016/B978-012159270-7/50009-9; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hovestadt Thomas, 2009, P97; Hughes CL, 2003, P ROY SOC B-BIOL SCI, V270, pS147, DOI 10.1098/rsbl.2003.0049; Ims Rolf A., 1997, P247, DOI 10.1016/B978-012323445-2/50015-8; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Merckx T, 2007, ANIM BEHAV, V74, P1029, DOI 10.1016/j.anbehav.2006.12.020; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Neve G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-84; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pavoine S, 2005, ENVIRON ECOL STAT, V12, P125, DOI 10.1007/s10651-005-1037-2; PAVOINE S, 2010, ECOLOGICAL IN PRESS; Plaistow SJ, 2009, PHILOS T R SOC B, V364, P1049, DOI 10.1098/rstb.2008.0251; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; R Development Core Team, 2009, R FDN STAT COMP; Rao C. R., 1986, ENCY STAT SCI, V7, P614; Roff Derek A., 2001, P191; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Schtickzelle N, 2006, ECOLOGY, V87, P1057, DOI 10.1890/0012-9658(2006)87[1057:DDWHFI]2.0.CO;2; STEVENS VM, 2010, BIOL REV IN PRESS, DOI DOI 10.1111/J.1469-185X.2009.00119.X; Stirling DG, 2002, J EVOLUTION BIOL, V15, P277, DOI 10.1046/j.1420-9101.2002.00389.x; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; Watt WB, 1996, MOL BIOL EVOL, V13, P699, DOI 10.1093/oxfordjournals.molbev.a025631	43	69	71	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11123	10.1371/journal.pone.0011123	http://dx.doi.org/10.1371/journal.pone.0011123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559551	Green Published, gold, Green Submitted			2022-12-25	WOS:000278775900013
J	Wolf, J; Reimer, TA; Schuck, S; Ruder, C; Gerlach, K; Muller, EC; Otto, A; Dorken, B; Rehm, A				Wolf, Jana; Reimer, Tatiana A.; Schuck, Sebastian; Rueder, Constantin; Gerlach, Kerstin; Mueller, Eva-Christina; Otto, Albrecht; Doerken, Bernd; Rehm, Armin			Role of EBAG9 protein in coat protein complex I-dependent glycoprotein maturation and secretion processes in tumor cells	FASEB JOURNAL			English	Article						vesicle trafficking; mechanisms of disease; tumor pathogenesis; secretory pathway; immunomodulation	TO-GOLGI TRANSPORT; O-LINKED OLIGOSACCHARIDES; CANINE KIDNEY-CELLS; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; IMMUNE-RESPONSES; COPI VESICLES; LIVING CELLS; INTERMEDIATE COMPARTMENT; MOLECULAR-CLONING	Many proteins mature within the secretory pathway by the acquisition of glycans. Failure to maintain the proper distribution of the glycosylation machinery might lead to disease. High expression levels of the ubiquitous Golgi protein estrogen receptor-binding fragment-associated gene 9 (EBAG9) in human tumors correlate with poor clinical prognosis, and EBAG9 overexpression in epithelial cell lines induces truncated glycans, typical of many carcinomas. Here, we addressed the pathogenetic link between EBAG9 expression and the alteration of the cellular glycome. We applied confocal microscopy, live imaging, pulse-chase labeling in conjunction with immunoprecipitation, and enzymatic activity assays in a variety of EBAG9-overexpressing or depleted epithelial tumor cell lines. EBAG9 shuttles between the ER-Golgi intermediate compartment and the cis-Golgi, and we demonstrate association of EBAG9 with coat protein complex I (COPI)-coated transport vesicles. EBAG9 overexpression imposes delay of endoplasmic reticulum-to-Golgi transport and mislocalizes components of the ER quality control and glycosylation machinery. Conversely, EBAG9 down-regulation accelerates glycoprotein transport through the Golgi and enhances mannosidase activity. Thus, EBAG9 acts as a negative regulator of a COPI-dependent ER-to-Golgi transport pathway in epithelial cells and represents a novel pathogenetic principle in which interference with intracellular membrane trafficking results in the emergence of a tumor-associated glycome.-Wolf, J., Reimer, T. A., Schuck, S., Ruder, C., Gerlach, K., Muller, E.-C., Otto, A., Dorken, B., Rehm, A. Role of EBAG9 protein in coat protein complex I-dependent glycoprotein maturation and secretion processes in tumor cells. FASEB J. 24, 4000-4019 (2010). www.fasebj.org	[Schuck, Sebastian] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Wolf, Jana; Reimer, Tatiana A.; Rueder, Constantin; Gerlach, Kerstin; Mueller, Eva-Christina; Otto, Albrecht; Doerken, Bernd; Rehm, Armin] Max Delbruck Ctr Mol Med, Dept Hematol Oncol & Tumorimmunol, D-13125 Berlin, Germany; [Doerken, Bernd; Rehm, Armin] Charite, Dept Hematol Oncol & Tumorimmunol, Virchow Clin, D-13353 Berlin, Germany	Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rehm, A (corresponding author), Max Delbruck Ctr Mol Med, Dept Haematol Oncol & Tumorimmunol, Robert Rossle Str 10, D-13125 Berlin, Germany.	arehm@mdc-berlin.de		Schuck, Sebastian/0000-0002-6388-0661	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Jennifer Lippincott-Schwartz (National Institute of Child Health and Human Development, Bethesda, MD, USA), Ludger Johannes (Institut Curie, Paris, France), Thomas Sudhof (University of Texas Southwestern Medical Center, Dallas, TX, USA), Brian Storrie (University of Arkansas for Medical Sciences, Little Rock, AR, USA), Mark A. McNiven (Mayo Clinic, Rochester, MN, USA), Richard D. Cummings (Emory University School of Medicine, Atlanta, GA, USA), Jean Gruenberg (Universite de Geneve, Geneva, Switzerland), and Ingo Morano (Max Delbruck Center for Molecular Medicine, Berlin, Germany) for providing essential reagents, and K. Simons for continuous support. The authors also thank U. Karsten and U.E. Hopken for critical evaluation of the manuscript. This work was supported by a grant from Deutsche Forschungsgemeinschaft (to A.R).	Akahira J, 2004, BRIT J CANCER, V90, P2197, DOI 10.1038/sj.bjc.6601832; Aoe T, 1999, J BIOL CHEM, V274, P20545, DOI 10.1074/jbc.274.29.20545; Bannykh SI, 1997, J CELL BIOL, V138, P1, DOI 10.1083/jcb.138.1.1; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Cavallaro U, 2001, BBA-REV CANCER, V1552, P39, DOI 10.1016/S0304-419X(01)00038-5; Cichon G, 1999, J GENE MED, V1, P360, DOI 10.1002/(SICI)1521-2254(199909/10)1:5<360::AID-JGM54>3.0.CO;2-Q; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cudic M, 2002, BIOORGAN MED CHEM, V10, P3859, DOI 10.1016/S0968-0896(02)00388-7; Daniels R, 2004, CELL BIOCHEM BIOPHYS, V41, P113, DOI 10.1385/CBB:41:1:113; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; EGEA G, 1993, J CELL SCI, V105, P819; Engelsberg A, 2003, J BIOL CHEM, V278, P22998, DOI 10.1074/jbc.M301361200; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; GRIFFITHS G, 1995, J CELL SCI, V108, P2839; Hakomori S, 1996, CANCER RES, V56, P5309; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Hauri HP, 2000, J CELL SCI, V113, P587; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hong XJ, 2009, CANCER SCI, V100, P961, DOI 10.1111/j.1349-7006.2009.01129.x; Jensen T, 2001, EUR J IMMUNOL, V31, P3197, DOI 10.1002/1521-4141(200111)31:11<3197::AID-IMMU3197>3.0.CO;2-5; Johannes L, 2002, AM J PHYSIOL-GASTR L, V283, pG1, DOI 10.1152/ajpgi.00088.2002; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Klumperman J, 1998, J CELL SCI, V111, P3411; KTISTAKIS NT, 1995, MOL BIOL CELL, V6, P135, DOI 10.1091/mbc.6.2.135; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Luna A, 2002, MOL BIOL CELL, V13, P866, DOI 10.1091/mbc.01-12-0579; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Monlauzeur L, 1998, J BIOL CHEM, V273, P30263, DOI 10.1074/jbc.273.46.30263; Newsom-Davis TE, 2009, CANCER RES, V69, P2018, DOI 10.1158/0008-5472.CAN-08-3589; Ogushi T, 2005, CANCER RES, V65, P3700, DOI 10.1158/0008-5472.CAN-04-3497; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Pernet-Gallay K, 2002, TRAFFIC, V3, P822, DOI 10.1034/j.1600-0854.2002.31107.x; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rehm A, 2001, EMBO J, V20, P1573, DOI 10.1093/emboj/20.7.1573; Reimer TA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-47; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Ruder C, 2005, MOL BIOL CELL, V16, P1245, DOI 10.1091/mbc.E04-09-0817; Ruder C, 2009, J CLIN INVEST, V119, P2184, DOI 10.1172/JCI37760; Rutz C, 2009, TRAFFIC, V10, P994, DOI 10.1111/j.1600-0854.2009.00934.x; Sannerud R, 2003, CURR OPIN CELL BIOL, V15, P438, DOI 10.1016/S0955-0674(03)00077-2; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Schuck S, 2007, TRAFFIC, V8, P47, DOI 10.1111/j.1600-0854.2006.00506.x; SCHWEIZER A, 1991, J CELL BIOL, V113, P45, DOI 10.1083/jcb.113.1.45; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0; Stephens DJ, 2000, J CELL SCI, V113, P2177; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Storrie B, 2002, TRAFFIC, V3, P521, DOI 10.1034/j.1600-0854.2002.30802.x; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Takahashi S, 2003, INT J CANCER, V106, P310, DOI 10.1002/ijc.11205; TANG BL, 1993, J CELL BIOL, V120, P325, DOI 10.1083/jcb.120.2.325; Tisdale EJ, 1997, J CELL BIOL, V137, P581, DOI 10.1083/jcb.137.3.581; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Tsuboi S, 1998, J BIOL CHEM, V273, P30680, DOI 10.1074/jbc.273.46.30680; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; Tsuchiya F, 2001, BIOCHEM BIOPH RES CO, V284, P2, DOI 10.1006/bbrc.2001.4892; Tsuiji H, 2003, GLYCOBIOLOGY, V13, P521, DOI 10.1093/glycob/cwg065; Tsuneizumi M, 2001, CLIN CANCER RES, V7, P3526; Ungar D, 2006, TRENDS CELL BIOL, V16, P113, DOI 10.1016/j.tcb.2005.12.004; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Watanabe T, 1998, MOL CELL BIOL, V18, P442, DOI 10.1128/MCB.18.1.442; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Whitehouse C, 1997, J CELL BIOL, V137, P1229, DOI 10.1083/jcb.137.6.1229; Zhang XL, 2006, CURR MED CHEM, V13, P1141, DOI 10.2174/092986706776360897	90	4	4	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					4000	4019		10.1096/fj.09-153452	http://dx.doi.org/10.1096/fj.09-153452			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20570965				2022-12-25	WOS:000285005900037
J	Oda, Y; Yoshimura, Y; Ohnishi, H; Tadokoro, M; Katsube, Y; Sasao, M; Kubo, Y; Hattori, K; Saito, S; Horimoto, K; Yuba, S; Ohgushi, H				Oda, Yasuaki; Yoshimura, Yasuhide; Ohnishi, Hiroe; Tadokoro, Mika; Katsube, Yoshihiro; Sasao, Mari; Kubo, Yoko; Hattori, Koji; Saito, Shigeru; Horimoto, Katsuhisa; Yuba, Shunsuke; Ohgushi, Hajime			Induction of Pluripotent Stem Cells from Human Third Molar Mesenchymal Stromal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-THERAPY; HUMAN FIBROBLASTS; IN-VITRO; GENERATION; MOUSE; PTIP; EFFICIENCY; CHROMATIN; LIVER	The expression of four transcription factors (OCT3/4, SOX2, KLF4, and MYC) can reprogram mouse as well as human somatic cells to induced pluripotent stem (iPS) cells. We generated iPS cells from mesenchymal stromal cells (MSCs) derived from human third molars (wisdom teeth) by retroviral transduction of OCT3/4, SOX2, and KLF4 without MYC, which is considered as oncogene. Interestingly, some of the clonally expanded MSCs could be used for iPS cell generation with 30-100-fold higher efficiency when compared with that of other clonally expanded MSCs and human dermal fibroblasts. Global gene expression profiles demonstrated some up-regulated genes regarding DNA repair/histone conformational change in the efficient clones, suggesting that the processes of chromatin remodeling have important roles in the cascade of iPS cells generation. The generated iPS cells resembled human embryonic stem (ES) cells in many aspects, including morphology, ES marker expression, global gene expression, epigenetic states, and the ability to differentiate into the three germ layers in vitro and in vivo. Because human third molars are discarded as clinical waste, our data indicate that clonally expanded MSCs derived from human third molars are a valuable cell source for the generation of iPS cells.	[Kubo, Yoko; Hattori, Koji; Yuba, Shunsuke; Ohgushi, Hajime] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Tissue Engn Res Grp, Hyogo 6610974, Japan; [Saito, Shigeru; Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Biol Network Team, Koto Ku, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Ohgushi, H (corresponding author), 3-11-46 Nakouji, Amagasaki, Hyogo 6610974, Japan.	hajime-ohgushi@aist.go.jp	Saito, Shigeru/B-2785-2012	Saito, Shigeru/0000-0002-8708-9102; Yoshimura, Yasuhide/0000-0002-9121-8667; Ohnishi, Hiroe/0000-0003-3437-680X	Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the project for realization of regenerative medicine of the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cavazzana-Calvo M, 2007, J CLIN INVEST, V117, P1456, DOI 10.1172/JCI30953; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ikeda E, 2006, BIOCHEM BIOPH RES CO, V342, P1257, DOI 10.1016/j.bbrc.2006.02.101; Ikeda E, 2008, DIFFERENTIATION, V76, P495, DOI 10.1111/j.1432-0436.2007.00245.x; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim D, 2009, STEM CELLS, V27, P1516, DOI 10.1002/stem.79; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lilyestrom W, 2010, J MOL BIOL, V395, P983, DOI 10.1016/j.jmb.2009.11.062; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murata K, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-4; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	52	94	101	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29270	29278		10.1074/jbc.M109.055889	http://dx.doi.org/10.1074/jbc.M109.055889			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20595386	Green Published, hybrid			2022-12-25	WOS:000281740100029
J	Ding, JZ; Zhang, Z; Roberts, GJ; Falcone, M; Miao, YW; Shao, YL; Zhang, XJC; Andrews, DW; Lin, JL				Ding, Jingzhen; Zhang, Zhi; Roberts, G. Jane; Falcone, Mina; Miao, Yiwei; Shao, Yuanlong; Zhang, Xuejun C.; Andrews, David W.; Lin, Jialing			Bcl-2 and Bax Interact via the BH1-3 Groove-BH3 Motif Interface and a Novel Interface Involving the BH4 Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; FAMILY PROTEINS; NONIONIC DETERGENTS; ALPHA-HELIX; CELL-DEATH; APOPTOSIS; DIMERIZATION; ACTIVATION; DOMAIN; OLIGOMERIZATION	The interaction of Bcl-2 family proteins at the mitochondrial outer membrane controls membrane permeability and thereby the apoptotic program. The anti-apoptotic protein Bcl-2 binds to the pro-apoptotic protein Bax to prevent Bax homo-oligomerization required for membrane permeabilization. Here, we used site-specific photocross-linking to map the surfaces of Bax and Bcl-2 that interact in the hetero-complex formed in a Triton X-100 micelle as a membrane surrogate. Heterodimer-specific photoadducts were detected from multiple sites in Bax and Bcl-2. Many of the interaction sites are located in the Bcl-2 homology 3 (BH3) region of Bax and the BH1-3 groove of Bcl-2 that likely form the BH3-BH1-3 groove interface. However, other interaction sites form a second interface that includes helix 6 of Bax and the BH4 region of Bcl-2. Loss-of-function mutations in the BH3 region of Bax and the BH1 region of Bcl-2 disrupted the BH3-BH1-3 interface, as expected. Surprisingly the second interface was also disrupted by these mutations. Similarly, a loss-of-function mutation in the BH4 region of Bcl-2 that forms part of the second interface also disrupted both interfaces. As expected, both kinds of mutation abolished Bcl-2-mediated inhibition of Bax oligomerization in detergent micelles. Therefore, Bcl-2 binds Bax through two interdependent interfaces to inhibit the pro-apoptotic oligomerization of Bax.	[Lin, Jialing] Univ Oklahoma, Dept Biochem & Mol Biol, Hlth Sci Ctr, Oklahoma City, OK 73126 USA; [Roberts, G. Jane; Falcone, Mina; Andrews, David W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Miao, Yiwei; Shao, Yuanlong] Texas A&M Univ, Dept Mol & Cellular Med, Syst Hlth Sci Ctr, College Stn, TX 77843 USA; [Zhang, Xuejun C.] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Chinese Academy of Sciences; Institute of Biophysics, CAS	Lin, JL (corresponding author), 940 Stanton L Young Blvd,Biomed Sci Bldg 935,POB, Oklahoma City, OK 73126 USA.	jialing-lin@ouhsc.edu	ding, Jingzhen/B-5427-2015	Andrews, David/0000-0002-9266-7157	National Institutes of Health [GM062964]; Canadian Institutes of Health [FRN 12517]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062964 (to J. L.). This work was also supported by Canadian Institutes of Health Research Grant FRN 12517 (to D. W. A.).	Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Denisov AY, 2007, BIOCHEMISTRY-US, V46, P734, DOI 10.1021/bi062080a; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Feng Y, 2008, J BIOCHEM, V143, P243, DOI 10.1093/jb/mvm216; Fiebig AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-213; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Hirotani M, 1999, J BIOL CHEM, V274, P20415, DOI 10.1074/jbc.274.29.20415; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin JL, 2001, J BIOL CHEM, V276, P41733, DOI 10.1074/jbc.M103475200; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; O'Neill JW, 2006, J MOL BIOL, V356, P367, DOI 10.1016/j.jmb.2005.11.032; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ottilie S, 1997, J BIOL CHEM, V272, P16955, DOI 10.1074/jbc.272.27.16955; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Peng J, 2009, APOPTOSIS, V14, P1145, DOI 10.1007/s10495-009-0389-8; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; TSUJIMOTO Y, 1987, ONCOGENE, V2, P3; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zha HB, 1997, J BIOL CHEM, V272, P31482, DOI 10.1074/jbc.272.50.31482; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200; Zhang Z, 2010, J BIOL CHEM, V285, P17614, DOI 10.1074/jbc.M110.113456	61	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28749	28763		10.1074/jbc.M110.148361	http://dx.doi.org/10.1074/jbc.M110.148361			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20584903	hybrid, Green Published			2022-12-25	WOS:000281594000041
J	Kang, N; Jun, AH; Bhutia, YD; Kannan, N; Unadkat, JD; Govindarajan, R				Kang, Nayoung; Jun, Ah Hyun; Bhutia, Yangzom Doma; Kannan, Natarajan; Unadkat, Jashvant D.; Govindarajan, Rajgopal			Human Equilibrative Nucleoside Transporter-3 (hENT3) Spectrum Disorder Mutations Impair Nucleoside Transport, Protein Localization, and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; ESCHERICHIA-COLI; GENE; MITOCHONDRIA; DELTA-F508; GLYCINE; PACKING; RESCUE; FAMILY; CELLS	Accumulating evidence reveals that sole mutations in hENT3 cause a spectrum of human genetic disorders. Among these include H syndrome, characterized by scleroderma, hyperpigmentation, hypertrichosis, hepatomegaly, cardiac abnormalities and musculoskeletal deformities, pigmented hypertrichotic dermatosis with insulin-dependent diabetes syndrome, characterized by autoantibody-negative diabetes mellitus and skin deformities, familial Rosai-Dorfman disease, characterized by short stature, familial histiocytosis and sinus histiocytosis with massive lymphadenopathy (SHML), characterized by severe tissue infiltration of immune cells and swollen lymph nodes. hENT3 spectrum disorders share a common mutation and share overlapping clinical manifestations that display many intriguing resemblances to mitochondrial and lysosomal disorders. Although earlier studies identify hENT3 as a mitochondrial and a lysosomal nucleoside transporter, the precise connections between hENT3 and the pathophysiology of these disorders remain unresolved. In this study, we performed functional and biochemical characterization of these mutations in hENT3. We report severe reductions/losses of hENT3 nucleoside transport functions of hENT3 syndrome mutants. In addition to transport alterations, we provide evidence for possible loss of hENT3 functions in all H and pigmented hypertrichotic dermatosis with insulin-dependent diabetes syndromes due to either mis-trafficking or altered stability of mutant hENT3 proteins.	[Kang, Nayoung; Jun, Ah Hyun; Bhutia, Yangzom Doma; Govindarajan, Rajgopal] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Unadkat, Jashvant D.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Washington; University of Washington Seattle	Govindarajan, R (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Rm 234 A,RC Wilson Pharm Bldg, Athens, GA 30602 USA.	rgovinda@rx.uga.edu		Unadkat, Jashvant/0000-0002-4820-8455	NCI, National Institutes of Health [5 P50-CA128613-SPORE]; Department of Pharmaceutical and Biomedical Sciences (University of Georgia); NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Pharmaceutical and Biomedical Sciences (University of Georgia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported, in whole or in part, by NCI, National Institutes of Health Award 5 P50-CA128613-SPORE in Head-and-Neck Cancer (to R. G.). This work was also supported by the Department of Pharmaceutical and Biomedical Sciences (University of Georgia).	Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BALLINGER SW, 1994, NAT GENET, V7, P458, DOI 10.1038/ng0894-458; BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Cliffe ST, 2009, HUM MOL GENET, V18, P2257, DOI 10.1093/hmg/ddp161; Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392; Ermolova NV, 2005, BIOCHEMISTRY-US, V44, P7669, DOI 10.1021/bi0502801; Errasti-Murugarren E, 2009, FASEB J, V23, P172, DOI 10.1096/fj.08-113902; Flanagan SA, 2007, LEUKEMIA LYMPHOMA, V48, P1816, DOI 10.1080/10428190701528491; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Molho-Pessach V, 2008, AM J HUM GENET, V83, P529, DOI 10.1016/j.ajhg.2008.09.013; Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders CR, 2001, BIOCHEMISTRY-US, V40, P9453, DOI 10.1021/bi010894f; SenGupta DJ, 2002, BIOCHEMISTRY-US, V41, P1512, DOI 10.1021/bi015833w; Singh OV, 2008, MOL CELL PROTEOMICS, V7, P1099, DOI 10.1074/mcp.M700303-MCP200; Thomson M, 1998, BBA-MOL CELL RES, V1403, P211, DOI 10.1016/S0167-4889(98)00069-X; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]	27	59	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28343	28352		10.1074/jbc.M110.109199	http://dx.doi.org/10.1074/jbc.M110.109199			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595384	Green Published, hybrid			2022-12-25	WOS:000281404100076
J	Singleton, WCJ; McInnes, KT; Cater, MA; Winnall, WR; McKirdy, R; Yu, Y; Taylor, PE; Ke, BX; Richardson, DR; Mercer, JFB; La Fontaine, S				Singleton, William C. J.; McInnes, Kelly T.; Cater, Michael A.; Winnall, Wendy R.; McKirdy, Ross; Yu, Yu; Taylor, Philip E.; Ke, Bi-Xia; Richardson, Des R.; Mercer, Julian F. B.; La Fontaine, Sharon			Role of Glutaredoxin1 and Glutathione in Regulating the Activity of the Copper-transporting P-type ATPases, ATP7A and ATP7B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN WILSON PROTEIN; S-GLUTATHIONYLATION; MENKES; TRAFFICKING; EXPRESSION; MECHANISM; BINDING; THIOLTRANSFERASE; INTERPLAY; DOMAINS	The copper-transporting P-type ATPases (Cu-ATPases), ATP7A and ATP7B, are essential for the regulation of intracellular copper homeostasis. In this report we describe new roles for glutathione (GSH) and glutaredoxin1 (GRX1) in Cu homeostasis through their regulation of Cu-ATPase activity. GRX1 is a thiol oxidoreductase that catalyzes the reversible reduction of GSH-mixed disulfides to their respective sulfhydryls (deglutathionylation). Here, we demonstrated that glutathionylation of the Cu-ATPases and their interaction with GRX1 were affected by alterations in Cu levels. The data support our hypothesis that the Cu-ATPases serve as substrates for Cu-dependent GRX1-mediated deglutathionylation. This in turn liberates the Cu-ATPase cysteinyl thiol groups for Cu binding and transport. GSH depletion experiments led to reversible inhibition of the Cu-ATPases that correlated with effects on intracellular Cu levels and GRX1 activity. Finally, knockdown of GRX1 expression resulted in an increase in intracellular Cu accumulation. Together, these data directly implicate GSH and GRX1 with important new roles in redox regulation of the Cu-ATPases, through modulation of Cu binding by the Cu-ATPase cysteine motifs.	[Singleton, William C. J.; McInnes, Kelly T.; McKirdy, Ross; Taylor, Philip E.; Ke, Bi-Xia; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Burwood, Vic 3125, Australia; [Singleton, William C. J.; McInnes, Kelly T.; McKirdy, Ross; Taylor, Philip E.; Ke, Bi-Xia; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Strateg Res Ctr Mol & Med Res, Burwood, Vic 3125, Australia; [Cater, Michael A.] Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia; [Winnall, Wendy R.] Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic 3168, Australia; [Yu, Yu; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia	Deakin University; Deakin University; Monash University; University of Sydney	La Fontaine, S (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, 221 Burwood Highway, Burwood, Vic 3125, Australia.	sharon.lafontaine@deakin.edu.au	Yu, Yu/AAD-7947-2019; La Fontaine, Sharon/G-7113-2018; Mercer, Julian/R-8583-2019	Yu, Yu/0000-0002-0209-0586; La Fontaine, Sharon/0000-0002-9948-074X; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274	Deakin University; National Health and Medical Research Council of Australia (NHMRC); Australian Research Council; University of Sydney Faculty of Medicine; Cancer Institute of New South Wales	Deakin University; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Sydney Faculty of Medicine(University of Sydney); Cancer Institute of New South Wales	This work was supported by grants from Deakin University and the National Health and Medical Research Council of Australia (NHMRC) (to S. L. and J. F. B. M.), a NHMRC biomedical research fellowship (to M. A. C.), a NHMRC senior principal research fellowship and grants from the NHMRC and the Australian Research Council (to D. R. R.), and a University of Sydney Faculty of Medicine postgraduate scholarship and Cancer Institute of New South Wales research scholarship (to Y. Y.).	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; [Anonymous], 1995, METABOLIC BASIS INHE; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Bertini I, 2010, COORDIN CHEM REV, V254, P506, DOI 10.1016/j.ccr.2009.07.024; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; Chen HHW, 2008, MOL PHARMACOL, V74, P697, DOI 10.1124/mol.108.047969; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Craythorn RG, 2009, MOL HUM REPROD, V15, P757, DOI 10.1093/molehr/gap058; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Davis AV, 2008, NAT CHEM BIOL, V4, P148, DOI 10.1038/nchembio0308-148; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Eaton P, 2002, J MOL CELL CARDIOL, V34, P1549, DOI 10.1006/jmcc.2002.2108; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; FREEDMAN JH, 1989, BIOCHEM BIOPH RES CO, V164, P134, DOI 10.1016/0006-291X(89)91693-8; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Hall AG, 1999, EUR J CLIN INVEST, V29, P238; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Ke BX, 2006, AM J PHYSIOL-REG I, V290, pR1460, DOI 10.1152/ajpregu.00806.2005; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; La Fontaine S, 2010, INT J BIOCHEM CELL B, V42, P206, DOI 10.1016/j.biocel.2009.11.007; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lim CM, 2006, BIOCHEM BIOPH RES CO, V348, P428, DOI 10.1016/j.bbrc.2006.07.067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mattie MD, 2004, AM J PHYSIOL-CELL PH, V286, pC293, DOI 10.1152/ajpcell.00293.2003; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Miras R, 2008, J BIOL INORG CHEM, V13, P195, DOI 10.1007/s00775-007-0310-2; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Raghavachari N, 2001, INVEST OPHTH VIS SCI, V42, P1002; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Saeed U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002459; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shelton MD, 2008, MOL CELLS, V25, P332; Song JJ, 2003, BIOCHEM J, V373, P845, DOI 10.1042/BJ20030275; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; TERADA T, 1994, BIOCHEM MOL BIOL INT, V32, P239; van den Berghe PVE, 2010, J BIOL INORG CHEM, V15, P37, DOI 10.1007/s00775-009-0592-7; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; White AR, 2003, J NEUROSCI RES, V71, P889, DOI 10.1002/jnr.10537; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200	52	56	57	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27111	27121		10.1074/jbc.M110.154468	http://dx.doi.org/10.1074/jbc.M110.154468			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566629	hybrid, Green Published			2022-12-25	WOS:000281172700042
J	Spain, MM; Caruso, JA; Swaminathan, A; Pile, LA				Spain, Marla M.; Caruso, Joseph A.; Swaminathan, Aishwarya; Pile, Lori A.			Drosophila SIN3 Isoforms Interact with Distinct Proteins and Have Unique Biological Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; CELLULAR SENESCENCE; STRUCTURAL BASIS; COREPRESSOR; FAMILY; YEAST; COMPONENT; IDENTIFICATION	The SIN3 corepressor serves as a scaffold for the assembly of histone deacetylase (HDAC) complexes. SIN3 and its associated HDAC have been shown to have critical roles in both development and the regulation of cell cycle progression. Although multiple SIN3 isoforms have been reported in simple to complex eukaryotic organisms, the mechanisms by which such isoforms regulate specific biological processes are still largely uncharacterized. To gain insight into how SIN3 isoform-specific function contributes to the growth and development of a metazoan organism, we have affinity-purified two SIN3 isoform-specific complexes, SIN3 187 and 220, from Drosophila S2 cells and embryos. We have identified a number of proteins common to the complexes, including the HDAC RPD3, as well as orthologs of several proteins known to have roles in regulating cell proliferation in other organisms. We additionally identified factors, including the histone demethylase little imaginal discs and histone-interacting protein p55, that exhibited a preferential interaction with the largest SIN3 isoform. Our experiments indicate that the isoforms are associated with distinct HDAC activity and are recruited to unique and shared sites along polytene chromosome arms. Furthermore, although expression of SIN3 220 can substitute for genetic loss of other isoforms, expression of SIN3 187 does not support Drosophila viability. Together our findings suggest that SIN3 isoforms serve distinct roles in transcriptional regulation by partnering with different histone-modifying enzymes.	[Spain, Marla M.; Swaminathan, Aishwarya; Pile, Lori A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Caruso, Joseph A.] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA	Wayne State University; Wayne State University	Pile, LA (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	loripile@wayne.edu	Swaminathan, Aishwarya/I-4242-2019; Caruso, Joseph A./U-8429-2019	Swaminathan, Aishwarya/0000-0001-9082-502X; Caruso, Joseph A./0000-0003-2900-3996	American Cancer Society; Wayne State University; NIEHS, National Institutes of Health [P30-ES006639]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Wayne State University; NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a research scholar grant from the American Cancer Society (to L. A. P.) and graduate enhancement research support from Wayne State University (to M. M. S. and A. S.). The Proteomics Core Facility of the Institute of Environmental Health Sciences at Wayne State University is supported by NIEHS, National Institutes of Health, Grant P30-ES006639.	Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Bowen AJ, 2010, J MOL BIOL, V395, P937, DOI 10.1016/j.jmb.2009.11.065; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Dang VD, 1999, MOL CELL BIOL, V19, P2351; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Ekwall K, 2005, TRENDS GENET, V21, P608, DOI 10.1016/j.tig.2005.08.009; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Ge Z, 2010, FASEB J, V24, P579, DOI 10.1096/fj.09-140087; Grandinetti KB, 2009, CANCER RES, V69, P6430, DOI 10.1158/0008-5472.CAN-09-0537; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Lee N, 2009, MOL CELL BIOL, V29, P1401, DOI 10.1128/MCB.01643-08; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Loewith R, 2001, J BIOL CHEM, V276, P24068, DOI 10.1074/jbc.M102176200; Matyash A, 2009, J BIOL CHEM, V284, P3012, DOI 10.1074/jbc.M806163200; McCallum SA, 2006, BIOCHEMISTRY-US, V45, P11974, DOI 10.1021/bi060687l; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Neufeld TP, 1998, GENETICS, V148, P277; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Nourani A, 2003, J BIOL CHEM, V278, P19171, DOI 10.1074/jbc.C300036200; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Sambasivan R, 2008, J BIOSCIENCES, V33, P27, DOI 10.1007/s12038-008-0019-6; Sambrook J, 2001, MOL CLONING LAB MANU; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Sharma V, 2008, DEV DYNAM, V237, P3040, DOI 10.1002/dvdy.21706; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Singh N, 2005, DEV BIOL, V278, P242, DOI 10.1016/j.ydbio.2004.11.011; Smith KT, 2010, CHEM BIOL, V17, P65, DOI 10.1016/j.chembiol.2009.12.010; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Swaminathan A, 2010, MECH DEVELOP, V127, P96, DOI 10.1016/j.mod.2009.10.003; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Taylor-Harding B, 2004, MOL CELL BIOL, V24, P9124, DOI 10.1128/MCB.24.20.9124-9136.2004; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Vermaak D, 1999, MOL CELL BIOL, V19, P5847; Viiri KM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-149; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; WANG HM, 1993, MOL CELL BIOL, V13, P1805, DOI 10.1128/MCB.13.3.1805; Weake VM, 2009, GENE DEV, V23, P2818, DOI 10.1101/gad.1846409; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yochum GS, 2001, MOL CELL BIOL, V21, P4110, DOI 10.1128/MCB.21.13.4110-4118.2001; Zhang W, 2007, EMBO REP, V8, P952, DOI 10.1038/sj.embor.7401049; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhao C, 2003, J BIOL CHEM, V278, P43901, DOI 10.1074/jbc.M302714200	69	28	28	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27457	27467		10.1074/jbc.M110.130245	http://dx.doi.org/10.1074/jbc.M110.130245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566628	Green Published, hybrid			2022-12-25	WOS:000281172700075
J	Wiley, M; Sweeney, KR; Chan, DA; Brown, KM; McMurtrey, C; Howard, EW; Giaccia, AJ; Blader, IJ				Wiley, Mandi; Sweeney, Kristin R.; Chan, Denise A.; Brown, Kevin M.; McMurtrey, Curtis; Howard, Eric W.; Giaccia, Amato J.; Blader, Ira J.			Toxoplasma gondii Activates Hypoxia-inducible Factor (HIF) by Stabilizing the HIF-1 alpha Subunit via Type I Activin-like Receptor Kinase Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; NF-KAPPA-B; GENE-EXPRESSION; MURINE MACROPHAGES; HUMAN FIBROBLASTS; DOWN-REGULATION; IMMUNE EVASION; PROTEIN-KINASE; MESSENGER-RNA; PROLYL	Toxoplasma gondii is an intracellular protozoan parasite that can cause devastating disease in fetuses and immune-compromised individuals. We previously reported that the alpha subunit of the host cell transcription factor, hypoxia-inducible factor-1 (HIF-1), is up-regulated by infection and necessary for Toxoplasma growth. Under basal conditions, HIF-1 alpha is constitutively expressed but rapidly targeted for proteasomal degradation after two proline residues are hydroxylated by a family of prolyl hydroxylases (PHDs). The PHDs are alpha-ketoglutarate-dependent dioxygenases that have low K-m values for oxygen, making them important cellular oxygen sensors. Thus, when oxygen levels decrease, HIF-1 alpha is not hydroxylated, and HIF-1 is activated. How Toxoplasma activates HIF-1 under normoxic conditions remains unknown. Here, we report that Toxoplasma infection increases HIF-1 alpha stability by preventing HIF-1 alpha prolyl hydroxylation. Infection significantly decreases PHD2 abundance, which is the key prolyl hydroxylase for regulating HIF-1 alpha. The effects of Toxoplasma on HIF-1 alpha abundance and prolyl hydroxylase activity require activin-like receptor kinase signaling. Finally, parasite growth is severely diminished when signaling from this family of receptors is inhibited. Together, these data indicate that PHD2 is a key host cell factor for T. gondii growth and represent a novel mechanism by which a microbial pathogen subverts host cell signaling and transcription to establish its replicative niche.	[Wiley, Mandi; Sweeney, Kristin R.; Brown, Kevin M.; McMurtrey, Curtis; Blader, Ira J.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Howard, Eric W.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Chan, Denise A.; Giaccia, Amato J.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA; [Chan, Denise A.] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco; Stanford University	Blader, IJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BMSB 1019,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.				National Institutes of Health [AI069986]; American Cancer Society [MBC-114461]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI069986. This work was also supported by American Cancer Society Grant MBC-114461 (to I. J. B.).	Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Arrais-Silva WW, 2005, EXP MOL PATHOL, V78, P49, DOI 10.1016/j.yexmp.2004.09.002; Barbosa BF, 2008, CLIN EXP IMMUNOL, V151, P536, DOI 10.1111/j.1365-2249.2007.03583.x; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; BERMUDEZ LE, 1993, INFECT IMMUN, V61, P4126, DOI 10.1128/IAI.61.10.4126-4130.1993; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Blader IJ, 2009, APMIS, V117, P458, DOI 10.1111/j.1600-0463.2009.02453.x; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; COPPENS I, 2001, EXPERT REV MOL MED, P1; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; Gail M, 2001, MOL GENET GENOMICS, V265, P905, DOI 10.1007/s004380100487; Goebel S, 1999, MED MICROBIOL IMMUN, V187, P221, DOI 10.1007/s004300050096; HALONEN SK, 1994, J EUKARYOT MICROBIOL, V41, P65, DOI 10.1111/j.1550-7408.1994.tb05936.x; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; HUNTER CA, 1993, INFECT IMMUN, V61, P4038, DOI 10.1128/IAI.61.10.4038-4044.1993; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Kim L, 2006, J IMMUNOL, V177, P2584, DOI 10.4049/jimmunol.177.4.2584; Kim L, 2006, J CELL SCI, V119, P2119, DOI 10.1242/jcs.02934; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P2658, DOI 10.1073/pnas.0711918105; Lee SK, 2005, J DERMATOL SCI, V40, P95, DOI 10.1016/j.jdermsci.2005.06.008; Liu XH, 2002, J BIOL CHEM, V277, P50081, DOI 10.1074/jbc.M201095200; Luder CGK, 1998, CLIN EXP IMMUNOL, V112, P308; Mason NJ, 2004, INFECT IMMUN, V72, P5662, DOI 10.1128/IAI.72.10.5662-5667.2004; Masson N, 2003, J CELL SCI, V116, P3041, DOI 10.1242/jcs.00655; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazanet MM, 2002, J IMMUNOL, V169, P3581, DOI 10.4049/jimmunol.169.7.3581; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Molestina RE, 2003, J CELL SCI, V116, P4359, DOI 10.1242/jcs.00683; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nagineni CN, 2002, CLIN EXP IMMUNOL, V128, P372, DOI 10.1046/j.1365-2249.2002.01815.x; Nakamura M, 2009, VIROLOGY, V387, P442, DOI 10.1016/j.virol.2009.02.036; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nash PB, 1998, J IMMUNOL, V160, P1824; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Payne TM, 2003, J CELL SCI, V116, P4345, DOI 10.1242/jcs.00756; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Phelps ED, 2008, INFECT IMMUN, V76, P4703, DOI 10.1128/IAI.01447-07; Reissmann E, 2001, GENE DEV, V15, P2010, DOI 10.1101/gad.201801; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Schluter D, 2001, INFECT IMMUN, V69, P7889, DOI 10.1128/IAI.69.12.7889-7893.2001; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sinai AP, 1997, J CELL SCI, V110, P2117; Sodhi A, 2000, CANCER RES, V60, P4873; Spear W, 2006, CELL MICROBIOL, V8, P339, DOI 10.1111/j.1462-5822.2005.00628.x; SWEENEY KR, 2010, EUKARYOT CELL; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Thornton RD, 2000, BIOCHEM J, V350, P307, DOI 10.1042/0264-6021:3500307; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Wakisaka N, 2004, MOL CELL BIOL, V24, P5223, DOI 10.1128/MCB.24.12.5223-5234.2004; Walker' ME, 2008, MICROBES INFECT, V10, P1440, DOI 10.1016/j.micinf.2008.08.014; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang YB, 2009, CELL MICROBIOL, V11, P983, DOI 10.1111/j.1462-5822.2009.01305.x; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742; Zimmermann S, 2006, J IMMUNOL, V176, P1840, DOI 10.4049/jimmunol.176.3.1840	90	46	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26852	26860		10.1074/jbc.M110.147041	http://dx.doi.org/10.1074/jbc.M110.147041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20581113	hybrid, Green Published			2022-12-25	WOS:000281172700016
J	Emery, AC; Pshenichkin, S; Takoudjou, GR; Grajkowska, E; Wolfe, BB; Wroblewski, JT				Emery, Andrew C.; Pshenichkin, Sergey; Takoudjou, Guy Rodrigue; Grajkowska, Ewa; Wolfe, Barry B.; Wroblewski, Jarda T.			The Protective Signaling of Metabotropic Glutamate Receptor 1 Is Mediated by Sustained, beta-Arrestin-1-dependent ERK Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ELEMENT-BINDING PROTEIN; GLUTAMATE-RECEPTOR-1 INTERNALIZATION; DEPENDENCE RECEPTOR; REGULATED KINASES; ACTIVATION; AGONIST; CELLS; ANTAGONIST; PATHWAYS	Metabotropic glutamate receptor 1 (mGlu1) is a G protein-coupled receptor that enhances the hydrolysis of membrane phosphoinositides. In addition to its role in synaptic transmission and plasticity, mGlu1 has been shown to be involved in neuroprotection and neurodegeneration. In this capacity, we have reported previously that in neuronal cells, mGlu1a exhibits the properties of a dependence receptor, inducing apoptosis in the absence of glutamate, while promoting neuronal survival in its presence (Pshenichkin, S., Dolinska, M., Klauzinska, M., Luchenko, V., Grajkowska, E., and Wroblewski, J. T. (2008) Neuropharmacology 55, 500-508). Here, using CHO cells expressing mGlu1a receptors, we show that the protective effect of glutamate does not rely on the classical mGlu1 signal transduction. Instead, mGlu1a protective signaling is mediated by a novel, G protein-independent, pathway which involves the activation of the MAPK pathway and a sustained phosphorylation of ERK, which is distinct from the G protein-mediated transient ERK phosphorylation. Moreover, the sustained phosphorylation of ERK and protective signaling through mGlu1a receptors require expression of beta-arrestin-1, suggesting a possible role for receptor internalization in this process. Our data reveal the existence of a novel, noncanonical signaling pathway associated with mGlu1a receptors, which mediates glutamate-induced protective signaling.	[Wroblewski, Jarda T.] Georgetown Univ, Dept Pharmacol, Med Ctr, Washington, DC 20057 USA; [Emery, Andrew C.; Pshenichkin, Sergey; Wolfe, Barry B.; Wroblewski, Jarda T.] Georgetown Univ, Interdisciplinary Program Neurosci, Washington, DC 20057 USA	Georgetown University; Georgetown University	Wroblewski, JT (corresponding author), Georgetown Univ, Dept Pharmacol, Med Ctr, 3900 Reservoir Rd NW, Washington, DC 20057 USA.	wroblewj@georgetown.edu		Emery, Andrew/0000-0002-6760-2570	National Institutes of Health [NS37436]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037436, T32NS041218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant NS37436.	ANIKSZTEJN L, 1992, EUR J NEUROSCI, V4, P500, DOI 10.1111/j.1460-9568.1992.tb00900.x; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; BLEAKMAN D, 1992, MOL PHARMACOL, V42, P192; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Broca C, 2009, J BIOL CHEM, V284, P4332, DOI 10.1074/jbc.M807595200; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; BRUNO V, 1994, EUR J PHARMACOL, V256, P109, DOI 10.1016/0014-2999(94)90624-6; CHAO MV, 2003, SCI STKE, pPE38; Choe ES, 2001, MOL BRAIN RES, V94, P75, DOI 10.1016/S0169-328X(01)00217-0; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Diviani D, 1996, J BIOL CHEM, V271, P5049; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; HARVEY J, 1993, BRIT J PHARMACOL, V109, P1085, DOI 10.1111/j.1476-5381.1993.tb13733.x; Iacovelli L, 2003, J BIOL CHEM, V278, P12433, DOI 10.1074/jbc.M203992200; Jeanneteau F, 2006, P NATL ACAD SCI USA, V103, P10753, DOI 10.1073/pnas.0508189103; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kohara A, 2005, J PHARMACOL EXP THER, V315, P163, DOI 10.1124/jpet.105.087171; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; Lavreysen H, 2004, NEUROPHARMACOLOGY, V47, P961, DOI 10.1016/j.neuropharm.2004.08.007; Litschig S, 1999, MOL PHARMACOL, V55, P453; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Macey TA, 2006, J BIOL CHEM, V281, P34515, DOI 10.1074/jbc.M604278200; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukhin A, 1996, J NEUROSCI, V16, P6012; Mundell SJ, 2002, MOL PHARMACOL, V61, P1114, DOI 10.1124/mol.61.5.1114; Mundell SJ, 2001, J NEUROCHEM, V78, P546, DOI 10.1046/j.1471-4159.2001.00421.x; PICKERING DS, 1993, J NEUROCHEM, V61, P85, DOI 10.1111/j.1471-4159.1993.tb03540.x; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; PIN JP, 1995, NEUROPHARMACOLOGY, V1, P1; Pshenichkin S, 2008, NEUROPHARMACOLOGY, V55, P500, DOI 10.1016/j.neuropharm.2008.06.039; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sheffler DJ, 2008, NEUROPHARMACOLOGY, V55, P419, DOI 10.1016/j.neuropharm.2008.06.047; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; SILIPRANDI R, 1992, EUR J PHARMACOL, V219, P173, DOI 10.1016/0014-2999(92)90598-X; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; ZHONG LT, 1993, P NATL ACAD SCI USA, V90, P4533, DOI 10.1073/pnas.90.10.4533	49	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26041	26048		10.1074/jbc.M110.139899	http://dx.doi.org/10.1074/jbc.M110.139899			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566651	Green Published, hybrid			2022-12-25	WOS:000280921000019
J	Chen, JS; Hsu, YM; Chen, CC; Chen, LL; Lee, CC; Huang, TS				Chen, Jinn-Shiun; Hsu, Yuan-Ming; Chen, Chia-Chi; Chen, Li-Li; Lee, Chun-Chung; Huang, Tze-Sing			Secreted Heat Shock Protein 90 alpha Induces Colorectal Cancer Cell Invasion through CD91/LRP-1 and NF-kappa B-mediated Integrin alpha(V) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90; HSP90-ALPHA; RECEPTOR; HEAT-SHOCK-PROTEIN-90; INDUCTION; MIGRATION; CHAPERONE; EXOSOMES; MOTILITY; SURFACE	HCT-8 colon cancer cells secreted heat shock protein 90 alpha (HSP90 alpha) and had increased invasiveness upon serum starvation. The concentrated conditioned medium of serum-starved HCT-8 cells was able to stimulate the migration and invasion of non-serum-starved cells, which could be prevented by treatment with an anti-HSP90 alpha antibody. Recombinant HSP90 alpha (rHSP90 alpha) also enhanced HCT-8 cell migration and invasion, suggesting a stimulatory role of secreted HSP90 alpha in cancer malignancy. HSP90 alpha binding to CD91 alpha and Neu was evidenced by the proximity ligation assay, and rHSP90 alpha-induced HCT-8 cell invasion could be suppressed by the addition of anti-CD91 alpha or anti-Neu antibodies. Via CD91 alpha and Neu, rHSP90 alpha selectively induced integrin alpha(V) expression, and knockdown of integrin alpha(V) efficiently blocked rHSP90 alpha-induced HCT-8 cell invasion. rHSP90 alpha induced the activities of ERK, PI3K/Akt, and NF-kappa B p65, but only NF-kappa B activation was involved in HSP90 alpha induced integrin alpha(V) expression. Additionally, we investigated the serum levels of HSP90 alpha and the expression status of tumor integrin alpha(V) mRNA in colorectal cancer patients. Serum HSP90 alpha levels of colorectal cancer patients were significantly higher than those of normal volunteers (p < 0.001). Patients with higher serum HSP90 alpha levels significantly exhibited elevated levels of integrin alpha(V) mRNA in tumor tissues as compared with adjacent non-tumor tissues (p < 0.001). Furthermore, tumor integrin alpha(V) overexpression was significantly correlated with TNM (Tumor, Node, Metastasis) staging (p = 0.001).	[Chen, Jinn-Shiun] Chang Gung Univ, Chang Gung Mem Hosp, Div Colorectal Surg, Tao Yuan 333, Taiwan; [Hsu, Yuan-Ming; Chen, Chia-Chi; Chen, Li-Li; Lee, Chun-Chung; Huang, Tze-Sing] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli 350, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Health Research Institutes - Taiwan	Huang, TS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, 35 Keyan Rd, Zhunan Town 350, Miaoli, Taiwan.	tshuang@nhri.org.tw	Huang, Tze-Sing/C-9361-2013; Huang, Tze-Sing/E-3667-2010	Huang, Tze-Sing/0000-0001-8736-4330; 	National Health Research Institutes [CA-097-PP-13, CA-098-PP-10]; Chang Gung Memorial Hospital [CMRPG361691]; Department of Health, Taiwan, Republic of China [DOH99-TD-C-111-004]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Department of Health, Taiwan, Republic of China	This work was supported by Grants CA-097-PP-13 and CA-098-PP-10 from the National Health Research Institutes, Grant CMRPG361691 from Chang Gung Memorial Hospital, and Grant DOH99-TD-C-111-004 from the Department of Health, Taiwan, Republic of China.	Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; De Filippo A, 2008, J IMMUNOL, V181, P6525, DOI 10.4049/jimmunol.181.9.6525; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goetz MP, 2003, ANN ONCOL, V14, P1169, DOI 10.1093/annonc/mdg316; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iivanainen E, 2003, MICROSC RES TECHNIQ, V60, P13, DOI 10.1002/jemt.10238; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Max R, 1997, INT J CANCER, V71, P320, DOI 10.1002/(SICI)1097-0215(19970502)71:3<320::AID-IJC2>3.3.CO;2-3; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Xu A, 2007, J CANC MOL, V3, P107; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	23	85	96	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25458	25466		10.1074/jbc.M110.139345	http://dx.doi.org/10.1074/jbc.M110.139345			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558745	Green Published, hybrid			2022-12-25	WOS:000280682400039
J	Talwar, D; McConnachie, A; Welsh, P; Upton, M; O'Reilly, D; Smith, GD; Watt, G; Sattar, N				Talwar, Dinesh; McConnachie, Alex; Welsh, Paul; Upton, Mark; O'Reilly, Denis; Smith, George Davey; Watt, Graham; Sattar, Naveed			Which Circulating Antioxidant Vitamins Are Confounded by Socioeconomic Deprivation? The MIDSPAN Family Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR-DISEASE; VEGETABLE INTAKE; ASCORBIC-ACID; BETA-CAROTENE; RISK; CANCER; HEALTH; WOMEN; HEART	Background: Antioxidant vitamins are often described as having "independent'' associations with risk of cancer, cardiovascular disease (CVD) and mortality. We aimed to compare to what extent a range of antioxidant vitamins and carotenoids are associated with adulthood and childhood markers of socioeconomic deprivation and to adverse lifestyle factors. Methods and Findings: Socioeconomic and lifestyle measures were available in 1040 men and 1298 women from the MIDSPAN Family Study (30-59 years at baseline) together with circulating levels of vitamins A, C, E, and carotenoids (alpha-carotene, beta-carotene, lutein and lycopene). Markers of socioeconomic deprivation in adulthood were consistently as strongly associated with lower vitamin C and carotenoid levels as markers of adverse lifestyle; the inverse association with overcrowding was particularly consistent (vitamin C and carotenoids range from 19.1% [95% CI 30.3-6.0] to 38.8% [49.9-25.3] lower among those in overcrowded residencies). These associations were consistent after adjusting for month, classical CVD risk factors, body mass index, physical activity, vitamin supplements, dietary fat and fibre intake. Similar, but weaker, associations were seen for childhood markers of deprivation. The association of vitamin A or E were strikingly different; several adult adverse lifestyle factors associated with higher levels of vitamin A and E, including high alcohol intake for vitamin A (9.5% [5.7-13.5]) and waist hip ratio for vitamin E (9.5% [4.8-14.4]), with the latter associations partially explained by classical risk factors, particularly cholesterol levels. Conclusions: Plasma vitamin C and carotenoids have strong inverse associations with adulthood markers of social deprivation, whereas vitamin A and E appear positively related to specific adverse lifestyle factors. These findings should help researchers better contextualize blood antioxidant vitamin levels by illustrating the potential	[Talwar, Dinesh; O'Reilly, Denis] Glasgow Royal Infirm, Dept Clin Biochem, Glasgow G4 0SF, Lanark, Scotland; [McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Welsh, Paul; Sattar, Naveed] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Upton, Mark] Woodlands Family Med Ctr, Stockton On Tees, England; [Smith, George Davey] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England	University of Glasgow; University of Glasgow; University of Glasgow; University of Bristol	Talwar, D (corresponding author), Glasgow Royal Infirm, Dept Clin Biochem, Glasgow G4 0SF, Lanark, Scotland.	nsattar@clinmed.gla.ac.uk	Davey Smith, George/A-7407-2013; Welsh, Paul/H-5249-2019	Davey Smith, George/0000-0002-1407-8314; Welsh, Paul/0000-0002-7970-3643; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Upton, Mark/0000-0003-0839-1141	Wellcome Trust; NHS Cardiovascular Research and Development Programme; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NHS Cardiovascular Research and Development Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge support from the Wellcome Trust and the NHS Cardiovascular Research and Development Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rmeileh NME, 2008, OBESITY, V16, P1388, DOI 10.1038/oby.2008.211; Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Carstairs V., 1991, DEPRIVATION HLTH SCO; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Dubowitz T, 2008, AM J CLIN NUTR, V87, P1883, DOI 10.1093/ajcn/87.6.1883; Haire-Joshu D, 2004, J NUTR EDUC BEHAV, V36, P309, DOI 10.1016/S1499-4046(06)60400-4; Hart C, 2008, INT J EPIDEMIOL, V37, P604, DOI 10.1093/ije/dyn052; Hart CL, 2009, ALCOHOL ALCOHOLISM, V44, P332, DOI 10.1093/alcalc/agn125; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Jenab M, 2006, CARCINOGENESIS, V27, P2250, DOI 10.1093/carcin/bgl096; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Lawlor DA, 2005, HEART, V91, P1086, DOI 10.1136/hrt.2004.048934; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; MARGOLIS SA, 1988, CLIN CHEM, V34, P2217; Moats Caroline, 2007, Curr Atheroscler Rep, V9, P508, DOI 10.1007/s11883-007-0068-6; Morris CD, 2003, ANN INTERN MED, V139, P56, DOI 10.7326/0003-4819-139-1-200307010-00014; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Slatore CG, 2008, AM J RESP CRIT CARE, V177, P524, DOI 10.1164/rccm.200709-1398OC; SMITH GD, 2002, INT J EPIDEMIOL, V31, P710; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Upton MN, 2000, BMJ-BRIT MED J, V321, P88, DOI 10.1136/bmj.321.7253.88; Walsh Patrick C, 2005, J Urol, V174, P1823, DOI 10.1097/01.ju.0000183077.52404.ec; Wang XD, 2005, ALCOHOL, V35, P251, DOI 10.1016/j.alcohol.2005.04.006; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; Wright ME, 2006, AM J CLIN NUTR, V84, P1200, DOI 10.1093/ajcn/84.5.1200	28	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11312	10.1371/journal.pone.0011312	http://dx.doi.org/10.1371/journal.pone.0011312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593021	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000279140800013
J	Wu, DC; Paulson, RF				Wu, Dai-Chen; Paulson, Robert F.			Hypoxia Regulates BMP4 Expression in the Murine Spleen during the Recovery from Acute Anemia	PLOS ONE			English	Article							INDUCIBLE FACTOR; CHUVASH POLYCYTHEMIA; TRANSCRIPTIONAL ACTIVITY; STRESS ERYTHROPOIESIS; PROLINE HYDROXYLATION; ERYTHROID PROGENITORS; OXYGEN HOMEOSTASIS; STEM-CELLS; HIF2A GENE; PROTEIN	Background: Bone marrow erythropoiesis is primarily homeostatic, producing new erythrocytes at a constant rate. However at times of acute anemia, new erythrocytes must be rapidly produced much faster than bone marrow steady state erythropoiesis. At these times stress erythropoiesis predominates. Stress erythropoiesis occurs in the fetal liver during embryogenesis and in the adult spleen and liver. In adult mice, stress erythropoiesis utilizes a specialized population of stress erythroid progenitors that are resident in the spleen. In response to acute anemia, these progenitors rapidly expand and differentiate in response to three signals, BMP4, SCF and hypoxia. In absence of acute anemic stress, two of these signals, BMP4 and hypoxia, are not present and the pathway is not active. The initiating event in the activation of this pathway is the up-regulation of BMP4 expression in the spleen. Methodology/Principal Findings: In this paper we analyze the regulation of BMP4 expression in the spleen by hypoxia. Using stromal cell lines, we establish a role for hypoxia transcription factor HIFs (Hypoxia Inducible Factors) in the transcription of BMP4. We identified putative Hypoxia Responsive Elements (HREs) in the BMP4 gene using bioinformatics. Analysis of these elements showed that in vivo, Hif2 alpha binds two cis regulatory sites in the BMP4 gene, which regulate BMP4 expression during the recovery from acute anemia. Conclusions and Significance: These data show that hypoxia plays a key role in initiating the BMP4 dependent stress erythropoiesis pathway by regulating BMP4 expression.	[Wu, Dai-Chen; Paulson, Robert F.] Penn State Univ, Grad Program Biochem Microbiol & Mol Biol, University Pk, PA 16802 USA; [Wu, Dai-Chen] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Paulson, Robert F.] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Paulson, Robert F.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wu, DC (corresponding author), Penn State Univ, Grad Program Biochem Microbiol & Mol Biol, University Pk, PA 16802 USA.	rfp5@psu.edu			National Institutes of Health [RO1DK080040-01]; Paulson Lab; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paulson Lab; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health grant, RO1DK080040-01 (RFP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Zhiqiang Zhang for helpful suggestion on ChIP assay, Dr. Ross Hardison for providing the pMCSgLuc plasmid, and members of Paulson Lab for their support during this work.	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hegde S, 2007, MAMM GENOME, V18, P852, DOI 10.1007/s00335-007-9074-9; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lenox LE, 2009, EXP HEMATOL, V37, P549, DOI 10.1016/j.exphem.2009.01.004; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Maegdefrau U, 2009, J PATHOL, V218, P520, DOI 10.1002/path.2563; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Nakayama K, 2009, J BIOCHEM, V146, P757, DOI 10.1093/jb/mvp167; Percy MJ, 2008, BLOOD, V111, P5400, DOI 10.1182/blood-2008-02-137703; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; PERRY JM, 2008, BLOOD; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Porayette P, 2008, DEV BIOL, V317, P24, DOI 10.1016/j.ydbio.2008.01.047; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; VANWIJK R, 2009, HAEMATOLOGICA; Wang H, 2006, GENOME RES, V16, P1480, DOI 10.1101/gr.5353806; YANAI N, 1989, BLOOD, V74, P2391; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200	43	35	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11303	10.1371/journal.pone.0011303	http://dx.doi.org/10.1371/journal.pone.0011303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585586	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135800012
J	Badaut, C; Bertin, G; Rustico, T; Fievet, N; Massougbodji, A; Gaye, A; Deloron, P				Badaut, Cyril; Bertin, Gwladys; Rustico, Tatiana; Fievet, Nadine; Massougbodji, Achille; Gaye, Alioune; Deloron, Philippe			Towards the Rational Design of a Candidate Vaccine against Pregnancy Associated Malaria: Conserved Sequences of the DBL6 epsilon Domain of VAR2CSA	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; VAR GENES; ANTIGENIC VARIATION; PARASITE ADHESION; VARIANT ANTIGENS; ANTIBODIES; WOMEN; SURFACE	Background: Placental malaria is a disease linked to the sequestration of Plasmodium falciparum infected red blood cells (IRBC) in the placenta, leading to reduced materno-fetal exchanges and to local inflammation. One of the virulence factors of P. falciparum involved in cytoadherence to chondroitin sulfate A, its placental receptor, is the adhesive protein VAR2CSA. Its localisation on the surface of IRBC makes it accessible to the immune system. VAR2CSA contains six DBL domains. The DBL6 epsilon domain is the most variable. High variability constitutes a means for the parasite to evade the host immune response. The DBL6 epsilon domain could constitute a very attractive basis for a vaccine candidate but its reported variability necessitates, for antigenic characterisations, identifying and classifying commonalities across isolates. Methodology/Principal Findings: Local alignment analysis of the DBL6 epsilon domain had revealed that it is not as variable as previously described. Variability is concentrated in seven regions present on the surface of the DBL6 epsilon domain. The main goal of our work is to classify and group variable sequences that will simplify further research to determine dominant epitopes. Firstly, variable sequences were grouped following their average percent pairwise identity (APPI). Groups comprising many variable sequences sharing low variability were found. Secondly, ELISA experiments following the IgG recognition of a recombinant DBL6 epsilon domain, and of peptides mimicking its seven variable blocks, allowed to determine an APPI cut-off and to isolate groups represented by a single consensus sequence. Conclusions/Significance: A new sequence approach is used to compare variable regions in sequences that have extensive segmental gene relationship. Using this approach, the VAR2CSA DBL6 domain is composed of 7 variable blocks with limited polymorphism. Each variable block is composed of a limited number of consensus types. Based on peptide based ELISA, variable blocks with 85% or greater sequence identity are expected to be recognized equally well by antibody and can be considered the same consensus type. Therefore, the analysis of the antibody response against the classified small number of sequences should be helpful to determine epitopes.	[Badaut, Cyril; Bertin, Gwladys; Rustico, Tatiana; Fievet, Nadine; Deloron, Philippe] Inst Rech Dev, Mother & Child Faced Trop Infect Res Unit, UMR216, Paris, France; [Badaut, Cyril; Bertin, Gwladys; Deloron, Philippe] Univ Paris 05, Paris, France; [Massougbodji, Achille] Univ Abomey Calavi, Dept Zool & Genet, Fac Sci & Tech, Cotonou, Benin; [Gaye, Alioune] Ctr Sante Roi Baudoin Guediawaye, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi	Badaut, C (corresponding author), Inst Rech Dev, Mother & Child Faced Trop Infect Res Unit, UMR216, Paris, France.	cbadaut@gmail.com; Philippe.Deloron@ird.fr	Deloron, Philippe/G-6305-2010	Deloron, Philippe/0000-0003-4705-2484; Bertin, Gwladys/0000-0002-2218-9591; Fievet, Nadine/0000-0003-2272-9794; Badaut, Cyril/0000-0002-0064-6384	Institut de Medecine et d'Epidemiologie Appliquee [IMEA-0801]; European Commission [200889]; French National Agency [ANR-05-MIME-009-01]; National Agency of Research (ANR); Institute of Research for Development (IRD)	Institut de Medecine et d'Epidemiologie Appliquee; European Commission(European CommissionEuropean Commission Joint Research Centre); French National Agency(French National Research Agency (ANR)); National Agency of Research (ANR)(French National Research Agency (ANR)); Institute of Research for Development (IRD)	This study received financial support from the Institut de Medecine et d'Epidemiologie Appliquee (grant IMEA-0801), from the European Commission, FP7 program (grant 200889), and from the French National Agency for Research (grant ANR-05-MIME-009-01). C. Badaut was supported by the National Agency of Research (ANR) and by the Institute of Research for Development (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Briand V, 2008, J INFECT DIS, V198, P594, DOI 10.1086/590114; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Bull PC, 2007, MOL BIOCHEM PARASIT, V154, P98, DOI 10.1016/j.molbiopara.2007.03.011; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fievet N, 2006, INFECT GENET EVOL, V6, P459, DOI 10.1016/j.meegid.2006.02.006; Fried M, 1998, J MOL MED-JMM, V76, P162, DOI 10.1007/s001090050205; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; GOUDSMIT J, 1991, FASEB J, V5, P2427, DOI 10.1096/fasebj.5.10.2065891; KHUNRAE P, 2009, J MOL BIOL; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Maubert B, 1999, INFECT IMMUN, V67, P5367, DOI 10.1128/IAI.67.10.5367-5371.1999; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Ndam NGT, 2004, J INFECT DIS, V190, P2001, DOI 10.1086/425521; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Pasternak ND, 2009, INT J BIOCHEM CELL B, V41, P1463, DOI 10.1016/j.biocel.2008.12.012; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11276	10.1371/journal.pone.0011276	http://dx.doi.org/10.1371/journal.pone.0011276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585655	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135400021
J	Napolitano, G; Amente, S; Castiglia, V; Gargano, B; Ruda, V; Darzacq, X; Bensaude, O; Majello, B; Lania, L				Napolitano, Giuliana; Amente, Stefano; Castiglia, Virginia; Gargano, Barbara; Ruda, Vera; Darzacq, Xavier; Bensaude, Olivier; Majello, Barbara; Lania, Luigi			Caffeine Prevents Transcription Inhibition and P-TEFb/7SK Dissociation Following UV-Induced DNA Damage	PLOS ONE			English	Article							P-TEFB; 7SK SNRNP; CELL-CYCLE; CDK9/CYCLIN T1; PHOSPHORYLATION; ELONGATION; PROTEIN; KINASE; HEXIM1; FLAVOPIRIDOL	Background: The mechanisms by which DNA damage triggers suppression of transcription of a large number of genes are poorly understood. DNA damage rapidly induces a release of the positive transcription elongation factor b (P-TEFb) from the large inactive multisubunit 7SK snRNP complex. P-TEFb is required for transcription of most class II genes through stimulation of RNA polymerase II elongation and cotranscriptional pre-mRNA processing. Methodology/Principal Findings: We show here that caffeine prevents UV-induced dissociation of P-TEFb as well as transcription inhibition. The caffeine-effect does not involve PI3-kinase-related protein kinases, because inhibition of phosphatidylinositol 3-kinase family members (ATM, ATR and DNA-PK) neither prevents P-TEFb dissociation nor transcription inhibition. Finally, caffeine prevention of transcription inhibition is independent from DNA damage. Conclusion/Significance: Pharmacological prevention of P-TEFb/7SK snRNP dissociation and transcription inhibition following UV-induced DNA damage is correlated.	[Napolitano, Giuliana; Amente, Stefano; Castiglia, Virginia; Gargano, Barbara; Majello, Barbara; Lania, Luigi] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy; [Amente, Stefano; Lania, Luigi] Naples Oncogenom Ctr NOGEC, Naples, Italy; [Ruda, Vera; Darzacq, Xavier; Bensaude, Olivier] CNRS, UMR 8197, Inst Biol, Ecole Normale Super, Paris, France	University of Naples Federico II; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Napolitano, G (corresponding author), Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy.	majello@unina.it; lania@unina.it	Amente, Stefano/AAU-7605-2020	Amente, Stefano/0000-0003-0612-6096; Majello, Barbara/0000-0003-2789-3585; Bensaude, Olivier/0000-0002-0259-6608; Napolitano, Giuliana/0000-0002-1637-6016; Darzacq, Xavier/0000-0003-2537-8395	Associazione Italiana Ricerca sul Cancro [5366]; University of Naples (Polo delle Scienze e delle Tecnologie)	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); University of Naples (Polo delle Scienze e delle Tecnologie)	This work was supported by funds from Associazione Italiana Ricerca sul Cancro, Investigator Grant (IG) 5366 (LL) and by the University of Naples (Polo delle Scienze e delle Tecnologie) for a travel fellowship to GN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amente S, 2009, CELL CYCLE, V8, P1249, DOI 10.4161/cc.8.8.8286; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Chen B, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/01/007; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; Espinoza-Derout J, 2007, CARDIOVASC RES, V75, P129, DOI 10.1016/j.cardiores.2007.03.019; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kohoutek J, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-19; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Michels Annemieke A., 2008, Biotechnology Journal, V3, P1022, DOI 10.1002/biot.200800104; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Napolitano G, 2007, CELL CYCLE, V6, P1126, DOI 10.4161/cc.6.9.4137; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Santella L, 2005, CELL MOL LIFE SCI, V62, P2405, DOI 10.1007/s00018-005-5083-6; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575	36	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11245	10.1371/journal.pone.0011245	http://dx.doi.org/10.1371/journal.pone.0011245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574533	Green Published, Green Submitted, gold			2022-12-25	WOS:000279058300028
J	Proverbio, AM; Riva, F; Martin, E; Zani, A				Proverbio, Alice Mado; Riva, Federica; Martin, Eleonora; Zani, Alberto			Face Coding Is Bilateral in the Female Brain	PLOS ONE			English	Article							GENDER-DIFFERENCES; SEX-DIFFERENCES; RECOGNITION; PERCEPTION; SYSTEM; LATERALIZATION; SELECTIVITY; ASYMMETRY; EMOTION; DOMAIN	Background: It is currently believed that face processing predominantly activates the right hemisphere in humans, but available literature is very inconsistent. Methodology/Principal Findings: In this study, ERPs were recorded in 50 right-handed women and men in response to 390 faces (of different age and sex), and 130 technological objects. Results showed no sex difference in the amplitude of N170 to objects; a much larger face-specific response over the right hemisphere in men, and a bilateral response in women; a lack of face-age coding effect over the left hemisphere in men, with no differences in N170 to faces as a function of age; a significant bilateral face-age coding effect in women. Conclusions/Significance: LORETA reconstruction showed a significant left and right asymmetry in the activation of the fusiform gyrus (BA19), in women and men, respectively. The present data reveal a lesser degree of lateralization of brain functions related to face coding in women than men. In this light, they may provide an explanation of the inconsistencies in the available literature concerning the asymmetric activity of left and right occipito-temporal cortices devoted to face perception during processing of face identity, structure, familiarity or affective content.	[Proverbio, Alice Mado; Riva, Federica; Martin, Eleonora] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Zani, Alberto] CNR, Natl Res Council, Inst Bioimaging & Mol Physiol, I-20133 Milan, Italy	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR)	Proverbio, AM (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	mado.proverbio@unimib.it	Zani, Alberto/ABI-3498-2020; Zani, Alberto/ABG-8894-2020	Zani, Alberto/0000-0002-3906-7988; Proverbio, Alice Mado/0000-0002-5138-1523	University of Milano-Bicocca [2008/2009]; Institute of Bioimaging and Molecular Physiology of National Research Council (IBFM-CNR)	University of Milano-Bicocca; Institute of Bioimaging and Molecular Physiology of National Research Council (IBFM-CNR)	Supported by University of Milano-Bicocca 2008/2009 FAR grants to AMP and grants from the Institute of Bioimaging and Molecular Physiology of National Research Council (IBFM-CNR) to AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne VJ, 2005, NEUROPSYCHOLOGIA, V43, P953, DOI 10.1016/j.neuropsychologia.2004.08.007; DOMES G, 2009, HUMAN BRAIN IN PRESS; Ewbank MP, 2008, NEUROIMAGE, V40, P1857, DOI 10.1016/j.neuroimage.2008.01.049; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; Jemel B, 2005, NEUROPSYCHOLOGIA, V43, P2024, DOI 10.1016/j.neuropsychologia.2005.03.016; Jiang Y, 2009, NEUROIMAGE, V44, P1171, DOI 10.1016/j.neuroimage.2008.09.038; Johnson BW, 2002, NEUROREPORT, V13, P1929, DOI 10.1097/00001756-200210280-00020; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kemp AH, 2004, NEUROIMAGE, V21, P632, DOI 10.1016/j.neuroimage.2003.09.055; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Lee TMC, 2002, NEUROSCI LETT, V333, P13, DOI 10.1016/S0304-3940(02)00965-5; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; LIU J, 2009, J COGN NEUROSCI 0320; MCKELVIE SJ, 1993, J SOC BEHAV PERS, V8, P297; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Pourtois G, 2005, J COGNITIVE NEUROSCI, V17, P1043, DOI 10.1162/0898929054475181; Proverbio AM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-44; Proverbio AM, 2006, NEUROPSYCHOLOGIA, V44, P2987, DOI 10.1016/j.neuropsychologia.2006.06.015; Rhodes G, 2004, J COGNITIVE NEUROSCI, V16, P189, DOI 10.1162/089892904322984508; Righart R, 2006, CEREB CORTEX, V16, P1249, DOI 10.1093/cercor/bhj066; Rilea SL, 2004, BRAIN COGNITION, V56, P332, DOI 10.1016/j.bandc.2004.09.002; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Valkonen-Korhonen M, 2005, COGNITIVE BRAIN RES, V23, P277, DOI 10.1016/j.cogbrainres.2004.10.019; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Werheid K, 2007, BIOL PSYCHOL, V76, P100, DOI 10.1016/j.biopsycho.2007.06.008; WILLEMS RM, 2009, CEREB CORTE IN PRESS; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; Zanow F, 2004, BRAIN TOPOGR, V16, P287	38	51	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11242	10.1371/journal.pone.0011242	http://dx.doi.org/10.1371/journal.pone.0011242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	614KV	20574528	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058300026
J	Kawaguchi, H; Hirakawa, K; Miyauchi, K; Koike, K; Ohno, Y; Sakamoto, A				Kawaguchi, Hiroshi; Hirakawa, Keiko; Miyauchi, Kensuke; Koike, Kaoru; Ohno, Youkichi; Sakamoto, Atsuhiro			Pattern Recognition Analysis of Proton Nuclear Magnetic Resonance Spectra of Brain Tissue Extracts from Rats Anesthetized with Propofol or Isoflurane	PLOS ONE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; POSITRON EMISSION TOMOGRAPHY; BLOOD-FLOW; SEVOFLURANE ANESTHESIA; GENE-EXPRESSION; METABOLIC-RATE; IN-VIVO; HUMANS; ELECTROENCEPHALOGRAM; METABONOMICS	Background: General anesthesia is routinely used as a surgical procedure and its safety has been endorsed by clinical outcomes; however, its effects at the molecular level have not been elucidated. General anesthetics influence glucose metabolism in the brain. However, the effects of anesthetics on brain metabolites other than those related to glucose have not been well characterized. We used a pattern recognition analysis of proton nuclear magnetic resonance spectra to visualize the changes in holistic brain metabolic phenotypes in response to the widely used intravenous anesthetic propofol and the volatile anesthetic isoflurane. Methodology/Principal Findings: Rats were randomized into five groups (n = 7 each group). Propofol and isoflurane were administered to two groups each, for 2 or 6 h. The control group received no anesthesia. Brains were removed directly after anesthesia. Hydrophilic compounds were extracted from excised whole brains and measured by proton nuclear magnetic resonance spectroscopy. All spectral data were processed and analyzed by principal component analysis for comparison of the metabolite profiles. Data were visualized by plotting principal component (PC) scores. In the plots, each point represents an individual sample. The propofol and isoflurane groups were clustered separately on the plots, and this separation was especially pronounced when comparing the 6-h groups. The PC scores of the propofol group were clearly distinct from those of the control group, particularly in the 6-h group, whereas the difference in PC scores was more subtle in the isoflurane group and control groups. Conclusions/Significance: The results of the present study showed that propofol and isoflurane exerted differential effects on holistic brain metabolism under anesthesia.	[Kawaguchi, Hiroshi; Miyauchi, Kensuke; Sakamoto, Atsuhiro] Nippon Med Sch, Dept Anesthesiol, Bunkyo Ku, Tokyo 113, Japan; [Hirakawa, Keiko; Ohno, Youkichi] Nippon Med Sch, NMR Lab, Bunkyo Ku, Tokyo 113, Japan; [Hirakawa, Keiko; Ohno, Youkichi] Nippon Med Sch, Dept Legal Med, Bunkyo Ku, Tokyo 113, Japan; [Koike, Kaoru] Kyoto Univ, Grad Sch Med, Dept Primary Care & Emergency Med, Kyoto, Japan	Nippon Medical School; Nippon Medical School; Nippon Medical School; Kyoto University	Kawaguchi, H (corresponding author), Nippon Med Sch, Dept Anesthesiol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	hiro-kawaguchi@nms.ac.jp			Promotion and Mutual Aid Corporation for Private Schools of Japan; Science Research Promotion Fund; Department of Neurosurgery, Nippon Medical School; Fujitsu Limited	Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Science Research Promotion Fund; Department of Neurosurgery, Nippon Medical School; Fujitsu Limited	This work was supported by the Promotion and Mutual Aid Corporation for Private Schools of Japan and the Science Research Promotion Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mr. Takayuki Asakura, Department of Neurosurgery, Nippon Medical School, and Mr. Kohtaro Yuta, Fujitsu Limited for supporting this research.	Alkire MT, 1998, ANESTHESIOLOGY, V89, P323, DOI 10.1097/00000542-199808000-00007; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; ARTRU AA, 1992, J NEUROSURG ANESTH, V4, P99, DOI 10.1097/00008506-199204000-00005; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Brulatout S, 1996, J NEUROCHEM, V66, P2491; CARMICHAEL FJ, 1991, J PHARMACOL EXP THER, V259, P403; CROSBY G, 1982, ANESTHESIOLOGY, V56, P437, DOI 10.1097/00000542-198206000-00005; DAM M, 1990, ANESTHESIOLOGY, V73, P499, DOI 10.1097/00000542-199009000-00021; DOLIN SJ, 1992, BRIT J ANAESTH, V68, P523, DOI 10.1093/bja/68.5.523; Eilers H, 1999, ANESTH ANALG, V88, P1168, DOI 10.1097/00000539-199905000-00037; FOLCH J, 1956, CAN J BIOCHEM PHYS, V34, P305; GODOY MM, J VIRAL HEPAT; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Kalenka A, 2007, ANESTH ANALG, V104, P1129, DOI 10.1213/01.ane.0000260799.37107.e6; Kobayashi K, 2007, BRAIN RES, V1185, P1, DOI 10.1016/j.brainres.2007.09.011; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; Lindon JC, 2006, PHARM RES, V23, P1075, DOI 10.1007/s11095-006-0025-z; Lowes DA, 2005, ANESTH ANALG, V101, P697, DOI 10.1213/01.ANE.0000160587.72827.B4; Ludbrook GL, 2002, ANESTHESIOLOGY, V97, P1363, DOI 10.1097/00000542-200212000-00006; MAEKAWA T, 1986, ANESTHESIOLOGY, V65, P144, DOI 10.1097/00000542-198608000-00003; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; MATTA BF, 1995, ANESTHESIOLOGY, V83, P980, DOI 10.1097/00000542-199511000-00011; McCulloch TJ, 2007, ANESTHESIOLOGY, V106, P56, DOI 10.1097/00000542-200701000-00012; Nguyen HT, 2009, ANESTHESIOLOGY, V110, P326, DOI 10.1097/ALN.0b013e3181942b5b; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; ORI C, 1986, ANESTHESIOLOGY, V65, P152, DOI 10.1097/00000542-198608000-00004; Oshima T, 2002, ACTA ANAESTH SCAND, V46, P831, DOI 10.1034/j.1399-6576.2002.460713.x; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Pears MR, 2007, METABOLOMICS, V3, P121, DOI 10.1007/s11306-007-0051-9; Philippeos C, 2009, J BIOMOL NMR, V44, P127, DOI 10.1007/s10858-009-9329-8; Sakamoto A, 2005, GENE, V356, P39, DOI 10.1016/j.gene.2005.03.022; Serkova NJ, 2008, AM J PHYSIOL-LUNG C, V295, pL152, DOI 10.1152/ajplung.00515.2007; TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M; WESTERGAARD N, 1995, DEV NEUROSCI-BASEL, V17, P203, DOI 10.1159/000111288; YOSHIKAWA C, 2002, E-POLYMERS, V13, P1	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11172	10.1371/journal.pone.0011172	http://dx.doi.org/10.1371/journal.pone.0011172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567596	gold, Green Published, Green Submitted			2022-12-25	WOS:000278886300016
J	Chiavolini, D; Rangel-Moreno, J; Berg, G; Christian, K; Oliveira-Nascimento, L; Weir, S; Alroy, J; Randall, TD; Wetzler, LM				Chiavolini, Damiana; Rangel-Moreno, Javier; Berg, Gretchen; Christian, Kate; Oliveira-Nascimento, Laura; Weir, Susan; Alroy, Joseph; Randall, Troy D.; Wetzler, Lee M.			Bronchus-Associated Lymphoid Tissue (BALT) and Survival in a Vaccine Mouse Model of Tularemia	PLOS ONE			English	Article							CHOLERA-TOXIN-B; VIRULENT TYPE-A; FRANCISELLA-TULARENSIS; PROTECTIVE IMMUNITY; INTRANASAL VACCINATION; RESPIRATORY TULAREMIA; AEROSOL CHALLENGE; GAMMA-INTERFERON; DENDRITIC CELLS; VARYING DEGREES	Background: Francisella tularensis causes severe pulmonary disease, and nasal vaccination could be the ideal measure to effectively prevent it. Nevertheless, the efficacy of this type of vaccine is influenced by the lack of an effective mucosal adjuvant. Methodology/Principal Findings: Mice were immunized via the nasal route with lipopolysaccharide isolated from F. tularensis and neisserial recombinant PorB as an adjuvant candidate. Then, mice were challenged via the same route with the F. tularensis attenuated live vaccine strain (LVS). Mouse survival and analysis of a number of immune parameters were conducted following intranasal challenge. Vaccination induced a systemic antibody response and 70% of mice were protected from challenge as showed by their improved survival and weight regain. Lungs from mice recovering from infection presented prominent lymphoid aggregates in peribronchial and perivascular areas, consistent with the location of bronchus-associated lymphoid tissue (BALT). BALT areas contained proliferating B and T cells, germinal centers, T cell infiltrates, dendritic cells (DCs). We also observed local production of antibody generating cells and homeostatic chemokines in BALT areas. Conclusions: These data indicate that PorB might be an optimal adjuvant candidate for improving the protective effect of F. tularensis antigens. The presence of BALT induced after intranasal challenge in vaccinated mice might play a role in regulation of local immunity and long-term protection, but more work is needed to elucidate mechanisms that lead to its formation.	[Chiavolini, Damiana; Berg, Gretchen; Christian, Kate; Oliveira-Nascimento, Laura; Weir, Susan; Wetzler, Lee M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Rangel-Moreno, Javier; Randall, Troy D.] Univ Rochester, Sch Med, Div Allergy Immunol & Rheumatol, Rochester, NY USA; [Oliveira-Nascimento, Laura] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Alroy, Joseph] Tufts Univ, Sch Med, Dept Pathol, Cummings Sch Vet Med, Boston, MA 02111 USA; [Alroy, Joseph] Tufts Med Ctr, Boston, MA USA	Boston University; University of Rochester; Universidade de Sao Paulo; Tufts University; Tufts Medical Center	Chiavolini, D (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	lwetzler@bu.edu	Oliveira-Nascimento, Laura/I-4859-2012	de Oliveira Nascimento, Laura/0000-0002-4741-8493; Rangel-Moreno, Javier/0000-0002-9738-1182; Weir, Susan/0000-0001-5570-0221; Wetzler, Lee/0000-0002-6596-2986	National Institutes of Health/National Institute of Allergy and Infectious Diseases [U19 AI056543]; CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056543] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grant U19 AI056543. Laura de Oliveira Nascimento had financial support from CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; BIENENSTOCK J, 1973, LAB INVEST, V28, P693; Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x; BIENENSTOCK J, 1973, LAB INVEST, V28, P686; Bitsaktsis C, 2009, J IMMUNOL, V182, P4899, DOI 10.4049/jimmunol.0803242; Chen HD, 2003, AM J PATHOL, V163, P1341, DOI 10.1016/S0002-9440(10)63493-1; Chen HM, 2000, J CONTROL RELEASE, V67, P117, DOI 10.1016/S0168-3659(00)00199-1; Chiavolini D, 2008, CLIN VACCINE IMMUNOL, V15, P1322, DOI 10.1128/CVI.00125-08; Chiavolini D, 2008, INFECT IMMUN, V76, P486, DOI 10.1128/IAI.00862-07; Ciabattini A, 2008, VACCINE, V26, P4244, DOI 10.1016/j.vaccine.2008.05.049; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P39, DOI 10.1016/S0882-4010(02)00194-8; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Csaba N, 2009, ADV DRUG DELIVER REV, V61, P140, DOI 10.1016/j.addr.2008.09.005; DiTommaso A, 1996, INFECT IMMUN, V64, P974, DOI 10.1128/IAI.64.3.974-979.1996; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; FULOP M, 1995, VACCINE, V13, P1220, DOI 10.1016/0264-410X(95)00062-6; Fulop M, 2001, VACCINE, V19, P4465, DOI 10.1016/S0264-410X(01)00189-X; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; GOLOVLIOV I, 1995, VACCINE, V13, P261, DOI 10.1016/0264-410X(95)93311-V; Gregory SH, 2010, VACCINE, V28, P2908, DOI 10.1016/j.vaccine.2010.01.067; Hartley MG, 2004, INFECT IMMUN, V72, P4109, DOI 10.1128/IAI.72.7.4109-4113.2004; HIRABAYASHI Y, 1990, VACCINE, V8, P243, DOI 10.1016/0264-410X(90)90053-O; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; IWATA M, 1991, INFECT IMMUN, V59, P1514, DOI 10.1128/IAI.59.4.1514-1520.1991; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; Massari P, 2005, PROTEIN EXPRES PURIF, V44, P136, DOI 10.1016/j.pep.2005.04.021; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Moyron-Quiroz JE, 2006, IMMUNITY, V25, P643, DOI 10.1016/j.immuni.2006.08.022; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Oyston PCF, 2005, ANTON LEEUW INT J G, V87, P277, DOI 10.1007/s10482-004-6251-7; Pabst R, 2007, IMMUNOL LETT, V112, P1, DOI 10.1016/j.imlet.2007.06.009; Pammit MA, 2006, INFECT IMMUN, V74, P2063, DOI 10.1128/IAI.74.4.2063-2071.2006; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; QI HL, 1994, INFECT IMMUN, V62, P2432, DOI 10.1128/IAI.62.6.2432-2439.1994; Randall TD, 2010, J EXP MED, V207, P451, DOI 10.1084/jem.20100059; Rangel-Moreno J, 2007, P NATL ACAD SCI USA, V104, P10577, DOI 10.1073/pnas.0700591104; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Rangel-Moreno Javier, 2007, Inmunologia, V26, P13; Rodriguez F, 2001, J VET MED B, V48, P259, DOI 10.1046/j.1439-0450.2001.00434.x; SATO A, 1992, AM REV RESPIR DIS, V146, P473, DOI 10.1164/ajrccm/146.2.473; Suda T, 1999, CHEST, V115, P357, DOI 10.1378/chest.115.2.357; Tschernig T, 2000, PATHOBIOLOGY, V68, P1, DOI 10.1159/000028109; Tschernig Thomas, 2009, BMC Pulm Med, V9, P39, DOI 10.1186/1471-2466-9-39; Turner DL, 2007, J VIROL, V81, P2039, DOI 10.1128/JVI.02167-06; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; WU HY, 1993, INFECT IMMUN, V61, P314, DOI 10.1128/IAI.61.1.314-322.1993; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	51	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11156	10.1371/journal.pone.0011156	http://dx.doi.org/10.1371/journal.pone.0011156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585390	Green Published, gold			2022-12-25	WOS:000278886100019
J	Cohen, I; Maoz, M; Turm, H; Grisaru-Granovsky, S; Maly, B; Uziely, B; Weiss, E; Abramovitch, R; Gross, E; Barzilay, O; Qiu, Y; Bar-Shavit, R				Cohen, Irit; Maoz, Myriam; Turm, Hagit; Grisaru-Granovsky, Sorina; Maly, Bella; Uziely, Beatrice; Weiss, Einat; Abramovitch, Rinat; Gross, Eithan; Barzilay, Oded; Qiu, Yun; Bar-Shavit, Rachel			Etk/Bmx Regulates Proteinase-Activated-Receptor1 (PAR(1)) in Breast Cancer Invasion: Signaling Partners, Hierarchy and Physiological Significance	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; NONRECEPTOR TYROSINE KINASES; PLECKSTRIN-HOMOLOGY DOMAIN; CARCINOMA CELL INVASION; FOCAL ADHESION KINASE; THROMBIN RECEPTOR; TUMOR PROGRESSION; SH2 DOMAIN; EXPRESSION; TRAFFICKING	Background: While protease-activated-receptor 1 (PAR1) plays a central role in tumor progression, little is known about the cell signaling involved. Methodology/Principal Findings: We show here the impact of PAR1 cellular activities using both an orthotopic mouse mammary xenograft and a colorectal-liver metastasis model in vivo, with biochemical analyses in vitro. Large and highly vascularized tumors were generated by cells over-expressing wt hPar1, Y397Z hPar1, with persistent signaling, or Y381A hPar1 mutant constructs. In contrast, cells over-expressing the truncated form of hPar1, which lacks the cytoplasmic tail, developed small or no tumors, similar to cells expressing empty vector or control untreated cells. Antibody array membranes revealed essential hPar1 partners including Etk/Bmx and Shc. PAR(1) activation induces Etk/Bmx and Shc binding to the receptor C-tail to form a complex. Y/A mutations in the PAR1 C-tail did not prevent Shc-PAR(1) association, but enhanced the number of liver metastases compared with the already increased metastases obtained with wt hPar1. We found that Etk/Bmx first binds via the PH domain to a region of seven residues, located between C378-S384 in PAR(1) C-tail, enabling subsequent Shc association. Importantly, expression of the hPar1-7A mutant form (substituted A, residues 378384), which is incapable of binding Etk/Bmx, resulted in inhibition of invasion through Matrigel-coated membranes. Similarly, knocking down Etk/Bmx inhibited PAR1-induced MDA-MB-435 cell migration. In addition, intact spheroid morphogenesis of MCF10A cells is markedly disrupted by the ectopic expression of wt hPar1. In contrast, the forced expression of the hPar1-7A mutant results in normal ball-shaped spheroids. Thus, by preventing binding of Etk/Bmx to PAR(1) -C-tail, hPar1 oncogenic properties are abrogated. Conclusions/Significance: This is the first demonstration that a cytoplasmic portion of the PAR(1) C-tail functions as a scaffold site. We identify here essential signaling partners, determine the hierarchy of binding and provide a platform for therapeutic vehicles via definition of the critical PAR(1)-associating region in the breast cancer signaling niche.	[Cohen, Irit; Maoz, Myriam; Turm, Hagit; Grisaru-Granovsky, Sorina; Uziely, Beatrice; Weiss, Einat; Barzilay, Oded; Bar-Shavit, Rachel] Hadassah Univ Hosp, Dept Oncol, IL-91120 Jerusalem, Israel; [Maly, Bella] Hadassah Univ Hosp, Dept Pathol, IL-91120 Jerusalem, Israel; [Abramovitch, Rinat] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Gross, Eithan] Hadassah Univ Hosp, Dept Pediat Surg, IL-91120 Jerusalem, Israel; [Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University System of Maryland; University of Maryland Baltimore	Cohen, I (corresponding author), Hadassah Univ Hosp, Dept Oncol, IL-91120 Jerusalem, Israel.	rachel.bar-shavit@ekmd.huji.ac.il			Israel Scientific Foundation (ISF); Israel Cancer Research Fund ( ICRF); Fritz Thyssen Foundation	Israel Scientific Foundation (ISF)(Israel Science Foundation); Israel Cancer Research Fund ( ICRF); Fritz Thyssen Foundation	This research was supported by funds from the Israel Scientific Foundation (ISF), the Israel Cancer Research Fund (ICRF), and the Fritz Thyssen Foundation (to RB). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abassi YA, 2003, J BIOL CHEM, V278, P35636, DOI 10.1074/jbc.M306438200; ALBINI A, 1987, CANCER RES, V47, P3239; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Camerer E, 2004, BLOOD, V103, P152, DOI 10.1182/blood-2003-08-2707; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Collins LR, 1997, ONCOGENE, V15, P595, DOI 10.1038/sj.onc.1201220; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2003, J PATHOL, V200, P47, DOI 10.1002/path.1338; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Grisaru-Granovsky S, 2005, INT J CANCER, V113, P372, DOI 10.1002/ijc.20607; Groeger AM, 2004, HISTOPATHOLOGY, V44, P54, DOI 10.1111/j.1365-2559.2004.01750.x; Hammes SR, 1999, BIOCHEMISTRY-US, V38, P2486, DOI 10.1021/bi982527i; HEIN L, 1994, J BIOL CHEM, V269, P27719; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Kim O, 2002, J BIOL CHEM, V277, P30066, DOI 10.1074/jbc.M201713200; Kuruppu D, 2002, J SURG RES, V103, P47, DOI 10.1006/jsre.2001.6299; Lee LF, 2001, MOL CELL BIOL, V21, P8385, DOI 10.1128/MCB.21.24.8385-8397.2001; Ma YC, 1998, P NATL ACAD SCI USA, V95, P12197, DOI 10.1073/pnas.95.21.12197; Mao JH, 1998, EMBO J, V17, P5638, DOI 10.1093/emboj/17.19.5638; NAKAZATO Y, CANCER, V116, P2011; Obreztchikova M, 2006, J BIOL CHEM, V281, P20197, DOI 10.1074/jbc.M601859200; Paavonen K, 2004, MOL BIOL CELL, V15, P4226, DOI 10.1091/mbc.E04-03-0241; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; RICKLES FR, 1983, BLOOD, V62, P14; Salah Z, 2007, MOL CANCER RES, V5, P229, DOI 10.1158/1541-7786.MCR-06-0261; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Yin YJ, 2003, ARTERIOSCL THROM VAS, V23, P940, DOI 10.1161/01.ATV.0000066878.27340.22	43	25	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11135	10.1371/journal.pone.0011135	http://dx.doi.org/10.1371/journal.pone.0011135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559570	Green Published, Green Submitted, gold			2022-12-25	WOS:000278775900024
J	Lehmann, C; Lafferty, M; Garzino-Demo, A; Jung, N; Hartmann, P; Fatkenheuer, G; Wolf, JS; van Lunzen, J; Romerio, F				Lehmann, Clara; Lafferty, Mark; Garzino-Demo, Alfredo; Jung, Norma; Hartmann, Pia; Faetkenheuer, Gerd; Wolf, Jeffrey S.; van Lunzen, Jan; Romerio, Fabio			Plasmacytoid Dendritic Cells Accumulate and Secrete Interferon Alpha in Lymph Nodes of HIV-1 Patients	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE-ANTIRETROVIRAL-THERAPY; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; T-CELLS; I INTERFERON; HIV-1-INFECTED PATIENTS; IMMUNE ACTIVATION; PROGNOSTIC VALUE; RNA LEVELS	Circulating plasmacytoid dendritic cells (pDC) decline during HIV-1 infection, but at the same time they express markedly higher levels of interferon alpha (IFN alpha), which is associated with HIV-1 disease progression. Here we show an accumulation of pDC in lymph nodes (LN) of treatment-naive HIV-1 patients. This phenomenon was associated with elevated expression of the LN homing marker, CCR7, on pDC in peripheral blood of HIV-1 patients, which conferred increased migratory capacity in response to CCR7 ligands in ex vivo functional assays. LN-homed pDC of HIV-1 patients presented higher CD40 and lower BDCA2 levels, but unchanged CD83 and CD86 expression. In addition, these cells expressed markedly higher amounts of IFN alpha compared to uninfected individuals, and were undergoing faster rates of cell death. These results demonstrate for the first time that in asymptomatic, untreated HIV-1 patients circulating pDC up-regulate CCR7 expression, accumulate in lymph nodes, and express high amounts of IFN alpha before undergoing cell death. Since IFN alpha inhibits cell proliferation and modulates immune responses, chronically high levels of this cytokine in LN of HIV-1 patients may impair differentiation and immune function of bystander CD4(+) T cells, thus playing into the mechanisms of AIDS immunopathogenesis.	[Lehmann, Clara; Lafferty, Mark; Garzino-Demo, Alfredo; Romerio, Fabio] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA; [Lehmann, Clara; Romerio, Fabio] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Lehmann, Clara; Jung, Norma; Faetkenheuer, Gerd] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Lafferty, Mark; Garzino-Demo, Alfredo] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Wolf, Jeffrey S.] Univ Maryland, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [van Lunzen, Jan] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [van Lunzen, Jan] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Cologne; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg	Lehmann, C (corresponding author), Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA.	fromerio@ihv.umaryland.edu	Serei, Virian D/B-4616-2015; Lehmann, Clara/F-9671-2016	Lehmann, Clara/0000-0002-7042-1578; Garzino-Demo, Alfredo/0000-0002-4095-6950	National Institute of Neurological Disorders and Stroke (NINDS) [R01NS066842]; National Institute of Dental and Craniofacial Research [1R21DE15508-01]; German Federal Ministry of Research and Education (BMBF) [01KI0771]; National Institute of Allergy and Infectious Diseases (NIAID) [T32AI007540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE015508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066842] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work described was supported by awards R01NS066842 from the National Institute of Neurological Disorders and Stroke (NINDS) and 1R21DE15508-01 from the National Institute of Dental and Craniofacial Research (A.G.-D.). C. L. and N.J. were supported by the German Federal Ministry of Research and Education (BMBF grant 01KI0771). M. K. L. was a trainee under Institutional Training Grant T32AI007540 from the National Institute of Allergy and Infectious Diseases (NIAID). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NINDS or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Almeida M, 2005, AIDS, V19, P261; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Biron CA, 1998, ADV EXP MED BIOL, V452, P143; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown KN, 2007, J IMMUNOL, V178, P6958, DOI 10.4049/jimmunol.178.11.6958; Brown KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000413; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; de la Rosa G, 2003, J LEUKOCYTE BIOL, V73, P639, DOI 10.1189/jlb.1002516; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Desai S, 2007, JAIDS-J ACQ IMM DEF, V45, P501, DOI 10.1097/QAI.0b013e3180654811; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Diop OM, 2008, J VIROL, V82, P5145, DOI 10.1128/JVI.02433-07; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Foussat A, 2001, BLOOD, V98, P1678, DOI 10.1182/blood.V98.6.1678; FRANCIS ML, 1992, AIDS RES HUM RETROV, V8, P199, DOI 10.1089/aid.1992.8.199; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Graham LM, 2009, CYTOKINE, V48, P148, DOI 10.1016/j.cyto.2009.07.010; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kleeberger CA, 1999, CLIN DIAGN LAB IMMUN, V6, P14, DOI 10.1128/CDLI.6.1.14-19.1999; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Lehmann C, 2009, AIDS RES HUM RETROV, V25, P577, DOI 10.1089/aid.2008.0238; Lehmann C, 2008, JAIDS-J ACQ IMM DEF, V48, P522, DOI 10.1097/QAI.0b013e31817f97cf; Lore K, 2002, AIDS, V16, P683, DOI 10.1097/00002030-200203290-00003; Malleret B, 2008, IMMUNOLOGY, V124, P223, DOI 10.1111/j.1365-2567.2007.02758.x; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Pacanowski M, 2004, J INFECT DIS, V190, P1889, DOI 10.1086/425020; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Reimann KA, 2000, CLIN DIAGN LAB IMMUN, V7, P352, DOI 10.1128/CDLI.7.3.352-359.2000; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Siegal Frederick, 2003, Res Initiat Treat Action, V8, P10; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; SIMON A, 1991, J VIROL, V65, P968, DOI 10.1128/JVI.65.2.968-971.1991; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Tilton JC, 2008, J VIROL, V82, P3997, DOI 10.1128/JVI.01545-07; VONWUSSOW P, 1990, AIDS, V4, P119, DOI 10.1097/00002030-199002000-00004; Weinberg A, 2000, CLIN DIAGN LAB IMMUN, V7, P714, DOI 10.1128/CDLI.7.4.714-716.2000; Weinberg A, 2007, CLIN VACCINE IMMUNOL, V14, P1242, DOI 10.1128/CVI.00187-07; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Wu PP, 2008, CLIN IMMUNOL, V129, P40, DOI 10.1016/j.clim.2008.06.004; Yonezawa A, 2003, J VIROL, V77, P3777, DOI 10.1128/JVI.77.6.3777-3784.2003; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3851, DOI 10.1073/pnas.95.7.3851	67	63	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11110	10.1371/journal.pone.0011110	http://dx.doi.org/10.1371/journal.pone.0011110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559432	Green Published, gold, Green Submitted			2022-12-25	WOS:000278741100022
J	Ji, YR; Kim, MO; Kim, SH; Yu, DH; Shin, MJ; Kim, HJ; Yuh, HS; Bae, KB; Kim, JY; Park, HD; Lee, SG; Hyun, BH; Ryoo, ZY				Ji, Young Rae; Kim, Myoung Ok; Kim, Sung Hyun; Yu, Dong Hun; Shin, Mi Jung; Kim, Hei Jung; Yuh, Hyung Soo; Bae, Ki Beom; Kim, Jae Young; Park, Hum Dai; Lee, Sang Gyu; Hyun, Byung Hwa; Ryoo, Zae Young			Effects of Regulator of G Protein Signaling 19 (RGS19) on Heart Development and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN FUNCTION; WNT/BETA-CATENIN; NEGATIVE REGULATOR; PROGENITOR CELLS; STEM-CELL; PATHWAY; DIFFERENTIATION; MORPHOGENESIS; HYPERTROPHY; EXPRESSION	Wnt/Wg genes play a critical role in the development of various organisms. For example, the Wnt/beta-catenin signal promotes heart formation and cardiomyocyte differentiation in mice. Previous studies have shown that RGS19 ((r) under bar egulator of (G) under bar protein (s) under bar ignaling (19) under bar), which has G alpha subunits with GTPase activity, inhibits the Wnt/beta-catenin signal through inactivation of G alpha(o). In the present study, the effects of RGS19 on mouse cardiac development were observed. In P19 teratocarcinoma cells with RGS19 overexpression, RGS19 inhibited cardiomyocyte differentiation by blocking the Wnt signal. Additionally, several genes targeted by Wnt were down-regulated. For the in vivo study, we generated RGS19-overexpressing transgenic (RGS19 TG) mice. In these transgenic mice, septal defects and thin-walled ventricles were observed during the embryonic phase of development, and the expression of cardiogenesis-related genes, BMP4 and Mef2C, was reduced significantly. RGS19 TG mice showed increased expression levels of brain natriuretic peptide and beta-MHC, which are markers of heart failure, increase of cell proliferation, and electrocardiogram analysis shows abnormal ventricle repolarization. These data provide in vitro and in vivo evidence that RGS19 influenced cardiac development and had negative effects on heart function.	[Ryoo, Zae Young] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Coll Nat Sci, Taegu 702701, South Korea; [Kim, Jae Young] Kyungpook Natl Univ, Dept Biochem, Sch Dent, Brain Korea Project 21,IHBR, Taegu 702701, South Korea; [Hyun, Byung Hwa] Korea Res Inst Biosci & Biotechnol, Dis Model Res Ctr, Daegeon 305806, South Korea; [Park, Hum Dai] Daegu Univ, Dept Biotechnol, Sch Engn, Gyeongsang 712714, Gyeongbuk, South Korea	Kyungpook National University; Kyungpook National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Daegu University	Ryoo, ZY (corresponding author), Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Coll Nat Sci, 1370 Sankyuk Dong, Taegu 702701, South Korea.	jaewoong64@hanmail.net	RYOO, ZAEYOUNG/AAQ-1573-2020; Ji, Youngrae/AAK-9724-2021; Ji, Youngrae/AAK-9711-2021	Ji, Youngrae/0000-0002-8825-9783; 	National Research Foundation of Korea [NRF2009-0088343]; Korean government [2009-0063409]; Korea Ministry of Education, Science, and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government); Korea Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by Grant NRF2009-0088343 from the National Research Foundation of Korea, SRC Program of Korea Science and Engineering Foundation (KOSEF) Grant 2009-0063409 (funded by the Korean government), and the Regional Care Research Program from the Korea Ministry of Education, Science, and Technology.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Ai D, 2007, P NATL ACAD SCI USA, V104, P9319, DOI 10.1073/pnas.0701212104; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Braz JC, 2009, EUR J HEART FAIL, V11, P739, DOI 10.1093/eurjhf/hfp094; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cohen ED, 2007, J CLIN INVEST, V117, P1794, DOI 10.1172/JCI31731; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; HOGAN B, 1986, MANIPULATING MOUSE E; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Howes AL, 2006, J MOL CELL CARDIOL, V40, P597, DOI 10.1016/j.yjmcc.2005.12.003; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Korol O, 2008, DEV BIOL, V324, P131, DOI 10.1016/j.ydbio.2008.09.012; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Li XM, 2008, NAT NEUROSCI, V11, P262, DOI 10.1038/nn2053; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; McCulley DJ, 2008, DEV DYNAM, V237, P3200, DOI 10.1002/dvdy.21743; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Park MY, 1996, DEV BIOL, V177, P104, DOI 10.1006/dbio.1996.0149; Qu JX, 2007, J MOL CELL CARDIOL, V43, P319, DOI 10.1016/j.yjmcc.2007.06.006; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schuller U, 2007, BRAIN RES, V1140, P161, DOI 10.1016/j.brainres.2006.05.105; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Zamora M, 2007, P NATL ACAD SCI USA, V104, P18109, DOI 10.1073/pnas.0702415104	44	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28627	28634		10.1074/jbc.M109.073718	http://dx.doi.org/10.1074/jbc.M109.073718			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20562099	hybrid, Green Published			2022-12-25	WOS:000281594000026
J	Fujihara, C; Yamada, S; Ozaki, N; Takeshita, N; Kawaki, H; Takano-Yamamoto, T; Murakami, S				Fujihara, Chiharu; Yamada, Satoru; Ozaki, Nobuhiro; Takeshita, Nobuo; Kawaki, Harumi; Takano-Yamamoto, Teruko; Murakami, Shinya			Role of Mechanical Stress-induced Glutamate Signaling-associated Molecules in Cytodifferentiation of Periodontal Ligament Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; TOOTH MOVEMENT; STEM-CELLS; IN-VITRO; RECEPTOR; BONE; RAT; NEURONS; ACTIVATION; PATHWAY	In this study, we analyzed the effects of tensile mechanical stress on the gene expression profile of in vitro-maintained human periodontal ligament (PDL) cells. A DNA chip analysis identified 17 up-regulated genes in human PDL cells under the mechanical stress, including HOMER1 (homer homolog 1) and GRIN3A (glutamate receptor ionotropic N-methyl-D-aspartate 3A), which are related to glutamate signaling. RT-PCR and real-time PCR analyses revealed that human PDL cells constitutively expressed glutamate signaling-associated genes and that mechanical stress increased the expression of these mRNAs, leading to release of glutamate from human PDL cells and intracellular glutamate signal transduction. Interestingly, exogenous glutamate increased them RNAs of cytodifferentiation and mineralization-related genes as well as the ALP (alkaline phosphatase) activities during the cytodifferentiation of the PDL cells. On the other hand, the glutamate signaling inhibitors riluzole and (+)-MK801 maleate suppressed the alkaline phosphatase activities and mineralized nodule formation during the cytodifferentiation and mineralization. Riluzole inhibited the mechanical stress-induced glutamate signaling-associated gene expressions in human PDL cells. Moreover, in situ hybridization analyses showed up-regulation of glutamate signaling-associated gene expressions at tension sites in the PDL under orthodontic tooth movement in a mouse model. The present data demonstrate that the glutamate signaling induced by mechanical stress positively regulates the cytodifferentiation and mineralization of PDL cells.	[Fujihara, Chiharu; Yamada, Satoru; Ozaki, Nobuhiro; Murakami, Shinya] Osaka Univ, Grad Sch Dent, Div Oral Biol & Dis Control, Dept Periodontol, Suita, Osaka 5650871, Japan; [Takeshita, Nobuo; Kawaki, Harumi; Takano-Yamamoto, Teruko] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Orthodont & Dentofacial Orthoped,Aoba Ku, Sendai, Miyagi 9808578, Japan	Osaka University; Tohoku University	Murakami, S (corresponding author), Osaka Univ, Grad Sch Dent, Div Oral Biol & Dis Control, Dept Periodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	ipshinya@dent.osaka-u.ac.jp		Murakami, Shinya/0000-0002-5230-452X; Kawaki, Harumi/0000-0002-5528-7016	Japan Society for the Promotion of Science [20390529, 20390530]; Ministry of Health, Labor, and Welfare [H21-001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-aid 20390529 and 20390530 from the Japan Society for the Promotion of Science and Research Grant H21-001 from the Ministry of Health, Labor, and Welfare.	Ango F, 2002, MOL CELL NEUROSCI, V20, P323, DOI 10.1006/mcne.2002.1100; BERTRAND G, 1992, BRIT J PHARMACOL, V106, P354, DOI 10.1111/j.1476-5381.1992.tb14340.x; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Chenu C, 1998, BONE, V22, P295, DOI 10.1016/S8756-3282(97)00295-0; COHN S. A., 1965, ARCH ORAL BIOL, V10, P909, DOI 10.1016/0003-9969(65)90084-1; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661; de Araujo RMS, 2007, J PERIODONTAL RES, V42, P15, DOI 10.1111/j.1600-0765.2006.00906.x; Domon S, 2001, EUR J ORTHODONT, V23, P339, DOI 10.1093/ejo/23.4.339; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Harris SL, 2004, MOL CELL NEUROSCI, V25, P275, DOI 10.1016/j.mcn.2003.10.018; Henneman S, 2008, ARCH ORAL BIOL, V53, P161, DOI 10.1016/j.archoralbio.2007.08.010; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; Iemata M, 2007, J CELL PHYSIOL, V213, P721, DOI 10.1002/jcp.21145; Kanda T, 2007, J CELL BIOCHEM, V101, P1329, DOI 10.1002/jcb.21306; Kaneko S, 2001, J PERIODONTAL RES, V36, P9, DOI 10.1034/j.1600-0765.2001.00607.x; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lai DM, 2008, NEUROCHEM INT, V52, P470, DOI 10.1016/j.neuint.2007.08.010; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mao LM, 2003, J NEUROCHEM, V84, P233, DOI 10.1046/j.1471-4159.2003.01256.x; Matsuda N, 1998, ARCH ORAL BIOL, V43, P987, DOI 10.1016/S0003-9969(98)00079-X; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Moriyama Y, 2004, J BIOCHEM, V135, P155, DOI 10.1093/jb/mvh018; Muller S, 2009, STEM CELLS, V27, P431, DOI 10.1634/stemcells.2008-0234; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Ozaki S, 2005, J PERIODONTAL RES, V40, P110, DOI 10.1111/j.1600-0765.2004.00782.x; Patton AJ, 1998, BONE, V22, P645, DOI 10.1016/S8756-3282(98)00061-1; Pavlin D, 2001, CRIT REV ORAL BIOL M, V12, P414, DOI 10.1177/10454411010120050401; PICHE JE, 1989, J DENT RES, V68, P761, DOI 10.1177/00220345890680050201; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Sakai Y, 2009, J DENT RES, V88, P345, DOI 10.1177/0022034509334649; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; SOMERMAN MJ, 1988, J DENT RES, V67, P66, DOI 10.1177/00220345880670011301; Suriano AR, 2005, MOL CELL BIOL, V25, P9073, DOI 10.1128/MCB.25.20.9073-9081.2005; TAKANOYAMAMOTO T, 1994, J HISTOCHEM CYTOCHEM, V42, P885, DOI 10.1177/42.7.8014472; TORII K, 1980, BIOCHIM BIOPHYS ACTA, V627, P313; VIGNERY A, 1980, ANAT REC, V196, P191, DOI 10.1002/ar.1091960210; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Yamaguchi N, 2002, ARCH ORAL BIOL, V47, P465, DOI 10.1016/S0003-9969(02)00022-5	43	27	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28286	28297		10.1074/jbc.M109.097303	http://dx.doi.org/10.1074/jbc.M109.097303			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576613	Green Published, hybrid			2022-12-25	WOS:000281404100071
J	Chen, VP; Xie, HQ; Chan, WKB; Leung, KW; Chan, GKL; Choi, RCY; Bon, S; Massoulie, J; Tsim, KWK				Chen, Vicky P.; Xie, Heidi Q.; Chan, Wallace K. B.; Leung, K. Wing; Chan, Gallant K. L.; Choi, Roy C. Y.; Bon, Suzanne; Massoulie, Jean; Tsim, Karl W. K.			The PRiMA-linked Cholinesterase Tetramers Are Assembled from Homodimers HYBRID MOLECULES COMPOSED OF ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE DIMERS ARE UP-REGULATED DURING DEVELOPMENT OF CHICKEN BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH-MEMBRANE-ANCHOR; TERMINAL T-PEPTIDE; SYNAPTIC ACETYLCHOLINESTERASE; MUSCLE ACETYLCHOLINESTERASE; QUATERNARY ASSOCIATIONS; CHICKEN BRAIN; COLLAGEN TAIL; FORMS; DEGRADATION; EXPRESSION	Acetylcholinesterase (AChE) is anchored onto cell membranes by the transmembrane protein PRiMA (proline-rich membrane anchor) as a tetrameric globular form that is prominently expressed in vertebrate brain. In parallel, the PRiMA-linked tetrameric butyrylcholinesterase (BChE) is also found in the brain. A single type of AChE-BChE hybrid tetramer was formed in cell cultures by co-transfection of cDNAs encoding AChE(T) and BChE(T) with proline-rich attachment domain-containing proteins, PRiMA I, PRiMA II, or a fragment of ColQ having a C-terminal GPI addition signal (Q(N-GPI)). Using AChE and BChE mutants, we showed that AChE-BChE hybrids linked with PRiMA or Q(N-GPI) always consist of AChE(T) and BChE(T) homodimers. The dimer formation of AChE(T) and BChE(T) depends on the catalytic domains, and the assembly of tetramers with a proline-rich attachment domain-containing protein requires the presence of C-terminal "t-peptides" in cholinesterase subunits. Our results indicate that PRiMA-or ColQ-linked cholinesterase tetramers are assembled from AChE(T) or BChE(T) homodimers. Moreover, the PRiMA-linked AChE-BChE hybrids occur naturally in chicken brain, and their expression increases during development, suggesting that they might play a role in cholinergic neurotransmission.	[Chen, Vicky P.; Xie, Heidi Q.; Chan, Wallace K. B.; Leung, K. Wing; Chan, Gallant K. L.; Choi, Roy C. Y.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Chen, Vicky P.; Xie, Heidi Q.; Chan, Wallace K. B.; Leung, K. Wing; Chan, Gallant K. L.; Choi, Roy C. Y.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Bon, Suzanne; Massoulie, Jean] Ecole Normale Super, CNRS, Inst Biol, UMR 8197, F-75005 Paris, France	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk	CHEN, VICKY/C-9223-2016	CHEN, VICKY/0000-0003-3753-7170; Tsim, Karl/0000-0003-4808-1674; Leung, Ka Wing/0000-0002-6137-3877	Research Grants Council of Hong Kong [N_HKUST629/07, 662407, 662608, 660409, F-HK21/06T]; Croucher Foundation [CAS-CF07/08.SC03]; Centre National de la Recherche Scientifique; Ecole Normale Superieure; Association Francaise contre les Myopathies; French Ministry of Foreign Affairs	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Croucher Foundation; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); French Ministry of Foreign Affairs	This work was supported by Research Grants Council of Hong Kong Grants N_HKUST629/07, 662407, 662608, 660409, and F-HK21/06T and Croucher Foundation Grant CAS-CF07/08.SC03 (to K. W. K. T.) and grants from Centre National de la Recherche Scientifique, Ecole Normale Superieure, Association Francaise contre les Myopathies, and French Ministry of Foreign Affairs (to J. M.).	ANSELMET A, 1994, J NEUROCHEM, V62, P2158; Belbeoc'h S, 2004, EUR J BIOCHEM, V271, P1476, DOI 10.1111/j.1432-1033.2004.04052.x; Belbeoc'h S, 2003, EMBO J, V22, P3536, DOI 10.1093/emboj/cdg360; Blong RM, 1997, BIOCHEM J, V327, P747, DOI 10.1042/bj3270747; Bon S, 2004, EUR J BIOCHEM, V271, P33, DOI 10.1046/j.1432-1033.2003.03892.x; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; BON S, 1988, J NEUROCHEM, V51, P786, DOI 10.1111/j.1471-4159.1988.tb01813.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi RCY, 1996, NEUROSCI LETT, V217, P165, DOI 10.1016/0304-3940(96)13102-5; DUVAL N, 1992, EMBO J, V11, P3255, DOI 10.1002/j.1460-2075.1992.tb05403.x; DUVAL N, 1992, J CELL BIOL, V118, P641, DOI 10.1083/jcb.118.3.641; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Falasca C, 2005, J BIOL CHEM, V280, P878, DOI 10.1074/jbc.M409201200; Garcia-Ayllon MS, 2001, NEUROSCIENCE, V107, P199, DOI 10.1016/S0306-4522(01)00355-4; GOUGH NR, 1995, J NEUROCHEM, V65, P2734; KARNOVSKY MJ, 1964, HISTOCHEM CYTOCHEM, V12, P219; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; LEE SL, 1982, J BIOL CHEM, V257, P12282; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; Li H, 2008, BIOCHEM J, V411, P425, DOI 10.1042/BJ20071551; LI Y, 1991, J BIOL CHEM, V266, P23083; Liang D, 2009, FEBS J, V276, P94, DOI 10.1111/j.1742-4658.2008.06756.x; LOCKRIDGE O, 1990, PHARMACOL THERAPEUT, V47, P35, DOI 10.1016/0163-7258(90)90044-3; Massoulie J, 2005, CHEM-BIOL INTERACT, V157, P3, DOI 10.1016/j.cbi.2005.10.002; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; Massoulie J, 1998, J PHYSIOLOGY-PARIS, V92, P183, DOI 10.1016/S0928-4257(98)80007-7; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Mok MKW, 2009, NEUROSCI LETT, V461, P202, DOI 10.1016/j.neulet.2009.06.015; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Noureddine H, 2008, J BIOL CHEM, V283, P20722, DOI 10.1074/jbc.M801364200; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Perrier NA, 2005, J NEUROCHEM, V94, P629, DOI 10.1111/j.1471-4159.2005.03140.x; Perrier NA, 2003, EUR J NEUROSCI, V18, P1837, DOI 10.1046/j.1460-9568.2003.02914.x; RANDALL WR, 1987, EUR J BIOCHEM, V164, P95, DOI 10.1111/j.1432-1033.1987.tb10998.x; ROTUNDO RL, 1984, J BIOL CHEM, V259, P3186; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TSIM KWK, 1988, EMBO J, V7, P2451, DOI 10.1002/j.1460-2075.1988.tb03091.x; TSIM KWK, 1988, P NATL ACAD SCI USA, V85, P1262, DOI 10.1073/pnas.85.4.1262; Xie HQ, 2007, J BIOL CHEM, V282, P11765, DOI 10.1074/jbc.M608265200; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Xie HQ, 2009, BRAIN RES, V1265, P13, DOI 10.1016/j.brainres.2009.01.065; Xie WH, 2000, J PHARMACOL EXP THER, V293, P896	46	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27265	27278		10.1074/jbc.M110.113647	http://dx.doi.org/10.1074/jbc.M110.113647			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566626	Green Published, hybrid			2022-12-25	WOS:000281172700057
J	Leenders, JJ; Wijnen, WJ; Hiller, M; van der Made, I; Lentink, V; van Leeuwen, REW; Herias, V; Pokharel, S; Heymans, S; de Windt, LJ; Hoydal, MA; Pinto, YM; Creemers, EE				Leenders, Joost J.; Wijnen, Wino J.; Hiller, Monika; van der Made, Ingeborg; Lentink, Viola; van Leeuwen, Rick E. W.; Herias, Veronica; Pokharel, Saraswati; Heymans, Stephane; de Windt, Leon J.; Hoydal, Morten A.; Pinto, Yigal M.; Creemers, Esther E.			Regulation of Cardiac Gene Expression by KLF15, a Repressor of Myocardin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; PRESSURE-OVERLOAD; DISEASE GENE; CELL-GROWTH; PROTEIN; P38; HYPERTROPHY; FAMILY; PROMOTER; MYOCYTES	Pathological forms of left ventricular hypertrophy (LVH) often progress to heart failure. Specific transcription factors have been identified that activate the gene program to induce pathological forms of LVH. It is likely that apart from activating transcriptional inducers of LVH, constitutive transcriptional repressors need to be removed during the development of cardiac hypertrophy. Here, we report that the constitutive presence of Kruppel-like factor 15 (KLF15) is lost in pathological hypertrophy and that this loss precedes progression toward heart failure. We show that transforming growth factor-beta-mediated activation of p38 MAPK is necessary and sufficient to decrease KLF15 expression. We further show that KLF15 robustly inhibits myocardin, a potent transcriptional activator. Loss of KLF15 during pathological LVH relieves the inhibitory effects on myocardin and stimulates the expression of serum response factor target genes, such as atrial natriuretic factor. This uncovers a novel mechanism where activated p38 MAPK decreases KLF15, an important constitutive transcriptional repressor whose removal seems a vital step to allow the induction of pathological LVH.	[Leenders, Joost J.; Wijnen, Wino J.; Hiller, Monika; van der Made, Ingeborg; Pinto, Yigal M.; Creemers, Esther E.] Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Lentink, Viola; van Leeuwen, Rick E. W.; Herias, Veronica; Heymans, Stephane; de Windt, Leon J.] Univ Maastricht, Cardiovasc Res Inst, NL-6229 ER Maastricht, Netherlands; [Pokharel, Saraswati] Univ Louisville, Dept Pathol & Lab Med, Louisville, KY 40292 USA; [Hoydal, Morten A.] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, NO-7491 Trondheim, Norway	University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; University of Louisville; Norwegian University of Science & Technology (NTNU)	Creemers, EE (corresponding author), Acad Med Ctr, Heart Failure Res Ctr, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	e.e.creemers@amc.uva.nl	de Windt, Leon/AAO-6395-2020; Høydal, Morten A/K-2806-2012; Wijnen, Wino/P-4774-2015	de Windt, Leon/0000-0002-7793-2856; Høydal, Morten A/0000-0003-1804-2578; Wijnen, Wino/0000-0002-3513-3618; Creemers, Esther/0000-0002-9001-3854; Heymans, Stephane/0000-0001-9477-7803	Netherlands Heart Foundation [2003T302, 2007B077]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by Netherlands Heart Foundation Grants 2003T302 (to Y. M. P.) and 2007B077 (to E. E. C.).	Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Carballo S, 2009, CIRC RES, V105, P375, DOI 10.1161/CIRCRESAHA.109.196055; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Feinberg MW, 2004, TRENDS CARDIOVAS MED, V14, P241, DOI 10.1016/j.tcm.2004.06.005; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Liang QR, 2003, J MOL CELL CARDIOL, V35, P1385, DOI 10.1016/j.yjmcc.2003.10.001; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Strom CC, 2005, FEBS J, V272, P2684, DOI 10.1111/j.1742-4658.2005.04684.x; Uchida S, 2000, MOL CELL BIOL, V20, P7319, DOI 10.1128/MCB.20.19.7319-7331.2000; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	34	47	53	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27449	27456		10.1074/jbc.M110.107292	http://dx.doi.org/10.1074/jbc.M110.107292			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566642	Green Published, hybrid			2022-12-25	WOS:000281172700074
J	Teste, MA; Francois, JM; Parrou, JL				Teste, Marie-Ange; Francois, Jean Marie; Parrou, Jean-Luc			Characterization of a New Multigene Family Encoding Isomaltases in the Yeast Saccharomyces cerevisiae, the IMA Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-INDUCED INACTIVATION; MAL GENE-EXPRESSION; ALPHA-GLUCOSIDASE; CATABOLITE INACTIVATION; SUBSTRATE-SPECIFICITY; HEXOSE TRANSPORTERS; REGULATORY ELEMENTS; MALTOSE PERMEASE; FINGER PROTEINS; SHUTTLE VECTORS	It has been known for a long time that the yeast Saccharomyces cerevisiae can assimilate alpha-methylglucopyranoside and isomaltose. We here report the identification of 5 genes (YGR287c, YIL172c, YJL216c, YJL221c and YOL157c), which, similar to the SUCx, MALx, or HXTx multigene families, are located in the subtelomeric regions of different chromosomes. They share high nucleotide sequence identities between themselves (66-100%) and with the MALx2 genes (63-74%). Comparison of their amino acid sequences underlined a substitution of threonine by valine in region II, one of the four highly conserved regions of the alpha -glucosidase family. This change was previously shown to be sufficient to discriminate alpha-1,4-to alpha-1,6glucosidase activity in YGR287c (Yamamoto, K., Nakayama, A., Yamamoto, Y., and Tabata, S. (2004) Eur. J. Biochem. 271, 34143420). We showed that each of these five genes encodes a protein with alpha-glucosidase activity on isomaltose, and we therefore renamed these genes IMA1 to IMA5 for IsoMAltase. Our results also illustrated that sequence polymorphisms among this family led to interesting variability of gene expression patterns and of catalytic efficiencies on different substrates, which altogether should account for the absence of functional redundancy for growth on isomaltose. Indeed, deletion studies revealed that IMA1/YGR287c encodes the major isomaltase and that growth on isomaltose required the presence of AGT1, which encodes an alpha-glucoside transporter. Expressions of IMA1 and IMA5/YJL216c were strongly induced by maltose, isomaltose, and alpha-methylglucopyranoside, in accordance with their regulation by the Malx3p-transcription system. The physiological relevance of this IMAx multigene family in S. cerevisiae is discussed.	[Teste, Marie-Ange; Francois, Jean Marie; Parrou, Jean-Luc] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Teste, Marie-Ange; Francois, Jean Marie; Parrou, Jean-Luc] CNRS, UMR5504, F-31400 Toulouse, France; [Teste, Marie-Ange; Francois, Jean Marie; Parrou, Jean-Luc] INRA, Ingn Syst Biol & Procedes UMR792, F-31400 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Parrou, JL (corresponding author), Univ Toulouse, INSA, UPS, INP,LISBP, 135 Ave Rangueil, F-31077 Toulouse, France.	jean-luc.parrou@insa-toulouse.fr	parrou, jean-luc/A-6874-2015	Teste, Marie Ange/0000-0001-9173-9190	ANR Blanc [05-2-42128]	ANR Blanc(French National Research Agency (ANR))	This work was supported by ANR Blanc 05-2-42128 and Genopole Toulouse associated with transport, cleavage, or regulatory function. (to J. M. F.).	Alberti A, 2003, YEAST, V20, P1085, DOI 10.1002/yea.1025; Allosio-Ouarnier N, 2000, J I BREWING, V106, P45, DOI 10.1002/j.2050-0416.2000.tb00039.x; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blandin G, 2000, FEBS LETT, V487, P31, DOI 10.1016/S0014-5793(00)02275-4; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; Brondijk THC, 1998, J BIOL CHEM, V273, P15352, DOI 10.1074/jbc.273.25.15352; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Brown CJ, 1998, MOL BIOL EVOL, V15, P931, DOI 10.1093/oxfordjournals.molbev.a026009; BRUNELLI JP, 1993, YEAST, V9, P1299, DOI 10.1002/yea.320091203; Byrne KP, 2006, NUCLEIC ACIDS RES, V34, pD452, DOI 10.1093/nar/gkj041; CARLSON M, 1983, MOL CELL BIOL, V3, P351, DOI 10.1128/MCB.3.3.351; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CHANG YS, 1988, CURR GENET, V14, P201, DOI 10.1007/BF00376740; CHARRON MJ, 1989, GENETICS, V122, P307; CHENG Q, 1991, J BACTERIOL, V173, P1817, DOI 10.1128/jb.173.5.1817-1820.1991; Codon AC, 1998, APPL MICROBIOL BIOT, V49, P154, DOI 10.1007/s002530051152; DALE CJ, 1991, J I BREWING, V97, P187, DOI 10.1002/j.2050-0416.1991.tb01065.x; Day RE, 2002, YEAST, V19, P1015, DOI 10.1002/yea.894; Despons L, 2006, TRENDS GENET, V22, P10, DOI 10.1016/j.tig.2005.10.001; DUBIN RA, 1985, J BACTERIOL, V164, P605, DOI 10.1128/JB.164.2.605-610.1985; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gibson AW, 1997, GENETICS, V146, P1287; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Greatrix BW, 2006, CURR GENET, V49, P205, DOI 10.1007/s00294-005-0046-x; HAN EK, 1995, MOL MICROBIOL, V17, P1093, DOI 10.1111/j.1365-2958.1995.mmi_17061093.x; HAWTHORNE D. C., 1958, Heredity, V12, P273, DOI 10.1038/hdy.1958.29; He S, 2009, FEBS J, V276, P5432, DOI 10.1111/j.1742-4658.2009.07227.x; HOLZER H, 1989, RBC-CELL BIOL REV, V21, P305; HU Z, 1995, CURR GENET, V28, P258, DOI 10.1007/BF00309785; Hu Z, 1999, CURR GENET, V36, P1, DOI 10.1007/s002940050466; Hu Z, 2000, GENETICS, V154, P121; HUTSON DH, 1965, BIOCHEM J, V94, P783, DOI 10.1042/bj0940783; Jiang H, 2000, J BACTERIOL, V182, P647, DOI 10.1128/JB.182.3.647-654.2000; Jules M, 2004, APPL ENVIRON MICROB, V70, P2771, DOI 10.1128/AEM.70.5.2771-2778.2004; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KHAN NA, 1967, BIOCHIM BIOPHYS ACTA, V146, P173, DOI 10.1016/0005-2744(67)90084-8; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; Lucero Pilar, 2002, FEMS Yeast Research, V1, P307, DOI 10.1016/S1567-1356(01)00045-9; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Luo ZL, 2009, MICROBIOL-SGM, V155, P4036, DOI 10.1099/mic.0.030726-0; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; McCarter JD, 1996, J BIOL CHEM, V271, P6889, DOI 10.1074/jbc.271.12.6889; Medintz I, 1996, J BACTERIOL, V178, P2245, DOI 10.1128/jb.178.8.2245-2254.1996; Naumoff DG, 2010, DOKL BIOCHEM BIOPHYS, V432, P114, DOI 10.1134/S1607672910030051; NAUMOV GI, 1985, DOKLADY AKAD NAUKS S, V279, P1496; NEEDLEMAN R, 1991, MOL MICROBIOL, V5, P2079, DOI 10.1111/j.1365-2958.1991.tb02136.x; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9; Rintala E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-53; SIRENKO OI, 1995, CURR GENET, V27, P509, DOI 10.1007/BF00314440; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; TAMAKI H, 1978, MOL GEN GENET, V164, P205, DOI 10.1007/BF00267385; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; TENBERGE AM, 1972, MOL GEN GENET, V115, P80, DOI 10.1007/BF00272220; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Vidgren V, 2005, APPL ENVIRON MICROB, V71, P7846, DOI 10.1128/AEM.71.12.7846-7857.2005; WACH A, 1994, YEAST, V10, P1808; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Yamamoto K, 2004, EUR J BIOCHEM, V271, P3414, DOI 10.1111/j.1432-1033.2004.04276.x; Zaragoza O, 2001, BIOCHEM J, V359, P193, DOI 10.1042/0264-6021:3590193	67	42	54	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26815	26824		10.1074/jbc.M110.145946	http://dx.doi.org/10.1074/jbc.M110.145946			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562106	Green Published, hybrid			2022-12-25	WOS:000281172700012
J	Hawkins, BJ; Levin, MD; Doonan, PJ; Petrenko, NB; Davis, CW; Patel, VV; Madesh, M				Hawkins, Brian J.; Levin, Mark D.; Doonan, Patrick J.; Petrenko, Nataliya B.; Davis, Christiana W.; Patel, Vickas V.; Madesh, Muniswamy			Mitochondrial Complex II Prevents Hypoxic but Not Calcium- and Proapoptotic Bcl-2 Protein-induced Mitochondrial Membrane Potential Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY OPTIC NEUROPATHY; CYTOCHROME-C; RESPIRATORY-CHAIN; CELL-DEATH; SUCCINATE-DEHYDROGENASE; INNER MEMBRANE; CAROTID-BODY; APOPTOSIS; OXYGEN; SUPEROXIDE	Mitochondrial membrane potential loss has severe bioenergetic consequences and contributes to many human diseases including myocardial infarction, stroke, cancer, and neurodegeneration. However, despite its prominence and importance in cellular energy production, the basic mechanism whereby the mitochondrial membrane potential is established remains unclear. Our studies elucidate that complex II-driven electron flow is the primary means by which the mitochondrial membrane is polarized under hypoxic conditions and that lack of the complex II substrate succinate resulted in reversible membrane potential loss that could be restored rapidly by succinate supplementation. Inhibition of mitochondrial complex I and F0F1-ATP synthase induced mitochondrial depolarization that was independent of the mitochondrial permeability transition pore, Bcl-2 (B-cell lymphoma 2) family proteins, or high amplitude swelling and could not be reversed by succinate. Importantly, succinate metabolism under hypoxic conditions restores membrane potential and ATP levels. Furthermore, a reliance on complex II-mediated electron flow allows cells from mitochondrial disease patients devoid of a functional complex I to maintain a mitochondrial membrane potential that conveys both a mitochondrial structure and the ability to sequester agonist-induced calcium similar to that of normal cells. This finding is important as it sets the stage for complex II functional preservation as an attractive therapy to maintain mitochondrial function during hypoxia.	[Hawkins, Brian J.; Doonan, Patrick J.; Madesh, Muniswamy] Temple Univ, Dept Biochem, Philadelphia, PA 19140 USA; [Levin, Mark D.; Petrenko, Nataliya B.; Patel, Vickas V.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Davis, Christiana W.] Univ Penn, Inst Environm Med, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; University of Pennsylvania	Hawkins, BJ (corresponding author), 815 Mercer St,Rm N 134 SLU, Seattle, WA 98108 USA.	bhawkins@u.washington.edu; madeshm@temple.edu	Levin, Mark David/AAE-1013-2021	Levin, Mark David/0000-0002-2241-9828	American Heart Association [0530087N]; National Institutes of Health [HL086699, 1S10RR022511, HL074108, K99HL094536]; Pennsylvania Department of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022511] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086699, K08HL074108, K99HL094536, R00HL094536] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 0530087N, National Institutes of Health Grants HL086699 and 1S10RR022511 and Pennsylvania Department of Health (to M. M.) and National Institutes of Health Grant HL074108 (to V. V. P.).; Supported by National Institutes of Health Grant K99HL094536. To whom correspondence may be addressed: 815 Mercer St., Rm. N-134 SLU, Seattle, WA 98108. Tel.: 206-543-6140; E-mail: bhawkins@u.washington.edu.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bernardi P., 2007, V45, P481; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; CAPALDI RA, 1982, BIOCHIM BIOPHYS ACTA, V694, P291, DOI 10.1016/0304-4157(82)90009-0; Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; Csordas G, 2002, EMBO J, V21, P2198, DOI 10.1093/emboj/21.9.2198; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DUCHEN MR, 1992, J PHYSIOL-LONDON, V450, P33, DOI 10.1113/jphysiol.1992.sp019115; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; HALESTRAP AP, 1982, BIOCHEM J, V204, P49, DOI 10.1042/bj2040049; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hawkins BJ, 2007, MOL CELL BIOL, V27, P7582, DOI 10.1128/MCB.00493-07; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; KAUPPINEN RA, 1986, J NEUROCHEM, V47, P1864, DOI 10.1111/j.1471-4159.1986.tb13100.x; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; King T.E., 1967, METHOD ENZYMOL, V10, P275, DOI DOI 10.1016/0076-6879(67)10055-4; Kis B, 2003, J NEUROCHEM, V87, P969, DOI 10.1046/j.1471-4159.2003.02072.x; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lahiri S, 2006, PROG BIOPHYS MOL BIO, V91, P249, DOI 10.1016/j.pbiomolbio.2005.07.001; Lenaz G, 2007, AM J PHYSIOL-CELL PH, V292, pC1221, DOI 10.1152/ajpcell.00263.2006; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754; Maklashina E, 2004, FEBS LETT, V556, P64, DOI 10.1016/S0014-5793(03)01369-3; Milovanova T, 2006, AM J PHYSIOL-CELL PH, V290, pC66, DOI 10.1152/ajpcell.00094.2005; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITRA R, 1985, AM J PHYSIOL, V249, P1056, DOI 10.1152/ajpheart.1985.249.5.H1056; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Piantadosi CA, 2008, J BIOL CHEM, V283, P10967, DOI 10.1074/jbc.M709741200; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Saulle E, 2004, MOL CELL NEUROSCI, V25, P9, DOI 10.1016/j.mcn.2003.09.013; Storz P., 2006, SCI STKE, V2006, pre3, DOI DOI 10.1126/STKE.3322006RE3; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wyatt CN, 2004, J PHYSIOL-LONDON, V556, P175, DOI 10.1113/jphysiol.2003.058131; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	57	30	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26494	26505		10.1074/jbc.M110.143164	http://dx.doi.org/10.1074/jbc.M110.143164			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566649	Green Published, hybrid			2022-12-25	WOS:000280921000067
J	Jincho, Y; Araki, R; Hoki, Y; Tamura, C; Nakamura, M; Ando, S; Kasama, Y; Abe, M				Jincho, Yuko; Araki, Ryoko; Hoki, Yuko; Tamura, Chihiro; Nakamura, Miki; Ando, Shunsuke; Kasama, Yasuji; Abe, Masumi			Generation of Genome Integration-free Induced Pluripotent Stem Cells from Fibroblasts of C57BL/6 Mice without c-Myc Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE; INDUCTION	Although the induction of genome integration-free induced pluripotent stem cells (iPSCs) has been reported, c-Myc was still required for the efficient generation of these cells. Herein, we report mouse strain-dependent differences in the c-Myc dependence for iPSC generation and the successful generation of genome integration-free iPSCs without c-Myc transduction using C57BL/6 mouse embryonic fibroblasts. We performed 49 independent experiments and obtained a total of 24 iPSC clones, including 18 genome integration-free iPSC clones. These iPSCs were indistinguishable from embryonic stem cells and from iPSCs generated using other methods. Furthermore, the generation of three-factor iPSCs free of virus vectors revealed the contribution of c-Myc to the genomic integration of external genes. C57BL/6 is an inbred mouse strain with substantial advantages for use in genetic and molecular biological studies due to its use in the whole mouse genome sequencing project. Thus, the present series of C57BL/6 iPSCs generated by various procedures will serve as a valuable resource for future genetic studies of iPSC generation.	[Jincho, Yuko; Araki, Ryoko; Hoki, Yuko; Tamura, Chihiro; Nakamura, Miki; Ando, Shunsuke; Kasama, Yasuji; Abe, Masumi] Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 2638555, Japan; [Araki, Ryoko; Nakamura, Miki] Japan Sci & Technol Agcy, PRESTO, Tokyo 1020075, Japan	National Institutes for Quantum Science & Technology; Japan Science & Technology Agency (JST)	Abe, M (corresponding author), Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 2638555, Japan.	abemasum@nirs.go.jp		Abe, Masumi/0000-0003-1550-2006	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST)	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by a research grant from Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST).	Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STEVENS LC, 1974, DEV BIOL, V37, P369, DOI 10.1016/0012-1606(74)90155-9; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	25	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26384	26389		10.1074/jbc.M110.115915	http://dx.doi.org/10.1074/jbc.M110.115915			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554535	hybrid, Green Published			2022-12-25	WOS:000280921000057
J	Malivert, L; Ropars, V; Nunez, M; Drevet, P; Miron, S; Faure, G; Guerois, R; Mornon, JP; Revy, P; Charbonnier, JB; Callebaut, I; de Villartay, JP				Malivert, Laurent; Ropars, Virginie; Nunez, Marcela; Drevet, Pascal; Miron, Simona; Faure, Guilhem; Guerois, Raphael; Mornon, Jean-Paul; Revy, Patrick; Charbonnier, Jean-Baptiste; Callebaut, Isabelle; de Villartay, Jean-Pierre			Delineation of the Xrcc4-interacting Region in the Globular Head Domain of Cernunnos/XLF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; DNA-LIGASE-IV; END-JOINING FACTOR; CRYSTAL-STRUCTURE; HUMAN XLF; REPAIR PROTEIN; XRCC4; COMPLEX; XLF/CERNUNNOS; RECOMBINATION	In mammals, the majority of DNA double-strand breaks are processed by the nonhomologous end-joining (NHEJ) pathway, composed of seven factors: Ku70, Ku80, DNA-PKcs, Artemis, Xrcc4 (X4), DNA-ligase IV (L4), and Cernunnos/XLF. Cernunnos is part of the ligation complex, constituted by X4 and L4. To improve our knowledge on the structure and function of Cernunnos, we performed a systematic mutagenesis study on positions selected from an analysis of the recent three-dimensional structures of this factor. Ten of 27 screened mutants were nonfunctional in several DNA repair assays. Outside amino acids critical for the expression and stability of Cernunnos, we identified three amino acids (Arg(64), Leu(65), and Leu(115)) essential for the interaction with X4 and the proper function of Cernunnos. Docking the crystal structures of the two factors further validated this probable interaction surface of Cernunnos with X4.	[Revy, Patrick; de Villartay, Jean-Pierre] Hop Necker Enfants Malad, INSERM, U768, Unite Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France; [Ropars, Virginie; Nunez, Marcela; Drevet, Pascal; Faure, Guilhem; Guerois, Raphael; Charbonnier, Jean-Baptiste] CEA, Inst Biol & Technol Saclay, CNRS, Unites Rech Associees 2096,Lab Biol Struct & Radi, F-91191 Gif Sur Yvette, France; [Miron, Simona] Inst Curie, INSERM 759, Integrat Imaging Unit, F-91405 Orsay, France; [Mornon, Jean-Paul; Callebaut, Isabelle] Univ Paris 06, CNRS, UMR7590, Dept Biol Struct,IMPMC, F-75005 Paris, France; [Mornon, Jean-Paul; Callebaut, Isabelle] Univ Paris 07, F-75005 Paris, France; [Revy, Patrick; de Villartay, Jean-Pierre] Univ Paris 05, Fac Med Rene Descartes, F-75005 Paris, France; [de Villartay, Jean-Pierre] Hop Necker Enfants Malad, AP HP, Unite Immunol & Hematol, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	de Villartay, JP (corresponding author), Hop Necker Enfants Malad, INSERM, U768, Unite Dev Normal & Pathol Syst Immunitaire, 149 Rue Sevres, F-75015 Paris, France.	jean-pierre.de-villartay@inserm.fr	Revy, Patrick/H-8137-2017; de Villartay, jean pierre/H-9353-2017; Charbonnier, Jean-Baptiste/A-3868-2009; Miron, Simona/M-9223-2018; , raph/AAF-4380-2019	de Villartay, jean pierre/0000-0001-5987-0463; Charbonnier, Jean-Baptiste/0000-0002-5219-1983; Revy, Patrick/0000-0003-0758-8022; Ropars, Virginie/0000-0002-3372-6030; Malivert, Laurent/0000-0002-0944-6573; Faure, Guilhem/0000-0001-9537-2277	INSERM; Ligue National contre le Cancer (Equipe labellisee LA LIGUE); Institut National du Cancer a/Canceropole Ile-de-France; Agence Nationale pour la Recherche [ANR'06]; Commissariat a l'Energie Atomique [LRC-CEA 40V]; Association pour la Recherche sur le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue National contre le Cancer (Equipe labellisee LA LIGUE); Institut National du Cancer a/Canceropole Ile-de-France; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by institutional grants from INSERM as well as grants from the Ligue National contre le Cancer (Equipe labellisee LA LIGUE), the Institut National du Cancer a/Canceropole Ile-de-France, Agence Nationale pour la Recherche (ANR'06), and Commissariat a l'Energie Atomique (LRC-CEA 40V).; Supported by the Association pour la Recherche sur le Cancer and by ANR'06.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Braud S, 2005, J PROTEOME RES, V4, P2137, DOI 10.1021/pr050230i; Bryans M, 1999, MUTAT RES-DNA REPAIR, V433, P53, DOI 10.1016/S0921-8777(98)00063-9; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Callebaut I, 2006, J BIOL CHEM, V281, P13857, DOI 10.1074/jbc.C500473200; de Villartay JP, 2003, NAT REV IMMUNOL, V3, P962, DOI 10.1038/nri1247; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deshpande RA, 2007, DNA REPAIR, V6, P1507, DOI 10.1016/j.dnarep.2007.04.014; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hentges P, 2006, J BIOL CHEM, V281, P37517, DOI 10.1074/jbc.M608727200; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Li Y, 2008, EMBO J, V27, P290, DOI 10.1038/sj.emboj.7601942; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Malivert L, 2009, MOL CELL BIOL, V29, P1116, DOI 10.1128/MCB.01521-08; Modesti M, 2003, J MOL BIOL, V334, P215, DOI 10.1016/j.jmb.2003.09.031; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Recuero-Checa MA, 2009, DNA REPAIR, V8, P1380, DOI 10.1016/j.dnarep.2009.09.007; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Todd MJ, 2000, BIOCHEMISTRY-US, V39, P11876, DOI 10.1021/bi001013s; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137	29	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26475	26483		10.1074/jbc.M110.138156	http://dx.doi.org/10.1074/jbc.M110.138156			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558749	hybrid, Green Published			2022-12-25	WOS:000280921000065
J	Hwang, DS; Zeng, HB; Masic, A; Harrington, MJ; Israelachvili, JN; Waite, JH				Hwang, Dong Soo; Zeng, Hongbo; Masic, Admir; Harrington, Matthew J.; Israelachvili, Jacob N.; Waite, J. Herbert			Protein- and Metal-dependent Interactions of a Prominent Protein in Mussel Adhesive Plaques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; NUCLEAR-MAGNETIC-RESONANCE; MYTILUS-EDULIS; CROSS-LINKING; BYSSAL THREADS; FOOT PROTEINS; BLUE MUSSEL; SURFACES; DOPA; CALIFORNIANUS	The adhesive plaques of Mytilus byssus are investigated increasingly to determine the molecular requirements for wet adhesion. Mfp-2 is the most abundant protein in the plaques, but little is known about its function. Analysis of Mfp-2 films using the surface forces apparatus detected no interaction between films or between a film and bare mica; however, addition of Ca2+ and Fe3+ induced significant reversible bridging (work of adhesion W-ad approximate to 0.3 mJ/m(2) to 2.2 mJ/m(2)) between two films at 0.35 M salinity. The strongest observed Fe3+-mediated bridging approaches the adhesion of oriented avidin-biotin complexes. Raman microscopy of plaque sections supports the co-localization of Mfp-2 and iron, which interact by forming bis- or tris-DOPA-iron complexes. Mfp-2 adhered strongly to Mfp-5, a DOPA-rich interfacial adhesive protein, but not to another interfacial protein, Mfp-3, which may in fact displace Mfp-2 from mica. In the presence of metal ions or Mfp-5, Mfp-2 adhesion was fully reversible. These results suggest that plaque cohesiveness depends on Mfp-2 complexation of metal ions, particularly Fe3+ and also by Mfp-2 interaction with Mfp-5 at the plaque-substratum interface.	[Waite, J. Herbert] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; [Zeng, Hongbo] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada; [Masic, Admir; Harrington, Matthew J.] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany; [Israelachvili, Jacob N.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Alberta; Max Planck Society; University of California System; University of California Santa Barbara	Waite, JH (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	waite@lifesci.ucsb.edu	Hwang, Dong Soo/C-7291-2011; Zeng, Hongbo/C-8491-2011	Hwang, Dong Soo/0000-0002-2487-2255; Zeng, Hongbo/0000-0002-1432-5979; Masic, Admir/0000-0002-1207-4926	National Institutes of Health [R01 DE018468]; National Science Foundation Materials Research Science and Engineering Center [DMR05-20415]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Materials Research Science and Engineering Center(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health Grant R01 DE018468 and National Science Foundation Materials Research Science and Engineering Center Grant DMR05-20415.	Anderson KE, 2000, J EXP BIOL, V203, P3065; [Anonymous], 1992, INTERMOLECULAR SURFA; AVDEEF A, 1978, J AM CHEM SOC, V100, P5362, DOI 10.1021/ja00485a018; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g; DEYOUNG MB, 1987, ARCH BIOCHEM BIOPHYS, V254, P222, DOI 10.1016/0003-9861(87)90098-1; Fant C, 2002, BIOMACROMOLECULES, V3, P732, DOI 10.1021/bm025506j; Harrington MJ, 2007, J EXP BIOL, V210, P4307, DOI 10.1242/jeb.009753; Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044; HELM CA, 1991, P NATL ACAD SCI USA, V88, P8169, DOI 10.1073/pnas.88.18.8169; Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012; INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698; ISRAELACHVILI J, 1987, P NATL ACAD SCI USA, V84, P4722, DOI 10.1073/pnas.84.14.4722; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; ISRAELACHVILI JN, 1990, J MATER RES, V5, P2223, DOI 10.1557/JMR.1990.2223; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; KOHDA D, 1992, BIOCHEMISTRY-US, V31, P11928, DOI 10.1021/bi00162a036; Lee BP, 2006, MACROMOLECULES, V39, P1740, DOI 10.1021/ma0518959; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; NJUS D, 1978, BIOCHEMISTRY-US, V17, P4337, DOI 10.1021/bi00613a035; PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183; Rand MD, 1997, PROTEIN SCI, V6, P2059; Robinson MW, 2001, PARASITOLOGY, V123, P509, DOI 10.1017/S0031182001008630; RZEPECKI LM, 1992, BIOL BULL, V183, P123, DOI 10.2307/1542413; Sagert J, 2009, J EXP BIOL, V212, P2224, DOI 10.1242/jeb.029686; Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759; Suci PA, 2001, COLLOID SURFACE B, V22, P159, DOI 10.1016/S0927-7765(01)00149-7; Sun CJ, 2005, J BIOL CHEM, V280, P39332, DOI 10.1074/jbc.M508674200; Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s; Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3; Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602; WAITE JH, 1995, METHOD ENZYMOL, V258, P1; Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x; Wang JJ, 2008, ADV MATER, V20, P3872, DOI 10.1002/adma.200801140; Westwood G, 2007, MACROMOLECULES, V40, P3960, DOI 10.1021/ma0703002; Zeng HB, 2010, P NATL ACAD SCI USA, V107, P12850, DOI 10.1073/pnas.1007416107; Zhao H, 2006, J BIOL CHEM, V281, P11090, DOI 10.1074/jbc.M510792200; Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200	40	182	187	7	113	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25850	25858		10.1074/jbc.M110.133157	http://dx.doi.org/10.1074/jbc.M110.133157			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20566644	Green Published, hybrid			2022-12-25	WOS:000280682400077
J	Okamoto, S; Van Petegem, F; Patrauchan, MA; Eltis, LD				Okamoto, Sachi; Van Petegem, Filip; Patrauchan, Marianna A.; Eltis, Lindsay D.			AnhE, a Metallochaperone Involved in the Maturation of a Cobalt-dependent Nitrile Hydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-BINDING; ESCHERICHIA-COLI; CARBONIC-ANHYDRASE; RHODOCOCCUS-ERYTHROPOLIS; CYSTEINE RESIDUES; CRYSTAL-STRUCTURE; PROTEIN; IRON; INSIGHTS; ISCA	Acetonitrile hydratase (ANHase) of Rhodococcus jostii RHA1 is a cobalt-containing enzyme with no significant sequence identity with characterized nitrile hydratases. The ANHase structural genes anhA and anhB are separated by anhE, predicted to encode an 11.1-kDa polypeptide. An anhE deletion mutant did not grow on acetonitrile but grew on acetamide, the ANHase reaction product. Growth on acetonitrile was restored by providing anhE in trans. AnhA could be used to assemble ANHase in vitro, provided the growth medium was supplemented with 50 mu M CoCl2. Ten- to 100-fold less CoCl2 sufficed when anhE was co-expressed with anhA. Moreover, AnhA contained more cobalt when produced in cells containing AnhE. Chromatographic analyses revealed that AnhE existed as a monomer-dimer equilibrium (100 mM phosphate, pH 7.0, 25 degrees C). Divalent metal ions including Co2+, Cu2+, Zn2+, and Ni2+ stabilized the dimer. Isothermal titration calorimetry studies demonstrated that AnhE binds two half-equivalents of Co2+ with K-d of 0.12 +/- 0.06 nM and 110 +/- 35 nM, respectively. By contrast, AnhE bound only one half-equivalent of Zn2+ (K-d = 11 +/- 2 nM) and Ni2+ (K-d = 49 +/- 17 nM) and did not detectably bind Cu2+. Substitution of the sole histidine residue did not affect Co2+ binding. Holo-AnhE had a weak absorption band at 490 nm (epsilon = 9.7 +/- 0.1 M-1 cm(-1)), consistent with hexacoordinate cobalt. The data support a model in which AnhE acts as a dimeric metallochaperone to deliver cobalt to ANHase. This study provides insight into the maturation of NHases and metallochaperone function.	Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Van Petegem, Filip; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca	Eltis, Lindsay D/J-8272-2015; Van Petegem, Filip/M-6061-2016	Eltis, Lindsay D/0000-0002-6774-8158; Van Petegem, Filip/0000-0003-2728-8537	Genome Canada; Natural Sciences and Engineering Research Council (NSERC) of Canada	Genome Canada(Genome Canada); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from Genome Canada and a Discovery grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (to L.D.E.).	Adrait A, 1999, BIOCHEMISTRY-US, V38, P6248, DOI 10.1021/bi9823232; Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; BERTINI I, 1982, STRUCT BOND, V48, P45; Bilder PW, 2004, BIOCHEMISTRY-US, V43, P133, DOI 10.1021/bi035440s; Brennan BA, 1996, BIOCHEMISTRY-US, V35, P10068, DOI 10.1021/bi960163t; Colpas GJ, 1998, J BIOL INORG CHEM, V3, P150, DOI 10.1007/s007750050216; Colpas GJ, 1999, BIOCHEMISTRY-US, V38, P4078, DOI 10.1021/bi982435t; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; DEBUSSCHE L, 1992, J BACTERIOL, V174, P7445, DOI 10.1128/jb.174.22.7445-7451.1992; Ding HG, 2005, J BIOL CHEM, V280, P30432, DOI 10.1074/jbc.M504638200; DiTusa CA, 2001, BIOCHEMISTRY-US, V40, P5338, DOI 10.1021/bi001731e; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gray HB, 2003, P NATL ACAD SCI USA, V100, P3563, DOI 10.1073/pnas.0730378100; Hashimoto K, 2008, J BIOL CHEM, V283, P36617, DOI 10.1074/jbc.M806577200; Hashimoto Y, 2002, J INORG BIOCHEM, V91, P70, DOI 10.1016/S0162-0134(02)00373-2; Kalscheuer R, 1999, APPL MICROBIOL BIOT, V52, P508, DOI 10.1007/s002530051553; Komeda H, 1997, P NATL ACAD SCI USA, V94, P36, DOI 10.1073/pnas.94.1.36; Kovacs JA, 2004, CHEM REV, V104, P825, DOI 10.1021/cr020619e; Leach MR, 2005, BIOCHEMISTRY-US, V44, P12229, DOI 10.1021/bi050993j; Lu J, 2003, FEBS LETT, V553, P391, DOI 10.1016/S0014-5793(03)01070-6; MARCUS Y, 1994, J SOLUTION CHEM, V23, P831, DOI 10.1007/BF00972677; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Miura T, 1998, BBA-PROTEIN STRUCT M, V1384, P171, DOI 10.1016/S0167-4838(98)00015-6; NAGASAWA T, 1991, EUR J BIOCHEM, V196, P581, DOI 10.1111/j.1432-1033.1991.tb15853.x; Nakashima N, 2004, APPL ENVIRON MICROB, V70, P5557, DOI 10.1128/AEM.70.9.5557-5568.2004; Okamoto S, 2007, MOL MICROBIOL, V65, P828, DOI 10.1111/j.1365-2958.2007.05834.x; Payne MS, 1997, BIOCHEMISTRY-US, V36, P5447, DOI 10.1021/bi962794t; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shearer J, 2001, J AM CHEM SOC, V123, P463, DOI 10.1021/ja002642s; TU CK, 1985, BIOCHEMISTRY-US, V24, P5881, DOI 10.1021/bi00342a029; van der Geize R, 2001, FEMS MICROBIOL LETT, V205, P197, DOI 10.1016/S0378-1097(01)00464-5; Zambelli B, 2008, J MOL BIOL, V383, P1129, DOI 10.1016/j.jmb.2008.08.066; Zhou ZM, 2009, J BIOL CHEM, V284, P14930, DOI 10.1074/jbc.M808464200; Zhou Z, 2008, P NATL ACAD SCI USA, V105, P14849, DOI 10.1073/pnas.0803428105	41	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25126	25133		10.1074/jbc.M110.109223	http://dx.doi.org/10.1074/jbc.M110.109223			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558748	Green Published, hybrid			2022-12-25	WOS:000280682400004
J	Kang, YB; Chen, BJ; DeOliveira, D; Mito, J; Chao, NJ				Kang, Yubin; Chen, Benny J.; DeOliveira, Divino; Mito, Jeffrey; Chao, Nelson J.			Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; STEM-CELLS; BONE-MARROW; PROGENITOR CELLS; REPOPULATING CAPACITY; RAPID MOBILIZATION; NOD/SCID MICE; CD34(+) CELLS; G-CSF; PHARMACOKINETICS	The interaction between stromal cell-derived factor-1 (SDF-1) with CXCR4 chemokine receptors plays an important role in hematopoiesis following hematopoietic stem cell transplantation. We examined the efficacy of post transplant administration of a specific CXCR4 antagonist (AMD3100) in improving animal survival and in enhancing donor hematopoietic cell engraftment using a congeneic mouse transplantation model. AMD3100 was administered subcutaneously at 5 mg/kg body weight 3 times a week beginning at day +2 post-transplant. Post-transplant administration of AMD3100 significantly improves animal survival. AMD3100 reduces pro-inflammatory cytokine/chemokine production. Furthermore, post transplant administration of AMD3100 selectively enhances donor cell engraftment and promotes recovery of all donor cell lineages (myeloid cells, T and B lymphocytes, erythrocytes and platelets). This enhancement results from a combined effect of increased marrow niche availability and greater cell division induced by AMD3100. Our studies shed new lights into the biological roles of SDF-1/CXCR4 interaction in hematopoietic stem cell engraftment following transplantation and in transplant-related mortality. Our results indicate that AMD3100 provides a novel approach for enhancing hematological recovery following transplantation, and will likely benefit patients undergoing transplantation.	[Kang, Yubin] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA; [Kang, Yubin] Duke Univ, Med Ctr, Dept Med, Div Oncol, Durham, NC 27710 USA; [Kang, Yubin] Duke Univ, Med Ctr, Dept Med, Div Cellular Therapy, Durham, NC 27710 USA; [Chen, Benny J.; DeOliveira, Divino; Mito, Jeffrey; Chao, Nelson J.] Duke Univ, Med Ctr, Dept Med, Div Cellular Therapy Adult Bone Marrow Transplant, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Kang, YB (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA.	chao0002@mc.duke.edu			National Institutes of Health (NIH) [1U19 AI067798-01]; Genzyme Corp; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Corp(Sanofi-AventisGenzyme Corporation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by National Institutes of Health (NIH) grant 1U19 AI067798-01 (PI: NJC) and a research grant from Genzyme Corp (PI: NJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham M, 2009, LEUKEMIA, V23, P1378, DOI 10.1038/leu.2009.56; Battiwalla M, 2009, BONE MARROW TRANSPL, V43, P351, DOI 10.1038/bmt.2008.443; Beutler B, 2005, IMMUNOGENETICS, V57, P385, DOI 10.1007/s00251-005-0011-3; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Broxmeyer HE, 2007, ANN NY ACAD SCI, V1106, P1, DOI 10.1196/annals.1392.013; Calandra G, 2008, BONE MARROW TRANSPL, V41, P331, DOI 10.1038/sj.bmt.1705908; Cashman J, 2002, J EXP MED, V196, P1141, DOI 10.1084/jem.20010916; Cashman J, 2002, BLOOD, V99, P792, DOI 10.1182/blood.V99.3.792; CHEN B, 2010, PLOS ONE IN PRESS; Chen BJ, 2004, BLOOD, V103, P4344, DOI 10.1182/blood-2003-07-2534; Chen BJ, 2002, BLOOD, V99, P364, DOI 10.1182/blood.V99.1.364; Chen J, 2006, BLOOD, V107, P3764, DOI 10.1182/blood-2005-09-3593; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; De Klerck B, 2005, ARTHRITIS RES THER, V7, pR1208, DOI 10.1186/ar1806; Dekker A, 2006, J CLIN ONCOL, V24, P5207, DOI 10.1200/JCO.2006.06.1663; Devine SM, 2004, J CLIN ONCOL, V22, P1095, DOI 10.1200/JCO.2004.07.131; Devine SM, 2008, BLOOD, V112, P990, DOI 10.1182/blood-2007-12-130179; DiPersio JF, 2009, BLOOD, V113, P5720, DOI 10.1182/blood-2008-08-174946; DOMINICI M, 2009, BLOOD; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; Genzyme, 2009, PLER INJ INV BROCH V; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; KANG Y, 2009, HEMATOPOIETIC STEM C, P181; Kang YB, 2008, CURR OPIN HEMATOL, V15, P561, DOI 10.1097/MOH.0b013e32831366eb; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Larochelle A, 2006, BLOOD, V107, P3772, DOI 10.1182/blood-2005-09-3592; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Plett PA, 2002, EXP HEMATOL, V30, P1061, DOI 10.1016/S0301-472X(02)00880-9; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Slayton WB, 2007, STEM CELLS, V25, P2945, DOI 10.1634/stemcells.2007-0158; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; Verfaillie CM, 2002, J CLIN INVEST, V110, P303, DOI 10.1172/JCI200216376; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/nmeth.1309, 10.1038/NMETH.1309]; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC; Xu JG, 2008, J HEART LUNG TRANSPL, V27, P1302, DOI 10.1016/j.healun.2008.08.010; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhong JF, 2002, BLOOD, V100, P3521, DOI 10.1182/blood-2002-04-1256	53	37	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11316	10.1371/journal.pone.0011316	http://dx.doi.org/10.1371/journal.pone.0011316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596257	Green Published, Green Submitted, gold			2022-12-25	WOS:000279259900003
J	Yuan, J; Xu, BZ; Qi, ST; Tong, JS; Wei, LA; Li, M; Ouyang, YC; Hou, Y; Schatten, H; Sun, QY				Yuan, Ju; Xu, Bao-Zeng; Qi, Shu-Tao; Tong, Jing-Shan; Wei, Liang; Li, Mo; Ouyang, Ying-Chun; Hou, Yi; Schatten, Heide; Sun, Qing-Yuan			MAPK-Activated Protein Kinase 2 Is Required for Mouse Meiotic Spindle Assembly and Kinetochore-Microtubule Attachment	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; POLO-LIKE KINASE-1; AURORA-B; MITOTIC SPINDLE; CHROMOSOME SEGREGATION; SISTER CHROMATIDS; MAMMALIAN OOCYTES; MEIOSIS-I; MATURATION; P38	MAPK-activated protein kinase 2 (MK2), a direct substrate of p38 MAPK, plays key roles in multiple physiological functions in mitosis. Here, we show for the first time the unique distribution pattern of MK2 in meiosis. Phospho-MK2 was localized on bipolar spindle minus ends and along the interstitial axes of homologous chromosomes extending over centromere regions and arm regions at metaphase of first meiosis (MI stage) in mouse oocytes. At metaphase of second meiosis (MII stage), p-MK2 was localized on the bipolar spindle minus ends and at the inner centromere region of sister chromatids as dots. Knockdown or inhibition of MK2 resulted in spindle defects. Spindles were surrounded by irregular nondisjunction chromosomes, which were arranged in an amphitelic or syntelic/monotelic manner, or chromosomes detached from the spindles. Kinetochore-microtubule attachments were impaired in MK2-deficient oocytes because spindle microtubules became unstable in response to cold treatment. In addition, homologous chromosome segregation and meiosis progression were inhibited in these oocytes. Our data suggest that MK2 may be essential for functional meiotic bipolar spindle formation, chromosome segregation and proper kinetochore-microtubule attachments.	[Yuan, Ju; Xu, Bao-Zeng; Qi, Shu-Tao; Tong, Jing-Shan; Wei, Liang; Li, Mo; Ouyang, Ying-Chun; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Missouri System; University of Missouri Columbia	Yuan, J (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	Wei, Liang/U-4349-2017	Qi, Shutao/0000-0002-4073-1161; Tong, Jingshan/0000-0003-1640-5769	National Natural Science Foundation of China [30570944]; National Basic Research Program of China [2006CB504004, 2006CB944001]; Chinese Academy of Sciences (CAS) [KSCX2-YW-R-52]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	This work was sponsored by the National Natural Science Foundation of China (30570944), National Basic Research Program of China (2006CB504004, 2006CB944001), and Knowledge Innovation Program of the Chinese Academy of Sciences (CAS) (KSCX2-YW-R-52) to QYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; BENLEVY R, 1995, EMBO J, V14, P5920, DOI 10.1002/j.1460-2075.1995.tb00280.x; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Choi T, 1996, P NATL ACAD SCI USA, V93, P4730, DOI 10.1073/pnas.93.10.4730; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Davidson W, 2004, BIOCHEMISTRY-US, V43, P11658, DOI 10.1021/bi0495073; De La Fuente R, 2004, DEV BIOL, V272, P1, DOI 10.1016/j.ydbio.2003.12.012; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Fearns C, 2000, J LEUKOCYTE BIOL, V67, P705, DOI 10.1002/jlb.67.5.705; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Gorbsky GJ, 2001, CURR BIOL, V11, pR1001, DOI 10.1016/S0960-9822(01)00609-1; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; Holt JE, 2009, MOL HUM REPROD, V15, P139, DOI 10.1093/molehr/gap007; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Ishii S, 2008, P NATL ACAD SCI USA, V105, P4179, DOI 10.1073/pnas.0710140105; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kapoor TM, 2004, CURR BIOL, V14, pR1011, DOI 10.1016/j.cub.2004.11.026; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Lee J, 2006, CELL CYCLE, V5, P1448, DOI 10.4161/cc.5.13.2903; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Logarinho E, 2004, J CELL SCI, V117, P1757, DOI 10.1242/jcs.01033; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maia AF, 2007, CELL CYCLE, V6, P1367, DOI 10.4161/cc.6.11.4271; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Polanski Z, 1997, ZYGOTE, V5, P105, DOI 10.1017/S0967199400003774; POLANSKI Z, 1986, J REPROD FERTIL, V78, P103, DOI 10.1530/jrf.0.0780103; Revenkova E, 2005, REPRODUCTION, V130, P783, DOI 10.1530/rep.1.00864; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Sun QY, 1999, REPROD FERT DEVELOP, V11, P443, DOI 10.1071/RD00014; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tang J, 2008, ONCOGENE, V27, P6635, DOI 10.1038/onc.2008.262; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Tong C, 2002, BIOL REPROD, V67, P546, DOI 10.1095/biolreprod67.2.546; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Vician LJ, 2004, J NEUROSCI RES, V78, P315, DOI 10.1002/jnr.20251; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; WEISENBERG RC, 1976, NATURE, V263, P792, DOI 10.1038/263792a0; Xiong B, 2008, CELL CYCLE, V7, P1804, DOI 10.4161/cc.7.12.6019; Yang JW, 2007, REPRODUCTION, V134, P731, DOI 10.1530/REP-07-0149; Yao LJ, 2004, BIOL REPROD, V70, P1392, DOI 10.1095/biolreprod.103.025155; Yu LZ, 2007, CELL CYCLE, V6, P330, DOI 10.4161/cc.6.3.3805; Yuan J, 2009, CELL CYCLE, V8, P3384, DOI 10.4161/cc.8.20.9885	71	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11247	10.1371/journal.pone.0011247	http://dx.doi.org/10.1371/journal.pone.0011247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596525	gold, Green Submitted, Green Published			2022-12-25	WOS:000279259900002
J	Nougairede, A; Lagier, JC; Ninove, L; Sartor, C; Badiaga, S; Botelho, E; Brouqui, P; Zandotti, C; De Lamballerie, X; La Scola, B; Drancourt, M; Gould, EA; Charrel, RN; Raoult, D				Nougairede, Antoine; Lagier, Jean-Christophe; Ninove, Laetitia; Sartor, Catherine; Badiaga, Sekene; Botelho, Elizabeth; Brouqui, Philippe; Zandotti, Christine; De Lamballerie, Xavier; La Scola, Bernard; Drancourt, Michel; Gould, Ernest A.; Charrel, Remi N.; Raoult, Didier			Likely Correlation between Sources of Information and Acceptability of A/H1N1 Swine-Origin Influenza Virus Vaccine in Marseille, France	PLOS ONE			English	Article							HEALTH-CARE WORKERS; H5N1	Background: In France, there was a reluctance to accept vaccination against the A/H1N1 pandemic influenza virus despite government recommendation and investment in the vaccine programme. Methods and Findings: We examined the willingness of different populations to accept A/H1N1 vaccination (i) in a French hospital among 3315 employees immunized either by in-house medical personnel or mobile teams of MDs and (ii) in a shelter housing 250 homeless persons. Google was used to assess the volume of enquiries concerning incidence of influenza. We analyzed the information on vaccination provided by Google, the website of the major French newspapers, and PubMed. Two trust Surveys were used to assess public opinion on the trustworthiness of people in different professions. Paramedics were significantly more reluctant to accept immunisation than qualified medical staff. Acceptance was significantly increased when recommended directly by MDs. Anecdotal cases of directly observed severe infections were followed by enhanced acceptance of paramedical staff. Scientific literature was significantly more in favour of vaccination than Google and French newspaper websites. In the case of the newspaper websites, information correlated with their recognised political reputations, although they would presumably claim independence from political bias. The Trust Surveys showed that politicians were highly distrusted in contrast with doctors and pharmacists who were considered much more trustworthy. Conclusions: The low uptake of the vaccine could reflect failure to convey high quality medical information and advice relating to the benefits of being vaccinated. We believe that the media and internet contributed to this problem by raising concerns within the general population and that failure to involve GPs in the control programme may have been a mistake. GPs are highly regarded by the public and can provide face-to-face professional advice and information. The top-down strategy of vaccine programme management and information delivered by the Ministry of Health could have aggravated the problem, because the general population does not always trust politicians.	[Nougairede, Antoine; Ninove, Laetitia; Zandotti, Christine; De Lamballerie, Xavier; La Scola, Bernard; Drancourt, Michel; Charrel, Remi N.; Raoult, Didier] Hop Enfants La Timone, Assistance Publ Hop Marseille, Marseille, France; [Nougairede, Antoine; Ninove, Laetitia; De Lamballerie, Xavier; Gould, Ernest A.; Charrel, Remi N.] Univ Mediterranee, Inst Rech Dev, UMR Pathol Virales Emergentes 190, Marseille, France; [Lagier, Jean-Christophe; Badiaga, Sekene; Botelho, Elizabeth; Brouqui, Philippe; La Scola, Bernard; Drancourt, Michel; Raoult, Didier] Univ Mediterranee, CNRS, UMR 6236,IRD 3R198, Unite Rech Malad Infect & Trop Emergentes, Marseille, France; [Lagier, Jean-Christophe; Sartor, Catherine] Hop Conception, Assistance Publ Hop Marseille, Com Lutte Infect Nosocomiales, Marseille, France; [Badiaga, Sekene] Hop Nord Marseille, Assistance Publ Hop Marseille, Serv Accueil Urgences, Marseille, France; [Botelho, Elizabeth; Brouqui, Philippe] Hop Nord Marseille, Assistance Publ Hop Marseille, Serv Malad Infect & Trop, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Nougairede, A (corresponding author), Hop Enfants La Timone, Assistance Publ Hop Marseille, Marseille, France.	antoine.nougairede@yahoo.fr	LA SCOLA, Bernard/P-6477-2016; Badiaga, Sekene/P-5810-2016; Brouqui, Philippe/P-5771-2016; Lagier, Jean-Christophe/AAY-3837-2021; RAOULT, Didier/A-8434-2008	LA SCOLA, Bernard/0000-0001-8006-7704; Lagier, Jean-Christophe/0000-0003-0771-8245; RAOULT, Didier/0000-0002-0633-5974; Charrel, Remi/0000-0002-7675-8251	AP-HM Public Hospital	AP-HM Public Hospital	This study has been partly funded by AP-HM Public Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG FRANC SEC SAN, 2010, SUIV PHARM VACC GRIP; [Anonymous], 2001, NATURE, V409, P269; Badiaga S, 2009, EUR J PUBLIC HEALTH, V19, P157, DOI 10.1093/eurpub/ckn142; Breman JG, 2003, NEW ENGL J MED, V348, P463, DOI 10.1056/NEJMp025175; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; Christenson B, 2001, LANCET, V357, P1008, DOI 10.1016/S0140-6736(00)04237-9; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; *FRENCH MIN HLTH, 2009, GRIPP INF PROF; *FRENCH MIN HLTH, 2009, C PRESS GRIPP A H1N1; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; *HAUT CONS SANT PU, 2009, PAND GRIPP A H1N1 20; JONES JH, 2009, PLOS ONE, V8032, pN1; Kimura AC, 2007, AM J PUBLIC HEALTH, V97, P684, DOI 10.2105/AJPH.2005.082073; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; NOUGAIREDE A, 2009, PLOS CURRENTS INFLUE; Ofri D, 2009, NEW ENGL J MED, V361, P2594, DOI 10.1056/NEJMp0911047; PETIT G, 2009, NOUVEL OBSERVAT 1208; RACHIOTIS G, 2009, EURO SURVEILL, V15; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Sartor C, 2004, INFECT CONT HOSP EP, V25, P918, DOI 10.1086/502320; SCHWARZINGER M, PLOS ONE, V5; Schwarzinger M, 2010, VACCINE, V28, P2743, DOI 10.1016/j.vaccine.2010.01.027; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; VANDEN B, 2009, EUR J PUBLIC HEALTH, V19, P370; World Health Organization (WHO), 2009, INFL LIK ILLN US MEX; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552; 2009, MMWR MORB MORTAL WKL, V59, P357; 2009, READERS DIGEST; 2009, GOOGLE INSIGHTS SEAR	39	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11292	10.1371/journal.pone.0011292	http://dx.doi.org/10.1371/journal.pone.0011292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593024	gold, Green Submitted, Green Published			2022-12-25	WOS:000279140800005
J	Teng, KL; Chen, H; Lai, JB; Zhang, ZH; Fang, YY; Xia, R; Zhou, XP; Guo, HS; Xie, Q				Teng, Kunling; Chen, Hao; Lai, Jianbin; Zhang, Zhonghui; Fang, Yuanyuan; Xia, Ran; Zhou, Xueping; Guo, Huishan; Xie, Qi			Involvement of C4 Protein of Beet Severe Curly Top Virus (Family Geminiviridae) in Virus Movement	PLOS ONE			English	Article							ABUTILON MOSAIC GEMINIVIRUS; FINGER E3 LIGASE; ARABIDOPSIS-THALIANA; MUTATIONAL ANALYSIS; SYSTEMIC INFECTION; GENE-EXPRESSION; VIRAL MOVEMENT; CAPSID PROTEIN; DNA; PLANTS	Background: Beet severe curly top virus (BSCTV) is a leafhopper transmitted geminivirus with a monopartite genome. C4 proteins encoded by geminivirus play an important role in virus/plant interaction. Methods and Findings: To understand the function of C4 encoded by BSCTV, two BSCTV mutants were constructed by introducing termination codons in ORF C4 without affecting the amino acids encoded by overlapping ORF Rep. BSCTV mutants containing disrupted ORF C4 retained the ability to replicate in Arabidopsis protoplasts and in the agro-inoculated leaf discs of N. benthamiana, suggesting C4 is not required for virus DNA replication. However, both mutants did not accumulate viral DNA in newly emerged leaves of inoculated N. benthamiana and Arabidopsis, and the inoculated plants were asymptomatic. We also showed that C4 expression in plant could help C4 deficient BSCTV mutants to move systemically. C4 was localized in the cytosol and the nucleus in both Arabidopsis protoplasts and N. benthamiana leaves and the protein appeared to bind viral DNA and ds/ssDNA nonspecifically, displaying novel DNA binding properties. Conclusions: Our results suggest that C4 protein in BSCTV is involved in symptom production and may facilitate virus movement instead of virus replication.	[Teng, Kunling; Chen, Hao; Lai, Jianbin; Zhang, Zhonghui; Fang, Yuanyuan; Xia, Ran; Guo, Huishan; Xie, Qi] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Teng, Kunling; Chen, Hao; Lai, Jianbin; Zhang, Zhonghui; Xia, Ran; Xie, Qi] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, Beijing, Peoples R China; [Teng, Kunling; Fang, Yuanyuan; Guo, Huishan] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Microbiol, Beijing, Peoples R China; [Zhou, Xueping] Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Zhejiang University	Teng, KL (corresponding author), Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China.	qxie@genetics.ac.cn	Xie, Qi/P-1464-2016; Zhang, Zhong-hui/AAI-6333-2020	Xie, Qi/0000-0002-8262-9093; Zhang, Zhong-hui/0000-0003-3732-8010	Natural Science Foundation of China [CNSF30325030/30525004/30530400]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China, and the grant number is CNSF30325030/30525004/30530400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle HJ, 2002, ARCH VIROL, V147, P103, DOI 10.1007/s705-002-8305-8; Bechtold N, 1998, METH MOL B, V82, P259; Briddon RW, 1998, EUR J PLANT PATHOL, V104, P77, DOI 10.1023/A:1008669532438; BROUGH CL, 1992, PLANT MOL BIOL, V18, P703, DOI 10.1007/BF00020012; Chellappan P, 2005, P NATL ACAD SCI USA, V102, P10381, DOI 10.1073/pnas.0504439102; Chen H, 2010, PLANT J, V62, P12, DOI 10.1111/j.1365-313X.2009.04120.x; Dogra SC, 2009, PLANT MOL BIOL, V71, P25, DOI 10.1007/s11103-009-9506-x; English JJ, 1997, PLANT J, V12, P597, DOI 10.1046/j.1365-313X.1997.00597.x; ESAU K, 1973, VIROLOGY, V56, P454, DOI 10.1016/0042-6822(73)90049-4; ESAU K, 1977, J ULTRA MOL STRUCT R, V61, P78, DOI 10.1016/S0022-5320(77)90007-7; ETESSAMI P, 1991, J GEN VIROL, V72, P1005, DOI 10.1099/0022-1317-72-5-1005; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; FONTES EPB, 1994, J BIOL CHEM, V269, P8459; FRISCHMUTH T, 1992, VIROLOGY, V189, P808, DOI 10.1016/0042-6822(92)90612-S; Frischmuth T, 1998, J GEN VIROL, V79, P1265, DOI 10.1099/0022-1317-79-5-1265; Guevara-Gonzalez RG, 1999, PHYTOPATHOLOGY, V89, P540, DOI 10.1094/PHYTO.1999.89.7.540; Hehnle S, 2004, J VIROL, V78, P7698, DOI 10.1128/JVI.78.14.7698-7706.2004; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Hoogstraten RA, 1996, MOL PLANT MICROBE IN, V9, P594, DOI 10.1094/MPMI-9-0594; JUPIN I, 1994, VIROLOGY, V204, P82, DOI 10.1006/viro.1994.1512; Klute KA, 1996, J GEN VIROL, V77, P1369, DOI 10.1099/0022-1317-77-7-1369; Kotlizky G, 2000, VIROLOGY, V274, P32, DOI 10.1006/viro.2000.0415; Lai JB, 2009, PLANT J, V57, P905, DOI 10.1111/j.1365-313X.2008.03737.x; Latham JR, 1997, PLANT J, V11, P1273, DOI 10.1046/j.1365-313X.1997.11061273.x; MILLSLUJAN K, PROTOPLASMA, V239, P95; Noris E, 1998, J VIROL, V72, P10050, DOI 10.1128/JVI.72.12.10050-10057.1998; NOUEIRY AO, 1994, CELL, V76, P925, DOI 10.1016/0092-8674(94)90366-2; Piroux N, 2007, VIROLOGY, V362, P428, DOI 10.1016/j.virol.2006.12.034; Pooma W, 1996, J GEN VIROL, V77, P1947, DOI 10.1099/0022-1317-77-8-1947; RIGDEN JE, 1993, VIROLOGY, V193, P1001, DOI 10.1006/viro.1993.1215; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Rojas MR, 1998, CELL, V95, P105, DOI 10.1016/S0092-8674(00)81786-9; Rojas MR, 2001, VIROLOGY, V291, P110, DOI 10.1006/viro.2001.1194; Sanderfoot AA, 1996, PLANT PHYSIOL, V110, P23, DOI 10.1104/pp.110.1.23; SANDERFOOT AA, 1995, PLANT CELL, V7, P1185, DOI 10.1105/tpc.7.8.1185; Sanderfoot AA, 1996, TRENDS CELL BIOL, V6, P353, DOI 10.1016/0962-8924(96)10031-3; Soto MJ, 2005, VIROLOGY, V341, P257, DOI 10.1016/j.virol.2005.07.009; STANLEY J, 1986, EMBO J, V5, P1761, DOI 10.1002/j.1460-2075.1986.tb04424.x; STENGER DC, 1992, J GEN VIROL, V73, P237, DOI 10.1099/0022-1317-73-2-237; Stenger DC, 1997, PHYTOPATHOLOGY, V87, P737, DOI 10.1094/PHYTO.1997.87.7.737; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; WARD A, 1988, EMBO J, V7, P1583, DOI 10.1002/j.1460-2075.1988.tb02983.x; Ward BM, 1999, PLANT CELL, V11, P1267, DOI 10.1105/tpc.11.7.1267; Whitham SA, 1999, P NATL ACAD SCI USA, V96, P772, DOI 10.1073/pnas.96.2.772; Yazdi HRB, 2008, VIRUS GENES, V36, P539, DOI 10.1007/s11262-008-0224-2; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang SC, 2001, VIROLOGY, V290, P249, DOI 10.1006/viro.2001.1185; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	49	39	42	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11280	10.1371/journal.pone.0011280	http://dx.doi.org/10.1371/journal.pone.0011280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585583	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135800002
J	Gomes, ALV; Wee, LJK; Khan, AM; Gil, LHVG; Marques, ETA; Calzavara-Silva, CE; Tan, TW				Gomes, Ana Lisa V.; Wee, Lawrence J. K.; Khan, Asif M.; Gil, Laura H. V. G.; Marques, Ernesto T. A., Jr.; Calzavara-Silva, Carlos E.; Tan, Tin Wee			Classification of Dengue Fever Patients Based on Gene Expression Data Using Support Vector Machines	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; INTERFERON; INFECTION; ALGORITHMS; PREDICT; INNATE	Background: Symptomatic infection by dengue virus (DENV) can range from dengue fever (DF) to dengue haemorrhagic fever (DHF), however, the determinants of DF or DHF progression are not completely understood. It is hypothesised that host innate immune response factors are involved in modulating the disease outcome and the expression levels of genes involved in this response could be used as early prognostic markers for disease severity. Methodology/Principal Findings: mRNA expression levels of genes involved in DENV innate immune responses were measured using quantitative real time PCR (qPCR). Here, we present a novel application of the support vector machines (SVM) algorithm to analyze the expression pattern of 12 genes in peripheral blood mononuclear cells (PBMCs) of 28 dengue patients (13 DHF and 15 DF) during acute viral infection. The SVM model was trained using gene expression data of these genes and achieved the highest accuracy of similar to 85% with leave-one-out cross-validation. Through selective removal of gene expression data from the SVM model, we have identified seven genes (MYD88, TLR7, TLR3, MDA5, IRF3, IFN-alpha and CLEC5A) that may be central in differentiating DF patients from DHF, with MYD88 and TLR7 observed to be the most important. Though the individual removal of expression data of five other genes had no impact on the overall accuracy, a significant combined role was observed when the SVM model of the two main genes (MYD88 and TLR7) was re-trained to include the five genes, increasing the overall accuracy to similar to 96%. Conclusions/Significance: Here, we present a novel use of the SVM algorithm to classify DF and DHF patients, as well as to elucidate the significance of the various genes involved. It was observed that seven genes are critical in classifying DF and DHF patients: TLR3, MDA5, IRF3, IFN-alpha, CLEC5A, and the two most important MYD88 and TLR7. While these preliminary results are promising, further experimental investigation is necessary to validate their specific roles in dengue disease.	[Gomes, Ana Lisa V.; Gil, Laura H. V. G.; Marques, Ernesto T. A., Jr.] Fiocruz MS, Aggeu Magalhaes Res Ctr, CPqAM, Dept Virol & Expt Therapy, Recife, PE, Brazil; [Wee, Lawrence J. K.; Khan, Asif M.; Tan, Tin Wee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Calzavara-Silva, Carlos E.] Fiocruz MS, Dept Cellular & Mol Immunol, Rene Rachou Res Ctr, CPqRR, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fundacao Oswaldo Cruz	Gomes, ALV (corresponding author), Fiocruz MS, Aggeu Magalhaes Res Ctr, CPqAM, Dept Virol & Expt Therapy, Recife, PE, Brazil.	tinwee@bic.nus.edu.sg	Tan, Tin Wee/B-8963-2009; Khan, Mohammad Asif/F-4663-2010; Marques, Ernesto/L-4514-2013; Khan, M. Asif/ABE-7839-2021; Marques, Ernesto T. A/L-4967-2013; Gil, Laura Helena Vega Gonzales/AAX-5319-2021; Publica, Inct Saude/J-9544-2013; Calzavara-Silva, Carlos/ABF-2829-2021	Tan, Tin Wee/0000-0002-4062-2854; Khan, Mohammad Asif/0000-0001-9202-279X; Marques, Ernesto/0000-0003-3826-9358; Khan, M. Asif/0000-0001-9202-279X; Marques, Ernesto T. A/0000-0003-3826-9358; Gil, Laura Helena Vega Gonzales/0000-0002-8796-6080; Calzavara-Silva, Carlos/0000-0002-1406-6401	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Ciencia e Tecnologia do Estado de (FACEPE), Brazil; National Institutes of Health (NIH), USA	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de (FACEPE), Brazil; National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Ciencia e Tecnologia do Estado de (FACEPE), Brazil, the National Institutes of Health (NIH), USA. The first author ALVG was a visiting scientist with the Department of Biochemistry, National University of Singapore (NUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang C.- C., 2009, LIBSVM LIB SUPPORT V; Chen PC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-44; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; Cordeiro MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004945; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; KNIPE DP, 2007, FIELDS VIROLOGY, P250; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Munoz-Jordan JL, 2010, CURR TOP MICROBIOL, V338, P35, DOI 10.1007/978-3-642-02215-9_3; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Sun PF, 2009, VIROLOGY, V383, P207, DOI 10.1016/j.virol.2008.10.022; Tang EK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-95; Tang YC, 2007, IEEE ACM T COMPUT BI, V4, P365, DOI 10.1109/TCBB.2007.1028; Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; *WHO, 1997, HAEM FEV DIAGN TREAT; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	29	24	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11267	10.1371/journal.pone.0011267	http://dx.doi.org/10.1371/journal.pone.0011267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585645	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000279135400013
J	Kojima, S; Gatfield, D; Esau, CC; Green, CB				Kojima, Shihoko; Gatfield, David; Esau, Christine C.; Green, Carla B.			MicroRNA-122 Modulates the Rhythmic Expression Profile of the Circadian Deadenylase Nocturnin in Mouse Liver	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; RNA REGULATION; MICRO-RNA; IN-VIVO; MIR-122; GENE; IDENTIFICATION; RETINA; TARGET; TISSUE	Nocturnin is a circadian clock-regulated deadenylase thought to control mRNA expression post-transcriptionally through poly(A) tail removal. The expression of Nocturnin is robustly rhythmic in liver at both the mRNA and protein levels, and mice lacking Nocturnin are resistant to diet-induced obesity and hepatic steatosis. Here we report that Nocturnin expression is regulated by microRNA-122 (miR-122), a liver specific miRNA. We found that the 3'-untranslated region (3'-UTR) of Nocturnin mRNA harbors one putative recognition site for miR-122, and this site is conserved among mammals. Using a luciferase reporter construct with wild-type or mutant Nocturnin 3'-UTR sequence, we demonstrated that overexpression of miR-122 can down-regulate luciferase activity levels and that this effect is dependent on the presence of the putative miR-122 recognition site. Additionally, the use of an antisense oligonucleotide to knock down miR-122 in vivo resulted in significant up-regulation of both Nocturnin mRNA and protein expression in mouse liver during the night, resulting in Nocturnin rhythms with increased amplitude. Together, these data demonstrate that the normal rhythmic profile of Nocturnin expression in liver is shaped in part by miR-122. Previous studies have implicated Nocturnin and miR-122 as important post-transcriptional regulators of both lipid metabolism and circadian clock controlled gene expression in the liver. Therefore, the demonstration that miR-122 plays a role in regulating Nocturnin expression suggests that this may be an important intersection between hepatic metabolic and circadian control.	[Kojima, Shihoko; Green, Carla B.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Kojima, Shihoko; Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Gatfield, David] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Esau, Christine C.] Regulus Therapeut, Carlsbad, CA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Virginia; University of Geneva; Isis Pharmaceuticals Inc	Kojima, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	Carla.Green@utsouthwestern.edu	Gatfield, David/C-2354-2011	Gatfield, David/0000-0001-5114-2824; Kojima (xiao dao zhi bao zi), Shihoko/0000-0001-9579-7830	Federation of European Biochemical Societies (FEBS); International Human Frontier Science Program Organization (HFSP); NIH [GM076626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076626] Funding Source: NIH RePORTER	Federation of European Biochemical Societies (FEBS); International Human Frontier Science Program Organization (HFSP)(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D. G. received long-term fellowships from The Federation of European Biochemical Societies (FEBS) and The International Human Frontier Science Program Organization (HFSP). C. E. is employed by Regulus Therapeutics, but no further financial support (beyond salary) was provided to this project. This work was supported by NIH GM076626 (to C. B. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Garbarino-Pico E, 2007, RNA, V13, P745, DOI 10.1261/rna.286507; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kojima S, 2003, BIOCHEM BIOPH RES CO, V301, P1, DOI 10.1016/S0006-291X(02)02938-8; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; MARTINELLI R, 2010, OBESITY SILVER SPRIN; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nagel R, 2009, FEBS J, V276, P5447, DOI 10.1111/j.1742-4658.2009.07229.x; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200	37	65	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11264	10.1371/journal.pone.0011264	http://dx.doi.org/10.1371/journal.pone.0011264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582318	Green Published, gold, Green Submitted			2022-12-25	WOS:000279058500016
J	Markel, G; Bar-Haim, E; Zahavy, E; Cohen, H; Cohen, O; Shafferman, A; Velan, B				Markel, Gal; Bar-Haim, Erez; Zahavy, Eran; Cohen, Hila; Cohen, Ofer; Shafferman, Avigdor; Velan, Baruch			The Involvement of IL-17A in the Murine Response to Sub-Lethal Inhalational Infection with Francisella tularensis	PLOS ONE			English	Article							T-CELLS; INTRACELLULAR BACTERIUM; IMMUNE-RESPONSE; HOST-DEFENSE; TULAREMIA; LVS; ACTIVATION; RESISTANCE; GROWTH; MACROPHAGES	Background: Francisella tularensis is an intercellular bacterium often causing fatal disease when inhaled. Previous reports have underlined the role of cell-mediated immunity and IFN gamma in the host response to Francisella tularensis infection. Methodology/Principal Findings: Here we provide evidence for the involvement of IL-17A in host defense to inhalational tularemia, using a mouse model of intranasal infection with the Live Vaccine Strain (LVS). We demonstrate the kinetics of IL-17A production in lavage fluids of infected lungs and identify the IL-17A-producing lymphocytes as pulmonary gamma delta and Th17 cells. The peak of IL-17A production appears early during sub-lethal infection, it precedes the peak of immune activation and the nadir of the disease, and then subsides subsequently. Exogenous airway administration of IL-17A or of IL-23 had a limited yet consistent effect of delaying the onset of death from a lethal dose of LVS, implying that IL-17A may be involved in restraining the infection. The protective role for IL-17A was directly demonstrated by in vivo neutralization of IL-17A. Administration of anti IL-17A antibodies concomitantly to a sub-lethal airway infection with 0.1 x LD50 resulted in a fatal disease. Conclusion: In summary, these data characterize the involvement and underline the protective key role of the IL-17A axis in the lungs from inhalational tularemia.	[Markel, Gal; Bar-Haim, Erez; Cohen, Hila; Cohen, Ofer; Shafferman, Avigdor; Velan, Baruch] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel; [Zahavy, Eran] Israel Inst Biol Res, Dept Infect Dis, IL-70450 Ness Ziona, Israel		Markel, G (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	baruchv@iibr.gov.il	Bar-Haim, Erez/AAA-6444-2020	Bar-Haim, Erez/0000-0003-3435-8599	IIBR Research Funds	IIBR Research Funds	The study was funded by the IIBR Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Butchar JP, 2007, J IMMUNOL, V178, P4445, DOI 10.4049/jimmunol.178.7.4445; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Chen WX, 2004, MICROB PATHOGENESIS, V36, P311, DOI 10.1016/j.micpath.2004.02.003; Collazo CM, 2009, INFECT IMMUN, V77, P2010, DOI 10.1128/IAI.01322-08; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; Cowley SC, 1996, MOL MICROBIOL, V20, P867, DOI 10.1111/j.1365-2958.1996.tb02524.x; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; Cowley SC, 2003, J EXP MED, V198, P379, DOI 10.1084/jem.20030687; COWLEY SC, 2010, J IMMUNOL       0414; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; ELKINS KL, 1993, INFECT IMMUN, V61, P823, DOI 10.1128/IAI.61.3.823-829.1993; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; IAWKURA Y, 2008, IMMUNOL REV, V26, P57; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KOLLOCH RE, 2004, PERFUSION-GERMANY, V17, P467; Kroca M, 2000, CLIN EXP IMMUNOL, V120, P280, DOI 10.1046/j.1365-2249.2000.01215.x; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lopez MC, 2004, CELL IMMUNOL, V232, P75, DOI 10.1016/j.cellimm.2005.02.001; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Overbergh L, 2003, J Biomol Tech, V14, P33; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Poquet Y, 1998, INFECT IMMUN, V66, P2107, DOI 10.1128/IAI.66.5.2107-2114.1998; Pulendran B, 2004, IMMUNOL RES, V29, P187, DOI 10.1385/IR:29:1-3:187; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; SJOSTEDT A, 2007, ANN NY ACAD SCI, V1005, P1; TARVNIK A, 1989, REV INFECT DIS, V11, P440; Taylor GA, 2007, MICROBES INFECT, V9, P1644, DOI 10.1016/j.micinf.2007.09.004; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yee D, 1996, J IMMUNOL, V157, P5042	48	36	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11176	10.1371/journal.pone.0011176	http://dx.doi.org/10.1371/journal.pone.0011176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585449	Green Published, gold, Green Submitted			2022-12-25	WOS:000278977200003
J	Chen, HC; Xie, J; Zhang, Z; Su, LT; Yue, LX; Runnels, LW				Chen, Hsiang-Chin; Xie, Jia; Zhang, Zheng; Su, Li-Ting; Yue, Lixia; Runnels, Loren W.			Blockade of TRPM7 Channel Activity and Cell Death by Inhibitors of 5-Lipoxygenase	PLOS ONE			English	Article							SLOW-REACTING SUBSTANCE; FOCAL CEREBRAL-ISCHEMIA; ARACHIDONIC-ACID; NORDIHYDROGUAIARETIC ACID; HIPPOCAMPAL-NEURONS; MYOCARDIAL ISCHEMIA; DIVALENT-CATIONS; MG2+ HOMEOSTASIS; ACTIVATION; ADHESION	TRPM7 is a ubiquitous divalent-selective ion channel with its own kinase domain. Recent studies have shown that suppression of TRPM7 protein expression by RNA interference increases resistance to ischemia-induced neuronal cell death in vivo and in vitro, making the channel a potentially attractive pharmacological target for molecular intervention. Here, we report the identification of the 5-lipoxygenase inhibitors, NDGA, AA861, and MK886, as potent blockers of the TRPM7 channel. Using a cell-based assay, application of these compounds prevented cell rounding caused by overexpression of TRPM7 in HEK-293 cells, whereas inhibitors of 12-lipoxygenase and 15-lipoxygenase did not prevent the change in cell morphology. Application of the 5-lipoxygenase inhibitors blocked heterologously expressed TRPM7 whole-cell currents without affecting the protein's expression level or its cell surface concentration. All three inhibitors were also effective in blocking the native TRPM7 current in HEK-293 cells. However, two other 5-lipoxygenase specific inhibitors, 5,6-dehydroarachidonic acid and zileuton, were ineffective in suppressing TRPM7 channel activity. Targeted knockdown of 5-lipoxygenase did not reduce TRPM7 whole-cell currents. In addition, application of 5-hydroperoxyeicosatetraenoic acid (5-HPETE), the product of 5-lipoxygenase, or 5-HPETE's downstream metabolites, leukotriene B4 and leukotriene D4, did not stimulate TRPM7 channel activity. These data suggested that NDGA, AA861, and MK886 reduced the TRPM7 channel activity independent of their effect on 5-lipoxygenase activity. Application of AA861 and NDGA reduced cell death for cells overexpressing TRPM7 cultured in low extracellular divalent cations. Moreover, treatment of HEK-293 cells with AA861 increased cell resistance to apoptotic stimuli to a level similar to that obtained for cells in which TRPM7 was knocked down by RNA interference. In conclusion, NDGA, AA861, and MK886 are potent blockers of the TRPM7 channel capable of attenuating TRPM7's function during cell stress, making them effective tools for the biophysical characterization and suppression of TRPM7 channel conductance in vivo.	[Xie, Jia; Zhang, Zheng; Yue, Lixia] Univ Connecticut, Ctr Hlth, Calhoun Cardiol Ctr, Farmington, CT USA; [Xie, Jia; Zhang, Zheng; Yue, Lixia] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT USA; [Chen, Hsiang-Chin; Su, Li-Ting; Runnels, Loren W.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	University of Connecticut; University of Connecticut; Rutgers State University New Brunswick; Rutgers State University Medical Center	Yue, LX (corresponding author), Univ Connecticut, Ctr Hlth, Calhoun Cardiol Ctr, Farmington, CT USA.	lyue@uchc.edu; runnellw@umdnj.edu	Xie, Jia/L-9921-2014	Runnels, Loren/0000-0002-2537-7360	National Institutes of Health, National Institute of General Medical Science (NIGMS) [1R01GM080753]; National Heart, Lung and Blood Institute (NHLBI) [HL078960]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080753] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Science (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported by the National Institutes of Health, National Institute of General Medical Science (NIGMS) (www.nigms.nih.gov) grant number 1R01GM080753 to LR and National Heart, Lung and Blood Institute (NHLBI) (www.nhlbi.nih.gov) grant number HL078960 to LY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Adamek A, 2007, EUR J PHARMACOL, V571, P51, DOI 10.1016/j.ejphar.2007.05.040; ASHIDA Y, 1983, PROSTAGLANDINS, V26, P955, DOI 10.1016/0090-6980(83)90157-0; Baskaya MK, 1996, J NEUROSURG, V85, P112, DOI 10.3171/jns.1996.85.1.0112; CHUN JS, 1992, MOL BIOL CELL, V3, P481, DOI 10.1091/mbc.3.5.481; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; FIEDLER VB, 1985, J CARDIOVASC PHARM, V7, P983, DOI 10.1097/00005344-198509000-00027; Gwanyanya A, 2004, J PHYSIOL-LONDON, V559, P761, DOI 10.1113/jphysiol.2004.067637; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; HOPE WC, 1983, BIOCHEM PHARMACOL, V32, P367, DOI 10.1016/0006-2952(83)90569-5; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; INOUE K, 2010, J BIOL CHEM; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; Kitagawa K, 2004, BRAIN RES, V1004, P198, DOI 10.1016/j.brainres.2004.01.018; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; LEFKOWITH JB, 1991, J BIOL CHEM, V266, P1071; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Peters-Golden M, 2003, PROSTAG LEUKOTR ESS, V69, P99, DOI 10.1016/S0952-3278(03)00070-X; Rempe DA, 2009, NAT NEUROSCI, V12, P1215, DOI 10.1038/nn1009-1215; ROTHMAN SM, 1993, NEUROPHARMACOLOGY, V32, P1279, DOI 10.1016/0028-3908(93)90022-U; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SALARI H, 1984, PROSTA LEUKOTR MED, V13, P53, DOI 10.1016/0262-1746(84)90102-1; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Stockton RA, 2001, MOL BIOL CELL, V12, P1937, DOI 10.1091/mbc.12.7.1937; Su LT, 2010, J MOL BIOL, V396, P858, DOI 10.1016/j.jmb.2010.01.014; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; SUN HS, 2009, NAT NEUROSCI; Tian SL, 2007, NEUROSCI LETT, V419, P93, DOI 10.1016/j.neulet.2007.04.020; Uz T, 2008, NEUROSCI LETT, V436, P269, DOI 10.1016/j.neulet.2008.03.041; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470	49	58	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11161	10.1371/journal.pone.0011161	http://dx.doi.org/10.1371/journal.pone.0011161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567598	Green Published, gold, Green Submitted			2022-12-25	WOS:000278886300007
J	Stich, M; Manrubia, SC; Lazaro, E				Stich, Michael; Manrubia, Susanna C.; Lazaro, Ester			Variable Mutation Rates as an Adaptive Strategy in Replicator Populations	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; DEPENDENT RNA-POLYMERASE; ESCHERICHIA-COLI; EVOLUTION; ADAPTATION; MUTATORS; RESISTANCE; DYNAMICS; FIDELITY; FITNESS	For evolving populations of replicators, there is much evidence that the effect of mutations on fitness depends on the degree of adaptation to the selective pressures at play. In optimized populations, most mutations have deleterious effects, such that low mutation rates are favoured. In contrast to this, in populations thriving in changing environments a larger fraction of mutations have beneficial effects, providing the diversity necessary to adapt to new conditions. What is more, non-adapted populations occasionally benefit from an increase in the mutation rate. Therefore, there is no optimal universal value of the mutation rate and species attempt to adjust it to their momentary adaptive needs. In this work we have used stationary populations of RNA molecules evolving in silico to investigate the relationship between the degree of adaptation of an optimized population and the value of the mutation rate promoting maximal adaptation in a short time to a new selective pressure. Our results show that this value can significantly differ from the optimal value at mutation-selection equilibrium, being strongly influenced by the structure of the population when the adaptive process begins. In the short-term, highly optimized populations containing little variability respond better to environmental changes upon an increase of the mutation rate, whereas populations with a lower degree of optimization but higher variability benefit from reducing the mutation rate to adapt rapidly. These findings show a good agreement with the behaviour exhibited by actual organisms that replicate their genomes under broadly different mutation rates.	[Stich, Michael; Manrubia, Susanna C.; Lazaro, Ester] Ctr Astrobiol CSIC INTA, Dept Mol Evolut, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Stich, M (corresponding author), Ctr Astrobiol CSIC INTA, Dept Mol Evolut, Madrid, Spain.	lazarolm@inta.es	Lázaro, Ester/L-3398-2017; Manrubia, Susanna/K-4501-2014	Lázaro, Ester/0000-0001-7477-7822; Manrubia, Susanna/0000-0003-0134-2785	Spanish MICINN [FIS2008-05273]; Comunidad Autonoma de Madrid [MODELICO-CM/S2009ESP-1691]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid)	This work was financially supported by Spanish MICINN (www.micinn.es) through research project FIS2008-05273 and by Comunidad Autonoma de Madrid through project MODELICO-CM/S2009ESP-1691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002; Cases-Gonzalez C, 2008, J MOL BIOL, V384, P1120, DOI 10.1016/j.jmb.2008.10.014; Clune J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000187; Couce A, 2009, FEMS MICROBIOL REV, V33, P531, DOI 10.1111/j.1574-6976.2009.00165.x; De Visser JAGM, 2005, J EVOLUTION BIOL, V18, P779, DOI 10.1111/j.1420-9101.2005.00879.x; de Visser JAGM, 2002, MICROBIOL-SGM, V148, P1247, DOI 10.1099/00221287-148-5-1247; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Domingo E, 2008, EXPERT OPIN BIOL TH, V8, P1455, DOI 10.1517/14712598.8.10.1455 ; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Elena SF, 1999, J EVOLUTION BIOL, V12, P1078, DOI 10.1046/j.1420-9101.1999.00110.x; Fisher R.A., 1930, GENETICAL THEORY NAT; FONTANA W, 1987, BIOPHYS CHEM, V26, P123, DOI 10.1016/0301-4622(87)80017-0; Furio V, 2005, P NATL ACAD SCI USA, V102, P10233, DOI 10.1073/pnas.0501062102; GILLESPIE JH, 1981, EVOLUTION, V35, P468, DOI [10.2307/2408195, 10.1111/j.1558-5646.1981.tb04910.x]; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; HUYNEN MA, 1993, J THEOR BIOL, V165, P251, DOI 10.1006/jtbi.1993.1188; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; KIMURA M, 1967, GENET RES, V9, P23, DOI 10.1017/S0016672300010284; Lazaro E, 2003, P NATL ACAD SCI USA, V100, P10830, DOI 10.1073/pnas.1332668100; LeClerc JE, 1998, MUTAT RES-FUND MOL M, V400, P89; LEIGH EG, 1970, AM NAT, V104, P301, DOI 10.1086/282663; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Mansky LM, 2000, TRENDS GENET, V16, P512, DOI 10.1016/S0168-9525(00)02125-9; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; Orr HA, 2000, GENETICS, V155, P961; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Perales C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000658; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; QUINONES A, 1985, MOL GEN GENET, V201, P315, DOI 10.1007/BF00425677; Richardson AR, 2002, P NATL ACAD SCI USA, V99, P6103, DOI 10.1073/pnas.092568699; Schaaper RM, 1998, GENETICS, V148, P1579; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stich M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-110; Stich M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-46; Travis JMJ, 2002, P ROY SOC B-BIOL SCI, V269, P591, DOI 10.1098/rspb.2001.1902; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; WRIGHT S, 1932, P 6 INT C GEN, V1, P355	54	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11186	10.1371/journal.pone.0011186	http://dx.doi.org/10.1371/journal.pone.0011186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567506	Green Published, Green Accepted, gold			2022-12-25	WOS:000278886300028
J	Liu, FJ; Barchowsky, A; Opresko, PL				Liu, Fu-Jun; Barchowsky, Aaron; Opresko, Patricia L.			The Werner Syndrome Protein Suppresses Telomeric Instability Caused by Chromium (VI) Induced DNA Replication Stress	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HUMAN LUNG-CELLS; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; GENOMIC INSTABILITY; SYNDROME HELICASE; RECQ HELICASE; S-PHASE; CHROMOSOME INSTABILITY	Telomeres protect the chromosome ends and consist of guanine-rich repeats coated by specialized proteins. Critically short telomeres are associated with disease, aging and cancer. Defects in telomere replication can lead to telomere loss, which can be prevented by telomerase-mediated telomere elongation or activities of the Werner syndrome helicase/exonuclease protein (WRN). Both telomerase and WRN attenuate cytotoxicity induced by the environmental carcinogen hexavalent chromium (Cr(VI)), which promotes replication stress and DNA polymerase arrest. However, it is not known whether Cr(VI)induced replication stress impacts telomere integrity. Here we report that Cr(VI) exposure of human fibroblasts induced telomeric damage as indicated by phosphorylated H2AX (gamma H2AX) at telomeric foci. The induced gamma H2AX foci occurred in S-phase cells, which is indicative of replication fork stalling or collapse. Telomere fluorescence in situ hybridization (FISH) of metaphase chromosomes revealed that Cr(VI) exposure induced an increase in telomere loss and sister chromatid fusions that were rescued by telomerase activity. Human cells depleted for WRN protein exhibited a delayed reduction in telomeric and non-telomeric damage, indicated by gamma H2AX foci, during recovery from Cr(VI) exposure, consistent with WRN roles in repairing damaged replication forks. Telomere FISH of chromosome spreads revealed that WRN protects against Cr(VI)-induced telomere loss and downstream chromosome fusions, but does not prevent chromosome fusions that retain telomere sequence at the fusion point. Our studies indicate that environmentally induced replication stress leads to telomere loss and aberrations that are suppressed by telomerase-mediated telomere elongation or WRN functions in replication fork restoration.	[Liu, Fu-Jun; Barchowsky, Aaron; Opresko, Patricia L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, FJ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA.	plo4@pitt.edu		Opresko, Patricia/0000-0002-6470-2189	National Institute of Environmental Health Sciences [R01ES015052]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015052] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences (R01ES015052) and the Ellison Medical Foundation to P.L.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, AGING-US, V1, P219, DOI 10.18632/aging.100020; Arnoult N, 2009, GENE DEV, V23, P2915, DOI 10.1101/gad.544009; Baird DM, 2005, EXP GERONTOL, V40, P363, DOI 10.1016/j.exger.2005.02.008; Baird DM, 2004, HUM MOL GENET, V13, P1515, DOI 10.1093/hmg/ddh159; Balajee AS, 2004, EXP CELL RES, V300, P320, DOI 10.1016/j.yexcr.2004.07.022; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bridgewater LC, 1998, MOL CARCINOGEN, V23, P201; Bryant HE, 2006, MUTAT RES-FUND MOL M, V599, P116, DOI 10.1016/j.mrfmmm.2006.02.001; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; COGAN N, 1983, MUTAT RES, V683, P1; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Davalos AR, 2003, J CELL BIOL, V162, P1197, DOI 10.1083/jcb.200304016; Dhillon KK, 2007, AGING CELL, V6, P53, DOI 10.1111/j.1474-9726.2006.00260.x; Gagos S, 2008, CANCER RES, V68, P8146, DOI 10.1158/0008-5472.CAN-08-0945; Glaviano A, 2006, ONCOGENE, V25, P3424, DOI 10.1038/sj.onc.1209399; Glaviano A, 2009, MUTAGENESIS, V24, P25, DOI 10.1093/mutage/gen048; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Ha LN, 2004, CARCINOGENESIS, V25, P2265, DOI 10.1093/carcin/bgh242; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Li BM, 2009, AGING-US, V1, P289, DOI 10.18632/aging.100032; Liu FJ, 2009, TOXICOL SCI, V110, P307, DOI 10.1093/toxsci/kfp104; Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200; Multani AS, 2007, J CELL SCI, V120, P713, DOI 10.1242/jcs.03397; Newman JPA, 2008, J CELL PHYSIOL, V214, P796, DOI 10.1002/jcp.21276; Opresko PL, 2008, MECH AGEING DEV, V129, P79, DOI 10.1016/j.mad.2007.10.007; Opresko PL, 2007, MECH AGEING DEV, V128, P423, DOI 10.1016/j.mad.2007.05.009; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; *PHS, 2000, DEP HLTH HUM SERV AG; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Poon Steven S S, 2001, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1804s12; Quievryn G, 2003, BIOCHEMISTRY-US, V42, P1062, DOI 10.1021/bi0271547; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Rog O, 2009, MOL CELL, V33, P559, DOI 10.1016/j.molcel.2009.01.027; ROSSI ML, DNA REPAIR AMST; Rubio MA, 2004, EXP CELL RES, V298, P17, DOI 10.1016/j.yexcr.2004.04.004; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Slade PG, 2005, CHEM RES TOXICOL, V18, P1140, DOI 10.1021/tx050033y; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Sowd G, 2008, NUCLEIC ACIDS RES, V36, P4242, DOI 10.1093/nar/gkn385; Stackpole MM, 2007, MUTAT RES-FUND MOL M, V625, P145, DOI 10.1016/j.mrfmmm.2007.06.003; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tamblyn L, 2009, MUTAT RES-FUND MOL M, V660, P57, DOI 10.1016/j.mrfmmm.2008.10.013; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028; Wise Sandra S., 2008, Reviews on Environmental Health, V23, P39; Wise SS, 2004, MOL CELL BIOCHEM, V255, P103, DOI 10.1023/B:MCBI.0000007266.82705.d9; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Xie H, 2005, MUTAT RES-GEN TOX EN, V586, P160, DOI 10.1016/j.mrgentox.2005.06.002; Xie H, 2009, TOXICOL APPL PHARM, V234, P293, DOI 10.1016/j.taap.2008.10.010; Xu J, 1996, CARCINOGENESIS, V17, P1511, DOI 10.1093/carcin/17.7.1511; Zecevic A, 2009, CELL CYCLE, V8, P2769, DOI 10.4161/cc.8.17.9410; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	60	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11152	10.1371/journal.pone.0011152	http://dx.doi.org/10.1371/journal.pone.0011152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585393	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000278886100016
J	Henkel, M; Mitzner, D; Henklein, P; Meyer-Almes, FJ; Moroni, A; DiFrancesco, ML; Henkes, LM; Kreim, M; Kast, SM; Schubert, U; Thiel, G				Henkel, Michael; Mitzner, David; Henklein, Peter; Meyer-Almes, Franz-Josef; Moroni, Anna; DiFrancesco, Mattia L.; Henkes, Leonhard M.; Kreim, Michael; Kast, Stefan M.; Schubert, Ulrich; Thiel, Gerhard			The Proapoptotic Influenza A Virus Protein PB1-F2 Forms a Nonselective Ion Channel	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; LIPID-MEMBRANES; MITOCHONDRIAL PROTEIN; CONSTANT-PRESSURE; PORE FORMATION; CELL-DEATH; TRANSLOCATION; VIROPORINS; MECHANISMS; APOPTOSIS	Background: PB1-F2 is a proapoptotic influenza A virus protein of approximately 90 amino acids in length that is located in the nucleus, cytosol and in the mitochondria membrane of infected cells. Previous studies indicated that the molecule destabilizes planar lipid bilayers and has a strong inherent tendency for multimerization. This may be correlate with its capacity to induce mitochondrial membrane depolarization. Methodology/Principal Findings: Here, we investigated whether PB1-F2 is able to form ion channels within planar lipid bilayers and microsomes. For that purpose, a set of biologically active synthetic versions of PB1-F2 (sPB1-F2) derived from the IAV isolates A/Puerto Rico/8/34(H1N1)( IAV(PR8)), from A/Brevig Mission/1/1918( H1N1) (IAV(SF2)) or the H5N1 consensus sequence (IAV(BF2)) were used. Electrical and fluorimetric measurements show that all three peptides generate in planar lipid bilayers or in liposomes, respectively, a barely selective conductance that is associated with stochastic channel type fluctuations between a closed state and at least two defined open states. Unitary channel fluctuations were also generated when a truncated protein comprising only the 37 c-terminal amino acids of sPB1-F2 was reconstituted in bilayers. Experiments were complemented by extensive molecular dynamics simulations of the truncated fragment in a lipid bilayer. The results indicate that the c-terminal region exhibits a slightly bent helical fold, which is stable and remains embedded in the bilayer for over 180 ns. Conclusion/Significance: The data support the idea that PB1-F2 is able to form protein channel pores with no appreciable selectivity in membranes and that the c-terminus is important for this function. This information could be important for drug development.	[Henkel, Michael; Henkes, Leonhard M.; Kreim, Michael; Thiel, Gerhard] Tech Univ Darmstadt, Dept Bot, Darmstadt, Germany; [Mitzner, David; Schubert, Ulrich] ViroLogik GmbH, Innovat Ctr Med Technol & Pharmaceut IZMP, Erlangen, Germany; [Henklein, Peter] Humboldt Univ, Inst Biochem, Berlin, Germany; [Meyer-Almes, Franz-Josef] Hsch Darmstadt, Dept Chem & Biotechnol, Darmstadt, Germany; [Moroni, Anna; DiFrancesco, Mattia L.] Univ Milan, CNR, IBF, Milan, Italy; [Moroni, Anna; DiFrancesco, Mattia L.] Univ Milan, Dipartimento Biol, Milan, Italy; [Kast, Stefan M.] Tech Univ Dortmund, Dortmund, Germany; [Schubert, Ulrich] Univ Erlangen Nurnberg, Erlangen, Germany	Technical University of Darmstadt; Humboldt University of Berlin; Hochschule Darmstadt; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan; Dortmund University of Technology; University of Erlangen Nuremberg	Henkel, M (corresponding author), Tech Univ Darmstadt, Dept Bot, Darmstadt, Germany.	thiel@bio.tu-darmstadt.de	Meyer-Almes, Franz-Josef/D-9219-2017; moroni, anna/H-2097-2014; DiFrancesco, Mattia Lorenzo/AAC-1029-2022	Meyer-Almes, Franz-Josef/0000-0002-1001-3249; moroni, anna/0000-0002-1860-406X; DiFrancesco, Mattia Lorenzo/0000-0002-7511-4438; Thiel, Gerhard/0000-0002-2335-1351; Tripp, Ralph/0000-0002-2924-9956	Deutsche Forschungsgemeinschaft; Adolf-Messer-Stiftung; Fonds der Chemischen Industrie; European Drug Initiative on Channels and Transporters (EDICT)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Adolf-Messer-Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Drug Initiative on Channels and Transporters (EDICT)(European Commission)	GT received funding from Deutsche Forschungsgemeinschaft, SMK from Adolf-Messer-Stiftung and the Fonds der Chemischen Industrie, and AM from European Drug Initiative on Channels and Transporters (EDICT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8; Bruns K, 2007, J BIOL CHEM, V282, P353, DOI 10.1074/jbc.M606494200; Chanturiya AN, 2004, J VIROL, V78, P6304, DOI 10.1128/JVI.78.12.6304-6312.2004; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; CHEVALIER C, 2010, J BIOL CHEM IN PRESS; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Duclohier H, 2001, J MEMBRANE BIOL, V184, P1, DOI 10.1007/s00232-001-0077-2; EISENBERG M, 1973, J MEMBRANE BIOL, V14, P143, DOI 10.1007/BF01868075; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fischman Robert L., 2002, COLUM J ENV L, V27, P45; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4; Henklein P, 2005, J PEPT SCI, V11, P481, DOI 10.1002/psc.641; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; Lamb RA, 2001, NAT MED, V7, P1286, DOI 10.1038/nm1201-1286; Lowy RJ, 2003, INT REV IMMUNOL, V22, P425, DOI 10.1080/08830180305216; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Madan V, 2008, CELL MICROBIOL, V10, P437, DOI 10.1111/j.1462-5822.2007.01057.x; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; Mitzner D, 2009, CELL MICROBIOL, V11, P1502, DOI 10.1111/j.1462-5822.2009.01343.x; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nieva JL, 2003, FEBS LETT, V552, P68, DOI 10.1016/S0014-5793(03)00852-4; Roder R, 2008, J PEPT SCI, V14, P954, DOI 10.1002/psc.1031; Schlenkrich Michael, 1996, P31; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Tu K, 1995, BIOPHYS J, V69, P2558, DOI 10.1016/S0006-3495(95)80126-8; Webby RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/rstb.2001.0997; Yewdell J, 2002, CURR OPIN MICROBIOL, V5, P414, DOI 10.1016/S1369-5274(02)00346-6; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	40	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11112	10.1371/journal.pone.0011112	http://dx.doi.org/10.1371/journal.pone.0011112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559552	Green Published, gold			2022-12-25	WOS:000278775900006
J	Lu, XY; Chen, XX; Huang, LD; Zhu, CQ; Gu, YY; Ye, S				Lu, Xiao-ye; Chen, Xiao-xiang; Huang, Li-dong; Zhu, Chang-qing; Gu, Yue-ying; Ye, Shuang			Anti-alpha-Internexin Autoantibody from Neuropsychiatric Lupus Induce Cognitive Damage via Inhibiting Axonal Elongation and Promote Neuron Apoptosis	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEIN; CENTRAL-NERVOUS-SYSTEM; BRAIN-REACTIVE AUTOANTIBODIES; CEREBROSPINAL-FLUID; ERYTHEMATOSUS PATIENTS; AUTOIMMUNE MICE; PRONE MICE; ANTIPHOSPHOLIPID SYNDROME; INCLUSION DISEASE; CORTICAL-NEURONS	Background: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a major complication for lupus patients, which often leads to cognitive disturbances and memory loss and contributes to a significant patient morbidity and mortality. The presence of anti-neuronal autoantibodies (aAbs) has been identified; as examples, anti-NMDA receptors and anti-Ribsomal P aAbs have been linked to certain pathophysiological features of NPSLE. Methods and Findings: In the current study, we used a proteomic approach to identify an intermediate neurofilament alpha-internexin (INA) as a pathogenetically relevant autoantigen in NPSLE. The significance of this finding was then validated in an expanded of a cohort of NPSLE patients (n = 67) and controls (n = 270) by demonstrating that high titers of anti-INA aAb was found in both the serum and cerebrospinal fluid (CSF) of similar to 50% NPSLE. Subsequently, a murine model was developed by INA immunization that resulted in pronounced cognitive dysfunction that mimicked features of NPSLE. Histopathology in affected animals displayed cortical and hippocampal neuron apoptosis. In vitro studies further demonstrated that anti-INA Ab mediated neuronal damage via inhibiting axonal elongation and eventually driving the cells to apoptosis. Conclusions: Taken together, this study identified a novel anti-neurofilament aAb in NPSLE, and established a hitherto undescribed mechanism of aAb-mediated neuron damage that could have relevance to the pathophysiology of NPSLE.	[Lu, Xiao-ye; Chen, Xiao-xiang; Gu, Yue-ying; Ye, Shuang] Shanghai Jiao Tong Univ, Sch Med, Dept Rheumatol, Shanghai 200030, Peoples R China; [Huang, Li-dong] Shanghai Jiao Tong Univ, Sch Med, Dept Neurobiol, Shanghai 200030, Peoples R China; [Zhu, Chang-qing] Shanghai Jiao Tong Univ, Sch Med, Dept Emergency Med, Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Rheumatol, Shanghai 200030, Peoples R China.	guyueying88@yahoo.com.cn; ye_shuang2000@yahoo.com.cn	LU, Xiaoye/K-3611-2019		Shanghai Health Bureau; Shanghai Jiao Tong University	Shanghai Health Bureau; Shanghai Jiao Tong University	This study was supported by Shanghai Health Bureau Outstanding Young Medical Professional Program (S.Y.) and Shanghai Jiao Tong University SMC Scholar (S.Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afeltra A, 2003, NEUROLOGY, V61, P108, DOI 10.1212/01.WNL.0000058904.94330.A7; Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; ALARCONSEGOVIA D, 1978, NATURE, V271, P67, DOI 10.1038/271067a0; AlarconSegovia D, 1996, IMMUNOL TODAY, V17, P163; Arabo A, 2005, BEHAV BRAIN RES, V165, P126, DOI 10.1016/j.bbr.2005.06.038; Arnold SE, 1996, J COMP NEUROL, V367, P293, DOI 10.1002/(SICI)1096-9861(19960401)367:2<293::AID-CNE10>3.0.CO;2-S; Athlan ES, 1997, J BIOL CHEM, V272, P31073, DOI 10.1074/jbc.272.49.31073; Barry DM, 2007, EXP CELL RES, V313, P2110, DOI 10.1016/j.yexcr.2007.03.011; Beaulieu JM, 1999, BIOCHEM CELL BIOL, V77, P41, DOI 10.1139/bcb-77-1-41; Bhanji RA, 2007, CLIN IMMUNOL, V125, P247, DOI 10.1016/j.clim.2007.07.016; Cairns NJ, 2004, ACTA NEUROPATHOL, V108, P213, DOI 10.1007/s00401-004-0882-7; Cairns NJ, 2004, NEUROLOGY, V63, P1376; Chan SO, 1996, NEUROCHEM RES, V21, P449, DOI 10.1007/BF02527709; Chan SO, 1997, BRAIN RES, V775, P107, DOI 10.1016/S0006-8993(97)00834-2; Chien CL, 2005, J NEUROSCI RES, V80, P693, DOI 10.1002/jnr.20506; CHIEN CL, 1994, GENE, V149, P289, DOI 10.1016/0378-1119(94)90163-5; Chien CL, 1996, J NEUROBIOL, V29, P304, DOI 10.1002/(SICI)1097-4695(199603)29:3<304::AID-NEU3>3.0.CO;2-D; CHING GY, 1991, J BIOL CHEM, V266, P19459; Ching GY, 1999, J NEUROSCI, V19, P2974; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Colasanti T, 2009, J NEUROIMMUNOL, V212, P3, DOI 10.1016/j.jneuroim.2009.05.003; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Diamond B, 2006, ADV IMMUNOL, V89, P289, DOI 10.1016/S0065-2776(05)89007-8; Diamond B, 2003, ARTHRITIS RHEUM, V48, P2710, DOI 10.1002/art.11278; Diamond B, 2006, PLOS MED, V3, P2186, DOI 10.1371/journal.pmed.0030498; FLIEGNER KH, 1990, EMBO J, V9, P749, DOI 10.1002/j.1460-2075.1990.tb08169.x; FLIEGNER KH, 1994, J COMP NEUROL, V342, P161, DOI 10.1002/cne.903420202; Fragoso-Loyo H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003347; Ho CL, 1996, CANCER METAST REV, V15, P483, DOI 10.1007/BF00054014; HOFFMAN SA, 1987, CLIN EXP IMMUNOL, V70, P74; Huerta PT, 2006, P NATL ACAD SCI USA, V103, P678, DOI 10.1073/pnas.0510055103; Huizinga TWJ, 2008, LUPUS, V17, P376, DOI 10.1177/0961203308090112; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; Katzav A, 2008, J AUTOIMMUN, V31, P393, DOI 10.1016/j.jaut.2008.09.002; Kimura A, 2008, LUPUS, V17, P16, DOI 10.1177/0961203307085112; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Kozora E, 2004, ARTHRIT RHEUM-ARTHR, V51, P810, DOI 10.1002/art.20692; Lalonde R, 2003, REV NEUROSCIENCE, V14, P369; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Lawrence DA, 2007, J NEUROIMMUNOL, V182, P185, DOI 10.1016/j.jneuroim.2006.10.017; Lee JY, 2009, NAT MED, V15, P91, DOI 10.1038/nm.1892; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LEE MK, 1994, CURR OPIN CELL BIOL, V6, P34, DOI 10.1016/0955-0674(94)90113-9; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Lefranc D, 2007, ARTHRITIS RHEUM-US, V56, P3420, DOI 10.1002/art.22863; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lu X, 2008, LUPUS, V17, P323, DOI 10.1177/0961203307088005; LU X, 2010, LUPUS           0223; Ma XX, 2006, J NEUROIMMUNOL, V179, P26, DOI 10.1016/j.jneuroim.2006.06.023; Maric D, 2001, BRAIN RES, V920, P183, DOI 10.1016/S0006-8993(01)03060-8; Matus S, 2007, J EXP MED, V204, P3221, DOI 10.1084/jem.20071285; Monastero R, 2001, J NEUROL SCI, V184, P33, DOI 10.1016/S0022-510X(00)00492-5; Mondal TK, 2008, BRAIN BEHAV IMMUN, V22, P949, DOI 10.1016/j.bbi.2008.01.013; NARENDRAN A, 1989, J NEUROIMMUNOL, V24, P113, DOI 10.1016/0165-5728(89)90105-7; Nie BM, 2008, NEUROPHARMACOLOGY, V54, P845, DOI 10.1016/j.neuropharm.2008.01.003; Nie BM, 2006, CHEM-BIOL INTERACT, V160, P225, DOI 10.1016/j.cbi.2006.02.001; Nived O, 2003, LUPUS, V12, P872, DOI 10.1191/0961203303lu495oa; PACHTER JS, 1985, J CELL BIOL, V101, P1316, DOI 10.1083/jcb.101.4.1316; Rajasalu T, 2004, IMMUNOL LETT, V94, P153, DOI 10.1016/j.imlet.2004.05.002; ROBBINS ML, 1988, ARTHRITIS RHEUM, V31, P623, DOI 10.1002/art.1780310507; Robertson J, 2002, BIOCHIMIE, V84, P1151, DOI 10.1016/S0300-9084(02)00025-1; Sabbadini MG, 1999, LUPUS, V8, P11, DOI 10.1191/096120399678847344; Sakic B, 2005, BIOL PSYCHIAT, V57, P679, DOI 10.1016/j.biopsych.2004.11.037; Sanna G, 2000, LUPUS, V9, P573, DOI 10.1191/096120300678828695; Sanna G, 2003, RHEUMATOLOGY, V42, P200, DOI 10.1093/rheumatology/keg080; Sasajima T, 2006, J NEUROIMMUNOL, V181, P150, DOI 10.1016/j.jneuroim.2006.09.003; Senecal JL, 2004, J RHEUMATOL, V31, P2093; SENECAL JL, 1988, ARTHRITIS RHEUM, V31, P864, DOI 10.1002/art.1780310707; Shea TB, 1999, CELL MOTIL CYTOSKEL, V43, P322, DOI 10.1002/(SICI)1097-0169(1999)43:4<322::AID-CM5>3.0.CO;2-B; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Shoenfeld Y, 2003, LUPUS, V12, P436, DOI 10.1191/0961203303lu409oa; Shoenfeld Y, 2008, J AUTOIMMUN, V30, P74, DOI 10.1016/j.jaut.2007.11.011; Sidor MM, 2005, J NEUROIMMUNOL, V165, P104, DOI 10.1016/j.jneuroim.2005.04.022; Sled JG, 2009, ARTHRITIS RHEUM-US, V60, P1764, DOI 10.1002/art.24523; Stinton LM, 2004, CLIN IMMUNOL, V110, P30, DOI 10.1016/j.clim.2003.10.005; Tin SK, 2005, J NEUROIMMUNOL, V169, P153, DOI 10.1016/j.jneuroim.2005.07.015; Trysberg E, 2003, ARTHRITIS RHEUM, V48, P2881, DOI 10.1002/art.11279; Watanabe H, 2004, BIOCHEM BIOPH RES CO, V321, P949, DOI 10.1016/j.bbrc.2004.07.051; Williams RC, 2004, ARTHRITIS RHEUM-US, V50, P1239, DOI 10.1002/art.20156; Williams RC, 1999, CLIN EXP RHEUMATOL, V17, P643; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Zack DJ, 1996, J IMMUNOL, V157, P2082; Zameer A, 2004, J NEUROIMMUNOL, V146, P133, DOI 10.1016/j.jneuroim.2003.10.052; Zhang J, 2009, J AUTOIMMUN, V33, P270, DOI 10.1016/j.jaut.2009.03.011; Zhang WW, 2008, NEUROSCI LETT, V443, P241, DOI 10.1016/j.neulet.2008.07.048; 1999, ARTHRITIS RHEUM, V42, P599	88	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11124	10.1371/journal.pone.0011124	http://dx.doi.org/10.1371/journal.pone.0011124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559547	Green Submitted, gold, Green Published			2022-12-25	WOS:000278775900014
J	Spraggon, G; Koesema, E; Scarselli, M; Malito, E; Biagini, M; Norais, N; Emolo, C; Barocchi, MA; Giusti, F; Hilleringmann, M; Rappuoli, R; Lesley, S; Covacci, A; Masignani, V; Ferlenghi, I				Spraggon, Glen; Koesema, Eric; Scarselli, Maria; Malito, Enrico; Biagini, Massimiliano; Norais, Nathalie; Emolo, Carla; Barocchi, Michele Anne; Giusti, Fabiola; Hilleringmann, Markus; Rappuoli, Rino; Lesley, Scott; Covacci, Antonello; Masignani, Vega; Ferlenghi, Ilaria			Supramolecular Organization of the Repetitive Backbone Unit of the Streptococcus pneumoniae Pilus	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; STRUCTURAL GENOMICS; IV PILI; SORTASE; SURFACE; VIRULENCE; SOFTWARE; PYOGENES; ADHESION; SEQUENCE	Streptococcus pneumoniae, like many other Gram-positive bacteria, assembles long filamentous pili on their surface through which they adhere to host cells. Pneumococcal pili are formed by a backbone, consisting of the repetition of the major component RrgB, and two accessory proteins (RrgA and RrgC). Here we reconstruct by transmission electron microscopy and single particle image reconstruction method the three dimensional arrangement of two neighbouring RrgB molecules, which represent the minimal repetitive structural domain of the native pilus. The crystal structure of the D2-D4 domains of RrgB was solved at 1.6 angstrom resolution. Rigid-body fitting of the X-ray coordinates into the electron density map enabled us to define the arrangement of the backbone subunits into the S. pneumoniae native pilus. The quantitative fitting provide evidence that the pneumococcal pilus consists uniquely of RrgB monomers assembled in a head-to-tail organization. The presence of short intra-subunit linker regions connecting neighbouring domains provides the molecular basis for the intrinsic pilus flexibility.	[Spraggon, Glen; Koesema, Eric; Malito, Enrico; Lesley, Scott] Genom Inst Novartis Res Fdn, San Diego, CA USA; [Scarselli, Maria; Malito, Enrico; Biagini, Massimiliano; Norais, Nathalie; Emolo, Carla; Barocchi, Michele Anne; Hilleringmann, Markus; Rappuoli, Rino; Covacci, Antonello; Masignani, Vega; Ferlenghi, Ilaria] Novartis Vaccines & Diagnost, Siena, Italy; [Giusti, Fabiola] Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy	Novartis; Novartis; University of Siena	Spraggon, G (corresponding author), Genom Inst Novartis Res Fdn, San Diego, CA USA.	gspraggon@gnf.org; ilaria.ferlenghi@novartis.com		Hilleringmann, Markus/0000-0001-7745-2038; Koesema, Eric/0000-0002-7743-0127	Novartis Vaccines and Diagnostics; Office of Science, Office of Basic Energy Sciences, Material Sciences Division of the U.S. Department of Energy [DE-AC03-76SF00098]	Novartis Vaccines and Diagnostics; Office of Science, Office of Basic Energy Sciences, Material Sciences Division of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by internal funding from Novartis Vaccines and Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Peter Schultz for continued support. The work in this paper is based on experiments conducted at beamline 5.0.3 of the advanced light source (ALS). The ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, Material Sciences Division of the U.S. Department of Energy under contract No. DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory. The Department of Evolutionary Biology of the University of Siena, Italy (Prof. Dallai R.) for the use of microscopy facilities and for all the valuable help.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; ABE S, 1990, JPN J VET SCI, V52, P11; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Elena SF, 2005, INT MICROBIOL, V8, P271; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; HARAUZ G, 1986, OPTIK, V73, P146; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Lesley M, 2002, CIN-COMPUT INFORM NU, V20, P229, DOI 10.1097/00024665-200211000-00008; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Salih O, 2008, J MOL BIOL, V379, P174, DOI 10.1016/j.jmb.2008.03.056; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WENYUAN S, 2002, INFECT IMMUN, V70, P1	56	50	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e10919	10.1371/journal.pone.0010919	http://dx.doi.org/10.1371/journal.pone.0010919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559564	Green Published, Green Submitted, gold			2022-12-25	WOS:000278775900002
J	Staubert, C; Boselt, I; Bohnekamp, J; Rompler, H; Enard, W; Schoneberg, T				Staeubert, Claudia; Boeselt, Iris; Bohnekamp, Jens; Roempler, Holger; Enard, Wolfgang; Schoeneberg, Torsten			Structural and Functional Evolution of the Trace Amine-Associated Receptors TAAR3, TAAR4 and TAAR5 in Primates	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; PROTEIN-COUPLED RECEPTORS; PHYLOGENETIC ANALYSIS; AMPHETAMINE; MODELS; FAMILY; SITES	The family of trace amine-associated receptors (TAAR) comprises 9 mammalian TAAR subtypes, with intact gene and pseudogene numbers differing considerably even between closely related species. To date the best characterized subtype is TAAR1, which activates the G(s) protein/adenylyl cyclase pathway upon stimulation by trace amines and psychoactive substances like MDMA or LSD. Recently, chemosensory function involving recognition of volatile amines was proposed for murine TAAR3, TAAR4 and TAAR5. Humans can smell volatile amines despite carrying open reading frame (ORF) disruptions in TAAR3 and TAAR4. Therefore, we set out to study the functional and structural evolution of these genes with a special focus on primates. Functional analyses showed that ligands activating the murine TAAR3, TAAR4 and TAAR5 do not activate intact primate and mammalian orthologs, although they evolve under purifying selection and hence must be functional. We also find little evidence for positive selection that could explain the functional differences between mouse and other mammals. Our findings rather suggest that the previously identified volatile amine TAAR3-5 agonists reflect the high agonist promiscuity of TAAR, and that the ligands driving purifying selection of these TAAR in mouse and other mammals still await discovery. More generally, our study points out how analyses in an evolutionary context can help to interpret functional data generated in single species.	[Staeubert, Claudia; Boeselt, Iris; Bohnekamp, Jens; Roempler, Holger; Schoeneberg, Torsten] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany; [Enard, Wolfgang] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany	Leipzig University; Max Planck Society	Staubert, C (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany.	schoberg@medizin.uni-leipzig.de	Enard, Wolfgang/K-3483-2014; Stäubert, Claudia/I-7397-2015	Stäubert, Claudia/0000-0003-0721-8507	Deutsche Forschungsgemeinschaft [SFB 610 TP A10]; Bundesministerium fur Bildung und Forschung (BMBF); LIFE (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment); German National Academic Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); LIFE (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment); German National Academic Foundation	This work was supported by the Deutsche Forschungsgemeinschaft, SFB 610 TP A10, Bundesministerium fur Bildung und Forschung (BMBF), LIFE (Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes and Environment) and the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai T, 2003, P NATL ACAD SCI USA, V100, P7708, DOI 10.1073/pnas.1230533100; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dupanloup I, 2006, BIOINFORMATICS, V22, P1815, DOI 10.1093/bioinformatics/btl280; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 1993, PHYLIP  PHYLOGENY IN; Gloriam DEI, 2005, MOL PHYLOGENET EVOL, V35, P470, DOI 10.1016/j.ympev.2004.12.003; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Grandy DK, 2007, PHARMACOL THERAPEUT, V116, P355, DOI 10.1016/j.pharmthera.2007.06.007; HASHIGUCHI Y, 2007, MOL BIOL EVOL; Hill Stephen J., 2001, Current Opinion in Pharmacology, V1, P526, DOI 10.1016/S1471-4892(01)00091-1; Hughes AL, 2007, HEREDITY, V99, P364, DOI 10.1038/sj.hdy.6801031; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lindemann L, 2005, TRENDS PHARMACOL SCI, V26, P274, DOI 10.1016/j.tips.2005.03.007; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Page SL, 2001, MOL PHYLOGENET EVOL, V18, P14, DOI 10.1006/mpev.2000.0895; Reese EA, 2007, J PHARMACOL EXP THER, V321, P178, DOI 10.1124/jpet.106.115402; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sangkuhl Katrin, 2005, Hum Mutat, V25, P505, DOI 10.1002/humu.9337; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; SNEAD AN, 2008, BIOORG MED CHEM LETT; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarnow P, 2003, J BIOL CHEM, V278, P48666, DOI 10.1074/jbc.M309941200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wainscott DB, 2007, J PHARMACOL EXP THER, V320, P475, DOI 10.1124/jpet.106.112532; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	38	43	44	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11133	10.1371/journal.pone.0011133	http://dx.doi.org/10.1371/journal.pone.0011133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559446	Green Published, gold, Green Submitted			2022-12-25	WOS:000278775900022
J	Oliveira, DL; Nakayasu, ES; Joffe, LS; Guimaraes, AJ; Sobreira, TJP; Nosanchuk, JD; Cordero, RJB; Frases, S; Casadevall, A; Almeida, IC; Nimrichter, L; Rodrigues, ML				Oliveira, Debora L.; Nakayasu, Ernesto S.; Joffe, Luna S.; Guimaraes, Allan J.; Sobreira, Tiago J. P.; Nosanchuk, Joshua D.; Cordero, Radames J. B.; Frases, Susana; Casadevall, Arturo; Almeida, Igor C.; Nimrichter, Leonardo; Rodrigues, Marcio L.			Characterization of Yeast Extracellular Vesicles: Evidence for the Participation of Different Pathways of Cellular Traffic in Vesicle Biogenesis	PLOS ONE			English	Article							UNCONVENTIONAL PROTEIN SECRETION; SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; FINE-STRUCTURE; MECHANISM; IDENTIFICATION; PROTEOMICS; TRANSPORT	Background: Extracellular vesicles in yeast cells are involved in the molecular traffic across the cell wall. In yeast pathogens, these vesicles have been implicated in the transport of proteins, lipids, polysaccharide and pigments to the extracellular space. Cellular pathways required for the biogenesis of yeast extracellular vesicles are largely unknown. Methodology/Principal Findings: We characterized extracellular vesicle production in wild type (WT) and mutant strains of the model yeast Saccharomyces cerevisiae using transmission electron microscopy in combination with light scattering analysis, lipid extraction and proteomics. WT cells and mutants with defective expression of Sec4p, a secretory vesicle-associated Rab GTPase essential for Golgi-derived exocytosis, or Snf7p, which is involved in multivesicular body (MVB) formation, were analyzed in parallel. Bilayered vesicles with diameters at the 100-300 nm range were found in extracellular fractions from yeast cultures. Proteomic analysis of vesicular fractions from the cells aforementioned and additional mutants with defects in conventional secretion pathways (sec1-1, fusion of Golgi-derived exocytic vesicles with the plasma membrane; bos1-1, vesicle targeting to the Golgi complex) or MVB functionality (vps23, late endosomal trafficking) revealed a complex and interrelated protein collection. Semi-quantitative analysis of protein abundance revealed that mutations in both MVB- and Golgi-derived pathways affected the composition of yeast extracellular vesicles, but none abrogated vesicle production. Lipid analysis revealed that mutants with defects in Golgi-related components of the secretory pathway had slower vesicle release kinetics, as inferred from intracellular accumulation of sterols and reduced detection of these lipids in vesicle fractions in comparison with WT cells. Conclusions/Significance: Our results suggest that both conventional and unconventional pathways of secretion are required for biogenesis of extracellular vesicles, which demonstrate the complexity of this process in the biology of yeast cells.	[Oliveira, Debora L.; Joffe, Luna S.; Nimrichter, Leonardo; Rodrigues, Marcio L.] Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, Rio De Janeiro, Brazil; [Nakayasu, Ernesto S.; Almeida, Igor C.] Univ Texas El Paso, Border Biomed Res Ctr, Dept Biol Sci, El Paso, TX 79968 USA; [Guimaraes, Allan J.; Nosanchuk, Joshua D.; Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Sobreira, Tiago J. P.] Univ Sao Paulo, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Nosanchuk, Joshua D.; Cordero, Radames J. B.; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Frases, Susana] Inst Nacl Metrol Normalizacao & Qualidade Ind, Lab Biotecnol, Rio De Janeiro, Brazil	University of Texas System; University of Texas El Paso; Yeshiva University; Albert Einstein College of Medicine; Universidade de Sao Paulo; Yeshiva University; Albert Einstein College of Medicine; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO)	Oliveira, DL (corresponding author), Inst Microbiol Prof Paulo de Goes, Lab Estudos Integrados Bioquim Microbiana, Rio De Janeiro, Brazil.	marcio@micro.ufrj.br	Nakayasu, Ernesto S./AAJ-8374-2020; Frases, Susana/W-9502-2019; Guimaraes, Allan/AAQ-2343-2020; Almeida, Igor C./AAF-9409-2019; Nimrichter, Leonardo/L-3545-2014; Guimaraes, Allan J/E-2160-2014; Rodrigues, Marcio/J-3727-2013; Cordero, Radamés JB/F-6912-2011; Sobreira, Tiago/C-1276-2008; Nosanchuk, Joshua/AAS-7801-2021	Nakayasu, Ernesto S./0000-0002-4056-2695; Frases, Susana/0000-0001-5875-9886; Guimaraes, Allan/0000-0002-2856-9667; Almeida, Igor C./0000-0002-2443-8213; Nimrichter, Leonardo/0000-0001-9281-6856; Guimaraes, Allan J/0000-0002-2856-9667; Rodrigues, Marcio/0000-0002-6081-3439; Cordero, Radamés JB/0000-0002-3026-7094; Sobreira, Tiago/0000-0002-0217-0084; 	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); NIH [HL059842, AI033774, AI052733, AI033142, AI52733-06A1, AI056070-01A2]; Interhemispheric Research Training Grant in Infectious Diseases, Fogarty International Center (NIH) [D43-TW007129]; Hirschl/Weill-Caulier Career Scientist Award; Training Program in Cellular and Molecular 414 Biology and Genetics [T32 GM007491]; NIH/NCRR [5G12RR008124-16A1]; Graduate School, University of Texas at El-Paso (UTEP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil; Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El-Paso (NIH) [5G12RR008124-16A1, 5G12RR008124-16A1S1]; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033774, R01AI056070, R37AI033142, R01AI052733, R01AI033142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interhemispheric Research Training Grant in Infectious Diseases, Fogarty International Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Hirschl/Weill-Caulier Career Scientist Award; Training Program in Cellular and Molecular 414 Biology and Genetics; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Graduate School, University of Texas at El-Paso (UTEP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El-Paso (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LN and MLR are supported by grants from the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). AC is supported by NIH awards HL059842, AI033774, AI052733, AI033142. AJG and LN were supported in part by an Interhemispheric Research Training Grant in Infectious Diseases, Fogarty International Center (NIH D43-TW007129). JDN is supported in part by NIH AI52733-06A1 and AI056070-01A2, and a Hirschl/Weill-Caulier Career Scientist Award. RJBC was supported by the Training Program in Cellular and Molecular 414 Biology and Genetics, T32 GM007491. ICA was partially supported by the NIH/NCRR grant 5G12RR008124-16A1. ESN was partially supported by the George A. Krutilek memorial graduate scholarship from Graduate School, University of Texas at El-Paso (UTEP). TJPS was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil. The authors thank the Biomolecule Analysis Core Facility, Border Biomedical Research Center/Biology/University of Texas at El-Paso (NIH grants #5G12RR008124-16A1 and 5G12RR008124-16A1S1), for the access to the LC-MS instrumentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Casadevall A, 2009, TRENDS MICROBIOL, V17, P158, DOI 10.1016/j.tim.2008.12.005; Chakraburtty K, 1998, BIOL CHEM, V379, P831, DOI 10.1515/bchm.1998.379.7.831; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; De Jesus M, 2009, EUKARYOT CELL, V8, P96, DOI 10.1128/EC.00331-08; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Eisenman HC, 2009, MICROBIOL-SGM, V155, P3860, DOI 10.1099/mic.0.032854-0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; Gatti JL, 2005, BIOL REPROD, V72, P1452, DOI 10.1095/biolreprod.104.036426; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Hu GG, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030042; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jurado JD, 2007, TOXICON, V49, P339, DOI 10.1016/j.toxicon.2006.10.004; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kovalchuke O, 1998, EUR J BIOCHEM, V258, P986, DOI 10.1046/j.1432-1327.1998.2580986.x; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Luo WJ, 1997, J CELL BIOL, V138, P731, DOI 10.1083/jcb.138.4.731; Martineau CN, 2007, GENETICS, V177, P1679, DOI 10.1534/genetics.107.081141; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Nakayasu ES, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.13; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nicola AM, 2009, EUKARYOT CELL, V8, P1373, DOI 10.1128/EC.00044-09; Nosanchuk Joshua D, 2008, Commun Integr Biol, V1, P37; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Oliveira DL, 2009, FUNGAL GENET BIOL, V46, P956, DOI 10.1016/j.fgb.2009.09.001; OLIVEIRA DL, INFECT IMMUN; Panepinto J, 2009, MOL MICROBIOL, V71, P1165, DOI 10.1111/j.1365-2958.2008.06588.x; Pereira RD, 1999, MOL CELL BIOCHEM, V201, P17, DOI 10.1023/A:1007007704657; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Schekman R, 2002, NAT MED, V8, P1055, DOI 10.1038/nm769; SCHEKMAN R, 1983, METHOD ENZYMOL, V96, P802; SCHEKMAN R, 2004, CELL, V116, pS19; Schekman Randy, 2004, Cell, VS116, pS13, DOI 10.1016/S0092-8674(03)00972-3; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Stephens DJ, 2001, J CELL SCI, V114, P1053; TAKEO K, 1973, J BACTERIOL, V113, P1442, DOI 10.1128/JB.113.3.1442-1448.1973; TAKEO K, 1973, J BACTERIOL, V113, P1449, DOI 10.1128/JB.113.3.1449-1454.1973; TU JL, 1993, GENETICS, V135, P17; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wuestehube LJ, 1996, GENETICS, V142, P393; Yoneda A, 2006, MOL BIOL CELL, V17, P5131, DOI 10.1091/mbc.E06-08-0701	64	157	163	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11113	10.1371/journal.pone.0011113	http://dx.doi.org/10.1371/journal.pone.0011113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559436	gold, Green Submitted, Green Published			2022-12-25	WOS:000278741100024
J	Marchese, FP; Aubareda, A; Tudor, C; Saklatvala, J; Clark, AR; Dean, JLE				Marchese, Francesco P.; Aubareda, Anna; Tudor, Corina; Saklatvala, Jeremy; Clark, Andrew R.; Dean, Jonathan L. E.			MAPKAP Kinase 2 Blocks Tristetraprolin-directed mRNA Decay by Inhibiting CAF1 Deadenylase Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AU-RICH ELEMENTS; POLY(A) BINDING-PROTEIN; P38 SIGNALING CASCADE; GENE-EXPRESSION; STABILITY; ALPHA; LOCALIZATION; TTP; CYCLOOXYGENASE-2	Tristetraprolin (TTP) directs its target AU-rich element (ARE)-containing mRNAs for degradation by promoting removal of the poly(A) tail. The p38 MAPK pathway regulates mRNA stability via the downstream kinase MAPK-activated protein kinase 2 (MAPKAP kinase 2 or MK2), which phosphorylates and prevents the mRNA-destabilizing function of TTP. We show that deadenylation of endogenous ARE-containing tumor necrosis factor mRNA is inhibited by p38 MAPK. To investigate whether phosphorylation of TTP by MK2 regulates TTP-directed deadenylation of ARE-containing mRNAs, we used a cell-free assay that reconstitutes the mechanism in vitro. We find that phosphorylation of Ser-52 and Ser-178 of TTP by MK2 results in inhibition of TTP-directed deadenylation of ARE-containing RNA. The use of 14-3-3 protein antagonists showed that regulation of TTP-directed deadenylation by MK2 is independent of 14-3-3 binding to TTP. To investigate the mechanism whereby TTP promotes deadenylation, it was necessary to identify the deadenylases involved. The carbon catabolite repressor protein (CCR)4.CCR4-associated factor (CAF)1 complex was identified as the major source of deadenylase activity in HeLa cells responsible for TTP-directed deadenylation. CAF1a and CAF1b were found to interact with TTP in an RNA-independent fashion. We find that MK2 phosphorylation reduces the ability of TTP to promote deadenylation by inhibiting the recruitment of CAF1 deadenylase in a mechanism that does not involve sequestration of TTP by 14-3-3. Cyclooxygenase-2 mRNA stability is increased in CAF1-depleted cells in which it is no longer p38 MAPK/MK2-regulated.	[Marchese, Francesco P.; Aubareda, Anna; Tudor, Corina; Saklatvala, Jeremy; Clark, Andrew R.; Dean, Jonathan L. E.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, Fac Med, London W6 8LH, England	Imperial College London; University of Oxford	Dean, JLE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, Fac Med, 65 Aspenlea Rd, London W6 8LH, England.	jonathan.dean@imperial.ac.uk	Marchese, Francesco P/AAA-6473-2021; Clark, Andrew/AAN-4043-2021	Marchese, Francesco P/0000-0002-6028-117X; Dean, Jonathan/0000-0002-0703-2756; Clark, Andy/0000-0003-4996-8322	Arthritis Research UK; MRC [G8623776] Funding Source: UKRI; Medical Research Council [G8623776] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are most grateful to J. Steitz, S. Hoshino, A. Virtanen, and M. Brook for provision of reagents. We also acknowledge Arthritis Research UK for support.	Alford KA, 2007, J BIOL CHEM, V282, P6232, DOI 10.1074/jbc.M610987200; Boeck R, 1996, J BIOL CHEM, V271, P432, DOI 10.1074/jbc.271.1.432; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Clark AR, 2009, ARTHRITIS RHEUM-US, V60, P3513, DOI 10.1002/art.24919; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Dean JLE, 2003, J BIOL CHEM, V278, P39470, DOI 10.1074/jbc.M306345200; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Korner CG, 1997, J BIOL CHEM, V272, P10448; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V295, pG421, DOI 10.1152/ajpgi.00508.2007; Schwede A, 2008, NUCLEIC ACIDS RES, V36, P3374, DOI 10.1093/nar/gkn108; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tchen CR, 2004, J BIOL CHEM, V279, P32393, DOI 10.1074/jbc.M402059200; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Tudor C, 2009, FEBS LETT, V583, P1933, DOI 10.1016/j.febslet.2009.04.039; Voeltz GK, 2001, GENE DEV, V15, P774, DOI 10.1101/gad.872201; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196	44	118	120	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27590	27600		10.1074/jbc.M110.136473	http://dx.doi.org/10.1074/jbc.M110.136473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595389	Green Published, hybrid			2022-12-25	WOS:000281404100014
J	Patel, HH; Hamuro, LL; Chun, BJ; Kawaraguchi, Y; Quick, A; Rebolledo, B; Pennypacker, J; Thurston, J; Rodriguez-Pinto, N; Self, C; Olson, G; Insel, PA; Giles, WR; Taylor, SS; Roth, DM				Patel, Hemal H.; Hamuro, Lora L.; Chun, Byeong Jo; Kawaraguchi, Yoshitaka; Quick, Alexander; Rebolledo, Brian; Pennypacker, Juniper; Thurston, Jackie; Rodriguez-Pinto, Natalia; Self, Christopher; Olson, Gary; Insel, Paul A.; Giles, Wayne R.; Taylor, Susan S.; Roth, David M.			Disruption of Protein Kinase A Localization Using a Trans-activator of Transcription (TAT)-conjugated A-kinase-anchoring Peptide Reduces Cardiac Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I REGULATORY SUBUNIT; SIGNALING COMPLEX; HEART; PKA; BINDING; PHOSPHORYLATION; RECEPTOR; COMPARTMENTATION; SPECIFICITY; CHANNELS	Localization of protein kinase A (PKA) via A-kinase-anchoring proteins (AKAPs) is important for cAMP responsiveness in many cellular systems, and evidence suggests that AKAPs play an important role in cardiac signaling. To test the importance of AKAP-mediated targeting of PKA on cardiac function, we designed a cell-permeable peptide, which we termed trans-activator of transcription (TAT)-AKAD for TAT-conjugated A-kinase-anchoring disruptor, using the PKA binding region of AKAP10 and tested the effects of this peptide in isolated cardiac myocytes and in Langendorff-perfused mouse hearts. We initially validated TAT-AKAD as a PKA localization inhibitor in cardiac myocytes by the use of confocal microscopy and cellular fractionation to show that treatment with the peptide disrupts type I and type II PKA regulatory subunits. Knockdown of PKA activity was demonstrated by decrease in phosphorylation of phospholamban and troponin I after beta-adrenergic stimulation in isolated myocytes. Treatment with TAT-AKAD reduced myocyte shortening and rates of contraction and relaxation. Injection of TAT-AKAD (1 mu M), but not scrambled control peptide, into the coronary circulation of isolated perfused hearts rapidly (<1 min) and reversibly decreased heart rate and peak left ventricular developed pressure. TAT-AKAD also had a pronounced effect on developed pressure (-dP/dt), consistent with a delayed relaxation of the heart. The effects of TAT-AKAD on heart rate and contractility persisted in hearts pretreated with isoproterenol. Disruption of PKA localization with TAT-AKAD thus had negative effects on chronotropy, inotropy, and lusitropy, thereby indicating a key role for AKAP-targeted PKA in control of heart rate and contractile function.	[Patel, Hemal H.; Chun, Byeong Jo; Kawaraguchi, Yoshitaka; Quick, Alexander; Roth, David M.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Pennypacker, Juniper; Taylor, Susan S.] Univ Calif San Diego, Dept Chem Biochem, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Hamuro, Lora L.; Rodriguez-Pinto, Natalia; Self, Christopher; Olson, Gary] Provid Pharmaceut, N Brunswick, NJ 08902 USA; [Thurston, Jackie; Giles, Wayne R.] Univ Calgary, Calgary, AB, Canada; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92093 USA; [Rebolledo, Brian; Roth, David M.] Dept Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Calgary; Howard Hughes Medical Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Hamuro, LL (corresponding author), Merck Res Labs, Preclin Drug Metab, 770 Sumneytown Pike,POB 4, West Point, PA 19486 USA.	lora_hamuro@merck.com	Patel, Hemal/C-7325-2019	Patel, Hemal/0000-0001-6722-9625; jeon, byeongjo/0000-0002-5240-4213	United States Public Health Service, National Institutes of Health [HL081400, HL066941, HL091071, DK054441, HL079788]; American Heart Association [060039N]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071, R43HL079788, R01HL081400, P01HL066941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	United States Public Health Service, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081400 (to D. M. R.), HL066941 (to P. A. I. and D. M. R.), HL091071 (to H. H. P.), DK054441 (to S. S. T.) and HL079788 (to L. L. H.) from the United States Public Health Service. This work was also supported by Scientist Development Grant 060039N (to H. H. P.) from the American Heart Association and a Veterans Affairs Merit grant (to D. M. R.) from the Department of Veterans Affairs.	Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; Brown RL, 2003, BIOCHEM BIOPH RES CO, V306, P394, DOI 10.1016/S0006-291X(03)00982-3; Burns LL, 2003, BIOCHEMISTRY-US, V42, P5754, DOI 10.1021/bi0265729; CADD GG, 1990, J BIOL CHEM, V265, P19502; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1992, J BIOL CHEM, V267, P13376; Clark D., 1996, GUIDE CARE USE LAB A; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Futaki S, 2003, J MOL RECOGNIT, V16, P260, DOI 10.1002/jmr.635; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Guy CA, 1997, METHOD ENZYMOL, V289, P67; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Kammerer S, 2003, P NATL ACAD SCI USA, V100, P4066, DOI 10.1073/pnas.2628028100; Kapiloff MS, 2002, MOL PHARMACOL, V62, P193, DOI 10.1124/mol.62.2.193; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Krall J, 1999, J MOL CELL CARDIOL, V31, P971, DOI 10.1006/jmcc.1999.0926; Landeen LK, 2008, AM J PHYSIOL-HEART C, V294, pH736, DOI 10.1152/ajpheart.00316.2007; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Neumann SA, 2009, PSYCHOPHYSIOLOGY, V46, P466, DOI 10.1111/j.1469-8986.2009.00802.x; Reinitz CA, 1997, ARCH BIOCHEM BIOPHYS, V348, P391, DOI 10.1006/abbi.1997.0401; RONA G, 1985, J MOL CELL CARDIOL, V17, P291, DOI 10.1016/S0022-2828(85)80130-9; Roth DM, 2004, AM J PHYSIOL-HEART C, V287, pH172, DOI 10.1152/ajpheart.01009.2003; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Sarma GN, 2010, STRUCTURE, V18, P155, DOI 10.1016/j.str.2009.12.012; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; SKALHEGG BS, 1994, SCIENCE, V263, P84, DOI 10.1126/science.8272870; Soughayer JS, 2004, BIOCHEMISTRY-US, V43, P8528, DOI 10.1021/bi036296d; Tingley WG, 2007, P NATL ACAD SCI USA, V104, P8461, DOI 10.1073/pnas.0610393104; Vinogradova TM, 2009, J MOL CELL CARDIOL, V47, P456, DOI 10.1016/j.yjmcc.2009.06.014; Waggoner Jason R, 2005, Heart Fail Clin, V1, P207, DOI 10.1016/j.hfc.2005.03.008; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Zhao M, 2004, MED RES REV, V24, P1, DOI 10.1002/med.10056	49	39	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27632	27640		10.1074/jbc.M110.146589	http://dx.doi.org/10.1074/jbc.M110.146589			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20581396	Green Published, hybrid			2022-12-25	WOS:000281404100019
J	Tolg, C; Hamilton, SR; Morningstar, L; Zhang, J; Zhang, S; Esguerra, KV; Telmer, PG; Luyt, LG; Harrison, R; McCarthy, JB; Turley, EA				Tolg, Cornelia; Hamilton, Sara R.; Morningstar, Lyndsey; Zhang, Jing; Zhang, S.; Esguerra, Kenneth V.; Telmer, Patrick G.; Luyt, Len G.; Harrison, Rene; McCarthy, James B.; Turley, Eva A.			RHAMM Promotes Interphase Microtubule Instability and Mitotic Spindle Integrity through MEK1/ERK1/2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYALURONAN-BINDING PROTEIN; SIGNAL-REGULATED KINASE; MEDIATED MOTILITY RHAMM; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; MAP KINASE; INTRACELLULAR HYALURONAN; FUNCTIONAL PROTEOMICS; CELL-PROLIFERATION; MULTIPLE-MYELOMA	An oncogenic form of RHAMM (receptor for hyaluronan-mediated motility, mouse, amino acids 163-794 termed RHAMM(Delta 163)) is a cell surface hyaluronan receptor and mitotic spindle protein that is highly expressed in aggressive human cancers. Its regulation of mitotic spindle integrity is thought to contribute to tumor progression, but the molecular mechanisms underlying this function have not previously been defined. Here, we report that intracellular RHAMM(Delta 163) modifies the stability of interphase and mitotic spindle microtubules through ERK1/2 activity. RHAMM(-/-) mouse embryonic fibroblasts exhibit strongly acetylated interphase microtubules, multi-pole mitotic spindles, aberrant chromosome segregation, and inappropriate cytokinesis during mitosis. These defects are rescued by either expression of RHAMM or mutant active MEK1. Mutational analyses show that RHAMM(Delta 163) binds to alpha- and beta-tubulin protein via a carboxyl-terminal leucine zipper, but in vitro analyses indicate this interaction does not directly contribute to tubulin polymerization/stability. Co-immunoprecipitation and pulldown assays reveal complexes of RHAMM(Delta 163), ERK1/2-MEK1, and alpha- and beta-tubulin and demonstrate direct binding of RHAMM(Delta 163) to ERK1 via a D-site motif. In vitro kinase analyses, expression of mutant RHAMM(Delta 163) defective in ERK1 binding in mouse embryonic fibroblasts, and blocking MEK1 activity collectively confirm that the effect of RHAMM(Delta 163) on interphase and mitotic spindle microtubules is mediated by ERK1/2 activity. Our results suggest a model wherein intracellular RHAMM(Delta 163) functions as an adaptor protein to control microtubule polymerization during interphase and mitosis as a result of localizing ERK1/2-MEK1 complexes to their tubulin-associated substrates.	[Esguerra, Kenneth V.; Luyt, Len G.; Turley, Eva A.] Univ Western Ontario, London Reg Canc Program, Dept Oncol & Chem, London, ON N6A 4L6, Canada; [Telmer, Patrick G.] Univ Western Ontario, London Reg Canc Program, Dept Oncol & Biochem, London, ON N6A 4L6, Canada; London Hlth Sci Ctr, London, ON N6A 4L6, Canada; [Harrison, Rene] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [McCarthy, James B.] Univ Minnesota, Mason Comprehens Canc Ctr, Tumor Biol & Res Program, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; University of Toronto; University Toronto Scarborough; University of Minnesota System; University of Minnesota Twin Cities	Turley, EA (corresponding author), Univ Western Ontario, London Reg Canc Program, Dept Oncol & Chem, London, ON N6A 4L6, Canada.	eva.turley@lhsc.on.ca	Luyt, Leonard/B-3543-2015	Luyt, Leonard/0000-0002-0941-4731; Hamilton, Sara/0000-0001-6062-2037	NCI [5R0119092]; Cancer Research Society, Montreal, Canada; Canadian Breast Cancer Society; London Regional Cancer Program	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Society, Montreal, Canada; Canadian Breast Cancer Society; London Regional Cancer Program	This work was supported, in whole or in part, by National Institutes of Health Grant 5R0119092 from NCI (to J. B. M. and E. A. T.). This work was also supported by a grant from the Cancer Research Society, Montreal, Canada (to E. A. T.), and by the Canadian Breast Cancer Society (partial salary to E. A. T.).; Supported by a Translational Breast Cancer Studentship from the London Regional Cancer Program.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Alberti C, 2009, EUR REV MED PHARMACO, V13, P13; Arce CA, 2008, FEBS J, V275, P4664, DOI 10.1111/j.1742-4658.2008.06615.x; Assmann V, 1999, J CELL SCI, V112, P3943; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bedard PL, 2010, NAT REV CLIN ONCOL, V7, P22, DOI 10.1038/nrclinonc.2009.186; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Crasta K, 2008, CELL CYCLE, V7, P2960, DOI 10.4161/cc.7.19.6783; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Evanko SP, 2004, J HISTOCHEM CYTOCHEM, V52, P1525, DOI 10.1369/jhc.4A6356.2004; Fang ZY, 2010, TRAFFIC, V11, P782, DOI 10.1111/j.1600-0854.2010.01062.x; Giannopoulos K, 2006, LEUKEMIA LYMPHOMA, V47, P2028, DOI 10.1080/10428190600709721; Greiner J, 2008, CLIN CANCER RES, V14, P7161, DOI 10.1158/1078-0432.CCR-08-1102; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Harrison RE, 2001, NEOPLASIA, V3, P385, DOI 10.1038/sj.neo.7900180; Holmfeldt P, 2009, CELL MOL LIFE SCI, V66, P3263, DOI 10.1007/s00018-009-0084-5; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kalmyrzaev B, 2008, CANCER EPIDEM BIOMAR, V17, P3618, DOI 10.1158/1055-9965.EPI-08-0216; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kim YH, 2008, BIOCHEM PHARMACOL, V75, P1946, DOI 10.1016/j.bcp.2008.02.016; Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511; Kotwaliwale C, 2006, CELL, V127, P1105, DOI 10.1016/j.cell.2006.11.032; Lefloch R, 2009, CELL CYCLE, V8, P705, DOI 10.4161/cc.8.5.7734; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Lynn BD, 2001, J COMP NEUROL, V439, P315, DOI 10.1002/cne.1353; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Matkovic K, 2009, INT J HEMATOL, V89, P159, DOI 10.1007/s12185-008-0248-3; Maxwell CA, 2005, CANCER RES, V65, P850; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.e02-07-0377; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Richter-Landsberg C, 2008, J MOL NEUROSCI, V35, P55, DOI 10.1007/s12031-007-9017-7; Roberts EC, 2006, PROTEOMICS, V6, P4541, DOI 10.1002/pmic.200600365; Schmitt M, 2008, BLOOD, V111, P1357, DOI 10.1182/blood-2007-07-099366; Schwartz J, 2009, AM J HEALTH-SYST PH, V66, pS3, DOI 10.2146/ajhp090438; Shinohara M, 2006, MOL BIOL CELL, V17, P5227, DOI 10.1091/mbc.E06-04-0284; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Sturgill TW, 2008, BIOCHEM BIOPH RES CO, V371, P1, DOI 10.1016/j.bbrc.2008.04.002; Tillement V, 2009, BIOL CELL, V101, P1, DOI 10.1042/BC20070162; Tolg C, 2003, ONCOGENE, V22, P6873, DOI 10.1038/sj.onc.1206811; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; von Dassow G, 2009, TRENDS CELL BIOL, V19, P165, DOI 10.1016/j.tcb.2009.01.008; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wang C, 1998, CLIN CANCER RES, V4, P567; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Xia F, 2008, MOL CELL BIOL, V28, P5299, DOI 10.1128/MCB.02039-07; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882; Ziebell MR, 2004, J COMPUT AID MOL DES, V18, P597, DOI 10.1007/s10822-004-5433-8	62	65	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26461	26474		10.1074/jbc.M110.121491	http://dx.doi.org/10.1074/jbc.M110.121491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558733	Green Published, hybrid			2022-12-25	WOS:000280921000064
J	Sanchez, J; Talamillo, A; Lopitz-Otsoa, F; Perez, C; Hjerpe, R; Sutherland, JD; Herboso, L; Rodriguez, MS; Barrio, R				Sanchez, Jonatan; Talamillo, Ana; Lopitz-Otsoa, Fernando; Perez, Coralia; Hjerpe, Roland; Sutherland, James D.; Herboso, Leire; Rodriguez, Manuel S.; Barrio, Rosa			Sumoylation Modulates the Activity of Spalt-like Proteins during Wing Development in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOWNES-BROCKS-SYNDROME; GENE-COMPLEX; OKIHIRO-SYNDROME; MUTATIONS; SALL1; UBC9; MORPHOGENESIS; MELANOGASTER; EXPRESSION; ENCODES	The Spalt-like family of zinc finger transcription factors is conserved throughout evolution and is involved in fundamental processes during development and during embryonic stem cell maintenance. Although human SALL1 is modified by SUMO-1 in vitro, it is not known whether this post-translational modification plays a role in regulating the activity of this family of transcription factors. Here, we show that the Drosophila Spalt transcription factors are modified by sumoylation. This modification influences their nuclear localization and capacity to induce vein formation through the regulation of target genes during wing development. Furthermore, spalt genes interact genetically with the sumoylation machinery to repress vein formation in intervein regions and to attain the wing final size. Our results suggest a new level of regulation of Sall activity in vivo during animal development through post-translational modification by sumoylation. The evolutionary conservation of this family of transcription factors suggests a functional role for sumoylation in vertebrate Sall members.	[Sutherland, James D.; Herboso, Leire; Rodriguez, Manuel S.; Barrio, Rosa] CIC bioGUNE, Derio 48160, Bizkaia, Spain; [Rodriguez, Manuel S.] CIC bioGUNE CIBERehd, Leioa 48940, Spain; [Rodriguez, Manuel S.] Univ Basque Country, Leioa 48940, Spain	CIC bioGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; University of Basque Country	Barrio, R (corresponding author), CIC bioGUNE, Bizkaia Technol Pk, Derio 48160, Bizkaia, Spain.	rbarrio@cicbiogune.es	Sutherland, James D/K-2686-2014; Barrio, Rosa/F-8712-2011; Lopitz-Otsoa, Fernando/A-1966-2017; Talamillo, Ana/AAA-4633-2019; RODRIGUEZ, Manuel S./D-5439-2018	Sutherland, James D/0000-0003-3229-793X; Barrio, Rosa/0000-0002-9663-0669; Lopitz-Otsoa, Fernando/0000-0001-8452-6939; Talamillo, Ana/0000-0003-3089-7675; Perez Fernandez, Coralia/0000-0002-1195-2563	Spanish Ministerio de Ciencia e Innovacion [BFU2008-01884, CSD2007-008-25120]; Departments of Education and Industry of the Basque Government [PI2009-16]; Etortek Research Programs; Bizkaia County	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Departments of Education and Industry of the Basque Government; Etortek Research Programs; Bizkaia County	This work was supported by Spanish Ministerio de Ciencia e Innovacion Grants BFU2008-01884 and CSD2007-008-25120, Departments of Education and Industry of the Basque Government Grant PI2009-16 and Etortek Research Programs 2008/2009, and the Bizkaia County.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Apionishev S, 2001, GENES CELLS, V6, P215, DOI 10.1046/j.1365-2443.2001.00413.x; Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434; Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101; Barrio R, 1996, DEV GENES EVOL, V206, P315, DOI 10.1007/s004270050058; Barrio R, 2007, DEV BIOL, V306, P66, DOI 10.1016/j.ydbio.2007.02.039; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bohren KM, 2007, PROTEIN EXPRES PURIF, V54, P289, DOI 10.1016/j.pep.2007.03.013; de Celis JF, 1999, DEVELOPMENT, V126, P2653; de Celis JF, 2000, MECH DEVELOP, V91, P31, DOI 10.1016/S0925-4773(99)00261-0; de Celis JF, 2009, INT J DEV BIOL, V53, P1385, DOI 10.1387/ijdb.072408jd; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lauberth SM, 2007, J BIOL CHEM, V282, P34858, DOI 10.1074/jbc.M703702200; Lunde K, 1998, DEVELOPMENT, V125, P4145; Miles WO, 2008, GENE DEV, V22, P2578, DOI 10.1101/gad.494808; Netzer C, 2002, BIOCHEM BIOPH RES CO, V296, P870, DOI 10.1016/S0006-291X(02)02003-X; Netzer C, 2001, HUM MOL GENET, V10, P3017, DOI 10.1093/hmg/10.26.3017; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Takanaka Y, 2005, MECH DEVELOP, V122, P1130, DOI 10.1016/j.mod.2005.05.004; Talamillo A, 2008, BIOCHEM SOC T, V36, P868, DOI 10.1042/BST0360868; Talamillo A, 2008, DEVELOPMENT, V135, P1659, DOI 10.1242/dev.020685; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481	28	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25841	25849		10.1074/jbc.M110.124024	http://dx.doi.org/10.1074/jbc.M110.124024			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20562097	Green Published, hybrid			2022-12-25	WOS:000280682400076
J	Wilkie, S; Burbridge, SE; Chiapero-Stanke, L; Pereira, ACP; Cleary, S; van der Stegen, SJC; Spicer, JF; Davies, DM; Maher, J				Wilkie, Scott; Burbridge, Sophie E.; Chiapero-Stanke, Laura; Pereira, Ana C. P.; Cleary, Siobhan; van der Stegen, Sjoukje J. C.; Spicer, James F.; Davies, David M.; Maher, John			Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELLS; PROSTATE-CANCER; TUMOR REJECTION; GENE-THERAPY; PHASE-I; GROWTH; CYTOKINE; IL-4; PROLIFERATION; INHIBITION	Polyclonal T-cells can be directed against cancer using transmembrane fusion molecules known as chimeric antigen receptors (CARs). Although preclinical studies have provided encouragement, pioneering clinical trials using CAR-based immunotherapy have been disappointing. Key obstacles are the need for robust expansion ex vivo followed by sustained survival of infused T-cells in patients. To address this, we have developed a system to achieve selective proliferation of CAR(+) T-cells using IL-4, a cytokine with several pathophysiologic and therapeutic links to cancer. A chimeric cytokine receptor (4 alpha beta) was engineered by fusion of the IL-4 receptor alpha (IL-4R alpha) ectodomain to the beta(c) subunit, used by IL-2 and IL-15. Addition of IL-4 to T-cells that express 4 alpha beta resulted in STAT3/STAT5/ERK phosphorylation and exponential proliferation, mimicking the actions of IL-2. Using receptor-selective IL-4 muteins, partnering of 4 alpha beta with gamma(c) was implicated in signal delivery. Next, human T-cells were engineered to co-express 4 alpha beta with a CAR specific for tumor-associated MUC1. These T-cells exhibited an unprecedented capacity to elicit repeated destruction of MUC1-expressing tumor cultures and expanded through several logs in vitro. Despite prolonged culture in IL-4, T-cells retained specificity for target antigen, type 1 polarity, and cytokine dependence. Similar findings were observed using CARs directed against two additional tumor-associated targets, demonstrating generality of application. Furthermore, this system allows rapid ex vivo expansion and enrichment of engineered T-cells from small blood volumes, under GMP-compliant conditions. Together, these findings provide proof of principle for the development of IL-4-enhanced T-cell immunotherapy of cancer.	[van der Stegen, Sjoukje J. C.; Spicer, James F.; Davies, David M.; Maher, John] Kings Coll London, Sch Med, Div Canc Studies, Res Oncol Sect, London SE1 9RT, England; [Maher, John] Barnet & Chase Farm Natl Hlth Serv Trust, Dept Immunol, Barnet EN5 3DJ, Herts, England; [Maher, John] Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, Dept Allergy & Immunol, London SE1 9RT, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Maher, J (corresponding author), Kings Coll London, Sch Med, Div Canc Studies, Res Oncol Sect, 3rd Floor Bermondsey Wing,Guys Hosp Campus,St Tho, London SE1 9RT, England.	john.maher@kcl.ac.uk		Maher, John/0000-0001-8275-8488; Papa, Sophie/0000-0002-9063-7675; Spicer, James/0000-0003-3732-8491	Breast Cancer Campaign Project [2006NovPR18]; Association for International Cancer Research Project [08-0419]; Guy's and St. Thomas' Charity, Experimental Cancer Medicine Centre (King's College London); Guy's and the Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre; St. Thomas' National Health Service Foundation Trust; King's College Hospital National Health Service Foundation Trust; Worldwide Cancer Research [08-0419] Funding Source: researchfish	Breast Cancer Campaign Project; Association for International Cancer Research Project; Guy's and St. Thomas' Charity, Experimental Cancer Medicine Centre (King's College London); Guy's and the Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre; St. Thomas' National Health Service Foundation Trust; King's College Hospital National Health Service Foundation Trust; Worldwide Cancer Research	This work was supported by Breast Cancer Campaign Project Grant 2006NovPR18, Association for International Cancer Research Project Grant 08-0419, Guy's and St. Thomas' Charity, Experimental Cancer Medicine Centre (King's College London) and by Guy's and the Department of Health via the National Institute for Health Research Comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service Foundation Trust in partnership with King's College London and King's College Hospital National Health Service Foundation Trust.	Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; Chavez ARD, 2009, ANN NY ACAD SCI, V1182, P14, DOI 10.1111/j.1749-6632.2009.05160.x; Conticello C, 2004, J IMMUNOL, V172, P5467, DOI 10.4049/jimmunol.172.9.5467; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Eguchi J, 2005, GENE THER, V12, P733, DOI 10.1038/sj.gt.3302401; Finney HM, 1998, J IMMUNOL, V161, P2791; Gasser S, 2000, J IMMUNOL, V164, P5659, DOI 10.4049/jimmunol.164.11.5659; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gooch JL, 2002, NEOPLASIA, V4, P324, DOI 10.1038/sj.neo.7900248; Haynes NM, 2002, J IMMUNOL, V169, P5780, DOI 10.4049/jimmunol.169.10.5780; Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016; HURFORD RK, 1995, NAT GENET, V10, P430, DOI 10.1038/ng0895-430; IZUHARA K, 1993, BIOCHEM BIOPH RES CO, V190, P992, DOI 10.1006/bbrc.1993.1147; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Kurtz DM, 2007, LEUKEMIA LYMPHOMA, V48, P1290, DOI 10.1080/10428190701355028; Lee SO, 2008, PROSTATE, V68, P85, DOI 10.1002/pros.20691; Li ZG, 2008, CANCER RES, V68, P8687, DOI 10.1158/0008-5472.CAN-08-0449; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Lo ASY, 2008, MOL IMMUNOL, V45, P1276, DOI 10.1016/j.molimm.2007.09.010; de Oliveira MVM, 2009, HEAD NECK-J SCI SPEC, V31, P1439, DOI 10.1002/hed.21121; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Majhail NS, 2004, INVEST NEW DRUG, V22, P421, DOI 10.1023/B:DRUG.0000036684.67675.fe; MITCHELL LC, 1989, J IMMUNOL, V142, P1548; Olver S, 2007, TISSUE ANTIGENS, V69, P293, DOI 10.1111/j.1399-0039.2007.00831.x; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Post DE, 2007, CANCER RES, V67, P6872, DOI 10.1158/0008-5472.CAN-06-3244; Prokopchuk O, 2005, BRIT J CANCER, V92, P921, DOI 10.1038/sj.bjc.6602416; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; SATYAM A, 2010, UROL ONCOL IN PRESS; Schuler T, 2003, J EXP MED, V198, P1487, DOI 10.1084/jem.20030849; Shanafelt AB, 1998, P NATL ACAD SCI USA, V95, P9454, DOI 10.1073/pnas.95.16.9454; Srivannaboon K, 2001, BLOOD, V97, P752, DOI 10.1182/blood.V97.3.752; Stephan MT, 2007, NAT MED, V13, P1440, DOI 10.1038/nm1676; Suzuki K, 2002, J EXP MED, V196, P27, DOI 10.1084/jem.20011682; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; TOI M, 1992, CANCER RES, V52, P275; TONY HP, 1994, EUR J BIOCHEM, V225, P659, DOI 10.1111/j.1432-1033.1994.00659.x; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Volpert OV, 1998, J EXP MED, V188, P1039, DOI 10.1084/jem.188.6.1039; Vukmanovic-Stejic M, 2000, BLOOD, V95, P231; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wilkie S, 2008, J IMMUNOL, V180, P4901, DOI 10.4049/jimmunol.180.7.4901; Wise GJ, 2000, J UROLOGY, V164, P722, DOI 10.1016/S0022-5347(05)67289-8; Zhang S, 2009, EUR J IMMUNOL, V39, P1252, DOI 10.1002/eji.200839152	50	125	151	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25538	25544		10.1074/jbc.M110.127951	http://dx.doi.org/10.1074/jbc.M110.127951			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20562098	hybrid, Green Published			2022-12-25	WOS:000280682400048
J	Booij, L; Tremblay, RE; Leyton, M; Seguin, JR; Vitaro, F; Gravel, P; Perreau-Linck, E; Levesque, ML; Durand, F; Diksic, M; Turecki, G; Benkelfat, C				Booij, Linda; Tremblay, Richard E.; Leyton, Marco; Seguin, Jean R.; Vitaro, Frank; Gravel, Paul; Perreau-Linck, Elisabeth; Levesque, Melissa L.; Durand, France; Diksic, Mirko; Turecki, Gustavo; Benkelfat, Chawki			Brain Serotonin Synthesis in Adult Males Characterized by Physical Aggression during Childhood: A 21-Year Longitudinal Study	PLOS ONE			English	Article							TEMPORAL-LOBE LESIONS; METHYL-L-TRYPTOPHAN; SYNTHESIS CAPACITY; PERSONALITY-DISORDER; ANTISOCIAL-BEHAVIOR; SYNTHESIS RATES; FRONTAL-LOBE; EARLY-ONSET; BOYS; TRAJECTORIES	Background: Adults exhibiting severe impulsive and aggressive behaviors have multiple indices of low serotonin (5-HT) neurotransmission. It remains unclear though whether low 5-HT mediates the behavior or instead reflects a pre-existing vulnerability trait. Methodology/Principal Findings: In the present study, positron emission tomography with the tracer alpha-[C-11]methyl-L-tryptophan (C-11-AMT) was used to compare 5-HT synthesis capacity in two groups of adult males from a 21-year longitudinal study (mean age +/- SD: 27.1+/-0.7): individuals with a history of childhood-limited high physical aggression (C-LHPA; N = 8) and individuals with normal (low) patterns of physical aggression (LPA; N = 18). The C-LHPA males had significantly lower trapping of C-11-AMT bilaterally in the orbitofrontal cortex and self-reported more impulsiveness. Despite this, in adulthood there were no group differences in plasma tryptophan levels, genotyping, aggression, emotional intelligence, working memory, computerized measures of impulsivity, psychosocial functioning/adjustment, and personal and family history of mood and substance abuse disorders. Conclusions/Significance: These results force a re-examination of the low 5-HT hypothesis as central in the biology of violence. They suggest that low 5-HT does not mediate current behavior and should be considered a vulnerability factor for impulsive-aggressive behavior that may or may not be expressed depending on other biological factors, experience, and environmental support during development.	[Booij, Linda; Leyton, Marco; Gravel, Paul; Perreau-Linck, Elisabeth; Levesque, Melissa L.; Durand, France; Benkelfat, Chawki] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychol, Montreal, PQ H3T 1C5, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin 2, Ireland; [Tremblay, Richard E.] INSERM, U669, Paris, France; [Tremblay, Richard E.; Seguin, Jean R.; Vitaro, Frank] Univ Montreal, Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Tremblay, Richard E.; Seguin, Jean R.] Univ Montreal, Dept Psychiat, Montreal, PQ H3T 1C5, Canada; [Leyton, Marco; Diksic, Mirko; Benkelfat, Chawki] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Leyton, Marco; Diksic, Mirko; Benkelfat, Chawki] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ H3A 2B4, Canada; [Vitaro, Frank] Univ Montreal, Sch Psychoeduc, Montreal, PQ H3T 1C5, Canada; [Turecki, Gustavo] McGill Univ, Douglas Hosp, McGill Grp Suicide Studies, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal; University College Dublin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Universite de Montreal; McGill University	Booij, L (corresponding author), Univ Montreal, Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada.	chawki.benkelfat@mcgill.ca	Séguin, Jean R./B-5349-2008; Turecki, Gustavo/K-5100-2015; Tremblay, Richard E./O-1360-2014; Leyton, Marco/AAY-7557-2020	Séguin, Jean R./0000-0003-3359-6202; Leyton, Marco/0000-0002-1243-2252; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institutes of Health Research (CIHR) [MOP57838]; Fonds de la recherche en sante Quebec (FRSQ); Netherlands Organization for Scientific research (NWO-VENI); FQRSC; SSHRC	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Netherlands Organization for Scientific research (NWO-VENI)(Netherlands Organization for Scientific Research (NWO)); FQRSC; SSHRC(Social Sciences and Humanities Research Council of Canada (SSHRC))	This study was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) to Drs. C. Benkelfat and R. E. Tremblay (MOP57838). Dr. L. Booij was supported by a postdoctoral fellowship from the Fonds de la recherche en sante Quebec (FRSQ) and by an award from the Netherlands Organization for Scientific research (NWO-VENI). The longitudinal study was supported by grants to Dr. R. E. Tremblay and collaborators from CIHR, FRSQ, FQRSC and SSHRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bar-On R, 2006, PSICOTHEMA, V18, P13; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; Barker ED, 2006, J CHILD PSYCHOL PSYC, V47, P783, DOI 10.1111/j.1469-7610.2005.01585.x; Barker ED, 2009, AM J PSYCHIAT, V166, P900, DOI 10.1176/appi.ajp.2009.08121770; Beck A.T., 1987, MANUAL BECK DEPRESSI; Booij L, 2007, BIOL PSYCHIAT, V61, p172S; Bremner JD, 2001, DEV PSYCHOPATHOL, V13, P473, DOI 10.1017/S0954579401003042; Brendgen M, 2008, CHILD DEV, V79, P13, DOI 10.1111/j.1467-8624.2007.01108.x; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Brown A.D., 1979, P139; Chugani DC, 1998, SYNAPSE, V28, P33, DOI 10.1002/(SICI)1098-2396(199801)28:1<33::AID-SYN5>3.0.CO;2-D; Chugani DC, 2000, J CEREBR BLOOD F MET, V20, P2, DOI 10.1097/00004647-200001000-00002; Chugani DC, 1999, ANN NEUROL, V45, P287, DOI 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9; COCCARO EF, 1989, ARCH GEN PSYCHIAT, V46, P587; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Constantino JN, 1997, AM J PSYCHIAT, V154, P1771, DOI 10.1176/ajp.154.12.1771; Cote SM, 2007, DEV PSYCHOPATHOL, V19, P37, DOI 10.1017/S0954579407070034; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; de Lara CL, 2007, BIOL PSYCHIAT, V62, P72, DOI 10.1016/j.biopsych.2006.09.008; Diksic M, 2001, J NEUROCHEM, V78, P1185, DOI 10.1046/j.1471-4159.2001.00536.x; Dionne G, 2003, DEV PSYCHOL, V39, P261, DOI 10.1037/0012-1649.39.2.261; Eagle DM, 2009, NEUROPSYCHOPHARMACOL, V34, P1311, DOI 10.1038/npp.2008.202; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; HAAPASALO J, 1994, J CONSULT CLIN PSYCH, V62, P1044, DOI 10.1037/0022-006X.62.5.1044; Hasegawa S, 2005, BRAIN RES BULL, V67, P248, DOI 10.1016/j.brainresbull.2005.07.009; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Howell S, 2007, AM J PRIMATOL, V69, P851, DOI 10.1002/ajp.20369; IABONI F, 1995, J ABNORM PSYCHOL, V104, P232, DOI 10.1037/0021-843X.104.1.232; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; LeMarquand DG, 1999, AM J PSYCHIAT, V156, P1771; Leyton M, 2006, EUR NEUROPSYCHOPHARM, V16, P220, DOI 10.1016/j.euroneuro.2005.09.006; Leyton M, 2005, INT J NEUROPSYCHOPH, V8, P633, DOI 10.1017/S1461145705005420; Leyton M, 2001, AM J PSYCHIAT, V158, P775, DOI 10.1176/appi.ajp.158.5.775; Loeber R, 2008, PHILOS T R SOC B, V363, P2491, DOI 10.1098/rstb.2008.0032; Lundquist P, 2007, J CEREBR BLOOD F MET, V27, P821, DOI 10.1038/sj.jcbfm.9600381; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nagin DS, 2001, ARCH GEN PSYCHIAT, V58, P389, DOI 10.1001/archpsyc.58.4.389; New AS, 2002, ARCH GEN PSYCHIAT, V59, P621, DOI 10.1001/archpsyc.59.7.621; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Nishizawa S, 1998, J CEREBR BLOOD F MET, V18, P1121, DOI 10.1097/00004647-199810000-00009; Okazawa H, 2000, J PSYCHIATR NEUROSCI, V25, P359; Okazawa H, 1998, J COMPUT ASSIST TOMO, V22, P777, DOI 10.1097/00004728-199809000-00021; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Rosa-Neto P, 2005, EUR J NUCL MED MOL I, V32, P1199, DOI 10.1007/s00259-005-1829-5; Sampson RJ, 2003, CRIMINOLOGY, V41, P555, DOI 10.1111/j.1745-9125.2003.tb00997.x; Seguin JR, 2004, BRAIN COGNITION, V55, P185, DOI 10.1016/s0278-2626(03)00273-2; Seguin JR, 1999, J CHILD PSYCHOL PSYC, V40, P1197, DOI 10.1111/1469-7610.00536; SEGUIN JR, 1995, J ABNORM PSYCHOL, V104, P614, DOI 10.1037/0021-843X.104.4.614; Serbin LA, 1998, DEV PSYCHOL, V34, P1246, DOI 10.1037/0012-1649.34.6.1246; Shoaf SE, 1998, NEUROPSYCHOPHARMACOL, V19, P345, DOI 10.1016/S0893-133X(98)00032-3; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Siever LJ, 1999, NEUROPSYCHOPHARMACOL, V20, P413, DOI 10.1016/S0893-133X(98)00111-0; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Tohyama Y, 2002, NEUROCHEM INT, V40, P603, DOI 10.1016/S0197-0186(01)00132-2; Tohyama Y, 2002, J NEUROCHEM, V80, P788, DOI 10.1046/j.0022-3042.2002.00757.x; TREMBLAY RE, 1991, J ABNORM CHILD PSYCH, V19, P285, DOI 10.1007/BF00911232; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; TREMBLAY RE, 1994, ARCH GEN PSYCHIAT, V51, P732; Tremblay RE, 2008, PHILOS T R SOC B, V363, P2613, DOI 10.1098/rstb.2008.0030; Verney C, 2002, ANAT REC, V267, P87, DOI 10.1002/ar.10089; VIRKKUNEN M, 1994, ARCH GEN PSYCHIAT, V51, P28; Young S, 1999, TRYPTOPHAN SEROTONIN	67	40	41	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11255	10.1371/journal.pone.0011255	http://dx.doi.org/10.1371/journal.pone.0011255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	614KX	20582306	gold, Green Published			2022-12-25	WOS:000279058500007
J	Guerron, AD; Rawat, R; Sali, A; Spurney, CF; Pistilli, E; Cha, HJ; Pandey, GS; Gernapudi, R; Francia, D; Farajian, V; Escolar, DM; Bossi, L; Becker, M; Zerr, P; de la Porte, S; Gordish-Dressman, H; Partridge, T; Hoffman, EP; Nagaraju, K				Guerron, Alfredo D.; Rawat, Rashmi; Sali, Arpana; Spurney, Christopher F.; Pistilli, Emidio; Cha, Hee-Jae; Pandey, Gouri S.; Gernapudi, Ramkishore; Francia, Dwight; Farajian, Viken; Escolar, Diana M.; Bossi, Laura; Becker, Magali; Zerr, Patricia; de la Porte, Sabine; Gordish-Dressman, Heather; Partridge, Terence; Hoffman, Eric P.; Nagaraju, Kanneboyina			Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the mdx Mouse Model of Duchenne Muscular Dystrophy	PLOS ONE			English	Article							GLUCOCORTICOID TREATMENT; MICE; STRENGTH; IMPROVES; CELLS; DEFLAZACORT; EXPRESSION; DIAPHRAGM; PERSISTENT; FIBROSIS	Background: The number of promising therapeutic interventions for Duchenne Muscular Dystrophy (DMD) is increasing rapidly. One of the proposed strategies is to use drugs that are known to act by multiple different mechanisms including inducing of homologous fetal form of adult genes, for example utrophin in place of dystrophin. Methodology/Principal Findings: In this study, we have treated mdx mice with arginine butyrate, prednisone, or a combination of arginine butyrate and prednisone for 6 months, beginning at 3 months of age, and have comprehensively evaluated the functional, biochemical, histological, and molecular effects of the treatments in this DMD model. Arginine butyrate treatment improved grip strength and decreased fibrosis in the gastrocnemius muscle, but did not produce significant improvement in muscle and cardiac histology, heart function, behavioral measurements, or serum creatine kinase levels. In contrast, 6 months of chronic continuous prednisone treatment resulted in deterioration in functional, histological, and biochemical measures. Arginine butyrate-treated mice gene expression profiling experiments revealed that several genes that control cell proliferation, growth and differentiation are differentially expressed consistent with its histone deacetylase inhibitory activity when compared to control (saline-treated) mdx mice. Prednisone and combination treated groups showed alterations in the expression of genes that control fibrosis, inflammation, myogenesis and atrophy. Conclusions/Significance: These data indicate that 6 months treatment with arginine butyrate can produce modest beneficial effects on dystrophic pathology in mdx mice by reducing fibrosis and promoting muscle function while chronic continuous treatment with prednisone showed deleterious effects to skeletal and cardiac muscle. Our results clearly indicate the usefulness of multiple assays systems to monitor both beneficial and toxic effects of drugs with broad range of in vivo activity.	[Guerron, Alfredo D.; Rawat, Rashmi; Sali, Arpana; Pandey, Gouri S.; Gernapudi, Ramkishore; Francia, Dwight; Farajian, Viken; Escolar, Diana M.; Gordish-Dressman, Heather; Partridge, Terence; Hoffman, Eric P.; Nagaraju, Kanneboyina] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Childrens Natl Med Ctr,Ctr Genet Med Res, Washington, DC 20052 USA; [Spurney, Christopher F.] Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA; [Pistilli, Emidio] Univ Penn, Pennsylvania Muscle Inst, Philadelphia, PA 19104 USA; [Cha, Hee-Jae] Kosin Univ, Coll Med, Dept Parasitol & Genet, Pusan, South Korea; [Bossi, Laura; Becker, Magali; Zerr, Patricia] Transgene SA, Illkirch Graffenstaden, France	Children's National Health System; George Washington University; Children's National Health System; University of Pennsylvania; Transgene SA	Guerron, AD (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Childrens Natl Med Ctr,Ctr Genet Med Res, Washington, DC 20052 USA.	knagaraju@cnmcresearch.org	Nagaraju, Kanneboyina/AAV-7684-2021; de la Porte, Sabine/N-5275-2018; Cruz, Alfredo Daniel Guerron/V-5188-2019; de la PORTE, Sabine/AAE-4208-2022; Nagaraju, Kanneboyina/ABA-6525-2021; Cha, Hee-Jae/AFO-8772-2022	Cruz, Alfredo Daniel Guerron/0000-0002-4632-1681; de la PORTE, Sabine/0000-0002-7725-8646; Hoffman, Eric/0000-0001-6470-5139	Faust Pharmaceuticals; Foundation to Eradicate Dystrophy; US Department of Defense [W81XWH-05-1-0616]; National Institutes of Health [RO1-AR050478, 5U54HD053177]; National Institutes of Health, Department of Health and Human Services [5U54HD053177, M01-RR020359]; Crystal Ball, Richmond VA; Muscular Dystrophy Association USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR020359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050478] Funding Source: NIH RePORTER	Faust Pharmaceuticals; Foundation to Eradicate Dystrophy; US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crystal Ball, Richmond VA; Muscular Dystrophy Association USA(Muscular Dystrophy Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Dr. Nagaraju is supported by Faust Pharmaceuticals; the Foundation to Eradicate Dystrophy; the US Department of Defense (W81XWH-05-1-0616); the National Institutes of Health (RO1-AR050478 and 5U54HD053177); and the Department of Defense (W81XWH-05-1-0616). Dr. Hoffman's research is supported in part by grant M01-RR020359; 5U54HD053177, from the National Institutes of Health, Department of Health and Human Services; the Crystal Ball, Richmond VA, Muscular Dystrophy Association USA; and the US Department of Defense (W81XWH-05-1-0616). The study design, data collection, data analysis and interpretation was done primarily by the team at Children's National Medical Center. However, the study design and draft manuscript was made available for comments and suggestions by the Faust Pharmaceuticals scientific staff. Faust Pharmaceuticals scientific staff played no role in the data collection, interpretation and decision to publish manuscript.	Anderson JE, 2000, CELL TRANSPLANT, V9, P551, DOI 10.1177/096368970000900411; Anderson JE, 1996, MUSCLE NERVE, V19, P1576, DOI 10.1002/(SICI)1097-4598(199612)19:12<1576::AID-MUS7>3.0.CO;2-7; Archer JD, 2006, FASEB J, V20, P738, DOI 10.1096/fj.05-4821fje; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Chazalette D, 2005, FEBS LETT, V579, P1079, DOI 10.1016/j.febslet.2004.12.081; Connolly AM, 2002, NEUROMUSCULAR DISORD, V12, P917, DOI 10.1016/S0960-8966(02)00180-3; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; De Luca A, 2002, NEUROMUSCULAR DISORD, V12, pS142, DOI 10.1016/S0960-8966(02)00100-1; Granchelli JA, 1996, RES COMMUN MOL PATH, V91, P287; Granchelli JA, 2000, NEUROMUSCULAR DISORD, V10, P235, DOI 10.1016/S0960-8966(99)00126-1; Hartel JV, 2001, MUSCLE NERVE, V24, P428, DOI 10.1002/1097-4598(200103)24:3<428::AID-MUS1018>3.3.CO;2-5; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; Hoey A. J., 2006, P AUSTR PHYSL SOC, V37, P57; HUDECKI MS, 1993, RES COMMUN CHEM PATH, V79, P45; Keeling RM, 2007, MUSCLE NERVE, V35, P43, DOI 10.1002/mus.20646; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; KumarSingh R, 1996, HUM MOL GENET, V5, P913, DOI 10.1093/hmg/5.7.913; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Miura P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002309; Morrissey JJ, 1996, J AM SOC NEPHROL, V7, P2202; Nagaraju K, 2000, J IMMUNOL, V164, P5459, DOI 10.4049/jimmunol.164.10.5459; Raben N, 2000, NEUROMUSCULAR DISORD, V10, P283, DOI 10.1016/S0960-8966(99)00117-0; REYES AA, 1994, AM J PHYSIOL, V267, P331; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; St-Pierre SJG, 2004, FASEB J, V18, P1937, DOI 10.1096/fj.04-1859fje; SWEAT F, 1964, ARCH PATHOL, V78, P69; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Yang LY, 1998, MUSCLE NERVE, V21, P394, DOI 10.1002/(SICI)1097-4598(199803)21:3<394::AID-MUS14>3.0.CO;2-#	30	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11220	10.1371/journal.pone.0011220	http://dx.doi.org/10.1371/journal.pone.0011220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574530	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058300013
J	Drumond, A; Nieto, R; Trigo, R; Ambrizzi, T; Souza, E; Gimeno, L				Drumond, Anita; Nieto, Raquel; Trigo, Ricardo; Ambrizzi, Tercio; Souza, Everaldo; Gimeno, Luis			A Lagrangian Identification of the Main Sources of Moisture Affecting Northeastern Brazil during Its Pre-Rainy and Rainy Seasons	PLOS ONE			English	Article							GENERAL-CIRCULATION MODEL; SEA-SURFACE TEMPERATURE; GLOBAL WATER CYCLE; SOUTH-AMERICA; ATMOSPHERIC BRANCH; TROPICAL ATLANTIC; PART I; PRECIPITATION; RAINFALL; VALIDATION	This work examines the sources of moisture affecting the semi-arid Brazilian Northeast (NEB) during its pre-rainy and rainy season (JFMAM) through a Lagrangian diagnosis method. The FLEXPART model identifies the humidity contributions to the moisture budget over a region through the continuous computation of changes in the specific humidity along back or forward trajectories up to 10 days period. The numerical experiments were done for the period that spans between 2000 and 2004 and results were aggregated on a monthly basis. Results show that besides a minor local recycling component, the vast majority of moisture reaching NEB area is originated in the south Atlantic basin and that the nearby wet Amazon basin bears almost no impact. Moreover, although the maximum precipitation in the "Poligono das Secas'' region (PS) occurs in March and the maximum precipitation associated with air parcels emanating from the South Atlantic towards PS is observed along January to March, the highest moisture contribution from this oceanic region occurs slightly later (April). A dynamical analysis suggests that the maximum precipitation observed in the PS sector does not coincide with the maximum moisture supply probably due to the combined effect of the Walker and Hadley cells in inhibiting the rising motions over the region in the months following April.	[Drumond, Anita; Nieto, Raquel; Gimeno, Luis] Univ Vigo, Fac Ciencias, EPhysLab, Orense, Spain; [Trigo, Ricardo] Univ Lisbon, CGUL IDL, P-1699 Lisbon, Portugal; [Trigo, Ricardo] Univ Lusofona, Dept Engn, Lisbon, Portugal; [Ambrizzi, Tercio] Univ Sao Paulo, Dept Ciencias Atmosfericas, Inst Astron Geofis & Ciencias Atmosfericas, Sao Paulo, Brazil; [Souza, Everaldo] Fed Univ Para, BR-66059 Belem, Para, Brazil	Universidade de Vigo; Universidade de Lisboa; Lusofona University; Universidade de Sao Paulo; Universidade Federal do Para	Drumond, A (corresponding author), Univ Vigo, Fac Ciencias, EPhysLab, Orense, Spain.	anitadru@uvigo.es	Drumond, Anita RM/G-5767-2013; Ambrizzi, Tercio/A-4636-2008; Trigo, Ricardo/Q-8391-2019; Nieto, Raquel/AAT-8925-2020; Trigo, Ricardo M/B-7044-2008; GIMENO, LUIS/B-8137-2008; De Souza, Everaldo/V-5163-2017	Drumond, Anita RM/0000-0002-0432-8842; Trigo, Ricardo/0000-0002-4183-9852; Nieto, Raquel/0000-0002-8984-0959; Trigo, Ricardo M/0000-0002-4183-9852; GIMENO, LUIS/0000-0002-0778-3605; De Souza, Everaldo/0000-0001-6045-0984	Spanish Ministry of Science and Innovation [SB2006-0209, CGL2008-05968-C02-02/CLI]; Conselho de REitores das Universidades Portuguesas (CRUP) [E-16/2008]; Ministerio de Ciencia y Tecnologia (MCYT) [HP2007-0064]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao para o amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselho de REitores das Universidades Portuguesas (CRUP); Ministerio de Ciencia y Tecnologia (MCYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao para o amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Spanish Ministry of Science and Innovation through the program "Programa de ayudas para la movilidad de profesores de Universidad e investigadores espanoles y extranjeros'' (SB2006-0209) and the project CGL2008-05968-C02-02/CLI; Portuguese-Spanish integrated action funded by Conselho de REitores das Universidades Portuguesas (CRUP) (E-16/2008) and Ministerio de Ciencia y Tecnologia (MCYT) (HP2007-0064); the Brazilian Institutions Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao para o amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUBAKER KL, 1993, J CLIMATE, V6, P1077, DOI 10.1175/1520-0442(1993)006<1077:EOCPR>2.0.CO;2; Burde GI, 2001, J CLIMATE, V14, P2497, DOI 10.1175/1520-0442(2001)014<2497:TEORPR>2.0.CO;2; Drumond A, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009547; Eltahir EAB, 1996, REV GEOPHYS, V34, P367, DOI 10.1029/96RG01927; Hastenrath S, 2001, INT J CLIMATOL, V21, P37, DOI 10.1002/joc.597; KALNAY E, 1996, B AM METEOROL SOC, V77, P471; MOLION L, 2002, BRAZILIAN J METEOROL, V17, P1; Moura AD, 2004, J CLIMATE, V17, P2667, DOI 10.1175/1520-0442(2004)017&lt;2667:CPFBNP&gt;2.0.CO;2; MOURA AD, 1981, J ATMOS SCI, V38, P2653, DOI 10.1175/1520-0469(1981)038<2653:OTDODI>2.0.CO;2; Nieto R, 2008, HYDROLOG SCI J, V53, P602, DOI 10.1623/hysj.53.3.602; Nieto R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027232; Nieto R, 2007, METEOROL Z, V16, P37, DOI 10.1127/0941-2948/2007/0176; Nobre P, 1996, J CLIMATE, V9, P2464, DOI 10.1175/1520-0442(1996)009<2464:VOSSTW>2.0.CO;2; Numaguti A, 1999, J GEOPHYS RES-ATMOS, V104, P1957, DOI 10.1029/1998JD200026; Pezzi LP, 2001, CLIM DYNAM, V17, P205, DOI 10.1007/s003820000104; RAO VB, 1995, INT J CLIMATOL, V15, P697, DOI 10.1002/joc.3370150608; Rao VB, 1997, AGR FOREST METEOROL, V85, P63, DOI 10.1016/S0168-1923(96)02390-8; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; SOUZA E, 2004, BRAZILIAN J METEOROL, V19, P113; SOUZA E, 2003, CLIMANALISE; Stohl A, 2005, J HYDROMETEOROL, V6, P961, DOI 10.1175/JHM470.1; Stohl A, 2004, J HYDROMETEOROL, V5, P656, DOI 10.1175/1525-7541(2004)005<0656:ALAOTA>2.0.CO;2; Stohl A, 1998, ATMOS ENVIRON, V32, P4245, DOI 10.1016/S1352-2310(98)00184-8; Sun LQ, 2006, J CLIMATE, V19, P1990, DOI 10.1175/JCLI3715.1; Trenberth KE, 1999, J CLIMATE, V12, P1368, DOI 10.1175/1520-0442(1999)012<1368:AMRROA>2.0.CO;2; Uvo CB, 1998, J CLIMATE, V11, P551, DOI 10.1175/1520-0442(1998)011<0551:TRBTPA>2.0.CO;2; Vera C, 2006, J CLIMATE, V19, P4977, DOI 10.1175/JCLI3896.1; WALISER DE, 1993, J CLIMATE, V6, P2162, DOI 10.1175/1520-0442(1993)006<2162:ASDCOT>2.0.CO;2; WHITE PW, 2002, IFS DOCUMENTATION; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Zhou JY, 2001, INT J CLIMATOL, V21, P1623, DOI 10.1002/joc.700	31	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11205	10.1371/journal.pone.0011205	http://dx.doi.org/10.1371/journal.pone.0011205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585458	Green Published, gold, Green Submitted			2022-12-25	WOS:000278977200010
J	de Jong, EP; Xie, HW; Onsongo, G; Stone, MD; Chen, XB; Kooren, JA; Refsland, EW; Griffin, RJ; Ondrey, FG; Wu, BL; Le, CT; Rhodus, NL; Carlis, JV; Griffin, TJ				de Jong, Ebbing P.; Xie, Hongwei; Onsongo, Getiria; Stone, Matthew D.; Chen, Xiao-Bing; Kooren, Joel A.; Refsland, Eric W.; Griffin, Robert J.; Ondrey, Frank G.; Wu, Baolin; Le, Chap T.; Rhodus, Nelson L.; Carlis, John V.; Griffin, Timothy J.			Quantitative Proteomics Reveals Myosin and Actin as Promising Saliva Biomarkers for Distinguishing Pre-Malignant and Malignant Oral Lesions	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TANDEM MASS-SPECTROMETRY; MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; WHOLE SALIVA; CANCER; EXPRESSION; IDENTIFICATION; CYTOSKELETON; INFLAMMATION; DISCOVERY	Background: Oral cancer survival rates increase significantly when it is detected and treated early. Unfortunately, clinicians now lack tests which easily and reliably distinguish pre-malignant oral lesions from those already transitioned to malignancy. A test for proteins, ones found in non-invasively-collected whole saliva and whose abundances distinguish these lesion types, would meet this critical need. Methodology/Principal Findings: To discover such proteins, in a first-of-its-kind study we used advanced mass spectrometry-based quantitative proteomics analysis of the pooled soluble fraction of whole saliva from four subjects with pre-malignant lesions and four with malignant lesions. We prioritized candidate biomarkers via bioinformatics and validated selected proteins by western blotting. Bioinformatic analysis of differentially abundant proteins and initial western blotting revealed increased abundance of myosin and actin in patients with malignant lesions. We validated those results by additional western blotting of individual whole saliva samples from twelve other subjects with pre-malignant oral lesions and twelve with malignant oral lesions. Sensitivity/specificity values for distinguishing between different lesion types were 100%/75% (p = 0.002) for actin, and 67%/83% (p < 0.00001) for myosin in soluble saliva. Exfoliated epithelial cells from subjects' saliva also showed increased myosin and actin abundance in those with malignant lesions, linking our observations in soluble saliva to abundance differences between pre-malignant and malignant cells. Conclusions/Significance: Salivary actin and myosin abundances distinguish oral lesion types with sensitivity and specificity rivaling other non-invasive oral cancer tests. Our findings provide a promising starting point for the development of non-invasive and inexpensive salivary tests to reliably detect oral cancer early.	[de Jong, Ebbing P.; Xie, Hongwei; Stone, Matthew D.; Kooren, Joel A.; Refsland, Eric W.; Griffin, Timothy J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Onsongo, Getiria; Carlis, John V.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Ondrey, Frank G.] Univ Minnesota, Dept Otalaryngol, Minneapolis, MN USA; [Wu, Baolin; Le, Chap T.] Univ Minnesota, Dept Biostat, Minneapolis, MN USA; [Rhodus, Nelson L.] Univ Minnesota, Dept Oral Med Diag & Radiol, Minneapolis, MN USA; [Chen, Xiao-Bing] Sun Yat Sen Univ, Guanghua Sch Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Griffin, Robert J.] Univ Arkansas Med Sci, Dept Radiat Oncol, Little Rock, AR 72205 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Sun Yat Sen University; University of Arkansas System; University of Arkansas Medical Sciences	Griffin, TJ (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	tgriffin@umn.edu		de Jong, Ebbing/0000-0002-0362-1772; Griffin, Timothy/0000-0001-6801-2559; WU, BAOLIN/0000-0001-6676-0422; Griffin, Robert/0000-0002-3574-2958	NIDCR, National Institutes of Health [R01DE17734]; Minnesota Medical Foundation; American Cancer Society [IRG-58-001-46]; Eli Lilly and Co.; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017734] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Minnesota Medical Foundation; American Cancer Society(American Cancer Society); Eli Lilly and Co.(Eli Lilly); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIDCR, National Institutes of Health Grant R01DE17734 and in part by grants from the Minnesota Medical Foundation, American Cancer Society Institutional Research Grant IRG-58-001-46, and a research award from Eli Lilly and Co. (to T.J.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt-Holland A, 2008, J INVEST DERMATOL, V128, P2498, DOI 10.1038/jid.2008.102; Cheng B, 2004, ORAL SURG ORAL MED O, V97, P465, DOI 10.1016/j.tripleo.2003.12.020; Feigin ME, 2009, CURR OPIN CELL BIOL, V21, P694, DOI 10.1016/j.ceb.2009.07.003; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Griffin TJ, 2007, J PROTEOME RES, V6, P4200, DOI 10.1021/pr070291b; Gurenlian JoAnn R, 2009, Dent Assist, V78, P8; Gurenlian JR., 2009, DENT ASSIST, V78, P41; Gurenlian JR, 2009, DENT ASSIST, V78, P12; Gurenlian JR, 2009, DENT ASSIST, V78, P38; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hofman LF, 2001, J NUTR, V131, p1621S, DOI 10.1093/jn/131.5.1621S; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Jokerst JV, 2010, NANOMEDICINE-UK, V5, P143, DOI 10.2217/NNM.09.94; Le CT, 2006, STAT METHODS MED RES, V15, P571, DOI 10.1177/0962280206070637; Li Q, 2009, J INT MED RES, V37, P446, DOI 10.1177/147323000903700220; Lingen MW, 2008, ORAL ONCOL, V44, P10, DOI 10.1016/j.oraloncology.2007.06.011; Liu SC, 2009, CANCER RES, V69, P6122, DOI 10.1158/0008-5472.CAN-08-3435; Lo WY, 2007, CLIN CHIM ACTA, V376, P101, DOI 10.1016/j.cca.2006.06.030; *NAT CANC I, 1993, SEER STAT REV 1975 2; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Qi YJ, 2005, PROTEOMICS, V5, P2960, DOI 10.1002/pmic.200401175; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ralhan R, 2009, J PROTEOME RES, V8, P300, DOI 10.1021/pr800501j; Ram S, 2005, INT J ORAL MAX SURG, V34, P521, DOI 10.1016/j.ijom.2004.10.008; Rhodus N, 2007, INSIDE DENT, V3, P1; Rhodus Nelson L, 2005, Dent Clin North Am, V49, P143, DOI 10.1016/j.cden.2004.07.003; Rhodus NL, 2004, CANCER DETECT PREV, V29, P42, DOI 10.1016/j.cdp.2004.10.003; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Shi Lin, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P106; Turhani D, 2006, ELECTROPHORESIS, V27, P1417, DOI 10.1002/elps.200500510; Uzquiano MC, 2008, MODERN PATHOL, V21, P540, DOI 10.1038/modpathol.3801051; Van Dyke TE, 2008, J PERIODONTOL, V79, P1601, DOI 10.1902/jop.2008.080173; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; WARNAKULASURIYA KAAS, 1991, CANCER DETECT PREV, V15, P331; Wong DT, 2006, EXPERT REV MOL DIAGN, V6, P267, DOI 10.1586/14737159.6.3.267; XIE H, 2005, MOL CELL PROTEOMICS; Xie HW, 2008, MOL CELL PROTEOMICS, V7, P486, DOI 10.1074/mcp.M700146-MCP200; Zhong LP, 2007, ORAL SURG ORAL MED O, V104, P377, DOI 10.1016/j.tripleo.2006.07.019; Zhong LP, 2006, ARCH ORAL BIOL, V51, P1112, DOI 10.1016/j.archoralbio.2006.05.005	40	67	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11148	10.1371/journal.pone.0011148	http://dx.doi.org/10.1371/journal.pone.0011148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567502	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886300004
J	Hlevnjak, M; Zitkovic, G; Zagrovic, B				Hlevnjak, Mario; Zitkovic, Gordan; Zagrovic, Bojan			Hydrophilicity Matching - A Potential Prerequisite for the Formation of Protein-Protein Complexes in the Cell	PLOS ONE			English	Article							LOCALIZATION; SIMULATIONS; RADII; RECOGNITION; ASSOCIATION; CYTOPLASM; DYNAMICS; MODEL; CUE; VAN	A binding event between two proteins typically consists of a diffusional search of binding partners for one another, followed by a specific recognition of the compatible binding sites resulting in the formation of the complex. However, it is unclear how binding partners find each other in the context of the crowded, constantly fluctuating, and interaction-rich cellular environment. Here we examine the non-specific component of protein-protein interactions, which refers to those physicochemical properties of the binding partners that are independent of the exact details of their binding sites, but which can affect their localization or diffusional search for one another. We show that, for a large set of high-resolution experimental 3D structures of binary, transient protein complexes taken from the DOCKGROUND database, the binding partners display a surprising, statistically significant similarity in terms of their total hydration free energies normalized by a size-dependent variable. We hypothesize that colocalization of binding partners, even within individual cellular compartments such as the cytoplasm, may be influenced by their relative hydrophilicity, potentially in response to local hydrophilic gradients.	[Hlevnjak, Mario; Zagrovic, Bojan] Mediterranean Inst Life Sci, Split, Croatia; [Zitkovic, Gordan] Univ Texas Austin, Dept Math, Austin, TX 78712 USA; [Zagrovic, Bojan] Univ Split, Dept Phys, Split, Croatia	University of Texas System; University of Texas Austin; University of Split	Zagrovic, B (corresponding author), Max F Perutz Labs GmbH, Dept Struct & Computat Biol, Lab Computat Biophys, Vienna, Austria.	bojan.zagrovic@univie.ac.at		Zagrovic, Bojan/0000-0003-3814-3675	National Foundation for Science, Higher Education and Technological Development of Croatia; EMBO (European Molecular Biology Organization); Unity Through Knowledge Fund	National Foundation for Science, Higher Education and Technological Development of Croatia; EMBO (European Molecular Biology Organization)(European Molecular Biology Organization (EMBO)); Unity Through Knowledge Fund	This work was supported in part by the National Foundation for Science, Higher Education and Technological Development of Croatia (http://www.nzz.hr) with an EMBO (European Molecular Biology Organization, http://www.embo.org) Installation grant to BZ, and the Unity Through Knowledge Fund (http://www.ukf.hr) with an UKF 1A grant to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agutter PS, 2000, BIOESSAYS, V22, P1018, DOI 10.1002/1521-1878(200011)22:11<1018::AID-BIES8>3.3.CO;2-P; Batada NN, 2006, PLOS COMPUT BIOL, V2, P343, DOI 10.1371/journal.pcbi.0020044; Batada NN, 2004, P NATL ACAD SCI USA, V101, P6445, DOI 10.1073/pnas.0401314101; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berg, 2018, RANDOM WALKS BIOL; Berg JM, 2006, BIOCHEMISTRY; Bickmore WA, 2002, EMBO J, V21, P1248, DOI 10.1093/emboj/21.6.1248; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Du PF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-518; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; Gao Y, 2007, PROTEINS, V69, P845, DOI 10.1002/prot.21714; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOTZ S, 1983, ENCY STAT SCI, V4, P212; Kundrotas PJ, 2006, BIOPHYS J, V91, P1724, DOI 10.1529/biophysj.106.086025; Lienqueo ME, 2002, J CHROMATOGR A, V978, P71, DOI 10.1016/S0021-9673(02)01358-4; Mahn A, 2009, J CHROMATOGR A, V1216, P1838, DOI 10.1016/j.chroma.2008.11.089; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Ridgway D, 2008, BIOPHYS J, V94, P3748, DOI 10.1529/biophysj.107.116053; Rowland RS, 1996, J PHYS CHEM-US, V100, P7384, DOI 10.1021/jp953141+; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Vendruscolo M, 2008, MOL BIOSYST, V4, P1170, DOI 10.1039/b805710a; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; WALTER H, 1995, FEBS LETT, V361, P135, DOI 10.1016/0014-5793(95)00159-7; Wieczorek G, 2008, BIOPHYS J, V95, P5030, DOI 10.1529/biophysj.108.136291	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11169	10.1371/journal.pone.0011169	http://dx.doi.org/10.1371/journal.pone.0011169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567518	Green Submitted, Green Published, gold			2022-12-25	WOS:000278886300015
J	Roa, S; Li, ZQ; Peled, JU; Zhao, CF; Edelmann, W; Scharff, MD				Roa, Sergio; Li, Ziqiang; Peled, Jonathan U.; Zhao, Chunfang; Edelmann, Winfried; Scharff, Matthew D.			MSH2/MSH6 Complex Promotes Error-Free Repair of AID-Induced dU:G Mispairs as well as Error-Prone Hypermutation of A:T Sites	PLOS ONE			English	Article							DNA-POLYMERASE-ETA; CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; MISMATCH-REPAIR; MICE DEFICIENT; B-CELLS; IMMUNOGLOBULIN GENES; STRAND BIAS; MSH6; MUTATIONS	Mismatch repair of AID-generated dU:G mispairs is critical for class switch recombination (CSR) and somatic hypermutation (SHM) in B cells. The generation of a previously unavailable Msh2(-/-) Msh6(-/-) mouse has for the first time allowed us to examine the impact of the complete loss of MutS alpha on lymphomagenesis, CSR and SHM. The onset of T cell lymphomas and the survival of Msh2(-/-) Msh6(-/-) and Msh2(-/-) Msh6(-/-) Msh3(-/-) mice are indistinguishable from Msh2(-/-) mice, suggesting that MSH2 plays the critical role in protecting T cells from malignant transformation, presumably because it is essential for the formation of stable MutS alpha heterodimers that maintain genomic stability. The similar defects on switching in Msh2(-/-), Msh2(-/-)Msh6(-/-) and Msh2(-/-)Msh6(-/-)Msh3(-/-) mice confirm that MutS alpha but not MutS beta plays an important role in CSR. Analysis of SHM in Msh2(-/-)Msh6(-/-) mice not only confirmed the error-prone role of MutS alpha in the generation of strand biased mutations at A:T bases, but also revealed an error-free role of MutS alpha when repairing some of the dU:G mispairs generated by AID on both DNA strands. We propose a model for the role of MutS alpha at the immunoglobulin locus where the local balance of error-free and error-prone repair has an impact in the spectrum of mutations introduced during Phase 2 of SHM.	[Roa, Sergio; Li, Ziqiang; Peled, Jonathan U.; Zhao, Chunfang; Edelmann, Winfried; Scharff, Matthew D.] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA	Yeshiva University	Scharff, MD (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA.	matthew.scharff@einstein.yu.edu	Roa, Sergio/H-9293-2015	Roa, Sergio/0000-0003-1095-0715; Peled, Jonathan/0000-0002-4029-7625	Spanish Ministry of Education and Science [EX-2006-0732]; LLS Fellowship; Albert Einstein College of Medicine [T32 GM 007288]; National Women's Division of the Albert Einstein College of Medicine;  [RO1CA76329];  [RO1CA93484];  [RO1CA72649];  [RO1CA102705]; NATIONAL CANCER INSTITUTE [R01CA102705, R01CA072649, R01CA076329, R01CA093484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); LLS Fellowship; Albert Einstein College of Medicine; National Women's Division of the Albert Einstein College of Medicine; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SR is supported by the Postdoctoral Fellowship EX-2006-0732 from the Spanish Ministry of Education and Science. ZL was supported by the LLS Fellowship and his current address is Beijing Novo Nordisk Pharmaceuticals Science and Technology Co. Ltd., China. JUP is supported by the Medical Scientist Training Program T32 GM 007288 at Albert Einstein College of Medicine. WE is supported by RO1CA76329 and RO1CA93484. MDS is supported by RO1CA72649 and RO1CA102705 and by the Harry Eagle Chair provided by the National Women's Division of the Albert Einstein College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Campbell MR, 2005, CANCER RES, V65, P2626, DOI 10.1158/0008-5472.CAN-04-3158; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Clark AB, 2007, NUCLEIC ACIDS RES, V35, P4114, DOI 10.1093/nar/gkm409; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Edelmann W, 2000, CANCER RES, V60, P803; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Franklin A, 2008, TRENDS IMMUNOL, V29, P167, DOI 10.1016/j.it.2008.01.008; Frey S, 1998, IMMUNITY, V9, P127, DOI 10.1016/S1074-7613(00)80594-4; Frieder D, 2009, MOL CELL BIOL, V29, P5148, DOI 10.1128/MCB.00647-09; Hegan DC, 2006, CARCINOGENESIS, V27, P2402, DOI 10.1093/carcin/bgl079; Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; KRIJGER PH, 2009, J EXP MED; Kunkel TA, 2003, DNA REPAIR, V2, P135, DOI 10.1016/S1568-7864(02)00224-0; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Li ZQ, 2006, IMMUNITY, V24, P393, DOI 10.1016/j.immuni.2006.02.011; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MacCarthy T, 2009, DNA REPAIR, V8, P137, DOI 10.1016/j.dnarep.2008.09.006; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Mayorov VI, 2005, J IMMUNOL, V174, P7781, DOI 10.4049/jimmunol.174.12.7781; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Reynaud CA, 2009, PHILOS T R SOC B, V364, P613, DOI 10.1098/rstb.2008.0206; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Scott RH, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048942; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Steele EJ, 2009, MOL IMMUNOL, V46, P305, DOI 10.1016/j.molimm.2008.10.021; Storb U, 2009, CELL CYCLE, V8, P3097, DOI 10.4161/cc.8.19.9658; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wei K, 2002, TRENDS MOL MED, V8, P346, DOI 10.1016/S1471-4914(02)02359-6; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Wilson TM, 2005, J EXP MED, V201, P637, DOI 10.1084/jem.20042066; Xiao Z, 2007, MOL IMMUNOL, V44, P2659, DOI 10.1016/j.molimm.2006.12.006	49	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11182	10.1371/journal.pone.0011182	http://dx.doi.org/10.1371/journal.pone.0011182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567595	Green Submitted, Green Published, gold			2022-12-25	WOS:000278886300024
J	Nakajima, Y; Nishikawa, A; Iguchi, A; Sakai, K				Nakajima, Yuichi; Nishikawa, Akira; Iguchi, Akira; Sakai, Kazuhiko			Gene Flow and Genetic Diversity of a Broadcast-Spawning Coral in Northern Peripheral Populations	PLOS ONE			English	Article							CLIMATE-CHANGE; MICROSATELLITE MARKERS; CARIBBEAN CORAL; REEF; DISPERSAL; CONNECTIVITY; REPRODUCTION; LOCI; RECRUITMENT	Recently, reef-building coral populations have been decreasing worldwide due to various disturbances. Population genetic studies are helpful for estimating the genetic connectivity among populations of marine sessile organisms with metapopulation structures such as corals. Moreover, the relationship between latitude and genetic diversity is informative when evaluating the fragility of populations. In this study, using highly variable markers, we examined the population genetics of the broadcast-spawning coral Acropora digitifera at 19 sites in seven regions along the 1,000 km long island chain of Nansei Islands, Japan. This area includes both subtropical and temperate habitats. Thus, the coral populations around the Nansei Islands in Japan are northern peripheral populations that would be subjected to environmental stresses different from those in tropical areas. The existence of high genetic connectivity across this large geographic area was suggested for all sites (F-ST <= 0.033) although small but significant genetic differentiation was detected among populations in geographically close sites and regions. In addition, A. digitifera appears to be distributed throughout the Nansei Islands without losing genetic diversity. Therefore, A. digitifera populations in the Nansei Islands may be able to recover relatively rapidly even when high disturbances of coral communities occur locally if populations on other reefs are properly maintained.	[Nakajima, Yuichi; Nishikawa, Akira; Iguchi, Akira; Sakai, Kazuhiko] Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Okinawa, Japan	University of the Ryukyus	Nakajima, Y (corresponding author), Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Okinawa, Japan.	yn_r160@yahoo.co.jp	Iguchi, Akira/I-3180-2016; Nakajima, Yuichi/A-4330-2013	Iguchi, Akira/0000-0002-8894-1977; Nakajima, Yuichi/0000-0001-6558-5378; Sakai, Kazuhiko/0000-0003-1905-5952	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science [16310158, 18651112]; Grants-in-Aid for Scientific Research [21247006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant for the 21st Century COE program "The Comprehensive Analyses on Biodiversity in Coral Reef and Island Ecosystems in Asian and Pacific Regions'' from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Monbukagakusho), and by the Japan Society for the Promotion of Science (Grants-In-Aid Nos. 16310158 and 18651112 to K. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Coffroth MA, 1998, EVOLUTION, V52, P379, DOI 10.1111/j.1558-5646.1998.tb01639.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; EXCOFFIER L, 1992, GENETICS, V131, P479; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; GAINES SD, 1992, NATURE, V360, P579, DOI 10.1038/360579a0; Gilg MR, 2007, MAR ECOL PROG SER, V351, P151, DOI 10.3354/meps07145; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GOWER JC, 1966, BIOMETRIKA, V53, P588, DOI 10.1093/biomet/53.3-4.588; Hayashibara T, 2002, CORAL REEFS, V21, P224; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Isomura N, 2008, MOL ECOL RESOUR, V8, P587, DOI 10.1111/j.1471-8286.2007.02004.x; Kojima S, 2005, ECOL RES, V20, P686, DOI 10.1007/s11284-005-0082-5; KramarskyWinter E, 1997, NATURE, V387, P137, DOI 10.1038/387137a0; Lirman D, 2000, MAR ECOL PROG SER, V197, P209, DOI 10.3354/meps197209; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Ministry of the Environment of Japan, 2004, COR REEF MON INV IR; Nakajima Yuichi, 2009, Plankton & Benthos Research, V4, P38; Nakajima Y, 2009, ZOOL SCI, V26, P209, DOI 10.2108/zsj.26.209; Nishihira M., 1995, HERMATYPIC CORALS JA; Nishikawa A, 2005, ZOOL SCI, V22, P391, DOI 10.2108/zsj.22.391; Nishikawa A, 2005, CORAL REEFS, V24, P318, DOI 10.1007/s00338-005-0484-4; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Purcell JFH, 2006, P ROY SOC B-BIOL SCI, V273, P1483, DOI 10.1098/rspb.2006.3470; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Ridgway T, 2008, MAR ECOL PROG SER, V354, P161, DOI 10.3354/meps07245; Smith LD, 1999, J EXP MAR BIOL ECOL, V235, P147, DOI 10.1016/S0022-0981(98)00178-6; Underwood JN, 2009, EVOL APPL, V2, P222, DOI 10.1111/j.1752-4571.2008.00065.x; Underwood JN, 2009, ECOL APPL, V19, P18, DOI 10.1890/07-1461.1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Oppen MJH, 2007, MOL ECOL NOTES, V7, P436, DOI 10.1111/j.1471-8286.2006.01610.x; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; van Oppen MJH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003401; Veron J.E.N., 2000, CORALS WORLD, V1-3; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Yasuda N, 2009, MOL ECOL, V18, P1574, DOI 10.1111/j.1365-294X.2009.04133.x	45	54	54	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11149	10.1371/journal.pone.0011149	http://dx.doi.org/10.1371/journal.pone.0011149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585399	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886100014
J	Leonardi, R; Rehg, JE; Rock, CO; Jackowski, S				Leonardi, Roberta; Rehg, Jerold E.; Rock, Charles O.; Jackowski, Suzanne			Pantothenate Kinase 1 Is Required to Support the Metabolic Transition from the Fed to the Fasted State	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ACTIVATED RECEPTOR-ALPHA; COA DEHYDROGENASE-DEFICIENCY; PEROXISOMAL NUDIX HYDROLASE; HEPATIC COENZYME-A; BETA-OXIDATION; FEEDBACK-REGULATION; GENE ENCODES; MALONYL-COA; PPAR-ALPHA	Coenzyme A (CoA) biosynthesis is regulated by the pantothenate kinases (PanK), of which there are four active isoforms. The PanK1 isoform is selectively expressed in liver and accounted for 40% of the total PanK activity in this organ. CoA synthesis was limited using a Pank1(-/-) knockout mouse model to determine whether the regulation of CoA levels was critical to liver function. The elimination of PanK1 reduced hepatic CoA levels, and fasting triggered a substantial increase in total hepatic CoA in both Pank1(-/-) and wild-type mice. The increase in hepatic CoA during fasting was blunted in the Pank1(-/-) mouse, and resulted in reduced fatty acid oxidation as evidenced by abnormally high accumulation of long-chain acyl-CoAs, acyl-carnitines, and triglycerides in the form of lipid droplets. The Pank1(-/-) mice became hypoglycemic during a fast due to impaired gluconeogenesis, although ketogenesis was normal. These data illustrate the importance of PanK1 and elevated liver CoA levels during fasting to support the metabolic transition from glucose utilization and fatty acid synthesis to gluconeogenesis and fatty acid oxidation. The findings also suggest that PanK1 may be a suitable target for therapeutic intervention in metabolic disorders that feature hyperglycemia and hypertriglyceridemia.	[Leonardi, Roberta; Rock, Charles O.; Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Leonardi, R (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018; Rehg, Jerold E/N-8111-2018	Jackowski, Suzanne/0000-0002-6855-1429; 	National Institutes of Health [GM062896]; Cancer Center (CORE) [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM062896 (S.J.), a Cancer Center (CORE) Support Grant CA21765, and the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 1997, AM J PHYSIOL-REG I, V272, pR1641, DOI 10.1152/ajpregu.1997.272.5.R1641; ARGMANN CA, 2006, CURRENT PROTOCOLS MO, V5; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLUNT AD, 1957, BRIT J NUTR, V11, P62, DOI 10.1079/BJN19570013; BNELER H, 2009, EXP NEUROL, V218, P235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRASS EP, 1992, J NUTR, V122, P2094, DOI 10.1093/jn/122.11.2094; CAHILL GF, 2008, ANNU REV NUTR, V26, P1; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Garland P B, 1968, Adv Enzyme Regul, V6, P3, DOI 10.1016/0065-2571(68)90005-8; Gasmi L, 2001, BIOCHEM J, V357, P33, DOI 10.1042/0264-6021:3570033; Hayflick SJ, 2003, CURR OPIN PEDIATR, V15, P572, DOI 10.1097/00008480-200312000-00005; HODGES RE, 1958, J CLIN INVEST, V37, P1642, DOI 10.1172/JCI103756; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; HURLEY LS, 1954, J NUTR, V54, P403; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Janssen U, 2002, J BIOL CHEM, V277, P19579, DOI 10.1074/jbc.M110993200; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Kelly CL, 1997, HUM MOL GENET, V6, P1451, DOI 10.1093/hmg/6.9.1451; KIRSCHBAUM N, 1990, J NUTR, V120, P1376, DOI 10.1093/jn/120.11.1376; Kompare M, 2008, SEMIN PEDIATR NEUROL, V15, P140, DOI 10.1016/j.spen.2008.05.008; KONDRUP J, 1973, BIOCHEM J, V132, P373, DOI 10.1042/bj1320373; Kuo YM, 2007, J INHERIT METAB DIS, V30, P310, DOI 10.1007/s10545-007-0560-8; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Leonardi R, 2007, P NATL ACAD SCI USA, V104, P1494, DOI 10.1073/pnas.0607621104; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; LUND H, 1986, BIOCHIM BIOPHYS ACTA, V876, P685, DOI 10.1016/0005-2760(86)90058-5; MARK M, 2007, CURRENT PROTOCOLS MO, V5; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Miinalainen IJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000543; Nyman LR, 2005, MOL GENET METAB, V86, P179, DOI 10.1016/j.ymgme.2005.07.021; Ofman R, 2006, BIOCHEM J, V393, P537, DOI 10.1042/BJ20050893; OLBRICH A, 1981, ANAL BIOCHEM, V113, P386, DOI 10.1016/0003-2697(81)90093-2; Prohl C, 2001, MOL CELL BIOL, V21, P1089, DOI 10.1128/MCB.21.4.1089-1097.2001; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Reilly SJ, 2008, J BIOCHEM, V144, P655, DOI 10.1093/jb/mvn114; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; Rock CO, 2003, J BACTERIOL, V185, P3410, DOI 10.1128/JB.185.11.3410-3415.2003; Rock CO, 2002, GENE, V291, P35, DOI 10.1016/S0378-1119(02)00564-4; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; ROSS BD, 1967, BIOCHEM J, V102, P942, DOI 10.1042/bj1020942; Schuler A Michele, 2002, ILAR J, V43, P57; SMITH CM, 1987, METABOLISM, V36, P115, DOI 10.1016/0026-0495(87)90003-5; SMITH CM, 1980, BIOCHEM J, V188, P175, DOI 10.1042/bj1880175; SMITH CM, 1978, J NUTR, V108, P854, DOI 10.1093/jn/108.5.854; SONG WJ, 1992, J BACTERIOL, V174, P6411, DOI 10.1128/JB.174.20.6411-6417.1992; SRINIVASAN V, 1976, INDIAN J BIOCHEM BIO, V13, P387; Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390; STRAUSS W, 1998, CURRENT PROTOCOLS MO, V1; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Van Vlies N, 2005, BIOCHEM J, V387, P185, DOI 10.1042/BJ20041489; van Vlies N, 2007, BBA-BIOENERGETICS, V1767, P1134, DOI 10.1016/j.bbabio.2007.07.001; VANBOCXLAER JF, 1993, CLIN CHEM, V39, P1911; Ventura FV, 1998, EUR J BIOCHEM, V253, P614, DOI 10.1046/j.1432-1327.1998.2530614.x; VOLTTI H, 1979, BIOCHEM J, V182, P95, DOI 10.1042/bj1820095; Waddell L, 2006, MOL GENET METAB, V87, P32, DOI 10.1016/j.ymgme.2005.09.020; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Williamson J R, 1968, Adv Enzyme Regul, V6, P67, DOI 10.1016/0065-2571(68)90008-3; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; WINTERS RW, 1952, ENDOCRINOLOGY, V50, P388, DOI 10.1210/endo-50-4-388; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Zhang YM, 2005, J BIOL CHEM, V280, P32594, DOI 10.1074/jbc.M506275200; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	75	70	72	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11107	10.1371/journal.pone.0011107	http://dx.doi.org/10.1371/journal.pone.0011107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559429	Green Published, Green Submitted, gold			2022-12-25	WOS:000278741100020
J	Loughlin, DT; Artlett, CM				Loughlin, Danielle T.; Artlett, Carol M.			Precursor of Advanced Glycation End Products Mediates ER-Stress-Induced Caspase-3 Activation of Human Dermal Fibroblasts through NAD(P)H Oxidase 4	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NADPH OXIDASE; MATRIX INTERACTIONS; INDUCED APOPTOSIS; OXIDATIVE STRESS; FOOT ULCERS; CELL-DEATH; CHOP; RAGE; EXPRESSION	Background: The precursor for advanced glycation end products, 3-deoxyglucosone (3DG) is highly upregulated in skin explants of diabetic cutaneous wounds, and has been shown to negatively impact dermal fibroblasts, which are crucial in wound remodeling. 3DG induces apoptosis however; the mechanisms involved in the apoptotic action of 3DG in the pathogenesis of diabetic chronic wounds are poorly understood. Therefore, we sought to delineate novel mechanisms involved with the 3DG-collagen induced apoptosis. Methodology/Principal Findings: Using human dermal fibroblasts, we demonstrated that 3DG-modified collagen induces oxidative stress and caspase-3 activation. Oxidative stress was found to be dependent on the upregulation of NAD(P)H oxidase 4 (Nox4), a reactive oxygen species (ROS) Nox homologue, triggering endoplasmic reticulum (ER) stress, as assessed by the ER stress-induced apoptosis marker Growth Arrest and DNA Damage-inducible gene 153 (GADD153). We demonstrated that 3DG-collagen activated GADD153 via phosphorylation of p38 mitogen activated protein kinase (MAPK), and this was dependent on upstream ROS. Inhibition of ROS and/or p38 MAPK abrogated 3DG-collagen induced caspase-3 activation. Our investigations also demonstrated that 3DG-collagen-induced caspase-3 activation did not signal through the canonical receptor for advanced glycation end products (RAGE) but through integrin alpha 1 beta 1. To further verify the role of integrins, neutralization of integrins alpha 1 beta 1 prevented 3DG-collagen-induced upregulation of ROS, GADD153, and caspase-3 activation; suggesting that 3DG-collagen signaling to the fibroblast is dependent on integrins alpha 1 beta 1. Conclusions/Significance: Taken together, these findings demonstrate for the first time that a RAGE independent mechanism is involved in 3DG-collagen-induced apoptosis. Moreover, the ER stress pathway through activation of Nox4 by integrins alpha 1 beta 1 plays a key role in 3DG-collagen-induced caspase-3 activation, which may play an important role in the pathogenesis of diabetic wounds.	[Loughlin, Danielle T.; Artlett, Carol M.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Loughlin, DT (corresponding author), Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.	carol.artlett@drexelmed.edu			Department of Defense [WX81XWh-07-1-0450]; Dynamis Therapeutics, Inc.	Department of Defense(United States Department of Defense); Dynamis Therapeutics, Inc.	This work was funded by grants to C.M. Artlett from the Department of Defense WX81XWh-07-1-0450 and from Dynamis Therapeutics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2007, AM J PHYSIOL-CELL PH, V292, pC850, DOI 10.1152/ajpcell.00356.2006; Alikhani M, 2007, BONE, V40, P345, DOI 10.1016/j.bone.2006.09.011; Alikhani ZB, 2005, J BIOL CHEM, V280, P12087, DOI 10.1074/jbc.M406313200; AOKI Y, 1993, DIABETOLOGIA, V36, P79, DOI 10.1007/BF00399098; Ariyama Y, 2008, METABOLISM, V57, P1625, DOI 10.1016/j.metabol.2008.06.019; Arnesen SM, 2006, MECH AGEING DEV, V127, P726, DOI 10.1016/j.mad.2006.05.003; Aronson D, 2003, J HYPERTENS, V21, P3, DOI 10.1097/00004872-200301000-00002; Baba SP, 2009, DIABETES, V58, P2486, DOI 10.2337/db09-0375; Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; Bucciarelli LG, 2002, CIRCULATION, V106, P2827, DOI 10.1161/01.CIR.0000039325.03698.36; Caron-Mazet J, 2007, ANN DERMATOL VENER, V134, P645, DOI 10.1016/S0151-9638(07)91825-6; CHEN J, 2009, MOL CELL BIOCH; Chen M, 1999, EXP CELL RES, V249, P231, DOI 10.1006/excr.1999.4473; Ding QX, 2005, BBA-MOL CELL RES, V1746, P18, DOI 10.1016/j.bbamcr.2005.08.006; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Edderkaoui M, 2005, AM J PHYSIOL-GASTR L, V289, pG1137, DOI 10.1152/ajpgi.00197.2005; Forbes JM, 2004, DIABETES, V53, P1813, DOI 10.2337/diabetes.53.7.1813; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Honore S, 2003, EXP CELL RES, V285, P59, DOI 10.1016/S0014-4827(02)00038-1; Huijberts MSP, 2008, DIABETES-METAB RES, V24, pS19, DOI 10.1002/dmrr.861; Jang HJ, 2008, NEUROSCI LETT, V443, P17, DOI 10.1016/j.neulet.2008.07.049; Li, 2000, Arterioscler Thromb Vasc Biol, V20, pE1; Loughlin DT, 2009, WOUND REPAIR REGEN, V17, P739, DOI 10.1111/j.1524-475X.2009.00532.x; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MAUCH C, 1990, RHEUM DIS CLIN N AM, V16, P93; Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Sassi-Gaha S, 2010, MATRIX BIOL, V29, P127, DOI 10.1016/j.matbio.2009.09.007; Schilder YDC, 2009, FREE RADICAL BIO MED, V46, P1598, DOI 10.1016/j.freeradbiomed.2009.03.013; SCHNIDER SL, 1981, J CLIN INVEST, V67, P1630, DOI 10.1172/JCI110198; Sekine Y, 2006, CURR MOL MED, V6, P87, DOI 10.2174/156652406775574541; Sen CK, 2003, WOUND REPAIR REGEN, V11, P431, DOI 10.1046/j.1524-475X.2003.11607.x; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	59	48	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11093	10.1371/journal.pone.0011093	http://dx.doi.org/10.1371/journal.pone.0011093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559423	Green Submitted, gold, Green Published			2022-12-25	WOS:000278741100009
J	Pulford, B; Reim, N; Bell, A; Veatch, J; Forster, G; Bender, H; Meyerett, C; Hafeman, S; Michel, B; Johnson, T; Wyckoff, AC; Miele, G; Julius, C; Kranich, J; Schenkel, A; Dow, S; Zabel, MD				Pulford, Bruce; Reim, Natalia; Bell, Aimee; Veatch, Jessica; Forster, Genevieve; Bender, Heather; Meyerett, Crystal; Hafeman, Scott; Michel, Brady; Johnson, Theodore; Wyckoff, A. Christy; Miele, Gino; Julius, Christian; Kranich, Jan; Schenkel, Alan; Dow, Steven; Zabel, Mark D.			Liposome-siRNA-Peptide Complexes Cross the Blood-Brain Barrier and Significantly Decrease PrPC on Neuronal Cells and PrPRES in Infected Cell Cultures	PLOS ONE			English	Article							PRION STRAIN DISCRIMINATION; SMALL INTERFERING RNA; CANINE KIDNEY-CELLS; HEPATITIS-B-VIRUS; LENTIVIRAL VECTORS; GENE-EXPRESSION; DNA COMPLEXES; NEUROLOGICAL DISORDERS; CYCLIC AMPLIFICATION; PROLONGS SURVIVAL	Background: Recent advances toward an effective therapy for prion diseases employ RNA interference to suppress PrPC expression and subsequent prion neuropathology, exploiting the phenomenon that disease severity and progression correlate with host PrPC expression levels. However, delivery of lentivirus encoding PrP shRNA has demonstrated only modest efficacy in vivo. Methodology/Principal Findings: Here we describe a new siRNA delivery system incorporating a small peptide that binds siRNA and acetylcholine receptors (AchRs), acting as a molecular messenger for delivery to neurons, and cationic liposomes that protect siRNA-peptide complexes from serum degradation. Conclusions/Significance: Liposome-siRNA-peptide complexes (LSPCs) delivered PrP siRNA specifically to AchR-expressing cells, suppressed PrPC expression and eliminated PrPRES formation in vitro. LSPCs injected intravenously into mice resisted serum degradation and delivered PrP siRNA throughout the brain to AchR and PrPC-expressing neurons. These data promote LSPCs as effective vehicles for delivery of PrP and other siRNAs specifically to neurons to treat prion and other neuropathological diseases.	[Pulford, Bruce; Reim, Natalia; Bell, Aimee; Veatch, Jessica; Forster, Genevieve; Bender, Heather; Meyerett, Crystal; Hafeman, Scott; Michel, Brady; Johnson, Theodore; Wyckoff, A. Christy; Julius, Christian; Schenkel, Alan; Dow, Steven; Zabel, Mark D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Miele, Gino] Pfizer Global Res & Dev, Translat Med Res Collaborat, Dundee, Scotland; [Kranich, Jan] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Colorado State University; Pfizer; University of Dundee; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Pulford, B (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mark.zabel@colostate.edu		Kranich, Jan/0000-0002-9928-4132	Colorado State University Infectious Disease Initiative	Colorado State University Infectious Disease Initiative	This work was funded by the Colorado State University Infectious Disease Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARICHELLO JM, METHODS MOL BIOL, V605, P461; BECK E, 1969, BRAIN, V92, P699, DOI 10.1093/brain/92.4.699; BECK E, 1964, BRAIN, V87, P153, DOI 10.1093/brain/87.1.153; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Campochiaro PA, 2006, GENE THER, V13, P559, DOI 10.1038/sj.gt.3302653; D'Costa J, 2009, CURR OPIN MOL THER, V11, P554; Dissen GA, 2009, METHODS, V49, P70, DOI 10.1016/j.ymeth.2009.06.004; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Dow SW, 1999, J IMMUNOL, V163, P1552; Dutertre M., CANC RES, V70, P896; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Erin N, 2009, INT J CANCER, V124, P1503, DOI 10.1002/ijc.24131; Fairman J, 2009, HUM VACCINES, V5, P141, DOI 10.4161/hv.5.3.6589; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gallozzi M, 2008, TRANSGENIC RES, V17, P783, DOI 10.1007/s11248-008-9179-2; GIESE A, 1995, BRAIN PATHOL, V5, P213, DOI 10.1111/j.1750-3639.1995.tb00597.x; Giese A, 1998, BRAIN PATHOL, V8, P449; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Gowen BB, 2009, ANTIVIR RES, V81, P37, DOI 10.1016/j.antiviral.2008.09.001; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; Kim Y, 2009, ANTIVIR RES, V84, P185, DOI 10.1016/j.antiviral.2009.09.002; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kutscher HL, 2010, J CONTROL RELEASE, V143, P31, DOI 10.1016/j.jconrel.2009.12.019; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leng Q, 2008, CANCER GENE THER, V15, P485, DOI 10.1038/cgt.2008.29; Leng Q, 2009, DRUG FUTURE, V34, P721, DOI 10.1358/dof.2009.034.09.1413267; LENTZ TL, 1982, SCIENCE, V215, P182, DOI 10.1126/science.7053569; Lin KD, 1999, BIOTECHNIQUES, V26, P318, DOI 10.2144/99262rr02; Lundberg C, 2008, CURR GENE THER, V8, P461, DOI 10.2174/156652308786847996; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; MOHUCZYDOMINIAK D, 1992, J AM SOC NEPHROL, V3, P170; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; Nadler LS, 1999, AM J PHYSIOL-CELL PH, V277, pC1220, DOI 10.1152/ajpcell.1999.277.6.C1220; NANOU A, 2009, PROG BRAIN RES, V200, P175; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Pai SI, 2006, GENE THER, V13, P464, DOI 10.1038/sj.gt.3302694; Pfeifer A, 2006, J CLIN INVEST, V116, P3204, DOI 10.1172/JCI29236; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; ROTHDIENER M, J CONTROL RELEASE; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Tilly G, 2003, BIOCHEM BIOPH RES CO, V305, P548, DOI 10.1016/S0006-291X(03)00805-2; Valori CF, 2008, CURR GENE THER, V8, P406, DOI 10.2174/156652308786848030; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Zabel MD, 2007, J IMMUNOL, V179, P6144, DOI 10.4049/jimmunol.179.9.6144; Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	71	72	111	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11085	10.1371/journal.pone.0011085	http://dx.doi.org/10.1371/journal.pone.0011085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559428	Green Published, Green Submitted, gold			2022-12-25	WOS:000278741100004
J	Sabetta, JR; DePetrillo, P; Cipriani, RJ; Smardin, J; Burns, LA; Landry, ML				Sabetta, James R.; DePetrillo, Paolo; Cipriani, Ralph J.; Smardin, Joanne; Burns, Lillian A.; Landry, Marie L.			Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults	PLOS ONE			English	Article							TRANSCRIPTION-PCR ASSAY; VITAMIN-D; SEASONAL-VARIATION; MEDICAL-CENTER; UNITED-STATES; INFLUENZA; VIRUSES; IMMUNOFLUORESCENCE; EPIDEMIOLOGY; DEFENSINS	Background: Declining serum concentrations of 25-hydroxyvitamin D seen in the fall and winter as distance increases from the equator may be a factor in the seasonal increased prevalence of influenza and other viral infections. This study was done to determine if serum 25-hydroxyvitamin D concentrations correlated with the incidence of acute viral respiratory tract infections. Methodology/Findings: In this prospective cohort study serial monthly concentrations of 25-hydroxyvitamin D were measured over the fall and winter 2009-2010 in 198 healthy adults, blinded to the nature of the substance being measured. The participants were evaluated for the development of any acute respiratory tract infections by investigators blinded to the 25-hydroxyvitamin D concentrations. The incidence of infection in participants with different concentrations of vitamin D was determined. One hundred ninety-five (98.5%) of the enrolled participants completed the study. Light skin pigmentation, lean body mass, and supplementation with vitamin D were found to correlate with higher concentrations of 25-hydroxyvitamin D. Concentrations of 38 ng/ml or more were associated with a significant (p<0.0001) two-fold reduction in the risk of developing acute respiratory tract infections and with a marked reduction in the percentages of days ill. Conclusions/Significance: Maintenance of a 25-hydroxyvitamin D serum concentration of 38 ng/ml or higher should significantly reduce the incidence of acute viral respiratory tract infections and the burden of illness caused thereby, at least during the fall and winter in temperate zones. The findings of the present study provide direction for and call for future interventional studies examining the efficacy of vitamin D supplementation in reducing the incidence and severity of specific viral infections, including influenza, in the general population and in subpopulations with lower 25-hydroxyvitamin D concentrations, such as pregnant women, dark skinned individuals, and the obese.	[Sabetta, James R.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Sabetta, James R.; Cipriani, Ralph J.; Smardin, Joanne; Burns, Lillian A.] Greenwich Hosp, Infect Dis Sect, Greenwich, CT USA; [DePetrillo, Paolo] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA; [Landry, Marie L.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA	Yale University; Wake Forest University; Wake Forest Baptist Medical Center; Yale University	Sabetta, JR (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.	jsabettamd@yahoo.com			Section of Infectious Diseases, Greenwich Hospital	Section of Infectious Diseases, Greenwich Hospital	This study was supported by a private grant from Jean and David Wallace of Greenwich, Connecticut to the Section of Infectious Diseases, Greenwich Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work on this study by the investigators was without any compensation, with all funding used for laboratory analysis and data recording.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cantorna MT, 2008, MOL ASPECTS MED, V29, P369, DOI 10.1016/j.mam.2008.04.004; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; COX DR, 1972, J R STAT SOC B, V187, P220; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Grant WB, 2008, PEDIATR INFECT DIS J, V27, P853, DOI 10.1097/INF.0b013e3181817bc1; Gropp R, 1999, HUM GENE THER, V10, P957, DOI 10.1089/10430349950018355; GWALTNEY JM, 1966, NEW ENGL J MED, V275, P1261, DOI 10.1056/NEJM196612082752301; Habib-Bein NF, 2003, J CLIN MICROBIOL, V41, P3597, DOI 10.1128/JCM.41.8.3597-3601.2003; HAMMOND GW, 1989, REV INFECT DIS, V11, P494; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; HOPESIMPSON RE, 1981, J HYG-CAMBRIDGE, V86, P35, DOI 10.1017/S0022172400068728; KHAJAVI A, 1977, CLIN PEDIATR, V16, P36, DOI 10.1177/000992287701600106; Landry ML, 2008, J CLIN VIROL, V43, P148, DOI 10.1016/j.jcv.2008.06.006; Landry ML, 2000, J CLIN MICROBIOL, V38, P708, DOI 10.1128/JCM.38.2.708-711.2000; LANDRY ML, 2009, J CLIN MICR IN PRESS; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052; MAXWELL JD, 1994, P NUTR SOC, V53, P533, DOI 10.1079/PNS19940063; MCLAUGHLIN M, 1974, LANCET, V1, P536; Najada AS, 2004, J TROP PEDIATRICS, V50, P364, DOI 10.1093/tropej/50.6.364; Nolte FS, 2007, J CLIN MICROBIOL, V45, P2779, DOI 10.1128/JCM.00669-07; Panozzo CA, 2007, PEDIATR INFECT DIS J, V26, pS41, DOI 10.1097/INF.0b013e318157da82; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; STAMP TCB, 1974, NATURE, V247, P563, DOI 10.1038/247563a0; THACKER SB, 1986, EPIDEMIOL REV, V8, P129, DOI 10.1093/oxfordjournals.epirev.a036291; TOR D, 2003, STAT MED, V27, P1069; Vieth R, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P995; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; 2005, 6 SIGMA DATA MINING	41	282	295	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11088	10.1371/journal.pone.0011088	http://dx.doi.org/10.1371/journal.pone.0011088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559424	gold, Green Published, Green Submitted			2022-12-25	WOS:000278741100005
J	Namkung, W; Thiagarajah, JR; Phuan, PW; Verkman, AS				Namkung, Wan; Thiagarajah, Jay R.; Phuan, Puay-Wah; Verkman, A. S.			Inhibition of Ca2+-activated Cl- channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea	FASEB JOURNAL			English	Article						CaCC; TMEM16A; tannic acid; CFTR; diarrhea; hypertension	AGE-DEPENDENT DIARRHEA; TMEM16A; BIOAVAILABILITY; EXPRESSION; OXIDATION; FAMILY; CELLS	TMEM16A was found recently to be a calcium-activated Cl- channel (CaCC). CaCCs perform important functions in cell physiology, including regulation of epithelial secretion, cardiac and neuronal excitability, and smooth muscle contraction. CaCC modulators are of potential utility for treatment of hypertension, diarrhea, and cystic fibrosis. Screening of drug and natural product collections identified tannic acid as an inhibitor of TMEM16A, with IC50 similar to 6 mu M and similar to 100% inhibition at higher concentrations. Tannic acid inhibited CaCCs in multiple cell types but did not affect CFTR Cl- channels. Structure-activity analysis indicated the requirement of gallic or digallic acid substituents on a macromolecular scaffold (gallotannins), as are present in green tea and red wine. Other polyphenolic components of teas and wines, including epicatechin, catechin, and malvidin-3-glucoside, poorly inhibited CaCCs. Remarkably, a 1000-fold dilution of red wine and 100-fold dilution of green tea inhibited CaCCs by >50%. Tannic acid, red wine, and green tea inhibited arterial smooth muscle contraction and intestinal Cl- secretion. Gallotannins are thus potent CaCC inhibitors whose biological activity provides a potential molecular basis for the cardioprotective and antisecretory benefits of red wine and green tea.-Namkung, W., Thiagarajah, J. R., Phuan, P.-W., Verkman, A. S. Inhibition of Ca2+-activated Cl- channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea. FASEB J. 24, 4178-4186 (2010). www.fasebj.org	[Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower,Box 0521, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			U.S. National Institutes of Health [HL73856, DK72517, DK86125, DK35124, EB00415, EY13574]; Cystic Fibrosis Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, P30DK072517, R01DK035124, RC1DK086125] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants HL73856, DK72517, DK86125, DK35124, EB00415, and EY13574, and Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation.	Actis-Goretta L, 2006, J AGR FOOD CHEM, V54, P229, DOI 10.1021/jf052263o; Aviram M, 2002, ANN NY ACAD SCI, V957, P146, DOI 10.1111/j.1749-6632.2002.tb02913.x; Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cordova AC, 2005, J AM COLL SURGEONS, V200, P428, DOI 10.1016/j.jamcollsurg.2004.10.030; Criddle DN, 1996, BRIT J PHARMACOL, V118, P1065, DOI 10.1111/j.1476-5381.1996.tb15507.x; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; DROOGMANS G, 1991, J PHYSIOL-LONDON, V440, P623, DOI 10.1113/jphysiol.1991.sp018728; Dufresne CJ, 2001, J NUTR BIOCHEM, V12, P404, DOI 10.1016/S0955-2863(01)00155-3; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; FITZPATRICK DF, 1993, AM J PHYSIOL, V265, pH774; Flesch M, 1998, AM J PHYSIOL-HEART C, V275, pH1183, DOI 10.1152/ajpheart.1998.275.4.H1183; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MAXWELL S, 1994, LANCET, V344, P193, DOI 10.1016/S0140-6736(94)92795-2; Moore RJ, 2009, BRIT J NUTR, V102, P1790, DOI 10.1017/S0007114509991218; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; Namkung W, 2009, J BIOL CHEM, V284, P15916, DOI 10.1074/jbc.M808021200; Nelson MT, 1997, J PHYSIOL-LONDON, V502, P259, DOI 10.1111/j.1469-7793.1997.259bk.x; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Palombo EA, 2006, PHYTOTHER RES, V20, P717, DOI 10.1002/ptr.1907; POWELL DW, 1980, SECRETORY DIARRHEA, P187; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Rolfe VE, 1997, J PHYSIOL-LONDON, V503, P347, DOI 10.1111/j.1469-7793.1997.347bh.x; Sayer B, 2002, BRIT J PHARMACOL, V135, P1794, DOI 10.1038/sj.bjp.0704633; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sumpio BE, 2006, J AM COLL SURGEONS, V202, P813, DOI 10.1016/j.jamcollsurg.2006.01.018; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x; Yang CS, 2008, MOL NUTR FOOD RES, V52, pS139, DOI 10.1002/mnfr.200700234; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	40	153	162	2	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4178	4186		10.1096/fj.10-160648	http://dx.doi.org/10.1096/fj.10-160648			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20581223	Green Published			2022-12-25	WOS:000283861100006
J	Alves, CS; Melo, MN; Franquelim, HG; Ferre, R; Planas, M; Feliu, L; Bardaji, E; Kowalczyk, W; Andreu, D; Santos, NC; Fernandes, MX; Castanho, MARB				Alves, Carla S.; Melo, Manuel N.; Franquelim, Henri G.; Ferre, Rafael; Planas, Marta; Feliu, Lidia; Bardaji, Eduard; Kowalczyk, Wioleta; Andreu, David; Santos, Nuno C.; Fernandes, Miguel X.; Castanho, Miguel A. R. B.			Escherichia coli Cell Surface Perturbation and Disruption Induced by Antimicrobial Peptides BP100 and pepR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; MEMBRANE; BACTERIA	The potential of antimicrobial peptides (AMPs) as an alternative to conventional therapies is well recognized. Insights into the biological and biophysical properties of AMPs are thus key to understanding their mode of action. In this study, the mechanisms adopted by two AMPs in disrupting the Gram-negative Escherichia coli bacterial envelope were explored. BP100 is a short cecropin A-melittin hybrid peptide known to inhibit the growth of phytopathogenic Gram-negative bacteria. pepR, on the other hand, is a novel AMP derived from the dengue virus capsid protein. Both BP100 and pepR were found to inhibit the growth of E. coli at micromolar concentrations. Zeta potential measurements of E. coli incubated with increasing peptide concentrations allowed for the establishment of a correlation between the minimal inhibitory concentration (MIC) of each AMP and membrane surface charge neutralization. While a neutralization-mediated killing mechanism adopted by either AMP is not necessarily implied, the hypothesis that surface neutralization occurs close to MIC values was confirmed. Atomic force microscopy (AFM) was then employed to visualize the structural effect of the interaction of each AMP with the E. coli cell envelope. At their MICs, BP100 and pepR progressively destroyed the bacterial envelope, with extensive damage already occurring 2 h after peptide addition to the bacteria. A similar effect was observed for each AMP in the concentration-dependent studies. At peptide concentrations below MIC values, only minor disruptions of the bacterial surface occurred.	[Castanho, Miguel A. R. B.] Univ Lisbon, Unidade Bioquim Fis, Inst Mol Med, Fac Med, P-1649028 Lisbon, Portugal; [Fernandes, Miguel X.] Univ Madeira, Ctr Quim Madeira, P-9000390 Funchal, Portugal; [Ferre, Rafael; Planas, Marta; Feliu, Lidia; Bardaji, Eduard] Univ Girona, Lab Innovacio Proc & Prod Sintesi Organ, Dept Quim, Girona 17071, Spain; [Kowalczyk, Wioleta; Andreu, David] Pompeu Fabra Univ, Dept Expt & Hlth Sci, E-08003 Barcelona, Spain	Universidade de Lisboa; Universidade da Madeira; Universitat de Girona; Pompeu Fabra University	Castanho, MARB (corresponding author), Univ Lisbon, Unidade Bioquim Fis, Inst Mol Med, Fac Med, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.	macastanho@fm.ul.pt	Andreu, David/I-4359-2014; Feliu, Lidia/H-8285-2015; Planas, Marta/E-4145-2015; BARDAJI, EDUARD/I-1211-2015; Fernandes, Miguel Xavier/A-4373-2013; Kowalczyk, Wioleta/F-5904-2014; Santos, Nuno/N-7248-2013; Franquelim, Henri/P-4985-2017; Fernandes, Miguel Xavier/AAP-6504-2020	Andreu, David/0000-0002-6317-6666; Feliu, Lidia/0000-0001-9792-6106; Planas, Marta/0000-0003-4988-4970; BARDAJI, EDUARD/0000-0001-6281-3646; Fernandes, Miguel Xavier/0000-0002-1840-616X; Santos, Nuno/0000-0002-0580-0475; Franquelim, Henri/0000-0001-6229-4276; Fernandes, Miguel Xavier/0000-0002-1840-616X; Alves, Carla Sophia/0000-0002-8891-5234; Melo, Manuel Nuno/0000-0001-6567-0513; Kowalczyk, Wioleta/0000-0001-5180-594X; Castanho, Miguel/0000-0001-7891-7562; FCCN, Bogus/0000-0003-1034-3552; FCCN, Bogus/0000-0001-6282-8004	Fundacao para Ciencia e Tecnologia, Portugal [SFRH/BD/24547/2005, SFRH/BD/24778/2005, SFRH/BD/39039/2007, PTDC/QUI/69937/2006, REEQ/140/BIO/2005]	Fundacao para Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the Fundacao para Ciencia e Tecnologia, Portugal (Fellowships SFRH/BD/24547/2005, SFRH/BD/24778/2005, and SFRH/BD/39039/2007, to C. S. A., M. N. M., and H. G. F., respectively, and Projects PTDC/QUI/69937/2006 and REEQ/140/BIO/2005).	Amro NA, 2000, LANGMUIR, V16, P2789, DOI 10.1021/la991013x; Andra J, 2004, ANTIMICROB AGENTS CH, V48, P1593, DOI 10.1128/AAC.48.5.1593-1599.2004; ANDREU D, 1992, FEBS LETT, V296, P190, DOI 10.1016/0014-5793(92)80377-S; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Bolshakova AV, 2001, ULTRAMICROSCOPY, V86, P121, DOI 10.1016/S0304-3991(00)00075-9; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Colville K, 2010, LANGMUIR, V26, P2639, DOI 10.1021/la902826n; Conte M, 2007, WORLD J MICROB BIOT, V23, P1679, DOI 10.1007/s11274-007-9415-6; da Silva A, 2005, WORLD J MICROB BIOT, V21, P1103, DOI 10.1007/s11274-005-0077-y; den Hertog AL, 2004, BIOCHEM J, V379, P665, DOI 10.1042/BJ20031785; Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007; Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385; Ferre R, 2006, APPL ENVIRON MICROB, V72, P3302, DOI 10.1128/AEM.72.5.3302-3308.2006; Ferre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Girasole M, 2007, BBA-BIOMEMBRANES, V1768, P1268, DOI 10.1016/j.bbamem.2007.01.014; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Huang HW, 2009, BIOPHYS J, V96, P3263, DOI 10.1016/j.bpj.2009.01.030; Huang HW, 2000, BIOCHEMISTRY-US, V39, P8347, DOI 10.1021/bi000946l; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; Li A, 2007, BBA-BIOMEMBRANES, V1768, P411, DOI 10.1016/j.bbamem.2006.12.010; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Matsuzaki K, 1999, FEBS LETT, V449, P221, DOI 10.1016/S0014-5793(99)00443-3; Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Oren Z, 1998, BIOPOLYMERS, V47, P451; Schaer-Zammaretti P, 2003, ULTRAMICROSCOPY, V97, P199, DOI 10.1016/S0304-3991(03)00044-5; Ubbink J, 2005, MICRON, V36, P293, DOI 10.1016/j.micron.2004.11.005; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	36	176	177	0	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27536	27544		10.1074/jbc.M110.130955	http://dx.doi.org/10.1074/jbc.M110.130955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20566635	hybrid, Green Published			2022-12-25	WOS:000281404100008
J	Jeon, YJ; Lee, KY; Cho, YY; Pugliese, A; Kim, HG; Jeong, CH; Bode, AM; Dong, Z				Jeon, Young Jin; Lee, Kun Yeong; Cho, Yong-Yeon; Pugliese, Angelo; Kim, Hong Gyum; Jeong, Chul-Ho; Bode, Ann M.; Dong, Zigang			Role of NEK6 in Tumor Promoter-induced Transformation in JB6 C141 Mouse Skin Epidermal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIMA-RELATED KINASE-6; ASPERGILLUS-NIDULANS; CANCER DEVELOPMENT; STAT3 ACTIVATION; FAMILY KINASES; PROTEIN-KINASE; PHOSPHORYLATION; SUBSTRATE; GENE	NEK6 (NIMA-related kinase 6) is a homologue of the Aspergillus nidulans protein NIMA (never in mitosis, gene A). We demonstrate that overexpression of NEK6 induces anchorage-independent transformation of JB6 Cl41 mouse epidermal cells. Tissue arrays and Western immunoblot analysis show that NEK6 is overexpressed in malignant tissues and several cancer cell lines. Our data also show that NEK6 interacts with STAT3, an oncogenic transcription factor, and phosphorylates STAT3 on Ser(727), which is important for transcriptional activation. Additional studies using NEK6 mutants suggested that the phosphorylation on both Ser(206) and Thr(210) of NEK6 is critical for STAT3 phosphorylation and anchorage-independent transformation of mouse epidermal cells. Notably, knockdown of NEK6 decreased colony formation and STAT3 Ser(727) phosphorylation. Based on our findings, the most likely mechanism that can account for this biological effect involves the activation of STAT3 through the phosphorylation on Ser(727). Because of the critical role that STAT3 plays in mediating oncogenesis, the stimulatory effects of NEK6 on STAT3 and cell transformation suggest that this family of serine/threonine kinases might represent a novel chemotherapeutic target.	[Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Jeon, Young Jin] Chosun Univ, Coll Med, Kwangju 501709, South Korea	University of Minnesota System; Chosun University	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020	Cho, Yong-Yeon/0000-0003-1107-2651	National Institutes of Health [CA077646, R37CA081064, CA111536, CA120388, ES016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA077646, R37CA081064, R01CA111536, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, R37CA081064, CA111536, CA120388, and ES016548. This work was also supported by the Hormel Foundation.	Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Belham C, 2001, CURR BIOL, V11, P1155, DOI 10.1016/S0960-9822(01)00369-4; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; Chen J, 2006, BIOCHEM BIOPH RES CO, V341, P1059, DOI 10.1016/j.bbrc.2005.12.228; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Lee EJ, 2007, BIOCHEM BIOPH RES CO, V358, P783, DOI 10.1016/j.bbrc.2007.04.203; Lee MY, 2008, CELL CYCLE, V7, P2705, DOI 10.4161/cc.7.17.6551; Lizcano JM, 2002, J BIOL CHEM, V277, P27839, DOI 10.1074/jbc.M202042200; Lu HT, 2007, CURR CANCER DRUG TAR, V7, P343, DOI 10.2174/156800907780809750; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; PU RT, 1995, EMBO J, V14, P995, DOI 10.1002/j.1460-2075.1995.tb07080.x; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Ying TH, 2008, CELL BIOL INT, V32, P210, DOI 10.1016/j.cellbi.2007.08.027; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Yu CY, 2002, ONCOGENE, V21, P3949, DOI 10.1038/sj.onc.1205499	26	33	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28126	28133		10.1074/jbc.M110.137190	http://dx.doi.org/10.1074/jbc.M110.137190			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20595392	Green Published, hybrid			2022-12-25	WOS:000288742300011
J	Meng, JM; Drolet, JR; Monks, BG; Golenbock, DT				Meng, Jianmin; Drolet, Joshua R.; Monks, Brian G.; Golenbock, Douglas T.			MD-2 Residues Tyrosine 42, Arginine 69, Aspartic Acid 122, and Leucine 125 Provide Species Specificity for Lipid IVA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TLR4-MD-2 COMPLEX; CUTTING EDGE; LIPOPOLYSACCHARIDE; RECEPTOR; TLR4; ENDOTOXIN; MICE; LPS; RESPONSIVENESS; ACTIVATION	Lipopolysaccharide (LPS) activates the innate immune response through the Toll-like receptor 4 (TLR4).MD-2 complex. A synthetic lipid A precursor, lipid IVA, induces an innate immune response in mice but not in humans. Both TLR4 and MD-2 are required for the agonist activity of lipid IVA in mice, with TLR4 interacting through specific surface charges at the dimerization interface. In this study, we used site-directed mutagenesis to identify the MD-2 residues that determine lipid IVA species specificity. A single mutation of murine MD-2 at the hydrophobic pocket entrance, E122K, substantially reduced the response to lipid IVA. Combining the murine MD-2 E122K with the murine TLR4 K367E/S386K/R434Q mutations completely abolished the response to lipid IVA, effectively converting the murine cellular response to a human-like response. In human cells, however, simultaneous mutations of K122E, K125L, Y41F, and R69G on human MD-2 were required to promote a response to lipid IVA. Combining the human MD-2 quadruple mutations with the human TLR4 E369K/Q436R mutations completely converted the human MD-2/human TLR4 receptor to a murine-like receptor. Because MD-2 residues 122 and 125 reside at the dimerization interface near the pocket entrance, surface charge differences here directly affect receptor dimerization. In comparison, residues 42 and 69 reside at the MD-2/TLR4 interaction surface opposite the dimerization interface. Surface charge differences there likely affect the binding angle and/or rigidity between MD-2 and TLR4, exerting an indirect influence on receptor dimerization and activation. Thus, surface charge differences at the two MD-2/TLR4 interfaces determine the species-specific activation of lipid IVA.	[Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, 364 Plantat St,LRB 208, Worcester, MA 01605 USA.	douglas.golenbock@umassmed.edu	Monks, Brian/B-8362-2015	Monks, Brian/0000-0003-4008-3093	National Institutes of Health [GM54060, U19 AI084048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060, R37GM054060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54060 (to D. T. G.) and U19 AI084048 (to J. M. and D. T. G.).	Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Perera PY, 1997, J IMMUNOL, V158, P4422; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	22	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27935	27943		10.1074/jbc.M110.134668	http://dx.doi.org/10.1074/jbc.M110.134668			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592019	Green Published, hybrid			2022-12-25	WOS:000281404100048
J	Ravasio, A; Olmeda, B; Bertocchi, C; Haller, T; Perez-Gil, J				Ravasio, Andrea; Olmeda, Barbara; Bertocchi, Cristina; Haller, Thomas; Perez-Gil, Jesus			Lamellar Bodies Form Solid Three-dimensional Films at the Respiratory Air-Liquid Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY SURFACTANT MEMBRANES; II CELLS; LUNG SURFACTANT; IN-VITRO; SECRETION; PROTEINS; CHOLESTEROL; COEXISTENCE; ADSORPTION; EXOCYTOSIS	Pulmonary surfactant is essential for lung function. It is assembled, stored and secreted as particulate entities (lamellar body-like particles; LBPs). LBPs disintegrate when they contact an air-liquid interface, leading to an instantaneous spreading of material and a decline in surface tension. Here, we demonstrate that the film formed by the adsorbed material spontaneously segregate into distinct ordered and disordered lipid phase regions under unprecedented near-physiological conditions and, unlike natural surfactant purified from bronchoalveolar lavages, dynamically reorganized into highly viscous multilayer domains with complex three-dimensional topographies. Multilayer domains, in coexistence with liquid phases, showed a progressive stiffening and finally solidification, probably driven by a self-driven disassembly of LBPs from a sub-surface compartment. We conclude that surface film formation from LBPs is a highly dynamic and complex process, leading to a more elaborated scenario than that observed and predicted by models using reconstituted, lavaged, or fractionated preparations.	[Ravasio, Andrea; Haller, Thomas] Innsbruck Med Univ, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Bertocchi, Cristina] Innsbruck Med Univ, Dept Internal Med 1, A-6020 Innsbruck, Austria; [Olmeda, Barbara; Perez-Gil, Jesus] Univ Complutense, Fac Biol, Dept Bioquim, E-28040 Madrid, Spain	Medical University of Innsbruck; Medical University of Innsbruck; Complutense University of Madrid	Haller, T (corresponding author), Innsbruck Med Univ, Dept Physiol & Med Phys, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	Thomas.Haller@i-med.ac.at; jpg@bbm1.ucm.es	Bertocchi, Cristina/GSJ-6994-2022; Haller, Thomas/H-9036-2015; Olmeda, Bárbara/H-1440-2015; Perez-Gil, Jesus/H-3102-2019; Ravasio, Andrea/G-6167-2011; Ravasio, Andrea/H-6722-2012	Bertocchi, Cristina/0000-0003-0907-1318; Haller, Thomas/0000-0001-9147-4081; Olmeda, Bárbara/0000-0001-6004-1603; Perez-Gil, Jesus/0000-0003-3587-7147; Ravasio, Andrea/0000-0001-7835-5133	Austrian FWF [P17501, P 20472]; Spanish Ministry of Science [BIO2009-09694, CSD2007-00010]; Community of Madrid [S2009MAT-1507]; European Commission [RTN-512229]; Austrian Science Fund (FWF) [P 20472] Funding Source: researchfish	Austrian FWF(Austrian Science Fund (FWF)); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Community of Madrid(Comunidad de Madrid); European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian FWF (P17501, P 20472), by Grants from Spanish Ministry of Science (BIO2009-09694, CSD2007-00010), and the Community of Madrid (S2009MAT-1507), and Marie Curie Network Pulmonet (RTN-512229) from the European Commission.	Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; BANGHAM AD, 1979, BIOCHIM BIOPHYS ACTA, V573, P552, DOI 10.1016/0005-2760(79)90229-7; de la Serna JB, 2009, BIOPHYS J, V97, P1381, DOI 10.1016/j.bpj.2009.06.040; Bertocchi C, 2005, BIOPHYS J, V89, P1353, DOI 10.1529/biophysj.104.053132; Cabre EJ, 2009, BIOPHYS J, V97, P768, DOI 10.1016/j.bpj.2009.04.057; Cheong N, 2007, J BIOL CHEM, V282, P23811, DOI 10.1074/jbc.M703927200; Dahim M, 2002, BIOPHYS J, V83, P1511, DOI 10.1016/S0006-3495(02)73921-0; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; Discher BM, 1996, BIOPHYS J, V71, P2583, DOI 10.1016/S0006-3495(96)79450-X; Fisher AB, 2010, AM J PHYSIOL-LUNG C, V299, pL51, DOI 10.1152/ajplung.00066.2010; Garcia-Verdugo I, 2008, AM J PHYSIOL-LUNG C, V295, pL708, DOI 10.1152/ajplung.00536.2007; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Gomez-Gil L, 2009, BIOPHYS J, V97, P2736, DOI 10.1016/j.bpj.2009.08.045; Haller T, 2004, AM J PHYSIOL-LUNG C, V286, pL1009, DOI 10.1152/ajplung.00342.2003; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Kashchiev D, 2001, EUR BIOPHYS J BIOPHY, V30, P34, DOI 10.1007/s002490000120; Larsson M, 2006, CHEM PHYS LIPIDS, V144, P137, DOI 10.1016/j.chemphyslip.2006.08.006; Miklavc P, 2009, BIOCHEM J, V424, P7, DOI 10.1042/BJ20091094; Nag K, 1998, BIOPHYS J, V74, P2983, DOI 10.1016/S0006-3495(98)78005-1; Ochs M, 2010, CELL PHYSIOL BIOCHEM, V25, P27, DOI 10.1159/000272061; Perez-Gil J, 1998, BBA-MOL BASIS DIS, V1408, P203, DOI 10.1016/S0925-4439(98)00068-4; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Possmayer F, 2001, COMP BIOCHEM PHYS A, V129, P209, DOI 10.1016/S1095-6433(01)00317-8; Ravasio A, 2008, J LIPID RES, V49, P2479, DOI 10.1194/jlr.D800029-JLR200; Rooney SA, 2001, COMP BIOCHEM PHYS A, V129, P233, DOI 10.1016/S1095-6433(01)00320-8; Sato Shigeru, 2001, Medical Electron Microscopy, V34, P142, DOI 10.1007/s007950170008; Schurch S, 2001, COMP BIOCHEM PHYS A, V129, P195, DOI 10.1016/S1095-6433(01)00316-6; SCHURCH S, 1995, BIOL NEONATE, V67, P61; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; Veldhuizen RAW, 1999, EXP LUNG RES, V25, P127, DOI 10.1080/019021499270349; Wemhoner A, 2006, J BIOMOL SCREEN, V11, P286, DOI 10.1177/1087057105285284; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; WILLIAMS MC, 1977, J CELL BIOL, V72, P260, DOI 10.1083/jcb.72.2.260; Yan WF, 2007, J APPL PHYSIOL, V102, P1739, DOI 10.1152/japplphysiol.00948.2006; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	36	28	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28174	28182		10.1074/jbc.M110.106518	http://dx.doi.org/10.1074/jbc.M110.106518			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20558742	Green Published, hybrid			2022-12-25	WOS:000281404100060
J	Peng, Y; Veneziano, SE; Gillispie, GD; Broderick, JB				Peng, Yi; Veneziano, Susan E.; Gillispie, Gregory D.; Broderick, Joan B.			Pyruvate Formate-lyase, Evidence for an Open Conformation Favored in the Presence of Its Activating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI PYRUVATE; LINEAR EXTRAPOLATION METHOD; UNIQUE IRON SITE; S-ADENOSYLMETHIONINE; PROTEIN SUPERFAMILY; ALPHA-CHYMOTRYPSIN; RADICAL-SAM; MECHANISM; CLUSTER; 4FE-4S	Pyruvate formate-lyase-activating enzyme (PFL-AE) activates pyruvate formate-lyase (PFL) by generating a catalytically essential radical on Gly-734 of PFL. Crystal structures of unactivated PFL reveal that Gly-734 is buried 8 angstrom from the surface of the protein in what we refer to here as the closed conformation of PFL. We provide here the first experimental evidence for an alternate open conformation of PFL in which: (i) the glycyl radical is significantly less stable; (ii) the activated enzyme exhibits lower catalytic activity; (iii) the glycyl radical undergoes less H/D exchange with solvent; and (iv) the T-m of the protein is decreased. The evidence suggests that in the open conformation of PFL, the Gly-734 residue is located not in its buried position in the enzyme active site but rather in a more solvent-exposed location. Further, we find that the presence of the PFL-AE increases the proportion of PFL in the open conformation; this observation supports the idea that PFL-AE accesses Gly-734 for direct hydrogen atom abstraction by binding to the Gly-734 loop in the open conformation, thereby shifting the closed 7 open equilibrium of PFL to the right. Together, our results lead to a model in which PFL can exist in either a closed conformation, with Gly-734 buried in the active site of PFL and harboring a stable glycyl radical, or an open conformation, with Gly-734 more solvent-exposed and accessible to the PFL-AE active site. The equilibrium between these two conformations of PFL is modulated by the interaction with PFL-AE.	[Peng, Yi; Veneziano, Susan E.; Broderick, Joan B.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Peng, Yi; Veneziano, Susan E.; Broderick, Joan B.] Montana State Univ, Astrobiol Biogeocatalysis Res Ctr, Bozeman, MT 59717 USA; [Gillispie, Gregory D.] Fluorescence Innovat, Bozeman, MT 59718 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Broderick, JB (corresponding author), Montana State Univ, Dept Chem & Biochem, 103 CBB, Bozeman, MT 59717 USA.	jbroderick@chemistry.montana.edu		Broderick, Joan/0000-0001-7057-9124	National Institutes of Health [GM54608]; Montana Board of Research and Commercialization Technology [08-48]; NASA Astrobiology Institute [NAI05-19]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM054608, R29GM054608, R01GM054608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana Board of Research and Commercialization Technology; NASA Astrobiology Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54608 (to J.B.B.). This work was also supported by Montana Board of Research and Commercialization Technology Grant 08-48 (to G. D. G.). The Astrobiology Biogeocatalysis Research Center is supported by the NASA Astrobiology Institute Grant NAI05-19.	AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; Baker SN, 2004, CHEM COMMUN, P940, DOI 10.1039/b401304m; Becker A, 2002, J BIOL CHEM, V277, P40036, DOI 10.1074/jbc.M205821200; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Beinert H, 1978, Methods Enzymol, V54, P435; BLASCHKOWSKI HP, 1982, EUR J BIOCHEM, V123, P563; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broderick JB, 1997, J AM CHEM SOC, V119, P7396, DOI 10.1021/ja9711425; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; FREY M, 1994, J BIOL CHEM, V269, P12432; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Greenfield Norma J, 2004, Methods Mol Biol, V261, P55; Henshaw TF, 2000, J AM CHEM SOC, V122, P8331, DOI 10.1021/ja002012q; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1111/j.1574-6968.1990.tb04108.x; KNAPPE J, 1974, EUR J BIOCHEM, V50, P253, DOI 10.1111/j.1432-1033.1974.tb03894.x; KNAPPE J, 1976, BIOCHEM BIOPH RES CO, V71, P1110, DOI 10.1016/0006-291X(76)90768-3; KNAPPE J, 1993, BIOCHEM SOC T, V21, P731, DOI 10.1042/bst0210731; Krebs C, 2002, J AM CHEM SOC, V124, P912, DOI 10.1021/ja017562i; Krebs C, 2000, J AM CHEM SOC, V122, P12497, DOI 10.1021/ja003335p; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; Lehtio L, 2002, ACTA CRYSTALLOGR D, V58, P2209, DOI 10.1107/S0907444902016402; Nnyepi MR, 2007, ARCH BIOCHEM BIOPHYS, V459, P1, DOI 10.1016/j.abb.2006.12.024; Pace CN, 2000, PROTEINS, P1; PARAST CV, 1995, BIOCHEMISTRY-US, V34, P2393, DOI 10.1021/bi00008a001; PARAST CV, 1995, J AM CHEM SOC, V117, P10601, DOI 10.1021/ja00147a034; PLAGA W, 1988, EUR J BIOCHEM, V178, P445, DOI 10.1111/j.1432-1033.1988.tb14468.x; Plaga W, 2000, FEBS LETT, V466, P45, DOI 10.1016/S0014-5793(99)01752-4; RODEL W, 1988, EUR J BIOCHEM, V177, P153, DOI 10.1111/j.1432-1033.1988.tb14356.x; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; UNKRIG V, 1989, EUR J BIOCHEM, V184, P723, DOI 10.1111/j.1432-1033.1989.tb15072.x; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Walsby CJ, 2005, INORG CHEM, V44, P727, DOI 10.1021/ic0484811; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s	40	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27224	27231		10.1074/jbc.M109.096875	http://dx.doi.org/10.1074/jbc.M109.096875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20571026	hybrid, Green Published			2022-12-25	WOS:000281172700053
J	Iharada, M; Miyaji, T; Fujimoto, T; Hiasa, M; Anzai, N; Omote, H; Moriyama, Y				Iharada, Masafumi; Miyaji, Takaaki; Fujimoto, Takahiro; Hiasa, Miki; Anzai, Naohiko; Omote, Hiroshi; Moriyama, Yoshinori			Type 1 Sodium-dependent Phosphate Transporter (SLC17A1 Protein) Is a Cl--dependent Urate Exporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE TRANSPORTER; URIC-ACID; CHLORIDE CONDUCTANCE; SYNAPTIC VESICLES; ANION TRANSPORT; APICAL MEMBRANE; XENOPUS OOCYTES; ORGANIC CATION; IDENTIFICATION; EXPRESSION	SLC17A1 protein (NPT1) is the first identified member of the SLC17 phosphate transporter family and mediates the transmembrane cotransport of Na+/P-i in oocytes. Although this protein is believed to be a renal polyspecific anion exporter, its transport properties are not well characterized. Here, we show that proteoliposomes containing purified SLC17A1 transport various organic anions such as p-aminohippuric acid and acetylsalicylic acid (aspirin) in an inside positive membrane potential (Delta psi)-dependent manner. We found that NPT1 also transported urate. The uptake characteristics were similar to that of SLC17 members in its Cl- dependence and inhibitor sensitivity. When arginine 138, an essential amino acid residue for members of the SLC17 family such as the vesicular glutamate transporter, was specifically mutated to alanine, the resulting mutant protein was inactive in Delta psi-dependent anion transport. Heterologously expressed and purified human NPT1 carrying the single nucleotide polymorphism mutation that is associated with increased risk of gout in humans exhibited 32% lower urate transport activity compared with the wild type protein. These results strongly suggested that NPT1 is a Cl--dependent polyspecific anion exporter involved in urate excretion under physiological conditions.	[Moriyama, Yoshinori] Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Miyaji, Takaaki; Moriyama, Yoshinori] Okayama Univ, Adv Sci Res Ctr, Okayama 7008530, Japan; [Anzai, Naohiko] Kyorin Univ, Dept Pharmacol, Sch Med, Tokyo 1818611, Japan	Okayama University; Okayama University; Kyorin University	Moriyama, Y (corresponding author), Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	moriyama@pharm.okayama-u.ac.jp	OMOTE, Hiroshi/B-1635-2011; ANZAI, NAOHIKO/K-9492-2017	ANZAI, NAOHIKO/0000-0003-0605-0458; Miyaji, Takaaki/0000-0002-7257-7621	Japanese Ministry of Education, Science, Sports, and Culture; Ajinomoto 3ARP; Brain Science Foundation; Salt Science Foundation	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ajinomoto 3ARP; Brain Science Foundation; Salt Science Foundation	This work was supported in part by grants-in-aid from the Japanese Ministry of Education, Science, Sports, and Culture (to H.O. and Y.M.), the Ajinomoto 3ARP, the Brain Science Foundation, and the Salt Science Foundation (to Y.M.).	Becker MA, 2006, RHEUM DIS CLIN N AM, V32, P275, DOI 10.1016/j.rdc.2006.02.005; Broer S, 1998, J MEMBRANE BIOL, V164, P71, DOI 10.1007/s002329900394; Busch AE, 1996, P NATL ACAD SCI USA, V93, P5347, DOI 10.1073/pnas.93.11.5347; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Inui K, 2000, KIDNEY INT, V58, P944, DOI 10.1046/j.1523-1755.2000.00251.x; Juge N, 2009, J BIOL CHEM, V284, P35073, DOI 10.1074/jbc.M109.062414; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Jutabha P, 2003, J BIOL CHEM, V278, P27930, DOI 10.1074/jbc.M303210200; Koepsell H, 2004, TRENDS PHARMACOL SCI, V25, P375, DOI 10.1016/j.tips.2004.05.005; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; MORIYAMA Y, 1995, J BIOL CHEM, V270, P22314, DOI 10.1074/jbc.270.38.22314; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; PRITCHARD JB, 1993, PHYSIOL REV, V73, P765, DOI 10.1152/physrev.1993.73.4.765; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Uchino H, 2000, BIOCHEM BIOPH RES CO, V270, P254, DOI 10.1006/bbrc.2000.2407; Urano W, 2010, ANN RHEUM DIS, V69, P1232, DOI 10.1136/ard.2008.106856; Ushijima H, 2008, BIOCHEM BIOPH RES CO, V374, P325, DOI 10.1016/j.bbrc.2008.07.034; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003	28	84	91	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26107	26113		10.1074/jbc.M110.122721	http://dx.doi.org/10.1074/jbc.M110.122721			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566650	Green Published, hybrid			2022-12-25	WOS:000280921000027
J	Xiao, D; Powolny, AA; Moura, MB; Kelley, EE; Bommareddy, A; Kim, SH; Hahm, ER; Normolle, D; Van Houten, B; Singh, SV				Xiao, Dong; Powolny, Anna A.; Moura, Michelle B.; Kelley, Eric E.; Bommareddy, Ajay; Kim, Su-Hyeong; Hahm, Eun-Ryeong; Normolle, Daniel; Van Houten, Bennett; Singh, Shivendra V.			Phenethyl Isothiocyanate Inhibits Oxidative Phosphorylation to Trigger Reactive Oxygen Species-mediated Death of Human Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; MITOCHONDRIAL-MEMBRANE; PHENYLETHYL ISOTHIOCYANATE; SUPEROXIDE; CARCINOGENESIS; DEGRADATION; ACTIVATION; GENERATION; VEGETABLES; INDUCTION	Phenethyl isothiocyanate (PEITC), a constituent of edible cruciferous vegetables such as watercress, not only affords significant protection against chemically induced cancer in experimental rodents but also inhibits growth of human cancer cells by causing apoptotic and autophagic cell death. However, the underlying mechanism of PEITC-induced cell death is not fully understood. Using LNCaP and PC-3 human prostate cancer cells as a model, we demonstrate that the PEITC-induced cell death is initiated by production of reactive oxygen species (ROS) resulting from inhibition of oxidative phosphorylation (OXPHOS). Exposure of LNCaP and PC-3 cells to pharmacologic concentrations of PEITC resulted in ROS production, which correlated with inhibition of complex III activity, suppression of OXPHOS, and ATP depletion. These effects were not observed in a representative normal human prostate epithelial cell line (PrEC). The ROS production by PEITC treatment was not influenced by cyclosporin A. The Rho-0 variants of LNCaP and PC-3 cells were more resistant to PEITC-mediated ROS generation, apoptotic DNA fragmentation, and collapse of mitochondrial membrane potential compared with respective wild-type cells. The PEITC treatment resulted in activation of Bax in wild-type LNCaP and PC-3 cells, but not in their respective Rho-0 variants. Furthermore, RNA interference of Bax and Bak conferred significant protection against PEITC-induced apoptosis. The Rho-0 variants of LNCaP and PC-3 cells also resisted PEITC-mediated autophagy. In conclusion, the present study provides novel insight into the molecular circuitry of PEITC-induced cell death involving ROS production due to inhibition of complex III and OXPHOS.	[Xiao, Dong; Powolny, Anna A.; Moura, Michelle B.; Bommareddy, Ajay; Kim, Su-Hyeong; Hahm, Eun-Ryeong; Van Houten, Bennett; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Xiao, Dong; Powolny, Anna A.; Moura, Michelle B.; Bommareddy, Ajay; Kim, Su-Hyeong; Hahm, Eun-Ryeong; Van Houten, Bennett; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA; [Kelley, Eric E.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Normolle, Daniel] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15213 USA; [Normolle, Daniel] Univ Pittsburgh, Biostat Facil, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, SV (corresponding author), 2-32A Hillman Canc Ctr Res Pavil,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	singhs@upmc.edu	Van Houten, Bennett/K-2284-2019	Normolle, Daniel/0000-0001-8675-5014	National Cancer Institute [CA101753, CA115498, CA129347]; NATIONAL CANCER INSTITUTE [R01CA129347, R01CA101753, R01CA115498] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health, USPHS Grants CA101753, CA115498, and CA129347 awarded by the National Cancer Institute.	Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BERNARDES CF, 1994, BBA-BIOENERGETICS, V1188, P93, DOI 10.1016/0005-2728(94)90026-4; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; BROWN H, 1999, APPL MIXED MODELS ME, P33; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Chen YR, 2002, J BIOL CHEM, V277, P39334, DOI 10.1074/jbc.M202070200; Choi S, 2007, CARCINOGENESIS, V28, P151, DOI 10.1093/carcin/bgl144; Dikalov SI, 2007, BIOCHEM PHARMACOL, V73, P972, DOI 10.1016/j.bcp.2006.12.012; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Hecht SS, 2000, DRUG METAB REV, V32, P395, DOI 10.1081/DMR-100102342; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim JH, 2006, CARCINOGENESIS, V27, P475, DOI 10.1093/carcin/bgi272; Kim WH, 2004, MOL PHARMACOL, V66, P1383, DOI 10.1124/mol.104.001347; Kim YA, 2007, MOL CANCER THER, V6, P1599, DOI 10.1158/1535-7163.MCT-06-0754; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kolonel LN, 2000, CANCER EPIDEM BIOMAR, V9, P795; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; MORSE MA, 1989, CANCER RES, V49, P549; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Pereira MA, 1995, ANTICANCER RES, V15, P1953; STONER GD, 1991, CANCER RES, V51, P2063; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Wang LG, 2006, CARCINOGENESIS, V27, P2124, DOI 10.1093/carcin/bgl075; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wu XJ, 2007, CANCER BIOL THER, V6, P646, DOI 10.4161/cbt.6.5.4092; Xiao D, 2005, CLIN CANCER RES, V11, P2670, DOI 10.1158/1078-0432.CCR-04-1545; Xiao D, 2004, MOL CANCER THER, V3, P567; Xiao D, 2002, CANCER RES, V62, P3615; Xiao D, 2007, CANCER RES, V67, P2239, DOI 10.1158/0008-5472.CAN-06-3645; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Xiao D, 2006, CARCINOGENESIS, V27, P2223, DOI 10.1093/carcin/bgl087; Xiao D, 2009, PHARM RES-DORDR, V26, P1729, DOI 10.1007/s11095-009-9883-5; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yang YM, 2002, CANCER RES, V62, P2; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	48	134	136	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26558	26569		10.1074/jbc.M109.063255	http://dx.doi.org/10.1074/jbc.M109.063255			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20571029	hybrid, Green Published			2022-12-25	WOS:000280921000072
J	Guan, WJ; Jiang, HF; Guo, XX; Mancera, E; Xu, L; Li, YD; Steinmetz, L; Li, YQ; Gu, ZL				Guan, Wenjun; Jiang, Huifeng; Guo, Xiaoxian; Mancera, Eugenio; Xu, Lin; Li, Yudong; Steinmetz, Lars; Li, Yongquan; Gu, Zhenglong			Antagonistic Changes in Sensitivity to Antifungal Drugs by Mutations of an Important ABC Transporter Gene in a Fungal Pathogen	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; AMPHOTERICIN-B; ECOLOGICAL SPECIALIZATION; YEAST; PDR5; MECHANISMS; PATIENT; PROTEIN	Fungal pathogens can be lethal, especially among immunocompromised populations, such as patients with AIDS and recipients of tissue transplantation or chemotherapy. Prolonged usage of antifungal reagents can lead to drug resistance and treatment failure. Understanding mechanisms that underlie drug resistance by pathogenic microorganisms is thus vital for dealing with this emerging issue. In this study, we show that dramatic sequence changes in PDR5, an ABC (ATP-binding cassette) efflux transporter protein gene in an opportunistic fungal pathogen, caused the organism to become hypersensitive to azole, a widely used antifungal drug. Surprisingly, the same mutations conferred growth advantages to the organism on polyenes, which are also commonly used antimycotics. Our results indicate that Pdr5p might be important for ergosterol homeostasis. The observed remarkable sequence divergence in the PDR5 gene in yeast strain YJM789 may represent an interesting case of adaptive loss of gene function with significant clinical implications.	[Guan, Wenjun; Guo, Xiaoxian; Li, Yudong; Li, Yongquan] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Guan, Wenjun; Jiang, Huifeng; Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Mancera, Eugenio; Steinmetz, Lars] European Mol Biol Lab, Heidelberg, Germany; [Xu, Lin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	Zhejiang University; Cornell University; European Molecular Biology Laboratory (EMBL); Cornell University	Guan, WJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	lyq@zju.edu.cn; zg27@cornell.edu	li, Yu/HCI-9086-2022; Li, Yudong/GSN-4036-2022; li, yu/HGL-9518-2022; xu, lin/H-8560-2016; Mancera, Eugenio/M-6334-2016	Mancera, Eugenio/0000-0003-0146-8732; Steinmetz, Lars/0000-0002-3962-2865	Cornell University; Zhejiang University	Cornell University; Zhejiang University	The study was supported by the faculty startup funds from Cornell University awarded to Z.G. and the Future Academic Stars project of Zhejiang University to W.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; BALZI E, 1994, J BIOL CHEM, V269, P2206; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Chen XJ, 2001, J BACTERIOL, V183, P3939, DOI 10.1128/JB.183.13.3939-3948.2001; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chu P, 2009, CURR MED RES OPIN, V25, P3011, DOI 10.1185/03007990903379077; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; de Thozee CP, 2007, MOL MICROBIOL, V63, P811, DOI 10.1111/j.1365-2958.2006.05562.x; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Dismukes WE, 2000, CLIN INFECT DIS, V30, P653, DOI 10.1086/313748; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Goffeau A, 2008, NATURE, V452, P541, DOI 10.1038/452541a; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; Groeschke J, 2006, J PHARMACEUT BIOMED, V42, P362, DOI 10.1016/j.jpba.2006.04.011; Groll AH, 2009, SEMIN HEMATOL, V46, P212, DOI 10.1053/j.seminhematol.2009.03.003; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; HIRATA D, 1994, CURR GENET, V26, P285, DOI 10.1007/BF00310491; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kontoyiannis DP, 2000, J ANTIMICROB CHEMOTH, V46, P199, DOI 10.1093/jac/46.2.199; LEPPERT G, 1990, GENETICS, V125, P13; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Li WH, 2005, NATURE, V437, P50, DOI 10.1038/437050a; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Mamnun YM, 2004, FEBS LETT, V559, P111, DOI 10.1016/S0014-5793(04)00046-8; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; MCCUSKER JH, 1994, INFECT IMMUN, V62, P5447, DOI 10.1128/IAI.62.12.5447-5455.1994; MCCUSKER JH, 1994, GENETICS, V136, P1261; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Rose MD., 1990, METHODS YEAST GENETI; Ruhnke M, 2004, DRUGS, V64, P1163, DOI 10.2165/00003495-200464110-00002; Sambrook J., 2006, MOL CLONING LAB MANU, V3rd; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Seret ML, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-459; Shahi P, 2007, J BIOL CHEM, V282, P26822, DOI 10.1074/jbc.M704772200; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; STROUP JS, 2007, HOSP PHARM, V42, P532; Tamm M, 1999, RESPIRATION, V66, P199, DOI 10.1159/000029377; TAWFIK OW, 1989, J CLIN MICROBIOL, V27, P1689, DOI 10.1128/JCM.27.7.1689-1691.1989; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tutulan-Cunita AC, 2005, GENES CELLS, V10, P409, DOI 10.1111/j.1365-2443.2005.00847.x; Vandeputte P, 2008, ANTIMICROB AGENTS CH, V52, P3701, DOI 10.1128/AAC.00423-08; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; White KJ, 1998, J SOC CLIN PSYCHOL, V17, P11, DOI 10.1521/jscp.1998.17.1.11; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young LY, 2003, ANTIMICROB AGENTS CH, V47, P2717, DOI 10.1128/AAC.47.9.2717-2724.2003	60	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11309	10.1371/journal.pone.0011309	http://dx.doi.org/10.1371/journal.pone.0011309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593017	gold, Green Published, Green Submitted			2022-12-25	WOS:000279140800010
J	Xu, Y; Wagner, DR; Bekerman, E; Chiou, M; James, AW; Carter, D; Longaker, MT				Xu, Yue; Wagner, Diane R.; Bekerman, Elena; Chiou, Michael; James, Aaron W.; Carter, Dennis; Longaker, Michael T.			Connective Tissue Growth Factor in Regulation of RhoA Mediated Cytoskeletal Tension Associated Osteogenesis of Mouse Adipose-Derived Stromal Cells	PLOS ONE			English	Article							ADULT STEM-CELLS; GENE-EXPRESSION; MESENCHYMAL CELLS; RETINOIC ACID; BRANCHING MORPHOGENESIS; MECHANICAL-STRESS; EMBRYONIC LUNG; DIFFERENTIATION; BONE; STRAIN	Background: Cytoskeletal tension is an intracellular mechanism through which cells convert a mechanical signal into a biochemical response, including production of cytokines and activation of various signaling pathways. Methods/Principal Findings: Adipose-derived stromal cells (ASCs) were allowed to spread into large cells by seeding them at a low-density (1,250 cells/cm(2)), which was observed to induce osteogenesis. Conversely, ASCs seeded at a high-density (25,000 cells/cm(2)) featured small cells that promoted adipogenesis. RhoA and actin filaments were altered by changes in cell size. Blocking actin polymerization by Cytochalasin D influenced cytoskeletal tension and differentiation of ASCs. To understand the potential regulatory mechanisms leading to actin cytoskeletal tension, cDNA microarray was performed on large and small ASCs. Connective tissue growth factor (CTGF) was identified as a major regulator of osteogenesis associated with RhoA mediated cytoskeletal tension. Subsequently, knock-down of CTGF by siRNA in ASCs inhibited this osteogenesis. Conclusions/Significance: We conclude that CTGF is important in the regulation of cytoskeletal tension mediated ASC osteogenic differentiation.	[Xu, Yue; Wagner, Diane R.; Bekerman, Elena; Chiou, Michael; James, Aaron W.; Longaker, Michael T.] Stanford Univ, Hagey Pediat Regenerat Med Lab, Dept Surg, Sch Med, Stanford, CA 94305 USA; [Wagner, Diane R.; Carter, Dennis] Stanford Univ, Dept Mech Engn, Biomech Engn Div, Stanford, CA 94305 USA; [Wagner, Diane R.] Univ Notre Dame, Bioengn Grad Program & Aerosp & Mech Engn, Notre Dame, IN 46556 USA	Stanford University; Stanford University; University of Notre Dame	Longaker, MT (corresponding author), Stanford Univ, Hagey Pediat Regenerat Med Lab, Dept Surg, Sch Med, Stanford, CA 94305 USA.	Longaker@stanford.edu			National Institutes of Health [DE14526, DE13194]; Oak Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013194, R01DE014526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by National Institutes of Health grant numbers DE14526, DE13194 and the Oak Foundation to MTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Chiou M, 2006, BIOCHEM BIOPH RES CO, V343, P644, DOI 10.1016/j.bbrc.2006.02.171; Cicha I, 2008, ATHEROSCLEROSIS, V196, P136, DOI 10.1016/j.atherosclerosis.2007.03.016; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Djouad F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2153; Fukunaga T, 2003, BONE, V33, P911, DOI 10.1016/j.bone.2003.07.010; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gimble JM, 2004, ENDOCRINE, V23, P183, DOI 10.1385/ENDO:23:2-3:183; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Gimona M, 1996, P NATL ACAD SCI USA, V93, P9618, DOI 10.1073/pnas.93.18.9618; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Guilak F, 2004, BIORHEOLOGY, V41, P389; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Ingber D E, 2004, Mech Chem Biosyst, V1, P53; Ingber DE, 2005, SCAND J MED SCI SPOR, V15, P199, DOI 10.1111/j.1600-0838.2005.00481.x; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Inoue S, 2008, J BIOMAT SCI-POLYM E, V19, P893, DOI 10.1163/156856208784613541; Jagodzinski M, 2004, Eur Cell Mater, V7, P35; Kadota H, 2004, J BONE MINER METAB, V22, P293, DOI 10.1007/s00774-004-0486-2; Kaji H, 2003, LAB CHIP, V3, P208, DOI 10.1039/b304350a; Kitching R, 2002, J BONE MINER METAB, V20, P269, DOI 10.1007/s007740200039; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Kubota S, 2007, INT REV CYTOL, V257, P1, DOI 10.1016/S0074-7696(07)57001-4; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Malladi P, 2006, TISSUE ENG, V12, P2031, DOI 10.1089/ten.2006.12.2031; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Moore KA, 2005, DEV DYNAM, V232, P268, DOI 10.1002/dvdy.20237; Moore KA, 2002, J SURG RES, V104, P95, DOI 10.1006/jsre.2002.6418; Muehlich S, 2007, AM J PHYSIOL-CELL PH, V292, pC1732, DOI 10.1152/ajpcell.00552.2006; Nakama LH, 2006, J ORTHOP RES, V24, P393, DOI 10.1002/jor.20053; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Peake MA, 2000, J APPL PHYSIOL, V89, P2498, DOI 10.1152/jappl.2000.89.6.2498; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Sakai H, 2006, BONE, V39, P1290, DOI 10.1016/j.bone.2006.06.012; Schild C, 2004, BBA-MOL CELL RES, V1691, P33, DOI 10.1016/j.bbamcr.2003.12.001; Sherlock G, 2001, Brief Bioinform, V2, P350, DOI 10.1093/bib/2.4.350; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Tang J, 2006, J BIOL CHEM, V281, P6664, DOI 10.1074/jbc.M506991200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Webb K, 2006, J BIOMECH, V39, P1136, DOI 10.1016/j.jbiomech.2004.08.026; Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Xu Y, 2005, CURR OPIN MOL THER, V7, P300; Yamaai T, 2005, J BONE MINER METAB, V23, P280, DOI 10.1007/s00774-004-0600-5; Yamashiro T, 2001, J DENT RES, V80, P461, DOI 10.1177/00220345010800021201; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Zhao HJ, 2005, PROSTATE, V63, P187, DOI 10.1002/pros.20158	53	19	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11279	10.1371/journal.pone.0011279	http://dx.doi.org/10.1371/journal.pone.0011279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585662	Green Submitted, Green Published, gold			2022-12-25	WOS:000279135400023
J	Traggiai, E; Casati, A; Frascoli, M; Porcellini, S; Ponzoni, M; Sanvito, F; Leng, L; Bucala, R; Moretta, L; Grassi, F				Traggiai, Elisabetta; Casati, Anna; Frascoli, Michela; Porcellini, Simona; Ponzoni, Maurilio; Sanvito, Francesca; Leng, Lin; Bucala, Richard; Moretta, Lorenzo; Grassi, Fabio			Selective Preservation of Bone Marrow Mature Recirculating but Not Marginal Zone B Cells in Murine Models of Chronic Inflammation	PLOS ONE			English	Article							INDEPENDENT RESPONSES; MICE; DIFFERENTIATION; LYMPHOPOIESIS; CALRETICULIN; LYMPHOCYTES; ACTIVATION; EXPRESSION; INFECTION; SURVIVAL	Inflammation promotes granulopoiesis over B lymphopoiesis in the bone marrow (BM). We studied B cell homeostasis in two murine models of T cell mediated chronic inflammation, namely calreticulin-deficient fetal liver chimeras (FLC), which develop severe blepharitis and alopecia due to T cell hyper responsiveness, and inflammatory bowel disease (IBD) caused by injection of CD4(+) naive T cells into lymphopenic mice. We show herein that despite the severe depletion of B cell progenitors during chronic, peripheral T cell-mediated inflammation, the population of BM mature recirculating B cells is unaffected. These B cells are poised to differentiate to plasma cells in response to blood borne pathogens, in an analogous fashion to non-recirculating marginal zone (MZ) B cells in the spleen. MZ B cells nevertheless differentiate more efficiently to plasma cells upon polyclonal stimulation by Toll-like receptor (TLR) ligands, and are depleted during chronic T cell mediated inflammation in vivo. The preservation of mature B cells in the BM is associated with increased concentration of macrophage migration inhibitory factor (MIF) in serum and BM plasma. MIF produced by perivascular dendritic cells (DC) in the BM provides a crucial survival signal for recirculating B cells, and mice treated with a MIF inhibitor during inflammation showed significantly reduced mature B cells in the BM. These data indicate that MIF secretion by perivascular DC may promote the survival of the recirculating B cell pool to ensure responsiveness to blood borne microbes despite loss of the MZ B cell pool that accompanies depressed lymphopoiesis during inflammation.	[Traggiai, Elisabetta; Moretta, Lorenzo] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Casati, Anna; Frascoli, Michela; Porcellini, Simona; Grassi, Fabio] Inst Biomed Res, Bellinzona, Switzerland; [Casati, Anna; Grassi, Fabio] Univ Milan, Dept Biol & Genet Med Sci, Milan, Italy; [Ponzoni, Maurilio; Sanvito, Francesca] San Raffaele Sci Hosp, Pathol Unit, Milan, Italy; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Moretta, Lorenzo] Univ Genoa, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Universita della Svizzera Italiana; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Yale University; University of Genoa	Traggiai, E (corresponding author), Ist Giannina Gaslini, I-16148 Genoa, Italy.	elisabetta.traggiai@gmail.com; fabio.grassi@irb.unisi.ch	Moretta, Lorenzo/AAA-7239-2020	Moretta, Lorenzo/0000-0003-4658-1747; GRASSI, FABIO/0000-0003-3348-1712; Leng, Lin/0000-0002-0605-358X	Swiss National Science Foundation; Fondazione Ticinese per la Ricerca sul Cancro; Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; European Union [MUGEN LSHB-CT-2005-005203]; National Institutes of Health; Alliance for Lupus Research; Fondazione Stella Major	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondazione Ticinese per la Ricerca sul Cancro; Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Fondazione Stella Major	This work was supported by grants to F. G. from Swiss National Science Foundation, Fondazione Ticinese per la Ricerca sul Cancro, Fondazione per la Ricerca sulla Trasfusione e sui Trapianti, the Sixth Research Framework Programme of the European Union, Project MUGEN (MUGEN LSHB-CT-2005-005203) and to R. B. from the National Institutes of Health and Alliance for Lupus Research. A. C. is a recipient of a fellowship from Fondazione Stella Major. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2003, J IMMUNOL, V171, P317, DOI 10.4049/jimmunol.171.1.317; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Carey JB, 2008, J EXP MED, V205, P2043, DOI 10.1084/jem.20080559; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cariappa A, 2007, J IMMUNOL, V179, P2270, DOI 10.4049/jimmunol.179.4.2270; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Conde C, 1998, J IMMUNOL, V161, P7023; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Feeney AJ, 2001, J IMMUNOL, V167, P3486, DOI 10.4049/jimmunol.167.6.3486; Genestier L, 2007, J IMMUNOL, V178, P7779, DOI 10.4049/jimmunol.178.12.7779; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; HERMANS MHA, 1989, J IMMUNOL, V142, P67; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Porcellini S, 2006, J EXP MED, V203, P461, DOI 10.1084/jem.20051519; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; Thevenin C, 1998, J EXP MED, V188, P735, DOI 10.1084/jem.188.4.735; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104	31	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11262	10.1371/journal.pone.0011262	http://dx.doi.org/10.1371/journal.pone.0011262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582316	Green Published, Green Submitted, gold			2022-12-25	WOS:000279058500014
J	Renaudet, O; Dasgupta, G; Bettahi, I; Shi, A; Nesburn, AB; Dumy, P; BenMohamed, L				Renaudet, Olivier; Dasgupta, Gargi; Bettahi, Ilham; Shi, Alda; Nesburn, Anthony B.; Dumy, Pascal; BenMohamed, Lbachir			Linear and Branched Glyco-Lipopeptide Vaccines Follow Distinct Cross-Presentation Pathways and Generate Different Magnitudes of Antitumor Immunity	PLOS ONE			English	Article							CD8(+) T-CELL; MHC CLASS-I; TOLL-LIKE RECEPTOR-2; TOTALLY SYNTHETIC VACCINE; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; IMMUNOLOGICAL EVALUATION; CARBOHYDRATE ANTIGENS; LYMPHOCYTE RESPONSES; PROTECTIVE IMMUNITY	Background: Glyco-lipopeptides, a form of lipid-tailed glyco-peptide, are currently under intense investigation as B-and T-cell based vaccine immunotherapy for many cancers. However, the cellular and molecular mechanisms of glycolipopeptides (GLPs) immunogenicity and the position of the lipid moiety on immunogenicity and protective efficacy of GLPs remain to be determined. Methods/Principal Findings: We have constructed two structural analogues of HER-2 glyco-lipopeptide (HER-GLP) by synthesizing a chimeric peptide made of one universal CD4(+) epitope (PADRE) and one HER-2 CD8(+) T-cell epitope (HER420-429). The C-terminal end of the resulting CD4-CD8 chimeric peptide was coupled to a tumor carbohydrate B-cell epitope, based on a regioselectively addressable functionalized templates (RAFT), made of four alpha-GalNAc molecules. The resulting HER glycopeptide (HER-GP) was then linked to a palmitic acid moiety, attached either at the N-terminal end (linear HER-GLP-1) or in the middle between the CD4+ and CD8+ T cell epitopes (branched HER-GLP-2). We have investigated the uptake, processing and cross-presentation pathways of the two HER-GLP vaccine constructs, and assessed whether the position of linkage of the lipid moiety would affect the B-and T-cell immunogenicity and protective efficacy. Immunization of mice revealed that the linear HER-GLP-1 induced a stronger and longer lasting HER420-429-specific IFN-gamma producing CD8(+) T cell response, while the branched HER-GLP-2 induced a stronger tumor-specific IgG response. The linear HER-GLP-1 was taken up easily by dendritic cells (DCs), induced stronger DCs maturation and produced a potent TLR-2-dependent T-cell activation. The linear and branched HER-GLP molecules appeared to follow two different cross-presentation pathways. While regression of established tumors was induced by both linear HER-GLP-1 and branched HER-GLP-2, the inhibition of tumor growth was significantly higher in HER-GLP-1 immunized mice (p<0.005). Significance: These findings have important implications for the development of effective GLP based immunotherapeutic strategies against cancers.	[Renaudet, Olivier; Dasgupta, Gargi; Bettahi, Ilham; Shi, Alda; Nesburn, Anthony B.; BenMohamed, Lbachir] Univ Calif Irvine, Sch Med, Lab Cellular & Mol Immunol, Gavin Herbert Eye Inst, Irvine, CA 92717 USA; [BenMohamed, Lbachir] Univ Calif Irvine, Inst Immunol, Med Ctr, Irvine, CA 92717 USA; [BenMohamed, Lbachir] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Med Ctr, Irvine, CA 92717 USA; [Renaudet, Olivier; Dumy, Pascal] Univ Grenoble 1, CNRS, UMR 5250, Dept Chim Mol, Grenoble, France; [Renaudet, Olivier; Dumy, Pascal] Univ Grenoble 1, ICMG, FR 2607, Grenoble, France	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Renaudet, O (corresponding author), Univ Calif Irvine, Sch Med, Lab Cellular & Mol Immunol, Gavin Herbert Eye Inst, Irvine, CA 92717 USA.	Lbenmoha@uci.edu	Renaudet, Olivier/B-6120-2014; dumy, pascal/C-4863-2008; Renaudet, Olivier/M-1492-2019	Renaudet, Olivier/0000-0003-4963-3848; dumy, pascal/0000-0002-7660-763X; 	National Institutes of Health (NIH) [EY-014900, EY-019896]; Discovery Eye Foundation; Universite Joseph Fourier (UJF Grenoble); Centre National pour la Recherche Scientifique (CNRS); Nanobio Program; COST Action D-34; NATIONAL EYE INSTITUTE [R01EY019896, R01EY014900] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Discovery Eye Foundation; Universite Joseph Fourier (UJF Grenoble); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Nanobio Program; COST Action D-34(European Cooperation in Science and Technology (COST)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grants EY-014900 and EY-019896 to LBM from the National Institutes of Health (NIH), The Discovery Eye Foundation, the Universite Joseph Fourier (UJF Grenoble), the Centre National pour la Recherche Scientifique (CNRS), the Nanobio Program and the COST Action D-34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Andrieu M, 2003, J VIROL, V77, P1564, DOI 10.1128/JVI.77.2.1564-1570.2003; Bay S, 1997, J PEPT RES, V49, P620; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Belnoue E, 2004, J IMMUNOL, V173, P4882, DOI 10.4049/jimmunol.173.8.4882; Belz GT, 2002, CRIT REV IMMUNOL, V22, P439; Benmohamed L, 2000, VACCINE, V18, P2843, DOI 10.1016/S0264-410X(00)00068-2; BenMohamed L, 2000, HUM IMMUNOL, V61, P764, DOI 10.1016/S0198-8859(00)00139-7; BenMohamed L, 2004, INFECT IMMUN, V72, P4376, DOI 10.1128/IAI.72.8.4376-4384.2004; BenMohamed L, 2002, IMMUNOLOGY, V106, P113, DOI 10.1046/j.1365-2567.2002.01396.x; BenMohamed L, 2002, EUR J IMMUNOL, V32, P2274, DOI 10.1002/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C; BenMohamed L, 1997, EUR J IMMUNOL, V27, P1242, DOI 10.1002/eji.1830270528; BenMohamed L, 2002, LANCET INFECT DIS, V2, P425, DOI 10.1016/S1473-3099(02)00318-3; Bettahi I, 2007, INVEST OPHTH VIS SCI, V48, P4643, DOI 10.1167/iovs.07-0356; Bettahi I, 2006, VIRAL IMMUNOL, V19, P220, DOI 10.1089/vim.2006.19.220; Bettahi I, 2009, CANCER IMMUNOL IMMUN, V58, P187, DOI 10.1007/s00262-008-0537-y; Borsutzky S, 2005, J IMMUNOL, V174, P6308, DOI 10.4049/jimmunol.174.10.6308; Bourgeois C, 2003, EUR J IMMUNOL, V33, P3225, DOI 10.1002/eji.200324576; Buskas T, 2005, ANGEW CHEM INT EDIT, V44, P5985, DOI 10.1002/anie.200501818; Casillas S, 1997, DIS COLON RECTUM, V40, P977, DOI 10.1007/BF02051209; Chen LY, 2004, EUR J IMMUNOL, V34, P952, DOI 10.1002/eji.200324359; Chentoufi AA, 2010, J IMMUNOL, V184, P2561, DOI 10.4049/jimmunol.0902322; Chentoufi AA, 2010, CLIN VACCINE IMMUNOL, V17, P342, DOI 10.1128/CVI.00347-09; Chentoufi AA, 2009, ARCH IMMUNOL THER EX, V57, P409, DOI 10.1007/s00005-009-0049-2; Curigliano G, 2006, ANN ONCOL, V17, P750, DOI 10.1093/annonc/mdj083; CURIGLIANO G, 2005, ANN ONCOL; Dasgupta G, 2010, FUTURE MICROBIOL, V5, P1, DOI 10.2217/FMB.09.101; Davila E, 2003, CANCER RES, V63, P3281; Deliyannis G, 2002, J VIROL, V76, P4212, DOI 10.1128/JVI.76.9.4212-4221.2002; Dhodapkar MV, 2000, J CLIN INVEST, V105, pR9, DOI 10.1172/JCI9051; Dorfel D, 2005, BLOOD, V105, P3199, DOI 10.1182/blood-2004-09-3556; Durier C, 2006, AIDS, V20, P1039, DOI 10.1097/01.aids.0000222077.68243.22; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Fehr T, 2008, J IMMUNOL, V181, P165, DOI 10.4049/jimmunol.181.1.165; Gahery H, 2005, THERAPIE, V60, P243, DOI 10.2515/therapie:2005031; Gahery H, 2006, AIDS RES HUM RETROV, V22, P684, DOI 10.1089/aid.2006.22.684; Grigalevicius S, 2005, BIOCONJUGATE CHEM, V16, P1149, DOI 10.1021/bc050010v; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Hearn AR, 2004, J BIOL CHEM, V279, P51315, DOI 10.1074/jbc.M408279200; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HOEFFEL G, 2007, IMMUNITY; Hosmalin A, 2001, IMMUNOL LETT, V79, P97, DOI 10.1016/S0165-2478(01)00271-1; Hotta C, 2006, IMMUNOLOGY, V117, P97, DOI 10.1111/j.1365-2567.2005.02270.x; Ingale S, 2007, NAT CHEM BIOL, V3, P663, DOI 10.1038/nchembio.2007.25; Ingale S, 2009, CHEMBIOCHEM, V10, P455, DOI 10.1002/cbic.200800596; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Keding SJ, 2004, P NATL ACAD SCI USA, V101, P11937, DOI 10.1073/pnas.0401894101; Khan R, 2009, J HOSP MED, V4, P68, DOI 10.1002/jhm.381; Khan S, 2009, MOL IMMUNOL, V46, P1084, DOI 10.1016/j.molimm.2008.10.006; Kudryashov V, 2001, P NATL ACAD SCI USA, V98, P3264, DOI 10.1073/pnas.051623598; Larsson M, 2001, TRENDS IMMUNOL, V22, P141, DOI 10.1016/S1471-4906(01)01860-9; Lazoura E, 2005, CURR MED CHEM, V12, P629, DOI 10.2174/0929867053202188; Lee K, 2010, EXPERT REV VACCINES, V9, P29, DOI [10.1586/erv.09.146, 10.1586/ERV.09.146]; Lo-Man R, 2004, CANCER RES, V64, P4987, DOI 10.1158/0008-5472.CAN-04-0252; Lubaroff DM, 2009, ADV DRUG DELIVER REV, V61, P268, DOI 10.1016/j.addr.2008.12.005; Manimala JC, 2005, CHEMBIOCHEM, V6, P2229, DOI 10.1002/cbic.200500165; Maraskovsky E, 2004, CLIN CANCER RES, V10, P2879, DOI 10.1158/1078-0432.CCR-03-0245; Margalit A, 2006, J IMMUNOL, V176, P217, DOI 10.4049/jimmunol.176.1.217; Mesa C, 2004, IMMUNOL CELL BIOL, V82, P644, DOI 10.1111/j.0818-9641.2004.01279.x; Monu N, 2007, CURR OPIN IMMUNOL, V19, P66, DOI 10.1016/j.coi.2006.11.017; Monzavi-Karbassi B, 2001, INT IMMUNOL, V13, P1361, DOI 10.1093/intimm/13.11.1361; Moron G, 2004, TRENDS IMMUNOL, V25, P92, DOI 10.1016/j.it.2003.11.008; Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242; Nava-Parada P, 2007, CANCER RES, V67, P1326, DOI 10.1158/0008-5472.CAN-06-3290; Nesburn AB, 2006, OCUL SURF, V4, P178, DOI 10.1016/S1542-0124(12)70164-7; Norell H, 2010, CANCER IMMUNOL IMMUN, V59, P851, DOI 10.1007/s00262-009-0810-8; PEETERS CCAM, 1991, INFECT IMMUN, V59, P3504, DOI 10.1128/IAI.59.10.3504-3510.1991; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Pfender NA, 2008, J IMMUNOL, V180, P1398, DOI 10.4049/jimmunol.180.3.1398; Qi XY, 2009, CLIN CANCER RES, V15, P5840, DOI 10.1158/1078-0432.CCR-08-3285; Radhakrishnan VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011433; Renaudet O., 2008, CHEMMEDCHEM, V2, P425; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Roth A, 2005, BRIT J CANCER, V92, P1421, DOI 10.1038/sj.bjc.6602526; Roy KC, 2008, J IMMUNOL, V180, P2942, DOI 10.4049/jimmunol.180.5.2942; Ruby CE, 2009, CANCER IMMUNOL IMMUN, V58, P1941, DOI 10.1007/s00262-009-0687-6; Samanta S, 2010, BIOMATERIALS, V31, P1787, DOI 10.1016/j.biomaterials.2009.10.027; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shepherd C, 2010, CURR ONCOL REP, V12, P146, DOI 10.1007/s11912-010-0095-2; Slovin SF, 2005, IMMUNOL CELL BIOL, V83, P418, DOI 10.1111/j.1440-1711.2005.01350.x; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; SORENSEN AL, 2005, GLYCOBIOLOGY; Spohn R, 2004, VACCINE, V22, P2494, DOI 10.1016/j.vaccine.2003.11.074; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Svensson M, 1999, EUR J IMMUNOL, V29, P180, DOI 10.1002/(SICI)1521-4141(199901)29:01<180::AID-IMMU180>3.0.CO;2-W; Syrigos KN, 1999, ANTICANCER RES, V19, P5239; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Tseng JC, 2006, J NUCL MED, V47, P1136; van der Bruggen P, 2006, CURR OPIN IMMUNOL, V18, P98, DOI 10.1016/j.coi.2005.11.013; Vazquez-Martin C, 2004, ONCOLOGY-BASEL, V67, P159, DOI 10.1159/000081003; Vicente-Suarez I, 2009, IMMUNOL LETT, V125, P114, DOI 10.1016/j.imlet.2009.06.007; Vichier-Guerre S, 2004, BIOORG MED CHEM LETT, V14, P3567, DOI 10.1016/j.bmcl.2004.04.047; Vichier-Guerre S, 2003, J PEPT RES, V62, P117, DOI 10.1034/j.1399-3011.2003.00074.x; Warger T, 2007, IMMUNOL LETT, V109, P13, DOI 10.1016/j.imlet.2007.01.007; Watchmaker PB, 2010, J IMMUNOL, V184, P591, DOI 10.4049/jimmunol.0902062; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Xiang SD, 2008, EXPERT REV VACCINES, V7, P1103, DOI 10.1586/14760584.7.7.1103; Zhang X, 2009, MUCOSAL IMMUNOL, V2, P129, DOI 10.1038/mi.2008.81; Zhang XL, 2005, J VIROL, V79, P15289, DOI 10.1128/JVI.79.24.15289-15301.2005; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293; Zhu X., 2004, EUR J IMMUNOL, V34, P1142	106	66	70	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11216	10.1371/journal.pone.0011216	http://dx.doi.org/10.1371/journal.pone.0011216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574522	Green Published, gold			2022-12-25	WOS:000279058300011
J	Martinez-Seara, H; Rog, T; Karttunen, M; Vattulainen, I; Reigada, R				Martinez-Seara, Hector; Rog, Tomasz; Karttunen, Mikko; Vattulainen, Ilpo; Reigada, Ramon			Cholesterol Induces Specific Spatial and Orientational Order in Cholesterol/Phospholipid Membranes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PHOSPHATIDYLCHOLINE BILAYER; LIPID-MEMBRANES; STEROL STRUCTURE; FATTY-ACIDS; MODEL; RAFTS; PHOSPHOLIPIDS; PRESSURE; SPHINGOMYELIN	Background: In lipid bilayers, cholesterol facilitates the formation of the liquid-ordered phase and enables the formation of laterally ordered structures such as lipid rafts. While these domains have an important role in a variety of cellular processes, the precise atomic-level mechanisms responsible for cholesterol's specific ordering and packing capability have remained unresolved. Methodology/Principal Findings: Our atomic-scale molecular dynamics simulations reveal that this ordering and the associated packing effects in membranes largely result from cholesterol's molecular structure, which differentiates cholesterol from other sterols. We find that cholesterol molecules prefer to be located in the second coordination shell, avoiding direct cholesterol-cholesterol contacts, and form a three-fold symmetric arrangement with proximal cholesterol molecules. At larger distances, the lateral three-fold organization is broken by thermal fluctuations. For other sterols having less structural asymmetry, the three-fold arrangement is considerably lost. Conclusions/Significance: We conclude that cholesterol molecules act collectively in lipid membranes. This is the main reason why the liquid-ordered phase only emerges for Chol concentrations well above 10 mol% where the collective self-organization of Chol molecules emerges spontaneously. The collective ordering process requires specific molecular-scale features that explain why different sterols have very different membrane ordering properties: the three-fold symmetry in the Chol-Chol organization arises from the cholesterol off-plane methyl groups allowing the identification of raft-promoting sterols from those that do not promote rafts.	[Martinez-Seara, Hector; Reigada, Ramon] Univ Barcelona, Dept Phys Chem, Barcelona, Spain; [Martinez-Seara, Hector; Reigada, Ramon] Univ Barcelona, IQTCUB, Barcelona, Spain; [Rog, Tomasz; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Karttunen, Mikko] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada; [Vattulainen, Ilpo] Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Vattulainen, Ilpo] Aalto Univ, Sch Sci & Technol, Dept Appl Phys, Espoo, Finland	University of Barcelona; University of Barcelona; Tampere University; Western University (University of Western Ontario); University of Southern Denmark; Aalto University	Reigada, R (corresponding author), Univ Barcelona, Dept Phys Chem, Barcelona, Spain.	reigada@ub.edu	Martinez-Seara, Hector/D-3734-2014; Karttunen, Mikko/G-4531-2010; Rog, Tomasz/ABE-3044-2020; Reigada, Ramon/A-2450-2012; Vattulainen, Ilpo T/G-4224-2014	Martinez-Seara, Hector/0000-0001-9716-1713; Karttunen, Mikko/0000-0002-8626-3033; Rog, Tomasz/0000-0001-6765-7013; Reigada, Ramon/0000-0003-2177-7014	Secretaria de Estado de Educacion, Universidades, Investigacion y Desarrollo [FIS200603525]; Departament d'Universitats, Recerca i Societat de la Informacio [2009-SGR1055]; Academy of Finland; National Sciences and Engineering Research Council; SharcNet of Canada	Secretaria de Estado de Educacion, Universidades, Investigacion y Desarrollo; Departament d'Universitats, Recerca i Societat de la Informacio; Academy of Finland(Academy of Finland); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); SharcNet of Canada	Financial support was provided by the Secretaria de Estado de Educacion, Universidades, Investigacion y Desarrollo through project FIS200603525 (HMS, RR), by the Departament d'Universitats, Recerca i Societat de la Informacio through project 2009-SGR1055 (HMS, RR), by the Academy of Finland (TR, IV), and by the National Sciences and Engineering Research Council and SharcNet of Canada (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittoniemi J, 2006, J PHYS CHEM B, V110, P25562, DOI 10.1021/jp064931u; Ali MR, 2007, P NATL ACAD SCI USA, V104, P5372, DOI 10.1073/pnas.0611450104; Almeida PFF, 2009, BBA-BIOMEMBRANES, V1788, P72, DOI 10.1016/j.bbamem.2008.08.007; Bachar M, 2004, J PHYS CHEM B, V108, P7170, DOI 10.1021/jp036981u; Beattie ME, 2005, BIOPHYS J, V89, P1760, DOI 10.1529/biophysj.104.049635; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Berkowitz ML, 2009, BBA-BIOMEMBRANES, V1788, P86, DOI 10.1016/j.bbamem.2008.09.009; BLOCH K, 1991, BIOCH LIPIDS LIPOPRO, P363; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; Chong PLG, 2009, BBA-BIOMEMBRANES, V1788, P2, DOI 10.1016/j.bbamem.2008.10.010; CHONG PLG, 1994, P NATL ACAD SCI USA, V91, P10069, DOI 10.1073/pnas.91.21.10069; Czub J, 2006, BIOPHYS J, V90, P2368, DOI 10.1529/biophysj.105.072801; Dupuy AD, 2008, P NATL ACAD SCI USA, V105, P2848, DOI 10.1073/pnas.0712379105; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Holtje M, 2001, BBA-BIOMEMBRANES, V1511, P156, DOI 10.1016/S0005-2736(01)00270-X; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; Hung WC, 2007, BIOPHYS J, V92, P3960, DOI 10.1529/biophysj.106.099234; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Karttunen M, 2008, CURR TOP MEMBR, V60, P49, DOI 10.1016/S1063-5823(08)00002-1; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; Kucerka N, 2007, EUR PHYS J E, V23, P247, DOI 10.1140/epje/i2007-10202-8; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Li XM, 2003, BIOPHYS J, V85, P3788, DOI 10.1016/S0006-3495(03)74794-8; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Marrink SJ, 2008, J AM CHEM SOC, V130, P10, DOI 10.1021/ja076641c; Martinez-Seara H, 2008, BIOPHYS J, V95, P3295, DOI 10.1529/biophysj.108.138123; Martinez-Seara H, 2007, J PHYS CHEM B, V111, P11162, DOI 10.1021/jp071894d; Martinez-Seara H, 2009, J PHYS CHEM B, V113, P8347, DOI 10.1021/jp902131b; Martinez-Seara H, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2976443; Miao L, 2002, BIOPHYS J, V82, P1429, DOI 10.1016/S0006-3495(02)75497-0; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Ollila OHS, 2007, J STRUCT BIOL, V159, P311, DOI 10.1016/j.jsb.2007.01.012; Ollila S, 2007, J PHYS CHEM B, V111, P3139, DOI 10.1021/jp065424f; Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931; Pandit SA, 2004, BIOPHYS J, V87, P3312, DOI 10.1529/biophysj.104.046078; Pandit SA, 2009, BBA-BIOMEMBRANES, V1788, P136, DOI 10.1016/j.bbamem.2008.09.004; Patra M, 2004, J PHYS CHEM B, V108, P4485, DOI 10.1021/jp031281a; Pitman MC, 2004, BIOCHEMISTRY-US, V43, P15318, DOI 10.1021/bi048231w; Poyry S, 2008, J PHYS CHEM B, V112, P2922, DOI 10.1021/jp7100495; Radhakrishnan A, 2005, P NATL ACAD SCI USA, V102, P12662, DOI 10.1073/pnas.0506043102; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Rog T, 2006, BIOCHIMIE, V88, P449, DOI 10.1016/j.biochi.2005.10.005; Rog T, 2004, BIOPHYS CHEM, V107, P151, DOI 10.1016/j.bpc.2003.09.002; Rog T, 2001, BIOPHYS J, V81, P2190, DOI 10.1016/S0006-3495(01)75867-5; Rog T, 2007, BIOPHYS J, V92, P3346, DOI 10.1529/biophysj.106.095497; Rog T, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2996296; Rog T, 2009, J PHYS CHEM B, V113, P3413, DOI 10.1021/jp8077369; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stottrup BL, 2006, BIOPHYS J, V90, P3176, DOI 10.1529/biophysj.105.072959; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Tieleman DP, 2002, BIOPHYS J, V83, P1501, DOI 10.1016/S0006-3495(02)73920-9; Vainio S, 2006, J BIOL CHEM, V281, P348, DOI 10.1074/jbc.M509530200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JW, 2004, BIOCHEMISTRY-US, V43, P1010, DOI 10.1021/bi035696y	64	88	88	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11162	10.1371/journal.pone.0011162	http://dx.doi.org/10.1371/journal.pone.0011162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567600	gold, Green Published, Green Submitted			2022-12-25	WOS:000278886300008
J	Calounova, G; Livera, G; Zhang, XQ; Liu, K; Gosden, RG; Welsh, M				Calounova, Gabriela; Livera, Gabriel; Zhang, Xiao-Qun; Liu, Kui; Gosden, Roger G.; Welsh, Michael			The Src Homology 2 Domain-Containing Adapter Protein B (SHB) Regulates Mouse Oocyte Maturation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GROWTH-FACTOR; FOLLICLE DEVELOPMENT; FERTILITY PATHWAYS; C-KIT; DIFFERENTIATION; MICE; EXPRESSION; PROMOTES; PROLIFERATION	SHB (Src homology 2 domain-containing adapter protein B) is involved in receptor tyrosine kinase signaling. Mice deficient in the Shb gene have been found to exhibit a transmission ratio distortion with respect to inheritance of the Shb null allele among offspring and this phenomenon was linked to female gamete production. Consequently, we postulated that Shb plays a role for oocyte biology and thus decided to investigate oocyte formation, meiotic maturation, and early embryo development in relation to absence of the Shb gene. Oogenesis was apparently accelerated judging from the stages of oocyte development on fetal day 18.5 and one week postnatally in Shb(-/-) mice; but in adulthood ovarian follicle maturation was impaired in these mice. Completion of meiosis I (first polar body extrusion) was less synchronized, with a fraction of oocytes showing premature polar body extrusion in the absence of Shb. In vitro fertilization of mature oocytes isolated from Shb +/+, +/- and -/- mice revealed impaired early embryo development in the -/- embryos. Moreover, the absence of Shb enhanced ERK (extracellular-signal regulated kinase) and RSK (ribosomal S6 kinase) signaling in oocytes and these effects were paralleled by an increased ribosomal protein S6 phosphorylation and activation. It is concluded that SHB regulates normal oocyte and follicle development and that perturbation of SHB signaling causes defective meiosis I and early embryo development.	[Calounova, Gabriela; Welsh, Michael] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Livera, Gabriel] Univ Paris 07, CEA, INSERM, Lab Dev Gonads,UMR U967, Fontenay Aux Roses, France; [Zhang, Xiao-Qun] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Liu, Kui] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Gosden, Roger G.] Cornell Univ, Weill Med Coll, Ctr Reprod Med & Infertil, New York, NY 10021 USA	Uppsala University; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Uppsala University; Umea University; Cornell University	Calounova, G (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Michael.welsh@mcb.uu.se	LIVERA, Gabriel/F-5740-2019; Welsh, Michael/AAF-8564-2020	LIVERA, Gabriel/0000-0001-8436-4730; Welsh, Michael/0000-0002-5467-9755	Swedish Research Council [68X-10822]; Swedish Cancer Foundation [090779]; Swedish Diabetes Research Foundation; Wallenberg Family Foundation; Family Ernfors Fund; EMD Serono	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Diabetes Research Foundation; Wallenberg Family Foundation; Family Ernfors Fund; EMD Serono	Support from the Swedish Research Council (68X-10822), the Swedish Cancer Foundation (090779), the Swedish Diabetes Research Foundation, the Wallenberg Family Foundation and the Family Ernfors Fund is gratefully acknowledged. RGG is supported by an unrestricted grant from EMD Serono. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ABERCROMBIE M, 1946, J ANAT, V80, P37; Akerblom B, 2009, J ENDOCRINOL, V203, P271, DOI 10.1677/JOE-09-0198; Anneren C, 2003, CURR MOL MED, V3, P313, DOI 10.2174/1566524033479744; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Carabatsos MJ, 1998, DEV BIOL, V204, P373, DOI 10.1006/dbio.1998.9087; Dekel N, 2005, MOL CELL ENDOCRINOL, V234, P19, DOI 10.1016/j.mce.2004.09.010; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; FADDY MJ, 1987, CELL TISSUE KINET, V20, P551, DOI 10.1111/j.1365-2184.1987.tb01364.x; Funa NS, 2008, DIFFERENTIATION, V76, P443, DOI 10.1111/j.1432-0436.2007.00249.x; Funa NS, 2009, CANCER RES, V69, P2141, DOI 10.1158/0008-5472.CAN-08-3797; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; GONZALEZ R, 2009, REPROD TOXICOL; GONZALEZ R, 2009, TOXICOL IN VITRO; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Jagarlamudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006186; Kawamura K, 2009, DEV BIOL, V327, P62, DOI 10.1016/j.ydbio.2008.11.033; Klinger FG, 2002, DEV BIOL, V244, P85, DOI 10.1006/dbio.2002.0592; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kriz V, 2003, EXP CELL RES, V286, P40, DOI 10.1016/S0014-4827(03)00099-5; Kriz V, 2007, DEV DYNAM, V236, P2485, DOI 10.1002/dvdy.21257; Kriz V, 2006, J BIOL CHEM, V281, P34484, DOI 10.1074/jbc.M604084200; Kwintkiewicz J, 2009, SEMIN REPROD MED, V27, P43, DOI 10.1055/s-0028-1108009; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; Livera G, 2008, REPRODUCTION, V135, P3, DOI 10.1530/REP-07-0054; Matskova LV, 2007, ONCOGENE, V26, P4908, DOI 10.1038/sj.onc.1210298; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; McGinnis LK, 2009, DEV BIOL, V327, P280, DOI 10.1016/j.ydbio.2008.11.038; Mokhtari D, 2009, BIOCHEM BIOPH RES CO, V387, P553, DOI 10.1016/j.bbrc.2009.07.051; PACKER AI, 1994, DEV BIOL, V161, P194, DOI 10.1006/dbio.1994.1020; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Rolny C, 2005, EXP CELL RES, V308, P381, DOI 10.1016/j.yexcr.2005.04.020; Roy A, 2006, REPRODUCTION, V131, P207, DOI 10.1530/rep.1.00530; Saldeen J, 2006, BIOCHEM BIOPH RES CO, V344, P517, DOI 10.1016/j.bbrc.2006.03.129	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11155	10.1371/journal.pone.0011155	http://dx.doi.org/10.1371/journal.pone.0011155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585392	Green Submitted, gold, Green Published			2022-12-25	WOS:000278886100018
J	Smith, GR; Shanley, DP				Smith, Graham R.; Shanley, Daryl P.			Modelling the Response of FOXO Transcription Factors to Multiple Post-Translational Modifications Made by Ageing-Related Signalling Pathways	PLOS ONE			English	Article							CELL-CYCLE REGULATION; EXTENDS LIFE-SPAN; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; DIETARY RESTRICTION; INSULIN-RECEPTOR; NUCLEOCYTOPLASMIC OSCILLATIONS; PROMOTES TUMORIGENESIS; TARGET GENES; FACTOR MSN2	FOXO transcription factors are an important, conserved family of regulators of cellular processes including metabolism, cell-cycle progression, apoptosis and stress resistance. They are required for the efficacy of several of the genetic interventions that modulate lifespan. FOXO activity is regulated by multiple post-translational modifications (PTMs) that affect its subcellular localization, half-life, DNA binding and transcriptional activity. Here, we show how a mathematical modelling approach can be used to simulate the effects, singly and in combination, of these PTMs. Our model is implemented using the Systems Biology Markup Language (SBML), generated by an ancillary program and simulated in a stochastic framework. The use of the ancillary program to generate the SBML is necessary because the possibility that many regulatory PTMs may be added, each independently of the others, means that a large number of chemically distinct forms of the FOXO molecule must be taken into account, and the program is used to generate them. Although the model does not yet include detailed representations of events upstream and downstream of FOXO, we show how it can qualitatively, and in some cases quantitatively, reproduce the known effects of certain treatments that induce various single and multiple PTMs, and allows for a complex spatiotemporal interplay of effects due to the activation of multiple PTM-inducing treatments. Thus, it provides an important framework to integrate current knowledge about the behaviour of FOXO. The approach should be generally applicable to other proteins experiencing multiple regulations.	[Smith, Graham R.; Shanley, Daryl P.] Newcastle Univ, Inst Ageing & Hlth, Henry Wellcome Lab Biogerontol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Smith, GR (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Henry Wellcome Lab Biogerontol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	Daryl.Shanley@newcastle.ac.uk		Shanley, Daryl/0000-0003-3096-6386	BBSRC [BBC0082001]; EU [FP6 036894]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission)	This work was supported in part by the BBSRC (www.bbsrc.ac.uk)/EPSRC (www.epsrc.ac.uk) grant to CISBAN (BBC0082001), and was in part supported by, and carried out within, the EU (cordis.europa.eu/fp6/) funded Network of Excellence LifeSpan (FP6 036894). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Blinov ML, 2004, BIOINFORMATICS, V20, P3289, DOI 10.1093/bioinformatics/bth378; Borisov NM, 2005, BIOPHYS J, V89, P951, DOI 10.1529/biophysj.105.060533; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Colvin J, 2009, BIOINFORMATICS, V25, P910, DOI 10.1093/bioinformatics/btp066; Csikasz-Nagy A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.73; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Gevorgyan A, 2008, BIOINFORMATICS, V24, P2245, DOI 10.1093/bioinformatics/btn425; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Gillespie CS, 2006, BIOINFORMATICS, V22, P628, DOI 10.1093/bioinformatics/btk042; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Gonze D, 2008, J R SOC INTERFACE, V5, pS95, DOI 10.1098/rsif.2008.0141.focus; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Hlavacek WS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.80; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Imae M, 2003, J MOL ENDOCRINOL, V30, P253, DOI 10.1677/jme.0.0300253; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Karpac J, 2009, TRENDS ENDOCRIN MET, V20, P100, DOI 10.1016/j.tem.2008.11.004; Kim S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000665; Kirkwood TBL, 2003, NAT REV MOL CELL BIO, V4, P243, DOI 10.1038/nrm1051; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Kondo M, 2005, MECH AGEING DEV, V126, P642, DOI 10.1016/j.mad.2004.11.012; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kuningas M, 2007, J GERONTOL A-BIOL, V62, P960, DOI 10.1093/gerona/62.9.960; Le Novere N, 2001, BIOINFORMATICS, V17, P575, DOI 10.1093/bioinformatics/17.6.575; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martin OC, 2009, GENETICS, V183, P673, DOI 10.1534/genetics.109.104174; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mendes P, 2009, METHOD ENZYMOL, V467, P583, DOI 10.1016/S0076-6879(09)67022-1; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nowak K, 2007, BBA-GENE STRUCT EXPR, V1769, P244, DOI 10.1016/j.bbaexp.2007.04.001; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Partridge L, 2008, ONCOGENE, V27, P2351, DOI 10.1038/onc.2008.28; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Poolman MG, 2006, IEE P SYST BIOL, V153, P379, DOI 10.1049/ip-syb:20060012; Proctor CJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-75; Proctor CJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-17; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puszynski K, 2008, J THEOR BIOL, V254, P452, DOI 10.1016/j.jtbi.2008.05.039; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Schuur ER, 2001, J BIOL CHEM, V276, P33554, DOI 10.1074/jbc.M105555200; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Shapiro BE, 2003, BIOINFORMATICS, V19, P677, DOI 10.1093/bioinformatics/btg042; Smallbone K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-6; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, INT J ONCOL, V29, P643; Yang J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031910; Yu RX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001821; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	137	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11092	10.1371/journal.pone.0011092	http://dx.doi.org/10.1371/journal.pone.0011092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20567500	Green Submitted, Green Published, gold			2022-12-25	WOS:000278741100008
J	Starkey, JM; Zhao, YX; Sadygov, RG; Haidacher, SJ; LeJeune, WS; Dey, N; Luxon, BA; Kane, MA; Napoli, JL; Denner, L; Tilton, RG				Starkey, Jonathan M.; Zhao, Yingxin; Sadygov, Rovshan G.; Haidacher, Sigmund J.; LeJeune, Wanda S.; Dey, Nilay; Luxon, Bruce A.; Kane, Maureen A.; Napoli, Joseph L.; Denner, Larry; Tilton, Ronald G.			Altered Retinoic Acid Metabolism in Diabetic Mouse Kidney Identified by O-18 Isotopic Labeling and 2D Mass Spectrometry	PLOS ONE			English	Article							ALCOHOL-DEHYDROGENASE ADH1; VITAMIN-A; BINDING-PROTEIN; CYTOCHROME-P450 2E1; ACTIVATED RECEPTOR; OXIDATIVE STRESS; IN-VIVO; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; NUCLEAR RECEPTORS	Background: Numerous metabolic pathways have been implicated in diabetes-induced renal injury, yet few studies have utilized unbiased systems biology approaches for mapping the interconnectivity of diabetes-dysregulated proteins that are involved. We utilized a global, quantitative, differential proteomic approach to identify a novel retinoic acid hub in renal cortical protein networks dysregulated by type 2 diabetes. Methodology/Principal Findings: Total proteins were extracted from renal cortex of control and db/db mice at 20 weeks of age (after 12 weeks of hyperglycemia in the diabetic mice). Following trypsinization, O-18- and O-16-labeled control and diabetic peptides, respectively, were pooled and separated by two dimensional liquid chromatography (strong cation exchange creating 60 fractions further separated by nano-HPLC), followed by peptide identification and quantification using mass spectrometry. Proteomic analysis identified 53 proteins with fold change >= 1.5 and p <= 0.05 after Benjamini-Hochberg adjustment (out of 1,806 proteins identified), including alcohol dehydrogenase (ADH) and retinaldehyde dehydrogenase (RALDH1/ALDH1A1). Ingenuity Pathway Analysis identified altered retinoic acid as a key signaling hub that was altered in the diabetic renal cortical proteome. Western blotting and real-time PCR confirmed diabetes-induced upregulation of RALDH1, which was localized by immunofluorescence predominantly to the proximal tubule in the diabetic renal cortex, while PCR confirmed the downregulation of ADH identified with mass spectrometry. Despite increased renal cortical tissue levels of retinol and RALDH1 in db/db versus control mice, all-trans-retinoic acid was significantly decreased in association with a significant decrease in PPAR beta/delta mRNA. Conclusions/Significance: Our results indicate that retinoic acid metabolism is significantly dysregulated in diabetic kidneys, and suggest that a shift in all-trans-retinoic acid metabolism is a novel feature in type 2 diabetic renal disease. Our observations provide novel insights into potential links between altered lipid metabolism and other gene networks controlled by retinoic acid in the diabetic kidney, and demonstrate the utility of using systems biology to gain new insights into diabetic nephropathy.	[Zhao, Yingxin; Haidacher, Sigmund J.; LeJeune, Wanda S.; Dey, Nilay; Denner, Larry; Tilton, Ronald G.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA; [Starkey, Jonathan M.; Sadygov, Rovshan G.; Luxon, Bruce A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Tilton, Ronald G.] Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, Galveston, TX USA; [Zhao, Yingxin; Denner, Larry; Tilton, Ronald G.] Univ Texas Med Branch, Stark Diabet Ctr, Galveston, TX USA; [Zhao, Yingxin; Haidacher, Sigmund J.; LeJeune, Wanda S.; Denner, Larry; Tilton, Ronald G.] Univ Texas Med Branch, McCoy Diabet Mass Spectrometry Res Lab, Galveston, TX USA; [Zhao, Yingxin; Sadygov, Rovshan G.; Luxon, Bruce A.; Denner, Larry] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX USA; [Luxon, Bruce A.] Univ Texas Med Branch, Inst Translat Sci Biomed Informat Program, Galveston, TX USA; [Kane, Maureen A.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Berkeley	Starkey, JM (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA.	rgtilton@utmb.edu	Luxon, Bruce A/C-9140-2012	Starkey, Jonathan/0000-0002-9083-6455	American Diabetes Association; McCoy Diabetes Research Foundation; Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia [5T15LM007093]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); McCoy Diabetes Research Foundation; Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This project was supported by an American Diabetes Association (http://www.diabetes.org/) research grant (RGT), and the McCoy Diabetes Research Foundation (RGT and LD). JMS was supported by a training fellowship from the Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia (National Library of Medicine Training Program in Biomedical Informatics and Computational Biology Grant No. 5T15LM007093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn T, 2006, TOXICOL LETT, V166, P27, DOI 10.1016/j.toxlet.2006.05.009; Araki E, 2003, INTERNAL MED, V42, P7, DOI 10.2169/internalmedicine.42.7; Baena RM, 2002, EUR J CLIN NUTR, V56, P44, DOI 10.1038/sj.ejcn.1601279; Bai JX, 2006, J BIOL CHEM, V281, P5128, DOI 10.1074/jbc.M510484200; BASU TK, 1989, AM J CLIN NUTR, V50, P329, DOI 10.1093/ajcn/50.2.329; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Boerman MHEM, 1996, J BIOL CHEM, V271, P5610, DOI 10.1074/jbc.271.10.5610; BROWNLEE M, 1988, DIABETES METAB REV, V4, P437, DOI 10.1002/dmr.5610040503; Burns KD, 2000, AM J KIDNEY DIS, V36, P449, DOI 10.1053/ajkd.2000.16192; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elizondo G, 2000, J BIOL CHEM, V275, P39747, DOI 10.1074/jbc.M004987200; Elizondo G, 2009, BIOCHEM PHARMACOL, V77, P248, DOI 10.1016/j.bcp.2008.10.011; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Han SY, 2004, IMMUNOL CELL BIOL, V82, P568, DOI 10.1111/j.1440-1711.2004.01287.x; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Liu X, 2008, ACTA PHARMACOL SIN, V29, P1035, DOI 10.1111/j.1745-7254.2008.00849.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2000, J NUTR, V130, P1958, DOI 10.1093/jn/130.8.1958; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; MARTINOLI L, 1993, INT J VITAM NUTR RES, V63, P87; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Molotkov A, 2002, EUR J BIOCHEM, V269, P2607, DOI 10.1046/j.1432-1033.2002.02935.x; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Nishikawa T, 2000, KIDNEY INT, V58, pS26, DOI 10.1046/j.1523-1755.2000.07705.x; Njar VCO, 2006, BIOORGAN MED CHEM, V14, P4323, DOI 10.1016/j.bmc.2006.02.041; Noy N, 2007, BIOCHEMISTRY-US, V46, P13461, DOI 10.1021/bi7018699; Oates, 1999, Expert Opin Investig Drugs, V8, P2095, DOI 10.1517/13543784.8.12.2095; Olmedilla B, 1997, CLIN CHEM, V43, P1066; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Qian WJ, 2005, MOL CELL PROTEOMICS, V4, P700, DOI 10.1074/mcp.M500045-MCP200; Raza H, 2004, DIABETES, V53, P185, DOI 10.2337/diabetes.53.1.185; Rieck M, 2008, MOL PHARMACOL, V74, P1269, DOI 10.1124/mol.108.050625; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sharma K, 2003, AM J PHYSIOL-RENAL, V284, pF1138, DOI 10.1152/ajprenal.00315.2002; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Starkey JM, 2006, DIABETES, V55, P1252, DOI 10.2337/db05-1554; Strange K, 2005, AM J PHYSIOL-CELL PH, V288, pC968, DOI 10.1152/ajpcell.00598.2004; Szabo C, 2005, PHARMACOL RES, V52, P60, DOI 10.1016/j.phrs.2005.02.015; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; Wang T, 2008, J PHARMACOL EXP THER, V324, P674, DOI 10.1124/jpet.107.131045; Wang XD, 2005, ALCOHOL, V35, P251, DOI 10.1016/j.alcohol.2005.04.006; Wang ZQ, 2003, BRIT J CLIN PHARMACO, V55, P77, DOI 10.1046/j.1365-2125.2003.01731.x; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; Zhao YX, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-15; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	63	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11095	10.1371/journal.pone.0011095	http://dx.doi.org/10.1371/journal.pone.0011095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559430	Green Submitted, Green Published, gold			2022-12-25	WOS:000278741100011
J	Georgieva, ER; Ramlall, TF; Borbat, PP; Freed, JH; Eliezer, D				Georgieva, Elka R.; Ramlall, Trudy F.; Borbat, Peter P.; Freed, Jack H.; Eliezer, David			The Lipid-binding Domain of Wild Type and Mutant alpha-Synuclein COMPACTNESS AND INTERCONVERSION BETWEEN THE BROKEN AND EXTENDED HELIX FORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIR DISTANCE DISTRIBUTIONS; PARKINSONS-DISEASE; MEMBRANE INTERACTIONS; RESIDUAL STRUCTURE; PROTEIN; DYNAMICS; ESR; VESICLES; EPR; NMR	alpha-Synuclein (alpha S) is linked to Parkinson disease through its deposition in an amyloid fibril form within Lewy Body deposits, and by the existence of three alpha S point mutations that lead to early onset autosomal dominant Parkinsonism. The normal function of alpha S is thought to be linked to the ability of the protein to bind to the surface of synaptic vesicles. Upon binding to vesicles, alpha S undergoes a structural reorganization from a dynamic and disordered ensemble to a conformation consisting of a long extended helix. In the presence of small spheroidal detergent micelles, however, this extended helix conformation can convert into a broken helix state, in which a region near the middle of the helix unwinds to form a linker between the two resulting separated helices. Membrane-bound conformations of alpha S likely mediate the function of the protein, but may also play a role in the aggregation and toxicity of the protein. Here we have undertaken a study of the effects of the three known PD-linked mutations on the detergent-and membrane-bound conformations of alpha S, as well as factors that govern the transition of the protein between the extended helix and broken helix states. Using pulsed dipolar ESR measurements of distances up to 8.7 nm, we show that all three PD-linked alpha S mutants retain the ability to transition from the broken helix to the extended helix conformation. In addition, we find that the ratio of protein to detergent, rather than just the absolute detergent concentration, determines whether the protein adopts the broken or extended helix conformation.	[Georgieva, Elka R.; Borbat, Peter P.; Freed, Jack H.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Ramlall, Trudy F.; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Ramlall, Trudy F.; Eliezer, David] Weill Cornell Med Coll, Program Struct Biol, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University	Freed, JH (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	jhf3@cornell.edu; dae2005@med.cornell.edu	Borbat, Petr P/A-8658-2014; Georgieva, Elka R./AAA-6785-2021; borbat, peter/B-1616-2016	Georgieva, Elka R./0000-0001-9980-5260	National Institutes of Health, NIA [AG019391, AG025440]; National Institutes of Health, NCRR [P41-RR016242]; National Institutes of Health, NIBIB [EB03150]; Irma T. Hirschl Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR016292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025440, R01AG019391, R37AG019391] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Irma T. Hirschl Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG019391 and AG025440 (to D. E.) from the NIA and NCRR P41-RR016242 and NIBIB EB03150 (to J. H. F.), the Irma T. Hirschl Foundation, and a gift from Herbert and Ann Siegel (to D. E.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Banham JE, 2008, J MAGN RESON, V191, P202, DOI 10.1016/j.jmr.2007.11.023; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bhatnagar J, 2007, METHOD ENZYMOL, V423, P117, DOI 10.1016/S0076-6879(07)23004-6; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Boettcher JM, 2008, BIOCHEMISTRY-US, V47, P12357, DOI 10.1021/bi801450t; Borbat P.P., 2007, EPR NEWSLETTER, V17, P21; Borbat P, 2006, J AM CHEM SOC, V128, P10004, DOI 10.1021/ja063122l; Borbat PP, 2007, METHOD ENZYMOL, V423, P52, DOI 10.1016/S0076-6879(07)23003-4; Borbat PP, 1997, J MAGN RESON, V127, P155, DOI 10.1006/jmre.1997.1201; Borbat PP, 2002, J AM CHEM SOC, V124, P5304, DOI 10.1021/ja020040y; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chiang YW, 2005, J MAGN RESON, V177, P184, DOI 10.1016/j.jmr.2005.07.021; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Chill JH, 2006, PROTEIN SCI, V15, P684, DOI 10.1110/ps.051954706; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Eliezer D, 2008, PARKINSON'S DISEASE: MOLECULAR AND THERAPEUTIC INSIGHTS FROM MODEL SYSTEMS, P575, DOI 10.1016/B978-0-12-374028-1.00042-7; Ferreon ACM, 2007, BIOCHEMISTRY-US, V46, P4499, DOI 10.1021/bi602461y; Ferreon ACM, 2010, ANGEW CHEM INT EDIT, V49, P3469, DOI 10.1002/anie.201000378; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Flory P. J., 1969, STAT MECH CHAIN MOL, V8, P699, DOI [10.1002/bip.1969.360080514, DOI 10.1002/BIP.1969.360080514]; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Hustedt EJ, 2006, BIOPHYS J, V90, P340, DOI 10.1529/biophysj.105.068544; Irizarry MC, 1996, J NEUROPATH EXP NEUR, V55, P889, DOI 10.1097/00005072-199608000-00004; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jaroniec CP, 2005, BIOCHEMISTRY-US, V44, P16167, DOI 10.1021/bi051672a; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jeschke G, 2002, J MAGN RESON, V155, P72, DOI 10.1006/jmre.2001.2498; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee JC, 2005, J AM CHEM SOC, V127, P16388, DOI 10.1021/ja0561901; Lee JC, 2007, J PHYS CHEM B, V111, P2107, DOI 10.1021/jp068604y; Madine J, 2006, BIOCHEMISTRY-US, V45, P5783, DOI 10.1021/bi052151q; Madine J, 2008, MOL MEMBR BIOL, V25, P518, DOI 10.1080/09687680802467977; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Otzen DE, 2002, BIOPHYS J, V83, P2219, DOI 10.1016/S0006-3495(02)73982-9; Pandey AP, 2009, BIOPHYS J, V96, P540, DOI 10.1016/j.bpj.2008.10.011; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Ramakrishnan M, 2003, BIOCHEMISTRY-US, V42, P12919, DOI 10.1021/bi035048e; RAO IV, 1987, J COLLOID INTERF SCI, V119, P211, DOI 10.1016/0021-9797(87)90261-X; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Upadhyay AK, 2008, BIOCHEMISTRY-US, V47, P1554, DOI 10.1021/bi7021377; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	77	104	104	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28261	28274		10.1074/jbc.M110.157214	http://dx.doi.org/10.1074/jbc.M110.157214			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592036	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000281404100069
J	Mezo, AR; Sridhar, V; Badger, J; Sakorafas, P; Nienaber, V				Mezo, Adam R.; Sridhar, Vandana; Badger, John; Sakorafas, Paul; Nienaber, Vicki			X-ray Crystal Structures of Monomeric and Dimeric Peptide Inhibitors in Complex with the Human Neonatal Fc Receptor, FcRn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERFACES; IMMUNOGLOBULIN-G; 2.8 ANGSTROM; BINDING; IGG; MECHANISM; HORMONE	The neonatal Fc receptor, FcRn, is responsible for the long half-life of IgG molecules in vivo and is a potential therapeutic target for the treatment of autoimmune diseases. A family of peptides comprising the consensus motif GHFGGXY, where X is preferably a hydrophobic amino acid, was shown previously to inhibit the human IgG: human FcRn protein-protein interaction (Mezo, A. R., McDonnell, K. A., Tan Hehir, C. A., Low, S. C., Palombella, V. J., Stattel, J. M., Kamphaus, G. D., Fraley, C., Zhang, Y., Dumont, J. A., and Bitonti, A. J. (2008) Proc. Natl. Acad. Sci. U.S.A., 105, 2337-2342). Herein, the x-ray crystal structure of a representative monomeric peptide in complex with human FcRn was solved to 2.6 angstrom resolution. The structure shows that the peptide binds to human FcRn at the same general binding site as does the Fc domain of IgG. The data correlate well with structure-activity relationship data relating to how the peptide family binds to human FcRn. In addition, the x-ray crystal structure of a representative dimeric peptide in complex with human FcRn shows how the bivalent ligand can bridge two FcRn molecules, which may be relevant to the mechanism by which the dimeric peptides inhibit FcRn and increase IgG catabolism in vivo. Modeling of the peptide: FcRn structure as compared with available structural data on Fc and FcRn suggest that the His-6 and Phe-7 (peptide) partially mimic the interaction of His-310 and Ile-253 (Fc) in binding to FcRn, but using a different backbone topology.	[Mezo, Adam R.; Sakorafas, Paul] Biogen Idec Inc, Syntonix Subsidiary, Waltham, MA 02451 USA; [Sridhar, Vandana; Badger, John; Nienaber, Vicki] Zenobia Therapeut, La Jolla, CA 92037 USA	Biogen	Mezo, AR (corresponding author), 9 4th Ave, Waltham, MA 02451 USA.	adam.mezo@biogenidec.com						Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Collaborative Computational Project, 1994, ACTA CRYST D, V50, P760; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; GASTINEL LN, 2005, Patent No. 5623053; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liu Z, 1997, J EXP MED, V186, P777, DOI 10.1084/jem.186.5.777; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Low SC, 2009, AAPS J, V11, P432, DOI 10.1208/s12248-009-9120-5; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonnell KA, 2010, J MED CHEM, V53, P1587, DOI 10.1021/jm901128z; Mezo AR, 2008, BIOORGAN MED CHEM, V16, P6394, DOI 10.1016/j.bmc.2008.05.004; Mezo AR, 2008, P NATL ACAD SCI USA, V105, P2337, DOI 10.1073/pnas.0708960105; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; *RIG AM CORP, 2008, MIFIT 8 MAN; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Vaughn DE, 1997, BIOCHEMISTRY-US, V36, P9374, DOI 10.1021/bi970841r; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Vaughn DE, 1997, J MOL BIOL, V274, P597, DOI 10.1006/jmbi.1997.1388; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Yu ZY, 1999, NEW ENGL J MED, V340, P227, DOI 10.1056/NEJM199901213400311	33	33	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27694	27701		10.1074/jbc.M110.120667	http://dx.doi.org/10.1074/jbc.M110.120667			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592032	Green Published, hybrid			2022-12-25	WOS:000281404100025
J	Cooke, SL; Ng, CKY; Melnyk, N; Garcia, MJ; Hardcastle, T; Temple, J; Langdon, S; Huntsman, D; Brenton, JD				Cooke, S. L.; Ng, C. K. Y.; Melnyk, N.; Garcia, M. J.; Hardcastle, T.; Temple, J.; Langdon, S.; Huntsman, D.; Brenton, J. D.			Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma	ONCOGENE			English	Article						ovarian cancer; heterogeneity; evolution; chemotherapy	ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER CELL-LINES; BREAST-CANCER; CHROMOSOMAL INSTABILITY; TUMOR HETEROGENEITY; DISEASE PROGRESSION; COPY NUMBER; MUTATIONS; EXPRESSION; RESISTANCE	Resistance to chemotherapy in ovarian cancer is poorly understood. Evolutionary models of cancer predict that, following treatment, resistance emerges either because of outgrowth of an intrinsically resistant sub-clone or evolves in residual disease under the selective pressure of treatment. To investigate genetic evolution in high-grade serous (HGS) ovarian cancers, we first analysed cell line series derived from three cases of HGS carcinoma before and after platinum resistance had developed (PEO1, PEO4 and PEO6; PEA1 and PEA2; and PEO14 and PEO23). Analysis with 24-colour fluorescence in situ hybridisation and single nucleotide polymorphism (SNP) array comparative genomic hybridisation (CGH) showed mutually exclusive endoreduplication and loss of heterozygosity events in clones present at different time points in the same individual. This implies that platinum-sensitive and -resistant disease was not linearly related, but shared a common ancestor at an early stage of tumour development. Array CGH analysis of six paired pre- and post-neoadjuvant treatment HGS samples from the CTCR-OV01 clinical study did not show extensive copy number differences, suggesting that one clone was strongly dominant at presentation. These data show that cisplatin resistance in HGS carcinoma develops from pre-existing minor clones but that enrichment for these clones is not apparent during short-term chemotherapy treatment. Oncogene (2010) 29, 4905-4913; doi: 10.1038/onc.2010.245; published online 28 June 2010	[Cooke, S. L.; Ng, C. K. Y.; Garcia, M. J.; Hardcastle, T.; Temple, J.; Brenton, J. D.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Melnyk, N.; Huntsman, D.] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Langdon, S.] Univ Edinburgh, Div Pathol, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	Cancer Research UK; CRUK Cambridge Institute; British Columbia Cancer Agency; University of Edinburgh	Brenton, JD (corresponding author), Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England.	james.brenton@cancer.org.uk	Brenton, James D/B-3174-2008; Ng, Charlotte K Y/AAA-1670-2020; Huntsman, David/ABE-6082-2020; García, María J/G-1361-2016; Ng, Charlotte K Y/AAY-3178-2021	Brenton, James D/0000-0002-5738-6683; García, María J/0000-0002-2236-9912; Ng, Charlotte K Y/0000-0002-6100-0026; Hardcastle, Thomas/0000-0002-9328-5011	Cancer Research UK; University of Cambridge; Hutchison Whampoa Ltd; Cambridge Experimental Cancer Medicine Centre; NIHR Biomedical Research Centre; Cancer Research UK [19556] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); Hutchison Whampoa Ltd; Cambridge Experimental Cancer Medicine Centre; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)	We thank Paul Edwards for helpful discussion of the paper. We thank our patients and members of the Gynaecological Oncology Multidisciplinary Team at Cambridge University Hospitals NHS Foundation Trust for their participation in the CTCR-OV01 clinical study. This work was funded by Cancer Research UK. We acknowledge the support of the University of Cambridge, Hutchison Whampoa Ltd, the Cambridge Experimental Cancer Medicine Centre and the NIHR Biomedical Research Centre.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Alsop AE, 2006, CANCER GENET CYTOGEN, V164, P97, DOI 10.1016/j.cancergencyto.2005.09.011; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bayani J, 2002, CANCER RES, V62, P3466; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Curto M, 2008, BRIT J CANCER, V98, P256, DOI 10.1038/sj.bjc.6604002; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herzog TJ, 2006, NAT CLIN PRACT ONCOL, V3, P604, DOI 10.1038/ncponc0637; Herzog TJ, 2004, CLIN CANCER RES, V10, P7439, DOI 10.1158/1078-0432.CCR-04-0683; Hofmann WK, 2003, BLOOD, V102, P659, DOI 10.1182/blood-2002-06-1756; KAMB A, 1994, SCIENCE, V264, P440; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Khalique L, 2007, J PATHOL, V211, P286, DOI 10.1002/path.2112; Koebel Martin, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800077X; LANGDON SP, 1988, CANCER RES, V48, P6166; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; MARKMAN M, 1991, J CLIN ONCOL, V9, P389, DOI 10.1200/JCO.1991.9.3.389; McAlpine JN, 2008, GYNECOL ONCOL, V110, P360, DOI 10.1016/j.ygyno.2008.05.019; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ouellet V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-152; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Roschke AV, 2002, NEOPLASIA, V4, P19, DOI 10.1038/sj.neo.7900197; Ruijter ET, 1996, J PATHOL, V180, P295; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Sakai W, 2009, CANCER RES, V69, P6381, DOI 10.1158/0008-5472.CAN-09-1178; Schulmann K, 2005, GASTROENTEROLOGY, V129, P74, DOI 10.1053/j.gastro.2005.04.011; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shibata K, 1998, BIOCHEM BIOPH RES CO, V246, P205, DOI 10.1006/bbrc.1998.8581; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Swisher EM, 2008, CANCER RES, V68, P2581, DOI 10.1158/0008-5472.CAN-08-0088; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Trofatter J A, 1993, Cell, V75, P826; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Zhu YM, 1999, BRIT J CANCER, V79, P1151, DOI 10.1038/sj.bjc.6690183	41	118	122	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	35					4905	4913		10.1038/onc.2010.245	http://dx.doi.org/10.1038/onc.2010.245			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	646XP	20581869	Green Accepted			2022-12-25	WOS:000281578700005
J	Zipfel, PA; Brady, DC; Kashatus, DF; Ancrile, BD; Tyler, DS; Counter, CM				Zipfel, P. A.; Brady, D. C.; Kashatus, D. F.; Ancrile, B. D.; Tyler, D. S.; Counter, C. M.			Ral activation promotes melanomagenesis	ONCOGENE			English	Article						melanoma; RalA; RalB; NRas	GTPASES; CANCER; PATHWAYS; EXPRESSION; FAMILY; GROWTH; RAIA	Up to one-third of human melanomas are characterized by an oncogenic mutation in the gene encoding the small guanosine triphosphatase (GTPase) NRAS. Ras proteins activate three primary classes of effectors, namely, Rafs, phosphatidyl-inositol-3-kinases (PI3Ks) and Ral guanine exchange factors (RalGEFs). In melanomas lacking NRAS mutations, the first two effectors can still be activated through an oncogenic BRAF mutation coupled with a loss of the PI3K negative regulator PTEN. This suggests that Ras effectors promote melanoma, regardless of whether they are activated by oncogenic NRas. The only major Ras effector pathway not explored for its role in melanoma is the RalGEF-Ral pathway, in which Ras activation of RalGEFs converts the small GTPases RalA and RalB to an active guanosine triphosphate-bound state. We report that RalA is activated in several human melanoma cancer cell lines harboring an oncogenic NRAS allele, an oncogenic BRAF allele or wild-type NRAS and BRAF alleles. Furthermore, short hairpin RNA (shRNA)-mediated knockdown of RalA, and to a lesser extent of RalB, variably inhibited the tumorigenic growth of melanoma cell lines having these three genotypes. Thus, as is the case for Raf and PI3K signaling, Rals also contribute to melanoma tumorigenesis. Oncogene (2010) 29, 4859-4864; doi:10.1038/onc.2010.224; published online 21 June 2010	[Zipfel, P. A.; Tyler, D. S.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Zipfel, P. A.; Tyler, D. S.] Durham VA Med Ctr, Durham, NC USA; [Brady, D. C.; Kashatus, D. F.; Ancrile, B. D.; Counter, C. M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Counter, C. M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University	Tyler, DS (corresponding author), Duke Univ, Med Ctr, Dept Surg, LSRC Bldg Room C225,Res Dr, Durham, NC 27710 USA.	tyler002@mc.duke.edu; count004@mc.duke.edu	Kashatus, David F/D-8299-2012; Brady, Donita/E-3801-2012	Kashatus, David F/0000-0001-8007-0612; Counter, Christopher M/0000-0003-0748-3079	American Cancer Society; National Institutes of Health [CA94184]; Leukemia & Lymphoma Fellowship; Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA094184] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Fellowship; Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by an American Cancer Society Grant to PAZ, a Leukemia & Lymphoma Fellowship to DFK, a Veterans Affairs Merit Review Grant to DST and a National Institutes of Health grant (CA94184) to CMC. We thank Dr Hillard Siegler (Duke University Medical Center) for all melanoma cell lines except SKMel28 cells.	Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bodempudi V, 2009, MOL CELL BIOL, V29, P3964, DOI 10.1128/MCB.01153-08; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; DAdamo DR, 1997, ONCOGENE, V14, P1295, DOI 10.1038/sj.onc.1200950; de Gorter DJJ, 2008, BLOOD, V111, P3364, DOI 10.1182/blood-2007-08-106583; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Miller MJ, 1998, MOL CELL BIOL, V18, P3718, DOI 10.1128/MCB.18.7.3718; Mishra PJ, 2010, ONCOGENE, V29, P2449, DOI 10.1038/onc.2009.521; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Smith SC, 2007, CLIN CANCER RES, V13, P3803, DOI 10.1158/1078-0432.CCR-06-2419; Sowalsky AG, 2010, ONCOGENE, V29, P45, DOI 10.1038/onc.2009.307; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; White MA, 1996, J BIOL CHEM, V271, P16439, DOI 10.1074/jbc.271.28.16439; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07	28	30	32	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	34					4859	4864		10.1038/onc.2010.224	http://dx.doi.org/10.1038/onc.2010.224			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	643VB	20562921	Green Accepted			2022-12-25	WOS:000281326400011
J	Olsen, AK; Andreassen, A; Singh, R; Wiger, R; Duale, N; Farmer, PB; Brunborg, G				Olsen, Ann-Karin; Andreassen, Ashild; Singh, Rajinder; Wiger, Richard; Duale, Nur; Farmer, Peter B.; Brunborg, Gunnar			Environmental Exposure of the Mouse Germ Line: DNA Adducts in Spermatozoa and Formation of De Novo Mutations during Spermatogenesis	PLOS ONE			English	Article							SPERM CHROMATIN-STRUCTURE; POLYCYCLIC AROMATIC-HYDROCARBONS; NUCLEOTIDE EXCISION-REPAIR; IN-VITRO FERTILIZATION; CHILDHOOD BRAIN-TUMORS; DIOL EPOXIDE; STRUCTURE ASSAY; CIGARETTE-SMOKING; PREGNANCY RATES; TRANSGENIC MICE	Background: Spermatozoal DNA damage is associated with poor sperm quality, disturbed embryonic development and early embryonic loss, and some genetic diseases originate from paternal de novo mutations. We previously reported poor repair of bulky DNA-lesions in rodent testicular cells. Methodology/Principal Findings: We studied the fate of DNA lesions in the male germ line. B[a] PDE-N(2)-dG adducts were determined by liquid chromatography-tandem mass spectrometry, and de novo mutations were measured in the cll-transgene, in Big Blue (R) mice exposed to benzo[a] pyrene (B[a] P; 3x50 mg/kg bw, i.p.). Spermatozoa were harvested at various time-points following exposure, to study the consequences of exposure during the different stages of spermatogenesis. B[a] PDE-N(2)-dG adducts induced by exposure of spermatocytes or later stages of spermatogenesis persisted at high levels in the resulting spermatozoa. Spermatozoa originating from exposed spermatogonia did not contain DNA adducts; however de novo mutations had been induced (p = 0.029), specifically GC-TA transversions, characteristic of B[a] P mutagenesis. Moreover, a specific spectrum of spontaneous mutations was consistently observed in spermatozoa. Conclusions/Significance: A temporal pattern of genotoxic consequences following exposure was identified, with an initial increase in DNA adduct levels in spermatozoa, believed to influence fertility, followed by induction of germ line de novo mutations with possible consequences for the offspring.	[Olsen, Ann-Karin; Andreassen, Ashild; Wiger, Richard; Duale, Nur; Brunborg, Gunnar] Norwegian Inst Publ Hlth, Div Environm Med, Oslo, Norway; [Singh, Rajinder; Farmer, Peter B.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England	Norwegian Institute of Public Health (NIPH); University of Leicester	Olsen, AK (corresponding author), Norwegian Inst Publ Hlth, Div Environm Med, Oslo, Norway.	ann.karin.olsen@fhi.no	Singh, Raj/HDN-1244-2022; Singh, Raj/A-5398-2011	Olsen, Ann-Karin/0000-0003-3982-5213	Research Council of Norway [148703]; Environmental Cancer Risk, Nutrition and Individual Susceptibility; European Union Network of Excellence [FOOD-CT-2005-513943]	Research Council of Norway(Research Council of Norway); Environmental Cancer Risk, Nutrition and Individual Susceptibility; European Union Network of Excellence(European Commission)	This work was supported by The Research Council of Norway [148703 to AKO], and by Environmental Cancer Risk, Nutrition and Individual Susceptibility, a European Union Network of Excellence (ECNIS, Contract No. FOOD-CT-2005-513943, to RS and PBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WT, 1987, J MOL BIOL, V194, P391, DOI 10.1016/0022-2836(87)90669-3; Ahmadi A, 1999, J EXP ZOOL, V284, P696, DOI 10.1002/(SICI)1097-010X(19991101)284:6&lt;696::AID-JEZ11&gt;3.0.CO;2-E; Andersson AM, 2008, INT J ANDROL, V31, P74, DOI 10.1111/j.1365-2605.2007.00853.x; Andreassen A, 2006, MUTAT RES-GEN TOX EN, V604, P60, DOI 10.1016/j.mrgentox.2006.01.004; Andrew SE, 2000, CARCINOGENESIS, V21, P1291, DOI 10.1093/carcin/21.7.1291; Barber R, 2002, P NATL ACAD SCI USA, V99, P6877, DOI 10.1073/pnas.102015399; Borini A, 2006, HUM REPROD, V21, P2876, DOI 10.1093/humrep/del251; CAROTHERS AM, 1990, CARCINOGENESIS, V11, P189; Cordier S, 2004, AM J EPIDEMIOL, V159, P1109, DOI 10.1093/aje/kwh154; Cordier S, 1997, CANCER CAUSE CONTROL, V8, P688, DOI 10.1023/A:1018419118841; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; DOUGLAS GR, 1994, MUTAGENESIS, V9, P451, DOI 10.1093/mutage/9.5.451; DUBROVA YE, 1993, NAT GENET, V5, P92, DOI 10.1038/ng0993-92; EVENSON DP, 1989, ENVIRON MOL MUTAGEN, V14, P79, DOI 10.1002/em.2850140203; EVENSON DP, 1993, ENVIRON MOL MUTAGEN, V21, P144, DOI 10.1002/em.2850210208; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Fraga CG, 1996, MUTAT RES-FUND MOL M, V351, P199, DOI 10.1016/0027-5107(95)00251-0; FRAGA CG, 1991, P NATL ACAD SCI USA, V88, P11003, DOI 10.1073/pnas.88.24.11003; Frydman N, 2008, FERTIL STERIL, V89, P92, DOI 10.1016/j.fertnstert.2007.02.022; GENEROSO WM, 1982, MUTAT RES, V94, P155, DOI 10.1016/0027-5107(82)90178-6; Harbach PR, 1999, ENVIRON MOL MUTAGEN, V33, P132, DOI 10.1002/(SICI)1098-2280(1999)33:2<132::AID-EM5>3.0.CO;2-2; Hassan MAM, 2004, FERTIL STERIL, V81, P384, DOI 10.1016/j.fertnstert.2003.06.027; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Hull MGR, 2000, FERTIL STERIL, V74, P725, DOI 10.1016/S0015-0282(00)01501-6; Irvine DS, 2000, J ANDROL, V21, P33; Jansen J, 2001, NUCLEIC ACIDS RES, V29, P1791, DOI 10.1093/nar/29.8.1791; KOHLER SW, 1991, ENVIRON MOL MUTAGEN, V18, P316, DOI 10.1002/em.2850180421; Lee KM, 2009, LEUKEMIA RES, V33, P250, DOI 10.1016/j.leukres.2008.06.031; Lin MH, 2008, FERTIL STERIL, V90, P352, DOI 10.1016/j.fertnstert.2007.06.018; Loft S, 2003, HUM REPROD, V18, P1265, DOI 10.1093/humrep/deg202; Makova KD, 2004, GENOME RES, V14, P567, DOI 10.1101/gr.1971104; MEISTRICH ML, 1986, BIOL REPROD, V34, P17, DOI 10.1095/biolreprod34.1.17; NELSON K, 1989, NEW ENGL J MED, V320, P19, DOI 10.1056/NEJM198901053200104; Ni ZY, 1997, MUTAT RES-FUND MOL M, V381, P77, DOI 10.1016/S0027-5107(97)00151-6; Olsen Ann-Karin, 2005, Toxicol Appl Pharmacol, V207, P521, DOI 10.1016/j.taap.2005.01.060; Oskam IC, 2005, REPRODUCTION, V130, P731, DOI 10.1530/rep.1.00690; Plichart M, 2008, EUR J CANCER PREV, V17, P376, DOI 10.1097/CEJ.0b013e3282f75e6f; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P188, DOI 10.1093/humrep/del364; RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013; Schmid TE, 2003, HUM REPROD, V18, P1474, DOI 10.1093/humrep/deg259; Shane BS, 2000, CARCINOGENESIS, V21, P715, DOI 10.1093/carcin/21.4.715; Shen HM, 2000, FREE RADICAL BIO MED, V28, P529, DOI 10.1016/S0891-5849(99)00234-8; Singh R, 2006, CHEM RES TOXICOL, V19, P868, DOI 10.1021/tx060011r; SIPINEN V, 2010, MUTAGENESIS; Sorahan T, 1997, BRIT J CANCER, V76, P1525, DOI 10.1038/bjc.1997.589; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Suter L, 1997, CYTOMETRY, V27, P161, DOI 10.1002/(SICI)1097-0320(19970201)27:2<161::AID-CYTO8>3.0.CO;2-J; VERHOFSTAD N, 2009, ENV MOL MUTAGEN; VOGEL F, 1975, ADV HUM GENET, V5, P223; Walter CA, 2004, DNA REPAIR, V3, P495, DOI 10.1016/j.dnarep.2004.01.005; Xu GG, 2005, BIOL REPROD, V73, P123, DOI 10.1095/biolreprod.104.039123; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105; Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279; Yoon JH, 2004, CANCER RES, V64, P7321, DOI 10.1158/0008-5472.CAN-04-1094; Yoon JH, 2001, CANCER RES, V61, P7110; Zenzes MT, 1999, FERTIL STERIL, V72, P330, DOI 10.1016/S0015-0282(99)00230-7; Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125; Zini A, 2008, HUM REPROD, V23, P2663, DOI 10.1093/humrep/den321; Zitzmann M, 2003, FERTIL STERIL, V79, P1550, DOI 10.1016/S0015-0282(03)00339-X	61	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11349	10.1371/journal.pone.0011349	http://dx.doi.org/10.1371/journal.pone.0011349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596530	Green Published, Green Submitted, gold			2022-12-25	WOS:000279259900020
J	Chan, TC; Hsiao, CK; Lee, CC; Chiang, PH; Kao, CL; Liu, CM; King, CC				Chan, Ta-Chien; Hsiao, Chuhsing Kate; Lee, Chang-Chun; Chiang, Po-Huang; Kao, Chuan-Liang; Liu, Chung-Ming; King, Chwan-Chuen			The Impact of Matching Vaccine Strains and Post-SARS Public Health Efforts on Reducing Influenza-Associated Mortality among the Elderly	PLOS ONE			English	Article							SURVEILLANCE SURVEILLANCE DATA; ACUTE RESPIRATORY SYNDROME; HEMAGGLUTINATION-INHIBITION; B VIRUS; EPIDEMIC	Public health administrators do not have effective models to predict excess influenza-associated mortality and monitor viral changes associated with it. This study evaluated the effect of matching/mismatching vaccine strains, type/subtype pattern changes in Taiwan's influenza viruses, and the impact of post-SARS (severe acute respiratory syndrome) public health efforts on excess influenza-associated mortalities among the elderly. A negative binomial model was developed to estimate Taiwan's monthly influenza-associated mortality among the elderly. We calculated three winter and annual excess influenza-associated mortalities [ pneumonia and influenza (P&I), respiratory and circulatory, and all-cause] from the 1999-2000 through the 2006-2007 influenza seasons. Obtaining influenza virus sequences from the months/years in which death from P&I was excessive, we investigated molecular variation in vaccine-mismatched influenza viruses by comparing hemagglutinin 1 (HA1) of the circulating and vaccine strains. We found that the higher the isolation rate of A (H3N2) and vaccine-mismatched influenza viruses, the greater the monthly P&I mortality. However, this significant positive association became negative for higher matching of A (H3N2) and public health efforts with post-SARS effect. Mean excess P&I mortality for winters was significantly higher before 2003 than after that year [mean +/- S.D.: 1.44 +/- 1.35 vs. 0.35 +/- 1.13, p = 0.04]. Further analysis revealed that vaccine-matched circulating influenza A viruses were significantly associated with lower excess P&I mortality during post-SARS winters (i.e., 2005-2007) than during pre-SARS winters [0.0360.06 vs. 1.5761.27, p = 0.01]. Stratification of these vaccine-matching and post-SARS effect showed substantial trends toward lower elderly excess P&I mortalities in winters with either mismatching vaccines during the post-SARS period or matching vaccines during the pre-SARS period. Importantly, all three excess mortalities were at their highest in May, 2003, when inter-hospital nosocomial infections were peaking. Furthermore, vaccine-mismatched H3N2 viruses circulating in the years with high excess P&I mortality exhibited both a lower amino acid identity percentage of HA1 between vaccine and circulating strains and a higher numbers of variations at epitope B. Our model can help future decision makers to estimate excess P&I mortality effectively, select and test virus strains for antigenic variation, and evaluate public health strategy effectiveness.	[Chan, Ta-Chien; Hsiao, Chuhsing Kate; Lee, Chang-Chun; Kao, Chuan-Liang; King, Chwan-Chuen] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan; [Chan, Ta-Chien; Chiang, Po-Huang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Hlth Policy Res, Zhunan, Taiwan; [Hsiao, Chuhsing Kate; King, Chwan-Chuen] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Kao, Chuan-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Liu, Chung-Ming] Natl Taiwan Univ, Global Change Res Ctr, Taipei 10764, Taiwan; [Liu, Chung-Ming] Natl Taiwan Univ, Coll Sci, Dept Atmospher Sci, Taipei 10764, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Chan, TC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan.	chwanchuen@gmail.com	Chan, Ta-Chien/C-8992-2012; Chiang, Po-Huang/E-3996-2010	King, Chwan-Chuen/0000-0002-6078-2601; KAO, CHUAN-LIANG/0000-0002-1020-2605; hsiao, chuhsing kate/0000-0003-4905-8484	Taiwan's National Health Research Institute [98A1-PHSP09-018]; Taiwan-Centers for Disease Control [DOH95-DC-1021]; National Institutes of Health in the United States; Emory University [2U19AI05726606, HHSN266200700006C]	Taiwan's National Health Research Institute; Taiwan-Centers for Disease Control; National Institutes of Health in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University	This research was supported by four grants: #98A1-PHSP09-018 from Taiwan's National Health Research Institute, #DOH95-DC-1021 from Taiwan-Centers for Disease Control, and financial support from the National Institutes of Health in the United States and collaboration with Dr. Rafi Ahmed, Dr. C.L. Yang, and Dr. R. Compans at Emory University (grant #2U19AI05726606 and grant #HHSN266200700006C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Casella G., 2002, STAT INFERENCE, V2nd; Chambers TM, 2009, EQUINE VET J, V41, P87, DOI 10.2746/042516408X371937; Chen JM, 2007, ARCH VIROL, V152, P415, DOI 10.1007/s00705-006-0852-6; Chen JZ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-30; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chu DC, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-228; *CTR DIS CONTR, LAB VIR SURV REP; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hai R, 2008, J VIROL, V82, P10580, DOI 10.1128/JVI.01213-08; Hsieh Yu-Chia, 2005, Journal of Microbiology Immunology and Infection, V38, P238; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004; LONDI T, 2008, TAIWAN TODAY; Lu TH, 2007, HEALTH POLICY, V83, P375, DOI 10.1016/j.healthpol.2007.03.001; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; Pan K, 2009, VACCINE, V27, P5033, DOI 10.1016/j.vaccine.2009.05.068; Pechirra P, 2005, J MED VIROL, V77, P541, DOI 10.1002/jmv.20490; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shaw K, 2006, PUBLIC HEALTH, V120, P8, DOI 10.1016/j.puhe.2005.10.002; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; *TAIW CDC, 2008, PROGR STAND ANT ANT; *TAIW CDC, 2010, INFL EXPR TAIW WEEK; Tan XD, 2004, HEALTH EDUC RES, V19, P576, DOI 10.1093/her/cyg074; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tsai HP, 2006, J CLIN MICROBIOL, V44, P2705, DOI 10.1128/JCM.02694-05; *US BUR CENS, 2000, IT DAT BAS IDB; Wahl A, 2009, J VIROL, V83, P9206, DOI 10.1128/JVI.00932-09; Wang CS, 2007, VACCINE, V25, P1196, DOI 10.1016/j.vaccine.2006.10.015; *WHO, WHO REC INFL VACC CO; *WIK, 2009, 2009 FLU PAND COUNTR; Wong TW, 2005, AM J INFECT CONTROL, V33, P580, DOI 10.1016/j.ajic.2005.05.025; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Wung Cathy H Y, 2008, World Hosp Health Serv, V44, P14; Wung CH, 2008, WORLD HOSP HLTH SERV, V44, P18; Yen MY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007962	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11317	10.1371/journal.pone.0011317	http://dx.doi.org/10.1371/journal.pone.0011317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615NA	20592764	Green Submitted, gold, Green Published			2022-12-25	WOS:000279140800017
J	Piron, F; Nicolai, M; Minoia, S; Piednoir, E; Moretti, A; Salgues, A; Zamir, D; Caranta, C; Bendahmane, A				Piron, Florence; Nicolai, Maryse; Minoia, Silvia; Piednoir, Elodie; Moretti, Andre; Salgues, Aurelie; Zamir, Dani; Caranta, Carole; Bendahmane, Abdelhafid			An Induced Mutation in Tomato eIF4E Leads to Immunity to Two Potyviruses	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTORS; INDUCED POINT MUTATIONS; REVERSE GENETICS TOOL; VENOUS-MOTTLE-VIRUS; ARABIDOPSIS-THALIANA; IN-SILICO; RECESSIVE RESISTANCE; FUNCTIONAL GENOMICS; MOLECULAR-BIOLOGY; FRUIT-DEVELOPMENT	Background: The characterization of natural recessive resistance genes and Arabidopsis virus-resistant mutants have implicated translation initiation factors of the eIF4E and eIF4G families as susceptibility factors required for virus infection and resistance function. Methodology/Principal Findings: To investigate further the role of translation initiation factors in virus resistance we set up a TILLING platform in tomato, cloned genes encoding for translation initiation factors eIF4E and eIF4G and screened for induced mutations that lead to virus resistance. A splicing mutant of the eukaryotic translation initiation factor, S.l_eIF4E1 G1485A, was identified and characterized with respect to cap binding activity and resistance spectrum. Molecular analysis of the transcript of the mutant form showed that both the second and the third exons were miss-spliced, leading to a truncated mRNA. The resulting truncated eIF4E1 protein is also impaired in cap-binding activity. The mutant line had no growth defect, likely because of functional redundancy with others eIF4E isoforms. When infected with different potyviruses, the mutant line was immune to two strains of Potato virus and Pepper mottle virus and susceptible to Tobacco each virus. Conclusions/Significance: Mutation analysis of translation initiation factors shows that translation initiation factors of the eIF4E family are determinants of plant susceptibility to RNA viruses and viruses have adopted strategies to use different isoforms. This work also demonstrates the effectiveness of TILLING as a reverse genetics tool to improve crop species. We have also developed a complete tool that can be used for both forward and reverse genetics in tomato, for both basic science and crop improvement. By opening it to the community, we hope to fulfill the and scientists who are using tomato as their model of study.	[Piron, Florence; Minoia, Silvia; Piednoir, Elodie; Bendahmane, Abdelhafid] Uni EVRY, CNRS, INRA, UMR,Unite Rech Genom Vegetale, Evry, France; [Nicolai, Maryse; Moretti, Andre; Salgues, Aurelie; Caranta, Carole] INRA, UR1052, Unite Genet & Ameliorat Fruits & Legumes, F-84143 Montfavet, France; [Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, Inst Plant Sci, IL-76100 Rehovot, Israel	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Hebrew University of Jerusalem	Piron, F (corresponding author), Uni EVRY, CNRS, INRA, UMR,Unite Rech Genom Vegetale, Evry, France.	bendahm@evry.inra.fr		Bendahmane, Abdelhafid/0000-0003-3246-868X; Piron Prunier, Florence/0000-0003-2652-5123	GENOPLANTE [GENOTILL 097-098, TRANSVIR GNP05003G]; EU-SOL; INRA	GENOPLANTE; EU-SOL; INRA	This work was supported by GENOPLANTE (GENOTILL 097-098 and TRANSVIR GNP05003G), EU-SOL and INRA Transfert. F.P., M.N. and E.P. were supported by fellowships from the same projects. The M82 TILLING platform was developed within the frame of the European EUSOL Integrated Project. The M82 TILLING platform is open to the scientific communities worldwide for collaborations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Albar L, 2006, PLANT J, V47, P417, DOI 10.1111/j.1365-313X.2006.02792.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bentley A, 2000, GENETICS, V156, P1169; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Caranta C, 1996, THEOR APPL GENET, V92, P15, DOI 10.1007/BF00222946; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Comai L, 2006, PLANT J, V45, P684, DOI 10.1111/j.1365-313X.2006.02670.x; Combe JP, 2005, PLANT MOL BIOL, V57, P749, DOI 10.1007/s11103-005-3098-x; D'Agostino N, 2007, NUCLEIC ACIDS RES, V35, pD901, DOI 10.1093/nar/gkl921; Dalmais M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r43; Doganlar S, 2002, GENOME, V45, P1189, DOI 10.1139/G02-091; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Fei ZJ, 2004, PLANT J, V40, P47, DOI 10.1111/j.1365-313X.2004.02188.x; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Greene EA, 2003, GENETICS, V164, P731; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Hwang J, 2009, MOL CELLS, V27, P329, DOI 10.1007/s10059-009-0042-y; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Maule AJ, 2007, MOL PLANT PATHOL, V8, P223, DOI 10.1111/J.1364-3703.2007.00386.X; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; Moury B, 2004, MOL PLANT MICROBE IN, V17, P322, DOI 10.1094/MPMI.2004.17.3.322; Nicaise V, 2007, FEBS LETT, V581, P1041, DOI 10.1016/j.febslet.2007.02.007; OHYAMA A, 1995, PLANT CELL PHYSIOL, V36, P369, DOI 10.1093/oxfordjournals.pcp.a078769; Parrella G, 2002, THEOR APPL GENET, V105, P855, DOI 10.1007/s00122-002-1005-2; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Perry JA, 2003, PLANT PHYSIOL, V131, P866, DOI 10.1104/pp.102.017384; Revers F, 1999, MOL PLANT MICROBE IN, V12, P367, DOI 10.1094/MPMI.1999.12.5.367; Rigola D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004761; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; ROBINSON NL, 1988, PLANT PHYSIOL, V87, P727, DOI 10.1104/pp.87.3.727; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruffel S, 2005, MOL GENET GENOMICS, V274, P346, DOI 10.1007/s00438-005-0003-x; Ruffel S, 2004, GENE, V338, P209, DOI 10.1016/j.gene.2004.05.010; Ruffel S, 2006, J GEN VIROL, V87, P2089, DOI 10.1099/vir.0.81817-0; Sambrook J., 2002, MOL CLONING LAB MANU; Schaad MC, 2000, VIROLOGY, V273, P300, DOI 10.1006/viro.2000.0416; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Stack SM, 2009, CYTOGENET GENOME RES, V124, P339, DOI 10.1159/000218137; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; VANCE VB, 1992, VIROLOGY, V191, P19, DOI 10.1016/0042-6822(92)90162-I; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Yeam I, 2007, PLANT CELL, V19, P2913, DOI 10.1105/tpc.107.050997	63	155	168	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11313	10.1371/journal.pone.0011313	http://dx.doi.org/10.1371/journal.pone.0011313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593023	gold, Green Published			2022-12-25	WOS:000279140800014
J	Almeida, OP; Alfonso, H; Hankey, GJ; Flicker, L				Almeida, Osvaldo P.; Alfonso, Helman; Hankey, Graeme J.; Flicker, Leon			Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MAJOR DEPRESSION; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; WESTERN-AUSTRALIA; EXCESS MORTALITY; RATE-VARIABILITY; OLDER PERSONS; RISK; COMMUNITY	Context: Depression is associated with increased mortality, but it is unclear if this relationship is dose-dependent and if it can be modified by treatment with antidepressants. Objective: To determine if (1) the association between depression and mortality is independent of other common potential causes of death in later life, (2) there is a dose-response relationship between increasing severity of depression and mortality rates, and (3) the use of antidepressant drugs reduces mortality rates. Methods: Cohort study of 5,276 community-dwelling men aged 68-88 years living in Perth, Australia. We used the Geriatric Depression Scale 15-items (GDS-15) to ascertain the presence and severity of depression. GDS-15 >= 7 indicates the presence of clinically significant depression. Men were also grouped according to the severity of symptoms: "no symptoms'' (GDS-15=0), "questionable'' (1 <= GDS-15 <= 4), "mild to moderate'' (5 <= GDS-15 <= 9), and "severe'' (GDS-15 >= 10). Participants listed all medications used regularly. We used the Western Australian Data Linkage System to monitor mortality. Results: There were 883 deaths between the study assessment and the 30th June 2008 (mean follow-up of participants: 6.0 +/- 1.1 years). The adjusted mortality hazard (MH) of men with clinically significant depression was 1.98 (95%CI = 1.61-2.43), and increased with the severity of symptoms: 1.39 (95%CI = 1.13-1.71) for questionable, 2.71 (95%CI = 2.13-3.46) for mild/moderate, and 3.32 (95%CI: 2.31-4.78) for severe depression. The use of antidepressants increased MH (HR = 1.31, 95%CI = 1.02-1.68). Compared with men who were not depressed and were not taking antidepressants, MH increased from 1.22 (95%CI = 0.91-1.63) for men with no depression who were using antidepressants to 1.85 (95%CI = 1.47-2.32) for participants who were depressed but were not using antidepressants, and 2.97 (95%CI = 1.94-4.54) for those who were depressed and were using antidepressants. All analyses were adjusted for age, educational attainment, migrant status, physical activity, smoking and alcohol use and the Charlson comorbidity index. Conclusions: The mortality associated with depression increases with the severity of depressive symptoms and is largely independent of comorbid conditions. The use of antidepressants does not reduce the mortality rates of older men with persistent symptoms of depression.	[Almeida, Osvaldo P.; Alfonso, Helman; Flicker, Leon] Univ Western Australia, Western Australia Ctr Hlth & Ageing, Med Res Ctr, Perth, WA 6009, Australia; [Almeida, Osvaldo P.; Alfonso, Helman] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia; [Hankey, Graeme J.] Royal Perth Hosp, Stroke Unit, Perth, WA, Australia; [Hankey, Graeme J.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA, Australia	University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia	Almeida, OP (corresponding author), Univ Western Australia, Western Australia Ctr Hlth & Ageing, Med Res Ctr, Perth, WA 6009, Australia.	osvaldo.almeida@uwa.edu.au	Almeida, Osvaldo P./A-4925-2008; Flicker, Leon/A-9039-2008; Hankey, Graeme J/H-4968-2014; Flicker, Leon/AAE-1530-2022	Almeida, Osvaldo P./0000-0002-8689-6199; Hankey, Graeme J/0000-0002-6044-7328; Flicker, Leon/0000-0002-3650-0475	National Health and Medical Research Council of Australia [279408, 379600, 403963, 513823, 634492]; MBF Foundation of Australia [DS 080608]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MBF Foundation of Australia	The conduct of this project was supported by competitive unrestricted project grants from the National Health and Medical Research Council of Australia (grant numbers: 279408, 379600, 403963, 513823 and 634492), and from the MBF Foundation of Australia (grant number DS 080608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2004, W AUSTR STAT IND 136; Adamson JA, 2005, J AM GERIATR SOC, V53, P1128, DOI 10.1111/j.1532-5415.2005.53355.x; Ahto M, 2007, INT J GERIATR PSYCH, V22, P757, DOI 10.1002/gps.1735; Almeida OP, 2005, J AFFECT DISORDERS, V86, P317, DOI 10.1016/j.jad.2005.02.014; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Almeida OP, 2007, AM J GERIAT PSYCHIAT, V15, P506, DOI 10.1097/01.JGP.0000246869.49892.77; Andersohn F, 2009, AM J PSYCHIAT, V166, P591, DOI 10.1176/appi.ajp.2008.08071065; Baldessarini RJ, 2007, HARVARD REV PSYCHIAT, V15, P133, DOI 10.1080/10673220701551102; Ben-Ezra M, 2006, J AM GERIATR SOC, V54, P906, DOI 10.1111/j.1532-5415.2006.00741.x; BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164; Blazer DG, 2004, J AM GERIATR SOC, V52, P2052, DOI 10.1111/j.1532-5415.2004.52564.x; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; BRANDES LJ, 1992, CANCER RES, V52, P3796; Carney RM, 2005, ARCH INTERN MED, V165, P1486, DOI 10.1001/archinte.165.13.1486; Carney RM, 2009, AM J PSYCHIAT, V166, P410, DOI 10.1176/appi.ajp.2008.08081239; Cassidy K, 2004, AUST NZ J PSYCHIAT, V38, P940, DOI 10.1080/j.1440-1614.2004.01485.x; Chahine LM, 2010, HARVARD REV PSYCHIAT, V18, P158, DOI 10.3109/10673221003747690; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cox LS, 2004, J GEN INTERN MED, V19, P828, DOI 10.1111/j.1525-1497.2004.30423.x; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Dalton SO, 2000, EPIDEMIOLOGY, V11, P171, DOI 10.1097/00001648-200003000-00015; Dalton SO, 2008, EPIDEMIOLOGY, V19, P546, DOI 10.1097/EDE.0b013e318176bf98; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Ensinck KTJL, 2002, AM J EPIDEMIOL, V156, P1043, DOI 10.1093/aje/kwf148; Freedman L, 1999, EPIDEMIOLOGY, V10, P54, DOI 10.1097/00001648-199901000-00010; Gallo JJ, 2007, ANN INTERN MED, V146, P689, DOI 10.7326/0003-4819-146-10-200705150-00002; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Glassman AH, 2007, ARCH GEN PSYCHIAT, V64, P1025, DOI 10.1001/archpsyc.64.9.1025; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Katon W, 2005, ARCH INTERN MED, V165, P2497, DOI 10.1001/archinte.165.21.2497; Kerse N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002423; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Maraldi C, 2007, ARCH INTERN MED, V167, P1137, DOI 10.1001/archinte.167.11.1137; Mehta KM, 2003, J GERONTOL A-BIOL, V58, P461; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Penninx BWJH, 1999, ARCH GEN PSYCHIAT, V56, P889, DOI 10.1001/archpsyc.56.10.889; Pfaff JJ, 2009, MED J AUSTRALIA, V190, pS75, DOI 10.5694/j.1326-5377.2009.tb02475.x; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Pulska T, 1997, INT J GERIATR PSYCH, V12, P942, DOI 10.1002/(SICI)1099-1166(199709)12:9<942::AID-GPS668>3.0.CO;2-Z; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ryan J, 2008, BRIT J PSYCHIAT, V192, P12, DOI 10.1192/bjp.bp.107.039164; Schoevers RA, 2009, INT J GERIATR PSYCH, V24, P169, DOI 10.1002/gps.2088; Schoevers RA, 2000, BRIT J PSYCHIAT, V177, P336, DOI 10.1192/bjp.177.4.336; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Surtees PG, 2008, NEUROLOGY, V70, P788, DOI 10.1212/01.wnl.0000304109.18563.81; Surtees PG, 2008, AM J PSYCHIAT, V165, P515, DOI 10.1176/appi.ajp.2007.07061018; Takeshita J, 2002, AM J PSYCHIAT, V159, P1127, DOI 10.1176/appi.ajp.159.7.1127; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303; Tiemeier H, 2005, J CLIN EPIDEMIOL, V58, P1134, DOI 10.1016/j.jclinepi.2005.07.001; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van den Brink CL, 2005, AM J PUBLIC HEALTH, V95, P2029, DOI 10.2105/AJPH.2004.050914; Whang W, 2009, J AM COLL CARDIOL, V53, P950, DOI 10.1016/j.jacc.2008.10.060; Wilson RS, 2003, AM J EPIDEMIOL, V158, P827, DOI 10.1093/aje/kwg224; World Health Organisation, 2005, FRUIT VEG HLTH JOINT; Wulsin LR, 2005, PSYCHOSOM MED, V67, P697, DOI 10.1097/01.psy.0000181274.56785.28; Xu WN, 2006, LANCET ONCOL, V7, P301, DOI 10.1016/S1470-2045(06)70622-2; Zheng DY, 1997, ANN EPIDEMIOL, V7, P213, DOI 10.1016/S1047-2797(97)00014-8	62	61	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11266	10.1371/journal.pone.0011266	http://dx.doi.org/10.1371/journal.pone.0011266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615KY	20585644	Green Submitted, Green Published, gold			2022-12-25	WOS:000279135400012
J	Beckers, GJL; Gahr, M				Beckers, Gabriel J. L.; Gahr, Manfred			Neural Processing of Short-Term Recurrence in Songbird Vocal Communication	PLOS ONE			English	Article							STIMULUS-SPECIFIC ADAPTATION; LOCAL-FIELD POTENTIALS; MALE ZEBRA FINCHES; AUDITORY-CORTEX; NATURAL SOUNDS; FUNCTIONAL-ORGANIZATION; CAUDAL TELENCEPHALON; MISMATCH NEGATIVITY; TAENOPYGIA-GUTTATA; RECEPTIVE-FIELDS	Background: Many situations involving animal communication are dominated by recurring, stereotyped signals. How do receivers optimally distinguish between frequently recurring signals and novel ones? Cortical auditory systems are known to be pre-attentively sensitive to short-term delivery statistics of artificial stimuli, but it is unknown if this phenomenon extends to the level of behaviorally relevant delivery patterns, such as those used during communication. Methodology/Principal Findings: We recorded and analyzed complete auditory scenes of spontaneously communicating zebra finch (Taeniopygia guttata) pairs over a week-long period, and show that they can produce tens of thousands of short-range contact calls per day. Individual calls recur at time scales (median interval 1.5 s) matching those at which mammalian sensory systems are sensitive to recent stimulus history. Next, we presented to anesthetized birds sequences of frequently recurring calls interspersed with rare ones, and recorded, in parallel, action and local field potential responses in the medio-caudal auditory forebrain at 32 unique sites. Variation in call recurrence rate over natural ranges leads to widespread and significant modulation in strength of neural responses. Such modulation is highly call-specific in secondary auditory areas, but not in the main thalamo-recipient, primary auditory area. Conclusions/Significance: Our results support the hypothesis that pre-attentive neural sensitivity to short-term stimulus recurrence is involved in the analysis of auditory scenes at the level of delivery patterns of meaningful sounds. This may enable birds to efficiently and automatically distinguish frequently recurring vocalizations from other events in their auditory scene.	[Beckers, Gabriel J. L.; Gahr, Manfred] Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany	Max Planck Society	Beckers, GJL (corresponding author), Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany.	beckers@orn.mpg.de			Max Planck Society	Max Planck Society(Max Planck Society)	The study was financed by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., 1982, LOCAL CORTICAL CIRCU; Alted F., 2002, PYTABLES HIERARCHICA; Amin N, 2007, J NEUROPHYSIOL, V97, P3517, DOI 10.1152/jn.01066.2006; BAAYEN R, 2008, J MEM LANG, V59, P412; BARLOW H, 1961, SENS COMMUN, P182; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Boersma P., 1993, P I PHONETIC SCI, V17, P97; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Boumans T, 2007, EUR J NEUROSCI, V26, P2613, DOI 10.1111/j.1460-9568.2007.05865.x; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Cohen L., 1995, TIME FREQUENCY ANAL; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; Cousillas H, 2005, HEARING RES, V207, P10, DOI 10.1016/j.heares.2005.01.008; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; FORTUNE ES, 1992, J COMP NEUROL, V325, P388, DOI 10.1002/cne.903250306; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gardner TJ, 2006, P NATL ACAD SCI USA, V103, P6094, DOI 10.1073/pnas.0601707103; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Gehr DD, 1999, NEUROREPORT, V10, P375, DOI 10.1097/00001756-199902050-00030; Gill P, 2008, J NEUROPHYSIOL, V99, P2809, DOI 10.1152/jn.01270.2007; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jones E., 2001, SCIPY OPEN SOURCE SC; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lewicki MS, 1996, J NEUROSCI, V16, P6987; Malone BJ, 2001, J NEUROPHYSIOL, V86, P1113, DOI 10.1152/jn.2001.86.3.1113; Marler Peter, 2004, P132, DOI 10.1016/B978-012473070-0/50008-6; May P, 1999, J COMPUT NEUROSCI, V6, P99, DOI 10.1023/A:1008896417606; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Nagel KI, 2008, NEURON, V58, P938, DOI 10.1016/j.neuron.2008.04.028; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; R Development Core Team, 2009, R FDN STAT COMP; RIBLER R, 1996, NASA C PUBL, V3321, P3; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; SQUIRES KC, 1976, SCIENCE, V193, P1142, DOI 10.1126/science.959831; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Venables W., 2013, MODERN APPL STAT S, V53, P86; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; WILD JM, 1993, J COMP NEUROL, V337, P32; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; ZANN R, 1996, ZEBRA FINCH	55	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11129	10.1371/journal.pone.0011129	http://dx.doi.org/10.1371/journal.pone.0011129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567499	Green Submitted, Green Published, gold			2022-12-25	WOS:000278886300002
J	Drechsel, DA; Patel, M				Drechsel, Derek A.; Patel, Manisha			Respiration-dependent H2O2 Removal in Brain Mitochondria via the Thioredoxin/Peroxiredoxin System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE PRODUCTION; OXIDATIVE STRESS; MAMMALIAN PEROXIREDOXIN; PARKINSONS-DISEASE; THIOREDOXIN; EXPRESSION; CATALASE; NEURODEGENERATION; GLUTATHIONE; INHIBITION	Mitochondrial reactive oxygen species (ROS) play an important role in both physiological cell signaling processes and numerous pathological states, including neurodegenerative disorders such as Parkinson disease. While mitochondria are considered the major cellular source of ROS, their role in ROS removal remains largely unknown. Using polarographic methods for real-time detection of steady-state H2O2 levels, we were able to quantitatively measure the contributions of potential systems toward H2O2 removal by brain mitochondria. Isolated rat brain mitochondria showed significant rates of exogenous H2O2 removal (9-12 nmol/min/mg of protein) in the presence of substrates, indicating a respiration-dependent process. Glutathione systems showed only minimal contributions: 25% decrease with glutathione reductase inhibition and no effect by glutathione peroxidase inhibition. In contrast, inhibitors of thioredoxin reductase, including auranofin and 1-chloro-2,4-dini-trobenzene, attenuated H2O2 removal rates in mitochondria by 80%. Furthermore, a 50% decrease in H2O2 removal was observed following oxidation of peroxiredoxin. Differential oxidation of glutathione or thioredoxin proteins by copper (II) or arsenite, respectively, provided further support for the thioredoxin/peroxiredoxin system as the major contributor to mitochondrial H2O2 removal. Inhibition of the thioredoxin system exacerbated mitochondrial H2O2 production by the redox cycling agent, paraquat. Additionally, decreases in H2O2 removal were observed in intact dopaminergic neurons with thioredoxin reductase inhibition, implicating this mechanism in whole cell systems. Therefore, in addition to their recognized role in ROS production, mitochondria also remove ROS. These findings implicate respiration- and thioredoxin-dependent ROS removal as a potentially important mitochondrial function that may contribute to physiological and pathological processes in the brain.	[Drechsel, Derek A.; Patel, Manisha] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Patel, M (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Res Bldg 2,12700 E 19th Ave,Mailstop C238-P15,POB, Aurora, CO 80045 USA.	manisha.patel@ucdenver.edu			National Institutes of Health [RO1NS04748, RO1NS039587]; NINDS [1F31NS061438]; American Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039587, R01NS045748, F31NS061438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS04748 and RO1NS039587 (to M. P.) and 1F31NS061438 (to D. A. D.) from NINDS. This work was also supported by an American Foundation for Pharmaceutical Education pre-doctoral fellowship (to D. A. D.).	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Boveris A, 2000, IUBMB LIFE, V50, P245, DOI 10.1080/15216540051080912; Brown KK, 2008, FREE RADICAL BIO MED, V45, P494, DOI 10.1016/j.freeradbiomed.2008.04.030; Castello PR, 2008, J PHARMACOL EXP THER, V324, P970, DOI 10.1124/jpet.107.132134; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chae HZ, 1999, METHOD ENZYMOL, V300, P219; Chinta SJ, 2009, FREE RADICAL BIO MED, V46, P939, DOI 10.1016/j.freeradbiomed.2009.01.010; Drechsel DA, 2009, METHOD ENZYMOL, V456, P381, DOI 10.1016/S0076-6879(08)04421-2; Gitler C, 2002, BIOCHEM BIOPH RES CO, V290, P624, DOI 10.1006/bbrc.2001.6214; GUIDOT DM, 1995, J CLIN INVEST, V96, P1131, DOI 10.1172/JCI118100; Halliwell B, 2004, CURR MED CHEM, V11, P1085, DOI 10.2174/0929867043365404; Hansen JM, 2006, FREE RADICAL BIO MED, V40, P138, DOI 10.1016/j.freeradbiomed.2005.09.023; HERTZMAN C, 1990, AM J IND MED, V17, P349, DOI 10.1002/ajim.4700170307; Hill KE, 1997, BIOCHEM BIOPH RES CO, V234, P293, DOI 10.1006/bbrc.1997.6618; Hinerfeld D, 2004, J NEUROCHEM, V88, P657, DOI 10.1046/j.1471-4159.2003.02195.x; JENSEN PK, 1966, BIOCHIM BIOPHYS ACTA, V122, P167, DOI 10.1016/0926-6593(66)90058-0; Jurado J, 2003, J BIOL CHEM, V278, P45546, DOI 10.1074/jbc.M307866200; Kim SH, 2001, J NEURAL TRANSM-SUPP, P223; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; PRASAD KN, 1994, IN VITRO CELL DEV-AN, V30A, P596; RADI R, 1991, J BIOL CHEM, V266, P22028; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Rogers Kara E., 2005, Proceedings of the American Association for Cancer Research Annual Meeting, V46, P454; Rybnikova E, 2000, EUR J NEUROSCI, V12, P1669, DOI 10.1046/j.1460-9568.2000.00059.x; Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200; Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; SINET PM, 1980, J NEUROCHEM, V34, P1421, DOI 10.1111/j.1471-4159.1980.tb11222.x; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Watson WH, 2008, BIOCHEM BIOPH RES CO, V368, P832, DOI 10.1016/j.bbrc.2008.02.006; Wendel A, 1981, Methods Enzymol, V77, P325; Zoccarato F, 2004, J BIOL CHEM, V279, P4166, DOI 10.1074/jbc.M308143200	46	147	154	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27850	27858		10.1074/jbc.M110.101196	http://dx.doi.org/10.1074/jbc.M110.101196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20558743	Green Published, hybrid			2022-12-25	WOS:000281404100040
J	Pierroz, DD; Bonnet, N; Baldock, PA; Ominsky, MS; Stolina, M; Kostenuik, PJ; Ferrari, SL				Pierroz, Dominique D.; Bonnet, Nicolas; Baldock, Paul A.; Ominsky, Michael S.; Stolina, Marina; Kostenuik, Paul J.; Ferrari, Serge L.			Are Osteoclasts Needed for the Bone Anabolic Response to Parathyroid Hormone? A STUDY OF INTERMITTENT PARATHYROID HORMONE WITH DENOSUMAB OR ALENDRONATE IN KNOCK-IN MICE EXPRESSING HUMANIZED RANKL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTMENOPAUSAL WOMEN; CORTICAL POROSITY; OSTEOPROTEGERIN; TERIPARATIDE; OSTEOPOROSIS; DENSITY; RESORPTION; INCREASES; TURNOVER; RECEPTOR	PTH stimulates osteoblastic cells to form new bone and to produce osteoblast-osteoclast coupling factors such as RANKL. Whether osteoclasts or their activity are needed for PTH anabolism remains uncertain. We treated ovariectomized huRANKL knock-in mice with a human RANKL inhibitor denosumab (DMAb), alendronate (Aln), or vehicle for 4 weeks, followed by co-treatment with intermittent PTH for 4 weeks. Loss of bone mass and microarchitecture was prevented by Aln and further significantly improved by DMAb. PTH improved bone mass, microstructure, and strength, and was additive to Aln but not to DMAb. Aln inhibited biochemical and histomorphometrical indices of bone turnover, -i.e. osteocalcin and bone formation rate (BFR) on cancellous bone surfaces-, and Dmab inhibited them further. However Aln increased whereas Dmab suppressed osteoclast number and surfaces. PTH significantly increased osteocalcin and bone formation indices, in the absence or presence of either antiresorptive, although BFR remained lower in presence of Dmab. To further evaluate PTH effects in the complete absence of osteoclasts, high dose PTH was administered to RANK(-/-) mice. PTH increased osteocalcin similarly in RANK(-/-) and WT mice. It also increased BMD in RANK(-/-) mice, although less than in WT. These results further indicate that osteoclasts are not strictly required for PTH anabolism, which presumably still occurs via stimulation of modeling-based bone formation. However the magnitude of PTH anabolic effects on the skeleton, in particular its additive effects with antiresorptives, depends on the extent of the remodeling space, as determined by the number and activity of osteoclasts on bone surfaces.	[Ferrari, Serge L.] Univ Hosp Geneva, HUGs, Dept Rehabil & Geriatr, Serv Bone Dis, CH-1211 Geneva 14, Switzerland; [Pierroz, Dominique D.; Bonnet, Nicolas; Ferrari, Serge L.] Fac Med, CH-1211 Geneva 14, Switzerland; [Baldock, Paul A.] St Vincents Hosp, Garvan Inst Med Res, Bone & Mineral Program, Sydney, NSW 2010, Australia; [Ominsky, Michael S.; Stolina, Marina; Kostenuik, Paul J.] Amgen Inc, Metab Disorders Res, Thousand Oaks, CA 91320 USA	University of Geneva; University of Geneva; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Amgen	Ferrari, SL (corresponding author), Univ Hosp Geneva, HUGs, Dept Rehabil & Geriatr, Serv Bone Dis, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	Serge.Ferrari@unige.ch	Ferrari, Serge/ABD-2730-2020; Baldock, Paul/B-3840-2012	Ferrari, Serge/0000-0002-1372-4417; Bonnet, Nicolas/0000-0001-9832-5767	Amgen Inc.	Amgen Inc.(Amgen)	This work was supported by Amgen Inc.	Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI [10.1359/jbmr.080324, 10.1359/JBMR.080324]; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; Brown JP, 2009, J BONE MINER RES, V24, P153, DOI [10.1359/JBMR.0809010, 10.1359/jbmr.080901]; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chavassieux P, 2008, J BONE MINER RES, V23, P1076, DOI 10.1359/JBMR.080231; Cosman F, 2008, CALCIFIED TISSUE INT, V82, pS59; Cosman F, 2005, NEW ENGL J MED, V353, P566, DOI 10.1056/NEJMoa050157; Cosman F, 2008, CURR OPIN ENDOCRINOL, V15, P495, DOI 10.1097/MED.0b013e32831a46d6; Dempster DW, 1999, J CLIN ENDOCR METAB, V84, P1562, DOI 10.1210/jc.84.5.1562; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Erben RG, 1996, ANAT REC, V246, P39, DOI 10.1002/(SICI)1097-0185(199609)246:1<39::AID-AR5>3.0.CO;2-A; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Finkelstein JS, 2006, J CLIN ENDOCR METAB, V91, P2882, DOI 10.1210/jc.2006-0190; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Fox J, 2007, BONE, V41, P321, DOI 10.1016/j.bone.2007.04.197; Girotra M, 2006, REV ENDOCR METAB DIS, V7, P113, DOI 10.1007/s11154-006-9007-z; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; HODSMAN AB, 1993, BONE, V14, P523, DOI 10.1016/8756-3282(93)90190-L; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Johnston S, 2007, ENDOCRINOLOGY, V148, P4466, DOI 10.1210/en.2007-0229; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Kostenuik PJ, 2005, CURR OPIN PHARMACOL, V5, P618, DOI 10.1016/j.coph.2005.06.005; Kostenuik PJ, 2001, ENDOCRINOLOGY, V142, P4295, DOI 10.1210/en.142.10.4295; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Lindsay R, 2006, J BONE MINER RES, V21, P366, DOI 10.1359/JBMR.051109; Ma YFL, 2006, J BONE MINER RES, V21, P855, DOI 10.1359/JBMR.060314; Martin TJ, 2006, ANN NY ACAD SCI, V1068, P458, DOI 10.1196/annals.1346.043; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; Ominsky MS, 2007, J BONE MINER RES, V22, pS88; Ominsky MS, 2008, J BONE MINER RES, V23, pS61; Ominsky MS, 2009, J BONE MINER RES, V24, P1234, DOI [10.1359/JBMR.090215, 10.1359/jbmr.090215]; Pierroz DD, 2009, J BONE MINER RES, V24, P775, DOI [10.1359/JBMR.081237, 10.1359/jbmr.081237]; Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C; Samadfam R, 2007, ENDOCRINOLOGY, V148, P2778, DOI 10.1210/en.2006-1475; Samadfam R, 2007, J BONE MINER RES, V22, P55, DOI 10.1359/JBMR.060915; Sato M, 2004, J BONE MINER RES, V19, P623, DOI 10.1359/JBMR.040112; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Takahashi H., 1964, H FORD HOSP MED B, V12, P359; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	47	71	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28164	28173		10.1074/jbc.M110.101964	http://dx.doi.org/10.1074/jbc.M110.101964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20558734	Green Published, hybrid			2022-12-25	WOS:000281404100059
J	Schwarzer, S; Nobles, M; Tinker, A				Schwarzer, Sarah; Nobles, Muriel; Tinker, Andrew			Do Caveolae Have a Role in the Fidelity and Dynamics of Receptor Activation of G-protein-gated Inwardly Rectifying Potassium Channels?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; RAT ATRIAL MYOCYTES; GIRK CHANNELS; K+-CHANNEL; MUSCARINIC RECEPTOR; DESENSITIZATION; IDENTIFICATION; EXPRESSION; MEMBRANE; AGONIST	In atrial and nodal cardiac myocytes, M2 muscarinic receptors activate inhibitory G-proteins (G(i/o)), which in turn stimulate G-protein-gated inwardly rectifying K+ channels through direct binding of the G beta gamma subunit. Despite also releasing G beta gamma, G(s)-coupled receptors such as the beta-adrenergic receptor are not able to prominently activate this current. An appealing hypothesis would be if components were sequestered in membrane domains such as caveolae/rafts. Using biochemical fractionation followed by Western blotting and/or radioligand binding experiments, we examined the distribution of the components in stable HEK293 and HL-1 cells, which natively express the transduction cascade. The channel, M2 muscarinic, and A1 adenosine receptors were located in noncaveolar/nonraft fractions. G(i)alpha(1/2) was enriched in both caveolar/raft and noncaveolar/nonraft fractions. In contrast, G(s)alpha was only enriched in caveolar/raft fractions. We constructed YFP-tagged caveolin-2 (YFP-Cav2) and chimeras with the M2 (M2-YFP-Cav2) and A1 (A1-YFP-Cav2) receptors. Analysis of gradient fractions showed that these receptor chimeras were now localized to caveolae-enriched fractions. Microscopy showed that M2-YFP and A1-YFP had a diffuse homogenous membrane signal. YFP-Cav2, M2-YFP-Cav2, and A1-YFP-Cav2 revealed a more punctuate pattern. Finally, we looked at the consequences for signaling. Activation via M2-YFP-Cav2 or A1-YFP-Cav2 revealed substantially slower kinetics compared with M2-YFP or A1-YFP and was reversed by the addition of methyl-beta-cyclodextrin. Thus the localization of the channel signal transduction cascade in non-cholesterol rich domains substantially enhances the speed of signaling. The presence of G(s)alpha solely in caveolae may account for signaling selectivity between G(i/o) and G(s)-coupled receptors.	[Schwarzer, Sarah; Nobles, Muriel; Tinker, Andrew] UCL, BHF Labs, Dept Med, Rayne Inst, London WC1E 6JJ, England	University of London; King's College London; University College London	Tinker, A (corresponding author), UCL, BHF Labs, Dept Med, Rayne Inst, 5 Univ St, London WC1E 6JJ, England.	a.tinker@ucl.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Bender K, 2004, J PHYSIOL-LONDON, V561, P471, DOI 10.1113/jphysiol.2004.072462; Benians A, 2005, J BIOL CHEM, V280, P13383, DOI 10.1074/jbc.M410163200; Benians A, 2003, J BIOL CHEM, V278, P10851, DOI 10.1074/jbc.M212299200; Benians A, 2003, P NATL ACAD SCI USA, V100, P6239, DOI 10.1073/pnas.1037595100; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chen CY, 2006, B MATH BIOL, V68, P863, DOI 10.1007/s11538-005-9058-4; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; Delling M, 2002, J NEUROSCI, V22, P7154; Drici MD, 2000, BRIT J PHARMACOL, V131, P569, DOI 10.1038/sj.bjp.0703611; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Fialka I, 1997, ELECTROPHORESIS, V18, P2582, DOI 10.1002/elps.1150181414; Fleischmann BK, 2004, J CLIN INVEST, V114, P994, DOI 10.1172/JCI200415925; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kuzhikandathil EV, 2000, J GEN PHYSIOL, V115, P697, DOI 10.1085/jgp.115.6.697; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leaney JL, 2004, AM J PHYSIOL-CELL PH, V287, pC182, DOI 10.1152/ajpcell.00540.2003; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Mercier I, 2009, LAB INVEST, V89, P614, DOI 10.1038/labinvest.2009.23; Murthy KS, 2000, J BIOL CHEM, V275, P30211, DOI 10.1074/jbc.M002194200; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Nobles M, 2010, PFLUG ARCH EUR J PHY, V460, P99, DOI 10.1007/s00424-010-0799-z; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rimoldi V, 2003, ONCOGENE, V22, P6054, DOI 10.1038/sj.onc.1206612; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Roseberry AG, 1999, J BIOL CHEM, V274, P33671, DOI 10.1074/jbc.274.47.33671; Rusinova R, 2007, J BIOL CHEM, V282, P34019, DOI 10.1074/jbc.M704928200; Sadja R, 2003, NEURON, V39, P9, DOI 10.1016/S0896-6273(03)00402-1; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Sodickson DL, 1996, J NEUROSCI, V16, P6374; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Wellner-Kienitz MC, 2001, J BIOL CHEM, V276, P37347, DOI 10.1074/jbc.M106234200; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Yamada M, 1998, PHARMACOL REV, V50, P723; Yamanushi TT, 2007, AM J PHYSIOL-HEART C, V292, pH1737, DOI 10.1152/ajpheart.01287.2005; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151	56	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27817	27826		10.1074/jbc.M110.103598	http://dx.doi.org/10.1074/jbc.M110.103598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20562107	Green Published, hybrid			2022-12-25	WOS:000281404100037
J	Snow, JW; Kim, J; Currie, CR; Xu, JA; Orkin, SH				Snow, Jonathan W.; Kim, Jonghwan; Currie, Caroline R.; Xu, Jian; Orkin, Stuart H.			Sumoylation Regulates Interaction of FOG1 with C-terminal-binding Protein (CTBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ERYTHROID-DIFFERENTIATION; SUMO MODIFICATION; MAMMALIAN-CELLS; FINGER PROTEIN; REPRESSION; HEMATOPOIESIS; ACTIVATION; GENE; LINEAGE	Erythropoietic and megakaryocytic programs are specified from multipotential progenitors by the transcription factor GATA1. FOG1, a GATA1-interaction partner, is critical for GATA1 function in several contexts by bringing multiple complexes into association with GATA1 to facilitate activation or repression of target genes. To further elucidate regulation of these associations by cellular and extracellular cues, we examined FOG1 for post-translational modifications. We found that FOG1 is SUMOylated and phosphorylated in erythroid cells in a differentiation-dependent manner. Removal of the SUMOylation sites in FOG1 does not impair nuclear localization, protein stability, or chromatin occupancy. However, SUMOylation of FOG1 modulates interactions with C-terminal binding protein family members, specifically promoting CTBP1 binding. Phosphorylation of FOG1 modulates SUMOylation and, therefore, indirectly regulates the CTBP interaction. Post-translational modification of FOG1 may contribute to control of co-occupancy by CTBP family members, the NuRD complex, and GATA1 at differentially regulated genes.	[Orkin, Stuart H.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Snow, Jonathan W.; Kim, Jonghwan; Currie, Caroline R.; Orkin, Stuart H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Snow, Jonathan W.; Kim, Jonghwan; Xu, Jian; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kim, Jonghwan; Xu, Jian; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	orkin@bloodgroup.tch.harvard.edu	Kim, Jonghwan/AAR-2815-2021	Kim, Jonghwan/0000-0002-9919-9843	National Institutes of Health [HL32259]; Leukemia and Lymphoma Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL32259 (to S. H. O.).; Supported in part by a Leukemia and Lymphoma Society Fellowship.	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chretien S, 1996, EMBO J, V15, P4174, DOI 10.1002/j.1460-2075.1996.tb00792.x; Chun TH, 2003, CIRC RES, V92, P1201, DOI 10.1161/01.RES.0000076893.70898.36; Collavin L, 2004, P NATL ACAD SCI USA, V101, P8870, DOI 10.1073/pnas.0308605101; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; Fernandez-Lloris R, 2006, FEBS LETT, V580, P1215, DOI 10.1016/j.febslet.2006.01.031; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Garriga-Canut M, 2004, J BIOL CHEM, V279, P23597, DOI 10.1074/jbc.M313987200; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Huang H, 2009, MOL CELL BIOL, V29, P4103, DOI 10.1128/MCB.00090-09; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; KIM J, 2005, CURR PROTOC MOL BIOL, pCH21; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Lee HY, 2009, MOL CELL, V36, P984, DOI 10.1016/j.molcel.2009.11.005; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; ORKIN SH, 1992, BLOOD, V80, P575; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Seeler JS, 2007, CURR TOP MICROBIOL, V313, P49; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Shyu YC, 2005, MOL CELL BIOL, V25, P10365, DOI 10.1128/MCB.25.23.10365-10378.2005; Siatecka M, 2007, MOL CELL BIOL, V27, P8547, DOI 10.1128/MCB.00589-07; Snow JW, 2009, J BIOL CHEM, V284, P29310, DOI 10.1074/jbc.M109.043497; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; Vyas P, 1999, BLOOD, V93, P2867; Vyas P, 2007, CURR OPIN PEDIATR, V19, P9, DOI 10.1097/MOP.0b013e328013e7b2; WEISS MJ, 1995, EXP HEMATOL, V23, P99; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhao LJ, 2008, ONCOGENE, V27, P5214, DOI 10.1038/onc.2008.162; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	63	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28064	28075		10.1074/jbc.M109.096909	http://dx.doi.org/10.1074/jbc.M109.096909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20587419	Green Published, hybrid			2022-12-25	WOS:000288742300005
J	Liss, AS; Tiwari, R; Kralova, J; Bose, HR				Liss, A. S.; Tiwari, R.; Kralova, J.; Bose, H. R., Jr.			Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappa B oncogenesis	ONCOGENE			English	Article						v-Rel; Rel/NF-kappa B; oncogenesis; AP-1; Ras; MAPK	DNA-BINDING; C-JUN; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTORS; TRANSDUCTION PATHWAY; HUMAN CANCER; ATF-2; PHOSPHORYLATION; EXPRESSION; KINASE	Cell transformation by the v-rel oncogene is mediated by the aberrant expression of genes that are normally tightly regulated by other Rel/NF-kappa B family members. Although a number of genes inappropriately activated or suppressed by v-Rel have been identified, their contributions to the v-Rel transformation process have been poorly characterized. Here, we examine the role of individual AP-1 proteins in v-Rel-mediated transformation. v-Rel-transformed cells exhibit elevated RNA and protein expression of c-Fos, c-Jun and ATF2 and sustained repression of Fra-2. c-Fos and c-Jun are essential in both the initiation and maintenance of v-Rel-mediated transformation, whereas Fra-2 is dispensable. By employing a c-Jun dimerization mutant, we further identified Fos/Jun heterodimers as major contributors to the v-Rel transformation process. The inability of c-Rel to induce the expression of c-Fos and c-Jun contributes to its weaker oncogenic potential relative to v-Rel. Our studies also demonstrate that v-Rel may induce AP-1 members by directly upregulating gene expression (c-fos and ATF2) and by activating pathways that stimulate AP-1 activity. Although elevated expression of ATF2 is also required for v-Rel-mediated transformation, its ectopic overexpression is inhibitory. Investigating the mode of ATF2 regulation revealed a positive feedback mechanism whereby ATF2 induces p38 MAPK phosphorylation to further induce its own activity. In addition, these studies identified Ha-Ras as an effector of v-Rel-mediated transformation and reveal a novel role for ATF2 in the inhibition of the Ras-Raf-MEK-ERK signaling pathway. Overall, these studies reveal distinct and complex roles of AP-1 proteins in Rel/NF-kappa B oncogenesis. Oncogene (2010) 29, 4925-4937; doi: 10.1038/onc.2010.239; published online 21 June 2010	[Liss, A. S.; Tiwari, R.; Kralova, J.; Bose, H. R., Jr.] Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bose, HR (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, 1 Univ Stn A5000, Austin, TX 78712 USA.	bose@mail.utexas.edu	Liss, Andrew/L-9696-2019; Kralova, Jarmila/G-3834-2014	Kralova, Jarmila/0000-0002-4735-8857	National Cancer Institute [CA33192, CA098151]; NATIONAL CANCER INSTITUTE [R01CA033192, R01CA098151] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ashley Sims for her technical assistance and Marc Castellazzi for providing the Coll and Jun2 luciferase reporter vectors. This study was supported by Public Health Service Grants CA33192 and CA098151 from the National Cancer Institute.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chin M, 2009, ONCOGENE, V28, P2100, DOI 10.1038/onc.2009.74; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; DYER RB, 1995, BIOTECHNIQUES, V19, P192; Ewert D, 1999, ACTA VIROL, V43, P133; Fujii Masahiro, 1997, Leukemia (Basingstoke), V11, P402; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; HOWE LR, 1993, ONCOGENE, V8, P2583; HRDLICKOVA R, 1994, J VIROL, V68, P308; Hrdlickova R, 2001, MOL CELL BIOL, V21, P6369; Kalaitzidis D, 2002, ONCOGENE, V21, P8759, DOI 10.1038/sj.onc.1206033; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kralova J, 1998, MOL CELL BIOL, V18, P2997, DOI 10.1128/MCB.18.5.2997; Lewis JS, 2005, ONCOL RES, V15, P113, DOI 10.3727/096504005776367924; Liss AS, 2002, J VIROL, V76, P4928, DOI 10.1128/JVI.76.10.4928-4939.2002; LISS AS, 2008, ENCY VIROLOGY, P412; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Majid SM, 2006, ONCOGENE, V25, P756, DOI 10.1038/sj.onc.1209107; Mathas S, 2005, BLOOD, V106, P4287, DOI 10.1182/blood-2004-09-3620; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Nehyba J, 1997, ONCOGENE, V14, P2881, DOI 10.1038/sj.onc.1201150; Rassidakis GZ, 2005, MODERN PATHOL, V18, P1365, DOI 10.1038/modpathol.3800419; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ricote M, 2006, J PATHOL, V208, P401, DOI 10.1002/path.1910; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; STEPHENS RM, 1983, P NATL ACAD SCI-BIOL, V80, P6229, DOI 10.1073/pnas.80.20.6229; Sun HY, 2000, CURR BIOL, V10, P281, DOI 10.1016/S0960-9822(00)00359-6; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Zoumpourlis V, 2000, ONCOGENE, V19, P4011, DOI 10.1038/sj.onc.1203732	46	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	35					4925	4937		10.1038/onc.2010.239	http://dx.doi.org/10.1038/onc.2010.239			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	646XP	20562914	Green Accepted			2022-12-25	WOS:000281578700007
J	Xiong, J; Du, Q; Liang, Z				Xiong, J.; Du, Q.; Liang, Z.			Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein	ONCOGENE			English	Article						microRNA; c-Myc binding protein; MYCBP; miR-22; cancer; cell growth	CELL-PROLIFERATION; AMY-1; IDENTIFICATION; EXPRESSION; REPRESSION; S-AKAP84; SUBUNIT; NETWORK; COMPLEX; KINASE	Oncogenic c-Myc has been described to modulate the expression of a subset of microRNAs (miRNAs), which include miR-22; however, the mechanism through which a miRNA controls c-Myc activity remains unclear. Here we report a novel anti-c-Myc function mediated by miR-22. Ectopically expressed miR-22 inhibited cell proliferation and anchorage-independent growth of human cancer cell lines. Microarray screening and western analyses revealed that miR-22 repressed the c-Myc-binding protein MYCBP, a positive regulator of c-Myc. Consistent with this, reporter assays showed that miR-22-mediated MYCBP gene suppression largely depends on the conserved miR-22 target site within the MYCBP 3'-untranslational region (3'UTR), implying that MYCBP mRNA is a direct miR-22 target. Depletion of MYCBP using small interfering RNA (siRNA) recapitulated the miR-22-induced anti-growth effect on tumor cells, whereas ectopically expressed MYCBP rescued cells from the growth suppression mediated by miR-22. Moreover, repression of MYCBP by miR-22 downregulated a panel of E-box-containing c-Myc target genes. Our results suggest that miR-22 acts as a tumor suppressor through direct repression of MYCBP expression and subsequent reduction of oncogenic c-Myc activities. As c-Myc inhibits the expression of miR-22, we propose a novel positive feedback loop formed by oncogenic c-Myc to accelerate cell proliferation by suppressing miR-22, a potent inhibitor of MYCBP. Oncogene (2010) 29, 4980-4988; doi: 10.1038/onc.2010.241; published online 21 June 2010	[Liang, Z.] Peking Univ, Inst Mol Med, Lab Nucle Acid Technol, Beijing 100871, Peoples R China	Peking University	Liang, Z (corresponding author), Peking Univ, Inst Mol Med, Lab Nucle Acid Technol, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.	liangz@pku.edu.cn	Xiong, Jianhua/D-6099-2015; Liang, Zicai/A-2646-2013	Xiong, Jianhua/0000-0002-2740-4027; 	National High-tech R&D Program of China [2007AA02Z165, 2008DFA30770]; National Basic Research Program of China [2007CB512100]; National Natural Science Foundation of China [30873187, 30771085, 30871385]; Department of Education of China [20070001011, 200800010019]	National High-tech R&D Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education of China	We thank Tianjing Cai for excellent technical assistance, and Dr Iain C Bruce for critical reading of the paper. This work was supported by the National High-tech R&D Program of China (2007AA02Z165, 2008DFA30770), the National Basic Research Program of China (2007CB512100), the National Natural Science Foundation of China (30873187, 30771085 and 30871385) and by grants from the Department of Education of China (20070001011 and 200800010019).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Furusawa M, 2002, J BIOL CHEM, V277, P50885, DOI 10.1074/jbc.M206387200; Furusawa M, 2001, J BIOL CHEM, V276, P36647, DOI 10.1074/jbc.M103885200; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lei CX, 2009, HUM REPROD, V24, P2879, DOI 10.1093/humrep/dep250; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Neely LA, 2006, NAT METHODS, V3, P41, DOI 10.1038/NMETH825; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Taira T, 1998, GENES CELLS, V3, P549, DOI 10.1046/j.1365-2443.1998.00206.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yukitake H, 2002, J BIOL CHEM, V277, P45480, DOI 10.1074/jbc.M206201200	37	113	118	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	35					4980	4988		10.1038/onc.2010.241	http://dx.doi.org/10.1038/onc.2010.241			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	646XP	20562918				2022-12-25	WOS:000281578700012
J	Kogai, T; Liu, YY; Richter, LL; Mody, K; Kagechika, H; Brent, GA				Kogai, Takahiko; Liu, Yan-Yun; Richter, Laura L.; Mody, Kaizeen; Kagechika, Hiroyuki; Brent, Gregory A.			Retinoic Acid Induces Expression of the Thyroid Hormone Transporter, Monocarboxylate Transporter 8 (Mct8)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PLASMINOGEN-ACTIVATOR GENE; BREAST-CANCER CELLS; SODIUM/IODIDE SYMPORTER; INDUCED TRANSCRIPTION; RETINOBENZOIC ACIDS; BINDING PROTEINS; RECEPTOR-ALPHA; START SITES; DIFFERENTIATION	Retinoic acid (RA) and thyroid hormone are critical for differentiation and organogenesis in the embryo. Mct8 (monocarboxylate transporter 8), expressed predominantly in the brain and placenta, mediates thyroid hormone uptake from the circulation and is required for normal neural development. RA induces differentiation of F9 mouse teratocarcinoma cells toward neurons as well as extraembryonal endoderm. We hypothesized that Mct8 is functionally expressed in F9 cells and induced by RA. All-trans-RA (tRA) and other RA receptor (RAR) agonists dramatically (>300-fold) induced Mct8. tRA treatment significantly increased uptake of triiodothyronine and thyroxine (4.1- and 4.3-fold, respectively), which was abolished by a selective Mct8 inhibitor, bromosulfophthalein. Sequence inspection of the Mct8 promoter region and 5'-rapid amplification of cDNA ends PCR analysis in F9 cells identified 11 transcription start sites and a proximal Sp1 site but no TATA box. tRA significantly enhanced Mct8 promoter activity through a consensus RA-responsive element located 6.6 kilobases upstream of the coding region. A chromatin immunoprecipitation assay demonstrated binding of RAR and retinoid X receptor to the RA response element. The promotion of thyroid hormone uptake through the transcriptional up-regulation of Mct8 by RAR is likely to be important for extraembryonic endoderm development and neural differentiation. This finding demonstrates cross-talk between RA signaling and thyroid hormone signaling in early development at the level of the thyroid hormone transporter.	[Kogai, Takahiko; Liu, Yan-Yun; Richter, Laura L.; Mody, Kaizeen; Brent, Gregory A.] Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Los Angeles, CA 90073 USA; [Kogai, Takahiko; Liu, Yan-Yun; Richter, Laura L.; Mody, Kaizeen; Brent, Gregory A.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90073 USA; [Kogai, Takahiko; Liu, Yan-Yun; Richter, Laura L.; Mody, Kaizeen; Brent, Gregory A.] Univ Calif Los Angeles, Dept Physiol, David Geffen Sch Med, Los Angeles, CA 90073 USA; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tokyo Medical & Dental University (TMDU)	Kogai, T (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Mol Endocrinol Lab, Bldg 114,Rm 230,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	tkogai@ucla.edu; gbrent@ucla.edu		Kagechika, Hiroyuki/0000-0002-6747-1013	Veterans Affairs; National Institutes of Health [RO1 CA089364]; NATIONAL CANCER INSTITUTE [R01CA089364] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Veterans Affairs Merit Review Funds. This work was also supported by National Institutes of Health Grant RO1 CA089364 (to G. A. B.).	BANKER DE, 1991, MOL CELL BIOL, V11, P5079, DOI 10.1128/MCB.11.10.5079; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; Bulens F, 1997, J BIOL CHEM, V272, P663; Chan SY, 2006, J ENDOCRINOL, V189, P465, DOI 10.1677/joe.1.06582; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Flajollet S, 2006, J BIOL CHEM, V281, P20338, DOI 10.1074/jbc.M603023200; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2001, ENDOCRINOLOGY, V142, P4339, DOI 10.1210/en.142.10.4339; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Friesema ECH, 2006, MOL ENDOCRINOL, V20, P2761, DOI 10.1210/me.2005-0256; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Furlow JD, 2006, TRENDS ENDOCRIN MET, V17, P38, DOI 10.1016/j.tem.2006.01.007; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Hagenbuch B, 2007, BEST PRACT RES CL EN, V21, P209, DOI 10.1016/j.beem.2007.03.004; Hager GL, 2000, J STEROID BIOCHEM, V74, P249, DOI 10.1016/S0960-0760(00)00100-X; Han YH, 2009, J BIOL CHEM, V284, P18503, DOI 10.1074/jbc.M109.007708; Horie S, 2001, J BIOL CHEM, V276, P2440, DOI 10.1074/jbc.M004942200; Jansen J, 2005, THYROID, V15, P757, DOI 10.1089/thy.2005.15.757; Johansson S, 1997, ANAT EMBRYOL, V195, P483, DOI 10.1007/s004290050067; KAGECHIKA H, 1989, J MED CHEM, V32, P834, DOI 10.1021/jm00124a016; KAGECHIKA H, 1988, J MED CHEM, V31, P2182, DOI 10.1021/jm00119a021; Kogai T, 2005, ENDOCRINOLOGY, V146, P3059, DOI 10.1210/en.2004-1334; Kogai T, 2004, CANCER RES, V64, P415, DOI 10.1158/0008-5472.CAN-03-2285; Kogai T, 2008, J CLIN ENDOCR METAB, V93, P1884, DOI 10.1210/jc.2007-1627; Komiya S, 2005, GENES CELLS, V10, P1065, DOI 10.1111/j.1365-2443.2005.00899.x; KRAFT JC, 1994, J CRAN GENET DEV BIO, V14, P75; KUFF EL, 1980, DEV BIOL, V77, P103, DOI 10.1016/0012-1606(80)90459-5; LEE LR, 1994, MOL ENDOCRINOL, V8, P746, DOI 10.1210/me.8.6.746; LEHMANN JM, 1992, MOL CELL BIOL, V12, P2976, DOI 10.1128/MCB.12.7.2976; LIU Y, 1994, MOL CELL ENDOCRINOL, V103, P149; Liu YY, 2002, ENDOCRINOLOGY, V143, P2664, DOI 10.1210/en.143.7.2664; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; MARUYAMA K, 1994, GENE, V138, P171; Merchiers P, 1999, FEBS LETT, V456, P149, DOI 10.1016/S0014-5793(99)00942-4; Santos NC, 2010, ENDOCRINOLOGY, V151, P2361, DOI 10.1210/en.2009-1338; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Sugiura M, 2007, BIOCHEM BIOPH RES CO, V360, P741, DOI 10.1016/j.bbrc.2007.06.109; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Teng S, 2008, MOL PHARMACEUT, V5, P67, DOI 10.1021/mp700102q; van der Deure WM, 2007, BEST PRACT RES CL EN, V21, P339, DOI 10.1016/j.beem.2007.03.006; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wirth EK, 2009, J NEUROSCI, V29, P9439, DOI 10.1523/JNEUROSCI.6055-08.2009; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	51	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27279	27288		10.1074/jbc.M110.123158	http://dx.doi.org/10.1074/jbc.M110.123158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573951	hybrid, Green Published			2022-12-25	WOS:000281172700058
J	Xu, GM; Wang, JA; Wang, LQ; Tian, XY; Yang, HH; Fan, KQ; Yang, KQ; Tan, HR				Xu, Gangming; Wang, Juan; Wang, Linqi; Tian, Xiuyun; Yang, Haihua; Fan, Keqiang; Yang, Keqian; Tan, Huarong			"Pseudo" gamma-Butyrolactone Receptors Respond to Antibiotic Signals to Coordinate Antibiotic Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-COELICOLOR A3(2); COMPLETE GENOME SEQUENCE; VENEZUELAE ISP5230; GENE-CLUSTER; SECONDARY METABOLISM; BINDING-PROTEIN; PATHWAY; REGULATOR; CHLORAMPHENICOL; IDENTIFICATION	In actinomycetes, the onset of secondary metabolite biosynthesis is often triggered by the quorum-sensing signal gamma-butyrolactones (GBLs) via specific binding to their cognate receptors. However, the presence of multiple putative GBL receptor homologues in the genome suggests the existence of an alternative regulatory mechanism. Here, in the model streptomycete Streptomyces coelicolor, ScbR2 (SCO6286, a homologue of GBL receptor) is shown not to bind the endogenous GBL molecule SCB1, hence designated "pseudo" GBL receptor. Intriguingly, it could bind the endogenous antibiotics actinorhodin and undecylprodigiosin as ligands, leading to the derepression of KasO, an activator of a cryptic type I polyketide synthase gene cluster. Likewise, JadR2 is also a putative GBL receptor homologue in Streptomyces venezuelae, the producer of chloramphenicol and cryptic antibiotic jadomycin. It is shown to coordinate their biosynthesis via direct repression of JadR1, which activates jadomycin biosynthesis while repressing chloramphenicol biosynthesis directly. Like ScbR2, JadR2 could also bind these two disparate antibiotics, and the interactions lead to the derepression of jadR1. The antibiotic responding activities of these pseudo GBL receptors were further demonstrated in vivo using the lux reporter system. Overall, these results suggest that pseudo GBL receptors play a novel role to coordinate antibiotic biosynthesis by binding and responding to antibiotics signals. Such an antibiotic-mediated regulatory mechanism could be a general strategy to coordinate antibiotic biosynthesis in the producing bacteria.	[Xu, Gangming; Wang, Juan; Wang, Linqi; Tian, Xiuyun; Yang, Haihua; Fan, Keqiang; Yang, Keqian; Tan, Huarong] Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Yang, KQ (corresponding author), Chinese Acad Sci, State Key Lab Microbial Resources, Inst Microbiol, Beijing 100101, Peoples R China.	yangkq@im.ac.cn; tanhr@im.ac.cn	Wang, Linqi/K-6256-2016; Fan, Keqiang/E-5366-2012	Wang, Linqi/0000-0002-5243-341X; Fan, Keqiang/0000-0003-2420-1889; Tian, Xiuyun/0000-0001-8557-633X; Xu, Gangming/0000-0003-2894-7805	Ministry of Science and Technology of China [2009CB118905]; National Natural Science Foundation of China [31030242, 30870041]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2009CB118905 and National Natural Science Foundation of China Grants 31030242 and 30870041.	Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Bunet R, 2008, J BACTERIOL, V190, P3293, DOI 10.1128/JB.01989-07; Bystrykh LV, 1996, J BACTERIOL, V178, P2238, DOI 10.1128/jb.178.8.2238-2244.1996; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Gray KM, 2001, MICROBIOL-SGM, V147, P2379, DOI 10.1099/00221287-147-8-2379; He J, 2001, MICROBIOL-SGM, V147, P2817, DOI 10.1099/00221287-147-10-2817; Healy FG, 2009, J BACTERIOL, V191, P4786, DOI 10.1128/JB.00437-09; Huang J, 2005, MOL MICROBIOL, V58, P1276, DOI 10.1111/j.1365-2958.2005.04879.x; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jiang H, 2006, RES MICROBIOL, V157, P666, DOI 10.1016/j.resmic.2006.02.004; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kitani S, 2008, GENE, V425, P9, DOI 10.1016/j.gene.2008.07.043; Lazdunski AM, 2004, NAT REV MICROBIOL, V2, P581, DOI 10.1038/nrmicro924; Matsuno K, 2004, ARCH MICROBIOL, V181, P52, DOI 10.1007/s00203-003-0625-5; Mo S, 2008, CHEM BIOL, V15, P137, DOI 10.1016/j.chembiol.2007.11.015; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Nishida H, 2007, ENVIRON MICROBIOL, V9, P1986, DOI 10.1111/j.1462-2920.2007.01314.x; Pan YY, 2009, MOL MICROBIOL, V72, P710, DOI 10.1111/j.1365-2958.2009.06681.x; Pawlik K, 2007, ARCH MICROBIOL, V187, P87, DOI 10.1007/s00203-006-0176-7; Piraee M, 2004, MICROBIOL-SGM, V150, P85, DOI 10.1099/mic.0.26319-0; RAMOS JL, 2005, MICROBIOL MOL BIOL R, V326, P356; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; STRAUCH E, 1991, MOL MICROBIOL, V5, P289, DOI 10.1111/j.1365-2958.1991.tb02109.x; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; Takano E, 2000, J BIOL CHEM, V275, P11010, DOI 10.1074/jbc.275.15.11010; Takano E, 2001, MOL MICROBIOL, V41, P1015, DOI 10.1046/j.1365-2958.2001.02562.x; Takano E, 2005, MOL MICROBIOL, V56, P465, DOI 10.1111/j.1365-2958.2005.04543.x; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Wang SL, 2008, J BACTERIOL, V190, P4061, DOI 10.1128/JB.01954-07; Wohlert SE, 2001, J NAT PROD, V64, P1077, DOI 10.1021/np010067f; YANG KQ, 1995, J BACTERIOL, V177, P6111, DOI 10.1128/jb.177.21.6111-6117.1995; Yang YH, 2005, APPL ENVIRON MICROB, V71, P5050, DOI 10.1128/AEM.71.9.5050-5055.2005; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039	40	99	106	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27440	27448		10.1074/jbc.M110.143081	http://dx.doi.org/10.1074/jbc.M110.143081			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562102	Green Published, hybrid			2022-12-25	WOS:000281172700073
J	Park, KS; Choi, KH; Kim, YS; Hong, BS; Kim, OY; Kim, JH; Yoon, CM; Koh, GY; Kim, YK; Gho, YS				Park, Kyong-Su; Choi, Kyoung-Ho; Kim, You-Sun; Hong, Bok Sil; Kim, Oh Youn; Kim, Ji Hyun; Yoon, Chang Min; Koh, Gou-Young; Kim, Yoon-Keun; Gho, Yong Song			Outer Membrane Vesicles Derived from Escherichia coli Induce Systemic Inflammatory Response Syndrome	PLOS ONE			English	Article							ZEA-MAYS L; NEISSERIA-MENINGITIDIS; PERIPLASMIC PROTEINS; CYTOKINE PRODUCTION; SEVERE SEPSIS; SEPTIC SHOCK; LIPOPOLYSACCHARIDE; ASSOCIATION; BACTERIA; ORGAN	Sepsis, characterized by a systemic inflammatory state that is usually related to Gram-negative bacterial infection, is a leading cause of death worldwide. Although the annual incidence of sepsis is still rising, the exact cause of Gram-negative bacteria-associated sepsis is not clear. Outer membrane vesicles (OMVs), constitutively secreted from Gram-negative bacteria, are nano-sized spherical bilayered proteolipids. Using a mouse model, we showed that intraperitoneal injection of OMVs derived from intestinal Escherichia coli induced lethality. Furthermore, OMVs induced host responses which resemble a clinically relevant condition like sepsis that was characterized by piloerection, eye exudates, hypothermia, tachypnea, leukopenia, disseminated intravascular coagulation, dysfunction of the lungs, hypotension, and systemic induction of tumor necrosis factor-alpha and interleukin-6. Our study revealed a previously unidentified causative microbial signal in the pathogenesis of sepsis, suggesting OMVs as a new therapeutic target to prevent and/or treat severe sepsis caused by Gram-negative bacterial infection.	[Park, Kyong-Su; Kim, You-Sun; Hong, Bok Sil; Kim, Oh Youn; Kim, Ji Hyun; Yoon, Chang Min; Kim, Yoon-Keun; Gho, Yong Song] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea; [Choi, Kyoung-Ho] Catholic Univ Korea, Coll Med, Dept Emergency Med, Seoul, South Korea; [Koh, Gou-Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Korea Advanced Institute of Science & Technology (KAIST)	Park, KS (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea.	juinea@postech.ac.kr; ysgho@postech.ac.kr	Koh, Gou Young/C-1615-2011; Hong, Bok Sil/GYQ-5150-2022	Kyoung ho, Choi/0000-0003-2301-2250; Hong, Bok Sil/0000-0002-2710-7727	Korean Ministry of Education, Science and Technology [FPR08B1-240]	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Korean Ministry of Education, Science and Technology, FPR08B1-240 of the 21C Frontier Functional Proteomics Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; BAKER CC, 1983, SURGERY, V94, P331; Beveridge TJ, 1996, MICROB DRUG RESIST, V2, P1, DOI 10.1089/mdr.1996.2.1; Blackwell TS, 1996, BRIT J ANAESTH, V77, P110, DOI 10.1093/bja/77.1.110; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chelius MK, 2000, APPL ENVIRON MICROB, V66, P783, DOI 10.1128/AEM.66.2.783-787.2000; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; COSTERTON JW, 1974, BACTERIOL REV, V38, P87, DOI 10.1128/MMBR.38.1.87-110.1974; da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665; DINARELLO CA, 1997, CHEST S, V112, P321, DOI DOI 10.1378/CHEST.112.6_SUPPLEMENT.321S; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Kesty NC, 2004, J BIOL CHEM, V279, P2069, DOI 10.1074/jbc.M307628200; Kitchens RL, 2000, CHEM IMMUNOL, V74, P61; Klinzing S, 2000, RES EXP MED, V200, P27; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liang MD, 2005, J INFECT DIS, V191, P939, DOI 10.1086/427815; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Mirlashari MR, 2001, CYTOKINE, V13, P91, DOI 10.1006/cyto.2000.0803; Namork E, 2002, LANCET, V360, P1741, DOI 10.1016/S0140-6736(02)11721-1; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Oftung F, 1999, FEMS IMMUNOL MED MIC, V26, P75, DOI 10.1016/S0928-8244(99)00125-X; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; Rice TW, 2005, ANNU REV MED, V56, P225, DOI 10.1146/annurev.med.56.082103.104356; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Zhang HW, 1997, J IMMUNOL, V159, P4868	45	112	117	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11334	10.1371/journal.pone.0011334	http://dx.doi.org/10.1371/journal.pone.0011334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596524	gold, Green Published, Green Submitted			2022-12-25	WOS:000279259900007
J	Dejean, A; Leroy, C; Corbara, B; Roux, O; Cereghino, R; Orivel, J; Boulay, R				Dejean, Alain; Leroy, Celine; Corbara, Bruno; Roux, Olivier; Cereghino, Regis; Orivel, Jerome; Boulay, Raphael			Arboreal Ants Use the "Velcro (R) Principle'' to Capture Very Large Prey	PLOS ONE			English	Article							AURITA GROUP; FOOD BODIES; DOLICHODERINAE; BLOCHMANNIA; FORMICIDAE; BEHAVIOR; PLANTS	Plant-ants live in a mutualistic association with host plants known as "myrmecophytes'' that provide them with a nesting place and sometimes with extra-floral nectar (EFN) and/or food bodies (FBs); the ants can also attend sap-sucking Hemiptera for their honeydew. In return, plant-ants, like most other arboreal ants, protect their host plants from defoliators. To satisfy their nitrogen requirements, however, some have optimized their ability to capture prey in the restricted environment represented by the crowns of trees by using elaborate hunting techniques. In this study, we investigated the predatory behavior of the ant Azteca andreae which is associated with the myrmecophyte Cecropia obtusa. We noted that up to 8350 ant workers per tree hide side-by-side beneath the leaf margins of their host plant with their mandibles open, waiting for insects to alight. The latter are immediately seized by their extremities, and then spread-eagled; nestmates are recruited to help stretch, carve up and transport prey. This group ambush hunting technique is particularly effective when the underside of the leaves is downy, as is the case for C. obtusa. In this case, the hook-shaped claws of the A. andreae workers and the velvet-like structure of the underside of the leaves combine to act like natural Velcro (R) that is reinforced by the group ambush strategy of the workers, allowing them to capture prey of up to 13,350 times the mean weight of a single worker.	[Dejean, Alain; Leroy, Celine; Roux, Olivier; Orivel, Jerome] CNRS, Ecol Forets Guyane UMR CNRS 8172, Kourou, France; [Corbara, Bruno] Univ Clermont Ferrand, Clermont Univ, Clermont Ferrand, France; [Corbara, Bruno] CNRS, UMR 6023, Lab Microorganismes Genome & Environm, Aubiere, France; [Cereghino, Regis] CNRS, EcoLab, Lab Ecol Fonct, Toulouse, France; [Cereghino, Regis] Univ Toulouse, UPS, INPT, EcoLab, Toulouse, France; [Boulay, Raphael] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Boulay, Raphael] Univ Granada, Fac Ciencias, Dept Biol Anim, Granada, Spain	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Granada	Dejean, A (corresponding author), CNRS, Ecol Forets Guyane UMR CNRS 8172, Campus Agron, Kourou, France.	alain.dejean@wanadoo.fr	Leroy, Celine/I-4857-2016; Roux, Olivier/A-1181-2011; Orivel, Jerome/C-4034-2011; CEREGHINO, Regis/G-9500-2011; Boulay, Raphael/I-3735-2015; Roux, Olivier/I-5675-2016	Leroy, Celine/0000-0003-4859-8040; Orivel, Jerome/0000-0002-5636-3228; Boulay, Raphael/0000-0002-0138-0856; Cereghino, Regis/0000-0003-3981-3159; CORBARA, Bruno/0000-0003-4232-8234; Roux, Olivier/0000-0001-5440-0219; Dejean, Alain/0000-0002-3561-2248	French Centre National de la Recherche Scientifique [2ID]; European Community	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission)	This study was funded by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID) and the Programme Convergence 2007-2013, Region Guyane from the European Community (project DEGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davidson DW, 2005, OECOLOGIA, V142, P221, DOI 10.1007/s00442-004-1722-0; Davidson DW., 2005, FLORA NEOTROPICA MON, P214; de Souza DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-29; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; DEJEAN A, 2009, AZTECA NATURWISSENSC, V96, P57; Dejean A, 2008, BIOL J LINN SOC, V93, P63, DOI 10.1111/j.1095-8312.2007.00927.x; Federle W, 2004, J EXP BIOL, V207, P67, DOI 10.1242/jeb.00716; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Fischer RC, 2002, OECOLOGIA, V133, P186, DOI 10.1007/s00442-002-1000-y; Guerrero RJ, 2010, J HYMENOPT RES, V19, P51; Heil M, 2004, CHEMOECOLOGY, V14, P45, DOI 10.1007/s00049-003-0257-x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Longino JT, 2007, ZOOTAXA, P1; MORAIS HC, 1994, INSECT SOC, V41, P339, DOI 10.1007/BF01242307; MORAIS HC, 1998, AZTECA CF LANUGINOSA; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102; Wojtusiak J, 1995, TROP ZOOL, V8, P309, DOI 10.1080/03946975.1995.10539287	23	31	33	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11331	10.1371/journal.pone.0011331	http://dx.doi.org/10.1371/journal.pone.0011331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593032	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000279140800028
J	Mumcuoglu, M; Bagislar, S; Yuzugullu, H; Alotaibi, H; Senturk, S; Telkoparan, P; Gur-Dedeoglu, B; Cingoz, B; Bozkurt, B; Tazebay, UH; Yulug, IG; Akcali, KC; Ozturk, M				Mumcuoglu, Mine; Bagislar, Sevgi; Yuzugullu, Haluk; Alotaibi, Hani; Senturk, Serif; Telkoparan, Pelin; Gur-Dedeoglu, Bala; Cingoz, Burcu; Bozkurt, Betul; Tazebay, Uygar H.; Yulug, Isik G.; Akcali, K. Can; Ozturk, Mehmet			The Ability to Generate Senescent Progeny as a Mechanism Underlying Breast Cancer Cell Heterogeneity	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; ESTROGEN-RECEPTOR-ALPHA; EXPRESSION; INACTIVATION; P21(WAF1/CIP1); TAMOXIFEN; SUBTYPES; CULTURE; CRISIS; TUMORS	Background: Breast cancer is a remarkably heterogeneous disease. Luminal, basal-like, "normal-like", and ERBB2+ subgroups were identified and were shown to have different prognoses. The mechanisms underlying this heterogeneity are poorly understood. In our study, we explored the role of cellular differentiation and senescence as a potential cause of heterogeneity. Methodology/Principal Findings: A panel of breast cancer cell lines, isogenic clones, and breast tumors were used. Based on their ability to generate senescent progeny under low-density clonogenic conditions, we classified breast cancer cell lines as senescent cell progenitor (SCP) and immortal cell progenitor (ICP) subtypes. All SCP cell lines expressed estrogen receptor (ER). Loss of ER expression combined with the accumulation of p21(Cip1) correlated with senescence in these cell lines. p21(Cip1) knockdown, estrogen-mediated ER activation or ectopic ER overexpression protected cells against senescence. In contrast, tamoxifen triggered a robust senescence response. As ER expression has been linked to luminal differentiation, we compared the differentiation status of SCP and ICP cell lines using stem/progenitor, luminal, and myoepithelial markers. The SCP cells produced CD24+ or ER+ luminal-like and ASMA+ myoepithelial-like progeny, in addition to CD44+ stem/progenitor-like cells. In contrast, ICP cell lines acted as differentiation-defective stem/progenitor cells. Some ICP cell lines generated only CD44+/CD24-/ER-/ASMA-progenitor/stem-like cells, and others also produced CD24+/ER-luminal-like, but not ASMA+ myoepithelial-like cells. Furthermore, gene expression profiles clustered SCP cell lines with luminal A and "normal-like" tumors, and ICP cell lines with luminal B and basal-like tumors. The ICP cells displayed higher tumorigenicity in immunodeficient mice. Conclusions/Significance: Luminal A and "normal-like" breast cancer cell lines were able to generate luminal-like and myoepithelial-like progeny undergoing senescence arrest. In contrast, luminal B/basal-like cell lines acted as stem/progenitor cells with defective differentiation capacities. Our findings suggest that the malignancy of breast tumors is directly correlated with stem/progenitor phenotypes and poor differentiation potential.	[Mumcuoglu, Mine; Bagislar, Sevgi; Yuzugullu, Haluk; Alotaibi, Hani; Senturk, Serif; Telkoparan, Pelin; Gur-Dedeoglu, Bala; Cingoz, Burcu; Tazebay, Uygar H.; Yulug, Isik G.; Akcali, K. Can; Ozturk, Mehmet] Bilkent Univ, BilGen Genet & Biotechnol Ctr, Dept Mol Biol & Genet, Ankara, Turkey; [Bagislar, Sevgi; Yuzugullu, Haluk; Ozturk, Mehmet] Univ Grenoble 1, INSERM, CRI, U823, Grenoble, France; [Bozkurt, Betul] Ankara Numune Res & Teaching Hosp, Dept Surg, Ankara, Turkey	Ihsan Dogramaci Bilkent University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Ankara Numune Training & Research Hospital	Mumcuoglu, M (corresponding author), Bilkent Univ, BilGen Genet & Biotechnol Ctr, Dept Mol Biol & Genet, Ankara, Turkey.	ozturkm@ujf-grenoble.fr	ozturk, mehmet/G-3330-2014; OZTURK, MEHMET/AAS-7241-2021; Dedeoglu, Bala Gur/O-1604-2014; Senturk, Serif/A-1263-2017; Alotaibi, Hani/W-7129-2019; Insal, Burcu/AAD-5924-2020; Alotaibi, Hani/R-3158-2016; Dedeoglu, Bala Gur/ABC-2436-2020	OZTURK, MEHMET/0000-0002-6092-9706; Dedeoglu, Bala Gur/0000-0002-4320-5685; Senturk, Serif/0000-0003-3963-2294; Alotaibi, Hani/0000-0001-7423-9653; Alotaibi, Hani/0000-0001-7423-9653; Dedeoglu, Bala Gur/0000-0002-4320-5685; Yulug, Isik/0000-0002-7577-2502; Insal, Burcu/0000-0003-3354-6424; Bagislar Bremang, Sevgi/0000-0003-3203-9607; Akcali, Kamil/0000-0002-7816-6938; TAZEBAY, UYGAR HALIS/0000-0003-1999-8213; TELKOPARAN-AKILLILAR, Pelin/0000-0003-0337-0763	TUBITAK (The Scientific and Technological Research Council of Turkey); DPT (State Planning Office of Turkey); TUBA (Turkish Academy of Sciences); Institut National de Cancer; INSERM of France	TUBITAK (The Scientific and Technological Research Council of Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); DPT (State Planning Office of Turkey)(Turkiye Cumhuriyeti Kalkinma Bakanligi); TUBA (Turkish Academy of Sciences)(Turkish Academy of Sciences); Institut National de Cancer; INSERM of France	This work was supported by TUBITAK (The Scientific and Technological Research Council of Turkey), DPT (State Planning Office of Turkey) and TUBA (Turkish Academy of Sciences). Additional funding was from Institut National de Cancer and INSERM of France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alotaibi H, 2006, BIOCHEM BIOPH RES CO, V345, P1487, DOI 10.1016/j.bbrc.2006.05.049; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Booth BW, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1538; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DUBIK D, 1992, ONCOGENE, V7, P1587; Early Breast Cancer Trialists' Collaborative Group, 1998, LANCET, V351, P1451; Ford CE, 2009, P NATL ACAD SCI USA, V106, P3919, DOI 10.1073/pnas.0809516106; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Gur-Dedeoglu B, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-396; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Mukherjee S, 2005, J BIOL CHEM, V280, P17617, DOI 10.1074/jbc.M502278200; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Shyamala G, 2006, CANCER RES, V66, P10391, DOI 10.1158/0008-5472.CAN-06-0321; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stampfer MR, 2003, CANCER LETT, V194, P199, DOI 10.1016/S0304-3835(02)00707-3; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Yeh IT, 2008, ARCH PATHOL LAB MED, V132, P349, DOI 10.1043/1543-2165(2008)132[349:AOITBL]2.0.CO;2	34	16	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11288	10.1371/journal.pone.0011288	http://dx.doi.org/10.1371/journal.pone.0011288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585577	Green Published, gold, Green Submitted			2022-12-25	WOS:000279135800003
J	Sayama, K; Kajiya, K; Sugawara, K; Sato, S; Hirakawa, S; Shirakata, Y; Hanakawa, Y; Dai, XJ; Ishimatsu-Tsuji, Y; Metzger, D; Chambon, P; Akira, S; Paus, R; Kishimoto, J; Hashimoto, K				Sayama, Koji; Kajiya, Kentaro; Sugawara, Koji; Sato, Shintaro; Hirakawa, Satoshi; Shirakata, Yuji; Hanakawa, Yasushi; Dai, Xiuju; Ishimatsu-Tsuji, Yumiko; Metzger, Daniel; Chambon, Pierre; Akira, Shizuo; Paus, Ralf; Kishimoto, Jiro; Hashimoto, Koji			Inflammatory Mediator TAK1 Regulates Hair Follicle Morphogenesis and Anagen Induction Shown by Using Keratinocyte-Specific TAK1-Deficient Mice	PLOS ONE			English	Article							B SIGNALING PATHWAYS; KAPPA-B; ECTODERMAL DYSPLASIA; INCONTINENTIA PIGMENTI; COMPREHENSIVE GUIDE; ECTODYSPLASIN-A; EDA GENE; PROTEIN; SKIN; EPIDERMIS	Transforming growth factor-beta-activated kinase 1 (TAK1) is a member of the NF-kappa B pathway and regulates inflammatory responses. We previously showed that TAK1 also regulates keratinocyte growth, differentiation, and apoptosis. However, it is unknown whether TAK1 has any role in epithelial-mesenchymal interactions. To examine this possibility, we studied the role of TAK1 in mouse hair follicle development and cycling as an instructive model system. By comparing keratinocyte-specific TAK1-deficient mice (Map3k7(fl/fl)K5-Cre) with control mice, we found that the number of hair germs (hair follicles precursors) in Map3k7(fl/fl)K5-Cre mice was significantly reduced at E15.5, and that subsequent hair follicle morphogenesis was retarded. Next, we analyzed the role of TAK1 in the cyclic remodeling in follicles by analyzing hair cycle progression in mice with a tamoxifen-inducible keratinocyte-specific TAK1 deficiency (Map3k7(fl/fl)K14-Cre-ER(T2)). After active hair growth (anagen) was induced by depilation, TAK1 was deleted by topical tamoxifen application. This resulted in significantly retarded anagen development in TAK1-deficient mice. Deletion of TAK1 in hair follicles that were already in anagen induced premature, apoptosis-driven hair follicle regression, along with hair follicle damage. These studies provide the first evidence that the inflammatory mediator TAK1 regulates hair follicle induction and morphogenesis, and is required for anagen induction and anagen maintenance.	[Sayama, Koji; Hirakawa, Satoshi; Shirakata, Yuji; Hanakawa, Yasushi; Dai, Xiuju; Hashimoto, Koji] Ehime Univ, Dept Dermatol, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Kajiya, Kentaro; Ishimatsu-Tsuji, Yumiko; Kishimoto, Jiro] Shiseido Innovat Sci Res & Dev Ctr, Skin Biol Res Grp, Yokohama, Kanagawa, Japan; [Sugawara, Koji; Paus, Ralf] Univ Lubeck, Dept Dermatol, Lubeck, Germany; [Sato, Shintaro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Tokyo, Japan; [Metzger, Daniel; Chambon, Pierre] Coll France, IGBMC, CNRS, INSERM,UdS, Illkirch Graffenstaden, France; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester, Lancs, England	Ehime University; Shiseido Company, Limited; University of Lubeck; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Osaka University; University of Manchester	Sayama, K (corresponding author), Ehime Univ, Dept Dermatol, Grad Sch Med, Matsuyama, Ehime 790, Japan.	sayama@m.ehime-u.ac.jp	Akira, Shizuo/C-3134-2009; KISHIMOTO, JIRO/AAD-7857-2019; Tsuji, Yumiko/AAV-9817-2020; Paus, Ralf/F-6243-2011; Paus, Ralf/B-5279-2015	Sugawara, Koji/0000-0003-1662-3272; Paus, Ralf/0000-0002-3492-9358; Sato, Shintaro/0000-0001-5156-3354; Kajiya, Kentaro/0000-0002-5224-7051; Metzger, Daniel/0000-0002-5555-046X	Ministries of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Deutsche Forschungsgemeinschaft [DFG 345 Pa/12-2]; College de France	Ministries of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); College de France	This study was supported in part by grants from the Ministries of Education, Culture, Sports, Science, and Technology of Japan to K.S. and K.H., by Health and Labor Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labor, and Welfare of Japan to K.H., by the Deutsche Forschungsgemeinschaft (DFG 345 Pa/12-2) to R.P., and by the College de France to P.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Courtney JM, 2005, ARCH ORAL BIOL, V50, P159, DOI 10.1016/j.archoralbio.2004.11.019; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; Fessing MY, 2006, AM J PATHOL, V169, P2075, DOI 10.2353/ajpath.2006.060227; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Hendrix S, 2005, J INVEST DERMATOL, V125, P42, DOI 10.1111/j.0022-202X.2005.23787.x; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Lindner G, 2000, FASEB J, V14, P319, DOI 10.1096/fasebj.14.2.319; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0; Morlon A, 2005, HUM MOL GENET, V14, P3751, DOI 10.1093/hmg/ddi405; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ohnemus U, 2006, ENDOCR REV, V27, P677, DOI 10.1210/er.2006-0020; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 2004, DIFFERENTIATION, V72, P489, DOI 10.1111/j.1432-0436.2004.07209004.x; PAUS R, 1990, BRIT J DERMATOL, V122, P777, DOI 10.1111/j.1365-2133.1990.tb06266.x; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Sakurai H, 2002, BIOCHEM BIOPH RES CO, V297, P1277, DOI 10.1016/S0006-291X(02)02379-3; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Schmidt-Ullrich R, 2006, DEVELOPMENT, V133, P1045, DOI 10.1242/dev.02278; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Stratis A, 2006, J INVEST DERMATOL, V126, P614, DOI 10.1038/sj.jid.5700092; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Zhang N, 2009, J GLOB INF MANAG, V17, P49, DOI 10.4018/jgim.2009010103	45	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11275	10.1371/journal.pone.0011275	http://dx.doi.org/10.1371/journal.pone.0011275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585657	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135400020
J	Van Sluis, GL; Nieuwdorp, M; Kamphuisen, PW; van der Vlag, J; Van Noorden, CJF; Spek, CA				Van Sluis, Geerte L.; Nieuwdorp, Max; Kamphuisen, Pieter W.; van der Vlag, Johan; Van Noorden, Cornelis J. F.; Spek, C. Arnold			A Low Molecular Weight Heparin Inhibits Experimental Metastasis in Mice Independently of the Endothelial Glycocalyx	PLOS ONE			English	Article							BOVINE TESTICULAR HYALURONIDASE; SULFATE PROTEOGLYCAN; CANCER; HEPARANASE; EXPRESSION; SYNDECAN-1; ANGIOGENESIS; CD44; MODE	Background: Some low molecular weight heparins (LMWHs) prolong survival of cancer patients and inhibit experimental metastasis. The underlying mechanisms are still not clear but it has been suggested that LMWHs (at least in part) limit metastasis by preventing cancer cell-induced destruction of the endothelial glycocalyx. Methodology/Principal Findings: To prove or refute this hypothesis, we determined the net effects of the endothelial glycocalyx in cancer cell extravasation and we assessed the anti-metastatic effect of a clinically used LMWH in the presence and absence of an intact endothelial glycocalyx. We show that both exogenous enzymatic degradation as well as endogenous genetic modification of the endothelial glycocalyx decreased pulmonary tumor formation in a murine experimental metastasis model. Moreover, LMWH administration significantly reduced the number of pulmonary tumor foci and thus experimental metastasis both in the presence or absence of an intact endothelial glycocalyx. Conclusions: In summary, this paper shows that the net effect of the endothelial glycocalyx enhances experimental metastasis and that a LMWH does not limit experimental metastasis by a process involving the endothelial glycocalyx.	[Van Sluis, Geerte L.; Nieuwdorp, Max; Kamphuisen, Pieter W.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Van Sluis, Geerte L.; Spek, C. Arnold] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Van Sluis, Geerte L.; Van Noorden, Cornelis J. F.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Van Sluis, Geerte L.] Univ Amsterdam, Acad Med Ctr, Dept Clin Oncol, NL-1105 AZ Amsterdam, Netherlands; [van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen Ctr Mol Life Sci,Nephrol Res Lab, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Van Sluis, GL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.a.spek@amc.uva.nl	Van der Vlag, Johan/E-4636-2010; Spek, Arnold/AAC-5866-2019	Van der Vlag, Johan/0000-0001-7843-5918; Spek, Arnold/0000-0002-2149-4068; Kamphuisen, Pieter/0000-0002-6263-0177				Akl EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006652; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bruggemann LW, 2008, THROMB HAEMOSTASIS, V99, P787, DOI 10.1160/TH07-11-0702; Bruggemann LW, 2008, J CELL MOL MED, V12, P2622, DOI 10.1111/j.1582-4934.2008.00316.x; EARNSHAW JS, 1985, BIOCHEM PHARMACOL, V34, P2199, DOI 10.1016/0006-2952(85)90418-6; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Hostettler N, 2007, FASEB J, V21, P3562, DOI 10.1096/fj.07-8450com; IRIMURA T, 1986, BIOCHEMISTRY-US, V25, P5322, DOI 10.1021/bi00366a050; Kainulainen V, 1996, J BIOL CHEM, V271, P18759, DOI 10.1074/jbc.271.31.18759; Liu DC, 1996, P NATL ACAD SCI USA, V93, P7832, DOI 10.1073/pnas.93.15.7832; Maksimenko AV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P862, DOI 10.1023/A:1025794830705; Maksimenko AV, 2001, EUR J PHARM BIOPHARM, V51, P33, DOI 10.1016/S0939-6411(00)00136-3; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Mousa SA, 2006, THROMB HAEMOSTASIS, V96, P816, DOI 10.1160/TH06-05-0289; Muckenschnabel I, 1998, CANCER LETT, V131, P71, DOI 10.1016/S0304-3835(98)00203-1; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Niers TMH, 2007, CRIT REV ONCOL HEMAT, V61, P195, DOI 10.1016/j.critrevonc.2006.07.007; Niers TMH, 2009, J THROMB HAEMOST, V7, P1595, DOI 10.1111/j.1538-7836.2009.03529.x; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; SLUIS GLV, 2009, BLOOD, V114, P1968; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Vink H, 2000, CIRCULATION, V101, P1500, DOI 10.1161/01.CIR.101.13.1500; VLODAVSKY I, 1994, INVAS METAST, V14, P290; Vlodavsky I, 2007, THROMB RES, V120, pS112, DOI 10.1016/S0049-3848(07)70139-1; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Zeng CX, 1998, INT J CANCER, V77, P396; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811	37	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11200	10.1371/journal.pone.0011200	http://dx.doi.org/10.1371/journal.pone.0011200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574516	gold, Green Published, Green Submitted			2022-12-25	WOS:000279058300006
J	del Rio, B; Seegers, JFML; Gomes-Solecki, M				del Rio, Beatriz; Seegers, Jos F. M. L.; Gomes-Solecki, Maria			Immune Response to Lactobacillus plantarum Expressing Borrelia burgdorferi OspA Is Modulated by the Lipid Modification of the Antigen	PLOS ONE			English	Article							CD8(+) T-CELLS; LACTOCOCCUS-LACTIS; ORAL IMMUNIZATION; MUCOSAL IMMUNIZATION; PROTECTIVE IMMUNITY; ESCHERICHIA-COLI; NEUTRALIZING ANTIBODIES; HELICOBACTER-PYLORI; TREPONEMA-PALLIDUM; ANATOMICAL BASIS	Background: Over the past decade there has been increasing interest in the use of lactic acid bacteria as mucosal delivery vehicles for vaccine antigens, microbicides and therapeutics. We investigated the mechanism by which a mucosal vaccine based in recombinant lactic acid bacteria breaks the immunological tolerance of the gut in order to elicit a protective immune response. Methodology/Principal Findings: We analyzed how the lipid modification of OspA affects the localization of the antigen in our delivery vehicle using a number of biochemistry techniques. Furthermore, we examined how OspA-expressing L. plantarum breaks the oral tolerance of the gut by stimulating human intestinal epithelial cells, peripheral blood mononuclear cells and monocyte derived dendritic cells and measuring cytokine production. We show that the leader peptide of OspA targets the protein to the cell envelope of L. plantarum, and it is responsible for protein export across the membrane. Mutation of the lipidation site in OspA redirects protein localization within the cell envelope. Further, we show that lipidated-OspA-expressing L. plantarum does not induce secretion of the pro-inflammatory cytokine IL-8 by intestinal epithelial cells. In addition, it breaks oral tolerance of the gut via Th1/Th2 cell mediated immunity, as shown by the production of pro-and anti-inflammatory cytokines by human dendritic cells, and by the production of IgG2a and IgG1 antibodies, respectively. Conclusions/Significance: Lipid modification of OspA expressed in L. plantarum modulates the immune response to this antigen through a Th1/Th2 immune response.	[del Rio, Beatriz; Gomes-Solecki, Maria] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; [Seegers, Jos F. M. L.] Lactrys Biopharmaceut BV, Leiden, Netherlands; [Gomes-Solecki, Maria] Biopeptides Corp, Valhalla, NY USA; [Gomes-Solecki, Maria] Biopeptides Corp, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center	del Rio, B (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA.	mgomesso@uthsc.edu	del Rio, beatriz/L-3082-2014	del Rio, beatriz/0000-0001-8107-1975	NIH-NIAID [R44 AI074092, R43 AI072810]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI074092, R43AI072810] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from NIH-NIAID, R44 AI074092 and R43 AI072810 to MGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1996, VACCINE, V14, P1384, DOI 10.1016/S0264-410X(96)00036-9; Ascon MA, 1998, INFECT IMMUN, V66, P5470; Bermudez-Humaran LG, 2005, J IMMUNOL, V175, P7297, DOI 10.4049/jimmunol.175.11.7297; Bermudez-Humaran LG, 2003, FEMS MICROBIOL LETT, V224, P307, DOI 10.1016/S0378-1097(03)00475-0; Cho HJ, 2007, VACCINE, V25, P8049, DOI 10.1016/j.vaccine.2007.09.024; Daniel C, 2009, VACCINE, V27, P1141, DOI 10.1016/j.vaccine.2008.12.022; De BK, 2000, VACCINE, V18, P1811, DOI 10.1016/S0264-410X(99)00481-8; del Rio B, 2008, CLIN VACCINE IMMUNOL, V15, P1429, DOI 10.1128/CVI.00169-08; Dieye Y, 2003, APPL ENVIRON MICROB, V69, P7281, DOI 10.1128/AEM.69.12.7281-7288.2003; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; Gahery-Segard H, 2000, J VIROL, V74, P1694, DOI 10.1128/JVI.74.4.1694-1703.2000; Gomes-Solecki MJC, 2006, VACCINE, V24, P4440, DOI 10.1016/j.vaccine.2005.08.089; Gu Q, 2009, FEMS IMMUNOL MED MIC, V56, P197, DOI 10.1111/j.1574-695X.2009.00566.x; Hamilton-Miller JMT, 2003, INT J ANTIMICROB AG, V22, P360, DOI 10.1016/S0924-8579(03)00153-5; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Kajikawa A, 2007, VACCINE, V25, P3599, DOI 10.1016/j.vaccine.2007.01.055; Khoo UY, 1997, J IMMUNOL, V158, P3626; Kohler JJ, 2000, INFECT IMMUN, V68, P4370, DOI 10.1128/IAI.68.7.4370-4373.2000; Lee JS, 2006, J VIROL, V80, P4079, DOI 10.1128/JVI.80.8.4079-4087.2006; Li YG, 2007, VACCINE, V25, P902, DOI 10.1016/j.vaccine.2006.09.034; LINKAMSTER H, 1994, FEMS IMMUNOL MED MIC, V10, P55, DOI 10.1111/j.1574-695X.1994.tb00011.x; Maassen CBM, 1999, VACCINE, V17, P2117, DOI 10.1016/S0264-410X(99)00010-9; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Medina M, 2008, INFECT IMMUN, V76, P2696, DOI 10.1128/IAI.00119-08; Mestecky J, 2007, J IMMUNOL, V179, P5633, DOI 10.4049/jimmunol.179.9.5633; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Moorthy G, 2007, VACCINE, V25, P3636, DOI 10.1016/j.vaccine.2007.01.070; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; PERDIGON G, 1991, J DAIRY RES, V58, P485, DOI 10.1017/S0022029900030090; Peters C, 2003, J IMMUNOL, V170, P5176, DOI 10.4049/jimmunol.170.10.5176; Pouwels PH, 1996, J BIOTECHNOL, V44, P183, DOI 10.1016/0168-1656(95)00140-9; RADOLF JD, 1988, INFECT IMMUN, V56, P490, DOI 10.1128/IAI.56.2.490-498.1988; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Scavone P, 2007, MICROBES INFECT, V9, P821, DOI 10.1016/j.micinf.2007.02.023; Sellati TJ, 1998, J IMMUNOL, V160, P5455; Shata MT, 2001, VACCINE, V20, P623, DOI 10.1016/S0264-410X(01)00330-9; Sim ACN, 2008, VACCINE, V26, P1145, DOI 10.1016/j.vaccine.2007.12.047; Skjolaas KA, 2007, VET IMMUNOL IMMUNOP, V115, P299, DOI 10.1016/j.vetimm.2006.10.012; Spear GT, 2008, J REPROD IMMUNOL, V78, P76, DOI 10.1016/j.jri.2007.11.001; Venema R, 2003, J BIOL CHEM, V278, P14739, DOI 10.1074/jbc.M209857200; WEIS JJ, 1994, INFECT IMMUN, V62, P4632, DOI 10.1128/IAI.62.10.4632-4636.1994; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Wu CM, 2007, FEMS IMMUNOL MED MIC, V50, P354, DOI 10.1111/j.1574-695X.2007.00255.x; Yigang XU, 2008, IMMUNOLOGY, V124, P68, DOI 10.1111/j.1365-2567.2007.02738.x	49	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11199	10.1371/journal.pone.0011199	http://dx.doi.org/10.1371/journal.pone.0011199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585451	gold, Green Submitted, Green Published			2022-12-25	WOS:000278977200006
J	Valera, E; Isaacs, MJ; Kawakami, Y; Belmonte, JCI; Choe, S				Valera, Elvira; Isaacs, Michael J.; Kawakami, Yasuhiko; Izpisua Belmonte, Juan Carlos; Choe, Senyon			BMP-2/6 Heterodimer Is More Effective than BMP-2 or BMP-6 Homodimers as Inductor of Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; ACTIVITY IN-VITRO; DEFINITIVE ENDODERM; SIGNALING PATHWAYS; OSTEOGENIC DIFFERENTIATION; MESODERM INDUCTION; SELF-RENEWAL; RECEPTOR; BETA; FGF	Background: Bone Morphogenetic Protein (BMP) signaling pathways are involved in differentiation of stem cells into diverse cell types, and thus BMPs can be used as main guidance molecules for in vitro differentiation of human stem cells. Methodology/Principal Findings: We have analyzed the ability for inducing differentiation of the heterodimer BMP-2/BMP-6 (BMP-2/6) compared to the homodimers BMP-2 or BMP-6, using human embryonic stem (hES) cells H9 as model system. When incubated in a medium with high concentration of basic fibroblastic growth factor (FGF2), 100 ng/ml of human recombinant BMPs induced morphological changes and differentiation of hES cells in 24 to 48 hours. After 5 days, expression of differentiation markers was induced and quantified by quantitative PCR (qPCR) and flow cytometry. BMP-2/6 exhibited stronger activity for the induction of the expression of trophectodermal (CDX2) and endodermal (SOX17, GATA4, AFP) markers than BMP-2 or BMP-6 homodimers. BMP-2/6 also induced the expression of BMPR2 gene more effectively than BMP-2 or BMP-6 when used at the same concentration and time. Moreover, the percentage of cells expressing the surface endodermal marker CXCR4 was also increased for the heterodimer when compared to both homodimers. BMP-2/6 was a more potent activator of Smad-dependent (SMAD1/5) and Smad-independent signaling (mitogen-activated protein kinases ERK and p38) than BMP-2 and BMP-6, and the activation of these pathways might play a role in its increased potency for inducing hES cell differentiation. Conclusions/Significance: Therefore, we conclude that BMP-2/6 is more potent than BMP-2 or BMP-6 for inducing differentiation of hES cells, and it can be used as a more powerful substitute of these BMPs in in vitro differentiation guidance.	[Valera, Elvira; Choe, Senyon] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA USA; [Valera, Elvira; Isaacs, Michael J.; Choe, Senyon] Joint Ctr Biosci, Inchon, South Korea; [Kawakami, Yasuhiko; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA USA	Salk Institute; Salk Institute	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA USA.	choe@salk.edu		Kawakami, Yasuhiko/0000-0002-0043-9705	National Institutes of Health [HD013527, HD042167]; CIRM; Korea Stem Cell Research Center; WCU; G. Harold and Leila Y. Mathers Charitable Foundation; Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (Spain); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD013527, R01HD042167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Korea Stem Cell Research Center; WCU; G. Harold and Leila Y. Mathers Charitable Foundation; Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was partly supported by grants from the National Institutes of Health HD013527 (SC) and HD042167 (JCIB), CIRM (SC), Korea Stem Cell Research Center and WCU (SC), and the G. Harold and Leila Y. Mathers Charitable Foundation (JCIB). EV was the recipient of a fellowship from the Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III (Spain) in collaboration with the Salk Institute for Biological Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Aoki H, 2001, J CELL SCI, V114, P1483; Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Czyz J, 2003, BIOL CHEM, V384, P1391, DOI 10.1515/BC.2003.155; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Groppe J, 2003, J BONE JOINT SURG AM, V85A, P52, DOI 10.2106/00004623-200300003-00010; Hassel S, 2003, J BONE JOINT SURG AM, V85A, P44, DOI 10.2106/00004623-200300003-00009; Herpin A, 2007, FEBS J, V274, P2977, DOI 10.1111/j.1742-4658.2007.05840.x; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Isaacs MJ, 2010, MOL ENDOCRINOL, V24, P1469, DOI 10.1210/me.2009-0496; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; King CC, 2008, REGEN MED, V3, P175, DOI 10.2217/17460751.3.2.175; Kobayashi M, 2008, CLONING STEM CELLS, V10, P495, DOI 10.1089/clo.2008.0030; Kugimiya F, 2005, J BIOL CHEM, V280, P35704, DOI 10.1074/jbc.M505166200; LaVaute TM, 2009, STEM CELLS, V27, P1741, DOI 10.1002/stem.99; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Mehta A, 2008, CELL BIOL INT, V32, P1412, DOI 10.1016/j.cellbi.2008.08.012; MIYAZONO K, 1994, ADV IMMUNOL, V55, P181; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murphy CL, 2002, TISSUE ENG, V8, P551, DOI 10.1089/107632702760240472; Nakayama K, 2003, J BONE MINER RES, V18, P827, DOI 10.1359/jbmr.2003.18.5.827; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Nohe A, 2003, J CELL SCI, V116, P3277, DOI 10.1242/jcs.00519; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Rozen S, 2000, Methods Mol Biol, V132, P365; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Wagner TU, 2007, FEBS J, V274, P2968, DOI 10.1111/j.1742-4658.2007.05839.x; Wang L, 2010, ANN BIOMED ENG, V38, P77, DOI 10.1007/s10439-009-9841-8; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zachos TA, 2006, J ORTHOP RES, V24, P1279, DOI 10.1002/jor.20068; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468; Zhou J, 2008, STEM CELLS DEV, V17, P737, DOI 10.1089/scd.2007.0186; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018	58	75	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11167	10.1371/journal.pone.0011167	http://dx.doi.org/10.1371/journal.pone.0011167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567515	Green Published, gold, Green Submitted			2022-12-25	WOS:000278886300013
J	Sambo, MR; Trovoada, MJ; Benchimol, C; Quinhentos, V; Goncalves, L; Velosa, R; Marques, MI; Sepulveda, N; Clark, TG; Mustafa, S; Wagner, O; Coutinho, A; Penha-Goncalves, C				Sambo, Maria Rosario; Trovoada, Maria Jesus; Benchimol, Carla; Quinhentos, Vatusia; Goncalves, Ligia; Velosa, Rute; Marques, Maria Isabel; Sepulveda, Nuno; Clark, Taane G.; Mustafa, Stefan; Wagner, Oswald; Coutinho, Antonio; Penha-Goncalves, Carlos			Transforming Growth Factor Beta 2 and Heme Oxygenase 1 Genes Are Risk Factors for the Cerebral Malaria Syndrome in Angolan Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ENDOTHELIAL-CELL ACTIVATION; N-TERMINAL DOMAIN; CLINICAL-FEATURES; GHANAIAN CHILDREN; TGF-BETA; ASSOCIATION; PROTECTION; INFECTION; PROMOTER	Background: Cerebral malaria (CM) represents a severe outcome of the Plasmodium falciparum infection. Recent genetic studies have correlated human genes with severe malaria susceptibility, but there is little data on genetic variants that increase the risk of developing specific malaria clinical complications. Nevertheless, susceptibility to experimental CM in the mouse has been linked to host genes including Transforming Growth Factor Beta 2 (TGFB2) and Heme oxygenase-1 (HMOX1). Here, we tested whether those genes were governing the risk of progressing to CM in patients with severe malaria syndromes. Methodology/Principal Findings: We report that the clinical outcome of P. falciparum infection in a cohort of Angolan children (n = 430) correlated with nine TGFB2 SNPs that modify the risk of progression to CM as compared to other severe forms of malaria. This genetic effect was explained by two haplotypes harboring the CM-associated SNPs (Pcorrec. = 0.035 and 0.036). In addition, one HMOX1 haplotype composed of five CM-associated SNPs increased the risk of developing the CM syndrome (Pcorrec. = 0.002) and was under-transmitted to children with uncomplicated malaria (P = 0.036). Notably, the HMOX1-associated haplotype conferred increased HMOX1 mRNA expression in peripheral blood cells of CM patients (P = 0.012). Conclusions/Significance: These results represent the first report on CM genetic risk factors in Angolan children and suggest the novel hypothesis that genetic variants of the TGFB2 and HMOX1 genes may contribute to confer a specific risk of developing the CM syndrome in patients with severe P. falciparum malaria. This work may provide motivation for future studies aiming to replicate our findings in larger populations and to confirm a role for these genes in determining the clinical course of malaria.	[Sambo, Maria Rosario; Trovoada, Maria Jesus; Goncalves, Ligia; Velosa, Rute; Marques, Maria Isabel; Sepulveda, Nuno; Coutinho, Antonio; Penha-Goncalves, Carlos] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Sambo, Maria Rosario; Benchimol, Carla; Quinhentos, Vatusia] Hosp Pediat David Bernardino, Luanda, Angola; [Sambo, Maria Rosario] Univ Agostinho Neto, Fac Med, Luanda, Angola; [Clark, Taane G.] London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth, London WC1, England; [Clark, Taane G.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Mustafa, Stefan; Wagner, Oswald] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Instituto Gulbenkian de Ciencia; University Agostinho Neto; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Medical University of Vienna	Sambo, MR (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	cpenha@igc.gulbenkian.pt	Sepulveda, Nuno/AAA-5544-2021; Gonçalves, Lígia Antunes/F-6242-2014; Penha-Goncalves, Carlos/F-4640-2012; Clark, Taane G./AAM-2570-2020; Sepulveda, Nuno/S-9936-2019	Gonçalves, Lígia Antunes/0000-0001-9804-6899; Clark, Taane G./0000-0001-8985-9265; Vieira, Rute/0000-0002-3599-7299; Marques, Maria Isabel/0000-0003-2261-7338; Sepulveda, Nuno/0000-0002-8542-1706; Coutinho, Antonio/0000-0002-0857-9227; Penha-Goncalves, Carlos/0000-0001-7225-1907	Instituto Gulbenkian de Ciencia	Instituto Gulbenkian de Ciencia	This project was supported by the Instituto Gulbenkian de Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Pinto EAE, 2008, TROP DOCT, V38, P66, DOI 10.1258/td.2006.006352; Aucan C, 2003, GENES IMMUN, V4, P275, DOI 10.1038/sj.gene.6363962; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Bauer PR, 2002, MICROCIRCULATION, V9, P463, DOI 10.1038/sj.mn.7800159; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; Bienzle U, 2005, TROP MED INT HEALTH, V10, P668, DOI 10.1111/j.1365-3156.2005.01444.x; Burgner D, 2003, HUM GENET, V112, P379, DOI 10.1007/s00439-002-0882-4; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Cunha-Rodrigues M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-32; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; Deininger MH, 2000, J INFECT DIS, V181, P2111, DOI 10.1086/315493; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; FAUARMENGOL LG, SNPASSOC R PACKAGE P; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fry AE, 2008, GENES IMMUN, V9, P462, DOI 10.1038/gene.2008.38; FRY AE, 2009, HUM MOL GENET, V29, P29; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Gyan BA, 2004, CLIN EXP IMMUNOL, V138, P145, DOI 10.1111/j.1365-2249.2004.02590.x; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Issifou S, 2007, AM J TROP MED HYG, V77, P1015, DOI 10.4269/ajtmh.2007.77.1015; JALLOW M, 2009, NAT GENET, V24, P24; Koch O, 2002, J INFECT DIS, V185, P1684, DOI 10.1086/340516; Kun JFJ, 1999, AM J TROP MED HYG, V61, P776, DOI 10.4269/ajtmh.1999.61.776; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Liu YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004037; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Ndiaye R, 2005, TISSUE ANTIGENS, V65, P474, DOI 10.1111/j.1399-0039.2005.00388.x; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Ohashi J, 2001, JPN J INFECT DIS, V54, P114; Omer FM, 2000, PARASITOL TODAY, V16, P18, DOI 10.1016/S0169-4758(99)01562-8; Omer FM, 1998, J EXP MED, V188, P39, DOI 10.1084/jem.188.1.39; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; Omi Kazuya, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P1; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Snounou G, 1996, Methods Mol Biol, V50, P263; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; STEVENSON MM, 2010, TRENDS PARASITOL, P8; Takeda M, 2005, JPN J INFECT DIS, V58, P268; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Zhao JH, 2002, BIOINFORMATICS, V18, P1694, DOI 10.1093/bioinformatics/18.12.1694	58	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11141	10.1371/journal.pone.0011141	http://dx.doi.org/10.1371/journal.pone.0011141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585394	Green Published, Green Accepted, gold			2022-12-25	WOS:000278886100011
J	Marji, J; O'Donoghue, SI; McClintock, D; Satagopam, VP; Schneider, R; Ratner, D; Worman, HJ; Gordon, LB; Djabali, K				Marji, Jackleen; O'Donoghue, Sean I.; McClintock, Dayle; Satagopam, Venkata P.; Schneider, Reinhard; Ratner, Desiree; Worman, Howard J.; Gordon, Leslie B.; Djabali, Karima			Defective Lamin A-Rb Signaling in Hutchinson-Gilford Progeria Syndrome and Reversal by Farnesyltransferase Inhibition	PLOS ONE			English	Article							RETINOBLASTOMA GENE-PRODUCT; MOUSE MODEL; SYNDROME MUTATION; NUCLEAR LAMINA; PROTEIN; CELLS; MISREGULATION; PRELAMIN; DISEASE; MITOSIS	Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare premature aging disorder caused by a de novo heterozygous point mutation G608G (GGC>GGT) within exon 11 of LMNA gene encoding A-type nuclear lamins. This mutation elicits an internal deletion of 50 amino acids in the carboxyl-terminus of prelamin A. The truncated protein, progerin, retains a farnesylated cysteine at its carboxyl terminus, a modification involved in HGPS pathogenesis. Inhibition of protein farnesylation has been shown to improve abnormal nuclear morphology and phenotype in cellular and animal models of HGPS. We analyzed global gene expression changes in fibroblasts from human subjects with HGPS and found that a lamin A-Rb signaling network is a major defective regulatory axis. Treatment of fibroblasts with a protein farnesyltransferase inhibitor reversed the gene expression defects. Our study identifies Rb as a key factor in HGPS pathogenesis and suggests that its modulation could ameliorate premature aging and possibly complications of physiological aging.	[Marji, Jackleen; McClintock, Dayle; Ratner, Desiree; Djabali, Karima] Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10027 USA; [O'Donoghue, Sean I.; Satagopam, Venkata P.; Schneider, Reinhard] EMBL, Heidelberg, Germany; [Worman, Howard J.] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA; [Worman, Howard J.] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA; [Gordon, Leslie B.] Brown Univ, Dept Pediat, Warren Albert Med Sch, Providence, RI 02912 USA; [Djabali, Karima] Tech Univ Munich, Dept Dermatol, Munich, Germany	Columbia University; European Molecular Biology Laboratory (EMBL); Columbia University; Columbia University; Brown University; Technical University of Munich	Marji, J (corresponding author), Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10027 USA.	kd206@columbia.edu	Luzuriaga, Jennifer/C-9494-2016; Gordon, Leslie B./AAJ-5793-2021; Schneider, Reinhard/C-5441-2009; O'Donoghue, Sean/A-9522-2012	Schneider, Reinhard/0000-0002-8278-1618; Ratner, Desiree/0000-0002-1217-1929; O'Donoghue, Sean/0000-0001-9520-6623; Satagopam, Venkata/0000-0002-6532-5880	National Institutes of Health [R01AG025240, K01AR048594, R01AG025302]; Irving Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR048594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025302, R01AG025240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irving Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Institutes of Health (R01AG025240) to H.J.W., and by the Irving Foundation and the National Institutes of Health (Grants K01AR048594 and R01AG025302) to K.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; CHAUDHARY N, 1993, J CELL BIOL, V122, P295, DOI 10.1083/jcb.122.2.295; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Fong LG, 2009, HUM MOL GENET, V18, P2462, DOI 10.1093/hmg/ddp184; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gilford H, 1904, BRIT MED J, V1904, P914; Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; GORDON LB, 2007, J GERONTOL A-BIOL, V63, P777; Hutchinson J, 1886, LANCET, V1, P923; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; LIN F, 1993, J BIOL CHEM, V268, P16321; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; MANCINI MA, 1994, P NATL ACAD SCI USA, V91, P418, DOI 10.1073/pnas.91.1.418; Markiewicz E, 2005, J CELL SCI, V118, P409, DOI 10.1242/jcs.01630; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; OZAKI T, 1994, ONCOGENE, V9, P2649; Park WY, 2001, BIOCHEM BIOPH RES CO, V282, P934, DOI 10.1006/bbrc.2001.4632; RODRIGUEZ S, 2009, EUROPEAN J HUMAN GEN, V28; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Wang Y, 2008, HUM MOL GENET, V17, P2357, DOI 10.1093/hmg/ddn136; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968	43	48	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11132	10.1371/journal.pone.0011132	http://dx.doi.org/10.1371/journal.pone.0011132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559568	gold, Green Published, Green Submitted			2022-12-25	WOS:000278775900021
J	Brenkman, AB; van den Broek, NJF; de Keizer, PLJ; van Gent, DC; Burgering, BMT				Brenkman, Arjan B.; van den Broek, Niels J. F.; de Keizer, Peter L. J.; van Gent, Dik C.; Burgering, Boudewijn M. T.			The DNA damage repair protein Ku70 interacts with FOXO4 to coordinate a conserved cellular stress response	FASEB JOURNAL			English	Article						oxidative stress; p27(kip1); aging	FORKHEAD TRANSCRIPTION FACTOR; STRAND BREAK REPAIR; LIFE-SPAN; V(D)J RECOMBINATION; CAENORHABDITIS-ELEGANS; TUMOR SUPPRESSORS; OXIDATIVE STRESS; FACTOR AFX; KINASE-B; KU80	In this study, we searched for proteins regulating the tumor suppressor and life-span regulator FOXO4. Through an unbiased tandem-affinity purification strategy combined with mass spectrometry, we identified the heterodimer Ku70/Ku80 (Ku), a DNA double-strand break repair component. Using biochemical interaction studies, we found Ku70 to be necessary and sufficient for the interaction. FOXO4 mediates its tumor-suppressive function in part through transcriptional regulation of the cell cycle arrest p27(kip1) gene. Immunoblotting, luciferase reporter assays, and flow cytometry showed that Ku70 inhibited FOXO4-mediated p27(kip1) transcription and cell cycle arrest induction by >40%. In contrast, Ku70 RNAi but not control RNAi significantly increased p27(kip1) transcription. In addition, in contrast to wild-type mouse embryonic stem (ES) cells, Ku70(-/-) ES cells showed significantly increased FOXO activity, which was rescued by Ku70 reexpression. Immunofluorescence studies demonstrated that Ku70 sequestered FOXO4 in the nucleus. Interestingly, the Ku70-FOXO4 interaction stoichiometry followed a nonlinear dose-response curve by hydrogen peroxide-generated oxidative stress. Low levels of oxidative stress increased interaction stoichiometry up to 75%, peaking at 50 mu M, after which dissociation occurred. Because the Ku70 ortholog in the roundworm Caenorhabditis elegans was shown to regulate life span involving C. elegans FOXO, our findings suggest a conserved critical Ku70 role for FOXO function toward coordination of a survival program, regulated by the magnitude of oxidative damage.-Brenkman, A. B., van den Broek, N. J. F., de Keizer, P. L. J., van Gent, D. C., Burgering, B. M. T. The DNA damage repair protein Ku70 interacts with FOXO4 to coordinate a conserved cellular stress response. FASEB J. 24, 4271-4280 (2010). www.fasebj.org	[Brenkman, Arjan B.; van den Broek, Niels J. F.] Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands; [Brenkman, Arjan B.; van den Broek, Niels J. F.; de Keizer, Peter L. J.; Burgering, Boudewijn M. T.] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 EA Utrecht, Netherlands; [Brenkman, Arjan B.; van den Broek, Niels J. F.; de Keizer, Peter L. J.; Burgering, Boudewijn M. T.] Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 EA Utrecht, Netherlands; [Brenkman, Arjan B.; van den Broek, Niels J. F.] Netherlands Metabol Ctr, Utrecht, Netherlands; [van Gent, Dik C.] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	Brenkman, AB (corresponding author), Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, Lundlaan 6, NL-3584 EA Utrecht, Netherlands.	a.b.brenkman@umcutrecht.nl	de+Keizer, Peter/AAD-5320-2020	de+Keizer, Peter/0000-0002-6948-925X; van Gent, Dik C./0000-0003-1473-8148	European Commission [LSHC-CT-2004-503438]; Netherlands Organization for Scientific Research	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	A.B.B. was supported by the European Commission Transfog Consortium (LSHC-CT-2004-503438). P.L.J.D. was supported by a Netherlands Organization for Scientific Research grant to B.M.T.B. The authors thank Dr. W. W. M. Pijnappel for his help in culturing ES cells, and Dr. R. van Gent, Dr. K. Mulder, and Dr. E. Kalkhoven for their helpful discussion and critical reading of this manuscript. The authors declare no conflicts of interest.	BLIER PR, 1993, J BIOL CHEM, V268, P7594; Brenkman AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002819; Brenkman AB, 2008, CANCER RES, V68, P7597, DOI 10.1158/0008-5472.CAN-08-1059; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Brunet A, 2007, NAT GENET, V39, P1306, DOI 10.1038/ng1107-1306; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Holcomb VB, 2007, MECH AGEING DEV, V128, P601, DOI 10.1016/j.mad.2007.08.006; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lei H, 2009, MOL CANCER RES, V7, P1294, DOI 10.1158/1541-7786.MCR-08-0531; Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2; Li H, 2009, ONCOGENE, V28, P1875, DOI 10.1038/onc.2009.57; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Lieber MR, 2004, DNA REPAIR, V3, P817, DOI 10.1016/j.dnarep.2004.03.015; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; McColl G, 2005, FASEB J, V19, P1716, DOI 10.1096/fj.04-2447fje; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Tuteja R, 2000, CRIT REV BIOCHEM MOL, V35, P1, DOI 10.1080/10409230091169177; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	48	30	30	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2010	24	11					4271	4280		10.1096/fj.10-158717	http://dx.doi.org/10.1096/fj.10-158717			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20570964				2022-12-25	WOS:000283861100015
J	Sokolov, A; Radhakrishnan, A				Sokolov, Anna; Radhakrishnan, Arun			Accessibility of Cholesterol in Endoplasmic Reticulum Membranes and Activation of SREBP-2 Switch Abruptly at a Common Cholesterol Threshold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGOLYSIN-O; CONDENSED COMPLEXES; BINDING; CYTOLYSIN; PORE; MECHANISM; INSERTION; PHOSPHOLIPIDS; METABOLISM; TRANSPORT	Recent studies have shown that cooperative interactions in endoplasmic reticulum (ER) membranes between Scap, cholesterol, and Insig result in switch-like control over activation of SREBP-2 transcription factors. This allows cells to rapidly adjust rates of cholesterol synthesis and uptake in response to even slight deviations from physiological set-point levels, thereby ensuring cholesterol homeostasis. In the present study we directly probe for the accessibility of cholesterol in purified ER membranes. Using a soluble cholesterol-binding bacterial toxin, perfringolysin O, we show that cholesterol accessibility increases abruptly at similar to 5 mol% ERcholesterol, the same concentration at which SREBP-2 activation is halted. This switch-like change in cholesterol accessibility is observed not only in purified ER membranes but also in liposomes made from ER lipid extracts. The accessibility of cholesterol in membranes is related to its chemical activity. Complex formation between cholesterol and some ER phospholipids can result in sharp changes in cholesterol chemical activity and its accessibility to perfringolysin O or membrane sensors like Scap. The control of the availability of the cholesterol ligand to participate in cooperative Scap/cholesterol/Insig interactions further sharpens the sensitive switch that exerts precise control over cholesterol levels in cell membranes.	[Sokolov, Anna; Radhakrishnan, Arun] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University	Radhakrishnan, A (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	arun314@yahoo.com	Radhakrishnan, Arun/Q-7437-2019	Radhakrishnan, Arun/0000-0002-7266-7336				Anderson TG, 2001, BIOPHYS J, V81, P2774, DOI 10.1016/S0006-3495(01)75920-6; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1978, J BIOL CHEM, V253, P1121; CHALVARDJIAN A, 1970, ANAL BIOCHEM, V36, P225, DOI 10.1016/0003-2697(70)90352-0; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; McConnell H, 2006, P NATL ACAD SCI USA, V103, P1184, DOI 10.1073/pnas.0510514103; McConnell HM, 2003, BBA-BIOMEMBRANES, V1610, P159, DOI 10.1016/S0005-2736(03)00015-4; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097; Radhakrishnan A, 2005, P NATL ACAD SCI USA, V102, P12662, DOI 10.1073/pnas.0506043102; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; REY P, 1977, J AM CHEM SOC, V99, P1637, DOI 10.1021/ja00447a059; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Solovyova AS, 2004, BIOPHYS J, V87, P540, DOI 10.1529/biophysj.104.039974; VAN MEER G, 2008, NAT REV MOL CELL BIO, V9, P112; ZAMBRANO F, 1975, BIOCHIM BIOPHYS ACTA, V380, P357, DOI 10.1016/0005-2760(75)90104-6; Zitzer A, 2003, FEBS LETT, V553, P229, DOI 10.1016/S0014-5793(03)01023-8	29	68	68	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29480	29490		10.1074/jbc.M110.148254	http://dx.doi.org/10.1074/jbc.M110.148254			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20573965	Green Published, hybrid			2022-12-25	WOS:000281740100050
J	Duderstadt, KE; Mott, ML; Crisona, NJ; Chuang, K; Yang, H; Berger, JM				Duderstadt, Karl E.; Mott, Melissa L.; Crisona, Nancy J.; Chuang, Kevin; Yang, Haw; Berger, James M.			Origin Remodeling and Opening in Bacteria Rely on Distinct Assembly States of the DnaA Initiator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; REPLICATION-ORIGIN; RECOGNITION COMPLEX; BINDING DOMAIN; T-ANTIGEN; IN-VITRO; MUTATIONAL ANALYSIS; STRUCTURAL BASIS; PROTEIN DNAA; AMINO-ACIDS	The initiation of DNA replication requires the melting of chromosomal origins to provide a template for replisomal polymerases. In bacteria, the DnaA initiator plays a key role in this process, forming a large nucleoprotein complex that opens DNA through a complex and poorly understood mechanism. Using structure-guided mutagenesis, biochemical, and genetic approaches, we establish an unexpected link between the duplex DNA-binding domain of DnaA and the ability of the protein to both self-assemble and engage single-stranded DNA in an ATP-dependent manner. Intersubunit cross-talk between this domain and the DnaA ATPase region regulates this link and is required for both origin unwinding in vitro and initiator function in vivo. These findings indicate that DnaA utilizes at least two different oligomeric conformations for engaging single- and double-stranded DNA, and that these states play distinct roles in controlling the progression of initiation.	[Mott, Melissa L.; Crisona, Nancy J.; Chuang, Kevin; Berger, James M.] Univ Calif Berkeley, Calif Inst Quantitat Biol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Yang, Haw] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Princeton University	Berger, JM (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biol, Dept Mol & Cell Biol, 374D Stanley Hall 3220, Berkeley, CA 94720 USA.	jmberger@berkeley.edu		Duderstadt, Karl/0000-0002-1279-7841	National Institutes of Health Molecular Biophysics [T32 GM008295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM071747, T32GM008295, R01GM071747] Funding Source: NIH RePORTER	National Institutes of Health Molecular Biophysics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Institutes of Health Molecular Biophysics Training Grant T32 GM008295.	Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Alexandrov AI, 2002, J BIOL CHEM, V277, P44886, DOI 10.1074/jbc.M207022200; ASAI T, 1990, EMBO J, V9, P4065, DOI 10.1002/j.1460-2075.1990.tb07628.x; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blaesing F, 2000, MOL MICROBIOL, V36, P557, DOI 10.1046/j.1365-2958.2000.01881.x; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Carr KM, 2001, J BIOL CHEM, V276, P44919, DOI 10.1074/jbc.M107463200; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; Crisona NJ, 2006, J BIOL CHEM, V281, P18927, DOI 10.1074/jbc.M603068200; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Felczak MM, 2005, J BIOL CHEM, V280, P24627, DOI 10.1074/jbc.M503684200; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; GILLE H, 1991, EMBO J, V10, P1579, DOI 10.1002/j.1460-2075.1991.tb07678.x; Giraldo R, 2003, FEMS MICROBIOL REV, V26, P533, DOI 10.1111/j.1574-6976.2003.tb00629.x; Grimwade JE, 2007, MOL MICROBIOL, V66, P428, DOI 10.1111/j.1365-2958.2007.05930.x; Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001; Kawakami H, 2005, J BIOL CHEM, V280, P27420, DOI 10.1074/jbc.M502764200; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kornberg A., 1992, DNA REPLICATION; KOWALSKI D, 1984, NUCLEIC ACIDS RES, V12, P7071, DOI 10.1093/nar/12.18.7071; KOWALSKI D, 1989, EMBO J, V8, P4335, DOI 10.1002/j.1460-2075.1989.tb08620.x; Langer U, 1996, MOL MICROBIOL, V21, P301, DOI 10.1046/j.1365-2958.1996.6481362.x; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Li ZY, 1999, PROTEIN EXPRES PURIF, V17, P41, DOI 10.1006/prep.1999.1094; Marians KJ, 2008, NAT STRUCT MOL BIOL, V15, P125, DOI 10.1038/nsmb0208-125; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; McGarry KC, 2004, P NATL ACAD SCI USA, V101, P2811, DOI 10.1073/pnas.0400340101; Meinke G, 2007, PLOS BIOL, V5, P144, DOI 10.1371/journal.pbio.0050023; Miller DT, 2009, P NATL ACAD SCI USA, V106, P18479, DOI 10.1073/pnas.0909472106; Mizushima T, 1998, J BIOL CHEM, V273, P20847, DOI 10.1074/jbc.273.33.20847; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Remus D, 2005, J BIOL CHEM, V280, P39740, DOI 10.1074/jbc.M508515200; ROTH A, 1995, EMBO J, V14, P2106, DOI 10.1002/j.1460-2075.1995.tb07202.x; Ryan VT, 2004, MOL MICROBIOL, V51, P1347, DOI 10.1046/j.1365-2958.2003.03906.x; Schuck S, 2007, J VIROL, V81, P3293, DOI 10.1128/JVI.02432-06; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; SIMMONS DT, 1993, J VIROL, V67, P4227, DOI 10.1128/JVI.67.7.4227-4236.1993; Simmons LA, 2003, MOL MICROBIOL, V49, P849, DOI 10.1046/j.1365-2958.2003.03603.x; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; Stenlund A, 2003, NAT REV MOL CELL BIO, V4, P777, DOI 10.1038/nrm1226; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; Sutton MD, 1997, J MOL BIOL, V274, P546, DOI 10.1006/jmbi.1997.1425; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Tugal T, 1998, J BIOL CHEM, V273, P32421, DOI 10.1074/jbc.273.49.32421; Valle M, 2000, MOL CELL BIOL, V20, P34, DOI 10.1128/MCB.20.1.34-41.2000; WEBER K, 1969, J BIOL CHEM, V244, P4406; Weigel C, 1999, MOL MICROBIOL, V34, P53, DOI 10.1046/j.1365-2958.1999.01568.x; Weigel C, 2002, MOL MICROBIOL, V46, P1149, DOI 10.1046/j.1365-2958.2002.03232.x; YANG L, 1993, P NATL ACAD SCI USA, V90, P5086, DOI 10.1073/pnas.90.11.5086	63	62	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28229	28239		10.1074/jbc.M110.147975	http://dx.doi.org/10.1074/jbc.M110.147975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595381	hybrid, Green Published			2022-12-25	WOS:000281404100066
J	Burch, ML; Ballinger, ML; Yang, SNY; Getachew, R; Itman, C; Loveland, K; Osman, N; Little, PJ				Burch, Micah L.; Ballinger, Mandy L.; Yang, Sundy N. Y.; Getachew, Robel; Itman, Catherine; Loveland, Kate; Osman, Narin; Little, Peter J.			Thrombin Stimulation of Proteoglycan Synthesis in Vascular Smooth Muscle Is Mediated by Protease-activated Receptor-1 Transactivation of the Transforming Growth Factor beta Type I Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; ATHEROSCLEROSIS; SMAD; GROWTH-FACTOR-BETA-1; ANTAGONIST; BIGLYCAN; DISEASE; PAR-1; CELLS	Growth factors modify the structure of the glycosaminoglycan (GAG) chains on biglycan leading to enhanced LDL binding. G-protein receptor-coupled agonists such as thrombin, signal changes the structure of proteoglycans produced by vascular smooth muscle cells (VSMCs). One component of classical G-protein- coupled receptor (GPCR) signaling invokes transactivation of protein tyrosine kinase receptors such as the epidermal growth factor receptor. Serine/threonine receptor growth factors such as transforming growth factor-(TGF)-beta are potent activators of proteoglycan synthesis. We have used the model of proteoglycan synthesis to demonstrate that the signaling paradigm of GPCR signaling can be extended to include the transactivation of serine/threonine receptor, specifically the TGF-beta type I receptor (T beta RI) also known as activin-like kinase (ALK) V. Thrombin stimulated elongation of GAG chains and increased proteoglycan core protein expression and these responses were blocked by the T beta RI antagonist, SB431542 and T beta RI siRNA knockdown, as well as several protease-activated receptor (PAR)-1 antagonists. The canonical downstream response to TGF-beta is increased C-terminal phosphorylation of the transcription factor Smad2 generating phospho-Smad2C (phosphorylation of Smad2 C-terminal region). Thrombin stimulated increased phospho-Smad2C levels, and the response was blocked by SB431542 and JNJ5177094. The proteolytically inactive thrombin mimetic thrombin-receptor activating peptide also stimulated an increase in cytosolic phospho-Smad2C. Signaling pathways for growth factor regulated proteoglycan synthesis represent therapeutic targets for the prevention of atherosclerosis, but the novel finding of a GPCR-mediated transactivation of a serine/threonine growth factor receptor almost certainly has implications well beyond the synthesis of proteoglycans.	[Burch, Micah L.; Ballinger, Mandy L.; Yang, Sundy N. Y.; Getachew, Robel; Osman, Narin; Little, Peter J.] BakerIDI Heart & Diabet Inst, Diabet & Cell Biol Lab, Melbourne, Vic 3004, Australia; [Burch, Micah L.; Osman, Narin; Little, Peter J.] Monash Univ, Alfred Hosp, Cent & Eastern Clin Sch, Dept Med, Melbourne, Vic 3004, Australia; [Burch, Micah L.; Osman, Narin; Little, Peter J.] Monash Univ, Alfred Hosp, Cent & Eastern Clin Sch, Dept Immunol, Melbourne, Vic 3004, Australia; [Itman, Catherine; Loveland, Kate] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Itman, Catherine; Loveland, Kate] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Monash University	Little, PJ (corresponding author), BakerIDI Heart & Diabet Inst, Diabet & Cell Biol Lab, Melbourne, Vic 3004, Australia.	peter.little@bakeridi.edu.au	Little, Peter J./F-9865-2015; Loveland, Kate L/X-4404-2019	Little, Peter J./0000-0002-0335-3835; Loveland, Kate L/0000-0002-5750-8046; yang, sundy/0000-0003-2418-1611; Ballinger, Mandy/0000-0002-9706-0514	National Health and Medical Research Council of Australia [268928, 472611, 418934]; Diabetes Australia Research Trust; National Heart Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust; National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by National Health and Medical Research Council of Australia Project Grants 268928 and 472611, Development Grant 418934 (to P. J. L.) and Fellowship (to P .J. L.); project grants from the Diabetes Australia Research Trust (to P. J. L. and N. O.); and a grant-in-aid from the National Heart Foundation of Australia (to P. J. L.).	Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Ballinger ML, 2004, CELL MOL LIFE SCI, V61, P1296, DOI 10.1007/s00018-004-3389-4; Coughlin SR, 1999, THROMB HAEMOSTASIS, V82, P353; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dabbagh K, 1998, THROMB HAEMOSTASIS, V79, P405; Dadlani H, 2008, J BIOL CHEM, V283, P7844, DOI 10.1074/jbc.M703125200; Damiano BP, 2003, CARDIOVASC DRUG REV, V21, P313; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Harris H, 2004, CYTOKINE, V25, P85, DOI 10.1016/j.cyto.2003.10.002; Hozawa A, 2007, ARCH INTERN MED, V167, P573, DOI 10.1001/archinte.167.6.573; Ivey ME, 2008, THROMB RES, V123, P288, DOI 10.1016/j.thromres.2008.04.019; JANSSENS WJ, 1982, BLOOD VESSELS, V19, P126; Konishi A, 2003, J BIOL CHEM, V278, P35049, DOI 10.1074/jbc.M304913200; Lefkowitz RJ, 2007, BBA-BIOMEMBRANES, V1768, P748, DOI 10.1016/j.bbamem.2006.11.001; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Little PJ, 2008, CURR OPIN LIPIDOL, V19, P448, DOI 10.1097/MOL.0b013e32830dd7c4; Little PJ, 2007, VASC HEALTH RISK MAN, V3, P117; Little PJ, 2002, ARTERIOSCL THROM VAS, V22, P55, DOI 10.1161/hq0102.101100; Liu YL, 2009, FASEB J, V23, P2299, DOI 10.1096/fj.08-127910; Maryanoff Bruce E., 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P13, DOI 10.2174/1568016033356724; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; NEYLON CB, 1990, CIRC RES, V67, P814, DOI 10.1161/01.RES.67.4.814; NEYLON CB, 1992, J BIOL CHEM, V267, P7295; Nigro J, 2002, ATHEROSCLEROSIS, V162, P119, DOI 10.1016/S0021-9150(01)00704-3; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saito Y, 2001, J MOL CELL CARDIOL, V33, P3, DOI 10.1006/jmcc.2000.1272; Smith NJ, 2006, HYPERTENSION, V48, P173, DOI 10.1161/01.HYP.0000232641.84521.92; TAIPALE J, 1992, J BIOL CHEM, V267, P25378; Tang H, 2005, BLOOD, V105, P1977, DOI 10.1182/blood-2004-08-3308; Ungefroren H, 2005, J BIOL CHEM, V280, P2644, DOI 10.1074/jbc.M411925200; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069	36	62	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26798	26805		10.1074/jbc.M109.092767	http://dx.doi.org/10.1074/jbc.M109.092767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20571025	hybrid, Green Published			2022-12-25	WOS:000281172700010
J	Haeusler, RA; Han, S; Accili, D				Haeusler, Rebecca A.; Han, Seongah; Accili, Domenico			Hepatic FoxO1 Ablation Exacerbates Lipid Abnormalities during Hyperglycemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; FATTY-ACID SYNTHESIS; FORKHEAD PROTEIN FOXO1; INSULIN-RESISTANCE; DEPENDENT REGULATION; DIABETES-MELLITUS; VLDL PRODUCTION; PPAR-ALPHA; MICE; LIVER	Patients with diabetes suffer disproportionately from impaired lipid metabolism and cardiovascular disease, but the relevant roles of insulin resistance and hyperglycemia in these processes are unclear. Transcription factor FoxO1 is regulated dually by insulin and nutrients. In this study, we addressed the hypothesis that, in addition to its established role to regulate hepatic glucose production, FoxO1 controls aspects of lipid metabolism in the diabetic liver. Mice with a liver-specific deletion of FoxO1 (L-FoxO1) and their control littermates were rendered hyperglycemic by streptozotocin administration. Subsequently, we monitored serum lipids, liver VLDL secretion, and hepatic expression of genes related to lipid metabolism. Hepatic FoxO1 ablation resulted in increased VLDL secretion, increased cholesterol, and increased plasma free fatty acids, three hallmarks of the diabetic state. L-FoxO1 mice expressed increased levels of SREBP-2 and FGF21 without affecting lipogenic genes. We propose that FoxO1 fine tunes lipolysis through its actions on FGF21 and that hepatic FoxO1 ablation increases availability of substrates for hepatic triglyceride and cholesterol synthesis and VLDL secretion. The implications of these findings are that FoxO1 protects against excessive hepatic lipid production during hyperglycemia and that its inhibition by intensive insulin treatment may exacerbate paradoxically the lipid abnormalities of diabetes.	[Haeusler, Rebecca A.; Han, Seongah; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University	Accili, D (corresponding author), 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu		Haeusler, Rebecca/0000-0002-6973-9845	National Institutes of Health (Columbia Diabetes & Endocrinology Research Center) [P01HL87123, T32DK07328, P30DK63608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608, T32DK007328] Funding Source: NIH RePORTER	National Institutes of Health (Columbia Diabetes & Endocrinology Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P01HL87123, T32DK07328, and P30DK63608 (Columbia Diabetes & Endocrinology Research Center).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Annuzzi G, 2004, ARTERIOSCL THROM VAS, V24, P2397, DOI 10.1161/01.ATV.0000146267.71816.30; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Chakrabarti P, 2009, J BIOL CHEM, V284, P13296, DOI 10.1074/jbc.C800241200; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; Goldberg IJ, 2008, DIABETES, V57, P1674, DOI 10.2337/db08-0083; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Haeusler RA, 2008, CELL METAB, V8, P7, DOI 10.1016/j.cmet.2008.06.010; Han S, 2009, J CLIN INVEST, V119, P1029, DOI 10.1172/JCI36523; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lewis GF, 1996, DIABETES CARE, V19, P390, DOI 10.2337/diacare.19.4.390; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; McPherson R, 2004, BIOCHEM CELL BIOL, V82, P201, DOI 10.1139/o03-090; Millar JS, 2006, J LIPID RES, V47, P2297, DOI 10.1194/jlr.M600213-JLR200; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; REAVEN EP, 1974, J CLIN INVEST, V54, P1167, DOI 10.1172/JCI107860; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sobel BE, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2007.07.002; Takahashi T, 2003, METABOLISM, V52, P1354, DOI 10.1016/S0026-0495(03)00202-6; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	47	58	61	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26861	26868		10.1074/jbc.M110.134023	http://dx.doi.org/10.1074/jbc.M110.134023			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573950	hybrid, Green Published			2022-12-25	WOS:000281172700017
J	Kovacs, JM; Hannan, JP; Eisenmesser, EZ; Holers, VM				Kovacs, James M.; Hannan, Jonathan P.; Eisenmesser, Elan Z.; Holers, V. Michael			Biophysical Investigations of Complement Receptor 2 (CD21 and CR2)-Ligand Interactions Reveal Amino Acid Contacts Unique to Each Receptor-Ligand Pair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; HUMAN LYMPHOCYTES-B; C3D RECEPTOR; BINDING-SITE; GP350/220 BINDING; ANTIGEN RECEPTOR; EBV/C3D RECEPTOR; NMR-SPECTROSCOPY; FRAGMENT C3D; IFN-ALPHA	Human complement receptor type 2 (CR2 and CD21) is a cell membrane receptor, with 15 or 16 extracellular short consensus repeats (SCRs), that promotes B lymphocyte responses and bridges innate and acquired immunity. The most distally located SCRs, SCR1-2, mediate the interaction of CR2 with its four known ligands (C3d, EBV gp350, IFN alpha, and CD23). To ascertain specific interacting residues on CR2, we utilized NMR studies wherein gp350 and IFN alpha were titrated into N-15-labeled SCR1-2, and chemical shift changes indicative of specific intermolecular interactions were identified. With backbone assignments made, the chemical shift changes were mapped onto the crystal structure of SCR1-2. With regard to gp350, the binding region of CR2 is primarily focused on SCR1 and the inter-SCR linker, specifically residues Asn(11), Arg(13), Ala(22), Arg(28), Ser(32), Arg(36), Lys(41), Lys(57), Tyr(64), Lys(67), Tyr(68), Arg(83), Gly(84), and Arg(89). With regard to IFN alpha, the binding is similar to the CR2-C3d interaction with specific residues being Arg(13), Tyr(16), Arg(28), Ser(42), Lys(48), Lys(50), Tyr(68), Arg(83), Gly(84), and Arg(89). We also report thermodynamic properties of each ligand-receptor pair determined using isothermal titration calorimetry. The CR2-C3d interaction was characterized as a two-mode binding interaction with K-d values of 0.13 and 160 mu M, whereas the CR2-gp350 and CR2-IFN alpha interactions were characterized as single site binding events with affinities of 0.014 and 0.035 mu M, respectively. The compilation of chemical binding maps suggests specific residues on CR2 that are uniquely important in each of these three binding interactions.	[Kovacs, James M.; Holers, V. Michael] Univ Colorado, Denver Sch Med, Dept Med & Immunol, Aurora, CO 80045 USA; [Eisenmesser, Elan Z.] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Hannan, Jonathan P.] Univ Edinburgh, Inst Struct & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Edinburgh	Holers, VM (corresponding author), 1775 Aurora Ct,M20-3102E Mail Stop B115, Aurora, CO 80045 USA.	michael.holers@ucdenver.edu		Hannan, Jonathan/0000-0003-3318-2341	National Institutes of Health [R0-1 CA053615]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA053615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R0-1 CA053615 (to V. M. H.). This work was also supported by an American Heart Association predoctoral fellowship (to J. M. K.) and assisted by the University of Colorado Denver-Rocky Mountain Regional 900 MHz Facility.	AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; AHEARN JM, 1988, P NATL ACAD SCI USA, V85, P9307, DOI 10.1073/pnas.85.23.9307; Asokan R, 2006, J IMMUNOL, V177, P383, DOI 10.4049/jimmunol.177.1.383; AUBRY JP, 1994, J IMMUNOL, V152, P5806; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; BOHNSACK JF, 1988, J IMMUNOL, V141, P2569; CAREL JC, 1990, J BIOL CHEM, V265, P12293; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CARTER RH, 1988, J IMMUNOL, V141, P457; CARTER RH, 1989, J IMMUNOL, V143, P1755; COOPER NR, 1988, ANNU REV IMMUNOL, V6, P85; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELCAYRE AX, 1993, J VIROL, V67, P2918, DOI 10.1128/JVI.67.5.2918-2921.1993; DELCAYRE AX, 1991, EMBO J, V10, P919, DOI 10.1002/j.1460-2075.1991.tb08025.x; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FINGEROTH JD, 1988, J VIROL, V62, P1442, DOI 10.1128/JVI.62.4.1442-1447.1988; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; FUJISAKU A, 1989, J BIOL CHEM, V264, P2118; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Haan KM, 2001, VIROLOGY, V290, P106, DOI 10.1006/viro.2001.1141; HADDAD RS, 1989, J VIROL, V63, P4998, DOI 10.1128/JVI.63.12.4998-5005.1989; Hannan JP, 2005, J MOL BIOL, V346, P845, DOI 10.1016/j.jmb.2004.12.007; HOLERS VM, 1995, PRINCIPLES PRACTICES, P363; IIDA K, 1983, J EXP MED, V158, P1021, DOI 10.1084/jem.158.4.1021; Kovacs JM, 2009, J BIOL CHEM, V284, P9513, DOI 10.1074/jbc.M808404200; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; LUXEMBOURG AT, 1994, J IMMUNOL, V153, P4448; Lyubchenko T, 2005, J IMMUNOL, V174, P3264, DOI 10.4049/jimmunol.174.6.3264; MARTIN DR, 1991, J EXP MED, V174, P1299, DOI 10.1084/jem.174.6.1299; Molesworth SJ, 2000, J VIROL, V74, P6324, DOI 10.1128/JVI.74.14.6324-6332.2000; MOLINA H, 1991, J BIOL CHEM, V266, P12173; MOORE MD, 1987, P NATL ACAD SCI USA, V84, P9194, DOI 10.1073/pnas.84.24.9194; MOORE MD, 1989, J BIOL CHEM, V264, P20576; Morikis D, 2004, J IMMUNOL, V172, P7537, DOI 10.4049/jimmunol.172.12.7537; Mullen MM, 2002, MOL CELL, V9, P375, DOI 10.1016/S1097-2765(02)00465-3; NEMEROW GR, 1987, J VIROL, V61, P1416, DOI 10.1128/JVI.61.5.1416-1420.1987; NEMEROW GR, 1985, J VIROL, V55, P347, DOI 10.1128/JVI.55.2.347-351.1985; NEMEROW GR, 1989, CELL, V56, P369, DOI 10.1016/0092-8674(89)90240-7; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prota AE, 2002, P NATL ACAD SCI USA, V99, P10641, DOI 10.1073/pnas.162360499; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Spriggs MK, 1996, J VIROL, V70, P5557, DOI 10.1128/JVI.70.8.5557-5563.1996; Szakonyi G, 2006, NAT STRUCT MOL BIOL, V13, P996, DOI 10.1038/nsmb1161; Takahashi K, 1997, J IMMUNOL, V159, P1557; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; Tolnay M, 1998, CLIN IMMUNOL IMMUNOP, V88, P123, DOI 10.1006/clin.1998.4552; TUVESON DA, 1991, J EXP MED, V173, P1083, DOI 10.1084/jem.173.5.1083; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WEIS JJ, 1984, P NATL ACAD SCI-BIOL, V81, P881, DOI 10.1073/pnas.81.3.881; WEIS JJ, 1988, J EXP MED, V167, P1047, DOI 10.1084/jem.167.3.1047; WEIS JJ, 1986, P NATL ACAD SCI USA, V83, P5639, DOI 10.1073/pnas.83.15.5639; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Young KA, 2008, J VIROL, V82, P11217, DOI 10.1128/JVI.01673-08; Young KA, 2007, J BIOL CHEM, V282, P36614, DOI 10.1074/jbc.M706324200; Zhang L, 2007, J MOL BIOL, V369, P567, DOI 10.1016/j.jmb.2007.02.101; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008	60	10	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27251	27258		10.1074/jbc.M110.106617	http://dx.doi.org/10.1074/jbc.M110.106617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558730	hybrid, Green Published			2022-12-25	WOS:000281172700056
J	Meshki, J; Caino, MC; von Burstin, VA; Griner, E; Kazanietz, MG				Meshki, John; Caino, M. Cecilia; von Burstin, Vivian A.; Griner, Erin; Kazanietz, Marcelo G.			Regulation of Prostate Cancer Cell Survival by Protein Kinase C epsilon Involves Bad Phosphorylation and Modulation of the TNF alpha/JNK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTER-INDUCED APOPTOSIS; EPIDERMAL-GROWTH-FACTOR; PKC-EPSILON; MOLECULAR-MECHANISMS; MEDIATED APOPTOSIS; SIGNALING PATHWAYS; EPITHELIAL-CELLS; DOWN-REGULATION; GLIOMA-CELLS; DELTA-PKC	Protein kinase C epsilon (PKC epsilon), a diacyglycerol- and phorbol ester-responsive serine-threonine kinase, has been implicated in mitogenic and survival control, and it is markedly overexpressed in human tumors, including in prostate cancer. Although prostate cancer cells undergo apoptosis in response to phorbol ester stimulation via PKC delta-mediated release of death factors, the involvement of PKC epsilon in this response is not known. PKC epsilon depletion by RNAi or expression of a dominant negative kinase-dead PKC epsilon mutant potentiated the apoptotic response of PMA and sensitized LNCaP cells to the death receptor ligand TNF alpha. On the other hand, overexpression of PKC epsilon by adenoviral means protected LNCaP cells against apoptotic stimuli. Interestingly, PKC epsilon RNAi depletion significantly enhanced the release of TNF alpha in response to PMA and greatly potentiated JNK activation by this cytokine. Further mechanistic analysis revealed that PMA fails to promote phosphorylation of Bad in Ser(112) in PKC epsilon-depleted LNCaP cells, whereas PKC epsilon overexpression greatly enhanced Bad phosphorylation. This effect was independent of Akt, ERK, or p90Rsk, well established kinases for Ser(112) in Bad. Moreover, expression of a S112A-Bad mutant potentiated PMA-induced apoptosis. Finally, we found that upon activation PKC epsilon accumulated in mitochondrial fractions in LNCaP cells and that Bad was a substrate of PKC epsilon in vitro. Our results established that PKC epsilon modulates survival in prostate cancer cells via multiple pathways.	[Meshki, John; Caino, M. Cecilia; von Burstin, Vivian A.; Griner, Erin; Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Kazanietz, MG (corresponding author), 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu		Caino, M. Cecilia/0000-0001-8294-8070	National Institutes of Health [R01-CA89202]; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA89202 (to M. G. K.).	Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Bertolotto C, 2000, J BIOL CHEM, V275, P37246, DOI 10.1074/jbc.M007732200; BLUMBERG PM, 1988, CANCER RES, V48, P1; BORNER C, 1995, J BIOL CHEM, V270, P78, DOI 10.1074/jbc.270.1.78; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Cacace AM, 1998, J CELL PHYSIOL, V175, P314, DOI 10.1002/(SICI)1097-4652(199806)175:3<314::AID-JCP9>3.0.CO;2-R; Chang Q, 2003, BRIT J PHARMACOL, V140, P41, DOI 10.1038/sj.bjp.0705398; Chopra DP, 2004, CANCER LETT, V203, P145, DOI 10.1016/j.canlet.2003.09.016; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DAY ML, 1994, CELL GROWTH DIFFER, V5, P735; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Garzotto M, 1999, CANCER RES, V59, P5194; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Ikezoe T, 2004, BRIT J CANCER, V90, P2017, DOI 10.1038/sj.bjc.6601834; Kampfer S, 2001, J BIOL CHEM, V276, P42834, DOI 10.1074/jbc.M102047200; Kilpatrick LE, 2004, AM J PHYSIOL-CELL PH, V287, pC633, DOI 10.1152/ajpcell.00486.2003; Koren R, 2004, ONCOL REP, V11, P321; Lu DM, 2006, J BIOL CHEM, V281, P22799, DOI 10.1074/jbc.M603390200; McJilton MA, 2003, ONCOGENE, V22, P7958, DOI 10.1038/sj.onc.1206795; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Mukherjee S, 2009, J ENVIRON PATHOL TOX, V28, P269, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i4.30; Nakagawa M, 2005, J BIOL CHEM, V280, P33926, DOI 10.1074/jbc.M505748200; Okhrimenko H, 2005, CANCER RES, V65, P7301, DOI 10.1158/0008-5472.CAN-05-1064; Powell CT, 2006, INT J CANCER, V118, P1572, DOI 10.1002/ijc.21511; Sastry KSR, 2006, J BIOL CHEM, V281, P27367, DOI 10.1074/jbc.M511485200; Sastry KSR, 2006, J BIOL CHEM, V281, P20891, DOI 10.1074/jbc.M602928200; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shinohara H, 2001, BIOCHEM BIOPH RES CO, V284, P1162, DOI 10.1006/bbrc.2001.5104; Shiroshita N, 2001, J PHARMACOL EXP THER, V297, P868; Sivaprasad U, 2007, CELL DEATH DIFFER, V14, P851, DOI 10.1038/sj.cdd.4402077; Steinberg R, 2007, J BIOL CHEM, V282, P32288, DOI 10.1074/jbc.M704001200; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Wu DQ, 2002, CANCER RES, V62, P2423; Xiao LQ, 2008, METHOD ENZYMOL, V446, P123, DOI 10.1016/S0076-6879(08)01607-8; Xiao LQ, 2009, J BIOL CHEM, V284, P29365, DOI 10.1074/jbc.M109.007971; Xiao LQ, 2009, MOL CARCINOGEN, V48, P187, DOI 10.1002/mc.20476; Yin LH, 2005, J BIOL CHEM, V280, P5533, DOI 10.1074/jbc.M405266200; Yu R, 2000, CANCER RES, V60, P2384; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	48	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26033	26040		10.1074/jbc.M110.128371	http://dx.doi.org/10.1074/jbc.M110.128371			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566643	Green Published, hybrid			2022-12-25	WOS:000280921000018
J	Bahlai, CA; Xue, YG; McCreary, CM; Schaafsma, AW; Hallett, RH				Bahlai, Christine A.; Xue, Yingen; McCreary, Cara M.; Schaafsma, Arthur W.; Hallett, Rebecca H.			Choosing Organic Pesticides over Synthetic Pesticides May Not Effectively Mitigate Environmental Risk in Soybeans	PLOS ONE			English	Article							PEST-MANAGEMENT; APPLE PRODUCTION; APHID; PREDATORS; SUPPRESSION; IMPACTS; SYSTEMS	Background: Selection of pesticides with small ecological footprints is a key factor in developing sustainable agricultural systems. Policy guiding the selection of pesticides often emphasizes natural products and organic-certified pesticides to increase sustainability, because of the prevailing public opinion that natural products are uniformly safer, and thus more environmentally friendly, than synthetic chemicals. Methodology/Principal Findings: We report the results of a study examining the environmental impact of several new synthetic and certified organic insecticides under consideration as reduced-risk insecticides for soybean aphid (Aphis glycines) control, using established and novel methodologies to directly quantify pesticide impact in terms of biocontrol services. We found that in addition to reduced efficacy against aphids compared to novel synthetic insecticides, organic approved insecticides had a similar or even greater negative impact on several natural enemy species in lab studies, were more detrimental to biological control organisms in field experiments, and had higher Environmental Impact Quotients at field use rates. Conclusions/Significance: These data bring into caution the widely held assumption that organic pesticides are more environmentally benign than synthetic ones. All pesticides must be evaluated using an empirically-based risk assessment, because generalizations based on chemical origin do not hold true in all cases.	[Bahlai, Christine A.; Xue, Yingen; McCreary, Cara M.; Hallett, Rebecca H.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Schaafsma, Arthur W.] Univ Guelph, Dept Plant Agr, Ridgetown, ON, Canada	University of Guelph; University of Guelph	Bahlai, CA (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	rhallett@uoguelph.ca	Bahlai, Christie/L-5500-2019	Bahlai, Christie/0000-0002-8937-8709; Schaafsma, Arthur W/0000-0002-5527-5664	Natural Sciences and Engineering Council of Canada; Agriculture and Agri-Food Canada (AAFC); Ontario Ministry of Agriculture, Food and Rural Affairs - University of Guelph	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada); Ontario Ministry of Agriculture, Food and Rural Affairs - University of Guelph	The authors acknowledge funding from the Natural Sciences and Engineering Council of Canada (http://www.nserc-crsng.gc.ca/), Agriculture and Agri-Food Canada (AAFC) (http://www.agr.gc.ca/index_e.php) and the Ontario Ministry of Agriculture, Food and Rural Affairs - University of Guelph partnership (http://www.uoguelph.ca/research/omafra/). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. AAFC suggested the insecticide list for testing, and this is the only role any funders played in study design.	*AGR AGR CAN, 2003, PEST RISK RED MIN PR; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7782, DOI 10.1073/pnas.87.19.7782; AVERY AA, 2006, ORGANIC PESTICIDE US, P58; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; *CAN GEN STAND BOA, 2008, ORG PROD SYST PERM S; Costamagna AC, 2007, ECOL APPL, V17, P441, DOI 10.1890/06-0284; Desneux N, 2006, ENVIRON ENTOMOL, V35, P1342, DOI 10.1603/0046-225X(2006)35[1342:SOPGOT]2.0.CO;2; Elliot SL, 2002, CROP PROT, V21, P427, DOI 10.1016/S0261-2194(02)00036-4; *EUR COMM, 1991, COUNC DIR 15 JUL 199; Heimpel GE, 2004, ANN ENTOMOL SOC AM, V97, P249, DOI 10.1603/0013-8746(2004)097[0249:PFIBCO]2.0.CO;2; HENDERSON CF, 1955, J ECON ENTOMOL, V48, P157, DOI 10.1093/jee/48.2.157; *HLTH CAN PEST MAN, 2009, PMRA REEV WORKPL APR; JAMES KH, 1990, RISK ANAL, V10, P367; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kovach J., 1992, NEW YORK FOOD LIFE, V139, P1; Levitan L, 1995, AGR ECOSYST ENVIRON, V55, P153, DOI 10.1016/0167-8809(95)00622-Y; Lynch D, 2009, CAN J PLANT SCI, V89, P621, DOI 10.4141/CJPS08165; LYNCH S, 1996, P 3 NAT IPM S WORKSH; *MIN SCI TECHN PEO, 2001, NAT HIGH TECH R D PR; OLSON KD, 2008, FARMERS AWARENESS US; *OMAFRA, 2005, FIELD CROP PROT GUID; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; Rutledge CE, 2004, ANN ENTOMOL SOC AM, V97, P240, DOI 10.1603/0013-8746(2004)097[0240:SAPATU]2.0.CO;2; *SAT CAN, 2009, CER OILS REV; Shepherd M., 2003, ASSESSMENT ENV IMPAC; Suckling DM, 1999, AGR ECOSYST ENVIRON, V73, P129, DOI 10.1016/S0167-8809(99)00022-5; Tette J., METHOD MEASURE ENV I; THOMPSON DG, 2006, REV ENV FATE EFFECTS, P245; Trewavas A, 2001, NATURE, V410, P409, DOI 10.1038/35068639; *UK DEP ENV FOOD R, 2005, DEP REP 2005; Xue Y, 2009, ENVIRON ENTOMOL, V38, P708, DOI 10.1603/022.038.0322	32	81	85	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11250	10.1371/journal.pone.0011250	http://dx.doi.org/10.1371/journal.pone.0011250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582315	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058500002
J	Chambrion, C; Le Naour, F				Chambrion, Celia; Le Naour, Francois			The Tetraspanins CD9 and CD81 Regulate CD9P1-Induced Effects on Cell Migration	PLOS ONE			English	Article							GROWTH-FACTOR; MICE LACKING; MAJOR CD9; PROTEIN; BINDING; EWI-2; WEB; CD151; ALPHA-3-BETA-1; ASSOCIATION	CD9P-1 is a cell surface protein with immunoglobulin domains and an unknown function that specifically associates with tetraspanins CD9 and CD81. Overexpression of CD9P-1 in HEK-293 cells induces dramatic changes in cell spreading and migration on various matrices. Experiments using time-lapse videomicroscopy revealed that CD9P-1 expression has led to higher cell motility on collagen I but lower motility on fibronectin through a beta 1-integrins dependent mechanism. On collagen I, the increase in cell motility induced by CD9P-1 expression was found to involve integrin alpha 2 beta 1 and CD9P-1 was observed to associate with this collagen receptor. The generation of CD9P-1 mutants demonstrated that the transmembrane and the cytoplasmic domains are necessary for inducing effects on cell motility. On the other hand, expression of tetraspanins CD9 or CD81 was shown to reverse the effects of CD9P-1 on cell motility on collagen I or fibronectin with a concomitant association with CD9P-1. Thus, the ratio of expression levels between CD9P-1 and its tetraspanin partners can regulate cell motility.	[Chambrion, Celia] INSERM, U1004, Villejuif, France; [Chambrion, Celia; Le Naour, Francois] Univ Paris 11, Inst Andre Lwoff, Villejuif, France; [Le Naour, Francois] INSERM, U785, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Chambrion, C (corresponding author), INSERM, U1004, Villejuif, France.	francois.le-naour@inserm.fr			Univ. Paris-Sud 11	Univ. Paris-Sud 11	This work was supported by BQR (bonus qualite recherche) from Univ. Paris-Sud 11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Andre M, 2007, PROTEOMICS, V7, P3880, DOI 10.1002/pmic.200700355; Andre M, 2009, J PROTEOMICS, V73, P93, DOI 10.1016/j.jprot.2009.08.005; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Clark KL, 2001, J IMMUNOL, V167, P5115, DOI 10.4049/jimmunol.167.9.5115; Cowin AJ, 2006, J INVEST DERMATOL, V126, P680, DOI 10.1038/sj.jid.5700142; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; Feigelson SW, 2003, J BIOL CHEM, V278, P51203, DOI 10.1074/jbc.M303601200; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; Horvath G, 1998, J BIOL CHEM, V273, P30537, DOI 10.1074/jbc.273.46.30537; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kolesnikova TV, 2004, BLOOD, V103, P3013, DOI 10.1182/blood-2003-07-2201; Lagaudriere-Gesbert C, 1997, CELL IMMUNOL, V182, P105, DOI 10.1006/cimm.1997.1223; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; Le Naour F, 2006, PROTEOMICS, V6, P6447, DOI 10.1002/pmic.200600282; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lozahic S, 2000, EUR J IMMUNOL, V30, P900, DOI 10.1002/1521-4141(200003)30:3<900::AID-IMMU900>3.0.CO;2-X; Maecker HT, 1997, J EXP MED, V185, P1505, DOI 10.1084/jem.185.8.1505; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; RASBABD WS, 2007, IMAGEJ; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Shoham T, 2003, J IMMUNOL, V171, P4062, DOI 10.4049/jimmunol.171.8.4062; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Sterk LMT, 2002, J CELL SCI, V115, P2615; Sterk LMT, 2002, J CELL SCI, V115, P1161; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Takada Y, 2007, GENOME BIOL, V8, P215; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; von Lindern JJ, 2003, J VIROL, V77, P3624, DOI 10.1128/JVI.77.6.3624-3633.2003; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u; Zhang XA, 2002, MOL BIOL CELL, V13, P1, DOI 10.1091/mbc.01-10-0481; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	48	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11219	10.1371/journal.pone.0011219	http://dx.doi.org/10.1371/journal.pone.0011219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574531	Green Published, Green Submitted, gold			2022-12-25	WOS:000279058300012
J	Osenberg, S; Yaacov, NP; Safran, M; Moshkovitz, S; Shtrichman, R; Sherf, O; Jacob-Hirsch, J; Keshet, G; Amariglio, N; Itskovitz-Eldor, J; Rechavi, G				Osenberg, Sivan; Yaacov, Nurit Paz; Safran, Michal; Moshkovitz, Sharon; Shtrichman, Ronit; Sherf, Ofra; Jacob-Hirsch, Jasmine; Keshet, Gilmor; Amariglio, Ninette; Itskovitz-Eldor, Joseph; Rechavi, Gideon			Alu Sequences in Undifferentiated Human Embryonic Stem Cells Display High Levels of A-to-I RNA Editing	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; DOUBLE-STRANDED-RNA; FEEDER-FREE GROWTH; GENE-EXPRESSION; MESSENGER-RNA; HUMAN TRANSCRIPTOME; NUCLEAR RETENTION; HUMAN BLASTOCYSTS; DEAMINASE ADAR1; INOSINE RNA	Adenosine to Inosine (A-to-I) RNA editing is a site-specific modification of RNA transcripts, catalyzed by members of the ADAR (Adenosine Deaminase Acting on RNA) protein family. RNA editing occurs in human RNA in thousands of different sites. Some of the sites are located in protein-coding regions but the majority is found in non-coding regions, such as 3'UTRs, 5'UTRs and introns - mainly in Alu elements. While editing is found in all tissues, the highest levels of editing are found in the brain. It was shown that editing levels within protein-coding regions are increased during embryogenesis and after birth and that RNA editing is crucial for organism viability as well as for normal development. In this study we characterized the A-to-I RNA editing phenomenon during neuronal and spontaneous differentiation of human embryonic stem cells (hESCs). We identified high editing levels of Alu repetitive elements in hESCs and demonstrated a global decrease in editing levels of non-coding Alu sites when hESCs are differentiating, particularly into the neural lineage. Using RNA interference, we showed that the elevated editing levels of Alu elements in undifferentiated hESCs are highly dependent on ADAR1. DNA microarray analysis showed that ADAR1 knockdown has a global effect on gene expression in hESCs and leads to a significant increase in RNA expression levels of genes involved in differentiation and development processes, including neurogenesis. Taken together, we speculate that A-to-I editing of Alu sequences plays a role in the regulation of hESC early differentiation decisions.	[Osenberg, Sivan; Yaacov, Nurit Paz; Safran, Michal; Moshkovitz, Sharon; Sherf, Ofra; Jacob-Hirsch, Jasmine; Keshet, Gilmor; Amariglio, Ninette; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Osenberg, Sivan; Yaacov, Nurit Paz; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Itskovitz-Eldor, Joseph] Rambam Med Ctr, Dept Obstet & Gynecol, Haifa, Israel; [Shtrichman, Ronit; Itskovitz-Eldor, Joseph] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis & Forman Families Stem Cell Ctr, IL-31096 Haifa, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Osenberg, S (corresponding author), Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel.	Ninette.Amariglio@sheba.health.gov.il		Keshet, Gilmor/0000-0002-1907-3029	Flight Attendant Medical Research Institute (FAMRI); Bio-Med Morasha ISF [1942/08]; Israel Ministry for Science and Technology; Kahn Family Foundation	Flight Attendant Medical Research Institute (FAMRI); Bio-Med Morasha ISF; Israel Ministry for Science and Technology; Kahn Family Foundation	This work was supported in part by grants from the Flight Attendant Medical Research Institute (FAMRI), Bio-Med Morasha ISF (Grant No. 1942/08), and the Israel Ministry for Science and Technology (Scientific Infrastructure Program) as well as the Kahn Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amariglio N, 2007, BLOOD CELL MOL DIS, V39, P151, DOI 10.1016/j.bcmd.2007.04.003; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2002, J ANAT, V200, P225, DOI 10.1046/j.1469-7580.2002.00032.x; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Barbon A, 2003, MOL BRAIN RES, V117, P168, DOI 10.1016/S0169-328X(03)00317-6; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Bodnar MS, 2004, STEM CELLS DEV, V13, P243, DOI 10.1089/154732804323099172; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Kawahara Y, 2004, DEV BRAIN RES, V148, P151, DOI 10.1016/j.devbrainres.2003.11.008; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Koren-Michowitz M, 2008, LEUKEMIA RES, V32, P421, DOI 10.1016/j.leukres.2007.07.003; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Lykke-Andersen S, 2007, RNA, V13, P1732, DOI 10.1261/rna.567807; Maas Stefan, 2006, RNA Biol, V3, P1; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Ohman M, 2007, BIOCHIMIE, V89, P1171, DOI 10.1016/j.biochi.2007.06.002; Osenberg S, 2009, RNA, V15, P1632, DOI 10.1261/rna.1581809; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Scadden ADJ, 2001, EMBO J, V20, P4243, DOI 10.1093/emboj/20.15.4243; Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang QQ, 2005, CURR BIOL, V15, P384, DOI 10.1016/j.cub.2005.01.046; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang WD, 2005, J BIOL CHEM, V280, P3946, DOI 10.1074/jbc.M407876200; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	67	64	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11173	10.1371/journal.pone.0011173	http://dx.doi.org/10.1371/journal.pone.0011173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574523	Green Published, gold, Green Submitted			2022-12-25	WOS:000279058300005
J	Terao, M; Watanabe, J; Yagi, A; Nishida, S				Terao, Masahiko; Watanabe, Junji; Yagi, Akihiro; Nishida, Shin'ya			Smooth Pursuit Eye Movements Improve Temporal Resolution for Color Perception	PLOS ONE			English	Article							IMPROVED VISUAL SENSITIVITY; CORTICAL AREAS MT; PERCEIVED MOTION; SMEAR; COMPRESSION; ADAPTATION; DIRECTION; NEURONS; SIGNALS; TIME	Human observers see a single mixed color (yellow) when different colors (red and green) rapidly alternate. Accumulating evidence suggests that the critical temporal frequency beyond which chromatic fusion occurs does not simply reflect the temporal limit of peripheral encoding. However, it remains poorly understood how the central processing controls the fusion frequency. Here we show that the fusion frequency can be elevated by extra-retinal signals during smooth pursuit. This eye movement can keep the image of a moving target in the fovea, but it also introduces a backward retinal sweep of the stationary background pattern. We found that the fusion frequency was higher when retinal color changes were generated by pursuit-induced background motions than when the same retinal color changes were generated by object motions during eye fixation. This temporal improvement cannot be ascribed to a general increase in contrast gain of specific neural mechanisms during pursuit, since the improvement was not observed with a pattern flickering without changing position on the retina or with a pattern moving in the direction opposite to the background motion during pursuit. Our findings indicate that chromatic fusion is controlled by a cortical mechanism that suppresses motion blur. A plausible mechanism is that eye-movement signals change spatiotemporal trajectories along which color signals are integrated so as to reduce chromatic integration at the same locations (i.e., along stationary trajectories) on the retina that normally causes retinal blur during fixation.	[Terao, Masahiko; Watanabe, Junji; Nishida, Shin'ya] NTT Corp, NTT Commun Sci Labs, Kyoto, Japan; [Terao, Masahiko] Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Watanabe, Junji] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Terao, Masahiko; Yagi, Akihiro] Kwansei Gakuin Univ, Grad Sch Humanities, Nishinomiya, Hyogo, Japan	Nippon Telegraph & Telephone Corporation; University of Tokyo; Japan Society for the Promotion of Science; Kwansei Gakuin University	Terao, M (corresponding author), NTT Corp, NTT Commun Sci Labs, Kyoto, Japan.	masahiko_terao@mac.com			Nippon Telegraph and Telephone Corporation; Japan Society for the Promotion of Science	Nippon Telegraph and Telephone Corporation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Nippon Telegraph and Telephone Corporation and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CH, 1990, NATURE, V343, P419, DOI 10.1038/343419b0; Bedell HE, 1996, CURR BIOL, V6, P1032, DOI 10.1016/S0960-9822(02)00650-4; BURR D, 1980, NATURE, V284, P164, DOI 10.1038/284164a0; Burr D, 2004, CURR BIOL, V14, pR381, DOI 10.1016/j.cub.2004.05.011; BURR D, 1986, TRENDS NEUROSCI, V9, P304, DOI 10.1016/0166-2236(86)90088-3; BURR DC, 1981, PROC R SOC SER B-BIO, V211, P321, DOI 10.1098/rspb.1981.0010; Burr DC, 1997, P ROY SOC B-BIOL SCI, V264, P431, DOI 10.1098/rspb.1997.0061; Cavanagh P, 2008, J VISION, V8, DOI 10.1167/8.12.1; DELANGEDZN H, 1958, J OPT SOC AM, V48, P777, DOI 10.1364/JOSA.48.000777; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; HONDA H, 1991, VISION RES, V31, P1915, DOI 10.1016/0042-6989(91)90186-9; Jiang Y, 2007, NAT NEUROSCI, V10, P657, DOI 10.1038/nn1879; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; LEE BB, 1989, J PHYSIOL-LONDON, V414, P223, DOI 10.1113/jphysiol.1989.sp017685; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Nishida S, 2007, CURR BIOL, V17, P366, DOI 10.1016/j.cub.2006.12.041; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Schutz AC, 2008, NAT NEUROSCI, V11, P1211, DOI 10.1038/nn.2194; Schutz AC, 2009, VISUAL NEUROSCI, V26, P329, DOI 10.1017/S0952523809990083; Schutz AC, 2007, J VISION, V7, DOI 10.1167/7.13.3; Shady S, 2004, P NATL ACAD SCI USA, V101, P5170, DOI 10.1073/pnas.0303452101; TERAO M, SOC NEUR ANN M CHIC; Tolias AS, 2005, NAT NEUROSCI, V8, P591, DOI 10.1038/nn1446; Tong JL, 2007, VISION RES, V47, P1011, DOI 10.1016/j.visres.2006.12.002; Tong JL, 2009, VISION RES, V49, P2835, DOI 10.1016/j.visres.2009.08.019; Tong JL, 2005, VISION RES, V45, P1519, DOI 10.1016/j.visres.2004.12.004; Vul E, 2006, NAT NEUROSCI, V9, P873, DOI 10.1038/nn1723; Watanabe J, 2007, J VISION, V7, DOI 10.1167/7.11.3; WISOWATY JJ, 1981, J OPT SOC AM, V71, P970, DOI 10.1364/JOSA.71.000970	31	11	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11214	10.1371/journal.pone.0011214	http://dx.doi.org/10.1371/journal.pone.0011214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574511	Green Published, Green Submitted, gold			2022-12-25	WOS:000279058300009
J	Fu, S; Tong, XH; Cai, CG; Zhao, Y; Wu, Y; Li, YY; Xu, JJ; Zhang, XJC; Xu, L; Chen, W; Rao, ZH				Fu, Sheng; Tong, Xiaohang; Cai, Chenguang; Zhao, Ying; Wu, Yang; Li, Yuanyuan; Xu, Junjie; Zhang, Xuejun C.; Xu, Long; Chen, Wei; Rao, Zihe			The Structure of Tumor Endothelial Marker 8 (TEM8) Extracellular Domain and Implications for Its Receptor Function for Recognizing Anthrax Toxin	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; VON-WILLEBRAND-FACTOR; PROTECTIVE ANTIGEN; CRYSTAL-STRUCTURE; PORE FORMATION; A-DOMAIN; CELLULAR RECEPTORS; LETHAL FACTOR; IN-VIVO; BINDING	Anthrax toxin, which is released from the Gram-positive bacterium Bacillus anthracis, is composed of three proteins: protective antigen (PA), lethal factor (LF), and edema factor (EF). PA binds a receptor on the surface of the target cell and further assembles into a homo-heptameric pore through which EF and LF translocate into the cytosol. Two distinct cellular receptors for anthrax toxin, TEM8/ANTXR1 and CMG2/ANTXR2, have been identified, and it is known that their extracellular domains bind PA with low and high affinities, respectively. Here, we report the crystal structure of the TEM8 extracellular vWA domain at 1.7 angstrom resolution. The overall structure has a typical integrin fold and is similar to that of the previously published CMG2 structure. In addition, using structure-based mutagenesis, we demonstrate that the putative interface region of TEM8 with PA (consisting of residues 56, 57, and 154-160) is responsible for the PA-binding affinity differences between the two receptors. In particular, Leu56 was shown to be a key factor for the lower affinity of TEM8 towards PA compared with CMG2. Because of its high affinity for PA and low expression in normal tissues, an isolated extracellular vWA domain of the L56A TEM8 variant may serve as a potent antitoxin and a potential therapeutic treatment for anthrax infection. Moreover, as TEM8 is often over-expressed in tumor cells, our TEM8 crystal structure may provide new insights into how to design PA mutants that preferentially target tumor cells.	[Fu, Sheng; Tong, Xiaohang; Wu, Yang; Li, Yuanyuan; Zhang, Xuejun C.; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Fu, Sheng; Tong, Xiaohang; Zhao, Ying; Wu, Yang; Li, Yuanyuan; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Cai, Chenguang; Xu, Junjie; Chen, Wei] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Xu, Long] Beijing Inst Biotechnol, Lab Prot Engn, Beijing, Peoples R China; [Rao, Zihe] Nankai Univ, Coll Sci, Tianjin 300071, Peoples R China; [Rao, Zihe] Nankai Univ, Tianjin State Lab Prot Sci, Tianjin 300071, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; Beijing Institute of Microbiology & Epidemiology; Nankai University; Nankai University	Fu, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	chenwei0226@yahoo.com.cn; raozh@xtal.tsinghua.edu.cn	Rao, Zihe/HCH-6944-2022; li, yuanyuan/GZA-4435-2022; Wu, Yang/N-8460-2014	Wu, Yang/0000-0002-1544-1947	"973" Project [2006CB806503, 2007CB914301, 2007CB914304]; "863" Project [2006AA02A322]; National Major Project [2009ZX10004-304]; Ministry of Science and Technology [2006DFB32420]; National Institutes of Health/NIAID [U19AI06269]	"973" Project(National Basic Research Program of China); "863" Project(National High Technology Research and Development Program of China); National Major Project; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Institutes of Health/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the State "973" Project (Grant no. 2006CB806503, 2007CB914301 and 2007CB914304), "863" Project (Grant No. 2006AA02A322), the National Major Project (Grant No. 2009ZX10004-304), the Ministry of Science and Technology International Collaboration Project (Grant no. 2006DFB32420) and National Institutes of Health/NIAID, U19AI06269 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2003, J BIOL CHEM, V278, P49342, DOI 10.1074/jbc.M307900200; Chen KH, 2007, J BIOL CHEM, V282, P9834, DOI 10.1074/jbc.M611142200; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hotchkiss KA, 2005, EXP CELL RES, V305, P133, DOI 10.1016/j.yexcr.2004.12.025; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Krishnan V, 2007, J MOL BIOL, V367, P224, DOI 10.1016/j.jmb.2006.12.039; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P6367, DOI 10.1073/pnas.0401506101; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnyk RA, 2006, J BIOL CHEM, V281, P1630, DOI 10.1074/jbc.M511164200; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nabel GJ, 2009, NEW ENGL J MED, V361, P191, DOI 10.1056/NEJMe0903259; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Scobie HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000329; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Tama F, 2006, PROTEIN SCI, V15, P2190, DOI 10.1110/ps.062293906; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wild MA, 2003, NAT BIOTECHNOL, V21, P1305, DOI 10.1038/nbt891; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106	40	25	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11203	10.1371/journal.pone.0011203	http://dx.doi.org/10.1371/journal.pone.0011203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585457	Green Submitted, gold, Green Published			2022-12-25	WOS:000278977200008
J	Bonte, D; De Roissart, A; Vandegehuchte, ML; Ballhorn, DJ; Van Leeuwen, T; de la Pena, E				Bonte, Dries; De Roissart, Annelies; Vandegehuchte, Martijn L.; Ballhorn, Daniel J.; Van Leeuwen, Thomas; de la Pena, Eduardo			Local Adaptation of Aboveground Herbivores towards Plant Phenotypes Induced by Soil Biota	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; BELOW-GROUND INTERACTIONS; ROOT HERBIVORY; SPIDER-MITE; TRADE-OFFS; MICROBIAL COMMUNITY; GENETIC-VARIATION; GROWTH; EVOLUTION; RESISTANCE	Background: Soil biota may trigger strong physiological responses in plants and consequently induce distinct phenotypes. Plant phenotype, in turn, has a strong impact on herbivore performance. Here, we tested the hypothesis that aboveground herbivores are able to adapt to plant phenotypes induced by soil biota. Methodology and Principal Findings: We bred spider mites for 15 generations on snap beans with three different belowground biotic interactions: (i) no biota (to serve as control), (ii) arbuscular mycorrhizal fungi and (ii) root-feeding nematodes. Subsequently, we conducted a reciprocal selection experiment using these spider mites, which had been kept on the differently treated plants. Belowground treatments induced changes in plant biomass, nutrient composition and water content. No direct chemical defence through cyanogenesis was detected in any of the plant groups. Growth rates of spider mites were higher on the ecotypes on which they were bred for 15 generations, although the statistical significance disappeared for mites from the nematode treatment when corrected for all multiple comparisons. Conclusion/Significance: These results demonstrate that belowground biota may indeed impose selection on the aboveground insect herbivores mediated by the host plant. The observed adaptation was driven by variable quantitative changes of the different separately studied life history traits (i. e. fecundity, longevity, sex-ratio, time to maturity).	[Bonte, Dries; De Roissart, Annelies; Vandegehuchte, Martijn L.; de la Pena, Eduardo] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Ballhorn, Daniel J.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [De Roissart, Annelies; Van Leeuwen, Thomas] Univ Ghent, Dept Crop Protect, B-9000 Ghent, Belgium	Ghent University; University of Minnesota System; University of Minnesota Twin Cities; Ghent University	Bonte, D (corresponding author), Univ Ghent, Dept Biol, B-9000 Ghent, Belgium.	Dries.Bonte@Ugent.be	Bonte, Dries/AAH-3913-2021; de la Pena, Eduardo/B-8037-2015; Van Leeuwen, Thomas/H-5036-2013	Bonte, Dries/0000-0002-3320-7505; de la Pena, Eduardo/0000-0002-6057-6664; Vandegehuchte, Martijn L./0000-0003-1283-4654; Van Leeuwen, Thomas/0000-0003-4651-830X	FWO Research Network; FWO [G.0057.09]; DFG [3966/1-1]	FWO Research Network(FWO); FWO(FWO); DFG(German Research Foundation (DFG))	DB, ADR, MV and EDLP were supported by the FWO Research Network "Eco-evolutionary dynamics in natural and anthropogenic communities" and FWO project G.0057.09. EDLP and TVL are postdoctoral fellows and MLV a PhD candidate at the Fund for Scientific Research, Flanders. DJB gratefully acknowledges funding through the DFG (grant 3966/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RE, 1965, PLANT DIS REPTR, V49; Agrawal AA, 2002, AM NAT, V159, P553, DOI 10.1086/339463; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Ballhorn DJ, 2007, J CHEM ECOL, V33, P2195, DOI 10.1007/s10886-007-9380-4; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; Ballhorn DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005450; Bardgett RD, 2005, TRENDS ECOL EVOL, V20, P634, DOI 10.1016/j.tree.2005.08.005; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; Barot S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001248; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bezemer TM, 2005, ECOL LETT, V8, P652, DOI 10.1111/j.1461-0248.2005.00762.x; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Coley PD, 2006, OIKOS, V115, P219, DOI 10.1111/j.2006.0030-1299.14928.x; Denton CS, 1999, SOIL BIOL BIOCHEM, V31, P155, DOI 10.1016/S0038-0717(98)00118-7; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; FRITZ RS, 1990, OECOLOGIA, V82, P325, DOI 10.1007/BF00317479; FRITZ RS, 1988, ECOLOGY, V69, P845, DOI 10.2307/1941034; Fuller VL, 2008, NEW PHYTOL, V180, P27, DOI 10.1111/j.1469-8137.2008.02508.x; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Graham JH, 2000, PLANT SOIL, V220, P207, DOI 10.1023/A:1004709209009; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Hoffmann D, 2009, OECOLOGIA, V158, P663, DOI 10.1007/s00442-008-1179-7; ISO, 2005, 59832 ISO; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.ecolsys.21.1.243; Johnson MTJ, 2007, OIKOS, V116, P941, DOI 10.1111/j.0030-1299.2007.15773.x; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Johnson SN, 2009, FUNCT ECOL, V23, P699, DOI 10.1111/j.1365-2435.2009.01550.x; JOOSTEN L, 2009, PLANT SOIL; Kaplan I, 2008, ECOL LETT, V11, P841, DOI 10.1111/j.1461-0248.2008.01200.x; Karban R, 2004, EVOL ECOL, V18, P283, DOI 10.1023/B:EVEC.0000035063.70344.03; KOIDE R, 1985, NEW PHYTOL, V99, P449, DOI 10.1111/j.1469-8137.1985.tb03672.x; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Magalhaes S, 2007, J EVOLUTION BIOL, V20, P2016, DOI 10.1111/j.1420-9101.2007.01365.x; MASTERS GJ, 1993, OIKOS, V66, P148, DOI 10.2307/3545209; MASTERS GJ, 1995, ACTA OECOL, V16, P135; Mopper S, 2000, ECOLOGY, V81, P1577, DOI 10.1890/0012-9658(2000)081[1577:SVILPS]2.0.CO;2; MOPPER S, 1995, EVOLUTION, V49, P810, DOI [10.2307/2410404, 10.1111/j.1558-5646.1995.tb02317.x]; Mopper S, 1996, TRENDS ECOL EVOL, V11, P235, DOI 10.1016/0169-5347(96)10036-7; NAHRSTEDT A, 1985, PLANT SYST EVOL, V150, P35, DOI 10.1007/BF00985566; Orians CM, 1996, OECOLOGIA, V105, P388, DOI 10.1007/BF00328742; Poll J, 2007, FEMS MICROBIOL ECOL, V62, P268, DOI 10.1111/j.1574-6941.2007.00383.x; Reynolds HL, 2006, OECOLOGIA, V147, P348, DOI 10.1007/s00442-005-0270-6; Scheirs J, 2005, EVOL ECOL, V19, P551, DOI 10.1007/s10682-005-2004-y; Schoonhoven L.M., 1998, INSECT PLANT BIOL PH; Shen CS, 1997, ECOL ENTOMOL, V22, P335, DOI 10.1046/j.1365-2311.1997.00078.x; Smiley RW, 2005, PLANT DIS, V89, P958, DOI 10.1094/PD-89-0958; Sudova R, 2008, PLANT SOIL, V308, P55, DOI 10.1007/s11104-008-9605-5; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JN, 2005, CURR BIOL, V15, pR992, DOI 10.1016/j.cub.2005.11.046; Tikkanen OP, 2003, FOREST ECOL MANAG, V177, P587, DOI 10.1016/S0378-1127(02)00330-4; van Dam NM, 2005, ENTOMOL EXP APPL, V115, P161, DOI 10.1111/j.1570-7458.2005.00241.x; van Dam NM, 2003, BASIC APPL ECOL, V4, P63, DOI 10.1078/1439-1791-00133; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; van Ruijven J, 2005, ECOL LETT, V8, P30, DOI 10.1111/j.1461-0248.2004.00688.x; VANDEGEHUCHTE ML, 2010, OIKOS IN PRESS; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wolfe BE, 2005, ECOL LETT, V8, P218, DOI 10.1111/j.1461-0248.2004.00716.x; Yano S, 2002, EXP APPL ACAROL, V27, P1, DOI 10.1023/A:1021518221031; Yano S, 2001, EXP APPL ACAROL, V25, P371, DOI 10.1023/A:1017926017081	65	34	34	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11174	10.1371/journal.pone.0011174	http://dx.doi.org/10.1371/journal.pone.0011174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567507	gold, Green Published, Green Submitted			2022-12-25	WOS:000278886300017
J	Huang, HH; Su, M; Li, XY; Li, H; Tian, DP; Gao, YX; Guo, YB				Huang, Haihua; Su, Min; Li, Xiaoyun; Li, Hui; Tian, Dongping; Gao, Yuxia; Guo, Yubai			Y-Chromosome Evidence for Common Ancestry of Three Chinese Populations with a High Risk of Esophageal Cancer	PLOS ONE			English	Article							MODERN HUMAN-ORIGIN; FAMILIAL AGGREGATION; POLYMORPHISMS; AREA; LOCI; ASIA	High rates of esophageal cancer (EC) are found in people of the Henan Taihang Mountain, Fujian Minnan, and Chaoshan regions of China. Historical records describe great waves of populations migrating from north-central China (the Henan and Shanxi Hans) through coastal Fujian Province to the Chaoshan plain. Although these regions are geographically distant, we hypothesized that EC high-risk populations in these three areas could share a common ancestry. Accordingly, we used 16 East Asian-specific Y-chromosome biallelic markers (single nucleotide polymorphisms; Y-SNPs) and six Y-chromosome short tandem repeat (Y-STR) loci to infer the origin of the EC high-risk Chaoshan population (CSP) and the genetic relationship between the CSP and the EC high-risk Henan Taihang Mountain population (HTMP) and Fujian population (FJP). The predominant haplogroups in these three populations are O3*, O3e*, and O3e1, with no significant difference between the populations in the frequency of these genotypes. Frequency distribution and principal component analysis revealed that the CSP is closely related to the HTMP and FJP, even though the former is geographically nearer to other populations (Guangfu and Hakka clans). The FJP is between the CSP and HTMP in the principal component plot. The CSP, FJP and HTMP are more closely related to Chinese Hans than to minorities, except Manchu Chinese, and are descendants of Sino-Tibetans, not Baiyues. Correlation analysis, hierarchical clustering analysis, and phylogenetic analysis (neighbor-joining tree) all support close genetic relatedness among the CSP, FJP and HTMP. The network for haplogroup O3 (including O3*, O3e* and O3e1) showed that the HTMP have highest STR haplotype diversity, suggesting that the HTMP may be a progenitor population for the CSP and FJP. These findings support the potentially important role of shared ancestry in understanding more about the genetic susceptibility in EC etiology in high-risk populations and have implications for determining the molecular basis of this disease.	[Huang, Haihua; Su, Min; Li, Xiaoyun; Tian, Dongping; Gao, Yuxia; Guo, Yubai] Shantou Univ, Coll Med, Dept Pathol, Key Immunopathol Lab Guangdong Prov, Shantou, Guangdong, Peoples R China; [Huang, Haihua] Shantou Univ, Coll Med, Affiliated Hosp 2, Shantou, Guangdong, Peoples R China; [Li, Hui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Li, Hui] Fudan Univ, Sch Life Sci, Ctr Anthropol Studies, Shanghai 200433, Peoples R China; [Li, Hui] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Shantou University; Shantou University; Fudan University; Fudan University; Yale University	Huang, HH (corresponding author), Shantou Univ, Coll Med, Dept Pathol, Key Immunopathol Lab Guangdong Prov, Shantou, Guangdong, Peoples R China.	minsu@stu.edu.cn	Li, Hui/A-2014-2010		National Natural Science Foundation of China [30210103904]; Key Natural Science Foundation of Guangdong Province, China [A1080203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (No. 30210103904) and Key Natural Science Foundation of Guangdong Province, China (No. A1080203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BA GJ, 2007, J FORENSIC MED, V23, P206; Chang-Claude J, 1997, INT J EPIDEMIOL, V26, P1159, DOI 10.1093/ije/26.6.1159; CHEN WS, 1996, CHIN J CANC, V15, P274; CHEN ZH, 2001, OUTLINE CHAOSHAN CUL, P40; Ellis N, 2002, GENOME RES, V12, P339; FEI XT, 1999, PATTERN DIVERSITY UN, P4; Feng C. J., 2005, FORENSIC SCI TECHNOL, V3, P23; GE JX, 1997, MIGRATION HIST CHINA, P7; He Yan, 2006, Yichuan, V28, P1495, DOI 10.1360/yc-006-1495; HU N, 1992, INT J EPIDEMIOL, V21, P877, DOI 10.1093/ije/21.5.877; HUANG T, 1999, ORIGIN DEV CHANSHAN, P1; Huang ZP, 2000, KEY ENG MAT, V177-1, P1, DOI 10.4028/www.scientific.net/KEM.177-180.1; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Ke YH, 2001, SCI CHINA SER C, V44, P225, DOI 10.1007/BF02879329; KUANG JZ, 2005, PENAL TECHNOL, V1, P19; Li Hui, 2003, Acta Genetica Sinica, V30, P873; Liu HX, 2007, J HUAZHONG U SCI-MED, V27, P601, DOI 10.1007/s11596-007-0532-0; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; PENG XE, 2003, CHIN J PREV CONTR CH, V11, P212; ROOHULLAH, 2005, PAK J MED RES, V44, P101; Sambrook J, 1996, MOL CLONING LAB MANU, P463; SI MQ, 2007, HIST MIRROR, V1, P120; Stewart B.W., 2003, WORLD CANC REPORT; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; SU M, 2005, P 1 ASS INT AC C ES, P149; Su M, 2004, WORLD J GASTROENTERO, V10, P2163; Su M, 2007, EUR J EPIDEMIOL, V22, P43, DOI 10.1007/s10654-006-9086-x; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; WEN B, 2004, THESIS FUDAN U, P1; Wu W. W., 2005, FORENSIC SCI TECHNOL, V5, P11; XIE CG, 2003, J HANSHAN TEACHERS C, V24, P1; YANG XX, 2005, J DALI U, V4, P24; [俞建昆 YU Jiankun], 2006, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V12, P247; Yu Liang, 2005, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V22, P337; ZHANG XH, 2006, J FORENSIC MED, V22, P210; Zhao Jian-Min, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P94; ZOU XN, 2002, B CHIN CANC, V11, P446; 文波, 2003, [中国科学. C辑, 生命科学, Science in China], V33, P375; 王冬花, 2006, [中国法医学杂志, Chinese Journal of Forensic Medicine], V21, P302; 杨剑, 2002, [中国法医学杂志, Chinese Journal of Forensic Medicine], V17, P346; 李飚, 2006, [中国法医学杂志, Chinese Journal of Forensic Medicine], V21, P172; 陈水琴, 2005, [中国法医学杂志, Chinese Journal of Forensic Medicine], V20, P174	42	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11118	10.1371/journal.pone.0011118	http://dx.doi.org/10.1371/journal.pone.0011118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559544	Green Published, Green Submitted, gold			2022-12-25	WOS:000278775900009
J	Mancuso, M; Sammarco, MC; Grabczyk, E				Mancuso, Miriam; Sammarco, Mimi C.; Grabczyk, Ed			Transposon Tn7 Preferentially Inserts into GAA circle TTC Triplet Repeats under Conditions Conducive to Y circle R circle Y Triplex Formation	PLOS ONE			English	Article							DNA STRUCTURES; RNA-POLYMERASE; GENE; TRANSCRIPTION; RECOGNITION; LENGTH	Background: Expansion of an unstable GAA circle TTC repeat in the first intron of the FXN gene causes Friedreich ataxia by reducing frataxin expression. Structure formation by the repeat has been implicated in both frataxin repression and GAA circle TTC instability. The GAA circle TTC sequence is capable of adopting multiple non-B DNA structures including Y circle R circle Y and R circle R circle Y triplexes. Lower pH promotes the formation of Y circle R circle Y triplexes by GAA circle TTC. Here we used the bacterial transposon Tn7 as an in vitro tool to probe whether GAA circle TTC repeats can attract a well-characterized recombinase. Methodology/Principal Findings: Tn7 showed a pH-dependent preference for insertion into uninterrupted regions of a Friedreich ataxia patient-derived repeat, inserting 48, 39 and 14 percent of the time at pH 7, pH 8 and pH 9, respectively. Moreover, Tn7 also showed orientation and region specific insertion within the repeat at pH 7 and pH 8, but not at pH 9. In contrast, transposon Tn5 showed no strong preference for or against the repeat during in vitro transposition at any pH tested. Y circle R circle Y triplex formation was reduced in predictable ways by transposon interruption of the GAA circle TTC repeat. However, transposon interruptions in the GAA circle TTC repeats did not increase the in vitro transcription efficiency of the templates. Conclusions/Significance: We have demonstrated that transposon Tn7 will recognize structures that form spontaneously in GAA circle TTC repeats and insert in a specific orientation within the repeat. The conditions used for in vitro transposition span the physiologically relevant range suggesting that long GAA circle TTC repeats can form triplex structures in vivo, attracting enzymes involved in DNA repair, recombination and chromatin modification.	[Mancuso, Miriam; Sammarco, Mimi C.; Grabczyk, Ed] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Mancuso, Miriam] Louisiana State Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Mancuso, M (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA.	egrabc@lsuhsc.edu		Sammarco, Mimi/0000-0001-9491-5735	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH) [R01NS046567]; Friedreich's Ataxia Research Alliance (FARA); Muscular Dystrophy Association (MDA); LSUHSC Research Enhancement Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046567] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Friedreich's Ataxia Research Alliance (FARA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); LSUHSC Research Enhancement Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health (NIH) grant R01NS046567 from the National Institute of Neurological Disorders and Stroke and by grants from the Friedreich's Ataxia Research Alliance (FARA http://www.curefa.org/) and the Muscular Dystrophy Association (MDA http://www.mda.org/) to EG. Open Access publication charges for this article were paid by an LSUHSC Research Enhancement Fund grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio JL, 1998, J MOL BIOL, V275, P811, DOI 10.1006/jmbi.1997.1520; BAINTON RJ, 1993, CELL, V72, P931, DOI 10.1016/0092-8674(93)90581-A; Banerjee A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006193; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Biery MC, 2000, NUCLEIC ACIDS RES, V28, P1067, DOI 10.1093/nar/28.5.1067; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; COLLIER DA, 1990, J BIOL CHEM, V265, P10652; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Filla A, 1996, AM J HUM GENET, V59, P554; Filutowicz M, 1998, GENE, V223, P195, DOI 10.1016/S0378-1119(98)00367-9; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P4930, DOI 10.1093/nar/28.24.4930; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; HTUN H, 1988, SCIENCE, V241, P1791, DOI 10.1126/science.3175620; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; Kuduvalli PN, 2001, EMBO J, V20, P924, DOI 10.1093/emboj/20.4.924; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ohshima K, 1999, NEUROLOGY, V53, P1854, DOI 10.1212/WNL.53.8.1854; Pandolfo M, 2008, ARCH NEUROL-CHICAGO, V65, P1296, DOI 10.1001/archneur.65.10.1296; Parks AR, 2009, CELL, V138, P685, DOI 10.1016/j.cell.2009.06.011; Pearson CE, 1998, CURR OPIN STRUC BIOL, V8, P321, DOI 10.1016/S0959-440X(98)80065-1; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Posey JE, 2006, PLOS BIOL, V4, P1934, DOI 10.1371/journal.pbio.0040350; Potaman VN, 2004, NUCLEIC ACIDS RES, V32, P1224, DOI 10.1093/nar/gkh274; Raghavan SC, 2006, BIOESSAYS, V28, P480, DOI 10.1002/bies.20353; Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200; Rao JE, 2000, P NATL ACAD SCI USA, V97, P3936, DOI 10.1073/pnas.080061497; Rao JE, 2001, J MOL BIOL, V307, P1161, DOI 10.1006/jmbi.2001.4553; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Usdin K, 2000, CELL MOL LIFE SCI, V57, P914, DOI 10.1007/PL00000734; WADDELL CS, 1989, P NATL ACAD SCI USA, V86, P3958, DOI 10.1073/pnas.86.11.3958; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307	40	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11121	10.1371/journal.pone.0011121	http://dx.doi.org/10.1371/journal.pone.0011121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559546	Green Published, gold, Green Submitted			2022-12-25	WOS:000278775900012
J	Noujaim, SF; Stuckey, JA; Ponce-Balbuena, D; Ferrer-Villada, T; Lopez-Izquierdo, A; Pandit, S; Calvo, CJ; Grzeda, KR; Berenfeld, O; Chapula, JAS; Jalife, J				Noujaim, Sami F.; Stuckey, Jeanne A.; Ponce-Balbuena, Daniela; Ferrer-Villada, Tania; Lopez-Izquierdo, Angelica; Pandit, Sandeep; Calvo, Conrado J.; Grzeda, Krzysztof R.; Berenfeld, Omer; Sanchez Chapula, Jose A.; Jalife, Jose			Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets	FASEB JOURNAL			English	Article						chloroquine; fibrillation; I-K1; I-KATP; I-KACh	ATRIAL-FIBRILLATION; CLINICAL CHARACTERIZATION; FUNCTIONAL REENTRY; CURRENT I-K1; CHLOROQUINE; MUTATION; KIR2.1; MECHANISM; CURRENTS; SYSTEM	Atrial and ventricular tachyarrhythmias can be perpetuated by up-regulation of inward rectifier potassium channels. Thus, it may be beneficial to block inward rectifier channels under conditions in which their function becomes arrhythmogenic (e.g., inherited gain-of-function mutation channelopathies, ischemia, and chronic and vagally mediated atrial fibrillation). We hypothesize that the antimalarial quinoline chloroquine exerts potent antiarrhythmic effects by interacting with the cytoplasmic domains of Kir2.1 (I-K1), Kir3.1 (I-KACh), or Kir6.2 (I-KATP) and reducing inward rectifier potassium currents. In isolated hearts of three different mammalian species, intracoronary chloroquine perfusion reduced fibrillatory frequency (atrial or ventricular), and effectively terminated the arrhythmia with resumption of sinus rhythm. In patch-clamp experiments chloroquine blocked I-K1, I-KACh, and I-KATP. Comparative molecular modeling and ligand docking of chloroquine in the intracellular domains of Kir2.1, Kir3.1, and Kir6.2 suggested that chloroquine blocks or reduces potassium flow by interacting with negatively charged amino acids facing the ion permeation vestibule of the channel in question. These results open a novel path toward discovering antiarrhythmic pharma-cophores that target specific residues of the cytoplasmic domain of inward rectifier potassium channels.-Noujaim, S. F., Stuckey, J. A., Ponce-Balbuena, D., Ferrer-Villada, T., Lopez-Izquierdo, A., Pandit, S., Calvo, C. J., Grzeda, K. R., Berenfeld, O., Sanchez Chapula, J. A., Jalife, J. Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets. FASEB J. 24, 4302-4312 (2010). www.fasebj.org	[Noujaim, Sami F.; Pandit, Sandeep; Calvo, Conrado J.; Grzeda, Krzysztof R.; Berenfeld, Omer; Jalife, Jose] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48108 USA; [Stuckey, Jeanne A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48108 USA; [Ponce-Balbuena, Daniela; Ferrer-Villada, Tania; Lopez-Izquierdo, Angelica; Sanchez Chapula, Jose A.] Univ Colima, Unidad Invest Carlos Mendez, Ctr Univ Invest Biomed, Colima, Mexico	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universidad de Colima	Jalife, J (corresponding author), Univ Michigan, Ctr Arrhythmia Res, 5025 Venture Dr, Ann Arbor, MI 48108 USA.	jjalife@umich.edu	Lopez Izquierdo, Angelica/B-4445-2013; Jalife, Jose/L-4833-2015; Lopez-Izquierdo, Angelica/AAD-7355-2021; Jalife, Jose/AAJ-9156-2021; LOPEZ-IZQUIERDO, ANGELICA/R-6018-2019; Calvo, Conrado/H-8348-2016; Lopez-Izquierdo, Angelica/B-9404-2016	Jalife, Jose/0000-0003-0080-3500; Lopez-Izquierdo, Angelica/0000-0002-2620-7750; Jalife, Jose/0000-0003-0080-3500; Calvo, Conrado/0000-0002-1700-4863; Berenfeld, Omer/0000-0001-9532-7871	National Heart, Lung, and Blood Institute [P01-HL039707, P01-HL087226, R01-HL080159, R01 HL60843]; Leducq Foundation; American Heart Association (AHA); University of Michigan Center for Structural Biology; Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia, Mexico [CB-2008-01-105941]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL039707, R01HL080159, R01HL060843, P01HL087226] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation(Leducq Foundation); American Heart Association (AHA)(American Heart Association); University of Michigan Center for Structural Biology(University of Michigan System); Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by National Heart, Lung, and Blood Institute grants P01-HL039707, P01-HL087226, R01-HL080159, and R01 HL60843; the Leducq Foundation, (J.J.), an American Heart Association (AHA) Scientist Development Grant (S.P.); an AHA Postdoctoral Fellowship (S.F.N.); the University of Michigan Center for Structural Biology; and Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia, Mexico, grant CB-2008-01-105941 (J.A.S.C.). The authors thank Elliot Wang and Drs. Steven R. Ennis and Jerome Kalifa for technical assistance and useful discussions.	Atienza F, 2006, CIRCULATION, V114, P2434, DOI 10.1161/CIRCULATIONAHA.106.633735; Avina-Zubieta JA, 1998, ANN RHEUM DIS, V57, P582, DOI 10.1136/ard.57.10.582; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; Benavides-Haro DE, 2000, N-S ARCH PHARMACOL, V361, P311, DOI 10.1007/s002109900185; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURRELL ZL, 1958, NEW ENGL J MED, V258, P798, DOI 10.1056/NEJM195804172581608; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Dobrev D, 2002, CARDIOVASC RES, V54, P397, DOI 10.1016/S0008-6363(01)00555-7; Ehrlich JR, 2008, J CARDIOVASC PHARM, V52, P129, DOI 10.1097/FJC.0b013e31816c4325; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita A, 2000, PHARMACOL THERAPEUT, V85, P39, DOI 10.1016/S0163-7258(99)00050-9; GRAY RA, 1995, CIRCULATION, V91, P2454, DOI 10.1161/01.CIR.91.9.2454; Gribble FM, 2000, BRIT J PHARMACOL, V131, P756, DOI 10.1038/sj.bjp.0703638; Haissaguerre M, 2009, J CARDIOVASC ELECTR, V20, P93, DOI 10.1111/j.1540-8167.2008.01326.x; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; KUJANIK S, 2007, ACTA MED MARTINIANA, V7, P3; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lu CW, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040816; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mzayek Fawaz, 2007, PLoS Clin Trials, V2, pe6, DOI 10.1371/journal.pctr.0020006; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Pandit SV, 2005, BIOPHYS J, V88, P3806, DOI 10.1529/biophysj.105.060459; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Peters S, 2007, EUROPACE, V9, P162, DOI 10.1093/europace/eul188; Ponce-Balbuena D, 2009, J PHARMACOL EXP THER, V331, P563, DOI 10.1124/jpet.109.156075; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Priori SG, 2004, ANN NY ACAD SCI, V1015, P96, DOI 10.1196/annals.1302.008; Rodriguez-Menchaca AA, 2008, P NATL ACAD SCI USA, V105, P1364, DOI 10.1073/pnas.0708153105; Saksena S, 2001, PACE, V24, P1435, DOI 10.1046/j.1460-9592.2001.01435.x; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; Sanchez-Capula JA, 2001, J PHARMACOL EXP THER, V297, P437; Sarmast F, 2003, CARDIOVASC RES, V59, P863, DOI 10.1016/S0008-6363(03)00540-6; Sowunmi A, 1999, T ROY SOC TROP MED H, V93, P78, DOI 10.1016/S0035-9203(99)90189-X; Tie H, 2000, BRIT J PHARMACOL, V130, P1967, DOI 10.1038/sj.bjp.0703470; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Uchida T, 1999, CIRCULATION, V99, P704, DOI 10.1161/01.CIR.99.5.704; Varro A, 2004, CURR MED CHEM, V11, P1, DOI 10.2174/0929867043456296; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD222, DOI 10.1093/nar/gkm800; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Zhang L, 2005, CIRCULATION, V111, pE222	42	43	45	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4302	4312		10.1096/fj.10-163246	http://dx.doi.org/10.1096/fj.10-163246			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20585026	Green Submitted, Green Published			2022-12-25	WOS:000283861100018
J	Cho, HH; Cahill, CM; Vanderburg, CR; Scherzer, CR; Wang, B; Huang, XD; Rogers, JT				Cho, Hyun-Hee; Cahill, Catherine M.; Vanderburg, Charles R.; Scherzer, Clemens R.; Wang, Bin; Huang, Xudong; Rogers, Jack T.			Selective Translational Control of the Alzheimer Amyloid Precursor Protein Transcript by Iron Regulatory Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; RESPONSIVE-ELEMENT; RNA-BINDING; NEURODEGENERATIVE DISEASE; PHOSPHOMIMETIC MUTATION; 5'-UNTRANSLATED REGION; TARGETED DELETION; ALPHA-SYNUCLEIN; BRAIN IRON; FERRITIN	Iron influx increases the translation of the Alzheimer amyloid precursor protein (APP) via an iron-responsive element (IRE) RNA stem loop in its 5'-untranslated region. Equal modulated interaction of the iron regulatory proteins (IRP1 and IRP2) with canonical IREs controls iron-dependent translation of the ferritin subunits. However, our immunoprecipitation RT-PCR and RNA binding experiments demonstrated that IRP1, but not IRP2, selectively bound the APP IRE in human neural cells. This selective IRP1 interaction pattern was evident in human brain and blood tissue from normal and Alzheimer disease patients. We computer-predicted an optimal novel RNA stem loop structure for the human, rhesus monkey, and mouse APP IREs with reference to the canonical ferritin IREs but also the IREs encoded by erythroid heme biosynthetic aminolevulinate synthase and Hif-2 alpha mRNAs, which preferentially bind IRP1. Selective 2'-hydroxyl acylation analyzed by primer extension analysis was consistent with a 13-base single-stranded terminal loop and a conserved GC-rich stem. Biotinylated RNA probes deleted of the conserved CAGA motif in the terminal loop did not bind to IRP1 relative to wild type probes and could no longer base pair to form a predicted AGA triloop. An AGU pseudo-triloop is key for IRP1 binding to the canonical ferritin IREs. RNA probes encoding the APP IRE stem loop exhibited the same high affinity binding to rhIRP1 as occurs for the H-ferritin IRE (35pM). Intracellular iron chelation increased binding of IRP1 to the APP IRE, decreasing intracellular APP expression in SH-SY5Y cells. Functionally, shRNA knockdown of IRP1 caused increased expression of neural APP consistent with IRP1-APP IRE-driven translation.	[Cahill, Catherine M.; Rogers, Jack T.] Harvard Univ, Massachusetts Gen Hosp, Neurochem Lab, Dept Psychiat Neurosci,Sch Med, Charlestown, MA 02129 USA; [Vanderburg, Charles R.] Massachusetts Gen Hosp, Harvard NeuroDiscovery Ctr, Boston, MA 02129 USA; [Wang, Bin] Marshall Univ, Dept Chem, Huntington, WV 25755 USA; [Scherzer, Clemens R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Huang, Xudong] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Marshall University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cahill, CM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Neurochem Lab, Dept Psychiat Neurosci,Sch Med, Bldg 149,Rm 2510,13th St, Charlestown, MA 02129 USA.	ccahill@helix.mgh.harvard.edu; jrogers@partners.org	Huang, Xudong/D-9711-2018; Vanderburg, Charles/C-4516-2013	Huang, Xudong/0000-0002-4811-1901; Rogers, Jack/0000-0003-1262-8578; Scherzer, Clemens/0000-0002-0567-9193; Vanderburg, Charles/0000-0001-8979-5054	National Institutes of Health [AG20181]; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant AG20181 (to J. T. R.). This work was also supported by a Zenith award from the Alzheimer's Association (to J. T. R.).	Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Allerson CR, 1999, J BIOL CHEM, V274, P26439, DOI 10.1074/jbc.274.37.26439; Avramovich-Tirosh Y, 2007, J NEUROCHEM, V100, P490, DOI 10.1111/j.1471-4159.2006.04258.x; Bandyopadhyay S, 2006, J NEURAL TRANSM-SUPP, P237; Bartzokis G, 2004, ANN NY ACAD SCI, V1012, P224, DOI 10.1196/annals.1306.019; Beaudoin ME, 2008, NUCLEIC ACIDS RES, V36, P6835, DOI 10.1093/nar/gkn792; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Cahill CM, 2009, BBA-GEN SUBJECTS, V1790, P615, DOI 10.1016/j.bbagen.2008.12.001; Chen GH, 2007, CARCINOGENESIS, V28, P785, DOI 10.1093/carcin/bgl210; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; CONNOR JR, 1995, J NEUROCHEM, V65, P717; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; dos Santos CO, 2008, J BIOL CHEM, V283, P26956, DOI 10.1074/jbc.M802421200; Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; Fillebeen C, 2005, BIOCHEM J, V388, P143, DOI 10.1042/BJ20041623; Fillebeen C, 2003, MOL CELL BIOL, V23, P6973, DOI 10.1128/MCB.23.19.6973-6981.2003; Fischer P, 1997, LIFE SCI, V60, P2273, DOI 10.1016/S0024-3205(97)00282-8; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Galy B, 2006, NAT GENET, V38, P967, DOI 10.1038/ng0906-967; Ghosh MC, 2008, P NATL ACAD SCI USA, V105, P12028, DOI 10.1073/pnas.0805361105; Goforth JB, 2010, RNA, V16, P154, DOI 10.1261/rna.1857210; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Janssen S, 2010, BIOINFORMATICS, V26, P632, DOI 10.1093/bioinformatics/btq014; Jefferies WA, 2001, J ALZHEIMERS DIS, V3, P339, DOI 10.3233/JAD-2001-3309; JELLINGER K, 1990, J NEURAL TRANSM-PARK, V2, P327, DOI 10.1007/BF02252926; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2000, BIOCHEMISTRY-US, V39, P6235, DOI 10.1021/bi9924765; Khan MA, 2009, J BIOL CHEM, V284, P30122, DOI 10.1074/jbc.M109.041061; Kim DK, 2001, NEUROPSYCHOPHARMACOL, V25, P84, DOI 10.1016/S0893-133X(00)00230-X; KIM HY, 1995, J BIOL CHEM, V270, P4983, DOI 10.1074/jbc.270.10.4983; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Leibold EA, 2001, HISTOCHEM CELL BIOL, V115, P195; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Li HL, 2009, STRUCTURE, V17, P326, DOI 10.1016/j.str.2009.01.007; Lin E, 2001, J BIOL CHEM, V276, P27685, DOI 10.1074/jbc.M100941200; Liu GJ, 2006, J STRUCT BIOL, V155, P45, DOI 10.1016/j.jsb.2005.12.011; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maloney B, 2004, FASEB J, V18, P1288, DOI 10.1096/fj.03-1703fje; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Morse LJ, 2004, J MOL NEUROSCI, V24, P129, DOI 10.1385/JMN:24:1:129; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Pinero DJ, 2000, CELL MOL BIOL, V46, P761; Pitula JS, 2004, P NATL ACAD SCI USA, V101, P10907, DOI 10.1073/pnas.0404308101; Reznichenko L, 2006, J NEUROCHEM, V97, P527, DOI 10.1111/j.1471-4159.2006.03770.x; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; ROGERS J, 2002, Patent No. 2002034766; Rogers JT, 2008, BIOCHEM SOC T, V36, P1282, DOI 10.1042/BST0361282; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; SCHUBERT D, 1995, BIOCHEM BIOPH RES CO, V216, P702, DOI 10.1006/bbrc.1995.2678; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith MA, 1997, J NEUROSCI, V17, P2653; Smith SR, 2004, ANN NY ACAD SCI, V1012, P65, DOI 10.1196/annals.1306.006; Squitti R, 2003, NEUROLOGY, V60, P2013, DOI 10.1212/01.WNL.0000068013.27968.29; Starzynski RR, 2005, J BIOL CHEM, V280, P4207, DOI 10.1074/jbc.M411055200; TANZI RE, 1991, NATURE, V350, P564, DOI 10.1038/350564a0; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Thomson AM, 2000, J BIOL CHEM, V275, P31609, DOI 10.1074/jbc.M002354200; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Westmark CJ, 2005, J NEUROPATH EXP NEUR, V64, P1037, DOI 10.1097/01.jnen.0000189835.71574.e1; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Wolfe MS, 2006, SCI AM, V294, P72, DOI 10.1038/scientificamerican0506-72; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xie ZC, 2007, J BIOL CHEM, V282, P4318, DOI 10.1074/jbc.M609293200; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004; Zumbrennen KB, 2009, MOL CELL BIOL, V29, P2219, DOI 10.1128/MCB.00004-09	91	113	121	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 8	2010	285	41					31217	31232		10.1074/jbc.M110.149161	http://dx.doi.org/10.1074/jbc.M110.149161			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	661WX	20558735	Green Published, hybrid			2022-12-25	WOS:000282764600016
J	Ballottari, M; Girardon, J; Betterle, N; Morosinotto, T; Bassi, R				Ballottari, Matteo; Girardon, Julien; Betterle, Nico; Morosinotto, Tomas; Bassi, Roberto			Identification of the Chromophores Involved in Aggregation-dependent Energy Quenching of the Monomeric Photosystem II Antenna Protein Lhcb5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING-COMPLEX; TIME-RESOLVED FLUORESCENCE; PIGMENT-PIGMENT INTERACTIONS; A/B BINDING-PROTEINS; FAR-RED FLUORESCENCE; HIGHER-PLANT ANTENNA; CHLOROPHYLL FLUORESCENCE; MUTATION ANALYSIS; IN-VITRO; ELECTRON CRYSTALLOGRAPHY	Non-photochemical quenching (NPQ) of excess absorbed light energy is a fundamental process that regulates photosynthetic light harvesting in higher plants. Among several proposed NPQ mechanisms, aggregation-dependent quenching (ADQ) and charge transfer quenching have received the most attention. In vitro spectroscopic features of both mechanisms correlate with very similar signals detected in more intact systems and in vivo, where full NPQ can be observed. A major difference between the models is the proposed quenching site, which is predominantly the major trimeric light-harvesting complex II in ADQ and exclusively monomeric Lhcb proteins in charge transfer quenching. Here, we studied ADQ in both monomeric and trimeric Lhcb proteins, investigating the activities of each antenna subunit and their dependence on zeaxanthin, a major modulator of NPQ in vivo. We found that monomeric Lhcb proteins undergo stronger quenching than light-harvesting complex II during aggregation and that this is enhanced by binding to zeaxanthin, as occurs during NPQ in vivo. Finally, the analysis of Lhcb5 mutants showed that chlorophyll 612 and 613, in close contact with lutein bound at site L1, are important facilitators of ADQ.	[Ballottari, Matteo; Girardon, Julien; Betterle, Nico; Bassi, Roberto] Univ Verona, Dipartimento Biotecnol, I-37134 Verona, Italy; [Morosinotto, Tomas] Univ Padua, Dipartimento Biol, I-35121 Padua, Italy	University of Verona; University of Padua	Bassi, R (corresponding author), Univ Verona, Dipartimento Biotecnol, Ca Vignal 1,Str Grazie 15, I-37134 Verona, Italy.	roberto.bassi@univr.it	Morosinotto, Tomas/AAC-3188-2019; Ballottari, Matteo/N-1916-2019; Betterle, Nico/AAE-1004-2021	Morosinotto, Tomas/0000-0002-0803-7591; Ballottari, Matteo/0000-0001-8410-3397; Betterle, Nico/0000-0002-7556-6696; bassi, roberto/0000-0002-4140-8446	Italian Ministry of Research [20073YHRLE]; EU [238017]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); EU(European Commission)	This work was supported by Italian Ministry of Research Special Fund for Basic Research Grant PRIN 20073YHRLE and by EU project 238017 HARVEST.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-71; Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; BARZDA V, 1994, BIOCHEMISTRY-US, V33, P10837, DOI 10.1021/bi00201a034; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; BASSI R, 1991, J PHOTOCH PHOTOBIO B, V9, P335, DOI 10.1016/1011-1344(91)80170-M; Berera R, 2006, P NATL ACAD SCI USA, V103, P5343, DOI 10.1073/pnas.0508530103; BETTERLE N, 2010, ARCH BIOCH IN PRESS; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Calhoun TR, 2009, J PHYS CHEM B, V113, P16291, DOI 10.1021/jp908300c; Cellini B, 2006, BIOCHEMISTRY-US, V45, P14140, DOI 10.1021/bi061496l; Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; DAINESE P, 1991, J BIOL CHEM, V266, P8136; DAINESE P, 1992, RES PHOTOSYNTHESIS, V1, P13; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Gastaldelli M, 2003, J BIOL CHEM, V278, P19190, DOI 10.1074/jbc.M212125200; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; HORTON P, 1988, BIOCHIM BIOPHYS ACTA, V932, P107, DOI 10.1016/0005-2728(88)90144-2; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; HORTON P, 1992, PHOTOSYNTH RES, V34, P375, DOI 10.1007/BF00029812; Jahns P, 2001, J BIOL CHEM, V276, P22154, DOI 10.1074/jbc.M102147200; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Johnson MP, 2009, J BIOL CHEM, V284, P23592, DOI 10.1074/jbc.M109.013557; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KUHLBRANDT W, 1991, NATURE, V350, P130, DOI 10.1038/350130a0; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, PLANT CELL, V21, P1798, DOI 10.1105/tpc.109.066571; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Morosinotto T, 2005, J BIOL CHEM, V280, P20612, DOI 10.1074/jbc.M500705200; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; MULLINEAUX CW, 1993, BIOCHIM BIOPHYS ACTA, V1141, P23, DOI 10.1016/0005-2728(93)90184-H; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; NOCTOR G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P320, DOI 10.1016/S0005-2728(05)80143-4; Novoderezhkin VI, 2005, J PHYS CHEM B, V109, P10493, DOI 10.1021/jp044082f; Pagano A, 1998, J BIOL CHEM, V273, P17154, DOI 10.1074/jbc.273.27.17154; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Passarini F, 2009, J BIOL CHEM, V284, P29536, DOI 10.1074/jbc.M109.036376; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Rogl H, 1999, BIOCHEMISTRY-US, V38, P16214, DOI 10.1021/bi990739p; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2009, PHOTOSYNTH RES, V99, P173, DOI 10.1007/s11120-008-9387-x; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 1996, BIOCHEMISTRY-US, V35, P674, DOI 10.1021/bi9524878; RUBAN AV, 1994, PHOTOSYNTH RES, V40, P181, DOI 10.1007/BF00019335; RUBAN AV, 1991, BIOCHIM BIOPHYS ACTA, V1059, P355, DOI 10.1016/S0005-2728(05)80221-X; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; van Oort B, 2007, FEBS LETT, V581, P3528, DOI 10.1016/j.febslet.2007.06.070; van Oort B, 2010, BIOPHYS J, V98, P922, DOI 10.1016/j.bpj.2009.11.012; Wehner A, 2006, J BIOL CHEM, V281, P21924, DOI 10.1074/jbc.M602915200; Wentworth M, 2004, BIOCHEMISTRY-US, V43, P501, DOI 10.1021/bi034975i; Wentworth M, 2000, FEBS LETT, V471, P71, DOI 10.1016/S0014-5793(00)01369-7; Wentworth M, 2001, BIOCHEMISTRY-US, V40, P9902, DOI 10.1021/bi0103718	92	30	31	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28309	28321		10.1074/jbc.M110.124115	http://dx.doi.org/10.1074/jbc.M110.124115			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20584907	hybrid, Green Published			2022-12-25	WOS:000281404100073
J	Okazaki, Y; Ohshima, N; Yoshizawa, I; Kamei, Y; Mariggio, S; Okamoto, K; Maeda, M; Nogusa, Y; Fujioka, Y; Izumi, T; Ogawa, Y; Shiro, Y; Wada, M; Kato, N; Corda, D; Yanaka, N				Okazaki, Yuri; Ohshima, Noriyasu; Yoshizawa, Ikumi; Kamei, Yasutomi; Mariggio, Stefania; Okamoto, Keiko; Maeda, Masahiro; Nogusa, Yoshihito; Fujioka, Yuichiro; Izumi, Takashi; Ogawa, Yoshihiro; Shiro, Yoshitsugu; Wada, Masanobu; Kato, Norihisa; Corda, Daniela; Yanaka, Noriyuki			A Novel Glycerophosphodiester Phosphodiesterase, GDE5, Controls Skeletal Muscle Development via a Non-enzymatic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ALPHA-DEFENSINS; PROTEIN; METABOLISM; ENZYME; GLPQ; GENE; DIFFERENTIATION; EXPRESSION; CHOLINE	Mammalian glycerophosphodiester phosphodiesterases (GP-PDEs) have been identified recently and shown to be implicated in several physiological functions. This study isolated a novel GP-PDE, GDE5, and showed that GDE5 selectively hydrolyzes glycerophosphocholine (GroPCho) and controls skeletal muscle development. We show that GDE5 expression was reduced in atrophied skeletal muscles in mice and that decreasing GDE5 abundance promoted myoblastic differentiation, suggesting that decreased GDE5 expression has a counter-regulatory effect on the progression of skeletal muscle atrophy. Forced expression of full-length GDE5 in cultured myoblasts suppressed myogenic differentiation. Unexpectedly, a truncated GDE5 construct (GDE5 Delta C471), which contained a GP-PDE sequence identified in other GP-PDEs but lacked GroPCho phosphodiesterase activity, showed a similar inhibitory effect. Furthermore, transgenic mice specifically expressing GDE5 Delta C471 in skeletal muscle showed less skeletal muscle mass, especially type II fiber-rich muscle. These results indicate that GDE5 negatively regulates skeletal muscle development even without GroPCho phosphodiesterase activity, providing novel insight into the biological significance of mammalian GP-PDE function in a non-enzymatic mechanism.	[Okazaki, Yuri; Yoshizawa, Ikumi; Okamoto, Keiko; Maeda, Masahiro; Nogusa, Yoshihito; Fujioka, Yuichiro; Kato, Norihisa; Yanaka, Noriyuki] Hiroshima Univ, Dept Mol & Appl Biosci, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Ohshima, Noriyasu; Izumi, Takashi] Gunma Univ, Dept Biochem, Grad Sch Med, Gunma 3718511, Japan; [Kamei, Yasutomi; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Dept Mol Med & Metab, Med Res Inst, Tokyo 1138510, Japan; [Mariggio, Stefania; Corda, Daniela] Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Italy; [Mariggio, Stefania; Corda, Daniela] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Shiro, Yoshitsugu] RIKEN SPring 8 Ctr, Harima Inst, Hongo 6795148, Japan; [Wada, Masanobu] Hiroshima Univ, Dept Human Sci, Grad Sch Integrated Arts & Sci, Higashihiroshima 7398521, Japan	Hiroshima University; Gunma University; Tokyo Medical & Dental University (TMDU); Consorzio Mario Negri Sud; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); RIKEN; Hiroshima University	Yanaka, N (corresponding author), Hiroshima Univ, Dept Mol & Appl Biosci, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan.	yanaka@hiroshima-u.ac.jp	Shiro, Yoshitsugu Y/J-3757-2014; Corda, Daniela/K-6385-2016; Mariggio', Stefania/H-5467-2015; Yanaka, Noriyuki/P-9096-2016	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Corda, Daniela/0000-0002-3614-751X; Mariggio', Stefania/0000-0002-6397-3016; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Telethon Italia	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Telethon Italia(Fondazione Telethon)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by Telethon Italia.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Bachmann AS, 2006, GENE, V371, P144, DOI 10.1016/j.gene.2005.11.023; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; BURG MB, 1995, AM J PHYSIOL-RENAL, V268, pF983, DOI 10.1152/ajprenal.1995.268.6.F983; BURT CT, 1976, BIOCHEMISTRY-US, V15, P4850, DOI 10.1021/bi00667a015; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; Corda D, 2009, CELL MOL LIFE SCI, V66, P3449, DOI 10.1007/s00018-009-0113-4; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Fan X, 2001, MOL MICROBIOL, V41, P1029, DOI 10.1046/j.1365-2958.2001.02571.x; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Filippi BM, 2008, BBA-MOL CELL RES, V1783, P2311, DOI 10.1016/j.bbamcr.2008.07.021; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Gallazzini M, 2008, P NATL ACAD SCI USA, V105, P11026, DOI 10.1073/pnas.0805496105; Gallazzini M, 2006, P NATL ACAD SCI USA, V103, P15260, DOI 10.1073/pnas.0607133103; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; Ghedini PC, 2008, MUSCLE NERVE, V38, P1585, DOI 10.1002/mus.21183; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; Han WH, 2009, FEBS J, V276, P6603, DOI 10.1111/j.1742-4658.2009.07370.x; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kang H, 2007, J NEUROSCI, V27, P5948, DOI 10.1523/JNEUROSCI.0621-07.2007; KATES M, 1972, LABORATORY TECHNIQUE, V3, P347; LARSON TJ, 1988, ARCH BIOCHEM BIOPHYS, V260, P577, DOI 10.1016/0003-9861(88)90484-5; LARSON TJ, 1983, J BIOL CHEM, V258, P5428; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; Mancini R, 2003, MOL BIOL CELL, V14, P503, DOI 10.1091/mbc.E02-04-0179; Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje; Nogusa Y, 2004, GENE, V337, P173, DOI 10.1016/j.gene.2004.04.026; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Sprott H, 2000, RHEUMATOLOGY, V39, P1121, DOI 10.1093/rheumatology/39.10.1121; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; Turchanowa L, 2000, EUR J CLIN INVEST, V30, P72; van der Rest B, 2004, BIOCHEM J, V379, P601, DOI 10.1042/BJ20031489; van der Rest B, 2002, PLANT PHYSIOL, V130, P244, DOI 10.1104/pp.003392; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035; YOUNKIN DP, 1987, NEUROLOGY, V37, P165, DOI 10.1212/WNL.37.1.165; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zheng B, 2000, P NATL ACAD SCI USA, V97, P3999, DOI 10.1073/pnas.97.8.3999; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	51	42	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27652	27663		10.1074/jbc.M110.106708	http://dx.doi.org/10.1074/jbc.M110.106708			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576599	Green Published, hybrid			2022-12-25	WOS:000281404100021
J	Ruan, L; Osawa, M; Hosoda, N; Imai, S; Machiyama, A; Katada, T; Hoshino, S; Shimada, I				Ruan, Lin; Osawa, Masanori; Hosoda, Nao; Imai, Shunsuke; Machiyama, Asako; Katada, Toshiaki; Hoshino, Shin-ichi; Shimada, Ichio			Quantitative Characterization of Tob Interactions Provides the Thermodynamic Basis for Translation Termination-coupled Deadenylase Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A)-BINDING PROTEIN; ANTIPROLIFERATIVE ACTIVITY; STRUCTURAL BASIS; TOB/BTG1 FAMILY; MEMBER; RECOGNITION; DOMAIN; YEAST; PABC; TURNOVER	Translation termination-coupled deadenylation is the first and often the rate-limiting step of eukaryotic mRNA decay in which two deadenylases, Ccr4-Caf1 and Pan2, play key roles. One of the deadenylases, Caf1, associates with Tob, which recruits Caf1 to the poly(A) tail through interactions with a cytoplasmic poly(A)-binding protein 1 (PABPC1). We previously proposed that the competition between Tob and eRF3 (a translation termination factor that interacts with PABPC1) is responsible for the regulation of deadenylase activity. However, the molecular mechanism of the regulation should be addressed by investigating the binding affinity and the cellular levels of these proteins. In this work, we characterized the human Tob interactions with Caf1 and a C-terminal domain of PABPC1 (PABC). Nuclear magnetic resonance (NMR) and Western blot analyses revealed that Tob consists of a structured N-terminal BTG-Tob domain and an unstructured C-terminal region with two conserved PAM2 (PABPC1-interacting motif 2) motifs. The BTG-TOB domain associates with Caf1, whereas the C-terminal PAM2 motif binds to PABC, with a K-d value of 20 mu M. Furthermore, we demonstrated that the levels of eRF3 and Tob in HeLa cells are 4-5 mu M and less than 0.2 mu M, respectively. On the basis of these results, we propose a thermodynamic mechanism for the translation termination-coupled deadenylation mediated by the Tob-Caf1 complex.	[Ruan, Lin; Osawa, Masanori; Imai, Shunsuke; Machiyama, Asako; Shimada, Ichio] Univ Tokyo, Dept Phys Chem, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Katada, Toshiaki] Univ Tokyo, Dept Physiol Chem, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Hosoda, Nao; Hoshino, Shin-ichi] Nagoya City Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan	University of Tokyo; University of Tokyo; Nagoya City University; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp	Osawa, Masanori/GRS-5726-2022	Hoshino, Shinichi/0000-0001-6135-7896; Osawa, Masanori/0000-0002-1285-4316; Imai, Shunsuke/0000-0001-9346-2359	Japan New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology; Takeda Science Foundation	Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Economy, Trade, and Industry (METI); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Japan New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade, and Industry (METI) (to I. S.), a grant-in-aid for scientific research on priority areas from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to M. O. and I. S.), and a grant from the Takeda Science Foundation (to M. O.).	Albrecht M, 2004, BIOCHEM BIOPH RES CO, V316, P129, DOI 10.1016/j.bbrc.2004.02.024; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Goddard T.D., 2004, SPARKY 3; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Kozlov G, 2004, EMBO J, V23, P272, DOI 10.1038/sj.emboj.7600048; Kozlov G, 2010, J MOL BIOL, V397, P397, DOI 10.1016/j.jmb.2010.01.032; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Matsuda S, 1996, ONCOGENE, V12, P705; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805	26	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27624	27631		10.1074/jbc.M110.138867	http://dx.doi.org/10.1074/jbc.M110.138867			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595394	Green Published, hybrid			2022-12-25	WOS:000281404100018
J	Lin, T; Ponn, A; Hu, X; Law, BK; Lu, J				Lin, T.; Ponn, A.; Hu, X.; Law, B. K.; Lu, J.			Requirement of the histone demethylase LSD1 in Snail-mediated transcriptional repression during epithelial-mesenchymal transition	ONCOGENE			English	Article						EMT; E-cadherin; Snail; histone modifications; LSD1; bivalent	E-CADHERIN REPRESSION; LYSINE DEMETHYLASES; TUMOR PROGRESSION; GENE-EXPRESSION; CHROMATIN; PROTEIN; DIFFERENTIATION; METHYLATION; DISEASE; COMPLEX	Epithelial-mesenchymal transition (EMT) has pivotal roles during embryonic development and carcinoma progression. Members of the Snai1 family of zinc finger transcription factors are central mediators of EMT and induce EMT in part by directly repressing epithelial markers such as E-cadherin, a gatekeeper of the epithelial phenotype and a suppressor of tumor invasion. However, the molecular mechanism underlying Snai1-mediated transcriptional repression remains incompletely understood. Here we show that Snai1 physically interacts with and recruits the histone demethylase LSD1 (KDM1A) to epithelial gene promoters. LSD1 removes dimethylation of lysine 4 on histone H3 (H3K4m2), a covalent histone modification associated with active chromatin. Importantly, LSD1 is essential for Snai1-mediated transcriptional repression and for maintenance of the silenced state of Snai1 target genes in invasive cancer cells. In the absence of LSD1, Snai1 fails to repress E-cadherin. In cancer cells in which E-cadherin is silenced, depletion of LSD1 results in partial de-repression of epithelial genes and elevated H3K4m2 levels at the E-cadherin promoter. These results underline the critical role of LSD1 in Snai1-dependent transcriptional repression of epithelial markers and suggest that the LSD1 complex could be a potential therapeutic target for prevention of EMT-associated tumor invasion. Oncogene (2010) 29, 4896-4904; doi: 10.1038/onc.2010.234; published online 21 June 2010	[Lin, T.; Ponn, A.; Hu, X.; Lu, J.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Law, B. K.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Hu, X.] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Jilin University	Lu, J (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, POB 103633, Gainesville, FL 32610 USA.	jrlu@ufl.edu	Lin, Tong/G-4105-2012; Law, Brian/L-6043-2019; Lu, Jianrong/F-5240-2013	Lu, Jianrong/0000-0002-4969-6040	Stop! Children's Cancer, Florida Bankhead-Coley Cancer Research Program [09BN-12-23092]; The National Cancer Institute [R01CA137021]; University of Florida, Gainesville, FL, USA; NATIONAL CANCER INSTITUTE [R01CA137021] Funding Source: NIH RePORTER	Stop! Children's Cancer, Florida Bankhead-Coley Cancer Research Program; The National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Florida, Gainesville, FL, USA(University of Florida); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We appreciate technical assistance from Linbao Ai and Heiman Wang. We are grateful to Mien-Chie Hung (MD Anderson Cancer Center, Texas, USA), M Angela Nieto (Instituto de Neurociencias CSIC-UMH, Spain), Suming Huang, Yi Qiu and Lizi Wu for kindly providing reagents. We thank Mike Kilberg and Jorg Bungert for critical reading of the paper. This study was supported by grants to JL from Stop! Children's Cancer, Florida Bankhead-Coley Cancer Research Program (09BN-12-23092), The National Cancer Institute (R01CA137021) and to AP from the University Scholars Program at University of Florida, Gainesville, FL, USA.	Ao A, 2008, P NATL ACAD SCI USA, V105, P7821, DOI 10.1073/pnas.0711677105; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hajra KM, 2002, CANCER RES, V62, P1613; Hay ED, 1995, ACTA ANAT, V154, P8; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	33	205	219	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	35					4896	4904		10.1038/onc.2010.234	http://dx.doi.org/10.1038/onc.2010.234			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	646XP	20562920	Green Accepted			2022-12-25	WOS:000281578700004
J	Jeelani, G; Husain, A; Sato, D; Ali, V; Suematsu, M; Soga, T; Nozaki, T				Jeelani, Ghulam; Husain, Afzal; Sato, Dan; Ali, Vahab; Suematsu, Makoto; Soga, Tomoyoshi; Nozaki, Tomoyoshi			Two Atypical L-Cysteine-regulated NADPH-dependent Oxidoreductases Involved in Redox Maintenance, L-Cystine and Iron Reduction, and Metronidazole Activation in the Enteric Protozoan Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE SYNTHASE; ESCHERICHIA-COLI; NAD(P)H-FLAVIN OXIDOREDUCTASE; HYPERTHERMOPHILIC ARCHAEON; HYDROGEN-PEROXIDE; GIARDIA-LAMBLIA; SMALL-SUBUNIT; FERREDOXIN; CLONING; COMPLEX	We discovered novel catalytic activities of two atypical NADPH-dependent oxidoreductases (EhNO1/2) from the enteric protozoan parasite Entamoeba histolytica. EhNO1/2 were previously annotated as the small subunit of glutamate synthase (glutamine: 2-oxoglutarate amidotransferase) based on similarity to authentic bacterial homologs. As E. histolytica lacks the large subunit of glutamate synthase, EhNO1/2 were presumed to play an unknown role other than glutamine/glutamate conversion. Transcriptomic and quantitative reverse PCR analyses revealed that supplementation or deprivation of extracellular L-cysteine caused dramatic up- or down-regulation, respectively, of EhNO2, but not EhNO1 expression. Biochemical analysis showed that these FAD-and 2[4Fe-4S]-containing enzymes do not act as glutamate synthases, a conclusion which was supported by phylogenetic analyses. Rather, they catalyze the NADPH-dependent reduction of oxygen to hydrogen peroxide and L-cystine to L-cysteine and also function as ferric and ferredoxin-NADP(+) reductases. EhNO1/2 showed notable differences in substrate specificity and catalytic efficiency; EhNO1 had lower K-m and higher k(cat)/K-m values for ferric ion and ferredoxin than EhNO2, whereas EhNO2 preferred L-cystine as a substrate. In accordance with these properties, only EhNO1 was observed to physically interact with intrinsic ferredoxin. Interestingly, EhNO1/2 also reduced metronidazole, and E. histolytica transformants overexpressing either of these proteins were more sensitive to metronidazole, suggesting that EhNO1/2 are targets of this anti-amebic drug. To date, this is the first report to demonstrate that small subunit-like proteins of glutamate synthase could play an important role in redox maintenance, L-cysteine/L-cystine homeostasis, iron reduction, and the activation of metronidazole.	[Jeelani, Ghulam; Husain, Afzal; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Jeelani, Ghulam] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Sato, Dan; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Ali, Vahab] Rajendra Mem Res Inst Med Sci, Dept Biochem, Patna 800007, Bihar, India; [Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, Tokyo 1608582, Japan	National Institute of Infectious Diseases (NIID); Keio University; Keio University; Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Keio University	Nozaki, T (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	nozaki@nih.go.jp	Suematsu, Makoto/I-8135-2013; Suematsu, Makoto/O-5762-2018; Soga, Tomoyoshi/B-8105-2014; HUSAIN, AFZAL/GRO-1733-2022	Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Soga, Tomoyoshi/0000-0001-9502-2509; HUSAIN, AFZAL/0000-0002-6627-5520	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18GS0314, 18050006, 18073001]; Ministry of Health, Labour, and Welfare of Japan [H20-Shinkosaiko-016]; Japan Health Sciences Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation	This work was supported by Grants-in-aid for Scientific Research 18GS0314, 18050006, and 18073001 (to T. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labour, and Welfare of Japan (H20-Shinkosaiko-016), and a grant for research to promote the development of anti-AIDS pharmaceuticals from the Japan Health Sciences Foundation (to T. N.).	Andersson JO, 2002, EUKARYOT CELL, V1, P304, DOI 10.1128/EC.1.2.304-310.2002; [Anonymous], 1997, Epidemiol Bull, V18, P13; BAND RN, 1979, J PROTOZOOL, V26, P282, DOI 10.1111/j.1550-7408.1979.tb02781.x; Barchini E, 1996, ARCH MICROBIOL, V166, P51, DOI 10.1007/s002030050354; Bracha Rivka, 2006, PLoS Pathog, V2, pe48, DOI 10.1371/journal.ppat.0020048; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruchhaus I, 1997, BIOCHEM J, V326, P785, DOI 10.1042/bj3260785; CHEN JS, 1979, ANAL BIOCHEM, V93, P216, DOI 10.1016/S0003-2697(79)80140-2; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; Deane SM, 1996, GENE, V177, P261, DOI 10.1016/0378-1119(96)00282-X; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; FOUST GP, 1969, J BIOL CHEM, V244, P964; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; GILLIN FD, 1981, EXP PARASITOL, V51, P382, DOI 10.1016/0014-4894(81)90125-9; GILLIN FD, 1981, EXP PARASITOL, V52, P9, DOI 10.1016/0014-4894(81)90055-2; GILLIN FD, 1980, J PROTOZOOL, V27, P474, DOI 10.1111/j.1550-7408.1980.tb05402.x; GOLDMAN P, 1986, BIOCHEM PHARMACOL, V35, P43, DOI 10.1016/0006-2952(86)90553-8; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.mi.48.100194.003523; Hoffman JS, 2001, CURR OPIN GASTROEN, V17, P30, DOI 10.1097/00001574-200101000-00006; ICHIKAWA Y, 1980, FLAVINS FLAVOPROTEIN, P677; INOUYE S, 1994, FEBS LETT, V347, P163, DOI 10.1016/0014-5793(94)00528-1; JABLONSKI E, 1978, BIOCHEMISTRY-US, V17, P672, DOI 10.1021/bi00597a018; Jongsareejit B, 1997, MOL GEN GENET, V254, P635, DOI 10.1007/s004380050461; KERSCHER L, 1982, TRENDS BIOCHEM SCI, V7, P371, DOI 10.1016/0968-0004(82)90118-9; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Latimer MT, 1996, J BIOL CHEM, V271, P24023, DOI 10.1074/jbc.271.39.24023; Leao-Helder AN, 2004, FEBS LETT, V577, P491, DOI 10.1016/j.febslet.2004.10.055; Leitsch D, 2007, PLOS BIOL, V5, P1820, DOI 10.1371/journal.pbio.0050211; LESUISSE E, 1990, BIOCHIM BIOPHYS ACTA, V1038, P253, DOI 10.1016/0167-4838(90)90213-Y; LO HS, 1980, MOL BIOCHEM PARASIT, V2, P23, DOI 10.1016/0166-6851(80)90045-6; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; LUDLUM DB, 1988, CARCINOGENESIS, V9, P593, DOI 10.1093/carcin/9.4.593; Maralikova B, 2010, CELL MICROBIOL, V12, P331, DOI 10.1111/j.1462-5822.2009.01397.x; Morandi P, 2000, BIOCHEMISTRY-US, V39, P727, DOI 10.1021/bi9920329; MORENO SNJ, 1985, ENVIRON HEALTH PERSP, V64, P199, DOI 10.2307/3430010; MULLER M, 1986, BIOCHEM PHARMACOL, V35, P37, DOI 10.1016/0006-2952(86)90552-6; MULLER M, 1983, SURGERY, V93, P165; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; Nakada-Tsukui K, 2009, CELL MICROBIOL, V11, P1471, DOI 10.1111/j.1462-5822.2009.01341.x; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Olson JW, 2000, BIOCHEMISTRY-US, V39, P16213, DOI 10.1021/bi001744s; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Pal D, 2009, ANTIMICROB AGENTS CH, V53, P458, DOI 10.1128/AAC.00909-08; PELANDA R, 1993, J BIOL CHEM, V268, P3099; RATTI S, 1985, J BACTERIOL, V163, P724, DOI 10.1128/JB.163.2.724-729.1985; REEVES RE, 1984, ADV PARASIT, V23, P105, DOI 10.1016/S0065-308X(08)60286-9; Rosenbaum K, 1998, BIOCHEMISTRY-US, V37, P17598, DOI 10.1021/bi9815997; Sambrook J, 2001, MOL CLONING LAB MANU; Saum SH, 2006, J BACTERIOL, V188, P6808, DOI 10.1128/JB.00781-06; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Srivastava M, 2001, J BIOL CHEM, V276, P15481, DOI 10.1074/jbc.M006920200; Stutz HE, 2004, BBA-GENE STRUCT EXPR, V1676, P71, DOI 10.1016/j.bbaexp.2003.11.001; THURMAN RG, 1972, EUR J BIOCHEM, V25, P420, DOI 10.1111/j.1432-1033.1972.tb01711.x; Tokoro M, 2003, J BIOL CHEM, V278, P42717, DOI 10.1074/jbc.M212414200; Toth A, 2008, FEMS MICROBIOL LETT, V282, P8, DOI 10.1111/j.1574-6968.2008.01085.x; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Vanoni MA, 1998, BIOCHEMISTRY-US, V37, P1828, DOI 10.1021/bi972342w; Vanoni MA, 1999, CELL MOL LIFE SCI, V55, P617, DOI 10.1007/s000180050319; WEINBACH EC, 1974, EXP PARASITOL, V35, P232, DOI 10.1016/0014-4894(74)90027-7; WEST SB, 1982, CHEM-BIOL INTERACT, V41, P265, DOI 10.1016/0009-2797(82)90105-3; WHO Model List of Essential Medicines, 2007, WHO MOD LIST ESS MED; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; ZANETTI G, 1988, BIOCHEMISTRY-US, V27, P3753, DOI 10.1021/bi00410a035; ZANETTI G, 1984, J BIOL CHEM, V259, P6153	71	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26889	26899		10.1074/jbc.M110.106310	http://dx.doi.org/10.1074/jbc.M110.106310			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592025	Green Published, hybrid			2022-12-25	WOS:000281172700020
J	Leonard, R; Wopfner, N; Pabst, M; Stadlmann, J; Petersen, BO; Duus, JO; Himly, M; Radauer, C; Gadermaier, G; Razzazi-Fazeli, E; Ferreira, F; Altmann, F				Leonard, Renaud; Wopfner, Nicole; Pabst, Martin; Stadlmann, Johannes; Petersen, Bent O.; Duus, Jens O.; Himly, Martin; Radauer, Christian; Gadermaier, Gabriele; Razzazi-Fazeli, Ebrahim; Ferreira, Fatima; Altmann, Friedrich			A New Allergen from Ragweed (Ambrosia artemisiifolia) with Homology to Art v 1 from Mugwort	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLLEN ALLERGENS; AMINO-ACIDS; O-GLYCANS; HYPERSENSITIVITY; GLYCOSYLATION; SENSITIZATION; PROTEINS; RESIDUES; BIOLOGY; BINDING	Art v 1, the major pollen allergen of the composite plant mugwort (Artemisia vulgaris) has been identified recently as a thionin-like protein with a bulky arabinogalactan-protein moiety. A close relative of mugwort, ragweed (Ambrosia artemisiifolia) is an important allergen source in North America, and, since 1990, ragweed has become a growing health concern in Europe as well. Weed pollen-sensitized patients demonstrated IgE reactivity to a ragweed pollen protein of apparently 29-31 kDa. This reaction could be inhibited by the mugwort allergen Art v 1. The purified ragweed pollen protein consisted of a 57-amino acid-long defensin-like domain with high homology to Art v 1 and a C-terminal proline-rich domain. This part contained hydroxyproline-linked arabinogalactan chains with one galactose and 5 to 20 and more alpha-arabinofuranosyl residues with some beta-arabinoses in terminal positions as revealed by high field NMR. The ragweed protein contained only small amounts of the single hydroxyproline-linked beta-arabinosyl residues, which form an important IgE binding determinant in Art v 1. cDNA clones for this protein were obtained from ragweed flowers. Immunological characterization revealed that the recombinant ragweed protein reacted with >30% of the weed pollen allergic patients. Therefore, this protein from ragweed pollen constitutes a novel important ragweed allergen and has been designated Amb a 4.	[Leonard, Renaud; Pabst, Martin; Stadlmann, Johannes; Altmann, Friedrich] Univ Nat Resources & Appl Life Sci BOKU, Dept Chem, A-1190 Vienna, Austria; [Wopfner, Nicole; Himly, Martin; Gadermaier, Gabriele; Ferreira, Fatima] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, Dept Mol Biol, A-5020 Salzburg, Austria; [Petersen, Bent O.; Duus, Jens O.] Carlsberg Lab, DK-2500 Valby, Denmark; [Radauer, Christian] Med Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria; [Razzazi-Fazeli, Ebrahim] Univ Vet Med, Core Facil Res, VetOMICS, A-1220 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Salzburg University; Medical University of Vienna; University of Veterinary Medicine Vienna	Altmann, F (corresponding author), Univ Nat Resources & Appl Life Sci BOKU, Dept Chem, A-1190 Vienna, Austria.	friedrich.altmann@boku.ac.at	Stadlmann, Johannes/AAC-3157-2021; Ferreira, Fatima/AAB-4321-2019; Ferreira, Fatima/E-4889-2011; Gadermaier, Gabriele/L-5997-2015; Duus, Jens Øllgaard/N-4279-2013; Radauer, Christian/AAN-6260-2021; Pabst, Martin/GOH-1766-2022; Himly, Martin/D-1568-2015	Stadlmann, Johannes/0000-0001-5693-6690; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Gadermaier, Gabriele/0000-0002-4886-417X; Duus, Jens Øllgaard/0000-0003-3625-1250; Radauer, Christian/0000-0001-9920-4449; Pabst, Martin/0000-0001-9897-0723; Altmann, Friedrich/0000-0002-0112-7877; Leonard, Renaud/0000-0001-5023-1032; Himly, Martin/0000-0001-5416-085X; Razzazi-Fazeli, Ebrahim/0000-0002-3343-0301	Austrian Science Fund [S8802, P19172]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported in part by the Austrian Science Fund (S8802 and P19172).	ALTMANN F, 1992, ANAL BIOCHEM, V204, P215, DOI 10.1016/0003-2697(92)90164-3; Altmann F, 2000, J GEN VIROL, V81, P1111, DOI 10.1099/0022-1317-81-4-1111; Asero R, 2006, CLIN EXP ALLERGY, V36, P658, DOI 10.1111/j.1365-2222.2006.02477.x; Bollig K, 2007, CARBOHYD RES, V342, P2557, DOI 10.1016/j.carres.2007.08.008; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DeSamblanx GW, 1997, J BIOL CHEM, V272, P1171, DOI 10.1074/jbc.272.2.1171; Dragosits M, 2009, J PROTEOME RES, V8, P1380, DOI 10.1021/pr8007623; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Fernandez-Rivas M, 2006, J ALLERGY CLIN IMMUN, V118, P481, DOI 10.1016/j.jaci.2006.05.012; Gadermaier G, 2008, ALLERGY, V63, P1543, DOI 10.1111/j.1398-9995.2008.01780.x; Gadermaier G, 2004, CURR ALLERGY ASTHM R, V4, P391, DOI 10.1007/s11882-004-0090-5; Goodrum LJ, 2000, PHYTOCHEMISTRY, V54, P99, DOI 10.1016/S0031-9422(00)00043-1; Gupta N, 1996, J ALLERGY CLIN IMMUN, V98, P903, DOI 10.1016/S0091-6749(96)80006-6; Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje; Himly M, 2003, J ALLERGY CLIN IMMUN, V111, P882, DOI 10.1067/mai.2003.163; Hirschwehr R, 1998, J ALLERGY CLIN IMMUN, V101, P196, DOI 10.1016/S0091-6749(98)70384-7; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; KJAER M, 1994, METHODS ENZYMOL, V239, P288; LAMPORT DTA, 1969, BIOCHEMISTRY-US, V8, P1155, DOI 10.1021/bi00831a049; Leonard R, 2005, J BIOL CHEM, V280, P7932, DOI 10.1074/jbc.M410407200; MUTSCHLECHNER S, 2003, 22 C EUR AC ALL CLIN; Oberhuber C, 2008, INT ARCH ALLERGY IMM, V145, P94, DOI 10.1159/000108134; Radauer C, 2007, J ALLERGY CLIN IMMUN, V120, P518, DOI 10.1016/j.jaci.2007.07.024; ROEBBER M, 1991, Journal of Allergy and Clinical Immunology, V87, P324, DOI 10.1016/0091-6749(91)92021-R; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; SUBIZA J, 1989, J ALLERGY CLIN IMMUN, V84, P353, DOI 10.1016/0091-6749(89)90420-X; TAPUHI Y, 1981, ANAL BIOCHEM, V115, P123, DOI 10.1016/0003-2697(81)90534-0; Winder J S, 1993, Methods Mol Biol, V16, P313, DOI 10.1385/0-89603-234-5:313; Wopfner N, 2008, ALLERGY, V63, P872, DOI 10.1111/j.1398-9995.2008.01635.x; Wopfner N, 2005, INT ARCH ALLERGY IMM, V138, P337, DOI 10.1159/000089188	30	57	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27192	27200		10.1074/jbc.M110.127118	http://dx.doi.org/10.1074/jbc.M110.127118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576600	Green Published, hybrid			2022-12-25	WOS:000281172700050
J	Zhao, TT; Le Francois, BG; Goss, G; Ding, K; Bradbury, PA; Dimitroulakos, J				Zhao, T. T.; Le Francois, B. G.; Goss, G.; Ding, K.; Bradbury, P. A.; Dimitroulakos, J.			Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: potential regulation by targeting rho proteins	ONCOGENE			English	Article						epidermal growth factor receptor mevalonate pathway; AKT; lovastatin; rho GTPases	GROWTH-FACTOR RECEPTOR; MEVALONATE PATHWAY; MTOR INHIBITORS; LUNG-CANCER; PHASE-III; COMBINATION; ERLOTINIB; GTPASES; TRIALS; RAS	We recently showed the ability of lovastatin to inhibit the function of the epidermal growth factor receptor (EGFR) and its downstream signaling of the phosphatidylinositol-3 kinase/AKT pathway. Combining lovastatin with gefitinib, a potent EGFR inhibitor, induced synergistic cytotoxicity in various tumor-derived cell lines. In this study, lovastatin treatment was found to inhibit ligand-induced EGFR dimerization in squamous cell carcinoma cells and its activation of AKT and its downstream targets 4E-binding protein 1 and S6 kinase 1. This inhibition was associated with global protein translational inhibition shown by a decrease in RNA associated polysome fractions. The effects of lovastatin on EGFR function were reversed by the addition of geranylgeranyl pyrophosphate, which functions as a protein membrane anchor. Lovastatin treatment induced actin cytoskeletal disorganization and the expression of geranylgeranylated rho family proteins that regulate the actin cytoskeleton, including rhoA. Lovastatin-induced rhoA was inactive as EGF stimulation failed to activate rhoA and inhibition of the rho-associated kinase, a target and mediator of rhoA function, with Y-27632 also showed inhibitory effects on EGFR dimerization. The ability of lovastatin to inhibit EGFR dimerization is a novel exploitable mechanism regulating this therapeutically relevant target. To explore the potential clinical significance of this combination, we evaluated the effect of statin on the overall survival (OS) and disease-specific survival (DSS) of patients with advanced non-small-cell lung cancer enrolled in the NCIC Clinical Trials Group phase III clinical trials BR21 (EGFR tyrosine kinase inhibitor erlotinib versus placebo) and BR18 (carboplatin and paclitaxel with or without the metalloproteinase inhibitor BMS275291). In BR18, use of statin did not affect OS or DSS. In BR21, patients showed a trend for improvement in OS (HR: 0.69, P = 0.098) and DSS (HR: 0.62, P = 0.048), but there was no statin x treatment interaction effect (P = 0.34 and P = 0.51 for OS and DSS, respectively). Oncogene (2010) 29, 4682-4692; doi:10.1038/onc.2010.219; published online 21 June 2010	[Zhao, T. T.; Le Francois, B. G.; Dimitroulakos, J.] Ottawa Hosp, Res Inst, Ctr Canc Therapeut, Ottawa, ON K1H 1C4, Canada; [Zhao, T. T.; Goss, G.] Ottawa Hosp, Res Inst, Dept Med Oncol, Ottawa, ON K1H 1C4, Canada; [Dimitroulakos, J.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Dimitroulakos, J.] Univ Ottawa, Dept Biochem, Ottawa, ON, Canada; [Ding, K.; Bradbury, P. A.] Queens Univ, NCIC Clin Trials Grp, Kingston, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Queens University - Canada; Canadian Cancer Trials Group	Dimitroulakos, J (corresponding author), Ottawa Hosp, Res Inst, Ctr Canc Therapeut, 503 Smyth Rd,3rd Floor, Ottawa, ON K1H 1C4, Canada.	jdimitroulakos@ohri.ca	Dimitroulakos, Jim/AAK-3398-2020		Canadian Institute of Health Research; Ontario Institute for Cancer Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research	Research support from the Canadian Institute of Health Research (JD) and the Ontario Institute for Cancer Research (JD) is greatly appreciated. We thank Dr D. Gray, Apotex Canada and AstraZeneca UK for generously providing the reagents used in this study.	Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Boulougouris P, 2001, ANTICANCER RES, V21, P2769; Breathnach OS, 2001, J CLIN ONCOL, V19, P1734, DOI 10.1200/JCO.2001.19.6.1734; Cabebe Elwyn, 2007, Curr Treat Options Oncol, V8, P15, DOI 10.1007/s11864-007-0022-4; Cicha I, 2004, ARTERIOSCL THROM VAS, V24, P2046, DOI 10.1161/01.ATV.0000145943.19099.a3; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168; Dimitroulakos J, 2002, NEOPLASIA, V4, P337, DOI 10.1038/sj.neo.7900247; Dimitroulakos J, 2006, CLIN CANCER RES, V12, p4426S, DOI 10.1158/1078-0432.CCR-06-0089; Doherty L, 2006, NEUROLOGY, V67, P156, DOI 10.1212/01.wnl.0000223844.77636.29; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Herbst RS, 2003, SEMIN ONCOL, V30, P34, DOI 10.1016/S0093-7754(03)00184-2; Herbst RS, 2002, EXPERT OPIN INV DRUG, V11, P837, DOI 10.1517/13543784.11.6.837; Leighl NB, 2005, J CLIN ONCOL, V23, P2831, DOI 10.1200/JCO.2005.04.044; Lunn JA, 2000, AM J PHYSIOL-CELL PH, V279, pC2019, DOI 10.1152/ajpcell.2000.279.6.C2019; Mantha AJ, 2005, CLIN CANCER RES, V11, P2398, DOI 10.1158/1078-0432.CCR-04-1951; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Niknejad N, 2007, J BIOL CHEM, V282, P29748, DOI 10.1074/jbc.M705859200; Oksvold MP, 2001, EUR J CELL BIOL, V80, P285, DOI 10.1078/0171-9335-00160; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Pallet N, 2006, M S-MED SCI, V22, P947, DOI 10.1051/medsci/20062211947; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Sebti Said, 1997, Current Opinion in Oncology, V9, P557, DOI 10.1097/00001622-199711000-00011; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; SORKIN A, 1991, J BIOL CHEM, V266, P23453; SOROKIN A, 1994, J BIOL CHEM, V269, P9752; Thibault A, 1996, CLIN CANCER RES, V2, P483; Thomas AL, 2003, SEMIN ONCOL, V30, P32, DOI 10.1016/S0093-7754(03)00123-4	36	49	49	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	33					4682	4692		10.1038/onc.2010.219	http://dx.doi.org/10.1038/onc.2010.219			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	641LK	20562912	Bronze			2022-12-25	WOS:000281127400007
J	Nowak, M; Arredouani, MS; Tun-Kyi, A; Schmidt-Wolf, I; Sanda, MG; Balk, SP; Exley, MA				Nowak, Michael; Arredouani, Mohammed S.; Tun-Kyi, Adrian; Schmidt-Wolf, Ingo; Sanda, Martin G.; Balk, Steven P.; Exley, Mark A.			Defective NKT Cell Activation by CD1d+TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; KILLER T-CELLS; DENDRITIC CELLS; IFN-GAMMA; RECEPTOR EXPRESSION; IMMUNE-RESPONSES; CD1 MOLECULES; MURINE CD1; MOUSE; CANCER	Numerical and functional defects of invariant natural killer T cells (iNKT) have been documented in human and mouse cancers, resulting in a defect in IFN production in several malignancies. iNKT cells recognize glycolipids presented on CD1d molecules by dendritic and related cells, leading to their activation and thereby regulating immune reactions. Activated iNKT cells cytokine secretion and cytotoxicity can inhibit existing and spontaneous tumor growth, progression, and metastasis. We have identified functional iNKT cell defects in the murine TRAMP prostate cancer model. We found that iNKT cells show the ability to migrate into TRAMP prostate tumors. This infiltration was mediated through CCL2: CCR5 chemokine: receptor interaction. Prostate tumor cells expressing CD1d partially activated iNKT cells, as appreciated by up-regulation of CD25, PD-1 and the IL-12R. However, despite inducing up-regulation of these activation markers and, hence, delivering positive signals, prostate tumor cells inhibited the IL-12-induced STAT4 phosphorylation in a cell-cell contact dependent but CD1d-independent manner. Consequently, tumor cells did not induce secretion of IFN gamma by iNKT cells. Blocking the inhibitory Ly49 receptor on iNKT cells in the presence of alpha-GalCer restored their IFN gamma production in vivo and in vitro. However, Ly49 blockade alone was not sufficient. Importantly, this defect could be also be reversed into vigorous secretion of IFN gamma by the addition of both IL-12 and the exogenous CD1d ligand alpha-galactosylceramide, but not by IL-12 alone, both in vivo and in vitro. These data underscore the potential to optimize iNKT-based therapeutic approaches.	[Nowak, Michael; Tun-Kyi, Adrian; Balk, Steven P.; Exley, Mark A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol,Dept Med, Boston, MA 02215 USA; [Nowak, Michael; Schmidt-Wolf, Ingo] Univ Bonn, Dept Hematol & Oncol, D-5300 Bonn, Germany; [Arredouani, Mohammed S.; Sanda, Martin G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Div Urol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Bonn; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Nowak, M (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol,Dept Med, Boston, MA 02215 USA.	michael.nowak@ukb.uni-bonn.de	Sanda, Martin G/A-6202-2013; Sanda, Martin G/B-2023-2015	Exley, Mark/0000-0002-5088-1032	NIH [R01 DK 066917]; Prostate Cancer Foundation; DOD [W81XWH-09-1-0156]; NATIONAL CANCER INSTITUTE [R21CA143748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DF/HCC Prostate Cancer SPORE Development Award (MAE), NIH R01 DK 066917 (MAE), Prostate Cancer Foundation Competitive Award (MAE) and DOD Prostate Cancer Development Award W81XWH-09-1-0156 (SPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beldi G, 2008, HEPATOLOGY, V48, P841, DOI 10.1002/hep.22401; Bellone M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008646; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BLEICHER PA, 1990, SCIENCE, V250, P679, DOI 10.1126/science.1700477; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; Chang WS, 2008, J IMMUNOL, V181, P6707, DOI 10.4049/jimmunol.181.10.6707; Cocco C, 2009, CURR MOL MED, V9, P459, DOI 10.2174/156652409788167140; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Fais F, 2004, INT J CANCER, V109, P402, DOI 10.1002/ijc.11723; Fasso M, 2008, P NATL ACAD SCI USA, V105, P3509, DOI 10.1073/pnas.0712269105; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Mandal M, 1998, MOL IMMUNOL, V35, P525, DOI 10.1016/S0161-5890(98)00055-8; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Mazzucchelli L, 1996, AM J PATHOL, V149, P501; Metelitsa LS, 2004, J EXP MED, V199, P1213, DOI 10.1084/jem.20031462; Metelitsa LS, 2003, LEUKEMIA, V17, P1068, DOI 10.1038/sj.leu.2402943; Molling JW, 2005, INT J CANCER, V116, P87, DOI 10.1002/ijc.20998; Moodycliffe AM, 2000, NAT IMMUNOL, V1, P521, DOI 10.1038/82782; Motohashi S, 2008, CANCER SCI, V99, P638, DOI 10.1111/j.1349-7006.2008.00730.x; Nowak M, 2007, INT REV IMMUNOL, V26, P95, DOI 10.1080/08830180601070195; Ortaldo JR, 2005, MOL IMMUNOL, V42, P445, DOI 10.1016/j.molimm.2004.07.024; Parekh VV, 2009, J IMMUNOL, V182, P2816, DOI 10.4049/jimmunol.0803648; Parekh VV, 2005, CRIT REV IMMUNOL, V25, P183, DOI 10.1615/CritRevImmunol.v25.i3.20; Park SH, 1998, J IMMUNOL, V160, P3128; Reddy M, 2005, CELL IMMUNOL, V236, P123, DOI 10.1016/j.cellimm.2005.08.018; Roark JH, 1998, J IMMUNOL, V160, P3121; Shi MQ, 2005, EXP ONCOL, V27, P125; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; van der Vliet HJJ, 2008, J IMMUNOL, V180, P7287, DOI 10.4049/jimmunol.180.11.7287; VANDERVLIER HJ, 2003, CANCER RES, V53, P4101; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Yang YF, 2000, INT IMMUNOL, V12, P1669, DOI 10.1093/intimm/12.12.1669	46	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11311	10.1371/journal.pone.0011311	http://dx.doi.org/10.1371/journal.pone.0011311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593019	Green Submitted, Green Published, gold			2022-12-25	WOS:000279140800012
J	Wiens, KM; Lee, HL; Shimada, H; Metcalf, AE; Chao, MY; Lien, CL				Wiens, Katie M.; Lee, Hyuna L.; Shimada, Hiroyuki; Metcalf, Anthony E.; Chao, Michael Y.; Lien, Ching-Ling			Platelet-Derived Growth Factor Receptor beta Is Critical for Zebrafish Intersegmental Vessel Formation	PLOS ONE			English	Article							PDGF-B; GENE-EXPRESSION; PERICYTE LOSS; DEFICIENT; CELLS	Background: Platelet-derived growth factor receptor beta (PDGFR beta) is a tyrosine kinase receptor known to affect vascular development. The zebrafish is an excellent model to study specific regulators of vascular development, yet the role of PDGF signaling has not been determined in early zebrafish embryos. Furthermore, vascular mural cells, in which PDGFR beta functions cell autonomously in other systems, have not been identified in zebrafish embryos younger than 72 hours post fertilization. Methodology/Principal Findings: In order to investigate the role of PDGFR beta in zebrafish vascular development, we cloned the highly conserved zebrafish homolog of PDGFR beta. We found that pdgfr beta is expressed in the hypochord, a developmental structure that is immediately dorsal to the dorsal aorta and potentially regulates blood vessel development in the zebrafish. Using a PDGFR tyrosine kinase inhibitor, a morpholino oligonucleotide specific to PDGFR beta, and a dominant negative PDGFR beta transgenic line, we found that PDGFR beta is necessary for angiogenesis of the intersegmental vessels. Significance/Conclusion: Our data provide the first evidence that PDGFR beta signaling is required for zebrafish angiogenesis. We propose a novel mechanism for zebrafish PDGFR beta signaling that regulates vascular angiogenesis in the absence of mural cells.	[Wiens, Katie M.; Lee, Hyuna L.; Lien, Ching-Ling] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Wiens, Katie M.; Lee, Hyuna L.; Shimada, Hiroyuki; Lien, Ching-Ling] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Shimada, Hiroyuki] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Metcalf, Anthony E.; Chao, Michael Y.] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA	University of Southern California; Children's Hospital Los Angeles; University of Southern California; California State University System; California State University San Bernardino	Wiens, KM (corresponding author), Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA.	clien@chla.usc.edu			National Institute of Heart, Lung and Blood [HL096121]; American Heart Association [0730214N]; Wright Foundation; Saban Research Institute; California Institute of Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096121] Funding Source: NIH RePORTER	National Institute of Heart, Lung and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Wright Foundation; Saban Research Institute; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Heart, Lung and Blood (HL096121, www.nhlbi.nih.gov), the American Heart Association (0730214N, www.americanheart.org), the Wright Foundation (www.wrightfoundation.com), the Research Career Development Award from the Saban Research Institute to C-L.L., and a California Institute of Regenerative Medicine training fellowship (www.cirm.ca.gov) to K.M.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Childs S, 2002, DEVELOPMENT, V129, P973; Cleaver O, 2000, DEVELOPMENT, V127, P869; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Drake Christopher J., 2003, Birth Defects Research, V69, P73, DOI 10.1002/bdrc.10003; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002850; Nishioka C, 2008, BLOOD, V111, P5086, DOI 10.1182/blood-2007-06-098079; NUSSLEINVOLHARD.RD, 2002, ZEBRAFISH; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santoro MM, 2009, MECH DEVELOP, V126, P638, DOI 10.1016/j.mod.2009.06.1080; Scheer N, 2002, MECH DEVELOP, V112, P9, DOI 10.1016/S0925-4773(01)00621-9; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00	36	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11324	10.1371/journal.pone.0011324	http://dx.doi.org/10.1371/journal.pone.0011324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593033	Green Published, gold, Green Submitted			2022-12-25	WOS:000279140800021
J	Howard, J; Merrifield, M				Howard, Jeanette; Merrifield, Matt			Mapping Groundwater Dependent Ecosystems in California	PLOS ONE			English	Article							GREAT-BASIN; VEGETATION; MANAGEMENT	Background: Most groundwater conservation and management efforts focus on protecting groundwater for drinking water and for other human uses with little understanding or focus on the ecosystems that depend on groundwater. However, groundwater plays an integral role in sustaining certain types of aquatic, terrestrial and coastal ecosystems, and their associated landscapes. Our aim was to illuminate the connection between groundwater and surface ecosystems by identifying and mapping the distribution of groundwater dependent ecosystems (GDEs) in California. Methodology/Principal Findings: To locate where groundwater flow sustains ecosystems we identified and mapped groundwater dependent ecosystems using a GIS. We developed an index of groundwater dependency by analyzing geospatial data for three ecosystem types that depend on groundwater: (1) springs and seeps; (2) wetlands and associated vegetation alliances; and (3) stream discharge from groundwater sources (baseflow index). Each variable was summarized at the scale of a small watershed (Hydrologic Unit Code-12; mean size = 9,570 ha; n = 4,621), and then stratified and summarized to 10 regions of relative homogeneity in terms of hydrologic, ecologic and climatic conditions. We found that groundwater dependent ecosystems are widely, although unevenly, distributed across California. Although different types of GDEs are clustered more densely in certain areas of the state, watersheds with multiple types of GDEs are found in both humid (e. g. coastal) and more arid regions. Springs are most densely concentrated in the North Coast and North Lahontan, whereas groundwater dependent wetlands and associated vegetation alliances are concentrated in the North and South Lahontan and Sacramento River hydrologic regions. The percentage of land area where stream discharge is most dependent on groundwater is found in the North Coast, Sacramento River and Tulare Lake regions. GDE clusters are located at the highest percentage in the North Coast (an area of the highest annual rainfall totals), North Lahontan (an arid, high desert climate with low annual rainfall), and Sacramento River hydrologic regions. That GDEs occur in such distinct climatic and hydrologic settings reveals the widespread distribution of these ecosystems. Conclusions/Significance: Protection and management of groundwater-dependent ecosystems are hindered by lack of information on their diversity, abundance and location. By developing a methodology that uses existing datasets to locate GDEs, this assessment addresses that knowledge gap. We report here on the application of this method across California, but believe the method can be expanded to regions where spatial data exist.	[Howard, Jeanette; Merrifield, Matt] Nature Conservancy, San Francisco, CA USA	Nature Conservancy	Howard, J (corresponding author), Nature Conservancy, San Francisco, CA USA.	Jeanette_howard@tnc.org						*AMEC EARTH ENV, 2005, SANT CLAR RIV ENH MA; [Anonymous], OFFICIAL J EUROPEAN; Brown J., 2009, GROUNDWATER DEPENDEN; Brown J, 2011, FRONT ECOL ENVIRON, V9, P97, DOI 10.1890/090108; Brussard P. F., 1999, STATUS TRENDS NATION, P505; BURK N, 2005, 117 UT GEOL SURV; *CA DEP WAT RES, 1998, B CAL DEP WAT RES, V160; *CA DEP WAT RES, 2003, B CAL DEP WAT RES, V118; Eamus D, 2006, AUST J BOT, V54, P91, DOI 10.1071/BT06029; FOSTER S, 2006, GWMATE BRIEFING NOTE; Giordano M, 2007, AGRICULTURAL GROUNDWATER REVOLUTION: OPPORTUNITIES AND THREATS TO DEVELOPMENT, P1, DOI 10.1079/9781845931728.0000; *GREENINFO NETW, 2009, CAL PROT AR DAT V1 4; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Institute of Hydrology, 1980, LOW FLOW STUD; MacKay H, 2006, AUST J BOT, V54, P231, DOI 10.1071/BT05047; Mount J.F., 1995, CALIFORNIA RIVERS ST; Murray Brad R., 2003, Ecological Management & Restoration, V4, P110, DOI 10.1046/j.1442-8903.2003.00144.x; Naumburg E, 2005, ENVIRON MANAGE, V35, P726, DOI 10.1007/s00267-004-0194-7; O'Grady AP, 2006, AUST J BOT, V54, P145, DOI 10.1071/BT04164; Patten DT, 2008, ENVIRON MANAGE, V41, P398, DOI 10.1007/s00267-007-9035-9; Pringle CM, 2000, ECOL APPL, V10, P971, DOI 10.1890/1051-0761(2000)010[0971:TTUSPL]2.0.CO;2; Pringle CM, 2001, ECOL APPL, V11, P981, DOI 10.1890/1051-0761(2001)011[0981:HCATMO]2.0.CO;2; Sax J. L., 2002, REV LAWS ESTABLISHIN; SIMLEY JD, 2009, 20093054 US GEOL SUR; Soil Survey Staff Natural Resources Conservation Service, US GEN SOIL MAP STAT; United States Environmental Protection Agency (USEPA) and United States Geological Survey (USGS), 2005, NAT HYDR DAT PLUS NH; US Fish and Wildlife Service, NAT WETL INV; *USDA FOR SERV, CALVEG MAPP CAL; van der Kamp G, 2009, HYDROGEOL J, V17, P203, DOI 10.1007/s10040-008-0367-1; Wahl KL, 1988, P S WAT USE DAT WAT, P239; Wahl KL, 1995, P TEX WAT 95 COMP C, P77; WOLOCK DM, 2003, 03146 US GEOL SURV	32	67	71	7	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11249	10.1371/journal.pone.0011249	http://dx.doi.org/10.1371/journal.pone.0011249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585640	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135400011
J	Ganguly, A; Basu, S; Chakraborty, P; Chatterjee, S; Sarkar, A; Chatterjee, M; Choudhuri, SK				Ganguly, Avishek; Basu, Soumya; Chakraborty, Paramita; Chatterjee, Shilpak; Sarkar, Avijit; Chatterjee, Mitali; Choudhuri, Soumitra Kumar			Targeting Mitochondrial Cell Death Pathway to Overcome Drug Resistance with a Newly Developed Iron Chelate	PLOS ONE			English	Article							BREAST-CANCER CELLS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; IN-VIVO; MEDIATED APOPTOSIS; ANTICANCER DRUGS; CARCINOMA-CELLS; COPPER CHELATE; TUMOR-CELLS; EXPRESSION	Background: Multi drug resistance (MDR) or cross-resistance to multiple classes of chemotherapeutic agents is a major obstacle to successful application of chemotherapy and a basic problem in cancer biology. The multidrug resistance gene, MDR1, and its gene product P-glycoprotein (P-gp) are an important determinant of MDR. Therefore, there is an urgent need for development of novel compounds that are not substrates of P-glycoprotein and are effective against drug-resistant cancer. Methodology/Principal Findings: In this present study, we have synthesized a novel, redox active Fe (II) complex (chelate), iron N-(2-hydroxy acetophenone) glycinate (FeNG). The structure of the complex has been determined by spectroscopic means. To evaluate the cytotoxic effect of FeNG we used doxorubicin resistant and/or sensitive T lymphoblastic leukemia cells and show that FeNG kills both the cell types irrespective of their MDR phenotype. Moreover, FeNG induces apoptosis in doxorubicin resistance T lymphoblastic leukemia cell through mitochondrial pathway via generation reactive oxygen species (ROS). This is substantiated by the fact that the antioxidant N-acetyle-cysteine (NAC) could completely block ROS generation and, subsequently, abrogated FeNG induced apoptosis. Therefore, FeNG induces the doxorubicin resistant T lymphoblastic leukemia cells to undergo apoptosis and thus overcome MDR. Conclusion/Significance: Our study provides evidence that FeNG, a redox active metal chelate may be a promising new therapeutic agent against drug resistance cancers.	[Ganguly, Avishek; Basu, Soumya; Chakraborty, Paramita; Chatterjee, Shilpak; Choudhuri, Soumitra Kumar] Chittaranjan Natl Canc Inst, Dept In Vitro Carcinogenesis & Cellular Chemother, Kolkata, India; [Sarkar, Avijit; Chatterjee, Mitali] Postgrad Inst Med Educ & Res, Dept Pharmacol, Kolkata, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Ganguly, A (corresponding author), Chittaranjan Natl Canc Inst, Dept In Vitro Carcinogenesis & Cellular Chemother, Kolkata, India.	soumitra01@yahoo.com	Chakraborty, Paramita/AAL-9606-2020; Ganguly, Avishek/R-6138-2019; Basu, Soumya/Y-9112-2019; Chatterjee, Mitali/AAV-2129-2021	Chakraborty, Paramita/0000-0002-0320-8697; Basu, Soumya/0000-0002-1726-0154; 	Indian Council of Medical Research (ICMR), New Delhi [3/2/2/200/2009/NCD-III, 5/13/18/2007/NCD-III]	Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR))	This investigation received financial support from the Indian Council of Medical Research (ICMR), New Delhi, No. 3/2/2/200/2009/NCD-III and No. 5/13/18/2007/NCD-III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2000, J NEUROL SCI, V176, P88, DOI 10.1016/S0022-510X(00)00317-8; Baul TSB, 2001, APPL ORGANOMET CHEM, V15, P947; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007048; Dakternieks D, 1998, ORGANOMETALLICS, V17, P3058, DOI 10.1021/om9800290; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2008, CLIN CANCER RES, V14, P2405, DOI 10.1158/1078-0432.CCR-07-4525; Engel RH, 2006, FRONT BIOSCI-LANDMRK, V11, P300, DOI 10.2741/1798; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Gillet JP, 2004, CANCER RES, V64, P8987, DOI 10.1158/0008-5472.CAN-04-1978; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; GOTTESMAN MM, 1993, CANCER RES, V53, P747; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Ikeda T, 2003, CANCER RES, V63, P5551; Iuchi K, 2008, BIOCHEM PHARMACOL, V76, P974, DOI 10.1016/j.bcp.2008.07.038; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KIMMIG A, 1990, CANCER RES, V50, P6793; KOOPMAN G, 1994, BLOOD, V84, P1414; Latchoumycandane C, 2006, TOXICOL APPL PHARM, V217, P125, DOI 10.1016/j.taap.2006.08.001; Majumder S, 2003, EUR J MED CHEM, V38, P893, DOI 10.1016/j.ejmech.2003.08.002; Majumder S, 2006, CANCER LETT, V244, P16, DOI 10.1016/j.canlet.2005.11.030; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Maret W, 2010, METALLOMICS, V2, P117, DOI 10.1039/b915804a; Matarrese P, 2001, BIOCHEM J, V355, P587, DOI 10.1042/bj3550587; Mookerjee A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-267; Mookerjee A, 2006, CLIN CANCER RES, V12, P4339, DOI 10.1158/1078-0432.CCR-06-0001; Muscella A, 2008, BRIT J PHARMACOL, V153, P34, DOI 10.1038/sj.bjp.0707576; Muscella A, 2002, J ENDOCRINOL, V173, P315, DOI 10.1677/joe.0.1730315; PASTAN I, 1993, NEW ENGL J MED, V316, P385; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; RONINSON IB, 1992, BIOCHEM PHARMACOL, V43, P95, DOI 10.1016/0006-2952(92)90666-7; Sanchez-Alcazar JA, 2000, CELL DEATH DIFFER, V7, P1090, DOI 10.1038/sj.cdd.4400740; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; VANDENABEELE P, 2006, CELL DEATH DIFFER, pPE44; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	39	41	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11253	10.1371/journal.pone.0011253	http://dx.doi.org/10.1371/journal.pone.0011253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582168	gold, Green Published, Green Submitted			2022-12-25	WOS:000279058500005
J	Shulman, JM; Chibnik, LB; Aubin, C; Schneider, JA; Bennett, DA; De Jager, PL				Shulman, Joshua M.; Chibnik, Lori B.; Aubin, Cristin; Schneider, Julie A.; Bennett, David A.; De Jager, Philip L.			Intermediate Phenotypes Identify Divergent Pathways to Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; ZINC-FINGER PROTEIN; COGNITIVE IMPAIRMENT; SUSCEPTIBILITY GENES; CLINICAL-DIAGNOSIS; AD PATHOLOGY; ALLELE; RISK; VARIANTS	Background: Recent genetic studies have identified a growing number of loci with suggestive evidence of association with susceptibility to Alzheimer's disease (AD). However, little is known of the role of these candidate genes in influencing intermediate phenotypes associated with a diagnosis of AD, including cognitive decline or AD neuropathologic burden. Methods/Principal Findings: Thirty-two single nucleotide polymorphisms (SNPs) previously implicated in AD susceptibility were genotyped in 414 subjects with both annual clinical evaluation and completed brain autopsies from the Religious Orders Study and the Rush Memory and Aging Project. Regression analyses evaluated the relation of SNP genotypes to continuous measures of AD neuropathology and cognitive function proximate to death. A SNP in the zinc finger protein 224 gene (ZNF224, rs3746319) was associated with both global AD neuropathology (p = 0.009) and global cognition (p = 0.002); whereas, a SNP at the phosphoenolpyruvate carboxykinase locus (PCK1, rs8192708) was selectively associated with global cognition (p = 3.57 x 10(-4)). The association of ZNF224 with cognitive impairment was mediated by neurofibrillary tangles, whereas PCK1 largely influenced cognition independent of AD pathology, as well as Lewy bodies and infarcts. Conclusions/Significance: The findings support the association of several loci with AD, and suggest how intermediate phenotypes can enhance analysis of susceptibility loci in this complex genetic disorder.	[Shulman, Joshua M.; Chibnik, Lori B.; Aubin, Cristin; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Shulman, Joshua M.; Chibnik, Lori B.; Aubin, Cristin; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [Shulman, Joshua M.; Chibnik, Lori B.; Aubin, Cristin; De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University; Rush University	Shulman, JM (corresponding author), Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, 75 Francis St, Boston, MA 02115 USA.	pdejager@rics.bwh.harvard.edu		Chibnik, Lori/0000-0001-6293-806X	NIH [K08AG034290, P30AG10161, R01AG15819, R01AG17917]; Beth Israel Deaconess Medical Center; Harvard/MIT Health Sciences and Technology; NATIONAL INSTITUTE ON AGING [R01AG015819, P30AG010161, R01AG017917, K08AG034290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beth Israel Deaconess Medical Center; Harvard/MIT Health Sciences and Technology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	JMS is supported by NIH grant K08AG034290 and by the Clinical Investigator Training Program: Beth Israel Deaconess Medical Center and Harvard/MIT Health Sciences and Technology, in collaboration with Pfizer Inc. and Merck & Co. The Religious Orders Study and the Rush Memory and Aging Project were supported by NIH grants P30AG10161, R01AG15819, R01AG17917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; [Anonymous], 1997, Neurobiol Aging, V18, pS1; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Arvanitakis Z, 2006, NEUROLOGY, V67, P1960, DOI 10.1212/01.wnl.0000247053.45483.4e; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2005, J NEUROL NEUROSUR PS, V76, P1194, DOI 10.1136/jnnp.2004.054445; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bennett DA, 2003, NEUROLOGY, V60, P246, DOI 10.1212/01.WNL.0000042478.08543.F7; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cao HN, 2004, J CLIN ENDOCR METAB, V89, P898, DOI 10.1210/jc.2003-031361; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; COUSIN E, 2009, NEUROBIOLOG IN PRESS; Ertekin-Taner N, 2007, NEUROL CLIN, V25, P611, DOI 10.1016/j.ncl.2007.03.009; FEULNER TM, 2009, MOL PSYCHIA IN PRESS; Figgins JA, 2009, AM J MED GENET B, V150B, P520, DOI 10.1002/ajmg.b.30851; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Hamilton G, 2007, AM J MED GENET B, V144B, P508, DOI 10.1002/ajmg.b.30503; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li YH, 2006, HUM MOL GENET, V15, P2560, DOI 10.1093/hmg/ddl178; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Liu F, 2007, AM J HUM GENET, V81, P17, DOI 10.1086/518720; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; McQueen MB, 2007, AM J MED GENET B, V144B, P987, DOI 10.1002/ajmg.b.30500; Medugno L, 2005, GENE, V359, P35, DOI 10.1016/j.gene.2005.06.021; Medugno L, 2007, GENE, V403, P125, DOI 10.1016/j.gene.2007.07.036; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mortimer JA, 2009, ALZ DIS ASSOC DIS, V23, P152, DOI 10.1097/WAD.0b013e318190a855; Papassotiropoulos A, 2003, ARCH NEUROL-CHICAGO, V60, P29, DOI 10.1001/archneur.60.1.29; Peskind ER, 2006, ARCH NEUROL-CHICAGO, V63, P936, DOI 10.1001/archneur.63.7.936; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Willer CJ, 2007, DIABETES, V56, P256, DOI 10.2337/db06-0461; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	52	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11244	10.1371/journal.pone.0011244	http://dx.doi.org/10.1371/journal.pone.0011244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574532	gold, Green Published			2022-12-25	WOS:000279058300027
J	Spinella, F; Rosano, L; Del Duca, M; Di Castro, V; Nicotra, MR; Natali, PG; Bagnato, A				Spinella, Francesca; Rosano, Laura; Del Duca, Martina; Di Castro, Valeriana; Nicotra, Maria Rita; Natali, Pier Giorgio; Bagnato, Anna			Endothelin-1 Inhibits Prolyl Hydroxylase Domain 2 to Activate Hypoxia-Inducible Factor-1 alpha in Melanoma Cells	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; GROWTH-FACTOR; MALIGNANT-MELANOMA; FACTOR-I; GENE-EXPRESSION; B RECEPTOR; PROLINE HYDROXYLATION; TUMOR ANGIOGENESIS; OVARIAN-CARCINOMA; HIF-ALPHA	Background: The endothelin B receptor (ET(B)R) promotes tumorigenesis and melanoma progression through activation by endothelin (ET)-1, thus representing a promising therapeutic target. The stability of hypoxia-inducible factor (HIF)-1 alpha is essential for melanomagenesis and progression, and is controlled by site-specific hydroxylation carried out by HIF-prolyl hydroxylase domain (PHD) and subsequent proteosomal degradation. Principal Findings: Here we found that in melanoma cells ET-1, ET-2, and ET-3 through ET(B)R, enhance the expression and activity of HIF-1 alpha and HIF-2 alpha that in turn regulate the expression of vascular endothelial growth factor (VEGF) in response to ETs or hypoxia. Under normoxic conditions, ET-1 controls HIF-alpha stability by inhibiting its degradation, as determined by impaired degradation of a reporter gene containing the HIF-1 alpha oxygen-dependent degradation domain encompassing the PHD-targeted prolines. In particular, ETs through ET(B)R markedly decrease PHD2 mRNA and protein levels and promoter activity. In addition, activation of phosphatidylinositol 3-kinase (PI3K)-dependent integrin linked kinase (ILK)-AKT-mammalian target of rapamycin (mTOR) pathway is required for ET(B)R-mediated PHD2 inhibition, HIF-1 alpha, HIF-2 alpha, and VEGF expression. At functional level, PHD2 knockdown does not further increase ETs-induced in vitro tube formation of endothelial cells and melanoma cell invasiveness, demonstrating that these processes are regulated in a PHD2-dependent manner. In human primary and metastatic melanoma tissues as well as in cell lines, that express high levels of HIF-1 alpha, ET(B)R expression is associated with low PHD2 levels. In melanoma xenografts, ET(B)R blockade by ET(B)R antagonist results in a concomitant reduction of tumor growth, angiogenesis, HIF-1 alpha, and HIF-2 alpha expression, and an increase in PHD2 levels. Conclusions: In this study we identified the underlying mechanism by which ET-1, through the regulation of PHD2, controls HIF-1 alpha stability and thereby regulates angiogenesis and melanoma cell invasion. These results further indicate that targeting ET(B)R may represent a potential therapeutic treatment of melanoma by impairing HIF-1 alpha stability.	[Spinella, Francesca; Rosano, Laura; Del Duca, Martina; Di Castro, Valeriana; Natali, Pier Giorgio; Bagnato, Anna] Regina Elena Inst Canc Res, Lab Mol Pathol, Rome, Italy; [Nicotra, Maria Rita] CNR, Mol Biol & Pathol Inst, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR)	Spinella, F (corresponding author), Regina Elena Inst Canc Res, Lab Mol Pathol, Rome, Italy.	bagnato@ifo.it	Rosanò, Laura/AAB-7821-2019; Rosanò, Laura/I-9266-2012; Bagnato, Anna/G-9747-2016; Di Castro, Valeriana/H-8873-2017; ROSANO', Laura/AAK-1424-2020; Rosanò, Laura/B-2863-2018; spinella, francesca/AAZ-8982-2020	Rosanò, Laura/0000-0002-3981-8593; Bagnato, Anna/0000-0002-7269-9522; Di Castro, Valeriana/0000-0002-1899-3683; ROSANO', Laura/0000-0002-9962-6411; Rosanò, Laura/0000-0002-9962-6411; 	Associazione Italiana Ricerca sul Cancro; Ministero della Salute	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy)	Associazione Italiana Ricerca sul Cancro and Ministero della Salute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Bagnato A, 2004, CANCER RES, V64, P1436, DOI 10.1158/0008-5472.CAN-03-2344; Bagnato A, 2003, TRENDS ENDOCRIN MET, V14, P44, DOI 10.1016/S1043-2760(02)00010-3; Bedogni B, 2005, CANCER CELL, V8, P443, DOI 10.1016/j.ccr.2005.11.005; Berchner-Pfannschmidt U, 2007, J BIOL CHEM, V282, P1788, DOI 10.1074/jbc.M607065200; Berking C, 2004, CANCER RES, V64, P807, DOI 10.1158/0008-5472.CAN-03-3438; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Demunter A, 2001, VIRCHOWS ARCH, V438, P485, DOI 10.1007/s004280000362; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Giatromanolaki A, 2003, MELANOMA RES, V13, P493, DOI 10.1097/00008390-200310000-00008; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; GOLUB SH, 1976, J NATL CANCER I, V56, P167, DOI 10.1093/jnci/56.1.167; Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Knowles HJ, 2004, CIRC RES, V95, P162, DOI 10.1161/01.RES.0000134924.89412.70; Knowles Jonathan, 2005, Current Vascular Pharmacology, V3, P309, DOI 10.2174/157016105774329462; Lacal PM, 2008, EUR J CANCER, V44, P1914, DOI 10.1016/j.ejca.2008.06.032; Lahav R, 2005, INT J DEV BIOL, V49, P173, DOI 10.1387/ijdb.041951rl; Lahav R, 2004, CANCER RES, V64, P8945, DOI 10.1158/0008-5472.CAN-04-1510; Lahav R, 1999, P NATL ACAD SCI USA, V96, P11496, DOI 10.1073/pnas.96.20.11496; LEVIN ER, 1995, NEW ENGL J MED, V333, P356, DOI 10.1056/NEJM199508103330607; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Patel N, 2008, BLOOD, V112, P856, DOI 10.1182/blood-2007-12-130567; Postovit LM, 2006, CANCER RES, V66, P7833, DOI 10.1158/0008-5472.CAN-06-0731; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rosano L, 2006, MOL CANCER THER, V5, P833, DOI 10.1158/1535-7163.MCT-05-0523; Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; SPINELLA F, 2009, CANCER RES, V69, P2224; Spinella F, 2007, CANCER RES, V67, P1725, DOI 10.1158/0008-5472.CAN-06-2606; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Tang CH, 2007, J BIOL CHEM, V282, P25406, DOI 10.1074/jbc.M701001200; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; Wilson JL, 2006, CANCER RES, V66, P11802, DOI 10.1158/0008-5472.CAN-06-1222; Wu SR, 2008, MOL THER, V16, P1227, DOI 10.1038/mt.2008.90	50	44	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11241	10.1371/journal.pone.0011241	http://dx.doi.org/10.1371/journal.pone.0011241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574527	Green Published, gold, Green Submitted			2022-12-25	WOS:000279058300025
J	Coley, W; Van Duyne, R; Carpio, L; Guendel, I; Kehn-Hall, K; Chevalier, S; Narayanan, A; Luu, T; Lee, N; Klase, Z; Kashanchi, F				Coley, William; Van Duyne, Rachel; Carpio, Lawrence; Guendel, Irene; Kehn-Hall, Kylene; Chevalier, Sebastien; Narayanan, Aarthi; Luu, Truong; Lee, Norman; Klase, Zachary; Kashanchi, Fatah			Absence of DICER in Monocytes and Its Regulation by HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; STEM-CELLS; SILENCING PATHWAY; HUMAN MACROPHAGES; GENE-EXPRESSION; TAR ELEMENT; INFECTION; RNA	MicroRNAs (miRNAs) are a class of small RNA molecules that function to control gene expression and restrict viral replication in host cells. The production of miRNAs is believed to be dependent upon the DICER enzyme. Available evidence suggests that in T lymphocytes, HIV-1 can both suppress and co-opt the host's miRNA pathway for its own benefit. In this study, we examined the state of miRNA production in monocytes and macrophages as well as the consequences of viral infection upon the production of miRNA. Monocytes in general express low amounts of miRNA-related proteins, and DICER in particular could not be detected until after monocytes were differentiated into macrophages. In the case where HIV-1 was present prior to differentiation, the expression of DICER was suppressed. MicroRNA chip results for RNA isolated from transfected and treated cells indicated that a drop in miRNA production coincided with DICER protein suppression in macrophages. We found that the expression of DICER in monocytes is restricted by miR-106a, but HIV-1 suppressed DICER expression via the viral gene Vpr. Additionally, analysis of miRNA expression in monocytes and macrophages revealed evidence that some miRNAs can be processed by both DICER and PIWIL4. Results presented here have implications for both the pathology of viral infections in macrophages and the biogenesis of miRNAs. First, HIV-1 suppresses the expression and function of DICER in macrophages via a previously unknown mechanism. Second, the presence of miRNAs in monocytes lacking DICER indicates that some miRNAs can be generated by proteins other than DICER.	[Coley, William; Van Duyne, Rachel; Carpio, Lawrence; Guendel, Irene; Kehn-Hall, Kylene; Narayanan, Aarthi; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Dept Mol & Microbiol, Manassas, VA 20110 USA; [Klase, Zachary] NIAID, Bethesda, MD 20892 USA; [Chevalier, Sebastien] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; [Luu, Truong; Lee, Norman] George Washington Univ, Sch Med, Dept Physiol & Pharmacol, Washington, DC 20037 USA	George Mason University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University	Kashanchi, F (corresponding author), George Mason Univ, Natl Ctr Biodefense & Infect Dis, Dept Mol & Microbiol, Discovery Hall,Rm 306,10900 Univ Blvd,MS 1H8, Manassas, VA 20110 USA.	fkashanc@gmu.edu	Van Duyne, Rachel/ABI-2429-2020; Kehn-Hall, Kylene/I-5752-2013; Van Duyne, Rachel/I-7365-2019	Van Duyne, Rachel/0000-0003-2914-6874; Kehn-Hall, Kylene/0000-0001-8036-7213	National Institutes of Health [AI078859, AI074410, AI043894]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043894, R21AI074410, R21AI078859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI078859, AI074410, and AI043894.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-95; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Gillim-Ross L, 2005, VIRAL IMMUNOL, V18, P190, DOI 10.1089/vim.2005.18.190; Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; HO DD, 1986, J CLIN INVEST, V77, P1712, DOI 10.1172/JCI112491; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lin H, 2008, COLD SH Q B, V73, P273, DOI 10.1101/sqb.2008.73.056; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Liou LY, 2004, INT J BIOCHEM CELL B, V36, P1767, DOI 10.1016/j.biocel.2004.02.018; Liu YP, 2009, NUCLEIC ACIDS RES, V37, P6194, DOI 10.1093/nar/gkp644; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; OKADA Y, 1995, IMMUNOPHARMACOLOGY, V30, P27, DOI 10.1016/0162-3109(95)98646-K; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; PANG S, 1990, NATURE, V343, P85, DOI 10.1038/343085a0; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Provost P, 2006, VIRUS RES, V121, P107, DOI 10.1016/j.virusres.2006.06.015; Ruiz ME, 1998, J IMMUNOL, V161, P4169; SCHUITEMAKER H, 1992, J CLIN INVEST, V89, P1154, DOI 10.1172/JCI115697; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Smith PD, 2003, J LEUKOCYTE BIOL, V74, P642, DOI 10.1189/jlb.0503219; STANLEY SK, 1992, J IMMUNOL, V149, P689; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Sugimoto K, 2007, BIOCHEM BIOPH RES CO, V359, P497, DOI 10.1016/j.bbrc.2007.05.136; Sunamoto M, 2003, KIDNEY INT, V64, P1695, DOI 10.1046/j.1523-1755.2003.00283.x; SUZAN M, 1991, J IMMUNOL, V146, P377; Suzuki K, 2008, J BIOL CHEM, V283, P23353, DOI 10.1074/jbc.M709651200; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Zhu T, 2002, J ANTIMICROB CHEMOTH, V50, P309, DOI 10.1093/jac/dkf143; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	56	66	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31930	31943		10.1074/jbc.M110.101709	http://dx.doi.org/10.1074/jbc.M110.101709			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20584909	hybrid, Green Published			2022-12-25	WOS:000282683000006
J	Papareddy, P; Kalle, M; Kasetty, G; Morgelin, M; Rydengard, V; Albiger, B; Lundqvist, K; Malmsten, M; Schmidtchen, A				Papareddy, Praveen; Kalle, Martina; Kasetty, Gopinath; Morgelin, Matthias; Rydengard, Victoria; Albiger, Barbara; Lundqvist, Katarina; Malmsten, Martin; Schmidtchen, Artur			C-terminal Peptides of Tissue Factor Pathway Inhibitor Are Novel Host Defense Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL ANTIMICROBIAL PEPTIDES; HEPARIN-BINDING; INNATE IMMUNITY; PSEUDOMONAS-AERUGINOSA; ANTIBACTERIAL PEPTIDES; COMPLEMENT-SYSTEM; ESCHERICHIA-COLI; PROTEIN; POLYPEPTIDES; DOMAIN	Tissue factor pathway inhibitor (TFPI) inhibits tissue factor-induced coagulation, but may, via its C terminus, also modulate cell surface, heparin, and lipopolysaccharide interactions as well as participate in growth inhibition. Here we show that C-terminal TFPI peptide sequences are antimicrobial against the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, Gram-positive Bacillus subtilis and Staphylococcus aureus, as well as the fungi Candida albicans and Candida parapsilosis. Fluorescence studies of peptide-treated bacteria, paired with analysis of peptide effects on liposomes, showed that the peptides exerted membrane-breaking effects similar to those seen for the "classic" human antimicrobial peptide LL-37. The killing of E. coli, but not P. aeruginosa, by the C-terminal peptide GGLIKTKRKRKKQRVKIAYEEIFVKNM (GGL27), was enhanced in human plasma and largely abolished in heat-inactivated plasma, a phenomenon linked to generation of antimicrobial C3a and activation of the classic pathway of complement activation. Furthermore, GGL27 displayed anti-endotoxic effects in vitro and in vivo in a mouse model of LPS shock. Importantly, TFPI was found to be expressed in the basal layers of normal epidermis, and was markedly up-regulated in acute skin wounds as well as wound edges of chronic leg ulcers. Furthermore, C-terminal fragments of TFPI were associated with bacteria present in human chronic leg ulcers. These findings suggest a new role for TFPI in cutaneous defense against infections.	[Schmidtchen, Artur] Lund Univ, Dept Clin Sci, Biomed Ctr, Div Dermatol & Venereol, SE-22184 Lund, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Malmsten, Martin] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden	Lund University; Lund University; Uppsala University	Schmidtchen, A (corresponding author), Lund Univ, Dept Clin Sci, Biomed Ctr, Div Dermatol & Venereol, Tornavagen 10, SE-22184 Lund, Sweden.	artur.schmidtchen@med.lu.se	Schmidtchen, Artur/F-9507-2015	Papareddy, Praveen/0000-0002-3872-478X	Swedish Research Council [521-2009-3378, 7480, 621-2003-4022]; Royal Physiographic Society in Lund; Welander-Finsen, Crafoord, Osterlund, and Kock Foundations; Marianne and Marcus Wallenberg Foundation; XImmune AB; The Swedish Government Funds for Clinical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society in Lund; Welander-Finsen, Crafoord, Osterlund, and Kock Foundations; Marianne and Marcus Wallenberg Foundation; XImmune AB; The Swedish Government Funds for Clinical Research	This work was supported by grants from the Swedish Research Council (projects 521-2009-3378, 7480, and 621-2003-4022), the Royal Physiographic Society in Lund, the Welander-Finsen, Crafoord, Osterlund, and Kock Foundations, the Marianne and Marcus Wallenberg Foundation, XImmune AB, and The Swedish Government Funds for Clinical Research.	Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; CARLEMALM E, 1985, J MICROSC-OXFORD, V140, P55, DOI 10.1111/j.1365-2818.1985.tb02660.x; Crawley JTB, 2008, ARTERIOSCL THROM VAS, V28, P233, DOI 10.1161/ATVBAHA.107.141606; CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; Cunningham AC, 2002, BIOCHEM J, V367, P451, DOI 10.1042/BJ20020696; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Ettelaie C, 1999, FEBS LETT, V463, P341, DOI 10.1016/S0014-5793(99)01663-4; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Ganz T, 2001, Semin Respir Infect, V16, P4; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hembrough TA, 2004, BLOOD, V103, P3374, DOI 10.1182/blood-2003-07-2234; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Li A, 1998, THROMB HAEMOSTASIS, V80, P423, DOI 10.1055/s-0037-1615224; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Lundqvist K, 2004, THROMB HAEMOSTASIS, V92, P281, DOI 10.1160/TH03-12-0732; Lwaleed BA, 2006, J PATHOL, V208, P327, DOI 10.1002/path.1871; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; Maroney SA, 2010, THROMB RES, V125, pS52, DOI 10.1016/j.thromres.2010.01.038; Meyer-Hoffert U, 2008, FASEB J, V22, P2427, DOI 10.1096/fj.07-103440; Mine S, 2002, BIOCHEMISTRY-US, V41, P78, DOI 10.1021/bi011299g; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; Ohkura N, 1997, BLOOD, V90, P1883, DOI 10.1182/blood.V90.5.1883; PAPAREDDY P, PLOS PATHOG, V6; Park CT, 1997, BLOOD, V89, P4268, DOI 10.1182/blood.V89.12.4268; PEREIRA HA, 1995, J LEUKOCYTE BIOL, V57, P805, DOI 10.1002/jlb.57.6.805; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; Rydengard V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000116; Schirm S, 2009, J INFECT DIS, V199, P1807, DOI 10.1086/599097; Schmidtchen A, 2001, ACTA DERM-VENEREOL, V81, P406; Sjogren H, 2005, BIOPHYS CHEM, V116, P11, DOI 10.1016/j.bpc.2005.01.007; Tossi A, 2000, BIOPOLYMERS, V55, P4; Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475; Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115; WESSELSCHMIDT R, 1992, BLOOD, V79, P2004; Yamamoto N, 2010, PEPTIDES, V31, P794, DOI 10.1016/j.peptides.2010.01.006; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; Yun TH, 2009, BLOOD, V113, P1139, DOI 10.1182/blood-2008-05-157180; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	50	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28387	28398		10.1074/jbc.M110.127019	http://dx.doi.org/10.1074/jbc.M110.127019			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592020	Green Published, hybrid			2022-12-25	WOS:000281404100081
J	Pereira, JH; Ralston, CY; Douglas, NR; Meyer, D; Knee, KM; Goulet, DR; King, JA; Frydman, J; Adams, PD				Pereira, Jose H.; Ralston, Corie Y.; Douglas, Nicholai R.; Meyer, Daniel; Knee, Kelly M.; Goulet, Daniel R.; King, Jonathan A.; Frydman, Judith; Adams, Paul D.			Crystal Structures of a Group II Chaperonin Reveal the Open and Closed States Associated with the Protein Folding Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT KINETIC-ANALYSIS; EUKARYOTIC CHAPERONIN; ARCHAEAL CHAPERONIN; ATP-BINDING; IN-VIVO; GROEL; MECHANISM; REFINEMENT; COMPLEX; CONFORMATION	Chaperonins are large protein complexes consisting of two stacked multisubunit rings, which open and close in an ATP-dependent manner to create a protected environment for protein folding. Here, we describe the first crystal structure of a group II chaperonin in an open conformation. We have obtained structures of the archaeal chaperonin from Methanococcus maripaludis in both a peptide acceptor (open) state and a protein folding (closed) state. In contrast with group I chaperonins, in which the equatorial domains share a similar conformation between the open and closed states and the largest motions occurs at the intermediate and apical domains, the three domains of the archaeal chaperonin subunit reorient as a single rigid body. The large rotation observed from the open state to the closed state results in a 65% decrease of the folding chamber volume and creates a highly hydrophilic surface inside the cage. These results suggest a completely distinct closing mechanism in the group II chaperonins as compared with the group I chaperonins.	[Pereira, Jose H.; Ralston, Corie Y.; Adams, Paul D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Douglas, Nicholai R.; Meyer, Daniel; Frydman, Judith] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Douglas, Nicholai R.; Meyer, Daniel; Frydman, Judith] Stanford Univ, BioX Program, Stanford, CA 94305 USA; [Knee, Kelly M.; Goulet, Daniel R.; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Adams, PD (corresponding author), 1 Cyclotron Rd, Berkeley, CA 94720 USA.	pdadams@lbl.gov	Adams, Paul David/A-1977-2013; Meyer, Daniel/B-7324-2014	Adams, Paul David/0000-0001-9333-8219; Meyer, Daniel/0000-0001-8948-052X; , judith/0000-0003-2302-6943	Nanomedicine Development Center [2PN2EY016525]; NIGMS, National Institutes of Health; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER	Nanomedicine Development Center; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was performed as part of the Center for Protein Folding Machinery and National Institutes of Health Roadmap-supported Nanomedicine Development Center (Grant 2PN2EY016525). The Berkeley Center for Structural Biology is supported in part by NIGMS, National Institutes of Health, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2009, J APPL CRYSTALLOGR, V42, P607, DOI 10.1107/S0021889809023528; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Chaudhry C, 2004, J MOL BIOL, V342, P229, DOI 10.1016/j.jmb.2004.07.015; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Dobrzynski JK, 1996, BIOCHEMISTRY-US, V35, P15870, DOI 10.1021/bi961114j; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GUAGLIARDI A, 1994, PROTEIN SCI, V3, P1436, DOI 10.1002/pro.5560030910; Gutsche I, 2000, CURR BIOL, V10, P405, DOI 10.1016/S0960-9822(00)00421-8; Gutsche I, 2001, J STRUCT BIOL, V135, P139, DOI 10.1006/jsbi.2001.4373; Horovitz A, 2001, J STRUCT BIOL, V135, P104, DOI 10.1006/jsbi.2001.4377; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Iizuka R, 2003, J BIOL CHEM, V278, P44959, DOI 10.1074/jbc.M305484200; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kafri G, 2003, J MOL BIOL, V326, P981, DOI 10.1016/S0022-2836(03)00046-9; Kafri G, 2001, PROTEIN SCI, V10, P445, DOI 10.1110/ps.44401; Kubota S, 2006, P NATL ACAD SCI USA, V103, P8360, DOI 10.1073/pnas.0600195103; LIN ZL, 1995, J BIOL CHEM, V270, P1011, DOI 10.1074/jbc.270.3.1011; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Llorca O, 1999, NAT STRUCT BIOL, V6, P639; Mande SC, 1996, SCIENCE, V271, P203, DOI 10.1126/science.271.5246.203; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nitsch M, 1998, NAT STRUCT BIOL, V5, P855, DOI 10.1038/2296; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Rommelaere H, 1999, BIOCHEMISTRY-US, V38, P3246, DOI 10.1021/bi9815905; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Roseman AM, 2001, J STRUCT BIOL, V135, P115, DOI 10.1006/jsbi.2001.4374; Saibil HR, 2002, ADV PROTEIN CHEM, V59, P45; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sewell BT, 2004, NAT STRUCT MOL BIOL, V11, P1128, DOI 10.1038/nsmb844; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jmb.2003.11.028; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Taubes G, 1996, SCIENCE, V271, P1493, DOI 10.1126/science.271.5255.1493; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	58	55	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27958	27966		10.1074/jbc.M110.125344	http://dx.doi.org/10.1074/jbc.M110.125344			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573955	hybrid, Green Published			2022-12-25	WOS:000281404100050
J	Tejero, J; Hannibal, L; Mustovich, A; Stuehr, DJ				Tejero, Jesus; Hannibal, Luciana; Mustovich, Anthony; Stuehr, Dennis J.			Surface Charges and Regulation of FMN to Heme Electron Transfer in Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL EQUILIBRIUM; REDUCTASE DOMAIN; TETRAHYDROBIOPTERIN; CALMODULIN; CATALYSIS; BINDING; FLAVIN; SUBSTRATE; PTERIN; BRAIN	The nitric-oxide synthases (NOS, EC 1.14.13.39) are modular enzymes containing attached flavoprotein and heme (NOSoxy) domains. To generate nitric oxide (NO), the NOS FMN subdomain must interact with the NOSoxy domain to deliver electrons to the heme for O-2 activation during catalysis. The molecular basis and how the interaction is regulated is unclear. We explored the role of eight positively charged residues that create an electropositive patch on NOSoxy in enabling the electron transfer by incorporating mutations that neutralized or reversed their individual charges. Stopped-flow and steady-state experiments revealed that individual charges at Lys(423), Lys(620), and Lys(660) were the most important in enabling heme reduction in nNOS. Charge reversal was more disruptive than neutralization in all cases, and the effects on heme reduction were not due to a weakening in the thermodynamic driving force for heme reduction. Mutant NO synthesis activities displayed a complex pattern that could be simulated by a global model for NOS catalysis. This analysis revealed that the mutations impact the NO synthesis activity only through their effects on heme reduction rates. We conclude that heme reduction and NO synthesis in nNOS is enabled by electrostatic interactions involving Lys(423), Lys(620), and Lys(660), which form a triad of positive charges on the NOSoxy surface. A simulated docking study reveals how electrostatic interactions of this triad can enable an FMN-NOSoxy interaction that is productive for electron transfer.	[Tejero, Jesus; Hannibal, Luciana; Mustovich, Anthony; Stuehr, Dennis J.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stuehr, DJ (corresponding author), Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Hannibal, Luciana/AAY-7689-2021; Tejero, Jesus/G-3953-2017	Hannibal, Luciana/0000-0002-0911-5758; Tejero, Jesus/0000-0003-3245-9978	National Institutes of Health [CA53914, GM51491, HL76491]; American Heart Association [0625632B]; NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53914, GM51491, and HL76491 (to D.J.S.). This work was also supported by American Heart Association Postdoctoral Fellowship 0625632B (to J.T.).	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1999, EMBO J, V18, P6271, DOI 10.1093/emboj/18.22.6271; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Feng CJ, 2008, FEBS LETT, V582, P2768, DOI 10.1016/j.febslet.2008.07.005; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Gao YT, 2004, J BIOL CHEM, V279, P18759, DOI 10.1074/jbc.M308936200; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 1999, EMBO J, V18, P6260, DOI 10.1093/emboj/18.22.6260; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; Gorren ACF, 2002, BIOCHEMISTRY-US, V41, P7819, DOI 10.1021/bi025675o; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Haque MM, 2009, J BIOL CHEM, V284, P19237, DOI 10.1074/jbc.M109.013144; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Kang SA, 2005, P NATL ACAD SCI USA, V102, P15465, DOI 10.1073/pnas.0505176102; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; Leys D, 2003, NAT STRUCT BIOL, V10, P219, DOI 10.1038/nsb894; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; Matter H, 2005, J MED CHEM, V48, P4783, DOI 10.1021/jm050007x; MCMILLAN K, 1993, BIOCHEMISTRY-US, V32, P9875, DOI 10.1021/bi00089a001; Medina M, 2008, PROTEINS, V72, P848, DOI 10.1002/prot.21979; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Ost TWB, 2005, J BIOL CHEM, V280, P965, DOI 10.1074/jbc.M411191200; Panda K, 2003, J BIOL CHEM, V278, P37122, DOI 10.1074/jbc.M304456200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Pfeiffer S, 1999, ANGEW CHEM INT EDIT, V38, P1715, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1714::AID-ANIE1714>3.0.CO;2-3; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Salerno JC, 2008, FEBS LETT, V582, P1395, DOI 10.1016/j.febslet.2008.03.051; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Shimanuki T, 1999, J BIOL CHEM, V274, P26956, DOI 10.1074/jbc.274.38.26956; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Tetreault M, 2002, BIOCHEMISTRY-US, V41, P5807, DOI 10.1021/bi012053e; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Toogood HS, 2005, J BIOL CHEM, V280, P30361, DOI 10.1074/jbc.M505562200; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wei CC, 2008, J BIOL CHEM, V283, P11734, DOI 10.1074/jbc.M709250200; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682; Yadav J, 2004, CHEM LETT, V33, P752, DOI 10.1246/cl.2004.752; Yumoto T, 2000, J INORG BIOCHEM, V82, P163, DOI 10.1016/S0162-0134(00)00142-2	60	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27232	27240		10.1074/jbc.M110.138842	http://dx.doi.org/10.1074/jbc.M110.138842			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592038	Green Published, hybrid			2022-12-25	WOS:000281172700054
J	Chen, C; Sun, QH; Narayanan, B; Nuss, DL; Herzberg, O				Chen, Chen; Sun, Qihong; Narayanan, Buvaneswari; Nuss, Donald L.; Herzberg, Osnat			Structure of Oxalacetate Acetylhydrolase, a Virulence Factor of the Chestnut Blight Fungus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-METHYLISOCITRATE LYASE PRPB; PETAL DEATH PROTEIN; CRYSTAL-STRUCTURE; OXALATE PRODUCTION; ISOCITRATE LYASE; OXALIC-ACID; CRYPHONECTRIA-PARASITICA; ENZYME SUPERFAMILY; ESCHERICHIA-COLI; CATALYSIS	Oxalacetate acetylhydrolase (OAH), a member of the phosphoenolpyruvate mutase/isocitrate lyase superfamily, catalyzes the hydrolysis of oxalacetate to oxalic acid and acetate. This study shows that knock-out of the oah gene in Cryphonectria parasitica, the chestnut blight fungus, reduces the ability of the fungus to form cankers on chestnut trees, suggesting that OAH plays a key role in virulence. OAH was produced in Escherichia coli and purified, and its catalytic rates were determined. Oxalacetate is the main OAH substrate, but the enzyme also acts as a lyase of (2R, 3S)-dimethyl malate with similar to 1000-fold lower efficacy. The crystal structure of OAH was determined alone, in complex with a mechanism-based inhibitor, 3,3-difluorooxalacetate (DFOA), and in complex with the reaction product, oxalate, to a resolution limit of 1.30, 1.55, and 1.65 angstrom, respectively. OAH assembles into a dimer of dimers with each subunit exhibiting an (alpha/beta)(8) barrel fold and each pair swapping the 8th alpha-helix. An active site "gating loop" exhibits conformational disorder in the ligand-free structure. To obtain the structures of the OAH center dot ligand complexes, the ligand-free OAH crystals were soaked briefly with DFOA or oxalacetate. DFOA binding leads to ordering of the gating loop in a conformation that sequesters the ligand from the solvent. DFOA binds in a gem-diol form analogous to the oxalacetate intermediate/transition state. Oxalate binds in a planar conformation, but the gating loop is largely disordered. Comparison between the OAH structure and that of the closely related enzyme, 2,3-dimethylmalate lyase, suggests potential determinants of substrate preference.	[Herzberg, Osnat] Univ Maryland, W M Keck Lab Struct Biol, Ctr Adv Res Biotechnol, Inst Biotechnol, Rockville, MD 20850 USA; [Sun, Qihong; Nuss, Donald L.] Univ Maryland, Ctr Biosyst Res, Inst Biotechnol, Rockville, MD 20850 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Herzberg, O (corresponding author), Univ Maryland, W M Keck Lab Struct Biol, Ctr Adv Res Biotechnol, Inst Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	osnat@umd.edu			National Institutes of Health [P01-GM057890, GM55981]; National Science Foundation [MCB9813271]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057890, R01GM055981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-GM057890 (to O. H.) and GM55981 (to D. N.). This work was also supported by National Science Foundation Grant MCB9813271 (to O. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANAGNOSTAKIS SL, 1982, SCIENCE, V215, P466, DOI 10.1126/science.215.4532.466; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Britton KL, 2000, STRUCTURE, V8, P349, DOI 10.1016/S0969-2126(00)00117-9; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Chaudhuri BN, 2003, STRUCTURE, V11, P753, DOI 10.1016/S0969-2126(03)00106-0; Chen CCH, 2006, BIOCHEMISTRY-US, V45, P11491, DOI 10.1021/bi061208l; CHURCHILL ACL, 1990, CURR GENET, V17, P25, DOI 10.1007/BF00313245; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; EMLY M, 1981, J AM CHEM SOC, V103, P628, DOI 10.1021/ja00393a022; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Grimm C, 2003, J MOL BIOL, V328, P609, DOI 10.1016/S0022-2836(03)00358-9; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Han Y, 2007, J BIOL CHEM, V282, P9581, DOI 10.1074/jbc.M608961200; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; HAVIR EA, 1983, PHYSIOL PLANT PATHOL, V23, P369, DOI 10.1016/0048-4059(83)90021-8; HERZBERG O, 1991, PROTEINS, V11, P223, DOI 10.1002/prot.340110307; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; HILLMAN BI, 1990, PHYTOPATHOLOGY, V80, P950, DOI 10.1094/Phyto-80-950; Huang K, 1999, STRUCT FOLD DES, V7, P539, DOI 10.1016/S0969-2126(99)80070-7; Joosten HJ, 2008, PROTEINS, V70, P157, DOI 10.1002/prot.21622; Jordan CR, 1996, HOLZFORSCHUNG, V50, P312, DOI 10.1515/hfsg.1996.50.4.312; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kirkland BH, 2005, J MED ENTOMOL, V42, P346, DOI 10.1603/0022-2585(2005)042[0346:OAAAFA]2.0.CO;2; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Lan XW, 2008, CURR GENET, V53, P59, DOI 10.1007/s00294-007-0162-x; Lane BG, 2002, IUBMB LIFE, V53, P67, DOI 10.1080/15216540211474; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leatherbarrow R J, 2007, GRAFIT VERSION 6; Liu SJ, 2004, BIOCHEMISTRY-US, V43, P4447, DOI 10.1021/bi036255h; Liu SJ, 2005, BIOCHEMISTRY-US, V44, P2949, DOI 10.1021/bi0479712; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P16365, DOI 10.1021/bi051776l; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Nakagawa Y., 1999, J Infect Chemother, V5, P97, DOI 10.1007/s101560050016; Narayanan B, 2009, J MOL BIOL, V386, P486, DOI 10.1016/j.jmb.2008.12.037; Narayanan BC, 2008, BIOCHEMISTRY-US, V47, P167, DOI 10.1021/bi701954p; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; POLLACK SJ, 1992, EUR J BIOCHEM, V209, P735, DOI 10.1111/j.1432-1033.1992.tb17342.x; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Simanshu DK, 2003, BIOCHEM BIOPH RES CO, V311, P193, DOI 10.1016/j.bbrc.2003.09.193; SWAIN AL, 1989, J BIOL CHEM, V264, P16620; Teplyakov A, 2005, BIOCHEMISTRY-US, V44, P16377, DOI 10.1021/bi051779y; von Delft F, 2003, STRUCTURE, V11, P985, DOI 10.1016/S0969-2126(03)00158-8; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Welch AJ, 2007, PLANT SCI, V172, P488, DOI 10.1016/j.plantsci.2006.10.015; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	52	35	36	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26685	26696		10.1074/jbc.M110.117804	http://dx.doi.org/10.1074/jbc.M110.117804			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558740	hybrid, Green Published			2022-12-25	WOS:000280921000083
J	Wang, Y; Ngo, VN; Marani, M; Yang, Y; Wright, G; Staudt, LM; Downward, J				Wang, Y.; Ngo, V. N.; Marani, M.; Yang, Y.; Wright, G.; Staudt, L. M.; Downward, J.			Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells	ONCOGENE			English	Article						KRAS; synthetic lethal; oncogene addiction; epithelial-mesenchymal transition	EPITHELIAL-MESENCHYMAL TRANSITIONS; E-CADHERIN EXPRESSION; RNA INTERFERENCE; P53-MEDIATED APOPTOSIS; TUMOR PROGRESSION; CANCER-CELLS; FACTOR SLUG; LINES; GROWTH; GENE	Activating mutations in the KRAS gene are among the most prevalent genetic changes in human cancers. To identify synthetic lethal interactions in cancer cells harbouring mutant KRAS, we performed a large-scale screen in isogenic paired colon cancer cell lines that differ by a single allele of mutant KRAS using an inducible short hairpin RNA interference library. Snail2, a zinc finger transcriptional repressor encoded by the SNAI2 gene, was found to be selectively required for the long-term survival of cancer cells with mutant KRAS that have undergone epithelial-mesenchymal transition (EMT), a transdifferentiation event that is frequently seen in advanced tumours and is promoted by RAS activation. Snail2 expression is regulated by the RAS pathway and is required for EMT. Our findings support Snail2 as a possible target for the treatment of the broad spectrum of human cancers of epithelial origin with mutant RAS that have undergone EMT and are characterized by a high degree of chemoresistance and radioresistance. Oncogene (2010) 29, 4658-4670; doi:10.1038/onc.2010.218; published online 21 June 2010	[Wang, Y.; Marani, M.; Downward, J.] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3PX, England; [Ngo, V. N.; Yang, Y.; Staudt, L. M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wright, G.] NCI, Biometr Res Branch, DCTD, NIH, Bethesda, MD 20892 USA	Cancer Research UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	julian.downward@cancer.org.uk	Downward, Julian/A-3251-2012; Wright, George W/M-1660-2017; Staudt, Louis/AAC-5324-2019	Wang, Yihua/0000-0001-5561-0648; Ngo, Vu/0000-0002-9501-6990; Downward, Julian/0000-0002-2331-4729	Cancer Research UK; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011008, ZIABC011007] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Alberto Bardelli for providing SW48 and SW48 KRAS G13D cells and Senji Shirasawa for providing HCT-116, HKe-3 and HKh-2 cells. This work was supported by funding from Cancer Research UK and from the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Cully M, 2008, CELL, V133, P1292, DOI 10.1016/j.cell.2008.06.020; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; DOBZHANSKY T, 1946, GENETICS, V31, P269; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Downward J, 2004, ONCOGENE, V23, P8376, DOI 10.1038/sj.onc.1208073; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hajra KM, 2002, CANCER RES, V62, P1613; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Inoue A, 2002, CANCER CELL, V2, P279, DOI 10.1016/S1535-6108(02)00155-1; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Joyce T, 2009, CLIN EXP METASTAS, V26, P569, DOI 10.1007/s10585-009-9256-9; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Katoh M, 2005, ONCOL REP, V14, P1083; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Losada J, 2003, ONCOGENE, V22, P4205, DOI 10.1038/sj.onc.1206467; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Schmidt CR, 2005, SURGERY, V138, P306, DOI 10.1016/j.surg.2005.06.007; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Vannini I, 2007, CELL ONCOL, V29, P279; Vitali R, 2008, CLIN CANCER RES, V14, P4622, DOI 10.1158/1078-0432.CCR-07-5210; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wang Z, 2007, ONCOGENE, V26, P1222, DOI 10.1038/sj.onc.1209902; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029	50	86	89	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2010	29	33					4658	4670		10.1038/onc.2010.218	http://dx.doi.org/10.1038/onc.2010.218			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	641LK	20562906	Green Accepted			2022-12-25	WOS:000281127400005
J	Imada, H; Hoki, M; Suehiro, Y; Okuyama, T; Kurabayashi, D; Shimada, A; Naruse, K; Takeda, H; Kubo, T; Takeuchi, H				Imada, Haruka; Hoki, Masahito; Suehiro, Yuji; Okuyama, Teruhiro; Kurabayashi, Daisuke; Shimada, Atsuko; Naruse, Kiyoshi; Takeda, Hiroyuki; Kubo, Takeo; Takeuchi, Hideaki			Coordinated and Cohesive Movement of Two Small Conspecific Fish Induced by Eliciting a Simultaneous Optomotor Response	PLOS ONE			English	Article							MEDAKA ORYZIAS-LATIPES; EMERGENT PROPERTIES; SCHOOLING BEHAVIOR; SHOALING BEHAVIOR; GENE INDUCTION; ZEBRAFISH; SIZE; QUANTIFICATION; GENERATION; SYSTEM	Background: In animal groups such as herds, schools, and flocks, a certain distance is maintained between adjacent individuals, allowing them to move as a cohesive unit. Proximate causations of the cohesive and coordinated movement under dynamic conditions, however, have been poorly understood. Methodology/Principal Findings: We established a novel and simple behavioral assay using pairs of small fish (medaka and dwarf pufferfish) by eliciting a simultaneous optomotor response (OMR). We demonstrated that two homospecific fish began to move cohesively and maintained a distance of 2 to 4 cm between them when an OMR was elicited simultaneously in the fish. The coordinated and cohesive movement was not exhibited under a static condition. During the cohesive movement, the relative position of the two fish was not stable. Furthermore, adult medaka exhibited the cohesive movement but larvae did not, despite the fact that an OMR could be elicited in larvae, indicating that this ability to coordinate movement develops during maturation. The cohesive movement was detected in homospecific pairs irrespective of body-color, sex, or albino mutation, but was not detected between heterospecific pairs, suggesting that coordinated movement is based on a conspecific interaction. Conclusions/Significance: Our findings demonstrate that coordinated behavior between a pair of animals was elicited by a simultaneous OMR in two small fish. This is the first report to demonstrate induction of a schooling-like movement in a pair of fish by an OMR and to investigate the effect of age, sex, body color, and species on coordination between animals under a dynamic condition.	[Imada, Haruka; Hoki, Masahito; Suehiro, Yuji; Okuyama, Teruhiro; Shimada, Atsuko; Takeda, Hiroyuki; Kubo, Takeo; Takeuchi, Hideaki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Kurabayashi, Daisuke] Tokyo Inst Technol, Dept Mech & Control Engn, Tokyo 152, Japan; [Naruse, Kiyoshi] Natl Inst Basic Biol, Lab BioResource, Okazaki, Japan	University of Tokyo; Tokyo Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Imada, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	takeuchi@biol.s.u-tokyo.ac.jp	Takeuchi, Hideaki/W-6739-2018; TAKEDA, HIROYUKI/G-4950-2014; Kurabayashi, Daisuke/C-6878-2015; TAKEUCHI, HIDEAKI/G-4969-2014; KUBO, TAKEO/G-4951-2014	Takeuchi, Hideaki/0000-0001-6610-3895; Kurabayashi, Daisuke/0000-0002-3186-6531; Kubo, Takeo/0000-0002-5914-5269	Ministry of Education, Culture, Sports, Science, and Technology [21700341]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was totally supported by the Ministry of Education, Culture, Sports, Science, and Technology, Scientific Research on Priority Areas (Area No. 454, Mobiligence Project) and Grant-in-Aid for Young Scientists (B) 21700341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, LIVING GROUPS; AOKI I, 1984, B JPN SOC SCI FISH, V50, P751; Barber I, 2000, P ROY SOC B-BIOL SCI, V267, P151, DOI 10.1098/rspb.2000.0980; Carvalho PSM, 2002, ANIM BEHAV, V64, P1, DOI 10.1006/anbe.2002.3028; Crook AC, 1999, MAR ECOL PROG SER, V176, P17, DOI 10.3354/meps176017; Deguchi T, 2009, DEV GROWTH DIFFER, V51, P769, DOI 10.1111/j.1440-169X.2009.01135.x; EMLEN J. T., 1952, AUK, V69, P160; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hiramatsu K, 2000, J FAC AGR KYUSHU U, V45, P237; Kamei Y, 2009, NAT METHODS, V6, P79, DOI [10.1038/NMETH.1278, 10.1038/nmeth.1278]; Kato S, 2004, J NEUROSCI METH, V134, P1, DOI 10.1016/j.jneumeth.2003.09.028; KRAUSE J, 1994, ETHOLOGY, V98, P128; Krause J, 2000, BIOL REV, V75, P477; KUROYANAGI Y, BRAIN RES, V1323, P33; MAGURRAN AE, 1986, J FISH BIOL, V29, P159, DOI 10.1111/j.1095-8649.1986.tb05007.x; Masuda R, 1998, J FISH BIOL, V52, P483, DOI 10.1006/jfbi.1997.0597; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Nakamura S, 2008, DEV GROWTH DIFFER, V50, P415, DOI [10.1111/j.1440-169X.2008.01027.x, 10.1111/j.1440-169x.2008.01027.x]; NAKAMURA YOSHIO, 1952, BULL JAPANESE SOC SCI FISH, V18, P93; Nakayama K, 2005, ENVIRON TOXICOL CHEM, V24, P2588, DOI 10.1897/04-518R2.1; Okubo A., 1986, Advances in Biophysics, V22, P1, DOI 10.1016/0065-227X(86)90003-1; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; PARRISH KJ, 1997, ANIMAL GROUPS 3 DIME, P126; PARTRIDGE BL, 1980, BEHAV ECOL SOCIOBIOL, V6, P277, DOI 10.1007/BF00292770; PITCHER JT, 1972, ANIM BEHAV, V21, P673; Reebs SG, 2001, BEHAVIOUR, V138, P797, DOI 10.1163/156853901753172656; SHAW E, 1967, J COMP PHYSIOL PSYCH, V63, P385, DOI 10.1037/h0024636; SHAW E, 1965, ANIM BEHAV, V13, P330, DOI 10.1016/0003-3472(65)90052-7; SHAW E, 1970, DEV EVOLUTION BEHAVI, P453; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; Soria M, 2007, J FISH BIOL, V71, P1257, DOI 10.1111/j.1095-8649.2007.01554.x; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; Tsubokawa T, 2009, SOC NEUROSCI-UK, V4, P276, DOI 10.1080/17470910802625215; Viscido SV, 2007, ECOL MODEL, V206, P153, DOI 10.1016/j.ecolmodel.2007.03.042; Viscido SV, 2005, ECOL MODEL, V183, P347, DOI 10.1016/j.ecolmodel.2004.08.019	37	32	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11248	10.1371/journal.pone.0011248	http://dx.doi.org/10.1371/journal.pone.0011248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582314	gold, Green Published, Green Submitted			2022-12-25	WOS:000279058500010
J	Thibodeaux, GN; Liang, XA; Moncivais, K; Umeda, A; Singer, O; Alfonta, L; Zhang, ZWJ				Thibodeaux, Gabrielle Nina; Liang, Xiang; Moncivais, Kathryn; Umeda, Aiko; Singer, Oded; Alfonta, Lital; Zhang, Zhiwen Jonathan			Transforming a Pair of Orthogonal tRNA-aminoacyl-tRNA Synthetase from Archaea to Function in Mammalian Cells	PLOS ONE			English	Article							SITE-SPECIFIC INCORPORATION; GENETIC-CODE; ESCHERICHIA-COLI; PROTEINS; SUPPRESSOR; ACIDS; AMBER	A previously engineered Methanocaldococcus jannaschii tRNA(CUA)(Tyr)-tyrosyl-tRNA synthetase pair orthogonal to Escherichia coli was modified to become orthogonal in mammalian cells. The resulting tRNA(CUA)(Tyr)-tyrosyl-tRNA synthetase pair was able to suppress an amber codon in the green fluorescent protein, GFP, and in a foldon protein in mammalian cells. The methodology reported here will allow rapid transformation of the much larger collection of existing tyrosyl-tRNA synthetases that were already evolved for the incorporation of an array of over 50 unnatural amino acids into proteins in Escherichia coli into proteins in mammalian cells. Thus we will be able to introduce a large array of possibilities for protein modifications in mammalian cells.	[Thibodeaux, Gabrielle Nina; Liang, Xiang; Moncivais, Kathryn; Umeda, Aiko; Zhang, Zhiwen Jonathan] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Singer, Oded] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Alfonta, Lital] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel	University of Texas System; University of Texas Austin; Salk Institute; Ben Gurion University	Thibodeaux, GN (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.	alfontal@bgu.ac.il; zhang@mail.utexas.edu	Alfonta, Lital/AAB-9689-2022; Alfonta, Lital/B-6101-2012	Alfonta, Lital/0000-0002-3805-8625; Alfonta, Lital/0000-0002-3805-8625	Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers; Welch Foundation [F1618]; NIH [R01 CA120168]; NATIONAL CANCER INSTITUTE [R01CA120168] Funding Source: NIH RePORTER	Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers; Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	L. A. acknowledges the Edmond J. Safra Center for the Design and Engineering of Functional Biopolymers for funding this research, (URL of Funding Agency: http://www.edmondjsafra.org/). Z. Z. acknowledges a Welch Foundation Research Grant (F1618) and NIH R01 CA120168. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chin JW, 2003, CHEM BIOL, V10, P511, DOI 10.1016/S1074-5521(03)00123-6; Drabkin HJ, 1996, MOL CELL BIOL, V16, P907; EDWARDS H, 1990, MOL CELL BIOL, V10, P1633, DOI 10.1128/MCB.10.4.1633; Kohrer C, 2001, P NATL ACAD SCI USA, V98, P14310, DOI 10.1073/pnas.251438898; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Monahan SL, 2003, CHEM BIOL, V10, P573, DOI 10.1016/S1074-5521(03)00124-8; Nemoto N, 1999, FEBS LETT, V462, P43, DOI 10.1016/S0014-5793(99)01474-X; Nordin BE, 1999, J BIOL CHEM, V274, P6835, DOI 10.1074/jbc.274.11.6835; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Tsunoda M, 2007, NUCLEIC ACIDS RES, V35, P4289, DOI 10.1093/nar/gkm417; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wu X, 2009, J AM CHEM SOC, V131, P12497, DOI 10.1021/ja9026067; YOUNG JF, 1983, SCIENCE, V221, P873, DOI 10.1126/science.6308765; Zhang ZW, 2004, P NATL ACAD SCI USA, V101, P8882, DOI 10.1073/pnas.0307029101	17	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11263	10.1371/journal.pone.0011263	http://dx.doi.org/10.1371/journal.pone.0011263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582317	gold, Green Submitted, Green Published			2022-12-25	WOS:000279058500015
J	Melo, GC; Reyes-Lecca, RC; Vitor-Silva, S; Monteiro, WM; Martins, M; Benzecry, SG; Alecrim, MDC; Lacerda, MVG				Melo, Gisely Cardoso; Reyes-Lecca, Roberto Carlos; Vitor-Silva, Sheila; Monteiro, Wuelton Marcelo; Martins, Marilaine; Benzecry, Silvana Gomes; Costa Alecrim, Maria das Gracas; Guimaraes Lacerda, Marcus Vinicius			Concurrent Helminthic Infection Protects Schoolchildren with Plasmodium vivax from Anemia	PLOS ONE			English	Article							ASCARIS-LUMBRICOIDES INFECTION; HOOKWORM INFECTION; FALCIPARUM-MALARIA; CHILDREN; EPIDEMIOLOGY; HEMOGLOBIN; DISTRICT; AFRICA; ASSOCIATION; COMMUNITIES	Background: Plasmodium vivax is responsible for a significant portion of malaria cases worldwide, especially in Asia and Latin America, where geo-helminthiasis have a high prevalence. Impact of the interaction between vivax malaria and intestinal helminthes has been poorly explored. The objective of this study was to evaluate the influence of intestinal helminthiasis on the concentration of hemoglobin in children with Plasmodium vivax malaria in rural areas in the municipality of Careiro, in the Western Brazilian Amazon. Methodology/Principal Findings: A cohort study was conducted from April to November 2008, enrolling children from 5 to 14 years old in two rural areas endemic for malaria. A cross-sectional evaluation was performed in April to actively detect cases of malaria and document baseline hemoglobin and nutritional status. Children were followed-up for six months through passive case detection of malaria based on light microscopy. Throughout the follow-up interval, hemoglobin value and stool examination (three samples on alternate days) were performed on children who developed P. vivax malaria. For 54 schoolchildren with a single infection by P. vivax, hemoglobin during the malaria episode was similar to the baseline hemoglobin for children co-infected with Ascaris lumbricoides (n = 18), hookworm (n = 11) and Trichuris trichiura (n = 9). In children without intestinal helminthes, a significant decrease in the hemoglobin during the malarial attack was seen as compared to the baseline concentration. In the survival analysis, no difference was seen in the time (in days) from the baseline cross-sectional to the first malarial infection, between parasitized and nonparasitized children. Conclusion/Significance: For the first time, a cohort study showed that intestinal helminthes protect against hemoglobin decrease during an acute malarial attack by P. vivax.	[Melo, Gisely Cardoso; Vitor-Silva, Sheila; Monteiro, Wuelton Marcelo; Martins, Marilaine; Benzecry, Silvana Gomes; Costa Alecrim, Maria das Gracas; Guimaraes Lacerda, Marcus Vinicius] Univ State Amazonas, Manaus, Amazonas, Brazil; [Martins, Marilaine; Guimaraes Lacerda, Marcus Vinicius] Trop Med Fdn Amazonas, Manaus, Amazonas, Brazil; [Reyes-Lecca, Roberto Carlos] Univ Brasilia, BR-70910900 Brasilia, DF, Brazil; [Costa Alecrim, Maria das Gracas; Guimaraes Lacerda, Marcus Vinicius] Nilton Lins Univ Ctr, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universidade de Brasilia; Centro Universitario Nilton Lins	Melo, GC (corresponding author), Univ State Amazonas, Manaus, Amazonas, Brazil.	marcuslacerda.br@gmail.com	melo, gisely/GZK-5350-2022		Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) [1514-08]; Superintendencia da Zona Franca de Manaus (SUFRAMA) [016/2004]	Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Superintendencia da Zona Franca de Manaus (SUFRAMA)	This study was funded by Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (grant number 1514-08) and by Superintendencia da Zona Franca de Manaus (SUFRAMA) (Grant number 016/2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAL AM TIM SER EP DA; [Anonymous], 2008, WORLD MAL REP 2008; Araujo Claudio Fernández, 2005, Rev. Soc. Bras. Med. Trop., V38, P69; Boia M N, 1999, Cad Saude Publica, V15, P497, DOI 10.1590/S0102-311X1999000300006; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Brooker S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-99; Brutus L, 2007, AM J TROP MED HYG, V77, P1091, DOI 10.4269/ajtmh.2007.77.1091; Brutus L, 2006, AM J TROP MED HYG, V75, P194, DOI 10.4269/ajtmh.2006.75.194; BUCK AA, 1978, TROPENMED PARASITOL, V29, P61; Bueno LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009623; Caicedo O, 2009, AM J TROP MED HYG, V80, P146, DOI 10.4269/ajtmh.2009.80.146; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Faust E.C., 1939, Journal of Parasitology Urbana, V25, P241, DOI 10.2307/3272508; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Le Hesran JY, 2004, T ROY SOC TROP MED H, V98, P397, DOI 10.1016/j.trstmh.2003.10.009; LUTZ Adolpho, 1919, Memorias do Instituto Oswaldo Cruz, V11, P121, DOI 10.1590/S0074-02761919000100006; McDevitt Michael A, 2004, Curr Hematol Rep, V3, P97; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; MURRAY J, 1978, AM J CLIN NUTR, V31, P1363, DOI 10.1093/ajcn/31.8.1363; MURRAY MJ, 1977, AM J CLIN NUTR, V30, P2117, DOI 10.1093/ajcn/30.12.2117; Nacher M, 2005, ANN TROP MED PARASIT, V99, P623, DOI 10.1179/136485905X51364; Nacher M, 2004, CLIN REV ALLERG IMMU, V26, P85, DOI 10.1007/s12016-004-0003-3; Nacher M, 2000, PARASITE IMMUNOL, V22, P107, DOI 10.1046/j.1365-3024.2000.00284.x; Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834; Nacher M, 2001, J PARASITOL, V87, P912, DOI 10.1645/0022-3395(2001)087[0912:CASMPF]2.0.CO;2; Nacher M, 2001, AM J TROP MED HYG, V65, P644, DOI 10.4269/ajtmh.2001.65.644; Nacher M, 2001, AM J TROP MED HYG, V65, P335, DOI 10.4269/ajtmh.2001.65.335; Nacher M, 2001, AM J TROP MED HYG, V65, P136, DOI 10.4269/ajtmh.2001.65.136; Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2; Ndyomugyenyi R, 2008, T ROY SOC TROP MED H, V102, P130, DOI 10.1016/j.trstmh.2007.09.015; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; OLIVEIRA M, 2004, HEMATOLOGICAL CHARAC; Pearson Richard D., 2002, Curr Infect Dis Rep, V4, P59, DOI 10.1007/s11908-002-0068-1; Petney TN, 1998, INT J PARASITOL, V28, P377, DOI 10.1016/S0020-7519(97)00189-6; Shulman CE, 1996, T ROY SOC TROP MED H, V90, P535, DOI 10.1016/S0035-9203(96)90312-0; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; STEPHENSON LS, 1985, AM J TROP MED HYG, V34, P519, DOI 10.4269/ajtmh.1985.34.519; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; Stoltzfus RJ, 2000, J NUTR, V130, P1724, DOI 10.1093/jn/130.7.1724; Tatala S, 1998, AM J CLIN NUTR, V68, P171, DOI 10.1093/ajcn/68.1.171; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; *WHO, 2002, MAL FIL OTH PAR DIS; World Health Organization, 2006, MICR DIAGN MAL; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yang Y, 2008, ENVIRON FLUID MECH, V8, P19, DOI 10.1007/s10652-008-9052-0	53	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11206	10.1371/journal.pone.0011206	http://dx.doi.org/10.1371/journal.pone.0011206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574512	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058300008
J	Ota, KT; Monsey, MS; Wu, MS; Schafe, GE				Ota, Kristie T.; Monsey, Melissa S.; Wu, Melissa S.; Schafe, Glenn E.			Synaptic Plasticity and NO-cGMP-PKG Signaling Regulate Pre- and Postsynaptic Alterations at Rat Lateral Amygdala Synapses Following Fear Conditioning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE; MEMORY CONSOLIDATION; STRUCTURAL-CHANGES; ERK/MAP KINASE; ACTIVATION; RECEPTOR; APLYSIA; NMDA	In vertebrate models of synaptic plasticity, signaling via the putative "retrograde messenger'' nitric oxide (NO) has been hypothesized to serve as a critical link between functional and structural alterations at pre- and postsynaptic sites. In the present study, we show that auditory Pavlovian fear conditioning is associated with significant and long-lasting increases in the expression of the postsynaptically-localized protein GluR1 and the presynaptically-localized proteins synaptophysin and synapsin in the lateral amygdala (LA) within 24 hrs following training. Further, we show that rats given intra-LA infusion of either the NR2B-selective antagonist Ifenprodil, the NOS inhibitor 7-Ni, or the PKG inhibitor Rp-8-Br-PET-cGMPS exhibit significant decreases in training-induced expression of GluR1, synaptophysin, and synapsin immunoreactivity in the LA, while those rats infused with the PKG activator 8-Br-cGMP exhibit a significant increase in these proteins in the LA. In contrast, rats given intra-LA infusion of the NO scavenger c-PTIO exhibit a significant decrease in synapsin and synaptophysin expression in the LA, but no significant impairment in the expression of GluR1. Finally, we show that intra-LA infusions of the ROCK inhibitor Y-27632 or the CaMKII inhibitor KN-93 impair training-induced expression of GluR1, synapsin, and synaptophysin in the LA. These findings suggest that the NO-cGMP-PKG, Rho/ROCK, and CaMKII signaling pathways regulate fear memory consolidation, in part, by promoting both pre- and post-synaptic alterations at LA synapses. They further suggest that synaptic plasticity in the LA during auditory fear conditioning promotes alterations at presynaptic sites via NO-driven "retrograde signaling''.	[Ota, Kristie T.; Monsey, Melissa S.; Wu, Melissa S.; Schafe, Glenn E.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Schafe, Glenn E.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA	Yale University; Yale University	Ota, KT (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	glenn.schafe@yale.edu			National Institutes of Health [MH 073949]; Yale University; National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institutes of Health (MH 073949 to G. E. S.) and by Yale University. K.T.O. is supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov I, 2003, NEURON, V37, P135, DOI 10.1016/S0896-6273(02)01129-7; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Apergis-Schoute AM, 2005, J NEUROSCI, V25, P5730, DOI 10.1523/JNEUROSCI.0096-05.2005; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; FARB CR, 1995, J COMP NEUROL, V362, P86, DOI 10.1002/cne.903620106; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; LIN XY, 1994, P ROY SOC B-BIOL SCI, V255, P215, DOI 10.1098/rspb.1994.0031; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Lu YF, 1999, J NEUROSCI, V19, P10250; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Monfort P, 2002, J NEUROSCI, V22, P10116; Murphy GG, 1997, SCIENCE, V278, P467, DOI 10.1126/science.278.5337.467; Murphy GG, 1996, P NATL ACAD SCI USA, V93, P9931, DOI 10.1073/pnas.93.18.9931; Nikonenko I, 2003, J NEUROSCI, V23, P8498; Ninan I, 2004, NEURON, V42, P129, DOI 10.1016/S0896-6273(04)00143-6; Ninan I, 2006, EMBO J, V25, P4361, DOI 10.1038/sj.emboj.7601318; Nithianantharajah J, 2008, NEUROBIOL LEARN MEM, V90, P36, DOI 10.1016/j.nlm.2007.12.002; Ota KT, 2008, LEARN MEMORY, V15, P792, DOI 10.1101/lm.1114808; OTA KT, 2010, LEARN MEM IN PRESS; Overeem KA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.002.2010; Radley JJ, 2006, EUR J NEUROSCI, V24, P876, DOI 10.1111/j.1460-9568.2006.04962.x; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Roberts AC, 2003, TRENDS NEUROSCI, V26, P662, DOI 10.1016/j.tins.2003.09.014; Rodrigues SM, 2004, J NEUROSCI, V24, P3281, DOI 10.1523/JNEUROSCI.5303-03.2004; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Schafe GE, 2005, EUR J NEUROSCI, V22, P201, DOI 10.1111/j.1460-9568.2005.04209.x; Schafe GE, 2000, J NEUROSCI, V20, P8177; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Son H, 1998, LEARN MEMORY, V5, P231; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Yeh SH, 2006, MOL PHARMACOL, V69, P299, DOI 10.1124/mol.105.017194; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	51	61	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11236	10.1371/journal.pone.0011236	http://dx.doi.org/10.1371/journal.pone.0011236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574537	Green Published, gold			2022-12-25	WOS:000279058300020
J	Aruscavage, PJ; Hellwig, S; Bass, BL				Aruscavage, P. Joseph; Hellwig, Sabine; Bass, Brenda L.			Small DNA Pieces in C. elegans Are Intermediates of DNA Fragmentation during Apoptosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ENDONUCLEASE-G; INNATE IMMUNITY; GENETIC-CONTROL; DEGRADATION; ROLES; NUC-1	While studying small noncoding RNA in C. elegans, we discovered that protocols used for isolation of RNA are contaminated with small DNA pieces. After electrophoresis on a denaturing gel, the DNA fragments appear as a ladder of bands,,10 nucleotides apart, mimicking the pattern of nuclease digestion of DNA wrapped around a nucleosome. Here we show that the small DNA pieces are products of the DNA fragmentation that occurs during apoptosis, and correspondingly, are absent in mutant strains incapable of apoptosis. In contrast, the small DNA pieces are present in strains defective for the engulfment process of apoptosis, suggesting they are produced in the dying cell prior to engulfment. While the small DNA pieces are also present in a number of strains with mutations in predicted nucleases, they are undetectable in strains containing mutations in nuc-1, which encodes a DNase II endonuclease. We find that the small DNA pieces can be labeled with terminal deoxynucleotidyltransferase only after phosphatase treatment, as expected if they are products of DNase II cleavage, which generates a 39 phosphate. Our studies reveal a previously unknown intermediate in the process of apoptotic DNA fragmentation and thus bring us closer to defining this important pathway.	[Aruscavage, P. Joseph; Bass, Brenda L.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Hellwig, Sabine] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Aruscavage, PJ (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	bbass@biochem.utah.edu		Hellwig, Sabine/0000-0002-9809-947X	National Institutes of General Medical Sciences [RO1GM067106]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067106] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds to B.L.B. from National Institutes of General Medical Sciences (RO1GM067106; http://www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conradt Barbara, 2005, WormBook, P1; Conradt B, 2009, ANNU REV GENET, V43, P493, DOI 10.1146/annurev.genet.42.110807.091533; Duret L, 2000, GENETICS, V156, P1661; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; EMMONS SW, 1979, P NATL ACAD SCI USA, V76, P1333, DOI 10.1073/pnas.76.3.1333; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Lai HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007348; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lyon CJ, 2000, GENE, V252, P147, DOI 10.1016/S0378-1119(00)00213-4; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; NOLL M, 1974, NUCLEIC ACIDS RES, V1, P1573, DOI 10.1093/nar/1.11.1573; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; PORTMAN DS, 2006, PROFILING C ELEGANS; PRUNELL A, 1979, SCIENCE, V204, P855, DOI 10.1126/science.441739; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; SOLLNERWEBB B, 1978, CELL, V14, P611, DOI 10.1016/0092-8674(78)90246-5; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; Welker NC, 2007, RNA, V13, P1090, DOI 10.1261/rna.542107; Widlak P, 2001, J BIOL CHEM, V276, P48404, DOI 10.1074/jbc.M108461200; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Wu YC, 2000, GENE DEV, V14, P536; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	33	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11217	10.1371/journal.pone.0011217	http://dx.doi.org/10.1371/journal.pone.0011217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585459	Green Published, Green Accepted, gold			2022-12-25	WOS:000278977200017
J	Kennedy, J; Katsuta, H; Jung, MH; Marselli, L; Goldfine, AB; Balis, UJ; Sgroi, D; Bonner-Weir, S; Weir, GC				Kennedy, Jeffrey; Katsuta, Hitoshi; Jung, Min-Ho; Marselli, Lorella; Goldfine, Allison B.; Balis, Ulysses J.; Sgroi, Dennis; Bonner-Weir, Susan; Weir, Gordon C.			Protective Unfolded Protein Response in Human Pancreatic Beta Cells Transplanted into Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATING TRANSCRIPTION FACTOR-3; LASER CAPTURE MICRODISSECTION; ISLET AMYLOID POLYPEPTIDE; ER STRESS; DIABETES-MELLITUS; OXIDATIVE STRESS; GENE-EXPRESSION; KINASE IRE1; PATHWAY		[Kennedy, Jeffrey; Katsuta, Hitoshi; Jung, Min-Ho; Marselli, Lorella; Goldfine, Allison B.; Bonner-Weir, Susan; Weir, Gordon C.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Cell Biol & Regenerat Med,Res Div, Boston, MA 02115 USA; [Kennedy, Jeffrey; Katsuta, Hitoshi; Jung, Min-Ho; Marselli, Lorella; Goldfine, Allison B.; Bonner-Weir, Susan; Weir, Gordon C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Balis, Ulysses J.; Sgroi, Dennis] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Pathol Unit, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kennedy, J (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Cell Biol & Regenerat Med,Res Div, Boston, MA 02115 USA.	gordon.weir@joslin.harvard.edu	Sgroi, Dennis/AAV-2487-2021	Marselli, Lorella/0000-0002-6698-2962; Balis, Ulysses/0000-0002-4168-1477; Bonner-Weir, Susan/0000-0003-4682-0656	American Diabetes Association; Juvenile Diabetes Research Foundation; National Institutes of Health [RO1 DK66056, P30 DK36836]; Diabetes Research and Wellness Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066056, P30DK036836] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Wellness Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the American Diabetes Association, the Juvenile Diabetes Research Foundation, the National Institutes of Health (RO1 DK66056 and P30 DK36836 - the Advanced Microscopy, Bioinformatics, and Genomics Cores of Joslin Diabetes and Endocrinology Research Center), and the Diabetes Research and Wellness Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Carlsson PO, 2002, J CLIN ENDOCR METAB, V87, P5418, DOI 10.1210/jc.2002-020728; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; HALBAN PA, 2010, J CLIN ENDOCRINOL ME; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Hull RL, 2009, DIABETOLOGIA, V52, P1102, DOI 10.1007/s00125-009-1329-4; ISHIGAKI S, 2009, CELL DEATH DIFFER; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; King AJF, 2007, DIABETES, V56, P2312, DOI 10.2337/db07-0191; Kurisu J, 2003, GENES CELLS, V8, P189, DOI 10.1046/j.1365-2443.2003.00625.x; Lau J, 2009, CURR OPIN ORGAN TRAN, V14, P688, DOI 10.1097/MOT.0b013e32833239ff; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Linetsky E, 1997, DIABETES, V46, P1120, DOI 10.2337/diabetes.46.7.1120; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Marselli L, 2009, METHODS MOL BIOL, V560, P87, DOI 10.1007/978-1-59745-448-3_8; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Rickels MR, 2005, DIABETES, V54, P100, DOI 10.2337/diabetes.54.1.100; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weitgasser R, 1999, DIABETOLOGIA, V42, P256; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081	42	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11211	10.1371/journal.pone.0011211	http://dx.doi.org/10.1371/journal.pone.0011211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585452	Green Published, gold			2022-12-25	WOS:000278977200014
J	Parker, R; Melathopoulos, AP; White, R; Pernal, SF; Guarna, MM; Foster, LJ				Parker, Robert; Melathopoulos, Andony P.; White, Rick; Pernal, Stephen F.; Guarna, M. Marta; Foster, Leonard J.			Ecological Adaptation of Diverse Honey Bee (Apis mellifera) Populations	PLOS ONE			English	Article							GENE-EXPRESSION VARIATION; RNA; QUANTIFICATION; HYMENOPTERA; CYSTEAMINE; PROTEOMICS; SELECTION; ONTOLOGY; VANIN-1; LARVAE	Background: Honey bees are complex eusocial insects that provide a critical contribution to human agricultural food production. Their natural migration has selected for traits that increase fitness within geographical areas, but in parallel their domestication has selected for traits that enhance productivity and survival under local conditions. Elucidating the biochemical mechanisms of these local adaptive processes is a key goal of evolutionary biology. Proteomics provides tools unique among the major 'omics disciplines for identifying the mechanisms employed by an organism in adapting to environmental challenges. Results: Through proteome profiling of adult honey bee midgut from geographically dispersed, domesticated populations combined with multiple parallel statistical treatments, the data presented here suggest some of the major cellular processes involved in adapting to different climates. These findings provide insight into the molecular underpinnings that may confer an advantage to honey bee populations. Significantly, the major energy-producing pathways of the mitochondria, the organelle most closely involved in heat production, were consistently higher in bees that had adapted to colder climates. In opposition, up-regulation of protein metabolism capacity, from biosynthesis to degradation, had been selected for in bees from warmer climates. Conclusions: Overall, our results present a proteomic interpretation of expression polymorphisms between honey bee ecotypes and provide insight into molecular aspects of local adaptation or selection with consequences for honey bee management and breeding. The implications of our findings extend beyond apiculture as they underscore the need to consider the interdependence of animal populations and their agro-ecological context.	[Parker, Robert; Guarna, M. Marta; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Parker, Robert; Guarna, M. Marta; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Melathopoulos, Andony P.; Pernal, Stephen F.] Agr & Agri Food Canada, Beaverlodge, SK, Canada; [White, Rick] Univ British Columbia, Dept Stat, Stat Consulting & Res Lab, Vancouver, BC V6T 1W5, Canada	University of British Columbia; University of British Columbia; Agriculture & Agri Food Canada; University of British Columbia	Parker, R (corresponding author), Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada.	ljfoster@interchange.ubc.ca		Parker, Robert/0000-0003-3989-8893; Guarna, Maria Marta/0000-0002-4638-9475	Genome British Columbia; British Columbia Honey Producers Association; Canadian Honey Council and Canadian Association of Professional Apiculturists; British Columbia Blueberry Council; British Columbia Cranberry Marketing Association; Agri-Food Canada's Advancing Canadian Agriculture and Agri-Food (ACAAF)	Genome British Columbia; British Columbia Honey Producers Association; Canadian Honey Council and Canadian Association of Professional Apiculturists; British Columbia Blueberry Council; British Columbia Cranberry Marketing Association; Agri-Food Canada's Advancing Canadian Agriculture and Agri-Food (ACAAF)(Agriculture & Agri Food Canada)	This work was supported by funding from Genome British Columbia, the British Columbia Honey Producers Association through the Boone-Hodgson-Wilkinson Fund, the Canadian Honey Council and Canadian Association of Professional Apiculturists through the Canadian Bee Research Fund, the British Columbia Blueberry Council, the British Columbia Cranberry Marketing Association and Agri-Food Canada's Advancing Canadian Agriculture and Agri-Food (ACAAF) program. The latter is part of a Collective Outcome project with the cooperation of the Investment Agriculture Foundation of British Columbia, the Alberta Agriculture and Food Council, the Saskatchewan Council for Community Development, the Manitoba Rural Adaptation Council, the Ontario Agricultural Adaptation Council, the Conseil pour le developpement de l'agriculture du Quebec, and Agri-Futures Nova Scotia. Mass spectrometry infrastructure used in this project was supported by the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund and the Michael Smith Foundation through the British Columbia Proteomics Network (BCPN). LJF is the Canada Research Chair in Quantitative Proteomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; [Anonymous], BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; Arakawa Kazuharu, 2005, In Silico Biology, V5, P419; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Boersema PJ, 2008, PROTEOMICS, V8, P4624, DOI 10.1002/pmic.200800297; Bouga M, 2005, BIOCHEM GENET, V43, P471, DOI 10.1007/s10528-005-8163-2; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Crane E., 1975, HONEY ACOMPREHENSIVE; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; de Hoog CL, 2004, ANNU REV GENOM HUM G, V5, P267, DOI 10.1146/annurev.genom.4.070802.110305; DIETZ A, 1992, HIVE HONEY BEE, P23; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Foret S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-472; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Fridlyand LE, 2006, MED HYPOTHESES, V67, P1034, DOI 10.1016/j.mehy.2006.04.057; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Karr TL, 2008, HEREDITY, V100, P200, DOI 10.1038/sj.hdy.6801008; Khomenko T, 2009, AM J PHYSIOL-GASTR L, V296, pG1277, DOI 10.1152/ajpgi.90257.2008; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P2715, DOI 10.1001/jama.2008.823; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Montgomery D. C., 2005, DESIGN ANAL EXPT; MORTENSEN P, 2009, J PROTEOME RES; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NIELSEN D, 1994, EXPERIENTIA, V50, P867, DOI 10.1007/BF01956474; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Riessberger-Galle U, 2001, J INVERTEBR PATHOL, V77, P231, DOI 10.1006/jipa.2001.5032; Robinson GE, 2006, INSECT MOL BIOL, V15, P535, DOI 10.1111/j.1365-2583.2006.00698.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; STURTEVANT AP, 1953, J ECON ENTOMOL, V46, P855, DOI 10.1093/jee/46.5.855; Szabo T. I., 1991, Bee Science, V1, P144; SZABO TI, 1987, J APICULT RES, V26, P47, DOI 10.1080/00218839.1987.11100734; SZABO TI, 1987, J APICULT RES, V26, P170, DOI 10.1080/00218839.1987.11100755; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van Delden Wilke, 1997, EXS, V83, P97; Van Engelsdorp D, 2000, J ECON ENTOMOL, V93, P1606, DOI 10.1603/0022-0493-93.6.1606; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807	52	40	41	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11096	10.1371/journal.pone.0011096	http://dx.doi.org/10.1371/journal.pone.0011096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559562	gold, Green Published, Green Submitted			2022-12-25	WOS:000278775900003
J	Maderna, P; Cottell, DC; Toivonen, T; Dufton, N; Dalli, J; Perretti, M; Godson, C				Maderna, Paola; Cottell, David C.; Toivonen, Tiina; Dufton, Neil; Dalli, Jesmond; Perretti, Mauro; Godson, Catherine			FPR2/ALX receptor expression and internalization are critical for lipoxin A(4) and annexin-derived peptide-stimulated phagocytosis	FASEB JOURNAL			English	Article						resolution; inflammation	ASPIRIN-TRIGGERED LIPOXINS; LEUCYL-L-PHENYLALANINE; APOPTOTIC CELLS; HUMAN-NEUTROPHILS; LIPID MEDIATORS; STABLE ANALOGS; IN-VIVO; INFLAMMATION; RESOLUTION; MACROPHAGES	Lipoxins (LXs) are endogenously produced eicosanoids with well-described anti-inflammatory and proresolution activities, stimulating nonphlogistic phagocytosis of apoptotic cells by macrophages. LXA(4) and the glucocorticoid-derived annexin A1 peptide (Ac2-26) bind to a common G-protein-coupled receptor, termed FPR2/ALX. However, direct evidence of the involvement of FPR2/ALX in the anti-inflammatory and proresolution activity of LXA(4) is still to be investigated. Here we describe FPR2/ALX trafficking in response to LXA(4) and Ac2-26 stimulation. We have transfected cells with HA-tagged FPR2/ALX and studied receptor trafficking in unstimulated, LXA(4) (1-10 nM)- and Ac2-26 (30 mu M)-treated cells using multiple approaches that include immunofluorescent confocal microscopy, immuno-gold labeling of cryosections, and ELISA and investigated receptor trafficking in agonist-stimulated phagocytosis. We conclude that PKC-dependent internalization of FPR2/ALX is required for phagocytosis. Using bone marrow-derived macrophages (BMDMs) from mice in which the FPR2/ALX ortholog Fpr2 had been deleted, we observed the nonredundant function for this receptor in LXA(4) and Ac2-26 stimulated phagocytosis of apoptotic neutrophils. LXA(4) stimulated phagocytosis 1.7-fold above basal (P<0.001) by BMDMs from wild-type mice, whereas no effect was found on BMDMs from Fpr2(-/-) mice. Similarly, Ac2-26 stimulates phagocytosis by BMDMs from wild-type mice 1.5-fold above basal (P<0.05). However, Ac2-26 failed to stimulate phagocytosis by BMDMs isolated from Fpr2(-/-) mice relative to vehicle. These data reveal novel and complex mechanisms of the FPR2/ALX receptor trafficking and functionality in the resolution of inflammation.-Maderna, P., Cottell, D. C., Toivonen, T., Dufton, N., Dalli, J., Perretti, M., Godson, C. FPR2/ALX receptor expression and internalization are critical for lipoxin A(4) and annexin-derived peptide-stimulated phagocytosis. FASEB J. 24, 4240-4249 (2010). www.fasebj.org	[Godson, Catherine] Univ Coll Dublin, UCD Diabet Res Ctr, Conway Inst, UCD Sch Med & Med Sci, Dublin 4, Ireland; [Cottell, David C.; Toivonen, Tiina] Univ Coll Dublin, Electron Microscopy Lab, UCD Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Dufton, Neil; Dalli, Jesmond; Perretti, Mauro] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, London, England	University College Dublin; University College Dublin; University of London; Queen Mary University London	Godson, C (corresponding author), Univ Coll Dublin, UCD Diabet Res Ctr, Conway Inst, UCD Sch Med & Med Sci, Dublin 4, Ireland.	catherine.godson@ucd.ie	Dufton, Neil P/AAI-9571-2020	Dufton, Neil P/0000-0002-6283-9210; Godson, Catherine/0000-0003-0655-1041; Dalli, Jesmond/0000-0001-6328-3640	UCD; Health Research Board, Ireland; Science Foundation Ireland; EU [LSHM-CT-2004-00503]; Programme for Research in Third Level Institutions (PRTLI); Wellcome Trust [086867/Z/08]	UCD; Health Research Board, Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); EU(European Commission); Programme for Research in Third Level Institutions (PRTLI); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank Prof. Gareth Griffiths (University of Oslo, Oslo, Norway) for the helpful discussion. This work was supported by UCD Seed Funding (P.M., D.C.C.), Health Research Board, Ireland (C.G.), Science Foundation Ireland (C.G.), the EU FP6 EICOSANOX programme LSHM-CT-2004-00503 (P.M. and C.G.) and funded under the Programme for Research in Third Level Institutions (PRTLI), administered by the Higher Education Authority (P.M., D.C.C., T.T., C.G.). The support of the Wellcome Trust (086867/Z/08; M.P.) is also acknowledged.	BRANDENBURG LO, J NEUROCHEM, V113, P749; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; COLGAN SP, 1993, J CLIN INVEST, V92, P75, DOI 10.1172/JCI116601; DUFTON N, J IMMUNOL, V184, P2611; Ernst S, 2004, CELL MOL LIFE SCI, V61, P1684, DOI 10.1007/s00018-004-4116-x; Filep JG, 1999, BLOOD, V94, P4132, DOI 10.1182/blood.V94.12.4132.424k25_4132_4142; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; FIORE S, 1992, J BIOL CHEM, V267, P16168; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; Kieran NE, 2004, KIDNEY INT, V65, P1145, DOI 10.1111/j.1523-1755.2004.00487.x; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; LEE TH, 1989, CLIN SCI, V77, P195, DOI 10.1042/cs0770195; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Maderna P, 2005, PROSTAG LEUKOTR ESS, V73, P179, DOI 10.1016/j.plefa.2005.05.004; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Maderna P, 2002, AM J PATHOL, V160, P2275, DOI 10.1016/S0002-9440(10)61175-3; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; McMahon B, 2004, AM J PHYSIOL-RENAL, V286, pF189, DOI 10.1152/ajprenal.00224.2003; Mitchell D, 2007, J BIOL CHEM, V282, P15606, DOI 10.1074/jbc.M611004200; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; O'Sullivan TP, 2007, J MED CHEM, V50, P5894, DOI 10.1021/jm060270d; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Papayianni A, 1996, J IMMUNOL, V156, P2264; PAPAYIANNI A, 1995, KIDNEY INT, V47, P1295, DOI 10.1038/ki.1995.184; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Perretti M, 2003, TRENDS PHARMACOL SCI, V24, P574, DOI 10.1016/j.tips.2003.09.010; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Perretti M, 2004, J LEUKOCYTE BIOL, V76, P25, DOI 10.1189/jlb.1103552; PERRETTI M, 1995, BIOCHEM PHARMACOL, V50, P1037, DOI 10.1016/0006-2952(95)00238-U; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Reville K, 2006, J IMMUNOL, V176, P1878, DOI 10.4049/jimmunol.176.3.1878; Romano M, 2007, THESCIENTIFICWORLDJO, V7, P1393, DOI 10.1100/tsw.2007.186; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SOYOMBO O, 1994, ALLERGY, V49, P230, DOI 10.1111/j.1398-9995.1994.tb02654.x; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	52	133	147	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4240	4249		10.1096/fj.10-159913	http://dx.doi.org/10.1096/fj.10-159913			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20570963	Green Accepted			2022-12-25	WOS:000283861100012
J	Vonk, WIM; Wijmenga, C; Berger, R; van de Sluis, B; Klomp, LWJ				Vonk, Willianne I. M.; Wijmenga, Cisca; Berger, Ruud; van de Sluis, Bart; Klomp, Leo W. J.			Cu,Zn Superoxide Dismutase Maturation and Activity Are Regulated by COMMD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; COPPER CHAPERONE CCS; AMYOTROPHIC-LATERAL-SCLEROSIS; EPITHELIAL SODIUM-CHANNEL; WILSON-DISEASE PROTEIN; COMMD1-DEPENDENT UBIQUITINATION; DIRECTLY INTERACTS; ACTIVATION; MURR1; METAL	The maturation and activation of the anti-oxidant Cu, Zn superoxide dismutase (SOD1) are highly regulated processes that require several post-translational modifications. The maturation of SOD1 is initiated by incorporation of zinc and copper ions followed by disulfide oxidation leading to the formation of enzymatically active homodimers. Our present data indicate that homodimer formation is a regulated final step in SOD1 maturation and implicate the recently characterized copper homeostasis protein COMMD1 in this process. COMMD1 interacts with SOD1, and this interaction requires CCS-mediated copper incorporation into SOD1. COMMD1 does not regulate disulfide oxidation of SOD1 but reduces the level of SOD1 homodimers. RNAi-mediated knockdown of COMMD1 expression results in a significant induction of SOD1 activity and a consequent decrease in superoxide anion concentrations, whereas overexpression of COMMD1 exerts exactly the opposite effects. Here, we identify COMMD1 as a novel protein regulating SOD1 activation and associate COMMD1 function with the production of free radicals.	Univ Med Ctr Utrecht, Dept Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands; Netherlands Metabol Ctr, NL-3584 EA Utrecht, Netherlands; [Vonk, Willianne I. M.; Wijmenga, Cisca; van de Sluis, Bart] Univ Med Ctr Utrecht, Complex Genet Sect, NL-3584 EA Utrecht, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9713 AV Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen	Vonk, WIM (corresponding author), Dept Metab & Endocrine Dis, POB 85090, NL-3508 AB Utrecht, Netherlands.	w.i.m.vonk@umcutrecht.nl	Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365; Vonk, Willianne/0000-0002-5906-3933	Netherlands Organization for Scientific Research NWO [40-00812-98-03106]	Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research NWO Grant 40-00812-98-03106.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Brady GF, 2010, MOL CELL BIOL, V30, P1923, DOI 10.1128/MCB.00900-09; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Burkhead JL, 2009, J BIOL CHEM, V284, P696, DOI 10.1074/jbc.M804766200; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; de Bie P, 2006, BIOCHEM J, V398, P63, DOI 10.1042/BJ20051664; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; GALIAZZO F, 1991, EUR J BIOCHEM, V196, P545, DOI 10.1111/j.1432-1033.1991.tb15848.x; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; Huang Y, 2008, J BIOL CHEM, V283, P11453, DOI 10.1074/jbc.M708544200; Ke Y, 2010, AM J PHYSIOL-RENAL, V298, pF1445, DOI 10.1152/ajprenal.00257.2009; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Leitch JM, 2009, J BIOL CHEM, V284, P24679, DOI 10.1074/jbc.R109.040410; Lian M, 2009, J BIOL CHEM, V284, P17998, DOI 10.1074/jbc.M809752200; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maine GN, 2009, BIOCHEM J, V417, P601, DOI 10.1042/BJ20080854; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Muller PAJ, 2009, TRAFFIC, V10, P514, DOI 10.1111/j.1600-0854.2009.00892.x; Petrovic N, 1996, J BIOL CHEM, V271, P28331, DOI 10.1074/jbc.271.45.28331; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Stasser JP, 2007, BIOCHEMISTRY-US, V46, P11845, DOI 10.1021/bi700566h; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Thoms HC, 2010, CANCER RES, V70, P139, DOI 10.1158/0008-5472.CAN-09-1397; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, CELL CYCLE, V6, P2091, DOI 10.4161/cc.6.17.4646; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332	43	33	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28991	29000		10.1074/jbc.M110.101477	http://dx.doi.org/10.1074/jbc.M110.101477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20595380	Green Published, hybrid			2022-12-25	WOS:000281594000064
J	Chi, CN; Bach, A; Gottschalk, M; Kristensen, AS; Stromgaard, K; Jemth, P				Chi, Celestine N.; Bach, Anders; Gottschalk, Marie; Kristensen, Anders S.; Stromgaard, Kristian; Jemth, Per			Deciphering the Kinetic Binding Mechanism of Dimeric Ligands Using a Potent Plasma-stable Dimeric Inhibitor of Postsynaptic Density Protein-95 as an Example	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM PDZ DOMAINS; DESIGN; AFFINITY	Dimeric ligands can be potent inhibitors of protein-protein or enzyme-substrate interactions. They have increased affinity and specificity toward their targets due to their ability to bind two binding sites simultaneously and are therefore attractive in drug design. However, few studies have addressed the kinetic mechanism of interaction of such bivalent ligands. We have investigated the binding interaction of a recently identified potent plasma-stable dimeric pentapeptide and PDZ1-2 of postsynaptic density protein-95 (PSD-95) using protein engineering in combination with fluorescence polarization, isothermal titration calorimetry, and stopped-flow fluorimetry. We demonstrate that binding occurs via a two-step process, where an initial binding to either one of the two PDZ domains is followed by an intramolecular step, which produces the bidentate complex. We have determined all rate constants involved in the binding reaction and found evidence for a conformational transition of the complex. Our data demonstrate the importance of a slow dissociation for a successful dimeric ligand but also highlight the possibility of optimizing the intramolecular association rate. The results may therefore aid the design of dimeric inhibitors in general.	[Bach, Anders; Gottschalk, Marie; Kristensen, Anders S.; Stromgaard, Kristian] Univ Copenhagen, Dept Med Chem, DK-2100 Copenhagen, Denmark; [Chi, Celestine N.; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	University of Copenhagen; Uppsala University	Stromgaard, K (corresponding author), Univ Copenhagen, Dept Med Chem, Univ Pk 2, DK-2100 Copenhagen, Denmark.	krst@farma.ku.dk; Per.Jemth@imbim.uu.se	Kristensen, Anders Skov/B-4414-2009	Kristensen, Anders Skov/0000-0001-8955-6790; Bach, Anders/0000-0003-4305-9910; Stromgaard, Kristian/0000-0003-2206-4737	Swedish Research Council; Carl Trygger Foundation; O. E. and Edla Johansson Foundation; Lundbeck Foundation; Danish Council for Independent Research, Technology and Production Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; O. E. and Edla Johansson Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF))	This work was supported by grants from the Swedish Research Council, the Carl Trygger Foundation and the O. E. and Edla Johansson Foundation (to P.J.), the Lundbeck Foundation (to K. S.), and the Danish Council for Independent Research, Technology and Production Sciences (to A. B.).	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bach A, 2009, ANGEW CHEM INT EDIT, V48, P9685, DOI 10.1002/anie.200904741; Chi CN, 2006, J BIOL CHEM, V281, P36811, DOI 10.1074/jbc.M607883200; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; Clemons PA, 1999, CURR OPIN CHEM BIOL, V3, P112, DOI 10.1016/S1367-5931(99)80020-9; Corson TW, 2008, ACS CHEM BIOL, V3, P677, DOI 10.1021/cb8001792; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Harris BZ, 2001, J CELL SCI, V114, P3219; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; HOPFNER KP, 1993, BIOCHEMISTRY-US, V32, P2947, DOI 10.1021/bi00063a004; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Paduch M, 2007, CHEMBIOCHEM, V8, P443, DOI 10.1002/cbic.200600389; SZEWCZUK Z, 1993, BIOCHEMISTRY-US, V32, P3396, DOI 10.1021/bi00064a025; Tian L, 2009, BIOCHEMISTRY-US, V48, P264, DOI 10.1021/bi801630b; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022; Zhou HX, 2003, J MOL BIOL, V329, P1, DOI 10.1016/S0022-2836(03)00372-3; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P15069, DOI 10.1021/bi015795g	27	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28252	28260		10.1074/jbc.M110.124040	http://dx.doi.org/10.1074/jbc.M110.124040			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576616	hybrid, Green Published			2022-12-25	WOS:000281404100068
J	Fernandez-Leiro, R; Pereira-Rodriguez, A; Cerdan, ME; Becerra, M; Sanz-Aparicio, J				Fernandez-Leiro, Rafael; Pereira-Rodriguez, Angel; Esperanza Cerdan, M.; Becerra, Manuel; Sanz-Aparicio, Juliana			Structural Analysis of Saccharomyces cerevisiae alpha-Galactosidase and Its Complexes with Natural Substrates Reveals New Insights into Substrate Specificity of GH27 Glycosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIMA-RELATED KINASE-6; STAT3 ACTIVATION; FAMILY KINASES; PROTEIN-KINASE; NEK6; TRANSFORMATION; PROMOTION; GENE	alpha-Galactosidases catalyze the hydrolysis of terminal alpha-1,6-galactosyl units from galacto-oligosaccharides and polymeric galactomannans. The crystal structures of tetrameric Saccharomyces cerevisiae alpha-galactosidase and its complexes with the substrates melibiose and raffinose have been determined to 1.95, 2.40, and 2.70 angstrom resolution. The monomer folds into a catalytic (alpha/beta) 8 barrel and a C-terminal beta-sandwich domain with unassigned function. This pattern is conserved with other family 27 glycosidases, but this enzyme presents a unique 45-residue insertion in the beta-sandwich domain that folds over the barrel protecting it from the solvent and likely explaining its high stability. The structure of the complexes and the mutational analysis show that oligomerization is a key factor in substrate binding, as the substrates are located in a deep cavity making direct interactions with the adjacent subunit. Furthermore, docking analysis suggests that the supplementary domain could be involved in binding sugar units distal from the scissile bond, therefore ascribing a role in fine-tuning substrate specificity to this domain. It may also have a role in promoting association with the polymeric substrate because of the ordered arrangement that the four domains present in one face of the tetramer. Our analysis extends to other family 27 glycosidases, where some traits regarding specificity and oligomerization can be formulated on the basis of their sequence and the structures available. These results improve our knowledge on the activity of this important family of enzymes and give a deeper insight into the structural features that rule modularity and protein-carbohydrate interactions.	[Fernandez-Leiro, Rafael; Sanz-Aparicio, Juliana] CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estruct, E-28006 Madrid, Spain; [Fernandez-Leiro, Rafael; Pereira-Rodriguez, Angel; Esperanza Cerdan, M.; Becerra, Manuel] Univ A Coruna, Fac Ciencias, Dept Biol Celular & Mol, La Coruna 15071, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Universidade da Coruna	Sanz-Aparicio, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estruct, Serrano 119, E-28006 Madrid, Spain.	xjulia@iqfr.csic.es	Fernandez-Leiro, Rafael/L-6095-2017; Becerra, Manuel/N-6358-2019; Becerra, Manuel/E-2878-2017; Sanz-Aparicio, Julia/F-6201-2013; CERDAN, MARIA ESPERANZA/D-5644-2013	Fernandez-Leiro, Rafael/0000-0002-7941-0357; Becerra, Manuel/0000-0003-0913-9749; Becerra, Manuel/0000-0003-0913-9749; Sanz-Aparicio, Julia/0000-0002-6849-8621; CERDAN, MARIA ESPERANZA/0000-0001-8540-1417	Xunta de Galicia [07TAL010103PR]; FEDER; Direccion General de Investigacion [BIO2007-67708-C04-04]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); FEDER(European Commission); Direccion General de Investigacion(Spanish Government)	Research performed at the Universidade da Coruna was supported by Grant 07TAL010103PR from Xunta de Galicia co-financed by FEDER (CEE). General support during 2008-2010 was provided by Xunta de Galicia. Research performed at the Consejo Superior de Investigaciones Cientificas was supported by Grant BIO2007-67708-C04-04 from the Direccion General de Investigacion. This work is a product of the project "Factoria de Cristalizacion" from the program Consolider-Ingenio 2010.	Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Belham C, 2001, CURR BIOL, V11, P1155, DOI 10.1016/S0960-9822(01)00369-4; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; Chen J, 2006, BIOCHEM BIOPH RES CO, V341, P1059, DOI 10.1016/j.bbrc.2005.12.228; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Lee EJ, 2007, BIOCHEM BIOPH RES CO, V358, P783, DOI 10.1016/j.bbrc.2007.04.203; Lee MY, 2008, CELL CYCLE, V7, P2705, DOI 10.4161/cc.7.17.6551; Lizcano JM, 2002, J BIOL CHEM, V277, P27839, DOI 10.1074/jbc.M202042200; Lu HT, 2007, CURR CANCER DRUG TAR, V7, P343, DOI 10.2174/156800907780809750; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; PU RT, 1995, EMBO J, V14, P995, DOI 10.1002/j.1460-2075.1995.tb07080.x; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Ying TH, 2008, CELL BIOL INT, V32, P210, DOI 10.1016/j.cellbi.2007.08.027; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Yu CY, 2002, ONCOGENE, V21, P3949, DOI 10.1038/sj.onc.1205499	26	32	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28020	28033		10.1074/jbc.M110.144584	http://dx.doi.org/10.1074/jbc.M110.144584			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592022	Green Published, hybrid			2022-12-25	WOS:000281404100055
J	Giladi, M; Boyman, L; Mikhasenko, H; Hiller, R; Khananshvili, D				Giladi, Moshe; Boyman, Liron; Mikhasenko, Helen; Hiller, Reuben; Khananshvili, Daniel			Essential Role of the CBD1-CBD2 Linker in Slow Dissociation of Ca2+ from the Regulatory Two-domain Tandem of NCX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; NA+/CA2+ EXCHANGER; NA+-CA2+ EXCHANGER; CA2+-BINDING DOMAIN; DYNAMIC PROPERTIES; BINDING PROPERTIES; CRYSTAL-STRUCTURES; STEADY-STATE; SENSOR; MODULATION	In NCX proteins CBD1 and CBD2 domains are connected through a short linker (3 or 4 amino acids) forming a regulatory tandem (CBD12). Only three of the six CBD12 Ca2+-binding sites contribute to NCX regulation. Two of them are located on CBD1 (K-d = similar to 0.2 mu M), and one is on CBD2 (K-d = similar to 5 mu M). Here we analyze how the intrinsic properties of individual regulatory sites are affected by linker-dependent interactions in CBD12 (AD splice variant). The three sites of CBD12 and CBD1 + CBD2 have comparable K-d values but differ dramatically in their Ca2+ dissociation kinetics. CBD12 exhibits multiphasic kinetics for the dissociation of three Ca2+ ions (k(r) = 280 s(-1), k(f) = 7 s(-1), and k(s) = 0.4 s(-1)), whereas the dissociation of two Ca2+ ions from CBD1(k(f) = 16 s(-1)) and one Ca2+ ion from CBD2 (k(r) = 125 s(-1)) is monophasic. Insertion of seven alanines into the linker (CBD12-7Ala) abolishes slow dissociation of Ca2+, whereas the kinetic and equilibrium properties of three Ca2+ sites of CBD12-7Ala and CBD1 + CBD2 are similar. Therefore, the linker-dependent interactions in CBD12 decelerate the Ca2+ on/off kinetics at a specific CBD1 site by 50-80-fold, thereby representing Ca2+ "occlusion" at CBD12. Notably, the kinetic and equilibrium properties of the remaining two sites of CBD12 are "linker-independent," so their intrinsic properties are preserved in CBD12. In conclusion, the dynamic properties of three sites are specifically modified, conserved, diversified, and integrated by the linker in CBD12, thereby generating a wide range dynamic sensor.	[Giladi, Moshe; Boyman, Liron; Mikhasenko, Helen; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Khananshvili, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel.	dhanan@post.tau.ac.il		Giladi, Moshe/0000-0002-8589-6920; Khananshvili, Daniel/0000-0002-4202-9966	Israeli Ministry of Health [2010-3-6266]; USA-Israeli Binational Research Grant [2009334]; Israel Science Foundation [23/10]	Israeli Ministry of Health; USA-Israeli Binational Research Grant; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by Israeli Ministry of Health Grant 2010-3-6266, USA-Israeli Binational Research Grant 2009334, and Israel Science Foundation Grant 23/10.	Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Baazov D, 1999, BIOCHEMISTRY-US, V38, P1435, DOI 10.1021/bi981429u; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; Blaustein MP, 2007, P NATL ACAD SCI USA, V104, P18349, DOI 10.1073/pnas.0709008104; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boyman L, 2008, BIOCHEMISTRY-US, V47, P6602, DOI 10.1021/bi8004279; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; Breukels V, 2010, PROTEINS, V78, P1813, DOI 10.1002/prot.22695; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chaptal Vincent, 2007, Channels (Austin), V1, P397; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Guatimosim S, 2002, J MOL CELL CARDIOL, V34, P941, DOI 10.1006/jmcc.2002.2032; Herrick DZ, 2009, J MOL BIOL, V390, P913, DOI 10.1016/j.jmb.2009.06.007; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Hryshko LV, 1996, J GEN PHYSIOL, V108, P67, DOI 10.1085/jgp.108.1.67; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; Kargacin GJ, 2003, J THEOR BIOL, V221, P245, DOI 10.1006/jtbi.2003.3187; KHANANSHVILI D, 1995, BIOCHEMISTRY-US, V34, P10290, DOI 10.1021/bi00032a024; KHANANSHVILI D, 1994, BIOCHEMISTRY-US, V33, P312, DOI 10.1021/bi00167a041; Khananshvili D, 1996, BIOCHEMISTRY-US, V35, P15933, DOI 10.1021/bi961099i; KHANANSHVILI D, 1988, BIOCHEMISTRY-US, V27, P8290, DOI 10.1021/bi00421a045; KHANANSHVILI D, 1998, ADV MOL CEL A&B, V23, P311; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; LEE SL, 1994, J BIOL CHEM, V269, P14849; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Montaville P, 2007, J BIOL CHEM, V282, P5015, DOI 10.1074/jbc.M606746200; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Ottolia M, 2004, BIOPHYS J, V87, P899, DOI 10.1529/biophysj.104.043471; Ottolia M, 2010, CHANNELS, V4, P159, DOI 10.4161/chan.4.3.11386; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Reeves JP, 2008, CHANNELS, V2, P322, DOI 10.4161/chan.2.5.6897; Sher AA, 2008, PROG BIOPHYS MOL BIO, V96, P377, DOI 10.1016/j.pbiomolbio.2007.07.018; Weber CR, 2001, J GEN PHYSIOL, V117, P119, DOI 10.1085/jgp.117.2.119; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Wu MS, 2010, J BIOL CHEM, V285, P2554, DOI 10.1074/jbc.M109.059162; Wu MS, 2009, J MOL BIOL, V387, P104, DOI 10.1016/j.jmb.2009.01.045	51	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28117	28125		10.1074/jbc.M110.127001	http://dx.doi.org/10.1074/jbc.M110.127001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20587421	Green Published, hybrid			2022-12-25	WOS:000288742300010
J	Huang, BL; Brugger, SM; Lyons, KM				Huang, Bau-Lin; Brugger, Sean M.; Lyons, Karen M.			Stage-specific Control of Connective Tissue Growth Factor (CTGF/CCN2) Expression in Chondrocytes by Sox9 and beta-Catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTROPHIC CHONDROCYTES; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; CELL-GROWTH; C-MAF; TRANSCRIPTION; DIFFERENTIATION; CHONDROGENESIS; PROTEIN; PROLIFERATION	CCN2/connective tissue growth factor is highly expressed in hypertrophic chondrocytes and is required for chondrogenesis. However, the transcriptional mechanisms controlling its expression in cartilage are largely unknown. The activity of the Ccn2 promoter was, therefore, investigated in osteochondro-progenitor cells and hypertrophic chondrocytes to ascertain these mechanisms. Sox9 and T-cell factor (TCF). lymphoid enhancer factor (LEF) factors contain HMG domains and bind to related consensus sites. TCF.LEF factors are normally repressive but when bound to DNA in a complex with beta-catenin become activators of gene expression. In silico analysis of the Ccn2 proximal promoter identified multiple consensus TCF.LEF elements, one of which was also a consensus binding site for Sox9. Using luciferase reporter constructs, the TCF.LEF.Sox9 site was found to be involved in stage-specific expression of Ccn2. Luciferase, electrophoretic mobility shift assay (EMSA), and ChIP analysis revealed that Sox9 represses Ccn2 expression by binding to the consensus TCF.LEF.Sox9 site. On the other hand, the same assays showed that in hypertrophic chondrocytes, TCF.LEF .beta-catenin complexes occupy the consensus TCF.LEF.Sox9 site and activate Ccn2 expression. Furthermore, transgenic mice in which lacZ expression is driven under the control of the proximal Ccn2 promoter revealed that the proximal Ccn2 promoter responded to Wnt signaling in cartilage. Hence, we propose that differential occupancy of the TCF.LEF.Sox9 site by Sox9 versus beta-catenin restricts high levels of Ccn2 expression to hypertrophic chondrocytes.	[Huang, Bau-Lin; Brugger, Sean M.; Lyons, Karen M.] Univ Calif Los Angeles, Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Huang, Bau-Lin; Brugger, Sean M.; Lyons, Karen M.] Orthoped Hosp, Los Angeles, CA 90095 USA; [Huang, Bau-Lin] Univ Calif Los Angeles, Sch Dent, Dept Oral Biol, Los Angeles, CA 90095 USA; [Lyons, Karen M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lyons, KM (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.	klyons@mednet.ucla.edu	Huang, Bau-Lin/K-8317-2019; Huang, Bau-Lin/S-4133-2019	Huang, Bau-Lin/0000-0003-3747-6697	National Institutes of Health [AR052686]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR052686.	Akiyama H, 1996, J BONE MINER RES, V11, P22; Akiyama H, 1999, J CELL PHYSIOL, V181, P169, DOI 10.1002/(SICI)1097-4652(199910)181:1<169::AID-JCP18>3.0.CO;2-5; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Brown AJ, 2008, BONE, V43, P689, DOI 10.1016/j.bone.2008.05.022; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; Eguchi T, 2002, BIOCHEM BIOPH RES CO, V295, P445, DOI 10.1016/S0006-291X(02)00700-3; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Erwin WM, 2006, ARTHRITIS RHEUM-US, V54, P3859, DOI 10.1002/art.22258; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hata K, 2008, J CLIN INVEST, V118, P3098, DOI 10.1172/JCI31373; Holmes A, 2003, J BIOL CHEM, V278, P41728, DOI 10.1074/jbc.M305019200; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kobayashi T, 2005, ENDOCRINOLOGY, V146, P1012, DOI 10.1210/en.2004-1343; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Newman B, 2001, J CELL BIOL, V154, P659, DOI 10.1083/jcb.200106040; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nishida T, 2007, J CELL COMMUN SIGNAL, V1, P45, DOI 10.1007/s12079-007-0005-z; Oka M, 2007, J HISTOCHEM CYTOCHEM, V55, P1245, DOI 10.1369/jhc.7A7263.2007; Omoteyama K, 2006, BIOCHEM BIOPH RES CO, V339, P1089, DOI 10.1016/j.bbrc.2005.11.119; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pateder DB, 2001, J CELL PHYSIOL, V188, P343, DOI 10.1002/jcp.1118; Reinhold MI, 2007, J BIOL CHEM, V282, P3653, DOI 10.1074/jbc.M608995200; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; SCHREIBER E, 1989, SOMAT CELL MOLEC GEN, V15, P591, DOI 10.1007/BF01534920; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Shimo T, 2005, J BONE MINER RES, V20, P867, DOI 10.1359/JBMR.041235; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhang C, 2003, DEVELOPMENT, V130, P5609, DOI 10.1242/dev.00798	56	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27702	27712		10.1074/jbc.M110.108498	http://dx.doi.org/10.1074/jbc.M110.108498			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20571031	Green Published, hybrid			2022-12-25	WOS:000281404100026
J	Lakshmipathy, SK; Gupta, R; Pinkert, S; Etchells, SA; Hartl, FU				Lakshmipathy, Sathish Kumar; Gupta, Rashmi; Pinkert, Stefan; Etchells, Stephanie Anne; Hartl, F. Ulrich			Versatility of Trigger Factor Interactions with Ribosome-Nascent Chain Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; NEWLY SYNTHESIZED PROTEINS; ESCHERICHIA-COLI RIBOSOME; TRANSLATING RIBOSOMES; POLYPEPTIDE-CHAINS; IN-VIVO; CHAPERONE; BINDING; MEMBRANE; SEQUENCE	Trigger factor (TF) is the first molecular chaperone that interacts with nascent chains emerging from bacterial ribosomes. TF is a modular protein, consisting of an N-terminal ribosome binding domain, a PPIase domain, and a C-terminal domain, all of which participate in polypeptide binding. To directly monitor the interactions of TF with nascent polypeptide chains, TF variants were site-specifically labeled with an environmentally sensitive NBD fluorophore. We found a marked increase in TF-NBD fluorescence during translation of firefly luciferase (Luc) chains, which expose substantial regions of hydrophobicity, but not with nascent chains lacking extensive hydrophobic segments. TF remained associated with Luc nascent chains for 111 +/- 7 s, much longer than it remained bound to the ribosomes (t(1/2) similar to 10-14 s). Thus, multiple TF molecules can bind per nascent chain during translation. The Escherichia coli cytosolic proteome was classified into predicted weak and strong interactors for TF, based on the occurrence of continuous hydrophobic segments in the primary sequence. The residence time of TF on the nascent chain generally correlated with the presence of hydrophobic regions and the capacity of nascent chains to bury hydrophobicity. Interestingly, TF bound the signal sequence of a secretory protein, pOmpA, but not the hydrophobic signal anchor sequence of the inner membrane protein FtsQ. On the other hand, proteins lacking linear hydrophobic segments also recruited TF, suggesting that TF can recognize hydrophobic surface features discontinuous in sequence. Moreover, TF retained significant affinity for the folded domain of the positively charged, ribosomal protein S7, indicative of an alternative mode of TF action. Thus, unlike other chaperones, TF appears to employ multiple mechanisms to interact with a wide range of substrate proteins.	[Lakshmipathy, Sathish Kumar; Gupta, Rashmi; Pinkert, Stefan; Etchells, Stephanie Anne; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Pinkert, Stefan/A-5534-2009; Hartl, F. Ulrich/Y-8206-2019					Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Comellas-Bigier M, 2005, J MOL BIOL, V349, P99, DOI 10.1016/j.jmb.2005.03.016; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Eisner G, 2003, J CELL BIOL, V163, P35, DOI 10.1083/jcb.200306069; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Jakob RP, 2009, P NATL ACAD SCI USA, V106, P20282, DOI 10.1073/pnas.0909544106; Jong WSP, 2004, EUR J BIOCHEM, V271, P4779, DOI 10.1111/j.1432-1033.2004.04442.x; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Maier T, 2005, CURR OPIN STRUC BIOL, V15, P204, DOI 10.1016/j.sbi.2005.03.005; MALKIN LI, 1967, J MOL BIOL, V26, P329, DOI 10.1016/0022-2836(67)90301-4; Martinez-Hackert E, 2009, CELL, V138, P923, DOI 10.1016/j.cell.2009.07.044; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Michel G, 2003, J BIOL CHEM, V278, P19463, DOI 10.1074/jbc.M300794200; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raine A, 2004, BIOCHIMIE, V86, P495, DOI 10.1016/j.biochi.2004.05.004; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Schulze-Gahmen U, 2005, ACTA CRYSTALLOGR D, V61, P1343, DOI [10.1107/S090744490502264X, 10.1107/S09074490502264X]; Shi Y, 2007, PROTEIN SCI, V16, P1165, DOI 10.1110/ps.062623707; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Ullers RS, 2006, J BIOL CHEM, V281, P13999, DOI 10.1074/jbc.M600638200; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x	51	33	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27911	27923		10.1074/jbc.M110.134163	http://dx.doi.org/10.1074/jbc.M110.134163			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595383	Green Published, hybrid			2022-12-25	WOS:000281404100046
J	Levy-Adam, F; Feld, S; Cohen-Kaplan, V; Shteingauz, A; Gross, M; Arvatz, G; Naroditsky, I; Ilan, N; Doweck, I; Vlodavsky, I				Levy-Adam, Flonia; Feld, Sari; Cohen-Kaplan, Victoria; Shteingauz, Anna; Gross, Miriam; Arvatz, Gil; Naroditsky, Inna; Ilan, Neta; Doweck, Ilana; Vlodavsky, Israel			Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN HEPARANASE; EXTRACELLULAR-MATRIX; ENZYMATIC-ACTIVITY; CANCER METASTASIS; TUMOR PROGRESSION; PATIENT SURVIVAL; CELLULAR UPTAKE; NECK-CANCER; EXPRESSION; PROTEOGLYCANS	Heparanase activity is highly implicated in cell dissemination associated with tumor metastasis, angiogenesis, and inflammation. Heparanase expression is induced in many hematological and solid tumors, associated with poor prognosis. Heparanase homolog, termed heparanase 2 (Hpa2), was cloned based on sequence homology. Detailed characterization of Hpa2 at the biochemical, cellular, and clinical levels has not been so far reported, and its role in normal physiology and pathological disorders is obscure. We provide evidence that unlike heparanase, Hpa2 is not subjected to proteolytic processing and exhibits no enzymatic activity typical of heparanase. Notably, the full-length Hpa2c protein inhibits heparanase enzymatic activity, likely due to its high affinity to heparin and heparan sulfate and its ability to associate physically with heparanase. Hpa2 expression was markedly elevated in head and neck carcinoma patients, correlating with prolonged time to disease recurrence (follow-up to failure; p = 0.006) and inversely correlating with tumor cell dissemination to regional lymph nodes (N-stage; p = 0.03). Hpa2 appears to restrain tumor metastasis, likely by attenuating heparanase enzymatic activity, conferring a favorable outcome of head and neck cancer patients.	[Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Naroditsky, Inna] Dept Pathol, IL-31096 Haifa, Israel; [Doweck, Ilana] Carmel Hosp, Dept Otolaryngol Head & Neck Surg, IL-34362 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services; Carmel Medical Center	Vlodavsky, I (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, POB 9649, IL-31096 Haifa, Israel.	Vlodavsk@cc.huji.ac.il		Doweck, Ilana/0000-0002-1065-0299	National Institutes of Health (NCI) [RO1-CA106456]; Israel Science Foundation [549/06]; Israel Cancer Research Fund; DKFZ-MOST; Rappaport Family Institute; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Science Foundation(Israel Science Foundation); Israel Cancer Research Fund; DKFZ-MOST; Rappaport Family Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-CA106456 (NCI). This work was also supported by grants from the Israel Science Foundation (549/06), the Israel Cancer Research Fund, the DKFZ-MOST cooperation program in cancer research, and the Rappaport Family Institute Fund.	Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; Bar-Sela G, 2006, HISTOPATHOLOGY, V49, P188, DOI 10.1111/j.1365-2559.2006.02469.x; Ben-Izhak O, 2006, NEOPLASIA, V8, P879, DOI 10.1593/neo.06382; Ben-Zaken O, 2008, INT J BIOCHEM CELL B, V40, P530, DOI 10.1016/j.biocel.2007.09.003; Casu B, 2004, J MED CHEM, V47, P838, DOI 10.1021/jm030893g; Cohen E, 2005, FEBS LETT, V579, P2334, DOI 10.1016/j.febslet.2005.03.030; de Moura JP, 2009, INT J GYNECOL CANCER, V19, P1494, DOI 10.1111/IGC.0b013e3181a834a2; Doweck I, 2006, NEOPLASIA, V8, P1055, DOI 10.1593/neo.06577; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Fairweather JK, 2008, BIOORGAN MED CHEM, V16, P699, DOI 10.1016/j.bmc.2007.10.044; Fears CY, 2006, MATRIX BIOL, V25, P443, DOI 10.1016/j.matbio.2006.07.003; Ferro V, 2004, MINI-REV MED CHEM, V4, P693, DOI 10.2174/1389557043403729; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2007, FASEB J, V21, P3986, DOI 10.1096/fj.07-8866com; Goldshmidt O, 2002, EXP CELL RES, V281, P50, DOI 10.1006/excr.2002.5651; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kussie PH, 1999, BIOCHEM BIOPH RES CO, V261, P183, DOI 10.1006/bbrc.1999.0962; Levy-Adam F, 2005, J BIOL CHEM, V280, P20457, DOI 10.1074/jbc.M414546200; Levy-Adam F, 2003, BIOCHEM BIOPH RES CO, V308, P885, DOI 10.1016/S0006-291X(03)01478-5; Levy-Adam F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002319; LIDER O, 1995, P NATL ACAD SCI USA, V92, P5037, DOI 10.1073/pnas.92.11.5037; McKenzie E, 2000, BIOCHEM BIOPH RES CO, V276, P1170, DOI 10.1006/bbrc.2000.3586; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Nadav L, 2002, J CELL SCI, V115, P2179; Nagler R, 2007, CANCER-AM CANCER SOC, V110, P2732, DOI 10.1002/cncr.23095; NAKAJIMA M, 1983, SCIENCE, V220, P611, DOI 10.1126/science.6220468; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Peretti T, 2008, EUR J GASTROEN HEPAT, V20, P756, DOI 10.1097/MEG.0b013e3282fc2649; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Simizu S, 2004, J BIOL CHEM, V279, P2697, DOI 10.1074/jbc.M300541200; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Temkin V, 2004, J ALLERGY CLIN IMMUN, V113, P703, DOI 10.1016/j.jaci.2003.11.038; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; VLODAVSKY I, 1983, CANCER RES, V43, P2704; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; WEICHSELBAUM RR, 1989, HEAD NECK-J SCI SPEC, V11, P437, DOI 10.1002/hed.2880110510; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zetser A, 2003, CANCER RES, V63, P7733	51	92	95	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28010	28019		10.1074/jbc.M110.116384	http://dx.doi.org/10.1074/jbc.M110.116384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576607	Green Published, hybrid			2022-12-25	WOS:000281404100054
J	Pinta, E; Duda, KA; Hanuszkiewicz, A; Salminen, TA; Bengoechea, JA; Hyytiainen, H; Lindner, B; Radziejewska-Lebrecht, J; Holst, O; Skurnik, M				Pinta, Elise; Duda, Katarzyna Anna; Hanuszkiewicz, Anna; Salminen, Tiina A.; Antonio Bengoechea, Jose; Hyytiainen, Heidi; Lindner, Buko; Radziejewska-Lebrecht, Joanna; Holst, Otto; Skurnik, Mikael			Characterization of the Six Glycosyltransferases Involved in the Biosynthesis of Yersinia enterocolitica Serotype O:3 Lipopolysaccharide Outer Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI O166; TAIL-LIKE BACTERIOCIN; PATHOGENIC YERSINIAE; BIOLOGICAL ROLE; SIDE-CHAIN; ANTIGEN; O-3; PHAGE; POLYSACCHARIDE; VIRULENCE	Yersinia enterocolitica (Ye) is a Gram-negative bacterium; Ye serotype O:3 expresses lipopolysaccharide (LPS) with a hexasaccharide branch known as the outer core (OC). The OC is important for the resistance of the bacterium to cationic antimicrobial peptides and also functions as a receptor for bacteriophage phi R1-37 and enterocoliticin. The biosynthesis of the OC hexasaccharide is directed by the OC gene cluster that contains nine genes (wzx, wbcKLMNOPQ, and gne). In this study, we inactivated the six OC genes predicted to encode glycosyltransferases (GTase) one by one by nonpolar mutations to assign functions to their gene products. The mutants expressed no OC or truncated OC oligosaccharides of different lengths. The truncated OC oligosaccharides revealed that the minimum structural requirements for the interactions of OC with bacteriophage phi R1-37, enterocoliticin, and OC-specific monoclonal antibody 2B5 were different. Furthermore, using chemical and structural analyses of the mutant LPSs, we could assign specific functions to all six GTases and also revealed the exact order in which the transferases build the hexasaccharide. Comparative modeling of the catalytic sites of glucosyltransferases WbcK and WbcL followed by site-directed mutagenesis allowed us to identify Asp-182 and Glu-181, respectively, as catalytic base residues of these two GTases. In general, conclusive evidence for specific GTase functions have been rare due to difficulties in accessibility of the appropriate donors and acceptors; however, in this work we were able to utilize the structural analysis of LPS to get direct experimental evidence for five different GTase specificities.	[Pinta, Elise; Hyytiainen, Heidi; Skurnik, Mikael] Univ Helsinki, Haartman Inst, Infect Biol Res Program, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Pinta, Elise] Univ Turku, Dept Med Biochem & Genet, FIN-20520 Turku, Finland; [Duda, Katarzyna Anna; Radziejewska-Lebrecht, Joanna] Univ Silesia, Dept Microbiol, PL-40032 Katowice, Poland; [Duda, Katarzyna Anna; Hanuszkiewicz, Anna; Holst, Otto] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, D-23845 Borstel, Germany; [Lindner, Buko] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany; [Salminen, Tiina A.] Abo Akad Univ, Dept Biochem & Pharm, FIN-20520 Turku, Finland; [Antonio Bengoechea, Jose] Fdn Caubet CIMERA Illes Balears, Program Infect & Immun, Bunyola 07110, Spain; [Antonio Bengoechea, Jose] CSIC, Bunyola 07110, Spain; [Skurnik, Mikael] Univ Helsinki, Cent Hosp, Diagnost Lab, FIN-00029 Helsinki, Finland	University of Helsinki; University of Turku; University of Silesia in Katowice; Forschungszentrum Borstel; Forschungszentrum Borstel; Abo Akademi University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Helsinki; Helsinki University Central Hospital	Skurnik, M (corresponding author), Univ Helsinki, Haartman Inst, Infect Biol Res Program, Dept Bacteriol & Immunol, POB 21, FIN-00014 Helsinki, Finland.	mikael.skurnik@helsinki.fi	Salminen, Tiina A./AAM-5443-2021; Skurnik, Mikael/I-8477-2019; Salminen, Tiina A/G-7492-2019; Duda, Katarzyna/M-5274-2018; Lindner, Buko/G-9731-2014	Salminen, Tiina A./0000-0002-4135-8020; Skurnik, Mikael/0000-0001-8791-9260; Salminen, Tiina A/0000-0002-4135-8020; Duda, Katarzyna/0000-0001-7701-3262; Bengoechea, Jose/0000-0002-9677-8751; Hyytiainen, Heidi/0000-0002-3109-9600	Tor, Joe, and Pentti Borgs Memorial Fund; Sigrid Juselius Foundation; Fondo de Investigacion Sanitaria [PI03/0881]; Consejo Superior Investigaciones Cientificas Proyecto Intramural [200820I174]; Academy of Finland [114075, 104361, 50441]; Glycoscience Graduate School	Tor, Joe, and Pentti Borgs Memorial Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Consejo Superior Investigaciones Cientificas Proyecto Intramural; Academy of Finland(Academy of Finland); Glycoscience Graduate School	This work was supported by Tor, Joe, and Pentti Borgs Memorial Fund and Sigrid Juselius Foundation (to T. A. S.), Fondo de Investigacion Sanitaria Grant PI03/0881, Consejo Superior Investigaciones Cientificas Proyecto Intramural 200820I174 (to J. A. B.), Academy of Finland Projects 114075, 104361, and 50441 (to M. S.), and Glycoscience Graduate School funds (to E. P.).	ALHENDY A, 1992, INFECT IMMUN, V60, P870, DOI 10.1128/IAI.60.3.870-875.1992; Ali T, 2007, CARBOHYD RES, V342, P274, DOI 10.1016/j.carres.2006.11.023; Anderson MS, 2000, FEMS MICROBIOL LETT, V191, P169, DOI 10.1111/j.1574-6968.2000.tb09335.x; Anisimov AP, 2005, INFECT IMMUN, V73, P7324, DOI 10.1128/IAI.73.11.7324-7331.2005; APPLEYARD RK, 1954, GENETICS, V39, P440; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Bengoechea JA, 2004, MOL MICROBIOL, V52, P451, DOI 10.1111/j.1365-2958.2004.03987.x; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; Bengoechea JA, 1996, INFECT IMMUN, V64, P4891, DOI 10.1128/IAI.64.12.4891-4899.1996; Biedzka-Sarek M, 2005, INFECT IMMUN, V73, P2232, DOI 10.1128/IAI.73.4.2232-2244.2005; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Edwards KJ, 2005, J BACTERIOL, V187, P2939, DOI 10.1128/JB.187.9.2939-2947.2005; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Holst O., 2007, COMPREHENSIVE GLYCOS, P123, DOI DOI 10.1016/B978-044451967-2/00004-0; JANN K, 1965, BIOCHEM Z, V342, P1; Johnson MS, 1996, METHOD ENZYMOL, V266, P575; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; Kiljunen S, 2005, MICROBIOL-SGM, V151, P4093, DOI 10.1099/mic.0.28265-0; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Liu B, 2010, MICROBIOL-SGM, V156, P1642, DOI 10.1099/mic.0.037325-0; MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991; MULLERLOENNIES S, 1994, EUR J BIOCHEM, V224, P751, DOI 10.1111/j.1432-1033.1994.t01-1-00751.x; Oertelt C, 2001, EUR J BIOCHEM, V268, P554, DOI 10.1046/j.1432-1327.2001.01891.x; Pajunen M, 2000, J BACTERIOL, V182, P5114, DOI 10.1128/JB.182.18.5114-5120.2000; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; PEKKOLAHEINO K, 1987, ACTA PATH MICRO IM C, V95, P27; Pinta E, 2009, CHEM-EUR J, V15, P9747, DOI 10.1002/chem.200901255; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Radziejewska-Lebrecht J, 1998, ACTA BIOCHIM POL, V45, P1011, DOI 10.18388/abp.1998_4358; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Regue M, 2005, J BACTERIOL, V187, P4198, DOI 10.1128/JB.187.12.4198-4206.2005; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sirisena DM, 2003, J APPL MICROBIOL, V94, P686, DOI 10.1046/j.1365-2672.2003.01897.x; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Skurnik M, 2003, ADV EXP MED BIOL, V529, P187; Skurnik M, 2003, CARBOHYD RES, V338, P2521, DOI 10.1016/S0008-6215(03)00305-7; SKURNIK M, 1995, MOL MICROBIOL, V17, P575, DOI 10.1111/j.1365-2958.1995.mmi_17030575.x; SKURNIK M, 1984, J APPL BACTERIOL, V56, P355, DOI 10.1111/j.1365-2672.1984.tb01362.x; Skurnik M, 1999, GENETICS OF BACTERIALS POLYSACCHARIDES, P23; Skurnik M., 2004, YERSINIA MOL CELLULA, P215; Skurnik M, 2007, J BACTERIOL, V189, P7244, DOI 10.1128/JB.00605-07; Strauch E, 2003, ADV EXP MED BIOL, V529, P249; Strauch E, 2001, APPL ENVIRON MICROB, V67, P5634, DOI 10.1128/AEM.67.12.5634-5642.2001; Yang JH, 2009, J BACTERIOL, V191, P1891, DOI 10.1128/JB.01532-08; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang LJ, 1995, CONTRIB TO MICROBIOL, V13, P310; ZHANG LJ, 1994, J BACTERIOL, V176, P1756, DOI 10.1128/jb.176.6.1756-1760.1994	54	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28333	28342		10.1074/jbc.M110.111336	http://dx.doi.org/10.1074/jbc.M110.111336			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595390	Green Published, hybrid			2022-12-25	WOS:000281404100075
J	Zhou, QOL; Jiang, ZY; Mabardy, AS; Del Campo, CM; Lambright, DG; Holik, J; Fogarty, KE; Straubhaar, J; Nicoloro, S; Chawla, A; Czech, MP				Zhou, Qiong L.; Jiang, Zhen Y.; Mabardy, Allan S.; Del Campo, Claudia M.; Lambright, David G.; Holik, John; Fogarty, Kevin E.; Straubhaar, Juerg; Nicoloro, Sarah; Chawla, Anil; Czech, Michael P.			A Novel Pleckstrin Homology Domain-containing Protein Enhances Insulin-stimulated Akt Phosphorylation and GLUT4 Translocation in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-B; PHOSPHATIDYLINOSITOL 3-KINASE; MITOCHONDRIAL BIOGENESIS; BINDING POCKET; AGC KINASES; ACTIVATION; IDENTIFICATION; MECHANISM; LL5-BETA; PDK1	Protein kinase B/Akt protein kinases control an array of diverse functions, including cell growth, survival, proliferation, and metabolism. We report here the identification of pleckstrin homology-like domain family B member 1 (PHLDB1) as an insulin-responsive protein that enhances Akt activation. PHLDB1 contains a pleckstrin homology domain, which we show binds phosphatidylinositol PI(3,4)P-2, PI(3,5)P-2, and PI(3,4,5)P-3, as well as a Forkhead-associated domain and coiled coil regions. PHLDB1 expression is increased during adipocyte differentiation, and it is abundant in many mouse tissues. Both endogenous and HA- or GFP-tagged PHLDB1 displayed a cytoplasmic disposition in unstimulated cultured adipocytes but translocated to the plasma membrane in response to insulin. Depletion of PHLDB1 by siRNA inhibited insulin stimulation of Akt phosphorylation but not tyrosine phosphorylation of IRS-1. RNAi-based silencing of PHLDB1 in cultured adipocytes also attenuated insulin-stimulated deoxyglucose transport and Myc-GLUT4-EGFP translocation to the plasma membrane, whereas knockdown of the PHLDB1 isoform PHLDB2 failed to attenuate insulin-stimulated deoxyglucose transport. Furthermore, adenovirus-mediated expression of PHLDB1 in adipocytes enhanced insulin-stimulated Akt and p70 S6 kinase phosphorylation, as well as GLUT4 translocation. These results indicate that PHLDB1 is a novel modulator of Akt protein kinase activation by insulin.	[Jiang, Zhen Y.] Sanford Burnham Med Res Inst Lake Nona, Diabet & Obes Res Ctr, Metab Signaling & Dis Program, Orlando, FL 32827 USA; [Zhou, Qiong L.; Mabardy, Allan S.; Del Campo, Claudia M.; Lambright, David G.; Fogarty, Kevin E.; Straubhaar, Juerg; Nicoloro, Sarah; Chawla, Anil; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Holik, John] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Jiang, ZY (corresponding author), Sanford Burnham Med Res Inst Lake Nona, Diabet & Obes Res Ctr, Metab Signaling & Dis Program, Orlando, FL 32827 USA.	zjiang@sanfordburnham.org; Michael.Czech@umassmed.edu		Nicoloro, Sarah/0000-0002-8638-4556	National Institutes of Health [DK060564]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK060564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK060564 (to M. P. C.). This work was also supported by an American Diabetes Association Junior Faculty Award (to Z. Y. J.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Bellve KD, 2006, J BIOL CHEM, V281, P16139, DOI 10.1074/jbc.M511370200; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Buser CA, 1998, METH MOL B, V84, P267; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja Veronique, 2009, J Chem Biol, V2, P11, DOI 10.1007/s12154-009-0016-8; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; HARRISON SA, 1990, J BIOL CHEM, V265, P20106; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Katoh M, 2003, INT J ONCOL, V23, P1477; Kishi M, 2005, J CELL BIOL, V169, P355, DOI 10.1083/jcb.200411012; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Murray JT, 2004, BIOCHEM J, V384, P489, DOI 10.1042/BJ20041058; Paranavitane V, 2003, J BIOL CHEM, V278, P1328, DOI 10.1074/jbc.M208352200; Paranavitane V, 2007, CELL SIGNAL, V19, P817, DOI 10.1016/j.cellsig.2006.10.007; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003	43	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27581	27589		10.1074/jbc.M110.146886	http://dx.doi.org/10.1074/jbc.M110.146886			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20587420	Green Published, hybrid			2022-12-25	WOS:000281404100013
J	Ishimaru, D; Zuraw, L; Ramalingam, S; Sengupta, TK; Bandyopadhyay, S; Reuben, A; Fernandes, DJ; Spicer, EK				Ishimaru, Daniella; Zuraw, Lisa; Ramalingam, Sivakumar; Sengupta, Tapas K.; Bandyopadhyay, Sumita; Reuben, Adrian; Fernandes, Daniel J.; Spicer, Eleanor K.			Mechanism of Regulation of bcl-2 mRNA by Nucleolin and A plus U-rich Element-binding Factor 1 (AUF1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; HELA CYTOPLASMIC EXTRACTS; DOMAINS DETERMINE; PROTEIN-BINDING; LEUKEMIA-CELLS; IDENTIFICATION; TURNOVER; STABILIZATION; COMPLEX; DESTABILIZATION	The antiapoptotic Bcl-2 protein is overexpressed in a variety of cancers, particularly leukemias. In some cell types this is the result of enhanced stability of bcl-2 mRNA, which is controlled by elements in its 3'-untranslated region. Nucleolin is one of the proteins that binds to bcl-2 mRNA, thereby increasing its half-life. Here, we examined the site on the bcl-2 3'-untranslated region that is bound by nucleolin as well as the protein binding domains important for bcl-2 mRNA recognition. RNase foot-printing and RNA fragment binding assays demonstrated that nucleolin binds to a 40-nucleotide region at the 5' end of the 136-nucleotide bcl-2 AU-rich element (ARE(bcl-2)). The first two RNA binding domains of nucleolin were sufficient for high affinity binding to ARE(bcl-2). In RNA decay assays, ARE(bcl-2) transcripts were protected from exosomal decay by the addition of nucleolin. AUF1 has been shown to recruit the exosome to mRNAs. When MV-4-11 cell extracts were immunodepleted of AUF1, the rate of decay of ARE(bcl-2) transcripts was reduced, indicating that nucleolin and AUF1 have opposing roles in bcl-2 mRNA turnover. When the function of nucleolin in MV-4-11 cells was impaired by treatment with the nucleolin-targeting aptamer AS1411, association of AUF1 with bcl-2 mRNA was increased. This suggests that the degradation of bcl-2 mRNA induced by AS1411 results from both interference with nucleolin protection of bcl-2 mRNA and recruitment of the exosome by AUF1. Based on our findings, we propose a model that illustrates the opposing roles of nucleolin and AUF1 in regulating bcl-2 mRNA stability.	[Ishimaru, Daniella; Ramalingam, Sivakumar; Sengupta, Tapas K.; Bandyopadhyay, Sumita; Fernandes, Daniel J.; Spicer, Eleanor K.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Reuben, Adrian] Med Univ S Carolina, Dept Med, Div Gastroenterol & Hepatol, Charleston, SC 29425 USA; [Zuraw, Lisa] The Citadel, Dept Chem, Charleston, SC 29409 USA	Medical University of South Carolina; Medical University of South Carolina	Spicer, EK (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, POB 250509, Charleston, SC 29425 USA.	spicer@musc.edu	Sengupta, Tapas K/P-7126-2014; Ogunwobi, Olorunseun/F-3172-2010		National Institutes of Health [CA 87553, CA 109254]; Antisoma Research Limited, UK; NATIONAL CANCER INSTITUTE [R01CA087553, R01CA109254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antisoma Research Limited, UK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grants CA 87553 (to E. K. S.) and CA 109254 (to D. J. F.) from the National Institutes of Health and an unrestricted grant from Antisoma Research Limited, UK (to D. J. F.).	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Bandyopadhyay S, 2003, BIOCHEM PHARMACOL, V66, P1151, DOI 10.1016/S0006-2952(03)00453-2; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Bose SK, 2006, BIOCHEM J, V396, P99, DOI 10.1042/BJ20051548; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CY, 2000, GENE DEV, V14, P1236; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; David PS, 2007, RNA, V13, P1453, DOI 10.1261/rna.501707; Fahling M, 2005, BBA-GENE STRUCT EXPR, V1731, P32, DOI 10.1016/j.bbaexp.2005.08.005; Finger LD, 2003, NUCLEIC ACIDS RES, V31, P6461, DOI 10.1093/nar/gkg866; Ford LP, 1999, METHODS, V17, P21, DOI 10.1006/meth.1998.0703; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; GhisolfiNieto L, 1996, J MOL BIOL, V260, P34, DOI 10.1006/jmbi.1996.0380; Ginisty H, 2000, J BIOL CHEM, V275, P18845, DOI 10.1074/jbc.M002350200; Ginisty H, 2001, J BIOL CHEM, V276, P14338, DOI 10.1074/jbc.M011120200; Girvan AC, 2006, MOL CANCER THER, V5, P1790, DOI 10.1158/1535-7163.MCT-05-0361; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Ishimaru D, 2009, MOL CANCER RES, V7, P1354, DOI 10.1158/1541-7786.MCR-08-0476; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lapucci A, 2002, J BIOL CHEM, V277, P16139, DOI 10.1074/jbc.M201377200; Lee PT, 2007, MOL BIOL CELL, V18, P5004, DOI 10.1091/mbc.E07-04-0384; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Schiavone N, 2000, FASEB J, V14, P174, DOI 10.1096/fasebj.14.1.174; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Serin G, 1996, BIOCHIMIE, V78, P530, DOI 10.1016/0300-9084(96)84759-6; Serin G, 1997, J BIOL CHEM, V272, P13109, DOI 10.1074/jbc.272.20.13109; Singh K, 2004, J IMMUNOL, V173, P976, DOI 10.4049/jimmunol.173.2.976; Sokoloski KJ, 2008, METHOD ENZYMOL, V448, P139, DOI 10.1016/S0076-6879(08)02608-6; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; ZAIDI SHE, 1995, J BIOL CHEM, V270, P17292, DOI 10.1074/jbc.270.29.17292; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zhang YD, 2006, NUCLEIC ACIDS RES, V34, P485, DOI 10.1093/nar/gkj459; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	53	77	81	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27182	27191		10.1074/jbc.M109.098830	http://dx.doi.org/10.1074/jbc.M109.098830			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20571027	hybrid, Green Published			2022-12-25	WOS:000281172700049
J	Cao, G; Lee, KP; van der Wijst, J; de Graaf, M; van der Kemp, A; Bindels, RJM; Hoenderop, JGJ				Cao, Gang; Lee, Kyu Pil; van der Wijst, Jenny; de Graaf, Mark; van der Kemp, AnneMiete; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Methionine Sulfoxide Reductase B1 (MsrB1) Recovers TRPM6 Channel Activity during Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVITY; FUNCTIONAL EXPRESSION; RESIDUES; ACTIVATION; MODULATION; MAGNESIUM; DOMAIN; CA2+; AUTOPHOSPHORYLATION; HYPOMAGNESEMIA	Mg2+ is an essential ion for many cellular processes, including protein synthesis, nucleic acid stability, and numerous enzymatic reactions. Mg2+ homeostasis in mammals depends on the equilibrium between intestinal absorption, renal excretion, and exchange with bone. The transient receptor potential melastatin type 6 (TRPM6) is an epithelial Mg2+ channel, which is abundantly expressed in the luminal membrane of the renal and intestinal cells. It functions as the gatekeeper of transepithelial Mg2+ transport. Remarkably, TRPM6 combines a Mg2+-permeable channel with an alpha-kinase domain. Here, by the Ras recruitment system, we identified methionine sulfoxide reductase B1 (MsrB1) as an interacting protein of the TRPM6 alpha-kinase domain. Importantly, MsrB1 and TRPM6 are both present in the renal Mg2+-transporting distal convoluted tubules. MsrB1 has no effect on TRPM6 channel activity in the normoxic conditions. However, hydrogen peroxide (H2O2) decreased TRPM6 channel activity. Co-expression of MsrB1 with TRPM6 attenuated the inhibitory effect of H2O2 (TRPM6, 67 +/- 5% of control; TRPM6 + MsrB1, 81 +/- 5% of control). Cell surface biotinylation assays showed that H2O2 treatment does not affect the expression of TRPM6 at the plasma membrane. Next, mutation of Met(1755) to Ala in TRPM6 reduced the inhibitory effect of H2O2 on TRPM6 channel activity (TRPM6 M1755A: 84 +/- 10% of control), thereby mimicking the action of MsrB1. Thus, these data suggest that MsrB1 recovers TRPM6 channel activity by reducing the oxidation of Met(1755) and could, thereby, function as a modulator of TRPM6 during oxidative stress.	[Cao, Gang; Lee, Kyu Pil; van der Wijst, Jenny; de Graaf, Mark; van der Kemp, AnneMiete; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, 286 Physiol,POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@fysiol.umcn.nl	Hoenderop, Joost G.J./H-8047-2014; Bindels, René JM/B-9824-2013; van der Wijst, Jenny/D-9726-2016; van der Wijst, Jenny/T-1620-2019	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; van der Wijst, Jenny/0000-0002-1547-516X; van der Wijst, Jenny/0000-0002-1547-516X; lee, kyu pil/0000-0002-7192-4791	Netherlands Organization for Scientific Research (ZonMw) [9120.6110, 9120.8026]; European Science Foundation; Dutch Kidney Foundation [C03.6017]	Netherlands Organization for Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); European Science Foundation(European Science Foundation (ESF)European Commission); Dutch Kidney Foundation	This work was supported by the Netherlands Organization for Scientific Research (ZonMw Grants 9120.6110, 9120.8026), a European Young Investigator award from the European Science Foundation, and the Dutch Kidney Foundation (Grant C03.6017).	Aronheim A, 2001, METHODS, V24, P29, DOI 10.1006/meth.2001.1153; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Ciorba MA, 1997, P NATL ACAD SCI USA, V94, P9932, DOI 10.1073/pnas.94.18.9932; Clark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001876; Clark K, 2008, FEBS LETT, V582, P2993, DOI 10.1016/j.febslet.2008.07.043; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Eckers A, 2009, REDOX REP, V14, P141, DOI 10.1179/135100009X392610; Eisfeld J., 2007, V179, P237; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fomenko DE, 2009, J BIOL CHEM, V284, P5986, DOI 10.1074/jbc.M805770200; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Grimellec C L, 1975, Pflugers Arch, V354, P117, DOI 10.1007/BF00579943; GRUBBS RD, 1987, MAGNESIUM, V6, P113; Hansel A, 2003, REDOX REP, V8, P384, DOI 10.1179/135100003225003429; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Jung S, 2002, FEBS LETT, V527, P91, DOI 10.1016/S0014-5793(02)03171-X; Kohchi C, 2009, ANTICANCER RES, V29, P817; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Kuschel L, 1999, FEBS LETT, V456, P17, DOI 10.1016/S0014-5793(99)00917-5; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; MADSEN KM, 1988, J ELECTRON MICR TECH, V9, P187, DOI 10.1002/jemt.1060090206; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; McNulty S, 2005, PFLUG ARCH EUR J PHY, V451, P235, DOI 10.1007/s00424-005-1440-4; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095; Nabuchi Y, 1995, PHARMACEUT RES, V12, P2049, DOI 10.1023/A:1016281031373; Naziroglu M, 2007, NEUROCHEM RES, V32, P1990, DOI 10.1007/s11064-007-9386-x; Rempe DA, 2009, NAT NEUROSCI, V12, P1215, DOI 10.1038/nn1009-1215; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Santarelli LC, 2006, J PHYSIOL-LONDON, V571, P329, DOI 10.1113/jphysiol.2005.101089; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thebault S, 2008, J BIOL CHEM, V283, P19999, DOI 10.1074/jbc.M800167200; Topala CN, 2007, CELL CALCIUM, V41, P513, DOI 10.1016/j.ceca.2006.10.003; Ushio-Fukai M, 2009, CURR OPIN NEPHROL HY, V18, P153, DOI 10.1097/MNH.0b013e3283252efe; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Vetter T, 2002, CURR OPIN NEPHROL HY, V11, P403, DOI 10.1097/00041552-200207000-00006; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2009, HUM MOL GENET, V18, P4367, DOI 10.1093/hmg/ddp392; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Yao YH, 1996, BIOCHEMISTRY-US, V35, P2767, DOI 10.1021/bi951712i; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	57	61	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26081	26087		10.1074/jbc.M110.103655	http://dx.doi.org/10.1074/jbc.M110.103655			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20584906	hybrid, Green Published			2022-12-25	WOS:000280921000024
J	Fu, ZJ; Runquist, JA; Montgomery, C; Miziorko, HM; Kim, JJP				Fu, Zhuji; Runquist, Jennifer A.; Montgomery, Christa; Miziorko, Henry M.; Kim, Jung-Ja P.			Functional Insights into Human HMG-CoA Lyase from Structures of Acyl-CoA-containing Ternary Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEVALONII 3-HYDROXY-3-METHYLGLUTARYL-COA LYASE; COENZYME-A; CRYSTAL-STRUCTURE; ACETYL-COENZYME; MALATE SYNTHASE; ENZYME; MECHANISM; SUBSTRATE; DEHYDROGENASE; CATALYSIS	HMG-CoA lyase (HMGCL) is crucial to ketogenesis, and inherited human mutations are potentially lethal. Detailed understanding of the HMGCL reaction mechanism and the molecular basis for correlating human mutations with enzyme deficiency have been limited by the lack of structural information for enzyme liganded to an acyl-CoA substrate or inhibitor. Crystal structures of ternary complexes of WT HMGCL with the competitive inhibitor 3-hydroxyglutaryl-CoA and of the catalytically deficient HMGCL R41M mutant with substrate HMG-CoA have been determined to 2.4 and 2.2 angstrom, respectively. Comparison of these beta/alpha-barrel structures with those of unliganded HMGCL and R41M reveals substantial differences for Mg2+ coordination and positioning of the flexible loop containing the conserved HMGCL "signature" sequence. In the R41M-Mg2+-substrate ternary complex, loop residue Cys(266) (implicated in active-site function by mechanistic and mutagenesis observations) is more closely juxtaposed to the catalytic site than in the case of unliganded enzyme or the WT enzyme-Mg2+-3-hydroxyglutaryl-CoA inhibitor complex. In both ternary complexes, the S-stereoisomer of substrate or inhibitor is specifically bound, in accord with the observed Mg2+ liganding of both C3 hydroxyl and C5 carboxyl oxygens. In addition to His(233) and His(235) imidazoles, other Mg2+ ligands are the Asp(42) carboxyl oxygen and an ordered water molecule. This water, positioned between Asp(42) and the C3 hydroxyl of bound substrate/inhibitor, may function as a proton shuttle. The observed interaction of Arg(41) with the acyl-CoA C1 carbonyl oxygen explains the effects of Arg(41) mutation on reaction product enolization and explains why human Arg(41) mutations cause drastic enzyme deficiency.	[Montgomery, Christa; Miziorko, Henry M.] Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of Missouri System; University of Missouri Kansas City; Medical College of Wisconsin	Miziorko, HM (corresponding author), Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.	miziorkoh@umkc.edu; jjkim@mcw.edu			National Institutes of Health [GM29076, DK21491, RR07707]; United Stated Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; Office of Biological and Environmental Research [DE-AC02-06CH11357]; Marion Merrell Dow Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK021491, R01DK021491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Stated Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marion Merrell Dow Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM29076 (to J.-J. P. K.) and DK21491 (to H. M. M.). Use of the Advanced Photon Source was supported by the United Stated Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38, and Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. Use of BioCARS Sector 14 was supported by National Center for Research Resources Grant RR07707 from the National Institutes of Health.; Supported in part by Marion Merrell Dow Foundation endowment funds (to H. M. M.).	Anstrom DM, 2003, PROTEIN SCI, V12, P1822, DOI 10.1110/ps.03174303; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carrasco P, 2007, MOL GENET METAB, V91, P120, DOI 10.1016/j.ymgme.2007.03.007; Casals N, 2003, J BIOL CHEM, V278, P29016, DOI 10.1074/jbc.M304276200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forouhar F, 2006, J BIOL CHEM, V281, P7533, DOI 10.1074/jbc.M507996200; Fu ZJ, 2006, J BIOL CHEM, V281, P7526, DOI 10.1074/jbc.M506880200; Fullerton SWB, 2006, BIOORGAN MED CHEM, V14, P3002, DOI 10.1016/j.bmc.2005.12.022; GIBSON KM, 1988, EUR J PEDIATR, V148, P180, DOI 10.1007/BF00441397; HANSON KR, 1975, ACCOUNTS CHEM RES, V8, P1, DOI 10.1021/ar50085a001; HRUZ PW, 1992, PROTEIN SCI, V1, P1144, DOI 10.1002/pro.5560010908; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; KRAMER PR, 1980, J BIOL CHEM, V255, P1023; KRAMER PR, 1983, BIOCHEMISTRY-US, V22, P2353, DOI 10.1021/bi00279a008; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; MESSNER B, 1975, EUR J BIOCHEM, V53, P255, DOI 10.1111/j.1432-1033.1975.tb04064.x; NARASIMHAN C, 1995, BIOCHEMISTRY-US, V34, P9930, DOI 10.1021/bi00031a015; NARASIMHAN C, 1994, ARCH BIOCHEM BIOPHYS, V312, P467, DOI 10.1006/abbi.1994.1333; Pie J, 2007, MOL GENET METAB, V92, P198, DOI 10.1016/j.ymgme.2007.06.020; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; ROBERTS JR, 1994, J BIOL CHEM, V269, P17841; ROBERTS JR, 1995, J BIOL CHEM, V270, P17311, DOI 10.1074/jbc.270.29.17311; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; ROUSSEL A, 1999, TURBO FRODO; SIDDIQI MA, 1967, J BACTERIOL, V93, P207, DOI 10.1128/JB.93.1.207-214.1967; Smith CV, 2003, J BIOL CHEM, V278, P1735, DOI 10.1074/jbc.M209248200; STEGINK LD, 1968, J BIOL CHEM, V243, P5272; Tuinstra RL, 2004, BIOCHEMISTRY-US, V43, P5287, DOI 10.1021/bi0499765; Tuinstra RL, 2003, J BIOL CHEM, V278, P37092, DOI 10.1074/jbc.M304472200; Tuinstra RL, 2002, ARCH BIOCHEM BIOPHYS, V408, P286, DOI 10.1016/S0003-9861(02)00584-2; Wang SP, 1998, HUM MOL GENET, V7, P2057, DOI 10.1093/hmg/7.13.2057	36	16	16	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26341	26349		10.1074/jbc.M110.139931	http://dx.doi.org/10.1074/jbc.M110.139931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558737	Green Published, hybrid			2022-12-25	WOS:000280921000052
J	Gahring, LC; Rogers, SW				Gahring, Lorise C.; Rogers, Scott W.			Nicotinic Receptor Subunit alpha 5 Modifies Assembly, Up-regulation, and Response to Pro-inflammatory Cytokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; BINDING-SITES; RAT-BRAIN; CHOLINERGIC-RECEPTOR; HIPPOCAMPAL-NEURONS; IN-VIVO; BETA 4; EXPRESSION; CELLS; PHARMACOLOGY	In the mammalian brain high affinity nicotine-binding sites are composed of at least the alpha 4 and beta 2 subunits. Additional nicotinic acetylcholine receptor subunits that are often co-expressed with alpha 4 + beta 2 include alpha 5. The introduction of alpha 5 into 293 cells expressing alpha 4 + beta 2 strongly favors assembly of alpha 4 + alpha 5 + beta 2 receptors, increases constitutive ligand binding density as measured using [H-3] epibatidine, but reduces the magnitude of up-regulation in response to chronic nicotine. In contrast, when beta 4 is substituted for beta 2, alpha 5 interferes with the assembly of these receptors, demonstrating an important role for the beta subunit in this process. When cells co-express alpha 4 + alpha 5 + beta 2 + beta 4, over 50% of the subunit associations include all four subunits, but they fail to be detected using [H-3] epibatidine binding. However, complexes of alpha 4 + alpha 5 + beta 2 do preferentially emerge from these subunit mixtures, and these mixtures bind ligand. In previous studies of alpha 4 + beta 2 + beta 4 co-expression by 293 cells, the inflammatory cytokines IL-1 beta and TNF alpha influenced the outcome of receptor assembly (Gahring, L. C., Days, E. L., Kaasch, T., Gonzalez de Mendoza, M., Owen, L., Persiyanov, K., and Rogers, S. W. (2005) J. Neuroimmunol. 166, 88-101). When alpha 5 is included in this subunit mixture, and cells are exposed to either inflammatory cytokine, subunit association is no longer altered. These findings suggest that alpha 5 is an influential modulator of alpha 4 + beta 2 nicotinic acetylcholine receptor assembly and stabilizes their expression in response to fluctuations in external conditions.	[Rogers, Scott W.] Univ Utah, Sch Med 2C132, Salt Lake City Vet Affairs Geriatr Res Educ & Cli, Salt Lake City, UT 84132 USA; [Gahring, Lorise C.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA; [Rogers, Scott W.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Geriatric Research Education & Clinical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rogers, SW (corresponding author), Univ Utah, Sch Med 2C132, Salt Lake City Vet Affairs Geriatr Res Educ & Cli, 30 North,1900 East, Salt Lake City, UT 84132 USA.	scott.rogers@hsc.utah.edu			National Institutes of Health [AG017517, AG029838, DA025057]; Veterans Affairs; NATIONAL INSTITUTE ON AGING [R01AG017517, R01AG029838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants AG017517 (to S. W. R.), AG029838 (to L. C. G.), and DA025057 (to L. C. G. and S. W. R.). This work was also supported by a Veterans Affairs-Merit award (to L. C. G.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Albuquerque EX, 1997, J PHARMACOL EXP THER, V280, P1117; Alkondon M, 2001, J NEUROPHYSIOL, V86, P3043, DOI 10.1152/jn.2001.86.6.3043; Alkondon M, 1996, J PHARMACOL EXP THER, V279, P1491; ANAND R, 1991, J BIOL CHEM, V266, P11192; Arredondo J, 2003, LAB INVEST, V83, P207, DOI 10.1097/01.LAB.0000053917.46614.12; Bruschweiler-Li L, 2010, NEUROSCIENCE, V166, P864, DOI 10.1016/j.neuroscience.2010.01.026; Carlson NG, 1998, J NEUROBIOL, V35, P29, DOI 10.1002/(SICI)1097-4695(199804)35:1<29::AID-NEU3>3.0.CO;2-D; Cauley K, 1996, J NEUROBIOL, V30, P303, DOI 10.1002/(SICI)1097-4695(199606)30:2<303::AID-NEU11>3.0.CO;2-K; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; DINELEYMILLER K, 1992, MOL BRAIN RES, V16, P339, DOI 10.1016/0169-328X(92)90244-6; Flores CM, 1996, J NEUROSCI, V16, P7892; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; Gahring LC, 2005, J NEUROIMMUNOL, V166, P88, DOI 10.1016/j.jneuroim.2005.05.007; Gahring LC, 2005, NEUROBIOL AGING, V26, P973, DOI 10.1016/j.neurobiolaging.2004.07.005; Gahring LC, 2004, J COMP NEUROL, V468, P322, DOI 10.1002/cne.10942; Gahring LC, 2008, J BIOL CHEM, V283, P693, DOI 10.1074/jbc.M707330200; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; MARKS MJ, 1985, J PHARMACOL EXP THER, V235, P619; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; O'Hara BF, 1999, MOL BRAIN RES, V66, P71, DOI 10.1016/S0169-328X(99)00004-2; Orr-Urtreger A, 2005, NEUROREPORT, V16, P1123, DOI 10.1097/00001756-200507130-00018; Osborne-Hereford AV, 2008, J NEUROIMMUNOL, V193, P130, DOI 10.1016/j.jneuroim.2007.10.029; PAULSON HL, 1991, J CELL BIOL, V113, P1371, DOI 10.1083/jcb.113.6.1371; Picciotto M R, 1999, Nicotine Tob Res, V1 Suppl 2, pS121; Rogers SW, 1998, J NEUROSCI, V18, P4825; ROGERS SW, 1992, J NEUROSCI, V12, P4611; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; SCHWARTZ RD, 1985, J NEUROCHEM, V45, P427, DOI 10.1111/j.1471-4159.1985.tb04005.x; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Sudweeks SN, 2000, J PHYSIOL-LONDON, V527, P515, DOI 10.1111/j.1469-7793.2000.00515.x; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Walsh H, 2008, J BIOL CHEM, V283, P6022, DOI 10.1074/jbc.M703432200; Wang DW, 2009, CHIN J TRAUMATOL, V12, P355, DOI 10.3760/cma.j.issn.1008-1275.2009.06.007; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595; Xiao YX, 2004, BIOORG MED CHEM LETT, V14, P1845, DOI 10.1016/j.bmcl.2003.09.105; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Zoli M, 2002, J NEUROSCI, V22, P8785	48	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26049	26057		10.1074/jbc.M110.105346	http://dx.doi.org/10.1074/jbc.M110.105346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566638	Green Published, hybrid			2022-12-25	WOS:000280921000020
J	Shimura, T; Kakuda, S; Ochiai, Y; Nakagawa, H; Kuwahara, Y; Takai, Y; Kobayashi, J; Komatsu, K; Fukumoto, M				Shimura, T.; Kakuda, S.; Ochiai, Y.; Nakagawa, H.; Kuwahara, Y.; Takai, Y.; Kobayashi, J.; Komatsu, K.; Fukumoto, M.			Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3 beta-mediated cyclin D1 overexpression	ONCOGENE			English	Article						cyclin D1; AKT; fractionated-radiation; radioresistance; DNA-PK	STRAND BREAK RESPONSE; CANCER STEM-CELLS; DNA-DAMAGE; NUCLEAR EXPORT; MAMMALIAN-CELLS; PROTEIN-KINASE; PHOSPHORYLATION; REPAIR; REPLICATION; INHIBITION	Recurrence is frequently associated with the acquisition of radioresistance by tumors and resulting failures in radiotherapy. We report, in this study, that long-term fractionated radiation (FR) exposures conferred radioresistance to the human tumor cells, HepG2 and HeLa with cyclin D1 overexpression. A positive feedback loop was responsible for the cyclin D1 overexpression in which constitutively active AKT was involved. AKT is known to inactivate glycogen synthase kinase-3 beta (GSK3 beta), which is essential for the proteasomal degradation of cyclin D1. The resulting cyclin D1 overexpression led to the forced progression of S-phase with the induction of DNA double strand breaks. Cyclin D1-dependent DNA damage activated DNA-dependent protein kinase (DNA-PK), which in turn activated AKT and inactivated GSK3 beta, thus completing a positive feedback loop of cyclin D1 overproduction. Cyclin D1 overexpression led to the activation of DNA damage response (DDR) consisted of ataxia telangiectasia mutated (ATM)- and Chk1-dependent DNA damage checkpoint and homologous recombination repair (HRR). Long-term FR cells repaired radiation-induced DNA damage faster than non-FR cells. Thus, acquired radioresistance of long-term FR cells was the result of alterations in DDR mediated by cyclin D1 overexpression. Inhibition of the AKT/GSK3 beta/cyclin D1/Cdk4 pathway by the AKT inhibitor, Cdk4 inhibitor or cyclin D1 targeting small interfering RNA (siRNA) suppressed the radioresistance. Present observations give a mechanistic insight for acquired radioresistance of tumor cells by cyclin D1 overexpression, and provide novel therapeutic targets for recurrent radioresistant tumors. Oncogene (2010) 29, 4826-4837; doi:10.1038/onc.2010.238; published online 21 June 2010	[Shimura, T.; Kakuda, S.; Ochiai, Y.; Nakagawa, H.; Kuwahara, Y.; Fukumoto, M.] Tohoku Univ, Dept Pathol, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Kakuda, S.; Takai, Y.] Tohoku Univ, Grad Sch Med, Dept Therapeut Radiol, Sendai, Miyagi 9808575, Japan; [Kobayashi, J.; Komatsu, K.] Kyoto Univ, Dept Genome Dynam, Ctr Radiat Biol, Kyoto, Japan	Tohoku University; Tohoku University; Kyoto University	Fukumoto, M (corresponding author), Tohoku Univ, Dept Pathol, Inst Dev Aging & Canc, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	fukumoto@idac.tohoku.ac.jp	Kobayashi, Junya/AAX-6390-2021; Fukumoto, Manabu/L-1444-2019	Kobayashi, Junya/0000-0003-4645-7500; 	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour and Welfare of Japan; Interdisciplinary Research, Tohoku University;  [Start-up-20810003];  [Wakate-B-21710054]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Interdisciplinary Research, Tohoku University; ; 	We thank Dr Ohtsura Niwa and Dr Keiko Nakayama for their critical reading of the paper. We thank Dr J Alan Diehl for providing pFleX-cyclin D1 expression vectors. We thank Dr Shuntaro Ikawa for providing some chemicals. This study was in part supported by the Grant-in-Aid for young scientists (Start-up-20810003) and (Wakate-B-21710054), by the Grant-in-Aid from Ministry of Education, Culture, Sports, Science and Technology, by grants from the Ministry of Health, Labour and Welfare of Japan, and by the 'Frontier Science Research Program' in the Center for Interdisciplinary Research, Tohoku University.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bani-Hani K, 2000, J NATL CANCER I, V92, P1316, DOI 10.1093/jnci/92.16.1316; BARTKOVA J, 1994, INT J CANCER, V58, P568, DOI 10.1002/ijc.2910580420; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Benzeno S, 2006, ONCOGENE, V25, P6291, DOI 10.1038/sj.onc.1209644; Bommi-Reddy A, 2008, P NATL ACAD SCI USA, V105, P16484, DOI 10.1073/pnas.0806574105; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Cann KL, 2007, BIOCHEM CELL BIOL, V85, P663, DOI 10.1139/O07-135; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chang AR, 2008, HEAD NECK-J SCI SPEC, V30, P852, DOI 10.1002/hed.20788; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; FILMUS J, 1994, ONCOGENE, V9, P3627; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; GILLETT C, 1994, CANCER RES, V54, P1812; Gladden AB, 2005, J CELL BIOCHEM, V96, P906, DOI 10.1002/jcb.20613; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Higuchl E, 2007, HEAD NECK-J SCI SPEC, V29, P940, DOI 10.1002/hed.20632; Hitomi M, 1999, CURR BIOL, V9, P1075, DOI 10.1016/S0960-9822(99)80476-X; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lin DI, 2008, ONCOGENE, V27, P1231, DOI 10.1038/sj.onc.1210738; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; PAGANO M, 1994, GENE DEV, V8, P1627, DOI 10.1101/gad.8.14.1627; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Russell A, 1999, ONCOGENE, V18, P1983, DOI 10.1038/sj.onc.1202511; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shimura T, 2008, J MOL BIOL, V375, P1152, DOI 10.1016/j.jmb.2007.11.006; Shimura T, 2007, J MOL BIOL, V367, P665, DOI 10.1016/j.jmb.2007.01.018; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Veuger SJ, 2003, CANCER RES, V63, P6008; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343	48	109	114	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2010	29	34					4826	4837		10.1038/onc.2010.238	http://dx.doi.org/10.1038/onc.2010.238			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	643VB	20562919				2022-12-25	WOS:000281326400008
J	Boye, SE; Boye, SL; Pang, JJ; Ryals, R; Everhart, D; Umino, Y; Neeley, AW; Besharse, J; Barlow, R; Hauswirth, WW				Boye, Shannon E.; Boye, Sanford L.; Pang, Jijing; Ryals, Renee; Everhart, Drew; Umino, Yumiko; Neeley, Andy W.; Besharse, Joseph; Barlow, Robert; Hauswirth, William W.			Functional and Behavioral Restoration of Vision by Gene Therapy in the Guanylate Cyclase-1 (GC1) Knockout Mouse	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; ADENOASSOCIATED VIRUS; RETINAL DEGENERATION; PHOTORECEPTOR CELLS; RESTORES VISION; CONE VISION; EXPRESSION; ROD; TRANSDUCTION; MUTATIONS	Background: Recessive mutations in guanylate cyclase-1 (Gucy2d) are associated with severe, early onset Leber congenital amaurosis-1(LCA1). Gucy2d encodes guanylate cyclase (GC1) is expressed in photoreceptor outer segment membranes and produces cGMP in these cells. LCA1 patients present in infancy with severely impaired vision and extinguished electroretinogram (ERG) but retain some photoreceptors in both their macular and peripheral retina for years. Like LCA1 patients, loss of cone function in the GC1 knockout (GC1KO) mouse precedes cone degeneration. The purpose of this study was to test whether delivery of functional GC1 to cone cells of the postnatal GC1KO mouse could restore function to these cells. Methodology/Principal Findings: Serotype 5 AAV vectors containing either a photoreceptor-specific, rhodopsin kinase (hGRK1) or ubiquitous (smCBA) promoter driving expression of wild type murine GC1 were subretinally delivered to one eye of P14 GC1KO mice. Visual function (ERG) was analyzed in treated and untreated eyes until 3 months post injection. AAV-treated, isogenic wild type and uninjected control mice were evaluated for restoration of visual behavior using optomotor testing. At 3 months post injection, all animals were sacrificed, and their treated and untreated retinas assayed for expression of GC1 and localization of cone arrestin. Cone-mediated function was restored to treated eyes of GC1KO mice (ERG amplitudes were similar to 45% of normal). Treatment effect was stable for at least 3 months. Robust improvements in cone-mediated visual behavior were also observed, with responses of treated mice being similar or identical to that of wild type mice. AAV-vectored GC1 expression was found in photoreceptors and cone cells were preserved in treated retinas. Conclusions/Significance: This is the first demonstration of gene-based restoration of both visual function/vision-elicited behavior and cone preservation in a mammalian model of GC1 deficiency. Importantly, results were obtained using a well characterized, clinically relevant AAV vector. These results lay the ground work for the development of an AAV-based gene therapy vector for the treatment of LCA1.	[Boye, Shannon E.; Boye, Sanford L.; Pang, Jijing; Ryals, Renee; Neeley, Andy W.; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Everhart, Drew; Umino, Yumiko; Barlow, Robert] SUNY Upstate Med Univ, Coll Med, Dept Ophthalmol, Syracuse, NY USA; [Besharse, Joseph] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Medical College of Wisconsin	Boye, SE (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA.	shaire@ufl.edu		Boye, Shannon/0000-0002-7312-3197; hauswirth, william/0000-0002-3244-4947	National Institutes of Health (NIH) [EY13729, EY11123, EY08571]; Macular Vision Research Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [P30EY008571, U10EY013729, R01EY011123] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health (NIH) grants EY13729, EY11123, and EY08571, and by grants from the Macular Vision Research Foundation (www.mvrg.org), the Foundation Fighting Blindness (www.blindness.org), Hope for Vision (www.hopeforvision.org), and Research to Prevent Blindness, Inc. (www.rpbusa.org). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BELTRAN W, 2010, GENE THERAP IN PRESS; Bereta G, 2010, J BIOL CHEM, V285, P1899, DOI 10.1074/jbc.M109.061713; Bhowmick R, 2009, TRAFFIC, V10, P648, DOI 10.1111/j.1600-0854.2009.00896.x; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chung DC, 2009, J AAPOS, V13, P587, DOI 10.1016/j.jaapos.2009.10.004; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Coleman JE, 2004, INVEST OPHTH VIS SCI, V45, P3397, DOI 10.1167/iovs.04-0392; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Glushakova LG, 2006, MOL VIS, V12, P298; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Huang YJ, 1998, INVEST OPHTH VIS SCI, V39, P2405; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Karan S, 2010, MOL CELL BIOCHEM, V334, P141, DOI 10.1007/s11010-009-0322-z; Khani SC, 2007, INVEST OPHTH VIS SCI, V48, P3954, DOI 10.1167/iovs.07-0257; KOMAROMY AM, 2010, HUM MOL GENET   0421; Li WS, 2009, MOL VIS, V15, P267; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; Lotery AJ, 2003, HUM GENE THER, V14, P1663, DOI 10.1089/104303403322542301; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Milam AH, 2003, OPHTHALMOLOGY, V110, P549, DOI 10.1016/S0161-6420(02)01757-8; Natkunarajah M, 2008, GENE THER, V15, P463, DOI 10.1038/sj.gt.3303074; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; PANG J, 2010, GENE THER       0318; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; PASADHIKA S, 2009, INVEST OPHTHALMOL VI; PAWLYK BS, 2010, HUM GENE THER   0412; Perrault I, 1999, MOL GENET METAB, V68, P200, DOI 10.1006/mgme.1999.2906; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault I, 2000, EUR J HUM GENET, V8, P578, DOI 10.1038/sj.ejhg.5200503; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; Sun X, 2010, GENE THER, V17, P117, DOI 10.1038/gt.2009.104; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Timmers A, 2001, MOL VIS, V7, P131; ULSHAFER RJ, 1984, EXP EYE RES, V39, P125, DOI 10.1016/0014-4835(84)90003-4; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Williams GA, 2007, VISION RES, V47, P2037, DOI 10.1016/j.visres.2007.03.023; Williams ML, 2006, PLOS MED, V3, P904, DOI 10.1371/journal.pmed.0030201; Yang GS, 2002, J VIROL, V76, P7651, DOI 10.1128/JVI.76.15.7651-7660.2002; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602	55	78	82	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11306	10.1371/journal.pone.0011306	http://dx.doi.org/10.1371/journal.pone.0011306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593011	Green Submitted, Green Published, gold			2022-12-25	WOS:000279140800008
J	Lay, CC; Davis, MF; Chen-Bee, CH; Frostig, RD				Lay, Christopher C.; Davis, Melissa F.; Chen-Bee, Cynthia H.; Frostig, Ron D.			Mild Sensory Stimulation Completely Protects the Adult Rodent Cortex from Ischemic Stroke	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; RAT BARREL CORTEX; FUNCTIONAL-ORGANIZATION; INTRINSIC SIGNAL; FOCAL ISCHEMIA; INFARCT SIZE; PLASTICITY; OCCLUSION; CHLORIDE; MODEL	Despite progress in reducing ischemic stroke damage, complete protection remains elusive. Here we demonstrate that, after permanent occlusion of a major cortical artery (middle cerebral artery; MCA), single whisker stimulation can induce complete protection of the adult rat cortex, but only if administered within a critical time window. Animals that receive early treatment are histologically and behaviorally equivalent to healthy controls and have normal neuronal function. Protection of the cortex clearly requires reperfusion to the ischemic area despite permanent occlusion. Using blood flow imaging and other techniques we found evidence of reversed blood flow into MCA branches from an alternate arterial source via collateral vessels (inter-arterial connections), a potential mechanism for reperfusion. These findings suggest that the cortex is capable of extensive blood flow reorganization and more importantly that mild sensory stimulation can provide complete protection from impending stroke given early intervention. Such non-invasive, non-pharmacological intervention has clear translational potential.	[Lay, Christopher C.; Davis, Melissa F.; Chen-Bee, Cynthia H.; Frostig, Ron D.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA; [Lay, Christopher C.; Davis, Melissa F.; Frostig, Ron D.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [Frostig, Ron D.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Lay, CC (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	rfrostig@uci.edu		Davis, Melissa/0000-0003-2252-3075	National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) [NS-48350, NS-55832]; University of California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055832, R01NS066001, R01NS048350] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of California(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health-National Institute of Neurological Disorders and Stroke (NIH-NINDS) NS-48350, NS-55832, and the University of California Irvine's Faculty Mentor Program (FMP) 2009-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abookasis D, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3116709; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Brett-Green BA, 2001, J NEUROSCI, V21, P9944, DOI 10.1523/JNEUROSCI.21-24-09944.2001; BRIERS JD, 1995, OPT COMMUN, V116, P36, DOI 10.1016/0030-4018(95)00042-7; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Burnett MG, 2006, STROKE, V37, P1327, DOI 10.1161/01.STR.0000217305.82123.d8; Chen-Bee CH, 2000, J NEUROSCI METH, V97, P157, DOI 10.1016/S0165-0270(00)00180-1; Chen-Bee CH, 2007, J NEUROSCI, V27, P4572, DOI 10.1523/JNEUROSCI.0326-07.2007; Chenbee CH, 1996, J NEUROPHYSIOL, V76, P884, DOI 10.1152/jn.1996.76.2.884; Choi B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2341196; COYLE P, 1987, STROKE, V18, P1133, DOI 10.1161/01.STR.18.6.1133; Cramer SC, 2008, CURR OPIN NEUROL, V21, P76, DOI 10.1097/WCO.0b013e3282f36cb6; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; FOX G, 1993, STROKE, V24, P2087, DOI 10.1161/01.STR.24.12.2087; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Frostig RD, 2006, CURR OPIN NEUROBIOL, V16, P445, DOI 10.1016/j.conb.2006.06.001; Frostig RD, 2009, FRONT NEUROSCI, P255; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Goldlust EJ, 1996, STROKE, V27, P1657, DOI 10.1161/01.STR.27.9.1657; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Lavie G, 2001, BRAIN RES, V901, P195, DOI 10.1016/S0006-8993(01)02356-3; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; LLOYDJONES D, 2009, CIRCULATION, V21, pE181; Luhmann HJ, 2005, BEHAV BRAIN RES, V157, P39, DOI 10.1016/j.bbr.2004.06.006; LUNDY EF, 1986, J PHARMACOL METHOD, V16, P201, DOI 10.1016/0160-5402(86)90042-2; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; Mehdiratta M, 2007, PROG CARDIOVASC DIS, V49, P430, DOI 10.1016/j.pcad.2006.12.001; MOLLER A, 2006, NEURONAL PLASTICITY; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Niiro M, 1996, J NEUROSCI METH, V64, P19, DOI 10.1016/0165-0270(95)00058-5; PARK CK, 1988, NEUROPATH APPL NEURO, V14, P289, DOI 10.1111/j.1365-2990.1988.tb00889.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; REIS DJ, 1991, J CEREBR BLOOD F MET, V11, P810, DOI 10.1038/jcbfm.1991.139; Sagher O, 2003, J NEUROSURG, V99, P131, DOI 10.3171/jns.2003.99.1.0131; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHROETER M, 1995, EXP BRAIN RES, V106, P1; SCHWARTING RKW, 1991, PSYCHOPHARMACOLOGY, V103, P19, DOI 10.1007/BF02244068; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Wang-Fischer Y, 2009, MANUAL STROKE MODELS; WEI L, 1995, STROKE, V26, P1459, DOI 10.1161/01.STR.26.8.1459; Whitaker VR, 2007, J CEREBR BLOOD F MET, V27, P57, DOI 10.1038/sj.jcbfm.9600318; Xerri C, 2008, BEHAV BRAIN RES, V192, P26, DOI 10.1016/j.bbr.2008.02.038	52	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11270	10.1371/journal.pone.0011270	http://dx.doi.org/10.1371/journal.pone.0011270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585659	gold, Green Published			2022-12-25	WOS:000279135400016
J	Djiane, A; Mlodzik, M				Djiane, Alexandre; Mlodzik, Marek			The Drosophila GIPC Homologue Can Modulate Myosin Based Processes and Planar Cell Polarity but Is Not Essential for Development	PLOS ONE			English	Article							PDZ DOMAIN; INTERACTING PROTEIN; C-TERMINUS; RECEPTOR; POLARIZATION; VI; DETERMINANTS; EPITHELIA; EXCLUSION; KERMIT	Epithelia often show, in addition to the ubiquitous apico-basal (A/B) axis, a polarization within the plane of the epithelium, perpendicular to the A/B axis. Such planar cell polarity (PCP) is for example evident in the regular arrangement of the stereocilia in the cochlea of the mammalian inner ear or in (almost) all Drosophila adult external structures. GIPCs (GAIP interacting protein, C terminus) were first identified in mammals and bind to the G alpha i GTPase activating protein RGS-GAIP. They have been proposed to act in a G-protein coupled complex controlling vesicular trafficking. Although GIPCs have been found to bind to numerous proteins including Frizzled receptors, which participate in PCP establishment, there is little in vivo evidence for the functional role(s) of GIPCs. We show here that overexpressed Drosophila dGIPC alters PCP generation in the wing. We were however unable to find any binding between dGIPC and the Drosophila receptors Fz1 and Fz2. The effect of overexpressed dGIPC is likely due to an effect on the actin cytoskeleton via myosins, since it is almost entirely suppressed by removing a genomic copy of the Myosin VI/jaguar gene. Surprisingly, although dGIPC can interfere with PCP generation and myosin based processes, the complete loss-of-function of dGIPC gives viable adults with no PCP or other detectable defects arguing for a non-essential role of dGIPC in viability and normal Drosophila development.	[Djiane, Alexandre] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Mlodzik, Marek] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY USA	University of Cambridge; Icahn School of Medicine at Mount Sinai	Djiane, A (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	marek.mlodzik@mssm.edu		Djiane, Alexandre/0000-0001-6210-2713	National Institutes of Health [RO1 GM62917]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health grant RO1 GM62917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Djiane A, 2000, DEVELOPMENT, V127, P3091; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Katoh M, 2002, INT J MOL MED, V9, P585; Kearney JB, 2004, DEV BIOL, V275, P473, DOI 10.1016/j.ydbio.2004.08.047; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Ligensa T, 2001, J BIOL CHEM, V276, P33419, DOI 10.1074/jbc.M104509200; Morrison JK, 2008, GENETICS, V179, P711, DOI 10.1534/genetics.107.085969; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Petritsch C, 2003, DEV CELL, V4, P273, DOI 10.1016/S1534-5807(03)00020-0; Rorth P, 1998, DEVELOPMENT, V125, P1049; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Tan C, 2001, DEVELOPMENT, V128, P3665; Toba G, 1999, GENETICS, V151, P725; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Wu JL, 2006, DEVELOPMENT, V133, P3651, DOI 10.1242/dev.02547	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11228	10.1371/journal.pone.0011228	http://dx.doi.org/10.1371/journal.pone.0011228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574526	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058300017
J	Yew, NS; Zhao, HM; Hong, EG; Wu, IH; Przybylska, M; Siegel, C; Shayman, JA; Arbeeny, CM; Kim, JK; Jiang, CW; Cheng, SH				Yew, Nelson S.; Zhao, Hongmei; Hong, Eun-Gyoung; Wu, I-Huan; Przybylska, Malgorzata; Siegel, Craig; Shayman, James A.; Arbeeny, Cynthia M.; Kim, Jason K.; Jiang, Canwen; Cheng, Seng H.			Increased Hepatic Insulin Action in Diet-Induced Obese Mice Following Inhibition of Glucosylceramide Synthase	PLOS ONE			English	Article							GANGLIOSIDE GM3; ADIPOSE-TISSUE; RESISTANCE; SENSITIVITY; STEATOSIS; LIVER; MECHANISMS; MEDIATORS; MUSCLE	Background: Obesity is characterized by the accumulation of fat in the liver and other tissues, leading to insulin resistance. We have previously shown that a specific inhibitor of glucosylceramide synthase, which inhibits the initial step in the synthesis of glycosphingolipids (GSLs), improved glucose metabolism and decreased hepatic steatosis in both ob/ob and diet-induced obese (DIO) mice. Here we have determined in the DIO mouse model the efficacy of a related small molecule compound, Genz-112638, which is currently being evaluated clinically for the treatment of Gaucher disease, a lysosomal storage disorder. Methodology/Principal Findings: DIO mice were treated with the Genz-112638 for 12 to 16 weeks by daily oral gavage. Genz-112638 lowered HbA1c levels and increased glucose tolerance. Whole body adiposity was not affected in normal mice, but decreased in drug-treated obese mice. Drug treatment also significantly lowered liver triglyceride levels and reduced the development of hepatic steatosis. We performed hyperinsulinemic-euglycemic clamps on the DIO mice treated with Genz-112638 and showed that insulin-mediated suppression of hepatic glucose production increased significantly compared to the placebo treated mice, indicating a marked improvement in hepatic insulin sensitivity. Conclusions/Significance: These results indicate that GSL inhibition in obese mice primarily results in an increase in insulin action in the liver, and suggests that GSLs may have an important role in hepatic insulin resistance in conditions of obesity.	[Yew, Nelson S.; Zhao, Hongmei; Wu, I-Huan; Przybylska, Malgorzata; Siegel, Craig; Arbeeny, Cynthia M.; Jiang, Canwen; Cheng, Seng H.] Genzyme Corp, Framingham, MA 01701 USA; [Hong, Eun-Gyoung; Kim, Jason K.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Hong, Eun-Gyoung] Hallym Univ, Coll Med, Dept Endocrinol & Med, Seoul, South Korea; [Shayman, James A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Sanofi-Aventis; Genzyme Corporation; Yale University; Hallym University; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester	Yew, NS (corresponding author), Genzyme Corp, Framingham, MA 01701 USA.	nelson.yew@genzyme.com	Cheng, Seng H/AAC-6564-2022	Kim, Jason/0000-0002-7185-042X	Genzyme Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080756, R01DK055823] Funding Source: NIH RePORTER	Genzyme Corporation(Sanofi-AventisGenzyme Corporation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Genzyme Corporation. Genzyme had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; BIJL N, 2009, HEPATOLOGY; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Buse JB, 2003, WILLIAMS TXB ENDOCRI, P1427; Edgerton DS, 2009, FRONT BIOSCI-LANDMRK, V14, P1169, DOI 10.2741/3301; Girard J, 2006, J CLIN INVEST, V116, P302, DOI 10.1172/JCI27743; Glaros EN, 2007, BIOCHEM PHARMACOL, V73, P1340, DOI 10.1016/j.bcp.2006.12.023; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Home PD, 2008, DIABETES OBES METAB, V10, P699, DOI 10.1111/j.1463-1326.2007.00761.x; Inokuchi J, 2006, BIOL PHARM BULL, V29, P1532, DOI 10.1248/bpb.29.1532; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kasahara K, 2000, GLYCOCONJUGATE J, V17, P153, DOI 10.1023/A:1026576804247; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719; Zhao HM, 2009, HEPATOLOGY, V50, P85, DOI 10.1002/hep.22970	28	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11239	10.1371/journal.pone.0011239	http://dx.doi.org/10.1371/journal.pone.0011239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574539	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058300023
J	Zhou, KY; Wang, GT; Wang, YR; Jin, HH; Yang, SX; Liu, CB				Zhou, Keiyu; Wang, Guangtao; Wang, Yirong; Jin, Hanghuang; Yang, Shuxu; Liu, Chibo			The Potential Involvement of E-cadherin and beta-catenins in Meningioma	PLOS ONE			English	Article							BRAIN EDEMA; EXPRESSION; COMPLEX; GENE	Objective: To investigate the potential involvements of E-cadherin and beta-catenin in meningioma. Methods: Immunohistochemistry staining was performed on samples from patients with meningioma. The results were graded according to the positive ratio and intensity of tissue immunoreactivity. The expression of E-cadherin and beta-catenin in meningioma was analyzed by its relationship with WHO2007 grading, invasion, peritumoral edema and postoperative recurrence. Results: The positive rates of E-cadherin in meningioma WHO I, II, III were 92.69%, 33.33% and 0, respectively, (P<0.05); while the positive rates of beta-catenin in meningioma WHO I, II, III were 82.93%, 33.33% and 20.00%, respectively, (P<0.05). The positive rate of E-cadherin in meningioma without invasion (94.12%) was higher than that with invasion (46.67%) (P<0.05). The difference in the positive rate of beta-catenin between meningioma without invasion (88.24%) and meningioma with invasion (33.33%, P<0.05) was also statically significant. The positive rates of beta-cadherin in meningioma with peritumoral edema 0, 1, 2, 3 were 93.75%, 85.71%, 60.00% and 0 respectively, (P<0.05); the positive rates of beta-catenin in meningioma with peritumoral edema 0, 1, 2, 3 were 87.50%, 85.71%, 30.00% and 0 respectively, (P<0.01). The positive rates of E-cadherin in meningioma with postoperative recurrence were 33.33%, and the positive rate with postoperative non-recurrence was 90.00% (P<0.01). The positive rates of beta-catenin in meningioma with postoperative recurrence and non-recurrence were 11.11%, 85.00%, respectively (P<0.01). Conclusion: The expression levels of E-cadherin and beta-catenin correlated closely to the WHO 2007 grading criteria for meningioma. In atypical or malignant meningioma, the expression levels of E-cadherin and beta-catenin were significantly lower. The expression levels of E-cadherin and beta-catenin were also closely correlated with the invasion status of meningioma, the size of the peritumoral edema and the recurrent probabilities of the meningioma, all in an inverse correlationship. Taken together, the present study provided novel molecular targets in clinical treatments to meningioma.	[Zhou, Keiyu; Wang, Guangtao; Jin, Hanghuang] Taizhou Univ, Affiliated Taizhou Municipal Hosp, Dept Neurosurg, Taizhou, Peoples R China; [Wang, Yirong; Yang, Shuxu] Zhejiang Univ, Coll Med Sci, Dept Neurosurg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Chibo] Taizhou Univ, Affiliated Taizhou Municipal Hosp, Dept Lab Med, Taizhou, Peoples R China	Taizhou University; Zhejiang University; Taizhou University	Zhou, KY (corresponding author), Taizhou Univ, Affiliated Taizhou Municipal Hosp, Dept Neurosurg, Taizhou, Peoples R China.	liuchibo@126.com			Affiliated Taizhou Municipal Hospital	Affiliated Taizhou Municipal Hospital	The study was supported by The Affiliated Taizhou Municipal Hospital.	Akat K, 2008, CELL TISSUE RES, V331, P401, DOI 10.1007/s00441-007-0512-5; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Asano K, 2004, J NEURO-ONCOL, V70, P3, DOI 10.1023/B:NEON.0000040811.14908.f2; BERX G, 1995, GENOMICS, V26, P281, DOI 10.1016/0888-7543(95)80212-5; Brunner EC, 2006, HISTOPATHOLOGY, V49, P178, DOI 10.1111/j.1365-2559.2006.02440.x; Curtis MW, 2008, CELL COMMUN ADHES, V15, P365, DOI 10.1080/15419060802460748; Durand A, 2008, CLIN NEUROPATHOL, V27, P334; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Erdemir F, 2007, INT UROL NEPHROL, V39, P1031, DOI 10.1007/s11255-006-9159-5; Goldman CK, 1997, NEUROSURGERY, V40, P1269, DOI 10.1097/00006123-199706000-00029; Guzman P, 2006, REV MED CHILE, V134, P1002; Jagannathan J, 2008, SKULL BASE-INTERD AP, V18, P173, DOI 10.1055/s-2007-1003925; Klaeboe L, 2005, INT J CANCER, V117, P996, DOI 10.1002/ijc.21255; Marosi C, 2008, CRIT REV ONCOL HEMAT, V67, P153, DOI 10.1016/j.critrevonc.2008.01.010; Metindir J, 2008, EUR J GYNAECOL ONCOL, V29, P489; Motta FJN, 2008, GENET MOL RES, V7, P295, DOI 10.4238/vol7-2gmr424; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Restucci B, 2007, ANTICANCER RES, V27, P3083; Shimada S, 2005, PATHOL INT, V55, P1, DOI 10.1111/j.1440-1827.2005.01786.x; Simis A, 2008, SURG NEUROL, V70, P471, DOI 10.1016/j.surneu.2008.03.006; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Utsuki S, 2005, CLIN NEUROPATHOL, V24, P8; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Zidar N, 2008, VIRCHOWS ARCH, V453, P267, DOI 10.1007/s00428-008-0649-y	24	45	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11231	10.1371/journal.pone.0011231	http://dx.doi.org/10.1371/journal.pone.0011231			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574529	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058300018
J	Horney, JA; Moore, Z; Davis, M; MacDonald, PDM				Horney, Jennifer A.; Moore, Zack; Davis, Meredith; MacDonald, Pia D. M.			Intent to Receive Pandemic Influenza A (H1N1) Vaccine, Compliance with Social Distancing and Sources of Information in NC, 2009	PLOS ONE			English	Article								Background: Public adherence to influenza vaccination recommendations has been low, particularly among younger adults and children under 2, despite the availability of safe and effective seasonal vaccine. Intention to receive 2009 pandemic influenza A (H1N1) vaccine has been estimated to be 50% in select populations. This report measures knowledge of and intention to receive pandemic vaccine in a population-based setting, including target groups for seasonal and H1N1 influenza. Methodology and Principal Findings: On August 28-29, 2009, we conducted a population-based survey in 2 counties in North Carolina. The survey used the 3067 two-stage cluster sampling methodology to identify 210 target households. Prevalence ratios (PR) and 95% confidence intervals (CI) were estimated. Knowledge of pandemic influenza A (H1N1) vaccine was high, with 165 (80%) aware that a vaccine was being prepared. A total of 133 (64%) respondents intended to receive pandemic vaccine, 134 (64%) intended to receive seasonal vaccine, and 109 (53%) intended to receive both. Reporting great concern about H1N1 infection (PR 1.55; 95% CI: 1.30, 1.85), receiving seasonal influenza vaccine in 2008-09 (PR 1.47; 95% CI: 1.18, 1.82), and intending to receive seasonal influenza vaccine in 2009-10 (PR 1.27; 95% CI: 1.14, 1.42) were associated with intention to receive pandemic vaccine. Not associated were knowledge of vaccine, employment, having children under age 18, gender, race/ethnicity and age. Reasons cited for not intending to get vaccinated include not being at risk for infection, concerns about vaccine side effects and belief that illness caused by pandemic H1N1 would be mild. Forty-five percent of households with children under 18 and 65% of working adults reported ability to comply with self-isolation at home for 7-10 days if recommended by authorities. Conclusions and Significance: This is the first report of a population based rapid assessment used to assess knowledge and intent to receive pandemic vaccine in a community sample. Intention to receive pandemic and seasonal vaccines was higher than previously published reports. To reach persons not intending to receive pandemic vaccine, public health communications should focus on the perceived risk of infection and concerns about vaccine safety.	[Horney, Jennifer A.; MacDonald, Pia D. M.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Moore, Zack] N Carolina Div Publ Hlth, Raleigh, NC USA; [Davis, Meredith] N Carolina Inst Publ Hlth, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Horney, JA (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.	jen.horney@unc.edu	Horney, Jennifer/ABG-2433-2020	Horney, Jennifer/0000-0003-3060-0894; MacDonald, Pia/0000-0003-1340-8905	Robert Wood Johnson Foundation (RWJF)	Robert Wood Johnson Foundation (RWJF)(Robert Wood Johnson Foundation (RWJF))	This publication was supported by a quick strike grant from the Robert Wood Johnson Foundation (RWJF) as part of the Public Health Practice Based Research Networks (http://www.rwjf.org/). The contents are solely the responsibility of the authors and do not necessarily represent official views of RWJF. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 1999, INT J QUAL HEALTH C, V11, P187, DOI 10.1093/intqhc/11.3.187; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; BLENDON RJ, 2009, SURVEY FINDS JUST 40; *CDCP, 2009, GEN INF 2009 H1N1 VA; *CDCP, 2009, INFL SELF REP VACC C; *CDCP, 2006, EST INFL VACC TARG P; *CDCP, 2009, GUID STAT LOC HLTH O; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Euler G. L., 2009, Morbidity and Mortality Weekly Report, V58, P1091; Frerichs RR, 2001, ANNU REV PUBL HEALTH, V22, P231, DOI 10.1146/annurev.publhealth.22.1.231; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; HENDERSON RH, 1973, B WORLD HEALTH ORGAN, V48, P183; Henrich N, 2009, Emerg Health Threats J, V2, pe8, DOI 10.3134/ehtj.09.008; Lemeshow S, 1985, World Health Stat Q, V38, P65; Malilay J, 1996, B WORLD HEALTH ORGAN, V74, P399; Maurer J, 2009, VACCINE, V27, P5732, DOI 10.1016/j.vaccine.2009.07.080; Moore Z., 2009, Morbidity and Mortality Weekly Report, V58, P1401; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Seale H, 2009, MED J AUSTRALIA, V191, P267, DOI 10.5694/j.1326-5377.2009.tb02781.x	19	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11226	10.1371/journal.pone.0011226	http://dx.doi.org/10.1371/journal.pone.0011226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	613KE	20585462	Green Published, gold			2022-12-25	WOS:000278977200019
J	Lotoski, LC; Simons, FER; Chooniedass, R; Liem, J; Ostopowich, I; Becker, AB; HayGlass, KT				Lotoski, Larisa C.; Simons, F. Estelle R.; Chooniedass, Rishma; Liem, Joel; Ostopowich, Isha; Becker, Allan B.; HayGlass, Kent T.			Are Plasma IL-10 Levels a Useful Marker of Human Clinical Tolerance in Peanut Allergy?	PLOS ONE			English	Article							FOOD HYPERSENSITIVITY; SERUM INTERLEUKIN-10; CELLS; PREVALENCE; CHILDREN; SENSITIZATION; ASSOCIATION; ANAPHYLAXIS; DERMATITIS; BIOMARKERS	Background: Food allergies are a major component of the burden of allergic disease. Accurate risk assessment for prediction of future clinical reactivity or clinical tolerance is limited by currently available techniques. Recent studies suggest that constitutively elevated global serum levels of IL-10, a cytokine that down-regulates both Th1 and Th2 cytokine production, may be useful in identifying human clinical tolerance to foods. Objective: Determine the usefulness of constitutive IL-10 levels as a marker of clinical tolerance to peanut in children and adults. Methodology/Principal Findings: 107 subjects who were clinically tolerant to peanut and 94 subjects who were clinically allergic to peanut participated. Plasma was analyzed via ELISA to quantify the frequency of individuals with constitutive IL-10 levels and the intensity of those responses. The data were then stratified by age, gender and clinical status to assess the utility of this putative biomarker in specific at-risk groups. All 201 subjects had readily quantified plasma IL-10. Levels were no higher in subjects who were clinically tolerant to peanut than those in individuals clinically allergic to peanut. Stratification by age, gender or both did not improve the capacity of IL-10 levels to identify clinical tolerance to peanut. Conclusions/Significance: Plasma IL-10 levels are neither a useful biomarker of clinical tolerance to peanut nor a potential tool for identification of clinical tolerance to peanut in humans.	[Lotoski, Larisa C.; Simons, F. Estelle R.; Ostopowich, Isha; Becker, Allan B.; HayGlass, Kent T.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Simons, F. Estelle R.; Chooniedass, Rishma; Becker, Allan B.; HayGlass, Kent T.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Liem, Joel] Windsor Allergy Asthma Educ Ctr, Windsor, ON, Canada	University of Manitoba; University of Manitoba	Lotoski, LC (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	hayglass@cc.umanitoba.ca		HayGlass, Kent/0000-0002-4621-7737	AllerGen NCE; Canadian Institutes for Health Research (CIHR)	AllerGen NCE; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funded by operating grants and a studentship from AllerGen NCE and the Canadian Institutes for Health Research (CIHR). K. T. H. holds the Canada Research Chair in Immune Regulation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Alonso R, 2007, ALLERGY, V62, P710, DOI 10.1111/j.1398-9995.2007.01333.x; Ben-Shoshan M, 2009, J ALLERGY CLIN IMMUN, V123, P783, DOI 10.1016/j.jaci.2009.02.004; Bock SA, 2007, J ALLERGY CLIN IMMUN, V119, P1016, DOI 10.1016/j.jaci.2006.12.622; Borekci B, 2007, AM J REPROD IMMUNOL, V58, P56, DOI 10.1111/j.1600-0897.2007.00491.x; Burks AW, 2008, LANCET, V371, P1538, DOI 10.1016/S0140-6736(08)60659-5; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hourihane JO, 2005, CLIN EXP ALLERGY, V35, P1227, DOI 10.1111/j.1365-2222.2005.02312.x; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jensen-Jarolim E, 2008, ALLERGY, V63, P610, DOI 10.1111/j.1398-9995.2008.01645.x; LeBovidge JS, 2009, J ALLERGY CLIN IMMUN, V124, P1282, DOI 10.1016/j.jaci.2009.08.045; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Mortz CG, 2005, PEDIAT ALLERG IMM-UK, V16, P501, DOI 10.1111/j.1399-3038.2005.00302.x; Nakazato J, 2008, PEDIAT ALLERG IMM-UK, V19, P605, DOI 10.1111/j.1399-3038.2007.00692.x; Niggemann B, 2010, ALLERGY, V65, P2, DOI 10.1111/j.1398-9995.2009.02170.x; Ostblom E, 2008, ALLERGY, V63, P211, DOI 10.1111/j.1398-9995.2007.01559.x; Pereira B, 2005, J ALLERGY CLIN IMMUN, V116, P884, DOI 10.1016/j.jaci.2005.05.047; Qiao HL, 2007, EUR J CLIN PHARMACOL, V63, P263, DOI 10.1007/s00228-006-0245-5; SALKIE ML, 1984, CLIN BIOCHEM, V17, P362, DOI 10.1016/S0009-9120(84)90734-3; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schaub S, 2009, AM J TRANSPLANT, V9, P1347, DOI 10.1111/j.1600-6143.2009.02645.x; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Simons FER, 2007, J ALLERGY CLIN IMMUN, V120, pS2, DOI [10.1016/j.jaci.2007.05.001, 10.1016/j.jaci.2007.05.016]; Stefura William P., 2008, V138, P107, DOI 10.1007/978-1-59745-366-0_10; Stone SF, 2009, J ALLERGY CLIN IMMUN, V124, P786, DOI 10.1016/j.jaci.2009.07.055; Summers CW, 2008, J ALLERGY CLIN IMMUN, V121, P632, DOI 10.1016/j.jaci.2007.12.003; Venter C, 2010, ALLERGY, V65, P103, DOI 10.1111/j.1398-9995.2009.02176.x; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11192	10.1371/journal.pone.0011192	http://dx.doi.org/10.1371/journal.pone.0011192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567520	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886300030
J	Rosenblum, G; Van den Steen, PE; Cohen, SR; Bitler, A; Brand, DD; Opdenakker, G; Sagi, I				Rosenblum, Gabriel; Van den Steen, Philippe E.; Cohen, Sidney R.; Bitler, Arkady; Brand, David D.; Opdenakker, Ghislain; Sagi, Irit			Direct Visualization of Protease Action on Collagen Triple Helical Structure	PLOS ONE			English	Article							CYANOGEN-BROMIDE PEPTIDES; CHICK CARTILAGE COLLAGEN; ATOMIC-FORCE MICROSCOPY; MATRIX METALLOPROTEINASES; GELATINASE-A; INTERSTITIAL COLLAGENASE; OSTEOGENESIS IMPERFECTA; NEUTROPHIL COLLAGENASE; SUBSTRATE-SPECIFICITY; CLEAVAGE	Enzymatic processing of extracellular matrix (ECM) macromolecules by matrix metalloproteases (MMPs) is crucial in mediating physiological and pathological cell processes. However, the molecular mechanisms leading to effective physiological enzyme-ECM interactions remain elusive. Only scant information is available on the mode by which matrix proteases degrade ECM substrates. An example is the enzymatic degradation of triple helical collagen II fragments, generated by the collagenase MMP-8 cleavage, during the course of acute inflammatory conditions by gelatinase B/MMP-9. As is the case for many other matrix proteases, it is not clear how MMP-9 recognizes, binds and digests collagen in this important physiological process. We used single molecule imaging to directly visualize this protease during its interaction with collagen fragments. We show that the initial binding is mediated by the diffusion of the protease along the ordered helix on the collagen L fragment, with preferential binding of the collagen tail. As the reaction progressed and prior to collagen degradation, gelatin-like morphologies resulting from the denaturation of the triple helical collagen were observed. Remarkably, this activity was independent of enzyme proteolysis and was accompanied by significant conformational changes of the working protease. Here we provide the first direct visualization of highly complex mechanisms of macromolecular interactions governing the enzymatic processing of ECM substrates by physiological protease.	[Rosenblum, Gabriel; Sagi, Irit] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Van den Steen, Philippe E.; Opdenakker, Ghislain] Univ Leuven, Immunobiol Lab, Rega Inst Med Res, Leuven, Belgium; [Cohen, Sidney R.; Bitler, Arkady] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Brand, David D.] Univ Tennessee, Hlth Sci Ctr, Dept Vet Affairs, Memphis, TN USA	Weizmann Institute of Science; KU Leuven; Weizmann Institute of Science; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Rosenblum, G (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	irit.sagi@weizmann.ac.il	Cohen, Sidney R./J-7153-2012; Opdenakker, Ghislain/Q-3130-2017; Van den Steen, Philippe E/K-5132-2012; Opdenakker, Ghislain/V-8562-2019	Cohen, Sidney R./0000-0003-4255-3351; Opdenakker, Ghislain/0000-0003-1714-2294; Van den Steen, Philippe E/0000-0002-7334-9145; Opdenakker, Ghislain/0000-0003-1714-2294; Brand, David/0000-0002-9260-7963	Israel Science Foundation; Kimmelman Center at the Weizmann Institute; Ambach family fund; Geconcerteerde OnderzoeksActies [GOA 2007-2011]; Scientific Research-Flanders (FWO-Vlaanderen); Excellence Financing, Belgium [EF 05/015]	Israel Science Foundation(Israel Science Foundation); Kimmelman Center at the Weizmann Institute; Ambach family fund; Geconcerteerde OnderzoeksActies; Scientific Research-Flanders (FWO-Vlaanderen)(FWO); Excellence Financing, Belgium	This work is supported by the Israel Science Foundation, the Kimmelman Center at the Weizmann Institute, the Ambach family fund and by the Geconcerteerde OnderzoeksActies (GOA 2007-2011), the Fund for Scientific Research-Flanders (FWO-Vlaanderen) and Excellence Financing (EF 05/015), Belgium. P.V.d.S. is a postdoctoral researcher of the FWO-Vlaanderen. I. S. is the incumbent of the Pontecorvo professorial chair. The authors acknowledge support of the Gerhard Schmidt Minerva center for supramolecular architectures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Bozec L, 2005, BIOPHYS J, V88, P4223, DOI 10.1529/biophysj.104.055228; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Collier IE, 2001, BIOPHYS J, V81, P2370, DOI 10.1016/S0006-3495(01)75883-3; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Geurts N, 2008, BIOCHEMISTRY-US, V47, P2689, DOI 10.1021/bi702260q; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Gioia M, 2009, J MOL BIOL, V386, P419, DOI 10.1016/j.jmb.2008.12.021; HASTY KA, 1987, J BIOL CHEM, V262, P10048; JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; Kuznetsova NV, 2003, J MOL BIOL, V331, P191, DOI 10.1016/S0022-2836(03)00715-0; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; MILLER EJ, 1971, BIOCHEMISTRY-US, V10, P3030, DOI 10.1021/bi00792a007; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; SELAPASSWELL N, 2009, BIOCH BIOPHYS ACTA; Sun HB, 2000, ANAL BIOCHEM, V283, P153, DOI 10.1006/abio.2000.4629; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650; YONATH A, 1975, FEBS LETT, V57, P93, DOI 10.1016/0014-5793(75)80159-1	44	56	57	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11043	10.1371/journal.pone.0011043	http://dx.doi.org/10.1371/journal.pone.0011043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585385	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886100005
J	Bower, NI; Johnston, IA				Bower, Neil I.; Johnston, Ian A.			Transcriptional Regulation of the IGF Signaling Pathway by Amino Acids and Insulin-Like Growth Factors during Myogenesis in Atlantic Salmon	PLOS ONE			English	Article							MUSCLE-CELL DIFFERENTIATION; TROUT ONCORHYNCHUS-MYKISS; FACTOR BINDING PROTEIN-5; FACTOR-II RECEPTOR; SKELETAL-MUSCLE; GENE-EXPRESSION; IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE; MESSENGER-RNA; C2C12 MYOBLASTS	The insulin-like growth factor signalling pathway is an important regulator of skeletal muscle growth. We examined the mRNA expression of components of the insulin-like growth factor (IGF) signalling pathway as well as Fibroblast Growth Factor 2 (FGF2) during maturation of myotubes in primary cell cultures isolated from fast myotomal muscle of Atlantic salmon (Salmo salar). The transcriptional regulation of IGFs and IGFBP expression by amino acids and insulin-like growth factors was also investigated. Proliferation of cells was 15% d(-1) at days 2 and 3 of the culture, increasing to 66% d(-1) at day 6. Three clusters of elevated gene expression were observed during the maturation of the culture associated with mono-nucleic cells (IGFBP5.1 and 5.2, IGFBP-6, IGFBP-rP1, IGFBP-2.2 and IGF-II), the initial proliferation phase (IGF-I, IGFBP-4, FGF2 and IGF-IRb) and terminal differentiation and myotube production (IGF2R, IGF-IRa). In cells starved of amino acids and serum for 72 h, IGF-I mRNA decreased 10-fold which was reversed by amino acid replacement. Addition of IGF-I and amino acids to starved cells resulted in an 18-fold increase in IGF-I mRNA indicating synergistic effects and the activation of additional pathway(s) leading to IGF-I production via a positive feedback mechanism. IGF-II, IGFBP-5.1 and IGFBP-5.2 expression was unchanged in starved cells, but increased with amino acid replacement. Synergistic increases in expression of IGFBP5.2 and IGFBP-4, but not IGFBP5.1 were observed with addition of IGF-I, IGF-II or insulin and amino acids to the medium. IGF-I and IGF-II directly stimulated IGFBP-6 expression, but not when amino acids were present. These findings indicate that amino acids alone are sufficient to stimulate myogenesis in myoblasts and that IGF-I production is controlled by both endocrine and paracrine pathways. A model depicting the transcriptional regulation of the IGF pathway in Atlantic salmon muscle following feeding is proposed.	[Bower, Neil I.; Johnston, Ian A.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews, Fife, Scotland	University of St Andrews	Bower, NI (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews, Fife, Scotland.	nib@st-andrews.ac.uk	Johnston, Ian A./AAE-2044-2019; Johnston, Ian A/D-6592-2013; Bower, Neil/K-1478-2014	Johnston, Ian A/0000-0002-7796-5754; Bower, Neil/0000-0002-6764-6063	Biotechnology and Biological Research Council [BB/D015391/1]; Biotechnology and Biological Sciences Research Council [BB/D015391/1] Funding Source: researchfish; BBSRC [BB/D015391/1] Funding Source: UKRI	Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Research Council (grant BB/D015391/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Adams GR, 2006, APPL PHYSIOL NUTR ME, V31, P782, DOI 10.1139/h06-053; Allendorf F.W., 1984, P1; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Anthony JC, 2000, J NUTR, V130, P2413; Atherton PJ, 2010, AMINO ACIDS, V38, P1533, DOI 10.1007/s00726-009-0377-x; Bach LA, 2005, GROWTH HORM IGF RES, V15, P185, DOI 10.1016/j.ghir.2005.04.001; BAILEY GS, 1978, P NATL ACAD SCI USA, V75, P5575, DOI 10.1073/pnas.75.11.5575; Bardonnet A, 2000, CAN J FISH AQUAT SCI, V57, P497, DOI 10.1139/cjfas-57-2-497; Boker C, 1997, J CELL SCI, V110, P1023; Bower NI, 2010, AM J PHYSIOL-REG I, V298, pR1615, DOI 10.1152/ajpregu.00114.2010; Bower NI, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-80; Bower NI, 2008, J EXP BIOL, V211, P3859, DOI 10.1242/jeb.024117; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chauvigne F, 2003, GEN COMP ENDOCR, V132, P209, DOI 10.1016/S0016-6480(03)00081-9; Chu CH, 2008, J ENDOCRINOL, V197, P381, DOI 10.1677/JOE-07-0619; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; Clemmons DR, 1998, MOL CELL ENDOCRINOL, V140, P19, DOI 10.1016/S0303-7207(98)00024-0; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15; Duan CM, 1999, P NATL ACAD SCI USA, V96, P15274, DOI 10.1073/pnas.96.26.15274; Duan CM, 1999, J BIOL CHEM, V274, P37147, DOI 10.1074/jbc.274.52.37147; Engert JC, 1996, J CELL BIOL, V135, P431, DOI 10.1083/jcb.135.2.431; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; EWTON DZ, 1994, J CELL PHYSIOL, V161, P277, DOI 10.1002/jcp.1041610212; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Frost RA, 2002, ENDOCRINOLOGY, V143, P492, DOI 10.1210/en.143.2.492; Gabillard JC, 2006, J ENDOCRINOL, V191, P15, DOI 10.1677/joe.1.06869; GIORGETTI S, 1993, J BIOL CHEM, V268, P7358; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JOHNSTON IA, 1993, MAR BIOL, V115, P7, DOI 10.1007/BF00349380; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KADRI S, 1995, FUNCT ECOL, V9, P790, DOI 10.2307/2390254; Kang JX, 1997, P NATL ACAD SCI USA, V94, P13671, DOI 10.1073/pnas.94.25.13671; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KOUMANS JTM, 1990, CELL TISSUE RES, V261, P173, DOI 10.1007/BF00329450; Layne MD, 1999, EXP CELL RES, V249, P177, DOI 10.1006/excr.1999.4465; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Li MY, 2009, AM J PHYSIOL-REG I, V296, pR558, DOI 10.1152/ajpregu.90439.2008; Macqueen DJ, 2008, DEV GENES EVOL, V218, P1, DOI 10.1007/s00427-007-0194-8; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; Montserrat N, 2007, CELL TISSUE RES, V330, P503, DOI 10.1007/s00441-007-0507-2; Motyka B, 2000, CELL, V103, P491, DOI 10.1016/S0092-8674(00)00140-9; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rousse S, 1998, ENDOCRINOLOGY, V139, P1487, DOI 10.1210/en.139.4.1487; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; SARBASSOV DD, 1995, P NATL ACAD SCI USA, V92, P10874, DOI 10.1073/pnas.92.24.10874; Schiller HB, 2009, MOL BIOL CELL, V20, P745, DOI 10.1091/mbc.E08-06-0569; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seurin D, 2002, EUR J CANCER, V38, P2058, DOI 10.1016/S0959-8049(02)00240-X; Shavlakadze T, 2006, GROWTH HORM IGF RES, V16, P157, DOI 10.1016/j.ghir.2005.11.003; SMITH CK, 1994, J CELL PHYSIOL, V159, P379, DOI 10.1002/jcp.1041590222; SPIZZ G, 1986, J BIOL CHEM, V261, P9483; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; TALBOT C, 1986, COMP BIOCHEM PHYS A, V85, P445, DOI 10.1016/0300-9629(86)90427-5; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XL, 2009, AM J PHYSIOL-REG I, V296, pR1348, DOI 10.1152/ajpregu.90969.2008; Weyman CM, 1998, ENDOCRINOLOGY, V139, P1794, DOI 10.1210/en.139.4.1794; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Yamaguchi A, 2006, PFLUG ARCH EUR J PHY, V453, P203, DOI 10.1007/s00424-006-0127-9; Zhou JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003926	75	80	83	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11100	10.1371/journal.pone.0011100	http://dx.doi.org/10.1371/journal.pone.0011100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559434	Green Submitted, Green Published, gold			2022-12-25	WOS:000278741100014
J	Chen, JK; Liu, J; Han, QK; Qin, DJ; Xu, JY; Chen, Y; Yang, JQ; Song, H; Yang, DS; Peng, MX; He, WZ; Li, RH; Wang, H; Gan, Y; Ding, K; Zeng, LW; Lai, LX; Esteban, MA; Pei, DQ				Chen, Jiekai; Liu, Jing; Han, Qingkai; Qin, Dajiang; Xu, Jianyong; Chen, You; Yang, Jiaqi; Song, Hong; Yang, Dongshan; Peng, Meixiu; He, Wenzhi; Li, Ronghui; Wang, Hao; Gan, Yi; Ding, Ke; Zeng, Lingwen; Lai, Liangxue; Esteban, Miguel A.; Pei, Duanqing			Towards an Optimized Culture Medium for the Generation of Mouse Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC FIBROBLASTS; INDUCTION; PROMOTE	Generation of induced pluripotent stem cells from somatic cells using defined factors has potential relevant applications in regenerative medicine and biology. However, this promising technology remains inefficient and time consuming. We have devised a serum free culture medium termed iSF1 that facilitates the generation of mouse induced pluripotent stem cells. This optimization of the culture medium is sensitive to the presence of Myc in the reprogramming factors. Moreover, we could reprogram meningeal cells using only two factors Oct4/Klf4. Therefore, iSF1 represents a basal medium that may be used for mechanistic studies and testing new reprogramming approaches.	[Chen, Jiekai; Liu, Jing; Han, Qingkai; Qin, Dajiang; Xu, Jianyong; Chen, You; Yang, Jiaqi; Song, Hong; Yang, Dongshan; Peng, Meixiu; He, Wenzhi; Li, Ronghui; Wang, Hao; Gan, Yi; Ding, Ke; Zeng, Lingwen; Lai, Liangxue; Esteban, Miguel A.; Pei, Duanqing] Chinese Acad Sci, Stem Cell & Canc Biol Grp, Chinese Acad Sci Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med,Guang, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences	Pei, DQ (corresponding author), Chinese Acad Sci, Stem Cell & Canc Biol Grp, Chinese Acad Sci Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med,Guang, Guangzhou 510530, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Ding, Ke/B-3257-2010; Li, Ronghui/AAB-4545-2019; Yang, Dongshan/N-3333-2014; Lai, Liangxue/H-4545-2011	Li, Ronghui/0000-0001-6329-5895; Yang, Dongshan/0000-0003-2449-8651; Ding, Ke/0000-0001-9016-812X; Chen, Jiekai/0000-0001-5168-7074; ding, ke/0000-0001-8167-0476	National Natural Science Foundation of China [30630039, 30700410, 30871404, 90813033]; National Natural Science Fund for Distinguished Young Scholars [30725012]; Chinese Academy of Sciences [KSCX2-YW-R-48, KSCX1-YW-02-1]; Bureau of Science and Technology of Guangzhou Municipality [2008A1-E4011]; Ministry of Science and Technology 973 program of China [2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese Academy of Sciences(Chinese Academy of Sciences); Bureau of Science and Technology of Guangzhou Municipality; Ministry of Science and Technology 973 program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30630039, 30700410, 30871404, and 90813033; National Natural Science Fund for Distinguished Young Scholars Grant 30725012; Knowledge Innovation Project of the Chinese Academy of Sciences Grants KSCX2-YW-R-48 and KSCX1-YW-02-1; Bureau of Science and Technology of Guangzhou Municipality Grant 2008A1-E4011; and Ministry of Science and Technology 973 program of China Grants 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, and 2009CB940902.	Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Qin DJ, 2007, CELL RES, V17, P959, DOI 10.1038/cr.2007.92; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva N, 2008, REVSTAT-STAT J, V6, P253; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	50	53	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31066	31072		10.1074/jbc.M110.139436	http://dx.doi.org/10.1074/jbc.M110.139436			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20595395	Green Published, hybrid			2022-12-25	WOS:000282135500071
J	Lobo, GP; Amengual, J; Li, HNM; Golczak, M; Bonet, ML; Palczewski, K; von Lintig, J				Lobo, Glenn P.; Amengual, Jaume; Li, Hua Nan M.; Golczak, Marcin; Luisa Bonet, M.; Palczewski, Krzysztof; von Lintig, Johannes			beta,beta-Carotene Decreases Peroxisome Proliferator Receptor gamma Activity and Reduces Lipid Storage Capacity of Adipocytes in a beta,beta-Carotene Oxygenase 1-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-RETINOIC ACID; VITAMIN-A SUPPLEMENTATION; BETA-CAROTENE; DIABETES-MELLITUS; ADIPOSE-TISSUE; PPAR-GAMMA; METABOLIZING ENZYME; ACTIVATED RECEPTOR; LEPTIN EXPRESSION; SERUM CAROTENOIDS	Increasing evidence has been provided for a connection between retinoid metabolism and the activity of peroxisome proliferator receptors (Ppars) in the control of body fat reserves. Two different precursors for retinoids exist in the diet as preformed vitamin A (all-trans-retinol) and provitamin A (beta,beta-carotene). For retinoid production, beta,beta-carotene is converted to retinaldehyde by beta,beta-carotenemonooxygenase 1 (Bcmo1). Previous analysis showed that Bcmo1 knock-out mice develop dyslipidemia and are more susceptible to diet-induced obesity. However, the role of Bcmo1 for adipocyte retinoid metabolism has yet not been well defined. Here, we showed that Bcmo1 mRNA and protein expression are induced during adipogenesis in NIH 3T3-L1 cells. In mature adipocytes, beta,beta-carotene but not all-trans-retinol was metabolized to retinoic acid (RA). RA decreased the expression of Ppar gamma and CCAAT/enhancer-binding protein alpha, key lipogenic transcription factors, and reduced the lipid content of mature adipocytes. This process was inhibited by the retinoic acid receptor antagonist LE450, showing that it involves canonical retinoid signaling. Accordingly, gavage of beta,beta-carotenebut not all-trans-retinol induced retinoid signaling and decreased Ppar gamma expression in white adipose tissue of vitamin A-deficient mice. Our study identifies beta,beta-carotene as a critical physiological precursor for RA production in adipocytes and implicates provitamin A as a dietary regulator of body fat reserves.	[Lobo, Glenn P.; Amengual, Jaume; Li, Hua Nan M.; Golczak, Marcin; Palczewski, Krzysztof; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Luisa Bonet, M.] Univ Illes Balears, Lab Mol Biol Nutr & Biotechnol, Palma de Mallorca 07122, Spain; [Luisa Bonet, M.] CIBERobn, Palma de Mallorca 07122, Spain	Case Western Reserve University; Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	von Lintig, J (corresponding author), Case Western Reserve Univ, Dept Pharmacol W333, 10900 Euclid Ave, Cleveland, OH 44160 USA.	Johannes.vonlintig@case.edu	Bonet, M.Luisa/H-6722-2015; Lobo, Glenn P./AAI-9736-2020	Bonet, M.Luisa/0000-0002-8698-0630; 	National Institutes of Health [EY019641, EY009339, T30-EY11373]; NATIONAL EYE INSTITUTE [R01EY009339, R01EY019641, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019641, EY009339, and T30-EY11373.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bonet ML, 2003, CELL MOL LIFE SCI, V60, P1311, DOI 10.1007/s00018-003-2290-x; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Burrows TL, 2009, OBESITY, V17, P162, DOI 10.1038/oby.2008.495; Coyne T, 2005, AM J CLIN NUTR, V82, P685, DOI 10.1093/ajcn/82.3.685; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; Felipe F, 2005, BBA-MOL BASIS DIS, V1740, P258, DOI 10.1016/j.bbadis.2004.11.014; Felipe F, 2004, DIABETES, V53, P882, DOI 10.2337/diabetes.53.4.882; Felipe F, 2003, INT J OBESITY, V27, P60, DOI 10.1038/sj.ijo.0802188; Fierce Y, 2008, ARCH BIOCHEM BIOPHYS, V472, P126, DOI 10.1016/j.abb.2008.02.010; Ford ES, 1999, AM J EPIDEMIOL, V149, P168, DOI 10.1093/oxfordjournals.aje.a009783; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; Gorocica-Buenfil MA, 2007, J ANIM SCI, V85, P3355, DOI 10.2527/jas.2007-0172; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hollung K, 2004, J CELL BIOCHEM, V92, P307, DOI 10.1002/jcb.20047; Isken A, 2007, J BIOL CHEM, V282, P1144, DOI 10.1074/jbc.M609109200; Kagechika H, 1997, BIOCHEM BIOPH RES CO, V231, P243, DOI 10.1006/bbrc.1997.6087; Kawada T, 1996, INT J OBESITY, V20, pS52; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; Mercader J, 2008, CELL PHYSIOL BIOCHEM, V22, P363, DOI 10.1159/000149815; Mercader J, 2007, CELL PHYSIOL BIOCHEM, V20, P1061, DOI 10.1159/000110717; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; NOY N, 1992, BIOCHIM BIOPHYS ACTA, V1106, P151, DOI 10.1016/0005-2736(92)90233-C; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Ramakrishna V, 2008, ACTA DIABETOL, V45, P41, DOI 10.1007/s00592-007-0018-3; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Sergeant MJ, 2009, J BIOL CHEM, V284, P5257, DOI 10.1074/jbc.M805453200; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Ylonen K, 2003, AM J CLIN NUTR, V77, P1434; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; ZOVICH DC, 1992, J BIOL CHEM, V267, P13884	50	104	107	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27891	27899		10.1074/jbc.M110.132571	http://dx.doi.org/10.1074/jbc.M110.132571			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573961	Green Published, hybrid			2022-12-25	WOS:000281404100044
J	Kong, B; Michalski, CW; Hong, X; Valkovskaya, N; Rieder, S; Abiatari, I; Streit, S; Erkan, M; Esposito, I; Friess, H; Kleeff, J				Kong, B.; Michalski, C. W.; Hong, X.; Valkovskaya, N.; Rieder, S.; Abiatari, I.; Streit, S.; Erkan, M.; Esposito, I.; Friess, H.; Kleeff, J.			AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-beta-mediated ERK signaling	ONCOGENE			English	Article						pancreatic cancer; AZGP1; EMT; MET; transdifferentiation; transforming growth factor-beta	GROWTH-FACTOR-BETA; K-RAS; CELL-LINE; CONFERS RESISTANCE; GENE-EXPRESSION; STELLATE CELLS; INDUCTION; ZN-ALPHA-2-GLYCOPROTEIN; PROGRESSION; ACTIVATION	Epithelial-to-mesenchymal transdifferentiation (EMT) mediated by transforming growth factor-beta (TGF-beta) signaling leads to aggressive cancer progression. In this study, we identified zinc-alpha 2-glycoprotein (AZGP1, ZAG) as a tumor suppressor in pancreatic ductal adenocarcinoma whose expression is lost due to histone deacetylation. In vitro, ZAG silencing strikingly increased invasiveness of pancreatic cancer cells accompanied by the induction of a mesenchymal phenotype. Expression analysis of a set of EMT markers showed an increase in the expression of mesenchymal markers (vimentin (VIM) and integrin-alpha 5) and a concomitant reduction in the expression of epithelial markers (cadherin 1 (CDH1), desmoplakin and keratin-19). Blockade of endogenous TGF-beta signaling inhibited these morphological changes and the downregulation of CDH1, as elicited by ZAG silencing. In a ZAG-negative cell line, human recombinant ZAG (rZAG) specifically inhibited exogenous TGF-beta-mediated tumor cell invasion and VIM expression. Furthermore, rZAG blocked TGF-beta-mediated ERK2 phosphorylation. PCR array analysis revealed that ZAG-induced epithelial transdifferentiation was accompanied by a series of concerted cellular events including a shift in the energy metabolism and prosurvival signals. Thus, epigenetically regulated ZAG is a novel tumor suppressor essential for maintaining an epithelial phenotype. Oncogene (2010) 29, 5146-5158; doi:10.1038/onc.2010.258; published online 28 June 2010	[Kong, B.; Michalski, C. W.; Hong, X.; Valkovskaya, N.; Rieder, S.; Abiatari, I.; Streit, S.; Erkan, M.; Friess, H.; Kleeff, J.] Tech Univ Munich, Dept Surg, D-81675 Munich, Germany; [Esposito, I.] Tech Univ Munich, Inst Pathol, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich	Kleeff, J (corresponding author), Tech Univ Munich, Dept Surg, Ismaningerstr 22, D-81675 Munich, Germany.	kleeff@chir.med.tu-muenchen.de	Kleeff, Jorg/B-2124-2009; Michalski, Christoph/U-9167-2019; Abiatari, Ivane/ABC-6247-2021	Kleeff, Jorg/0000-0003-3432-6669; Abiatari, Ivane/0000-0002-1118-3477	European Union; Commission for Clinical Research of the TU Munich; Ministry of Education of China	European Union(European Commission); Commission for Clinical Research of the TU Munich; Ministry of Education of China(Ministry of Education, China)	We thank Felicitas Altmayr, Tanja Rossmann-Bloeck, Manja Thorwirth and Carmen Marthen for excellent technical support. This study was in part supported by the European Union (within the framework of the 'MolDiagPaca' project; to JK, CWM and HF) and by the commission for clinical research of the TU Munich (KKF). BK received a fellowship from the Scholarship Council of the Ministry of Education of China.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Benfield AP, 2007, ARCH BIOCHEM BIOPHYS, V462, P47, DOI 10.1016/j.abb.2007.03.010; Biliran H, 2005, CLIN CANCER RES, V11, P6075, DOI 10.1158/1078-0432.CCR-04-2419; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; BUERGI W, 1961, J BIOL CHEM, V236, P1066; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Dembinski JL, 2009, CLIN EXP METASTAS, V26, P611, DOI 10.1007/s10585-009-9260-0; DIEZITZA I, 1993, EUR J CANCER, V29A, P1256, DOI 10.1016/0959-8049(93)90068-Q; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Ellenrieder V, 2001, CANCER RES, V61, P4222; Esposito I, 2007, J CLIN PATHOL, V60, P885, DOI 10.1136/jcp.2006.038257; Evdokimova V, 2009, CELL CYCLE, V8, P2901, DOI 10.4161/cc.8.18.9537; Finkel E, 1996, LANCET, V347, P1034, DOI 10.1016/S0140-6736(96)90163-4; Freemantle SJ, 2007, J CELL BIOCHEM, V102, P869, DOI 10.1002/jcb.21519; FRENETTE G, 1987, PROSTATE, V11, P257, DOI 10.1002/pros.2990110306; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Giehl K, 2000, ONCOGENE, V19, P2930, DOI 10.1038/sj.onc.1203612; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hale LP, 2001, CLIN CANCER RES, V7, P846; Hamada S, 2007, J CELL PHYSIOL, V213, P768, DOI 10.1002/jcp.21148; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Ketterer K, 2009, CANCER LETT, V277, P72, DOI 10.1016/j.canlet.2008.11.028; Khasawneh J, 2009, P NATL ACAD SCI USA, V106, P3354, DOI 10.1073/pnas.0802864106; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Lecanda J, 2009, CELL CYCLE, V8, P742, DOI 10.4161/cc.8.5.7871; LEMOINE NR, 1992, GASTROENTEROLOGY, V102, P230, DOI 10.1016/0016-5085(92)91805-E; Lim JH, 2008, J CELL BIOCHEM, V105, P1117, DOI 10.1002/jcb.21914; Longnecker DS, 1998, PANCREAS, V17, P323, DOI 10.1097/00006676-199811000-00001; Lung FDT, 2003, BIOPOLYMERS, V71, P132, DOI 10.1002/bip.10396; Marrades MP, 2008, J PHYSIOL BIOCHEM, V64, P61, DOI 10.1007/BF03168235; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Michalski CW, 2007, ANN SURG, V246, P786, DOI 10.1097/SLA.0b013e318070d56e; Michalski CW, 2007, GASTROENTEROLOGY, V132, P1968, DOI 10.1053/j.gastro.2007.02.035; Michalski CW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001701; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; OHKUBO I, 1990, BIOCHIM BIOPHYS ACTA, V1034, P152, DOI 10.1016/0304-4165(90)90069-9; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x; Rolli V, 2007, FEBS LETT, V581, P394, DOI 10.1016/j.febslet.2006.12.047; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Russell ST, 2010, ENDOCRINOLOGY, V151, P948, DOI 10.1210/en.2009-0827; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Subramanian G, 2004, CANCER RES, V64, P5200, DOI 10.1158/0008-5472.CAN-04-0018; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wan M, 2005, AM J PATHOL, V166, P1379, DOI 10.1016/S0002-9440(10)62356-5; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Zhang WW, 2007, CANCER BIOL THER, V6, P218, DOI 10.4161/cbt.6.2.3623	55	64	69	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	37					5146	5158		10.1038/onc.2010.258	http://dx.doi.org/10.1038/onc.2010.258			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	650QZ	20581862				2022-12-25	WOS:000281867200004
J	Lamy, C; Goodchild, SJ; Weatherall, KL; Jane, DE; Liegeois, JF; Seutin, V; Marrion, NV				Lamy, Cedric; Goodchild, Samuel J.; Weatherall, Kate L.; Jane, David E.; Liegeois, Jean-Francois; Seutin, Vincent; Marrion, Neil V.			Allosteric Block of K(Ca)2 Channels by Apamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNELS; SMALL-CONDUCTANCE; METHYL-LAUDANOSINE; SKELETAL-MUSCLE; PORE REGION; BEE VENOM; TETRAETHYLAMMONIUM; BINDING; BRAIN	Activation of small conductance calcium-activated potassium (K(Ca)2) channels can regulate neuronal firing and synaptic plasticity. They are characterized by their high sensitivity to the bee venom toxin apamin, but the mechanism of block is not understood. For example, apamin binds to both K(Ca)2.2 and K(Ca)2.3 with the same high affinity (K-D similar to 5 pM for both subtypes) but requires significantly higher concentrations to block functional current (IC50 values of similar to 100 pM and similar to 5 nM, respectively). This suggests that steps beyond binding are needed for channel block to occur. We have combined patch clamp and binding experiments on cell lines with molecular modeling and mutagenesis to gain more insight into the mechanism of action of the toxin. An outer pore histidine residue common to both subtypes was found to be critical for both binding and block by the toxin but not for block by tetraethylammonium (TEA) ions. These data indicated that apamin blocks K(Ca)2 channels by binding to a site distinct from that used by TEA, supported by a finding that the onset of block by apamin was not affected by the presence of TEA. Structural modeling of ligand-channel interaction indicated that TEA binds deep within the channel pore, which contrasted with apamin being modeled to interact with the channel outer pore by utilizing the outer pore histidine residue. This multidisciplinary approach suggested that apamin does not behave as a classical pore blocker but blocks using an allosteric mechanism that is consistent with observed differences between binding affinity and potency of block.	[Goodchild, Samuel J.; Weatherall, Kate L.; Jane, David E.; Marrion, Neil V.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Lamy, Cedric; Seutin, Vincent] Univ Liege, Pharmacol Lab, B-4000 Liege, Belgium; [Lamy, Cedric; Seutin, Vincent] Univ Liege, Grp Interdisciplinaire Genoprote Appl Neurosci, B-4000 Liege, Belgium; [Liegeois, Jean-Francois] Univ Liege, Med Chem Lab, B-4000 Liege, Belgium; [Liegeois, Jean-Francois] Univ Liege, Ctr Interfac Rech Medicament, B-4000 Liege, Belgium	University of Bristol; University of Liege; University of Liege; University of Liege; University of Liege	Marrion, NV (corresponding author), Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England.	N.V.Marrion@bris.ac.uk	Seutin, Vincent/A-7219-2011		Belgian Science Policy Interuniversity Attraction Poles program; Walloon region of Belgium [516131]; MRC [G0601812] Funding Source: UKRI; Medical Research Council [G0601841B, G0601812] Funding Source: researchfish	Belgian Science Policy Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Walloon region of Belgium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Belgian Science Policy Interuniversity Attraction Poles program and by a "FIRST-Doctorant Entreprise International" grant (Grant 516131) from the Walloon region of Belgium (to C. L.).	Ahern CA, 2006, J GEN PHYSIOL, V128, P649, DOI 10.1085/jgp.200609654; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; Bretschneider F, 1999, BIOPHYS J, V76, P2351, DOI 10.1016/S0006-3495(99)77392-3; CASTLE NA, 1993, EUR J PHARMACOL, V236, P201, DOI 10.1016/0014-2999(93)90590-E; COOK NS, 1985, J PHYSIOL-LONDON, V358, P373, DOI 10.1113/jphysiol.1985.sp015556; Dale TJ, 2002, N-S ARCH PHARMACOL, V366, P470, DOI 10.1007/s00210-002-0622-2; Dilly S, 2005, J ENZYM INHIB MED CH, V20, P517, DOI 10.1080/14756360500210989; Finlayson K, 2001, NEUROPHARMACOLOGY, V41, P341, DOI 10.1016/S0028-3908(01)00067-3; Goodchild SJ, 2009, J GEN PHYSIOL, V134, P295, DOI 10.1085/jgp.200910252; Graulich A, 2005, BIOORGAN MED CHEM, V13, P1201, DOI 10.1016/j.bmc.2004.11.025; Grunnet M, 2001, PFLUG ARCH EUR J PHY, V441, P544, DOI 10.1007/s004240000447; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hille B., 2001, IONIC CHANNELS EXCIT, P539; HUGUES M, 1982, J BIOL CHEM, V257, P2762; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Jager H, 2004, TOXICON, V43, P951, DOI 10.1016/j.toxicon.2004.03.025; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; LABBEJULLIE C, 1991, EUR J BIOCHEM, V196, P639, DOI 10.1111/j.1432-1033.1991.tb15860.x; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Li WY, 2009, P NATL ACAD SCI USA, V106, P1075, DOI 10.1073/pnas.0812008106; Liegeois JF, 2003, CURR MED CHEM, V10, P625, DOI 10.2174/0929867033457908; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; Molina A, 1997, J PHYSIOL-LONDON, V499, P361, DOI 10.1113/jphysiol.1997.sp021933; Monaghan AS, 2004, J BIOL CHEM, V279, P1003, DOI 10.1074/jbc.M308070200; Nolting A, 2007, J BIOL CHEM, V282, P3478, DOI 10.1074/jbc.M607213200; PEASE JHB, 1988, BIOCHEMISTRY-US, V27, P8491, DOI 10.1021/bi00422a029; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Rosa JC, 1998, J MED CHEM, V41, P2, DOI 10.1021/jm970571a; Scuvee-Moreau J, 2002, J PHARMACOL EXP THER, V302, P1176, DOI 10.1124/jpet.302.3.1176; Shakkottai VG, 2001, J BIOL CHEM, V276, P43145, DOI 10.1074/jbc.M106981200; Soh H, 2001, BIOPHYS J, V80, P2207, DOI 10.1016/S0006-3495(01)76193-0; Sorensen US, 2008, J MED CHEM, V51, P7625, DOI 10.1021/jm800809f; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; VINCENT JP, 1975, BIOCHEMISTRY-US, V14, P2521, DOI 10.1021/bi00682a035	35	61	63	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27067	27077		10.1074/jbc.M110.110072	http://dx.doi.org/10.1074/jbc.M110.110072			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562108	Green Published, hybrid			2022-12-25	WOS:000281172700038
J	Broser, M; Gabdulkhakov, A; Kern, J; Guskov, A; Muh, F; Saenger, W; Zouni, A				Broser, Matthias; Gabdulkhakov, Azat; Kern, Jan; Guskov, Albert; Mueh, Frank; Saenger, Wolfram; Zouni, Athina			Crystal Structure of Monomeric Photosystem II from Thermosynechococcus elongatus at 3.6-angstrom Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; OXYGEN-EVOLVING CENTER; ABSORPTION SPECTROSCOPY; ANGSTROM RESOLUTION; SINGLE-CRYSTALS; MN4CA CLUSTER; CYANOBACTERIAL; PROTEIN; CRYSTALLOGRAPHY; EVOLUTION	The membrane-embedded photosystem II core complex (PSIIcc) uses light energy to oxidize water in photosynthesis. Information about the spatial structure of PSIIcc obtained from x-ray crystallography was so far derived from homodimeric PSIIcc of thermophilic cyanobacteria. Here, we report the first crystallization and structural analysis of the monomeric form of PSIIcc with high oxygen evolution capacity, isolated from Thermosynechococcus elongatus. The crystals belong to the space group C222(1), contain one monomer per asymmetric unit, and diffract to a resolution of 3.6 angstrom. The x-ray diffraction pattern of the PSIIcc-monomer crystals exhibit less anisotropy (dependence of resolution on crystal orientation) compared with crystals of dimeric PSIIcc, and the packing of the molecules within the unit cell is different. In the monomer, 19 protein subunits, 35 chlorophylls, two pheophytins, the non-heme iron, the primary plastoquinone Q(A), two heme groups, 11 beta-carotenes, 22 lipids, seven detergent molecules, and the Mn4Ca cluster of the water oxidizing complex could be assigned analogous to the dimer. Based on the new structural information, the roles of lipids and protein subunits in dimer formation of PSIIcc are discussed. Due to the lack of non-crystallographic symmetry and the orientation of the membrane normal of PSIIcc perpendicular (similar to 87 degrees) to the crystallographic b-axis, further information about the structure of the Mn4Ca cluster is expected to become available from orientation-dependent spectroscopy on this new crystal form.	[Gabdulkhakov, Azat; Guskov, Albert; Saenger, Wolfram] Free Univ Berlin, Inst Chem & Biochem Crystallog, D-14195 Berlin, Germany; [Zouni, Athina] Tech Univ Berlin, Inst Chem, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany	Free University of Berlin; Technical University of Berlin	Saenger, W (corresponding author), Free Univ Berlin, Inst Chem & Biochem Crystallog, Takustr 6, D-14195 Berlin, Germany.	saenger@chemie.fu-berlin.de; athina.zouni@tu-berlin.de	Gabdulkhakov, Azat/H-4343-2013; Guskov, Albert/G-1286-2016; Kern, Jan/G-2586-2013	Gabdulkhakov, Azat/0000-0003-1016-5936; Guskov, Albert/0000-0003-2340-2216; Kern, Jan/0000-0002-7272-1603	Deutsche Forschungsgemeinschaft [Sfb 498, A4, C7]; Deutsche Forschungsgemeinschaft, Technische Universitat Berlin [B1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, Technische Universitat Berlin(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft within the framework of Sfb 498 (projects A4 and C7) and the Deutsche Forschungsgemeinschaft-Cluster of Excellence "UniCat" (project B1) coordinated by the Technische Universitat Berlin.	Bentley FK, 2008, BIOCHEMISTRY-US, V47, P11637, DOI 10.1021/bi800804h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARK LC, 1956, T AM SOC ART INT ORG, V2, P41; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kato Y, 2009, J BIOCHEM, V146, P463, DOI 10.1093/jb/mvp073; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; Kern J, 2005, PHOTOSYNTH RES, V84, P153, DOI 10.1007/s11120-004-7077-x; Kern J, 2007, PHOTOSYNTH RES, V94, P183, DOI 10.1007/s11120-007-9201-1; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Kruse O, 2000, J BIOL CHEM, V275, P6509, DOI 10.1074/jbc.275.9.6509; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B., 2005, THESIS FREIE U BERLI; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; Matsuoka H, 2006, J PHYS CHEM B, V110, P13242, DOI 10.1021/jp055008f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muh F, 2008, BBA-BIOMEMBRANES, V1778, P2298, DOI 10.1016/j.bbamem.2008.05.016; Nakamura Y, 2002, DNA RES, V9, P135, DOI 10.1093/dnares/9.4.135; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pushkar Y, 2007, J BIOL CHEM, V282, P7198, DOI 10.1074/jbc.M610505200; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Renger G, 2009, PHOTOSYNTH RES, V102, P487, DOI 10.1007/s11120-009-9434-2; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; ROTH M, 1991, BIOCHEMISTRY-US, V30, P9403, DOI 10.1021/bi00103a003; SCHLODDER E, 1987, BIOCHIM BIOPHYS ACTA, V890, P23, DOI 10.1016/0005-2728(87)90064-8; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Sproviero EM, 2008, J AM CHEM SOC, V130, P6728, DOI 10.1021/ja801979n; Teutloff C, 2009, PHYS CHEM CHEM PHYS, V11, P6715, DOI 10.1039/b908093g; Wydrzynski T. J., 2005, PHOTOSYSTEM; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Zouni A, 2005, BIOCHEMISTRY-US, V44, P4572, DOI 10.1021/bi047685q; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	41	54	83	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26255	26262		10.1074/jbc.M110.127589	http://dx.doi.org/10.1074/jbc.M110.127589			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558739	hybrid, Green Published			2022-12-25	WOS:000280921000042
J	Liu, JY; Zhang, DY; Mi, XY; Xia, Q; Yu, YH; Zuo, ZH; Guo, W; Zhao, XW; Cao, J; Yang, Q; Zhu, A; Yang, WC; Shi, XL; Li, JX; Huang, CS				Liu, Jinyi; Zhang, Dongyun; Mi, Xiaoyi; Xia, Qing; Yu, Yonghui; Zuo, Zhenghong; Guo, Wei; Zhao, Xuewei; Cao, Jia; Yang, Qing; Zhu, Angela; Yang, Wancai; Shi, Xianglin; Li, Jingxia; Huang, Chuanshu			p27 Suppresses Arsenite-induced Hsp27/Hsp70 Expression through Inhibiting JNK2/c-Jun- and HSF-1-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1 EXPRESSION; CELL-DEATH; P27(KIP1); CANCER; TRANSFORMATION; INDUCTION; APOPTOSIS; PROTEIN; GROWTH; HSP70	p27 is an atypical tumor suppressor that can regulate the activity of cyclin-dependent kinases and G(0)-to-S phase transitions. More recent studies reveal that p27 may also exhibit its tumor-suppressive function through regulating many other essential cellular events. However, the molecular mechanisms underlying these anticancer effects of p27 are largely unknown. In this study, we found that depletion of p27 expression by either gene knock-out or knockdown approaches resulted in up-regulation of both Hsp27 and Hsp70 expression at mRNA- and promoter-derived transcription as well as protein levels upon arsenite exposure, indicating that p27 provides a negative signal for regulating the expression of Hsp27 and Hsp70. Consistently, arsenite-induced activation of JNK2/c-Jun and HSF-1 pathways was also markedly elevated in p27 knock-out (p27(-/-)) and knockdown (p27 shRNA) cells. Moreover, interference with the expression or function of JNK2, c-Jun, and HSF-1, but not JNK1, led to dramatic inhibition of arsenite-induced Hsp27 and Hsp70 expression. Collectively, our results demonstrate that p27 suppresses Hsp27 and Hsp70 expression at the transcriptional level specifically through JNK2/c-Jun- and HSF-1-dependent pathways upon arsenite exposure, which provides additional important molecular mechanisms for the tumor-suppressive function of p27.	[Zhang, Dongyun; Mi, Xiaoyi; Xia, Qing; Yu, Yonghui; Zuo, Zhenghong; Guo, Wei; Zhao, Xuewei; Yang, Qing; Zhu, Angela; Li, Jingxia; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Liu, Jinyi; Cao, Jia] Third Mil Med Univ, Prevent Med Coll, Dept Hyg Toxicol, Chongqing 400038, Peoples R China; [Liu, Jinyi; Cao, Jia] Third Mil Med Univ, Prevent Med Coll, Toxicogen Lab, Chongqing 400038, Peoples R China; [Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Shi, Xianglin] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA	New York University; Army Medical University; Army Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Kentucky	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org	Zuo, Zhenghong/G-4615-2010; Yu, Yonghui/AAZ-4093-2021; Yang, Wancai/G-3750-2010; Yang, Wancai/O-7655-2019	Yang, Wancai/0000-0001-7437-9197; Huang, Chuanshu/0000-0003-4133-5096	NCI [CA112557, CA119028-05S110]; NIEHS [ES012451, ES010344]; NATIONAL CANCER INSTITUTE [R01CA119028, R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012451, P42ES010344] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grants CA112557 and CA119028-05S110 from NCI and Grants ES012451 and ES010344 from NIEHS.	Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Csermely P., 2007, MOL ASPECTS STRESS R; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; Ding J, 2009, CURR CANCER DRUG TAR, V9, P81, DOI 10.2174/156800909787313995; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kossatz U, 2007, CELL RES, V17, P832, DOI 10.1038/cr.2007.86; Leaner VD, 2005, MOL CELL BIOL, V25, P3324, DOI 10.1128/MCB.25.8.3324-3337.2005; Lee HY, 2005, CLIN CANCER RES, V11, P6065, DOI 10.1158/1078-0432.CCR-05-0009; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Moeller SJ, 2003, MOL CELL BIOL, V23, P3735, DOI 10.1128/MCB.23.11.3735-3752.2003; Oesterreich S, 1996, BIOCHEM BIOPH RES CO, V222, P155, DOI 10.1006/bbrc.1996.0714; Ouyang WM, 2008, ENVIRON HEALTH PERSP, V116, P1, DOI 10.1289/ehp.10403; Prasad KV, 2007, J BIOSCIENCES, V32, P585, DOI 10.1007/s12038-007-0058-4; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Sugiyama Y, 2001, J BIOL CHEM, V276, P12084, DOI 10.1074/jbc.M010811200; TSENG WP, 1968, J NATL CANCER I, V40, P453; Wang JP, 2002, TOXICOL LETT, V133, P17, DOI 10.1016/S0378-4274(02)00086-3; Wong HR, 2005, AM J PHYSIOL-CELL PH, V289, pC1152, DOI 10.1152/ajpcell.00138.2005; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2009, TOXICOL APPL PHARM, V235, P18, DOI 10.1016/j.taap.2008.11.002	28	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26058	26065		10.1074/jbc.M110.100271	http://dx.doi.org/10.1074/jbc.M110.100271			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566634	Green Published, hybrid			2022-12-25	WOS:000280921000021
J	Weinman, EJ; Steplock, D; Zhang, YH; Biswas, R; Bloch, RJ; Shenolikar, S				Weinman, Edward J.; Steplock, Deborah; Zhang, Yinghua; Biswas, Rajatsubhra; Bloch, Robert J.; Shenolikar, Shirish			Cooperativity between the Phosphorylation of Thr(95) and Ser(77) of NHERF-1 in the Hormonal Regulation of Renal Phosphate Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE CELLS; PARATHYROID-HORMONE; FACTOR-I; EXCHANGER; DOPAMINE; NPT2A; PTH	The phosphorylation of the sodium-hydrogen exchanger regulatory factor-1 (NHERF-1) plays a key role in the regulation of renal phosphate transport by parathyroid hormone (PTH) and dopamine. Ser(77) in the first PDZ domain of NHERF-1 is a downstream target of both hormones. The current experiments explore the role of Thr(95), another phosphate acceptor site in the PDZ I domain, on hormone-mediated regulation of phosphate transport in the proximal tubule of the kidney. The substitution of alanine for threonine at position 95 (T95A) significantly decreased the rate and extent of in vitro phosphorylation of Ser(77) by PKC. In NHERF-1-null proximal tubule cells, neither PTH nor dopamine inhibited sodium-dependent phosphate transport. Infection of the cells with adenovirus expressing full-length WT GFP-NHERF-1 increased basal phosphate transport and restored the inhibitory effect of both PTH and dopamine. Infection with full-length NHERF-1 containing a T95A mutation, however, increased basal phosphate transport but not the responsiveness to either hormone. As determined by surface plasmon resonance, the substitution of serine for aspartic acid (S77D) in the PDZ I domain decreased the binding affinity to the sodium-dependent phosphate transporter 2a (Npt2a) as compared with WT PDZ I, but a T95D mutation had no effect on binding. Finally, cellular studies indicated that both PTH and dopamine treatment increased the phosphorylation of Thr(95). These studies indicate a remarkable cooperativity between the phosphorylation of Thr(95) and Ser(77) of NHERF-1 in the hormonal regulation of renal phosphate transport. The phosphorylation of Thr(95) facilitates the phosphorylation of Ser(77). This, in turn, results in the dissociation of NHERF-1 from Npt2a and a decrease in phosphate transport in renal proximal tubule cells.	[Weinman, Edward J.; Steplock, Deborah; Biswas, Rajatsubhra] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.; Zhang, Yinghua; Bloch, Robert J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Weinman, Edward J.] Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD 21201 USA; [Shenolikar, Shirish] Duke Natl Univ Singapore, Grad Sch Med, Program Neurosci & Behav Disorders, Singapore 169857, Singapore	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National University of Singapore	Weinman, EJ (corresponding author), Univ Maryland Hosp, Div Nephrol, Rm N3W143,22 S Greene St, Baltimore, MD 21201 USA.	eweinman1440@yahoo.com			National Institutes of Health [DK55881]; Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55881 (to E.J.W.) and by a grant from the Research Service, Department of Veterans Affairs (to E.J.W.).	Cunningham R, 2006, AM J PHYSIOL-RENAL, V291, pF896, DOI 10.1152/ajprenal.00036.2006; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2010, J BIOL CHEM, V285, P13454, DOI 10.1074/jbc.M109.094359; Weinman EJ, 2009, AM J PHYSIOL-RENAL, V297, pF1560, DOI 10.1152/ajprenal.90657.2008; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903	12	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25134	25138		10.1074/jbc.M110.132423	http://dx.doi.org/10.1074/jbc.M110.132423			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20571032	Green Published, hybrid			2022-12-25	WOS:000280682400005
J	Zhao, YC; Kull, FJ; Cochran, JC				Zhao, Yu Cheng; Kull, F. Jon; Cochran, Jared C.			Modulation of the Kinesin ATPase Cycle by Neck Linker Docking and Microtubule Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC MECHANISM; MOTOR; EG5; THERMODYNAMICS; PROCESSIVITY; HYDROLYSIS; PATHWAY; DOMAIN; FORCE; NCD	Kinesin motor proteins use an ATP hydrolysis cycle to perform various functions in eukaryotic cells. Many questions remain about how the kinesin mechanochemical ATPase cycle is fine-tuned for specific work outputs. In this study, we use isothermal titration calorimetry and stopped-flow fluorometry to determine and analyze the thermodynamics of the human kinesin-5 (Eg5/KSP) ATPase cycle. In the absence of micro-tubules, the binding interactions of kinesin-5 with both ADP product and ATP substrate involve significant enthalpic gains coupled to smaller entropic penalties. However, when the wildtype enzyme is titrated with a non-hydrolyzable ATP analog or the enzyme is mutated such that it is able to bind but not hydrolyze ATP, substrate binding is 10-fold weaker than ADP binding because of a greater entropic penalty due to the structural re-arrangements of switch 1, switch 2, and loop L5 on ATP binding. We propose that these rearrangements are reversed upon ATP hydrolysis and phosphate release. In addition, experiments on a truncated kinesin-5 construct reveal that upon nucleotide binding, both the N-terminal cover strand and the neck linker interact to modulate kinesin-5 nucleotide affinity. Moreover, interactions with microtubules significantly weaken the affinity of kinesin-5 for ADP without altering the affinity of the enzyme for ATP in the absence of ATP hydrolysis. Together, these results define the energy landscape of a kinesin ATPase cycle in the absence and presence of microtubules and shed light on the role of molecular motor mechanochemistry in cellular microtubule dynamics.	[Zhao, Yu Cheng; Kull, F. Jon; Cochran, Jared C.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College	Cochran, JC (corresponding author), 6128 Burke Lab, Hanover, NH 03755 USA.	Jared.Cochran@Dartmouth.edu		Zhao, Peter/0000-0003-1430-1034	National Institutes of Health through the NIAMS [F32AR054653]; Dartmouth College; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR054653] Funding Source: NIH RePORTER	National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dartmouth College; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant F32AR054653 through the NIAMS (to J.C.C.). This work was also supported by the Dartmouth College Zabriskie Fellowship (to Y.C.Z.). S The on-line version of this article (available at http://www.jbc.org) contains supplemental Experimental Procedures, Figs. S1-S3, and Tables S1 and S2.	Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; COLE DG, 1994, J BIOL CHEM, V269, P22913; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Kull FJ, 2002, J CELL SCI, V115, P15; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Ma YZ, 1997, J BIOL CHEM, V272, P717, DOI 10.1074/jbc.272.2.717; Mackey AT, 2000, BIOCHEMISTRY-US, V39, P1346, DOI 10.1021/bi991918+; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Maliga Z, 2006, J BIOL CHEM, V281, P7977, DOI 10.1074/jbc.M511955200; Marx A, 2005, ADV PROTEIN CHEM, V71, P299, DOI 10.1016/S0065-3233(04)71008-6; Moyer ML, 1996, BIOCHEMISTRY-US, V35, P6321, DOI 10.1021/bi960017n; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pechatnikova E, 1997, J BIOL CHEM, V272, P30735, DOI 10.1074/jbc.272.49.30735; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Pretz MG, 2006, BIOCHEMISTRY-US, V45, P15056, DOI 10.1021/bi061230e; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Sheth PR, 2009, BIOCHEMISTRY-US, V48, P11045, DOI 10.1021/bi900946r; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394	33	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25213	25220		10.1074/jbc.M110.123067	http://dx.doi.org/10.1074/jbc.M110.123067			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558732	hybrid, Green Published			2022-12-25	WOS:000280682400014
J	Sokolowski, P; Saison, F; Giles, W; McGrath, S; Smith, D; Smith, J; Smith, R				Sokolowski, Peter; Saison, Francis; Giles, Warwick; McGrath, Shaun; Smith, David; Smith, Julia; Smith, Roger			Human Uterine Wall Tension Trajectories and the Onset of Parturition	PLOS ONE			English	Article							TOTAL INTRAUTERINE VOLUME; MYOMETRIAL THICKNESS; GROWTH-RETARDATION; LABOR; PRESSURE; PREDICTION; PREGNANCY	Uterine wall tension is thought to be an important determinant of the onset of labor in pregnant women. We characterize human uterine wall tension using ultrasound from the second trimester of pregnancy until parturition and compare preterm, term and twin pregnancies. A total of 320 pregnant women were followed from first antenatal visit to delivery during the period 2000-2004 at the John Hunter Hospital, NSW, Australia. The uterine wall thickness, length, anterior-posterior diameter and transverse diameter were determined by serial ultrasounds. Subjects were divided into three groups: women with singleton pregnancies and spontaneous labor onset, either preterm or term and women with twin pregnancies. Intrauterine pressure results from the literature were combined with our data to form trajectories for uterine wall thickness, volume and tension for each woman using the prolate ellipsoid method and the groups were compared at 20, 25 and 30 weeks gestation. Uterine wall tension followed an exponential curve, with results increasing throughout pregnancy with the site of maximum tension on the anterior wall. For those delivering preterm, uterine wall thickness was increased P<0.05 compared with term. For twin pregnancies intrauterine volume was increased compared to singletons (P<0.001), but wall thickness was not. There was no evidence for increased tension in those delivering preterm or those with twin gestations. These data are not consistent with a role for high uterine wall tension as a causal factor in preterm spontaneous labor in singleton or twin gestations. It seems likely that hormonal differences in multiple gestations are responsible for increased rates of preterm birth in this group rather than increased tension.	[Sokolowski, Peter; Saison, Francis; Giles, Warwick; McGrath, Shaun; Smith, Julia; Smith, Roger] Univ Newcastle, Mothers & Babies Res Ctr, Hunter Med Res Inst, John Hunter Hosp, Newcastle, NSW 2308, Australia; [Sokolowski, Peter] Univ Newcastle, Sch Elect Engn & Comp Sci, Callaghan, NSW 2308, Australia; [Smith, David] Univ Western Australia, Fac Engn Comp & Math, Crawley, Australia	Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; University of Newcastle; University of Western Australia	Sokolowski, P (corresponding author), Univ Newcastle, Mothers & Babies Res Ctr, Hunter Med Res Inst, John Hunter Hosp, Newcastle, NSW 2308, Australia.	peters@ieee.org	Smith, David W/H-5856-2014	Smith, David W/0000-0003-4864-0288; Smith, Roger/0000-0003-4720-0280; Sokolowski, Peter/0000-0001-8910-1294	Australian Postgraduate Award [2001-2002]; Thyne Reid Trust	Australian Postgraduate Award(Australian Government); Thyne Reid Trust	Peter Sokolowski received Australian Postgraduate Award support (2001-2002). Funding for this study was received from the Thyne Reid Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON AB, 1967, AM J OBSTET GYNECOL, V97, P992, DOI 10.1016/0002-9378(67)90529-7; Beeby PJ, 1996, J PAEDIATR CHILD H, V32, P512, DOI 10.1111/j.1440-1754.1996.tb00965.x; BLOCH E. D., 1997, 1 COURSE GEOMETRIC T; Buhimschi CS, 2005, AM J OBSTET GYNECOL, V193, P762, DOI 10.1016/j.ajog.2005.01.053; Conde-Agudelo A, 2000, OBSTET GYNECOL, V95, P899, DOI 10.1016/S0029-7844(99)00640-7; Csapo A, 1970, Obstet Gynecol Surv, V25, P403, DOI 10.1097/00006254-197005000-00001; Cunningham FG, 1997, WILLIAMS OBSTETRICS, P607; Degani S, 1998, J ULTRAS MED, V17, P661, DOI 10.7863/jum.1998.17.10.661; FISK NM, 1992, BRIT J OBSTET GYNAEC, V99, P18, DOI 10.1111/j.1471-0528.1992.tb14385.x; GARDNER MO, 1995, OBSTET GYNECOL, V85, P553, DOI 10.1016/0029-7844(94)00455-M; GOHARI P, 1977, AM J OBSTET GYNECOL, V127, P255, DOI 10.1016/0002-9378(77)90464-1; GROSSMAN M, 1982, J CLIN ULTRASOUND, V10, P17, DOI 10.1002/jcu.1870100104; James G., 1976, MATH DICT; LEVINE SC, 1979, J CLIN ULTRASOUND, V7, P21, DOI 10.1002/jcu.1870070109; Lye SJ, 2001, FRONT HORM RES, V27, P165; MANABE Y, 1992, PROSTAGLANDINS, V44, P119, DOI 10.1016/0090-6980(92)90073-3; Minakami H, 2000, Twin Res, V3, P2, DOI 10.1375/twin.3.1.2; Monga M, 2004, MATERNAL FETAL MED P, P69; PLATT JF, 1990, J CLIN ULTRASOUND, V18, P15, DOI 10.1002/jcu.1870180105; PROBSTEIN KF, 1994, PHYSICOCHEMICAL HYDR; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; SFAKIANAKI AK, 2008, AM J OBSTET GYNECOL, V198, pNI162; Skowronski MD, 2006, IEEE T BIO-MED ENG, V53, P1983, DOI 10.1109/TBME.2006.877104; Smith R, 2009, J CLIN ENDOCR METAB, V94, P2066, DOI 10.1210/jc.2008-2257; STEER PJ, 1993, BRIT J OBSTET GYNAEC, V100, P32, DOI 10.1111/j.1471-0528.1993.tb10634.x; ULMSTEN U, 1979, ACTA OBSTET GYN SCAN, V58, P547, DOI 10.3109/00016347909154617; Warner BB, 2000, CLIN PERINATOL, V27, P347, DOI 10.1016/S0095-5108(05)70025-7; WATHES DC, 1982, J REPROD FERTIL, V65, P497, DOI 10.1530/jrf.0.0650497	28	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11037	10.1371/journal.pone.0011037	http://dx.doi.org/10.1371/journal.pone.0011037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585649	Green Submitted, Green Published, gold			2022-12-25	WOS:000279135400002
J	Ahmed, SSSJ; Santosh, W				Ahmed, Shiek S. S. J.; Santosh, Winkins			Metallomic Profiling and Linkage Map Analysis of Early Parkinson's Disease: A New Insight to Aluminum Marker for the Possible Diagnosis	PLOS ONE			English	Article							ALZHEIMER A-BETA; INTER-ELEMENT RELATIONS; OXIDATIVE STRESS; NEURODEGENERATION; SCHIZOPHRENIA; RISK; IRON; HOMEOSTASIS; COMPLEXITY; CU(II)	Background: Parkinson's disease (PD) is the most common neurodegenerative disorder. The diagnosis of PD is challenging and currently none of the biochemical tests have proven to help in diagnosis. Serum metallomic analysis may suggest the possibility of diagnosis of PD. Methodology/Results: The metallomic analysis was targeted on 31 elements obtained from 42 healthy controls and 45 drug naive PD patients using ICP-AES and ICP-MS to determine the concentration variations of elements between PD and normal. The targeted metallomic analysis showed the significant variations in 19 elements of patients compared to healthy control (p < 0.04). The partial least squares discriminant analysis (PLS-DA) showed aluminium, copper, iron, manganese and zinc are the key elements, contributes the separation of PD patients from control samples. The correlation coefficient analysis and element-element ratio confirm the imbalance of inter-elements relationship in PD patients' serum. Furthermore, elements linkage map analysis showed aluminium is a key element involved in triggering of phosphorus, which subsequently lead to imbalance of homeostatic in PD serum. The execution of neural network using elements concentrations provides 95% accuracy in detection of disease. Conclusions/Significance: These results suggest that there is a disturbance in the elements homeostasis and inter-elements relationship in PD patients' serum. The analysis of serum elements helps in linking the underlying cellular processes such as oxidative stress, neuronal dysfunction and apoptosis, which are the dominating factors in PD. Also, these results increase the prospect of detection of early PD from serum through neural network algorithm.	[Ahmed, Shiek S. S. J.; Santosh, Winkins] SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur, Tamil Nadu, India	SRM Institute of Science & Technology Chennai	Ahmed, SSSJ (corresponding author), SRM Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur, Tamil Nadu, India.	parkinresearch@gmail.com	Santosh, Winkins/ACE-9180-2022	Santosh, Winkins/0000-0002-8368-6014	SRM University, Kattankulathur, Tamil Nadu, India	SRM University, Kattankulathur, Tamil Nadu, India	SRM University, Kattankulathur, Tamil Nadu, India provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RA, 1992, EUR J CLIN NUTR, V46, P879; Ahmed SSSJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-63; AHMED SSS, 2009, VIB SPECTRO IN PRESS; ALIAS AG, 1972, BIOL PSYCHIAT, V4, P231; Alimonti A, 2007, NEUROTOXICOLOGY, V28, P450, DOI 10.1016/j.neuro.2006.12.001; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; BASUN H, 1991, J NEURAL TRANSM-PARK, V3, P231; Bharathi, 2006, BRAIN RES REV, V52, P275, DOI 10.1016/j.brainresrev.2006.04.003; Bharathi, 2006, Current Alzheimer Research, V3, P311, DOI 10.2174/156720506778249399; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Carri MT, 2003, BRAIN RES BULL, V61, P365, DOI 10.1016/S0361-9230(03)00179-5; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; GARRUTO RM, 1993, ALZHEIMERS DIS ADV C, P257; GELB, 1999, ARCH NEUROL-CHICAGO, V56, P33; Ghribi O, 2001, MOL BRAIN RES, V96, P30, DOI 10.1016/S0169-328X(01)00256-X; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; GILLIAN L, 1997, NATL COMMITTEE CLIN, V17, P1; Guttman M, 2003, CAN MED ASSOC J, V168, P293; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; Hagve Tor-Arne, 2009, Tidsskr Nor Laegeforen, V129, P863, DOI 10.4045/tidsskr.08.0084; Harrison-Findik DD, 2009, WORLD J GASTROENTERO, V15, P1186, DOI 10.3748/wjg.15.1186; Hasegawa T, 2003, ANAL SCI, V19, P147, DOI 10.2116/analsci.19.147; Hegde ML, 2004, J TRACE ELEM MED BIO, V18, P163, DOI 10.1016/j.jtemb.2004.09.003; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hur CI, 2008, CLIN ORTHOP RELAT R, V466, P696, DOI 10.1007/s11999-007-0093-3; JIMENEZJIMENEZ FJ, 1992, J NEUROL SCI, V112, P30; KALRA J, 1992, MOL CELL BIOCHEM, V110, P165, DOI 10.1007/BF02454194; KOICHI W, 2003, BIOMED RES TRACE ELE, V14, P275; Kuloglu M, 2002, CELL BIOCHEM FUNCT, V20, P171, DOI 10.1002/cbf.940; Malecki EA, 2001, BRAIN RES BULL, V55, P225, DOI 10.1016/S0361-9230(01)00456-7; Mustak MS, 2008, CLIN CHIM ACTA, V394, P47, DOI 10.1016/j.cca.2008.04.003; *NAT COMM CLIN LAB, NAT COMM CLIN LAB ST; Nikolov IG, 2009, BLOOD PURIFICAT, V27, P350, DOI 10.1159/000209248; O'Keeffe GC, 2009, ANN NY ACAD SCI, V1180, P97, DOI 10.1111/j.1749-6632.2009.04943.x; OLATUNBOSUN DA, 1975, BRIT J PSYCHIAT, V127, P119, DOI 10.1192/bjp.127.2.119; Park W, 2009, DIABETES RES CLIN PR, V83, P119, DOI 10.1016/j.diabres.2008.08.018; Pfeiffer C. C., 1972, International Review of Neurobiology, P141; Rao KSJ, 1999, ALZHEIMERS REP, V2, P241; Savory J, 1999, NEUROTOXICOLOGY, V20, P805; Savory J, 2003, J INORG BIOCHEM, V97, P151, DOI 10.1016/S0162-0134(03)00258-7; SEILER HG, 1994, HDB METALS CLIN ANAL, P10; Strong Michael J., 1994, P39; TAKUYA H, 2001, ANAL SCI, V17, P979; Vasudevaraju BP, 2008, INDIAN J MED RES, V128, P545; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Youdim M. B. H., 1982, IRON DEFICIENCY BRAI, P39; ZECCA L, 1994, J NEUROCHEM, V62, P1097	50	64	66	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11252	10.1371/journal.pone.0011252	http://dx.doi.org/10.1371/journal.pone.0011252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582167	gold, Green Submitted, Green Published			2022-12-25	WOS:000279058500004
J	Shah, NR; Sunderland, A; Grdzelishvili, VZ				Shah, Nirav R.; Sunderland, Amanda; Grdzelishvili, Valery Z.			Cell Type Mediated Resistance of Vesicular Stomatitis Virus and Sendai Virus to Ribavirin	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; MOUTH-DISEASE VIRUS; ANTIVIRAL ACTIVITY; LETHAL MUTAGENESIS; IMP DEHYDROGENASE; ADENOSINE KINASE; GENE-EXPRESSION; INFECTED-CELLS; IN-VITRO	Ribavirin (RBV) is a synthetic nucleoside analog with broad spectrum antiviral activity. Although RBV is approved for the treatment of hepatitis C virus, respiratory syncytial virus, and Lassa fever virus infections, its mechanism of action and therapeutic efficacy remains highly controversial. Recent reports show that the development of cell-based resistance after continuous RBV treatment via decreased RBV uptake can greatly limit its efficacy. Here, we examined whether certain cell types are naturally resistant to RBV even without prior drug exposure. Seven different cell lines from various host species were compared for RBV antiviral activity against two nonsegmented negative-strand RNA viruses, vesicular stomatitis virus (VSV, a rhabdovirus) and Sendai virus (SeV, a paramyxovirus). Our results show striking differences between cell types in their response to RBV, ranging from virtually no antiviral effect to very effective inhibition of viral replication. Despite differences in viral replication kinetics for VSV and SeV in the seven cell lines, the observed pattern of RBV resistance was very similar for both viruses, suggesting that cellular rather than viral determinants play a major role in this resistance. While none of the tested cell lines was defective in RBV uptake, dramatic variations were observed in the long-term accumulation of RBV in different cell types, and it correlated with the antiviral efficacy of RBV. While addition of guanosine neutralized RBV only in cells already highly resistant to RBV, actinomycin D almost completely reversed the RBV effect (but not uptake) in all cell lines. Together, our data suggest that RBV may inhibit the same virus via different mechanisms in different cell types depending on the intracellular RBV metabolism. Our results strongly point out the importance of using multiple cell lines of different origin when antiviral efficacy and potency are examined for new as well as established drugs in vitro.	[Shah, Nirav R.; Sunderland, Amanda; Grdzelishvili, Valery Z.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Shah, NR (corresponding author), Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA.	vzgrdzel@uncc.edu	Grdzelishvili, Valery Z./AFL-6027-2022	Grdzelishvili, Valery/0000-0001-8715-3840	state of North Carolina; NIH [5R03AI078122]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI078122] Funding Source: NIH RePORTER	state of North Carolina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up funds provided by the state of North Carolina and by NIH Grant 5R03AI078122 (to V.Z.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; BALZARINI J, 1993, J BIOL CHEM, V268, P24591; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Buckwold VE, 2003, ANTIMICROB AGENTS CH, V47, P2293, DOI 10.1128/AAC.47.7.2293-2298.2003; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; Cuevas Jose M., 2005, Infection Genetics and Evolution, V5, P55, DOI 10.1016/S1567-1348(04)00064-4; Das SC, 2006, J VIROL, V80, P6368, DOI 10.1128/JVI.00211-06; Dixit NM, 2006, CELL MOL LIFE SCI, V63, P832, DOI 10.1007/s00018-005-5455-y; Elia G, 2008, ANTIVIR RES, V77, P108, DOI 10.1016/j.antiviral.2007.09.004; Endres CJ, 2009, J PHARMACOL EXP THER, V329, P387, DOI 10.1124/jpet.108.145854; Fukuchi Y, 2010, J HEPATOL, V52, P486, DOI 10.1016/j.jhep.2010.01.011; Gish RG, 2006, J ANTIMICROB CHEMOTH, V57, P8, DOI 10.1093/jac/dki405; Glue P, 1999, SEMIN LIVER DIS, V19, P17; HRUSKA JF, 1980, ANTIMICROB AGENTS CH, V17, P770, DOI 10.1128/AAC.17.5.770; Ibarra KD, 2009, J VIROL, V83, P4538, DOI 10.1128/JVI.02280-08; Jarvis SM, 1998, BRIT J PHARMACOL, V123, P1587, DOI 10.1038/sj.bjp.0701775; Jordan I, 1999, J VIROL, V73, P7903, DOI 10.1128/JVI.73.9.7903-7906.1999; LARSON EW, 1976, ANTIMICROB AGENTS CH, V10, P770, DOI 10.1128/AAC.10.4.770; Leyssen P, 2005, J VIROL, V79, P1943, DOI 10.1128/JVI.79.3.1943-1947.2005; Loustaud-Ratti V, 2008, HEPATOLOGY, V47, P1453, DOI 10.1002/hep.22217; MALINOSKI F, 1980, VIROLOGY, V102, P473, DOI 10.1016/0042-6822(80)90117-8; Martin P, 2008, J GASTROEN HEPATOL, V23, P844, DOI 10.1111/j.1440-1746.2008.05398.x; Marucco DA, 2008, J ANTIMICROB CHEMOTH, V61, P919, DOI 10.1093/jac/dkn013; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Maynard M, 2008, ANTIVIR THER, V13, P607; Murphy AM, 2009, J VIROL, V83, P1669, DOI 10.1128/JVI.01438-08; PAGE T, 1990, INT J BIOCHEM, V22, P379, DOI 10.1016/0020-711X(90)90140-X; Parker WB, 2005, VIRUS RES, V107, P165, DOI 10.1016/j.virusres.2004.11.006; Pelaez A, 2009, J HEART LUNG TRANSPL, V28, P67, DOI 10.1016/j.healun.2008.10.008; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, J VIROL, V79, P2346, DOI 10.1128/JVI.79.4.2346-2355.2005; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; SIDWELL RW, 1975, CHEMOTHERAPY, V21, P205, DOI 10.1159/000221861; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; SMEE DF, 1982, ANTIMICROB AGENTS CH, V21, P66, DOI 10.1128/AAC.21.1.66; SMEE DF, 1986, ANTIMICROB AGENTS CH, V30, P117, DOI 10.1128/AAC.30.1.117; Sun YJ, 2007, ANTIMICROB AGENTS CH, V51, P84, DOI 10.1128/AAC.00790-06; TOLTZIS P, 1988, ANTIMICROB AGENTS CH, V32, P492, DOI 10.1128/AAC.32.4.492; TOLTZIS P, 1986, ANTIMICROB AGENTS CH, V29, P1010, DOI 10.1128/AAC.29.6.1010; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Wiegand MA, 2007, J VIROL, V81, P13835, DOI 10.1128/JVI.00914-07; WILLIS RC, 1978, P NATL ACAD SCI USA, V75, P3042, DOI 10.1073/pnas.75.7.3042; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; WRAY SK, 1985, ANTIVIR RES, V5, P29, DOI 10.1016/0166-3542(85)90012-9; Wu JZ, 2005, ANTIMICROB AGENTS CH, V49, P2164, DOI 10.1128/AAC.49.6.2164-2171.2005; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003	49	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11265	10.1371/journal.pone.0011265	http://dx.doi.org/10.1371/journal.pone.0011265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582319	Green Published, gold, Green Submitted			2022-12-25	WOS:000279058500017
J	Gesprasert, G; Wichukchinda, N; Mori, M; Shiino, T; Auwanit, W; Sriwanthana, B; Pathipvanich, P; Sawanpanyalert, P; Miura, T; Auewarakul, P; Thitithanyanont, A; Ariyoshi, K				Gesprasert, Goragoch; Wichukchinda, Nuanjun; Mori, Masahiko; Shiino, Teiichiro; Auwanit, Wattana; Sriwanthana, Busarawan; Pathipvanich, Panita; Sawanpanyalert, Pathom; Miura, Toshiyuki; Auewarakul, Prasert; Thitithanyanont, Arunee; Ariyoshi, Koya			HLA-Associated Immune Pressure on Gag Protein in CRF01_AE-Infected Individuals and Its Association with Plasma Viral Load	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-LYMPHOCYTE EPITOPES; ESCAPE MUTATIONS; HIV-1 INFECTION; VACCINE DESIGN; CLASS-I; TRANSMISSION; ADAPTATION; POLYMORPHISMS; POPULATION	Background: The human leukocyte antigen (HLA)-restricted cytotoxic T-lymphocyte (CTL) immune response is one of the major factors determining the genetic diversity of human immunodeficiency virus (HIV). There are few population-based analyses of the amino acid variations associated with the host HLA type and their clinical relevance for the Asian population. Here, we identified HLA-associated polymorphisms in the HIV-1 CRF01_AE Gag protein in infected married couples, and examined the consequences of these HLA-selected mutations after transmission to HLA-unmatched recipients. Methodology/Principal Findings: One hundred sixteen HIV-1-infected couples were recruited at a government hospital in northern Thailand. The 1.7-kb gag gene was amplified and directly sequenced. We identified 56 associations between amino acid variations in Gag and HLA alleles. Of those amino acid variations, 35 (62.5%) were located within or adjacent to regions reported to be HIV-specific CTL epitopes restricted by the relevant HLA. Interestingly, a significant number of HLA-associated amino acid variations appear to be unique to the CRF01_AE-infected Thai population. Variations in the capsid protein (p24) had the strongest associations with the viral load and CD4 cell count. The mutation and reversion rates after transmission to a host with a different HLA environment varied considerably. The p24 T242N variant escape from B57/58 CTL had a significant impact on the HIV-1 viral load of CRF01_AE-infected patients. Conclusions/Significance: HLA-associated amino acid mutations and the CTL selection pressures on the p24 antigen appear to have the most significant impact on HIV replication in a CRF01_AE-infected Asian population. HLA-associated mutations with a low reversion rate accumulated as a footprint in this Thai population. The novel HLA-associated mutations identified in this study encourage us to acquire more extensive information about the viral dynamics of HLA-associated amino acid polymorphisms in a given population as effective CTL vaccine targets.	[Gesprasert, Goragoch; Thitithanyanont, Arunee] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand; [Wichukchinda, Nuanjun; Auwanit, Wattana; Sriwanthana, Busarawan; Sawanpanyalert, Pathom] Minist Publ Hlth, Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Mori, Masahiko; Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Shiino, Teiichiro] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan; [Pathipvanich, Panita] Lampang Hosp, Day Care Ctr, Lampang, Thailand; [Miura, Toshiyuki] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Tokyo, Japan; [Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10400, Thailand; [Ariyoshi, Koya] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan	Mahidol University; Ministry of Public Health - Thailand; Nagasaki University; National Institute of Infectious Diseases (NIID); University of Tokyo; Mahidol University; Nagasaki University	Thitithanyanont, A (corresponding author), Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand.	scaty@mahidol.ac.th	Thitithanyanont, Arunee/AAN-4383-2021; Auewarakul, Prasert/D-6015-2011	Thitithanyanont, Arunee/0000-0002-9756-4763; Auewarakul, Prasert/0000-0002-4745-4291	National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand; Japan International Cooperation Agency (JICA); Japan Ministry of Health, Labour and Welfare; Nagasaki University; Ministry of Public Health of Thailand; Department of Medical Sciences, Thailand	National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand; Japan International Cooperation Agency (JICA); Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Nagasaki University; Ministry of Public Health of Thailand; Department of Medical Sciences, Thailand	This study was mainly supported by the National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand and the Japan International Cooperation Agency (JICA) and partially by the Japan Ministry of Health, Labour and Welfare, Nagasaki University gCOE Program, Ministry of Public Health of Thailand and Department of Medical Sciences, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Fongsatikul Ladda, 1997, Journal of the Medical Association of Thailand, V80, pS38; FRAHM BBN, 2008, HIV MOL IMMUNOLOGY 2, P3; Furutsuki T, 2004, J VIROL, V78, P8437, DOI 10.1128/JVI.78.16.8437-8445.2004; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lau KA, 2007, AIDS REV, V9, P218; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2009, J VIROL, V83, P4605, DOI 10.1128/JVI.02017-08; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Romphruk A, 1996, J Med Assoc Thai, V79, P732; Ruxrungtham K, 2004, LANCET, V364, P69, DOI 10.1016/S0140-6736(04)16593-8; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Stephens HAF, 2005, TRENDS IMMUNOL, V26, P41, DOI 10.1016/j.it.2004.11.001; Wichukchinda N, 2007, AIDS RES HUM RETROV, V23, P686, DOI 10.1089/aid.2006.0212; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	35	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11179	10.1371/journal.pone.0011179	http://dx.doi.org/10.1371/journal.pone.0011179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567513	Green Published, gold, Green Submitted			2022-12-25	WOS:000278886300021
J	Lanyon, LJ; Denham, SL				Lanyon, Linda J.; Denham, Susan L.			Modelling Visual Neglect: Computational Insights into Conscious Perception	PLOS ONE			English	Article							OBJECT-BASED ATTENTION; INFERIOR TEMPORAL CORTEX; PARIETAL CORTEX; BIASED COMPETITION; ORBITOFRONTAL CORTEX; SELECTIVE ATTENTION; UNILATERAL NEGLECT; FRONTAL-LOBE; SEARCH; INHIBITION	Background: Visual neglect is an attentional deficit typically resulting from parietal cortex lesion and sometimes frontal lesion. Patients fail to attend to objects and events in the visual hemifield contralateral to their lesion during visual search. Methodology/Principal Finding: The aim of this work was to examine the effects of parietal and frontal lesion in an existing computational model of visual attention and search and simulate visual search behaviour under lesion conditions. We find that unilateral parietal lesion in this model leads to symptoms of visual neglect in simulated search scan paths, including an inhibition of return (IOR) deficit, while frontal lesion leads to milder neglect and to more severe deficits in IOR and perseveration in the scan path. During simulations of search under unilateral parietal lesion, the model's extrastriate ventral stream area exhibits lower activity for stimuli in the neglected hemifield compared to that for stimuli in the normally perceived hemifield. This could represent a computational correlate of differences observed in neuroimaging for unconscious versus conscious perception following parietal lesion. Conclusions/Significance: Our results lead to the prediction, supported by effective connectivity evidence, that connections between the dorsal and ventral visual streams may be an important factor in the explanation of perceptual deficits in parietal lesion patients and of conscious perception in general.	[Lanyon, Linda J.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Human Vis & Eye Movement Lab, Vancouver, BC V5Z 1M9, Canada; [Lanyon, Linda J.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada; [Lanyon, Linda J.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Denham, Susan L.] Univ Plymouth, Sch Psychol, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England	University of British Columbia; University of British Columbia; University of British Columbia; University of Plymouth	Lanyon, LJ (corresponding author), Univ British Columbia, Dept Ophthalmol & Visual Sci, Human Vis & Eye Movement Lab, Vancouver, BC V5Z 1M9, Canada.	llanyon@eyecarecentre.org	Lanyon, Linda/L-9238-2019	Lanyon, Linda/0000-0002-0885-1825; denham, susan/0000-0002-0988-5672	Michael Smith Foundation for Health	Michael Smith Foundation for Health(Michael Smith Foundation for Health Research)	LL was supported by a Michael Smith Foundation for Health Research Post-Doctoral Fellowship (www.MSFHR.org) during the final stages and write-up of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrmann M, 2004, CORTEX, V40, P247, DOI 10.1016/S0010-9452(08)70120-5; Behrmann M, 1997, NEUROPSYCHOLOGIA, V35, P1445, DOI 10.1016/S0028-3932(97)00058-4; BINDER J, 1992, ARCH NEUROL-CHICAGO, V49, P1187, DOI 10.1001/archneur.1992.00530350109026; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corchs S, 2002, CEREB CORTEX, V12, P339, DOI 10.1093/cercor/12.4.339; DAMASIO AR, 1980, NEUROPSYCHOLOGIA, V18, P123, DOI 10.1016/0028-3932(80)90058-5; Danziger S, 1998, J EXP PSYCHOL HUMAN, V24, P1467, DOI 10.1037/0096-1523.24.5.1467; Deco G, 2002, NEUROCOMPUTING, V44, P775, DOI 10.1016/S0925-2312(02)00471-X; Deco G, 2001, LECT NOTES ARTIF INT, V2036, P114; Deco G, 2002, EUR J NEUROSCI, V16, P1994, DOI 10.1046/j.1460-9568.2002.02279.x; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Driver J, 2001, NEUROIMAGE, V14, pS68, DOI 10.1006/nimg.2001.0842; Farivar R, 2009, J NEUROSCI, V29, P5336, DOI 10.1523/JNEUROSCI.4978-08.2009; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HEILMAN KM, 1972, NEUROLOGY, V22, P660, DOI 10.1212/WNL.22.6.660; Heinke D, 2003, PSYCHOL REV, V110, P29, DOI 10.1037//0033-295X.110.1.29; Hodgson TL, 2002, NEUROPSYCHOLOGIA, V40, P1891, DOI 10.1016/S0028-3932(02)00064-7; Husain M, 2001, BRAIN, V124, P941, DOI 10.1093/brain/124.5.941; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Karnath HO, 1998, J COGNITIVE NEUROSCI, V10, P680, DOI 10.1162/089892998563095; Klein RM, 1999, PSYCHOL SCI, V10, P346, DOI 10.1111/1467-9280.00166; Lanyon L, 2005, PROG NEURAL PROCESS, V16, P239, DOI 10.1142/9789812701886_0025; Lanyon L, 2005, LECT NOTES COMPUT SC, V3368, P42; Lanyon LJ, 2009, COGN NEURODYNAMICS, V3, P223, DOI 10.1007/s11571-008-9073-x; Lanyon LJ, 2004, NEUROCOMPUTING, V58, P655, DOI 10.1016/j.neucom.2004.01.110; Lanyon LJ, 2004, NEURAL NETWORKS, V17, P873, DOI 10.1016/j.neunet.2004.03.012; Mannan SK, 2005, J COGNITIVE NEUROSCI, V17, P340, DOI 10.1162/0898929053124983; Milner A. D., 1995, VISUAL BRAIN ACTION; Motter BC, 1998, VISION RES, V38, P1805, DOI 10.1016/S0042-6989(97)00349-0; Mozer MC, 1997, J COGNITIVE NEUROSCI, V9, P171, DOI 10.1162/jocn.1997.9.2.171; Na DL, 1999, NEUROLOGY, V52, P1569, DOI 10.1212/WNL.52.8.1569; Niemeier M, 2000, NEUROLOGY, V54, P515, DOI 10.1212/WNL.54.2.515; POSNER MI, 1984, J NEUROSCI, V4, P1863; Pouget A, 1997, PHILOS T R SOC B, V352, P1449, DOI 10.1098/rstb.1997.0131; Rees G, 2002, NEUROCASE, V8, P387, DOI 10.1093/neucas/8.5.387; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Rieger JW, 2008, BRAIN RES, V1233, P89, DOI 10.1016/j.brainres.2008.07.108; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rolls ET, 2002, COMPUTATIONAL NEUROS; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Tipper SP, 1996, J EXP PSYCHOL HUMAN, V22, P1289, DOI 10.1037//0096-1523.22.5.1289; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Usher M, 1996, J COGNITIVE NEUROSCI, V8, P311, DOI 10.1162/jocn.1996.8.4.311; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; WATSON RT, 1979, NEUROLOGY, V29, P690, DOI 10.1212/WNL.29.5.690; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481	52	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11128	10.1371/journal.pone.0011128	http://dx.doi.org/10.1371/journal.pone.0011128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559559	Green Published, Green Submitted, gold			2022-12-25	WOS:000278775900018
J	Paige, SL; Osugi, T; Afanasiev, OK; Pabon, L; Reinecke, H; Murry, CE				Paige, Sharon L.; Osugi, Tomoaki; Afanasiev, Olga K.; Pabon, Lil; Reinecke, Hans; Murry, Charles E.			Endogenous Wnt/beta-Catenin Signaling Is Required for Cardiac Differentiation in Human Embryonic Stem Cells	PLOS ONE			English	Article							PRIMITIVE STREAK; WNT; CARDIOMYOCYTES; SPECIFICATION; INDUCTION	Background: Wnt/beta-catenin signaling is an important regulator of differentiation and morphogenesis that can also control stem cell fates. Our group has developed an efficient protocol to generate cardiomyocytes from human embryonic stem (ES) cells via induction with activin A and BMP4. Methodology/Principal Findings: We tested the hypothesis that Wnt/beta-catenin signals control both early mesoderm induction and later cardiac differentiation in this system. Addition of exogenous Wnt3a at the time of induction enhanced cardiac differentiation, while early inhibition of endogenous Wnt/beta-catenin signaling with Dkk1 inhibited cardiac differentiation, as indicated by quantitative RT-PCR analysis for beta-myosin heavy chain (beta-MHC), cardiac troponin T (cTnT), Nkx2.5, and flow cytometry analysis for sarcomeric myosin heavy chain (sMHC). Conversely, late antagonism of endogenously produced Wnts enhanced cardiogenesis, indicating a biphasic role for the pathway in human cardiac differentiation. Using quantitative RT-PCR, we show that canonical Wnt ligand expression is induced by activin A/BMP4 treatment, and the extent of early Wnt ligand expression can predict the subsequent efficiency of cardiogenesis. Measurement of Brachyury expression showed that addition of Wnt3a enhances mesoderm induction, whereas blockade of endogenously produced Wnts markedly inhibits mesoderm formation. Finally, we show that Wnt/beta-catenin signaling is required for Smad1 activation by BMP4. Conclusions/Significance: Our data indicate that induction of mesoderm and subsequent cardiac differentiation from human ES cells requires fine-tuned cross talk between activin A/BMP4 and Wnt/beta-catenin pathways. Controlling these pathways permits efficient generation of cardiomyocytes for basic studies or cardiac repair applications.	[Paige, Sharon L.; Osugi, Tomoaki; Afanasiev, Olga K.; Pabon, Lil; Reinecke, Hans; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Paige, Sharon L.; Osugi, Tomoaki; Afanasiev, Olga K.; Pabon, Lil; Reinecke, Hans; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Paige, Sharon L.; Osugi, Tomoaki; Afanasiev, Olga K.; Pabon, Lil; Reinecke, Hans; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Paige, SL (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	murry@u.washington.edu			NIH [R01 HL64387, P01 HL03174, R01 HL084642, P01 GM081719, F30 HL095343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064387, P01HL003174, F30HL095343, R01HL084642] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01 HL64387, P01 HL03174, R01 HL084642, and P01 GM081719. Sharon Paige was supported through NIH F30 HL095343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Fukuda K, 2006, CIRC RES, V98, P1002, DOI 10.1161/01.RES.0000218272.18669.6e; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Liao R, 2007, PROG CARDIOVASC DIS, V50, P18, DOI 10.1016/j.pcad.2007.03.001; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Nakanishi M, 2009, FASEB J, V23, P114, DOI 10.1096/fj.08-111203; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	22	196	213	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11134	10.1371/journal.pone.0011134	http://dx.doi.org/10.1371/journal.pone.0011134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559569	Green Submitted, Green Published, gold			2022-12-25	WOS:000278775900023
J	Johnson, E; Seachrist, DD; DeLeon-Rodriguez, CM; Lozada, KL; Miedler, J; Abdul-Karim, FW; Keri, RA				Johnson, Emhonta; Seachrist, Darcie D.; DeLeon-Rodriguez, Carlos M.; Lozada, Kristen L.; Miedler, John; Abdul-Karim, Fadi W.; Keri, Ruth A.			HER2/ErbB2-induced Breast Cancer Cell Migration and Invasion Require p120 Catenin Activation of Rac1 and Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; E-CADHERIN; EXPRESSION PATTERNS; BETA-CATENIN; ADHESION COMPLEX; TRANSGENIC MICE; ERBB2; P120-CATENIN; METASTASIS; CARCINOMA	Breast cancers that overexpress the receptor tyrosine kinase ErbB2/HER2/Neu result in poor patient outcome because of extensive metastatic progression. Herein, we delineate a molecular mechanism that may govern this malignant phenotype. ErbB2 induction of migration requires activation of the small GTPases Rac1 and Cdc42. The ability of ErbB2 to activate these small GTPases necessitated expression of p120 catenin, which is itself up-regulated by signaling through ErbB2 and the tyrosine kinase Src. Silencing p120 in ErbB2-dependent breast cancer cell lines dramatically inhibited migration and invasion as well as activation of Rac1 and Cdc42. In contrast, overexpression of constitutively active mutants of these GTPases reversed the effects of p120 silencing. Lastly, ectopic expression of p120 promoted migration and invasion and potentiated metastatic progression of a weakly metastatic, ErbB2-dependent breast cancer cell line. These results suggest that p120 acts as an obligate intermediate between ErbB2 and Rac1/Cdc42 to modulate the metastatic potential of breast cancer cells.	[Johnson, Emhonta; Seachrist, Darcie D.; DeLeon-Rodriguez, Carlos M.; Lozada, Kristen L.; Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Abdul-Karim, Fadi W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Sch Med, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Miedler, John; Abdul-Karim, Fadi W.] Univ Hosp Cleveland, Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Keri, RA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	rak5@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088	National Institutes of Health [R01 CA090398, T32 CA059366]; Department of Defense [W81XWH-09-1-0070]; University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE [T32CA059366, R01CA090398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA090398. This work was also supported by National Institutes of Health Research Oncology Training Grant T32 CA059366, a Continuing Umbrella Research Experience (Cure) Supplement to National Institutes of Health Grant R01 CA090398, Department of Defense Grant USAMRMC W81XWH-09-1-0070, and a University Hospitals of Cleveland Pathology Research Associates Grant (to F. W. A.-K. and R. A. K.).	Aho S, 2002, J CELL SCI, V115, P1391; Alexe G, 2007, J BIOSCIENCES, V32, P1027, DOI 10.1007/s12038-007-0102-4; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Bremnes RM, 2002, LUNG CANCER, V36, P115, DOI 10.1016/S0169-5002(01)00471-8; Cleton-Jansen AM, 2002, BREAST CANCER RES, V4, P5, DOI 10.1186/bcr416; Corsino PE, 2008, NEOPLASIA, V10, P1240, DOI 10.1593/neo.08710; DA SILVA L, 2008, AM J SURG PATHOL, V32, P773; Dabbs DJ, 2007, AM J SURG PATHOL, V31, P427, DOI 10.1097/01.pas.0000213386.63160.3f; Dalgin GS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-291; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dillon DA, 1998, AM J PATHOL, V152, P75; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Gold JS, 1998, CANCER LETT, V132, P193, DOI 10.1016/S0304-3835(98)00190-6; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Howard Eugene M, 2004, Int J Clin Oncol, V9, P154; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Johnson E, 2004, J BIOL CHEM, V279, P31041, DOI 10.1074/jbc.M400024200; Kallakury BVS, 2001, HUM PATHOL, V32, P849, DOI 10.1053/hupa.2001.26463; Karatzas G, 2000, HEPATO-GASTROENTEROL, V47, P1465; Karayiannakis AJ, 1998, J PATHOL, V185, P413; Karayiannakis AJ, 1999, ANTICANCER RES, V19, P4401; Kashiwagi S, 2010, BRIT J CANCER, V103, P249, DOI 10.1038/sj.bjc.6605735; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Kreizenbeck GM, 2008, CANCER EPIDEM BIOMAR, V17, P949, DOI 10.1158/1055-9965.EPI-07-2729; Landis MD, 2005, ONCOGENE, V24, P5173, DOI 10.1038/sj.onc.1208712; Liu Y, 2009, CANCER SCI, V100, P441, DOI 10.1111/j.1349-7006.2008.01067.x; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; Mastracci TL, 2005, MODERN PATHOL, V18, P741, DOI 10.1038/modpathol.3800362; MCGRATH PC, 1994, SURG ONCOL, V3, P69, DOI 10.1016/0960-7404(94)90002-7; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Nakopoulou L, 2000, ANTICANCER RES, V20, P4571; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Qiao M, 2007, CANCER RES, V67, P5293, DOI 10.1158/0008-5472.CAN-07-0877; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Shibata T, 2004, AM J PATHOL, V164, P2269, DOI 10.1016/S0002-9440(10)63783-2; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Stern DF, 2003, EXP CELL RES, V284, P89, DOI 10.1016/S0014-4827(02)00103-9; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Turashvili Gjulisa, 2007, Biomedical Papers (Olomouc), V151, P59; VANSLOOTEN HJ, 1995, BRIT J CANCER, V72, P22, DOI 10.1038/bjc.1995.271; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wijnhoven BPL, 2005, J SURG ONCOL, V92, P116, DOI 10.1002/jso.20344; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xu Y, 2009, BRIT J CANCER, V100, P633, DOI 10.1038/sj.bjc.6604901; Yamauchi J, 2008, J CELL BIOL, V181, P351, DOI 10.1083/jcb.200709033; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	59	62	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29491	29501		10.1074/jbc.M110.136770	http://dx.doi.org/10.1074/jbc.M110.136770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20595387	Green Published, hybrid			2022-12-25	WOS:000281740100051
J	Habrukowich, C; Han, DK; Le, A; Rezaul, K; Pan, W; Ghosh, M; Li, ZG; Dodge-Kafka, K; Jiang, XJ; Bittman, R; Hla, T				Habrukowich, Cheryl; Han, David K.; Le, Andrew; Rezaul, Karim; Pan, Wei; Ghosh, Mallika; Li, Zaiguo; Dodge-Kafka, Kimberly; Jiang, Xuejun; Bittman, Robert; Hla, Timothy			Sphingosine Interaction with Acidic Leucine-rich Nuclear Phosphoprotein-32A (ANP32A) Regulates PP2A Activity and Cyclooxygenase (COX)-2 Expression in Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCTION; APOPTOSIS; PATHWAY; DEATH; SPHINGOSINE-1-PHOSPHATE; DIFFERENTIATION; IDENTIFICATION; SPHINGOMYELIN; SPHINGOLIPIDS	Sphingolipid metabolites regulate cell fate by acting on specific cellular targets. Although the influence of sphingolipids in cellular signaling has been well recognized, the exact molecular targets and how these targets influence cellular signaling mechanisms remain poorly understood. Toward this goal, we used affinity chromatography coupled with proteomics technology and identified acidic leucine-rich nuclear phosphoprotein- 32A (ANP32A), an inhibitor of protein phosphatase 2A (PP2A) as a direct target of sphingosine, N, N'-dimethyl sphingosine (DMS) and phytosphingosine but not dihydrosphingosine or sphingosine 1-phosphate. Treatment of human umbilical vein endothelial cells (HUVEC) with DMS, which is not phosphorylated by sphingosine kinases, led to the activation of PP2A activity. Suppression of ANP32A with siRNA enhanced basal and DMS-activated PP2A activity suggesting that the sphingoid base binds to and relieves the inhibitory action of ANP32A on the PP2A complex. Indeed, DMS relieved the ANP32A-mediated inhibition of PP2A enzyme complex in vitro. Interestingly, DMS treatment induced the p38 stress-activated protein kinase (SAPK) and expression of cyclooxygenase (COX)-2 transcript and protein. Knockdown of ANP32A expression further induced p38 SAPK and COX-2. These data identify ANP32A as a novel molecular target of sphingoid bases that regulates cellular signaling events and inflammatory gene expression.	[Habrukowich, Cheryl; Han, David K.; Rezaul, Karim; Ghosh, Mallika; Hla, Timothy] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA; [Habrukowich, Cheryl; Han, David K.; Rezaul, Karim; Ghosh, Mallika; Hla, Timothy] Univ Connecticut, Ctr Hlth, Calhoun Cardiol Ctr, Dept Cell Biol, Farmington, CT 06030 USA; [Hla, Timothy] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA; [Pan, Wei; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Li, Zaiguo; Bittman, Robert] CUNY, Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	University of Connecticut; University of Connecticut; Cornell University; Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; Queens College NY (CUNY)	Hla, T (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA.	tih2002@med.cornell.edu	Hla, Timothy/G-5873-2012; Ghosh, Mallika/Q-2976-2016	Hla, Timothy/0000-0001-8355-4065; Ghosh, Mallika/0000-0002-5090-1275	National Institutes of Health [HL67330, CA77839, CA113890, HL83187]; NATIONAL CANCER INSTITUTE [P01CA077839, R01CA113890] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187, R01HL082705, R01HL067330, R37HL067330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67330 and CA77839 (to T. H.), CA113890 (to X. J.), and HL83187 (to R. B.).	AMES BN, 1960, J BIOL CHEM, V235, P769; Argraves KM, 2002, ADV EXP MED BIOL, V507, P439; Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Avdi NJ, 2002, J BIOL CHEM, V277, P40687, DOI 10.1074/jbc.M204455200; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Ferguson-Yankey SR, 2002, YEAST, V19, P573, DOI 10.1002/yea.861; FRANGIONI JV, 1993, J CELL SCI, V105, P481; Ghosh M, 2007, J EXP MED, V204, P2053, DOI 10.1084/jem.20070828; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Huyton T, 2007, PROTEIN SCI, V16, P1308, DOI 10.1110/ps.072803507; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lemonnier LA, 2003, ARCH BIOCHEM BIOPHYS, V419, P129, DOI 10.1016/j.abb.2003.08.023; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Megidish T, 1998, J BIOL CHEM, V273, P21834, DOI 10.1074/jbc.273.34.21834; MERRILL AH, 1997, J NUTR, V127, P830; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Nava VE, 2000, CANCER RES, V60, P4468; OHTA H, 1995, CANCER RES, V55, P691; Pan W, 2009, J BIOL CHEM, V284, P6946, DOI 10.1074/jbc.M805801200; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Santa-Coloma TA, 2003, CEREBELLUM, V2, P310, DOI 10.1080/14734220310017212; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Urs AN, 2006, ENDOCRINOLOGY, V147, P5249, DOI 10.1210/en.2006-0355; Yoon CH, 2009, MOL CANCER RES, V7, P361, DOI 10.1158/1541-7786.MCR-08-0069; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824	36	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26825	26831		10.1074/jbc.M110.147058	http://dx.doi.org/10.1074/jbc.M110.147058			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558741	Green Published, hybrid			2022-12-25	WOS:000281172700013
J	Lin, J; Yang, QY; Wilder, PT; Carrier, F; Weber, DJ				Lin, Jing; Yang, Qingyuan; Wilder, Paul T.; Carrier, France; Weber, David J.			The Calcium-binding Protein S100B Down-regulates p53 and Apoptosis in Malignant Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; TUMOR-SUPPRESSOR PROTEIN; UV-RADIATION; CANCER-CELLS; PIFITHRIN-ALPHA; DIFFERENTIAL EXPRESSION; P53-MEDIATED APOPTOSIS; P53-INDUCED APOPTOSIS; CARCINOMA-CELLS; MDM2 GENE	The S100B-p53 protein complex was discovered in C8146A malignant melanoma, but the consequences of this interaction required further study. When S100B expression was inhibited in C8146As by siRNA (siRNA(S100B)), wt p53 mRNA levels were unchanged, but p53 protein, phosphorylated p53, and p53 gene products (i.e. p21 and PIDD) were increased. siRNAS100B transfections also restored p53-dependent apoptosis in C8146As as judged by poly (ADP-ribose) polymerase cleavage, DNA ladder formation, caspase 3 and 8 activation, and aggregation of the Fas death receptor (+UV); whereas, siRNA(S100B) had no effect in SK-MEL-28 cells containing elevated S100B and inactive p53 (p53R145L mutant). siRNA(S100B)-mediated apoptosis was independent of the mitochondria, because no changes were observed in mitochondrial membrane potential, cytochrome c release, caspase 9 activation, or ratios of pro- and anti-apoptotic proteins (BAX, Bcl-2, and Bcl-X-L). As expected, cells lacking S100B (LOX-IM VI) were not affected by siRNA(S100B), and introduction of S100B reduced their UV-induced apoptosis activity by 7-fold, further demonstrating that S100B inhibits apoptosis activities in p53-containing cells. In other wild-type p53 cells (i.e. C8146A, UACC-2571, and UACC-62), S100B was found to contribute to cell survival after UV treatment, and for C8146As, the decrease in survival after siRNAS100B transfection (+UV) could be reversed by the p53 inhibitor, pifithrin-alpha. In summary, reducing S100B expression with siRNA was sufficient to activate p53, its transcriptional activation activities, and p53-dependent apoptosis pathway(s) in melanoma involving the Fas death receptor and perhaps PIDD. Thus, a well known marker for malignant melanoma, S100B, likely contributes to cancer progression by down-regulating the tumor suppressor protein, p53.	[Yang, Qingyuan; Carrier, France] Univ Maryland, Dept Radiat Oncol, Sch Med, Baltimore, MD 21201 USA; [Lin, Jing; Wilder, Paul T.; Weber, David J.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Wilder, Paul T.; Carrier, France; Weber, David J.] Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Carrier, F (corresponding author), Univ Maryland, Dept Radiat Oncol, Sch Med, 655 W Baltimore St, Baltimore, MD 21201 USA.	fcarr001@umaryland.edu; dweber@umaryland.edu	Weber, David J/B-5349-2011	Weber, David J/0000-0002-8824-1110; Carrier, France/0000-0002-5517-5284	National Institutes of Health [GM58888, CA107331]; American Cancer Society [CDD107745]; NATIONAL CANCER INSTITUTE [R01CA107331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58888 and CA107331 (to D.J.W.). This work was also supported by American Cancer Society Grant CDD107745 (to D.J.W.).	Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Bates S, 1996, CURR OPIN GENET DEV, V6, P12, DOI 10.1016/S0959-437X(96)90004-0; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Benchimol S, 2001, CELL DEATH DIFFER, V8, P1049, DOI 10.1038/sj.cdd.4400918; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Boni R, 1997, BRIT J DERMATOL, V137, P39, DOI 10.1046/j.1365-2133.1997.17651853.x; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Butz K, 1998, ONCOGENE, V17, P781, DOI 10.1038/sj.onc.1201995; Camby I, 1999, BRAIN PATHOL, V9, P1; Camphausen K, 2003, CANCER RES, V63, P1990; Chen Y, 2001, CANCER RES, V61, P6437; Cheng LHH, 2001, HEAD NECK-J SCI SPEC, V23, P972, DOI 10.1002/hed.1141; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chopin V, 2004, ONCOGENE, V23, P21, DOI 10.1038/sj.onc.1207020; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; Delphin C, 1999, J BIOL CHEM, V274, P10539, DOI 10.1074/jbc.274.15.10539; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Fan XL, 2005, APOPTOSIS, V10, P63, DOI 10.1007/s10495-005-6062-y; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Fraser M, 2006, ONCOGENE, V25, P2203, DOI 10.1038/sj.onc.1209251; Geara FB, 1996, SURG CLIN N AM, V76, P1383, DOI 10.1016/S0039-6109(05)70521-1; Haapajarvi T, 1999, EXP CELL RES, V248, P272, DOI 10.1006/excr.1999.4403; Hansson LO, 1997, ANTICANCER RES, V17, P3071; Hastak K, 2005, FASEB J, V19, P789, DOI 10.1096/fj.04-2226fje; Hauschild A, 1999, MELANOMA RES, V9, P155, DOI 10.1097/00008390-199904000-00008; Heizmann Claus W, 2002, Methods Mol Biol, V172, P69; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Huo JX, 2004, CELL DEATH DIFFER, V11, P99, DOI 10.1038/sj.cdd.4401322; Izumaru S, 2004, INT J ONCOL, V24, P1245; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kramer DL, 1999, CANCER RES, V59, P1278; Kulms D, 1999, P NATL ACAD SCI USA, V96, P7974, DOI 10.1073/pnas.96.14.7974; Kuo PC, 2004, J BIOL CHEM, V279, P55875, DOI 10.1074/jbc.M407985200; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Latonen L, 2003, CELL SIGNAL, V15, P95, DOI 10.1016/S0898-6568(02)00044-X; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lin J, 2004, J BIOL CHEM, V279, P34071, DOI 10.1074/jbc.M405419200; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; LIN J, 2006, AACR M, pA1168; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Maelandsmo GM, 1997, INT J CANCER, V74, P464, DOI 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9; Magrini R, 2007, J CELL BIOCHEM, V100, P1276, DOI 10.1002/jcb.21122; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; MEYSKENS F JR, 1981, Stem Cells (Basel), V1, P61; Meyskens F L Jr, 1981, Front Radiat Ther Oncol, V16, P55; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MONTANO X, 1994, ONCOGENE, V9, P1455; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; OConnor PM, 1997, CANCER RES, V57, P4285; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Rieber M, 2000, INT J CANCER, V86, P462, DOI 10.1002/(SICI)1097-0215(20000515)86:4<462::AID-IJC3>3.0.CO;2-B; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Satyamoorthy K, 2000, CELL GROWTH DIFFER, V11, P467; Saucedo LJ, 1998, CELL GROWTH DIFFER, V9, P119; Sawa H, 2001, Brain Tumor Pathol, V18, P109, DOI 10.1007/BF02479423; Schafer T, 2003, FASEB J, V17, P660, DOI 10.1096/fj.02-0774com; Scotto C, 1998, MOL CELL BIOL, V18, P4272, DOI 10.1128/MCB.18.7.4272; Scotto C, 1999, MOL CELL BIOL, V19, P7168; Senatus PB, 2006, MOL CANCER THER, V5, P20, DOI 10.1158/1535-7163.MCT-05-0181; Takai D, 2006, FREE RADICAL RES, V40, P1138, DOI 10.1080/10715760600838381; THOMSON SP, 1982, CANCER RES, V42, P4606; van Dieck J, 2010, ONCOGENE, V29, P2024, DOI 10.1038/onc.2009.490; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; Walton MI, 2005, MOL CANCER THER, V4, P1369, DOI 10.1158/1535-7163.MCT-04-0341; Wang JA, 1999, INT J RADIAT BIOL, V75, P301, DOI 10.1080/095530099140483; Wilder PT, 2006, BBA-MOL CELL RES, V1763, P1284, DOI 10.1016/j.bbamcr.2006.08.024; Wu L, 1997, MOL MED, V3, P441, DOI 10.1007/BF03401691; Wu ZH, 2005, CELL, V123, P980, DOI 10.1016/j.cell.2005.11.025; Zeng XY, 2000, CANCER RES, V60, P6184; Zhang H, 2006, CANCER LETT, V244, P229, DOI 10.1016/j.canlet.2005.12.021; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	78	85	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27487	27498		10.1074/jbc.M110.155382	http://dx.doi.org/10.1074/jbc.M110.155382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20587415	hybrid, Green Published			2022-12-25	WOS:000281172700078
J	Reinehr, R; Sommerfeld, A; Haussinger, D				Reinehr, Roland; Sommerfeld, Annika; Haeussinger, Dieter			Insulin Induces Swelling-dependent Activation of the Epidermal Growth Factor Receptor in Rat Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD95 MEMBRANE TRAFFICKING; FAMILY KINASE YES; SIGNAL-TRANSDUCTION; SRC; INVOLVEMENT; PHOSPHORYLATION; HYPEROSMOLARITY; REGENERATION; PROTEOLYSIS; MODULATION	The aim of the study was to analyze whether the proliferative effects of insulin in rat liver involve cross-signaling toward the epidermal growth factor receptor (EGFR) and whether this is mediated by insulin-induced hepatocyte swelling. Studies were performed in the perfused rat liver and in primary rat hepatocytes. Insulin (35 nmol/liter) induced phosphorylation of the EGFR at position Tyr(845) and Tyr(1173), but not at Tyr(1045), suggesting that EGF is not involved in insulin-induced EGFR activation. Insulin-induced EGFR phosphorylation and subsequent ERK1/2 phosphorylation were sensitive to bumetanide, indicating an involvement of insulin-induced hepatocyte swelling. In line with this, hypoosmotic (225 mosmol/liter) hepatocyte swelling also induced EGFR and ERK1/2 activation. Insulin- and hypoosmolarity-induced EGFR activation were sensitive to inhibition by an integrin-antagonistic RGD peptide, an integrin beta 1 subtype-blocking antibody, and the c-Src inhibitor PP-2, indicating the involvement of the recently described integrin-dependent osmosensing/signaling pathway (Schliess, F., Reissmann, R., Reinehr, R., vom Dahl, S., and Haussinger, D. (2004) J. Biol. Chem. 279, 21294-21301). As shown by immunoprecipitation studies, insulin and hypoosmolarity induced a rapid, RGD peptide-, integrin beta 1-blocking antibody and PP-2-sensitive association of c-Src with the EGFR. As for control, insulin-induced insulin receptor substrate-1 phosphorylation remained unaffected by the RGD peptide, PP-2, or inhibition of the EGFR tyrosine kinase activity by AG1478. Both insulin and hypoosmolarity induced a significant increase in BrdU uptake in primary rat hepatocytes, which was sensitive to RGD peptide-, integrin beta 1-blocking antibody, PP-2, AG1478, and PD098059. It is concluded that insulin- or hypoosmolarity-induced hepatocyte swelling triggers an integrin- and c-Src kinase-dependent EGFR activation, which may explain the proliferative effects of insulin.	[Reinehr, Roland; Sommerfeld, Annika; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016		Deutsche Forschungsgemeinschaft (Dusseldorf) [575]	Deutsche Forschungsgemeinschaft (Dusseldorf)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 575 "Experimentelle Hepatologie" (Dusseldorf).	Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555; Eberle A, 2005, HEPATOLOGY, V41, P315, DOI 10.1002/hep.20564; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Fujioka T, 2001, EUR J BIOCHEM, V268, P25, DOI 10.1046/j.1432-1327.2001.01831.x; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; HAUSSINGER D, 1992, TRENDS PHARMACOL SCI, V13, P371, DOI 10.1016/0165-6147(92)90114-L; Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9; Haussinger Dieter, 2004, Molecular Aspects of Medicine, V25, P221, DOI 10.1016/j.mam.2004.02.001; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nystrom FH, 1999, CELL SIGNAL, V11, P563, DOI 10.1016/S0898-6568(99)00025-X; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; Poppleton HM, 1999, ARCH BIOCHEM BIOPHYS, V363, P227, DOI 10.1006/abbi.1998.1095; Ravid T, 2002, J BIOL CHEM, V277, P31214, DOI 10.1074/jbc.M204677200; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Reinehr R, 2004, GASTROENTEROLOGY, V127, P1540, DOI 10.1053/j.gastro.2004.08.056; Reinehr R, 2004, J BIOL CHEM, V279, P23977, DOI 10.1074/jbc.M401519200; Reinehr R, 2002, HEPATOLOGY, V36, P602, DOI 10.1053/jhep.2002.35447; Reinehr R, 2009, BIOL CHEM, V390, P1033, DOI 10.1515/BC.2009.106; Schliess F, 2004, J BIOL CHEM, V279, P21294, DOI 10.1074/jbc.M313901200; Schliess F, 2001, BIOL CHEM, V382, P1063, DOI 10.1515/BC.2001.133; Sies H, 1978, Methods Enzymol, V52, P48; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Taha C, 1999, J MEMBRANE BIOL, V169, P1, DOI 10.1007/PL00005896; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; vom Dahl S, 2003, J BIOL CHEM, V278, P27088, DOI 10.1074/jbc.M210699200; VOMDAHL S, 1995, BIOCHEM J, V308, P529, DOI 10.1042/bj3080529; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201	39	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25904	25912		10.1074/jbc.M110.125781	http://dx.doi.org/10.1074/jbc.M110.125781			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20571033	hybrid, Green Published			2022-12-25	WOS:000280921000005
J	Strauss, K; Goebel, C; Runz, H; Mobius, W; Weiss, S; Feussner, I; Simons, M; Schneider, A				Strauss, Katrin; Goebel, Cornelia; Runz, Heiko; Moebius, Wiebke; Weiss, Sievert; Feussner, Ivo; Simons, Mikael; Schneider, Anja			Exosome Secretion Ameliorates Lysosomal Storage of Cholesterol in Niemann-Pick Type C Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DERIVED EXOSOMES; PURIFIED NPC1 PROTEIN; ALZHEIMERS-DISEASE; INTRACELLULAR TRAFFICKING; REGGIE/FLOTILLIN PROTEINS; BENZODIAZEPINE-RECEPTOR; MEMBRANE MICRODOMAINS; C1-DEFICIENT NEURONS; CORTICAL-NEURONS; DISTAL AXONS	Niemann-Pick type C1 disease is an autosomal-recessive lysosomal storage disorder. Loss of function of the npc1 gene leads to abnormal accumulation of free cholesterol and sphingolipids within the late endosomal and lysosomal compartments resulting in progressive neurodegeneration and dysmyelination. Here, we show that oligodendroglial cells secrete cholesterol by exosomes when challenged with cholesterol or U18666A, which induces late endosomal cholesterol accumulation. Up-regulation of exosomal cholesterol release was also observed after siRNA-mediated knockdown of NPC1 and in fibroblasts derived from NPC1 patients and could be reversed by expression of wild-type NPC1. We provide evidence that exosomal cholesterol secretion depends on the presence of flotillin. Our findings indicate that exosomal release of cholesterol may serve as a cellular mechanism to partially bypass the traffic block that results in the toxic lysosomal cholesterol accumulation in Niemann-Pick type C1 disease. Furthermore, we suggest that secretion of cholesterol by exosomes contributes to maintain cellular cholesterol homeostasis.	[Moebius, Wiebke; Schneider, Anja] Max Planck Inst Expt Med, Neurogenet Dept, D-37075 Gottingen, Germany; [Strauss, Katrin; Schneider, Anja] Univ Med Goettingen, Dept Psychiat & Psychotherapy, D-37075 Gottingen, Germany; [Goebel, Cornelia; Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Albrecht von Haller Inst Plant Sci, D-37077 Gottingen, Germany; [Runz, Heiko] Univ Heidelberg, Dept Human Genet, D-69120 Heidelberg, Germany; Univ Med Goettingen, Dept Neurol, D-37075 Gottingen, Germany	Max Planck Society; University of Gottingen; Ruprecht Karls University Heidelberg	Schneider, A (corresponding author), Max Planck Inst Expt Med, Neurogenet Dept, Hermann Rein Str 3, D-37075 Gottingen, Germany.	aschnei8@gwdg.de	Schneider, Anja/F-5293-2010; Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Simons, Mikael/0000-0001-5329-192X; /0000-0002-2902-7165; Schneider, Anja/0000-0001-9540-8700	Faculty of Medicine, Georg-August-University Gottingen, Germany [0010/1401870]; Center of Molecular Physiology of the Brain Gottingen; Novartis; European Research Council	Faculty of Medicine, Georg-August-University Gottingen, Germany; Center of Molecular Physiology of the Brain Gottingen; Novartis(Novartis); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Research Program, Faculty of Medicine, Georg-August-University Gottingen, Germany (Grant 0010/1401870 and Heidenreich-Siebold-Program (to A.S.)), the Center of Molecular Physiology of the Brain Gottingen and a Novartis fellowship (to A.S.), and by an European Research Council starting grant (to M.S.).	Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Bauer SHJ, 2001, ANAL BIOCHEM, V298, P25, DOI 10.1006/abio.2001.5330; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chang TY, 2010, IUBMB LIFE, V62, P261, DOI 10.1002/iub.305; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Karten B, 2002, J NEUROCHEM, V83, P1154, DOI 10.1046/j.1471-4159.2002.01220.x; Karten B, 2003, J BIOL CHEM, V278, P4168, DOI 10.1074/jbc.M205406200; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Klein D, 2005, BIOCHEM BIOPH RES CO, V327, P663, DOI 10.1016/j.bbrc.2004.12.054; Kokubo H, 2003, BRAIN RES, V965, P83, DOI 10.1016/S0006-8993(02)04140-9; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P122, DOI 10.1016/j.bbamem.2006.09.014; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Montecalvo A, 2008, J IMMUNOL, V180, P3081, DOI 10.4049/jimmunol.180.5.3081; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Phillips SE, 2008, J NEUROSCI, V28, P6569, DOI 10.1523/JNEUROSCI.5529-07.2008; Roitbak T, 2005, BIOCHEM J, V392, P29, DOI 10.1042/BJ20050645; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Tashiro Y, 2004, EUR J NEUROSCI, V20, P2015, DOI 10.1111/j.1460-9568.2004.03677.x; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; VIDAL M, 1989, J CELL PHYSIOL, V140, P455, DOI 10.1002/jcp.1041400308; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Xie CL, 2000, J NEUROPATH EXP NEUR, V59, P1106, DOI 10.1093/jnen/59.12.1106; Zakharova L, 2007, J CELL PHYSIOL, V212, P174, DOI 10.1002/jcp.21013	55	158	167	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26279	26288		10.1074/jbc.M110.134775	http://dx.doi.org/10.1074/jbc.M110.134775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554533	Green Published, hybrid			2022-12-25	WOS:000280921000045
J	Cho, HJ; Park, SM; Hwang, EM; Baek, KE; Kim, IK; Nam, IK; Im, MJ; Park, SH; Bae, S; Park, JY; Yoo, J				Cho, Hee Jun; Park, Sun-Mi; Hwang, Eun Mi; Baek, Kyoung Eun; Kim, In-Kyu; Nam, In-Koo; Im, Min-Ju; Park, Seung-Ho; Bae, Seran; Park, Jae-Yong; Yoo, Jiyun			Gadd45b Mediates Fas-induced Apoptosis by Enhancing the Interaction between p38 and Retinoblastoma Tumor Suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; KINASE-ACTIVITY; PROTEIN; ACTIVATION; CELLS; MTK1/MEKK4; EXPRESSION; GADD45A-DEFICIENT; RADIATION; PATHWAY	Gadd45b has been known as a positive mediator of apoptosis induced by certain cytokines and oncogenes. Here, we identified Gadd45b as an effector of Fas-induced apoptosis and found that p38-mediated Rb hyperphosphorylation is one of the mechanisms of Fas-induced apoptosis in murine hepatocyte AML12 cells. Gadd45b has been shown to activate p38 through its physical interaction with MTK1 and induce apoptosis. However, in this study, we have showed that the function of Gadd45b during Fas-induced apoptosis in AML12 cells is different from that reported in previous studies. Depletion of Gadd45b expression did not inhibit the phosphorylation of p38, but it suppressed p38-mediated Rb phosphorylation and apoptosis in response to Fas stimulation by reducing the interaction between p38 and Rb. Ectopic expression of Gadd45b was sufficient to enhance this interaction. These findings suggest that Gadd45b mediates p38-induced Rb phosphorylation by enhancing the interaction between p38 and Rb during Fas-induced apoptosis in murine hepatocytes.	[Cho, Hee Jun; Park, Sun-Mi; Baek, Kyoung Eun; Kim, In-Kyu; Nam, In-Koo; Im, Min-Ju; Park, Seung-Ho; Bae, Seran; Yoo, Jiyun] Gyeongsang Natl Univ, Coll Nat Sci, Dept Microbiol, Life Sci Res Inst, Jinju 660701, South Korea; [Hwang, Eun Mi] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul 136791, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Physiol, Jinju 660751, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Sch Med, Med Res Ctr Neural Dysfunct, Jinju 660751, South Korea	Gyeongsang National University; Korea Institute of Science & Technology (KIST); Gyeongsang National University; Gyeongsang National University	Yoo, J (corresponding author), Gyeongsang Natl Univ, Coll Nat Sci, Dept Microbiol, Life Sci Res Inst, Jinju 660701, South Korea.	yooj@gsnu.ac.kr	Hwang, Eun Mi/HHN-3030-2022	Kim, In-Kyu/0000-0002-8427-8311; Park, Jae-Yong/0000-0001-7698-7890	Ministry of Health and Welfare, Republic of Korea [0420050]; Korean government (MOEHRD) [KRF-2005-003-C00140]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This study was supported by Grant 0420050 from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea and Korea Research Foundation Grant KRF-2005-003-C00140 funded by the Korean government (MOEHRD, Basic Research Promotion Fund).	Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Engelmann A, 2008, ONCOGENE, V27, P1429, DOI 10.1038/sj.onc.1210772; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; Fulda S, 2001, ONCOGENE, V20, P1063, DOI 10.1038/sj.onc.1204141; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hou ST, 2002, J BIOL CHEM, V277, P48764, DOI 10.1074/jbc.M206336200; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KEARSEY JM, 1995, ONCOGENE, V11, P1675; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; PAPATHANASIOU MA, 1991, MOL CELL BIOL, V11, P1009, DOI 10.1128/MCB.11.2.1009; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Wang S, 1999, EMBO J, V18, P1559, DOI 10.1093/emboj/18.6.1559; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; Zazzeroni F, 2003, BLOOD, V102, P3270, DOI 10.1182/blood-2003-03-0689; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361; Zhang W, 2001, INT J ONCOL, V18, P749	29	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25500	25505		10.1074/jbc.M109.091413	http://dx.doi.org/10.1074/jbc.M109.091413			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20558744	Green Published, hybrid			2022-12-25	WOS:000280682400043
J	Fromigue, O; Hay, E; Barbara, A; Marie, PJ				Fromigue, Olivia; Hay, Eric; Barbara, Alain; Marie, Pierre J.			Essential Role of Nuclear Factor of Activated T Cells (NFAT)-mediated Wnt Signaling in Osteoblast Differentiation Induced by Strontium Ranelate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX MINERALIZATION; BONE-FORMATION; CALCINEURIN; CALCIUM; NFAT; BETA; OSTEOCLASTOGENESIS; TRANSCRIPTION; OSTEOPOROSIS; PATHWAY	The antiosteoporotic treatment strontium ranelate (SrRan) was shown to increase bone mass and strength by dissociating bone resorption and bone formation. To identify the molecular mechanisms of action of SrRan on osteoblasts, we investigated its effects on calcineurin-NFAT (nuclear factor of activated T cells) signaling, an important calcium sensitive pathway controlling bone formation. Using murine MC3T3-E1 and primary murine osteoblasts, we demonstrate that SrRan induces NFATc1 nuclear translocation, as shown by immunocytochemical and Western blot analyses. Molecular analysis showed that SrRan increased NFATc1 transactivation in osteoblasts, an effect that was fully abrogated by the calcineurin inhibitors cyclosporin A or FK506, confirming that SrRan activates NFATc1 signaling in osteoblasts. This has functional implications because calcineurin inhibitors blunted the enhanced osteoblast replication and expression of the osteoblast phenotypic markers Runx2, alkaline phosphatase, and type I collagen induced by SrRan. We further found that SrRan increased the expression of Wnt3a and Wnt5a as well as beta-catenin transcriptional activity in osteoblasts, and these effects were abolished by calcineurin inhibitors. The Wnt inhibitors sFRP1 and DKK1 abolished SrRan-induced osteoblast gene expression. Furthermore, blunting the Wnt5a receptor Ryk or RhoA that acts downstream of Ryk abrogated cell proliferation and osteoblast gene expression induced by SrRan. These results indicate that activation of NFATc1 and downstream canonical and non-canonical Wnt signaling pathways mediate SrRan-induced osteoblastic cell replication and differentiation, which provides novel insights into the mechanisms of action of this antiosteoporotic agent in osteoblastogenesis.	[Fromigue, Olivia; Hay, Eric; Barbara, Alain; Marie, Pierre J.] Hop Lariboisiere, INSERM, UMR606, Lab Osteoblast Biol & Pathol,U606, F-75475 Paris 10, France; [Fromigue, Olivia; Hay, Eric; Barbara, Alain; Marie, Pierre J.] Univ Paris Diderot, UMR606, F-75475 Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, UMR606, Lab Osteoblast Biol & Pathol,U606, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr	Fromigue, Olivia/B-8225-2013	Fromigue, Olivia/0000-0002-3050-6155; Hay, Eric/0000-0002-0131-9983	Inserm, University Paris Diderot; Institut de Recherches Servier (IRIS, Courbevoie, France)	Inserm, University Paris Diderot(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut de Recherches Servier (IRIS, Courbevoie, France)	This work was supported by grants from Inserm, University Paris Diderot, and the Institut de Recherches Servier (IRIS, Courbevoie, France).	Ali MM, 2007, J CELL SCI, V120, P2565, DOI 10.1242/jcs.005090; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Ammann P, 2007, J BONE MINER RES, V22, P1419, DOI 10.1359/jbmr.070607; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Arlot ME, 2008, J BONE MINER RES, V23, P215, DOI 10.1359/JBMR.071012; Arnsdorf EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005388; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4; Chattopadhyay N, 2007, BIOCHEM PHARMACOL, V74, P438, DOI 10.1016/j.bcp.2007.04.020; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Choudhary S, 2007, J BONE MINER RES, V22, P1002, DOI 10.1359/JBMR.070321; Coulombe J, 2004, BIOCHEM BIOPH RES CO, V323, P1184, DOI 10.1016/j.bbrc.2004.08.209; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dai YS, 2005, MOL CELL BIOL, V25, P9936, DOI 10.1128/MCB.25.22.9936-9948.2005; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fromigue O, 2009, J CELL MOL MED, V13, P2189, DOI 10.1111/j.1582-4934.2009.00673.x; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Guo J, 2008, BONE, V43, P961, DOI 10.1016/j.bone.2008.06.011; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hott M, 2003, BONE, V33, P115, DOI 10.1016/S8756-3282(03)00115-7; Ikeda F, 2006, J IMMUNOL, V177, P2384, DOI 10.4049/jimmunol.177.4.2384; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Liu Y, 2007, MOL ENDOCRINOL, V21, P376, DOI 10.1210/me.2006-0342; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Marie PJ, 2005, CURR OPIN PHARMACOL, V5, P633, DOI 10.1016/j.coph.2005.05.005; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Riggs BL, 2005, J BONE MINER RES, V20, P177, DOI 10.1359/JBMR.041114; Smerdel-Ramoya A, 2008, J BIOL CHEM, V283, P22690, DOI 10.1074/jbc.M710140200; Sun L, 2007, AM J PHYSIOL-RENAL, V292, pF285, DOI 10.1152/ajprenal.00415.2005; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yeo HJ, 2007, J BIOL CHEM, V282, P35318, DOI 10.1074/jbc.M702435200; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhu LL, 2007, BIOCHEM BIOPH RES CO, V355, P307, DOI 10.1016/j.bbrc.2007.01.120	53	98	111	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25251	25258		10.1074/jbc.M110.110502	http://dx.doi.org/10.1074/jbc.M110.110502			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554534	Green Published, hybrid			2022-12-25	WOS:000280682400018
J	Buglino, JA; Resh, MD				Buglino, John A.; Resh, Marilyn D.			Identification of Conserved Regions and Residues within Hedgehog Acyltransferase Critical for Palmitoylation of Sonic Hedgehog	PLOS ONE			English	Article							CHOLESTEROL MODIFICATION; LYSOPHOSPHOLIPID ACYLTRANSFERASE; LIPID MODIFICATIONS; MBOAT FAMILY; FATTY-ACIDS; PROTEIN; MEMBRANE; ENCODES; RANGE; SPECIFICITY	Background: Sonic hedgehog (Shh) is a palmitoylated protein that plays key roles in mammalian development and human cancers. Palmitoylation of Shh is required for effective long and short range Shh-mediated signaling. Attachment of palmitate to Shh is catalyzed by Hedgehog acyltransferase (Hhat), a member of the membrane bound O-acyl transferase (MBOAT) family of multipass membrane proteins. The extremely hydrophobic composition of MBOAT proteins has limited their biochemical characterization. Except for mutagenesis of two conserved residues, there has been no structure-function analysis of Hhat, and the regions of the protein required for Shh palmitoylation are unknown. Methodology/Principal Findings: Here we undertake a systematic approach to identify residues within Hhat that are required for protein stability and/or enzymatic activity. We also identify a second, novel MBOAT homology region (residues 196-234) that is required for Hhat activity. In total, ten deletion mutants and eleven point mutants were generated and analyzed. Truncations at the N- and C-termini of Hhat yielded inactive proteins with reduced stability. Four Hhat mutants with deletions within predicted loop regions and five point mutants retained stability but lost palmitoylation activity. We purified two point mutants, W378A and H379A, with defective Hhat activity. Kinetic analyses revealed alterations in apparent K(m) and V(max) for Shh and/or palmitoyl CoA, changes that likely explain the catalytic defects observed for these mutants. Conclusions/Significance: This study has pinpointed specific regions and multiple residues that regulate Hhat stability and catalysis. Our findings should be applicable to other MBOAT proteins that mediate lipid modification of Wnt proteins and ghrelin, and should serve as a model for understanding how secreted morphogens are modified by palmitoyl acyltransferases.	[Buglino, John A.; Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; [Buglino, John A.; Resh, Marilyn D.] Cornell Univ, Grad Program Biochem Cell & Mol Biol, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Buglino, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	m-resh@ski.mskcc.org		Resh, Marilyn/0000-0001-6118-9466	National Institutes of Health [GM57966, GM008539]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008539, R01GM057966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health grants GM57966 and GM008539. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217; Callejo A, 2008, P NATL ACAD SCI USA, V105, P912, DOI 10.1073/pnas.0705603105; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chang CCY, 1998, J BIOL CHEM, V273, P35132, DOI 10.1074/jbc.273.52.35132; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Guo ZM, 2001, J LIPID RES, V42, P1282; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Ho KS, 2002, CURR OPIN NEUROBIOL, V12, P57, DOI 10.1016/S0959-4388(02)00290-8; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Matsuda S, 2008, GENES CELLS, V13, P879, DOI 10.1111/j.1365-2443.2008.01212.x; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PESECKIS SM, 1993, J BIOL CHEM, V268, P5107; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200	43	42	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11195	10.1371/journal.pone.0011195	http://dx.doi.org/10.1371/journal.pone.0011195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585641	Green Submitted, Green Published, gold			2022-12-25	WOS:000279135400008
J	Pal, S; Dolai, S; Yadav, RK; Adak, S				Pal, Swati; Dolai, Subhankar; Yadav, Rajesh K.; Adak, Subrata			Ascorbate Peroxidase from Leishmania major Controls the Virulence of Infective Stage of Promastigotes by Regulating Oxidative Stress	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; APOPTOTIC CELLS; DEVELOPMENTAL MODIFICATION; CYTOKINE PRODUCTION; IN-VITRO; TGF-BETA; METACYCLOGENESIS; DIFFERENTIATION; DONOVANI	Background: Peroxidase represents a heterogeneous group of distinct enzyme family that plays extremely diverse biological functions. Ascorbate peroxidase from Leishmania major (LmAPX) has been shown to be central to the redox defense system of Leishmania. To investigate further its exact physiological role in Leishmania, we attempted to create LmAPX-knockout mutants by gene replacement in L. major strains. Methodology/Principal Findings: The null mutant cell culture contains a higher percentage of metacyclic and apoptotic cells compared to both wild type and LmAPX overexpressing cells. Flowcytometric analysis reveals the presence of a higher concentration of intracellular H2O2, indicative of increased oxidative stress in parasites lacking LmAPX. IC50 value for exogenously added H2O2 shows that deletion of LmAPX in L. major renders the cell more susceptible to H2O2. Real time PCR studies demonstrate an elevated mRNA level of non-selenium glutathione peroxidase in LmAPX null mutant cell line, suggesting that these enzymes were induced to compensate the LmAPX enzyme. The null mutant cells exhibit hypervirulence after infection with macrophages as well as inoculation into BALB/c mice; in contrast, overexpressing cells show avirulence. Conclusions/Significance: Collectively, these data provide strong evidence that LmAPX is an important factor for controlling parasite differentiation and survival within macrophages.	[Pal, Swati; Dolai, Subhankar; Yadav, Rajesh K.; Adak, Subrata] Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Pal, S (corresponding author), Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata, W Bengal, India.	adaks@iicb.res.in		Pal, Swati/0000-0001-6179-4316; YADAV, RAJESH/0000-0002-4239-0428	Department of Science and Technology [SR/SO/BB-54/2005]; Council of Scientific and Industrial Research (CSIR) [NWP 0038]	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Department of Science and Technology Grant SR/SO/BB-54/2005, Council of Scientific and Industrial Research (CSIR) Project NWP 0038, CSIR Fellowships (to S.P., S.D. and R.K.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak S, 2005, BIOCHEM J, V390, P465, DOI 10.1042/BJ20050311; Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; BARRAL A, 1995, AM J PATHOL, V147, P947; BARRAL A, 1993, P NATL ACAD SCI USA, V90, P3442, DOI 10.1073/pnas.90.8.3442; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Castro H, 2008, ANTIOXID REDOX SIGN, V10, P1593, DOI 10.1089/ars.2008.2050; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Cunningham ML, 2001, SCIENCE, V292, P285, DOI 10.1126/science.1057740; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; Dolai S, 2007, BBA-GEN SUBJECTS, V1770, P247, DOI 10.1016/j.bbagen.2006.10.001; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dolai S, 2009, EUKARYOT CELL, V8, P1721, DOI 10.1128/EC.00198-09; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 1998, BIOCHEM SOC T, V26, P653, DOI 10.1042/bst0260653; Flohe L, 2008, ANTIOXID REDOX SIGN, V10, P1485, DOI 10.1089/ars.2008.2059; GREEN SJ, 1990, J IMMUNOL, V145, P4290; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; Henson PM, 2004, IMMUNITY, V21, P604, DOI 10.1016/j.immuni.2004.11.002; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; MURRAY HW, 1988, J INFECT DIS, V158, P1372, DOI 10.1093/infdis/158.6.1372; NELSON BJ, 1991, J IMMUNOL, V146, P1849; REINER NE, 1990, J CLIN INVEST, V85, P1914, DOI 10.1172/JCI114654; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; SACKS DL, 1990, MOL BIOCHEM PARASIT, V42, P225, DOI 10.1016/0166-6851(90)90165-I; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; SACKS DL, 1985, J IMMUNOL, V135, P564; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; SACKS DL, 1989, EXP PARASITOL, V69, P100, DOI 10.1016/0014-4894(89)90176-8; Saraiva EM, 2005, EXP PARASITOL, V110, P39, DOI 10.1016/j.exppara.2005.01.004; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Yadav RK, 2008, BBA-PROTEINS PROTEOM, V1784, P863, DOI 10.1016/j.bbapap.2008.02.006	39	62	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11271	10.1371/journal.pone.0011271	http://dx.doi.org/10.1371/journal.pone.0011271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585663	gold, Green Published, Green Submitted			2022-12-25	WOS:000279135400017
J	Hasegawa, K; Miwa, J				Hasegawa, Koichi; Miwa, Johji			Genetic and Cellular Characterization of Caenorhabditis elegans Mutants Abnormal in the Regulation of Many Phase II Enzymes	PLOS ONE			English	Article							OXIDATIVE-STRESS-RESPONSE; C-ELEGANS; FACTOR SKN-1; LIFE-SPAN; ACRYLAMIDE; EXPRESSION; LONGEVITY; SPECIFICATION; INHIBITION; MECHANISMS	Background: The phase II detoxification enzymes execute a major protective role against xenobiotics as well as endogenous toxicants. To understand how xenobiotics regulate phase II enzyme expression, acrylamide was selected as a model xenobiotic chemical, as it induces a large number and a variety of phase II enzymes, including numerous glutathione S-transferases (GSTs) in Caenorhabditis elegans. Methodology/Principal Findings: To begin dissecting genetically xenobiotics response pathways (xrep), 24 independent mutants of C. elegans that exhibited abnormal GST expression or regulation against acrylamide were isolated by screening about 3.5 x 10(5) genomes of gst::gfp transgenic strains mutagenized with ethyl methanesulfonate (EMS). Complementation testing assigned the mutants to four different genes, named xrep-1, -2, -3, and -4. One of the genes, xrep-1, encodes WDR-23, a nematode homologue of WD repeat-containing protein WDR23. Loss-of-function mutations in xrep-1 mutants resulted in constitutive expression of many GSTs and other phase II enzymes in the absence of acrylamide, and the wild-type xrep-1 allele carried on a DNA construct successfully cured the mutant phenotype of the constitutive enzyme expression. Conclusions/Significance: Genetic and cellular characterization of xrep-1 mutants suggest that a large number of GSTs and other phase II enzymes induced by acrylamide are under negative regulation by XREP-1 (WDR-23), which is likely to be a functional equivalent of mammalian Keap1 and a regulator of SKN-1, a C. elegans analogue of cap-n-collar Nrf2 (nuclear factor erythroid 2-related factor 2).	[Hasegawa, Koichi; Miwa, Johji] Chubu Univ, Coll Biosci & Biotechnol, Aichi, Japan	Chubu University	Hasegawa, K (corresponding author), Chubu Univ, Coll Biosci & Biotechnol, Aichi, Japan.	miwa@isc.chubu.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Chubu University	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chubu University	This work was supported by a Grant-in-Aid for Scientific Research to JM and a JSPS research fund to KH of the Japanese Ministry of Education, Culture, Sports, Science and Technology and by the Chubu University special research fund to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzal B, 2009, ENVIRON HEALTH PERSP, V117, P1293, DOI 10.1289/ehp.0800317; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; BRENNER S, 1974, GENETICS, V77, P71; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Dybing E, 2008, TOXICOL LETT, V180, P110, DOI 10.1016/j.toxlet.2008.05.007; Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Hasegawa K, 2004, TOXICOL LETT, V152, P183, DOI 10.1016/j.toxlet.2004.04.037; HASEGAWA K, 2010, TRANSCRIPTO IN PRESS; Hasegawa K, 2008, TOXICOL SCI, V101, P215, DOI 10.1093/toxsci/kfm276; Hasegawa K, 2007, TOXICOL LETT, V175, P82, DOI 10.1016/j.toxlet.2007.09.013; Hasegawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009267; HAYES JD, 2005, ANN REV PHARM TOXICO, V88, P45; Hudson Andrew M., 2008, V48, P6, DOI 10.1007/978-0-387-09595-0_2; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Jowsey IR, 2001, BIOCHEM J, V359, P507, DOI 10.1042/0264-6021:3590507; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lindblom TH, 2006, J EXP ZOOL PART A, V305A, P720, DOI 10.1002/jez.a.324; Maduro M, 1996, GENE, V183, P77, DOI 10.1016/S0378-1119(96)00491-X; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; ODLAND L, 1994, TOXICOL IN VITRO, V8, P263, DOI 10.1016/0887-2333(94)90192-9; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Park SK, 2009, AGING CELL, V8, P258, DOI 10.1111/j.1474-9726.2009.00473.x; Sumner SCJ, 2003, TOXICOL SCI, V75, P260, DOI 10.1093/toxsci/kfg191; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tan SW, 2009, CRIT REV TOXICOL, V39, P228, DOI 10.1080/10408440802233259; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030	39	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11194	10.1371/journal.pone.0011194	http://dx.doi.org/10.1371/journal.pone.0011194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20585349	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886300032
J	Lagana, A; Russo, F; Sismeiro, C; Giugno, R; Pulvirenti, A; Ferro, A				Lagana, Alessandro; Russo, Francesco; Sismeiro, Catarina; Giugno, Rosalba; Pulvirenti, Alfredo; Ferro, Alfredo			Variability in the Incidence of miRNAs and Genes in Fragile Sites and the Role of Repeats and CpG Islands in the Distribution of Genetic Material	PLOS ONE			English	Article							VIRAL INTEGRATION; MESSENGER-RNAS; MICRORNA GENES; FRA3B; LUNG; ELEMENTS; FREQUENT; REVEALS; REGIONS; BREAKPOINTS	Background: Chromosomal fragile sites are heritable specific loci especially prone to breakage. Some of them are associated with human genetic disorders and several studies have demonstrated their importance in genome instability in cancer. MicroRNAs (miRNAs) are small non-coding RNAs responsible of post-transcriptional gene regulation and their involvement in several diseases such as cancer has been widely demonstrated. The altered expression of miRNAs is sometimes due to chromosomal rearrangements and epigenetic events, thus it is essential to study miRNAs in the context of their genomic locations, in order to find significant correlations between their aberrant expression and the phenotype. Principal Findings: Here we use statistical models to study the incidence of human miRNA genes on fragile sites and their association with cancer-specific translocation breakpoints, repetitive elements, and CpG islands. Our results show that, on average, fragile sites are denser in miRNAs and also in protein coding genes. However, the distribution of miRNAs and protein coding genes in fragile versus non-fragile sites depends on chromosome. We find also a positive correlation between fragility and repeats, and between miRNAs and CpG islands. Conclusion: Our results show that the relationship between site fragility and miRNA density is far more complex than previously thought. For example, we find that protein coding genes seem to be following similar patterns as miRNAs, if considered their overall distribution. However, once we allow for differences at the chromosome level in our statistical analysis, we find that distribution of miRNA and protein coding genes in fragile sites is very different from that of miRNA. This is a novel result that we believe may help discover new potential correlations between the localization of miRNAs and their crucial role in biological processes and in the development of diseases.	[Lagana, Alessandro; Giugno, Rosalba; Pulvirenti, Alfredo; Ferro, Alfredo] Univ Catania, Dept Math & Comp Sci, Catania, Italy; [Russo, Francesco; Ferro, Alfredo] Univ Catania, Dept Biomed Sci, Catania, Italy; [Sismeiro, Catarina] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England	University of Catania; University of Catania; Imperial College London	Lagana, A (corresponding author), Univ Catania, Dept Math & Comp Sci, Catania, Italy.	lagana@dmi.unict.it; ferro@dmi.unict.it	Pulvirenti, Alfredo/I-7272-2018; Russo, Francesco/X-3055-2018	Pulvirenti, Alfredo/0000-0002-9764-0295; Russo, Francesco/0000-0001-9257-4359; Giugno, Rosalba/0000-0001-9843-7638	PROGETTO FIRB ITALY-ISRAEL [RBIN04BYZ7]	PROGETTO FIRB ITALY-ISRAEL	This research was supported by PROGETTO FIRB ITALY-ISRAEL Grant n. RBIN04BYZ7: "Algorithms for Patterns Discovery and Retrieval in discrete structures with applications to Bioinformatics." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker NA, 2002, ONCOGENE, V21, P8713, DOI 10.1038/sj.onc.1205950; Bednarek AK, 2001, CANCER RES, V61, P8068; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; BORGAONKAR DS, 1975, CYTOGENET CELL GENET, V14, P252, DOI 10.1159/000130355; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Burrow AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-59; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Daheron L, 2001, GENE CHROMOSOME CANC, V31, P382, DOI 10.1002/gcc.1157; Dallol A, 2002, CANCER RES, V62, P5874; Demirhan O, 2008, ALCOHOL ALCOHOLISM, V43, P127, DOI 10.1093/alcalc/agm155; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; FERRO A, 2009, NETTAB 2009 CAT IT J; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; Goransson M, 2009, ONCOGENE, V28, P270, DOI 10.1038/onc.2008.378; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grover D, 2004, BIOINFORMATICS, V20, P813, DOI 10.1093/bioinformatics/bth005; Hewett DR, 1998, MOL CELL, V1, P773, DOI 10.1016/S1097-2765(00)80077-5; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lagana A, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap008; Laissue P, 2009, J MED GENET, V46, P455, DOI 10.1136/jmg.2008.065086; Lehnert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004456; Levy A, 2008, NUCLEIC ACIDS RES, V36, pD47, DOI 10.1093/nar/gkm949; LEWANDOWSKA U, 2009, PHYSL PHARM S1, V60, P47; LI Y, 1925, CANCER SCI, V100, P1234; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lukusa T, 2008, BBA-GENE REGUL MECH, V1779, P3, DOI 10.1016/j.bbagrm.2007.10.005; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Matuszek G, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-102; Mendes-da-Silva P, 2000, J CLIN PATHOL-MOL PA, V53, P184, DOI 10.1136/mp.53.4.184; MITELMAN F, 2008, MITELMAN DATABASE CH; Morelli C, 2002, ONCOGENE, V21, P7266, DOI 10.1038/sj.onc.1205573; Novo FJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-33; Paradee W, 1996, GENOMICS, V35, P87, DOI 10.1006/geno.1996.0326; POPESCU NC, 1990, HUM GENET, V84, P383; Rassool FV, 1996, GENOMICS, V35, P109, DOI 10.1006/geno.1996.0329; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Scotto L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-58; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Shivapurkar N, 1999, CLIN CANCER RES, V5, P17; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Sutherland GR, 2003, CYTOGENET GENOME RES, V100, P77, DOI 10.1159/000072840; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; Wilke CM, 1996, HUM MOL GENET, V5, P187, DOI 10.1093/hmg/5.2.187; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9; Zahed L, 2002, CLIN GENET, V62, P310, DOI 10.1034/j.1399-0004.2002.620410.x; Zimonjic DB, 1997, CANCER RES, V57, P1166	63	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11166	10.1371/journal.pone.0011166	http://dx.doi.org/10.1371/journal.pone.0011166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567512	gold, Green Submitted, Green Published			2022-12-25	WOS:000278886300012
J	Secchiero, P; Zorzet, S; Tripodo, C; Corallini, F; Melloni, E; Caruso, L; Bosco, R; Ingrao, S; Zavan, B; Zauli, G				Secchiero, Paola; Zorzet, Sonia; Tripodo, Claudio; Corallini, Federica; Melloni, Elisabetta; Caruso, Lorenzo; Bosco, Raffaella; Ingrao, Sabrina; Zavan, Barbara; Zauli, Giorgio			Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts	PLOS ONE			English	Article							STROMAL CELLS; ENDOTHELIAL-CELLS; LEUKEMIA CELLS; TUMOR STROMA; IN-VIVO; CANCER; GROWTH; PROLIFERATION; FIBROBLASTS; EXPRESSION	Background: Although multimodality treatment can induce high rate of remission in many subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with incurable disease. The effect of human bone marrow (BM) mesenchymal stem cells (MSC) on tumor cell growth is controversial, and no specific information is available on the effect of BM-MSC on NHL. Methodology/Principal Findings: The effect of BM-MSC was analyzed in two in vivo models of disseminated non-Hodgkin's lymphomas with an indolent (EBV- Burkitt-type BJAB, median survival = 46 days) and an aggressive (EBV+ B lymphoblastoid SKW6.4, median survival = 27 days) behavior in nude-SCID mice. Intra-peritoneal (i.p.) injection of MSC (4 days after i.p. injection of lymphoma cells) significantly increased the overall survival at an optimal MSC: lymphoma ratio of 1: 10 in both xenograft models (BJAB+MSC, median survival = 58.5 days; SKW6.4+MSC, median survival = 40 days). Upon MSC injection, i.p. tumor masses developed more slowly and, at the histopathological observation, exhibited a massive stromal infiltration coupled to extensive intra-tumor necrosis. In in vitro experiments, we found that: i) MSC/lymphoma co-cultures modestly affected lymphoma cell survival and were characterized by increased release of pro-angiogenic cytokines with respect to the MSC, or lymphoma, cultures; ii) MSC induce the migration of endothelial cells in transwell assays, but promoted endothelial cell apoptosis in direct MSC/endothelial cell co-cultures. Conclusions/Significance: Our data demonstrate that BM-MSC exhibit anti-lymphoma activity in two distinct xenograft SCID mouse models of disseminated NHL.	[Secchiero, Paola; Corallini, Federica; Melloni, Elisabetta; Caruso, Lorenzo; Bosco, Raffaella; Zauli, Giorgio] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Zorzet, Sonia] Univ Trieste, Dept Life Sci, Trieste, Italy; [Tripodo, Claudio; Ingrao, Sabrina] Univ Palermo, Dept Human Pathol, Palermo, Italy; [Zavan, Barbara] Univ Padua, Dept Histol & Microbiol, Padua, Italy	University of Ferrara; University of Trieste; University of Palermo; University of Padua	Secchiero, P (corresponding author), Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy.	giorgio.zauli@unife.it	Zauli, Giorgio/ABE-8001-2020; Melloni, Elisabetta/AAW-7880-2021; Tripodo, Claudio/O-4536-2016; Tripodo, Claudio/AAB-6004-2022; Caruso, Lorenzo/AAH-8056-2021; Melloni, Elisabetta/AAB-3890-2019; secchiero, paola/G-9689-2015	Tripodo, Claudio/0000-0002-0821-6231; Tripodo, Claudio/0000-0002-0821-6231; Caruso, Lorenzo/0000-0001-9895-3990; Melloni, Elisabetta/0000-0002-7829-0824; secchiero, paola/0000-0003-4101-7987; Zauli, Giorgio/0000-0002-3750-8698; Sonia, Zorzet/0000-0001-5161-3542	Associazione Italiana per la Ricerca contro il Cancro (AIRC); CariFe Foundation	Associazione Italiana per la Ricerca contro il Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); CariFe Foundation(Fondazione Carife)	This work was supported by Associazione Italiana per la Ricerca contro il Cancro (AIRC) grant and by CariFe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Choi YB, 2010, VIROLOGY, V397, P369, DOI 10.1016/j.virol.2009.11.024; Clarke CA, 2002, CANCER-AM CANCER SOC, V94, P2015, DOI 10.1002/cncr.10403; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Edelmann J, 2008, LEUKEMIA RES, V32, P1565, DOI 10.1016/j.leukres.2008.03.003; GUEST I, 2009, INT J CANC; Hamada H, 2005, CANCER SCI, V96, P149, DOI 10.1111/j.1349-7006.2005.00032.x; Iwamoto S, 2007, J CLIN INVEST, V117, P1049, DOI 10.1172/JCI30235; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KAYA NE, 2007, LEUKEMIA RES, V31, P899; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kidd S, 2008, CYTOTHERAPY, V10, P657, DOI 10.1080/14653240802486517; Lazennec G, 2008, STEM CELLS, V26, P1387, DOI 10.1634/stemcells.2007-1006; Lwin T, 2007, LEUKEMIA, V21, P1521, DOI 10.1038/sj.leu.2404723; Marini FC, 2009, CYTOTHERAPY, V11, P375, DOI 10.1080/14653240903098195; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Ning H, 2008, LEUKEMIA, V22, P593, DOI 10.1038/sj.leu.2405090; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Ruan J, 2006, CLIN CANCER RES, V12, P5622, DOI 10.1158/1078-0432.CCR-06-1204; Sato T, 2004, GYNECOL ONCOL, V92, P47, DOI 10.1016/j.ygyno.2003.09.012; Secchiero P, 2005, BLOOD, V105, P3413, DOI 10.1182/blood-2004-10-4111; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2007, CURR DRUG METAB, V8, P395, DOI 10.2174/138920007780655432; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Trouillon R, 2010, BIOCHEMISTRY-US, V49, P3282, DOI 10.1021/bi902122w; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	39	108	116	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11140	10.1371/journal.pone.0011140	http://dx.doi.org/10.1371/journal.pone.0011140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585401	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886100010
J	Madronal, N; Lopez-Aracil, C; Rangel, A; del Rio, JA; Delgado-Garcia, JM; Gruart, A				Madronal, Noelia; Lopez-Aracil, Cristina; Rangel, Alejandra; del Rio, Jose A.; Delgado-Garcia, Jose M.; Gruart, Agnes			Effects of Enriched Physical and Social Environments on Motor Performance, Associative Learning, and Hippocampal Neurogenesis in Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ADULT NEUROGENESIS; DENTATE GYRUS; SYNAPTIC-TRANSMISSION; CELL-PROLIFERATION; CA3-CA1 SYNAPSE; TRANSGENIC MICE; BEHAVING MICE; GRANULE CELLS; NEURONS	We have studied the motor abilities and associative learning capabilities of adult mice placed in different enriched environments. Three-month-old animals were maintained for a month alone (AL), alone in a physically enriched environment (PHY), and, finally, in groups in the absence (SO) or presence (SOPHY) of an enriched environment. The animals' capabilities were subsequently checked in the rotarod test, and for classical and instrumental learning. The PHY and SOPHY groups presented better performances in the rotarod test and in the acquisition of the instrumental learning task. In contrast, no significant differences between groups were observed for classical eyeblink conditioning. The four groups presented similar increases in the strength of field EPSPs (fEPSPs) evoked at the hippocampal CA3-CA1 synapse across classical conditioning sessions, with no significant differences between groups. These trained animals were pulse-injected with bromodeoxyuridine (BrdU) to determine hippocampal neurogenesis. No significant differences were found in the number of NeuN/BrdU double-labeled neurons. We repeated the same BrdU study in one-month-old mice raised for an additional month in the above-mentioned four different environments. These animals were not submitted to rotarod or conditioned tests. Non-trained PHY and SOPHY groups presented more neurogenesis than the other two groups. Thus, neurogenesis seems to be related to physical enrichment at early ages, but not to learning acquisition in adult mice.	[Madronal, Noelia; Lopez-Aracil, Cristina; Delgado-Garcia, Jose M.; Gruart, Agnes] Pablo de Olavide Univ, Div Neurosci, Seville, Spain; [Rangel, Alejandra; del Rio, Jose A.] Univ Barcelona, Catalonian Inst Bioengn, Barcelona, Spain; [Rangel, Alejandra; del Rio, Jose A.] Univ Barcelona, Dept Cell Biol, Barcelona, Spain; [Rangel, Alejandra; del Rio, Jose A.] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain	Universidad Pablo de Olavide; University of Barcelona; University of Barcelona; CIBERNED	Madronal, N (corresponding author), Pablo de Olavide Univ, Div Neurosci, Seville, Spain.	agrumas@upo.es	Delgado-Garcia, Jose M./V-1567-2019; Del Rio Fernandez, Jose A/AAD-1121-2020; del rio, jose antonio/L-9232-2014	del rio, jose antonio/0000-0002-5214-4909; Rangel, Alejandra/0000-0001-6536-6263	Spanish Ministerio de Ciencia e Innovacion [BFU2009-10848, BFU2008-00899, BFU2008-03390]; Generalitat de Catalunya [SGR2009-0366]; Junta de Andalucia [CVI-02487]; Instituto Carlos III; FP7-EU [PRIORITY, DEVANX]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Junta de Andalucia(Junta de Andalucia); Instituto Carlos III(Instituto de Salud Carlos III); FP7-EU	Grant sponsor: Spanish Ministerio de Ciencia e Innovacion; Grant numbers: BFU2009-10848, BFU2008-00899, and BFU2008-03390. Grant sponsor: Generalitat de Catalunya; Grant number: SGR2009-0366. Grant sponsor: Junta de Andalucia; Grant number: CVI-02487. Grant sponsor: Instituto Carlos III. Grant sponsor: FP7-EU; Grant numbers: PRIORITY and DEVANX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein I, 2009, BIOL LETTERS, V5, P141, DOI 10.1098/rsbl.2008.0511; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; DELRIO JA, 1989, DEV BRAIN RES, V49, P311, DOI 10.1016/0165-3806(89)90033-3; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dhanushkodi A, 2007, BEHAV NEUROSCI, V121, P491, DOI 10.1037/0735-7044.121.3.491; Dominguez-del-Toro E, 2004, EUR J NEUROSCI, V20, P1945, DOI 10.1111/j.1460-9568.2004.03643.x; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Eleore L, 2007, BEHAV NEUROSCI, V121, P1203, DOI 10.1037/0735-7044.121.6.1203; Fontana X, 2006, CEREB CORTEX, V16, P301, DOI 10.1093/cercor/bhi120; Foster TC, 2001, J NEUROPHYSIOL, V85, P1377, DOI 10.1152/jn.2001.85.4.1377; Gottlieb M, 2006, NEUROBIOL DIS, V23, P374, DOI 10.1016/j.nbd.2006.03.017; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; GREEN EJ, 1986, J NEUROPHYSIOL, V55, P739, DOI 10.1152/jn.1986.55.4.739; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; HANCOCK MB, 1984, J HISTOCHEM CYTOCHEM, V32, P311, DOI 10.1177/32.3.6198359; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; HEBB DO, AM PSYCHOL, V2, P306; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Klempin F, 2007, EUR ARCH PSY CLIN N, V257, P271, DOI 10.1007/s00406-007-0731-5; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Madronal N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.007.2009; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; O'Callaghan RM, 2009, HIPPOCAMPUS, V19, P1019, DOI 10.1002/hipo.20591; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pham TM, 1999, BEHAV BRAIN RES, V103, P63, DOI 10.1016/S0166-4328(99)00019-4; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; ROSENZWEIG M R, 1969, Developmental Psychobiology, V2, P87, DOI 10.1002/dev.420020208; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SORIANO E, 1991, J HISTOCHEM CYTOCHEM, V39, P255, DOI 10.1177/39.3.1671576; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Takatsuki K, 2003, J NEUROSCI, V23, P17; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Waddell J, 2008, EUR J NEUROSCI, V27, P3020, DOI 10.1111/j.1460-9568.2008.06222.x	50	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11130	10.1371/journal.pone.0011130	http://dx.doi.org/10.1371/journal.pone.0011130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559565	gold, Green Published, Green Submitted			2022-12-25	WOS:000278775900019
J	Smith, B; Treadwell, J; Zhang, DL; Ly, D; McKinnell, I; Walker, PR; Sikorska, M				Smith, Brandon; Treadwell, Julie; Zhang, Dongling; Ly, Dao; McKinnell, Iain; Walker, P. Roy; Sikorska, Marianna			Large-Scale Expression Analysis Reveals Distinct MicroRNA Profiles at Different Stages of Human Neurodevelopment	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; NERVOUS-SYSTEM; CELL-LINE; DEVELOPMENTAL REGULATION; MICROARRAY ANALYSIS; ALZHEIMERS-DISEASE; SMALL RNAS; REST; BRAIN; MOUSE	Background: MicroRNAs (miRNAs) are short non-coding RNAs predicted to regulate one third of protein coding genes via mRNA targeting. In conjunction with key transcription factors, such as the repressor REST (RE1 silencing transcription factor), miRNAs play crucial roles in neurogenesis, which requires a highly orchestrated program of gene expression to ensure the appropriate development and function of diverse neural cell types. Whilst previous studies have highlighted select groups of miRNAs during neural development, there remains a need for amenable models in which miRNA expression and function can be analyzed over the duration of neurogenesis. Principal Findings: We performed large-scale expression profiling of miRNAs in human NTera2/D1 (NT2) cells during retinoic acid (RA)-induced transition from progenitors to fully differentiated neural phenotypes. Our results revealed dynamic changes of miRNA patterns, resulting in distinct miRNA subsets that could be linked to specific neurodevelopmental stages. Moreover, the cell-type specific miRNA subsets were very similar in NT2-derived differentiated cells and human primary neurons and astrocytes. Further analysis identified miRNAs as putative regulators of REST, as well as candidate miRNAs targeted by REST. Finally, we confirmed the existence of two predicted miRNAs; pred-MIR191 and pred-MIR222 associated with SLAIN1 and FOXP2, respectively, and provided some evidence of their potential co-regulation. Conclusions: In the present study, we demonstrate that regulation of miRNAs occurs in precise patterns indicative of their roles in cell fate commitment, progenitor expansion and differentiation into neurons and glia. Furthermore, the similarity between our NT2 system and primary human cells suggests their roles in molecular pathways critical for human in vivo neurogenesis.	[Smith, Brandon; Treadwell, Julie; Zhang, Dongling; Ly, Dao; McKinnell, Iain; Walker, P. Roy; Sikorska, Marianna] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Smith, B (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	brandon.smith@nrc-cnrc.gc.ca	Smith, Brandon/ABF-2934-2021		National Research Council Canada	National Research Council Canada	Funding for this work was provided by the National Research Council Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Byrd AS, 2004, NEURON GLIA BIOL, V1, P317, DOI 10.1017/S1740925X05000207; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; DAMJANOV I, 1984, CELL DIFFER DEV, V15, P133, DOI 10.1016/0045-6039(84)90065-4; Dogini DB, 2008, J MOL NEUROSCI, V35, P331, DOI 10.1007/s12031-008-9068-4; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Goff Loyal A, 2005, RNA Biol, V2, P93, DOI 10.4161/rna.2.3.2059; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; Hohjoh H, 2007, BIOCHEM BIOPH RES CO, V362, P360, DOI 10.1016/j.bbrc.2007.07.189; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang B, 2009, ACTA BIOCH BIOPH SIN, V41, P231, DOI 10.1093/abbs/gmp006; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Przyborski SA, 2000, EUR J NEUROSCI, V12, P3521, DOI 10.1046/j.1460-9568.2000.00230.x; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Walker PR, 2006, CONT NEUROS, P59, DOI 10.1007/978-1-59745-021-8_6; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zeng Y, 2009, MOL PHARMACOL, V75, P259, DOI 10.1124/mol.108.052118; Zhang Man Cang, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P341; Zhou Guang-Sheng, 2008, Zhiwu Shengtai Xuebao, V32, P65	67	58	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11109	10.1371/journal.pone.0011109	http://dx.doi.org/10.1371/journal.pone.0011109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559549	Green Published, Green Submitted, gold			2022-12-25	WOS:000278775900005
J	Makela, J; Koivuniemi, R; Korhonen, L; Lindholm, D				Makela, Johanna; Koivuniemi, Raili; Korhonen, Laura; Lindholm, Dan			Interferon-gamma Produced by Microglia and the Neuropeptide PACAP Have Opposite Effects on the Viability of Neural Progenitor Cells	PLOS ONE			English	Article							ACTIVATING POLYPEPTIDE PACAP; CENTRAL-NERVOUS-SYSTEM; VASOACTIVE-INTESTINAL-PEPTIDE; STEM-CELLS; RAT-BRAIN; IN-VITRO; GROWTH-FACTOR; NEUROGENESIS; PROLIFERATION; DEATH	Inflammation is part of many neurological disorders and immune reactions may influence neuronal progenitor cells (NPCs) contributing to the disease process. Our knowledge about the interplay between different cell types in brain inflammation are not fully understood. It is important to know the mechanisms and factors involved in order to enhance regeneration and brain repair. We show here that NPCs express receptors for interferon-gamma (IFN gamma), and IFN gamma activates the signal transducer and activator of transcription (STAT) protein-1. IFN gamma reduced cell proliferation in NPCs by upregulation of the cell cycle protein p21 as well as induced cell death of NPCs by activating caspase-3. Studies of putative factors for rescue showed that the neuropeptide, Pituitary adenylate cyclase-activating polypeptide (PACAP) increased cell viability, the levels of p-Bad and reduced caspase-3 activation in the NPCs. Medium from cultured microglia contained IFN gamma and decreased the viability of NPCs, whilst blocking with anti-IFN gamma antibodies counteracted this effect. The results show that NPCs are negatively influenced by IFN gamma whereas PACAP is able to modulate its action. The interplay between IFN gamma released from immune cells and PACAP is of importance in brain inflammation and may affect the regeneration and recruitment of NPCs in immune diseases. The observed effects of IFN gamma on NPCs deserve to be taken into account in human anti-viral therapies particularly in children with higher rates of brain stem cell proliferation.	[Makela, Johanna; Koivuniemi, Raili; Korhonen, Laura; Lindholm, Dan] Biomedicum 2 Helsinki, Minerva Med Res Inst, Helsinki, Finland; [Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem, Helsinki, Finland	University of Helsinki; University of Helsinki	Makela, J (corresponding author), Biomedicum 2 Helsinki, Minerva Med Res Inst, Helsinki, Finland.	dan.lindholm@helsinki.fi	Lindholm, Dan/B-3777-2014; Korhonen, Laura/AAW-3256-2020; Koivuniemi, Raili/AAF-2173-2021	Koivuniemi, Raili/0000-0002-0359-7178; Korhonen, Laura/0000-0002-1837-5930	Sigrid Juselius; Liv och Halsa; Magnus Ehrnrooth and Signe and Ane Gyllenberg Foundations, Minerva; Academy of Finland	Sigrid Juselius(Sigrid Juselius Foundation); Liv och Halsa; Magnus Ehrnrooth and Signe and Ane Gyllenberg Foundations, Minerva; Academy of Finland(Academy of Finland)	Supported by Sigrid Juselius, Liv och Halsa, Magnus Ehrnrooth and Signe and Ane Gyllenberg Foundations, Minerva and the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Arimura A, 2007, PEPTIDES, V28, P1617, DOI 10.1016/j.peptides.2007.06.006; Armstrong BD, 2008, NEUROSCIENCE, V151, P63, DOI 10.1016/j.neuroscience.2007.09.084; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Brannvall K, 2005, EUR J NEUROSCI, V21, P871, DOI 10.1111/j.1460-9568.2005.03942.x; Brannvall K, 2002, MOL CELL NEUROSCI, V21, P512, DOI 10.1006/mcne.2002.1194; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dafny N, 2005, EUR J PHARMACOL, V523, P1, DOI 10.1016/j.ejphar.2005.08.029; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; De Simone R, 1998, CYTOKINE, V10, P418, DOI 10.1006/cyto.1997.0314; Delcourt N, 2007, EMBO J, V26, P1542, DOI 10.1038/sj.emboj.7601608; Delgado M, 2003, J LEUKOCYTE BIOL, V73, P155, DOI 10.1189/jlb.0702372; Dogrukol-Ak D, 2004, CURR PHARM DESIGN, V10, P1325, DOI 10.2174/1381612043384934; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gooch JL, 2000, CELL GROWTH DIFFER, V11, P335; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Jaworski DM, 2000, DEV BRAIN RES, V120, P27, DOI 10.1016/S0165-3806(99)00192-3; Lindberg C, 2005, J NEUROSCI RES, V82, P10, DOI 10.1002/jnr.20615; Lindholm D, 1998, ANN NY ACAD SCI, V865, P189, DOI 10.1111/j.1749-6632.1998.tb11178.x; Lindholm D, 2004, BIOCHEM BIOPH RES CO, V321, P753, DOI 10.1016/j.bbrc.2004.06.138; Lum M, 2009, J NEUROIMMUNOL, V206, P32, DOI 10.1016/j.jneuroim.2008.10.009; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Mercer A, 2004, J NEUROSCI RES, V76, P205, DOI 10.1002/jnr.20038; Mertens C, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.033; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nagao M, 2007, MOL CELL BIOL, V27, P3982, DOI 10.1128/MCB.00170-07; Ohta S, 2006, J NEUROSCI RES, V84, P1177, DOI 10.1002/jnr.21026; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Piltti K, 2006, ONCOGENE, V25, P4880, DOI 10.1038/sj.onc.1209492; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Scharf E, 2008, J MOL NEUROSCI, V36, P79, DOI 10.1007/s12031-008-9097-z; Shioda Seiji, 2000, Acta Anatomica Nipponica, V75, P487; Sippel M, 2009, FEBS LETT, V583, P2213, DOI 10.1016/j.febslet.2009.06.018; Skoglosa Y, 1999, MOL BRAIN RES, V65, P1, DOI 10.1016/S0169-328X(98)00294-0; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Steen H, 2008, BIOCHEM BIOPH RES CO, V366, P432, DOI 10.1016/j.bbrc.2007.11.146; Sundberg M, 2006, J NEUROSCI, V26, P5402, DOI 10.1523/JNEUROSCI.4906-05.2006; Takei N, 1998, J NEUROSCI RES, V54, P698, DOI 10.1002/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5; Takei N, 2000, EUR J NEUROSCI, V12, P2273, DOI 10.1046/j.1460-9568.2000.00118.x; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; VAUDRY D, 2000, PHARMACOL REV, V269, P324; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8	50	48	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11091	10.1371/journal.pone.0011091	http://dx.doi.org/10.1371/journal.pone.0011091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559421	Green Published, gold, Green Submitted			2022-12-25	WOS:000278741100007
J	Kepseu, WD; Sepulchre, JA; Reverchon, S; Nasser, W				Kepseu, Wilfred D.; Sepulchre, Jacques-Alexandre; Reverchon, Sylvie; Nasser, William			Toward a Quantitative Modeling of the Synthesis of the Pectate Lyases, Essential Virulence Factors in Dickeya dadantii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM ERWINIA-CHRYSANTHEMI; PECTINOLYSIS GENES; REGULATORY NETWORKS; KDGR; REPRESSOR; PROTEIN; DEGRADATION; INTEGRATION; SIMULATION; FIS	A dynamic mathematical model has been developed and validated to describe the synthesis of pectate lyases (Pels), the major virulence factors in Dickeya dadantii. This work focuses on the simultaneous modeling of the metabolic degradation of pectin by Pel enzymes and the genetic regulation of pel genes by 2-keto-3-deoxygluconate (KDG), a catabolite product of pectin that inactivates KdgR, one of the main repressors of pel genes. This modeling scheme takes into account the fact that the system is composed of two time-varying compartments: the extracellular medium, where Pel enzymes cleave pectin into oligomers, and the bacterial cytoplasm where, after internalization, oligomers are converted to KDG. Using the quasi-stationary state approximations, the model consists of some nonlinear differential equations for which most of the parameters could be estimated from the literature or from independent experiments. The few remaining unknown parameters were obtained by fitting the model equations against a set of Pel activity data. Model predictions were verified by measuring the time courses of bacterial growth, Pel production, pel mRNA accumulation, and pectin consumption under various growth conditions. This work reveals that pectin is almost totally consumed before the burst of Pel production. This paradoxical behavior can be interpreted as an evolutionary strategy to control the diffusion process so that as soon as a small amount of pectin is detected by the bacteria in its surroundings, it anticipates more pectin to come. The model also predicts the possibility of bistable steady states in the presence of constant pectin compounds.	Univ Nice Sophia Antipolis, CNRS, UMR 6618, Inst Non Lineaire Nice, F-06560 Valbonne, France; [Reverchon, Sylvie; Nasser, William] Univ Lyon 1, UMR CNRS 5240, Inst Natl Sci Appl BayerCorpSci, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1		jacques.alexandre-sepulchre@inln.cnrs.fr	Sylvie, Reverchon/P-7932-2016; NASSER, William/C-9611-2019	Sylvie, Reverchon/0000-0002-0478-3474; NASSER, William/0000-0001-9848-3597	French Ministry of Research [ANR-07-BLAN-0212]	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by Agence Nationale de la Recherche Program Regupath Grant ANR-07-BLAN-0212, which was financed by the French Ministry of Research.	Baldazzi V, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000812; Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200; COLLMER A, 1986, ANNU REV PHYTOPATHOL, V24, P383, DOI 10.1146/annurev.py.24.090186.002123; Condemine G, 2007, J BACTERIOL, V189, P5955, DOI 10.1128/JB.00218-07; Franza T, 2002, MOL PLANT MICROBE IN, V15, P1181, DOI 10.1094/MPMI.2002.15.11.1181; FUNAHASHI A, 2003, BIOSILICO, V1, P59; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Hugouvieux-Cotte-Pattat N, 2001, MOL MICROBIOL, V41, P1125, DOI 10.1046/j.1365-2958.2001.02565.x; HUGOUVIEUXCOTTEPATTAT N, 1994, J BACTERIOL, V176, P2386, DOI 10.1128/JB.176.8.2386-2392.1994; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Kepseu WD, 2010, J BIOL SYST, V18, P173, DOI 10.1142/S0218339010003172; Kohn KW, 2001, CHAOS, V11, P84, DOI 10.1063/1.1338126; KOTOUJANSKY A, 1982, J BACTERIOL, V150, P122, DOI 10.1128/JB.150.1.122-131.1982; Lautier T, 2007, MOL MICROBIOL, V66, P1474, DOI 10.1111/j.1365-2958.2007.06012.x; Lautier T, 2007, MOL MICROBIOL, V66, P1491, DOI 10.1111/j.1365-2958.2007.06010.x; Miller J. H., 1972, EXPT MOL GENETICS, P431; MORAN F, 1968, ARCH BIOCHEM BIOPHYS, V123, P298, DOI 10.1016/0003-9861(68)90138-0; NASSER W, 1994, J MOL BIOL, V236, P427, DOI 10.1006/jmbi.1994.1155; NASSER W, 1991, FEMS MICROBIOL LETT, V81, P73, DOI [10.1016/S0378-1097(99)00516-9, 10.1111/j.1574-6968.1991.tb04715.x]; Nasser W, 2002, MOL MICROBIOL, V43, P733, DOI 10.1046/j.1365-2958.2002.02782.x; NASSER W, 1992, MOL MICROBIOL, V6, P257, DOI 10.1111/j.1365-2958.1992.tb02007.x; Nasser W, 1997, MOL MICROBIOL, V26, P1071, DOI 10.1046/j.1365-2958.1997.6472020.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reverchon S, 1997, J BACTERIOL, V179, P3500, DOI 10.1128/jb.179.11.3500-3508.1997; REVERCHON S, 1991, MOL MICROBIOL, V5, P2203, DOI 10.1111/j.1365-2958.1991.tb02150.x; Reverchon S, 1998, MOL MICROBIOL, V29, P1407, DOI 10.1046/j.1365-2958.1998.01023.x; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; Ropers D, 2006, BIOSYSTEMS, V84, P124, DOI 10.1016/j.biosystems.2005.10.005; Sepulchre JA, 2007, J THEOR BIOL, V244, P239, DOI 10.1016/j.jtbi.2006.08.010; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tardy F, 1997, J BACTERIOL, V179, P2503, DOI 10.1128/jb.179.8.2503-2511.1997; Verhulst, 1845, NOUVEAUX MEMOIRES AC, V18, P1; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	33	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28565	28576		10.1074/jbc.M110.114710	http://dx.doi.org/10.1074/jbc.M110.114710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20581112	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000281594000020
J	Chen, SG; Yadav, SP; Surewicz, WK				Chen, Shugui; Yadav, Satya P.; Surewicz, Witold K.			Interaction between Human Prion Protein and Amyloid-beta (A beta) Oligomers ROLE OF N-TERMINAL RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; ALZHEIMERS-DISEASE; PEPTIDE; BINDING; NEURODEGENERATION; FIBRILLOGENESIS; CHAPERONE; AFFINITY; MEMORY; RISK	Soluble oligomers of A beta 42 peptide are believed to play a major role in the pathogenesis of Alzheimer disease (AD). It was recently found that at least some of the neurotoxic effects of these oligomers may be mediated by specific binding to the prion protein, PrPC, on the cell surface (Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Nature 457, 1128-1132). Here we characterized the interaction between synthetic A beta 42 oligomers and the recombinant human prion protein (PrP) using two biophysical techniques: site-directed spin labeling and surface plasmon resonance. Our data indicate that this binding is highly specific for a particular conformation adopted by the peptide in soluble oligomeric species. The binding appears to be essentially identical for the Met(129) and Val(129) polymorphic forms of human PrP, suggesting that the role of PrP codon 129 polymorphism as a risk factor in AD is due to factors unrelated to the interaction with A beta oligomers. It was also found that in addition to the previously identified similar to 95-110 segment, the second region of critical importance for the interaction with A beta 42 oligomers is a cluster of basic residues at the extreme N terminus of PrP (residues 23-27). The deletion of any of these segments results in a major loss of the binding function, indicating that these two regions likely act in concert to provide a high affinity binding site for A beta 42 oligomers. This insight may help explain the interplay between the postulated protective and pathogenic roles of PrP in AD and may contribute to the development of novel therapeutic strategies as well.	[Chen, Shugui; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Yadav, Satya P.] Cleveland Clin Fdn, Lerner Res Inst, Mol Biotechnol Core Lab, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Surewicz, WK (corresponding author), 2109 Adelbert Rd, Cleveland, OH 44106 USA.	witold.surewicz@case.edu			National Institutes of Health [NS38604, NS44158]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044158, R01NS038604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS38604 and NS44158 (to W. K. S.).	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Dermaut B, 2003, ANN NEUROL, V53, P409, DOI 10.1002/ana.10507; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mchaourab HS, 2002, J BIOL CHEM, V277, P40557, DOI 10.1074/jbc.M206250200; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riemenschneider M, 2004, NEUROLOGY, V63, P364, DOI 10.1212/01.WNL.0000130198.72589.69; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Schuck P, 1997, CURR OPIN BIOTECH, V8, P498, DOI 10.1016/S0958-1669(97)80074-2; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Sorgato MC, 2009, PRION, V3, P202, DOI 10.4161/pri.3.4.10012; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tatzelt J, 2007, FEBS J, V274, P606, DOI 10.1111/j.1742-4658.2007.05633.x; Visudtiphole V, 2006, BIOCHEM BIOPH RES CO, V351, P113, DOI 10.1016/j.bbrc.2006.10.003; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	45	214	217	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26377	26383		10.1074/jbc.M110.145516	http://dx.doi.org/10.1074/jbc.M110.145516			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20576610	Green Published, hybrid			2022-12-25	WOS:000280921000056
J	Einholm, AP; Toustrup-Jensen, MS; Holm, R; Andersen, JP; Vilsen, B				Einholm, Anja Pernille; Toustrup-Jensen, Mads S.; Holm, Rikke; Andersen, Jens Peter; Vilsen, Bente			The Rapid-onset Dystonia Parkinsonism Mutation D923N of the Na+,K+-ATPase alpha 3 Isoform Disrupts Na+ Interaction at the Third Na+ Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH TRANSMEMBRANE SEGMENT; CYTOPLASMIC-BINDING SITES; CATION-BINDING; K+-ATPASE; FUNCTIONAL CONSEQUENCES; CONFORMATIONAL-CHANGES; ENERGY TRANSDUCTION; CRYSTAL-STRUCTURE; ION SELECTIVITY; AMINO-ACIDS	Rapid-onset dystonia parkinsonism (RDP), a rare neurological disorder, is caused by mutation of the neuron-specific alpha 3-isoform of Na+,K+-ATPase. Here, we present the functional consequences of RDP mutation D923N. Relative to the wild type, the mutant exhibits a remarkable similar to 200-fold reduction of Na+ affinity for activation of phosphorylation from ATP, reflecting a defective interaction of the E-1 form with intracellular Na+. This is the largest effect on Na+ affinity reported so far for any Na+, K+-ATPase mutant. D923N also affects the interaction with extracellular Na+ normally driving the E1P to E2P conformational transition backward. However, no impairment of K+ binding was observed for D923N, leading to the conclusion that Asp(923) is specifically associated with the third Na+ site that is selective toward Na+. The crystal structure of the Na+, K+-ATPase in E-2 form shows that Asp(923) is located in the cytoplasmic half of transmembrane helix M8 inside a putative transport channel, which is lined by residues from the transmembrane helices M5, M7, M8, and M10 and capped by the C terminus, recently found involved in recognition of the third Na+ ion. Structural modeling of the E-1 form of Na+, K+-ATPase based on the Ca2+-ATPase crystal structure is consistent with the hypothesis that Asp(923) contributes to a site binding the third Na+ ion. These results in conjunction with our previous findings with other RDP mutants suggest that a selective defect in the handling of Na+ may be a general feature of the RDP disorder.	[Einholm, Anja Pernille; Toustrup-Jensen, Mads S.; Holm, Rikke; Andersen, Jens Peter; Vilsen, Bente] Aarhus Univ, Dept Physiol & Biophys, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, DK-8000 Aarhus C, Denmark	Aarhus University; Danmarks Grundforskningsfond	Vilsen, B (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Ole Worms Alle 6,Bldg 1180, DK-8000 Aarhus C, Denmark.	bv@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300; Vilsen, Bente/0000-0002-4727-9382; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861	Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; L'Oreal Denmark, UNESCO; Royal Danish Academy of Science	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); L'Oreal Denmark, UNESCO(L'Oreal Group); Royal Danish Academy of Science	This work was supported in part by grants from the Danish Medical Research Council, the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat), and the Lundbeck Foundation (to B.V.) and from the Danish Medical Research Council and the "For Women in Science Program" of L'Oreal Denmark, UNESCO, and the Royal Danish Academy of Science (to A.P.E.).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Arguello JM, 1999, ARCH BIOCHEM BIOPHYS, V367, P341, DOI 10.1006/abbi.1999.1278; Arguello JM, 1999, ARCH BIOCHEM BIOPHYS, V364, P254, DOI 10.1006/abbi.1999.1124; ARGUELLO JM, 1994, J BIOL CHEM, V269, P6892; ARGUELLO JM, 1995, J BIOL CHEM, V270, P22764, DOI 10.1074/jbc.270.39.22764; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; Blostein R, 1997, J BIOL CHEM, V272, P24987, DOI 10.1074/jbc.272.40.24987; BLOSTEIN R, 1983, J BIOL CHEM, V258, P7948; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; Burnay M, 2003, J BIOL CHEM, V278, P19237, DOI 10.1074/jbc.M300946200; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; FAHN S, 1968, J BIOL CHEM, V243, P1993; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; Jorgensen PL, 2001, BBA-BIOENERGETICS, V1505, P57, DOI 10.1016/S0005-2728(00)00277-2; Kamm C, 2008, NEUROLOGY, V70, P1501, DOI 10.1212/01.wnl.0000310431.41036.e0; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; Li CM, 2006, J MEMBRANE BIOL, V213, P1, DOI 10.1007/s00232-006-0035-0; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; POST RL, 1972, J BIOL CHEM, V247, P6530; POULSEN H, 2010, NATURE IN PRESS; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Schneeberger A, 1999, J MEMBRANE BIOL, V168, P221, DOI 10.1007/s002329900511; Schneeberger A, 2001, J MEMBRANE BIOL, V179, P263, DOI 10.1007/s002320010051; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Skou J. C, 1991, SODIUM PUMP RECENT D, P317; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Vilsen B, 1999, BIOCHEMISTRY-US, V38, P11389, DOI 10.1021/bi990951t; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; VILSEN B, 1995, ACTA PHYSIOL SCAND, V154, P1; Vilsen B, 1997, ANN NY ACAD SCI, V834, P297, DOI 10.1111/j.1749-6632.1997.tb52260.x; Yamamoto S, 1996, J PHYSIOL-LONDON, V495, P733, DOI 10.1113/jphysiol.1996.sp021629; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106; YODA A, 1987, J BIOL CHEM, V262, P110; YODA S, 1986, J BIOL CHEM, V261, P1147; Zanotti-Fregonara P, 2008, J NEUROL SCI, V273, P148, DOI 10.1016/j.jns.2008.06.033	57	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26245	26254		10.1074/jbc.M110.123976	http://dx.doi.org/10.1074/jbc.M110.123976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20576601	hybrid, Green Published			2022-12-25	WOS:000280921000041
J	Jung, HJ; Kim, JH; Shim, JS; Kwon, HJ				Jung, Hye Jin; Kim, Jong Hyeon; Shim, Joong Sup; Kwon, Ho Jeong			A Novel Ca2+/Calmodulin Antagonist HBC Inhibits Angiogenesis and Down-regulates Hypoxia-inducible Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; HISTONE DEACETYLASE INHIBITORS; CELL-CYCLE PROGRESSION; COLON-CANCER CELLS; HEPATOCELLULAR-CARCINOMA; TUMOR ANGIOGENESIS; MAMMALIAN TARGET; GENE-EXPRESSION; CALMODULIN; CALCIUM	Recent reports have shown that Ca2+/calmodulin (Ca2+/CaM) signaling plays a crucial role in angiogenesis. We previously developed a new Ca2+/CaM antagonist, HBC (4-{3,5-bis-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-4,5-dihydropyrazol-1-yl}benzoic acid), from a curcumin-based synthetic chemical library. Here, we investigated its anti-angiogenic activity and mode of action. HBC potently inhibited the proliferation of human umbilical vascular endothelial cells with no cytotoxicity. Furthermore, HBC blocked in vitro characteristics of angiogenesis such as tube formation and chemoinvasion, as well as neo-vascularization of the chorioallantoic membrane of growing chick embryos in vivo. Notably, HBC markedly inhibited expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) at the translational level during hypoxia, thereby reducing HIF-1 transcriptional activity and expression of its major target gene, vascular endothelial growth factor. In addition, combination treatment with HBC and various HIF-1 inhibitors, including suberoylanilide hydroxamic acid, rapamycin, and terpestacin, had greater anti-angiogenic activity than treatment with each single agent. Collectively, our findings indicate that HBC is a new anti-angiogenic agent targeting HIF that can be used to explore the biological role of Ca2+/CaM in angiogenesis.	[Jung, Hye Jin; Kim, Jong Hyeon; Shim, Joong Sup; Kwon, Ho Jeong] Yonsei Univ, Coll Life Sci & Biotechnol, Chem Genom Lab, Dept Biotechnol,Translat Res Ctr Prot Funct Contr, Seoul 120749, South Korea	Yonsei University	Kwon, HJ (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Chem Genom Lab, Dept Biotechnol,Translat Res Ctr Prot Funct Contr, Seoul 120749, South Korea.	kwonhj@yonsei.ac.kr	Shim, Joong Sup/G-8383-2011; Shim, Joong Sup/O-2848-2016; 권, 호정/AAS-3642-2021	Shim, Joong Sup/0000-0003-0167-7307; Shim, Joong Sup/0000-0003-0167-7307; 	National R&D Program for Cancer Control [0620350]; Ministry of Health & Welfare, the Translational Research Center for Protein Function Control, NRF [2009-0083522]; Korean Government (MEST) [2009-0092964, 2010-0017984]; Brain Korea 21 project, Republic of Korea	National R&D Program for Cancer Control(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Health & Welfare, the Translational Research Center for Protein Function Control, NRF; Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Korea 21 project, Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by grants from the National R&D Program for Cancer Control (0620350), Ministry of Health & Welfare, the Translational Research Center for Protein Function Control, NRF (2009-0083522), the National Research Foundation of Korea Grant funded by the Korean Government (MEST) (2009-0092964 and 2010-0017984), and from the Brain Korea 21 project, Republic of Korea.	Andre T, 1998, REV MED INTERNE, V19, P904, DOI 10.1016/S0248-8663(99)80063-0; ARNOULD T, 1992, J CELL PHYSIOL, V152, P215, DOI 10.1002/jcp.1041520127; Bangoura G, 2004, WORLD J GASTROENTERO, V10, P525, DOI 10.3748/wjg.v10.i4.525; Burkitt K, 2009, MOL CANCER THER, V8, P1148, DOI 10.1158/1535-7163.MCT-08-0944; Capuozzo E, 1997, BBA-MOL CELL RES, V1357, P123, DOI 10.1016/S0167-4889(97)00021-9; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Das SB, 2005, ONCOL REP, V14, P1059; Folkman J, 2001, SEMIN ONCOL, V28, P536, DOI 10.1053/sonc.2001.29543; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; HAIT WN, 1986, J CLIN ONCOL, V4, P994, DOI 10.1200/JCO.1986.4.6.994; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Huang XZ, 2008, CANCER BIOL THER, V7, P468, DOI 10.4161/cbt.7.3.5457; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Jeon KS, 2005, BIOCHEM BIOPH RES CO, V330, P1268, DOI 10.1016/j.bbrc.2005.03.109; Jung HJ, 2003, J ANTIBIOT, V56, P492, DOI 10.7164/antibiotics.56.492; Jung HJ, 2010, J BIOL CHEM, V285, P11584, DOI 10.1074/jbc.M109.087809; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mottet D, 2003, J CELL PHYSIOL, V194, P30, DOI 10.1002/jcp.10176; Mukhopadhyay D, 1996, BIOCHEM BIOPH RES CO, V229, P733, DOI 10.1006/bbrc.1996.1873; NAKAYAMA S, 1994, ANNU REV BIOPH BIOM, V23, P473, DOI 10.1146/annurev.bb.23.060194.002353; Pang R, 2006, CANCER LETT, V242, P151, DOI 10.1016/j.canlet.2006.01.008; Pencreach E, 2009, CLIN CANCER RES, V15, P1297, DOI 10.1158/1078-0432.CCR-08-0889; Rodriguez-Mora OG, 2005, CANCER RES, V65, P5408, DOI 10.1158/0008-5472.CAN-05-0271; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SCHULLER HM, 1991, CARCINOGENESIS, V12, P2301, DOI 10.1093/carcin/12.12.2301; SCHULLER HM, 1990, CANCER RES, V50, P1645; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Seta KA, 2004, CELL CALCIUM, V36, P331, DOI 10.1016/j.ceca.2004.02.006; Shen WG, 2007, CELL BIOL INT, V31, P126, DOI 10.1016/j.cellbi.2006.09.017; Shim JS, 2004, CHEM BIOL, V11, P1455, DOI 10.1016/j.chembiol.2004.08.015; Shim JS, 2002, BIOORGAN MED CHEM, V10, P2987, DOI 10.1016/S0968-0896(02)00129-3; Stull JT, 2001, J BIOL CHEM, V276, P2311, DOI 10.1074/jbc.R000030200; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Tang XW, 2003, BIOCHEM J, V374, P137, DOI 10.1042/BJ20021910; Torimura T, 1998, HUM PATHOL, V29, P986, DOI 10.1016/S0046-8177(98)90205-2; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; VEIGL ML, 1983, BIOCHIM BIOPHYS ACTA, V738, P21, DOI 10.1016/0304-419X(84)90018-0; Verheul HMW, 2008, CLIN CANCER RES, V14, P3589, DOI 10.1158/1078-0432.CCR-07-4306; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WEI JW, 1982, CANCER RES, V42, P2571; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	49	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25867	25874		10.1074/jbc.M110.135632	http://dx.doi.org/10.1074/jbc.M110.135632			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20554536	Green Published, hybrid			2022-12-25	WOS:000280682400079
J	Bower, JJ; Karaca, GF; Zhou, Y; Simpson, DA; Cordeiro-Stone, M; Kaufmann, WK				Bower, J. J.; Karaca, G. F.; Zhou, Y.; Simpson, D. A.; Cordeiro-Stone, M.; Kaufmann, W. K.			Topoisomerase II alpha maintains genomic stability through decatenation G(2) checkpoint signaling	ONCOGENE			English	Article						decatenation; G(2) checkpoint; topoisomerase II alpha; topoisomerase II beta; chromosomal instability	CELL-CYCLE; DNA TOPOISOMERASES; BREAST-CANCER; CHROMOSOME SEGREGATION; IONIZING-RADIATION; GENE-EXPRESSION; BETA; POISONS; ROLES; BISDIOXOPIPERAZINES	Topoisomerase II alpha (topoII alpha) is an essential mammalian enzyme that topologically modifies DNA and is required for chromosome segregation during mitosis. Previous research suggests that inhibition of topoII decatenatory activity triggers a G(2) checkpoint response, which delays mitotic entry because of insufficient decatenation of daughter chromatids. Here we examine the effects of both topoII alpha and topoII beta on decatenatory activity in cell extracts, DNA damage and decatenation G(2) checkpoint function, and the frequencies of p16(INK4A) allele loss and gain. In diploid human fibroblast lines, depletion of topoII alpha by small-interfering RNA was associated with severely reduced decatenatory activity, delayed progression from G(2) into mitosis and insensitivity to G(2) arrest induced by the topoII catalytic inhibitor ICRF-193. Furthermore, interphase nuclei of topoII alpha-depleted cells showed increased frequencies of losses and gains of the tumor suppressor genetic locus p16(INK4A). This study shows that the topoII alpha protein is required for decatenation G(2) checkpoint function, and inactivation of decatenation and the decatenation G(2) checkpoint leads to abnormal chromosome segregation and genomic instability. Oncogene (2010) 29, 4787-4799; doi:10.1038/onc.2010.232; published online 21 June 2010	[Bower, J. J.; Karaca, G. F.; Zhou, Y.; Simpson, D. A.; Cordeiro-Stone, M.; Kaufmann, W. K.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Bower, J. J.; Cordeiro-Stone, M.; Kaufmann, W. K.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Cordeiro-Stone, M.; Kaufmann, W. K.] Univ N Carolina, Ctr Environm Hlth & Susceptibil, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kaufmann, WK (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Rm 31-345 Lineberger Comprehens Canc Ctr,CB 7295, Chapel Hill, NC 27599 USA.	bill_kaufmann@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; , UNC Flow Cytometry Core/AGU-9839-2022		NIH-NCI Ruth L. Kirschstein National Research Service [1F32CA134155-01]; PHS [CA81343, P30-ES10126]; NATIONAL CANCER INSTITUTE [F32CA134155, R01CA081343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	NIH-NCI Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial Support: This work was supported by an NIH-NCI Ruth L. Kirschstein National Research Service Award Grant # 1F32CA134155-01 (JJ Bower) and PHS grants CA81343 and P30-ES10126 (WK Kaufmann).	Akimitsu N, 2003, GENES CELLS, V8, P393, DOI 10.1046/j.1365-2443.2003.00643.x; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Bandele OJ, 2008, CHEM RES TOXICOL, V21, P936, DOI 10.1021/tx700434v; Bandele OJ, 2007, BIOCHEMISTRY-US, V46, P6097, DOI 10.1021/bi7000664; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Beser AR, 2007, PATHOL ONCOL RES, V13, P180, DOI 10.1007/BF02893497; Biersack H, 1996, P NATL ACAD SCI USA, V93, P8288, DOI 10.1073/pnas.93.16.8288; Bower JJ, 2010, CELL CYCLE, V9, P1617, DOI 10.4161/cc.9.8.11470; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Coelho PA, 2008, PLOS BIOL, V6, P1758, DOI 10.1371/journal.pbio.0060207; Cortes F, 2003, MUTAT RES-REV MUTAT, V543, P59, DOI 10.1016/S1383-5742(02)00070-4; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Deming PB, 2002, J BIOL CHEM, V277, P36832, DOI 10.1074/jbc.M206109200; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Diaz-Martinez LA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000053; Doherty SC, 2003, J NATL CANCER I, V95, P1859, DOI 10.1093/jnci/djg120; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Emmons M, 2006, BIOCHEM PHARMACOL, V72, P11, DOI 10.1016/j.bcp.2006.03.017; Franchitto A, 2003, CANCER RES, V63, P3289; Goswami PC, 1996, MOL CELL BIOL, V16, P1500; Gromova I, 1998, BIOCHEMISTRY-US, V37, P16645, DOI 10.1021/bi981391l; HECK MMS, 1988, P NATL ACAD SCI USA, V85, P1086, DOI 10.1073/pnas.85.4.1086; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jarvinen TAH, 1996, AM J PATHOL, V148, P2073; Jensen LH, 2000, J BIOL CHEM, V275, P2137, DOI 10.1074/jbc.275.3.2137; Johnson M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp480; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kaufmann WK, 1997, CELL GROWTH DIFFER, V8, P1105; Larsen A K, 1996, Prog Cell Cycle Res, V2, P229; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Lorusso V, 2007, ANN ONCOL, V18, P70, DOI 10.1093/annonc/mdm229; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Maeshima K, 2005, CHROMOSOMA, V114, P365, DOI 10.1007/s00412-005-0023-7; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Nakagawa T, 2004, CANCER RES, V64, P4826, DOI 10.1158/0008-5472.CAN-04-0871; Park I, 2006, EXP CELL RES, V312, P1996, DOI 10.1016/j.yexcr.2006.02.029; Robinson HMR, 2007, CELL CYCLE, V6, P1265, DOI 10.4161/cc.6.10.4225; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Sehested M, 1996, BIOCHEM PHARMACOL, V51, P879, DOI 10.1016/0006-2952(95)02241-4; Simpson Dennis A, 2005, J Carcinog, V4, P18, DOI 10.1186/1477-3163-4-18; van Doorn-Khosrovani SBV, 2007, CARCINOGENESIS, V28, P1703, DOI 10.1093/carcin/bgm102; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Xiao H, 2003, P NATL ACAD SCI USA, V100, P3239, DOI 10.1073/pnas.0736401100; Zhou T, 2006, ENVIRON HEALTH PERSP, V114, P553, DOI 10.1289/ehp.8026	51	64	65	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2010	29	34					4787	4799		10.1038/onc.2010.232	http://dx.doi.org/10.1038/onc.2010.232			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	643VB	20562910	Green Accepted, Green Submitted			2022-12-25	WOS:000281326400005
J	Maher-Laporte, M; Berthiaume, F; Moreau, M; Julien, LA; Lapointe, G; Mourez, M; DesGroseillers, L				Maher-Laporte, Marjolaine; Berthiaume, Frederic; Moreau, Mireille; Julien, Louis-Andre; Lapointe, Gabriel; Mourez, Michael; DesGroseillers, Luc			Molecular Composition of Staufen2-Containing Ribonucleoproteins in Embryonic Rat Brain	PLOS ONE			English	Article							BINDING PROTEIN STAUFEN2; MESSENGER-RNA TRANSPORT; POLY(A)-BINDING PROTEIN; NUCLEAR EXPORT; TRANSLATION; YB-1; COMPLEXES; GRANULES; KINESIN; DOMAIN	Messenger ribonucleoprotein particles (mRNPs) are used to transport mRNAs along neuronal dendrites to their site of translation. Numerous mRNA-binding and regulatory proteins within mRNPs finely regulate the fate of bound-mRNAs. Their specific combination defines different types of mRNPs that in turn are related to specific synaptic functions. One of these mRNA-binding proteins, Staufen2 (Stau2), was shown to transport dendritic mRNAs along microtubules. Its knockdown expression in neurons was shown to change spine morphology and synaptic functions. To further understand the molecular mechanisms by which Stau2 modulates synaptic function in neurons, it is important to identify and characterize protein cofactors that regulate the fate of Stau2-containing mRNPs. To this end, a proteomic approach was used to identify co-immunoprecipitated proteins in Staufen2-containing mRNPs isolated from embryonic rat brains. The proteomic approach identified mRNA-binding proteins (PABPC1, hnRNP H1, YB1 and hsc70), proteins of the cytoskeleton (alpha- and beta-tubulin) and RUFY3 a poorly characterized protein. While PABPC1 and YB1 associate with Stau2-containing mRNPs through RNAs, hsc70 is directly bound to Stau2 and this interaction is regulated by ATP. PABPC1 and YB1 proteins formed puncta in dendrites of embryonic rat hippocampal neurons. However, they poorly co-localized with Stau2 in the large dendritic complexes suggesting that they are rather components of Stau2-containing mRNA particles. All together, these results represent a further step in the characterization of Stau2-containing mRNPs in neurons and provide new tools to study and understand how Stau2-containing mRNPs are transported, translationally silenced during transport and/or locally expressed according to cell needs.	[Maher-Laporte, Marjolaine; Moreau, Mireille; Julien, Louis-Andre; Lapointe, Gabriel; DesGroseillers, Luc] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Maher-Laporte, M (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada.	luc.desgroseillers@umontreal.ca			Canadian Institutes of Health Research (CIHR) [MOP 62751, MGC-57079]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by operating [MOP 62751] and group [MGC-57079] grants from the Canadian Institutes of Health Research (CIHR-www.cihr-irsc.gc.ca/) to LDG. MML and LAJ were supported by a postgraduate scholarship and an undergraduate student research award, respectively, from the Natural Sciences and Engineering Research Council of Canada (NSERC-www.nserc-crsng.gc.ca/). MM held a Canada Research Chair on Bacterial Animal Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenstein F, 2005, J BIOL CHEM, V280, P6496, DOI 10.1074/jbc.M412742200; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Bassell GJ, 1999, FASEB J, V13, P447, DOI 10.1096/fasebj.13.3.447; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; Chernov Konstantin G., 2008, BMC Biochemistry, V9, P23, DOI 10.1186/1471-2091-9-23; Duchaine TF, 2002, J CELL SCI, V115, P3285; Dugre-Brisson S, 2005, NUCLEIC ACIDS RES, V33, P4797, DOI 10.1093/nar/gki794; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Elvira G, 2006, J NEUROCHEM, V96, P105, DOI 10.1111/j.1471-4159.2005.03523.x; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2006, CELL CYCLE, V5, P1143, DOI 10.4161/cc.5.11.2784; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Goetze B, 2006, J CELL BIOL, V172, P221, DOI 10.1083/jcb.200509035; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Jeong JH, 2007, J NEUROCHEM, V102, P2073, DOI 10.1111/j.1471-4159.2007.04697.x; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim KC, 2006, NEUROSCI LETT, V397, P48, DOI 10.1016/j.neulet.2005.11.047; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kose S, 2005, J CELL BIOL, V171, P19, DOI 10.1083/jcb.200506074; Lebeau G, 2008, MOL CELL BIOL, V28, P2896, DOI 10.1128/MCB.01844-07; LEWIS SA, 1990, NATURE, V345, P674, DOI 10.1038/345674a0; Macchi P, 2004, J BIOL CHEM, V279, P31440, DOI 10.1074/jbc.C400226200; Maher-Laporte M, 2010, BMB REP, V43, P344, DOI 10.5483/BMBRep.2010.43.5.344; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mazumder B, 2001, MOL CELL BIOL, V21, P6440, DOI 10.1128/MCB.21.19.6440-6449.2001; Miki T, 2004, J BIOL CHEM, V279, P47473, DOI 10.1074/jbc.M407883200; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Mohr E, 2001, P NATL ACAD SCI USA, V98, P7072, DOI 10.1073/pnas.111146598; Monshausen M, 2004, NEUROMOL MED, V6, P127, DOI 10.1385/NMM:6:2-3:127; Mori T, 2007, J BIOL CHEM, V282, P19884, DOI 10.1074/jbc.M700770200; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Patel GP, 2005, NUCLEIC ACIDS RES, V33, P7074, DOI 10.1093/nar/gki1014; Sanchez-Carbente MD, 2008, PROG BRAIN RES, V169, P41, DOI 10.1016/S0079-6123(07)00003-9; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552	57	20	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11350	10.1371/journal.pone.0011350	http://dx.doi.org/10.1371/journal.pone.0011350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596529	Green Published, Green Submitted, gold			2022-12-25	WOS:000279259900021
J	Porter, KA; Kelley, LN; George, A; Harton, JA; Duus, KM				Porter, Kristen A.; Kelley, Lauren N.; George, Annette; Harton, Jonathan A.; Duus, Karen M.			Class II Transactivator (CIITA) Enhances Cytoplasmic Processing of HIV-1 Pr55Gag	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MHC CLASS-II; COMPLEX CLASS-II; INTRACELLULAR-TRANSPORT; SURFACE EXPRESSION; INFECTIOUS HIV-1; INVARIANT CHAIN; DENDRITIC CELLS; GTP-BINDING; TYPE-1	Background: The Pr55(gag) (Gag) polyprotein of HIV serves as a scaffold for virion assembly and is thus essential for progeny virion budding and maturation. Gag localizes to the plasma membrane (PM) and membranes of late endosomes, allowing for release of infectious virus directly from the cell membrane and/or upon exocytosis. The host factors involved in Gag trafficking to these sites are largely unknown. Upon activation, CD4+ T cells, the primary target of HIV infection, express the class II transcriptional activator (CIITA) and therefore the MHC class II isotype, HLA-DR. Similar to Gag, HLA-DR localizes to the PM and at the membranes of endosomes and specialized vesicular MHC class II compartments (MIICs). In HIV producer cells, transient HLA-DR expression induces intracellular Gag accumulation and impairs virus release. Methodology/Principal Findings: Here we demonstrate that both stable and transient expression of CIITA in HIV producer cells does not induce HLA-DR-associated intracellular retention of Gag, but does increase the infectivity of virions. However, neither of these phenomena is due to recapitulation of the class II antigen presentation pathway or CIITA-mediated transcriptional activation of virus genes. Interestingly, we demonstrate that CIITA, apart from its transcriptional effects, acts cytoplasmically to enhance Pr160(gag-pol) (Gag-Pol) levels and thereby the viral protease and Gag processing, accounting for the increased infectivity of virions from CIITA-expressing cells. Conclusions/Significance: This study demonstrates that CIITA enhances HIV Gag processing, and provides the first evidence of a novel, post-transcriptional, cytoplasmic function for a well-known transactivator.	[Porter, Kristen A.; Kelley, Lauren N.; George, Annette; Harton, Jonathan A.; Duus, Karen M.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College	Porter, KA (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	duusk@mail.amc.edu	Harton, Jonathan A/AAW-5283-2021; Porter, Kristen/AAF-4468-2021; Harton, Jonathan/F-2848-2010	Harton, Jonathan A/0000-0002-0350-1877; Harton, Jonathan/0000-0002-0350-1877; Porter, Kristen/0000-0002-9272-7180	Albany Medical College; National Institutes of Health/National Cancer Institute (NIH/NCI) [KO1CA095582]; NATIONAL CANCER INSTITUTE [K01CA095582] Funding Source: NIH RePORTER	Albany Medical College; National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Albany Medical College start-up funds (KMD, JAH) and National Institutes of Health/National Cancer Institute (NIH/NCI) KO1CA095582 (JAH) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; Berger AC, 2009, J CELL SCI, V122, P1, DOI 10.1242/jcs.035089; Bewry NN, 2007, J BIOL CHEM, V282, P26178, DOI 10.1074/jbc.M611747200; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Biswas P, 2004, J VIROL, V78, P2082, DOI 10.1128/JVI.78.4.2082-2087.2004; Blanco R, 2003, J BIOL CHEM, V278, P1086, DOI 10.1074/jbc.M205636200; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Cantin R, 1997, J VIROL, V71, P1922, DOI 10.1128/JVI.71.3.1922-1930.1997; Cantin R, 1997, BLOOD, V90, P1091, DOI 10.1182/blood.V90.3.1091.1091_1091_1100; Carter CA, 2002, TRENDS MICROBIOL, V10, P203, DOI 10.1016/S0966-842X(02)02350-8; Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chin KC, 1997, P NATL ACAD SCI USA, V94, P2501, DOI 10.1073/pnas.94.6.2501; DARKE PL, 1988, BIOCHEM BIOPH RES CO, V156, P297, DOI 10.1016/S0006-291X(88)80839-8; DAVIES MN, 2007, MOL IMMUNOL IN PRESS; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Duus KM, 2001, J VIROL, V75, P3916, DOI 10.1128/JVI.75.8.3916-3924.2001; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; Esser MT, 2001, J VIROL, V75, P6173, DOI 10.1128/JVI.75.13.6173-6182.2001; Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Finzi A, 2006, J VIROL, V80, P9789, DOI 10.1128/JVI.01055-06; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gluschankof P, 2002, VIROLOGY, V300, P160, DOI 10.1006/viro.2002.1531; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Harton JA, 2002, HUM IMMUNOL, V63, P588, DOI 10.1016/S0198-8859(02)00400-7; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; Holling TM, 2004, BIOCHEM PHARMACOL, V68, P1209, DOI 10.1016/j.bcp.2004.03.046; Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005; Holm GH, 2005, J VIROL, V79, P6299, DOI 10.1128/JVI.79.10.6299-6311.2005; Hussain A, 2008, J VIROL, V82, P893, DOI 10.1128/JVI.01373-07; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; KAPLAN AH, 1994, J VIROL, V68, P6782, DOI 10.1128/JVI.68.10.6782-6786.1994; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; Klein KC, 2007, AIDS REV, V9, P150; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Krawczyk M, 2007, NUCLEIC ACIDS RES, V35, P595, DOI 10.1093/nar/gkl980; Krawczyk M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000058; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Lindhofer H, 1995, VIROLOGY, V214, P624, DOI 10.1006/viro.1995.0074; Lipman MCI, 2001, EUR J CLIN INVEST, V31, P926, DOI 10.1046/j.1365-2362.2001.00928.x; Liu XA, 2003, J VIROL, V77, P3470, DOI 10.1128/JVI.77.6.3470-3476.2003; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Mattos-Graner RO, 2006, J BACTERIOL, V188, P3813, DOI 10.1128/JB.01845-05; Mehandru S, 2005, J ALLERGY CLIN IMMUN, V116, P419, DOI 10.1016/j.jaci.2005.05.040; Meissner EG, 2004, VIROLOGY, V328, P74, DOI 10.1016/j.virol.2004.07.019; MOLLE D, 2009, J BIOL CHEM; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morner A, 1999, J VIROL, V73, P2343; MUELLER B, 2009, J BIOL CHEM; Nie Z, 2002, CELL DEATH DIFFER, V9, P1172, DOI 10.1038/sj.cdd.4401094; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pettit SC, 1998, ADV EXP MED BIOL, V436, P15; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Rocha N, 2008, EMBO J, V27, P1, DOI 10.1038/sj.emboj.7601945; Rulli SJ, 2006, VIROLOGY, V347, P364, DOI 10.1016/j.virol.2005.12.012; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Shacklett Barbara L, 2010, Curr Infect Dis Rep, V12, P19, DOI 10.1007/s11908-009-0072-9; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Speck RR, 2000, ANTIMICROB AGENTS CH, V44, P1397, DOI 10.1128/AAC.44.5.1397-1403.2000; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; TAN X, 1993, J VIROL, V67, P6447, DOI 10.1128/JVI.67.11.6447-6452.1993; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060; YAHI N, 1992, J VIROL, V66, P4848, DOI 10.1128/JVI.66.8.4848-4854.1992; Zheng YH, 2003, NAT CELL BIOL, V5, P611, DOI 10.1038/ncb1000	79	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11304	10.1371/journal.pone.0011304	http://dx.doi.org/10.1371/journal.pone.0011304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585587	Green Submitted, gold, Green Published			2022-12-25	WOS:000279135800013
J	Alais, D; Cass, J				Alais, David; Cass, John			Multisensory Perceptual Learning of Temporal Order: Audiovisual Learning Transfers to Vision but Not Audition	PLOS ONE			English	Article							SHORT-TIME-INTERVALS; NEURAL MECHANISMS; DISCRIMINATION; OFFSET; PLASTICITY; DURATION; STIMULI; NEURONS; HUMANS; CORTEX	Background: An outstanding question in sensory neuroscience is whether the perceived timing of events is mediated by a central supra-modal timing mechanism, or multiple modality-specific systems. We use a perceptual learning paradigm to address this question. Methodology/Principal Findings: Three groups were trained daily for 10 sessions on an auditory, a visual or a combined audiovisual temporal order judgment (TOJ). Groups were pre-tested on a range TOJ tasks within and between their group modality prior to learning so that transfer of any learning from the trained task could be measured by post-testing other tasks. Robust TOJ learning (reduced temporal order discrimination thresholds) occurred for all groups, although auditory learning (dichotic 500/2000 Hz tones) was slightly weaker than visual learning (lateralised grating patches). Crossmodal TOJs also displayed robust learning. Post-testing revealed that improvements in temporal resolution acquired during visual learning transferred within modality to other retinotopic locations and orientations, but not to auditory or crossmodal tasks. Auditory learning did not transfer to visual or crossmodal tasks, and neither did it transfer within audition to another frequency pair. In an interesting asymmetry, crossmodal learning transferred to all visual tasks but not to auditory tasks. Finally, in all conditions, learning to make TOJs for stimulus onsets did not transfer at all to discriminating temporal offsets. These data present a complex picture of timing processes. Conclusions/Significance: The lack of transfer between unimodal groups indicates no central supramodal timing process for this task; however, the audiovisual-to-visual transfer cannot be explained without some form of sensory interaction. We propose that auditory learning occurred in frequency-tuned processes in the periphery, precluding interactions with more central visual and audiovisual timing processes. Functionally the patterns of featural transfer suggest that perceptual learning of temporal order may be optimised to object-centered rather than viewer-centered constraints.	[Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Cass, John] Univ Western Sydney, Sch Psychol, Milperra, Australia; [Cass, John] Univ Western Sydney, MARCS Auditory Labs, Milperra, Australia	University of Sydney; Western Sydney University; Western Sydney University	Alais, D (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	j.cass@uws.edu.au	Cass, John/AAC-7505-2021		Australian Research Council [DP0774697, DP0770299]	Australian Research Council(Australian Research Council)	This research was supported by Discovery Projects awarded by the Australian Research Council (JC: DP0774697; DA: DP0770299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; ALLAN LG, 1979, PERCEPT PSYCHOPHYS, V26, P340, DOI 10.3758/BF03204158; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Bair W, 2004, VISUAL NEUROSCI, V21, P671, DOI 10.1017/S0952523804215012; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A.S., 1990, AUDITORY SCENE ANAL; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burr D, 2006, PROG BRAIN RES, V155, P243, DOI 10.1016/S0079-6123(06)55014-9; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; CARLILE S, 1996, VIRTUAL AUDITORY SPA; Coulombe JL, 2008, STUD AM INDIAN LIT, V20, P1, DOI 10.1353/ail.0.0039; DIVENYI PL, 1978, PERCEPT PSYCHOPHYS, V24, P429, DOI 10.3758/BF03199740; Edwards CJ, 2002, NAT NEUROSCI, V5, P934, DOI 10.1038/nn916; EFRON R, 1970, PERCEPT PSYCHOPHYS, V8, P231, DOI 10.3758/BF03210211; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fahle M, 2002, PERCEPTUAL LEARNING; Folta K, 2003, VISION RES, V43, P1177, DOI 10.1016/S0042-6989(03)00041-5; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; GETTY DJ, 1975, PERCEPT PSYCHOPHYS, V18, P1, DOI 10.3758/BF03199358; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Grondin S, 1998, PSYCHOL RES-PSYCH FO, V61, P261, DOI 10.1007/s004260050030; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; Kim RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001532; King B, 2007, J RES READ, V30, P443, DOI 10.1111/j.1467-9817.2007.00346.x; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Majewska AK, 2006, TRENDS NEUROSCI, V29, P323, DOI 10.1016/j.tins.2006.04.002; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Michon J. A., 1985, TIME MIND BEHAV, P21; Moore B, 1986, FREQUENCY SELECTIVIT; Morgan MJ, 2008, J VISION, V8, DOI 10.1167/8.2.14; Mossbridge JA, 2008, LEARN MEMORY, V15, P13, DOI 10.1101/lm.573608; Mossbridge JA, 2006, J NEUROSCI, V26, P12708, DOI 10.1523/JNEUROSCI.2254-06.2006; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; PARKER DM, 1980, PERCEPT PSYCHOPHYS, V28, P365, DOI 10.3758/BF03204396; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PATTERSON RD, 1976, J ACOUST SOC AM, V59, P640, DOI 10.1121/1.380914; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAMMSAYER T, 1998, PSYCHOL BEITR, V40, P387; RAMMSAYER TH, 1992, NEUROPSYCHOBIOLOGY, V26, P71, DOI 10.1159/000118899; ROUSSEAU R, 1983, PERCEPT PSYCHOPHYS, V34, P541, DOI 10.3758/BF03205907; Schirmer A, 2004, COGNITIVE BRAIN RES, V21, P269, DOI 10.1016/j.cogbrainres.2004.04.003; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; SERVIERE J, 1977, VISION RES, V17, P65, DOI 10.1016/0042-6989(77)90202-4; SONG JH, 2008, J COGN NEUROSCI; Sowden PT, 2002, VISION RES, V42, P1249, DOI 10.1016/S0042-6989(02)00019-6; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Virsu V, 2008, EXP BRAIN RES, V186, P525, DOI 10.1007/s00221-007-1254-z; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Westheimer G, 1999, EXP BRAIN RES, V129, P121, DOI 10.1007/s002210050942; Wright BA, 1997, J NEUROSCI, V17, P3956	56	36	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11283	10.1371/journal.pone.0011283	http://dx.doi.org/10.1371/journal.pone.0011283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615KY	20585664	Green Submitted, gold, Green Published			2022-12-25	WOS:000279135400025
J	Coulon, V; Chebli, K; Cavelier, P; Blanchard, JM				Coulon, Vincent; Chebli, Karim; Cavelier, Patricia; Blanchard, Jean-Marie			A Novel Mouse c-fos Intronic Promoter That Responds to CREB and AP-1 Is Developmentally Regulated In Vivo	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; POTENTIAL INVOLVEMENT; SIGNAL-TRANSDUCTION; CONTROL ELEMENTS; NERVOUS-SYSTEM; NULL MUTATION; TRANSCRIPTION; ACTIVATION; SEQUENCES	Background: The c-fos proto-oncogene is an archetype for rapid and integrative transcriptional activation. Innumerable studies have focused on the canonical promoter, located upstream from the transcriptional start site. However, several regulatory sequences have been found in the first intron. Methodology/Principal Findings: Here we describe an extremely conserved region in c-fos first intron that contains a putative TATA box, and functional TRE and CRE sites. This fragment drives reporter gene activation in fibroblasts, which is enhanced by increasing intracellular calcium and cAMP and by cotransfection of CREB or c-Fos/c-Jun expression vectors. We produced transgenic mice expressing a lacZ reporter controlled by the intronic promoter. Lac Z expression of this promoter is restricted to the developing central nervous system (CNS) and the mesenchyme of developing mammary buds in embryos 12.5 days post-conception, and to brain tissue in adults. RT-QPCR analysis of tissue mRNA, including the anlage of the mammary gland and the CNS, confirms the existence of a novel, nested mRNA initiated in the first intron. Conclusions/Significance: Our results provide evidence for a novel, developmentally regulated promoter in the first intron of the c-fos gene.	[Coulon, Vincent; Chebli, Karim; Cavelier, Patricia; Blanchard, Jean-Marie] Univ Montpellier I, Univ Montpellier 2, CNRS, Inst Genet Mol Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Coulon, V (corresponding author), Univ Montpellier I, Univ Montpellier 2, CNRS, Inst Genet Mol Montpellier, Montpellier, France.	vincent.coulon@igmm.cnrs.fr	Coulon, Vincent/AFF-7934-2022; Coulon, Vincent/B-2437-2009	Coulon, Vincent/0000-0002-3168-8755; Coulon, Vincent/0000-0002-3168-8755	CNRS; Ligue Nationale Contre le Cancer; French Ministry of Research; French Ligue Nationale Contre le Cancer; Institut National du Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by grants from the CNRS (http://www.cnrs.fr/) and Ligue Nationale Contre le Cancer (http://www.ligue-cancer.net/). V. C. was supported by the French Ministry of Research (http://www.enseignementsup-recherche.gouv.fr/) and by the French Ligue Nationale Contre le Cancer, then Institut National du Cancer (http://www.e-cancer.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNEROT C, 1987, P NATL ACAD SCI USA, V84, P6795, DOI 10.1073/pnas.84.19.6795; Boulon S, 2002, MOL CELL BIOL, V22, P7769, DOI 10.1128/MCB.22.22.7769-7779.2002; CAUBET JF, 1989, MOL CELL BIOL, V9, P2269, DOI 10.1128/MCB.9.5.2269; CHATTON B, 1994, ONCOGENE, V9, P375; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; Coulon V, 1999, J BIOL CHEM, V274, P30439, DOI 10.1074/jbc.274.43.30439; Coulon V, 2007, J BIOL CHEM, V282, P33192, DOI 10.1074/jbc.M706119200; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DONY C, 1987, NATURE, V328, P711, DOI 10.1038/328711a0; DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; Herrera RE, 1997, CHROMOSOMA, V106, P284, DOI 10.1007/s004120050249; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KOVACS EJ, 1986, J IMMUNOL, V137, P3649; LAMB NJC, 1990, CELL, V61, P485, DOI 10.1016/0092-8674(90)90530-R; Lange CM, 2001, J NEUROCHEM, V77, P1293, DOI 10.1046/j.1471-4159.2001.00342.x; LEE G, 1994, MOL CELL BIOL, V14, P4579, DOI 10.1128/MCB.14.7.4579; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; LUCIBELLO FC, 1990, EMBO J, V9, P2827, DOI 10.1002/j.1460-2075.1990.tb07471.x; Maisonnasse-Charital Y, 2009, GENE, V430, P116, DOI 10.1016/j.gene.2008.10.014; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MECHTI N, 1991, MOL CELL BIOL, V11, P2832, DOI 10.1128/MCB.11.5.2832; MOHUN TJ, 1989, DEVELOPMENT, V107, P835; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; PAYLOR R, 1994, BRAIN RES, V651, P275, DOI 10.1016/0006-8993(94)90707-2; Philip A, 2000, J BIOL CHEM, V275, P5911, DOI 10.1074/jbc.275.8.5911; PIECHACZYK M, 1994, CRIT REV ONCOL HEMAT, V17, P93, DOI 10.1016/1040-8428(94)90021-3; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EUR J ENDOCRINOL, V145, P519, DOI 10.1530/eje.0.1450519; Ren XM, 2009, GENOMICS, V93, P159, DOI 10.1016/j.ygeno.2008.09.017; RENZ M, 1985, EMBO J, V4, P3711, DOI 10.1002/j.1460-2075.1985.tb04139.x; ROBERTSON LM, 1995, NEURON, V14, P241, DOI 10.1016/0896-6273(95)90282-1; Routal RV, 1999, J ANAT, V195, P211, DOI 10.1046/j.1469-7580.1999.19520211.x; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; Susini S, 2000, FASEB J, V14, P128, DOI 10.1096/fasebj.14.1.128; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; van Haasteren G, 2000, NEUROENDOCRINOLOGY, V72, P368, DOI 10.1159/000054606; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Watanabe Y, 1996, J NEUROSCI, V16, P3827	53	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11235	10.1371/journal.pone.0011235	http://dx.doi.org/10.1371/journal.pone.0011235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574536	Green Published, gold, Green Submitted			2022-12-25	WOS:000279058300019
J	Zarate, JM; Delhommeau, K; Wood, S; Zatorre, RJ				Zarate, Jean Mary; Delhommeau, Karine; Wood, Sean; Zatorre, Robert J.			Vocal Accuracy and Neural Plasticity Following Micromelody-Discrimination Training	PLOS ONE			English	Article							OLD-WORLD MONKEY; AUDITORY-CORTEX; FREQUENCY DISCRIMINATION; PITCH DISCRIMINATION; HUMAN BRAIN; FUNCTIONAL ACTIVATION; PROBABILISTIC ATLAS; ANTERIOR CINGULATE; MUSICAL RHYTHMS; PREMOTOR AREAS	Background: Recent behavioral studies report correlational evidence to suggest that non-musicians with good pitch discrimination sing more accurately than those with poorer auditory skills. However, other studies have reported a dissociation between perceptual and vocal production skills. In order to elucidate the relationship between auditory discrimination skills and vocal accuracy, we administered an auditory-discrimination training paradigm to a group of non-musicians to determine whether training-enhanced auditory discrimination would specifically result in improved vocal accuracy. Methodology/Principal Findings: We utilized micromelodies (i.e., melodies with seven different interval scales, each smaller than a semitone) as the main stimuli for auditory discrimination training and testing, and we used single-note and melodic singing tasks to assess vocal accuracy in two groups of non-musicians (experimental and control). To determine if any training-induced improvements in vocal accuracy would be accompanied by related modulations in cortical activity during singing, the experimental group of non-musicians also performed the singing tasks while undergoing functional magnetic resonance imaging (fMRI). Following training, the experimental group exhibited significant enhancements in micromelody discrimination compared to controls. However, we did not observe a correlated improvement in vocal accuracy during single-note or melodic singing, nor did we detect any training-induced changes in activity within brain regions associated with singing. Conclusions/Significance: Given the observations from our auditory training regimen, we therefore conclude that perceptual discrimination training alone is not sufficient to improve vocal accuracy in non-musicians, supporting the suggested dissociation between auditory perception and vocal production.	[Zarate, Jean Mary; Delhommeau, Karine; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [Zarate, Jean Mary; Wood, Sean; Zatorre, Robert J.] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada; [Wood, Sean] Univ Montreal, Dept Comp Sci, Montreal, PQ, Canada	McGill University; Universite de Montreal; Universite de Montreal	Zarate, JM (corresponding author), McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Montreal, PQ, Canada.	jean.zarate@mail.mcgill.ca	Zarate, Jean Mary/B-1450-2008; Zarate, Jean Mary/Q-1702-2019	Zarate, Jean Mary/0000-0002-7418-2199; Zarate, Jean Mary/0000-0002-7418-2199; Wood, Sean/0000-0002-6821-1619	Canadian Institutes of Health Research (CIHR) [11541, 14995]; Fondation Bettencourt Schueller; Eileen Peters McGill Majors Fellowship; Centre for Interdisciplinary Research in Music Media and Technology (CIRMMT)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fondation Bettencourt Schueller; Eileen Peters McGill Majors Fellowship; Centre for Interdisciplinary Research in Music Media and Technology (CIRMMT)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR 11541, 14995; RJZ), Fondation Bettencourt Schueller (KD), the Eileen Peters McGill Majors Fellowship (JMZ), and the Centre for Interdisciplinary Research in Music Media and Technology (CIRMMT; JMZ, SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004; Amir O, 2003, J ACOUST SOC AM, V113, P1102, DOI 10.1121/1.1536632; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; Bella SD, 2007, J ACOUST SOC AM, V121, P1182, DOI 10.1121/1.2427111; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Bradshaw E, 2005, J VOICE, V19, P431, DOI 10.1016/j.jvoice.2004.07.010; Brown S, 2004, COGNITIVE BRAIN RES, V20, P363, DOI 10.1016/j.cogbrainres.2004.03.016; Burnett TA, 2002, J ACOUST SOC AM, V112, P1058, DOI 10.1121/1.1487844; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Chouinard PA, 2006, NEUROSCIENTIST, V12, P143, DOI 10.1177/1073858405284255; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Cheveigne A, 2002, J ACOUST SOC AM, V111, P1917, DOI 10.1121/1.1458024; Delhommeau K, 2005, JARO-J ASSOC RES OTO, V6, P171, DOI 10.1007/s10162-005-5055-4; Delhommeau K, 2002, PERCEPT PSYCHOPHYS, V64, P426, DOI 10.3758/BF03194715; DEMANY L, 1985, J ACOUST SOC AM, V78, P1118, DOI 10.1121/1.393034; DIVENYI PL, 1978, J ACOUST SOC AM, V64, P1369, DOI 10.1121/1.382103; DOWLING WJ, 1978, PSYCHOL REV, V85, P341, DOI 10.1037/0033-295X.85.4.341; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Fox PT, 2001, NEUROIMAGE, V13, P196, DOI 10.1006/nimg.2000.0659; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Griffiths TD, 1999, NEUROREPORT, V10, P3825, DOI 10.1097/00001756-199912160-00019; Grimault N, 2003, HEARING RES, V184, P41, DOI 10.1016/S0378-5955(03)00214-4; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; JELINEK F, 1997, STAT METHODS SPEECH, P39; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Jones JA, 2005, CURR BIOL, V15, P1768, DOI 10.1016/j.cub.2005.08.063; Kleber B, 2007, NEUROIMAGE, V36, P889, DOI 10.1016/j.neuroimage.2007.02.053; Kleber B, 2010, CEREB CORTEX, V20, P1144, DOI 10.1093/cercor/bhp177; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Lombard E, 1911, ANN MALADIES OREILLE, P101; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nikjeh DA, 2009, J ACOUST SOC AM, V125, P328, DOI 10.1121/1.3021309; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Perry DW, 1999, NEUROREPORT, V10, P3979, DOI 10.1097/00001756-199912160-00046; PETRIDES M, 1986, J NEUROSCI, V6, P2054; Pfordresher PQ, 2007, MUSIC PERCEPT, V25, P95, DOI 10.1525/MP.2007.25.2.95; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Rinne T, 2007, NEUROSCI LETT, V416, P247, DOI 10.1016/j.neulet.2007.01.077; Roth Daphne Ari-Even, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P137; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; SIEGEL GM, 1974, J ACOUST SOC AM, V56, P1618, DOI 10.1121/1.1903486; Tomaiuolo F, 1999, EUR J NEUROSCI, V11, P3033, DOI 10.1046/j.1460-9568.1999.00718.x; Tournoux P., 1988, COPLANAR STEREOTAXIC; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Warren JD, 2006, NEUROIMAGE, V31, P1389, DOI 10.1016/j.neuroimage.2006.01.034; Warren JD, 2003, P NATL ACAD SCI USA, V100, P10038, DOI 10.1073/pnas.1730682100; Watts C, 2005, J VOICE, V19, P534, DOI 10.1016/j.jvoice.2004.09.001; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 2005, NEUROIMAGE, V28, P1056, DOI 10.1016/j.neuroimage.2005.06.053; WORSLEY KJ, 2005, CONNECTIVITY ANATOMI; Zarate JM, 2008, NEUROIMAGE, V40, P1871, DOI 10.1016/j.neuroimage.2008.01.026; Zarate JM, 2010, NEUROPSYCHOLOGIA, V48, P607, DOI 10.1016/j.neuropsychologia.2009.10.025; Zatorre RJ, 2001, ANN NY ACAD SCI, V930, P193, DOI 10.1111/j.1749-6632.2001.tb05734.x; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	73	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11181	10.1371/journal.pone.0011181	http://dx.doi.org/10.1371/journal.pone.0011181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567521	gold, Green Published, Green Submitted			2022-12-25	WOS:000278886300023
J	Marrazzo, JM; Thomas, KK; Fiedler, TL; Ringwood, K; Fredricks, DN				Marrazzo, Jeanne M.; Thomas, Katherine K.; Fiedler, Tina L.; Ringwood, Kathleen; Fredricks, David N.			Risks for Acquisition of Bacterial Vaginosis Among Women Who Report Sex with Women: A Cohort Study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASE; PREGNANT-WOMEN; VAGINAL FLORA; AFRICAN WOMEN; METRONIDAZOLE; LESBIANS; BEHAVIOR; LACTOBACILLI; ASSOCIATIONS; METAANALYSIS	Background: Bacterial vaginosis (BV) is common in women who have sex with women. While cross-sectional data support a role for sexual transmission, risks for incident BV have not been prospectively studied in this group. Methodology/Principal Findings: We studied risks for BV acquisition in a prospective cohort study of women (age 16-35 years) who reported sex with other women (>= 1 partner, prior year). Women were followed for one year with examinations at quarterly visits and for genital symptoms at any time. Species-specific 16S rRNA gene PCRs for BV-associated bacteria (BVAB) were applied to vaginal fluid obtained at enrollment. Sexual behaviors were ascertained by computer-assisted interview. Of 335 participants, 239 had no BV at baseline; 199 were seen in follow-up (median follow-up 355 days, 4.0 visits/ subject). Forty women experienced >= 1 BV episode. Risks for incident BV were presentation <= 14 days since onset of menses (hazard ratio (HR) 2.3 (95% CI, 1.2-4.7), report of new sex partner with BV history (HR 3.63 (1.1-11.9)), change in vaginal discharge (HR 2.6 (1.3-5.2)) and detection of any of several BVAB in vaginal fluid at enrollment, including BVAB1 (HR 6.3 (1.4-28.1)), BVAB2 (HR 18.2 (6.4-51.8)), BVAB3 (HR 12.6 (2.7-58.4)), G. vaginalis (HR 3.9 (1.5-10.4)), Atopobium vaginae (HR 4.2 (1.9-9.3)), Leptotrichia spp (9.3 (3.0-24.4)), and Megasphaera-1 (HR 11.5 (5.0-26.6)). Detection of Lactobacillus crispatus at enrollment conferred reduced risk for subsequent BV (HR 0.18 (0.08-0.4)). Detailed analysis of behavioral data suggested a direct dose-response relationship with increasing number of episodes of receptive oral-vulvovaginal sex (HR 1.02 (95% CI, 1.00-1.04). Conclusions/Significance: Vaginal detection of several BVAB in BV-negative women predicted subsequent BV, suggesting that changes in vaginal microbiota precede BV by weeks or months. BV acquisition was associated with report of new partner with BV; associations with sexual practices - specifically, receptive oral sex - require further investigation.	[Marrazzo, Jeanne M.; Thomas, Katherine K.; Ringwood, Kathleen] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Fiedler, Tina L.; Fredricks, David N.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Marrazzo, JM (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.	jmm2@uw.edu		Marrazzo, Jeanne/0000-0002-9277-7364; Thomas, Katherine K/0000-0002-7024-468X	National Institute of Allergy and Infectious Diseases [RO1 AI052228, R01 AI061628]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052228, R01AI061628] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support: National Institute of Allergy and Infectious Diseases grants RO1 AI052228 (JMM) and R01 AI061628 (DNF) (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Baeten JM, 2001, AM J OBSTET GYNECOL, V185, P380, DOI 10.1067/mob.2001.115862; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Culhane JF, 2002, AM J OBSTET GYNECOL, V187, P1272, DOI 10.1067/mob.2002.127311; Eschenbach DA, 2000, CLIN INFECT DIS, V30, P901, DOI 10.1086/313818; Evans AL, 2007, SEX TRANSM INFECT, V83, P470, DOI 10.1136/sti.2006.022277; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks David N, 2005, Curr Infect Dis Rep, V7, P463, DOI 10.1007/s11908-005-0049-2; Fredricks DN, 1999, BIOTECHNIQUES, V26, P198, DOI 10.2144/99262bm04; GORBACH PM, 2009, EFFECT ACASI REPORTI; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; HILLIER SL, 2002, TRIAL INTRAVAGINAL L; Hillier SL MJ., 2008, SEX TRANSM DIS, P737; INFECT DIS, 2009, J INFECT DIS, V200, P1662; Kissinger P, 1999, AM J EPIDEMIOL, V149, P950, DOI 10.1093/oxfordjournals.aje.a009739; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; MARRAZZO JM, SEX TRANSM IN PRESS; MARRAZZO JM, 2008, EFFICACY BEHAV INTER; MARRAZZO JM, 2008, ANN INTERN IN PRESS; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Sanchez S, 2004, AM J OBSTET GYNECOL, V191, P1898, DOI 10.1016/j.ajog.2004.06.089; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Sobel JD, 2006, AM J OBSTET GYNECOL, V194, P1283, DOI 10.1016/j.ajog.2005.11.041; Srinavasan S, 2008, HUMAN VAGINAL BACTER; Sweet R L, 2000, Infect Dis Obstet Gynecol, V8, P184, DOI 10.1155/S1064744900000260; SWIDSINSKI A, 2007, AM J OBSTET GYNECOL; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Webb PM, 1999, J ADOLESCENT HEALTH, V24, P383, DOI 10.1016/S1054-139X(99)00005-1	36	59	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11139	10.1371/journal.pone.0011139	http://dx.doi.org/10.1371/journal.pone.0011139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559445	gold, Green Published, Green Submitted			2022-12-25	WOS:000278775900026
J	Greenstein, RJ; Su, LY; Brown, ST				Greenstein, Robert J.; Su, Liya; Brown, Sheldon T.			The Thioamides Methimazole and Thiourea Inhibit Growth of M. avium Subspecies paratuberculosis in Culture	PLOS ONE			English	Article							MYCOBACTERIUM-PARATUBERCULOSIS; HASHIMOTOS-THYROIDITIS; GRAVES-DISEASE; CROHNS-DISEASE; DRUG-THERAPY; HYPERTHYROIDISM; MULTIPLICATION; TUBERCULOSIS; ACCUMULATION; MECHANISM	Background: Thyrotoxicosis is conceptualized as an "autoimmune'' disease with no accepted infectious etiology. There are increasingly compelling data that another "autoimmune'' affliction, Crohn disease, may be caused by Mycobacterium avium subspecies paratuberculosis (MAP). Like M. tb, MAP is systemic. We hypothesized that some cases of thyrotoxicosis may be initiated by a MAP infection. Because other thioamides treat tuberculosis, leprosy and M. avium complex, we hypothesized that a mode of action of some thioamide anti-thyrotoxicosis medications may include MAP growth inhibition. Methods: The effect of the thioamides, thiourea, methimazole and 6-propo-2-thiouracil (6-PTU) were studied in radiometric Bactec (R) culture, on ten strains of three mycobacterial species (six of MAP, two of M. avium and two of M. tb. complex). Data are presented as "cumulative growth index,'' (cGI) or "percent decrease in cumulative GI'' (%-Delta cGI). Principal Findings: Methimazole was the most effective thioamide at inhibiting MAP growth. At 128 mu g/ml: MAP UCF-4; 65%-Delta cGI & MAP ATCC 19698; 90%-Delta cGI. Thiourea inhibited MAP "Ben'' maximally; 70%-Delta cGI. Neither methimazole nor thiourea inhibited M. avium or M. tb. at the doses tested. 6-PTU has no inhibition on any strain studied, although a structurally analogous control, 5-PTU, was the most inhibitory thioamide tested. Significance: We show inhibition of MAP growth by the thioamides, thiourea and methimazole in culture. These data are compatible with the hypothesis that these thioamides may have anti-prokaryotic in addition to their well-established eukaryotic actions in thyrotoxic individuals.	[Greenstein, Robert J.] James J Peters VA Med Ctr, Dept Surg, Bronx, NY USA; [Greenstein, Robert J.; Su, Liya] James J Peters VA Med Ctr, Lab Mol Surg Res, Bronx, NY USA; [Brown, Sheldon T.] James J Peters VA Med Ctr, Dept Med, Bronx, NY USA; [Brown, Sheldon T.] Mt Sinai Sch Med, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Greenstein, RJ (corresponding author), James J Peters VA Med Ctr, Dept Surg, Bronx, NY USA.	BGAxis@aol.com			Bronx Veterans Medical Research Foundation, Inc. at the James J. Peters VAMC Bronx NY	Bronx Veterans Medical Research Foundation, Inc. at the James J. Peters VAMC Bronx NY	The authors thank Becton-Dickinson for providing the Bactec (R) vials. Becton-Dickinson had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other extramural funds were obtained. This material is the result of work supported with resources and the use of facilities at the James J. Peters VAMC Bronx NY. Other than the JJP VAMC Bronx Research and Development Committee reviewing, and approving, our submitted research protocol the James J. Peters VAMC Bronx NY had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by the Bronx Veterans Medical Research Foundation, Inc. at the James J. Peters VAMC Bronx NY. The Bronx Veterans Medical Research Foundation, Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTRAM MA, 1986, J INFECT DIS, V154, P194, DOI 10.1093/infdis/154.1.194; BIANCHI GP, 1995, ITAL J GASTROENTEROL, V27, P291; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; D'Amore M, 2010, J MED MICROBIOL, V59, P137, DOI 10.1099/jmm.0.013474-0; DAMATO JJ, 1990, VET MICROBIOL, V22, P31, DOI 10.1016/0378-1135(90)90122-C; Fajardo TT, 2006, AM J TROP MED HYG, V74, P457, DOI 10.4269/ajtmh.2006.74.457; Greenstein RJ, 2009, SEQUELAE AND LONG-TERM CONSEQUENCES OF INFECTIOUS DISEASES, P135; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000161; Greenstein RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000516; Greenstein RJ, 2009, INT J INFECT DIS, V13, pE254, DOI 10.1016/j.ijid.2008.10.016; Greenstein RJ, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-4; Greenstein RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002496; Inokuchi T, 2005, INTERNAL MED, V44, P303, DOI 10.2169/internalmedicine.44.303; JARNEROT G, 1975, ACTA MED SCAND, V197, P83; JOHNE HA, 1895, DTSCH Z TIERMED PATH, V21, P438; LAM DCC, 1979, BIOCHEM PHARMACOL, V28, P2289, DOI 10.1016/0006-2952(79)90692-0; Laurberg P, 2006, EUR J ENDOCRINOL, V155, P783, DOI 10.1530/eje.1.02295; LEVY L, 1978, P SOC EXP BIOL MED, V158, P582; LEVY L, 1975, AM REV RESPIR DIS, V111, P651; LEVY L, 1972, AM REV RESPIR DIS, V106, P917, DOI 10.1164/arrd.1972.106.6.917; LINDSAY RH, 1979, ENDOCRINOLOGY, V104, P1686, DOI 10.1210/endo-104-6-1686; LINDSAY RH, 1975, BIOCHEM PHARMACOL, V24, P463, DOI 10.1016/0006-2952(75)90129-X; MARCHANT B, 1971, METABOLISM, V20, P989, DOI 10.1016/0026-0495(71)90021-7; MARCHANT B, 1972, J CLIN ENDOCR METAB, V34, P847, DOI 10.1210/jcem-34-5-847; Nakamura H, 2007, J CLIN ENDOCR METAB, V92, P2157, DOI 10.1210/jc.2006-2135; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Phetsuksiri B, 2003, J BIOL CHEM, V278, P53123, DOI 10.1074/jbc.M311209200; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RASTOGI N, 1992, ANTIMICROB AGENTS CH, V36, P2843, DOI 10.1128/AAC.36.12.2843; RIDLEY D. S., 1962, LEPROSY REV, V33, P119; Schurr E, 2009, NEW ENGL J MED, V361, P2666, DOI 10.1056/NEJMe0910690; Shah SA, 1998, J CLIN GASTROENTEROL, V26, P117, DOI 10.1097/00004836-199803000-00006; Small PM, 2001, NEW ENGL J MED, V345, P189, DOI 10.1056/NEJM200107193450307; Stewart B. A., 1982, Advances in Irrigation. Volume 1., P1; Wang F, 2007, J EXP MED, V204, P73, DOI 10.1084/jem.20062100; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11099	10.1371/journal.pone.0011099	http://dx.doi.org/10.1371/journal.pone.0011099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559419	Green Published, gold, Green Submitted			2022-12-25	WOS:000278741100013
J	Gosmain, Y; Marthinet, E; Cheyssac, C; Guerardel, A; Mamin, A; Katz, LS; Bouzakri, K; Philippe, J				Gosmain, Yvan; Marthinet, Eric; Cheyssac, Claire; Guerardel, Audrey; Mamin, Aline; Katz, Liora S.; Bouzakri, Karim; Philippe, Jacques			Pax6 Controls the Expression of Critical Genes Involved in Pancreatic alpha Cell Differentiation and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON GENE; BETA-CELLS; TRANSCRIPTION FACTORS; PROMOTER ELEMENT; EARLY-ONSET; MAF; ACTIVATION; INTERACT; BINDING; IDENTIFICATION	The paired box homeodomain Pax6 is crucial for endocrine cell development and function and plays an essential role in glucose homeostasis. Indeed, mutations of Pax6 are associated with diabetic phenotype. Importantly, homozygous mutant mice for Pax6 are characterized by markedly decreased beta and delta cells and absent alpha cells. To better understand the critical role that Pax6 exerts in glucagon-producing cells, we developed a model of primary rat alpha cells. To study the transcriptional network of Pax6 in adult and differentiated alpha cells, we generated Pax6-deficient primary rat alpha cells and glucagon-producing cells, using either specific siRNA or cells expressing constitutively a dominant-negative form of Pax6. In primary rat alpha cells, we confirm that Pax6 controls the transcription of the Proglucagon and processing enzyme PC2 genes and identify three new target genes coding for MafB, cMaf, and NeuroD1/Beta2, which are all critical for Glucagon gene transcription and alpha cell differentiation. Furthermore, we demonstrate that Pax6 directly binds and activates the promoter region of the three genes through specific binding sites and that constitutive expression of a dominant-negative form of Pax6 in glucagon-producing cells (InR1G9) inhibits the activities of the promoters. Finally our results suggest that the critical role of Pax6 action on alpha cell differentiation is independent of those of Arx and Foxa2, two transcription factors that are necessary for alpha cell development. We conclude that Pax6 is critical for alpha cell function and differentiation through the transcriptional control of key genes involved in glucagon gene transcription, proglucagon processing, and alpha cell differentiation.	[Philippe, Jacques] Univ Geneva, Diabet Unit, Div Endocrinol Diabet & Nutr, Univ Hosp, CH-1211 Geneva 4, Switzerland; [Bouzakri, Karim] Univ Geneva, Univ Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva		Yvan.Gosmain@hcuge.ch			Swiss National Science Foundation; Novo-Nordisk, Switzerland; Biology and Cancer Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novo-Nordisk, Switzerland(Novo Nordisk); Biology and Cancer Research Foundation	This work was supported by the Swiss National Science Foundation, Novo-Nordisk, Switzerland, and the Biology and Cancer Research Foundation.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Bernier G, 2001, DEVELOPMENT, V128, P3987; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Chauhan BK, 2002, J BIOL CHEM, V277, P11539, DOI 10.1074/jbc.M110531200; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; CORDIERBUSSAT M, 1995, MOL CELL BIOL, V15, P3904; Dumonteil E, 1998, J BIOL CHEM, V273, P19945, DOI 10.1074/jbc.273.32.19945; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Gauthier BR, 2002, MOL ENDOCRINOL, V16, P170, DOI 10.1210/me.16.1.170; Gosmain Y, 2007, J BIOL CHEM, V282, P35024, DOI 10.1074/jbc.M702795200; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; Huang HP, 2002, MOL ENDOCRINOL, V16, P541, DOI 10.1210/me.16.3.541; Huang K, 1999, Hokkaido Igaku Zasshi, V74, P419; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; Jin TR, 1996, MOL CELL BIOL, V16, P19; KATAOKA K, 1994, MOL CELL BIOL, V14, P7581, DOI 10.1128/MCB.14.11.7581; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Meyer K, 1998, DIABETES, V47, P1974, DOI 10.2337/diabetes.47.12.1974; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Nishi M, 2005, DIABETIC MED, V22, P641, DOI 10.1111/j.1464-5491.2005.01469.x; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Nishimura W, 2006, DIABETES, V55, pA362; Parnaud G, 2009, MOL ENDOCRINOL, V23, P1264, DOI 10.1210/me.2009-0008; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; PHILIPPE J, 1995, J BIOL CHEM, V270, P3039, DOI 10.1074/jbc.270.7.3039; Planque N, 2001, J BIOL CHEM, V276, P35751, DOI 10.1074/jbc.M104523200; Ritz-Laser B, 1999, J BIOL CHEM, V274, P4124, DOI 10.1074/jbc.274.7.4124; ROUILLER DG, 1990, EXP CELL RES, V191, P305, DOI 10.1016/0014-4827(90)90019-7; Sakai M, 2001, NUCLEIC ACIDS RES, V29, P1228, DOI 10.1093/nar/29.5.1228; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Singh S, 1998, J BIOL CHEM, V273, P21531, DOI 10.1074/jbc.273.34.21531; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sussel L, 1998, DEVELOPMENT, V125, P2213; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; TAKAKI R, 1986, IN VITRO CELL DEV B, V22, P120; TURQUE N, 1994, MOL ENDOCRINOL, V8, P929, DOI 10.1210/me.8.7.929; VANDEWINKEL M, 1983, BIOCHEM BIOPH RES CO, V114, P835, DOI 10.1016/0006-291X(83)90857-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WANG M, 1995, J BIOL CHEM, V270, P12646, DOI 10.1074/jbc.270.21.12584; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Yamada R, 2003, DEVELOPMENT, V130, P1759, DOI 10.1242/dev.00399; Yasuda T, 2002, DIABETES, V51, P224, DOI 10.2337/diabetes.51.1.224	51	53	54	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33381	33393		10.1074/jbc.M110.147215	http://dx.doi.org/10.1074/jbc.M110.147215			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20592023	Green Published, hybrid			2022-12-25	WOS:000283048200073
J	Dai, XP; Hao, J; Hou, XJ; Hai, T; Fan, Y; Yu, Y; Jouneau, A; Wang, L; Zhou, Q				Dai, Xiangpeng; Hao, Jie; Hou, Xiao-jun; Hai, Tang; Fan, Yong; Yu, Yang; Jouneau, Alice; Wang, Liu; Zhou, Qi			Somatic Nucleus Reprogramming Is Significantly Improved by m-Carboxycinnamic Acid Bishydroxamide, a Histone Deacetylase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL LINES; MOUSE EMBRYOS; MAMMALIAN DEVELOPMENT; DNA METHYLATION; TRICHOSTATIN-A; IN-VITRO; ACETYLATION; CLONING; HETEROCHROMATIN; ESTABLISHMENT	Somatic cell nuclear transfer (SCNT) has shown tremendous potential for understanding the mechanisms of reprogramming and creating applications in the realms of agriculture, therapeutics, and regenerative medicine, although the efficiency of reprogramming is still low. Somatic nucleus reprogramming is triggered in the short time after transfer into recipient cytoplasm, and therefore, this period is regarded as a key stage for optimizing SCNT. Here we report that CBHA, a histone deacetylase inhibitor, modifies the acetylation status of somatic nuclei and increases the developmental potential of mouse cloned embryos to reach pre- and post-implantation stages. Furthermore, the cloned embryos treated by CBHA displayed higher efficiency in the derivation of nuclear transfer embryonic stem cell lines by promoting outgrowths. More importantly, CBHA increased blastocyst quality compared with trichostatin A, another prevalent histone deacetylase inhibitor reported previously. Use of CBHA should improve the productivity of SCNT for a variety of research and clinical applications, and comparisons of cells with different levels of pluripotency and treated with CBHA versus trichostatin A will facilitate studies of the mechanisms of reprogramming.	[Dai, Xiangpeng; Hao, Jie; Hou, Xiao-jun; Hai, Tang; Fan, Yong; Yu, Yang; Wang, Liu; Zhou, Qi] Chinese Acad Sci, State Key Lab Reprod Biol, Inst Zool, Beijing 100101, Peoples R China; [Dai, Xiangpeng; Hao, Jie] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Jouneau, Alice] INRA, UMR Biol Dev & Reprod 1198, F-78352 Jouy En Josas, France; [Jouneau, Alice] Ecole Natl Vet Alfort, F-94700 Maisons Alfort, France	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA)	Zhou, Q (corresponding author), Chinese Acad Sci, State Key Lab Reprod Biol, Inst Zool, 1st Beichen West Rd, Beijing 100101, Peoples R China.	qzhou@ioz.ac.cn		, Haitang/0000-0002-3192-0753; Jouneau, Alice/0000-0001-5985-9862	973 Program [2006CB944003, 2007CB947702]; 863 Program [2006AA02A101]; National Science Foundation of China [30525040]	973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by 973 Program Grants 2006CB944003 and 2007CB947702, 863 Program Grant 2006AA02A101, and National Science Foundation of China Grant 30525040.	Bartova E, 2005, J CELL SCI, V118, P5035, DOI 10.1242/jcs.02621; Bi GF, 2006, CELL MOL IMMUNOL, V3, P285; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Campbell KHS, 2007, THERIOGENOLOGY, V68, pS214, DOI 10.1016/j.theriogenology.2007.05.059; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Enright BP, 2005, BIOL REPROD, V72, P944, DOI 10.1095/biolreprod.104.033225; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Gao SR, 2004, BIOL REPROD, V70, P1162, DOI 10.1095/biolreprod.103.024216; Gregory RI, 2001, MOL CELL BIOL, V21, P5426, DOI 10.1128/MCB.21.16.5426-5436.2001; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Iager AE, 2008, CLONING STEM CELLS, V10, P371, DOI 10.1089/clo.2007.0002; Jeon BG, 2008, REPRODUCTION, V135, P815, DOI 10.1530/REP-07-0442; Kang YK, 2002, EMBO J, V21, P1092, DOI 10.1093/emboj/21.5.1092; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2006, FEBS LETT, V580, P1801, DOI 10.1016/j.febslet.2006.02.036; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Maalouf WE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-11; Martin C, 2006, DEV BIOL, V292, P317, DOI 10.1016/j.ydbio.2006.01.009; PAPAIOANNOU VE, 1988, DEVELOPMENT, V102, P793; POWER MA, 1993, ANAT EMBRYOL, V187, P493; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; STADTFELD M, 2010, NATURE IN PRESS; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Teranishi T, 2004, DEV BIOL, V266, P76, DOI 10.1016/j.ydbio.2003.10.004; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Wakayama S, 2005, BIOL REPROD, V72, P932, DOI 10.1095/biolreprod.104.035105; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhao CL, 2007, CELL RES, V17, P80, DOI 10.1038/sj.cr.7310139; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313; Zhou Q, 2001, BIOL REPROD, V65, P412, DOI 10.1093/biolreprod/65.2.412	42	57	61	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					31002	31010		10.1074/jbc.M110.136085	http://dx.doi.org/10.1074/jbc.M110.136085			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20566633	Green Published, hybrid			2022-12-25	WOS:000282135500065
J	Kaddatz, K; Adhikary, T; Finkernagel, F; Meissner, W; Muller-Brusselbach, S; Muller, R				Kaddatz, Kerstin; Adhikary, Till; Finkernagel, Florian; Meissner, Wolfgang; Mueller-Bruesselbach, Sabine; Mueller, Rolf			Transcriptional Profiling Identifies Functional Interactions of TGF beta and PPAR beta/delta Signaling SYNERGISTIC INDUCTION OF ANGPTL4 TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; PROLIFERATOR-ACTIVATED RECEPTORS; TUMOR-SUPPRESSOR; TARGET GENES; ALPHA; DELTA; EXPRESSION; SMAD3; INFLAMMATION; LIGANDS	Peroxisome proliferator-activated receptors (PPARs) not only play a key role in regulating metabolic pathways but also modulate inflammatory processes, pointing to a functional interaction between PPAR and cytokine signaling pathways. In this study, we show by genome-wide transcriptional profiling that PPAR beta/delta and transforming growth factor-beta (TGF beta) pathways functionally interact in human myofibroblasts and that a subset of these genes is cooperatively activated by TGF beta and PPAR beta/delta. Using the angiopoietin-like 4 (ANGPTL4) gene as a model, we demonstrate that two enhancer regions cooperate to mediate the observed synergistic response. A TGF beta-responsive enhancer located similar to 8 kb upstream of the transcriptional start site is regulated by a mechanism involving SMAD3, ETS1, RUNX, and AP-1 transcription factors that interact with multiple contiguous binding sites. A second enhancer (PPAR-E) consisting of three juxtaposed PPAR response elements is located in the third intron similar to 3.5 kb downstream of the transcriptional start site. The PPAR-E is strongly activated by all three PPAR subtypes, with a novel type of PPAR response element motif playing a central role. Although the PPAR-E is not regulated by TGF beta, it interacts with SMAD3, ETS1, RUNX2, and AP-1 in vivo, providing a possible mechanistic explanation for the observed synergism.	[Kaddatz, Kerstin; Adhikary, Till; Finkernagel, Florian; Meissner, Wolfgang; Mueller-Bruesselbach, Sabine; Mueller, Rolf] Univ Marburg, Inst Mol Biol & Tumor Res, D-35032 Marburg, Germany	Philipps University Marburg	Muller, R (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res, Emil Mannkopff Str 2, D-35032 Marburg, Germany.	rmueller@imt.uni-marburg.de	Müller, Rolf/L-4997-2016; Adhikary, Till/O-5678-2018	Müller, Rolf/0000-0003-3339-4248; Adhikary, Till/0000-0003-1951-5605	Deutsche Forschungsgemeinschaft [Mu601/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Mu601/12-1, the core facility of the SFB-TR17, and the LOEWE-Schwerpunkt "Tumor and Inflammation."	*AG TECHN, 2006, AG MICR HYBR CHAMB U; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Brown RJ, 2007, CURR DRUG TARGETS, V8, P1307, DOI 10.2174/138945007783220614; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Coll T, 2010, ENDOCRINOLOGY, V151, P1560, DOI 10.1210/en.2009-1211; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Ding GL, 2006, J MOL CELL CARDIOL, V40, P821, DOI 10.1016/j.yjmcc.2006.03.422; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Furumatsu T, 2009, INT J BIOCHEM CELL B, V41, P1198, DOI 10.1016/j.biocel.2008.10.032; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gehrke S, 2003, GENE, V322, P137, DOI 10.1016/j.gene.2003.08.010; Giehl K, 2007, CELLS TISSUES ORGANS, V185, P123, DOI 10.1159/000101313; Graulich W, 1999, GENE, V227, P55, DOI 10.1016/S0378-1119(98)00585-X; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Inoue I, 2002, BIOCHEM BIOPH RES CO, V290, P131, DOI 10.1006/bbrc.2001.6141; Ito Y, 2003, CANCER RES, V63, P6651; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Jerome V, 1998, HUM GENE THER, V9, P2653, DOI 10.1089/hum.1998.9.18-2653; Jinnin M, 2004, ONCOGENE, V23, P1656, DOI 10.1038/sj.onc.1207064; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kilgore KS, 2008, CURR OPIN INVEST DR, V9, P463; King AN, 2010, ANTI-CANCER AGENT ME, V10, P213; Kino T, 2007, EUR J CLIN INVEST, V37, P425, DOI 10.1111/j.1365-2362.2007.01796.x; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; LICHTENSTEIN L, BIOCH BIOPHYS ACTA, V1801, P415; Lindemann RK, 2001, J BIOL CHEM, V276, P46661, DOI 10.1074/jbc.M105816200; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Moserle L, 2009, CURR MOL MED, V9, P935, DOI 10.2174/156652409789712800; Muller-Brusselbach S, 2007, EMBO J, V26, P3686, DOI 10.1038/sj.emboj.7601803; Naruhn S, 2010, MOL PHARMACOL, V77, P171, DOI 10.1124/mol.109.060541; Nawa T, 2000, BIOCHEM BIOPH RES CO, V275, P406, DOI 10.1006/bbrc.2000.3332; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; Peraza MA, 2006, TOXICOL SCI, V90, P269, DOI 10.1093/toxsci/kfj062; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rival Y, 2002, EUR J PHARMACOL, V435, P143, DOI 10.1016/S0014-2999(01)01589-8; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Tan NS, 2004, EMBO J, V23, P4211, DOI 10.1038/sj.emboj.7600437; Ueberham U, 2009, INT J DEV NEUROSCI, V27, P501, DOI 10.1016/j.ijdevneu.2009.04.001; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zhang Y, 2000, J BIOL CHEM, V275, P16979, DOI 10.1074/jbc.M001526200; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	59	49	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29469	29479		10.1074/jbc.M110.142018	http://dx.doi.org/10.1074/jbc.M110.142018			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20595396	Green Published, hybrid			2022-12-25	WOS:000281740100049
J	Itoh, T; Takeda, S; Akao, Y				Itoh, Tomohiro; Takeda, Shu; Akao, Yukihiro			MicroRNA-208 Modulates BMP-2-stimulated Mouse Preosteoblast Differentiation by Directly Targeting V-ets Erythroblastosis Virus E26 Oncogene Homolog 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS; OSTEOGENIC DIFFERENTIATION; UP-REGULATION; STEM-CELLS; GROWTH; GENE; EXPRESSION; OSTEOPONTIN; DEGRADATION	MicroRNAs (miRs) represent a class of endogenous similar to 18-25 nucleotide RNAs that regulate gene expression through translational repression by binding to a target mRNA. These miRs regulate several biological functions, such as cell growth, cell differentiation, carcinogenesis, and so on. In a previous report, we have indicated that miR-141 and -200a act as preosteoblast differentiation modulators. In the present study, using microRNA array and in silico analyses, we found that miR-208 is closely involved in preosteoblast differentiation by partially regulating the expression of Ets1 (V-ets erythroblastosis virus E26 oncogene homolog 1), which transactivates osteopontin, runt-related transcription factor 2, parathyroid hormone-related protein, and type I procollagen. Furthermore, the enforced expression of mature miR-208 in murine preosteoblast in MC3T3-E1 cells or primary osteoblast cells remarkably attenuated BMP-2-induced preosteoblast differentiation. In addition, we determined that Ets1 is a target gene of miR-208 by using a sensor luciferase reporter assay. Taken together, these results suggest that the down-regulation of miR-208 in BMP-2-stimulated osteoblast differentiation is an important part of the regulatory machinery involved in early osteogenesis.	[Itoh, Tomohiro; Akao, Yukihiro] Gifu Int Inst Biotechnol, Gifu 5040838, Japan; [Takeda, Shu] Keio Univ, Div Endocrinol Metab & Nephrol, Shinjuku Ku, Tokyo 1608582, Japan; [Akao, Yukihiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011193, Japan	Keio University; Gifu University	Itoh, T (corresponding author), Gifu Int Inst Biotechnol, 1-1 Naka Fudogaoka, Gifu 5040838, Japan.	titoh@giib.or.jp	ITOH, Tomohiro/ABG-7076-2020		Ministry of Education, Culture, Sports, Science and Technology [21700715]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Young Scientists (B) 21700715 from the Ministry of Education, Culture, Sports, Science and Technology.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Azmi P, 2005, EUR J CANCER, V41, P2549, DOI 10.1016/j.ejca.2005.08.020; Azmi PB, 2009, ANTICANCER RES, V29, P2253; Cataisson C, 2003, MOL CELL ENDOCRINOL, V204, P155, DOI 10.1016/S0303-7207(02)00298-8; Connor MK, 2005, MOL CANCER RES, V3, P453, DOI 10.1158/1541-7786.MCR-04-0166; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Gao YG, 2005, EXP CELL RES, V304, P127, DOI 10.1016/j.yexcr.2004.10.031; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Hashimoto Y, 2010, CARCINOGENESIS, V31, P777, DOI 10.1093/carcin/bgq013; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; INOSE H, 2010, P NATL ACAD IN PRESS; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Jinnin M, 2004, ONCOGENE, V23, P1656, DOI 10.1038/sj.onc.1207064; John SA, 2008, J BIOL CHEM, V283, P951, DOI 10.1074/jbc.M705262200; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Newberry EP, 1997, MOL ENDOCRINOL, V11, P1129, DOI 10.1210/me.11.8.1129; Pei HP, 2005, CANCER RES, V65, P7205, DOI 10.1158/0008-5472.CAN-04-3566; Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008; Raouf A, 2000, ONCOGENE, V19, P1969, DOI 10.1038/sj.onc.1203505; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; Vary CPH, 2000, EXP CELL RES, V257, P213, DOI 10.1006/excr.2000.4879; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200; ZHAO C, P NATL ACAD SCI, V107, P1876	37	61	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27745	27752		10.1074/jbc.M110.105080	http://dx.doi.org/10.1074/jbc.M110.105080			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576608	Green Published, hybrid			2022-12-25	WOS:000281404100030
J	Liu, J; Afroza, H; Rader, DJ; Jin, WJ				Liu, Jun; Afroza, Huq; Rader, Daniel J.; Jin, Weijun			Angiopoietin-like Protein 3 Inhibits Lipoprotein Lipase Activity through Enhancing Its Cleavage by Proprotein Convertases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL LIPASE; PROHORMONE CONVERTASES; BINDING; METABOLISM; ANGPTL3; FAMILY; DOMAIN; HYPERTRIGLYCERIDEMIA; IDENTIFICATION; POPULATION	Lipoprotein lipase (LPL)-mediated lipolysis of triglycerides is the first and rate-limiting step in chylomicron/very low density lipoprotein clearance at the luminal surface of the capillaries. Angiopoietin-like protein 3 (ANGPTL3) is shown to inhibit LPL activity and plays important roles in modulating lipoprotein metabolism in vivo. However, the mechanism by which it inhibits LPL activity remains poorly understood. Using cell-based analysis of the interaction between ANGPTL3, furin, proprotein convertase subtilisin/kexin type 5 (PCSK5), paired amino acid converting enzyme-4 (PACE4), and LPL, we demonstrated that the cleavage of LPL by proprotein convertases is an inactivation process, similar to that seen for endothelial lipase cleavage. At physiological concentrations and in the presence of cells, ANGPTL3 is a potent inhibitor of LPL. This action is due to the fact that ANGPTL3 can enhance LPL cleavage by endogenous furin and PACE4 but not by PCSK5. This effect is specific to LPL but not endothelial lipase. Both N- and C-terminal domains of LPL are required for ANGPTL3-enhanced cleavage, and the N-terminal domain of ANGPTL3 is sufficient to exert its effect on LPL cleavage. Moreover, ANGPTL3 enhances LPL cleavage in the presence of either heparan sulfate proteoglycans or glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1). By enhancing LPL cleavage, ANGPTL3 dissociates LPL from the cell surface, inhibiting both the catalytic and noncatalytic functions of LPL. Taken together, our data provide a molecular connection between ANGPTL3, LPL, and proprotein convertases, which may represent a rapid signal communication among different metabolically active tissues to maintain energy homeostasis. These novel findings provide a new paradigm of specific protease-substrate interaction and further improve our knowledge of LPL biology.	[Afroza, Huq; Jin, Weijun] SUNY Hlth Sci Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Liu, Jun; Rader, Daniel J.; Jin, Weijun] Univ Penn, Sch Med, Translat Med & Therapeut & Cardiovasc Inst, Philadelphia, PA 19104 USA; [Liu, Jun] Sun Yat Sen Univ, Dept Cardiol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Pennsylvania; Pennsylvania Medicine; Sun Yat Sen University	Jin, WJ (corresponding author), SUNY Hlth Sci Ctr, Dept Cell Biol, BSB 2-106,450 Clarkson Ave, Brooklyn, NY 11203 USA.	weijun.jin@downstate.edu			NHLBI, National Institutes of Health [HL081861]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081861] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL081861 from NHLBI.	Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Fuki IV, 2003, J BIOL CHEM, V278, P34331, DOI 10.1074/jbc.M302181200; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Griffon N, 2009, J BIOL CHEM, V284, P23322, DOI 10.1074/jbc.M109.037002; Hegele RA, 2009, HUM MOL GENET, V18, P4189, DOI 10.1093/hmg/ddp361; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Jin WJ, 2003, CIRC RES, V92, P644, DOI 10.1161/01.RES.0000064502.47539.6D; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Li YL, 2008, ACTA BIOCH BIOPH SIN, V40, P459, DOI 10.1111/j.1745-7270.2008.00421.x; Liu HQ, 2000, BIOCHEMISTRY-US, V39, P9201, DOI 10.1021/bi0009441; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Miida T, 2010, CURR OPIN LIPIDOL, V21, P70, DOI 10.1097/MOL.0b013e328333269e; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1999, ANN NY ACAD SCI, V885, P57; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SEMENKOVICH CF, 1989, J BIOL CHEM, V264, P9030; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Stejskal D, 2007, GEN PHYSIOL BIOPHYS, V26, P230; Wang J, 2008, HUM MOL GENET, V17, P2894, DOI 10.1093/hmg/ddn188; Wicher I, 1996, J IMMUNOL METHODS, V192, P1, DOI 10.1016/0022-1759(95)00260-X; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yimaz Y, 2009, EUR J GASTROEN HEPAT, V21, P1247, DOI 10.1097/MEG.0b013e32832b77ae	33	88	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27561	27570		10.1074/jbc.M110.144279	http://dx.doi.org/10.1074/jbc.M110.144279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20581395	Green Published, hybrid			2022-12-25	WOS:000281404100011
J	Parvatiyar, MS; Pinto, JR; Liang, JS; Potter, JD				Parvatiyar, Michelle S.; Pinto, Jose Renato; Liang, Jingsheng; Potter, James D.			Predicting Cardiomyopathic Phenotypes by Altering Ca2+ Affinity of Cardiac Troponin C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOFIBRILLAR ADENOSINE-TRIPHOSPHATASE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; INDUCED STRUCTURAL-CHANGE; MAGNESIUM BINDING-SITES; SKINNED RABBIT PSOAS; THIN FILAMENT; SKELETAL-MUSCLE; DILATED CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY; FORCE DEVELOPMENT	Cardiac diseases associated with mutations in troponin sub-units include hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (RCM). Altered calcium handling in these diseases is evidenced by changes in the Ca2+ sensitivity of contraction. Mutations in the Ca2+ sensor, troponin C (TnC), were generated to increase/decrease the Ca2+ sensitivity of cardiac skinned fibers to create the characteristic effects of DCM, HCM, and RCM. We also used a reconstituted assay to determine the mutation effects on ATPase activation and inhibition. One mutant (A23Q) was found with HCM-like properties (increased Ca2+ sensitivity of force and normal levels of ATPase inhibition). Three mutants (S37G, V44Q, and L48Q) were identified with RCM-like properties (a large increase in Ca2+ sensitivity, partial loss of ATPase inhibition, and increased basal force). Two mutations were identified (E40A and I61Q) with DCM properties (decreased Ca2+ sensitivity, maximal force recovery, and activation of the ATPase at high [Ca2+]). Steady-state fluorescence was utilized to assess Ca2+ affinity in isolated cardiac (c) TnCs containing F27W and did not necessarily mirror the fiber Ca2+ sensitivity. Circular dichroism of mutant cTnCs revealed a trend where increased alpha-helical content correlated with increased Ca2+ sensitivity in skinned fibers and vice versa. The main findings from this study were as follows: 1) cTnC mutants demonstrated distinct functional phenotypes reminiscent of bona fide HCM, RCM, and DCM mutations; 2) a region in cTnC associated with increased Ca2+ sensitivity in skinned fibers was identified; and 3) the F27W reporter mutation affected Ca2+ sensitivity, maximal force, and ATPase activation of some mutants.	[Parvatiyar, Michelle S.; Pinto, Jose Renato; Liang, Jingsheng; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Rm 6083A,RMSB,1600 NW 10th Ave, Miami, FL 33136 USA.	jdpotter@miami.edu	parvatiyar, michelle/ABH-7542-2020; Pinto, Jose Renato/H-2631-2017	Pinto, Jose Renato/0000-0001-9092-4976; Parvatiyar, Michelle/0000-0002-9416-0069	National Institutes of Health [HL-42325]; American Heart Postdoctoral Fellowships [AHA 0825368E, AHA 09POST2300030]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R37HL042325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Postdoctoral Fellowships; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-42325 (to J. D. P.). This work was also supported by American Heart Postdoctoral Fellowships AHA 0825368E (to J. R. P.) and AHA 09POST2300030 (to M. S. P.).	Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642; Brenner B, 1998, ADV EXP MED BIOL, V453, P177; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; CHANDRA M, 1994, J BIOL CHEM, V269, P14988; Chang AN, 2005, J BIOL CHEM, V280, P34343, DOI 10.1074/jbc.M505014200; Chen ZY, 1997, J MOL CELL CARDIOL, V29, P2345, DOI 10.1006/jmcc.1997.0468; DASILVA ACR, 1993, EUR J BIOCHEM, V213, P599; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; EASTWOOD AB, 1979, TISSUE CELL, V11, P553, DOI 10.1016/0040-8166(79)90062-4; ELSALEH SC, 1987, J BIOL CHEM, V262, P17240; Endoh M, 1998, JPN HEART J, V39, P1; Fiske CH, 1925, J BIOL CHEM, V66, P375; Gagne SM, 1997, BIOCHEMISTRY-US, V36, P4386, DOI 10.1021/bi963076+; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; GUTH K, 1987, J BIOL CHEM, V262, P13627; Hershberger RE, 2009, CIRC-CARDIOVASC GENE, V2, P306, DOI 10.1161/CIRCGENETICS.108.846733; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Huang XP, 2004, ACTA PHARMACOL SIN, V25, P1569; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; Knott A, 2002, J MOL CELL CARDIOL, V34, P469, DOI 10.1006/jmcc.2002.1528; Kreutziger KL, 2008, J PHYSIOL-LONDON, V586, P3683, DOI 10.1113/jphysiol.2008.152181; Kubo T, 2007, J AM COLL CARDIOL, V49, P2419, DOI 10.1016/j.jacc.2007.02.061; KUREBAYASHI N, 1988, J PHYSIOL-LONDON, V403, P407, DOI 10.1113/jphysiol.1988.sp017256; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Leblanc L, 2000, ARCH BIOCHEM BIOPHYS, V384, P296, DOI 10.1006/abbi.2000.2103; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Li MX, 1997, BIOCHEMISTRY-US, V36, P12519, DOI 10.1021/bi971222l; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Malnic B, 1998, J BIOL CHEM, V273, P10594, DOI 10.1074/jbc.273.17.10594; Mathew L, 1998, DRUG AGING, V12, P191, DOI 10.2165/00002512-199812030-00003; McKay RT, 2000, BIOCHEMISTRY-US, V39, P12731, DOI 10.1021/bi001240u; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; MOEWS PC, 1975, J MOL BIOL, V91, P201, DOI 10.1016/0022-2836(75)90160-6; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; PEARLSTONE JR, 1983, J BIOL CHEM, V258, P2534; PEARLSTONE JR, 1992, BIOCHEMISTRY-US, V31, P6545, DOI 10.1021/bi00143a026; Pearlstone JR, 2000, J BIOL CHEM, V275, P35106, DOI 10.1074/jbc.M001000200; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; POLLESELLO P, 1994, J BIOL CHEM, V269, P28584; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; SCHOLZ H, 1986, J MOL CELL CARDIOL, V18, P79, DOI 10.1016/S0022-2828(86)80463-1; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; SMITH L, 1994, J BIOL CHEM, V269, P9857; SOLARO RJ, 1986, J PHARMACOL EXP THER, V238, P502; Sorsa T, 2001, J BIOL CHEM, V276, P9337, DOI 10.1074/jbc.M007484200; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031; ZOT AS, 1987, J BIOL CHEM, V262, P1966	74	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27785	27797		10.1074/jbc.M110.112326	http://dx.doi.org/10.1074/jbc.M110.112326			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20566645	Green Published, hybrid			2022-12-25	WOS:000281404100034
J	Casutt, MS; Huber, T; Brunisholz, R; Tao, ML; Fritz, G; Steuber, J				Casutt, Marco S.; Huber, Tamara; Brunisholz, Rene; Tao, Minli; Fritz, Guenter; Steuber, Julia			Localization and Function of the Membrane-bound Riboflavin in the Na+-translocating NADH:Quinone Oxidoreductase (Na+-NQR) from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; MULTIPLE SEQUENCE ALIGNMENT; PUMPING NADH; DETERGENT BINDING; NADHUBIQUINONE OXIDOREDUCTASE; UBIQUINONE OXIDOREDUCTASE; PROTEIN STRUCTURE; CRYSTAL-STRUCTURE; PROSTHETIC GROUPS; ESCHERICHIA-COLI	The sodium ion-translocating NADH: quinone oxidoreductase (Na+-NQR) from the human pathogen Vibrio cholerae is a respiratory membrane protein complex that couples the oxidation of NADH to the transport of Na+ across the bacterial membrane. The Na+-NQR comprises the six subunits NqrABCDEF, but the stoichiometry and arrangement of these subunits are unknown. Redox-active cofactors are FAD and a 2Fe-2S cluster on NqrF, covalently attached FMNs on NqrB and NqrC, and riboflavin and ubiquinone-8 with unknown localization in the complex. By analyzing the cofactor content and NADH oxidation activity of subcomplexes of the Na+-NQR lacking individual subunits, the riboflavin cofactor was unequivocally assigned to the membrane-bound NqrB subunit. Quantitative analysis of the N-terminal amino acids of the holo-complex revealed that NqrB is present in a single copy in the holo-complex. It is concluded that the hydrophobic NqrB harbors one riboflavin in addition to its covalently attached FMN. The catalytic role of two flavins in subunit NqrB during the reduction of ubiquinone to ubiquinol by the Na+-NQR is discussed.	[Huber, Tamara; Tao, Minli; Steuber, Julia] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Brunisholz, Rene] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Casutt, Marco S.; Fritz, Guenter] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany	University of Zurich; University of Freiburg	Steuber, J (corresponding author), Univ Stuttgart Hohenheim, Dept Microbiol, D-70599 Stuttgart, Germany.	julia.steuber@uni-hohenheim.de	Fritz, Guenter/E-2933-2013	Fritz, Guenter/0000-0002-4571-8812	Research Commission of the University of Zurich; EMDO Stiftung; Swiss National Science Foundation; Parkinson Schweiz	Research Commission of the University of Zurich; EMDO Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Parkinson Schweiz	This work was supported by fellowships from the Research Commission of the University of Zurich and the EMDO Stiftung (to M. S. C.), and by grants from the Swiss National Science Foundation and from Parkinson Schweiz (to J. S.).	Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2009, J BIOL CHEM, V284, P5533, DOI 10.1074/jbc.M808984200; Bogachev AV, 2001, BIOCHEMISTRY-US, V40, P7318, DOI 10.1021/bi002545b; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; DEMELER B, 2005, MODERN ANAL ULTRACEN; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Fadeeva MS, 2008, BIOCHEMISTRY-MOSCOW+, V73, P123, DOI 10.1134/S0006297908020028; FLEMING KG, 2008, CURR PROTOC PROTEIN, P1; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gemperli AC, 2002, J BIOL CHEM, V277, P33811, DOI 10.1074/jbc.M204860200; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; HAYASHI M, 1992, BIOCHIM BIOPHYS ACTA, V1099, P145, DOI 10.1016/0005-2728(92)90211-J; HEMPEL J, 2002, MODERN PROTEIN CHEM; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; MARCUS H, 1990, FEMS MICROBIOL LETT, V68, P149, DOI 10.1016/0378-1097(90)90141-C; Meier T, 2005, FEBS J, V272, P5474, DOI [10.1111/j.1742-4658.2005.04940.x, 10.1111/j.1742-4685.2005.04940.x]; MILPETZ F, 1995, TRENDS BIOCHEM SCI, V20, P204, DOI 10.1016/S0968-0004(00)89009-X; Mokhonov V, 2005, PROTEIN EXPRES PURIF, V40, P91, DOI 10.1016/j.pep.2004.10.002; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nakayama Y, 1998, FEBS LETT, V422, P240, DOI 10.1016/S0014-5793(98)00016-7; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; Pueyo JJ, 1996, BIOCHEM J, V313, P855, DOI 10.1042/bj3130855; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; ROST B, 1995, PROTEIN SCI, V4, P521; ROUGHEAD ZK, 1990, J NUTR, V120, P382, DOI 10.1093/jn/120.4.382; Sambrook J, 2001, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Steuber J, 1997, EUR J BIOCHEM, V249, P770, DOI 10.1111/j.1432-1033.1997.t01-2-00770.x; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; Tao ML, 2006, ACTA CRYSTALLOGR F, V62, P110, DOI 10.1107/S174430910504306X; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Walsh MA, 1998, EUR J BIOCHEM, V258, P362, DOI 10.1046/j.1432-1327.1998.2580362.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	68	34	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27088	27099		10.1074/jbc.M109.071126	http://dx.doi.org/10.1074/jbc.M109.071126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558724	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000281172700040
J	Connerth, M; Czabany, T; Wagner, A; Zellnig, G; Leitner, E; Steyrer, E; Daum, G				Connerth, Melanie; Czabany, Tibor; Wagner, Andrea; Zellnig, Guenther; Leitner, Erich; Steyrer, Ernst; Daum, Guenther			Oleate Inhibits Steryl Ester Synthesis and Causes Liposensitivity in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; ENDOPLASMIC-RETICULUM STRESS; LIPOTOXIC CELL-DEATH; SACCHAROMYCES-CEREVISIAE; LIPID PARTICLES; PEROXISOME; MEMBRANE; ACYLTRANSFERASE; PROLIFERATION; ESTERIFICATION	In the yeast Saccharomyces cerevisiae, neutral lipids can be synthesized by four acyltransferases, namely Dga1p and Lro1p producing triacylglycerols (TAG) and Are1p and Are2p forming steryl esters (SE). TAG and SE are stored in an organelle called lipid particles/droplet. Growth of yeast cells on oleate-supplemented media strongly induced proliferation of lipid particles and specifically the synthesis of TAG, which serve as the major pool for the excess of fatty acids. Surprisingly, SE synthesis was strongly inhibited under these conditions. Here, we show that this effect was not due to decreased expression of ARE2 encoding the major yeast SE synthase at the transcriptional level but to competitive enzymatic inhibition of Are2p by free oleate. Consequently, a triple mutant dga1 Delta lro1 Delta are1 Delta ARE2(+) grown on oleate did not form substantial amounts of SE and exhibited a growth phenotype similar to the dga1 Delta lro1 Delta are1 Delta are2(+) quadruple mutant, including lack of lipid particles. Growth of these mutants on oleate was strongly delayed, and cell viability was decreased but rescued by adaptation. In these strains, oleate stress caused morphological changes of intracellular membranes, altered phospholipid composition and formation of an additional lipid class, ethyl esters of fatty acids. In summary, our data showed that exposure to oleate led to disturbed lipid and membrane homeostasis along with liposensitivity of the yeast.	[Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Wagner, Andrea; Steyrer, Ernst] Med Univ Graz, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Zellnig, Guenther] Karl Franzens Univ Graz, Inst Plant Sci, A-8010 Graz, Austria; [Leitner, Erich] Graz Univ Technol, Inst Analyt Chem & Food Chem, A-8010 Graz, Austria	Graz University of Technology; Medical University of Graz; University of Graz; Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at	Leitner, Erich/AAG-8826-2021	Leitner, Erich/0000-0003-2520-2111; Czabany, Tibor/0000-0003-1754-6723	Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich [18857, W901-B05]	Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich(Austrian Science Fund (FWF))	This work was supported by the Fonds zur Forderung der Wissenschaftlichen Forschung in Osterreich, Projects 18857 and W901-B05 (to G. D.).	Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; Alhomsi K, 2006, ALCOHOL CLIN EXP RES, V30, P1121, DOI 10.1111/j.1530-0277.2006.00129.x; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; CASEY WM, 1993, BIOCHEM BIOPH RES CO, V193, P1297, DOI 10.1006/bbrc.1993.1766; Cnop M, 2007, DIABETES CARE, V30, P677, DOI 10.2337/dc06-1834; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cury-Boaventura MF, 2006, LIFE SCI, V78, P1448, DOI 10.1016/j.lfs.2005.07.038; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; De Gottardi A, 2007, LAB INVEST, V87, P792, DOI 10.1038/labinvest.3700590; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; DUROCHER V, 1990, CAN J PHYSIOL PHARM, V68, P1255, DOI 10.1139/y90-188; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; FERDINANDUS J, 1969, J BACTERIOL, V98, P1109, DOI 10.1128/JB.98.3.1109-1113.1969; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garbarino J, 2005, BIOCHEM SOC T, V33, P1182, DOI 10.1042/BST20051182; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; GRAU R, 1993, MOL MICROBIOL, V8, P535, DOI 10.1111/j.1365-2958.1993.tb01598.x; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; Hamel FG, 2009, METABOLISM, V58, P1047, DOI 10.1016/j.metabol.2009.04.005; JONES AL, 1966, J HISTOCHEM CYTOCHEM, V14, P215, DOI 10.1177/14.3.215; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kohlwein SD, 2007, CURR HYPERTENS REP, V9, P455, DOI 10.1007/s11906-007-0084-5; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Low CP, 2008, J CELL SCI, V121, P2671, DOI 10.1242/jcs.028977; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; MORIKAWA M, 1978, EUR J BIOCHEM, V84, P61, DOI 10.1111/j.1432-1033.1978.tb12141.x; MORRISON WR, 1964, J LIPID RES, V5, P600; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; RESNICK RJ, 1994, J BIOL CHEM, V269, P32336; Rosenberger S, 2009, BBA-MOL CELL BIOL L, V1791, P379, DOI 10.1016/j.bbalip.2009.01.015; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; Saleem RA, 2008, J CELL BIOL, V181, P281, DOI 10.1083/jcb.200710009; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; Smith JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100051; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Valachovic M, 2002, FEMS MICROBIOL LETT, V206, P121, DOI 10.1016/S0378-1097(01)00529-8; Valachovic M, 2001, FEMS MICROBIOL LETT, V197, P41, DOI 10.1111/j.1574-6968.2001.tb10580.x; VERGERES G, 1993, J CELL SCI, V106, P249; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wriessnegger T, 2007, BBA-MOL CELL BIOL L, V1771, P455, DOI 10.1016/j.bbalip.2007.01.004; WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yang HY, 1997, J BIOL CHEM, V272, P3980, DOI 10.1074/jbc.272.7.3980; Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	66	56	58	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26832	26841		10.1074/jbc.M110.122085	http://dx.doi.org/10.1074/jbc.M110.122085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20571028	Green Published, hybrid			2022-12-25	WOS:000281172700014
J	van Buul, JD; van Rijssel, J; van Alphen, FPJ; Hoogenboezem, M; Tol, S; Hoeben, KA; van Marle, J; Mul, EPJ; Hordijk, PL				van Buul, Jaap D.; van Rijssel, Jos; van Alphen, Floris P. J.; Hoogenboezem, Mark; Tol, Simon; Hoeben, Kees A.; van Marle, Jan; Mul, Erik P. J.; Hordijk, Peter L.			Inside-Out Regulation of ICAM-1 Dynamics in TNF-alpha-Activated Endothelium	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; LEUKOCYTE TRANSENDOTHELIAL MIGRATION; INTRACELLULAR DOMAIN; SIGNALING PATHWAY; CELLS; RHO; TRANSMIGRATION; PHOSPHORYLATION; RECRUITMENT; DIAPEDESIS	Background: During transendothelial migration, leukocytes use adhesion molecules, such as ICAM-1, to adhere to the endothelium. ICAM-1 is a dynamic molecule that is localized in the apical membrane of the endothelium and clusters upon binding to leukocytes. However, not much is known about the regulation of ICAM-1 clustering and whether membrane dynamics are linked to the ability of ICAM-1 to cluster and bind leukocyte integrins. Therefore, we studied the dynamics of endothelial ICAM-1 under non-clustered and clustered conditions. Principal Findings: Detailed scanning electron and fluorescent microscopy showed that the apical surface of endothelial cells constitutively forms small filopodia-like protrusions that are positive for ICAM-1 and freely move within the lateral plane of the membrane. Clustering of ICAM-1, using anti-ICAM-1 antibody-coated beads, efficiently and rapidly recruits ICAM-1. Using fluorescence recovery after photo-bleaching (FRAP), we found that clustering increased the immobile fraction of ICAM-1, compared to non-clustered ICAM-1. This shift required the intracellular portion of ICAM-1. Moreover, biochemical assays showed that ICAM-1 clustering recruited beta-actin and filamin. Cytochalasin B, which interferes with actin polymerization, delayed the clustering of ICAM-1. In addition, we could show that cytochalasin B decreased the immobile fraction of clustered ICAM-1-GFP, but had no effect on non-clustered ICAM-1. Also, the motor protein myosin-II is recruited to ICAM-1 adhesion sites and its inhibition increased the immobile fraction of both non-clustered and clustered ICAM-1. Finally, blocking Rac1 activation, the formation of lipid rafts, myosin-II activity or actin polymerization, but not Src, reduced the adhesive function of ICAM-1, tested under physiological flow conditions. Conclusions: Together, these findings indicate that ICAM-1 clustering is regulated in an inside-out fashion through the actin cytoskeleton. Overall, these data indicate that signaling events within the endothelium are required for efficient ICAM-1-mediated leukocyte adhesion.	[van Buul, Jaap D.; van Rijssel, Jos; van Alphen, Floris P. J.; Hoogenboezem, Mark; Tol, Simon; Mul, Erik P. J.; Hordijk, Peter L.] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Hoeben, Kees A.; van Marle, Jan] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Buul, JD (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.vanbuul@sanquin.nl	van Buul, Jaap D/AAJ-4371-2021	van Buul, Jaap D/0000-0003-0054-7949; van Rijssel, Jos/0000-0001-8077-1371; Hordijk, Peter/0000-0002-3348-078X; Mul, FPJ/0000-0002-8234-9972	Dutch Heart Foundation [2005T039]; NWO (The Netherlands Organisation for Scientific Research)-ZonMW (the Netherlands Organisation for Health Research and Development) [916.76.053]	Dutch Heart Foundation(Netherlands Heart Foundation); NWO (The Netherlands Organisation for Scientific Research)-ZonMW (the Netherlands Organisation for Health Research and Development)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This work has been funded by the Dutch Heart Foundation (grant no. 2005T039) and NWO (The Netherlands Organisation for Scientific Research)-ZonMW (the Netherlands Organisation for Health Research and Development) Veni grant 916.76.053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that	Alcaide P, 2009, MICROCIRCULATION, V16, P43, DOI 10.1080/10739680802273892; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; BACK AL, 1992, J IMMUNOL, V148, P710; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135; Celli L, 2006, J IMMUNOL, V177, P4113, DOI 10.4049/jimmunol.177.6.4113; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P1; Etienne S, 1998, J IMMUNOL, V161, P5755; Greenwood J, 2003, J IMMUNOL, V171, P2099, DOI 10.4049/jimmunol.171.4.2099; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kanters E, 2008, J BIOL CHEM, V283, P31830, DOI 10.1074/jbc.M804888200; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kluger Martin S, 2004, Adv Dermatol, V20, P163; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; Saito H, 2002, J LEUKOCYTE BIOL, V72, P829; Sans E, 2001, J IMMUNOL, V166, P544, DOI 10.4049/jimmunol.166.1.544; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007; Tilghman RW, 2002, FEBS LETT, V525, P83, DOI 10.1016/S0014-5793(02)03070-3; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; van Buul JD, 2007, ARTERIOSCL THROM VAS, V27, P1870, DOI 10.1161/ATVBAHA.107.145821; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Buul JD, 2009, THROMB HAEMOSTASIS, V101, P649, DOI 10.1160/TH08-11-0714; van Buul JD, 2002, J IMMUNOL, V168, P588, DOI 10.4049/jimmunol.168.2.588; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Vestweber D, 2007, Ernst Schering Found Symp Proc, P151; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Yang L, 2006, J IMMUNOL, V177, P6440, DOI 10.4049/jimmunol.177.9.6440	39	45	46	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11336	10.1371/journal.pone.0011336	http://dx.doi.org/10.1371/journal.pone.0011336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596527	gold, Green Published, Green Submitted			2022-12-25	WOS:000279259900009
J	Curlin, ME; Huang, ML; Lu, XY; Celum, CL; Sanchez, J; Selke, S; Baeten, JM; Zuckerman, RA; Erdman, DD; Corey, L				Curlin, Marcel E.; Huang, Meei-Li; Lu, Xiaoyan; Celum, Connie L.; Sanchez, Jorge; Selke, Stacy; Baeten, Jared M.; Zuckerman, Richard A.; Erdman, Dean D.; Corey, Lawrence			Frequent Detection of Human Adenovirus from the Lower Gastrointestinal Tract in Men Who Have Sex with Men	PLOS ONE			English	Article							ENTERIC VIRUSES; T-CELL; VACCINE VECTORS; HOMOSEXUAL-MEN; HIV-1 VACCINE; DOUBLE-BLIND; PREVALENCE; INFECTION; AIDS; ROTAVIRUS	Background: The association between baseline seropositivity to human adenovirus (HAdV) type 5 and increased HIV acquisition in the Step HIV Vaccine Study has raised questions concerning frequency of acquired and/or persistent Adenovirus infections among adults at high risk of HIV-1 infection. Methodology: To evaluate the frequency and pattern of HAdV shedding from the lower GI tract, we retrospectively tested rectal swabs for HAdVs in a cohort of 20 HSV-2 positive HIV-positive Peruvian men who have sex with men (MSM) undergoing rectal swabbing three times/week for 18 consecutive weeks, in a prospective study of HSV-2 suppression in HIV infection. Viral DNA was extracted and amplified using a sensitive multiplex PCR assay that detects all currently recognized HAdV types. Molecular typing of viruses was performed on selected samples by hexon gene sequencing. Baseline neutralizing antibody titers to HAdVs 25, 226, 235 and 248 were also assessed. Principal Findings: 15/20 individuals had HAdV detected during follow up. The median frequency of HAdV detection was 30% of samples (range 2.0% to 64.7%). HAdV shedding typically occurred on consecutive days in clustered episodes lasting a median of 4 days (range 1 to 9 days) separated by periods without shedding, suggesting frequent new infections or reactivation of latent infections over time. 8 of the 15 shedders had more than one type detected in follow-up. 20 HAdV types from species B, C, and D were identified, including HAdV-5, 226 and 248, HAdV types under development as potential vaccine candidates. 14/20 subjects were seropositive for HAdV-5; 15/20 for HAdV-26; 3/20 for HAdV-35; and 2/20 for HAdV-48. HAdV shedding did not correlate with CD4 count, plasma HIV-1 viral load, or titers to HAdV-5 or HAdV-35. The sole individual with HAdV-5 shedding was HAdV-5 seropositive. Conclusions: HAdV shedding was highly prevalent and diverse, including types presently under consideration as HIV vaccine vectors. Subclinical HAdV infection of the GI tract is common among MSM in Peru; the prevalence of HAdV in the enteric tract should be evaluated in other populations. The association between ongoing recent enteric HAdV and the immune response to recombinant HAdV vaccines should be evaluated.	[Curlin, Marcel E.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Curlin, Marcel E.; Huang, Meei-Li; Celum, Connie L.; Selke, Stacy; Baeten, Jared M.; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA USA; [Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Celum, Connie L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Celum, Connie L.; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Sanchez, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Zuckerman, Richard A.] Dartmouth Hitchcock Med Ctr, Div Infect Dis, Lebanon, NH 03766 USA; [Lu, Xiaoyan; Erdman, Dean D.] Ctr Dis Control & Prevent, Atlanta, GA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Dartmouth College; Centers for Disease Control & Prevention - USA	Curlin, ME (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	cemarcel@u.washington.edu	Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	GlaxoSmithKline; NIH CFAR Clinical Research and Laboratory Core [AI-27757, AI-38858, R37 AI-42528]; NIAID [AI-30731]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, U01AI038858, R37AI042528, P30AI027757] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NIH CFAR Clinical Research and Laboratory Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a research grant from GlaxoSmithKline and NIH CFAR Clinical Research and Laboratory Core Grants AI-27757 & AI-38858, R37 AI-42528 and NIAID Grant AI-30731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; ALBRECHT H, 1993, SCAND J GASTROENTERO, V28, P307, DOI 10.3109/00365529309090246; Baden LR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-O36; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; BUIMOVICIKLEIN E, 1988, J MED VIROL, V25, P371, DOI 10.1002/jmv.1890250402; Cinek O, 2006, J CLIN VIROL, V35, P33, DOI 10.1016/j.jcv.2005.03.007; CUNNINGHAM AL, 1988, J INFECT DIS, V158, P386, DOI 10.1093/infdis/158.2.386; DUREPAIRE N, 1995, J MED VIROL, V45, P56, DOI 10.1002/jmv.1890450111; Ebner K, 2005, J VIROL, V79, P12635, DOI 10.1128/JVI.79.20.12635-12642.2005; Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07; EVANS AS, 1958, AM J HYG, V67, P256, DOI 10.1093/oxfordjournals.aje.a119932; Gonzalez GG, 1998, J MED VIROL, V55, P288, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;288::AID-JMV6&gt;3.0.CO;2-X; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; GRAY JR, 1989, AM J GASTROENTEROL, V84, P1521; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; GUARINO A, 1993, AIDS, V7, P1435; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HIERHOLZER JC, 1988, J INFECT DIS, V158, P804, DOI 10.1093/infdis/158.4.804; HIERHOLZER JC, 1978, J CLIN MICROBIOL, V7, P499; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; HILLIS WD, 1973, INDIAN J MED RES, V61, P980; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; HORVATH J, 1986, J VIROL, V59, P189, DOI 10.1128/JVI.59.1.189-192.1986; HORWITZ MS, 1984, ANN NY ACAD SCI, V437, P161, DOI 10.1111/j.1749-6632.1984.tb37132.x; Huang ML, 2008, DIAGN MICR INFEC DIS, V62, P263, DOI 10.1016/j.diagmicrobio.2008.06.009; KALJOT KT, 1989, GASTROENTEROLOGY, V97, P1031, DOI 10.1016/0016-5085(89)91516-3; Kaye SB, 2005, J MED VIROL, V77, P227, DOI 10.1002/jmv.20440; KHOO SH, 1995, J INFECT DIS, V172, P629, DOI 10.1093/infdis/172.3.629; Kurosaki Kunikazu, 2004, Antiviral Chemistry & Chemotherapy, V15, P281; LAUGHON BE, 1988, GASTROENTEROLOGY, V94, P984, DOI 10.1016/0016-5085(88)90557-4; Leen AM, 2004, BLOOD, V104, P2432, DOI 10.1182/blood-2004-02-0646; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; LEW JF, 1991, J INFECT DIS, V164, P673, DOI 10.1093/infdis/164.4.673; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; MAST TC, 2009, VACCINE; Naesens L, 2005, ANTIMICROB AGENTS CH, V49, P1010, DOI 10.1128/AAC.49.3.1010-1016.2005; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Robb ML, 2008, LANCET, V372, P1857, DOI 10.1016/S0140-6736(08)61593-7; Rodriguez A, 2008, INFECT IMMUN, V76, P1709, DOI 10.1128/IAI.01614-07; Rodriguez-Baez N, 2002, J PEDIATR GASTR NUTR, V35, P64, DOI 10.1097/00005176-200207000-00014; Roy S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000503; SAULSBURY FT, 1980, J PEDIATR-US, V97, P61, DOI 10.1016/S0022-3476(80)80131-4; Schmidt W, 1996, J ACQ IMMUN DEF SYND, V13, P33, DOI 10.1097/00042560-199609000-00006; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THEA DM, 1993, T ROY SOC TROP MED H, V87, P263, DOI 10.1016/0035-9203(93)90119-B; Thomas P D, 1999, HIV Med, V1, P19, DOI 10.1046/j.1468-1293.1999.00004.x; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	52	10	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11321	10.1371/journal.pone.0011321	http://dx.doi.org/10.1371/journal.pone.0011321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593015	Green Published, Green Submitted, gold			2022-12-25	WOS:000279140800019
J	Nieto, C; Sadowy, E; de la Campa, AG; Hryniewicz, W; Espinosa, M				Nieto, Concha; Sadowy, Ewa; de la Campa, Adela G.; Hryniewicz, Waleria; Espinosa, Manuel			The relBE2Spn Toxin-Antitoxin System of Streptococcus pneumoniae: Role in Antibiotic Tolerance and Functional Conservation in Clinical Isolates	PLOS ONE			English	Article							MESSENGER-RNA INTERFERASE; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SERINE HYDROXAMATE; VIBRIO-CHOLERAE; CATALYTIC SITE; PLASMID; LOCI; STRESS	Type II (proteic) chromosomal toxin-antitoxin systems (TAS) are widespread in Bacteria and Archaea but their precise function is known only for a limited number of them. Out of the many TAS described, the relBE family is one of the most abundant, being present in the three first sequenced strains of Streptococcus pneumoniae (D39, TIGR4 and R6). To address the function of the pneumococcal relBE2Spn TAS in the bacterial physiology, we have compared the response of the R6-relBE2Spn wild type strain with that of an isogenic derivative, Delta relB2Spn under different stress conditions such as carbon and amino acid starvation and antibiotic exposure. Differences on viability between the wild type and mutant strains were found only when treatment directly impaired protein synthesis. As a criterion for the permanence of this locus in a variety of clinical strains, we checked whether the relBE2Spn locus was conserved in around 100 pneumococcal strains, including clinical isolates and strains with known genomes. All strains, although having various types of polymorphisms at the vicinity of the TA region, contained a functional relBE2Spn locus and the type of its structure correlated with the multilocus sequence type. Functionality of this TAS was maintained even in cases where severe rearrangements around the relBE2Spn region were found. We conclude that even though the relBE2Spn TAS is not essential for pneumococcus, it may provide additional advantages to the bacteria for colonization and/or infection.	[Nieto, Concha; Espinosa, Manuel] CSIC, Ctr Invest Biol, Madrid, Spain; [Sadowy, Ewa; Hryniewicz, Waleria] Natl Med Inst, Warsaw, Poland; [de la Campa, Adela G.] Inst Salud Carlos III, Ctr Nacl Microbiol, Majadahonda, Spain; [de la Campa, Adela G.] Inst Salud Carlos III, CIBER Enfermedades Resp, Majadahonda, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); National Medicines Institute Lekow (NIL); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Nieto, C (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	mespinosa@cib.csic.es	Hryniewicz, Waleria/J-3168-2012; de la Campa, Adela G/K-1654-2014; Espinosa, Manuel/M-5282-2019; Sadowy, Ewa/U-7930-2018; Nieto, Concha/ABG-2127-2020	de la Campa, Adela G/0000-0002-3598-2548; Sadowy, Ewa/0000-0003-0284-6440; Nieto, Concha/0000-0003-0790-3440	European Union (EU) [CP223111]; Comunidad de Madrid [CM-BIO0260-2006]; Spanish Ministry of Science and Innovation [BIO2008-02154, BFU2007-63575, CSD-2008-00013]	European Union (EU)(CGIAREuropean Commission); Comunidad de Madrid(Comunidad de Madrid); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research was performed under a collaborative project financed by the European Union (EU-CP223111, CAREPNEUMO, to M. E., E. S. and W. H.), by the Comunidad de Madrid (CM-BIO0260-2006, COMBACT, to M. E. and A. G. C.), and by the Spanish Ministry of Science and Innovation (Grants BIO2008-02154 to A. G. C, and BFU2007-63575 and CSD-2008-00013, INTERMODS, to M. E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 1996, FEMS MICROBIOL LETT, V140, P85; BRAVO A, 1988, MOL GEN GENET, V215, P146, DOI 10.1007/BF00331316; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Condon C, 2006, MOL MICROBIOL, V61, P573, DOI 10.1111/j.1365-2958.2006.05270.x; De Bast MS, 2008, J BACTERIOL, V190, P4603, DOI 10.1128/JB.00357-08; de la Campa AG, 2009, EMERG INFECT DIS, V15, P905, DOI 10.3201/eid1506.080684; de la Campa AG, 2004, EMERG INFECT DIS, V10, P1751, DOI 10.3201/eid1010.040382; Diago-Navarro E, 2009, FEBS J, V276, P4973, DOI 10.1111/j.1742-4658.2009.07199.x; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Fico S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-259; Francuski D, 2009, J MOL BIOL, V393, P898, DOI 10.1016/j.jmb.2009.08.048; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GIUDICELLI S, 1984, J BACTERIOL, V158, P1188, DOI 10.1128/JB.158.3.1188-1190.1984; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Jones BV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-46; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Kolodkin-Gal I, 2008, PLOS BIOL, V6, P2774, DOI 10.1371/journal.pbio.0060319; LACKS S, 1968, GENETICS, V60, P685; Lemonnier M, 2003, NUCLEIC ACIDS RES, V31, P3918, DOI 10.1093/nar/gkg463; Li GY, 2006, J MOL BIOL, V357, P139, DOI 10.1016/j.jmb.2005.12.035; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Maniatis T., 1982, MOL CLONING LAB MANU; Mankin AS, 2008, CURR OPIN MICROBIOL, V11, P414, DOI 10.1016/j.mib.2008.08.003; Martner A, 2008, INFECT IMMUN, V76, P4079, DOI 10.1128/IAI.01747-07; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Mine N, 2009, GENETICS, V181, P1557, DOI 10.1534/genetics.108.095190; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; NEUBAUER C, 2009, RELE CELL, V139, P1084; Nieto C, 2006, MOL MICROBIOL, V59, P1280, DOI 10.1111/j.1365-2958.2006.05027.x; Nieto C, 2007, J BACTERIOL, V189, P1266, DOI 10.1128/JB.01130-06; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; PUYET A, 1993, J MOL BIOL, V230, P800, DOI 10.1006/jmbi.1993.1202; Sadowy E, 2006, CLIN VACCINE IMMUNOL, V13, P139, DOI 10.1128/CVI.13.1.139-144.2006; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; TOSA T, 1971, J BACTERIOL, V106, P972, DOI 10.1128/JB.106.3.972-982.1971; TOSA T, 1971, J BACTERIOL, V106, P966, DOI 10.1128/JB.106.3.966-971.1971; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; WOZNIAK RAF, 2009, PLOS GENET; ZHOU LX, 1995, PLASMID, V33, P127, DOI 10.1006/plas.1995.1014	62	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11289	10.1371/journal.pone.0011289	http://dx.doi.org/10.1371/journal.pone.0011289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585658	gold, Green Published, Green Submitted			2022-12-25	WOS:000279135400030
J	Sanchez-Blazquez, P; Rodriguez-Munoz, M; Garzon, J				Sanchez-Blazquez, Pilar; Rodriguez-Munoz, Maria; Garzon, Javier			Mu-Opioid Receptors Transiently Activate the Akt-nNOS Pathway to Produce Sustained Potentiation of PKC-Mediated NMDAR-CaMKII Signaling	PLOS ONE			English	Article							PROTEIN-KINASE-II; NITRIC-OXIDE SYNTHASE; D-ASPARTATE RECEPTORS; G-ALPHA-SUBUNITS; MORPHINE ANTINOCICEPTIVE TOLERANCE; PERIAQUEDUCTAL GRAY-MATTER; RAT NEONATAL ASTROCYTES; DORSAL-HORN; SPINAL-CORD; GLUTAMATE RECEPTORS	Background: In periaqueductal grey (PAG) matter, cross-talk between the Mu-opioid receptor (MOR) and the glutamate N-methyl-D-Aspartate receptor (NMDAR)-CaMKII pathway supports the development of analgesic tolerance to morphine. In neurons, histidine triad nucleotide binding protein 1 (HINT1) connects the regulators of G protein signaling RGSZ1 and RGSZ2 to the C terminus of the MOR. In response to morphine, this HINT1-RGSZ complex binds PKC gamma, and afterwards, the interplay between PKC gamma, Src and Gz/Gi proteins leads to sustained potentiation of NMDAR-mediated glutamate responses. Methodology/Principal Findings: Following an intracerebroventricular (icv) injection of 10 nmol morphine, Akt was recruited to the synaptosomal membrane and activated by Thr308 and Ser473 phosphorylation. The Akt activation was immediately transferred to neural Nitric Oxide Synthase (nNOS) Ser1417. Afterwards, nitric oxide (NO)-released zinc ions recruited PKC gamma to the MOR to promote the Src-mediated phosphorylation of the Tyr1325 NMDAR2A subunit. This action increased NMDAR calcium flux and CaMKII was activated in a calcium-calmodulin dependent manner. CaMKII then acted on nNOS Ser847 to produce a sustained reduction in NO levels. The activation of the Akt-nNOS pathway was also reduced by the binding of these proteins to the MOR-HINT1 complex where they remained inactive. Tolerance to acute morphine developed as a result of phosphorylation of MOR cytosolic residues, uncoupling from the regulated G proteins which are transferred to RGSZ2 proteins. The diminished effect of morphine was prevented by LNNA, an inhibitor of nNOS function, and naltrindole, a delta-opioid receptor antagonist that also inhibits Akt. Conclusions/Significance: Analysis of the regulatory phosphorylation of the proteins included in the study indicated that morphine produces a transient activation of the Akt/PKB-nNOS pathway. This activation occurs upstream of PKC gamma and Src mediated potentiation of NMDAR activity, ultimately leading to morphine tolerance. In summary, the Akt-nNOS pathway acts as a primer for morphine-triggered events which leads to the sustained potentiation of the NMDAR-CaMKII pathway and MOR inhibition.	[Sanchez-Blazquez, Pilar; Garzon, Javier] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Sanchez-Blazquez, Pilar; Rodriguez-Munoz, Maria; Garzon, Javier] ISCII, CIBER Mental Hlth CIBERSAM, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Sanchez-Blazquez, P (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	jgarzon@cajal.csic.es		Garzon, Javier/0000-0002-0053-258X; Rodriguez-Munoz, Maria/0000-0001-6611-8050; Sanchez Blazquez, Pilar/0000-0002-7211-4504	Instituto de Salud Carlos III (ISCIII); Fondo de Investigacion Sanitaria (FIS) [PI080417, PS09/00332]; Center for Biomedical Research in Mental Health Network (CIBERSAM)	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Center for Biomedical Research in Mental Health Network (CIBERSAM)	The research was supported by the Instituto de Salud Carlos III (ISCIII), Fondo de Investigacion Sanitaria (FIS) PI080417 (Pilar Sanchez-Blazquez) and PS09/00332 (Javier Garzon). Maria Rodriguez-Munoz is currently supported by a Center for Biomedical Research in Mental Health Network (CIBERSAM) contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajit SK, 2007, CELL SIGNAL, V19, P723, DOI 10.1016/j.cellsig.2006.09.008; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; BARBARO NM, 1988, PROG BRAIN RES, V77, P165; Barbier E, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-132; Bittar RG, 2005, J CLIN NEUROSCI, V12, P515, DOI 10.1016/j.jocn.2004.10.005; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; BOUHASSIRA D, 1988, J PHARMACOL EXP THER, V247, P332; Brenner GJ, 2004, EUR J NEUROSCI, V20, P375, DOI 10.1111/j.1460-9568.2004.03506.x; Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0; Charlton JJ, 2008, NEURON, V58, P238, DOI 10.1016/j.neuron.2008.02.006; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chen YL, 2004, CANCER RES, V64, P8723, DOI 10.1158/0008-5472.CAN-03-3091; Chen YL, 2006, J NEUROIMMUNE PHARM, V1, P270, DOI 10.1007/s11481-006-9028-0; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; ELLIOTT K, 1994, PAIN, V56, P69, DOI 10.1016/0304-3959(94)90151-1; Fan GH, 1999, MOL PHARMACOL, V56, P39, DOI 10.1124/mol.56.1.39; FIELDS HL, 1988, PROG BRAIN RES, V77, P245; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Garzon J, 2005, NEUROPSYCHOPHARMACOL, V30, P1632, DOI 10.1038/sj.npp.1300726; Garzon J, 2005, NEUROPHARMACOLOGY, V48, P853, DOI 10.1016/j.neuropharm.2005.01.004; Garzon J, 2005, J BIOL CHEM, V280, P8951, DOI 10.1074/jbc.M407005200; Garzon Javier, 2008, Curr Drug Abuse Rev, V1, P222; GEBHART GF, 1988, PROG BRAIN RES, V77, P229; Glass MJ, 2009, NEUROSCIENCE, V163, P857, DOI 10.1016/j.neuroscience.2009.07.020; Grosshans DR, 2001, J NEUROCHEM, V76, P737, DOI 10.1046/j.1471-4159.2001.00034.x; Guang W, 2004, MOL PHARMACOL, V66, P1285, DOI 10.1124/mol.66.5.; Gundelfinger ED, 2006, TRENDS BIOCHEM SCI, V31, P366, DOI 10.1016/j.tibs.2006.05.007; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; Heinricher MM, 2001, PAIN, V92, P129, DOI 10.1016/S0304-3959(00)00480-2; Inoue M, 2003, J NEUROSCI, V23, P6529; Kelker MS, 2007, BIOCHEMISTRY-US, V46, P2333, DOI 10.1021/bi602341c; Kim MS, 2001, BIOCHEM PHARMACOL, V61, P779, DOI 10.1016/S0006-2952(01)00541-X; Kissin I, 2000, ANESTH ANALG, V91, P1483, DOI 10.1097/00000539-200012000-00035; Komeima K, 2000, J BIOL CHEM, V275, P28139; LAZORTHES Y, 1988, PROG BRAIN RES, V77, P395; Lee J, 2004, IMMUNOPHARM IMMUNOT, V26, P17, DOI 10.1081/IPH-120029941; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Liang D, 2004, NEUROSCIENCE, V123, P769, DOI 10.1016/j.neuroscience.2003.10.007; Lou LG, 1999, MOL PHARMACOL, V55, P557; Lu L, 2000, NEUROSCI LETT, V291, P191, DOI 10.1016/S0304-3940(00)01352-5; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Luginbuhl M, 2003, ANESTH ANALG, V96, P726, DOI 10.1213/01.ANE.0000048086.58161.18; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; MAO JR, 1995, BRAIN RES, V677, P257, DOI 10.1016/0006-8993(95)00161-I; Marinelli S, 2002, J NEUROSCI, V22, P10847; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; MOSKOWITZ AS, 1984, J NEUROSCI, V4, P1331; Muller DL, 2004, J PHARMACOL EXP THER, V310, P774, DOI 10.1124/jpet.104.066548; NAKANE M, 1991, BIOCHEM BIOPH RES CO, V180, P1396, DOI 10.1016/S0006-291X(05)81351-8; Narita M, 2004, NEUROSCIENCE, V124, P515, DOI 10.1016/j.neuroscience.2003.11.023; Owen SLF, 2007, ACTA NEUROCHIR SUPPL, V97, P111; Patten SA, 2009, P NATL ACAD SCI USA, V106, P6796, DOI 10.1073/pnas.0811171106; Pei L, 2004, J NEUROSCI, V24, P1149, DOI 10.1523/JNEUROSCI.3922-03.2004; Perroy J, 2008, J BIOL CHEM, V283, P6799, DOI 10.1074/jbc.M705661200; PORTOGHESE PS, 1988, EUR J PHARMACOL, V146, P185, DOI 10.1016/0014-2999(88)90502-X; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rodriguez-Munoz M, 2008, CELL SIGNAL, V20, P1855, DOI 10.1016/j.cellsig.2008.06.015; Rodriguez-Munoz M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-19; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sanchez-Blazquez P, 2005, NEUROPHARMACOLOGY, V48, P134, DOI 10.1016/j.neuropharm.2004.08.016; Sanchez-Blazquez P, 2008, NEUROPHARMACOLOGY, V54, P319, DOI 10.1016/j.neuropharm.2007.10.002; Sanchez-Blazquez P, 2009, CELL SIGNAL, V21, P1444, DOI 10.1016/j.cellsig.2009.05.003; SanchezBlazquez P, 1995, J PHARMACOL EXP THER, V275, P1590; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; Tan M, 2003, J NEUROSCI, V23, P10292; Toda N, 2009, ANESTHESIOLOGY, V110, P166, DOI 10.1097/ALN.0b013e31819146a9; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Wang ZJJ, 2003, EUR J PHARMACOL, V465, P199, DOI 10.1016/S0014-2999(03)01484-5; YAKSH TL, 1976, BRAIN RES, V114, P83, DOI 10.1016/0006-8993(76)91009-X; Yin DL, 2006, J NEUROIMMUNOL, V174, P101, DOI 10.1016/j.jneuroim.2006.02.001; Zou XJ, 2004, BRAIN RES, V1020, P95, DOI 10.1016/j.brainres.2004.06.017	78	50	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11278	10.1371/journal.pone.0011278	http://dx.doi.org/10.1371/journal.pone.0011278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585660	Green Submitted, Green Published, gold			2022-12-25	WOS:000279135400022
J	Vieira, ML; Atzingen, MV; Oliveira, TR; Oliveira, R; Andrade, DM; Vasconcellos, SA; Nascimento, ALTO				Vieira, Monica L.; Atzingen, Marina V.; Oliveira, Tatiane R.; Oliveira, Rosane; Andrade, Daniel M.; Vasconcellos, Silvio A.; Nascimento, Ana L. T. O.			In Vitro Identification of Novel Plasminogen-Binding Receptors of the Pathogen Leptospira interrogans	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; BORRELIA-BURGDORFERI; SURFACE PROTEIN; LIPL32; LIPOPROTEIN; ACTIVATION; INFECTION; SEQUENCE; SYSTEM; SERODIAGNOSIS	Background: Leptospirosis is a multisystem disease caused by pathogenic strains of the genus Leptospira. We have reported that Leptospira are able to bind plasminogen (PLG), to generate active plasmin in the presence of activator, and to degrade purified extracellular matrix fibronectin. Methodology/Principal Findings: We have now cloned, expressed and purified 14 leptospiral recombinant proteins. The proteins were confirmed to be surface exposed by immunofluorescence microscopy and were evaluated for their ability to bind plasminogen (PLG). We identified eight as PLG-binding proteins, including the major outer membrane protein LipL32, the previously published rLIC12730, rLIC10494, Lp29, Lp49, LipL40 and MPL36, and one novel leptospiral protein, rLIC12238. Bound PLG could be converted to plasmin by the addition of urokinase-type PLG activator (uPA), showing specific proteolytic activity, as assessed by its reaction with the chromogenic plasmin substrate, D-Val-Leu-Lys 4-nitroanilide dihydrochloride. The addition of the lysine analog 6-aminocaproic acid (ACA) inhibited the protein-PLG interaction, thus strongly suggesting the involvement of lysine residues in plasminogen binding. The binding of leptospiral surface proteins to PLG was specific, dose-dependent and saturable. PLG and collagen type IV competed with LipL32 protein for the same binding site, whereas separate binding sites were observed for plasma fibronectin. Conclusions/Significance: PLG-binding/activation through the proteins/receptors on the surface of Leptospira could help the bacteria to specifically overcome tissue barriers, facilitating its spread throughout the host.	[Vieira, Monica L.; Atzingen, Marina V.; Oliveira, Tatiane R.; Oliveira, Rosane; Andrade, Daniel M.; Nascimento, Ana L. T. O.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [Vieira, Monica L.; Oliveira, Rosane; Nascimento, Ana L. T. O.] Univ Sao Paulo, Inst Ciencias Biomed, Interunidades Biotecnol, BR-05508 Sao Paulo, Brazil; [Vasconcellos, Silvio A.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Lab Zoonoses Bacterianas VPS, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Vieira, ML (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	tabet@butantan.gov.br	Vieira, Mônica Larucci/D-1634-2012; Nascimento, Ana L. T. O./E-8488-2012; atzingen, marina/F-9266-2013; Vieira, Mônica/AAE-9391-2021	Vieira, Mônica Larucci/0000-0002-4162-8086; Nascimento, Ana L. T. O./0000-0003-4851-0870; atzingen, marina/0000-0002-3276-895X; Vieira, Mônica/0000-0002-4162-8086	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Fundacao Butantan, Brazil; FAPESP (Brazil)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan, Brazil; FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - www.fapesp.br), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - www.cnpq.br) and Fundacao Butantan, Brazil. MLV, MVA, TRO and RO have fellowships from FAPESP (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; ATZINGEN MV, 2009, J INFECT; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Carvalho E, 2009, FEBS LETT, V583, P1381, DOI 10.1016/j.febslet.2009.03.050; CASTELLINO FJA, 2003, PLASMINOGEN STRUCTUR; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004; Gomez RM, 2008, MICROB PATHOGENESIS, V45, P315, DOI 10.1016/j.micpath.2008.08.004; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Klempner MS, 1996, J INFECT DIS, V174, P97, DOI 10.1093/infdis/174.1.97; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LeBouder F, 2008, J VIROL, V82, P6820, DOI 10.1128/JVI.00246-08; Ledoux D, 2000, J BIOL CHEM, V275, P29383, DOI 10.1074/jbc.M000837200; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; LONGHI MT, 2009, J MED MICROBIOL; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Neves FO, 2007, ARCH MICROBIOL, V188, P523, DOI 10.1007/s00203-007-0273-2; Nordstrand A, 2001, INFECT IMMUN, V69, P5832, DOI 10.1128/IAI.69.9.5832-5839.2001; Okumura Y, 1999, FEBS LETT, V442, P39, DOI 10.1016/S0014-5793(98)01612-3; Oliveira TR, 2008, CLIN VACCINE IMMUNOL, V15, P1715, DOI 10.1128/CVI.00214-08; Pathirana RD, 2006, MICROBIOL-SGM, V152, P2381, DOI 10.1099/mic.0.28787-0; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Plank R, 2000, MICROBES INFECT, V2, P1265, DOI 10.1016/S1286-4579(00)01280-6; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Rojas M, 2008, ACTA TROP, V107, P54, DOI 10.1016/j.actatropica.2008.04.013; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; URANO T, 1987, J BIOL CHEM, V262, P15959; VERMA A, INFECT IMMUN; VIEIRA ML, J INFECT, V60, P52; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527, DOI 10.1097/00001432-200110000-00005; Viratyosin W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-181	72	59	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11259	10.1371/journal.pone.0011259	http://dx.doi.org/10.1371/journal.pone.0011259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582320	gold, Green Published, Green Submitted			2022-12-25	WOS:000279058500011
J	Verde, Z; Ruiz, JR; Santiago, C; Valle, B; Bandres, F; Calvo, E; Lucia, A; Gallego, FG				Verde, Zoraida; Ruiz, Jonatan R.; Santiago, Catalina; Valle, Beatriz; Bandres, Fernando; Calvo, Elpidio; Lucia, Alejandro; Gomez Gallego, Felix			A Novel, Single Algorithm Approach to Predict Acenocoumarol Dose Based on CYP2C9 and VKORC1 Allele Variants	PLOS ONE			English	Article							WARFARIN-TREATED PATIENTS; PHARMACOGENETICS; ANTICOAGULATION; RISK	The identification of CYP2C9 and VKORC1 genes has strongly stimulated the research on pharmacogenetics of coumarins in the last decade. We assessed the combined influence of CYP2C9 *2 and *3, and VKORC1 c.-1639G>A, 497C>G, and 1173C>T variants, on acenocoumarol dosage using a novel algorithm approach, in 193 outpatients who had achieved stable anticoagulation. We constructed an "acenocoumarol-dose genotype score'' (AGS, maximum score = 100) based on the number of alleles associated with higher acenocoumarol dosage carried by each subject for each polymorphism. The mean AGS was higher in the high-dose (>28mg/week) compared with the low-dose (<7mg/week) group (mean(SEM) of 84.1 +/- 3.4 vs. 62.2 +/- 4.8, P = 0.008). An AGS>70 was associated with an increased odds ratio (OR) of requiring high acenocoumarol dosage (OR: 3.347; 95%CI: 1.112-10.075; P = 0.032). In summary, although more research is necessary in other patient cohorts, and this algorithm should be replicated in an independent sample, our data suggest that the AGS algorithm could be used to help discriminating patients requiring high acenocoumarol doses to achieve stable anti-coagulation.	[Verde, Zoraida; Santiago, Catalina; Lucia, Alejandro; Gomez Gallego, Felix] Univ Europea Madrid, Madrid, Spain; [Ruiz, Jonatan R.] Karolinska Inst, Novum, Dept Biosci & Nutr, Unit Prevent Nutr, Huddinge, Sweden; [Valle, Beatriz; Calvo, Elpidio] Hosp Clin San Carlos, Madrid, Spain; [Bandres, Fernando] Fdn Tejerina, Madrid, Spain	European University of Madrid; Karolinska Institutet; Hospital Clinico San Carlos	Verde, Z (corresponding author), Univ Europea Madrid, Madrid, Spain.	alejandro.lucia@uem.es	RUIZ, JONATAN R/M-1338-2015; Santiago, Catalina/P-8177-2019; VERDE, ZORAIDA/A-9914-2012; Lucia, Alejandro/M-2759-2014; Santiago, Catalina/K-6803-2014; Gomez-Gallego, Felix/AAD-9617-2020; Gomez-Gallego, Felix/H-6925-2013	RUIZ, JONATAN R/0000-0002-7548-7138; Santiago, Catalina/0000-0003-3852-8217; VERDE, ZORAIDA/0000-0002-9260-7672; Lucia, Alejandro/0000-0002-3025-2060; Santiago, Catalina/0000-0003-3852-8217; Gomez-Gallego, Felix/0000-0002-1968-1761; BANDRES MOYA, FERNANDO/0000-0002-4675-8226; Lucia, Alejandro/0000-0002-5565-0997; Valle Borrego, Beatriz/0000-0001-8512-6283	Universidad Europea de Madrid; Fondo de Investigaciones Sanitarias (FIS) [PS09/00194]	Universidad Europea de Madrid; Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III)	This study was funded by Universidad Europea de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study (genotyping cost) was funded by the Fondo de Investigaciones Sanitarias (FIS, ref. # PS09/00194).	Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; Daly AK, 2009, GENOME MED, V1, DOI 10.1186/gm10; *FDA, FDA APPR UPD WARF CO; FERDER NS, J THROMB HAEMOST, V8, P95; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Meckley LM, 2008, THROMB HAEMOSTASIS, V100, P229, DOI 10.1160/TH07-09-0552; PEREZANDREU V, 2010, J THROMB HAEMOST; Ruiz JR, 2009, J PHYSIOL-LONDON, V587, P1527, DOI 10.1113/jphysiol.2008.166645; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Schalekamp T, 2010, CURR PHARM DESIGN, V16, P187, DOI 10.2174/138161210790112737; Schmeits PCJ, 2010, BRIT J HAEMATOL, V148, P955, DOI 10.1111/j.1365-2141.2009.08017.x; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Verde Z, 2009, THROMB HAEMOSTASIS, V101, P591, DOI 10.1160/TH08-09-0578; Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887; Yin T, 2007, THROMB RES, V120, P1, DOI 10.1016/j.thromres.2006.10.021; ZWEIG MH, 1993, CLIN CHEM, V39, P561	17	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11210	10.1371/journal.pone.0011210	http://dx.doi.org/10.1371/journal.pone.0011210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585445	Green Published, Green Submitted, gold			2022-12-25	WOS:000278977200013
J	Krintel, C; Klint, C; Lindvall, H; Morgelin, M; Holm, C				Krintel, Christian; Klint, Cecilia; Lindvall, Hakan; Morgelin, Matthias; Holm, Cecilia			Quarternary Structure and Enzymological Properties of the Different Hormone-Sensitive Lipase (HSL) Isoforms	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; TESTICULAR FORM; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; DOMAIN; PURIFICATION; ORGANIZATION; HYDROLYSIS	Background: Hormone-sensitive lipase (HSL) is a key enzyme in the mobilization of energy in the form of fatty acids from intracellular stores of neutral lipids. The enzyme has been shown to exist in different isoforms with different molecular masses (84 kDa, 89 kDa and 117 kDa) expressed in a tissue-dependent manner, where the predominant 84 kDa form in adipocytes is the most extensively studied. Methodology/Principal Findings: In this study we employed negative stain electron microscopy (EM) to analyze the quarternary structure of the different HSL isoforms. The results show that all three isoforms adopt a head-to-head homodimeric organization, where each monomer contains two structural domains. We also used enzymatic assays to show that despite the variation in the size of the N-terminal domain all three isoforms exhibit similar enzymological properties with regard to psychrotolerance and protein kinase A (PKA)-mediated phosphorylation and activation. Conclusions/Significance: We present the first data on the quaternary structure and domain organization of the three HSL isoforms. We conclude that despite large differences in the size of the N-terminal, non-catalytic domain all three HSL isoforms exhibit the same three-dimensional architecture. Furthermore, the three HSL isoforms are very similar with regard to two unique enzymological characteristics of HSL, i.e., cold adaptation and PKA-mediated activation.	[Krintel, Christian; Klint, Cecilia; Lindvall, Hakan; Holm, Cecilia] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Krintel, Christian] Lund Univ, Div Diabet Metab & Endocrinol, Dept Mol Biophys, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden	Lund University; Lund University; Lund University	Krintel, C (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	cecilia.holm@med.lu.se		krintel, christian/0000-0001-5925-5639	Swedish Research Council [11284]; Swedish Diabetes Association; Research School in Pharmaceutical Sciences (FLAK); Novo Nordisk; A. Pahlsson and Torsten and Ragnar Soderberg	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Research School in Pharmaceutical Sciences (FLAK); Novo Nordisk(Novo Nordisk); A. Pahlsson and Torsten and Ragnar Soderberg	Financial support was obtained from the Swedish Research Council (project no. 11284 to C.H.), the Swedish Diabetes Association, and the following foundations: Novo Nordisk, A. Pahlsson and Torsten and Ragnar Soderberg. C. Krintel was supported by the Research School in Pharmaceutical Sciences (FLAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; BASCHONG W, 1985, HISTOCHEMISTRY, V83, P409, DOI 10.1007/BF00509201; Ben Ali Y, 2004, BIOCHEMISTRY-US, V43, P9298, DOI 10.1021/bi049479o; BENGTSSON G, 1977, BIOCHEM J, V167, P109, DOI 10.1042/bj1670109; Contreras JA, 1998, PROTEIN EXPRES PURIF, V12, P93, DOI 10.1006/prep.1997.0821; Contreras JA, 1996, J BIOL CHEM, V271, P31426, DOI 10.1074/jbc.271.49.31426; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Griffon N, 2009, J BIOL CHEM, V284, P23322, DOI 10.1074/jbc.M109.037002; Grober J, 1997, BIOCHEM J, V328, P453, DOI 10.1042/bj3280453; HOLM C, 1987, BIOCHEM BIOPH RES CO, V148, P99, DOI 10.1016/0006-291X(87)91081-3; Holm C, 1999, METH MOL B, V109, P109; Holst LS, 1996, GENOMICS, V35, P441, DOI 10.1006/geno.1996.0383; Krintel C, 2009, FEBS J, V276, P4752, DOI 10.1111/j.1742-4658.2009.07172.x; Krintel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003756; LANGIN D, 1993, P NATL ACAD SCI USA, V90, P4897, DOI 10.1073/pnas.90.11.4897; Laurell H, 2000, PROTEIN ENG, V13, P711, DOI 10.1093/protein/13.10.711; Lindvall H, 2004, J BIOL CHEM, V279, P3828, DOI 10.1074/jbc.M311365200; Mairal A, 2002, BIOCHEM BIOPH RES CO, V291, P286, DOI 10.1006/bbrc.2002.6427; Mulder H, 1999, DIABETES, V48, P228, DOI 10.2337/diabetes.48.1.228; Osterlund T, 1999, J BIOL CHEM, V274, P15382, DOI 10.1074/jbc.274.22.15382; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; Shen WJ, 2000, BIOCHEMISTRY-US, V39, P2392, DOI 10.1021/bi992283h; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; SHIRAI K, 1982, J BIOL CHEM, V257, P1253; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Thorens B, 1995, DIABETES METAB, V21, P311; TORNQVIST H, 1972, J LIPID RES, V13, P424; Vallet-Erdtmann V, 2004, J BIOL CHEM, V279, P42875, DOI 10.1074/jbc.M403495200; Wong H, 1997, P NATL ACAD SCI USA, V94, P5594, DOI 10.1073/pnas.94.11.5594	34	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11193	10.1371/journal.pone.0011193	http://dx.doi.org/10.1371/journal.pone.0011193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567594	Green Published, gold, Green Submitted			2022-12-25	WOS:000278886300031
J	Levi, B; James, AW; Nelson, ER; Vistnes, D; Wu, B; Lee, M; Gupta, A; Longaker, MT				Levi, Benjamin; James, Aaron W.; Nelson, Emily R.; Vistnes, Dean; Wu, Benjamin; Lee, Min; Gupta, Ankur; Longaker, Michael T.			Human Adipose Derived Stromal Cells Heal Critical Size Mouse Calvarial Defects	PLOS ONE			English	Article							ADULT STEM-CELLS; BONE MORPHOGENETIC PROTEIN-2; IN-VITRO; MESENCHYMAL CELLS; OSTEOGENIC DIFFERENTIATION; SKELETAL TISSUE; RETINOIC ACID; CHONDROGENIC DIFFERENTIATION; HUMAN FAT; VIVO	Background: Human adipose-derived stromal cells (hASCs) represent a multipotent cell stromal cell type with proven capacity to differentiate along an osteogenic lineage. This suggests that they may be used to heal defects of the craniofacial or appendicular skeleton. We sought to substantiate the use of undifferentiated hASCs in the regeneration of a non-healing mouse skeletal defect. Methodology/Principal Findings: Human ASCs were harvested from female lipoaspirate. Critical-sized (4 mm) calvarial defects were created in the parietal bone of adult male nude mice. Defects were either left empty, treated with an apatite coated PLGA scaffold alone, or a scaffold with human ASCs. MicroCT scans were obtained at stratified time points post-injury. Histology, in situ hybridization, and histomorphometry were performed. Near complete healing was observed among hASC engrafted calvarial defects. This was in comparison to control groups that showed little healing (*P < 0.01). Human ASCs once engrafted differentiate down an osteogenic lineage, determined by qRT-PCR and histological co-expression assays using GFP labeled cells. ASCs were shown to persist within a defect site for two weeks (shown by sex chromosome analysis and quantified using Luciferase+ ASCs). Finally, rBMP-2 was observed to increase hASC osteogenesis in vitro and osseous healing in vivo. Conclusions/Significance: Human ASCs ossify critical sized mouse calvarial defects without the need for pre-differentiation. Recombinant differentiation factors such as BMP-2 may be used to supplement hASC mediated repair. Interestingly, ASC presence gradually dissipates from the calvarial defect site. This study supports the potential translation for ASC use in the treatment of human skeletal defects.	[Levi, Benjamin; James, Aaron W.; Nelson, Emily R.; Vistnes, Dean; Gupta, Ankur; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg,Hagey Pediat Regener, Stanford, CA 94305 USA; [Wu, Benjamin; Lee, Min] Univ Calif Los Angeles, Sch Med, Div Adv Prosthodont Biomat & Hosp Dent, Los Angeles, CA USA	Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Longaker, MT (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg,Hagey Pediat Regener, Stanford, CA 94305 USA.	Longaker@stanford.edu		Wu, Benjamin/0000-0001-5236-8534	National Institutes of Health, National Institute of Dental and Craniofacial Research [R01 DE-13194]; Oak Foundation; Hagey Foundation; National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [1F32AR057302-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013194] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Oak Foundation; Hagey Foundation; National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by National Institutes of Health, National Institute of Dental and Craniofacial Research grant R01 DE-13194, the Oak Foundation and Hagey Foundation to M.T.L. B.L. was supported by the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases grant 1F32AR057302-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalami OO, 2004, PLAST RECONSTR SURG, V114, P713, DOI 10.1097/01.PRS.0000131016.12754.30; Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Chim H, 2005, PLAST RECONSTR SURG, V116, P1726, DOI 10.1097/01.prs.0000182386.78775.cd; Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Dragoo JL, 2003, J ORTHOP RES, V21, P622, DOI 10.1016/S0736-0266(02)00238-3; Dragoo JL, 2005, PLAST RECONSTR SURG, V115, P1665, DOI 10.1097/01.PRS.0000161459.90856.AB; Dudas JR, 2006, ANN PLAS SURG, V56, P543, DOI 10.1097/01.sap.0000210629.17727.bd; Fang TD, 2006, PLAST RECONSTR SURG, V117, P1177, DOI 10.1097/01.prs.0000204581.59190.53; Gimble JM, 2004, ENDOCRINE, V23, P183, DOI 10.1385/ENDO:23:2-3:183; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Gimble JM, 2003, EXPERT OPIN BIOL TH, V3, P705, DOI 10.1517/14712598.3.5.705; Gosain AK, 2003, PLAST RECONSTR SURG, V112, P515, DOI 10.1097/01.PRS.0000070728.56716.51; Gosain AK, 2000, PLAST RECONSTR SURG, V106, P360, DOI 10.1097/00006534-200008000-00018; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Guilak F, 2004, BIORHEOLOGY, V41, P389; Gupta DM, 2008, J CRANIOFAC SURG, V19, P192, DOI 10.1097/scs.0b013e31815c93b7; Gupta DM, 2009, J CRANIOFAC SURG, V20, P860, DOI 10.1097/SCS.0b013e3181a9574b; Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735; Huang JI, 2004, PLAST RECONSTR SURG, V113, P585, DOI 10.1097/01.PRS.0000101063.27008.E1; James AW, 2008, PLAST RECONSTR SURG, V122, P53, DOI 10.1097/PRS.0b013e31817747b5; James AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007120; James AW, 2009, PLAST RECONSTR SURG, V123, P31, DOI 10.1097/PRS.0b013e3181904c19; JAMES AW, 2010, TISSUE ENG A; Kulakov AA, 2008, B EXP BIOL MED+, V146, P522, DOI 10.1007/s10517-009-0322-8; Kwan MD, 2008, HUM MOL GENET, V17, pR93, DOI 10.1093/hmg/ddn071; Lecoeur L, 1997, BIOMATERIALS, V18, P989, DOI 10.1016/S0142-9612(97)00025-2; Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002; LEVI B, 2010, PLAST RECONSTR S MAR; Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101; Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001; Panetta NJ, 2009, PANMINERVA MED, V51, P25; Panetta NJ, 2010, PLAST RECONSTR SURG, V125, P483, DOI 10.1097/PRS.0b013e3181c82d75; Panetta NJ, 2009, J CRANIOFAC SURG, V20, P1531, DOI 10.1097/SCS.0b013e3181b09c02; Panetta NJ, 2009, J CRANIOFAC SURG, V20, P347, DOI 10.1097/SCS.0b013e3181992371; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Wan DC, 2007, TISSUE ENG, V13, P1623, DOI 10.1089/ten.2006.0283; Wan DC, 2006, P NATL ACAD SCI USA, V103, P12335, DOI 10.1073/pnas.0604849103; Wolbank Susanne, 2007, Cell and Tissue Banking, V8, P163, DOI 10.1007/s10561-006-9027-7; Xu Y, 2005, CURR OPIN MOL THER, V7, P300; Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050; Xu Y, 2009, TISSUE ENG PT A, V15, P3697, DOI [10.1089/ten.tea.2009.0213, 10.1089/ten.TEA.2009.0213]; Xu Y, 2008, PLAST RECONSTR SURG, V122, P1649, DOI 10.1097/PRS.0b013e31818cbf44; Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	48	222	235	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11177	10.1371/journal.pone.0011177	http://dx.doi.org/10.1371/journal.pone.0011177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567510	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886300019
J	Pallesen, KJ; Brattico, E; Bailey, CJ; Korvenoja, A; Koivisto, J; Gjedde, A; Carlson, S				Pallesen, Karen Johanne; Brattico, Elvira; Bailey, Christopher J.; Korvenoja, Antti; Koivisto, Juha; Gjedde, Albert; Carlson, Synnove			Cognitive Control in Auditory Working Memory Is Enhanced in Musicians	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; GENERAL FLUID INTELLIGENCE; INDIVIDUAL-DIFFERENCES; PREFRONTAL CORTEX; BRAIN ACTIVATION; NEURAL MECHANISMS; PITCH PERCEPTION; BROCAS AREA; NONMUSICIANS; TASK	Musical competence may confer cognitive advantages that extend beyond processing of familiar musical sounds. Behavioural evidence indicates a general enhancement of both working memory and attention in musicians. It is possible that musicians, due to their training, are better able to maintain focus on task-relevant stimuli, a skill which is crucial to working memory. We measured the blood oxygenation-level dependent (BOLD) activation signal in musicians and non-musicians during working memory of musical sounds to determine the relation among performance, musical competence and generally enhanced cognition. All participants easily distinguished the stimuli. We tested the hypothesis that musicians nonetheless would perform better, and that differential brain activity would mainly be present in cortical areas involved in cognitive control such as the lateral prefrontal cortex. The musicians performed better as reflected in reaction times and error rates. Musicians also had larger BOLD responses than non-musicians in neuronal networks that sustain attention and cognitive control, including regions of the lateral prefrontal cortex, lateral parietal cortex, insula, and putamen in the right hemisphere, and bilaterally in the posterior dorsal prefrontal cortex and anterior cingulate gyrus. The relationship between the task performance and the magnitude of the BOLD response was more positive in musicians than in non-musicians, particularly during the most difficult working memory task. The results confirm previous findings that neural activity increases during enhanced working memory performance. The results also suggest that superior working memory task performance in musicians rely on an enhanced ability to exert sustained cognitive control. This cognitive benefit in musicians may be a consequence of focused musical training.	[Pallesen, Karen Johanne; Koivisto, Juha; Carlson, Synnove] Univ Helsinki, Inst Biomed Physiol, Neurosci Unit, Helsinki, Finland; [Pallesen, Karen Johanne; Bailey, Christopher J.; Gjedde, Albert] Aarhus Univ, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Pallesen, Karen Johanne; Bailey, Christopher J.; Gjedde, Albert] Aarhus Univ Hosp, Pathophysiol & Expt Tomog Ctr, DK-8000 Aarhus, Denmark; [Brattico, Elvira] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Brattico, Elvira] Univ Jyvaskyla, Finnish Ctr Excellence Interdisciplinary Music Re, Jyvaskyla, Finland; [Korvenoja, Antti] Univ Helsinki, Cent Hosp, Med Imaging Ctr, Helsinki, Finland; [Carlson, Synnove] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Carlson, Synnove] Aalto Univ, Low Temp Lab, Brain Res Unit, FIN-02150 Espoo, Finland	University of Helsinki; Aarhus University; Aarhus University; University of Helsinki; University of Jyvaskyla; University of Helsinki; Helsinki University Central Hospital; Tampere University; Aalto University	Pallesen, KJ (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	karenjohanne@pet.auh.dk	Brattico, Elvira/M-1455-2019; Carlson, Synnöve/G-2210-2013; Korvenoja, Antti/C-2292-2009; Gjedde, Albert/U-3751-2019; Korvenoja, Antti/AAG-1866-2019; Carlson, Synnöve/A-6337-2013; Carlson, Synnöve/AAM-2655-2021; Gjedde, Albert/I-2452-2019; Korvenoja, Antti/AAR-7461-2020	Korvenoja, Antti/0000-0003-4348-0449; Gjedde, Albert/0000-0002-3756-7401; Carlson, Synnöve/0000-0003-1462-7560; Korvenoja, Antti/0000-0003-4348-0449; Pallesen, Karen Johanne/0000-0001-7543-5891; Brattico, Elvira/0000-0003-0676-6464; Bailey, Christopher/0000-0003-3318-3344	Academy of Finland; University of Helsinki	Academy of Finland(Academy of Finland); University of Helsinki	The study was supported by the Academy of Finland (National Center of Excellence Program) and by a research grant from the University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2007, J NEUROSCI, V27, P3429, DOI 10.1523/JNEUROSCI.4273-06.2007; ALTENMULLER E, 1986, EUR ARCH PSY CLIN N, V235, P342, DOI 10.1007/BF00381003; Baddeley A., 2007, WORKING MEMORY THOUG; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Ben-Yehudah G, 2007, CEREBELLUM, V6, P193, DOI 10.1080/14734220701286195; BEVER TG, 1974, SCIENCE, V185, P537, DOI 10.1126/science.185.4150.537; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brattico E, 2001, MUSIC PERCEPT, V19, P199, DOI 10.1525/mp.2001.19.2.199; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Carlson S, 1998, CEREB CORTEX, V8, P743, DOI 10.1093/cercor/8.8.743; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; EVANS C, 1993, P 40 ANN M SOC NUCL; Evers S, 1999, BRAIN, V122, P75, DOI 10.1093/brain/122.1.75; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fishman YI, 2001, J NEUROPHYSIOL, V86, P2761, DOI 10.1152/jn.2001.86.6.2761; Forgeard Marie, 2008, PLoS One, V3, pe3566, DOI 10.1371/journal.pone.0003566; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gaab N, 2003, ANN NY ACAD SCI, V999, P385, DOI 10.1196/annals.1284.048; Gaab N, 2003, NEUROREPORT, V14, P2291, DOI 10.1097/00001756-200312190-00001; Gaab N, 2006, NEUROIMAGE, V31, P255, DOI 10.1016/j.neuroimage.2005.11.046; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.3.CO;2-A; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Ho YC, 2003, NEUROPSYCHOLOGY, V17, P439, DOI 10.1037/0894-4105.17.3.439; Hubert V, 2007, HUM BRAIN MAPP, V28, P1415, DOI 10.1002/hbm.20354; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Jarrold C, 2006, NEUROSCIENCE, V139, P39, DOI 10.1016/j.neuroscience.2005.07.002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kalakoski V, 2007, SCAND J PSYCHOL, V48, P87, DOI 10.1111/j.1467-9450.2007.00535.x; KAMEOKA A, 1969, J ACOUST SOC AM, V45, P1451, DOI 10.1121/1.1911623; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Khalfa S, 2005, NEUROREPORT, V16, P1981, DOI 10.1097/00001756-200512190-00002; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Koesch S, 2002, CLIN NEUROPHYSIOL, V113, P862, DOI 10.1016/S1388-2457(02)00050-0; Leung HC, 2005, CEREB CORTEX, V15, P1742, DOI 10.1093/cercor/bhi051; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Luria A R, 1965, J Neurol Sci, V2, P288, DOI 10.1016/0022-510X(65)90113-9; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Martinkauppi S, 2000, CEREB CORTEX, V10, P889, DOI 10.1093/cercor/10.9.889; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Ohbayashi M, 2003, SCIENCE, V301, P233, DOI 10.1126/science.1084884; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Pallesen KJ, 2005, ANN NY ACAD SCI, V1060, P450, DOI 10.1196/annals.1360.047; Pallesen KJ, 2009, J COGNITIVE NEUROSCI, V21, P1065, DOI 10.1162/jocn.2009.21086; Patston LLM, 2007, LATERALITY, V12, P262, DOI 10.1080/13576500701251981; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; Rama P, 2001, COGN AFFECT BEHAV NE, V1, P161, DOI 10.3758/CABN.1.2.161; Rama P, 2001, NEUROIMAGE, V13, P1090, DOI 10.1006/nimg.2001.0777; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Samson S, 2002, BRAIN, V125, P511, DOI 10.1093/brain/awf051; Sayala S, 2006, CEREB CORTEX, V16, P609, DOI 10.1093/cercor/bhj007; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schon D, 2005, MUSIC PERCEPT, V23, P105, DOI 10.1525/mp.2005.23.2.105; SHAPIRO BE, 1981, NEUROPSYCHOLOGIA, V19, P161, DOI 10.1016/0028-3932(81)90101-9; SIGNORET JL, 1987, REV NEUROL-FRANCE, V143, P172; Sluming V, 2007, J NEUROSCI, V27, P3799, DOI 10.1523/JNEUROSCI.0147-07.2007; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; STERNBERG S, 1969, ATTENTION PERFORMANC, V2; Tervaniemi M, 2001, ANN NY ACAD SCI, V930, P259, DOI 10.1111/j.1749-6632.2001.tb05737.x; Tillmann B, 2003, ANN NY ACAD SCI, V999, P209, DOI 10.1196/annals.1284.031; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaughn K, 2000, J AESTHET EDUC, V34, P149, DOI 10.2307/3333641; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; Warrier CM, 2004, BRAIN, V127, P1616, DOI 10.1093/brain/awh183; WICKENS DD, 1973, MEM COGNITION, V1, P485, DOI 10.3758/BF03208913; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1991, BRAIN, V114, P2403, DOI 10.1093/brain/114.6.2403; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006	93	141	145	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11120	10.1371/journal.pone.0011120	http://dx.doi.org/10.1371/journal.pone.0011120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559545	Green Published, gold, Green Submitted			2022-12-25	WOS:000278775900011
J	Li, XJ; Moore, DJ; Xiong, YL; Dawson, TM; Dawson, VL				Li, Xiaojie; Moore, Darren J.; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.			Reevaluation of Phosphorylation Sites in the Parkinson Disease-associated Leucine-rich Repeat Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL TOXICITY; LRRK2 MUTATION; G2019S; PREVALENCE; GENE	Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been identified as an important cause of late-onset, autosomal dominant familial Parkinson disease and contribute to sporadic Parkinson disease. LRRK2 is a large complex protein with multiple functional domains, including a Roc-GTPase, protein kinase, and multiple protein-protein interaction domains. Previous studies have suggested an important role for kinase activity in LRRK2-induced neuronal toxicity and inclusion body formation. Disease-associated mutations in LRRK2 also tend to increase kinase activity. Thus, enhanced kinase activity may therefore underlie LRRK2-linked disease. Similar to the closely related mixed-lineage kinases, LRRK2 can undergo autophosphorylation in vitro. Three putative autophosphorylation sites (Thr-2031, Ser-2032, and Thr-2035) have been identified within the activation segment of the LRRK2 kinase domain based on sequence homology to mixed-lineage kinases. Phosphorylation at one or more of these sites is critical for the kinase activity of LRRK2. Sensitive phopho-specific antibodies to each of these three sites have been developed and validated by ELISA, dot-blot, and Western blot analysis. Using these antibodies, we have found that all three putative sites are phosphorylated in LRRK2, and Ser-2032 and Thr-2035 are the two important sites that regulate LRRK2 kinase activity.	[Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, NeuroRegenerat Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA; [Li, Xiaojie; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Moore, Darren J.; Xiong, Yulan; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, NeuroRegenerat Program, 733 N Broadway,Suite 711, Baltimore, MD 21205 USA.	vdawson@jhmi.edu	Dawson, Valina/Y-9757-2019	Moore, Darren/0000-0003-2359-5679; Dawson, Valina/0000-0002-2915-3970	National Institutes of Health [NS38377]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS38377.	Aasly JO, 2005, ANN NEUROL, V57, P762, DOI 10.1002/ana.20456; Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Floris G, 2009, PARKINSONISM RELAT D, V15, P277, DOI 10.1016/j.parkreldis.2008.06.009; Gandhi PN, 2009, J NEUROSCI RES, V87, P1283, DOI 10.1002/jnr.21949; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Gorostidi A, 2009, NEUROGENETICS, V10, P157, DOI 10.1007/s10048-008-0162-0; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Haugarvoll K, 2008, NEUROLOGY, V70, P1456, DOI 10.1212/01.wnl.0000304044.22253.03; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Mata IF, 2009, NEUROGENETICS, V10, P347, DOI 10.1007/s10048-009-0187-z; Moller JC, 2008, EUR J NEUROL, V15, P743, DOI 10.1111/j.1468-1331.2008.02154.x; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; XIONG Y, PLOS GENET, V6; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	26	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 17	2010	285	38					29569	29576		10.1074/jbc.M110.127639	http://dx.doi.org/10.1074/jbc.M110.127639			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649BC	20595391	Green Published, hybrid			2022-12-25	WOS:000281740100058
J	Evesson, FJ; Peat, RA; Lek, A; Brilot, F; Lo, HP; Dale, RC; Parton, RG; North, KN; Cooper, ST				Evesson, Frances J.; Peat, Rachel A.; Lek, Angela; Brilot, Fabienne; Lo, Harriet P.; Dale, Russell C.; Parton, Robert G.; North, Kathryn N.; Cooper, Sandra T.			Reduced Plasma Membrane Expression of Dysferlin Mutants Is Attributed to Accelerated Endocytosis via a Syntaxin-4-associated Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; FER-1-LIKE PROTEIN; 3T3-L1 ADIPOCYTES; SYNTAXIN 4; T-SNARE; REPAIR; BINDING; SYNAPTOTAGMIN; CAVEOLIN-3	Ferlins are an ancient family of C2 domain-containing proteins, with emerging roles in vesicular trafficking and human disease. Dysferlin mutations cause inherited muscular dystrophy, and dysferlin also shows abnormal plasma membrane expression in other forms of muscular dystrophy. We establish dysferlin as a short-lived (protein half-life similar to 4-6 h) and transitory transmembrane protein (plasma membrane half-life similar to 3 h), with a propensity for rapid endocytosis when mutated, and an association with a syntaxin-4 endocytic route. Dysferlin plasma membrane expression and endocytic rate is regulated by the C2B-FerI-C2C motif, with a critical role identified for C2C. Disruption of C2C dramatically reduces plasma membrane dysferlin (by 2.5-fold), due largely to accelerated endocytosis (by 2.5-fold). These properties of reduced efficiency of plasma membrane expression due to accelerated endocytosis are also a feature of patient missense mutant L344P (within FerI, adjacent to C2C). Importantly, dysferlin mutants that demonstrate accelerated endocytosis also display increased protein lability via endosomal proteolysis, implicating endosomal-mediated proteolytic degradation as a novel basis for dysferlin-deficiency in patients with single missense mutations. Vesicular labeling studies establish that dysferlin mutants rapidly transit from EEA1-positive early endosomes through to dextran-positive lysosomes, co-labeled by syntaxin-4 at multiple stages of endosomal transit. In summary, our studies define a transient biology for dysferlin, relevant to emerging patient therapeutics targeting dysferlin replacement. We introduce accelerated endosomal-directed degradation as a basis for lability of dysferlin missense mutants in dysferlinopathy, and show that dysferlin and syntaxin- 4 similarly transit a common endosomal pathway in skeletal muscle cells.	[Evesson, Frances J.; Peat, Rachel A.; Lek, Angela; Brilot, Fabienne; Dale, Russell C.; North, Kathryn N.; Cooper, Sandra T.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Westmead, NSW 2145, Australia; [Evesson, Frances J.; Lek, Angela; North, Kathryn N.; Cooper, Sandra T.] Univ Sydney, Fac Med, Discipline Paediat & Child Hlth, Westmead, NSW 2145, Australia; [Lo, Harriet P.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Lo, Harriet P.; Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Sydney; University of Sydney; University of Queensland; University of Queensland	Cooper, ST (corresponding author), Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Locked Bag 4001, Westmead, NSW 2145, Australia.	SandraC3@chw.edu.au	Brilot, Fabienne/AAT-3138-2020; North, Kathryn N/K-6476-2012; Parton, Robert G/C-5673-2009; Lo, Harriet P/D-2052-2017	Brilot, Fabienne/0000-0002-7025-2276; North, Kathryn N/0000-0003-0841-8009; Parton, Robert G/0000-0002-7494-5248; Lo, Harriet P/0000-0002-3998-6132; Cooper, Sandra/0000-0002-7314-5097	Muscular Dystrophy Association, USA; NSW Muscular Dystrophy Association; Australian National Health and Medical Research Council; Brain Foundation Australia; Jain Foundation	Muscular Dystrophy Association, USA(Muscular Dystrophy Association); NSW Muscular Dystrophy Association; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Brain Foundation Australia; Jain Foundation	This work was supported by the Muscular Dystrophy Association, USA (STC Development Grant), the NSW Muscular Dystrophy Association (to S. T. C. and K. N. N.), the Australian National Health and Medical Research Council (301946 to K. N. N. and S. T. C.), the Brain Foundation Australia (to S. T. C.), and the Jain Foundation (to S. T. C.).	Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; Britton S, 2000, GENOMICS, V68, P313, DOI 10.1006/geno.2000.6290; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Chae YK, 1998, J BIOL CHEM, V273, P25659, DOI 10.1074/jbc.273.40.25659; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gerasimenko JV, 2001, CURR BIOL, V11, pR971, DOI 10.1016/S0960-9822(01)00577-2; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jackaman C, 2007, CELL MOTIL CYTOSKEL, V64, P914, DOI 10.1002/cm.20239; Jagadish MN, 1996, BIOCHEM J, V317, P945, DOI 10.1042/bj3170945; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lo HP, 2008, NEUROMUSCULAR DISORD, V18, P34, DOI 10.1016/j.nmd.2007.08.009; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; McNally EM, 2000, AM J MED GENET, V91, P305, DOI 10.1002/(SICI)1096-8628(20000410)91:4<305::AID-AJMG12>3.0.CO;2-S; McNeil PL, 2000, J CELL SCI, V113, P1891; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Pagan JK, 2003, CURR BIOL, V13, P156, DOI 10.1016/S0960-9822(03)00006-X; Piccolo F, 2000, ANN NEUROL, V48, P902, DOI 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.3.CO;2-Q; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; Rawat R, 2010, AM J PATHOL, V176, P2891, DOI 10.2353/ajpath.2010.090058; Roche JA, 2010, AM J PHYSIOL-CELL PH, V298, pC298, DOI 10.1152/ajpcell.00122.2009; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; SUMITANI S, 1995, BIOCHEM BIOPH RES CO, V213, P462, DOI 10.1006/bbrc.1995.2154; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	41	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28529	28539		10.1074/jbc.M110.111120	http://dx.doi.org/10.1074/jbc.M110.111120			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20595382	Green Published, hybrid			2022-12-25	WOS:000281594000017
J	Gao, N; Hibi, Y; Cueno, M; Asamitsu, K; Okamoto, T				Gao, Nan; Hibi, Yurina; Cueno, Marni; Asamitsu, Kaori; Okamoto, Takashi			A-kinase-interacting Protein 1 (AKIP1) Acts as a Molecular Determinant of PKA in NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MULTIPLE-MYELOMA CELLS; TRANSCRIPTIONAL ACTIVITY; ENDOTHELIAL-CELLS; SERINE KINASE; ACTIVATION; PHOSPHORYLATION; PATHWAY; ALPHA; P65	The cAMP-dependent protein kinase (PKA) signaling pathway plays a crucial role in the pathogenesis of many NF-kappa B-related diseases. However, there have been controversial reports with regard to the PKA actions in the regulation of NF-kappa B activity. In this study, we have demonstrated the effect of PKA on NF-kappa B activity in view of AKIP1 action; and in 293 and HeLa cells, where the endogenous AKIP1 expression is minimal, PKA-activating agents inhibited the NF-kappa B-dependent reporter gene expression, blocked the interaction of PKAc and p65 subunit of NF-kappa B, and attenuated PKA-dependent phosphorylation of p65 on Ser-276. This inhibitory function of PKAc in NF-kappa B signaling was reversed by overexpression of AKIP1 in 293 cells. In the breast cancer cell line, MDA-MB231 cells and MCF7 cells, where the endogenous AKIP1 is abundant, the PKA signal was found to be synergized with NF-kappa B activation; PKA-activating agents enhanced NF-kappa B-dependent transcriptional activity and the interaction between p65 and PKAc and augmented the phosphorylation of p65 on Ser-276. After RNAi knockdown of AKIP1 in these breast cancer cells, we observed that PKA-activating agents antagonized NF-kappa B-dependent activation. Meanwhile, PKA inhibitor suppressed NF-kappa B-induced breast cancer cell proliferation and multiple NF-kappa B-dependent anti-apoptotic gene expression. It is likely that expression of AKIP1 determines the relationship between these two signal transduction pathways. These findings explained controversial results from various independent groups regarding the action of PKA signaling on the NF-kappa B activation cascade and suggested a possible therapeutic potential of PKA inhibitor in developing anti-cancer strategies.	[Okamoto, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University	Okamoto, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Mol & Cellular Biol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	tokamoto@med.nagoya-cu.ac.jp		Asamitsu, Kaori/0000-0001-5333-8011				Arun P, 2009, CLIN CANCER RES, V15, P5974, DOI 10.1158/1078-0432.CCR-09-1352; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bendre MS, 2002, CANCER RES, V62, P5571; Carnegie GK, 2003, GENE DEV, V17, P1557, DOI 10.1101/gad.1095803; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Dai Y, 2004, BLOOD, V103, P2761, DOI 10.1182/blood-2003-09-3037; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Ghosh Sagar, 2008, Int J Biomed Sci, V4, P260; HAYASHI T, 1993, J BIOL CHEM, V268, P26790; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Kajino S, 2000, ONCOGENE, V19, P2233, DOI 10.1038/sj.onc.1203560; Kim YS, 2006, J BIOL CHEM, V281, P39051, DOI 10.1074/jbc.M604659200; Kitching R, 2003, BBA-GENE STRUCT EXPR, V1625, P116, DOI 10.1016/S0167-4781(02)00562-6; Koh SS, 2002, J BIOL CHEM, V277, P26031, DOI 10.1074/jbc.M110865200; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Majumdar S, 2003, ONCOGENE, V22, P1206, DOI 10.1038/sj.onc.1206184; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; Okamoto T, 1997, CURR TOP CELL REGUL, V35, P149, DOI 10.1016/S0070-2137(97)80006-4; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Sanda T, 2005, CLIN CANCER RES, V11, P1974, DOI 10.1158/1078-0432.CCR-04-1936; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Shimo T, 2006, J BONE MINER RES, V21, P1045, DOI 10.1359/JBMR.060416; Shono T, 1996, MOL CELL BIOL, V16, P4231; Specht K, 2004, BLOOD, V104, P1120, DOI 10.1182/blood-2003-11-3837; Srivastava RK, 1999, MOL CELL BIOCHEM, V195, P25, DOI 10.1023/A:1006990231186; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Takahashi N, 2002, EUR J BIOCHEM, V269, P4559, DOI 10.1046/j.1432-1033.2002.03157.x; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Xu HF, 2008, BREAST CANCER RES TR, V107, P63, DOI 10.1007/s10549-007-9536-5; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	47	63	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28097	28104		10.1074/jbc.M110.116566	http://dx.doi.org/10.1074/jbc.M110.116566			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	739TZ	20562110	Green Published, hybrid			2022-12-25	WOS:000288742300008
J	Gonzalez, DJ; Lee, SW; Hensler, ME; Markley, AL; Dahesh, S; Mitchell, DA; Bandeira, N; Nizet, V; Dixon, JE; Dorrestein, PC				Gonzalez, David J.; Lee, Shaun W.; Hensler, Mary E.; Markley, Andrew L.; Dahesh, Samira; Mitchell, Douglas A.; Bandeira, Nuno; Nizet, Victor; Dixon, Jack E.; Dorrestein, Pieter C.			Clostridiolysin S, a Post-translationally Modified Biotoxin from Clostridium botulinum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOLYSIN-S; MASS-SPECTROMETRY; MICROCIN C7; BIOSYNTHESIS; PEPTIDE; STREPTOCOCCUS; IDENTIFICATION; SPOROGENES; COMPONENT; PATHWAY	Through elaboration of its botulinum toxins, Clostridium botulinum produces clinical syndromes of infant botulism, wound botulism, and other invasive infections. Using comparative genomic analysis, an orphan nine-gene cluster was identified in C. botulinum and the related foodborne pathogen Clostridium sporogenes that resembled the biosynthetic machinery for streptolysin S, a key virulence factor from group A Streptococcus responsible for its hallmark beta-hemolytic phenotype. Genetic complementation, in vitro reconstitution, mass spectral analysis, and plasmid intergrational mutagenesis demonstrate that the streptolysin S-like gene cluster from Clostridium sp. is responsible for the biogenesis of a novel post-translationally modified hemolytic toxin, clostridiolysin S.	[Nizet, Victor; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gonzalez, David J.; Markley, Andrew L.; Dixon, Jack E.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Dixon, Jack E.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hensler, Mary E.; Dahesh, Samira; Nizet, Victor] Univ Calif San Diego, Div Pharmacol & Drug Discovery, Dept Pediat, La Jolla, CA 92093 USA; [Bandeira, Nuno] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Dixon, Jack E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Mitchell, Douglas A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Mitchell, Douglas A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Mitchell, Douglas A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Notre Dame; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Dorrestein, PC (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Biomed Sci Bldg,Rm 4090,9500 Gilman Dr,MC 0636, La Jolla, CA 92093 USA.	pdorrestein@ucsd.edu	Nizet, Victor/AAF-3190-2019; Mitchell, Doug/B-6349-2012; Dorrestein, Pieter/D-5012-2012; Dorrestein, Pieter/ABF-2930-2020; Mitchell, Douglas/C-4400-2011	Mitchell, Doug/0000-0002-9564-0953; Nizet, Victor/0000-0003-3847-0422; Bandeira, Nuno/0000-0001-8385-3655	National Institutes of Health Hemoglobin and Blood Protein Chemistry [5T32DK007233-34]; Beckman Foundation; NATIONAL CANCER INSTITUTE [T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090328] Funding Source: NIH RePORTER	National Institutes of Health Hemoglobin and Blood Protein Chemistry(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Hemoglobin and Blood Protein Chemistry Training Program Grant 5T32DK007233-34. This work was also supported by the Beckman Foundation.	Bandeira N, 2007, P NATL ACAD SCI USA, V104, P6140, DOI 10.1073/pnas.0701130104; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; CINADER B, 1950, J EXP MED, V92, P219, DOI 10.1084/jem.92.3.219; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Duda DM, 2005, J MOL BIOL, V349, P774, DOI 10.1016/j.jmb.2005.04.011; HaraKudo Y, 1997, MICROB PATHOGENESIS, V22, P31, DOI 10.1006/mpat.1996.0088; Hopkins CE, 2002, PROTEIN SCI, V11, P1591, DOI 10.1110/ps.3900102; Humar D, 2002, LANCET, V359, P124, DOI 10.1016/S0140-6736(02)07371-3; Igarashi Y, 2001, J ANTIBIOT, V54, P1045, DOI 10.7164/antibiotics.54.1045; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Mitchell DA, 2009, J BIOL CHEM, V284, P13004, DOI 10.1074/jbc.M900802200; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Regni CA, 2009, EMBO J, V28, P1953, DOI 10.1038/emboj.2009.146; Roush RF, 2008, J AM CHEM SOC, V130, P3603, DOI 10.1021/ja7101949; SAVANI J, 1978, J FOOD SCI, V43, P222, DOI 10.1111/j.1365-2621.1978.tb09776.x; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Sebaihia M, 2007, GENOME RES, V17, P1082, DOI 10.1101/gr.6282807; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; TSAIHONG JC, 1983, CURR MICROBIOL, V9, P333, DOI 10.1007/BF01588830; Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252; Zamble DB, 2001, P NATL ACAD SCI USA, V98, P7712, DOI 10.1073/pnas.141225698; Zamble DB, 2000, BIOCHEMISTRY-US, V39, P16190, DOI 10.1021/bi001398e	31	50	50	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28220	28228		10.1074/jbc.M110.118554	http://dx.doi.org/10.1074/jbc.M110.118554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20581111	Green Published, hybrid			2022-12-25	WOS:000281404100065
J	Yang, YC; Fann, MJ; Chang, WH; Tai, LH; Jiang, JH; Kao, LS				Yang, Ya-Chi; Fann, Ming-Ji; Chang, Wen-Hsin; Tai, Long-Hao; Jiang, Jhih-Hang; Kao, Lung-Sen			Regulation of Sodium-Calcium Exchanger Activity by Creatine Kinase under Energy-compromised Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; CARDIAC NA+-CA2+ EXCHANGER; K+-CL-COTRANSPORTER; NA+/CA2+ EXCHANGER; PLASMA-MEMBRANE; SODIUM/CALCIUM EXCHANGER; DEPENDENT REGULATION; CRYSTAL-STRUCTURE; SMOOTH-MUSCLE; MITOCHONDRIAL	Na+/Ca2+ exchanger (NCX) is one of the major mechanisms for removing Ca2+ from the cytosol especially in cardiac myocytes and neurons, where their physiological activities are triggered by an influx of Ca2+. NCX contains a large intracellular loop (NCXIL) that is responsible for regulating NCX activity. Recent evidence has shown that proteins, including kinases and phosphatases, associate with NCX1IL to form a NCX1 macromolecular complex. To search for the molecules that interact with NCX1IL and regulate NCX1 activity, we used the yeast two-hybrid method to screen a human heart cDNA library and found that the C-terminal region of sarcomeric mitochondrial creatine kinase (sMiCK) interacted with NCX1IL. Moreover, both sMiCK and the muscle-type creatine kinase (CKM) coimmuno-precipitated with NCX1 using lysates of cardiacmyocytes and HEK293T cells that transiently expressed NCX1 and various creatine kinases. Both sMiCK and CKM were able to produce a recovery in the decreased NCX1 activity that was lost under energy-compromised conditions. This regulation is mediated through a putative PKC phosphorylation site of sMiCK and CKM. The autophosphorylation and the catalytic activity of sMiCK and CKM are not required for their regulation of NCX1 activity. Our results suggest a novel mechanism for the regulation of NCX1 activity.	[Fann, Ming-Ji; Chang, Wen-Hsin; Tai, Long-Hao; Jiang, Jhih-Hang; Kao, Lung-Sen] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Fann, Ming-Ji; Chang, Wen-Hsin; Tai, Long-Hao; Jiang, Jhih-Hang; Kao, Lung-Sen] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Kao, Lung-Sen] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Kao, LS (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan.	lskao@ym.edu.tw	Jiang, Jhih-Hang/M-8237-2019	Jiang, Jhih-Hang/0000-0002-1543-1634	National Science Council [NSC94-2320-B010-032, NSC95-2320-B010-026-MY3]; Ministry of Education, Aim for the Top University Plan.	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Aim for the Top University Plan.(Ministry of Education, Taiwan)	This study was supported by grants from the National Science Council (NSC94-2320-B010-032, NSC95-2320-B010-026-MY3) and the Ministry of Education, Aim for the Top University Plan.	ACETO JF, 1992, ARCH BIOCHEM BIOPHYS, V298, P553, DOI 10.1016/0003-9861(92)90449-7; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; COLLINS A, 1992, J PHYSIOL-LONDON, V454, P27, DOI 10.1113/jphysiol.1992.sp019253; CONDRESCU M, 1995, J BIOL CHEM, V270, P9137, DOI 10.1074/jbc.270.16.9137; Crawford RM, 2001, FASEB J, V15, P102, DOI 10.1096/fj.01-0446fje; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Eder M, 1999, PROTEIN SCI, V8, P2258; Eder M, 2000, PROTEINS, V39, P216, DOI 10.1002/(SICI)1097-0134(20000515)39:3<216::AID-PROT40>3.0.CO;2-#; Eder M, 2000, J BIOL CHEM, V275, P27094; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GROSSE R, 1980, BIOCHIM BIOPHYS ACTA, V603, P142, DOI 10.1016/0005-2736(80)90397-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haworth RA, 1997, J MOL CELL CARDIOL, V29, P503, DOI 10.1006/jmcc.1996.0294; Ikari A, 1998, EUR J PHARMACOL, V360, P91, DOI 10.1016/S0014-2999(98)00659-1; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; IWAMOTO T, 1995, J BIOL CHEM, V270, P8996, DOI 10.1074/jbc.270.15.8996; Iwamoto T, 1996, J BIOL CHEM, V271, P13609, DOI 10.1074/jbc.271.23.13609; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; KOMURO I, 1992, P NATL ACAD SCI USA, V89, P4769, DOI 10.1073/pnas.89.10.4769; KUSUOKA H, 1993, J AM COLL CARDIOL, V21, P240, DOI 10.1016/0735-1097(93)90743-K; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; LI ZP, 1994, J BIOL CHEM, V269, P17434; Lin G, 2009, CELL MOL LIFE SCI, V66, P135, DOI 10.1007/s00018-008-8575-3; Mattiello JA, 1998, CARDIOVASC RES, V37, P424, DOI 10.1016/S0008-6363(97)00271-X; MOORE EDW, 1993, NATURE, V365, P657, DOI 10.1038/365657a0; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Nordentoft I, 2003, BIOCHEM J, V374, P165, DOI 10.1042/BJ20030087; Oceandy D, 2007, BIOCHEM SOC T, V35, P927, DOI 10.1042/BST0350927; Pan CY, 1998, BIOCHEM J, V336, P305, DOI 10.1042/bj3360305; Pan CY, 1997, J NEUROCHEM, V69, P1085; Pen CY, 2008, J NEUROCHEM, V107, P658, DOI 10.1111/j.1471-4159.2008.05637.x; Pulina MV, 2006, J BIOL CHEM, V281, P19645, DOI 10.1074/jbc.M602033200; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Ren XY, 2006, J BIOL CHEM, V281, P22808, DOI 10.1074/jbc.M604753200; Reppel M, 2007, CARDIOVASC RES, V75, P99, DOI 10.1016/j.cardiores.2007.03.018; SAKS VA, 1977, BIOCHIM BIOPHYS ACTA, V465, P550, DOI 10.1016/0005-2736(77)90272-3; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Shen YQ, 2001, ACTA CRYSTALLOGR D, V57, P1196, DOI 10.1107/S0907444901007703; Spindler M, 2004, AM J PHYSIOL-HEART C, V287, pH1039, DOI 10.1152/ajpheart.01016.2003; Steeghs K, 1997, J NEUROSCI METH, V71, P29, DOI 10.1016/S0165-0270(96)00124-0; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Stolz M, 2002, BIOCHEM J, V363, P785, DOI 10.1042/0264-6021:3630785; Tokumura A, 1998, BBA-LIPID LIPID MET, V1389, P67, DOI 10.1016/S0005-2760(97)00130-6; Wakimoto K, 2000, J BIOL CHEM, V275, P36991, DOI 10.1074/jbc.M004035200; Weber CR, 2003, CIRCULATION, V108, P2224, DOI 10.1161/01.CIR.0000095274.72486.94; Xu WY, 1997, ARCH BIOCHEM BIOPHYS, V341, P273, DOI 10.1006/abbi.1997.9954	52	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28275	28285		10.1074/jbc.M110.141424	http://dx.doi.org/10.1074/jbc.M110.141424			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576602	Green Published, hybrid			2022-12-25	WOS:000281404100070
J	Chakrabarty, A; Rexer, BN; Wang, SE; Cook, RS; Engelman, JA; Arteaga, CL				Chakrabarty, A.; Rexer, B. N.; Wang, S. E.; Cook, R. S.; Engelman, J. A.; Arteaga, C. L.			H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation by heregulin production and activation of HER3	ONCOGENE			English	Article						PIK3CA mutations; HER2 overexpression; HER3; heregulin; breast cancer	HUMAN BREAST-CANCER; TYROSINE KINASE INHIBITORS; GROWTH-FACTOR RECEPTOR; PIK3CA MUTATIONS; PHOSPHOINOSITIDE 3-KINASE; IN-VIVO; TRASTUZUMAB RESISTANCE; EPITHELIAL-CELLS; HIGH-FREQUENCY; PI3K PATHWAY	Hyperactivation of phosphatidylinositol-3 kinase (PI3K) can occur as a result of somatic mutations in PIK3CA, the gene encoding the p110 alpha subunit of PI3K. The HER2 oncogene is amplified in 25% of all breast cancers and some of these tumors also harbor PIK3CA mutations. We examined mechanisms by which mutant PI3K can enhance transformation and confer resistance to HER2-directed therapies. We introduced the PI3K mutations E545K and H1047R in MCF10A human mammary epithelial cells that also overexpress HER2. Both mutants conferred a gain of function to MCF10A/HER2 cells. Expression of H1047R PI3K, but not E545K PI3K, markedly upregulated the HER3/HER4 ligand heregulin (HRG). HRG siRNA inhibited growth of H1047R but not E545K-expressing cells and synergized with the HER2 inhibitors trastuzumab and lapatinib. The PI3K inhibitor BEZ235 markedly inhibited HRG and pAKT levels and, in combination with lapatinib, completely inhibited growth of cells expressing H1047R PI3K. These observations suggest that PI3K mutants enhance HER2-mediated transformation by amplifying the ligand-induced signaling output of the ErbB network. This also counteracts the full effect of therapeutic inhibitors of HER2. These data also suggest that mammary tumors that contain both HER2 gene amplification and PIK3CA mutations should be treated with a combination of HER2 and PI3K inhibitors. Oncogene (2010) 29, 5193-5203; doi:10.1038/onc.2010.257; published online 28 June 2010	[Chakrabarty, A.; Rexer, B. N.; Arteaga, C. L.] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Wang, S. E.; Cook, R. S.; Arteaga, C. L.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Cook, R. S.; Arteaga, C. L.] Vanderbilt Univ, Sch Med, Breast Canc Res Program, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Engelman, J. A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Canc Ctr,Dept Med, Charlestown, MA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital	Arteaga, CL (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Ingram Canc Ctr, 777 PRB,2220 Pierce Ave, Nashville, TN 37232 USA.	carlos.arteaga@vanderbilt.edu		Wang, Shizhen Emily/0000-0002-5036-8175	ACS Clinical Research [CRP-07-234]; Breast Cancer Specialized Program of Research Excellence (SPORE) [P50 CA98131]; Vanderbilt-Ingram Comprehensive Cancer Center [P30 CA68485];  [R01 CA80195]; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA080195, P50CA098131] Funding Source: NIH RePORTER	ACS Clinical Research; Breast Cancer Specialized Program of Research Excellence (SPORE); Vanderbilt-Ingram Comprehensive Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr H Shelton Earp III and Dr Carlos Garcia-Echeverria for providing the HER4 antibody and NVP-BEZ235, respectively. This work was supported by R01 CA80195 (CLA), ACS Clinical Research Professorship Grant CRP-07-234 (CLA), Breast Cancer Specialized Program of Research Excellence (SPORE) P50 CA98131 and Vanderbilt-Ingram Comprehensive Cancer Center Support Grant P30 CA68485.	Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carson JD, 2008, BIOCHEM J, V409, P519, DOI 10.1042/BJ20070681; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Geering B, 2007, BIOCHEM SOC T, V35, P199, DOI 10.1042/BST0350199; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lai YL, 2008, ANN SURG ONCOL, V15, P1064, DOI 10.1245/s10434-007-9751-7; Lee JY, 2007, SCIENCE, V317, P206, DOI 10.1126/science.1146073; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lerma E, 2008, VIRCHOWS ARCH, V453, P133, DOI 10.1007/s00428-008-0643-4; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li SY, 2006, BREAST CANCER RES TR, V96, P91, DOI 10.1007/s10549-005-9048-0; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Medina PJ, 2008, CLIN THER, V30, P1426, DOI 10.1016/j.clinthera.2008.08.008; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Revillion F, 2008, ANN ONCOL, V19, P73, DOI 10.1093/annonc/mdm431; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Yakes FM, 2002, CANCER RES, V62, P4132; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	52	78	83	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	37					5193	5203		10.1038/onc.2010.257	http://dx.doi.org/10.1038/onc.2010.257			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	650QZ	20581867	Green Accepted			2022-12-25	WOS:000281867200008
J	Gan, Y; Shi, C; Inge, L; Hibner, M; Balducci, J; Huang, Y				Gan, Y.; Shi, C.; Inge, L.; Hibner, M.; Balducci, J.; Huang, Y.			Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells	ONCOGENE			English	Article						EGFR; ERK; Akt; phosphorylation; signaling; cell migration	GROWTH-FACTOR RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; FOCAL ADHESION PROTEIN; E-CADHERIN EXPRESSION; DOWN-REGULATION; TUMOR PROGRESSION; ERBB RECEPTORS; BETA-CATENIN; C-CBL	Upregulation of epidermal growth factor receptor (EGFR) and subsequent increases in extracellular-regulated kinase (ERK) and Akt signaling are implicated in prostate cancer progression. Impaired endocytic downregulation of EGFR also contributes to oncogenic phenotypes such as metastasis. Thus, understanding the roles of divergent signaling pathways in the regulation of EGFR trafficking and EGFR-driven invasive migration may enable the development of more effective therapies. In this study, we use the human prostate cancer cell lines, DU145 and PC3, to investigate the effects of both the ERK and Akt pathways on epidermal growth factor (EGF)-mediated EGFR signaling, trafficking and cell motility. We show that DU145 and PC3 cells overexpress EGFR and migrate in a ligand (EGF)dependent manner. Next, we show that pharmacological inhibition of ERK (but not Akt) signaling enhances EGF-induced EGFR activation, ubiquitination and downregulation, and may lead to enhanced receptor turnover. These findings negatively correlate with ERK-mediated threonine phosphorylation of EGFR, implicating it as a possible mechanism. Further, we uncover that EGF promotes disassembly of cell-cell junctions, downregulation of E-cadherin and upregulation of the transcriptional repressor, Snail, typical characteristics of epithelial-mesenchymal transition (EMT). These effects are dependent on activation of Akt, as inhibition of Akt signaling abolishes EGF/EGFR-driven cell migration and EMT. Knockdown of endogenous Snail also prevents EGFR-mediated downregulation of E-cadherin, EMT and cell migration. Surprisingly, inhibition of the ERK pathway augments EGFR-dependent motility, occurring concomitantly with elevation of EGF-induced Akt activity. Collectively, our results suggest that EGF-triggered ERK activation has profound feedback on EGFR signaling and trafficking by EGFR threonine phosphorylation, and Akt has a pivotal role in EGFR-mediated cell migration by activating EMT. More important, our results also suggest that therapeutic targeting of ERK signaling may have undesirable outcomes (for example, augmenting EGFR-driven motility). Oncogene (2010) 29, 4947-4958; doi: 10.1038/onc.2010.240; published online 21 June 2010	[Gan, Y.; Shi, C.; Hibner, M.; Balducci, J.; Huang, Y.] St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ 85004 USA; [Inge, L.] St Josephs Hosp, Heart & Lung Inst, Phoenix, AZ 85004 USA; [Shi, C.] Huazhong Univ Sci & Technol, Dept Pathogen Biol, Tongji Med Coll, Wuhan 430074, Peoples R China	St. Joseph's Hospital and Medical Center; St. Joseph's Hospital and Medical Center; Huazhong University of Science & Technology	Huang, Y (corresponding author), St Josephs Hosp, Dept Obstet & Gynecol, 445 N 5th St,Suite 110, Phoenix, AZ 85004 USA.	yhuang@chw.edu	高, 雨莉/HGU-8187-2022		St Joseph's Foundation	St Joseph's Foundation	We thank Prof. Michael Croft for generously providing retroviral expression vector for constitutively active (myristoylated) Akt. This work was supported by a St Joseph's Foundation Startup Fund (to YH). Part of this work was presented at the 91st Endocrine Society Annual Meeting in Washington DC, USA, 2009.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Davies MA, 2002, CLIN CANCER RES, V8, P1904; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1; Hipp S, 2009, J CELL MOL MED, V13, P3858, DOI 10.1111/j.1582-4934.2008.00526.x; Huang Y, 2006, ONCOGENE, V25, P7565, DOI 10.1038/sj.onc.1209740; Huang Y, 2004, ENDOCRINOLOGY, V145, P3297, DOI 10.1210/en.2003-1658; Huang Y, 2003, J BIOL CHEM, V278, P18902, DOI 10.1074/jbc.M300939200; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kambhampati S, 2005, FRONT BIOSCI-LANDMRK, V10, P1355, DOI 10.2741/1625; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li X, 2008, CELL SIGNAL, V20, P2145, DOI 10.1016/j.cellsig.2008.08.006; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Ma FX, 2009, GENES CELLS, V14, P281, DOI 10.1111/j.1365-2443.2008.01267.x; Martin G. Steven, 2003, Cancer Cell, V4, P167, DOI 10.1016/S1535-6108(03)00216-2; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Schlessinger K, 2004, NAT CELL BIOL, V6, P913, DOI 10.1038/ncb1004-913; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; UMBAS R, 1994, CANCER RES, V54, P3929; UMBAS R, 1992, CANCER RES, V52, P5104; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang CC, 2009, CANCER CELL, V15, P355, DOI 10.1016/j.ccr.2009.04.003; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	48	220	228	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	35					4947	4958		10.1038/onc.2010.240	http://dx.doi.org/10.1038/onc.2010.240			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	646XP	20562913				2022-12-25	WOS:000281578700009
J	Hernandez-Guillamon, M; Mawhirt, S; Fossati, S; Blais, S; Pares, M; Penalba, A; Boada, M; Couraud, PO; Neubert, TA; Montaner, J; Ghiso, J; Rostagno, A				Hernandez-Guillamon, Mar; Mawhirt, Stephanie; Fossati, Silvia; Blais, Steven; Pares, Mireia; Penalba, Anna; Boada, Merce; Couraud, Pierre-Olivier; Neubert, Thomas A.; Montaner, Joan; Ghiso, Jorge; Rostagno, Agueda			Matrix Metalloproteinase 2 (MMP-2) Degrades Soluble Vasculotropic Amyloid-beta E22Q and L34V Mutants, Delaying Their Toxicity for Human Brain Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; APOLIPOPROTEIN-E GENOTYPE; SMOOTH-MUSCLE-CELLS; DUTCH-TYPE MUTANT; A-BETA; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; COMPACT PLAQUES; FOCAL ISCHEMIA	Patients carrying mutations within the amyloid-beta (A beta) sequence develop severe early-onset cerebral amyloid angiopathy with some of the related variants manifesting primarily with hemorrhagic phenotypes. Matrix metalloproteases (MMPs) are typically associated with blood brain barrier disruption and hemorrhagic transformations after ischemic stroke. However, their contribution to cerebral amyloid angiopathy-related hemorrhage remains unclear. Human brain endothelial cells challenged with A beta synthetic homologues containing mutations known to be associated in vivo with hemorrhagic manifestations (A beta E22Q and A beta L34V) showed enhanced production and activation of MMP-2, evaluated via Multiplex MMP antibody arrays, gel zymography, and Western blot, which in turn proteolytically cleaved in situ the A beta peptides. Immunoprecipitation followed by mass spectrometry analysis highlighted the generation of specific C-terminal proteolytic fragments, in particular the accumulation of A beta-(1-16), a result validated in vitro with recombinant MMP-2 and quantitatively evaluated using deuterium-labeled internal standards. Silencing MMP-2 gene expression resulted in reduced A beta degradation and enhanced apoptosis. Secretion and activation of MMP-2 as well as susceptibility of the A beta peptides to MMP-2 degradation were dependent on the peptide conformation, with fibrillar elements of A beta E22Q exhibiting negligible effects. Our results indicate that MMP-2 release and activation differentially degrades A beta species, delaying their toxicity for endothelial cells. However, taking into consideration MMP ability to degrade basement membrane components, these protective effects might also undesirably compromise blood brain barrier integrity and precipitate a hemorrhagic phenotype.	[Mawhirt, Stephanie; Fossati, Silvia; Ghiso, Jorge; Rostagno, Agueda] NYU, Sch Med, Dept Pathol, Skirball Inst, New York, NY 10016 USA; [Ghiso, Jorge] NYU, Sch Med, Dept Psychiat, Skirball Inst, New York, NY 10016 USA; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Dept Pharmacol, Skirball Inst, New York, NY 10016 USA; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Hernandez-Guillamon, Mar; Pares, Mireia; Penalba, Anna; Montaner, Joan] Univ Autonoma Barcelona, Hosp Vall Hebron, Inst Recerca, Neurovasc Res Lab, Barcelona 08035, Spain; [Boada, Merce; Montaner, Joan] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Neurol, Neurovasc Unit, Barcelona 08035, Spain; [Couraud, Pierre-Olivier] INSERM, Inst COCHIN, F-75014 Paris, France	New York University; New York University; New York University; New York University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Rostagno, A (corresponding author), NYU, Sch Med, Dept Pathol, Skirball Inst, 560 1st Ave,TH Rm 435, New York, NY 10016 USA.	agueda.rostagno@nyumc.org	Montaner, Joan/D-3063-2015	Montaner, Joan/0000-0003-4845-2279; Rostagno, Agueda/0000-0002-6817-2074; Hernandez Guillamon, Maria Mar/0000-0001-8844-0091; Fossati, Silvia/0000-0002-2047-222X	National Institutes of Health [NS051715, AG30539, NS050276]; Spanish Ministry of Health [PI070737]; Instituto de Salud Carlos III; Alzheimer's Association; American Heart Association; Spanish Ministry of Health (Instituto de Salud Carlos III); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276, R01NS051715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Alzheimer's Association(Alzheimer's Association); American Heart Association(American Heart Association); Spanish Ministry of Health (Instituto de Salud Carlos III)(Instituto de Salud Carlos IIISpanish Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS051715, AG30539, and NS050276. The work was also supported by Spanish Ministry of Health Grant PI070737, the Instituto de Salud Carlos III, the Alzheimer's Association, and the American Heart Association.; Recipient of a postdoctoral grant from the Spanish Ministry of Health (Instituto de Salud Carlos III).	Abilleira S, 2003, J NEUROSURG, V99, P65, DOI 10.3171/jns.2003.99.1.0065; Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bailey TL, 2004, NEUROL RES, V26, P573, DOI 10.1179/016164104225016272; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Bornebroek M, 1997, ANN NEUROL, V41, P695, DOI 10.1002/ana.410410523; Castano EM, 1996, J BIOL CHEM, V271, P32185, DOI 10.1074/jbc.271.50.32185; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen UL, 2009, BIOCHEM BIOPH RES CO, V378, P57, DOI 10.1016/j.bbrc.2008.10.173; Crouch PJ, 2009, J NEUROCHEM, V108, P1198, DOI 10.1111/j.1471-4159.2009.05870.x; Davis J, 1996, P NATL ACAD SCI USA, V93, P2996, DOI 10.1073/pnas.93.7.2996; de la Torre JC, 2004, NEUROL RES, V26, P517, DOI 10.1179/016164104225016254; Du R, 2008, NEURO-ONCOLOGY, V10, P254, DOI 10.1215/15228517-2008-001; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eisenhauer PB, 2000, J NEUROSCI RES, V60, P804, DOI 10.1002/1097-4547(20000615)60:6<804::AID-JNR13>3.3.CO;2-T; Esiri MM, 2001, LANCET, V357, P169; Ethell DW, 2002, CURR BIOL, V12, P1595, DOI 10.1016/S0960-9822(02)01140-5; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Feng Y, 2009, BIOCHEM BIOPH RES CO, V390, P1250, DOI 10.1016/j.bbrc.2009.10.130; Fossati S, 2010, FASEB J, V24, P229, DOI 10.1096/fj.09-139584; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Garcia-Alloza M, 2009, J NEUROCHEM, V109, P1636, DOI 10.1111/j.1471-4159.2009.06096.x; Gelfanova Valentina, 2007, Briefings in Functional Genomics & Proteomics, V6, P149, DOI 10.1093/bfgp/elm010; Gorelick PB, 2004, STROKE, V35, P2620, DOI 10.1161/01.STR.0000143318.70292.47; GRAF K, 1995, HYPERTENSION, V26, P230, DOI 10.1161/01.HYP.26.2.230; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Jung SS, 2003, J NEUROCHEM, V85, P1208, DOI 10.1046/j.1471-4159.2003.01745.x; KALARIA RN, 1992, CEREBROVAS BRAIN MET, V4, P226; Kumar-Singh S, 2009, INT J MOL SCI, V10, P1872, DOI 10.3390/ijms10041872; Lapchak PA, 2000, STROKE, V31, P3034, DOI 10.1161/01.STR.31.12.3034; Lee JM, 2005, J NEUROL SCI, V229, P249, DOI 10.1016/j.jns.2004.11.041; Lee JM, 2003, ANN NEUROL, V54, P379, DOI 10.1002/ana.10671; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Liao MQ, 2007, FEBS LETT, V581, P1161, DOI 10.1016/j.febslet.2007.02.026; Maat-Schieman M, 2005, NEUROPATHOLOGY, V25, P288, DOI 10.1111/j.1440-1789.2005.00631.x; Maia LF, 2006, CEREBROVASC DIS, V22, P155, DOI 10.1159/000093245; MANDYBUR TI, 1986, J NEUROPATH EXP NEUR, V45, P79, DOI 10.1097/00005072-198601000-00007; McCarty JH, 2005, ASSAY DRUG DEV TECHN, V3, P89, DOI 10.1089/adt.2005.3.89; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Morelli L, 2002, NEUROCHEM RES, V27, P1387, DOI 10.1023/A:1021679817756; Munoz FJ, 2002, J NEUROSCI, V22, P3081, DOI 10.1523/JNEUROSCI.22-08-03081.2002; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; O'Donnell HC, 2000, NEW ENGL J MED, V342, P240, DOI 10.1056/NEJM200001273420403; Obici L, 2005, ANN NEUROL, V58, P639, DOI 10.1002/ana.20571; Petty MA, 2001, BRAIN RES REV, V36, P23, DOI 10.1016/S0165-0173(01)00062-5; Portelius E, 2006, NEUROSCI LETT, V409, P215, DOI 10.1016/j.neulet.2006.09.044; Rensink AAM, 2003, BRAIN RES REV, V43, P207, DOI 10.1016/j.brainresrev.2003.08.001; Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; ROSENBERG GA, 1993, NEUROSCI LETT, V160, P117, DOI 10.1016/0304-3940(93)90927-D; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; ROSENBERG GA, 1992, BRAIN RES, V576, P203, DOI 10.1016/0006-8993(92)90681-X; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rostagno A, 2010, CELL MOL LIFE SCI, V67, P581, DOI 10.1007/s00018-009-0182-4; Rostagno A., 2009, CURR PROTOC CELL BIO, P31; Rostagno A, 2008, NEURODEGENER DIS, V5, P173, DOI 10.1159/000113694; Solito R, 2009, EXP CELL RES, V315, P385, DOI 10.1016/j.yexcr.2008.11.002; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200; Tomidokoro Y, 2010, AM J PATHOL, V176, P1841, DOI 10.2353/ajpath.2010.090636; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Tucker HM, 2000, J NEUROSCI, V20, P3937; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Van Nostrand WE, 1998, J NEUROCHEM, V70, P216; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; Viana RJS, 2009, CELL MOL LIFE SCI, V66, P1094, DOI 10.1007/s00018-009-8746-x; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Yamada M, 2000, NEUROPATHOLOGY, V20, P8, DOI 10.1046/j.1440-1789.2000.00268.x; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	81	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27144	27158		10.1074/jbc.M110.135228	http://dx.doi.org/10.1074/jbc.M110.135228			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576603	Green Published, hybrid			2022-12-25	WOS:000281172700045
J	Yoshida, A; Tomita, T; Kuzuyama, T; Nishiyama, M				Yoshida, Ayako; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto			Mechanism of Concerted Inhibition of alpha(2)beta(2)-type Hetero-oligomeric Aspartate Kinase from Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID BIOSYNTHESIS; THERMUS-THERMOPHILUS; ALLOSTERIC ENZYMES; CRYSTAL-STRUCTURE; ACT DOMAINS; ASPARTOKINASE; LYSINE; PROTEINS; PATHWAY; OPERON	Aspartate kinase (AK) is the first and committed enzyme of the biosynthetic pathway producing aspartate family amino acids, lysine, threonine, and methionine. AK from Corynebacterium glutamicum (CgAK), a bacterium used for industrial fermentation of amino acids, including glutamate and lysine, is inhibited by lysine and threonine in a concerted manner. To elucidate the mechanism of this unique regulation in CgAK, we determined the crystal structures in several forms: an inhibitory form complexed with both lysine and threonine, an active form complexed with only threonine, and a feedback inhibition-resistant mutant (S301F) complexed with both lysine and threonine. CgAK has a characteristic alpha(2)beta(2)-type heterotetrameric structure made up of two alpha subunits and two beta subunits. Comparison of the crystal structures between inhibitory and active forms revealed that binding inhibitors causes a conformational change to a closed inhibitory form, and the interaction between the catalytic domain in the alpha subunit and beta subunit (regulatory subunit) is a key event for stabilizing the inhibitory form. This study shows not only the first crystal structures of alpha(2)beta(2)-type AK but also the mechanism of concerted inhibition in CgAK.	[Yoshida, Ayako; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Nishiyama, Makoto/0000-0001-8143-8052; Kuzuyama, Tomohisa/0000-0002-7221-5858; Yoshida, Ayako/0000-0002-3668-9001	Ministry of Education, Culture, Sports, Science, and Technology Japan; Noda Institute for Scientific Research	Ministry of Education, Culture, Sports, Science, and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Noda Institute for Scientific Research(Noda Institute for Scientific Research)	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology Japan and the Noda Institute for Scientific Research.	Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; BLACK S, 1955, J BIOL CHEM, V213, P27; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; CIRILLO JD, 1994, MOL MICROBIOL, V11, P629, DOI 10.1111/j.1365-2958.1994.tb00342.x; Curien G, 2008, PLANT PHYSIOL BIOCH, V46, P325, DOI 10.1016/j.plaphy.2007.12.006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faehnle CR, 2006, ACTA CRYSTALLOGR F, V62, P962, DOI 10.1107/S1744309106038279; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; KALINOWSKI J, 1991, MOL MICROBIOL, V5, P1197, DOI 10.1111/j.1365-2958.1991.tb01893.x; KALINOWSKI J, 1990, MOL GEN GENET, V224, P317, DOI 10.1007/BF00262424; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Liu XY, 2008, J BIOL CHEM, V283, P16216, DOI 10.1074/jbc.M800760200; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; NISHIYAMA M, 1995, MICROBIOL-SGM, V141, P1211, DOI 10.1099/13500872-141-5-1211; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Robin AY, 2010, J MOL BIOL, V399, P283, DOI 10.1016/j.jmb.2010.04.014; ROGNES SE, 1980, NATURE, V287, P357, DOI 10.1038/287357a0; SHIIO I, 1969, J BIOCHEM-TOKYO, V65, P849, DOI 10.1093/oxfordjournals.jbchem.a129089; Somerville R. L., 1983, AMINO ACIDS BIOSYNTH, P147; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yoshida A, 2007, J MOL BIOL, V368, P521, DOI 10.1016/j.jmb.2007.02.017; Yoshida A, 2009, FEBS J, V276, P3124, DOI 10.1111/j.1742-4658.2009.07030.x	31	25	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27477	27486		10.1074/jbc.M110.111153	http://dx.doi.org/10.1074/jbc.M110.111153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573952	hybrid, Green Published			2022-12-25	WOS:000281172700077
J	Lin, YP; McDonough, SP; Sharma, Y; Chang, YF				Lin, Yi-Pin; McDonough, Sean P.; Sharma, Yogendra; Chang, Yung-Fu			The Terminal Immunoglobulin-Like Repeats of LigA and LigB of Leptospira Enhance Their Binding to Gelatin Binding Domain of Fibronectin and Host Cells	PLOS ONE			English	Article							PROTEIN-A; MOLECULAR CHARACTERIZATION; BACTERIAL ADHERENCE; C-TERMINUS; INTERROGANS; AFFINITY; LIPL32; REGION; ADHESIN; EXPRESSION	Leptospira spp. are pathogenic spirochetes that cause the zoonotic disease leptospirosis. Leptospiral immunoglobulin (Ig)like protein B (LigB) contributes to the binding of Leptospira to extracellular matrix proteins such as fibronectin, fibrinogen, laminin, elastin, tropoelastin and collagen. A high-affinity Fn-binding region of LigB has been localized to LigBCen2, which contains the partial 11th and full 12th Ig-like repeats (LigBCen2R) and 47 amino acids of the non-repeat region (LigBCen2NR) of LigB. In this study, the gelatin binding domain of fibronectin was shown to interact with LigBCen2R (KD = 1.9160.40 mM). Not only LigBCen2R but also other Ig-like domains of Lig proteins including LigAVar7'-8, LigAVar10, LigAVar11, LigAVar12, LigAVar13, LigBCen7'-8, and LigBCen9 bind to GBD. Interestingly, a large gain in affinity was achieved through an avidity effect, with the terminal domains, 13th (LigA) or 12th (LigB) Ig-like repeat of Lig protein (LigAVar7'-13 and LigBCen7'-12) enhancing binding affinity approximately 51 and 28 fold, respectively, compared to recombinant proteins without this terminal repeat. In addition, the inhibited effect on MDCKs cells can also be promoted by Lig proteins with terminal domains, but these two domains are not required for gelatin binding domain binding and cell adhesion. Interestingly, Lig proteins with the terminal domains could form compact structures with a round shape mediated by multidomain interaction. This is the first report about the interaction of gelatin binding domain of Fn and Lig proteins and provides an example of Lig-gelatin binding domain binding mediating bacterial-host interaction.	[Lin, Yi-Pin; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Sharma, Yogendra] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Cornell University; Cornell University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Lin, YP (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu			Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Biotechnology Research and Development Corporation (BRDC)	Harry M. Zweig Memorial Fund for Equine Research; New York State Science and Technology Foundation (CAT); Biotechnology Research and Development Corporation (BRDC)	This work was supported in part by the Harry M. Zweig Memorial Fund for Equine Research, the New York State Science and Technology Foundation (CAT), the Biotechnology Research and Development Corporation (BRDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; BENEVIDES JM, 2004, RAMAN SPECTROSCOPY P, P17; Callahan B, 2010, J BACTERIOL, V192, P326, DOI 10.1128/JB.01032-09; Carvalho E, 2009, FEBS LETT, V583, P1381, DOI 10.1016/j.febslet.2009.03.050; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006; FAISAL SM, 2003, VACCINE, V21, P2383; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089; Hammel M, 2007, PROTEIN SCI, V16, P2605, DOI 10.1110/ps.073170807; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; Ingham KC, 2004, J BIOL CHEM, V279, P42945, DOI 10.1074/jbc.M406984200; Joh D, 1998, EUR J BIOCHEM, V258, P897, DOI 10.1046/j.1432-1327.1998.2580897.x; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Laue T.M., 1992, COMPUTER AIDED INTER; Lin XP, 2008, J VET SCI, V9, P133; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196; Lin YP, 2009, BIOCHEM BIOPH RES CO, V389, P57, DOI 10.1016/j.bbrc.2009.08.089; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; LITVINOVICH SV, 1991, J MOL BIOL, V217, P563, DOI 10.1016/0022-2836(91)90758-X; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; POTTS JR, 1994, CURR OPIN CELL BIOL, V6, P648, DOI 10.1016/0955-0674(94)90090-6; PRETORIUS HT, 1981, BIOCHEMISTRY-US, V20, P2777, DOI 10.1021/bi00513a011; Probert WS, 2001, INFECT IMMUN, V69, P4129, DOI 10.1128/IAI.69.6.4129-4133.2001; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; SMITH AD, 1967, BIOCHEM J, V103, P483, DOI 10.1042/bj1030483; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Strickland AD, 2009, ANAL CHEM, V81, P2895, DOI 10.1021/ac801626x; Tu A.T., 1982, RAMAN SPECTROSCOPY B, P65; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; VANHOLDE KE, 1971, PHYSICAL BIOCH, P79; Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038; Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008	50	44	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11301	10.1371/journal.pone.0011301	http://dx.doi.org/10.1371/journal.pone.0011301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585579	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135800010
J	Lee, JE; Lee, JY; Wilusz, J; Tian, B; Wilusz, CJ				Lee, Jerome E.; Lee, Ju Youn; Wilusz, Jeffrey; Tian, Bin; Wilusz, Carol J.			Systematic Analysis of Cis-Elements in Unstable mRNAs Demonstrates that CUGBP1 Is a Key Regulator of mRNA Decay in Muscle Cells	PLOS ONE			English	Article							BINDING PROTEIN CUGBP1; EMBRYONIC STEM-CELLS; MYOTONIC-DYSTROPHY; SKELETAL-MUSCLE; GENE-EXPRESSION; MOUSE MODELS; STEADY-STATE; STABILITY; DIFFERENTIATION; HUR	Background: Dramatic changes in gene expression occur in response to extracellular stimuli and during differentiation. Although transcriptional effects are important, alterations in mRNA decay also play a major role in achieving rapid and massive changes in mRNA abundance. Moreover, just as transcription factor activity varies between different cell types, the factors influencing mRNA decay are also cell-type specific. Principal Findings: We have established the rates of decay for over 7000 transcripts expressed in mouse C2C12 myoblasts. We found that GU-rich (GRE) and AU-rich (ARE) elements are over-represented in the 3'UTRs of short-lived mRNAs and that these mRNAs tend to encode factors involved in cell cycle and transcription regulation. Stabilizing elements were also identified. By comparing mRNA decay rates in C2C12 cells with those previously measured for pluripotent and differentiating embryonic stem (ES) cells, we identified several groups of transcripts that exhibit cell-type specific decay rates. Further, whereas in C2C12 cells the impact of GREs on mRNA decay appears to be greater than that of AREs, AREs are more significant in ES cells, supporting the idea that cis elements make a cell-specific contribution to mRNA stability. GREs are recognized by CUGBP1, an RNA-binding protein and instability factor whose function is affected in several neuromuscular diseases. We therefore utilized RNA immunoprecipitation followed by microarray (RIP-Chip) to identify CUGBP1-associated transcripts. These mRNAs also showed dramatic enrichment of GREs in their 3'UTRs and encode proteins linked with cell cycle, and intracellular transport. Interestingly several CUGBP1 substrate mRNAs, including those encoding the myogenic transcription factors Myod1 and Myog, are also bound by the stabilizing factor HuR in C2C12 cells. Finally, we show that several CUGBP1-associated mRNAs containing 3'UTR GREs, including Myod1, are stabilized in cells depleted of CUGBP1, consistent with the role of CUGBP1 as a destabilizing factor. Conclusions: Taken together, our results systematically establish cis-acting determinants of mRNA decay rates in C2C12 myoblast cells and demonstrate that CUGBP1 associates with GREs to regulate decay of a wide range of mRNAs including several that are critical for muscle development.	[Lee, Jerome E.; Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA; [Wilusz, Jeffrey; Wilusz, Carol J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Lee, Ju Youn; Tian, Bin] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Colorado State University; Colorado State University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lee, JE (corresponding author), Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA.	cwilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021; Wilusz, Carol/F-7241-2017	Tian, Bin/0000-0001-8903-8256	Muscular Dystrophy Association [9426]; American Heart Association [10PRE2610140]; National Institutes of Health [R01GM084089, R01GM072481]; Colorado State University College Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072481, R01GM084089] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado State University College Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Muscular Dystrophy Association (Award 9426 to CJW), The American Heart Association (Award 10PRE2610140 to JEL), the National Institutes of Health (Award R01GM084089 to BT, and Award R01GM072481 to JW) and by a Colorado State University College Research Council Award to CJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botta A, 2007, GENE EXPRESSION, V13, P339; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Chen HH, 2007, BIOCHEM BIOPH RES CO, V357, P56, DOI 10.1016/j.bbrc.2007.03.113; Chen YW, 2003, J APPL PHYSIOL, V95, P2485, DOI 10.1152/japplphysiol.01161.2002; Corbeil-Girard LP, 2005, NEUROBIOL DIS, V18, P551, DOI 10.1016/j.nbd.2004.10.019; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Duttagupta R, 2005, MOL CELL BIOL, V25, P5499, DOI 10.1128/MCB.25.13.5499-5513.2005; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Frost RA, 2003, ENDOCRINOLOGY, V144, P1770, DOI 10.1210/en.2002-220808; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GHERZI R, 2009, CELL DEATH DIFFER; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; Graindorge A, 2008, NUCLEIC ACIDS RES, V36, P1861, DOI 10.1093/nar/gkn031; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hew Y, 2000, J BIOL CHEM, V275, P24857, DOI 10.1074/jbc.M002776200; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Hui JY, 2003, RNA, V9, P931, DOI 10.1261/rna.5660803; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kong J, 2006, MOL CELL BIOL, V26, P5603, DOI 10.1128/MCB.01845-05; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Marquis J, 2006, BIOCHEM J, V400, P291, DOI 10.1042/BJ20060490; Molin C, 2009, RNA, V15, P600, DOI 10.1261/rna.1403509; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Mukherjee N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.44; Paillard L, 2002, J BIOL CHEM, V277, P3232, DOI 10.1074/jbc.M109362200; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; ROTWEIN P, 1995, MOL ENDOCRINOL, V9, P913, DOI 10.1210/me.9.7.913; Salehzada T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007563; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takahashi N, 2000, BIOCHEM BIOPH RES CO, V277, P518, DOI 10.1006/bbrc.2000.3694; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Topisirovic I, 2009, MOL CELL BIOL, V29, P1152, DOI 10.1128/MCB.01532-08; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Warren GL, 2007, J PHYSIOL-LONDON, V582, P825, DOI 10.1113/jphysiol.2007.132373; Wein G, 2003, EUR J BIOCHEM, V270, P350, DOI 10.1046/j.1432-1033.2003.03396.x; Willett M, 2009, CELL SIGNAL, V21, P1504, DOI 10.1016/j.cellsig.2009.05.009; Wu XX, 2007, ENDOCRINE, V31, P5, DOI 10.1007/s12020-007-0007-x; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yu ZG, 2009, DIS MODEL MECH, V2, P500, DOI 10.1242/dmm.003301; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200; Zhang Y, 2009, MOL CELL BIOL, V29, P3791, DOI 10.1128/MCB.01865-08	69	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11201	10.1371/journal.pone.0011201	http://dx.doi.org/10.1371/journal.pone.0011201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574513	gold, Green Published, Green Submitted			2022-12-25	WOS:000279058300007
J	Jaramillo-Gutierrez, G; Molina-Cruz, A; Kumar, S; Barillas-Mury, C				Jaramillo-Gutierrez, Giovanna; Molina-Cruz, Alvaro; Kumar, Sanjeev; Barillas-Mury, Carolina			The Anopheles gambiae Oxidation Resistance 1 (OXR1) Gene Regulates Expression of Enzymes That Detoxify Reactive Oxygen Species	PLOS ONE			English	Article							NF-KAPPA-B; PLASMODIUM-BERGHEI; STRESS; DROSOPHILA; FAMILY; CELLS; MOSQUITOS; RESPONSES; PROTEINS; IMMUNITY	Background: OXR1 is an ancient gene, present in all eukaryotes examined so far that confers protection from oxidative stress by an unknown mechanism. The most highly conserved region of the gene is the carboxyl-terminal TLDc domain, which has been shown to be sufficient to prevent oxidative damage. Methodology/Principal Findings: OXR1 has a complex genomic structure in the mosquito A. gambiae, and we confirm that multiple splice forms are expressed in adult females. Our studies revealed that OXR1 regulates the basal levels of catalase (CAT) and glutathione peroxidase (Gpx) expression, two enzymes involved in detoxification of hydrogen peroxide, giving new insight into the mechanism of action of OXR1. Gene silencing experiments indicate that the Jun Kinase (JNK) gene acts upstream of OXR1 and also regulates expression of CAT and GPx. Both OXR1 and JNK genes are required for adult female mosquitoes to survive chronic oxidative stress. OXR1 silencing decreases P. berghei oocyst formation. Unexpectedly, JNK silencing has the opposite effect and enhances Plasmodium infection in the mosquito, suggesting that JNK may also mediate some, yet to be defined, antiparasitic response. Conclusion: The JNK pathway regulates OXR1 expression and OXR1, in turn, regulates expression of enzymes that detoxify reactive oxygen species (ROS) in Anopheles gambiae. OXR1 silencing decreases Plasmodium infection in the mosquito, while JNK silencing has the opposite effect and enhances infection.	[Jaramillo-Gutierrez, Giovanna; Molina-Cruz, Alvaro; Kumar, Sanjeev; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	cbarillas@niaid.nih.gov		Kumar, Sanjeev/0000-0003-3866-4593	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; BRANDT SM, 2008, GENETICS; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Durand M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-13; Elliott NA, 2004, MOL CELL BIOL, V24, P3180, DOI 10.1128/MCB.24.8.3180-3187.2004; Fischer H, 2001, BIOCHEM BIOPH RES CO, V281, P795, DOI 10.1006/bbrc.2001.4345; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Iordanov MS, 1999, J BIOL CHEM, V274, P25801, DOI 10.1074/jbc.274.36.25801; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; MEYER M, 1994, CHEM-BIOL INTERACT, V91, P91, DOI 10.1016/0009-2797(94)90029-9; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Natoli R, 2008, INVEST OPHTH VIS SCI, V49, P4561, DOI 10.1167/iovs.08-1722; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Storz G, 1996, EXS, V77, P239; Stowers RS, 1999, DEV BIOL, V213, P116, DOI 10.1006/dbio.1999.9358; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302; Volkert MR, 2000, P NATL ACAD SCI USA, V97, P14530, DOI 10.1073/pnas.260495897; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Zhou LZH, 2001, FREE RADICAL BIO MED, V31, P1405, DOI 10.1016/S0891-5849(01)00719-5	28	58	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11168	10.1371/journal.pone.0011168	http://dx.doi.org/10.1371/journal.pone.0011168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567517	gold, Green Published, Green Submitted			2022-12-25	WOS:000278886300014
J	Dusa, A; Mouton, C; Pecquet, C; Herman, M; Constantinescu, SN				Dusa, Alexandra; Mouton, Celine; Pecquet, Christian; Herman, Murielle; Constantinescu, Stefan N.			JAK2 V617F Constitutive Activation Requires JH2 Residue F595: A Pseudokinase Domain Target for Specific Inhibitors	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; RECEPTOR SURFACE EXPRESSION; PROTEIN-TYROSINE KINASES; POLYCYTHEMIA-VERA; ERYTHROPOIETIN RECEPTOR; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; CYTOKINE RECEPTOR	The JAK2 V617F mutation present in over 95% of Polycythemia Vera patients and in 50% of Essential Thrombocythemia and Primary Myelofibrosis patients renders the kinase constitutively active. In the absence of a three-dimensional structure for the full-length protein, the mechanism of activation of JAK2 V617F has remained elusive. In this study, we used functional mutagenesis to investigate the involvement of the JH2 alpha C helix in the constitutive activation of JAK2 V617F. We show that residue F595, located in the middle of the alpha C helix of JH2, is indispensable for the constitutive activity of JAK2 V617F. Mutation of F595 to Ala, Lys, Val or Ile significantly decreases the constitutive activity of JAK2 V617F, but F595W and F595Y are able to restore it, implying an aromaticity requirement at position 595. Substitution of F595 to Ala was also able to decrease the constitutive activity of two other JAK2 mutants, T875N and R683G, as well as JAK2 K539L, albeit to a lower extent. In contrast, the F595 mutants are activated by erythropoietin-bound EpoR. We also explored the relationship between the dimeric conformation of EpoR and several JAK2 mutants. Since residue F595 is crucial to the constitutive activation of JAK2 V617F but not to initiation of JAK2 activation by cytokines, we suggest that small molecules that target the region around this residue might specifically block oncogenic JAK2 and spare JAK2 wild-type.	[Dusa, Alexandra; Mouton, Celine; Pecquet, Christian; Herman, Murielle; Constantinescu, Stefan N.] Ludwig Inst Canc Res Ltd, Brussels, Belgium; [Dusa, Alexandra; Mouton, Celine; Pecquet, Christian; Herman, Murielle; Constantinescu, Stefan N.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain	Dusa, A (corresponding author), Ludwig Inst Canc Res Ltd, Brussels, Belgium.	Stefan.Constantinescu@bru.licr.org	Constantinescu, Stefan N/E-5277-2012	Constantinescu, Stefan N./0000-0002-8599-2699; Christian, Pecquet/0000-0002-8623-3483	Fonds National de la Recherche Scientifique (FNRS) Televie; Belgian American Educational Foundation; Fondation contre le cancer, Belgium; Atlantic Philanthropies, New York; Salus Sanguinis Foundation, Belgium; Action de Recherche Concertee (ARC) of the Universite catholique de Louvain [MEXP31]; Interuniversity Attraction Pole, Belgium [BCHM61B5]	Fonds National de la Recherche Scientifique (FNRS) Televie(Fonds de la Recherche Scientifique - FNRS); Belgian American Educational Foundation; Fondation contre le cancer, Belgium; Atlantic Philanthropies, New York; Salus Sanguinis Foundation, Belgium; Action de Recherche Concertee (ARC) of the Universite catholique de Louvain; Interuniversity Attraction Pole, Belgium(Belgian Federal Science Policy Office)	A. D. was funded by Fonds National de la Recherche Scientifique (FNRS) Televie and Belgian American Educational Foundation doctoral fellowships. Research was supported (for S.N.C.) by the Mandat Impulsion of the FNRS, grants from the Fondation contre le cancer, Belgium, by the Atlantic Philanthropies, New York, the Salus Sanguinis Foundation, Belgium, the Action de Recherche Concertee (ARC) MEXP31 of the Universite catholique de Louvain, and the Interuniversity Attraction Pole - Program BCHM61B5, Belgium. S.N.C. is a Research Associate of the FNRS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dusa A, 2008, J BIOL CHEM, V283, P12941, DOI 10.1074/jbc.M709302200; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Girault JA, 1998, MOL MED, V4, P751, DOI 10.1007/BF03401769; Gonfloni S, 1999, NAT STRUCT BIOL, V6, P760; HARPUR AG, 1992, ONCOGENE, V7, P1347; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kubatzky KF, 2005, J BIOL CHEM, V280, P14844, DOI 10.1074/jbc.M411251200; Lee TS, 2009, CANCER-AM CANCER SOC, V115, P1692, DOI 10.1002/cncr.24183; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Mesal RA, 2009, EXPERT OPIN EMERG DR, V14, P471, DOI 10.1517/14728210903066809; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Radtke S, 2002, J BIOL CHEM, V277, P11297, DOI 10.1074/jbc.M100822200; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; WILLIAMS NK, 2009, J MOL BIOL; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126; Ziemiecki Andrew, 1994, Trends in Cell Biology, V4, P207, DOI 10.1016/0962-8924(94)90143-0	46	64	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11157	10.1371/journal.pone.0011157	http://dx.doi.org/10.1371/journal.pone.0011157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585391	Green Published, gold, Green Submitted			2022-12-25	WOS:000278886100020
J	Symmonds, M; Emmanuel, JJ; Drew, ME; Batterham, RL; Dolan, RJ				Symmonds, Mkael; Emmanuel, Julian J.; Drew, Megan E.; Batterham, Rachel L.; Dolan, Raymond J.			Metabolic State Alters Economic Decision Making under Risk in Humans	PLOS ONE			English	Article							GHRELIN LEVELS; APPETITE; CHOICE; IMPULSIVITY; MODULATION; VARIANCE; LOGIC; RAT	Background: Animals' attitudes to risk are profoundly influenced by metabolic state (hunger and baseline energy stores). Specifically, animals often express a preference for risky (more variable) food sources when below a metabolic reference point (hungry), and safe (less variable) food sources when sated. Circulating hormones report the status of energy reserves and acute nutrient intake to widespread targets in the central nervous system that regulate feeding behaviour, including brain regions strongly implicated in risk and reward based decision-making in humans. Despite this, physiological influences per se have not been considered previously to influence economic decisions in humans. We hypothesised that baseline metabolic reserves and alterations in metabolic state would systematically modulate decision-making and financial risk-taking in humans. Methodology/Principal Findings: We used a controlled feeding manipulation and assayed decision-making preferences across different metabolic states following a meal. To elicit risk-preference, we presented a sequence of 200 paired lotteries, subjects' task being to select their preferred option from each pair. We also measured prandial suppression of circulating acyl-ghrelin (a centrally-acting orexigenic hormone signalling acute nutrient intake), and circulating leptin levels (providing an assay of energy reserves). We show both immediate and delayed effects on risky decision-making following a meal, and that these changes correlate with an individual's baseline leptin and changes in acyl-ghrelin levels respectively. Conclusions/Significance: We show that human risk preferences are exquisitely sensitive to current metabolic state, in a direction consistent with ecological models of feeding behaviour but not predicted by normative economic theory. These substantive effects of state changes on economic decisions perhaps reflect shared evolutionarily conserved neurobiological mechanisms. We suggest that this sensitivity in human risk-preference to current metabolic state has significant implications for both real-world economic transactions and for aberrant decision-making in eating disorders and obesity.	[Symmonds, Mkael; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Emmanuel, Julian J.; Drew, Megan E.; Batterham, Rachel L.] UCL, Dept Metab & Expt Therapeut, UCL Div Med, London, England	University of London; University College London; University of London; University College London	Symmonds, M (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	mkael@doctors.org.uk		Batterham, Rachel/0000-0002-5477-8585; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust; Medical Research Council; UCL/UCLH Comprehensive Biomedical Research Centre; MRC [G0601342, G108/551] Funding Source: UKRI; Medical Research Council [G0601342, G108/551] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL/UCLH Comprehensive Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Programme Grant to RJD. JE is in receipt of a Medical Research Council Training Fellowship. RLB receives funding from the UCL/UCLH Comprehensive Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Bacon IE, 2010, BEHAV ECOL, V21, P626, DOI 10.1093/beheco/arq031; BARNARD CJ, 1985, BEHAV ECOL SOCIOBIOL, V16, P161, DOI 10.1007/BF00295150; Batterham RL, 2007, NATURE, V450, P106, DOI 10.1038/nature06212; CARACO T, 1981, BEHAV ECOL SOCIOBIOL, V8, P213, DOI 10.1007/BF00299833; CARACO T, 1990, ANIM BEHAV, V39, P338, DOI 10.1016/S0003-3472(05)80879-6; Chandarana K, 2009, GASTROENTEROLOGY, V136, P2115, DOI 10.1053/j.gastro.2009.02.047; Chaudhri OB, 2008, ANNU REV PHYSIOL, V70, P239, DOI 10.1146/annurev.physiol.70.113006.100506; CROY MI, 1991, ANIM BEHAV, V42, P131, DOI 10.1016/S0003-3472(05)80613-X; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; English PJ, 2002, J CLIN ENDOCR METAB, V87, P2984, DOI 10.1210/jc.87.6.2984; Fessler DMT, 2002, INT J EAT DISORDER, V31, P376, DOI 10.1002/eat.10035; Figlewicz DP, 2007, PHYSIOL BEHAV, V91, P473, DOI 10.1016/j.physbeh.2006.10.008; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Grill HJ, 2002, FRONT NEUROENDOCRIN, V23, P2, DOI 10.1006/frne.2001.0224; HEY JD, 1994, ECONOMETRICA, V62, P1291, DOI 10.2307/2951750; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; HOUSTON AI, 1982, ANIM BEHAV, V30, P615, DOI 10.1016/S0003-3472(82)80075-4; Houston AI, 1999, MODELS ADAPTIVE BEHA; Hurly TA, 2003, ANIM BEHAV, V66, P751, DOI 10.1006/anbe.2003.2278; ISEN AM, 1983, ORGAN BEHAV HUM PERF, V31, P194, DOI 10.1016/0030-5073(83)90120-4; ISEN AM, 1987, ORGAN BEHAV HUM DEC, V39, P145, DOI 10.1016/0749-5978(87)90034-3; Kacelnik A, 1996, AM ZOOL, V36, P402; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Krugel U, 2003, EUR J PHARMACOL, V482, P185, DOI 10.1016/j.ejphar.2003.09.047; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; MCNAMARA JM, 1992, B MATH BIOL, V54, P355; Nasser JA, 2004, APPETITE, V43, P303, DOI 10.1016/j.appet.2004.04.006; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Pietras CJ, 2001, J EXP ANAL BEHAV, V76, P1, DOI 10.1901/jeab.2001.76-1; Pietras CJ, 2008, BEHAV PROCESS, V78, P358, DOI 10.1016/j.beproc.2008.01.016; Rasmussen EB, 2010, BEHAV PROCESS, V83, P23, DOI 10.1016/j.beproc.2009.09.001; REAL L, 1982, ECOLOGY, V63, P1617, DOI 10.2307/1940101; ROTHSCHILD M, 1971, J ECON THEORY, V3, P66, DOI 10.1016/0022-0531(71)90034-2; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; STEPHENS DW, 1981, ANIM BEHAV, V29, P628, DOI 10.1016/S0003-3472(81)80128-5; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; WUNDERLE JM, 1987, BEHAV ECOL SOCIOBIOL, V21, P249, DOI 10.1007/BF00292506; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	44	56	58	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11090	10.1371/journal.pone.0011090	http://dx.doi.org/10.1371/journal.pone.0011090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	612GZ	20585383	Green Published, gold			2022-12-25	WOS:000278886100007
J	Lin, XH; Novotny, M; Soderhall, K; Soderhall, I				Lin, Xionghui; Novotny, Marian; Soderhall, Kenneth; Soderhall, Irene			Ancient Cytokines, the Role of Astakines as Hematopoietic Growth Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACIFASTACUS-LENIUSCULUS; DROSOPHILA; PROTEINS; CELL; IDENTIFICATION; PROLIFERATION; CRUSTACEAN; HOMOLOGY; FAMILY	Hematopoiesis is the process by which hemocytes mature and subsequently enter the circulation. Vertebrate prokineticins (PKs) are known to take part in this process, as are the invertebrate prokineticin domain proteins, astakines. In Pacifastacus leniusculus, astakine 1 is essential for the release of new hemocytes into the open circulatory system of these animals. In addition to astakine 1, we have now cloned a homologue of astakine 1 with an insert of 13 amino acids, named as astakine 2. Both crustacean astakines lack the N-terminal AVIT motif, which is present in vertebrate PKs, and hence receptor binding differs from that of vertebrate PKs. We have found astakine-like sequences in 19 different invertebrate species, and the sequences show that some motifs are conserved among invertebrate groups. Previously we showed that astakine 1 is directly involved in hematopoiesis, and now we show that astakine 1 and astakine 2 have different roles in hemocyte lineage differentiation. Astakine 1 can stimulate proliferation of hematopoietic tissue (Hpt) cells (precursor of hemocytes) as well as specifically induce differentiation of Hpt cells along the semigranular cell lineage, whereas astakine 2 plays a role in granular cell differentiation. Moreover, we discuss the impact of the putative structures of different astakines in comparison with the vertebrate prokineticins.	[Lin, Xionghui; Soderhall, Kenneth; Soderhall, Irene] Uppsala Univ, Dept Comparat Physiol, S-75236 Uppsala, Sweden; [Novotny, Marian] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague 12843, Czech Republic	Uppsala University; Charles University Prague	Soderhall, I (corresponding author), Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	Irene.Soderhall@ebc.uu.se	Novotny, Marian/B-7036-2008; Soderhall, Irene/AAS-5433-2020	Novotny, Marian/0000-0001-8788-3202; Lin, Xionghui/0000-0001-7488-1435	Swedish Science Research Council; Swedish Research Council Formas	Swedish Science Research Council; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Swedish Science Research Council and the Swedish Research Council Formas.	Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Boisbouvier J, 1998, J MOL BIOL, V283, P205, DOI 10.1006/jmbi.1998.2057; Chaga Oleg, 1995, Animal Biology, V4, P59; Chen JC, 2005, MOL PHARMACOL, V67, P2070, DOI 10.1124/mol.105.011619; Chen LJ, 2008, J BIOL CHEM, V283, P23364, DOI 10.1074/jbc.M802375200; Crozatier M, 2007, CELL MICROBIOL, V9, P1117, DOI 10.1111/j.1462-5822.2007.00930.x; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dorsch M, 2005, J LEUKOCYTE BIOL, V78, P426, DOI 10.1189/jlb.0205061; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Hsiao CY, 2010, FISH SHELLFISH IMMUN, V28, P77, DOI 10.1016/j.fsi.2009.10.016; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kaser A, 2003, EMBO REP, V4, P469, DOI 10.1038/sj.embor.embor830; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; Lin XH, 2009, EXP CELL RES, V315, P1171, DOI 10.1016/j.yexcr.2009.01.001; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Negri L, 2007, LIFE SCI, V81, P1103, DOI 10.1016/j.lfs.2007.08.011; Radtke F, 2005, BIOESSAYS, V27, P1117, DOI 10.1002/bies.20315; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Wen SP, 2005, PEPTIDES, V26, P2412, DOI 10.1016/j.peptides.2005.05.012; Wu CL, 2008, PROTEOMICS, V8, P4226, DOI 10.1002/pmic.200800177	27	52	55	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28577	28586		10.1074/jbc.M110.138560	http://dx.doi.org/10.1074/jbc.M110.138560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20592028	Green Published, hybrid			2022-12-25	WOS:000281594000021
J	Marbois, B; Xie, LX; Choi, S; Hirano, K; Hyman, K; Clarke, CF				Marbois, Beth; Xie, Letian X.; Choi, Samuel; Hirano, Kathleen; Hyman, Kyle; Clarke, Catherine F.			para-Aminobenzoic Acid Is a Precursor in Coenzyme Q(6) Biosynthesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; UBIQUINONE BIOSYNTHESIS; P-AMINOBENZOATE; GENE DISRUPTION; GLUCOSE ESTER; YEAST; MUTANTS; ENZYME; 4-HYDROXYBENZOATE; MICROORGANISMS	Coenzyme Q (ubiquinone or Q) is a crucial mitochondrial lipid required for respiratory electron transport in eukaryotes. 4-Hydroxybenozoate (4HB) is an aromatic ring precursor that forms the benzoquinone ring of Q and is used extensively to examine Q biosynthesis. However, the direct precursor compounds and enzymatic steps for synthesis of 4HB in yeast are unknown. Here we show that para-aminobenzoic acid (pABA), a well known precursor of folate, also functions as a precursor for Q biosynthesis. A hexaprenylated form of pABA (prenyl-pABA) is normally present in wild-type yeast crude lipid extracts but is absent in yeast abz1 mutants starved for pABA. A stable C-13(6)-isotope of pABA (p-amino[aromatic-C-13(6)]benzoic acid ([C-13(6)]pABA)), is prenylated in either wild-type or abz1 mutant yeast to form prenyl-[C-13(6)]pABA. We demonstrate by HPLC and mass spectrometry that yeast incubated with either [C-13(6)]pABA or [C-13(6)]4HB generate both C-13(6)-demethoxy-Q (DMQ), a late stage Q biosynthetic intermediate, as well as the final product C-13(6)-coenzyme Q. Pulse-labeling analyses show that formation of prenyl-pABA occurs within minutes and precedes the synthesis of Q. Yeast utilizing pABA as a ring precursor produce another nitrogen containing intermediate, 4-imino-DMQ(6). This intermediate is produced in small quantities in wildtype yeast cultured in standard media and in abz1 mutants supplemented with pABA. We suggest a mechanism where Schiff base-mediated deimination forms DMQ(6) quinone, thereby eliminating the nitrogen contributed by pABA. This scheme results in the convergence of the 4HB and pABA pathways in eukaryotic Q biosynthesis and has implications regarding the action of pABA-based antifolates.	[Marbois, Beth; Xie, Letian X.; Choi, Samuel; Hirano, Kathleen; Hyman, Kyle; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Marbois, Beth; Clarke, Catherine F.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu			National Institutes of Health [GM4592, 4000QT]; National Science Foundation [0919609]; National Center For Research Resources [S10RR024605]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024605] Funding Source: NIH RePORTER; Direct For Biological Sciences [0919609] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant GM4592 (to C. F. C.). This work was also supported by National Science Foundation Grant 0919609 (to C. F. C. and B. M.). UCLA mass spectrometry resources were funded by a NIH grant 4000QT for mass spectrometry resources and Grant S10RR024605 from the National Center For Research Resources.	ALAM SS, 1975, ARCH BIOCHEM BIOPHYS, V171, P183, DOI 10.1016/0003-9861(75)90022-3; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Botet J, 2007, EUKARYOT CELL, V6, P2102, DOI 10.1128/EC.00266-07; Brachmann CB, 1998, YEAST, V14, P115; Brajcich BC, 2010, J BACTERIOL, V192, P436, DOI 10.1128/JB.01040-09; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Castelli LA, 2001, FEMS MICROBIOL LETT, V199, P181, DOI 10.1111/j.1574-6968.2001.tb10671.x; COHEN FS, 1977, J MEMBRANE BIOL, V37, P361, DOI 10.1007/BF01940940; COX GB, 1968, J BACTERIOL, V95, P1591, DOI 10.1128/JB.95.5.1591-1598.1968; DAVIS BD, 1951, J EXP MED, V94, P243, DOI 10.1084/jem.94.3.243; DAWSON RM, 1986, DATA BIOCH RES, P42; Dosselaere F, 2001, CRIT REV MICROBIOL, V27, P75, DOI 10.1080/20014091096710; EDMAN JC, 1993, YEAST, V9, P669, DOI 10.1002/yea.320090613; Eudes A, 2008, J BIOL CHEM, V283, P15451, DOI 10.1074/jbc.M709591200; Forsman U, 2010, NAT CHEM BIOL, V6, P515, DOI [10.1038/NCHEMBIO.372, 10.1038/nchembio.372]; GOEWERT RR, 1981, THESIS U ST LOUIS ST; Guldener U, 2004, MOL BIOL CELL, V15, P3811, DOI 10.1091/mbc.E03-09-0680; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HAMILTON JA, 1971, BIOCHEM J, V123, P435, DOI 10.1042/bj1230435; Hampele IC, 1997, J MOL BIOL, V268, P21, DOI 10.1006/jmbi.1997.0944; Iliades P, 2003, MICROB DRUG RESIST, V9, P249, DOI 10.1089/107662903322286454; Kawamukai M, 2009, BIOTECHNOL APPL BIOC, V53, P217, DOI 10.1042/BA20090035; Lenaz G., 1985, COENZYME Q, P165; LESTER RL, 1959, J BIOL CHEM, V234, P2169; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Olson R E, 1966, Vitam Horm, V24, P551; OLSON RE, 1983, VITAM HORM, V40, P1, DOI 10.1016/S0083-6729(08)60431-8; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; PARSON WW, 1964, P NATL ACAD SCI USA, V51, P444, DOI 10.1073/pnas.51.3.444; PENNOCK JF, 1983, BIOSYNTHESIS ISOPREN, P191; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; POON WW, 1995, ARCH BIOCHEM BIOPHYS, V320, P305, DOI 10.1016/0003-9861(95)90014-4; POON WW, 1997, MOL ASPECTS MED, V18, P121; Quinlivan EP, 2003, J BIOL CHEM, V278, P20731, DOI 10.1074/jbc.M302894200; REED LJ, 1959, J BIOL CHEM, V234, P904; SIEBERT M, 1994, MICROBIOL-SGM, V140, P897, DOI 10.1099/00221287-140-4-897; Sircar D, 2009, J PLANT PHYSIOL, V166, P1370, DOI 10.1016/j.jplph.2009.02.006; Stenmark P, 2001, J BIOL CHEM, V276, P33297, DOI 10.1074/jbc.C100346200; THRELFALL DR, 1970, BIOCHEM J, V118, pP55; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; TRUMPOWER BL, 1972, J BIOL CHEM, V247, P2499; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Young DM, 2005, ANNU REV MICROBIOL, V59, P519, DOI 10.1146/annurev.micro.59.051905.105823; YOUNG IG, 1973, J BACTERIOL, V114, P42, DOI 10.1128/JB.114.1.42-52.1973; [No title captured]	52	77	77	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27827	27838		10.1074/jbc.M110.151894	http://dx.doi.org/10.1074/jbc.M110.151894			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592037	hybrid, Green Published			2022-12-25	WOS:000281404100038
J	Qin, JZ; Van Buren, D; Huang, HS; Zhong, L; Mostoslavsky, R; Akbarian, S; Hock, H				Qin, Jinzhong; Van Buren, Denille; Huang, Hsien-Sung; Zhong, Lei; Mostoslavsky, Raul; Akbarian, Schahram; Hock, Hanno			Chromatin Protein L3MBTL1 Is Dispensable for Development and Tumor Suppression in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; POLYCOMB GROUP PROTEIN; HISTONE LYSINE METHYLATION; SEX-COMB; ZINC-FINGER; BINDING MODULES; HUMAN HOMOLOG; MBT REPEATS; MIDLEG SCM; GENE	L3MBTL1, a paralogue of Drosophila tumor suppressor lethal(3)malignant brain tumor (l(3)mbt), binds histones in a methylation state-dependent manner and contributes to higher order chromatin structure and transcriptional repression. It is the founding member of a family of MBT domain-containing proteins that has three members in Drosophila and nine in mice and humans. Knockdown experiments in cell lines suggested that L3MBTL1 has non-redundant roles in the suppression of oncogene expression. We generated a mutant mouse strain that lacks exons 13-20 of L3mbtl1. Markedly reduced levels of a mutant mRNA with an out-of-frame fusion of exons 12 and 21 were expressed, but a mutant protein was undetectable by Western blot analysis. L3MBTL1(-/-) mice developed and reproduced normally. The highest expression of L3MBTL1 was detected in the brain, but its disruption did not affect brain development, spontaneous movement, and motor coordination. Despite previous implications of L3mbtl1 in the biology of hematopoietic transcriptional regulators, lack of L3MBTL1 did not result in deficiencies in lymphopoiesis or hematopoiesis. In contrast with its demonstrated biochemical activities, embryonic stem (ES) cells lacking L3MBTL1 displayed no abnormalities in H4 lysine 20 (H4K20) mono-, di-, or trimethylation; had normal global chromatin density as assessed by micrococcal nuclease digests; and expressed normal levels of c-myc. Embryonic fibroblasts lacking L3MBTL1 displayed unaltered cell cycle arrest and down-regulation of cyclin E expression after irradiation. In cohorts of mice followed for more than 2 years, lack of L3MBTL1 did not alter normal lifespan or survival with or without sublethal irradiation.	[Qin, Jinzhong; Van Buren, Denille; Zhong, Lei; Mostoslavsky, Raul; Hock, Hanno] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Qin, Jinzhong; Van Buren, Denille; Hock, Hanno] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Qin, Jinzhong; Zhong, Lei; Mostoslavsky, Raul; Hock, Hanno] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hock, Hanno] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Huang, Hsien-Sung; Akbarian, Schahram] Univ Massachusetts, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; University of Massachusetts System; University of Massachusetts Worcester	Hock, H (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St,CPZN-4212, Boston, MA 02114 USA.	Hock.Hanno@mgh.harvard.edu		Huang, Hsien-Sung/0000-0003-2657-3635	NICHD, National Institutes of Health [HD 048489]; V Foundation; Kimmel Foundation; Ellison Foundation; Harvard Stem Cell Institute; Medical Discovery Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); V Foundation; Kimmel Foundation; Ellison Foundation(Lawrence Ellison Foundation); Harvard Stem Cell Institute; Medical Discovery Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HD 048489 from the NICHD (to S. A.). This work was also supported by a V Foundation Scholar Award and a Kimmel Foundation Scholar Award (to R. M.), a contribution from the Ellison Foundation to Massachusetts General Hospital (MGH) startup funds (to H. H.), and the Harvard Stem Cell Institute (to H. H.).; The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S4.; Recipient of an MGH Executive Committee on Research Fund for Medical Discovery Award.	Arai S, 2005, EMBO J, V24, P1863, DOI 10.1038/sj.emboj.7600654; Berger J, 1999, GENE, V237, P185, DOI 10.1016/S0378-1119(99)00285-1; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Bornemann D, 1996, DEVELOPMENT, V122, P1621; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Frankenberg S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-8; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Koga H, 1999, ONCOGENE, V18, P3799, DOI 10.1038/sj.onc.1202732; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li J, 2004, P NATL ACAD SCI USA, V101, P7341, DOI 10.1073/pnas.0308195101; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; MacGrogan D, 2004, GENE CHROMOSOME CANC, V41, P203, DOI 10.1002/gcc.20087; Mao JH, 2008, ONCOGENE, V27, P6596, DOI 10.1038/onc.2008.280; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Montini E, 1999, GENOMICS, V58, P65, DOI 10.1006/geno.1999.5755; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Peterson AJ, 2004, GENETICS, V167, P1225, DOI 10.1534/genetics.104.027474; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sathyamurthy A, 2003, J BIOL CHEM, V278, P46968, DOI 10.1074/jbc.M306469200; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; SIMON J, 1992, DEVELOPMENT, V114, P493; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Takada Y, 2007, DEVELOPMENT, V134, P579, DOI 10.1242/dev.02747; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Usui H, 2000, GENE, V248, P127, DOI 10.1016/S0378-1119(00)00131-1; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; Wismar J, 2001, FEBS LETT, V507, P119, DOI 10.1016/S0014-5793(01)02959-3	48	22	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27767	27775		10.1074/jbc.M110.115410	http://dx.doi.org/10.1074/jbc.M110.115410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592034	Green Published, hybrid			2022-12-25	WOS:000281404100032
J	Broecker, MJ; Schomburg, S; Heinz, DW; Jahn, D; Schubert, WD; Moser, J				Broecker, Markus J.; Schomburg, Sebastian; Heinz, Dirk W.; Jahn, Dieter; Schubert, Wolf-Dieter; Moser, Juergen			Crystal Structure of the Nitrogenase-like Dark Operative Protochlorophyllide Oxidoreductase Catalytic Complex (ChlN/ChlB)(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL SAM; ESCHERICHIA-COLI; PROTEIN; CLUSTER; BIOSYNTHESIS; CHLOROPHYLL; FERREDOXIN; REDUCTASE; MODEL; SITE	During (bacterio) chlorophyll biosynthesis of many photosynthetically active organisms, dark operative protochlorophyllide oxidoreductase (DPOR) catalyzes the two-electron reduction of ring D of protochlorophyllide to form chlorophyllide. DPOR is composed of the subunits ChlL, ChlN, and ChlB. Homodimeric ChlL(2) bearing an intersubunit [4Fe-4S] cluster is an ATP-dependent reductase transferring single electrons to the heterotetrameric (ChlN/ChlB)(2) complex. The latter contains two intersubunit [4Fe-4S] clusters and two protochlorophyllide binding sites, respectively. Here we present the crystal structure of the catalytic (ChlN/ChlB)(2) complex of DPOR from the cyanobacterium Thermosynechococcus elongatus at a resolution of 2.4 angstrom. Subunits ChlN and ChlB exhibit a related architecture of three subdomains each built around a central, parallel beta-sheet surrounded by alpha-helices. The (ChlN/ChlB)(2) crystal structure reveals a [4Fe-4S] cluster coordinated by an aspartate oxygen alongside three cysteine ligands. Two equivalent substrate binding sites enriched in aromatic residues for protochlorophyllide substrate binding are located at the interface of each ChlN/ChlB half-tetramer. The complete octameric (ChlN/ChlB)(2)(ChlL2)(2) complex of DPOR was modeled based on the crystal structure and earlier functional studies. The electron transfer pathway via the various redox centers of DPOR to the substrate is proposed.	[Schubert, Wolf-Dieter] Univ Western Cape, Chair Struct Biol, Dept Biotechnol, ZA-7535 Bellville, Cape Town, South Africa; [Broecker, Markus J.; Schomburg, Sebastian; Jahn, Dieter; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, D-38106 Braunschweig, Germany; [Heinz, Dirk W.; Schubert, Wolf-Dieter] Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany	University of the Western Cape; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Schubert, WD (corresponding author), Univ Western Cape, Chair Struct Biol, Dept Biotechnol, Private Bag X17, ZA-7535 Bellville, Cape Town, South Africa.	wschubert@uwc.ac.za	Schubert, Wolf-Dieter/A-5617-2009	Schubert, Wolf-Dieter/0000-0003-4998-519X	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft.	APEL K, 2001, REGULATION PHOTOSYNT; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Belyaeva OB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P173, DOI 10.1023/A:1002891531118; Bertero MG, 2005, J BIOL CHEM, V280, P14836, DOI 10.1074/jbc.M410457200; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Brocker MJ, 2008, J BIOL CHEM, V283, P29873, DOI 10.1074/jbc.M805206200; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; Brocker MJ, 2010, J BIOL CHEM, V285, P8268, DOI 10.1074/jbc.M109.087874; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Busch JLH, 1997, BIOCHEM J, V323, P95, DOI 10.1042/bj3230095; CALZOLAI L, 1995, BIOCHEMISTRY-US, V34, P11373, DOI 10.1021/bi00036a010; Chiu HJ, 2001, BIOCHEMISTRY-US, V40, P641, DOI 10.1021/bi001645e; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dobbek H, 2004, J AM CHEM SOC, V126, P5382, DOI 10.1021/ja037776v; Dobritzsch D, 2001, EMBO J, V20, P650, DOI 10.1093/emboj/20.4.650; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P411, DOI 10.1093/oxfordjournals.pcp.a028962; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2009, P NATL ACAD SCI USA, V106, P16962, DOI 10.1073/pnas.0907872106; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; Layer G, 2005, BIOL CHEM, V386, P971, DOI 10.1515/BC.2005.113; Mannan RM, 1996, EMBO J, V15, P1826, DOI 10.1002/j.1460-2075.1996.tb00532.x; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Minor W, 2002, ACTA PHYS POL A, V101, P613, DOI 10.12693/APhysPolA.101.613; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; MOURA JJG, 1982, J BIOL CHEM, V257, P6259; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Rousset C, 2008, FEBS LETT, V582, P2937, DOI 10.1016/j.febslet.2008.07.032; RUDIGER W, 2003, PORPHYRIN HDB, V13, P71; Sarma R, 2008, BIOCHEMISTRY-US, V47, P13004, DOI 10.1021/bi801058r; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schoefs B, 2001, PHOTOSYNTH RES, V70, P257, DOI 10.1023/A:1014769707404; Sham S, 2002, BIOCHEMISTRY-US, V41, P12498, DOI 10.1021/bi020347+; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Staples CR, 2007, J BACTERIOL, V189, P7392, DOI 10.1128/JB.00876-07; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Watzlich D, 2009, J BIOL CHEM, V284, P15530, DOI 10.1074/jbc.M901331200; ZHAO JD, 1992, BIOCHEMISTRY-US, V31, P5093, DOI 10.1021/bi00137a001	55	35	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27336	27345		10.1074/jbc.M110.126698	http://dx.doi.org/10.1074/jbc.M110.126698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558746	hybrid, Green Published			2022-12-25	WOS:000281172700063
J	Dmitriev, SE; Terenin, IM; Andreev, DE; Ivanov, PA; Dunaevsky, JE; Merrick, WC; Shatsky, IN				Dmitriev, Sergey E.; Terenin, Ilya M.; Andreev, Dmitri E.; Ivanov, Pavel A.; Dunaevsky, Jacov E.; Merrick, William C.; Shatsky, Ivan N.			GTP-independent tRNA Delivery to the Ribosomal P-site by a Novel Eukaryotic Translation Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR EIF1; MESSENGER-RNA; START CODON; MEMBRANE PROTEINS; GENE-EXPRESSION; IDENTIFICATION; BINDING; CELL; RECOGNITION; COMPLEXES	During translation, aminoacyl-tRNAs are delivered to the ribosome by specialized GTPases called translation factors. Here, we report the tRNA binding to the P-site of 40 S ribosomes by a novel GTP-independent factor eIF2D isolated from mammalian cells. The binding of tRNA(i)(Met) occurs after the AUG codon finds its position in the P-site of 40 S ribosomes, the situation that takes place during initiation complex formation on the hepatitis C virus internal ribosome entry site or on some other specific RNAs (leaderless mRNA and A-rich mRNAs with relaxed scanning dependence). Its activity in tRNA binding with 40 S subunits does not require the presence of the aminoacyl moiety. Moreover, the factor possesses the unique ability to deliver non-Met (elongator) tRNAs into the P-site of the 40 S subunit. The corresponding gene is found in all eukaryotes and includes an SUI1 domain present also in translation initiation factor eIF1. The versatility of translation initiation strategies in eukaryotes is discussed.	[Shatsky, Ivan N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119992, Russia; [Ivanov, Pavel A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119992, Russia; [Merrick, William C.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Lomonosov Moscow State University; Lomonosov Moscow State University; Case Western Reserve University	Shatsky, IN (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Bldg A, Moscow 119992, Russia.	shatsky@genebee.msu.su	Dunaevsky, Yakov E/H-6105-2012; Andreev, Dmitry/I-6346-2012; Terenin, Ilya/Q-6470-2019; Dmitriev, Sergey/D-9694-2011; Shatsky, Ivan N/A-5331-2012; Terenin, Ilya M/G-5306-2011	Andreev, Dmitry/0000-0001-5320-3045; Terenin, Ilya/0000-0002-4459-0781; Dmitriev, Sergey/0000-0002-1774-8475; 	Russian Foundation for Basic Research [08-04-00399]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Grant 08-04-00399 from the Russian Foundation for Basic Research (to I. N. S.).	ADAMS SL, 1975, J BIOL CHEM, V250, P9083; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Andreev DE, 2006, MOL CELL BIOL, V26, P3164, DOI 10.1128/MCB.26.8.3164-3169.2006; Andreev D, 2008, RNA, V14, P233, DOI 10.1261/rna.693208; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dang C, 2006, ONCOL REP, V16, P513; Dever TE, 2001, COLD SPRING HARB SYM, V66, P417, DOI 10.1101/sqb.2001.66.417; Deyo JE, 1998, DNA CELL BIOL, V17, P437, DOI 10.1089/dna.1998.17.437; Dmitriev SE, 2003, MOL CELL BIOL, V23, P8925, DOI 10.1128/MCB.23.24.8925-8933.2003; Dmitriev SE, 2007, MOL CELL BIOL, V27, P4685, DOI 10.1128/MCB.02138-06; FILIPOWICZ W, 1976, P NATL ACAD SCI USA, V73, P44, DOI 10.1073/pnas.73.1.44; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; JAKOI ER, 1995, BRAIN RES, V693, P124, DOI 10.1016/0006-8993(95)00599-L; JAKOI ER, 1987, J BIOL CHEM, V262, P1300; JAKOI ER, 1989, J CELL SCI, V93, P227; JAKOI ER, 1976, J CELL BIOL, V70, P97, DOI 10.1083/jcb.70.1.97; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolupaeva VG, 2005, RNA, V11, P470, DOI 10.1261/rna.7215305; Komar AA, 2005, J BIOL CHEM, V280, P15601, DOI 10.1074/jbc.M413728200; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lee M, 2007, CANCER IMMUNOL IMMUN, V56, P783, DOI 10.1007/s00262-006-0239-2; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Malygin A A, 2009, Mol Biol (Mosk), V43, P1070; MARCHASE RB, 1982, CELL, V28, P813, DOI 10.1016/0092-8674(82)90060-5; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; MERRICK WC, 1975, J BIOL CHEM, V250, P1197; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Perez-Arellano I, 2007, FEBS J, V274, P4972, DOI 10.1111/j.1742-4658.2007.06031.x; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Reinert LS, 2006, CANCER RES, V66, P8994, DOI 10.1158/0008-5472.CAN-06-1999; RON D, 2006, TRANSLATIONAL CONTRO, P345; Severt WL, 1999, J CELL SCI, V112, P3691; Shanina N. A., 2001, Molekulyarnaya Biologiya (Moscow), V35, P638; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Terenin IM, 2005, MOL CELL BIOL, V25, P7879, DOI 10.1128/MCB.25.17.7879-7888.2005; TZAREVA NV, 1994, FEBS LETT, V337, P189, DOI 10.1016/0014-5793(94)80271-8; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Wong QWL, 2008, MAR BIOTECHNOL, V10, P91, DOI 10.1007/s10126-007-9042-0; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Zoll WL, 2002, J BIOL CHEM, V277, P37079, DOI 10.1074/jbc.M207109200	50	109	110	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26779	26787		10.1074/jbc.M110.119693	http://dx.doi.org/10.1074/jbc.M110.119693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566627	Green Published, hybrid			2022-12-25	WOS:000281172700008
J	Siponen, MI; Wisniewska, M; Lehtio, L; Johansson, I; Svensson, L; Raszewski, G; Nilsson, L; Sigvardsson, M; Berglund, H				Siponen, Marina I.; Wisniewska, Magdalena; Lehtio, Lari; Johansson, Ida; Svensson, Linda; Raszewski, Grzegorz; Nilsson, Lennart; Sigvardsson, Mikael; Berglund, Helena			Structural Determination of Functional Domains in Early B-cell Factor (EBF) Family of Transcription Factors Reveals Similarities to Rel DNA-binding Proteins and a Novel Dimerization Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITION; ACTIVATION; SELECTION; CLONING	The early B-cell factor (EBF) transcription factors are central regulators of development in several organs and tissues. This protein family shows low sequence similarity to other protein families, which is why structural information for the functional domains of these proteins is crucial to understand their biochemical features. We have used a modular approach to determine the crystal structures of the structured domains in the EBF family. The DNA binding domain reveals a striking resemblance to the DNA binding domains of the Rel homology superfamily of transcription factors but contains a unique zinc binding structure, termed zinc knuckle. Further the EBF proteins contain an IPT/TIG domain and an atypical helix-loop-helix domain with a novel type of dimerization motif. The data presented here provide insights into unique structural features of the EBF proteins and open possibilities for detailed molecular investigations of this important transcription factor family.	[Siponen, Marina I.; Wisniewska, Magdalena; Johansson, Ida; Svensson, Linda] Karolinska Inst, Struct Genom Consortium, SE-17177 Stockholm, Sweden; [Siponen, Marina I.; Wisniewska, Magdalena; Johansson, Ida; Svensson, Linda] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Lehtio, Lari] Abo Akad Univ, Dept Biosci, FI-20520 Turku, Finland; [Raszewski, Grzegorz; Nilsson, Lennart] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden; [Sigvardsson, Mikael] Linkoping Univ, Fac Hlth Sci, Expt Hematopoiesis Unit, Dept Clin & Expt Med, SE-58183 Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Abo Akademi University; Karolinska Institutet; Linkoping University		Helena.Berglund@ki.se	Raszewski, Grzegorz/AAF-3418-2019; Nilsson, Lennart/B-7208-2009	Nilsson, Lennart/0000-0002-5067-6397; Sigvardsson, Mikael/0000-0001-8527-7276; Lehtio, Lari/0000-0001-7250-832X	Academy of Finland [128322]; Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Academy of Finland(Academy of Finland); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Academy of Finland (Grant 128322 to L. L.).; We gratefully acknowledge the beamline personnel at the BESSY (Berlin, Germany) and Diamond (Oxford, United Kingdom) synchrotron radiation facilities. We thank Par Nordlund and Johan Weigelt for useful discussions. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerblad P, 2002, MOL CELL BIOL, V22, P8015, DOI 10.1128/MCB.22.22.8015-8025.2002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Daburon V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-131; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fields S, 2008, MOL IMMUNOL, V45, P3786, DOI 10.1016/j.molimm.2008.05.018; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mott HR, 2003, J BIOL CHEM, V278, P17053, DOI 10.1074/jbc.M300155200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Patel K, 2007, BBA-PROTEINS PROTEOM, V1774, P1247, DOI 10.1016/j.bbapap.2007.07.010; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Smith EMK, 2005, BLOOD, V106, P1995, DOI 10.1182/blood-2004-12-4744; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; TRAVIS A, 1993, MOL CELL BIOL, V13, P3392, DOI 10.1128/MCB.13.6.3392; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 1997, J NEUROSCI, V17, P4149; Zhao F, 2003, MOL CELL BIOL, V23, P3837, DOI 10.1128/MCB.23.11.3837-3846.2003	36	16	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					25875	25879		10.1074/jbc.C110.150482	http://dx.doi.org/10.1074/jbc.C110.150482			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20592035	Green Published, hybrid			2022-12-25	WOS:000280921000001
J	Wei, J; Liu, WH; Yan, Z				Wei, Jing; Liu, Wenhua; Yan, Zhen			Regulation of AMPA Receptor Trafficking and Function by Glycogen Synthase Kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; RAB PROTEINS; SMALL GTPASE; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; GSK3; PHOSPHORYLATION; INTERNALIZATION; EXPRESSION; GSK-3-BETA	Accumulating evidence suggests that glycogen synthase kinase 3 (GSK-3) is a multifunctional kinase implicated in neuronal development, moodstabilization, and neurodegeneration. However, the synaptic actions of GSK-3 are largely unknown. In this study, we examined the impact of GSK-3 on AMPA receptor (AMPAR) channels, the major mediator of excitatory transmission, in cortical neurons. Application of GSK-3 inhibitors or knockdown of GSK-3 caused a significant reduction of the amplitude of miniature excitatory postsynaptic current (mEPSC), a readout of the unitary strength of synaptic AMPARs. Treatment with GSK-3 inhibitors also decreased surface and synaptic GluR1 clusters on dendrites and increased internalized GluR1 in cortical cultures. Rab5, the small GTPase controlling the transport from plasma membrane to early endosomes, was activated by GSK-3 inhibitors. Knockdown of Rab5 prevented GSK-3 inhibitors from regulating mEPSC amplitude. Guanyl nucleotide dissociation inhibitor (GDI), which regulates the cycle of Rab5 between membrane and cytosol, formed an increased complex with Rab5 after treatment with GSK-3 inhibitors. Blocking the function of GDI occluded the effect of GSK-3 inhibitors on mEPSC amplitude. In cells transfected with the non-phosphorylatable GDI mutant, GDI(S45A), GSK-3 inhibitors lost the capability to regulate GDI-Rab5 complex, mEPSC amplitude, and AMPAR surface expression. These results suggest that GSK-3, via altering the GDI-Rab5 complex, regulates Rab5-mediated endocytosis of AMPARs. It provides a potential mechanism underlying the role of GSK-3 in synaptic transmission and plasticity.	[Wei, Jing] Southeast Univ, Minist Educ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China; [Wei, Jing; Liu, Wenhua; Yan, Zhen] SUNY Buffalo, Sch Med & Biomed Sci, Dept Physiol & Biophys, Buffalo, NY 14214 USA	Southeast University - China; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wei, J (corresponding author), Southeast Univ, Minist Educ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210009, Jiangsu, Peoples R China.	jwei83@yahoo.com.cn; zhenyan@buffalo.edu			National Institutes of Health [NS69929, MH84233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS069929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS69929 and MH84233 (to Z. Y.).	Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Shisheva A, 1999, BIOCHEMISTRY-US, V38, P11711, DOI 10.1021/bi990200r; SHISHEVA A, 1994, MOL CELL BIOL, V14, P3459, DOI 10.1128/MCB.14.5.3459; STEELEMORTIMER O, 1993, FEBS LETT, V329, P313, DOI 10.1016/0014-5793(93)80244-O; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Welsh GI, 1996, TRENDS CELL BIOL, V6, P274, DOI 10.1016/0962-8924(96)10023-4; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhong P, 2008, J PHYSIOL-LONDON, V586, P4465, DOI 10.1113/jphysiol.2008.155143; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	41	73	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26369	26376		10.1074/jbc.M110.121376	http://dx.doi.org/10.1074/jbc.M110.121376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20584904	hybrid, Green Published			2022-12-25	WOS:000280921000055
J	Brauner, R; Bashamboo, A; Rouget, S; Goulet, M; Philibert, P; Sarda-Thibault, H; Trivin, C; Misrahi, M; Sultan, C; McElreavey, K				Brauner, Raja; Bashamboo, Anu; Rouget, Sebastien; Goulet, Marie; Philibert, Pascal; Sarda-Thibault, Helene; Trivin, Christine; Misrahi, Micheline; Sultan, Charles; McElreavey, Ken			Clinical, Biological and Genetic Analysis of Prepubertal Isolated Ovarian Cyst in 11 Girls	PLOS ONE			English	Article							MCCUNE-ALBRIGHT-SYNDROME; LUTEINIZING-HORMONE-RECEPTOR; CENTRAL PRECOCIOUS PUBERTY; ANTI-MULLERIAN HORMONE; GRANULOSA-CELL TUMOR; PREMATURE THELARCHE; FOLLICULAR CYSTS; SEXUAL PRECOCITY; FOLLOW-UP; MUTATIONS	Background: The cause of isolated gonadotropin-independent precocious puberty (PP) with an ovarian cyst is unknown in the majority of cases. Here, we describe 11 new cases of peripheral PP and, based on phenotypes observed in mouse models, we tested the hypothesis that mutations in the GNAS1, NR5A1, LHCGR, FSHR, NR5A1, StAR, DMRT4 and NOBOX may be associated with this phenotype. Methodology/Principal Findings: 11 girls with gonadotropin-independent PP were included in this study. Three girls were seen for a history of prenatal ovarian cyst, 6 girls for breast development, and 2 girls for vaginal bleeding. With one exception, all girls were seen before 8 years of age. In 8 cases, an ovarian cyst was detected, and in one case, suspected. One other case has polycystic ovaries, and the remaining case was referred for vaginal bleeding. Four patients had a familial history of ovarian anomalies and/or infertility. Mutations in the coding sequences of the candidate genes GNAS1, NR5A1, LHCGR, FSHR, NR5A1, StAR, DMRT4 and NOBOX were not observed. Conclusions/Significance: Ovarian PP shows markedly different clinical features from central PP. Our data suggest that mutations in the GNAS1, NR5A1, LHCGR, FSHR StAR, DMRT4 and NOBOX genes are not responsible for ovarian PP. Further research, including the identification of familial cases, is needed to understand the etiology of ovarian PP.	[Brauner, Raja; Rouget, Sebastien; Goulet, Marie] Univ Paris 05, Paris, France; [Brauner, Raja; Rouget, Sebastien; Goulet, Marie] Hop Bicetre, AP HP, Unite Endocrinol Pediat, Paris, France; [Bashamboo, Anu; Sultan, Charles; McElreavey, Ken] Inst Pasteur, Paris, France; [Philibert, Pascal] Hop Lapeyronie, Serv Hormonol Dev & Reprod, Montpellier, France; [Sarda-Thibault, Helene] Ctr Hosp Rene Dubos, Serv Pediat, Pontoise, France; [Trivin, Christine] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France; [Misrahi, Micheline] Univ Paris 11, INSERM, U854, Paris, France; [Misrahi, Micheline] Hop Bicetre, AP HP, Genet Mol Lab, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Montpellier; CHU de Montpellier; Centre Hospitalier Rene Dubos, Pontoise; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Brauner, R (corresponding author), Univ Paris 05, Paris, France.	kenmce@pasteur.fr	Philibert, Pascal/C-6728-2008	Philibert, Pascal/0000-0001-6384-521X; Rouget, Sebastien/0000-0001-9684-1485	Agence Nationale de la Recherche; GIS Institut des Maladies Rares; March of Dimes Foundation [1-FY07-490)]	Agence Nationale de la Recherche(French National Research Agency (ANR)); GIS Institut des Maladies Rares; March of Dimes Foundation(March of Dimes)	This work was supported by grants from the Agence Nationale de la Recherche, the GIS Institut des Maladies Rares (to Dr. McElreavey) and by a research grant (1-FY07-490) from the March of Dimes Foundation (to Dr. McElreavey). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciuniene J, 2006, MOL CELL BIOL, V26, P8984, DOI 10.1128/MCB.00959-06; Beau I, 1998, J CLIN INVEST, V102, P1352, DOI 10.1172/JCI3795; BREEN J L, 1977, Clinical Obstetrics and Gynecology, V20, P607, DOI 10.1097/00003081-197709000-00010; BRIDGES NA, 1995, CLIN ENDOCRINOL, V42, P135, DOI 10.1111/j.1365-2265.1995.tb01853.x; Cameron FJ, 1997, ACTA PAEDIATR, V86, P1016, DOI 10.1111/j.1651-2227.1997.tb15193.x; Caron KM, 1997, P NATL ACAD SCI USA, V94, P11540, DOI 10.1073/pnas.94.21.11540; de Vries L, 2006, EUR J ENDOCRINOL, V154, P891, DOI 10.1530/eje.1.02151; FRISCH LS, 1992, PEDIATRICS, V90, P102; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Kalfa N, 2006, J CLIN ENDOCR METAB, V91, P1842, DOI 10.1210/jc.2005-2710; KOSLOSKE AM, 1984, AM J DIS CHILD, V138, P147, DOI 10.1001/archpedi.1984.02140400033008; Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805; Long WQ, 2000, J CLIN ENDOCR METAB, V85, P540, DOI 10.1210/jc.85.2.540; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Lumbroso S, 2004, J CLIN ENDOCR METAB, V89, P2107, DOI 10.1210/jc.2003-031225; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Misrahi M, 1997, J CLIN ENDOCR METAB, V82, P2159, DOI 10.1210/jcem.82.7.4039; OERTER KE, 1990, J CLIN ENDOCR METAB, V71, P1251, DOI 10.1210/jcem-71-5-1251; Ottolenghi C, 2002, GENOMICS, V79, P333, DOI 10.1006/geno.2002.6711; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Pienkowski C, 1997, ACTA PAEDIATR, V86, P1019, DOI 10.1111/j.1651-2227.1997.tb15194.x; Prete G, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-27; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Rodriguez-Macias KA, 1999, ARCH DIS CHILD, V81, P53, DOI 10.1136/adc.81.1.53; Roman R, 2004, J PEDIATR-US, V145, P218, DOI 10.1016/j.jpeds.2004.05.025; Sempe M., 1979, AUXOLOGIE METHODE SE; Sir-Petermann T, 2006, J CLIN ENDOCR METAB, V91, P3105, DOI 10.1210/jc.2005-2693; Smits G, 2003, NEW ENGL J MED, V349, P760, DOI 10.1056/NEJMoa030064; STANHOPE R, 1985, ARCH DIS CHILD, V60, P116, DOI 10.1136/adc.60.2.116; Trivin C, 2006, CLIN ENDOCRINOL, V65, P239, DOI 10.1111/j.1365-2265.2006.02582.x; ZIPF WB, 1997, J PEDIAT, V95, P38	32	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11282	10.1371/journal.pone.0011282	http://dx.doi.org/10.1371/journal.pone.0011282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593028	gold, Green Published, Green Submitted			2022-12-25	WOS:000279140800004
J	Cohen, TS; Lawrence, GG; Margulies, SS				Cohen, Taylor S.; Lawrence, Gladys Gray; Margulies, Susan S.			Cultured Alveolar Epithelial Cells From Septic Rats Mimic In Vivo Septic Lung	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; TNF-ALPHA; TIGHT JUNCTIONS; CECAL LIGATION; ANIMAL-MODELS; SYNDROME ARDS; KAPPA-B; INJURY; SEPSIS; EXPRESSION	Sepsis results in the formation of pulmonary edema by increasing in epithelial permeability. Therefore we hypothesized that alveolar epithelial cells isolated from septic animals develop tight junctions with different protein composition and reduced barrier function relative to alveolar epithelial cells from healthy animals. Male rats (200-300g) were sacrificed 24 hours after cecal ligation and double puncture (2CLP) or sham surgery. Alveolar epithelial cells were isolated and plated on fibronectin-coated flexible membranes or permeable, non-flexible transwell substrates. After a 5 day culture period, cells were either lysed for western analysis of tight junction protein expressin (claudin 3, 4, 5, 7, 8, and 18, occludin, ZO-1, and JAM-A) and MAPk (JNK, ERK, an p38) signaling activation, or barrier function was examined by measuring transepithelial resistance (TER) or the flux of two molecular tracers (5 and 20 angstrom). Inhibitors of JNK (SP600125, 20 mu M) and ERK (U0126, 10 mu M) were used to determine the role of these pathways in sepsis induced epithelial barrier dysfunction. Expression of claudin 4, claudin 18, and occludin was significantly lower, and activation of JNK and ERK signaling pathways was significantly increased in 2CLP monolayers, relative to sham monolayers. Transepithelial resistance of the 2CLP monolayers was reduced significantly compared to sham (769 and 1234 ohm-cm(2), respectively), however no significant difference in the flux of either tracer was observed. Inhibition of ERK, not JNK, significantly increased TER and expression of claudin 4 in 2CLP monolayers, and prevented significant differences in claudin 18 expression between 2CLP and sham monolayers. We conclude that alveolar epithelial cells isolated from septic animals form confluent monolayers with impaired barrier function compared to healthy monolayers, and inhibition of ERK signaling partially reverses differences between these monolayers. This model provides a unique preparation for probing the mechanisms by which sepsis alters alveolar epithelium.	[Cohen, Taylor S.; Lawrence, Gladys Gray; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania	Cohen, TS (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	margulies@seas.upenn.edu	Cohen, Taylor/C-9927-2016	Cohen, Taylor/0000-0001-9368-0903	 [NIH RO1-HL57204]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057204] Funding Source: NIH RePORTER	; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by NIH RO1-HL57204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHULE MD, 1986, CHEST, V90, P895, DOI 10.1378/chest.90.6.895; Arndt PG, 2005, AM J RESP CRIT CARE, V171, P978, DOI 10.1164/rccm.200406-712OC; Arroliga AC, 2002, CHEST, V121, P1972, DOI 10.1378/chest.121.6.1972; Asaduzzaman M, 2008, CRIT CARE MED, V36, P482, DOI 10.1097/01.CCM.0B013E31816204FA; BAINES DL, 2009, PFLUGERS ARCH; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; BOROK Z, 1994, IN VITRO CELL DEV-AN, V30A, P99; Cavanaugh KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1179, DOI 10.1152/ajpcell.00355.2004; Cavanaugh KJ, 2002, AM J PHYSIOL-CELL PH, V283, pC1801, DOI 10.1152/ajpcell.00341.2002; Cohen TS, 2008, EUR RESPIR J, V32, P854, DOI 10.1183/09031936.00141007; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; DOBBS LG, 1988, BIOCHIM BIOPHYS ACTA, V970, P146, DOI 10.1016/0167-4889(88)90173-5; Duquesnes N, 2009, INT J BIOCHEM CELL B, V41, P1173, DOI 10.1016/j.biocel.2008.09.032; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Escobar GA, 2006, SURGERY, V140, P268, DOI 10.1016/j.surg.2006.03.008; FANG X, 2009, FASEB J, V23; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fein AM, 2000, CRIT CARE CLIN, V16, P289, DOI 10.1016/S0749-0704(05)70111-1; Fernandez AL, 2007, ALCOHOL, V41, P371, DOI 10.1016/j.alcohol.2007.04.010; Flores-Benitez D, 2009, AM J PHYSIOL-CELL PH, V297, pC611, DOI 10.1152/ajpcell.00622.2008; Gomez MI, 2005, J IMMUNOL, V175, P1930, DOI 10.4049/jimmunol.175.3.1930; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Kevil CG, 2000, AM J PHYSIOL-CELL PH, V279, pC21, DOI 10.1152/ajpcell.2000.279.1.C21; KIM KJ, 1982, J APPL PHYSIOL, V52, P1498, DOI 10.1152/jappl.1982.52.6.1498; KOVAL M, AM J RESP CELL MOL B, V42, P172; Lam HS, 2008, PATHOLOGY, V40, P141, DOI 10.1080/00313020701813735; Lee JW, 2007, J BIOL CHEM, V282, P24109, DOI 10.1074/jbc.M700821200; Levine GK, 2006, CRIT CARE MED, V34, P1746, DOI 10.1097/01.CCM.0000218813.77367.E2; Li QR, 2008, CLIN IMMUNOL, V126, P67, DOI 10.1016/j.clim.2007.08.017; Li QR, 2009, J PATHOL, V218, P210, DOI 10.1002/path.2525; Liaw WJ, 2005, SHOCK, V23, P88, DOI 10.1097/01.shk.0000145937.70085.89; Lindert J, 2007, AM J RESP CELL MOL, V36, P688, DOI 10.1165/rcmb.2006-0347OC; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; McElroy MC, 2004, EUR RESPIR J, V24, P664, DOI 10.1183/09031936.04.00096003; McIntyre RC, 2000, CRIT CARE MED, V28, P3314, DOI 10.1097/00003246-200009000-00034; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; Patel AS, 2005, AM J PHYSIOL-LUNG C, V289, pL489, DOI 10.1152/ajplung.00074.2005; Perlman CE, 2007, J APPL PHYSIOL, V103, P1037, DOI 10.1152/japplphysiol.00160.2007; Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shen LH, 2009, SHOCK, V31, P500, DOI 10.1097/SHK.0b013e318189017a; Singleton KD, 2005, SHOCK, V24, P583, DOI 10.1097/01.shk.0000185795.96964.71; Soong G, 2008, J BACTERIOL, V190, P2814, DOI 10.1128/JB.01567-07; THOMSEN GE, 1995, AM J RESP CRIT CARE, V152, P965, DOI 10.1164/ajrccm.152.3.7663811; TICE LW, 1977, TISSUE CELL, V9, P395, DOI 10.1016/0040-8166(77)90002-7; Tortolani PJ, 1999, J BONE JOINT SURG AM, V81A, P1596; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Uhlig U, 2002, EUR RESPIR J, V20, P946, DOI 10.1183/09031936.02.01612001; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; VILLAR J, 1994, CRIT CARE MED, V22, P914; Weiss YG, 2000, SHOCK, V13, P19, DOI 10.1097/00024382-200013010-00004; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR; ZHOU G, 2009, AM J PHYSL LUNG CELL	60	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11322	10.1371/journal.pone.0011322	http://dx.doi.org/10.1371/journal.pone.0011322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593014	Green Published, gold			2022-12-25	WOS:000279140800020
J	Pau, S; Okin, GS; Gillespie, TW				Pau, Stephanie; Okin, Gregory S.; Gillespie, Thomas W.			Asynchronous Response of Tropical Forest Leaf Phenology to Seasonal and EI Nino-Driven Drought	PLOS ONE			English	Article							EL-NINO; PRIMARY PRODUCTIVITY; RAIN-FOREST; IMPACT; PRECIPITATION; HAWAII; PHOTOSYNTHESIS; MORTALITY; GRADIENT; BIOMASS	The Hawaiian Islands are an ideal location to study the response of tropical forests to climate variability because of their extreme isolation in the middle of the Pacific, which makes them especially sensitive to EI Nino-Southern Oscillation (ENSO). Most research examining the response of tropical forests to drought or EI Nino have focused on rainforests, however, tropical dry forests cover a large area of the tropics and may respond very differently than rainforests. We use satellite-derived Normalized Difference Vegetation Index (NDVI) from February 2000-February 2009 to show that rainforests and dry forests in the Hawaiian Islands exhibit asynchronous responses in leaf phenology to seasonal and EI Nino-driven drought. Dry forest NDVI was more tightly coupled with precipitation compared to rainforest NDVI. Rainforest cloud frequency was negatively correlated with the degree of asynchronicity (Delta(NDVI)) between forest types, most strongly at a 1-month lag. Rainforest green-up and dry forest brown-down was particularly apparent during the 2002-003 EI Nino. The spatial pattern of NDVI response to the NINO 3.4 Sea Surface Temperature (SST) index during 2002-2003 showed that the leeward side exhibited significant negative correlations to increased SSTs, whereas the windward side exhibited significant positive correlations to increased SSTs, most evident at an 8 to 9-month lag. This study demonstrates that different tropical forest types exhibit asynchronous responses to seasonal and EI Nino-driven drought, and suggests that mechanisms controlling dry forest leaf phenology are related to water-limitation, whereas rainforests are more light-limited.	[Pau, Stephanie; Okin, Gregory S.; Gillespie, Thomas W.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Pau, S (corresponding author), NCEAS, Santa Barbara, CA USA.	pau@nceas.ucsb.edu	Okin, Greg/D-3226-2019	Okin, Gregory/0000-0002-0484-3537	NASA; UCLA; National Science Foundation [BCS0455052]	NASA(National Aeronautics & Space Administration (NASA)); UCLA; National Science Foundation(National Science Foundation (NSF))	The NASA Earth System Science Fellowship (http://science.nasa.gov/educators/earth-science-education-catalog/higher-education-programs/earthsystemscience-fellowship-program/) and UCLA Dissertation Year Fellowship (http://www.gdnet.ucla.edu/asis/stusup/stusup.htm) both provided dissertation funding (fees and living stipend) for Stephanie Pau. The National Science Foundation BCS0455052 provided additional research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba SI, 2002, J TROP ECOL, V18, P215, DOI 10.1017/S0266467402002146; Berlin KE, 2000, BIOTROPICA, V32, P90, DOI 10.1111/j.1744-7429.2000.tb00451.x; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; BOX EO, 1989, VEGETATIO, V80, P71, DOI 10.1007/BF00048034; Chu PS, 1997, J CLIMATE, V10, P2683, DOI 10.1175/1520-0442(1997)010<2683:TCOITV>2.0.CO;2; Chu PS, 2005, J CLIMATE, V18, P4796, DOI 10.1175/JCLI3578.1; CHU PS, 1995, J CLIMATE, V8, P1697, DOI 10.1175/1520-0442(1995)008<1697:HRAAEN>2.0.CO;2; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Eck TF, 1998, J GEOPHYS RES-ATMOS, V103, P31865, DOI 10.1029/98JD00399; ELTAHIR EAB, 1994, Q J ROY METEOR SOC, V120, P861, DOI 10.1002/qj.49712051806; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Goulden Michael L., 2004, Ecological Applications, V14, pS42; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Holbrook NM., 1995, SEASONALLY DRY TROPI; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Kolivras KN, 2007, PHYS GEOGR, V28, P76, DOI 10.2747/0272-3646.28.1.76; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; Lepers E, 2005, BIOSCIENCE, V55, P115, DOI 10.1641/0006-3568(2005)055[0115:ASOIOR]2.0.CO;2; Loope LL, 1998, CLIMATIC CHANGE, V39, P503, DOI 10.1023/A:1005372118420; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Nakagawa M, 2000, J TROP ECOL, V16, P355, DOI 10.1017/S0266467400001450; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; PRICE JP, 2007, HCSU000 U HAW; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; STRATTON LC, 2000, OECOLOGIA, V121, P1432; TRATTON LC, 2000, PLANT CELL ENVIRON, V23, P99; TUCKER CJ, 1986, INT J REMOTE SENS, V7, P1395, DOI 10.1080/01431168608948944; TUCKER CJ, 1985, SCIENCE, V227, P369, DOI 10.1126/science.227.4685.369; VANRIPER C, 1980, BIOTROPICA, V12, P282, DOI 10.2307/2387700; Wan ZM, 2008, REMOTE SENS ENVIRON, V112, P59, DOI 10.1016/j.rse.2006.06.026; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552; WRIGHT SJ, 1994, AM NAT, V143, P192, DOI 10.1086/285600	39	18	19	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11325	10.1371/journal.pone.0011325	http://dx.doi.org/10.1371/journal.pone.0011325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593034	Green Submitted, gold, Green Published			2022-12-25	WOS:000279140800022
J	Lee, BY; McGlone, SM; Bailey, RR; Wiringa, AE; Zimmer, SM; Smith, KJ; Zimmerman, RK				Lee, Bruce Y.; McGlone, Sarah M.; Bailey, Rachel R.; Wiringa, Ann E.; Zimmer, Shanta M.; Smith, Kenneth J.; Zimmerman, Richard K.			To Test or to Treat? An Analysis of Influenza Testing and Antiviral Treatment Strategies Using Economic Computer Modeling	PLOS ONE			English	Article							COST-EFFECTIVENESS; HEALTHY-ADULTS; CLINICAL-DIAGNOSIS; A H1N1; OSELTAMIVIR; UTILITY; CHILDREN; ILLNESS; VIRUS; VACCINATION	Background: Due to the unpredictable burden of pandemic influenza, the best strategy to manage testing, such as rapid or polymerase chain reaction (PCR), and antiviral medications for patients who present with influenza-like illness (ILI) is unknown. Methodology/Principal Findings: We developed a set of computer simulation models to evaluate the potential economic value of seven strategies under seasonal and pandemic influenza conditions: (1) using clinical judgment alone to guide antiviral use, (2) using PCR to determine whether to initiate antivirals, (3) using a rapid (point-of-care) test to determine antiviral use, (4) using a combination of a point-of-care test and clinical judgment, (5) using clinical judgment and confirming the diagnosis with PCR testing, (6) treating all with antivirals, and (7) not treating anyone with antivirals. For healthy younger adults (, 65 years old) presenting with ILI in a seasonal influenza scenario, strategies were only cost-effective from the societal perspective. Clinical judgment, followed by PCR and point-of-care testing, was found to be cost-effective given a high influenza probability. Doubling hospitalization risk and mortality (representing either higher risk individuals or more virulent strains) made using clinical judgment to guide antiviral decision-making cost-effective, as well as PCR testing, point-of-care testing, and point-of-care testing used in conjunction with clinical judgment. For older adults (>= 65 years old), in both seasonal and pandemic influenza scenarios, employing PCR was the most cost-effective option, with the closest competitor being clinical judgment (when judgment accuracy >= 50%). Point-of-care testing plus clinical judgment was cost-effective with higher probabilities of influenza. Treating all symptomatic ILI patients with antivirals was cost-effective only in older adults. Conclusions/Significance: Our study delineated the conditions under which different testing and antiviral strategies may be cost-effective, showing the importance of accuracy, as seen with PCR or highly sensitive clinical judgment.	[Lee, Bruce Y.; McGlone, Sarah M.; Bailey, Rachel R.; Wiringa, Ann E.; Zimmer, Shanta M.; Smith, Kenneth J.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; [Lee, Bruce Y.; McGlone, Sarah M.; Bailey, Rachel R.; Wiringa, Ann E.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA USA; [Lee, Bruce Y.; McGlone, Sarah M.; Bailey, Rachel R.; Wiringa, Ann E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Zimmerman, Richard K.] Univ Pittsburgh, Dept Family Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, BY (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA.	BYL1@pitt.edu		Slayton, Rachel/0000-0003-4699-8040; Smith, Kenneth J/0000-0001-8088-566X; Wiringa, Ann/0000-0002-6600-3592; Zimmerman, Richard/0000-0001-5941-6092	National Institute of General Medical Sciences Models of Infectious Agent Study (MIDAS) [1U54GM088491-0109]; National Library of Medicine [5R01LM009132-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009132] Funding Source: NIH RePORTER	National Institute of General Medical Sciences Models of Infectious Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by the National Institute of General Medical Sciences Models of Infectious Agent Study (MIDAS) grant 1U54GM088491-0109 and the National Library of Medicine grant 5R01LM009132-02. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; *BUR LAB STAT, 2009, OCC EMPL STAT MAY 20; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; *CDCP, 2009, UPD INT REC US ANT M; *CDCP, 2010, FLU ACT SURV FLU VIE; *CDCP, 2008, INFL ANT DRUG RES QU; *CDCP, 2009, 2009 2010 INFL SEAS; *CDCP, 2009, ANT DRUG RES STRAINS; *CDCP, 2009, INT REC CLIN INFL DI; Centers for Disease Control and Prevention, 2006, US INFL SENT PROV SU; Couch RB, 2000, NEW ENGL J MED, V343, P1778, DOI 10.1056/NEJM200012143432407; Cram P, 2001, PHARMACOECONOMICS, V19, P223, DOI 10.2165/00019053-200119030-00001; DEMICHELI V, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001269.PUB2.ART; ELLIS J, 2009, EVALUATION REAL TIME; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Gordon A, 2009, EMERG INFECT DIS, V15, P408, DOI 10.3201/eid1503.080238; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; LEVIT K, 2007, HCUP FACTS FIG 2007; Luce BR, 2008, VACCINE, V26, P2841, DOI 10.1016/j.vaccine.2008.03.046; Mauskopf JA, 2000, PHARMACOECONOMICS, V17, P611, DOI 10.2165/00019053-200017060-00007; Monto AS, 2008, PEDIATR INFECT DIS J, V27, pS110, DOI 10.1097/INF.0b013e318168b739; MOSCONA A, 2005, NEW ENGL J MED, V353, P1163; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Postma Maarten J, 2008, J Med Econ, V11, P743, DOI 10.3111/13696990802505557; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Roberts S, 2006, OBSTET GYNECOL, V107, P1323, DOI 10.1097/01.AOG.0000210225.45986.99; Rothberg MB, 2005, AM J MED, V118, P68, DOI 10.1016/j.amjmed.2004.03.044; Rothberg MB, 2003, J GEN INTERN MED, V18, P808, DOI 10.1046/j.1525-1497.2003.20822.x; Ruef C, 2007, INFECTION, V35, P49, DOI 10.1007/s15010-007-7207-4; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; Sander B, 2006, PHARMACOECONOMICS, V24, P373, DOI 10.2165/00019053-200624040-00007; Sintchenko V, 2002, J CLIN VIROL, V25, P15, DOI 10.1016/S1386-6532(00)00182-7; Smith KJ, 2002, AM J MED, V113, P300, DOI 10.1016/S0002-9343(02)01222-6; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; Talbird SE, 2009, AM J HEALTH-SYST PH, V66, P469, DOI 10.2146/ajhp080296; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; *THOMPS HLTH INC, 2008, PDR RED BOOK; Thompson SG, 2005, MED DECIS MAKING, V25, P416, DOI 10.1177/0272989X05276862; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; van Hal SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006620; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; WILMOTH JR, 2008, HUMAN MORTALITY DATA; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	53	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11284	10.1371/journal.pone.0011284	http://dx.doi.org/10.1371/journal.pone.0011284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585642	Green Published, Green Accepted, gold			2022-12-25	WOS:000279135400026
J	Rassy, D; Bobes, RJ; Rosas, G; Anaya, VH; Brehm, K; Hernandez, B; Cervantes, J; Pedraza, S; Morales, J; Villalobos, N; de Aluja, AS; Laclette, JP; Nunes, CM; Biondi, GF; Fragoso, G; Hernandez, M; Sciutto, E				Rassy, Dunia; Bobes, Raul J.; Rosas, Gabriela; Anaya, Victor H.; Brehm, Klaus; Hernandez, Beatriz; Cervantes, Jacquelynne; Pedraza, Saul; Morales, Julio; Villalobos, Nelly; de Aluja, Aline S.; Laclette, Juan P.; Nunes, Caris M.; Biondi, Germano F.; Fragoso, Gladis; Hernandez, Marisela; Sciutto, Edda			Characterization of S3Pvac Anti-Cysticercosis Vaccine Components: Implications for the Development of an Anti-Cestodiasis Vaccine	PLOS ONE			English	Article							TAENIA-SOLIUM CYSTICERCOSIS; CRASSICEPS MURINE CYSTICERCOSIS; SYNTHETIC PEPTIDE VACCINE; PORCINE CYSTICERCOSIS; IMMUNE-RESPONSE; FIELD TRIAL; RECOMBINANT; PIGS; ONCOSPHERE; PROTECTION	Background: Cysticercosis and hydatidosis seriously affect human health and are responsible for considerable economic loss in animal husbandry in non-developed and developed countries. S3Pvac and EG95 are the only field trial-tested vaccine candidates against cysticercosis and hydatidosis, respectively. S3Pvac is composed of three peptides (KETc1, GK1 and KETc12), originally identified in a Taenia crassiceps cDNA library. S3Pvac synthetically and recombinantly expressed is effective against experimentally and naturally acquired cysticercosis. Methodology/ Principal Findings: In this study, the homologous sequences of two of the S3Pvac peptides, GK1 and KETc1, were identified and further characterized in Taenia crassiceps WFU, Taenia solium, Taenia saginata, Echinococcus granulosus and Echinococcus multilocularis. Comparisons of the nucleotide and amino acid sequences coding for KETc1 and GK1 revealed significant homologies in these species. The predicted secondary structure of GK1 is almost identical between the species, while some differences were observed in the C terminal region of KETc1 according to 3D modeling. A KETc1 variant with a deletion of three C-terminal amino acids protected to the same extent against experimental murine cysticercosis as the entire peptide. On the contrary, immunization with the truncated GK1 failed to induce protection. Immunolocalization studies revealed the non stage-specificity of the two S3Pvac epitopes and their persistence in the larval tegument of all species and in Taenia adult tapeworms. Conclusions/ Significance: These results indicate that GK1 and KETc1 may be considered candidates to be included in the formulation of a multivalent and multistage vaccine against these cestodiases because of their enhancing effects on other available vaccine candidates.	[Rassy, Dunia; Bobes, Raul J.; Cervantes, Jacquelynne; Pedraza, Saul; Morales, Julio; Laclette, Juan P.; Fragoso, Gladis; Hernandez, Marisela; Sciutto, Edda] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico; [Rosas, Gabriela] Univ Autonoma Estado Morelos, Fac Med, Cuernavaca, Morelos, Mexico; [Anaya, Victor H.] Humboldt Univ, Inst Theoret Biol, Berlin, Germany; [Brehm, Klaus] Univ Wurzburg, Inst Hyg & Mikrobiol, Wurzburg, Germany; [Hernandez, Beatriz] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico; [Villalobos, Nelly; de Aluja, Aline S.] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Mexico City 04510, DF, Mexico; [Nunes, Caris M.] Univ Estadual Paulista, Dept Apoio Prod & Saude Anim, Aracatuba, Sao Paolo, Brazil; [Biondi, Germano F.] Univ Estadual Paulista, Fac Med Vet & Zootecnia Botucatu, Dept Hyg Vet & Saude Publ, Botucatu, SP, Brazil	Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Humboldt University of Berlin; University of Wurzburg; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade Estadual Paulista; Universidade Estadual Paulista	Rassy, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Inmunol, Mexico City 04510, DF, Mexico.	edda@servidor.unam.mx	Rosas, Gabriela/AAO-8127-2021; Nunes, Caris M/R-9337-2016	Nunes, Caris M/0000-0002-5463-3845; Anaya-Munoz, Victor Hugo/0000-0001-6136-7330; Sciutto, Edda/0000-0001-5608-5355	Consejo Nacional de Ciencia y Tecnologia [S52680-R/70072, CB-62471]; Direccion General de Asuntos del Personal Academico (DGAPA) [IN217908]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico (DGAPA)	This work was funded by the Consejo Nacional de Ciencia y Tecnologia S52680-R/70072, CB-62471 and Direccion General de Asuntos del Personal Academico (DGAPA) IN217908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASSANA E, 2010, INT J PARASITOLGAUDI, P18; BOUDET F, 1991, J IMMUNOL METHODS, V142, P73, DOI 10.1016/0022-1759(91)90294-P; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Bystroff Christopher, 2002, Bioinformatics, V18 Suppl 1, pS54; Chang SL, 2006, J HELMINTHOL, V80, P219, DOI 10.1079/JOH2005333; Cruz-Revilla C, 2006, J PARASITOL, V92, P864, DOI 10.1645/GE-779R1.1; Diaz MA, 2003, VET IMMUNOL IMMUNOP, V93, P81, DOI 10.1016/S0165-2427(03)00071-0; Everhart ME, 2004, J PARASITOL, V90, P79, DOI 10.1645/GE-3255; Flisser A, 2004, INFECT IMMUN, V72, P5292, DOI 10.1128/IAI.72.9.5292-5297.2004; Fragoso G, 1998, INFECT IMMUN, V66, P760, DOI 10.1128/IAI.66.2.760-764.1998; FREEMAN R, 1962, CAN J ZOOL, V969, P1800; GarciaAllan C, 1996, J HELMINTHOL, V70, P271, DOI 10.1017/S0022149X00015558; Gauci C, 2003, MOL BIOCHEM PARASIT, V127, P193, DOI 10.1016/S0166-6851(03)00005-7; GEMMELL MA, 1969, EXP PARASITOL, V26, P67, DOI 10.1016/0014-4894(69)90096-4; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gonzalez AE, 2005, AM J TROP MED HYG, V72, P837, DOI 10.4269/ajtmh.2005.72.837; Gottstein B, 2005, Ther Umsch, V62, P685, DOI 10.1024/0040-5930.62.10.685; HARRISON L J S, 1989, Acta Leidensia, V57, P143; Hoberg EP, 2002, MICROBES INFECT, V4, P859, DOI 10.1016/S1286-4579(02)01606-4; Huerta M, 2001, VACCINE, V20, P262, DOI 10.1016/S0264-410X(01)00249-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARRALDE C, 1989, AM J TROP MED HYG, V40, P282, DOI 10.4269/ajtmh.1989.40.282; Leon-Cabrera S, 2009, METHODS, V49, P346, DOI 10.1016/j.ymeth.2009.07.007; Lightowlers MW, 1999, INT J PARASITOL, V29, P531, DOI 10.1016/S0020-7519(99)00003-X; Lightowlers MW, 1996, PARASITE IMMUNOL, V18, P507, DOI 10.1046/j.1365-3024.1996.d01-20.x; Lightowlers MW, 1996, EXP PARASITOL, V84, P330, DOI 10.1006/expr.1996.0121; Manoutcharian K, 2004, VET IMMUNOL IMMUNOP, V99, P11, DOI 10.1016/j.vetimm.2003.12.009; Manoutcharian K, 1996, J PARASITOL, V82, P250, DOI 10.2307/3284156; Mariaux J, 1996, INT J PARASITOL, V26, P231, DOI 10.1016/0020-7519(95)00129-8; Molinari JL, 1997, VET PARASITOL, V69, P55, DOI 10.1016/S0304-4017(96)01102-8; Montero E, 2007, EXP PARASITOL, V116, P191, DOI 10.1016/j.exppara.2006.12.015; Morales J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000284; NASCIMENTO E, 1995, VET IMMUNOL IMMUNOP, V45, P127, DOI 10.1016/0165-2427(94)05327-O; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; ONYANGOABUJE JA, 1989, RES VET SCI, V47, P236, DOI 10.1016/S0034-5288(18)31212-8; Parkhouse RME, 2008, PARASITOL RES, V102, P921, DOI 10.1007/s00436-007-0853-8; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Plancarte A, 1999, INT J PARASITOL, V29, P643, DOI 10.1016/S0020-7519(99)00021-1; Rickard M D, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P287; Rosas G, 2002, MICROBES INFECT, V4, P1417, DOI 10.1016/S1286-4579(02)00025-4; Rosas G, 1998, J PARASITOL, V84, P516, DOI 10.2307/3284715; Rosas G, 2006, MICROBES INFECT, V8, P1277, DOI 10.1016/j.micinf.2005.12.006; Schantz PM, 2006, PARASITOL INT, V55, pS7, DOI 10.1016/j.parint.2005.11.050; Sciutto E, 2007, PARASITOLOGY, V134, P129, DOI 10.1017/S0031182006001132; SCIUTTO E, 1995, VET PARASITOL, V60, P53, DOI 10.1016/0304-4017(94)00781-7; Sciutto E, 2008, CURR TOP MED CHEM, V8, P415, DOI 10.2174/156802608783790839; Sclutto E, 2007, J PARASITOL, V93, P824, DOI 10.1645/GE-1018R1.1; Seed, 2001, PARASITISM DIVERSITY; Segura-Velazquez R, 2006, VACCINE, V24, P1073, DOI 10.1016/j.vaccine.2005.09.014; SMITH KJ, 1972, INT J PARASITOL, V2, P261; Smyth JD, 1969, PHYSL CESTODES; Spiliotis M, 2008, INT J PARASITOL, V38, P1025, DOI 10.1016/j.ijpara.2007.11.002; SUK J S, 1980, Korean Journal of Parasitology, V18, P1, DOI 10.3347/kjp.1980.18.1.1; Toledo A, 1999, INFECT IMMUN, V67, P2522, DOI 10.1128/IAI.67.5.2522-2530.1999; Toledo A, 2001, INFECT IMMUN, V69, P1766, DOI 10.1128/IAI.69.3.1766-1773.2001; Willms K, 2004, PARASITOL RES, V93, P262, DOI 10.1007/s00436-004-1125-5; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	58	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11287	10.1371/journal.pone.0011287	http://dx.doi.org/10.1371/journal.pone.0011287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585656	Green Submitted, Green Published, gold			2022-12-25	WOS:000279135400029
J	Rignell-Hydbom, A; Elfving, M; Ivarsson, SA; Lindh, C; Jonsson, BAG; Olofsson, P; Rylander, L				Rignell-Hydbom, Anna; Elfving, Maria; Ivarsson, Sten A.; Lindh, Christian; Jonsson, Bo A. G.; Olofsson, Per; Rylander, Lars			A Nested Case-Control Study of Intrauterine Exposure to Persistent Organochlorine Pollutants in Relation to Risk of Type 1 Diabetes	PLOS ONE			English	Article							ENVIRONMENTAL CONTAMINANTS; INCIDENCE TRENDS; RISING INCIDENCE; 1ST YEAR; INSULIN; POPULATION; EUROPE; CHILDREN; MELLITUS; ONSET	Background: The incidence of type 1 diabetes in Europe is increasing at a rate of about 3% per year and there is also an increasing incidence throughout the world. Type 1 diabetes is a complex disease caused by multiple genetic and environmental factors. Persistent organochlorine pollutants (POPs) have been suggested as a triggering factor for developing childhood type 1 diabetes. The aim of this case-control study was to assess possible impacts of in utero exposure to POPs on type 1 diabetes. Methodology/Principal Findings: The study was performed as a case-control study within a biobank in Malmo, a city located in the Southern part of Sweden. The study included 150 cases (children who had their diagnosis mostly before 18 years of age) and 150 controls, matched for gender and day of birth. 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) and the major DDT metabolite 1,1-dichloro-2,2-bis (p-chlorophenyl)-ethylene (p,p'-DDE) were used as a biomarkers for POP exposure. When comparing the quartile with the highest maternal serum concentrations of PCB-153 with the other quartiles, an odds ratio (OR) of 0.73 (95% confidence interval [CI] 0.42, 1.27) was obtained. Similar results was obtained for p,p'-DDE (OR 0.56, 95% CI 0.29, 1.08). Conclusions: The hypothesis that in utero exposure to POPs will trigger the risk for developing type 1 diabetes was not supported by the results. The risk estimates did, although not statistically significant, go in the opposite direction. However, it is not reasonable to believe that exposure to POPs should protect against type 1 diabetes.	[Rignell-Hydbom, Anna; Lindh, Christian; Jonsson, Bo A. G.; Rylander, Lars] Lund Univ, Div Occupat & Environm Med, Lund, Sweden; [Elfving, Maria] Lund Univ, Dept Pediat, Univ Lund Hosp, Lund, Sweden; [Ivarsson, Sten A.] Lund Univ, Dept Clin Sci, Unit Pediat Endocrinol, CRC, Malmo, Sweden; [Olofsson, Per] Lund Univ, Malmo Univ Hosp, Dept Obstet & Gynecol, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Rignell-Hydbom, A (corresponding author), Lund Univ, Div Occupat & Environm Med, Lund, Sweden.	anna.rignell-hydbom@med.lu.se		Rylander, Lars/0000-0001-8288-8207; Jonsson, Bo/0000-0002-8767-0589; Lindh, Christian/0000-0001-7435-9890	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Medical Faculty, Lund University	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Medical Faculty, Lund University	The project was made possible by grants from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, and the Medical Faculty, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Azam A, 2004, EXPERT OPIN BIOL TH, V4, P1569, DOI 10.1517/14712598.4.10.1569; BIGNERT A, COMMENTS NATL SWEDIS; BODANSKY HJ, 1992, BRIT MED J, V304, P1020, DOI 10.1136/bmj.304.6833.1020; Costa Lucio G., 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P367, DOI 10.2478/v10004-007-0025-3; Dahlquist GG, 1999, DIABETES CARE, V22, P1698, DOI 10.2337/diacare.22.10.1698; DAHLQUIST GG, 1995, DIABETES, V44, P408, DOI 10.2337/diabetes.44.4.408; Darnerud PO, 2006, FOOD CHEM TOXICOL, V44, P1597, DOI 10.1016/j.fct.2006.03.011; EBNER K, 1988, J ENVIRON SCI HEAL B, V23, P427, DOI 10.1080/03601238809372617; Elfving M, 2008, EXP DIABETES RES, DOI 10.1155/2008/271958; ENAN E, 1994, J BIOCHEM TOXICOL, V9, P97, DOI 10.1002/jbt.2570090207; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1; GINSBERGFELLNER F, 1985, LANCET, V2, P332; Glynn AW, 2000, SCI TOTAL ENVIRON, V263, P197, DOI 10.1016/S0048-9697(00)00703-8; Grandjean P, 2008, ENVIRON SCI TECHNOL, V42, P6991, DOI 10.1021/es800778q; Green A, 2000, LANCET, V355, P873; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Grimvall E, 1997, ARCH ENVIRON CON TOX, V32, P329, DOI 10.1007/s002449900193; Hertz-Picciotto I, 2008, BASIC CLIN PHARMACOL, V102, P146, DOI 10.1111/j.1742-7843.2007.00190.x; Hokanson R, 2004, HUM EXP TOXICOL, V23, P555, DOI 10.1191/0960327104ht488oa; Holladay SD, 1999, ENVIRON HEALTH PERSP, V107, P687, DOI 10.2307/3434328; Ilonen J, 2002, AM J MED GENET, V115, P30, DOI 10.1002/ajmg.10341; Jonsson Bo A G, 2005, Environ Health, V4, P27, DOI 10.1186/1476-069X-4-27; Longnecker MP, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454649; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; OSTMAN J, 1986, ACTA MED SCAND, V220, P437; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Remillard RBJ, 2002, ENVIRON HEALTH PERSP, V110, P853, DOI 10.1289/ehp.02110853; Rignell-Hydbom A, 2004, HUM REPROD, V19, P2066, DOI 10.1093/humrep/deh362; Sjodin A, 2000, ENVIRON HEALTH PERSP, V108, P1035, DOI 10.2307/3434955; Smith SA, 2002, BIOCHEM SOC T, V30, P1086, DOI 10.1042/BST0301086; Stene LC, 2003, AM J CLIN NUTR, V78, P1128, DOI 10.1093/ajcn/78.6.1128; Tan J, 2009, CHEMOSPHERE, V74, P428, DOI 10.1016/j.chemosphere.2008.09.045; Tuomilehto J, 1999, DIABETOLOGIA, V42, P655, DOI 10.1007/s001250051212; VOGEL CFA, 2003, J BIOL CHEM, V18, P8886	37	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11281	10.1371/journal.pone.0011281	http://dx.doi.org/10.1371/journal.pone.0011281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585661	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135400024
J	Beauliere, A; Toure, S; Alexandre, PK; Kone, K; Pouhe, A; Kouadio, B; Journy, N; Son, J; Ettiegne-Traore, V; Dabis, F; Eholie, S; Anglaret, X				Beauliere, Arnousse; Toure, Siaka; Alexandre, Pierre-Kebreau; Kone, Koko; Pouhe, Alex; Kouadio, Bertin; Journy, Neige; Son, Jerome; Ettiegne-Traore, Virginie; Dabis, Francois; Eholie, Serge; Anglaret, Xavier			The Financial Burden of Morbidity in HIV-Infected Adults on Antiretroviral Therapy in Cote d'Ivoire	PLOS ONE			English	Article							CATASTROPHIC HEALTH EXPENDITURE; OUT-OF-POCKET; DEVELOPING-COUNTRIES; LOW-INCOME; UNIVERSAL COVERAGE; CARE EXPENDITURES; ACCESS; BARRIERS; HOUSEHOLDS; INSURANCE	Background: Large HIV care programs frequently subsidize antiretroviral (ARV) drugs and CD4 tests, but patients must often pay for other health-related drugs and services. We estimated the financial burden of health care for households with HIV-infected adults taking antiretroviral therapy (ART) in Cote d'Ivoire. Methodology/Principal Findings: We conducted a cross-sectional survey. After obtaining informed consent, we interviewed HIV-infected adults taking ART who had consecutively attended one of 18 HIV care facilities in Abidjan. We collected information on socioeconomic and medical characteristics. The main economic indicators were household capacity-to-pay (overall expenses minus food expenses), and health care expenditures. The primary outcome was the percentage of households confronted with catastrophic health expenditures (health expenditures were defined as catastrophic if they were greater than or equal to 40% of the capacity-to-pay). We recruited 1,190 adults. Median CD4 count was 187/mm(3), median time on ART was 14 months, and 72% of subjects were women. Mean household capacity-to-pay was $213.7/month, mean health expenditures were $24.3/month, and 12.3% of households faced catastrophic health expenditures. Of the health expenditures, 75.3% were for the study subject (ARV drugs and CD4 tests, 24.6%; morbidity events diagnosis and treatment, 50.1%; transportation to HIV care centres, 25.3%) and 24.7% were for other household members. When we stratified by most recent CD4 count, morbidity events related expenses were significantly lower when subjects had higher CD4 counts. Conclusions/Significance: Many households in Cote d'Ivoire face catastrophic health expenditures that are not attributable to ARV drugs or routine follow-up tests. Innovative schemes should be developed to help HIV-infected patients on ART face the cost of morbidity events.	[Beauliere, Arnousse; Journy, Neige; Son, Jerome; Dabis, Francois; Anglaret, Xavier] Univ Bordeaux 2, INSERM, U897, F-33076 Bordeaux, France; [Beauliere, Arnousse; Toure, Siaka; Kone, Koko; Kouadio, Bertin; Journy, Neige; Son, Jerome; Dabis, Francois; Eholie, Serge; Anglaret, Xavier] Programme PAC CI, Abidjan, Cote Ivoire; [Alexandre, Pierre-Kebreau] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Toure, Siaka; Pouhe, Alex; Kouadio, Bertin] Assoc ACONDA VS, Abidjan, Cote Ivoire; [Kone, Koko] IPNETP, Abidjan, Cote Ivoire; [Ettiegne-Traore, Virginie] Minist Sante & Hyg Publ, Programme Natl Prise Charge Personnes Infect VIH, Abidjan, Cote Ivoire; [Eholie, Serge] CHU Treichville, Serv Malad Infect & Trop, Abidjan, Cote Ivoire	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Beauliere, A (corresponding author), Univ Bordeaux 2, INSERM, U897, F-33076 Bordeaux, France.	arnousse.beauliere@isped.u-bordeaux2.fr	Eholie, Serge/T-6008-2019; Anglaret, Xavier/T-2757-2019; DABIS, FRANCOIS/S-9298-2019; Anglaret, Xavier/F-7333-2013	DABIS, FRANCOIS/0000-0002-1614-8857; Anglaret, Xavier/0000-0003-3319-8423	French National Agency for Research on AIDS and viral hepatitis [ANRS 12137]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736] Funding Source: NIH RePORTER	French National Agency for Research on AIDS and viral hepatitis(ANRS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the French National Agency for Research on AIDS and viral hepatitis (ANRS 12137, France) (http://www.anrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2022, WORLD HLTH STAT; [Anonymous], 2008, PRIM HLTH CAR NOW MO; Bennett S, 2004, HEALTH POLICY PLANN, V19, P147, DOI 10.1093/heapol/czh018; Boyer S, 2009, B WORLD HEALTH ORGAN, V87, P279, DOI 10.2471/BLT.07.049643; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Carrin G, 2005, TROP MED INT HEALTH, V10, P799, DOI 10.1111/j.1365-3156.2005.01455.x; Carrin G, 2008, B WORLD HEALTH ORGAN, V86, P857, DOI 10.2471/BLT.07.049387; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Duraisamy P, 2006, AIDS CARE, V18, P121, DOI 10.1080/09540120500159359; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Furber AS, 2004, BMJ-BRIT MED J, V329, P1281, DOI 10.1136/bmj.329.7477.1281; Gilson L, 2001, HEALTH POLICY, V58, P37, DOI 10.1016/S0168-8510(01)00153-1; Hounton SH, 2008, AIDS CARE, V20, P582, DOI 10.1080/09540120701868303; International Monetary Fund (IMF), 2009, COT IV POV RED STRAT; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; Katz S, 2003, J AGING STUD, V17, P3, DOI 10.1016/S0890-4065(02)00086-5; Lange JMA, 2008, CURR OPIN HIV AIDS, V3, P509, DOI 10.1097/COH.0b013e3283031c67; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; *MIN LUTT CONTR SI, 2008, SUIV DECL ENG VIH SI; Molyneux C, 2007, HEALTH POLICY PLANN, V22, P381, DOI 10.1093/heapol/czm031; Msellati P, 2003, AIDS, V17, pS63, DOI 10.1097/00002030-200317003-00009; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74; Nombela N, 2006, JAIDS-J ACQ IMM DEF, V41, P225, DOI 10.1097/01.qai.0000179456.39185.9b; Onwujekwe O, 2009, HEALTH POLICY, V90, P223, DOI 10.1016/j.healthpol.2008.10.006; Palmer N, 2004, LANCET, V364, P1365, DOI 10.1016/S0140-6736(04)17195-X; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Pradhan M, 2002, HEALTH ECON, V11, P431, DOI 10.1002/hec.689; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Russell S, 1996, HEALTH POLICY PLANN, V11, P219, DOI 10.1093/heapol/11.3.219; Russell S, 2006, SOC SCI MED, V63, P1732, DOI 10.1016/j.socscimed.2006.04.017; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Savedoff W., 2003, HLTH SYSTEMS PERFORM; Somkotra T, 2009, HEALTH AFFAIR, V28, pW467, DOI 10.1377/hlthaff.28.3.w467; Souteyrand YP, 2008, AIDS, V22, pS161, DOI 10.1097/01.aids.0000327637.59672.02; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Taverne B, 2008, POLITICAL EC HIV AID, P273; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Van Damme W, 2003, LANCET, V362, P996, DOI 10.1016/S0140-6736(03)14375-9; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Veenstra N, 2005, BEST PRACT RES CL OB, V19, P197, DOI 10.1016/j.bpobgyn.2004.10.005; VINARD P, 2008, POLITICAL EC HIV AID, P291; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; WYSZEWIANSKI L, 1986, HEALTH SERV RES, V21, P617; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2006, SOC SCI MED, V62, P866, DOI 10.1016/j.socscimed.2005.07.004; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007	50	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11213	10.1371/journal.pone.0011213	http://dx.doi.org/10.1371/journal.pone.0011213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	613KE	20585454	gold, Green Published, Green Submitted			2022-12-25	WOS:000278977200016
J	Kachhap, SK; Rosmus, N; Collis, SJ; Kortenhorst, MSQ; Wissing, MD; Hedayati, M; Shabbeer, S; Mendonca, J; Deangelis, J; Marchionni, L; Lin, JQ; Hoti, N; Nortier, JWR; DeWeese, TL; Hammers, H; Carducci, MA				Kachhap, Sushant K.; Rosmus, Nadine; Collis, Spencer J.; Kortenhorst, Madeleine S. Q.; Wissing, Michel D.; Hedayati, Mohammad; Shabbeer, Shabana; Mendonca, Janet; Deangelis, Justin; Marchionni, Luigi; Lin, Jianqing; Hoti, Naseruddin; Nortier, Johan W. R.; DeWeese, Theodore L.; Hammers, Hans; Carducci, Michael A.			Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; DOUBLE-STRAND BREAKS; TOPOISOMERASE-II; VALPROIC ACID; IN-VITRO; CELL-LINES; EXPRESSION; DAMAGE; COMPLEX; EPIGENOMICS		[Kachhap, Sushant K.; Rosmus, Nadine; Kortenhorst, Madeleine S. Q.; Wissing, Michel D.; Shabbeer, Shabana; Mendonca, Janet; Deangelis, Justin; Marchionni, Luigi; Lin, Jianqing; Hoti, Naseruddin; DeWeese, Theodore L.; Hammers, Hans; Carducci, Michael A.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Prostate Canc Program, Baltimore, MD 21218 USA; [Collis, Spencer J.; Hedayati, Mohammad; DeWeese, Theodore L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA; [Nortier, Johan W. R.] Leiden Univ, Med Ctr, Div Med Oncol, Leiden, Netherlands	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kachhap, SK (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Prostate Canc Program, Baltimore, MD 21218 USA.	kachhsu@jhmi.edu	Marchionni, Luigi/S-6774-2017; Hoti, Naser/A-2530-2011; Carducci, Michael/R-8164-2019; qiao, zhixin/I-3408-2012	Marchionni, Luigi/0000-0002-7336-8071; Collis, Spencer/0000-0002-7874-1891	Flight Attendant Medical Research Institute; Prostate Cancer Foundation [P50-58236]; Dr. Saal van Zwanenberg Foundation	Flight Attendant Medical Research Institute; Prostate Cancer Foundation; Dr. Saal van Zwanenberg Foundation	The work is supported by Flight Attendant Medical Research Institute, David Koch Fund which was provided by the Prostate Cancer Foundation, Prostate Cancer Foundation Grant, Specialized Program of Research Excellence Grant P50-58236, and AEGON. MDW is supported by the Dr. Saal van Zwanenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bindra RS, 2007, ONCOGENE, V26, P2048, DOI 10.1038/sj.onc.1210001; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Borowiec JA, 2004, CELL CYCLE, V3, P627; Boutillier AL, 2003, J NEUROCHEM, V84, P814, DOI 10.1046/j.1471-4159.2003.01581.x; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Camphausen K, 2004, CLIN CANCER RES, V10, P6066, DOI 10.1158/1078-0432.CCR-04-0537; Camphausen K, 2007, J CLIN ONCOL, V25, P4051, DOI 10.1200/JCO.2007.11.6202; Carrassa L, 2003, CELL CYCLE, V2, P604, DOI 10.4161/cc.2.6.503; Chan Norman, 2007, Future Oncol, V3, P329, DOI 10.2217/14796694.3.3.329; Chinnaiyan P, 2005, INT J RADIAT ONCOL, V62, P223, DOI 10.1016/j.ijrobp.2004.12.088; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; DRAKE FH, 1989, BIOCHEMISTRY-US, V28, P8154, DOI 10.1021/bi00446a029; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Inoue K, 2006, ARTERIOSCL THROM VAS, V26, P2652, DOI 10.1161/01.ATV.0000247247.89787.e7; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Jones PA, 2002, ONCOGENE, V21, P5358, DOI 10.1038/sj.onc.1205597; Jung M, 2005, RADIAT RES, V163, P488, DOI 10.1667/RR3345; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kortenhorst MSQ, 2008, CLIN CANCER RES, V14, P6886, DOI 10.1158/1078-0432.CCR-08-0119; Lee E, 2004, TOXICOL SCI, V81, P121, DOI 10.1093/toxsci/kfh184; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lu Z, 2006, ONCOGENE, V25, P230, DOI 10.1038/sj.onc.1209025; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; MILNE JC, 2008, CURR OPIN CHEM BIOL; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088; Paoluzzi L, 2004, CANCER BIOL THER, V3, P612, DOI 10.4161/cbt.3.7.931; Petrini JHJ, 2007, SCIENCE, V316, P1138, DOI 10.1126/science.1143700; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shabbeer S, 2005, IDRUGS, V8, P144; Shabbeer S, 2007, PROSTATE, V67, P1099, DOI 10.1002/pros.20587; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Treszezamsky AD, 2007, CANCER RES, V67, P7078, DOI 10.1158/0008-5472.CAN-07-0601; Valentini A, 2007, DRUG METAB DISPOS, V35, P968, DOI 10.1124/dmd.107.014662; Walton TJ, 2008, PROSTATE, V68, P210, DOI 10.1002/pros.20673; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Xia QH, 2006, CANCER RES, V66, P7237, DOI 10.1158/0008-5472.CAN-05-0487; You JS, 2008, ONCOGENE, V27, P1376, DOI 10.1038/sj.onc.1210776	54	126	133	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11208	10.1371/journal.pone.0011208	http://dx.doi.org/10.1371/journal.pone.0011208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585447	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000278977200011
J	Volkova, VV; Howey, R; Savill, NJ; Woolhouse, MEJ				Volkova, Victoriya V.; Howey, Richard; Savill, Nicholas J.; Woolhouse, Mark E. J.			Sheep Movement Networks and the Transmission of Infectious Diseases	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; RISK-FACTORS; LIVESTOCK MOVEMENTS; ANIMAL MOVEMENTS; MOUTH-DISEASE; CATTLE; PARATUBERCULOSIS; HETEROGENEITIES; EPIDEMIOLOGY; DYNAMICS	Background and Methodology: Various approaches have been used to investigate how properties of farm contact networks impact on the transmission of infectious diseases. The potential for transmission of an infection through a contact network can be evaluated in terms of the basic reproduction number, R-0. The magnitude of R-0 is related to the mean contact rate of a host, in this case a farm, and is further influenced by heterogeneities in contact rates of individual hosts. The latter can be evaluated as the second order moments of the contact matrix (variances in contact rates, and co-variance between contacts to and from individual hosts). Here we calculate these quantities for the farms in a country-wide livestock network: >15,000 Scottish sheep farms in each of 4 years from July 2003 to June 2007. The analysis is relevant to endemic and chronic infections with prolonged periods of infectivity of affected animals, and uses different weightings of contacts to address disease scenarios of low, intermediate and high animal-level prevalence. Principal Findings and Conclusions: Analysis of networks of Scottish farms via sheep movements from July 2003 to June 2007 suggests that heterogeneities in movement patterns (variances and covariances of rates of movement on and off the farms) make a substantial contribution to the potential for the transmission of infectious diseases, quantified as R-0, within the farm population. A small percentage of farms (<20%) contribute the bulk of the transmission potential (>80%) and these farms could be efficiently targeted by interventions aimed at reducing spread of diseases via animal movement.	[Volkova, Victoriya V.; Howey, Richard; Savill, Nicholas J.; Woolhouse, Mark E. J.] Univ Edinburgh, Ctr Infect Dis, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Volkova, VV (corresponding author), Univ Edinburgh, Ctr Infect Dis, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	Victoriya.Volkova@ed.ac.uk		Savill, Nicholas/0000-0002-9769-6168; Woolhouse, Mark/0000-0003-3765-8167	Scottish Government; BBSRC; Wellcome Trust	Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was undertaken through the Centre of Excellence in Epidemiology, Population Health and Infectious Disease Control (EPIC) funded by the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RH and MEJW acknowledge additional support from the BBSRC and the Wellcome Trust.	ANDERSON R M, 1991; Beard PM, 2001, J CLIN MICROBIOL, V39, P1517, DOI 10.1128/JCM.39.4.1517-1521.2001; Daniels MJ, 2003, J WILDLIFE DIS, V39, P10, DOI 10.7589/0090-3558-39.1.10; Delahay RJ, 2007, VET J, V173, P287, DOI 10.1016/j.tvjl.2005.11.011; DIEKMANN O, 1990, J MATH BIOL, V28, P365; DOROGOVTSEV SN, 2003, EVOLUTION NETWORKS B, P264; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Galvani AP, 2005, NATURE, V438, P293, DOI 10.1038/438293a; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Green DM, 2007, J GEN VIROL, V88, P3486, DOI 10.1099/vir.0.83225-0; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Kenah E, 2007, J THEOR BIOL, V249, P706, DOI 10.1016/j.jtbi.2007.09.011; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Lindstrom T, 2010, PREV VET MED, V95, P23, DOI 10.1016/j.prevetmed.2010.03.002; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lord CC, 1996, MED VET ENTOMOL, V10, P19, DOI 10.1111/j.1365-2915.1996.tb00077.x; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; Ribbens S, 2009, PREV VET MED, V88, P57, DOI 10.1016/j.prevetmed.2008.08.002; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; van Schaik G, 2002, PREV VET MED, V54, P279, DOI 10.1016/S0167-5877(02)00004-1; van Schaik G, 1998, PREV VET MED, V34, P125, DOI 10.1016/S0167-5877(97)00085-8; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009; Volkova V, 2008, REPORT SEASONALITY M; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; WOOLHOUSE MEJ, 1991, P ROY SOC B-BIOL SCI, V245, P109, DOI 10.1098/rspb.1991.0095; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331	32	61	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11185	10.1371/journal.pone.0011185	http://dx.doi.org/10.1371/journal.pone.0011185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567504	gold, Green Published, Green Submitted			2022-12-25	WOS:000278886300027
J	Gainotti, S; Imperatori, SF; Spila-Alegiani, S; Maggiore, L; Galeotti, F; Vanacore, N; Petrini, C; Raschetti, R; Mariani, C; Clerici, F				Gainotti, Sabina; Imperatori, Susanna Fusari; Spila-Alegiani, Stefania; Maggiore, Laura; Galeotti, Francesca; Vanacore, Nicola; Petrini, Carlo; Raschetti, Roberto; Mariani, Claudio; Clerici, Francesca			How Are the Interests of Incapacitated Research Participants Protected through Legislation? An Italian Study on Legal Agency for Dementia Patients	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; SURROGATE CONSENT; DIAGNOSIS; PEOPLE	Background: Patients with dementia may have limited capacity to give informed consent to participate in clinical research. One possible way to safeguard the patients' interests in research is the involvement of a proxy in the recruitment process. In Italy, the system of proxy is determined by the courts. In this study we evaluate the timing for appointment of a legal proxy in Italy and identify predictive variables of appointment. Methodology/Principal Findings: Subjects were recruited among the outpatients seeking medical advice for cognitive complaints at the Centre for Research and Treatment of Cognitive Dysfunctions, University of Milan, "Luigi Sacco'' Hospital. The Centre was participating to the AdCare Study, a no-profit randomised clinical trial coordinated by the Italian National Institute of Health. The requirement that informed consent be given by a legal representative dramatically slowed down the recruitment process in AdCare, which was prematurely interrupted. The Centre for Research and Treatment of Cognitive Dysfunctions collected data on the timing required to appoint the legal representatives. Patients diagnosed with dementia and their caregivers were provided information on the Italian law on legal agency (law 6/2004). At each scheduled check-up the caregiver was asked whether she/he had applied to appoint a legal proxy for the patient and the time interval between the presentation of the law, the registration of the application at the law court chancellery and the sentence of appointment was registered. The study involved 169 demented patients. Seventy-eight patients (46.2%) applied to appoint a legal proxy. These subjects were usually younger, had been suffering from dementia for a longer time, had less than two children and made more use of memantine. The mean interval time between the presentation of the law and the patients' application to the law court chancellery was two months. The mean interval time between the patient's application to the law court chancellery and the sentence of appointment was four months. Conclusions/Significance: In Italy the requirement that legal representatives be appointed by the courts slows down subjects' participation in research. Other procedures for legal agency of the incapacitated patients may be adopted, taking as examples other EU countries' systems.	[Gainotti, Sabina; Spila-Alegiani, Stefania; Galeotti, Francesca; Vanacore, Nicola; Raschetti, Roberto] Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy; [Imperatori, Susanna Fusari; Maggiore, Laura; Mariani, Claudio; Clerici, Francesca] Univ Milan, Chair Neurol, Ctr Res & Treatment Cognit Dysfunct, L Sacco Hosp, Milan, Italy; [Petrini, Carlo] Natl Inst Hlth, Bioeth Unit, Off President, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Milan; Luigi Sacco Hospital; Istituto Superiore di Sanita (ISS)	Gainotti, S (corresponding author), Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy.	francesca.clerici1@unimi.it	; gainotti, sabina/A-6651-2015	Petrini, Carlo/0000-0002-7895-4440; gainotti, sabina/0000-0002-6006-9064	Italian Association on Dementia Research: "Associazione per la Ricerca sulle Demenze - ARD ONLUS''; Italian Medicines Agency (AIFA) [FARM68SY5C]	Italian Association on Dementia Research: "Associazione per la Ricerca sulle Demenze - ARD ONLUS''; Italian Medicines Agency (AIFA)	This study was partially supported by the Italian Association on Dementia Research: "Associazione per la Ricerca sulle Demenze - ARD ONLUS'', and by the Italian Medicines Agency (AIFA) within the independent drug research program, contract no. FARM68SY5C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; BARBIERI MP, 2008, CAREGIVER AMMINISTRA; Campbell EG, 2006, NEW ENGL J MED, V355, P2321, DOI 10.1056/NEJMsa061457; Caulfield Timothy, 2005, Health Law Rev, V13, P58; Clerici F, 2009, DRUG AGING, V26, P321, DOI 10.2165/00002512-200926040-00003; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; *EUR FOR GOOD CLIN, EFGCP REP PROC ETH R; *EUR PARL, 2001, OFFICIAL J L, V121, P34; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Kim SYH, 2005, NEUROLOGY, V65, P1395, DOI 10.1212/01.wnl.0000183144.61428.73; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; *NAT RES ETH SERV, 2007, RES INV AD UN CONS; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nuremberg Military Tribunals, 1949, NUREMBERG CODE REPRI, V2, P181; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; SACHS GA, 1994, CLIN RES, V42, P403; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Stocking CB, 2003, NEUROLOGY, V61, P1649, DOI 10.1212/01.WNL.0000098888.97357.06; Warner J, 2008, LANCET, V372, P183, DOI 10.1016/S0140-6736(08)61049-1; World Medical Association, 2008, DECL HELS ETH PRINC; 2004, MONITEUR BELGE  0507	27	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11150	10.1371/journal.pone.0011150	http://dx.doi.org/10.1371/journal.pone.0011150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585400	Green Published, gold, Green Submitted			2022-12-25	WOS:000278886100015
J	Chen, KY; Gracheva, EO; Yu, SC; Sheng, Q; Richmond, J; Featherstone, DE				Chen, Kaiyun; Gracheva, Elena O.; Yu, Szi-Chieh; Sheng, Qi; Richmond, Janet; Featherstone, David E.			Neurexin in Embryonic Drosophila Neuromuscular Junctions	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR SUBUNIT; ALPHA-LATROTOXIN RECEPTOR; CELL-ADHESION; SYNAPTIC-TRANSMISSION; NEUROLIGIN; PROTEIN; CASK; BINDING; PRESERVATION; RECRUITMENT	Background: Neurexin is a synaptic cell adhesion protein critical for synapse formation and function. Mutations in neurexin and neurexin-interacting proteins have been implicated in several neurological diseases. Previous studies have described Drosophila neurexin mutant phenotypes in third instar larvae and adults. However, the expression and function of Drosophila neurexin early in synapse development, when neurexin function is thought to be most important, has not been described. Methodology/Principal Findings: We use a variety of techniques, including immunohistochemistry, electron microscopy, in situ hybridization, and electrophysiology, to characterize neurexin expression and phenotypes in embryonic Drosophila neuromuscular junctions (NMJs). Our results surprisingly suggest that neurexin in embryos is present both pre and postsynaptically. Presynaptic neurexin promotes presynaptic active zone formation and neurotransmitter release, but along with postsynaptic neurexin, also suppresses formation of ectopic glutamate receptor clusters. Interestingly, we find that loss of neurexin only affects receptors containing the subunit GluRIIA. Conclusions/Significance: Our study extends previous results and provides important detail regarding the role of neurexin in Drosophila glutamate receptor abundance. The possibility that neurexin is present postsynaptically raises new hypotheses regarding neurexin function in synapses, and our results provide new insights into the role of neurexin in synapse development.	[Chen, Kaiyun; Gracheva, Elena O.; Yu, Szi-Chieh; Sheng, Qi; Richmond, Janet; Featherstone, David E.] Univ Illinois, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chen, KY (corresponding author), Univ Illinois, Chicago, IL 60680 USA.	def@uic.edu		Gracheva, Elena O/0000-0002-0846-3427	National Institutes of Health (NIH/NINDS)	National Institutes of Health (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the National Institutes of Health (NIH/NINDS) to D.E.F. and J.E.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Bennett MR, 2008, AUST NZ J PSYCHIAT, V42, P662, DOI 10.1080/00048670802203467; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Brose N, 1999, NATURWISSENSCHAFTEN, V86, P516, DOI 10.1007/s001140050666; Chen K, 2005, J NEUROSCI, V25, P6667, DOI 10.1523/JNEUROSCI.1527-05.2005; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; CRAIG AM, 2007, CURR OPIN NEUROBIOL; De Robertis EDP, 1964, HISTOPHYSIOLOGY SYNA; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Glessner JT, 2009, AUTISM GENOME WIDE C; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gray E. G., 1966, International Review of General and Experimental Zoology, V2, P139; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hata Y, 1996, J NEUROSCI, V16, P2488; Heine M, 2008, P NATL ACAD SCI USA, V105, P20947, DOI 10.1073/pnas.0804007106; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; KITTEL RJ, 2006, SCIENCE; LEVINSON JN, 2005, J BIOL CHEM; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Lucic V, 2005, STRUCTURE, V13, P423, DOI 10.1016/j.str.2005.02.005; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin JR, 1996, EMBO J, V15, P1865, DOI 10.1002/j.1460-2075.1996.tb00537.x; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PETRENKO AG, 1991, NATURE, V353, P65, DOI 10.1038/353065a0; Prokop A, 1999, CELL TISSUE RES, V297, P169, DOI 10.1007/s004410051345; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Rostaing P, 2004, J HISTOCHEM CYTOCHEM, V52, P1, DOI 10.1177/002215540405200101; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; SUN M, 2009, NEUROSCI RES; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Weimer Robby M., 2006, V351, P203; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005; Zordan MA, 2005, J NEUROPHYSIOL, V94, P1074, DOI 10.1152/jn.00954.2004	68	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11115	10.1371/journal.pone.0011115	http://dx.doi.org/10.1371/journal.pone.0011115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559439	Green Submitted, Green Published, gold			2022-12-25	WOS:000278741100026
J	Leung, YK; Du, JA; Huang, Y; Yao, XQ				Leung, Yuk Ki; Du, Juan; Huang, Yu; Yao, Xiaoqiang			Cyclic Nucleotide-Gated Channels Contribute to Thromboxane A(2)-Induced Contraction of Rat Small Mesenteric Arteries	PLOS ONE			English	Article							INDUCED CA2+ INFLUX; SMOOTH-MUSCLE; ROD; ACTIVATION; EXPRESSION; CNGA2; CELLS; PHOTORECEPTORS; CALCIUM; KINASE	Background: Thromboxane A(2) (TxA(2))-induced smooth muscle contraction has been implicated in cardiovascular, renal and respiratory diseases. This contraction can be partly attributed to TxA(2)-induced Ca2+ influx, which resulted in vascular contraction via Ca2+-calmodulin-MLCK pathway. This study aims to identify the channels that mediate TxA(2)-induced Ca2+ influx in vascular smooth muscle cells. Methodology/Principal Findings: Application of U-46619, a thromboxane A(2) mimic, resulted in a constriction in endothelium-denuded small mesenteric artery segments. The constriction relies on the presence of extracellular Ca2+, because removal of extracellular Ca2+ abolished the constriction. This constriction was partially inhibited by an L-type Ca2+ channel inhibitor nifedipine (0.5-1 mu M). The remaining component was inhibited by L-cis-diltiazem, a selective inhibitor for CNG channels, in a dose-dependent manner. Another CNG channel blocker LY83583 [6-(phenylamino)-5,8-quinolinedione] had similar effect. In the primary cultured smooth muscle cells derived from rat aorta, application of U46619 (100 nM) induced a rise in cytosolic Ca2+ ([ Ca2+](i)), which was inhibited by L-cis-diltiazem. Immunoblot experiments confirmed the presence of CNGA(2) protein in vascular smooth muscle cells. Conclusions/Significance: These data suggest a functional role of CNG channels in U-46619-induced Ca2+ influx and contraction of smooth muscle cells.	[Leung, Yuk Ki; Du, Juan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Leung, Yuk Ki; Du, Juan; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Du, Juan] Anhui Med Univ, Dept Physiol, He Fei, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Anhui Medical University	Leung, YK (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk	Leung, Yuk Ki/J-9365-2015; Yao, Xiaoqiang/I-5413-2016; Huang, Yu/K-2866-2017	Leung, Yuk Ki/0000-0002-5726-0140; Yao, Xiaoqiang/0000-0002-0687-8186; Huang, Yu/0000-0002-1277-6784	Hong Kong Research Grants Council [CUHK477307, CUHK477408, CUHK479109]; Chinese University of Hong Kong (CUHK); Li Ka Shing Institute of Health Sciences	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); Li Ka Shing Institute of Health Sciences	This study was supported by Hong Kong Research Grants Council Grants (CUHK477307, CUHK477408 and CUHK479109), Focused Investment Scheme of the Chinese University of Hong Kong (CUHK) and Li Ka Shing Institute of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARITA H, 1989, PROG LIPID RES, V28, P273, DOI 10.1016/0163-7827(89)90002-7; Bonigk W, 1999, J NEUROSCI, V19, P5332; Cassar S, 2004, MOL VIS, V10, P808; Cheng KT, 2003, HISTOCHEM CELL BIOL, V120, P475, DOI 10.1007/s00418-003-0596-2; Cheng KT, 2008, ARTERIOSCL THROM VAS, V28, P913, DOI 10.1161/ATVBAHA.107.148338; Ding CL, 1997, AM J PHYSIOL-CELL PH, V272, pC1335, DOI 10.1152/ajpcell.1997.272.4.C1335; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kruse LS, 2006, NEUROSCI LETT, V404, P202, DOI 10.1016/j.neulet.2006.05.045; Kwan HY, 2010, J VASC RES, V47, P148, DOI 10.1159/000235969; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; OGLETREE ML, 1987, FED PROC, V46, P133; RISPOLI G, 1988, EUR BIOPHYS J BIOPHY, V16, P65; Sakariassen KS, 2009, FUTUR CARDIOL, V5, P479, DOI [10.2217/fca.09.33, 10.2217/FCA.09.33]; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Shen B, 2008, J MOL CELL CARDIOL, V45, P437, DOI 10.1016/j.yjmcc.2008.06.005; SHORE SA, 1989, LUNG CELL BIOL, V41, P1012; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; STERN JH, 1986, P NATL ACAD SCI USA, V83, P1163, DOI 10.1073/pnas.83.4.1163; Tosun M, 1998, J PHARMACOL EXP THER, V284, P921; Tsang SY, 2004, HYPERTENSION, V44, P78, DOI 10.1161/01.HYP.0000131659.27081.19; Wilson DP, 2005, BIOCHEM J, V389, P763, DOI 10.1042/BJ20050237; Yao XQ, 1999, CARDIOVASC RES, V41, P282, DOI 10.1016/S0008-6363(98)00158-8; Yao XQ, 1999, LIFE SCI, V65, P55, DOI 10.1016/S0024-3205(99)00218-0	27	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11098	10.1371/journal.pone.0011098	http://dx.doi.org/10.1371/journal.pone.0011098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559420	gold, Green Submitted, Green Published			2022-12-25	WOS:000278741100012
J	Hakalahti, AE; Vierimaa, MM; Lilja, MK; Kumpula, EP; Tuusa, JT; Petaja-Repo, UE				Hakalahti, Anna E.; Vierimaa, Miia M.; Lilja, Minna K.; Kumpula, Esa-Pekka; Tuusa, Jussi T.; Petaja-Repo, Ulla E.			Human beta(1)-Adrenergic Receptor Is Subject to Constitutive and Regulated N-terminal Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; DELTA-OPIOID RECEPTOR; LUTEINIZING-HORMONE RECEPTOR; BETA-ADRENERGIC-RECEPTORS; V-2 VASOPRESSIN RECEPTOR; MEDIATED DOWN-REGULATION; ALPHA-CONVERTING ENZYME; ENDOPLASMIC-RETICULUM; BETA(2)-ADRENERGIC RECEPTORS; O-GLYCOSYLATION	The beta(1)-adrenergic receptor (beta(1)AR) is the predominant beta AR in the heart, mediating the catecholamine-stimulated increase in cardiac rate and force of contraction. Regulation of this important G protein-coupled receptor is nevertheless poorly understood. We describe here the biosynthetic profile of the human beta(1)AR and reveal novel features relevant to its regulation using an inducible heterologous expression system in HEK293(i) cells. Metabolic pulse-chase labeling and cell surface biotinylation assays showed that the synthesized receptors are efficiently and rapidly transported to the cell surface. The N terminus of the mature receptor is extensively modified by sialylated mucin-type O-glycosylation in addition to one N-glycan attached to Asn(15). Furthermore, the N terminus was found to be subject to limited proteolysis, resulting in two membrane-bound C-terminal fragments. N-terminal sequencing of the fragments identified two cleavage sites between Arg(31) and Leu(32) and Pro(52) and Leu(53), which were confirmed by cleavage site and truncation mutants. Metalloproteinase inhibitors were able to inhibit the cleavage, suggesting that it is mediated by a matrix metalloproteinase or a disintegrin and metalloproteinase (ADAM) family member. Most importantly, the N-terminal cleavage was found to occur not only in vitro but also in vivo. Receptor activation mediated by the beta AR agonist isoproterenol enhanced the cleavage in a concentration-and time-dependent manner, and it was also enhanced by direct stimulation of protein kinase C and adenylyl cyclase. Mutation of the Arg(31)-Leu(32) cleavage site stabilized the mature receptor. We hypothesize that the N-terminal cleavage represents a novel regulatory mechanism of cell surface beta(1)ARs.	[Hakalahti, Anna E.; Vierimaa, Miia M.; Lilja, Minna K.; Kumpula, Esa-Pekka; Tuusa, Jussi T.; Petaja-Repo, Ulla E.] Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, FI-90014 Oulu, Finland	University of Oulu	Petaja-Repo, UE (corresponding author), Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, FI-90014 Oulu, Finland.	Ulla.Petaja-Repo@oulu.fi	Petäjä-Repo, Ulla/AAV-6115-2021	Kumpula, Esa-Pekka/0000-0003-0335-5993	Sigrid Juselius Foundation; Academy of Finland [107922, 127199]; Finnish Foundation for Cardiovascular Research; Finnish Medical Society Duodecim	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Finnish Medical Society Duodecim	This work was supported in part by the Sigrid Juselius Foundation and Grants 107922 and 127199 from the Academy of Finland.; Supported by the Finnish Foundation for Cardiovascular Research and the Finnish Medical Society Duodecim.	Ando T, 2002, J CLIN INVEST, V110, P1667, DOI 10.1172/JCI200216991; Apaja PM, 2006, MOL BIOL CELL, V17, P2243, DOI 10.1091/mbc.E05-09-0875; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; BENOVIC JL, 1983, BIOCHEM BIOPH RES CO, V110, P504, DOI 10.1016/0006-291X(83)91178-6; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Brodde OE, 2006, J PHARMACOL SCI, V100, P323, DOI 10.1254/jphs.CRJ06001X; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Chazenbalk GD, 2004, ENDOCRINOLOGY, V145, P4, DOI 10.1210/en.2003-1002; Couet J, 1996, J BIOL CHEM, V271, P4545; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dunigan CD, 2002, BIOCHEMISTRY-US, V41, P8019, DOI 10.1021/bi025538r; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; GREEN SA, 1994, J BIOL CHEM, V269, P26215; Gupta A, 2008, J BIOL CHEM, V283, P10735, DOI 10.1074/jbc.M709454200; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Hall RA, 2004, SEMIN CELL DEV BIOL, V15, P281, DOI 10.1016/j.semcdb.2003.12.017; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jockers R, 1999, J BIOL CHEM, V274, P28900, DOI 10.1074/jbc.274.41.28900; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; JURSS R, 1985, BIOCHEMISTRY-US, V24, P3349; Kaezur V, 2007, J MOL RECOGNIT, V20, P392, DOI 10.1002/jmr.851; Kojro E, 1999, EUR J BIOCHEM, V266, P538, DOI 10.1046/j.1432-1327.1999.00892.x; KOJRO E, 1995, J BIOL CHEM, V270, P6476, DOI 10.1074/jbc.270.12.6476; KOZUKA M, 1991, J BIOL CHEM, V266, P16892; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Leskela TT, 2009, TRAFFIC, V10, P116, DOI 10.1111/j.1600-0854.2008.00846.x; Li JG, 2007, BIOCHEMISTRY-US, V46, P10960, DOI 10.1021/bi700443j; Liang W, 2004, J CELL SCI, V117, P723, DOI 10.1242/jcs.00878; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; Ludeman MJ, 2004, J BIOL CHEM, V279, P18592, DOI 10.1074/jbc.M310836200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; McLean AJ, 2000, BRIT J PHARMACOL, V130, P1825, DOI 10.1038/sj.bjp.0703506; Michineau S, 2006, BIOCHEMISTRY-US, V45, P2699, DOI 10.1021/bi051674v; Nakagawa M, 2001, FEBS LETT, V496, P19, DOI 10.1016/S0014-5793(01)02392-4; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rousseau G, 1996, MOL PHARMACOL, V49, P752; RUTLEDGE EA, 1994, BLOOD, V83, P580; Sadeghi H, 1999, GLYCOBIOLOGY, V9, P731, DOI 10.1093/glycob/9.7.731; Shiina T, 2000, J BIOL CHEM, V275, P29082, DOI 10.1074/jbc.M909757199; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; STILES GL, 1983, J BIOL CHEM, V258, P8443; SUZUKI T, 1992, MOL PHARMACOL, V41, P542; UMEMOTO J, 1977, J BIOL CHEM, V252, P8609; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; YARDEN Y, 1986, P NATL ACAD SCI USA, V83, P6795, DOI 10.1073/pnas.83.18.6795	59	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28850	28861		10.1074/jbc.M110.149989	http://dx.doi.org/10.1074/jbc.M110.149989			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20587416	Green Published, hybrid			2022-12-25	WOS:000281594000050
J	Paggetti, J; Largeot, A; Aucagne, R; Jacquel, A; Lagrange, B; Yang, XJ; Solary, E; Bastie, JN; Delva, L				Paggetti, J.; Largeot, A.; Aucagne, R.; Jacquel, A.; Lagrange, B.; Yang, X-J; Solary, E.; Bastie, J-N; Delva, L.			Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+cells	ONCOGENE			English	Article						MOZ; MLL; HOX genes; human CD34+cells	HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; ZINC-FINGER PROTEIN; HISTONE ACETYLTRANSFERASE COMPLEXES; CREB-BINDING-PROTEIN; HOMEOBOX GENES; TRANSCRIPTIONAL REGULATION; METHYLATION; H3; METHYLTRANSFERASE	MOZ and MLL, encoding a histone acetyltransferase (HAT) and a histone methyltransferase, respectively, are targets for recurrent chromosomal translocations found in acute myeloblastic or lymphoblastic leukemia. In MOZ (MOnocytic leukemia Zinc-finger protein)/CBP- or mixed lineage leukemia (MLL)-rearranged leukemias, abnormal levels of HOX transcription factors have been found to be critical for leukemogenesis. We show that MOZ and MLL cooperate to regulate these key genes in human cord blood CD34+ cells. These chromatin-modifying enzymes interact, colocalize and functionally cooperate, and both are recruited to multiple HOX promoters. We also found that WDR5, an adaptor protein essential for lysine 4 trimethylation of histone H3 (H3K4me3) by MLL, colocalizes and interacts with MOZ. We detected the binding of the HAT MOZ to H3K4me3, thus linking histone methylation to acetylation. In CD34+ cells, depletion of MLL causes release of MOZ from HOX promoters, which is correlated to defective histone activation marks, leading to repression of HOX gene expression and alteration of commitment of CD34+ cells into myeloid progenitors. Thus, our results unveil the role of the interaction between MOZ and MLL in CD34+ cells in which both proteins have a critical role in hematopoietic cell-fate decision, suggesting a new molecular mechanism by which MOZ or MLL deregulation leads to leukemogenesis. Oncogene (2010) 29, 5019-5031; doi:10.1038/onc.2010.254; published online 28 June 2010	[Paggetti, J.; Largeot, A.; Aucagne, R.; Jacquel, A.; Lagrange, B.; Bastie, J-N; Delva, L.] Univ Burgundy, Fac Med, INSERM, UMR 866, Dijon, France; [Yang, X-J] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ, Canada; [Solary, E.] Inst Gustave Roussy, INSERM, UMR 1009, F-94805 Villejuif, France; [Bastie, J-N] Univ Hosp CHU, Dept Clin Hematol, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CHU Dijon Bourgogne	Delva, L (corresponding author), Univ Bourgogne, Fac Med, IFR Sante STIC, INSERM,Ctr Rech,UMR 866, 7 Blvd Jeanne dArc, F-21000 Dijon, France.	Laurent.Delva@u-bourgogne.fr	Paggetti, Jerome/I-2786-2019; Jacquel, Arnaud/O-1928-2017; Jacquel, Arnaud/AAJ-4760-2021	Paggetti, Jerome/0000-0001-9460-5876; Jacquel, Arnaud/0000-0001-5062-8048; Jacquel, Arnaud/0000-0001-5062-8048; Aucagne, Romain/0000-0002-5644-3287; Solary, Eric/0000-0002-8629-1341; DELVA, Laurent/0000-0002-1086-3964; Largeot, Anne/0000-0002-9388-8461; Lagrange, Brice/0000-0002-4131-5995	Fondation de France (Leukemia Committee); Ligue contre le Cancer (Cote d'Or committee); Ligue contre le Cancer (Rhone committee); Conseil Regional de Bourgogne (FABER); Faculty of Medicine, Dijon; National Institute of Cancer; Ligue Nationale contre le Cancer; Agence Nationale de la Recherche of France; Canadian Cancer Society; Ministere de l'Enseignement Superieur et de la Recherche of France; Association pour la Recherche sur le Cancer (ARC); Inserm; Region Bourgogne; Ligue contre le Cancer; Saone-et-Loire committee; National committee	Fondation de France (Leukemia Committee)(Fondation de France); Ligue contre le Cancer (Cote d'Or committee); Ligue contre le Cancer (Rhone committee); Conseil Regional de Bourgogne (FABER)(Region Bourgogne-Franche-Comte); Faculty of Medicine, Dijon; National Institute of Cancer; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche of France(French National Research Agency (ANR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Ministere de l'Enseignement Superieur et de la Recherche of France; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Bourgogne(Region Bourgogne-Franche-Comte); Ligue contre le Cancer(Ligue nationale contre le cancer); Saone-et-Loire committee; National committee	We gratefully acknowledge Amandine Bataille, Amandine Chlemaire and Franck Menetrier for immunocytofluorescence assays; Andre Bouchot for epifluorescence microscopy; and Christine Arnould for confocal analysis (SERCOBIO, Universite de Bourgogne), and the Etablissement Francais du Sang (EFS) of Bourgogne Franche-Comte, which kindly supplied the cord blood buffy coats. We also thank Mustapha Oulad-Abdelghani for producing the anti-MOZ antibody. We thank Robert Slany, Issai Kitabayashi, Paul Shore, Michael Cleary and Edward Chan for providing plasmids. We appreciate the fine work performed by Magali Belt in correction of English text. This work was supported by funds from the Fondation de France (Leukemia Committee to LD), the Ligue contre le Cancer (Cote d'Or committee to LD), the Ligue contre le Cancer (Rhone committee to LD), the Conseil Regional de Bourgogne (FABER to LD), the Faculty of Medicine (to J-NB) in Dijon, the National Institute of Cancer (to ES), the Ligue Nationale contre le Cancer (Label to ES), the Agence Nationale de la Recherche of France (to ES and LD) and the Canadian Cancer Society (to XJY). JP was supported by fellowships from the Ministere de l'Enseignement Superieur et de la Recherche of France and the Association pour la Recherche sur le Cancer (ARC). AL was supported by fellowships from the Inserm and the Region Bourgogne. RA and AJ were supported by fellowships from the Ligue contre le Cancer, Saone-et-Loire committee and national committee, respectively. BL was supported by fellowships from the Ministere de l'Enseignement Superieur et de la Recherche of France.	Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; BORRESEN B, 1996, P 10 INT S MOLT SALT, V7, P11; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Bristow CAP, 2003, NUCLEIC ACIDS RES, V31, P2735, DOI 10.1093/nar/gkg401; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Champagne N, 2001, ONCOGENE, V20, P404, DOI 10.1038/sj.onc.1204114; Chan EM, 2007, EXP HEMATOL, V35, P1782, DOI 10.1016/j.exphem.2007.07.015; Crooks GM, 1999, BLOOD, V94, P519, DOI 10.1182/blood.V94.2.519.414k20_519_528; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Esteyries S, 2008, LEUKEMIA, V22, P663, DOI 10.1038/sj.leu.2404930; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Huang G, 2008, BLOOD, V112, P110; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kindle KB, 2005, MOL CELL BIOL, V25, P988, DOI 10.1128/MCB.25.3.988-1002.2005; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; KNITTEL T, 1995, DEVELOPMENT, V121, P1077; Kohlmann A, 2005, LEUKEMIA, V19, P953, DOI 10.1038/sj.leu.2403746; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nabirochkina E, 2002, MECH DEVELOP, V114, P119, DOI 10.1016/S0925-4773(02)00035-7; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Ohta K, 2005, J HEALTH SCI, V51, P253, DOI 10.1248/jhs.51.253; Ohta K, 2007, BIOCHEM J, V402, P559, DOI 10.1042/BJ20061194; Pelletier N, 2002, ONCOGENE, V21, P2729, DOI 10.1038/sj.onc.1205367; Perez-Campo FM, 2009, BLOOD, V113, P4866, DOI 10.1182/blood-2008-04-152017; Rokudai S, 2009, J BIOL CHEM, V284, P237, DOI 10.1074/jbc.M805101200; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SHEN WF, 1989, P NATL ACAD SCI USA, V86, P8536, DOI 10.1073/pnas.86.21.8536; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; van Oostveen JW, 1999, LEUKEMIA, V13, P1675, DOI 10.1038/sj.leu.2401562; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	62	40	40	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	36					5019	5031		10.1038/onc.2010.254	http://dx.doi.org/10.1038/onc.2010.254			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	647LN	20581860				2022-12-25	WOS:000281620100003
J	Stratton, RC; Squires, PE; Green, AK				Stratton, Rebecca C.; Squires, Paul E.; Green, Anne K.			17 beta-Estradiol Elevates cGMP and, via Plasma Membrane Recruitment of Protein Kinase GI alpha, Stimulates Ca2+ Efflux from Rat Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; ATRIAL-NATRIURETIC-PEPTIDE; ESTROGEN-RECEPTOR-ALPHA; PARTICULATE GUANYLYL CYCLASE; NON-GENOMIC ACTIONS; ER-ALPHA; CALCIUM OSCILLATIONS; PUMP ISOFORMS; ESTRADIOL; CELLS	Rapid non-genomic effects of 17 beta-estradiol, the principal circulating estrogen, have been observed in a wide variety of cell types. Here we investigate rapid signaling effects of 17 beta-estradiol in rat hepatocytes. We show that, above a threshold concentration of 1 nM, 17 beta-estradiol, but not 17 alpha-estradiol, stimulates particulate guanylyl cyclase to elevate cGMP, which through activation and plasma membrane recruitment of protein kinase G isoform I alpha, stimulates plasma membrane Ca2+-ATPase-mediated Ca2+ efflux from rat hepatocytes. These effects are extremely rapid in onset and are mimicked by a membrane-impermeant 17 beta-estradiol-BSA conjugate, suggesting that 17 beta-estradiol acts at the extracellular face of the plasma membrane. We also show that 17 beta-estradiol binds specifically to the intact hepatocyte plasma membrane through an interaction that is competed by an excess of atrial natriuretic peptide but also shows many similarities to the pharmacological characteristics of the putative gamma-adrenergic receptor. We, therefore, propose that the observed rapid signaling effects of 17 beta-estradiol are mediated either through the guanylyl cyclase A receptor for atrial natriuretic peptide or through the gamma-adrenergic receptor, which is either itself a transmembrane guanylyl cyclase or activates a transmembrane guanylyl cyclase through cross-talk signaling.	[Stratton, Rebecca C.; Squires, Paul E.; Green, Anne K.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Green, AK (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	A.K.Green@warwick.ac.uk		Squires, Paul/0000-0003-4547-6777	University of Warwick; Biotechnology and Biological Sciences Research Council	University of Warwick; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The University of Warwick Research Development Fund and a Biotechnology and Biological Sciences Research Council-funded Ph.D. studentship (to R. C. S.).	Abou-Mohamed G, 2003, PHARMACOLOGY, V69, P20, DOI 10.1159/000071268; Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BENHAM CD, 1988, J PHYSIOL-LONDON, V404, P767, DOI 10.1113/jphysiol.1988.sp017318; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; Biswas KH, 2009, J MOL EVOL, V68, P587, DOI 10.1007/s00239-009-9242-5; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bracamonte MP, 2002, AM J PHYSIOL-HEART C, V283, pH2389, DOI 10.1152/ajpheart.00184.2002; Bruges G, 2007, J RECEPT SIG TRANSD, V27, P189, DOI 10.1080/10799890701417899; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Chen ZJ, 1998, BIOCHEM BIOPH RES CO, V252, P639, DOI 10.1006/bbrc.1998.9716; Clarke R, 2001, PHARMACOL REV, V53, P25; de Vries AH, 2009, J HEPATOL, V50, pS66, DOI 10.1016/S0168-8278(09)60157-4; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Dostmann WRG, 2002, PHARMACOL THERAPEUT, V93, P203, DOI 10.1016/S0163-7258(02)00189-4; El-Mowafy AM, 2007, NUTR METAB CARDIOVAS, V17, P508, DOI 10.1016/j.numecd.2006.04.008; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Golden GA, 1998, CLIN NEUROPHARMACOL, V21, P181; Green AK, 2002, GASTROENTEROLOGY, V123, P1291, DOI 10.1053/gast.2002.35994; Green AK, 1999, CELL CALCIUM, V25, P173, DOI 10.1054/ceca.1998.0017; Green AK, 1997, CELL CALCIUM, V22, P99, DOI 10.1016/S0143-4160(97)90110-X; Green AK, 2007, J BIOL CHEM, V282, P34542, DOI 10.1074/jbc.M707115200; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; HIRST GDS, 1980, NATURE, V283, P767, DOI 10.1038/283767a0; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; HOWARD A, 1994, BIOCHEM J, V303, P275, DOI 10.1042/bj3030275; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Kan WH, 2008, ANN SURG, V248, P294, DOI 10.1097/SLA.0b013e318180a3db; Keung W, 2005, BRIT J PHARMACOL, V144, P71, DOI 10.1038/sj.bjp.0706018; Kim KH, 2009, IET ELECTR POWER APP, V3, P8, DOI 10.1049/iet-epa:20080030; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kummer U, 2005, BIOPHYS J, V89, P1603, DOI 10.1529/biophysj.104.057216; Leal AM, 1998, BIOCHEM PHARMACOL, V56, P1463, DOI 10.1016/S0006-2952(98)00248-2; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Marhl M, 2008, J THEOR BIOL, V252, P419, DOI 10.1016/j.jtbi.2007.11.006; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Morales A, 2005, EUR J NEUROSCI, V22, P2207, DOI 10.1111/j.1460-9568.2005.04432.x; Morales A, 2003, EUR J NEUROSCI, V18, P2505, DOI 10.1046/j.1460-9568.2003.02997.x; MURDOCH FE, 1991, MOL CELL ENDOCRINOL, V78, pC103, DOI 10.1016/0303-7207(91)90114-8; Nadal A, 2004, STEROIDS, V69, P531, DOI 10.1016/j.steroids.2004.05.010; Nadal A, 1998, FASEB J, V12, P1341, DOI 10.1096/fasebj.12.13.1341; Nadal A, 2000, P NATL ACAD SCI USA, V97, P11603, DOI 10.1073/pnas.97.21.11603; Nethrapalli IS, 2005, ENDOCRINOLOGY, V146, P56, DOI 10.1210/en.2004-1106; Numakawa Y, 2007, ENDOCRINOLOGY, V148, P627, DOI 10.1210/en.2006-1210; Olesen SP, 1998, BRIT J PHARMACOL, V123, P299, DOI 10.1038/sj.bjp.0701603; Pahle J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-139; Pande J, 2006, AM J PHYSIOL-CELL PH, V290, pC1341, DOI 10.1152/ajpcell.00573.2005; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; PIETRAS RJ, 1980, BIOCHEM J, V191, P743, DOI 10.1042/bj1910743; Piggott LA, 2006, J GEN PHYSIOL, V128, P3, DOI 10.1085/jgp.200509403; Pinkse MWH, 2009, J BIOL CHEM, V284, P16354, DOI 10.1074/jbc.M808521200; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Prakash YS, 1999, AM J PHYSIOL-HEART C, V276, pH926, DOI 10.1152/ajpheart.1999.276.3.H926; Prevot V, 1999, ENDOCRINOLOGY, V140, P652, DOI 10.1210/en.140.2.652; Pyriochou A, 2005, CELL SIGNAL, V17, P407, DOI 10.1016/j.cellsig.2004.09.008; Rambotti MG, 2000, HISTOCHEM J, V32, P231, DOI 10.1023/A:1004003101495; RASHATWAR SS, 1987, P NATL ACAD SCI USA, V84, P5685, DOI 10.1073/pnas.84.16.5685; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Rho EH, 2002, J APPL PHYSIOL, V92, P257, DOI 10.1152/jappl.2002.92.1.257; Ricchi M, 2006, J GASTROEN HEPATOL, V21, P894, DOI 10.1111/j.1440-1746.2006.04144.x; Ropero AB, 2002, MOL ENDOCRINOL, V16, P497, DOI 10.1210/me.16.3.497; Ropero AB, 1999, J PHYSIOL-LONDON, V521, P397, DOI 10.1111/j.1469-7793.1999.00397.x; Rossi AM, 2002, J CELL BIOCHEM, V87, P324, DOI 10.1002/jcb.10303; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Samadi A, 2002, PFLUG ARCH EUR J PHY, V444, P700, DOI 10.1007/s00424-002-0889-7; SanchezBueno A, 1997, CELL CALCIUM, V21, P125, DOI 10.1016/S0143-4160(97)90036-1; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Scheving LA, 1996, CANCER RES, V56, P5186; Soderling SH, 1998, J BIOL CHEM, V273, P15553, DOI 10.1074/jbc.273.25.15553; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Stratton RC, 2008, BIOCHEM BIOPH RES CO, V368, P965, DOI 10.1016/j.bbrc.2008.02.030; Su J, 2005, EXP BIOL MED, V230, P242; Szemraj J, 2003, POL J PHARMACOL, V55, P887; Taguchi Yasuto, 2004, Nucl Recept, V2, P5, DOI 10.1186/1478-1336-2-5; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; Vilatoba M, 2005, TRANSPL P, V37, P399, DOI 10.1016/j.transproceed.2004.12.053; Wagner AH, 2001, FASEB J, V15, P2121, DOI 10.1096/fj.01-0123com; Walf AA, 2008, STEROIDS, V73, P997, DOI 10.1016/j.steroids.2008.01.025; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; Yawo H, 1999, J NEUROSCI, V19, P5293; Yoshida Y, 1999, MOL CELL BIOCHEM, V190, P157, DOI 10.1023/A:1006991032073; Yunoki M, 2003, N-S ARCH PHARMACOL, V367, P76, DOI 10.1007/s00210-002-0667-2; Zabel U, 2002, NAT CELL BIOL, V4, P307, DOI 10.1038/ncb775; Zaitsu M, 2007, MOL IMMUNOL, V44, P1977, DOI 10.1016/j.molimm.2006.09.030; Zolle O, 2000, J BIOL CHEM, V275, P25892, DOI 10.1074/jbc.M000786200; Zylinska L, 1999, BBA-MOL CELL BIOL L, V1437, P257, DOI 10.1016/S1388-1981(99)00015-3	97	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27201	27212		10.1074/jbc.M110.103630	http://dx.doi.org/10.1074/jbc.M110.103630			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566641	Green Published, hybrid			2022-12-25	WOS:000281172700051
J	Sun, TJ; Hayakawa, K; Bateman, KS; Fraser, ME				Sun, Tianjun; Hayakawa, Koto; Bateman, Katherine S.; Fraser, Marie E.			Identification of the Citrate-binding Site of Human ATP-Citrate Lyase Using X-ray Crystallography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUCCINYL-COA SYNTHETASE; ESCHERICHIA-COLI; PROTEIN-KINASE; CRYSTAL-STRUCTURE; COENZYME-A; ENZYME; LIVER; PHOSPHORYLATION; DIPHOSPHATE; ACTIVATION	ATP-citrate lyase (ACLY) catalyzes the conversion of citrate and CoA into acetyl-CoA and oxaloacetate, coupled with the hydrolysis of ATP. In humans, ACLY is the cytoplasmic enzyme linking energy metabolism from carbohydrates to the production of fatty acids. In situ proteolysis of full-length human ACLY gave crystals of a truncated form, revealing the conformations of residues 2-425, 487-750, and 767-820 of the 1101-amino acid protein. Residues 2-425 form three domains homologous to the beta-subunit of succinyl-CoA synthetase (SCS), while residues 487-820 form two domains homologous to the alpha-subunit of SCS. The crystals were grown in the presence of tartrate or the substrate, citrate, and the structure revealed the citrate-binding site. A loop formed by residues 343-348 interacts via specific hydrogen bonds with the hydroxyl and carboxyl groups on the prochiral center of citrate. Arg-379 forms a salt bridge with the pro-R carboxylate of citrate. The pro-S carboxylate is free to react, providing insight into the stereospecificity of ACLY. Because this is the first structure of any member of the acyl-CoA synthetase (NDP-forming) superfamily in complex with its organic acid substrate, locating the citrate-binding site is significant for understanding the catalytic mechanism of each member, including the prototype SCS. Comparison of the CoA-binding site of SCSs with the similar structure in ACLY showed that ACLY possesses a different CoA-binding site. Comparisons of the nucleotide-binding site of SCSs with the similar structure in ACLY indicates that this is the ATP-binding site of ACLY.	[Sun, Tianjun; Hayakawa, Koto; Bateman, Katherine S.; Fraser, Marie E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Fraser, ME (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	frasm@ucalgary.ca		Fraser, Marie/0000-0001-8501-1494	Canadian Institutes of Health Research (CIHR) [MOP-42446]; Natural Sciences and Engineering Research Council of Canada (NSERC); National Institutes of Health; National Science Foundation; University of California; Henry Wheeler; Alberta Science and Research Authority; Alberta Heritage Foundation for Medical Research; NSERC; NRC; University of Saskatchewan	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of California(University of California System); Henry Wheeler; Alberta Science and Research Authority; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NRC(National Research Centre (NRC)); University of Saskatchewan	The work was supported through an operating grant from the Canadian Institutes of Health Research (CIHR) (Grant MOP-42446) and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). X-ray diffraction data were collected at the Canadian Macromolecular Crystallography Facility, beamline 08ID-1, of the Canadian Light Source (CLS) and at beamline 8.3.1 of the Advanced Light Source (ALS) at Lawrence Berkeley Lab, under an agreement with the Alberta Synchrotron Institute (ASI). The ALS is operated by the Dept. of Energy and supported by the National Institutes of Health. Beamline 8.3.1 was funded by the National Science Foundation, the University of California and Henry Wheeler. The ASI synchrotron access program was supported by grants from the Alberta Science and Research Authority and the Alberta Heritage Foundation for Medical Research. The CLS is supported by NSERC, NRC, CIHR, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoshima M, 2004, MOL MICROBIOL, V52, P751, DOI 10.1111/j.1365-2958.2004.04009.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman KS, 2002, BIOCHEMISTRY-US, V41, P14455, DOI 10.1021/bi020568f; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Clapham JC, 2007, DIABETES OBES METAB, V9, P259, DOI 10.1111/j.1463-1326.2006.00608.x; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; COTTAM GL, 1969, ARCH BIOCHEM BIOPHYS, V130, P304, DOI 10.1016/0003-9861(69)90037-X; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng JP, 2004, ACTA CRYSTALLOGR D, V60, P203, DOI 10.1107/S0907444903024491; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; ELSHOURBAGY NA, 1992, EUR J BIOCHEM, V204, P491, DOI 10.1111/j.1432-1033.1992.tb16659.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; Fraser ME, 2006, J BIOL CHEM, V281, P11058, DOI 10.1074/jbc.M511785200; Fraser ME, 2000, J MOL BIOL, V299, P1325, DOI 10.1006/jmbi.2000.3807; Fraser ME, 1999, J MOL BIOL, V285, P1633, DOI 10.1006/jmbi.1998.2324; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Groot Pieter H. E., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P211, DOI 10.2174/1568013033483357; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANSON KR, 1966, J AM CHEM SOC, V88, P2731, DOI 10.1021/ja00964a022; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; INOUE H, 1967, BIOCHEM BIOPH RES CO, V26, P602, DOI 10.1016/0006-291X(67)90108-8; INOUE H, 1966, J BIOCHEM, V60, P543, DOI 10.1093/oxfordjournals.jbchem.a128474; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joyce MA, 1999, BIOCHEMISTRY-US, V38, P7273, DOI 10.1021/bi990527s; Joyce MA, 2000, BIOCHEMISTRY-US, V39, P17, DOI 10.1021/bi991696f; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; KAUFMAN S, 1953, Fed Proc, V12, P704; Kim W, 2006, J BACTERIOL, V188, P6544, DOI 10.1128/JB.00523-06; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; PIERCE MW, 1981, J BIOL CHEM, V256, P8867; Potapova IA, 2000, BIOCHEMISTRY-US, V39, P1169, DOI 10.1021/bi992159y; RAMAKRISHNA S, 1990, BIOCHEMISTRY-US, V29, P7617, DOI 10.1021/bi00485a011; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Sambrook J, 2001, MOL CLONING LAB MANU; SANADI DR, 1956, J BIOL CHEM, V218, P505; Sanchez LB, 2000, J BIOL CHEM, V275, P5794, DOI 10.1074/jbc.275.8.5794; SINGH M, 1976, J BIOL CHEM, V251, P5242; SRERE PA, 1964, J BIOL CHEM, V239, P714; SRERE PA, 1953, J AM CHEM SOC, V75, P4874, DOI 10.1021/ja01115a547; Traini M, 1998, ELECTROPHORESIS, V19, P1941, DOI 10.1002/elps.1150191112; WEITZMAN PDJ, 1981, ADV MICROB PHYSIOL, V22, P185, DOI 10.1016/S0065-2911(08)60328-8; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; WELLS TNC, 1991, EUR J BIOCHEM, V199, P163, DOI 10.1111/j.1432-1033.1991.tb16105.x; WOLODKO WT, 1994, J BIOL CHEM, V269, P10883	60	65	70	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27418	27428		10.1074/jbc.M109.078667	http://dx.doi.org/10.1074/jbc.M109.078667			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558738	Green Published, hybrid			2022-12-25	WOS:000281172700071
J	Ishii, I; Akahoshi, N; Yamada, H; Nakano, S; Izumi, T; Suematsu, M				Ishii, Isao; Akahoshi, Noriyuki; Yamada, Hidenori; Nakano, Shintaro; Izumi, Takashi; Suematsu, Makoto			Cystathionine gamma-Lyase-deficient Mice Require Dietary Cysteine to Protect against Acute Lethal Myopathy and Oxidative Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-METABOLISM; BETA-SYNTHASE; ENDOTHELIAL DYSFUNCTION; HOMOCYSTEINE METABOLISM; GLUTATHIONE SYNTHESIS; TRANS-SULFURATION; ANIMAL-MODEL; METHIONINE; MOUSE; PATHWAY	Cysteine is considered a nonessential amino acid in mammals as it is synthesized from methionine via trans-sulfuration. However, premature infants or patients with hepatic failure may require dietary cysteine due to a lack of cystathionine gamma-lyase (CTH), a key trans-sulfuration enzyme. Here, we generated CTH-deficient (Cth(-/-)) mice as an animal model of cystathioninemia/cystathioninuria. Cth(-/-) mice developed normally in general but displayed hypercystathioninemia/hyperhomocysteinemia though not hypermethioninemia. When fed a low cyst(e)ine diet, Cth(-/-) mice showed acute skeletal muscle atrophy (myopathy) accompanied by enhanced gene expression of asparagine synthetase and reduced contents of glutathione in livers and skeletal muscles, and intracellular accumulation of LC3 and p62 in skeletal myofibers; they finally died of severe paralysis of the extremities. Cth(-/-) hepatocytes required cystine in a culture medium and showed greater sensitivity to oxidative stress. Cth(-/-) mice exhibited systemic vulnerability to oxidative injury, which became more prominent when they were fed the low cyst(e) ine diet. These results reveal novel roles of trans-sulfuration previously unrecognized in mice lacking another trans-sulfuration enzyme cystathionine beta-synthase (Cbs(-/-)). Because Cbs(-/-) mice display hyperhomocysteinemia and hypermethioninemia, our results raise questions against the homocysteine-based etiology of CBS deficiency and the current newborn screening for homocysteinemia using Guthrie's method, which detects hypermethioninemia.	[Ishii, Isao; Akahoshi, Noriyuki; Yamada, Hidenori; Nakano, Shintaro; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Ishii, Isao; Akahoshi, Noriyuki; Yamada, Hidenori] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Gunma 3718511, Japan; [Izumi, Takashi] Gunma Univ, Grad Sch Med, Dept Biochem, Gunma 3718511, Japan	Keio University; Gunma University; Gunma University	Ishii, I (corresponding author), Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	isao-ishii@umin.ac.jp	Suematsu, Makoto/I-8135-2013; Suematsu, Makoto/O-5762-2018	Suematsu, Makoto/0000-0002-7165-6336; Suematsu, Makoto/0000-0002-7165-6336; Ishii, Isao/0000-0002-5367-205X	Ministry of Education, Culture, Sports, Science and Technology of Japan [18590047, 22590292, 22790219, 17GS0419]; Japan Science and Technology Agency; Gunma University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Gunma University	This work was supported by Grants-in-aid for Scientific Research 18590047 and 22590292 (to I. I.) and 22790219 (to N. A.), Leading Project for Biosimulation (to M. S.), and Creative Science Research 17GS0419 (to M. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a research grant for Feasibility Study (to I. I.) from the Japan Science and Technology Agency; and research grants from Gunma University (to I. I. and N. A.)	Akahoshi N, 2008, HUM MOL GENET, V17, P1994, DOI 10.1093/hmg/ddn097; Akahoshi N, 2006, BIOL PHARM BULL, V29, P1799, DOI 10.1248/bpb.29.1799; AWATA S, 1984, BIOCHEM INT, V8, P171; Banta-Wright SA, 2004, J PERINAT NEONAT NUR, V18, P41, DOI 10.1097/00005237-200401000-00005; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; BITTLES AH, 1974, J MED GENET, V11, P121, DOI 10.1136/jmg.11.2.121; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180; FERRER JV, 1990, BIOCHEM J, V269, P531, DOI 10.1042/bj2690531; FINKELST.JD, 1966, P NATL ACAD SCI USA, V55, P865, DOI 10.1073/pnas.55.4.865; Finkelstein JD, 2000, SEMIN THROMB HEMOST, V26, P219, DOI 10.1055/s-2000-8466; FRIMPTER GW, 1963, NEW ENGL J MED, V268, P333, DOI 10.1056/NEJM196302142680701; Gan-Schreier H, 2010, J PEDIATR-US, V156, P427, DOI 10.1016/j.jpeds.2009.09.054; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HARRIS H, 1959, ANN HUM GENET, V23, P442, DOI 10.1111/j.1469-1809.1959.tb01485.x; HARVEY, 2003, MOL GENET METAB, V79, P6; Herrmann Wolfgang, 2002, Clin Lab, V48, P471; Ichinohe A, 2005, BIOCHEM BIOPH RES CO, V338, P1547, DOI 10.1016/j.bbrc.2005.10.118; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kaye CI, 2006, PEDIATRICS, V118, pE934, DOI 10.1542/peds.2006-1782; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kraus JP, 2009, MOL GENET METAB, V97, P250, DOI 10.1016/j.ymgme.2009.04.001; LAIDLAW SA, 1987, AM J CLIN NUTR, V46, P593, DOI 10.1093/ajcn/46.4.593; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P471, DOI 10.1073/pnas.86.2.471; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Matsuyama N, 2001, CLIN CHEM, V47, P2155; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Mudd S., 2001, METABOLIC MOL BASES, P2007; Mudd SH, 2000, ARTERIOSCL THROM VAS, V20, P1704, DOI 10.1161/01.ATV.20.7.1704; Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X; Nambu M, 1996, LIVER, V16, P19; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Naughten ER, 1998, EUR J PEDIATR, V157, pS84, DOI 10.1007/PL00014310; PERRY TL, 1968, NEW ENGL J MED, V278, P590, DOI 10.1056/NEJM196803142781104; Peterschmitt MJ, 1999, NEW ENGL J MED, V341, P1572, DOI 10.1056/NEJM199911183412103; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sastre J, 2005, FREE RADICAL BIO MED, V38, P575, DOI 10.1016/j.freeradbiomed.2004.11.029; Shintani T, 2009, HEPATOLOGY, V49, P141, DOI 10.1002/hep.22604; Stabler SP, 2002, METABOLISM, V51, P981, DOI 10.1053/meta.2002.34017; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Triguero A, 1997, BRIT J NUTR, V78, P823, DOI 10.1079/BJN19970198; Troen AM, 2003, P NATL ACAD SCI USA, V100, P15089, DOI 10.1073/pnas.2436385100; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Vargas JE, 1999, AM J OBSTET GYNECOL, V181, P753, DOI 10.1016/S0002-9378(99)70525-9; VINA J, 1995, AM J CLIN NUTR, V61, P1067, DOI 10.1093/ajcn/61.5.1067; VINA J, 1992, BRIT J NUTR, V68, P421, DOI 10.1079/BJN19920099; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Wang J, 2003, HUM GENET, V112, P404, DOI 10.1007/s00439-003-0906-8; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Weiss N, 2002, ARTERIOSCL THROM VAS, V22, P34, DOI 10.1161/hq1201.100456; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667	62	176	183	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26358	26368		10.1074/jbc.M110.147439	http://dx.doi.org/10.1074/jbc.M110.147439			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566639	Green Published, hybrid			2022-12-25	WOS:000280921000054
J	Li, QX; Ali, MA; Wang, KN; Sayre, D; Hamel, FG; Fischer, ER; Bennett, RG; Cohen, JI				Li, Qingxue; Ali, Mir A.; Wang, Kening; Sayre, Dean; Hamel, Frederick G.; Fischer, Elizabeth R.; Bennett, Robert G.; Cohen, Jeffrey I.			Insulin Degrading Enzyme Induces a Conformational Change in Varicella-Zoster Virus gE, and Enhances Virus Infectivity and Stability	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; 3-O-SULFATED HEPARAN-SULFATE; VZV GLYCOPROTEIN-E; N-TERMINAL DOMAIN; TO-CELL SPREAD; ENDOCYTIC ENTRY; TYPE-1 ENTRY; IN-VITRO; RECEPTOR; FUSION	Varicella-zoster virus (VZV) glycoprotein E (gE) is essential for virus infectivity and binds to a cellular receptor, insulin-degrading enzyme (IDE), through its unique amino terminal extracellular domain. Previous work has shown IDE plays an important role in VZV infection and virus cell-to-cell spread, which is the sole route for VZV spread in vitro. Here we report that a recombinant soluble IDE (rIDE) enhances VZV infectivity at an early step of infection associated with an increase in virus internalization, and increases cell-to-cell spread. VZV mutants lacking the IDE binding domain of gE were impaired for syncytia formation and membrane fusion. Pre-treatment of cell-free VZV with rIDE markedly enhanced the stability of the virus over a range of conditions. rIDE interacted with gE to elicit a conformational change in gE and rendered it more susceptible to proteolysis. Co-incubation of rIDE with gE modified the size of gE. We propose that the conformational change in gE elicited by IDE enhances infectivity and stability of the virus and leads to increased fusogenicity during VZV infection. The ability of rIDE to enhance infectivity of cell-free VZV over a wide range of incubation times and temperatures suggests that rIDE may be useful for increasing the stability of varicella or zoster vaccines.	[Li, Qingxue; Ali, Mir A.; Wang, Kening; Sayre, Dean; Cohen, Jeffrey I.] NIH, Lab Clin Infect Dis, Bethesda, MD 20892 USA; [Hamel, Frederick G.; Bennett, Robert G.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA; [Hamel, Frederick G.; Bennett, Robert G.] Omaha VA Med Ctr, Res Serv, Omaha, NE USA; [Fischer, Elizabeth R.] NIH, Res Technol Branch, Rocky Mt Labs, Hamilton, MT USA	National Institutes of Health (NIH) - USA; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; National Institutes of Health (NIH) - USA	Li, QX (corresponding author), NIH, Lab Clin Infect Dis, Bldg 10, Bethesda, MD 20892 USA.	jcohen@niaid.nih.gov			National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI000430] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MA, 2009, VIROLOGY, V386, P270, DOI 10.1016/j.virol.2009.01.023; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Bennett RG, 2009, ANN NY ACAD SCI, V1160, P38, DOI 10.1111/j.1749-6632.2008.03782.x; Berarducci B, 2006, J VIROL, V80, P9481, DOI 10.1128/JVI.00533-06; Berarducci B, 2010, P NATL ACAD SCI USA, V107, P282, DOI 10.1073/pnas.0912373107; Carpenter JE, 2009, J VIROL, V83, P6917, DOI 10.1128/JVI.00081-09; Chen JJ, 2004, CELL, V119, P915, DOI 10.1016/j.cell.2004.11.007; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; CLAPHAM PR, 1992, J VIROL, V66, P3531, DOI 10.1128/JVI.66.6.3531-3537.1992; Cohen JI, 1998, J INFECT DIS, V177, P1390, DOI 10.1086/517821; Cohen JI, 2001, VIROLOGY, V280, P62, DOI 10.1006/viro.2000.0741; COHEN JI, 2007, FIELDS VIROLOGY, P2773; Cole NL, 2003, REV MED VIROL, V13, P207, DOI 10.1002/rmv.377; Damico R, 2000, J VIROL, V74, P6469, DOI 10.1128/JVI.74.14.6469-6475.2000; Delos SE, 2005, J VIROL, V79, P3488, DOI 10.1128/JVI.79.6.3488-3499.2005; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; DUCKWORTH WC, 1974, DIABETES, V23, P536, DOI 10.2337/diab.23.6.536; Dveksler GS, 1996, J VIROL, V70, P4142, DOI 10.1128/JVI.70.6.4142-4145.1996; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Golden JW, 2002, J VIROL, V76, P7430, DOI 10.1128/JVI.76.15.7430-7443.2002; Hambleton S, 2007, J VIROL, V81, P7548, DOI 10.1128/JVI.00486-07; Hamel FG, 2003, ENDOCRINOLOGY, V144, P2404, DOI 10.1210/en.2002-0007; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; HARPER DR, 1990, J GEN VIROL, V71, P459, DOI 10.1099/0022-1317-71-2-459; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kawase M, 2009, J VIROL, V83, P712, DOI 10.1128/JVI.01933-08; KELLER PM, 1984, J VIROL, V52, P293, DOI 10.1128/JVI.52.1.293-297.1984; Kimura H, 1997, VIROLOGY, V233, P382, DOI 10.1006/viro.1997.8625; Kirschner AN, 2009, STRUCTURE, V17, P223, DOI 10.1016/j.str.2008.12.010; Kwon H, 2006, J VIROL, V80, P138, DOI 10.1128/JVI.80.1.138-148.2006; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Li QX, 2007, J VIROL, V81, P8525, DOI 10.1128/JVI.00286-07; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; LI QX, 1995, J VIROL, V69, P3987, DOI 10.1128/JVI.69.7.3987-3994.1995; Lopez M, 2001, J VIROL, V75, P5684, DOI 10.1128/JVI.75.12.5684-5691.2001; Lynch JA, 2006, J NEUROSCI RES, V83, P1262, DOI 10.1002/jnr.20809; Mallory S, 1997, J VIROL, V71, P8279, DOI 10.1128/JVI.71.11.8279-8288.1997; Maresova L, 2005, J VIROL, V79, P997, DOI 10.1128/JVI.79.2.997-1007.2005; Maresova L, 2001, J VIROL, V75, P9483, DOI 10.1128/JVI.75.19.9483-9492.2001; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Matsuyama S, 2009, J VIROL, V83, P11133, DOI 10.1128/JVI.00959-09; MCCLAIN DS, 1994, VIROLOGY, V198, P690, DOI 10.1006/viro.1994.1081; Milne RSB, 2005, J VIROL, V79, P6655, DOI 10.1128/JVI.79.11.6655-6663.2005; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Narayan S, 2003, J VIROL, V77, P1977, DOI 10.1128/JVI.77.3.1977-1983.2003; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Pager CT, 2006, VIROLOGY, V346, P251, DOI 10.1016/j.virol.2006.01.007; Park SS, 2006, J ORTHOP TRAUMA, V20, P11, DOI 10.1097/01.bot.0000189591.40267.09; Pasieka TJ, 2004, J VIROL, V78, P2884, DOI 10.1128/JVI.78.6.2884-2896.2004; PERLMAN RK, 1994, J BIOL CHEM, V269, P33140; PERLMAN RK, 1993, J BIOL CHEM, V268, P21538; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Rojek JM, 2010, J VIROL, V84, P573, DOI 10.1128/JVI.01697-09; Santos RA, 2000, VIROLOGY, V275, P306, DOI 10.1006/viro.2000.0507; Sato H, 2002, J VIROL, V76, P11012, DOI 10.1128/JVI.76.21.11012-11023.2002; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Snitkovsky S, 1998, P NATL ACAD SCI USA, V95, P7063, DOI 10.1073/pnas.95.12.7063; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Tiwari V, 2007, J GEN VIROL, V88, P1075, DOI 10.1099/vir.0.82476-0; Townsley AC, 2007, J VIROL, V81, P8613, DOI 10.1128/JVI.00606-07; Veettil MV, 2008, J VIROL, V82, P12126, DOI 10.1128/JVI.01146-08; Wang KN, 2005, J VIROL, V79, P14079, DOI 10.1128/JVI.79.22.14079-14087.2005	71	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11327	10.1371/journal.pone.0011327	http://dx.doi.org/10.1371/journal.pone.0011327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593027	gold, Green Published, Green Submitted			2022-12-25	WOS:000279140800024
J	Brumm, H; Farrington, H; Petren, K; Fessl, B				Brumm, Henrik; Farrington, Heather; Petren, Kenneth; Fessl, Birgit			Evolutionary Dead End in the Galapagos: Divergence of Sexual Signals in the Rarest of Darwin's Finches	PLOS ONE			English	Article							CHARACTER DISPLACEMENT; ALLOPATRIC SPECIATION; PREMATING ISOLATION; ADAPTIVE RADIATION; SECONDARY CONTACT; SYMPATRIC MORPHS; MANGROVE FINCH; BIRD SONG; SELECTION; DISCRIMINATION	Understanding the mechanisms underlying speciation remains a challenge in evolutionary biology. The adaptive radiation of Darwin's finches is a prime example of species formation, and their study has revealed many important insights into evolutionary processes. Here, we report striking differences in mating signals (songs), morphology and genetics between the two remnant populations of Darwin's mangrove finch Camarhynchus heliobates, one of the rarest species in the world. We also show that territorial males exhibited strong discrimination of sexual signals by locality: in response to foreign songs, males responded weaker than to songs from their own population. Female responses were infrequent and weak but gave approximately similar results. Our findings not only suggest speciation in the mangrove finch, thereby providing strong support for the central role of sexual signals during speciation, but they have also implications for the conservation of this iconic bird. If speciation is complete, the eastern species will face imminent extinction, because it has a population size of only 5-10 individuals.	[Brumm, Henrik] Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany; [Farrington, Heather; Petren, Kenneth] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Fessl, Birgit] Charles Darwin Res Stn, Santa Cruz, Galapagos, Ecuador; [Fessl, Birgit] Durrell Wildlife Conservat Trust, Jersey, Channel Islands, England	Max Planck Society; University of Cincinnati	Brumm, H (corresponding author), Max Planck Inst Ornithol, Commun & Social Behav Grp, Seewiesen, Germany.	brumm@orn.mpg.de		Fessl, Birgit/0000-0003-1260-6002; Petren, Kenneth/0000-0002-7936-6042	United Kingdom government [15005]; German Research Foundation [Br 2309/6-1]; Association for the Study of Animal Behaviour	United Kingdom government; German Research Foundation(German Research Foundation (DFG)); Association for the Study of Animal Behaviour	Funding was provided by the United Kingdom government's Darwin Initiative Fund (project #15005), the German Research Foundation (award Br 2309/6-1), and the Association for the Study of Animal Behaviour (Christopher Barnard Award for Outstanding Contributions by a New Investigator to HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker NK, 2008, ORNITOL NEOTROP, V19, P175; Bowman R. I., 1983, PATTERNS EVOLUTION G; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Darwin C., 1859, ORIGIN SPECIES MEANS; Dvorak M, 2004, ORYX, V38, P171, DOI 10.1017/S0030605304000316; Fessl B, 2010, PHILOS T R SOC B, V365, P1019, DOI 10.1098/rstb.2009.0288; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; GRANT BR, 1989, AM NAT, V133, P377, DOI 10.1086/284924; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; Grant BR, 2002, BIOL J LINN SOC, V76, P545, DOI 10.1046/j.1095-8312.2002.00076.x; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2009, P NATL ACAD SCI USA, V106, P20141, DOI 10.1073/pnas.0911761106; Grant PR, 1997, CONSERV BIOL, V11, P119, DOI 10.1046/j.1523-1739.1997.95399.x; HOLM S, 1979, SCAND J STAT, V6, P65; Huber SK, 2007, P R SOC B, V274, P1709, DOI 10.1098/rspb.2007.0224; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Lachlan RF, 2004, EVOLUTION, V58, P2049; LACK D, 1961, DARWINS FINCHES; Marshall DC, 2000, EVOLUTION, V54, P1313, DOI 10.1111/j.0014-3820.2000.tb00564.x; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Nicholls JA, 2006, J ANIM ECOL, V75, P549, DOI 10.1111/j.1365-2656.2006.01075.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Petren K, 1999, P ROY SOC B-BIOL SCI, V266, P321, DOI 10.1098/rspb.1999.0641; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Petren K, 1998, MOL ECOL, V7, P1782, DOI 10.1046/j.1365-294x.1998.00518.x; Petren K, 2010, PHILOS T R SOC B, V365, P1009, DOI 10.1098/rstb.2009.0316; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Podos J, 2007, ANIM BEHAV, V73, P833, DOI 10.1016/j.anbehav.2006.11.001; Podos J, 2010, PHILOS T R SOC B, V365, P1031, DOI 10.1098/rstb.2009.0289; Ptacek MB, 2002, GENETICA, V116, P329, DOI 10.1023/A:1021201030017; RATCLIFFE LM, 1985, ANIM BEHAV, V33, P290, DOI 10.1016/S0003-3472(85)80143-3; Saetre GP, 1997, NATURE, V387, P589; Sato A, 1999, P NATL ACAD SCI USA, V96, P5101, DOI 10.1073/pnas.96.9.5101; SNODGRASS RE, 1904, P WASHINGTON ACAD SC, V0005; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WILEY RH, 1991, AM NAT, V138, P973, DOI 10.1086/285263	41	7	8	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11191	10.1371/journal.pone.0011191	http://dx.doi.org/10.1371/journal.pone.0011191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585648	Green Submitted, gold, Green Published			2022-12-25	WOS:000279135400007
J	Pappas, C; Viswanathan, K; Chandrasekaran, A; Raman, R; Katz, JM; Sasisekharan, R; Tumpey, TM				Pappas, Claudia; Viswanathan, Karthik; Chandrasekaran, Aarthi; Raman, Rahul; Katz, Jacqueline M.; Sasisekharan, Ram; Tumpey, Terrence M.			Receptor Specificity and Transmission of H2N2 Subtype Viruses Isolated from the Pandemic of 1957	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; BINDING PROPERTIES; HEMAGGLUTININ; ORIGIN; SWINE; HA	Influenza viruses of the H2N2 subtype have not circulated among humans in over 40 years. The occasional isolation of avian H2 strains from swine and avian species coupled with waning population immunity to H2 hemagglutinin (HA) warrants investigation of this subtype due to its pandemic potential. In this study we examined the transmissibility of representative human H2N2 viruses, A/Albany/6/58 (Alb/58) and A/El Salvador/2/57 (ElSalv/57), isolated during the 1957/58 pandemic, in the ferret model. The receptor binding properties of these H2N2 viruses was analyzed using dose-dependent direct glycan array-binding assays. Alb/58 virus, which contains the 226L/228S amino acid combination in the HA and displayed dual binding to both alpha 2,6 and alpha 2,3 glycan receptors, transmitted efficiently to naive ferrets by respiratory droplets. Inefficient transmission was observed with ElSalv/57 virus, which contains the 226Q/228G amino acid combination and preferentially binds alpha 2,3 over alpha 2,6 glycan receptors. However, a unique transmission event with the ElSalv/57 virus occurred which produced a 226L/228G H2N2 natural variant virus that displayed an increase in binding specificity to alpha 2,6 glycan receptors and enhanced respiratory droplet transmissibility. Our studies provide a correlation between binding affinity to glycan receptors with terminal alpha 2,6-linked sialic acid and the efficiency of respiratory droplet transmission for pandemic H2N2 influenza viruses.	[Pappas, Claudia; Katz, Jacqueline M.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Viswanathan, Karthik; Chandrasekaran, Aarthi; Raman, Rahul; Sasisekharan, Ram] Harvard Univ, MIT, Div Hlth Sci & Technol,Dept Biol Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts Institute of Technology (MIT)	Pappas, C (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	tft9@cdc.gov			Centers for Disease Control and Prevention; NIH [U54 GM62116]; Singapore-MIT Alliance for Research and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance for Research and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The source of funding for this work was the Centers for Disease Control and Prevention. This work was partially supported by NIH grant U54 GM62116 (R. S) and the Singapore-MIT Alliance for Research and Technology (R. S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Dowdle WR, 2006, EMERG INFECT DIS, V12, P34, DOI 10.3201/eid1201.051013; Dowdle WR, 1999, B WORLD HEALTH ORGAN, V77, P820; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Glaser L, 2006, GLYCOCONJUGATE J, V23, P93, DOI 10.1007/s10719-006-5441-0; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Klimov AI, 1996, INT CONGR SER, V1123, P546; Lindstrom SE, 2004, VIROLOGY, V328, P101, DOI 10.1016/j.virol.2004.06.009; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Makarova NA, 1999, J GEN VIROL, V80, P3167, DOI 10.1099/0022-1317-80-12-3167; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; REED LJ, 1938, AM J HYG, V27; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; US Animal Health Association, 2006, REP COMM TRANSM DIS, P314; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu R, 2010, J VIROL, V84, P1715, DOI 10.1128/JVI.02162-09; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	35	91	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11158	10.1371/journal.pone.0011158	http://dx.doi.org/10.1371/journal.pone.0011158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574518	Green Published, Green Submitted, gold			2022-12-25	WOS:000279058300004
J	Buescher, E; Achberger, T; Amusan, I; Giannini, A; Ochsenfeld, C; Rus, A; Lahner, B; Hoekenga, O; Yakubova, E; Harper, JF; Guerinot, ML; Zhang, M; Salt, DE; Baxter, IR				Buescher, Elizabeth; Achberger, Tilman; Amusan, Idris; Giannini, Anthony; Ochsenfeld, Cherie; Rus, Ana; Lahner, Brett; Hoekenga, Owen; Yakubova, Elena; Harper, Jeffrey F.; Guerinot, Mary Lou; Zhang, Min; Salt, David E.; Baxter, Ivan R.			Natural Genetic Variation in Selected Populations of Arabidopsis thaliana Is Associated with Ionomic Differences	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MINERAL CONCENTRATIONS; PHOSPHATE DEFICIENCY; ALUMINUM TOLERANCE; LANDSBERG ERECTA; HIGH-RESOLUTION; QTL ANALYSIS; IDENTIFICATION; ACCUMULATION; PLANTS	Controlling elemental composition is critical for plant growth and development as well as the nutrition of humans who utilize plants for food. Uncovering the genetic architecture underlying mineral ion homeostasis in plants is a critical first step towards understanding the biochemical networks that regulate a plant's elemental composition (ionome). Natural accessions of Arabidopsis thaliana provide a rich source of genetic diversity that leads to phenotypic differences. We analyzed the concentrations of 17 different elements in 12 A. thaliana accessions and three recombinant inbred line (RIL) populations grown in several different environments using high-throughput inductively coupled plasma-mass spectroscopy (ICP-MS). Significant differences were detected between the accessions for most elements and we identified over a hundred QTLs for elemental accumulation in the RIL populations. Altering the environment the plants were grown in had a strong effect on the correlations between different elements and the QTLs controlling elemental accumulation. All ionomic data presented is publicly available at www.ionomicshub.org.	[Buescher, Elizabeth; Amusan, Idris] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Achberger, Tilman; Ochsenfeld, Cherie; Zhang, Min] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Giannini, Anthony] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Rus, Ana; Lahner, Brett; Yakubova, Elena; Salt, David E.; Baxter, Ivan R.] Purdue Univ, Ctr Plant Environm Stress Physiol, W Lafayette, IN 47907 USA; [Hoekenga, Owen] Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Harper, Jeffrey F.] Univ Nevada, Reno, NV 89557 USA; [Guerinot, Mary Lou] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Baxter, Ivan R.] ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cornell University; United States Department of Agriculture (USDA); Nevada System of Higher Education (NSHE); University of Nevada Reno; Dartmouth College; Donald Danforth Plant Science Center; United States Department of Agriculture (USDA)	Buescher, E (corresponding author), Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA.	ibaxter@danforthcenter.org	Baxter, Ivan R/A-1052-2009	Baxter, Ivan R/0000-0001-6680-1722; Hoekenga, Owen/0000-0003-4427-2000	NSF [DBI-0077378, IOS-0419695, DBI-0419435]; National Institutes of Health, the National Institute of General Medicine [R01 GM78536-01A1]; Indiana 21st Century Research and Technology Fund [912010479]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Institutes of Health, the National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana 21st Century Research and Technology Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by a grant from the NSF Plant Genome Research Program (DBI-0077378) awarded to Mary Lou Guerinot, David Eide, Jeff Harper, David E. Salt, Julian Schroeder and John Ward, NSF Arabidopsis 2010 program (IOS-0419695) awarded to Mary Lou Guerinot, Jeff Harper, David E. Salt, Julian Schroeder and John Ward, National Institutes of Health, the National Institute of General Medicine (R01 GM78536-01A1) awarded to David E. Salt, Mary Lou Guerinot and Ivan Baxter and the Indiana 21st Century Research and Technology Fund (912010479) to David E. Salt. Owen Hoekenga was supported by the NSF Plant Genome Research Program (DBI-0419435) awarded to Leon Kochian, Edward Buckler, Owen Hoekenga and Jocelyn Rose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Basten CJ, 2000, QTL CARTOGRAPHER VER; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Bentsink L, 2003, THEOR APPL GENET, V106, P1234, DOI 10.1007/s00122-002-1177-9; Borevitz JO, 2003, PLANT PHYSIOL, V132, P718, DOI 10.1104/pp.103.023549; Broadley MR, 2008, PLANT PHYSIOL, V146, P1707, DOI 10.1104/pp.107.114645; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHURCHILL GA, 1994, GENETICS, V138, P963; Ernst WHO, 2000, ENVIRON EXP BOT, V43, P55, DOI 10.1016/S0098-8472(99)00048-9; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Ghandilyan A, 2009, NEW PHYTOL, V184, P180, DOI 10.1111/j.1469-8137.2009.02953.x; Ghandilyan A, 2009, J EXP BOT, V60, P1409, DOI 10.1093/jxb/erp084; Hirsch J, 2006, BIOCHIMIE, V88, P1767, DOI 10.1016/j.biochi.2006.05.007; Hoekenga OA, 2003, PLANT PHYSIOL, V132, P936, DOI 10.1104/pp.103.023085; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; JANSEN RC, 1994, GENETICS, V136, P1447; Keurentjes JJB, 2008, CURR OPIN PLANT BIOL, V11, P123, DOI 10.1016/j.pbi.2008.01.006; Kobayashi Y, 2002, PLANT CELL PHYSIOL, V43, P1526, DOI 10.1093/pcp/pcf174; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Liu J, 2009, PLANT SOIL, V320, P255, DOI 10.1007/s11104-009-9891-6; Loudet O, 2003, PLANT PHYSIOL, V131, P345, DOI 10.1104/pp.102.010785; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morrissey J, 2009, PLANT CELL; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; Payne KA, 2004, NEW PHYTOL, V162, P535, DOI 10.1111/j.1469-8137.2004.01026.x; RABOY V, 1984, CROP SCI, V24, P431, DOI 10.2135/cropsci1984.0011183X002400030001x; Rauh BL, 2002, THEOR APPL GENET, V104, P743, DOI 10.1007/s00122-001-0815-y; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Vreugdenhil D, 2004, PLANT CELL ENVIRON, V27, P828, DOI 10.1111/j.1365-3040.2004.01189.x; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562; Waters BM, 2008, NEW PHYTOL, V179, P1033, DOI 10.1111/j.1469-8137.2008.02544.x; Waters BM, 2008, NEW PHYTOL, V177, P389, DOI 10.1111/j.1469-8137.2007.02288.x; Wu J, 2008, PLANT SOIL, V310, P25, DOI 10.1007/s11104-008-9625-1; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang LH, 2006, NEW PHYTOL, V170, P33, DOI 10.1111/j.1469-8137.2006.01635.x; Zhang LH, 2006, PHYSIOL PLANTARUM, V128, P212, DOI 10.1111/j.1399-3054.2006.00739.x	46	62	63	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11081	10.1371/journal.pone.0011081	http://dx.doi.org/10.1371/journal.pone.0011081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559418	Green Published, gold, Green Submitted			2022-12-25	WOS:000278741100003
J	Vempati, RK; Jayani, RS; Notani, D; Sengupta, A; Galande, S; Haldar, D				Vempati, Rahul K.; Jayani, Ranveer S.; Notani, Dimple; Sengupta, Amrita; Galande, Sanjeev; Haldar, Devyani			p300-mediated Acetylation of Histone H3 Lysine 56 Functions in DNA Damage Response in Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; H3K56 ACETYLATION; CELL-CYCLE; CHROMATIN DYNAMICS; H3-K56 ACETYLATION; REPLICATION; REPAIR; DEACETYLASE; ACETYLTRANSFERASE; STABILITY	The packaging of newly replicated and repaired DNA into chromatin is crucial for the maintenance of genomic integrity. Acetylation of histone H3 core domain lysine 56 (H3K56ac) has been shown to play a crucial role in compaction of DNA into chromatin following replication and repair in Saccharomyces cerevisiae. However, the occurrence and function of such acetylation has not been reported in mammals. Here we show that H3K56 is acetylated and that this modification is regulated in a cell cycle-dependent manner in mammalian cells. We also demonstrate that the histone acetyltransferase p300 acetylates H3K56 in vitro and in vivo, whereas hSIRT2 and hSIRT3 deacetylate H3K56ac in vivo. Further we show that following DNA damage H3K56 acetylation levels increased, and acetylated H3K56, which is localized at the sites of DNA repair. It also colocalized with other proteins involved in DNA damage signaling pathways such as phospho-ATM, CHK2, and p53. Interestingly, analysis of occurrence of H3K56 acetylation using ChIP-on-chip revealed its genome-wide spread, affecting genes involved in several pathways that are implicated in tumorigenesis such as cell cycle, DNA damage response, DNA repair, and apoptosis.	[Haldar, Devyani] Inst Life Sci, Dept Biol, Hyderabad 500046, Andhra Pradesh, India; [Jayani, Ranveer S.; Notani, Dimple; Galande, Sanjeev] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; [Galande, Sanjeev] Indian Inst Sci Educ & Res, Pune 411021, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Indian Institute of Science Education & Research (IISER) Pune	Haldar, D (corresponding author), Inst Life Sci, Dept Biol, Univ Hyderabad Campus, Hyderabad 500046, Andhra Pradesh, India.	devyanih@ilsresearch.org	Jayani, Ranveer/O-1939-2016	Jayani, Ranveer/0000-0002-7646-0711; Notani, Dimple/0000-0002-9460-8070	Institute of Life Sciences; Department of Biotechnology of the Government of India; Wellcome Trust	Institute of Life Sciences; Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Institute of Life Sciences (to D. H.) and grants from the Department of Biotechnology of the Government of India and the Wellcome Trust (to S. G.).	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Haldar D, 2008, EUKARYOT CELL, V7, P800, DOI 10.1128/EC.00379-07; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar PP, 2005, MOL CELL BIOL, V25, P1620, DOI 10.1128/MCB.25.5.1620-1633.2005; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kyrylenko S, 2003, CELL MOL LIFE SCI, V60, P1990, DOI 10.1007/s00018-003-3090-z; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Miller KM, 2006, CELL CYCLE, V5, P2561, DOI 10.4161/cc.5.22.3501; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Purbey PK, 2006, NAT PROTOC, V1, P1820, DOI 10.1038/nprot.2006.310; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shin JS, 2008, INT J ONCOL, V32, P435; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620	44	119	128	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28553	28564		10.1074/jbc.M110.149393	http://dx.doi.org/10.1074/jbc.M110.149393			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20587414	Green Published, hybrid			2022-12-25	WOS:000281594000019
J	Kaur, SJ; Nerlich, A; Bergmann, S; Rohde, M; Fulde, M; Zahner, D; Hanski, E; Zinkernagel, A; Nizet, V; Chhatwal, GS; Talay, SR				Kaur, Simran Jeet; Nerlich, Andreas; Bergmann, Simone; Rohde, Manfred; Fulde, Marcus; Zaehner, Dorothea; Hanski, Emanuel; Zinkernagel, Annelies; Nizet, Victor; Chhatwal, Gursharan S.; Talay, Susanne R.			The CXC Chemokine-degrading Protease SpyCep of Streptococcus pyogenes Promotes Its Uptake into Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; BINDING; INVASION; PHAGOCYTOSIS; FIBRONECTIN; DEGRADATION; SUFFICIENT; PEPTIDE; ENTRY; SFBI	Streptococcus pyogenes expresses the LPXTG motif-containing cell envelope serine protease SpyCep (also called ScpC, PrtS) that degrades and inactivates the major chemoattractant interleukin 8 (IL-8), thereby impairing host neutrophil recruitment. In this study, we identified a novel function of SpyCep: the ability to mediate uptake into primary human endothelial cells. SpyCep triggered its uptake into endothelial cells but not into human epithelial cells originating from pharynx or lung, indicating an endothelial cell-specific uptake mechanism. SpyCep mediated cellular invasion by an endosomal/lysosomal pathway distinct from the caveolae-mediated invasion pathway of S. pyogenes. Recombinant expression and purification of proteolytically active SpyCep and a series of subfragments allowed functional dissection of the domains responsible for endothelial cell invasion and IL-8 degradation. The N-terminal PR domain was sufficient to mediate endothelial cell invasion, whereas for IL-8-degrading activity, the protease domain and the flanking A domain were required. A polyclonal rabbit serum raised against the recombinant protease efficiently blocked the invasion-mediating activity of SpyCep but not its proteolytic function, further indicating that SpyCep-mediated internalization is independent from its enzymatic activity. SpyCep may thus specifically mediate its own uptake as secreted protein into human endothelial cells.	[Kaur, Simran Jeet; Nerlich, Andreas; Bergmann, Simone; Rohde, Manfred; Fulde, Marcus; Zaehner, Dorothea; Chhatwal, Gursharan S.; Talay, Susanne R.] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany; [Hanski, Emanuel] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Microbiol, IL-91010 Jerusalem, Israel; [Zinkernagel, Annelies; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Zinkernagel, Annelies; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Helmholtz Association; Helmholtz-Center for Infection Research; Hebrew University of Jerusalem; University of California System; University of California San Diego; University of California System; University of California San Diego	Talay, SR (corresponding author), Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, Inhoffenstr 7, D-38124 Braunschweig, Germany.	susanne.talay@helmholtz-hzi.de	Zinkernagel, Annelies S/F-1780-2017; Nerlich, Andreas/F-9336-2012; Nizet, Victor/AAF-3190-2019; hanski, emanuel/M-2696-2018	Zinkernagel, Annelies S/0000-0003-4700-1118; Nerlich, Andreas/0000-0001-8577-2744; hanski, emanuel/0000-0001-5054-0628; Nizet, Victor/0000-0003-3847-0422	Helmholtz Association, Germany [VWZN2038]; European Union [EU-CP223111]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	Helmholtz Association, Germany(Helmholtz Association); European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant VWZN2038 from the Niedersachsisches Ministerium fur Wissenschaft und Kultur of Lower Saxony the "Wiederein-stiegsprogramm" given by the Helmholtz Association, Germany (to S. R. T.), and "CAREPNEUMO" (Grant EU-CP223111, European Union) (to S. R. T. and S. B.).	Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Eran Y, 2007, MOL MICROBIOL, V63, P1209, DOI 10.1111/j.1365-2958.2007.05581.x; Fritzer A, 2009, BIOCHEM J, V422, P533, DOI 10.1042/BJ20090278; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Kurupati P, 2010, MOL MICROBIOL, V76, P1387, DOI 10.1111/j.1365-2958.2010.07065.x; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Nerlich A, 2009, J BIOL CHEM, V284, P20319, DOI 10.1074/jbc.M109.016501; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; Siezen RJ, 1999, ANTON LEEUW INT J G, V76, P139, DOI 10.1023/A:1002036906922; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9; ZINGARETTI C, 2010, FASEB J IN PRESS; Zinkernagel AS, 2008, CELL HOST MICROBE, V4, P170, DOI 10.1016/j.chom.2008.07.002	24	13	15	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27798	27805		10.1074/jbc.M109.098053	http://dx.doi.org/10.1074/jbc.M109.098053			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20562101	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000281404100035
J	Liu, W; Zabirnyk, O; Wang, H; Shiao, YH; Nickerson, ML; Khalil, S; Anderson, LM; Perantoni, AO; Phang, JM				Liu, W.; Zabirnyk, O.; Wang, H.; Shiao, Y-H; Nickerson, M. L.; Khalil, S.; Anderson, L. M.; Perantoni, A. O.; Phang, J. M.			miR-23b*targets proline oxidase, a novel tumor suppressor protein in renal cancer	ONCOGENE			English	Article						proline oxidase; miR-23b*; renal cancer; ROS; tumor suppressor	CELL CARCINOMA; DOWN-REGULATION; EXPRESSION; GENE; MICRORNAS; APOPTOSIS; HYPOXIA; MYC; BIOGENESIS; BINDING	Proline oxidase (POX) is a novel mitochondrial tumor suppressor that can suppress proliferation and induce apoptosis through the generation of reactive oxygen species (ROS) and decreasing hypoxia-inducible factor (HIF) signaling. Recent studies have shown the absence of expression of POX in human cancer tissues, including renal cancer. However, the mechanism for the loss of POX remains obscure. No genetic or epigenetic variation of POX gene was found. In this study, we identified the upregulated miR-23b* in renal cancer as an important regulator of POX. Ectopic overexpression of miR-23b* in normal renal cells resulted in striking downregulation of POX, whereas POX expression increased markedly when endogenous miR-23b* was knocked down by its antagomirs in renal cancer cells. Consistent with the POX-mediated tumor suppression pathway, these antagomirs induced ROS, inhibited HIF signaling and increased apoptosis. Furthermore, we confirmed the regulation of miR-23b* on POX and its function in the DLD1 Tet-off POX cell system. Using a luciferase reporter system, we verified the direct binding of miR-23b* to the POX mRNA 3'-untranslated region. In addition, pairs of human renal carcinoma and normal tissues showed a negative correlation between miR-23b* and POX protein expression, providing its clinical corroboration. Taken together, our results suggested that miR-23b*, by targeting POX, could function as an oncogene; decreasing miR-23b* expression may prove to be an effective way of inhibiting kidney tumor growth. Oncogene (2010) 29, 4914-4924; doi: 10.1038/onc.2010.237; published online 21 June 2010	[Liu, W.; Zabirnyk, O.; Shiao, Y-H; Khalil, S.; Anderson, L. M.; Phang, J. M.] NCI, Lab Comparat Carcinogenesis, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Wang, H.; Perantoni, A. O.] NCI, Lab Canc & Dev Biol, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Nickerson, M. L.] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liu, W (corresponding author), NCI, Lab Comparat Carcinogenesis, Ctr Canc Res, NIH, Bldg 538,Room 144, Frederick, MD 21702 USA.	liuwei3@mail.nih.gov; phangj@mail.nih.gov	Shiao, Yih-Horng/ABC-7262-2021; liu, wei/E-7340-2012	Shiao, Yih-Horng/0000-0001-9841-7784	NIH; National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010744, ZIABC010743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Anna E Maciag for insightful comments, Dr Matthew J Fivash for statistical analysis, Dr Miriam R Anver for evaluating POX immunohistochemical staining and miR-23b* in situ hybridization, Dr Chang H Kim for his help with the miRNA microarray. This research was supported (in part) by the Intramural Research Program of the NIH, the National Cancer Institute, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Donald SP, 2001, CANCER RES, V61, P1810; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Girgin C, 2001, UROL INT, V66, P78, DOI 10.1159/000056575; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guimbellot JS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-15; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu Y, 2008, ONCOGENE, V27, P6729, DOI 10.1038/onc.2008.322; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; Liu YM, 2005, CARCINOGENESIS, V26, P1335, DOI 10.1093/carcin/bgi083; Liu YM, 2009, CANCER RES, V69, P6414, DOI 10.1158/0008-5472.CAN-09-1223; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Maxwell SA, 2003, J BIOL CHEM, V278, P9784, DOI 10.1074/jbc.M210012200; Migliore C, 2008, CANCER RES, V68, P10128, DOI 10.1158/0008-5472.CAN-08-2148; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Pandhare J, 2006, J BIOL CHEM, V281, P2044, DOI 10.1074/jbc.M507867200; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; PHANG JM, 1985, CURR TOP CELL REGUL, V25, P91; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Smaldone MC, 2009, UROL ONCOL-SEMIN ORI, V27, P238, DOI 10.1016/j.urolonc.2007.12.001; Sowter HM, 2003, CANCER RES, V63, P6130; SUZUKI Y, 1992, JPN J CANCER RES, V83, P233, DOI 10.1111/j.1349-7006.1992.tb00091.x; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	43	121	126	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	35					4914	4924		10.1038/onc.2010.237	http://dx.doi.org/10.1038/onc.2010.237			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	646XP	20562915	Green Accepted			2022-12-25	WOS:000281578700006
J	Mo, PL; Wang, HB; Lu, H; Boyd, DD; Yan, CH				Mo, Pingli; Wang, Hongbo; Lu, Hua; Boyd, Douglas D.; Yan, Chunhong			MDM2 Mediates Ubiquitination and Degradation of Activating Transcription Factor 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCIBLE GENE; DNA-DAMAGE; P53 PROTEIN; ATF3; EXPRESSION; PATHWAYS; PROMOTER; TRANSACTIVATION; ONCOPROTEIN; REPRESSION	Activating transcription factor 3 (ATF3) is a common stress sensor, and its rapid induction by cellular stresses (e.g. DNA damage) is crucial for cells to mount appropriate responses (e.g. activating the tumor suppressor p53) and maintain homeostasis. Although emerging evidence suggests that dysregulation of ATF3 contributes to occurrences of human diseases including cancer, the mechanism(s) by which ATF3 expression is regulated is largely unknown. Here, we demonstrate that mouse double minute 2 (MDM2) is a bona fide E3 ubiquitin ligase for ATF3 and regulates ATF3 expression by promoting its degradation. MDM2 via its C-terminal RING finger can bind to the Basic region of ATF3 and mediate the addition of ubiquitin moieties to the ATF3 leucine zipper domain. As a consequence, ATF3, but not a mutant deficient in MDM2 binding (Delta 80-100), is degraded by MDM2-mediated proteolysis. Consistent with these results, ablation of MDM2 in cells not only increases basal ATF3 levels, but results in stabilization of ATF3 in late stages of DNA damage responses. Because ATF3 was recently identified as a p53 activator, these results suggest that MDM2 could inactivate p53 through an additional feedback mechanism involving ATF3. Therefore, we provide the first evidence demonstrating that ATF3 is regulated by a posttranslational mechanism.	Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Lu, Hua] Indiana Univ, Sch Med, Dept Biochem Mol Biol, Indianapolis, IN 46202 USA; [Lu, Hua] IU Simon Canc Ctr, Indianapolis, IN 46202 USA; [Boyd, Douglas D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Albany Medical College; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; University of Texas System; UTMD Anderson Cancer Center	Yan, CH (corresponding author), 47 New Scotland Ave,MC165, Albany, NY 12208 USA.	yanc@mail.amc.edu	王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339; Yan, Chunhong/0000-0002-3974-7991	Department of Defense [PC061106 (W81XWH-07-1-0095)]; National Institutes of Health/NCI [CA127724, CA095441, CA129828]; NATIONAL CANCER INSTITUTE [R01CA127724, R01CA095441, R01CA129828] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Department of Defense Grant PC061106 (W81XWH-07-1-0095) (to C. Y.) and National Institutes of Health/NCI Grants CA127724, CA095441, and CA129828 (to H. L.).	Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; DEOCALUNA R, 1995, NATURE, V0378; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Freedman DA, 1999, CANCER RES, V59, P1; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hai T, 1999, GENE EXPRESSION, V7, P321; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kranz D, 2008, J CELL BIOL, V182, P197, DOI 10.1083/jcb.200712014; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Robles AI, 2001, CANCER RES, V61, P6660; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3; Zhang Z, 2005, CURR CANCER DRUG TAR, V5, P9, DOI 10.2174/1568009053332618	35	39	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26908	26915		10.1074/jbc.M110.132597	http://dx.doi.org/10.1074/jbc.M110.132597			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592017	Green Published, hybrid			2022-12-25	WOS:000281172700022
J	Duan, MR; Smerdon, MJ				Duan, Ming-Rui; Smerdon, Michael J.			UV Damage in DNA Promotes Nucleosome Unwrapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; NUCLEOTIDE EXCISION-REPAIR; CHROMATIN REMODELING ACTIVITIES; CORE PARTICLE; HISTONE ACETYLATION; ANGSTROM RESOLUTION; SPONTANEOUS ACCESS; PYRIMIDINE DIMERS; CRYSTAL-STRUCTURE; TARGET SITES	The association of DNA with histones in chromatin impedes DNA repair enzymes from accessing DNA lesions. Nucleosomes exist in a dynamic equilibrium in which portions of the DNA molecule spontaneously unwrap, transiently exposing buried DNA sites. Thus, nucleosome dynamics in certain regions of chromatin may provide the exposure time and space needed for efficient repair of buried DNA lesions. We have used FRET and restriction enzyme accessibility to study nucleosome dynamics following DNA damage by UV radiation. We find that FRET efficiency is reduced in a dose-dependent manner, showing that the presence of UV photoproducts enhances spontaneous unwrapping of DNA from histones. Furthermore, this UV-induced shift in unwrapping dynamics is associated with increased restriction enzyme accessibility of histone-bound DNA after UV treatment. Surprisingly, the increased unwrapping dynamics is even observed in nucleosome core particles containing a single UV lesion at a specific site. These results highlight the potential for increased "intrinsic exposure" of nucleosome-associated DNA lesions in chromatin to repair proteins.	[Duan, Ming-Rui; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@wsu.edu	Duan, Mingrui/C-6644-2011		NIEHS [ES004106]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES004106 from the NIEHS.	ALLIS CD, 2007, EPIGENETICS, P193; Anderson JD, 2002, MOL CELL BIOL, V22, P7147, DOI 10.1128/MCB.22.20.7147-7157.2002; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Bucceri A, 2006, EMBO J, V25, P3123, DOI 10.1038/sj.emboj.7601196; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DOETSCH PW, 1985, NUCLEIC ACIDS RES, V13, P3285, DOI 10.1093/nar/13.9.3285; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P617; Gaillard H, 2003, J BIOL CHEM, V278, P17655, DOI 10.1074/jbc.M300770200; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; GALE JM, 1990, PHOTOCHEM PHOTOBIOL, V51, P411, DOI 10.1111/j.1751-1097.1990.tb01732.x; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Hanawalt PC, 1998, MUTAT RES-FUND MOL M, V400, P117, DOI 10.1016/S0027-5107(98)00084-0; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; Hoch DA, 2007, J MOL BIOL, V371, P971, DOI 10.1016/j.jmb.2007.05.075; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kelbauskas L, 2007, BIOCHEMISTRY-US, V46, P2239, DOI 10.1021/bi061289l; Kelbauskas L, 2008, BIOCHEMISTRY-US, V47, P9627, DOI 10.1021/bi8000775; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kosmoski JV, 1999, BIOCHEMISTRY-US, V38, P9485, DOI 10.1021/bi990297h; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P13; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Liu XQ, 2000, BIOCHEMISTRY-US, V39, P557, DOI 10.1021/bi991771m; LIU XQ, 1995, ANAL BIOCHEM, V229, P323, DOI 10.1006/abio.1995.1420; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mann DB, 1997, P NATL ACAD SCI USA, V94, P2215, DOI 10.1073/pnas.94.6.2215; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Ozturk N, 2008, BIOCHEMISTRY-US, V47, P10255, DOI 10.1021/bi801085a; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Polach KJ, 1999, METHOD ENZYMOL, V304, P278; Ramirez-Carrozzi V, 2001, METHODS, V25, P31, DOI 10.1006/meth.2001.1213; Schieferstein U, 1998, EMBO J, V17, P306, DOI 10.1093/emboj/17.1.306; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SMERDON MJ, 1978, P NATL ACAD SCI USA, V75, P4238, DOI 10.1073/pnas.75.9.4238; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Suter B, 2002, J MOL BIOL, V319, P395, DOI 10.1016/S0022-2836(02)00291-7; Svedruzic ZM, 2005, J BIOL CHEM, V280, P40051, DOI 10.1074/jbc.M509478200; Teng YM, 2005, DNA REPAIR, V4, P870, DOI 10.1016/j.dnarep.2005.04.006; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Zhang L, 2009, BIOCHEM CELL BIOL, V87, P265, DOI 10.1139/O08-101	56	47	48	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26295	26303		10.1074/jbc.M110.140087	http://dx.doi.org/10.1074/jbc.M110.140087			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20562439	Green Published, hybrid			2022-12-25	WOS:000280921000047
J	Weiss, MB; Vitolo, MI; Mohseni, M; Rosen, DM; Denmeade, SR; Park, BH; Weber, DJ; Bachman, KE				Weiss, M. B.; Vitolo, M. I.; Mohseni, M.; Rosen, D. M.; Denmeade, S. R.; Park, B. H.; Weber, D. J.; Bachman, K. E.			Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response	ONCOGENE			English	Article						p53; TP53; chromosomal instability; Doxorubicin; MCF-10A	BREAST-CANCER PATIENTS; TUMOR-SUPPRESSOR GENE; COLORECTAL-CANCER; CONTINUOUS-INFUSION; P53-DEFICIENT MICE; IN-VITRO; MUTATIONS; AMPLIFICATION; CHEMOTHERAPY; ANEUPLOIDY	The TP53 tumor suppressor gene is the most commonly mutated gene in human cancers. To evaluate the biological and clinical relevance of p53 loss, human somatic cell gene targeting was used to delete the TP53 gene in the non-tumorigenic epithelial cell line, MCF-10A. In all four p53-/- clones generated, cells acquired the capability for epidermal growth factor-independent growth and were defective in appropriate downstream signaling and cell cycle checkpoints in response to DNA damage. Interestingly, p53 loss induced chromosomal instability leading to features of transformation and the selection of clones with varying phenotypes. For example, p53-deficient clones were heterogeneous in their capacity for anchorage-independent growth and invasion. In addition, and of clinical importance, the cohort of p53-null clones showed sensitivity to chemotherapeutic interventions that varied depending not only on the type of chemotherapeutic agent, but also on the treatment schedule. In conclusion, deletion of the TP53 gene from MCF-10A cells eliminated p53 functions, as well as produced p53-/- clones with varying phenotypes possibly stemming from the distinct chromosomal changes observed. Such a model system will be useful to further understand the cancer-specific phenotypic changes that accompany p53 loss, as well as help to provide future treatment strategies for human malignancies that harbor aberrant p53. Oncogene (2010) 29, 4715-4724; doi:10.1038/onc.2010.220; published online 21 June 2010	[Weiss, M. B.; Vitolo, M. I.; Weber, D. J.; Bachman, K. E.] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Weiss, M. B.] Univ Maryland, Grad Program Mol Med, Baltimore, MD 21201 USA; [Mohseni, M.] Johns Hopkins Univ, Sch Med, Dept Human Genet, Baltimore, MD USA; [Rosen, D. M.; Denmeade, S. R.; Park, B. H.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD USA; [Weber, D. J.; Bachman, K. E.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore	Bachman, KE (corresponding author), GlaxoSmithKline Inc, Dept Oncol, 1250 S Collegeville Rd,UP1340, Collegeville, PA 19426 USA.	bpark2@jhmi.edu; dweber@umaryland.edu; kurtis.e.bachman@gsk.com	Weber, David J/B-5349-2011	Weber, David J/0000-0002-8824-1110; Vitolo, Michele/0000-0001-8055-9645	NIH [T32DK067872]; Susan G Komen Breast Cancer Foundation [PDF104506]; DOD [BC083057]; Avon Foundation [R01CA109274]; Breast Cancer Research Foundation [R01CA107331, R01GM58888]; Maryland Cigarette Restitution Fund; NATIONAL CANCER INSTITUTE [R01CA109274, R01CA107331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058888] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); DOD(United States Department of Defense); Avon Foundation; Breast Cancer Research Foundation; Maryland Cigarette Restitution Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Fred Bunz for providing TP53 knockout vectors and advice, and Joel Greschock for advice on copy number analysis. This work was supported by: NIH grant T32DK067872 (MBW), Susan G Komen Breast Cancer Foundation PDF104506 (MIV), DOD Breast Cancer Pre-doctoral Training Award BC083057 (MM), The Avon Foundation, R01CA109274, The Breast Cancer Research Foundation (BHP), R01CA107331 and R01GM58888 (DJW) and Maryland Cigarette Restitution Fund (KEB).	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Bachman KE, 2004, CANCER BIOL THER, V3, P221, DOI 10.4161/cbt.3.2.666; BISCHOFF FZ, 1990, CANCER RES, V50, P7979; Bomme L, 2001, INT J CANCER, V92, P816, DOI 10.1002/ijc.1275; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bunz F, 2002, CANCER RES, V62, P1129; Calistri D, 2006, CELL ONCOL, V28, P161; Campomenosi P, 1998, ANAL CELL PATHOL, V17, P1; Chiba S, 2000, EXP CELL RES, V258, P310, DOI 10.1006/excr.2000.4916; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Dutt A, 2007, CURR OPIN ONCOL, V19, P43, DOI 10.1097/CCO.0b013e328011a8c1; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Formenti SC, 1997, INT J RADIAT ONCOL, V39, P1059, DOI 10.1016/S0360-3016(97)00506-3; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 1997, ONCOGENE, V15, P1295, DOI 10.1038/sj.onc.1201482; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Greshock J, 2007, CANCER RES, V67, P10173, DOI 10.1158/0008-5472.CAN-07-2102; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Hyman E, 2002, CANCER RES, V62, P6240; Janus F, 1999, CELL MOL LIFE SCI, V55, P12, DOI 10.1007/s000180050266; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Korn WM, 1999, GENE CHROMOSOME CANC, V25, P82, DOI 10.1002/(SICI)1098-2264(199906)25:2<82::AID-GCC2>3.0.CO;2-6; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; LOTHE RA, 1992, J NATL CANCER I, V84, P1100, DOI 10.1093/jnci/84.14.1100; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Moon A, 2000, INT J CANCER, V85, P176, DOI 10.1002/(SICI)1097-0215(20000115)85:2<176::AID-IJC5>3.0.CO;2-E; Narayan S, 2004, ONCOGENE, V23, P5880, DOI 10.1038/sj.onc.1207792; Papa V, 1997, J ENDOCRINOL INVEST, V20, P531, DOI 10.1007/BF03348015; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rozan S, 1998, INT J CANCER, V79, P27, DOI 10.1002/(SICI)1097-0215(19980220)79:1<27::AID-IJC6>3.3.CO;2-8; Sengelov L, 1997, J CANCER RES CLIN, V123, P565, DOI 10.1007/s004320050106; SOULE HD, 1990, CANCER RES, V50, P6075; THORLACIUS S, 1993, CANCER RES, V53, P1637; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Varis A, 2003, BRIT J CANCER, V88, P1914, DOI 10.1038/sj.bjc.6600969; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Wallace-Brodeur RR, 1999, CELL MOL LIFE SCI, V55, P64, DOI 10.1007/s000180050270; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Wolmark N, 1998, J CLIN ONCOL, V16, P301; YAHANDA AM, 1995, MOL CELL BIOL, V15, P4249	49	32	34	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2010	29	33					4715	4724		10.1038/onc.2010.220	http://dx.doi.org/10.1038/onc.2010.220			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	641LK	20562907	Green Accepted			2022-12-25	WOS:000281127400010
J	Dvash, T; Lavon, N; Fan, GP				Dvash, Tamar; Lavon, Neta; Fan, Guoping			Variations of X Chromosome Inactivation Occur in Early Passages of Female Human Embryonic Stem Cells	PLOS ONE			English	Article							HUMAN BLASTOCYSTS; LINES; DIFFERENTIATION; PLURIPOTENCY; DERIVATION; FIBROBLASTS; METHYLATION; EXPRESSION; GENOME; CANCER	X chromosome inactivation (XCI) is a dosage compensation mechanism essential for embryonic development and cell physiology. Human embryonic stem cells (hESCs) derived from inner cell mass (ICM) of blastocyst stage embryos have been used as a model system to understand XCI initiation and maintenance. Previous studies of undifferentiated female hESCs at intermediate passages have shown three possible states of XCI; 1) cells in a pre-XCI state, 2) cells that already exhibit XCI, or 3) cells that never undergo XCI even upon differentiation. In this study, XCI status was assayed in ten female hESC lines between passage 5 and 15 to determine whether XCI variations occur in early passages of hESCs. Our results show that three different states of XCI already exist in the early passages of hESC. In addition, we observe one cell line with skewed XCI and preferential expression of X-linked genes from the paternal allele, while another cell line exhibits random XCI. Skewed XCI in undifferentiated hESCs may be due to clonal selection in culture instead of non-random XCI in ICM cells. We also found that XIST promoter methylation is correlated with silencing of XIST transcripts in early passages of hESCs, even in the pre-XCI state. In conclusion, XCI variations already take place in early passages of hESCs, which may be a consequence of in vitro culture selection during the derivation process. Nevertheless, we cannot rule out the possibility that XCI variations in hESCs may reflect heterogeneous XCI states in ICM cells that stochastically give rise to hESCs.	[Dvash, Tamar; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Dvash, Tamar; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Lavon, Neta] Cedars Sinai Med Ctr, Int Stem Cell Res Inst, Los Angeles, CA 90048 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Dvash, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	gfan@mednet.ucla.edu		Fan, Guoping/0000-0001-5235-6410	California Institute of Regenerative Medicine [TG2-01169, RC1-0111]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	The research was supported by the California Institute of Regenerative Medicine training grant TG2-01169 to T.D. and comprehensive grant RC1-0111 to G.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dvash T, 2004, BEST PRACT RES CL OB, V18, P929, DOI 10.1016/j.bpobgyn.2004.06.005; Dvash T, 2009, EPIGENETICS-US, V4, P19, DOI 10.4161/epi.4.1.7438; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Ganesan S, 2005, COLD SH Q B, V70, P93, DOI 10.1101/sqb.2005.70.045; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; LIU W, 2009, HUM REPROD; LU B, 2009, STEM CELLS; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Michienzi A, 2001, METHOD ENZYMOL, V341, P581, DOI 10.1016/S0076-6879(01)41178-5; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2009, FEBS LETT, V583, P1721, DOI 10.1016/j.febslet.2009.03.043; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; TANASIJEVIC B, 2009, EPIGENETICS, V4; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomkins DJ, 2002, EUR J HUM GENET, V10, P44, DOI 10.1038/sj.ejhg.5200757; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Zeng SM, 2003, PLACENTA, V24, P270, DOI 10.1053/plac.2002.0889; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	38	48	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11330	10.1371/journal.pone.0011330	http://dx.doi.org/10.1371/journal.pone.0011330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593031	Green Published, gold, Green Submitted			2022-12-25	WOS:000279140800027
J	Liu, SH; Navarro, G; Mauvais-Jarvis, F				Liu, Suhuan; Navarro, Guadalupe; Mauvais-Jarvis, Franck			Androgen Excess Produces Systemic Oxidative Stress and Predisposes to beta-Cell Failure in Female Mice	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; NONOBESE DIABETIC MICE; INSULIN-RESISTANCE; MOLECULAR-MECHANISMS; ENDOTHELIAL-CELLS; PANCREATIC-ISLETS; CANCER CELLS; TFM MOUSE; STREPTOZOTOCIN; GENERATION	In women, excess production of the male hormone, testosterone (T), is accompanied by insulin resistance. However, hyperandrogenemia is also associated with beta-cell dysfunction and type 2 diabetes raising the possibility that androgen receptor (AR) activation predisposes to beta-cell failure. Here, we tested the hypothesis that excess AR activation produces systemic oxidative stress thereby contributing to beta-cell failure. We used normal female mice (CF) and mice with androgen resistance by testicular feminization (Tfm). These mice were exposed to androgen excess and a beta-cell stress induced by streptozotocin (STZ). We find that following exposure to T, or the selective AR-agonist dehydrotestosterone (DHT), CF mice challenged with STZ, which are normally protected, are prone to beta-cell failure and insulin-deficient diabetes. Conversely, T-induced predisposition to beta-cell failure is abolished in Tfm mice. We do not observe any proapoptotic effect of DHT alone or in the presence of H2O2 in cultured mouse and human islets. However, we observe that exposure of CF mice to T or DHT provokes systemic oxidative stress, which is eliminated in Tfm mice. This work has significance for hyperandrogenic women; excess activation of AR by testosterone may provoke systemic oxidative stress. In the presence of a prior beta-cell stress, this may predispose to beta-cell failure.	[Liu, Suhuan; Navarro, Guadalupe; Mauvais-Jarvis, Franck] Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Liu, Suhuan; Mauvais-Jarvis, Franck] Northwestern Univ, NW Comprehens Ctr Obes, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Liu, SH (corresponding author), Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA.	f-mauvais-jarvis@northwestern.edu	Tuluc, Petronel/C-2527-2011		National Institutes of Health (NIH) [RO1 DK074970, P50 HD044405]; Juvenile Diabetes Research Foundation [1-2006-837]; March of Dimes [6-FY07-678]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile Diabetes Research Foundation International (JDRFI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD044405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); March of Dimes(March of Dimes); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation International (JDRFI)(Juvenile Diabetes Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (NIH) RO1 DK074970, P50 HD044405, Juvenile Diabetes Research Foundation 1-2006-837, March of Dimes 6-FY07-678. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Integrated Islet Distribution Program (IIDP) funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and with support from the Juvenile Diabetes Research Foundation International (JDRFI).	Achard C., 1921, B ACAD NATL MED, V86, P51; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Bao M, 2002, J IMMUNOL, V168, P5369, DOI 10.4049/jimmunol.168.10.5369; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; Cunningham RL, 2009, ENDOCRINOLOGY, V150, P5539, DOI 10.1210/en.2009-0640; Death AK, 2004, ENDOCRINOLOGY, V145, P1889, DOI 10.1210/en.2003-0789; Diamond MP, 1998, J CLIN ENDOCR METAB, V83, P4420, DOI 10.1210/jc.83.12.4420; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P942, DOI 10.1210/jc.81.3.942; FOX HS, 1992, J EXP MED, V175, P1409, DOI 10.1084/jem.175.5.1409; Friesen NTE, 2004, DIABETOLOGIA, V47, P676, DOI 10.1007/s00125-004-1367-x; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gille L, 2002, PHARMACOL TOXICOL, V90, P317, DOI 10.1034/j.1600-0773.2002.900605.x; Gonzalez F, 2006, J CLIN ENDOCR METAB, V91, P336, DOI 10.1210/jc.2005-1696; Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P310, DOI 10.1210/jc.2004-1006; HOLMANG A, 1992, AM J PHYSIOL, V262, pE851, DOI 10.1152/ajpendo.1992.262.6.E851; HOLMANG A, 1990, AM J PHYSIOL, V259, P555; HOLTE J, 1994, J CLIN ENDOCR METAB, V78, P1052, DOI 10.1210/jc.78.5.1052; Kan WH, 2008, J APPL PHYSIOL, V105, P595, DOI 10.1152/japplphysiol.00012.2008; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Ling SH, 2002, ENDOCRINOLOGY, V143, P1119, DOI 10.1210/en.143.3.1119; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; MACLAREN NK, 1980, DIABETES, V29, P710, DOI 10.2337/diab.29.9.710; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; MORROW PL, 1980, DIABETOLOGIA, V18, P247, DOI 10.1007/BF00251924; MURPHY L, 1994, ENDOCRINOLOGY, V135, P1372, DOI 10.1210/en.135.4.1372; OMEARA NM, 1993, J CLIN ENDOCR METAB, V76, P1241, DOI 10.1210/jc.76.5.1241; PAIK SG, 1982, DIABETES, V31, P724, DOI 10.2337/diabetes.31.8.724; Pansarasa O, 2002, EUR J APPL PHYSIOL, V87, P550, DOI 10.1007/s00421-002-0668-3; PEARCE RB, 1995, AUTOIMMUNITY, V20, P247, DOI 10.3109/08916939508995702; Ripple MO, 1999, ANTIOXID REDOX SIGN, V1, P71, DOI 10.1089/ars.1999.1.1-71; Rosmalen JGM, 2001, LAB INVEST, V81, P231, DOI 10.1038/labinvest.3780231; ROSSINI AA, 1978, ENDOCRINOLOGY, V103, P1518, DOI 10.1210/endo-103-4-1518; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; STEIN J, 1935, AM J OBSTET GYNECOL, V20, P181; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655	39	60	61	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11302	10.1371/journal.pone.0011302	http://dx.doi.org/10.1371/journal.pone.0011302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585581	Green Submitted, gold, Green Published			2022-12-25	WOS:000279135800011
J	Angelini, DJ; Su, QN; Kolosova, IA; Fan, CL; Skinner, JT; Yamaji-Kegan, K; Collector, M; Sharkis, SJ; Johns, RA				Angelini, Daniel J.; Su, Qingning; Kolosova, Irina A.; Fan, Chunling; Skinner, John T.; Yamaji-Kegan, Kazuyo; Collector, Michael; Sharkis, Saul J.; Johns, Roger A.			Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELM alpha) Recruits Bone Marrow-Derived Cells to the Murine Pulmonary Vasculature	PLOS ONE			English	Article							PROGENITOR CELLS; STEM-CELLS; HYPERTENSION; LUNG; ATHEROSCLEROSIS; CONTRIBUTE; SIMVASTATIN; EXPRESSION; FAMILY; FIZZ1	Background: Pulmonary hypertension (PH) is a disease of multiple etiologies with several common pathological features, including inflammation and pulmonary vascular remodeling. Recent evidence has suggested a potential role for the recruitment of bone marrow-derived (BMD) progenitor cells to this remodeling process. We recently demonstrated that hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELM alpha) is chemotactic to murine bone marrow cells in vitro and involved in pulmonary vascular remodeling in vivo. Methodology/Principal Findings: We used a mouse bone marrow transplant model in which lethally irradiated mice were rescued with bone marrow transplanted from green fluorescent protein (GFP)(+) transgenic mice to determine the role of HIMF in recruiting BMD cells to the lung vasculature during PH development. Exposure to chronic hypoxia and pulmonary gene transfer of HIMF were used to induce PH. Both models resulted in markedly increased numbers of BMD cells in and around the pulmonary vasculature; in several neomuscularized small (similar to 20 mm) capillary-like vessels, an entirely new medial wall was made up of these cells. We found these GFP(+) BMD cells to be positive for stem cell antigen-1 and c-kit, but negative for CD31 and CD34. Several of the GFP(+) cells that localized to the pulmonary vasculature were alpha-smooth muscle actin(+) and localized to the media layer of the vessels. This finding suggests that these cells are of mesenchymal origin and differentiate toward myofibroblast and vascular smooth muscle. Structural location in the media of small vessels suggests a functional role in the lung vasculature. To examine a potentialmechanism for HIMF-dependent recruitment of mesenchymal stem cells to the pulmonary vasculature, we performed a cell migration assay using cultured human mesenchymal stem cells (HMSCs). The addition of recombinant HIMF induced migration of HMSCs in a phosphoinosotide-3-kinase-dependent manner. Conclusions/Significance: These results demonstrate HIMF-dependent recruitment of BMD mesenchymal-like cells to the remodeling pulmonary vasculature.	[Angelini, Daniel J.; Su, Qingning; Kolosova, Irina A.; Fan, Chunling; Skinner, John T.; Yamaji-Kegan, Kazuyo; Johns, Roger A.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Collector, Michael; Sharkis, Saul J.] Johns Hopkins Univ, Sch Med, Dept Oncol & Canc Biol, Baltimore, MD 21205 USA; [Johns, Roger A.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Angelini, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	rajohns@jhmi.edu			NIH SCCOR [P50 084946]; NIH NHLBI [39706]; NIH [T32 GM075774-09, PO1 CA070970]; Maryland Stem Cell Fund Exploratory Grant; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075774] Funding Source: NIH RePORTER	NIH SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Fund Exploratory Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH SCCOR P50 084946 (RAJ), NIH NHLBI 39706 (RAJ), NIH fellowship T32 GM075774-09 (DJA), Maryland Stem Cell Fund Exploratory Grant (IAK), and NIH PO1 CA070970 (SJS, MC). The funders had no role in study design, data collection and anaysis, decision to publish, or preparation of the manuscript.	Aliotta JM, 2006, EXP HEMATOL, V34, P230, DOI 10.1016/j.exphem.2005.11.007; ANGELINI D, 2009, AM THOR SOC INT C; Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, pL582, DOI 10.1152/ajplung.90526.2008; Biankin SA, 2007, PATHOLOGY, V39, P247, DOI 10.1080/00313020701230807; Caplice NM, 2003, P NATL ACAD SCI USA, V100, P4754, DOI 10.1073/pnas.0730743100; Chung MJ, 2007, J PATHOL, V212, P180, DOI 10.1002/path.2161; Davie NJ, 2004, AM J PHYSIOL-LUNG C, V286, pL668, DOI 10.1152/ajplung.00108.2003; Girgis RE, 2003, AM J PHYSIOL-HEART C, V285, pH938, DOI 10.1152/ajpheart.01097.2002; Girgis RE, 2007, AM J PHYSIOL-LUNG C, V292, pL1105, DOI 10.1152/ajplung.00411.2006; Hayashida K, 2005, CHEST, V127, P1793, DOI 10.1378/chest.127.5.1793; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Lindvall J, 2002, BIOCHEM BIOPH RES CO, V293, P1319, DOI 10.1016/S0006-291X(02)00382-0; Liu TJ, 2004, AM J PATHOL, V164, P1315, DOI 10.1016/S0002-9440(10)63218-X; Quinlan TR, 2000, AM J PHYSIOL-LUNG C, V279, pL641, DOI 10.1152/ajplung.2000.279.4.L641; Saiura A, 2001, NAT MED, V7, P382, DOI 10.1038/86394; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Spees JL, 2008, FASEB J, V22, P1226, DOI 10.1096/fj.07-8076com; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Su QN, 2007, FASEB J, V21, P1376, DOI 10.1096/fj.06-6527com; Teng XW, 2003, CIRC RES, V92, P1065, DOI 10.1161/01.RES.0000073999.07698.33; Tong QS, 2006, AM J RESP CELL MOL, V35, P444, DOI 10.1165/rcmb.2005-0424OC; Xue C, 1996, HYPERTENSION, V28, P743, DOI 10.1161/01.HYP.28.5.743; Yamaji-Kegan K, 2006, AM J PHYSIOL-LUNG C, V291, pL1159, DOI 10.1152/ajplung.00168.2006	26	36	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11251	10.1371/journal.pone.0011251	http://dx.doi.org/10.1371/journal.pone.0011251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582166	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058500003
J	Vitzthum, K; Scutaru, C; Musial-Bright, L; Quarcoo, D; Welte, T; Spallek, M; Groneberg-Kloft, B				Vitzthum, Karin; Scutaru, Cristian; Musial-Bright, Lindy; Quarcoo, David; Welte, Tobias; Spallek, Michael; Groneberg-Kloft, Beatrix			Scientometric Analysis and Combined Density-Equalizing Mapping of Environmental Tobacco Smoke (ETS) Research	PLOS ONE			English	Article							OCCUPATIONAL-HEALTH; CIGARETTE-SMOKING; SECONDHAND SMOKE; RESEARCH OUTPUT; IMPACT FACTORS; EXPOSURE; SCIENCE; DISEASE; ASTHMA; INDEX	Background: Passive exposure to environmental tobacco smoke (ETS) is estimated to exert a major burden of disease. Currently, numerous countries have taken legal actions to protect the population against ETS. Numerous studies have been conducted in this field. Therefore, scientometric methods should be used to analyze the accumulated data since there is no such approach available so far. Methods and Results: A combination of scientometric methods and novel visualizing procedures were used, including density-equalizing mapping and radar charting techniques. 6,580 ETS-related studies published between 1900 and 2008 were identified in the ISI database. Using different scientometric approaches, a continuous increase of both quantitative and qualitative parameters was found. The combination with density-equalizing calculations demonstrated a leading position of the United States (2,959 items published) in terms of quantitative research activities. Charting techniques demonstrated that there are numerous bi- and multilateral networks between different countries and institutions in this field. Again, a leading position of American institutions was found. Conclusions: This is the first comprehensive scientometric analysis of data on global scientific activities in the field of environmental tobacco smoke research. The present findings can be used as a benchmark for funding allocation processes.	[Vitzthum, Karin; Scutaru, Cristian; Musial-Bright, Lindy; Quarcoo, David; Spallek, Michael] Free Univ Berlin, Charite Univ Med, Inst Occupat Med, Dept Informat Sci, D-1000 Berlin, Germany; [Groneberg-Kloft, Beatrix] Free Univ Berlin, Charite Univ Med, Otto Heubner Ctr, D-1000 Berlin, Germany; [Vitzthum, Karin; Scutaru, Cristian; Musial-Bright, Lindy; Quarcoo, David; Spallek, Michael; Groneberg-Kloft, Beatrix] Humboldt Univ, Berlin, Germany; [Vitzthum, Karin; Scutaru, Cristian; Welte, Tobias] Hanover Med Sch, Dept Resp Med, Hanover, NH USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Vitzthum, K (corresponding author), Free Univ Berlin, Charite Univ Med, Inst Occupat Med, Dept Informat Sci, D-1000 Berlin, Germany.	karin.vitzthum@charite.de	Scutaru, Cristian/AAD-4098-2020	Scutaru, Cristian/0000-0003-0753-9730; Quarcoo, David/0000-0001-6398-2118				Almeida OP, 2008, AM J GERIAT PSYCHIAT, V16, P92, DOI 10.1097/JGP.0b013e318157cad2; *AM CANC S, 2004, TOB FREE IN; Apter AJ, 2008, J ALLERGY CLIN IMMUN, V121, P839, DOI 10.1016/j.jaci.2007.12.1176; BLASHFIELD RK, 1982, SCHIZOPHRENIA BULL, V8, P1, DOI 10.1093/schbul/8.1.1; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; Borger Julia-Annik, 2008, J Occup Med Toxicol, V3 Suppl 1, pS7, DOI 10.1186/1745-6673-3-S1-S7; Carmella SG, 2009, CHEM RES TOXICOL, V22, P734, DOI 10.1021/tx800479s; Charavaryamath C, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-10; Chen RL, 2009, NEW ENGL J MED, V360, P1911, DOI 10.1056/NEJMc090277; de Solla Price D., 1977, SCI TECHNOLOGY SOC C; DEGRANDAORIVE JI, 2009, GAC SANIT; Garfield E, 1999, OCCUP MED-OXFORD, V49, P571, DOI 10.1093/occmed/49.8.571; GARFIELD E, 2007, 11 INT C INT SOC SCI; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Gehanno JF, 2000, OCCUP ENVIRON MED, V57, P706, DOI 10.1136/oem.57.10.706; Groneberg-Kloft B, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-6; Groneberg-Kloft Beatrix, 2007, Cough, V3, P6, DOI 10.1186/1745-9974-3-6; Groneberg-Kloft B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-16; Groneberg-Kloft Beatrix, 2008, Health Res Policy Syst, V6, P6, DOI 10.1186/1478-4505-6-6; Groneberg-Kloft B, 2009, J ASTHMA, V46, P147, DOI 10.1080/02770900802503115; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; de Granda-Orive JI, 2007, ARCH BRONCONEUMOL, V43, P212, DOI 10.1157/13100540; JACKSON R, 1988, INT J DERMATOL, V27, P16, DOI 10.1111/j.1365-4362.1988.tb02325.x; JI M, 2009, AM J PREV MED; Kraus T, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-4; Kusma B, 2009, INT J ENV RES PUB HE, V6, P1856, DOI 10.3390/ijerph6061856; Leone A, 2003, CURR PHARM DESIGN, V9, P2417, DOI 10.2174/1381612033453802; Llewellyn DJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b462; Max W, 2009, INT J ENV RES PUB HE, V6, P1633, DOI 10.3390/ijerph6051633; MCCUNNEY RJ, 1992, J OCCUP ENVIRON MED, V34, P279, DOI 10.1097/00043764-199203000-00012; Mohebbi Iraj, 2007, J Occup Med Toxicol, V2, P8, DOI 10.1186/1745-6673-2-8; *NAT HLTH I, 2010, HLTH NEWS; Ould-Kadi Farid, 2007, J Occup Med Toxicol, V2, P11, DOI 10.1186/1745-6673-2-11; Rachiotis G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-313; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Rosenlund M, 2001, EPIDEMIOLOGY, V12, P558, DOI 10.1097/00001648-200109000-00016; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; Schoeffel N, 2010, J EUR ACAD DERMATOL, V24, P85, DOI 10.1111/j.1468-3083.2009.03293.x; Sevinc A, 2005, J NATL MED ASSOC, V97, P116; Sevinc A, 2004, J NATL MED ASSOC, V96, P980; SMALL J, 2010, SMOKING BAN CALIFORN; Smith DR, 2007, IND HEALTH, V45, P730, DOI 10.2486/indhealth.45.730; Smith DR, 2008, IND HEALTH, V46, P519, DOI 10.2486/indhealth.46.519; Takahashi K, 1999, OCCUP MED-OXFORD, V49, P57, DOI 10.1093/occmed/49.1.57-a; *UN SD, 2009, DEM PROD; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; Yelin E, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-2	47	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11254	10.1371/journal.pone.0011254	http://dx.doi.org/10.1371/journal.pone.0011254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582305	Green Published, Green Submitted, gold			2022-12-25	WOS:000279058500006
J	Hubbe, M; Neves, WA; Harvati, K				Hubbe, Mark; Neves, Walter A.; Harvati, Katerina			Testing Evolutionary and Dispersion Scenarios for the Settlement of the New World	PLOS ONE			English	Article							MODERN HUMAN-POPULATIONS; UPPER CAVE; CLIMATE SIGNATURES; NATURAL-SELECTION; SKELETAL REMAINS; GENETIC-ANALYSIS; SOUTH-AMERICA; MORPHOLOGY; PLEISTOCENE; ORIGINS	Background: Discussion surrounding the settlement of the New World has recently gained momentum with advances in molecular biology, archaeology and bioanthropology. Recent evidence from these diverse fields is found to support different colonization scenarios. The currently available genetic evidence suggests a "single migration'' model, in which both early and later Native American groups derive from one expansion event into the continent. In contrast, the pronounced anatomical differences between early and late Native American populations have led others to propose more complex scenarios, involving separate colonization events of the New World and a distinct origin for these groups. Methodology/Principal Findings: Using large samples of Early American crania, we: 1) calculated the rate of morphological differentiation between Early and Late American samples under three different time divergence assumptions, and compared our findings to the predicted morphological differentiation under neutral conditions in each case; and 2) further tested three dispersal scenarios for the colonization of the New World by comparing the morphological distances among early and late Amerindians, East Asians, Australo-Melanesians and early modern humans from Asia to geographical distances associated with each dispersion model. Results indicate that the assumption of a last shared common ancestor outside the continent better explains the observed morphological differences between early and late American groups. This result is corroborated by our finding that a model comprising two Asian waves of migration coming through Bering into the Americas fits the cranial anatomical evidence best, especially when the effects of diversifying selection to climate are taken into account. Conclusions: We conclude that the morphological diversity documented through time in the New World is best accounted for by a model postulating two waves of human expansion into the continent originating in East Asia and entering through Beringia.	[Hubbe, Mark] Univ Catolica Norte, Inst Invest Arqueol & Museo, San Pedro De Atacama, Chile; [Neves, Walter A.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Lab Estudos Evolut Humanos, Sao Paulo, Brazil; [Harvati, Katerina] Univ Tubingen, Inst Uhr & Fruhgeschichte, Paleoanthropol Sect, Tubingen, Germany; [Harvati, Katerina] Univ Tubingen, Archaeol Mittelalters & Senckenberg Ctr Human Evo, Tubingen, Germany	Universidad Catolica del Norte; Universidade de Sao Paulo; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hubbe, M (corresponding author), Univ Catolica Norte, Inst Invest Arqueol & Museo, San Pedro De Atacama, Chile.	mhubbe@ucn.cl	Hubbe, Mark/AAC-1043-2020; Hubbe, Mark/G-3440-2012	Hubbe, Mark/0000-0003-4433-3942	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11070091]; Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP) [04/01253-0]; Conselho Nacional de Pesquisa (CNPq) [301126-04.6]; Max Planck Gesellschaft; EVAN Marie Curie Research Training Network [MRTN-CT-019564]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Max Planck Gesellschaft(Max Planck Society); EVAN Marie Curie Research Training Network(European Commission)	This work has been supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 11070091), Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP 04/01253-0), Conselho Nacional de Pesquisa (CNPq 301126-04.6), the Max Planck Gesellschaft and the EVAN Marie Curie Research Training Network MRTN-CT-019564. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CRAMONTAUBADEL N, 2009, AM J PHYS ANTHROPOL, V140, P205; Cunningham DL, 2003, J HUM EVOL, V45, P1, DOI 10.1016/S0047-2484(03)00064-2; Cunningham DL, 2002, J HUM EVOL, V42, P627, DOI 10.1006/jhev.2001.0547; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Dixon EJ, 2001, QUATERNARY SCI REV, V20, P277; DOW MM, 1985, AM J PHYS ANTHROPOL, V68, P367, DOI 10.1002/ajpa.1330680307; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gonzalez-Jose R, 2005, AM J PHYS ANTHROPOL, V128, P772, DOI 10.1002/ajpa.20165; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; GOWER JC, 1969, APPL STATIST, V18, P54, DOI DOI 10.2307/2346439; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Harvati K, 2009, J HUM EVOL, V57, P751, DOI 10.1016/j.jhevol.2009.07.008; Howells W.W., 1973, PAPERS PEABODY MUSEU, V67; HOWELLS WW, 1989, PAPERS PEABODY MUSEU, V79; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; KAMMINGA J, 1988, J HUM EVOL, V17, P739, DOI 10.1016/0047-2484(88)90064-4; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Konigsberg LW, 1997, J HUM EVOL, V32, P479, DOI 10.1006/jhev.1996.0125; LANDE R, 1979, EVOLUTION, V33, P402, DOI [10.2307/2407630, 10.1111/j.1558-5646.1979.tb04694.x]; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; LYNCH M, 1988, GENET RES, V51, P137, DOI 10.1017/S0016672300024150; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; MANTEL N, 1967, CANCER RES, V27, P209; Neves WA, 2005, P NATL ACAD SCI USA, V102, P18309, DOI 10.1073/pnas.0507185102; Neves WA, 1989, J HUM EVOL, V34, P219; Neves WA, 2007, AM J PHYS ANTHROPOL, V133, P1080, DOI 10.1002/ajpa.20637; ODEN NL, 1992, AM J PHYS ANTHROPOL, V89, P257, DOI 10.1002/ajpa.1330890209; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Powell J.F., 2005, 1 AM RACE EVOLUTION; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Relethford JH, 2004, HUM BIOL, V76, P499, DOI 10.1353/hub.2004.0060; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P53, DOI 10.1002/ajpa.1330950105; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; SMOUSE PE, 1992, YEARB PHYS ANTHROPOL, V35, P187; Sokal R. R., 2012, BIOMETRY; *STATSOFT INC, 2007, EL STAT TXB; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; TURELLI M, 1988, EVOLUTION, V42, P1085, DOI [10.2307/2408923, 10.1111/j.1558-5646.1988.tb02526.x]; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; WRIGHT RVS, 1995, J HUM EVOL, V29, P181, DOI 10.1006/jhev.1995.1053; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	47	48	57	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11105	10.1371/journal.pone.0011105	http://dx.doi.org/10.1371/journal.pone.0011105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	610NX	20559441	Green Published, Green Submitted, gold			2022-12-25	WOS:000278741100018
J	Doebbe, A; Keck, M; La Russa, M; Mussgnug, JH; Hankamer, B; Tekce, E; Niehaus, K; Kruse, O				Doebbe, Anja; Keck, Matthias; La Russa, Marco; Mussgnug, Jan H.; Hankamer, Ben; Tekce, Ercan; Niehaus, Karsten; Kruse, Olaf			The Interplay of Proton, Electron, and Metabolite Supply for Photosynthetic H-2 Production in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN PHOTOPRODUCTION; GENE-EXPRESSION; GREEN-ALGAE; DEPRIVATION; INDUCTION; PATHWAYS; BIOMASS	To obtain a detailed picture of sulfur deprivation-induced H-2 production in microalgae, metabolome analyses were performed during key time points of the anaerobic H-2 production process of Chlamydomonas reinhardtii. Analyses were performed using gas chromatography coupled to mass spectrometry (GC/MS), two-dimensional gas chromatography combined with time-of-flight mass spectrometry (GCxGC-TOFMS), lipid and starch analysis, and enzymatic determination of fermentative products. The studies were designed to provide a detailed metabolite profile of the solar Bio-H-2 production process. This work reports on the differential analysis of metabolic profiles of the high H-2-producing strain Stm6Glc4 and the wild-type cc406 (WT) before and during the H-2 production phase. Using GCxGC-TOFMS analysis the number of detected peaks increased from 128 peaks, previously detected by GC/MS techniques, to similar to 1168. More detailed analysis of the anaerobic H-2 production phase revealed remarkable differences between wild-type and mutant cells in a number of metabolic pathways. Under these physiological conditions the WT produced up to 2.6 times more fatty acids, 2.2 times more neutral lipids, and up to 4 times more fermentation products compared with Stm6Glc4. Based on these results, specific metabolic pathways involving the synthesis of fatty acids, neutral lipids, and fermentation products during anaerobiosis in C. reinhardtii have been identified as potential targets for metabolic engineering to further enhance substrate supply for the hydrogenase(s) in the chloroplast.	[Kruse, Olaf] Univ Bielefeld, Algae Biotech & Bioenergy Grp, D-33615 Bielefeld, Germany; [Keck, Matthias; Niehaus, Karsten] Univ Bielefeld, Proteome & Metabolome Res Grp, Ctr Biotechnol CeBiTec, D-33615 Bielefeld, Germany; [Hankamer, Ben] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Tekce, Ercan] LECO Instruments GmbH, D-41199 Monchengladbach, Germany	University of Bielefeld; University of Bielefeld; University of Queensland	Kruse, O (corresponding author), Univ Bielefeld, Algae Biotech & Bioenergy Grp, D-33615 Bielefeld, Germany.	olaf.kruse@uni-bielefeld.de	Kruse, Olaf/O-1127-2015; Niehaus, Karsten/A-3966-2010; Hankamer, Ben D/C-9688-2015	Hankamer, Ben D/0000-0001-9284-4929; Kruse, Olaf/0000-0001-9874-382X	Deutsche Bundesstiftung Umwelt [DBU 20006/828]	Deutsche Bundesstiftung Umwelt	This work was supported in part by the Deutsche Bundesstiftung Umwelt (Grant DBU 20006/828 to A.D.).	Barsch Aiko, 2004, Functional & Integrative Genomics, V4, P219, DOI 10.1007/s10142-004-0117-y; Beckmann J, 2009, J BIOTECHNOL, V142, P70, DOI 10.1016/j.jbiotec.2009.02.015; Brumfield KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008659; Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001; Chochois V, 2009, PLANT PHYSIOL, V151, P631, DOI 10.1104/pp.109.144576; Desplats C, 2009, J BIOL CHEM, V284, P4148, DOI 10.1074/jbc.M804546200; Doebbe A, 2007, J BIOTECHNOL, V131, P27, DOI 10.1016/j.jbiotec.2007.05.017; Dubini A, 2009, J BIOL CHEM, V284, P7201, DOI 10.1074/jbc.M803917200; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; Hankamer B, 2007, PHYSIOL PLANTARUM, V131, P10, DOI 10.1111/j.1399-3054.2007.00924.x; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; HEIM J, 2009, URINE DIABETIC VS NO; Hemschemeier A, 2008, EUKARYOT CELL, V7, P518, DOI 10.1128/EC.00368-07; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kosourov S, 2007, J BIOTECHNOL, V128, P776, DOI 10.1016/j.jbiotec.2006.12.025; Kruse O, 2005, PHOTOCH PHOTOBIO SCI, V4, P957, DOI 10.1039/b506923h; Kruse O, 2005, J BIOL CHEM, V280, P34170, DOI 10.1074/jbc.M503840200; Lohr M, 2009, CHLAMYDOMONAS SOURCE, P799, DOI [10.1016/B978-0-12-370873-1.00029-0, DOI 10.1016/B978-0-12-370873-1.00029-0]; Makarova VV, 2007, PHOTOSYNTH RES, V94, P79, DOI 10.1007/s11120-007-9219-4; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2007, PLANTA, V226, P1075, DOI 10.1007/s00425-007-0609-9; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Nguyen AV, 2008, EUKARYOT CELL, V7, P1965, DOI 10.1128/EC.00418-07; Niyogi K, 2009, CHLAMYDOMONAS SOURCE, P847, DOI DOI 10.1016/B978-0-12-370873-1.00031-9; Posewitz MC, 2004, PLANT CELL, V16, P2151, DOI 10.1105/tpc.104.021972; Posewitz MC, 2009, CHLAMYDOMONAS SOURCE, P217, DOI [10.1016/B978-0-12-370873, DOI 10.1016/B978-0-12-370873]; R- Development-Core-Team, 2009, R FDN STAT COMP; Ruhle T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-107; Rupprecht J, 2006, APPL MICROBIOL BIOT, V72, P442, DOI 10.1007/s00253-006-0528-x; Rupprecht J, 2009, J BIOTECHNOL, V142, P10, DOI 10.1016/j.jbiotec.2009.02.008; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Stern D. B., 2009, CHLAMYDOMONAS SOURCE, V2, P257; Surzycki R, 2007, P NATL ACAD SCI USA, V104, P17548, DOI 10.1073/pnas.0704205104; Torzillo G, 2009, INT J HYDROGEN ENERG, V34, P4529, DOI 10.1016/j.ijhydene.2008.07.093; Tsygankov A, 2002, INT J HYDROGEN ENERG, V27, P1239, DOI 10.1016/S0360-3199(02)00108-8; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; VALLON H, 2009, CHLAMYDOMONAS SOURCE, V2, P115; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Watt TF, 2009, J BIOTECHNOL, V140, P59, DOI 10.1016/j.jbiotec.2008.12.003; Welthagen W, 2005, METABOLOMICS, V1, P65, DOI 10.1007/s11306-005-1108-2; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Zhang LP, 2002, PHILOS T R SOC B, V357, P1499, DOI 10.1098/rstb.2002.1152; Zhang ZD, 2004, EUKARYOT CELL, V3, P1331, DOI 10.1128/EC.3.5.1331-1348.2004	52	55	55	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					30247	30260		10.1074/jbc.M110.122812	http://dx.doi.org/10.1074/jbc.M110.122812			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20581114	hybrid, Green Published			2022-12-25	WOS:000281984300061
J	Damkier, HH; Aalkjaer, C; Praetorius, J				Damkier, Helle Hasager; Aalkjaer, Christian; Praetorius, Jeppe			Na+-dependent HCO3- Import by the slc4a10 Gene Product Involves Cl- Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROGENIC NA+-HCO3-COTRANSPORTER; MOUSE CHOROID-PLEXUS; FUNCTIONAL-CHARACTERIZATION; PLASMA-MEMBRANE; EXCHANGER; STOICHIOMETRY; DISRUPTION; EXPRESSION; CLONING; NBC4	The slc4a10 gene encodes an electroneutral Na+-dependent HCO3- importer for which the precise mode of action remains unsettled. To resolve this issue, intracellular pH (pH(i)) recordings were performed upon acidification in the presence of CO2/HCO3- by 2',7'-bis(carboxyethyl)-5,6-carboxyfluorescein (BCECF) fluorometry of stably slc4a10-transfected NIH-3T3 fibroblasts. slc4a10 expression induced a significant Na+-dependent pHi recovery, which was accompanied by an increase in the intracellular Na+ concentration evaluated by use of the Na+-sensitive fluorophore CoroNa Green. The estimated Na+:HCO3- stoichiometry was 1:2. Cl- is most likely the counterion maintaining electroneutrality because (i) Na+-dependent pH(i) recovery was eliminated in Cl--depleted cells; (ii) acute extracellular Cl- removal led to a larger alkalization in slc4a10-transfected cells than in control cells; and (iii) the 4,4'-diisothiocyanato-stilbene-2,2'-disulfonic acid (DIDS)sensitive and Na+- and HCO3--dependent Cl-36(-)-efflux during pHi recovery was significantly greater in acidified slc4a10-transfected cells than in control cells. Charged amino acids specific to slc4a gene family members that transport Na+ and are expected to move more HCO3- molecules/turnover were targeted by site-directed mutagenesis. Na+-dependent pHi recovery was reduced in each of the single amino acid mutated cell lines (E890A, E892A, H976L, and H980G) compared with wild type slc4a10-transfected cells and completely eliminated in quadruple mutant cells. In conclusion, the data suggest that slc4a10 expressed in mammalian cells encodes a Na+-dependent Cl-/HCO3- exchanger in which four specific charged amino acids seem necessary for ion transport.	[Damkier, Helle Hasager; Aalkjaer, Christian; Praetorius, Jeppe] Aarhus Univ, Water & Salt Res Ctr, DK-8000 Aarhus, Denmark; [Damkier, Helle Hasager; Praetorius, Jeppe] Aarhus Univ, Dept Anat, DK-8000 Aarhus, Denmark; [Aalkjaer, Christian] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Damkier, HH (corresponding author), Wilhelm Meyers Alle 3, DK-8000 Aarhus C, Denmark.	hd@ana.au.dk	Praetorius, Jeppe/AAU-7893-2020	Praetorius, Jeppe/0000-0001-6109-247X; Damkier, Helle/0000-0001-7518-4017; Aalkjaer, Christian/0000-0003-2618-4015	Danish Medical Research Council; Karen Elise Jensens Fond; Lundbeck Foundation; Aarhus University Research Foundation; Novo Nordisk Foundation; Danish National Research Foundation (Danmarks Grundforskningsfond); Faculty of Health Sciences, Aarhus University	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Karen Elise Jensens Fond; Lundbeck Foundation(Lundbeckfonden); Aarhus University Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (Danmarks Grundforskningsfond)(Danmarks Grundforskningsfond); Faculty of Health Sciences, Aarhus University	This work was supported by the Danish Medical Research Council, Karen Elise Jensens Fond, the Lundbeck Foundation, Aarhus University Research Foundation, and the Novo Nordisk Foundation. The Water and Salt Research Center at Aarhus University was established and funded by the Danish National Research Foundation (Danmarks Grundforskningsfond).; Supported by the Faculty of Health Sciences, Aarhus University.	BORON W, 2009, MED PHYSL, P667; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Damkier HH, 2009, AM J PHYSIOL-CELL PH, V296, pC1291, DOI 10.1152/ajpcell.00062.2009; Giffard RG, 2003, EUR J NEUROSCI, V18, P2935, DOI 10.1046/j.1460-9568.2003.03053.x; Gross E, 2001, J PHYSIOL-LONDON, V531, P597, DOI 10.1111/j.1469-7793.2001.0597h.x; Guizouarn H, 2007, BLOOD, V110, P2158, DOI 10.1182/blood-2006-12-063420; Gurnett CA, 2008, ARCH NEUROL-CHICAGO, V65, P550, DOI 10.1001/archneur.65.4.550; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; Millar ID, 2008, BIOCHEM BIOPH RES CO, V373, P550, DOI 10.1016/j.bbrc.2008.06.053; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Parker MD, 2008, J BIOL CHEM, V283, P12777, DOI 10.1074/jbc.M707829200; Praetorius J, 2004, AM J PHYSIOL-CELL PH, V286, pC601, DOI 10.1152/ajpcell.00240.2003; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Sassani P, 2002, AM J PHYSIOL-CELL PH, V282, pC408, DOI 10.1152/ajpcell.00409.2001; Virkki LV, 2002, AM J PHYSIOL-CELL PH, V282, pC1278, DOI 10.1152/ajpcell.00589.2001; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	19	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26998	27007		10.1074/jbc.M110.108712	http://dx.doi.org/10.1074/jbc.M110.108712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566632	hybrid, Green Published			2022-12-25	WOS:000281172700031
J	Ohkawa, Y; Miyazaki, S; Hamamura, K; Kambe, M; Miyata, M; Tajima, O; Ohmi, Y; Yamauchi, Y; Furukawa, K; Furukawa, K				Ohkawa, Yuki; Miyazaki, Sayaka; Hamamura, Kazunori; Kambe, Mariko; Miyata, Maiko; Tajima, Orie; Ohmi, Yuhsuke; Yamauchi, Yoshio; Furukawa, Koichi; Furukawa, Keiko			Ganglioside GD3 Enhances Adhesion Signals and Augments Malignant Properties of Melanoma Cells by Recruiting Integrins to Glycolipid-enriched Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; MONOCLONAL-ANTIBODY; LINKED KINASE; TUMOR GANGLIOSIDES; PLATELET-ADHESION; SYNTHASE GENE; LIPID RAFTS; PHASE-I	Ganglioside GD3 is widely expressed in human malignant melanoma cell lines and tumors. Previously, we reported that GD(3+) cells show stronger tyrosine phosphorylation of focal adhesion kinase (FAK), p130(Cas), and paxillin when treated with fetal calf serum than GD3 - cells. In this study, we analyzed the changes in the signals mediated by the interaction between integrins and extracellular matrices (ECM) to clarify how GD3 enhances cell signals in the vicinity of the cell membrane. An adhesion assay with a real time cell electronic sensing system revealed that GD3 + cells had stronger adhesion to all extracellular matrices examined. In particular, GD3 + cells attached more strongly to collagen type I and type IV than controls. Correspondingly, they showed stronger tyrosine phosphorylation of FAK and paxillin during adhesion to collagen type I. In the floating pattern of detergent extracts, a high level of integrin beta 1 was found in glycolipid-enriched microdomain (GEM)/rafts in GD3 + cells before adhesion, whereas a smaller amount of integrin beta 1 was detected in the GEM/rafts of controls. Some phosphorylated forms of FAK as well as total FAK were found in GEM/rafts during cell adhesion only in GD3 + cells. Another signal consisting of integrin-linked kinase/Akt was also activated during adhesion more strongly in GD3 + cells than in controls. In double stained GD3 + cells, GD3 and integrin beta 1 co-localized at the focal adhesion with a punctate pattern. All these results suggested that integrins assembled and formed a cluster in GEM/rafts, leading to the enhanced signaling and malignant properties under GD3 expression.	[Ohkawa, Yuki; Miyazaki, Sayaka; Hamamura, Kazunori; Tajima, Orie; Ohmi, Yuhsuke; Yamauchi, Yoshio; Furukawa, Koichi; Furukawa, Keiko] Nagoya Univ, Dept Biochem 2, Grad Sch Med, Showa Ku, Nagoya, Aichi 4660065, Japan; [Kambe, Mariko; Miyata, Maiko; Tajima, Orie; Furukawa, Keiko] Chubu Univ, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan; [Kambe, Mariko; Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	Nagoya University; Chubu University; Chubu University	Furukawa, K (corresponding author), Nagoya Univ, Dept Biochem 2, Grad Sch Med, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp; keikofu@isc.chubu.ac.jp	OHMI, Yuhsuke/I-7302-2014; Yamauchi, Yoshio/I-7539-2014	Yamauchi, Yoshio/0000-0001-5559-4596; Hamamura, Kazunori/0000-0002-8143-338X	Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid from Japan Science and Technology Agency (JST), a Grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and a grant from the COE Project for Private Universities from MEXT.	Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; CARUBIA JM, 1984, BIOCHEM BIOPH RES CO, V120, P500, DOI 10.1016/0006-291X(84)91282-8; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Charalabopoulos K, 2005, EXP ONCOL, V27, P86; Chen HH, 2003, INT J CANCER, V103, P169, DOI 10.1002/ijc.10797; CHERESH DA, 1986, J CELL BIOL, V102, P688, DOI 10.1083/jcb.102.3.688; DIPPOLD WG, 1984, CANCER RES, V44, P806; Fang LH, 1997, CLIN EXP METASTAS, V15, P33; Forero A, 2006, CANCER BIOTHER RADIO, V21, P561, DOI 10.1089/cbr.2006.21.561; Fredman P, 2003, BIODRUGS, V17, P155, DOI 10.2165/00063030-200317030-00002; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Furukawa K., 1990, HUMAN MELANOMA BASIC, P15; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GRIFFITHS SL, 1986, J CELL BIOL, V102, P469, DOI 10.1083/jcb.102.2.469; HAKOMORI SI, 1993, ADV LIPID RES, V25, P147; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Hamamura K, 2008, BBA-GEN SUBJECTS, V1780, P513, DOI 10.1016/j.bbagen.2007.11.002; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; HARAGUCHI M, 1994, P NATL ACAD SCI USA, V91, P10455, DOI 10.1073/pnas.91.22.10455; HOUGHTON AN, 1985, P NATL ACAD SCI USA, V82, P1242, DOI 10.1073/pnas.82.4.1242; Hur EM, 2004, J BIOL CHEM, V279, P5852, DOI 10.1074/jbc.M311687200; ILIOPOULOS D, 1989, J NATL CANCER I, V81, P440, DOI 10.1093/jnci/81.6.440; Inoue M, 2002, J BIOL CHEM, V277, P29881, DOI 10.1074/jbc.M201631200; Kuphal S, 2005, CANCER METAST REV, V24, P195, DOI 10.1007/s10555-005-1572-1; Li RX, 2000, J BIOL CHEM, V275, P34213, DOI 10.1074/jbc.M906368199; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nakano J, 1996, J INVEST DERMATOL, V107, P543, DOI 10.1111/1523-1747.ep12582802; Nakano J, 1999, J INVEST DERM SYMP P, V4, P173, DOI 10.1038/sj.jidsp.5640204; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; Ogita H, 2008, INT REV CYTOL, V265, P1, DOI 10.1016/S0074-7696(07)65001-3; Ohkawa Y, 2008, BIOCHEM BIOPH RES CO, V373, P14, DOI 10.1016/j.bbrc.2008.05.149; Pande G, 2000, CURR OPIN CELL BIOL, V12, P569, DOI 10.1016/S0955-0674(00)00133-2; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; PORTOUKALIAN J, 1979, EUR J BIOCHEM, V94, P19, DOI 10.1111/j.1432-1033.1979.tb12866.x; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Ribon V, 1996, J BIOL CHEM, V271, P7375, DOI 10.1074/jbc.271.13.7375; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; Saito M, 1999, J BONE MINER RES, V14, P65, DOI 10.1359/jbmr.1999.14.1.65; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHRAW W, 1995, BIOCHEMISTRY-US, V34, P13760, DOI 10.1021/bi00042a006; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Toledo MS, 2005, J BIOL CHEM, V280, P16227, DOI 10.1074/jbc.M413713200; Turner CE, 2000, J CELL SCI, V113, P4139; Valentino LA, 1996, BBA-MOL BASIS DIS, V1316, P19, DOI 10.1016/0925-4439(95)00092-5; Wang XQ, 2001, J BIOL CHEM, V276, P8436, DOI 10.1074/jbc.M006097200; Weiss M, 2003, CANCER RES, V63, P3654; Wen FQ, 1999, ARTERIOSCL THROM VAS, V19, P519, DOI 10.1161/01.ATV.19.3.519; Wong RPC, 2007, MOL CANCER THER, V6, P1692, DOI 10.1158/1535-7163.MCT-07-0134; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Yanagisawa M, 2004, GENES CELLS, V9, P801, DOI 10.1111/j.1365-2443.2004.00764.x; Yoshida S, 2001, CANCER RES, V61, P4244; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	55	76	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27213	27223		10.1074/jbc.M109.087791	http://dx.doi.org/10.1074/jbc.M109.087791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20581115	Green Published, hybrid			2022-12-25	WOS:000281172700052
J	Kashiwayama, Y; Tomohiro, T; Narita, K; Suzumura, M; Glumoff, T; Hiltunen, JK; Van Veldhoven, PP; Hatanaka, Y; Imanaka, T				Kashiwayama, Yoshinori; Tomohiro, Takenori; Narita, Kotomi; Suzumura, Miyuki; Glumoff, Tuomo; Hiltunen, J. Kalervo; Van Veldhoven, Paul P.; Hatanaka, Yasumaru; Imanaka, Tsuneo			Identification of a Substrate-binding Site in a Peroxisomal beta-Oxidation Enzyme by Photoaffinity Labeling with a Novel Palmitoyl Derivative	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIFUNCTIONAL PROTEIN-DEFICIENCY; CHAIN FATTY-ACIDS; ACYL-COA OXIDASE; RAT-LIVER PEROXISOMES; MEMBRANE-PROTEIN; D-3-HYDROXYACYL-COA DEHYDRATASE; MULTIFUNCTIONAL ENZYME; ZELLWEGER-SYNDROME; BIOGENESIS DISORDERS; MOLECULAR-BASIS	Peroxisomes play an essential role in a number of important metabolic pathways including beta-oxidation of fatty acids and their derivatives. Therefore, peroxisomes possess various beta-oxidation enzymes and specialized fatty acid transport systems. However, the molecular mechanisms of these proteins, especially in terms of substrate binding, are still unknown. In this study, to identify the substrate-binding sites of these proteins, we synthesized a photoreactive palmitic acid analogue bearing a diazirine moiety as a photophore, and performed photoaffinity labeling of purified rat liver peroxisomes. As a result, an 80-kDa peroxisomal protein was specifically labeled by the photoaffinity ligand, and the labeling efficiency competitively decreased in the presence of palmitoyl-CoA. Mass spectrometric analysis identified the 80-kDa protein as peroxisomal multifunctional enzyme type 2 (MFE2), one of the peroxisomal beta-oxidation enzymes. Recombinant rat MFE2 was also labeled by the photoaffinity ligand, and mass spectrometric analysis revealed that a fragment of rat MFE2 (residues Trp(249) to Arg(251)) was labeled by the ligand. MFE2 mutants bearing these residues, MFE2(W249A) and MFE2(R251A), exhibited decreased labeling efficiency. Furthermore, MFE2(W249G), which corresponds to one of the disease-causing mutations in human MFE2, also exhibited a decreased efficiency. Based on the crystal structure of rat MFE2, these residues are located on the top of a hydrophobic cavity leading to an active site of MFE2. These data suggest that MFE2 anchors its substrate around the region from Trp(249) to Arg(251) and positions the substrate along the hydrophobic cavity in the proper direction toward the catalytic center.	[Tomohiro, Takenori; Suzumura, Miyuki; Hatanaka, Yasumaru] Toyama Univ, Lab Biorecognit Chem, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Kashiwayama, Yoshinori; Narita, Kotomi; Imanaka, Tsuneo] Toyama Univ, Dept Biol Chem, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Glumoff, Tuomo; Hiltunen, J. Kalervo] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; [Glumoff, Tuomo; Hiltunen, J. Kalervo] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Van Veldhoven, Paul P.] Katholieke Univ Leuven, Dept Mol Cell Biol, LIPIT, B-3000 Louvain, Belgium	University of Toyama; University of Toyama; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; KU Leuven	Hatanaka, Y (corresponding author), Toyama Univ, Lab Biorecognit Chem, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.	yasu@pha.u-toyama.ac.jp; imanaka@pha.u-toyama.ac.jp	, Van Veldhoven Paul/U-6359-2019	, Van Veldhoven Paul/0000-0002-4478-2564; Imanaka, Tsuneo/0000-0003-4677-1356; Hiltunen, Kalervo/0000-0002-3073-9602	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [18590049, 18790050, 18390036, 20390032]; CLUSTER (Cooperative Link of Unique Science and Technology for Economy Revitalization); Fugaku Trust	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CLUSTER (Cooperative Link of Unique Science and Technology for Economy Revitalization); Fugaku Trust	This work was supported in part by Grants-in-aid for the Research on Measures for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan and for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (18590049, 18790050, 18390036, and 20390032). This work also supported in part by grants from CLUSTER (Cooperative Link of Unique Science and Technology for Economy Revitalization) and the Fugaku Trust for Medicinal Research.	Adamski J, 1997, STEROIDS, V62, P159, DOI 10.1016/S0039-128X(96)00175-4; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; Baes M, 2000, J BIOL CHEM, V275, P16329, DOI 10.1074/jbc.M001994200; Breton R, 1996, STRUCTURE, V4, P905, DOI 10.1016/S0969-2126(96)00098-6; Brosius U, 2002, CELL MOL LIFE SCI, V59, P1058, DOI 10.1007/s00018-002-8486-7; Corey EJ, 1997, J AM CHEM SOC, V119, P12414, DOI 10.1021/ja973174y; DieuaideNoubhani M, 1997, BIOCHEM J, V321, P253, DOI 10.1042/bj3210253; DieuaideNoubhani M, 1996, EUR J BIOCHEM, V240, P660, DOI 10.1111/j.1432-1033.1996.0660h.x; DieuaideNoubhani M, 1997, BIOCHEM J, V325, P367, DOI 10.1042/bj3250367; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Ferdinandusse S, 2006, AM J HUM GENET, V78, P112, DOI 10.1086/498880; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fujiki Y, 2000, FEBS LETT, V476, P42, DOI 10.1016/S0014-5793(00)01667-7; FURUTA S, 1980, J BIOCHEM, V88, P1059, DOI 10.1093/oxfordjournals.jbchem.a133057; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; Haapalainen AM, 2003, STRUCTURE, V11, P87, DOI 10.1016/S0969-2126(02)00931-0; Hashimoto M, 2002, BIOORG MED CHEM LETT, V12, P2507, DOI 10.1016/S0960-894X(02)00522-X; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; Huyghe S, 2006, BBA-MOL CELL BIOL L, V1761, P973, DOI 10.1016/j.bbalip.2006.04.006; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; Imanaka T, 1996, J BIOL CHEM, V271, P3706; Jiang LL, 1996, J BIOCHEM, V120, P633; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P506; Jiang LL, 1996, J BIOCHEM-TOKYO, V120, P624; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KAMIJO K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P323, DOI 10.1016/0167-4781(92)90510-7; Kashiwayama Y, 2005, BBA-MOL CELL RES, V1746, P116, DOI 10.1016/j.bbamcr.2005.10.006; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; Leenders F, 1996, J BIOL CHEM, V271, P5438, DOI 10.1074/jbc.271.10.5438; LI JX, 1990, J BIOL CHEM, V265, P13629; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MANGROO D, 1993, BIOCHIM BIOPHYS ACTA, V1168, P280, DOI 10.1016/0005-2760(93)90183-A; MOSER HW, 1981, NEUROLOGY, V31, P1241, DOI 10.1212/WNL.31.10.1241; MOSER HW, 1980, ANN NEUROL, V7, P542, DOI 10.1002/ana.410070607; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Nakashima H, 2006, J AM CHEM SOC, V128, P15092, DOI 10.1021/ja066479y; Novikov D, 1997, BBA-MOL BASIS DIS, V1360, P229, DOI 10.1016/S0925-4439(97)00003-3; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; OSUMI T, 1979, BIOCHEM BIOPH RES CO, V89, P580, DOI 10.1016/0006-291X(79)90669-7; Qin YM, 1997, BIOCHEM J, V321, P21, DOI 10.1042/bj3210021; Qin YM, 1997, BIOCHEM J, V328, P377, DOI 10.1042/bj3280377; RAJASEKHARAN R, 1993, BIOCHEMISTRY-US, V32, P12386, DOI 10.1021/bi00097a016; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Suzuki Y, 1997, AM J HUM GENET, V61, P1153, DOI 10.1086/301599; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; van Grunsven EG, 1998, P NATL ACAD SCI USA, V95, P2128, DOI 10.1073/pnas.95.5.2128; van Grunsven EG, 1999, AM J HUM GENET, V64, P99, DOI 10.1086/302180; VANHOVE GF, 1993, J BIOL CHEM, V268, P10335; Wanders RJA, 2001, BIOCHEM SOC T, V29, P250, DOI 10.1042/0300-5127:0290250; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; WATKINS PA, 1989, J CLIN INVEST, V83, P771, DOI 10.1172/JCI113956; Ylianttila MS, 2006, J MOL BIOL, V358, P1286, DOI 10.1016/j.jmb.2006.03.001	53	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26315	26325		10.1074/jbc.M110.104547	http://dx.doi.org/10.1074/jbc.M110.104547			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566640	Green Published, hybrid			2022-12-25	WOS:000280921000049
J	Sergueev, KV; He, YX; Borschel, RH; Nikolich, MP; Filippov, AA				Sergueev, Kirill V.; He, Yunxiu; Borschel, Richard H.; Nikolich, Mikeljon P.; Filippov, Andrey A.			Rapid and Sensitive Detection of Yersinia pestis Using Amplification of Plague Diagnostic Bacteriophages Monitored by Real-Time PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENOME SEQUENCE; REACTION ASSAY; GAMMA-PHAGE; IDENTIFICATION; HYBRIDIZATION; VALIDATION; RESISTANCE; INFECTION; VIRULENCE	Background: Yersinia pestis, the agent of plague, has caused many millions of human deaths and still poses a serious threat to global public health. Timely and reliable detection of such a dangerous pathogen is of critical importance. Lysis by specific bacteriophages remains an essential method of Y. pestis detection and plague diagnostics. Methodology/Principal Findings: The objective of this work was to develop an alternative to conventional phage lysis tests - a rapid and highly sensitive method of indirect detection of live Y. pestis cells based on quantitative real-time PCR (qPCR) monitoring of amplification of reporter Y. pestis-specific bacteriophages. Plague diagnostic phages phi A1122 and L-413C were shown to be highly effective diagnostic tools for the detection and identification of Y. pestis by using qPCR with primers specific for phage DNA. The template DNA extraction step that usually precedes qPCR was omitted. phi A1122-specific qPCR enabled the detection of an initial bacterial concentration of 10(3) CFU/ml (equivalent to as few as one Y. pestis cell per 1-mu l sample) in four hours. L-413C-mediated detection of Y. pestis was less sensitive (up to 100 bacteria per sample) but more specific, and thus we propose parallel qPCR for the two phages as a rapid and reliable method of Y. pestis identification. Importantly, phi A1122 propagated in simulated clinical blood specimens containing EDTA and its titer rise was detected by both a standard plating test and qPCR. Conclusions/Significance: Thus, we developed a novel assay for detection and identification of Y. pestis using amplification of specific phages monitored by qPCR. The method is simple, rapid, highly sensitive, and specific and allows the detection of only live bacteria.	[Sergueev, Kirill V.; He, Yunxiu; Borschel, Richard H.; Nikolich, Mikeljon P.; Filippov, Andrey A.] Walter Reed Army Inst Res, Dept Emerging Bacterial Infect, Div Bacterial & Rickettsial Dis, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Sergueev, KV (corresponding author), Walter Reed Army Inst Res, Dept Emerging Bacterial Infect, Div Bacterial & Rickettsial Dis, Silver Spring, MD USA.	kirill.sergueev@amedd.army.mil; andrey.filippov@amedd.army.mil	Nikolich, Mikeljon P/ABC-9871-2021; Nikolich, Mikeljon/ABD-5270-2020; Filippov, Andrey/B-2856-2011	Nikolich, Mikeljon P/0000-0001-5770-8980; Filippov, Andrey/0000-0003-2256-861X	Defense Threat Reduction Agency, Joint Science and Technology Office, Medical ST Division	Defense Threat Reduction Agency, Joint Science and Technology Office, Medical ST Division(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by the Defense Threat Reduction Agency, Joint Science and Technology Office, Medical S&T Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshire TG, 2005, J CLIN MICROBIOL, V43, P4780, DOI 10.1128/JCM.43.9.4780-4788.2005; ADVIER M., 1933, Bulletin de la Societe de Pathologie Exotique, V26, P94; Amoako KK, 2010, J FOOD PROTECT, V73, P18, DOI 10.4315/0362-028X-73.1.18; Anisimov AP, 2006, J MED MICROBIOL, V55, P1461, DOI 10.1099/jmm.0.46697-0; Aucken HM, 2002, J CLIN MICROBIOL, V40, P292, DOI 10.1128/JCM.40.1.292-293.2002; Awais R, 2006, BIOTECHNOL PROGR, V22, P853, DOI 10.1021/bp060020q; Banaiee N, 2001, J CLIN MICROBIOL, V39, P3883, DOI 10.1128/JCM.39.11.3883-3888.2001; BERTANI LE, 1957, VIROLOGY, V4, P53, DOI 10.1016/0042-6822(57)90043-0; Blasco R, 1998, J APPL MICROBIOL, V84, P661, DOI 10.1046/j.1365-2672.1998.00393.x; BOBROV AG, 1999, PROBL PARTICULARLY D, V79, P138; BUTLER T, 1976, J INFECT DIS, V133, P493, DOI 10.1093/infdis/133.5.493; Butler T, 2009, CLIN INFECT DIS, V49, P736, DOI 10.1086/604718; CAMPBELL J, 1993, J CLIN MICROBIOL, V31, P758, DOI 10.1128/JCM.31.3.758-759.1993; Chase CJ, 2005, CLIN CHEM, V51, P1778, DOI 10.1373/clinchem.2005.051839; CHU MC, 2000, LAB MANUAL PLAGUE DI, P129; CRAIGIE J, 1946, BACTERIOL REV, V10, P73, DOI 10.1128/MMBR.10.3-4.73-88.1946; De Lappe N, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-155; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Edelman DC, 2003, BIOTECHNIQUES, V35, P368, DOI 10.2144/03352rr02; Edgar R, 2006, P NATL ACAD SCI USA, V103, P4841, DOI 10.1073/pnas.0601211103; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; FILIPPOV AA, 1990, FEMS MICROBIOL LETT, V67, P45, DOI 10.1111/j.1574-6968.1990.tb13833.x; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Galimand M, 2006, ANTIMICROB AGENTS CH, V50, P3233, DOI 10.1128/AAC.00306-06; Garcia E, 2003, J BACTERIOL, V185, P5248, DOI 10.1128/JB.185.17.5248-5262.2003; Garcia E, 2008, VIROLOGY, V372, P85, DOI 10.1016/j.virol.2007.10.032; GUNNISON JB, 1951, J INFECT DIS, V88, P254, DOI 10.1093/infdis/88.3.254; Higgins JA, 1998, J CLIN MICROBIOL, V36, P2284, DOI 10.1128/JCM.36.8.2284-2288.1998; HINNEBUSCH J, 1993, J CLIN MICROBIOL, V31, P1511, DOI 10.1128/JCM.31.6.1511-1514.1993; IMAMALIEV OG, 1986, STANDARDS STRAINS ME, P102; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Iqbal SS, 2000, MOL CELL PROBE, V14, P109, DOI 10.1006/mcpr.2000.0295; Kutin RK, 2009, J MICROBIOL METH, V76, P241, DOI 10.1016/j.mimet.2008.11.008; Kutyrev V V, 1989, Mol Gen Mikrobiol Virusol, P42; Larina VS, 1970, PROBL PARTICULARLY D, V11, P132; Loessner MJ, 1996, APPL ENVIRON MICROB, V62, P1133, DOI 10.1128/AEM.62.4.1133-1140.1996; Loiez C, 2003, J CLIN MICROBIOL, V41, P4873, DOI 10.1128/JCM.41.10.4873-4875.2003; Matero P, 2009, APMIS, V117, P34, DOI 10.1111/j.1600-0463.2008.00013.x; McAvin JC, 2003, MIL MED, V168, P852, DOI 10.1093/milmed/168.10.852; McNerney R, 2004, J CLIN MICROBIOL, V42, P2115, DOI 10.1128/JCM.42.5.2115-2120.2004; Melo AC, 2003, LETT APPL MICROBIOL, V37, P361, DOI 10.1046/j.1472-765X.2003.01377.x; NAUMOV AV, 1992, MANUAL PROPHYLAXIS P; Neubauer H, 2000, J VET MED B, V47, P573, DOI 10.1046/j.1439-0450.2000.00384.x; Neufeld T, 2003, ANAL CHEM, V75, P580, DOI 10.1021/ac026083e; NORKINA OV, 1994, J APPL BACTERIOL, V76, P240, DOI 10.1111/j.1365-2672.1994.tb01622.x; Oda M, 2004, APPL ENVIRON MICROB, V70, P527, DOI 10.1128/AEM.70.1.527-534.2004; Ogorzaly L, 2006, J VIROL METHODS, V138, P131, DOI 10.1016/j.jviromet.2006.08.004; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; POKROVSKAYA MP, 1929, GIGIENA EPIDEMIOL, V12, P31; Rahalison L, 2000, J CLIN MICROBIOL, V38, P260; Reiman RW, 2007, J MICROBIOL METH, V68, P651, DOI 10.1016/j.mimet.2006.11.004; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Samoilova SV, 1996, J MED MICROBIOL, V45, P440, DOI 10.1099/00222615-45-6-440; SANDERS MF, 1995, BIOLUMINESCENCE CHEM, P454; Schofield DA, 2009, J APPL MICROBIOL, V107, P1468, DOI 10.1111/j.1365-2672.2009.04332.x; Schofield DA, 2009, J CLIN MICROBIOL, V47, P3887, DOI 10.1128/JCM.01533-09; Stewart A, 2008, J MED MICROBIOL, V57, P324, DOI 10.1099/jmm.0.47485-0; Tomaso H, 2003, FEMS IMMUNOL MED MIC, V38, P117, DOI 10.1016/S0928-8244(03)00184-6; Tomaso H, 2008, CLIN CHEM LAB MED, V46, P1239, DOI 10.1515/CCLM.2008.251; Trebesius K, 1998, J CLIN MICROBIOL, V36, P2557, DOI 10.1128/JCM.36.9.2557-2564.1998; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Welkos SL, 1995, CONTRIB TO MICROBIOL, V13, P299; Woron AM, 2006, DIAGN MICR INFEC DIS, V56, P261, DOI 10.1016/j.diagmicrobio.2006.06.009; Yim PB, 2009, BIOTECHNOL BIOENG, V104, P1059, DOI 10.1002/bit.22488	69	37	40	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11337	10.1371/journal.pone.0011337	http://dx.doi.org/10.1371/journal.pone.0011337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596528	Green Submitted, gold, Green Published			2022-12-25	WOS:000279259900010
J	Pasco-Viel, E; Charles, C; Chevret, P; Semon, M; Tafforeau, P; Viriot, L; Laudet, V				Pasco-Viel, Emmanuel; Charles, Cyril; Chevret, Pascale; Semon, Marie; Tafforeau, Paul; Viriot, Laurent; Laudet, Vincent			Evolutionary Trends of the Pharyngeal Dentition in Cypriniformes (Actinopterygii: Ostariophysi)	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; TOOTH DEVELOPMENT; TELEOSTEI CYPRINIFORMES; MOLECULAR SYSTEMATICS; COBITOIDEA TELEOSTEI; FISH; REPLACEMENT; PAEDOCYPRIS; CYPRINIDAE; TEETH	Background: The fish order Cypriniformes is one of the most diverse ray-finned fish groups in the world with more than 3000 recognized species. Cypriniformes are characterized by a striking distribution of their dentition: namely the absence of oral teeth and presence of pharyngeal teeth on the last gill arch (fifth ceratobranchial). Despite this limited localisation, the diversity of tooth patterns in Cypriniformes is astonishing. Here we provide a further description of this diversity using X-ray microtomography and we map the resulting dental characters on a phylogenetic tree to explore evolutionary trends. Results: We performed a pilot survey of dental formulae and individual tooth shapes in 34 adult species of Cypriniformes by X-ray microtomography (using either conventional X-ray machine, or synchrotron microtomography when necessary) or by dissecting. By mapping morphological results in a phylogenetic tree, it emerges that the two super-families Cobitoidea and Cyprinoidea have followed two distinct evolutionary pathways. Furthermore, our analysis supports the hypothesis of a three-row dentition as ancestral for Cyprinoidea and a general trend in tooth row reduction in most derived lineages. Yet, this general scheme must be considered with caution as several events of tooth row gain and loss have occurred during evolutionary history of Cyprinoidea. Significance: Dentition diversity in Cypriniformes constitutes an excellent model to study the evolution of complex morphological structures. This morphological survey clearly advocates for extending the use of X-ray microtomography to study tooth morphology in Cypriniformes. Yet, our survey also underlines that improved knowledge of Cypriniformes life traits, such as feeding habits, is required as current knowledge is not sufficient to conclude on the link between diet and dental morphology.	[Pasco-Viel, Emmanuel; Chevret, Pascale; Semon, Marie; Viriot, Laurent; Laudet, Vincent] Univ Lyon, CNRS, INRA, Ecole Normale Super Lyon,Inst Genom Fonct Lyon, Lyon, France; [Charles, Cyril; Viriot, Laurent] Univ Poitiers, iPHEP, CNRS, UMR 6046, Poitiers, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; European Synchrotron Radiation Facility (ESRF)	Pasco-Viel, E (corresponding author), Univ Lyon, CNRS, INRA, Ecole Normale Super Lyon,Inst Genom Fonct Lyon, Lyon, France.	Laurent.Viriot@ens-lyon.fr; Vincent.Laudet@ens-lyon.fr	Charles, Cyril/E-7606-2011; Chevret, Pascale/B-7299-2009	Charles, Cyril/0000-0002-6930-039X; Viriot, Laurent/0000-0003-2092-588X; Tafforeau, Paul/0000-0002-5962-1683; Semon, Marie/0000-0003-3479-7524	Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT); Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF); Ecole Normale Superieure (ENS) of Lyon; Agence Nationale pour la Recherche (ANR) [ANR-09-BLAN-0127-02]	Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Synchrotron Radiation Facility (ESRF); Ecole Normale Superieure (ENS) of Lyon; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	This work has been funded by the Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT, www.education.gouv.fr), the Centre National de la Recherche Scientifique (CNRS, www.cnrs.fr), the European Synchrotron Radiation Facility (ESRF, www.esrf.eu) and Ecole Normale Superieure (ENS) of Lyon (www.ens-lyon.fr) as well as by Agence Nationale pour la Recherche (ANR) grant Bouillabaisse (www.agence-nationale-recherche.fr/ANR-09-BLAN-0127-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D, 2007, BIOINFORMATICS, V23, P14, DOI 10.1093/bioinformatics/btl558; Borday-Birraux V, 2006, EVOL DEV, V8, P130, DOI 10.1111/j.1525-142X.2006.00084.x; Boulenger G.A., 1909, CATALOGUE FRESHWATER, VI; BOULENGER GA, 1909, CATALOGUE FRESHWATER, V2; Britz R, 2009, J MORPHOL, V270, P389, DOI 10.1002/jmor.10698; Britz R, 2009, P ROY SOC B-BIOL SCI, V276, P2179, DOI 10.1098/rspb.2009.0141; Caton J, 2009, J ANAT, V214, P502, DOI 10.1111/j.1469-7580.2008.01014.x; CAVENDER TM, 1991, CYPRINID FISHES SYST, P34; CHANG M, 2008, SPECIAL PUBLICATIONS, V295, P337; Chen WJ, 2009, MOL PHYLOGENET EVOL, V52, P544, DOI 10.1016/j.ympev.2009.01.006; Chu Y.T., 1935, BIOL BULL+, V2, P1, DOI DOI 10.2307/1436747; Collin R, 2008, TRENDS ECOL EVOL, V23, P602, DOI 10.1016/j.tree.2008.06.013; Conway KW, 2008, ZOOTAXA, P1; Conway-Morris Simon., 1998, CRUCIBLE CREATION BU; Davidson EH, 2006, REG GEN GEN REG; Debiais-Thibaud M, 2008, EVOL DEV, V10, P464, DOI 10.1111/j.1525-142X.2008.00257.x; Debiais-Thibaud M, 2007, J EXP ZOOL PART B, V308B, P693, DOI 10.1002/jez.b.21183; EASTMAN JT, 1973, COPEIA, P45; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GAYET M, 1987, Contributions from the Museum of Paleontology University of Michigan, V27, P151; Golubtsov AS, 2005, J FISH BIOL, V67, P286, DOI 10.1111/j.0022-1112.2005.00724.x; GOSLINE WA, 1973, COPEIA, P761; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Heckel J., 1858, SUSSWASSERFISCHE OST; Honeycutt Rodney L, 2008, J Biol, V7, P9, DOI 10.1186/jbiol71; Huysseune A, 2008, EVOL DEV, V10, P6, DOI 10.1111/j.1525-142X.2007.00209.x; Huysseune A, 2004, BIOESSAYS, V26, P665, DOI 10.1002/bies.20039; Huysseune A, 2009, J ANAT, V214, P465, DOI 10.1111/j.1469-7580.2009.01053.x; Jackman WR, 2006, P NATL ACAD SCI USA, V103, P19390, DOI 10.1073/pnas.0609575103; Jayaram K. C., 1981, FRESHWATER FISHES IN; JORDAN DS, 1896, FISHES N MIDDLE AM, V1; Kottelat M, 2006, P ROY SOC B-BIOL SCI, V273, P895, DOI 10.1098/rspb.2005.3419; Kuratani S, 2009, DEV BIOL, V332, P61, DOI 10.1016/j.ydbio.2009.05.564; Lazzari V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003607; Liu J, 2009, SCI CHINA SER D, V52, P189, DOI 10.1007/s11430-009-0022-2; Mayden RL, 2007, J EXP ZOOL PART B, V308B, P642, DOI 10.1002/jez.b.21175; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; NAKAJIMA T, 1987, COPEIA, P208; Nelson J.S., 1991, CYPRINID FISHES SYST, P353; Nelson JS, 1984, FISHES WORLD; Organ CL, 2007, NATURE, V446, P180, DOI 10.1038/nature05621; Organ CL, 2009, NATURE, V461, P389, DOI 10.1038/nature08350; Otero O, 2001, J VERTEBR PALEONTOL, V21, P386, DOI 10.1671/0272-4634(2001)021[0386:TOKCFO]2.0.CO;2; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Patterson C., 1993, FOSS REC, V2, P622; Regan CT., 1911, FRESHWATER FISHES BR, DOI [10.5962/bhl.title.13625, DOI 10.5962/BHL.TITLE.13625]; Renaud S, 2005, P ROY SOC B-BIOL SCI, V272, P609, DOI 10.1098/rspb.2004.2992; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruber L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-38; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Scott JL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1002; Slechtova V, 2007, MOL PHYLOGENET EVOL, V44, P1358, DOI 10.1016/j.ympev.2007.02.019; Stock DW, 2007, J EXP ZOOL PART B, V308B, P523, DOI 10.1002/jez.b.21187; Stock DW, 2006, DEVELOPMENT, V133, P3127, DOI 10.1242/dev.02459; Streelman JT, 2007, ANNU REV ECOL EVOL S, V38, P655, DOI 10.1146/annurev.ecolsys.38.091206.095537; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Talwar P.K., 1992, INLAND FISHES INDIA, V1-2; Tang QY, 2006, MOL PHYLOGENET EVOL, V39, P347, DOI 10.1016/j.ympev.2005.08.007; TAYLOR W R, 1985, Cybium, V9, P107; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Van der heyden C, 2001, ARCH ORAL BIOL, V46, P1051, DOI 10.1016/S0003-9969(01)00064-4; Van der Heyden C, 2000, DEV DYNAM, V219, P486; Wang X, 2007, J NEUROIMMUNE PHARM, V2, P42, DOI 10.1007/s11481-006-9059-6; Wautier K, 2001, ARCH ORAL BIOL, V46, P67, DOI 10.1016/S0003-9969(00)00091-1; Winfield IJ, 1991, CYPRINID FISHES SYST; Xiao WH, 2001, MOL PHYLOGENET EVOL, V18, P163, DOI 10.1006/mpev.2000.0879; Zardoya R, 1999, J MOL EVOL, V49, P227, DOI 10.1007/PL00006545; Zhang ZY, 2009, SCIENCE, V323, P1232, DOI 10.1126/science.1167418	71	43	47	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11293	10.1371/journal.pone.0011293	http://dx.doi.org/10.1371/journal.pone.0011293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585584	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135800006
J	Wertheim, JO				Wertheim, Joel O.			The Re-Emergence of H1N1 Influenza Virus in 1977: A Cautionary Tale for Estimating Divergence Times Using Biologically Unrealistic Sampling Dates	PLOS ONE			English	Article							LENGTH DNA-COPY; A VIRUS; CLONING; EMERGENCE; EVOLUTION; GENOME	In 1977, H1N1 influenza A virus reappeared after a 20-year absence. Genetic analysis indicated that this strain was missing decades of nucleotide sequence evolution, suggesting an accidental release of a frozen laboratory strain into the general population. Recently, this strain and its descendants were included in an analysis attempting to date the origin of pandemic influenza virus without accounting for the missing decades of evolution. Here, we investigated the effect of using viral isolates with biologically unrealistic sampling dates on estimates of divergence dates. Not accounting for missing sequence evolution produced biased results and increased the variance of date estimates of the most recent common ancestor of the re-emergent lineages and across the entire phylogeny. Reanalysis of the H1N1 sequences excluding isolates with unrealistic sampling dates indicates that the 1977 re-emergent lineage was circulating for approximately one year before detection, making it difficult to determine the geographic source of reintroduction. We suggest that a new method is needed to account for viral isolates with unrealistic sampling dates.	Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA	University of California System; University of California San Diego	Wertheim, JO (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.	jwertheim@ucsd.edu			 [NIH-AI07384];  [NSF-0714991];  [NIH-AI47745]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007384] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JOW was funded by a fellowship from NIH-AI07384. Additional support came from NSF-0714991 and NIH-AI47745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEKLEMISHEV AB, 1984, BIOORG KHIM+, V10, P1535; BEKLEMISHEV AB, 1985, BIOORG KHIM+, V11, P641; BEKLEMISHEV AB, 1985, BIOORG KHIM+, V11, P628; BEVERIDGE WIB, 1978, NEW SCI, P790; Bush RM, 2000, P NATL ACAD SCI USA, V97, P6974, DOI 10.1073/pnas.97.13.6974; dos Reis M, 2009, J MOL EVOL, V69, P333, DOI 10.1007/s00239-009-9282-x; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Kerr PJ, 2009, J VIROL, V83, P12129, DOI 10.1128/JVI.01523-09; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; MCKINLEY RL, 1988, J EDUC MEAS, V25, P233, DOI 10.1111/j.1745-3984.1988.tb00305.x; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; World Health Organization, 1978, WKLY EPIDEMIOL REC, V53, P21; Worobey M, 2008, J VIROL, V82, P3769, DOI 10.1128/JVI.02207-07; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	21	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11184	10.1371/journal.pone.0011184	http://dx.doi.org/10.1371/journal.pone.0011184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567599	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886300026
J	Yewdall, AW; Drutman, SB; Jinwala, F; Bahjat, KS; Bhardwaj, N				Yewdall, Alice W.; Drutman, Scott B.; Jinwala, Felecia; Bahjat, Keith S.; Bhardwaj, Nina			CD8+T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells	PLOS ONE			English	Article							T-CELLS; IN-VIVO; APOPTOTIC CELLS; IMMUNE-SYSTEM; LYMPH-NODES; IMMUNOTHERAPY; MATURATION; COMPLEXES; OVALBUMIN; RESPONSES	Background: Immunotherapeutic strategies to stimulate anti-tumor immunity are promising approaches for cancer treatment. A major barrier to their success is the immunosuppressive microenvironment of tumors, which inhibits the functions of endogenous dendritic cells (DCs) that are necessary for the generation of anti-tumor CD8+ T cells. To overcome this problem, autologous DCs are generated ex vivo, loaded with tumor antigens, and activated in this non-suppressive environment before administration to patients. However, DC-based vaccines rarely induce tumor regression. Methodology/Principal Findings: We examined the fate and function of these DCs following their injection using murine models, in order to better understand their interaction with the host immune system. Contrary to previous assumptions, we show that DC vaccines have an insignificant role in directly priming CD8+ T cells, but instead function primarily as vehicles for transferring antigens to endogenous antigen presenting cells, which are responsible for the subsequent activation of T cells. Conclusions/Significance: This reliance on endogenous immune cells may explain the limited success of current DC vaccines to treat cancer and offers new insight into how these therapies can be improved. Future approaches should focus on creating DC vaccines that are more effective at directly priming T cells, or abrogating the tumor induced suppression of endogenous DCs.	[Yewdall, Alice W.; Drutman, Scott B.; Jinwala, Felecia; Bhardwaj, Nina] NYU, Sch Med, Inst Canc, New York, NY USA; [Bahjat, Keith S.] Providence Canc Ctr, Earle A Chiles Res Inst, Portland, OR USA	New York University	Yewdall, AW (corresponding author), Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA.	Nina.Bhardwaj@nyumc.org		Bhardwaj, Nina/0000-0003-1865-4187	Cancer Research Institute; Doris Duke Charitable Foundation; National Institutes of Health (NIH) [A1044628, A1071078, A1061684]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044628, R01AI071078] Funding Source: NIH RePORTER	Cancer Research Institute; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the Cancer Research Institute, the Doris Duke Charitable Foundation, and the National Institutes of Health (NIH) grants A1044628, A1071078, and A1061684 to N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Andre F, 2004, J IMMUNOL, V172, P2126, DOI 10.4049/jimmunol.172.4.2126; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baumjohann D, 2006, EUR J IMMUNOL, V36, P2544, DOI 10.1002/eji.200535742; BERENDT MJ, 1978, J EXP MED, V148, P1550, DOI 10.1084/jem.148.6.1550; Bhardwaj N, 2007, J CLIN INVEST, V117, P1130, DOI 10.1172/JCI32136; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; Dolan BP, 2006, J IMMUNOL, V176, P1447, DOI 10.4049/jimmunol.176.3.1447; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Figdor CG, 2004, NAT MED, V10, P475, DOI 10.1038/nm1039; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Labeur MS, 1999, J IMMUNOL, V162, P168; Lesterhuis WJ, 2008, CRIT REV ONCOL HEMAT, V66, P118, DOI 10.1016/j.critrevonc.2007.12.007; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Luketic L, 2007, J IMMUNOL, V179, P5024, DOI 10.4049/jimmunol.179.8.5024; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Munz C, 2005, J EXP MED, V202, P203, DOI 10.1084/jem.20050810; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; NIKOLICZUGIC J, 1990, EUR J IMMUNOL, V20, P2431, DOI 10.1002/eji.1830201111; O'Neill DW, 2004, BLOOD, V104, P2235, DOI 10.1182/blood-2003-12-4392; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schadendorf D, 2006, ANN ONCOL, V17, P563, DOI 10.1093/annonc/mdj138; Schlecht G, 2004, BLOOD, V104, P1808, DOI 10.1182/blood-2004-02-0426; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Smith AL, 1999, J EXP MED, V189, P593, DOI 10.1084/jem.189.3.593; Soruri A, 2005, INT J BIOCHEM CELL B, V37, P241, DOI 10.1016/j.biocel.2004.07.003; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	53	85	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11144	10.1371/journal.pone.0011144	http://dx.doi.org/10.1371/journal.pone.0011144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585396	Green Published, gold, Green Submitted			2022-12-25	WOS:000278886100012
J	Minozzi, G; Buggiotti, L; Stella, A; Strozzi, F; Luini, M; Williams, JL				Minozzi, Giulietta; Buggiotti, Laura; Stella, Alessandra; Strozzi, Francesco; Luini, Mario; Williams, John L.			Genetic Loci Involved in Antibody Response to Mycobacterium avium ssp. paratuberculosis in Cattle	PLOS ONE			English	Article							SUBSP PARATUBERCULOSIS; CROHNS-DISEASE; ASSOCIATION ANALYSIS; JOHNES-DISEASE; INFECTION; IDENTIFICATION; RESISTANCE; BLIMP-1; SUSCEPTIBILITY; POLYMORPHISMS	Background: Mycobacterium avium subsp. paratuberculosis (MAP) causes chronic enteritis in a wide range of animal species. In cattle, MAP causes a chronic disease called Johne's disease, or paratuberculosis, that is not treatable and the efficacy of vaccine control is controversial. The clinical phase of the disease is characterised by diarrhoea, weight loss, drop in milk production and eventually death. Susceptibility to MAP infection is heritable with heritability estimates ranging from 0.06 to 0.10. There have been several studies over the last few years that have identified genetic loci putatively associated with MAP susceptibility, however, with the availability of genome-wide high density SNP maker panels it is now possible to carry out association studies that have higher precision. Methodology/Principal Findings: The objective of the current study was to localize genes having an impact on Johne's disease susceptibility using the latest bovine genome information and a high density SNP panel (Illumina BovineSNP50 BeadChip) to perform a case/control, genome-wide association analysis. Samples from MAP case and negative controls were selected from field samples collected in 2007 and 2008 in the province of Lombardy, Italy. Cases were defined as animals serologically positive for MAP by ELISA. In total 966 samples were genotyped: 483 MAP ELISA positive and 483 ELISA negative. Samples were selected randomly among those collected from 119 farms which had at least one positive animal. Conclusion/Significance: The analysis of the genotype data identified several chromosomal regions associated with disease status: a region on chromosome 12 with high significance (P<5x10(-6)), while regions on chromosome 9, 11, and 12 had moderate significance (P<5x10(-5)). These results provide evidence for genetic loci involved in the humoral response to MAP. Knowledge of genetic variations related to susceptibility will facilitate the incorporation of this information into breeding programmes for the improvement of health status.	[Minozzi, Giulietta; Stella, Alessandra; Strozzi, Francesco; Williams, John L.] Polo Univ, Lodi, Italy; [Buggiotti, Laura] Ist Sperimentale Italiano Lazzaro Spallanzani, Lodi, Italy; [Stella, Alessandra] CNR, Ist Biol & Biotecnol Agr, Lodi, Italy; [Luini, Mario] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Lodi, Italy	IRCCS Lazzaro Spallanzani; Consiglio Nazionale delle Ricerche (CNR); IZS Lombardia e Emilia	Minozzi, G (corresponding author), Polo Univ, Parco Tecnol Padano, Lodi, Italy.	giulietta.minozzi@tecnoparco.org	Stella, Alessandra/AAY-7322-2020; Minozzi, Giulietta/K-8126-2017; stella, Alessandra/AAG-6401-2021; stella, Alessandra/ABB-1952-2021; Buggiotti, Laura/G-9777-2014	Minozzi, Giulietta/0000-0002-0020-8798; stella, Alessandra/0000-0003-2850-3964; stella, Alessandra/0000-0003-2850-3964; Buggiotti, Laura/0000-0002-7404-7800; Williams, John/0000-0001-5188-7957; Strozzi, Francesco/0000-0002-6845-6982	EC [FP7-KBBE-2007-1-1-2-211602]; Cariplo Foundation	EC(European CommissionEuropean Commission Joint Research Centre); Cariplo Foundation(Fondazione Cariplo)	This work was supported by the EC MacroSys project ref number FP7-KBBE-2007-1-1-2-211602, and partially by the Cariplo Foundation. Funding for GM and LB was provided by the EC MacroSys project ref number FP7-KBBE-2007-1-1-2-211602, and JLW and FS were funded by the Cariplo Foundation for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Ansari M, 2009, BLOOD, V114, P1383, DOI 10.1182/blood-2008-11-191098; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Beard PM, 2001, J CLIN MICROBIOL, V39, P1517, DOI 10.1128/JCM.39.4.1517-1521.2001; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Cetinkaya B, 1997, PREV VET MED, V32, P253, DOI 10.1016/S0167-5877(97)00028-7; Chang DH, 2000, NAT IMMUNOL, V1, P169, DOI 10.1038/77861; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Collins MT, 2005, CLIN DIAGN LAB IMMUN, V12, P685, DOI 10.1128/CDLI.12.6.685-692.2005; de Almeida DE, 2008, VET IMMUNOL IMMUNOP, V125, P234, DOI 10.1016/j.vetimm.2008.05.019; Falconer D. S, 1996, INTRO QUANTITATIVE G; Ghadiali AH, 2004, J CLIN MICROBIOL, V42, P5345, DOI 10.1128/JCM.42.11.5345-5348.2004; Gonda MG, 2007, ANIM GENET, V38, P389, DOI 10.1111/j.1365-2052.2007.01627.x; Gonda MG, 2006, J DAIRY SCI, V89, P1804, DOI 10.3168/jds.S0022-0302(06)72249-4; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Greig A, 1999, J CLIN MICROBIOL, V37, P1746, DOI 10.1128/JCM.37.6.1746-1751.1999; Harris JE, 2001, J FOOD PROTECT, V64, P2103, DOI 10.4315/0362-028X-64.12.2103; Hasonova L, 2006, VET MED-CZECH, V51, P193, DOI 10.17221/5539-VETMED; Hinger M, 2008, J DAIRY SCI, V91, P3237, DOI 10.3168/jds.2008-1021; Hinger M, 2007, J DAIRY SCI, V90, P1957, DOI 10.3168/jds.2006-510; Hugot JP, 2006, ANN NY ACAD SCI, V1072, P9, DOI 10.1196/annals.1326.011; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Koets AP, 2000, J DAIRY SCI, V83, P2702, DOI 10.3168/jds.S0022-0302(00)75164-2; LARSEN AB, 1975, AM J VET RES, V36, P255; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; MCCLURE HM, 1987, J INFECT DIS, V155, P1011, DOI 10.1093/infdis/155.5.1011; Mendoza JL, 2009, WORLD J GASTROENTERO, V15, P417, DOI 10.3748/wjg.15.417; Mortensen H, 2004, J DAIRY SCI, V87, P2108, DOI 10.3168/jds.S0022-0302(04)70029-6; Mrode R, 2009, J DAIRY SCI, V92, P5760, DOI 10.3168/jds.2008-1931; Mucha R, 2009, VET IMMUNOL IMMUNOP, V128, P381, DOI 10.1016/j.vetimm.2008.12.007; Nielsen SS, 2009, PREV VET MED, V88, P1, DOI 10.1016/j.prevetmed.2008.07.003; Olsen I, 2002, VET QUART, V24, P12, DOI 10.1080/01652176.2002.9695120; Pinedo PJ, 2009, PREV VET MED, V91, P189, DOI 10.1016/j.prevetmed.2009.05.020; Pinedo PJ, 2009, VET MICROBIOL, V134, P346, DOI 10.1016/j.vetmic.2008.09.052; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Roussel AJ, 2005, JAVMA-J AM VET MED A, V226, P773, DOI 10.2460/javma.2005.226.773; Schwartz D, 2000, CLIN MICROBIOL INFEC, V6, P303, DOI 10.1046/j.1469-0691.2000.00093.x; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Stabel J. R., 2006, Animal Health Research Reviews, V7, P61, DOI 10.1017/S1466252307001168; Taylor KH, 2006, MAMM GENOME, V17, P892, DOI 10.1007/s00335-005-0148-2; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Whittington RJ, 2001, AUST VET J, V79, P267, DOI 10.1111/j.1751-0813.2001.tb11980.x; Zwick LS, 2002, J VET DIAGN INVEST, V14, P326, DOI 10.1177/104063870201400409	48	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11117	10.1371/journal.pone.0011117	http://dx.doi.org/10.1371/journal.pone.0011117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559561	Green Published, gold, Green Submitted			2022-12-25	WOS:000278775900008
J	Mowat, FM; Luhmann, UFO; Smith, AJ; Lange, C; Duran, Y; Harten, S; Shukla, D; Maxwell, PH; Ali, RR; Bainbridge, JWB				Mowat, Freya M.; Luhmann, Ulrich F. O.; Smith, Alexander J.; Lange, Clemens; Duran, Yanai; Harten, Sarah; Shukla, Deepa; Maxwell, Patrick H.; Ali, Robin R.; Bainbridge, James W. B.			HIF-1alpha and HIF-2alpha Are Differentially Activated in Distinct Cell Populations in Retinal Ischaemia	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; OXYGEN-INDUCED RETINOPATHY; FACTOR-ALPHA; TARGET GENE; O-2 HOMEOSTASIS; FACTOR-I; ERYTHROPOIETIN; EXPRESSION; NEOVASCULARIZATION; HIF-1-ALPHA	Background: Hypoxia plays a key role in ischaemic and neovascular disorders of the retina. Cellular responses to oxygen are mediated by hypoxia-inducible transcription factors (HIFs) that are stabilised in hypoxia and induce the expression of a diverse range of genes. The purpose of this study was to define the cellular specificities of HIF-1alpha and HIF-2alpha in retinal ischaemia, and to determine their correlation with the pattern of retinal hypoxia and the expression profiles of induced molecular mediators. Methodology/Principal Findings: We investigated the tissue distribution of retinal hypoxia during oxygen-induced retinopathy (OIR) in mice using the bio-reductive drug pimonidazole. We measured the levels of HIF-1alpha and HIF-2alpha proteins by Western blotting and determined their cellular distribution by immunohistochemistry during the development of OIR. We measured the temporal expression profiles of two downstream mediators, vascular endothelial growth factor (VEGF) and erythropoietin (Epo) by ELISA. Pimonidazole labelling was evident specifically in the inner retina. Labelling peaked at 2 hours after the onset of hypoxia and gradually declined thereafter. Marked binding to Muller glia was evident during the early hypoxic stages of OIR. Both HIF-1alpha and HIF-2alpha protein levels were significantly increased during retinal hypoxia but were evident in distinct cellular distributions; HIF-1alpha stabilisation was evident in neuronal cells throughout the inner retinal layers whereas HIF-2alpha was restricted to Muller glia and astrocytes. Hypoxia and HIF-alpha stabilisation in the retina were closely followed by upregulated expression of the downstream mediators VEGF and EPO. Conclusions/Significance: Both HIF-1alpha and HIF-2alpha are activated in close correlation with retinal hypoxia but have contrasting cell specificities, consistent with differential roles in retinal ischaemia. Our findings suggest that HIF-2alpha activation plays a key role in regulating the response of Muller glia to hypoxia.	[Mowat, Freya M.; Luhmann, Ulrich F. O.; Smith, Alexander J.; Lange, Clemens; Duran, Yanai; Ali, Robin R.; Bainbridge, James W. B.] UCL, Inst Ophthalmol, Dept Genet, London, England; [Harten, Sarah; Shukla, Deepa; Maxwell, Patrick H.] UCL, Div Med, London, England	University of London; University College London; University of London; University College London	Mowat, FM (corresponding author), UCL, Inst Ophthalmol, Dept Genet, London, England.	j.bainbridge@ucl.ac.uk	Smith, Alexander/A-5142-2009; Maxwell, Patrick H/C-5557-2008; Luhmann, Ulrich/D-8905-2012; MOWAT, FREYA/AAD-5102-2021	Maxwell, Patrick H/0000-0002-0338-2679; Ali, Robin/0000-0003-3126-6517; Bainbridge, James/0000-0003-1318-8201; Mowat, Freya/0000-0002-8726-8768; Wilkinson, Sarah/0000-0002-1912-8384	Wellcome Trust [074617/Z/04/Z]; Medical Research Council [G03000341]; Department of Health through National Institute for Health Research to Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health through National Institute for Health Research to Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Wellcome Trust Grant 074617/Z/04/Z (http://www.wellcome.ac.uk/) and Medical Research Council Grant G03000341 (http://www.mrc.ac.uk/index.htm). JWBB receives financial support from the Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen WQ, 2008, NEUROBIOL DIS, V31, P433, DOI 10.1016/j.nbd.2008.05.020; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Cringle SJ, 2002, INVEST OPHTH VIS SCI, V43, P1922; Crosson LA, 2009, MOL VIS, V15, P296; Danylkova NO, 2006, BRAIN RES, V1096, P20, DOI 10.1016/j.brainres.2006.04.061; de Gooyer TE, 2006, INVEST OPHTH VIS SCI, V47, P5561, DOI 10.1167/iovs.06-0647; Ding K, 2005, INVEST OPHTH VIS SCI, V46, P1010, DOI 10.1167/iovs.04-0788; Dioum EM, 2008, INVEST OPHTH VIS SCI, V49, P2714, DOI 10.1167/iovs.07-1469; ERNEST JT, 1984, INVEST OPHTH VIS SCI, V25, P1129; Furlan D, 2007, SURG ONCOL, V16, pS25, DOI 10.1016/j.suronc.2007.10.014; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Geisen P, 2008, MOL VIS, V14, P345; Grimm C, 2005, SEMIN CELL DEV BIOL, V16, P531, DOI 10.1016/j.semcdb.2005.03.004; GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Katsura Y, 2005, DIABETES CARE, V28, P2252, DOI 10.2337/diacare.28.9.2252; Kaur C, 2006, INVEST OPHTH VIS SCI, V47, P1126, DOI 10.1167/iovs.05-0518; King CE, 2007, EXP NEUROL, V205, P48, DOI 10.1016/j.expneurol.2007.01.017; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Maxwell PH, 2002, SEMIN CELL DEV BIOL, V13, P29, DOI 10.1006/scdb.2001.0287; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saito Y, 2008, INVEST OPHTH VIS SCI, V49, P1591, DOI 10.1167/iovs.07-1356; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Thiersch M, 2009, EUR J NEUROSCI, V29, P2291, DOI 10.1111/j.1460-9568.2009.06781.x; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Weishaupt JH, 2004, INVEST OPHTH VIS SCI, V45, P1514, DOI 10.1167/iovs.03-1039; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; Yu DY, 2006, INVEST OPHTH VIS SCI, V47, P1109, DOI 10.1167/iovs.05-1118; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zhong LC, 2007, INVEST OPHTH VIS SCI, V48, P1212, DOI 10.1167/iovs.06-0757; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1735, DOI 10.1167/iovs.06-1037	55	71	73	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11103	10.1371/journal.pone.0011103	http://dx.doi.org/10.1371/journal.pone.0011103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559438	Green Published, gold, Green Submitted			2022-12-25	WOS:000278741100016
J	Ricci-Vitiani, L; Mollinari, C; di Martino, S; Biffoni, M; Pilozzi, E; Pagliuca, A; de Stefano, MC; Circo, R; Merlo, D; De Maria, R; Garaci, E				Ricci-Vitiani, Lucia; Mollinari, Cristiana; di Martino, Simona; Biffoni, Mauro; Pilozzi, Emanuela; Pagliuca, Alfredo; de Stefano, Maria Chiara; Circo, Rita; Merlo, Daniela; De Maria, Ruggero; Garaci, Enrico			Thymosin beta 4 targeting impairs tumorigenic activity of colon cancer stem cells	FASEB JOURNAL			English	Article						actin cytoskeleton; cell cycle; tumor growth; target therapy	INTEGRIN-LINKED KINASE; THERAPEUTIC TARGET; EXPRESSION; OVEREXPRESSION; METASTASIS; GENE; SURVIVAL; BETA(4); CYTOSKELETON; CARCINOMA	Thymosin beta 4 (T beta 4) is an actin-binding peptide overexpressed in several tumors, including colon carcinomas. The aim of this study was to investigate the role of T beta 4 in promoting the tumorigenic properties of colorectal cancer stem cells (CR-CSCs), which are responsible for tumor initiation and growth. We first found that CR-CSCs from different patients have higher T beta 4 levels than normal epithelial cells. Then, we used a lentiviral strategy to down-regulate T beta 4 expression in CR-CSCs and analyzed the effects of such modulation on proliferation, survival, and tumorigenic activity of CR-CSCs. Empty vector-transduced CR-CSCs were used as a control. Targeting of the T beta 4 produced CR-CSCs with a lower capacity to grow and migrate in culture and, interestingly, reduced tumor size and aggressiveness of CR-CSC-based xenografts in mice. Moreover, such loss in tumorigenic activity was accompanied by a significant increase of phosphatase and tensin homologue (PTEN) and a concomitant reduction of the integrin-linked kinase (ILK) expression, which resulted in a decreased activation of protein kinase B (Akt). Accordingly, exogenous expression of an active form of Akt rescued all the protumoral features lost after T beta 4 targeting in CR-CSCs. In conclusion, T beta 4 may have important implications for therapeutic intervention for treatment of human colon carcinoma.-Ricci-Vitiani, L., Mollinari, C., di Martino, S., Biffoni, M., Pilozzi, E., Pagliuca, A., Chiara de Stefano, M., Circo, R., Merlo, D., De Maria, R., Garaci, E. Thymosin beta 4 targeting impairs tumorigenic activity of colon cancer stem cells. FASEB J. 24, 4291-4301 (2010). www.fasebj.org	[Ricci-Vitiani, Lucia; di Martino, Simona; Biffoni, Mauro; Pagliuca, Alfredo; De Maria, Ruggero] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Mollinari, Cristiana; de Stefano, Maria Chiara; Merlo, Daniela] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Mollinari, Cristiana] CNR, Dept Neurobiol & Mol Med, Rome, Italy; [Pilozzi, Emanuela] Univ Roma La Sapienza, Dept Lab Med & Pathol, St Andrea Hosp, Rome, Italy; [De Maria, Ruggero] Mediterranean Inst Oncol, Catania, Italy; [Merlo, Daniela] IRCCS San Raffaele Pisana, Rome, Italy; [Garaci, Enrico] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Mediterranean Institute of Oncology; IRCCS San Raffaele Pisana; University of Rome Tor Vergata	De Maria, R (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	demaria@iss.it; garaci@tiscali.it	PILOZZI, Emanuela/AAC-1854-2022; de Stefano, Maria Chiara/N-6492-2017; De Maria, Ruggero/S-6385-2019; Merlo, Daniela/K-7986-2016; Pagliuca, Alfredo/AAI-3689-2020; Ricci Vitiani, Lucia/J-8320-2016; di Martino, Simona SdM/K-9304-2016; pagliuca, alfredo/J-3107-2012; Biffoni, Mauro/J-8318-2016; GARACI, ENRICO/AAB-3349-2021; Mollinari, Cristiana/K-4131-2016	PILOZZI, Emanuela/0000-0002-7110-9172; de Stefano, Maria Chiara/0000-0002-0770-1411; De Maria, Ruggero/0000-0003-2255-0583; Merlo, Daniela/0000-0003-4240-5762; Ricci Vitiani, Lucia/0000-0001-7336-5615; di Martino, Simona SdM/0000-0003-4533-3776; pagliuca, alfredo/0000-0002-8703-2077; Biffoni, Mauro/0000-0002-1304-9060; Mollinari, Cristiana/0000-0001-8112-5427	Italian Ministry of Health; Italian Ministry for University and Research [FIRB_RBIP06ZJ78]; Italian Association for Cancer Research (AIRC)	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The authors thank the Italian Ministry of Health, the Italian Ministry for University and Research (FIRB_RBIP06ZJ78) and the Italian Association for Cancer Research (AIRC) for supporting the colon CSC research. The authors thank Dr. Enrico Duranti for technical assistance.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bednarek R, 2008, J BIOL CHEM, V283, P1534, DOI 10.1074/jbc.M707539200; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Crowder RJ, 1998, J NEUROSCI, V18, P2933; DECLOITRE F, 1991, TUMOR BIOL, V12, P111, DOI 10.1159/000217695; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Golla R, 1997, CELL MOTIL CYTOSKEL, V38, P187, DOI 10.1002/(SICI)1097-0169(1997)38:2<187::AID-CM7>3.0.CO;2-4; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; HALL AK, 1991, INT J CANCER, V48, P672, DOI 10.1002/ijc.2910480507; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Ho JH, 2010, J ORTHOP RES, V28, P131, DOI 10.1002/jor.20956; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Huang HC, 2007, ONCOGENE, V26, P2781, DOI 10.1038/sj.onc.1210078; Huang WQ, 2006, CELL BIOL INT, V30, P514, DOI 10.1016/j.cellbi.2006.01.009; Iguchi K, 1999, BIOCHEM PHARMACOL, V57, P1105, DOI 10.1016/S0006-2952(99)00030-1; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kobayashi T, 2002, AM J PATHOL, V160, P869, DOI 10.1016/S0002-9440(10)64910-3; Koutrafouri V, 2001, BBA-GEN SUBJECTS, V1568, P60, DOI 10.1016/S0304-4165(01)00200-8; LOW TLK, 1982, J BIOL CHEM, V257, P1000; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; MOLL R, 1993, DIFFERENTIATION, V53, P75, DOI 10.1111/j.1432-0436.1993.tb00648.x; Mollinari C, 2009, J CELL SCI, V122, P4195, DOI 10.1242/jcs.056895; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Obara S, 2004, CANCER LETT, V208, P115, DOI 10.1016/j.canlet.2003.11.020; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Qiu FY, 2009, J CARDIOVASC PHARM, V53, P209, DOI 10.1097/FJC.0b013e318199f326; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Ricci-Vitiani L, 2008, GUT, V57, P538, DOI 10.1136/gut.2007.127837; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; SANDERS MC, 1992, P NATL ACAD SCI USA, V89, P4678, DOI 10.1073/pnas.89.10.4678; SANGER JM, 1995, CELL MOTIL CYTOSKEL, V31, P307, DOI 10.1002/cm.970310407; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Sosne G, 2001, EXP EYE RES, V72, P605, DOI 10.1006/exer.2000.0985; Steiniger SCJ, 2008, STEM CELLS, V26, P3037, DOI 10.1634/stemcells.2008-0397; Sun W, 2007, ANN NY ACAD SCI, V1112, P210, DOI 10.1196/annals.1415.013; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Wang WS, 2003, ONCOGENE, V22, P3297, DOI 10.1038/sj.onc.1206404; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Xie D, 2002, INT J ONCOL, V21, P499; YAMAMOTO T, 1993, BIOCHEM BIOPH RES CO, V193, P706, DOI 10.1006/bbrc.1993.1682; Yoganathan N, 2002, PHARMACOL THERAPEUT, V93, P233, DOI 10.1016/S0163-7258(02)00192-4; Zhang YQ, 2008, CANCER BIOL THER, V7, P419, DOI 10.4161/cbt.7.3.5415	51	32	34	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4291	4301		10.1096/fj.10-159970	http://dx.doi.org/10.1096/fj.10-159970			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20566622	Bronze			2022-12-25	WOS:000283861100017
J	Castelnuovo, M; Massone, S; Tasso, R; Fiorino, G; Gatti, M; Robello, M; Gatta, E; Berger, A; Strub, K; Florio, T; Dieci, G; Cancedda, R; Pagano, A				Castelnuovo, Manuele; Massone, Sara; Tasso, Roberta; Fiorino, Gloria; Gatti, Monica; Robello, Mauro; Gatta, Elena; Berger, Audrey; Strub, Katharina; Florio, Tullio; Dieci, Giorgio; Cancedda, Ranieri; Pagano, Aldo			An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells	FASEB JOURNAL			English	Article						anticancer drugs; ncRNA; neuroblastoma differentiation; RNA polymerase III	POLYMERASE-III; STEM-CELLS; GROWTH; CANCER; PROLIFERATION; TRANSCRIPTION; PROGNOSIS; RECEPTOR; GENE	Neuroblastoma (NB) is a pediatric cancer characterized by remarkable cell heterogeneity within the tumor nodules. Here, we demonstrate that the synthesis of a pol III-transcribed noncoding (nc) RNA (NDM29) strongly restricts NB development by promoting cell differentiation, a drop of malignancy processes, and a dramatic reduction of the tumor initiating cell (TIC) fraction in the NB cell population. Notably, the overexpression of NDM29 also confers to malignant NB cells an unpredicted susceptibility to the effects of antiblastic drugs used in NB therapy. Altogether, these results suggest the induction of NDM29 expression as possible treatment to increase cancer cells vulnerability to therapeutics and the measure of its synthesis in NB explants as prognostic factor of this cancer type.-Castelnuovo, M., Massone, S., Tasso, R., Fiorino, G., Gatti, M., Robello, M., Gatta, E., Berger, A., Strub, K., Florio, T., Dieci, G., Cancedda, R., Pagano, A. An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. FASEB J. 24, 4033-4046 (2010). www.fasebj.org	[Castelnuovo, Manuele; Massone, Sara; Tasso, Roberta; Gatti, Monica; Florio, Tullio; Cancedda, Ranieri; Pagano, Aldo] Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy; [Robello, Mauro; Gatta, Elena] Univ Genoa, Dept Phys, I-16132 Genoa, Italy; [Castelnuovo, Manuele; Massone, Sara; Tasso, Roberta; Cancedda, Ranieri; Pagano, Aldo] Natl Inst Canc Res Genoa, Genoa, Italy; [Fiorino, Gloria; Dieci, Giorgio] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Berger, Audrey; Strub, Katharina] Univ Geneva, Dept Cell Biol, Geneva, Switzerland	University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Parma; University of Geneva	Pagano, A (corresponding author), Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy.	aldo.pagano@unige.it	Pagano, Aldo/AAF-3974-2019; Florio, Tullio/A-2211-2012; Tasso, Roberta/J-7237-2016; Dieci, Giorgio/B-3434-2012; Tasso, Roberta/AFL-4297-2022; FLORIO, TULLIO/ABG-3182-2020	Pagano, Aldo/0000-0001-8035-9299; Florio, Tullio/0000-0002-2394-996X; Tasso, Roberta/0000-0003-0956-7006; Dieci, Giorgio/0000-0002-8792-3961; Monica, Gatti/0000-0002-2016-0285	Italian Ministry of University and Research-MIUR; Associazione Italiana Ricerca sul Cancro [IG9378, IG9089]	Italian Ministry of University and Research-MIUR(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The authors thank Dr. Alessandro Poggi (National Institute for Cancer Research, Genoa, Italy) for help in FACS analysis, and Dr. Gregory Hannon, (Cold Spring Harbor Laboratories, Cold Spring Harbor, NY, USA) for providing the pSHAG-ff1 plasmid. A.P. and R.C. were supported by the Italian Ministry of University and Research-MIUR (2007 International FIRB Program, 2007 PRIN Program). A.P. was also supported by the Associazione Italiana Ricerca sul Cancro (2009 AIRC Program no. IG9378). G.D. was supported by the Italian Ministry of University and Research (2007 PRIN Program). T.F. was supported by the Associazione Italiana Ricerca sul Cancro (2009 AIRC Program no. IG9089).	Amid C, 2001, CYTOGENET CELL GENET, V93, P284, DOI 10.1159/000056999; Brown TRP, 2000, GENE EXPRESSION, V9, P15; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; De Preter K, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-97; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; George RE, 2001, MED PEDIATR ONCOL, V36, P169, DOI 10.1002/1096-911X(20010101)36:1<169::AID-MPO1041>3.0.CO;2-U; HAURIE V, P NATL ACAD SCI US, V107, P4176; MCCLAY DR, 1981, P NATL ACAD SCI-BIOL, V78, P4975, DOI 10.1073/pnas.78.8.4975; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakai E, 2009, CANCER INVEST, V27, P901, DOI 10.3109/07357900801946679; Pagano A, 2007, PLOS GENET, V3, P174, DOI 10.1371/journal.pgen.0030001; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Pattarozzi A, 2008, MOL PHARMACOL, V73, P191, DOI 10.1124/mol.107.039974; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; ROBELLO M, 1993, NEUROSCIENCE, V53, P131, DOI 10.1016/0306-4522(93)90291-M; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Wu LP, 2003, EUKARYOT CELL, V2, P256, DOI 10.1128/EC.2.2.256-264.2003	21	59	62	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					4033	4046		10.1096/fj.10-157032	http://dx.doi.org/10.1096/fj.10-157032			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20581224	Green Published			2022-12-25	WOS:000285005900039
J	Chaturvedi, R; Bansal, K; Narayana, Y; Kapoor, N; Sukumar, N; Togarsimalemath, SK; Chandra, N; Mishra, S; Ajitkumar, P; Joshi, B; Katoch, VM; Patil, SA; Balaji, KN				Chaturvedi, Rashmi; Bansal, Kushagra; Narayana, Yeddula; Kapoor, Nisha; Sukumar, Namineni; Togarsimalemath, Shambhuprasad Kotresh; Chandra, Nagasuma; Mishra, Saurabh; Ajitkumar, Parthasarathi; Joshi, Beenu; Katoch, Vishwa Mohan; Patil, Shripad A.; Balaji, Kithiganahalli N.			The Multifunctional PE_PGRS11 Protein from Mycobacterium tuberculosis Plays a Role in Regulating Resistance to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; BOVIS BCG; PHOSPHOGLYCERATE MUTASE; P38 MAPK; CYCLOOXYGENASE-2 EXPRESSION; NONREPLICATING PERSISTENCE; SCANNING MUTAGENESIS; INFECTED MACROPHAGES; ACTIVE TUBERCULOSIS; INDUCED APOPTOSIS	Mycobacterium tuberculosis utilizes unique strategies to survive amid the hostile environment of infected host cells. Infection-specific expression of a unique mycobacterial cell surface antigen that could modulate key signaling cascades can act as a key survival strategy in curtailing host effector responses like oxidative stress. We demonstrate here that hypothetical PE_PGRS11 ORF encodes a functional phosphoglycerate mutase. The transcriptional analysis revealed that PE_PGRS11 is a hypoxia-responsive gene, and enforced expression of PE_PGRS11 by recombinant adenovirus or Mycobacterium smegmatis imparted resistance to alveolar epithelial cells against oxidative stress. PE_PGRS11-induced resistance to oxidative stress necessitated the modulation of genetic signatures like induced expression of Bcl2 or COX-2. This modulation of specific antiapoptotic molecular signatures involved recognition of PE_PGRS11 by TLR2 and subsequent activation of the PI3K-ERK1/ 2-NF-kappa B signaling axis. Furthermore, PE_PGRS11 markedly diminished H2O2-induced p38 MAPK activation. Interestingly, PE_PGRS11 protein was exposed at the mycobacterial cell surface and was involved in survival of mycobacteria under oxidative stress. Furthermore, PE_PGRS11 displayed differential B cell responses during tuberculosis infection. Taken together, our investigation identified PE_PGRS11 as an in vivo expressed immunodominant antigen that plays a crucial role in modulating cellular life span restrictions imposed during oxidative stress by triggering TLR2-dependent expression of COX-2 and Bcl2. These observations clearly provide a mechanistic basis for the rescue of pathogenic Mycobacterium-infected lung epithelial cells from oxidative stress.	[Chaturvedi, Rashmi; Bansal, Kushagra; Narayana, Yeddula; Kapoor, Nisha; Sukumar, Namineni; Togarsimalemath, Shambhuprasad Kotresh; Mishra, Saurabh; Ajitkumar, Parthasarathi; Balaji, Kithiganahalli N.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Chandra, Nagasuma] Indian Inst Sci, Supercomp Educ & Res Ctr, Bioinformat Ctr, Bangalore 560012, Karnataka, India; [Joshi, Beenu; Katoch, Vishwa Mohan] Natl Jalma Inst Leprosy & Other Mycobacterial Dis, Agra 282001, Uttar Pradesh, India; [Patil, Shripad A.] Natl Inst Mental Hlth & Neurosci, Dept Microbiol, Bangalore 560029, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; National Institute of Mental Health & Neurosciences - India	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in	MISHRA, SAURABH/N-5686-2017; Yeddula, Narayana/H-4893-2011	MISHRA, SAURABH/0000-0003-1590-884X; KOTRESH TOGARSIMALEMATH, SHAMBHUPRASAD/0000-0003-2935-5377; Chandra, Nagasuma/0000-0002-9939-8439	Department of Biotechnology (DBT); VINNOVA (The Swedish Governmental Agency for Innovation Systems); DBT, India; Department of Science and Technology (DST); Council for Scientific and Industrial Research	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); VINNOVA (The Swedish Governmental Agency for Innovation Systems)(Vinnova); DBT, India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by funds from the Department of Biotechnology (DBT); a collaborative grant (to the Indian Institute of Science and Karolinska Institute) from VINNOVA (The Swedish Governmental Agency for Innovation Systems) and DBT, India; the Department of Science and Technology (DST); and the Council for Scientific and Industrial Research and by infrastructure support from the Indian Council of Medical Research (Center for Advanced Study in Molecular Medicine), DST (Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions), and University Grants Commission (special assistance).	Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Bansal K, 2009, SCAND J IMMUNOL, V69, P11, DOI 10.1111/j.1365-3083.2008.02190.x; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; Barker LP, 2007, PLANTA MED, V73, P559, DOI 10.1055/s-2007-981522; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; CHAN J, 1989, P NATL ACAD SCI USA, V86, P2453, DOI 10.1073/pnas.86.7.2453; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Chao S, 2008, FLAVOUR FRAG J, V23, P444, DOI 10.1002/ffj.1904; Choi EM, 2005, BIOCHEM BIOPH RES CO, V328, P1107, DOI 10.1016/j.bbrc.2005.01.072; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Chowdhury RP, 2010, IUBMB LIFE, V62, P67, DOI 10.1002/iub.285; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Creson TK, 2009, J MOL NEUROSCI, V37, P123, DOI 10.1007/s12031-008-9122-2; De Zutter GS, 2001, P NATL ACAD SCI USA, V98, P6168, DOI 10.1073/pnas.111027698; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; GRISOLIA S, 1975, PHYSIOL CHEM PHYS M, V7, P219; GRISOLIA S, 1967, BIOCHIM BIOPHYS ACTA, V132, P56, DOI 10.1016/0005-2744(67)90191-X; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Higuchi Y, 2003, BIOCHEM PHARMACOL, V66, P1527, DOI 10.1016/S0006-2952(03)00508-2; HILL B, 1976, J GEN MICROBIOL, V96, P185, DOI 10.1099/00221287-96-1-185; HIRSCHFIELD GR, 1990, J BACTERIOL, V172, P1005, DOI 10.1128/jb.172.2.1005-1013.1990; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Khan N, 2008, CLIN VACCINE IMMUNOL, V15, P974, DOI 10.1128/CVI.00485-07; Koh KW, 2009, INFECT IMMUN, V77, P3337, DOI 10.1128/IAI.01175-08; Koh KW, 2009, MOL IMMUNOL, V46, P1312, DOI 10.1016/j.molimm.2008.11.008; Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85; Kondoh H, 2005, CANCER RES, V65, P177; Kondoh H, 2005, DRUG DISCOV TODAY, V2, P263; Kralova J, 2008, ONCOGENE, V27, P3010, DOI 10.1038/sj.onc.1210960; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Lin YG, 1998, INFECT IMMUN, V66, P1121, DOI 10.1128/IAI.66.3.1121-1126.1998; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Mendez-Samperio P, 2009, CELL IMMUNOL, V256, P12, DOI 10.1016/j.cellimm.2008.12.002; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Narayana Y, 2007, CLIN VACCINE IMMUNOL, V14, P1334, DOI 10.1128/CVI.00181-07; Paterson GK, 2009, MICROBIOL-SGM, V155, P3403, DOI 10.1099/mic.0.029553-0; PAYNE CM, 1995, LEUKEMIA LYMPHOMA, V19, P43, DOI 10.3109/10428199509059662; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Raverdy S, 2007, MOL BIOCHEM PARASIT, V156, P210, DOI 10.1016/j.molbiopara.2007.08.002; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Souto EO, 2001, AM J PHYSIOL-GASTR L, V280, pG805, DOI 10.1152/ajpgi.2001.280.5.G805; STANKIEWICZ PJ, 1986, J BIOL CHEM, V261, P2715; Sun WM, 1996, J BIOL CHEM, V271, P17226, DOI 10.1074/jbc.271.29.17226; Takahashi Y, 1998, EUR J BIOCHEM, V254, P497, DOI 10.1046/j.1432-1327.1998.2540497.x; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tse HM, 2002, J IMMUNOL, V168, P825, DOI 10.4049/jimmunol.168.2.825; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; West NP, 2000, INFECT IMMUN, V68, P4673, DOI 10.1128/IAI.68.8.4673-4680.2000; WILKINSON M, 1988, NUCLEIC ACIDS RES, V16, P10934, DOI 10.1093/nar/16.22.10934; Yamagishi N, 2008, FEBS J, V275, P4558, DOI 10.1111/j.1742-4658.2008.06598.x	77	47	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 1	2010	285	40					30389	30403		10.1074/jbc.M110.135251	http://dx.doi.org/10.1074/jbc.M110.135251			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653YS	20558725	Green Published, hybrid			2022-12-25	WOS:000282135500005
J	Tan, KM; Tesar, C; Wilton, R; Keigher, L; Babnigg, G; Joachimiak, A				Tan, Kemin; Tesar, Christine; Wilton, Rosemarie; Keigher, Laura; Babnigg, Gyorgy; Joachimiak, Andrzej			Novel alpha-glucosidase from human gut microbiome: substrate specificities and their switch	FASEB JOURNAL			English	Article						substrate selection and switch; glycoside hydrolase; GH31 family; isomannose binding; carbohydrate metabolism	MALTASE-GLUCOAMYLASE; DIVERSITY; GENE; ISOMALTASE; INTESTINE; SUBUNIT; CLONING; HEALTH; MODEL	The human intestine harbors a large number of microbes forming a complex microbial community that greatly affects the physiology and pathology of the host. In the human gut microbiome, the enrichment in certain protein gene families appears to be widespread. They include enzymes involved in carbohydrate metabolism such as glucoside hydrolases of dietary polysaccharides and glycoconjugates. We report the crystal structures (wild type, 2 mutants, and a mutant/substrate complex) and the enzymatic activity of a recombinant alpha-glucosidase from human gut bacterium Ruminococcus obeum. The first ever protein structures from this bacterium reveal a structural homologue to human intestinal maltase-glucoamylase with a highly conserved catalytic domain and reduced auxiliary domains. The alpha-glucosidase, a member of GH31 family, shows substrate preference for alpha(1-6) over alpha(1-4) glycosidic linkages and produces glucose from isomaltose as well as maltose. The preference can be switched by a single mutation at its active site, suggestive of widespread adaptation to utilization of a variety of polysaccharides by intestinal micro-organisms as energy resources.-Tan, K., Tesar, C., Wilton, R., Keigher, L., Babnigg, G., Joachimiak, A. Novel alpha-glucosidase from human gut microbiome: substrate specificities and their switch. FASEB J. 24, 3939-3949 (2010). www.fasebj.org	[Tan, Kemin; Tesar, Christine; Wilton, Rosemarie; Keigher, Laura; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom & Struct Biol Ctr, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Joachimiak, A (corresponding author), Argonne Natl Lab, Midwest Ctr Struct Genom & Struct Biol Ctr, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov		Wilton, Rosemarie/0000-0001-5221-6354	National Institutes of Health [GM074942]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; U.S. Department of Energy Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank members of the Structural Biology Center at Argonne National Laboratory for their help with data collection at the 19-ID beamline. The authors also thank Lindsey Butler for help in the preparation of this manuscript. This work was supported by National Institutes of Health grant GM074942 and by the U.S. Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. The atomic coordinates and structural factors of the wild-type Ro-aG1, D73A, and D307 mutants and D307/isomaltose complex have been deposited in the PDB databank under accession codes 3N04, 3M46, 3M6D, and 3MKK, respectively. The submitted manuscript has been created by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne"). Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under contract DE-AC02-06CH11357. The U.S. Government retains for itself, and others acting on its behalf, a paid-up nonexclusive, irrevocable worldwide license in said article to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; DAHLQVIST A, 1961, BIOCHEM J, V80, P547, DOI 10.1042/bj0800547; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hill MJ, 1997, EUR J CANCER PREV, V6, pS43, DOI 10.1097/00008469-199703001-00009; Hooper LV, 1998, BIOESSAYS, V20, P336, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;336::AID-BIES10&gt;3.0.CO;2-3; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kurakata Y, 2008, J MOL BIOL, V381, P116, DOI 10.1016/j.jmb.2008.05.061; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; LIN SL, 1995, J MOL BIOL, V248, P151, DOI 10.1006/jmbi.1995.0208; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; Mai V, 2009, WORLD J GASTROENTERO, V15, P81, DOI 10.3748/wjg.15.81; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; QIN J, NATURE, V464, P59; Scheffel F, 2004, BBA-BIOENERGETICS, V1656, P57, DOI 10.1016/j.bbabio.2004.01.005; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Singh V, 2009, FEMS IMMUNOL MED MIC, V55, P6, DOI 10.1111/j.1574-695X.2008.00497.x; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012	41	41	42	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					3939	3949		10.1096/fj.10-156257	http://dx.doi.org/10.1096/fj.10-156257			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20581222	Green Published			2022-12-25	WOS:000285005900031
J	Arragain, S; Handelman, SK; Forouhar, F; Wei, FY; Tomizawa, K; Hunt, JF; Douki, T; Fontecave, M; Mulliez, E; Atta, M				Arragain, Simon; Handelman, Samuel K.; Forouhar, Farhad; Wei, Fan-Yan; Tomizawa, Kazuhito; Hunt, John F.; Douki, Thierry; Fontecave, Marc; Mulliez, Etienne; Atta, Mohamed			Identification of Eukaryotic and Prokaryotic Methylthiotransferase for Biosynthesis of 2-Methylthio-N-6-threonylcarbamoyladenosine in tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIAB PROTEIN; ADENOSYLMETHIONINE; METHYLATION; THIOLATION; ENZYME; GENE; METHYLTHIOLATION; DERIVATIVES; EXPRESSION; IRON	Bacterial and eukaryotic transfer RNAs have been shown to contain hypermodified adenosine, 2-methylthio-N-6-threonylcarbamoyladenosine, at position 37 (A(37)) adjacent to the 3'-end of the anticodon, which is essential for efficient and highly accurate protein translation by the ribosome. Using a combination of bioinformatic sequence analysis and in vivo assay coupled to HPLC/MS technique, we have identified, from distinct sequence signatures, two methylthiotransferase (MTTase) subfamilies, designated as MtaB in bacterial cells and e-MtaB in eukaryotic and archaeal cells. Both subfamilies are responsible for the transformation of N-6-threonylcarbamoyladenosine into 2-methylthio-N-6-threonylcarbamoyladenosine. Recently, a variant within the human CDKAL1 gene belonging to the e-MtaB subfamily was shown to predispose for type 2 diabetes. CDKAL1 is thus the first eukaryotic MTTase identified so far. Using purified preparations of Bacillus subtilis MtaB (YqeV), a CDKAL1 bacterial homolog, we demonstrate that YqeV/CDKAL1 enzymes, as the previously studied MTTases MiaB and RimO, contain two [4Fe-4S] clusters. This work lays the foundation for elucidating the function of CDKAL1.	[Wei, Fan-Yan; Tomizawa, Kazuhito] Kumamoto Univ, Fac Life Sci, Dept Mol Physiol, Kumamoto 8608556, Japan; [Arragain, Simon; Fontecave, Marc; Mulliez, Etienne; Atta, Mohamed] Commissariat Energie Atom Grenoble, UMR CEA CNRS UJF 5249, IRTSV LCBM, F-38054 Grenoble 09, France; [Handelman, Samuel K.; Forouhar, Farhad; Hunt, John F.] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA; [Handelman, Samuel K.; Forouhar, Farhad; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Douki, Thierry] Commissariat Energie Atom Grenoble, DSM INaC SCIB UMR E3 CEA UJF, Lab Les Acides Nucle, F-38054 Grenoble 09, France; [Fontecave, Marc] Coll France, F-75005 Paris, France	Kumamoto University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Columbia University; Columbia University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; College de France	Wei, FY (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Mol Physiol, Honjo 1-1-1, Kumamoto 8608556, Japan.	fywei@kumamoto-u.ac.jp; mohamed.atta@cea.fr	Arragain, Simon/AAA-6356-2019; Thierry, Douki/H-2108-2018; Wei, Fan-Yan/AAD-8461-2021; Tomizawa, Kazuhito/F-2405-2015	Arragain, Simon/0000-0002-6500-0066; Thierry, Douki/0000-0002-5022-071X; Tomizawa, Kazuhito/0000-0002-5663-2627; Wei, Fan-Yan/0000-0002-4843-724X; Handelman, Samuel/0000-0001-6970-2172	Region Rhone Alpes [CIBLE2010]	Region Rhone Alpes(Region Auvergne-Rhone-Alpes)	Supported by Region Rhone Alpes CIBLE2010.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2001, FEMS MICROBIOL LETT, V197, P215, DOI 10.1111/j.1574-6968.2001.tb10606.x; Anton BP, 2008, P NATL ACAD SCI USA, V105, P1826, DOI 10.1073/pnas.0708608105; Arragain S, 2010, J BIOL CHEM, V285, P5792, DOI 10.1074/jbc.M109.065516; Auxilien S, 1999, J BIOL CHEM, V274, P4412, DOI 10.1074/jbc.274.7.4412; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Durant PC, 2005, BIOCHEMISTRY-US, V44, P8078, DOI 10.1021/bi050343f; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; ELKINS BN, 1974, BIOCHEMISTRY-US, V13, P4622, DOI 10.1021/bi00719a024; Esberg B, 1999, J BACTERIOL, V181, P7256, DOI 10.1128/JB.181.23.7256-7265.1999; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fontecave M, 2008, CHEM BIOL, V15, P209, DOI 10.1016/j.chembiol.2008.02.011; Fontecave M, 2003, CHEM REV, V103, P2149, DOI 10.1021/cr020427j; Fontecave M, 2001, CURR OPIN CHEM BIOL, V5, P506, DOI 10.1016/S1367-5931(00)00237-4; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; McCrate NE, 2006, NUCLEIC ACIDS RES, V34, P5361, DOI 10.1093/nar/gkl580; Pierrel F, 2003, J BIOL CHEM, V278, P29515, DOI 10.1074/jbc.M301518200; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Pierrel F, 2002, J BIOL CHEM, V277, P13367, DOI 10.1074/jbc.C100609200; REDDY DM, 1992, NUCLEIC ACIDS RES, V20, P5607, DOI 10.1093/nar/20.21.5607; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Turgay K, 1998, EMBO J, V17, P6730; Yang MM, 2010, MOL BIOL REP, V37, P2207, DOI 10.1007/s11033-009-9704-2	30	92	98	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28425	28433		10.1074/jbc.M110.106831	http://dx.doi.org/10.1074/jbc.M110.106831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20584901	hybrid, Green Published			2022-12-25	WOS:000281594000005
J	Heiny, JA; Kravtsova, VV; Mandel, F; Radzyukevich, TL; Benziane, B; Prokofiev, AV; Pedersen, SE; Chibalin, AV; Krivoi, II				Heiny, Judith A.; Kravtsova, Violetta V.; Mandel, Frederic; Radzyukevich, Tatiana L.; Benziane, Boubacar; Prokofiev, Alexander V.; Pedersen, Steen E.; Chibalin, Alexander V.; Krivoi, Igor I.			The Nicotinic Acetylcholine Receptor and the Na,K-ATPase alpha 2 Isoform Interact to Regulate Membrane Electrogenesis in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; SODIUM-CHANNEL INACTIVATION; DESENSITIZED STATES; AGONIST BINDING; BETA-SUBUNIT; T-TUBULES; CAVEOLIN-3; SITE; STIMULATION; INHIBIT	The nicotinic acetylcholine receptor (nAChR) and the Na,K-ATPase functionally interact in skeletal muscle (Krivoi, I. I., Drabkina, T. M., Kravtsova, V. V., Vasiliev, A. N., Eaton, M. J., Skatchkov, S. N., and Mandel, F. (2006) Pflugers Arch. 452, 756765; Krivoi, I., Vasiliev, A., Kravtsova, V., Dobretsov, M., and Mandel, F. (2003) Ann. N.Y. Acad. Sci. 986, 639-641). In this interaction, the specific binding of nanomolar concentrations of nicotinic agonists to the nAChR stimulates electrogenic transport by the Na,K-ATPase alpha 2 isozyme, causing membrane hyperpolarization. This study examines the molecular nature and membrane localization of this interaction. Stimulation of Na,K-ATPase activity by the nAChR does not require ion flow through open nAChRs. It can be induced by nAChR desensitization alone, in the absence of nicotinic agonist, and saturates when the nAChR is fully desensitized. It is enhanced by noncompetitive blockers of the nAChR (proadifen, QX-222), which promote non-conducting or desensitized states; and retarded by tetracaine, which stabilizes the resting nAChR conformation. The interaction operates at the neuromuscular junction as well as on extrajunctional sarcolemma. The Na,K-ATPase alpha 2 isozyme is enriched at the postsynaptic neuromuscular junction and co-localizes with nAChRs. The nAChR and Na,K-ATPase alpha subunits specifically coimmunoprecipitate with each other, phospholemman, and caveolin-3. In a purified membrane preparation from Torpedo californica enriched in nAChRs and the Na,K-ATPase, a ouabain-induced conformational change of the Na,K-ATPase enhances a conformational transition of the nAChR to a desensitized state. These results suggest a mechanism by which the nAChR in a desensitized state with high apparent affinity for agonist interacts with the Na,K-ATPase to stimulate active transport. The interaction utilizes a membrane-delimited complex involving protein-protein interactions, either directly or through additional protein partners. This interaction is expected to enhance neuromuscular transmission and muscle excitation.	[Kravtsova, Violetta V.; Prokofiev, Alexander V.; Krivoi, Igor I.] St Petersburg State Univ, Dept Gen Physiol, St Petersburg 199034, Russia; [Heiny, Judith A.; Mandel, Frederic; Radzyukevich, Tatiana L.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Pedersen, Steen E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Benziane, Boubacar; Chibalin, Alexander V.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden	Saint Petersburg State University; University System of Ohio; University of Cincinnati; Baylor College of Medicine; Karolinska Institutet	Krivoi, II (corresponding author), St Petersburg State Univ, Dept Gen Physiol, 7-9 Univ Emb, St Petersburg 199034, Russia.	iikrivoi@gmail.com	Kravtsova, Violetta V/K-1816-2013; Krivoi, Igor/K-3546-2013	Kravtsova, Violetta V/0000-0002-3382-5848; Krivoi, Igor/0000-0002-2690-9226; Chibalin, Alexander/0000-0002-6339-6271; Pedersen, Steen E./0000-0001-8755-8899	National Institutes of Health [HL6606]; Russian Foundation for Basic Research [10-04-00970a]; University of Cincinnati; Swedish Research Council; Novo-Nordisk Foundation; Hedlunds Foundation; Commission of the European Communities [LSHM-CT-2004-512013, LSHM-CT-2004-005272]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); University of Cincinnati; Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo-Nordisk Foundation(Novo Nordisk Foundation); Hedlunds Foundation; Commission of the European Communities(European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant HL6606, Russian Foundation for Basic Research 10-04-00970a, the Physiology Research Fund of the University of Cincinnati, the Swedish Research Council, Novo-Nordisk Foundation, Hedlunds Foundation, and Commission of the European Communities Grants LSHM-CT-2004-512013 EUGENEHEART and LSHM-CT-2004-005272 EXGENESIS.	Akk G, 1999, BRIT J PHARMACOL, V128, P1467, DOI 10.1038/sj.bjp.0702941; Andreeva IE, 2006, BIOCHEMISTRY-US, V45, P195, DOI 10.1021/bi0516024; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; Caldwell JH, 2000, MICROSC RES TECHNIQ, V49, P84, DOI 10.1002/(SICI)1097-0029(20000401)49:1<84::AID-JEMT9>3.0.CO;2-E; Carlson BM, 2003, J HISTOCHEM CYTOCHEM, V51, P1113, DOI 10.1177/002215540305100901; Carlson CG, 2001, PFLUG ARCH EUR J PHY, V442, P369; Dobretsov M, 2003, NEUROSCIENCE, V116, P1069, DOI 10.1016/S0306-4522(02)00922-3; Dostanic I, 2003, J BIOL CHEM, V278, P53026, DOI 10.1074/jbc.M308547200; EVERTS ME, 1994, AM J PHYSIOL, V266, pC925, DOI 10.1152/ajpcell.1994.266.4.C925; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Galbiati F, 2001, TRENDS MOL MED, V7, P435, DOI 10.1016/S1471-4914(01)02105-0; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gentry CL, 2001, J PHARMACOL EXP THER, V299, P1038; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hazelwood LA, 2008, J BIOL CHEM, V283, P36441, DOI 10.1074/jbc.M805520200; He SW, 2001, AM J PHYSIOL-REG I, V281, pR917, DOI 10.1152/ajpregu.2001.281.3.R917; HENNING RH, 1994, BRIT J PHARMACOL, V111, P459, DOI 10.1111/j.1476-5381.1994.tb14758.x; HICKS A, 1989, J PHYSIOL-LONDON, V414, P337, DOI 10.1113/jphysiol.1989.sp017691; Isshiki M, 1999, CELL CALCIUM, V26, P201, DOI 10.1054/ceca.1999.0073; JAIMOVICH E, 1986, BIOCHIM BIOPHYS ACTA, V855, P89, DOI 10.1016/0005-2736(86)90192-6; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; Kragenbrink R, 1996, SYNAPSE, V23, P219, DOI 10.1002/(SICI)1098-2396(199607)23:3<219::AID-SYN11>3.0.CO;2-U; Kravtsova V V, 2008, Ross Fiziol Zh Im I M Sechenova, V94, P1181; Krivoi I, 2003, ANN NY ACAD SCI, V986, P639, DOI 10.1111/j.1749-6632.2003.tb07272.x; Krivoi I I, 2004, Ross Fiziol Zh Im I M Sechenova, V90, P59; Krivoi II, 2006, PFLUG ARCH EUR J PHY, V452, P756, DOI 10.1007/s00424-006-0081-6; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liu LJ, 2006, AM J PHYSIOL-CELL PH, V291, pC569, DOI 10.1152/ajpcell.00002.2006; Mourot A, 2006, MOL PHARMACOL, V69, P452, DOI 10.1124/mol.105.017566; Nazarian J, 2007, PROTEOMICS, V7, P617, DOI 10.1002/pmic.200600686; NIKOLSKY EE, 1994, J PHYSIOL-LONDON, V477, P497, DOI 10.1113/jphysiol.1994.sp020210; Ockleford CD, 2002, J MICROSC-OXFORD, V206, P93, DOI 10.1046/j.1365-2818.2002.01011.x; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; PEDERSEN SE, 1986, J BIOL CHEM, V261, P3735; Pierre SV, 2006, CELL BIOCHEM BIOPHYS, V46, P303, DOI 10.1385/CBB:46:3:303; PRESSLEY TA, 1992, AM J PHYSIOL, V262, pC743, DOI 10.1152/ajpcell.1992.262.3.C743; Prince RJ, 1999, J BIOL CHEM, V274, P19623, DOI 10.1074/jbc.274.28.19623; Prince RJ, 1998, J BIOL CHEM, V273, P7843, DOI 10.1074/jbc.273.14.7843; Pritchard TJ, 2007, AM J PHYSIOL-HEART C, V293, pH1172, DOI 10.1152/ajpheart.00279.2007; Radzyukevich TL, 2009, P NATL ACAD SCI USA, V106, P2565, DOI 10.1073/pnas.0804150106; Radzyukevich TL, 2004, AM J PHYSIOL-CELL PH, V287, pC1300, DOI 10.1152/ajpcell.00231.2004; Rahkila P, 2001, EXP CELL RES, V267, P61, DOI 10.1006/excr.2001.5101; Raines DE, 1998, BIOCHEMISTRY-US, V37, P956, DOI 10.1021/bi971689w; Ralston E, 1999, EXP CELL RES, V246, P510, DOI 10.1006/excr.1998.4305; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; RUFF RL, 1988, MUSCLE NERVE, V11, P502, DOI 10.1002/mus.880110514; RUFF RL, 1987, J PHYSIOL-LONDON, V383, P339; Ryan SE, 2001, J BIOL CHEM, V276, P4796, DOI 10.1074/jbc.M007063200; Song XZ, 2000, BIOPHYS J, V78, P1324, DOI 10.1016/S0006-3495(00)76687-2; Song XZ, 2003, BIOCHEMISTRY-US, V42, P4197, DOI 10.1021/bi027405b; Sperelakis N, 2001, CELL PHYSL SOURCEBOO, P231; Spitzmaul G, 2009, BRIT J PHARMACOL, V157, P804, DOI 10.1111/j.1476-5381.2009.00214.x; Sunada Y, 2001, HUM MOL GENET, V10, P173, DOI 10.1093/hmg/10.3.173; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Voldstedlund M, 2001, CELL TISSUE RES, V306, P265, DOI 10.1007/s004410100439; VYSKOCIL F, 1983, NEUROSCIENCE, V9, P429, DOI 10.1016/0306-4522(83)90305-6; WAKSMAN G, 1976, FEBS LETT, V67, P335, DOI 10.1016/0014-5793(76)80560-1; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; Williams MW, 2001, J CELL SCI, V114, P751; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Wood SJ, 2001, PROG NEUROBIOL, V64, P393, DOI 10.1016/S0301-0082(00)00055-1; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Zahler R, 1996, CIRC RES, V78, P870, DOI 10.1161/01.RES.78.5.870	68	40	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28614	28626		10.1074/jbc.M110.150961	http://dx.doi.org/10.1074/jbc.M110.150961			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20595385	Green Published, hybrid			2022-12-25	WOS:000281594000025
J	Tkacz, ID; Gupta, SK; Volkov, V; Romano, M; Haham, T; Tulinski, P; Lebenthal, I; Michaeli, S				Tkacz, Itai Dov; Gupta, Sachin Kumar; Volkov, Vadim; Romano, Mali; Haham, Tomer; Tulinski, Pawel; Lebenthal, Ilana; Michaeli, Shulamit			Analysis of Spliceosomal Proteins in Trypanosomatids Reveals Novel Functions in mRNA Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICED-LEADER RNA; SMALL NUCLEAR-RNA; POLY(A) POLYMERASE; GENE-EXPRESSION; EDITING COMPLEX; SM PROTEINS; BRUCEI; POLYADENYLATION; SNRNP; CORE	In trypanosomatids, all mRNAs are processed via trans-splicing, although cis-splicing also occurs. In trans-splicing, a common small exon, the spliced leader (SL), which is derived from a small SL RNA species, is added to all mRNAs. Sm and Lsm proteins are core proteins that bind to U snRNAs and are essential for both these splicing processes. In this study, SmD3- and Lsm3-associated complexes were purified to homogeneity from Leishmania tarentolae. The purified complexes were analyzed by mass spectrometry, and 54 and 39 proteins were purified from SmD3 and Lsm complexes, respectively. Interestingly, among the proteins purified from Lsm3, no mRNA degradation factors were detected, as in Lsm complexes from other eukaryotes. The U1A complex was purified and mass spectrometry analysis identified, in addition to U1 small nuclear ribonucleoprotein (snRNP) proteins, additional co-purified proteins, including the polyadenylation factor CPSF73. Defects observed in cells silenced for U1 snRNP proteins suggest that the U1 snRNP functions exclusively in cis-splicing, although U1A also participates in polyadenylation and affects trans-splicing. The study characterized several trypanosome-specific nuclear factors involved in snRNP biogenesis, whose function was elucidated in Trypanosoma brucei. Conserved factors, such as PRP19, which functions at the heart of every cis-spliceosome, also affect SL RNA modification; GEMIN2, a protein associated with SMN (survival of motor neurons) and implicated in selective association of U snRNA with core Sm proteins in trypanosomes, is a master regulator of snRNP assembly. This study demonstrates the existence of trypanosomatid-specific splicing factors but also that conserved snRNP proteins possess trypanosome-specific functions.	[Michaeli, Shulamit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; Bar Ilan Univ, Adv Mat & Nanotechnol Inst, IL-52900 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Michaeli, S (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	michaes@mail.biu.ac.il	Michaeli, Shulamit/AAC-8255-2022; Tulinski, Pawel/P-8365-2014	Tulinski, Pawel/0000-0002-5033-5859	Deutsche Forcshungsgemeinschaft; Howard Hughes Medical Institute	Deutsche Forcshungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported the Deutsche Forcshungsgemeinschaft and by an International Research Scholar grant from the Howard Hughes Medical Institute (to S. M.).	Abelson J, 2008, NAT STRUCT MOL BIOL, V15, P1235, DOI 10.1038/nsmb1208-1235; Ambrosio DL, 2009, EUKARYOT CELL, V8, P990, DOI 10.1128/EC.00075-09; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Arhin GK, 2006, RNA, V12, P53, DOI 10.1261/rna.2223406; Barth S, 2008, EUKARYOT CELL, V7, P86, DOI 10.1128/EC.00215-07; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Biton M, 2006, MOL BIOCHEM PARASIT, V150, P132, DOI 10.1016/j.molbiopara.2006.07.004; BOELENS WC, 1993, CELL, V72, P881, DOI 10.1016/0092-8674(93)90577-D; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; delOlmo M, 1997, MOL GEN GENET, V255, P209, DOI 10.1007/s004380050491; Denker JA, 1996, RNA, V2, P746; Dossin FD, 2005, EUKARYOT CELL, V4, P960, DOI 10.1128/EC.4.5.960-970.2005; Gilinger G, 2001, NUCLEIC ACIDS RES, V29, P1556, DOI 10.1093/nar/29.7.1556; Goncharov I, 1999, J BIOL CHEM, V274, P12217, DOI 10.1074/jbc.274.18.12217; Guan F, 2007, RNA, V13, P2129, DOI 10.1261/rna.756707; GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Hury A, 2009, EUKARYOT CELL, V8, P56, DOI 10.1128/EC.00322-08; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lee JH, 2007, EUKARYOT CELL, V6, P641, DOI 10.1128/EC.00411-06; Lee JH, 2009, NUCLEIC ACIDS RES, V37, P3811, DOI 10.1093/nar/gkp236; Li F, 2009, P NATL ACAD SCI USA, V106, P12306, DOI 10.1073/pnas.0901754106; Li HJ, 2005, MOL CELL BIOL, V25, P2216, DOI 10.1128/MCB.25.6.2216-2226.2005; Liang XH, 2006, MOL BIOCHEM PARASIT, V145, P29, DOI 10.1016/j.molbiopara.2005.09.004; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Lucke S, 1997, EMBO J, V16, P4433, DOI 10.1093/emboj/16.14.4433; Lustig Y, 2007, EMBO REP, V8, P408, DOI 10.1038/sj.embor.7400930; Mair G, 2000, RNA, V6, P163, DOI 10.1017/S135583820099229X; Makarov EM, 2000, J MOL BIOL, V298, P567, DOI 10.1006/jmbi.2000.3685; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Mandelboim M, 2003, J BIOL CHEM, V278, P51469, DOI 10.1074/jbc.M308997200; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; NAKAAR V, 1994, MOL CELL BIOL, V14, P6736, DOI 10.1128/MCB.14.10.6736; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Palfi Z, 2000, P NATL ACAD SCI USA, V97, P8967, DOI 10.1073/pnas.150236097; Palfi Z, 2005, NUCLEIC ACIDS RES, V33, P2493, DOI 10.1093/nar/gki548; Palfi Z, 2009, GENE DEV, V23, P1650, DOI 10.1101/gad.526109; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Sturm NR, 1999, J BIOL CHEM, V274, P19361, DOI 10.1074/jbc.274.27.19361; Tkacz ID, 2008, MOL BIOCHEM PARASIT, V160, P22, DOI 10.1016/j.molbiopara.2008.03.003; Tkacz ID, 2007, RNA, V13, P30, DOI 10.1261/rna.174307; TSCHUDI C, 1990, CELL, V61, P459, DOI 10.1016/0092-8674(90)90527-L; Vazquez MP, 2009, MOL BIOCHEM PARASIT, V164, P137, DOI 10.1016/j.molbiopara.2008.12.009; Vethantham V, 2008, GENE DEV, V22, P499, DOI 10.1101/gad.1628208; Vethantham V, 2007, MOL CELL BIOL, V27, P8848, DOI 10.1128/MCB.01186-07; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang PP, 2006, EMBO J, V25, P4513, DOI 10.1038/sj.emboj.7601328; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Xu YX, 2000, J BIOL CHEM, V275, P27883; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010; Zamudio JR, 2007, MOL CELL BIOL, V27, P6084, DOI 10.1128/MCB.00647-07; Zamudio JR, 2006, EUKARYOT CELL, V5, P905, DOI 10.1128/EC.00080-06; Zeiner GM, 2004, MOL CELL BIOL, V24, P10390, DOI 10.1128/MCB.24.23.10390-10396.2004	66	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27982	27999		10.1074/jbc.M109.095349	http://dx.doi.org/10.1074/jbc.M109.095349			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20592024	Green Published, hybrid			2022-12-25	WOS:000281404100052
J	Zhao, XY; Zhao, L; Tian, TA; Zhang, Y; Tong, JY; Zheng, XF; Meng, AM				Zhao, Xinyi; Zhao, Long; Tian, Tian; Zhang, Yu; Tong, Jingyuan; Zheng, Xiaofeng; Meng, Anming			Interruption of cenph Causes Mitotic Failure and Embryonic Death, and Its Haploinsufficiency Suppresses Cancer in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROMERE-PROTEIN-H; CAUSES GENOME INSTABILITY; CHROMOSOME MISSEGREGATION; KINETOCHORE PROTEIN; PROGNOSTIC MARKER; VERTEBRATE CELLS; PATIENT SURVIVAL; NULL MICE; APOPTOSIS; GENE	Kinetochore proteins associate with centromeric DNA and spindle microtubules and play essential roles in chromosome segregation during mitosis. In this study, we uncovered a zebrafish mutant, stagnant and curly (stac), that carries the Tol2 transposon element inserted at the kinetochore protein H (cenph) locus. Mutant embryos exhibit discernible cell death as early as 20 hours postfertilization, extensive apoptosis, and upward curly tail during the pharyngula period and deform around 5 days postfertilization. The stac mutant phenotype can be rescued by cenph mRNA overexpression and mimicked by cenph knockdown with antisense morpholinos, suggesting the responsibility of cenph deficiency for stac mutants. We demonstrate that the intrinsic apoptosis pathway is hyperactivated in stac mutants and that p53 knockdown partially blocks excess apoptosis in stac mutants. Mitotic cells in stac mutants show chromosome missegregation and are usually arrested in G(2)/M phase. Furthermore, compared with wild type siblings, heterozygous stac fish develop invasive tumors at a dramatically reduced rate, suggesting a reduced cancer risk. Taken together, our findings uncover an essential role of cenph in mitosis and embryonic development and its association with tumor development.	[Zhao, Xinyi; Zhao, Long; Tian, Tian; Zhang, Yu; Tong, Jingyuan; Zheng, Xiaofeng; Meng, Anming] Tsinghua Univ, Coll Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China; [Meng, Anming] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Engn, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Zoology, CAS	Meng, AM (corresponding author), Tsinghua Univ, Coll Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Zhang, Yu/F-6583-2016; Zhao, Long/A-6439-2014; Meng, Anming/A-4785-2012	Zhao, Long/0000-0003-2691-7055; Meng, Anming/0000-0001-7228-3431; Zhang, Yu/0000-0001-5512-9272	Major Science Programs of China [2006CB943401]; National Basic Research Program of China [2005CB522502]; 863 Program [2006AA02Z167]	Major Science Programs of China; National Basic Research Program of China(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China)	This work was supported by Major Science Programs of China Grant 2006CB943401, National Basic Research Program of China Grant 2005CB522502, and the 863 Program Grant 2006AA02Z167.	Alonso A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r148; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; BRINKLEY BR, 1966, CHROMOSOMA, V19, P28, DOI 10.1007/BF00332792; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Feitsma H, 2008, MOL CANCER RES, V6, P685, DOI 10.1158/1541-7786.MCR-07-2167; Fowler KJ, 2000, GENOME RES, V10, P30; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Fukagawa T, 2008, FRONT BIOSCI-LANDMRK, V13, P2705, DOI 10.2741/2877; Geiger GA, 2006, CANCER RES, V66, P8172, DOI 10.1158/0008-5472.CAN-06-0466; Guo XZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-233; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Kalitsis P, 1998, P NATL ACAD SCI USA, V95, P1136, DOI 10.1073/pnas.95.3.1136; Kalitsis P, 2003, CHROMOSOME RES, V11, P345, DOI 10.1023/A:1024044008009; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; Liao WT, 2007, CLIN CANCER RES, V13, P508, DOI 10.1158/1078-0432.CCR-06-1512; Liao WT, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-74; Liao WT, 2009, CANCER-AM CANCER SOC, V115, P1507, DOI 10.1002/cncr.24128; McEwen BF, 2007, METHOD CELL BIOL, V79, P259, DOI 10.1016/S0091-679X(06)79011-2; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Negron JF, 2004, DEV DYNAM, V231, P161, DOI 10.1002/dvdy.20124; Nishihashi A, 2002, DEV CELL, V2, P463, DOI 10.1016/S1534-5807(02)00144-2; Orthaus S, 2006, BIOCHEM BIOPH RES CO, V348, P36, DOI 10.1016/j.bbrc.2006.06.187; Perez-Castro AV, 1998, DEV BIOL, V201, P135, DOI 10.1006/dbio.1998.9005; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Shigeishi H, 2006, ONCOL REP, V16, P1071; Spitsbergen JM, 2000, TOXICOL PATHOL, V28, P716, DOI 10.1177/019262330002800512; Sugata N, 2000, HUM MOL GENET, V9, P2919, DOI 10.1093/hmg/9.19.2919; Sugata N, 1999, J BIOL CHEM, V274, P27343, DOI 10.1074/jbc.274.39.27343; Tadeu AMB, 2008, EMBO J, V27, P2510, DOI 10.1038/emboj.2008.175; Tian T, 2009, J GENET GENOMICS, V36, P581, DOI 10.1016/S1673-8527(08)60150-2; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012; Zhang Y, 2009, J CELL SCI, V122, P2197, DOI 10.1242/jcs.040659; Zhao L, 2008, CARDIOVASC RES, V80, P200, DOI 10.1093/cvr/cvn177	48	19	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27924	27934		10.1074/jbc.M110.136077	http://dx.doi.org/10.1074/jbc.M110.136077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573960	Green Published, hybrid			2022-12-25	WOS:000281404100047
J	Bartkova, J; Hamerlik, P; Stockhausen, MT; Ehrmann, J; Hlobilkova, A; Laursen, H; Kalita, O; Kolar, Z; Poulsen, HS; Broholm, H; Lukas, J; Bartek, J				Bartkova, J.; Hamerlik, P.; Stockhausen, M-T; Ehrmann, J.; Hlobilkova, A.; Laursen, H.; Kalita, O.; Kolar, Z.; Poulsen, H. S.; Broholm, H.; Lukas, J.; Bartek, J.			Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas	ONCOGENE			English	Article						glioblastoma multiforme; DNA replication stress; oxidative DNA lesions; DNA damage checkpoints; p53 aberrations	ONCOGENE-INDUCED SENESCENCE; CANCER; REPAIR; CHECKPOINT; 53BP1; RADIORESISTANCE; PATHWAYS; BARRIER; BIOLOGY	Malignant gliomas, the deadliest of brain neoplasms, show rampant genetic instability and resistance to genotoxic therapies, implicating potentially aberrant DNA damage response (DDR) in glioma pathogenesis and treatment failure. Here, we report on gross, aberrant constitutive activation of DNA damage signalling in low-and high-grade human gliomas, and analyze the sources of such endogenous genotoxic stress. Based on analyses of human glioblastoma multiforme (GBM) cell lines, normal astrocytes and clinical specimens from grade II astrocytomas (n=41) and grade IV GBM (n=60), we conclude that the DDR machinery is constitutively activated in gliomas, as documented by phosphorylated histone H2AX (gamma H2AX), activation of the ATM-Chk2-p53 pathway, 53BP1 foci and other markers. Oxidative DNA damage (8-oxoguanine) was high in some GBM cell lines and many GBM tumors, while it was low in normal brain and grade II astrocytomas, despite the degree of DDR activation was higher in grade II tumors. Markers indicative of ongoing DNA replication stress (Chk1 activation, Rad17 phosphorylation, replication protein A foci and single-stranded DNA) were present in GBM cells under high-or low-oxygen culture conditions and in clinical specimens of both low-and high-grade tumors. The observed global checkpoint signaling, in contrast to only focal areas of overabundant p53 (indicative of p53 mutation) in grade II astrocytomas, are consistent with DDR activation being an early event in gliomagenesis, initially limiting cell proliferation (low Ki-67 index) and selecting for mutations of p53 and likely other genes that allow escape (higher Ki-67 index) from the checkpoint and facilitate tumor progression. Overall, these results support the potential role of the DDR machinery as a barrier to gliomagenesis and indicate that replication stress, rather than oxidative stress, fuels the DNA damage signalling in early stages of astrocytoma development. Oncogene (2010) 29, 5095-5102; doi:10.1038/onc.2010.249; published online 28 June 2010	[Bartkova, J.; Hamerlik, P.; Lukas, J.; Bartek, J.] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; [Bartkova, J.; Hamerlik, P.; Lukas, J.; Bartek, J.] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Hamerlik, P.; Bartek, J.] Palacky Univ, Inst Mol & Translat Med, Lab Genome Integr, CR-77147 Olomouc, Czech Republic; [Stockhausen, M-T; Poulsen, H. S.] Copenhagen Univ Hosp, Dept Radiat Biol, Copenhagen, Denmark; [Laursen, H.; Broholm, H.] Copenhagen Univ Hosp, Dept Neuropathol, Copenhagen, Denmark; [Kalita, O.] Univ Hosp, Dept Neurosurg, Olomouc, Czech Republic	Danish Cancer Society; Danish Cancer Society; Palacky University Olomouc; University of Copenhagen; University of Copenhagen; University Hospital Olomouc	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.	jil@cancer.dk; jb@cancer.dk	Ehrmann, Jiri/C-9074-2009; Kolar, Zdenek/A-4597-2008; Bartek, Jiri/G-5870-2014; , Petra/U-2260-2019; Kalita, Ondrej/I-8815-2016	Ehrmann, Jiri/0000-0002-8419-3414; Kolar, Zdenek/0000-0003-1838-5925; , Petra/0000-0002-5856-0161; Lukas, Jiri/0000-0001-9087-506X; Kalita, Ondrej/0000-0002-1356-023X	Danish Cancer Society; Danish National Research Foundation; Danish Research Council; Vilhelm Pedersen and Hustrus Mindelegat; Czech Ministry of Education [MSMT6198959216]; Grant Agency of the Czech Ministry of Health [NS10282-3/2009]; Lundbeck Foundation [R13-A1287]; European Commission [CZ.1.05/2.1.00/01.0030]	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Research Council(Det Frie Forskningsrad (DFF)); Vilhelm Pedersen and Hustrus Mindelegat; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Ministry of Health; Lundbeck Foundation(Lundbeckfonden); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank J Darling, University of Wolverhampton and CV Bree, University of Amsterdam for donating the SS859 and Gli-6 cells, respectively and MyungHee Lee for excellent technical assistance. Grant support was obtained from Danish Cancer Society, Danish National Research Foundation, Danish Research Council, Vilhelm Pedersen and Hustrus Mindelegat, Czech Ministry of Education (MSMT6198959216), Grant Agency of the Czech Ministry of Health (NS10282-3/2009), Lundbeck Foundation (R13-A1287) and European Commission (projects: CZ.1.05/2.1.00/01.0030, Active p53, Infla-Care, GENICA).	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2007, ONCOGENE, V26, P7414, DOI 10.1038/sj.onc.1210553; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Dungey FA, 2009, MOL CANCER THER, V8, P2243, DOI 10.1158/1535-7163.MCT-09-0201; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Knizetova P, 2008, CELL CYCLE, V7, P2553, DOI 10.4161/cc.7.16.6442; Li DD, 2005, EUR J NEUROSCI, V22, P1319, DOI 10.1111/j.1460-9568.2005.04335.x; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Mistrik M, 2009, CELL CYCLE, V8, P2592, DOI 10.4161/cc.8.16.9331; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nuciforo PG, 2007, CARCINOGENESIS, V28, P2082, DOI 10.1093/carcin/bgm108; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	30	136	137	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	36					5095	5102		10.1038/onc.2010.249	http://dx.doi.org/10.1038/onc.2010.249			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	647LN	20581868				2022-12-25	WOS:000281620100009
J	Shang, X; Vasudevan, SA; Yu, Y; Ge, N; Ludwig, AD; Wesson, CL; Wang, K; Burlingame, SM; Zhao, YJ; Rao, PH; Lu, X; Russell, HV; Okcu, MF; Hicks, MJ; Shohet, JM; Donehower, LA; Nuchtern, JG; Yang, J				Shang, X.; Vasudevan, S. A.; Yu, Y.; Ge, N.; Ludwig, A. D.; Wesson, C. L.; Wang, K.; Burlingame, S. M.; Zhao, Y-j; Rao, P. H.; Lu, X.; Russell, H. V.; Okcu, M. F.; Hicks, M. J.; Shohet, J. M.; Donehower, L. A.; Nuchtern, J. G.; Yang, J.			Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma	ONCOGENE			English	Article						neuroblastoma; DUSP26; MKP8; doxorubicin; p53; phosphatase	IN-VIVO; PATHWAY; PROTEIN; CANCER; PHOSPHORYLATION; TARGET; MDM2; THERAPY; KINASE; GROWTH	Chemoresistance is a major cause of treatment failure and poor outcome in neuroblastoma. In this study, we investigated the expression and function of dual-specificity phosphatase 26 (DUSP26), also known as mitogen-activated protein kinase phophatase-8, in human neuroblastoma. We found that DUSP26 was expressed in a majority of neuroblastoma cell lines and tissue specimens. Importantly, we found that DUSP26 promotes the resistance of human neuroblastoma to doxorubicin-induced apoptosis by acting as a p53 phosphatase to downregulate p53 tumor suppressor function in neuroblastoma cells. Inhibiting DUSP26 expression in the IMR-32 neuroblastoma cell line enhanced doxorubicin-induced p53 phosphorylation at Ser20 and Ser37, p21, Puma, Bax expression as well as apoptosis. In contrast, DUSP26 overexpression in the SK-N-SH cell line inhibited doxorubicin-induced p53 phosphorylation at Ser20 and Ser37, p21, Puma, Bax expression and apoptosis. Using in vitro and in vivo assays, we found that DUSP26 binds to p53 and dephosphorylates p53 at Ser20 and Ser37. In this report, we show that DUSP26 functions as a p53 phosphatase, which suppresses downstream p53 activity in response to genotoxic stress. This suggests that inhibition of this phosphatase may increase neuroblastoma chemosensitivity and DUSP26 is a novel therapeutic target for this aggressive pediatric malignancy. Oncogene (2010) 29, 4938-4946; doi: 10.1038/onc.2010.244; published online 21 June 2010	[Shang, X.; Vasudevan, S. A.; Wesson, C. L.; Burlingame, S. M.; Nuchtern, J. G.] Baylor Coll Med, Michael E DeBakey Dept Surg, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Shang, X.; Yu, Y.; Ge, N.; Ludwig, A. D.; Wang, K.; Burlingame, S. M.; Zhao, Y-j; Rao, P. H.; Russell, H. V.; Okcu, M. F.; Shohet, J. M.; Nuchtern, J. G.; Yang, J.] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Lu, X.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Hicks, M. J.] Baylor Coll Med, Dept Pathol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Donehower, L. A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Baylor College of Medicine; Baylor College of Medicine	Nuchtern, JG (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Dan L Duncan Canc Ctr, 6621 Fannin,CC650-00, Houston, TX 77030 USA.	nuchtern@bcm.edu; jianhuay@bcm.edu			Hope Street Kids Foundation; Bear Necessities Pediatric Cancer Foundation; American Cancer Society [RSG-06-070-01-TBE]; Society of University Surgeons; NIH/NCI-NRSA [1F32CA113059-01A1]; NATIONAL CANCER INSTITUTE [F32CA113059] Funding Source: NIH RePORTER	Hope Street Kids Foundation; Bear Necessities Pediatric Cancer Foundation; American Cancer Society(American Cancer Society); Society of University Surgeons; NIH/NCI-NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Xiangwei Wu for providing GFP-p53 expression plasmid and Mdm2-Luc reporter. The work was supported in part by the grants from the Hope Street Kids Foundation (to JY), the Bear Necessities Pediatric Cancer Foundation (to JY), the American Cancer Society Grant RSG-06-070-01-TBE (to JY), the Society of University Surgeons Ethicon Resident Scholarship (SAV) and the NIH/NCI-NRSA training grant 1F32CA113059-01A1 (SAV).	Amano T, 2009, J NEURO-ONCOL, V92, P357, DOI 10.1007/s11060-009-9844-1; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen L, 2007, CELL CYCLE, V6, P2685, DOI 10.4161/cc.6.21.4853; Eischen CM, 2009, CANCER CELL, V15, P161, DOI 10.1016/j.ccr.2009.02.004; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Goldman SC, 1996, AM J PATHOL, V148, P1381; Hupp TR, 2000, BIOCHEM J, V352, P1, DOI 10.1042/0264-6021:3520001; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Li LW, 2000, J BIOL CHEM, V275, P2410, DOI 10.1074/jbc.275.4.2410; London WB, 2005, J CLIN ONCOL, V23, P6459, DOI 10.1200/JCO.2005.05.571; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; MARUTA H, 1991, J BIOL CHEM, V266, P11661; Matthay KK, 1998, J CLIN ONCOL, V16, P1256, DOI 10.1200/JCO.1998.16.4.1256; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pestell KE, 2000, ONCOGENE, V19, P6607, DOI 10.1038/sj.onc.1204084; Shang XY, 2009, MOL CANCER THER, V8, P2461, DOI 10.1158/1535-7163.MCT-08-0857; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tweddle DA, 2003, CANCER LETT, V197, P93, DOI 10.1016/S0304-3835(03)00088-0; Tweddle DA, 2001, CANCER RES, V61, P8; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Vasudevan SA, 2005, BIOCHEM BIOPH RES CO, V330, P511, DOI 10.1016/j.bbrc.2005.03.028; Vasudevan SA, 2009, MOL CANCER THER, V8, P2478, DOI 10.1158/1535-7163.MCT-08-1132; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yu W, 2007, ONCOGENE, V26, P1178, DOI 10.1038/sj.onc.1209899; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200	34	45	46	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	35					4938	4946		10.1038/onc.2010.244	http://dx.doi.org/10.1038/onc.2010.244			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	646XP	20562916	Green Accepted			2022-12-25	WOS:000281578700008
J	D'Argenio, G; Petillo, O; Margarucci, S; Torpedine, A; Calarco, A; Koverech, A; Boccia, A; Paolella, G; Peluso, G				D'Argenio, Giuseppe; Petillo, Orsolina; Margarucci, Sabrina; Torpedine, Angela; Calarco, Anna; Koverech, Angela; Boccia, Angelo; Paolella, Giovanni; Peluso, Gianfranco			Colon OCTN2 Gene Expression Is Up-regulated by Peroxisome Proliferator-activated Receptor gamma in Humans and Mice and Contributes to Local and Systemic Carnitine Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC CATION TRANSPORTER; TISSUE DISTRIBUTION PATTERN; CATION/CARNITINE TRANSPORTER; FUNCTIONAL-CHARACTERISTICS; ULCERATIVE-COLITIS; SMALL-INTESTINE; ADIPOSE-TISSUE; PPAR-ALPHA; METABOLISM; RAT	In the large intestine organic cation transporter type-2 (OCTN2) is recognized as a transporter of compounds such as carnitine and colony sporulation factor, promoting health of the colon intestinal epithelium. Recent reports suggest that OCTN2 expression in small intestine is under control of peroxisome proliferator-activated receptor-alpha (PPAR alpha). However, PPAR alpha contribution to colonic OCTN2 expression remains controversial. Here we examined the transcriptional regulation of colon OCTN2 gene by PPAR alpha. To exclude any additional modulation of other PPAR to OCTN2 expression, we used both in vivo and in vitro PPAR-null models and specific PPAR inhibitors. The PPAR gamma agonists thiazolidinediones increased both OCTN2 mRNA and protein expression in colonic epithelial cell lines independently by PPAR alpha expression. The induction was blocked only by PPAR gamma antagonists or by gamma ORF4, a PPAR gamma isoform with dominant negative activity, suggesting a PPAR gamma-dependent mechanism. A conserved noncanonical PPAR-responsive element was found by computational analysis in the first intron of human OCTN2 gene and validated by EMSA assay. Promoter-reporter assays further confirmed transcriptional functionality of the putative PPAR response element, whereas selective mutation caused complete loss of responsiveness to PPAR gamma activation. Finally, adenovirus-mediated overexpression of constitutively active PPAR gamma mutant increased colon OCTN2 expression in PPAR alpha(-/-) mice. Interestingly, animals overexpressing colon PPAR gamma showed a significant increase in plasma carnitine, thus demonstrating the functional contribution of large intestine to systemic carnitine homeostasis. This study reveals a PPAR gamma-dependent absorption machinery in colon that is likely involved in the health of colon epithelium, in the microbiota-host interactions and in the absorption of nutraceuticals and drugs.	[Petillo, Orsolina; Margarucci, Sabrina; Torpedine, Angela; Calarco, Anna; Peluso, Gianfranco] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [D'Argenio, Giuseppe] Univ Naples Federico 2, Dipartimento Med Clin & Sperimentale, I-80131 Naples, Italy; [Koverech, Angela] Fac Med, I-00185 Rome, Italy; [Boccia, Angelo; Paolella, Giovanni] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, CEINGE Biotecnol Avanzate, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Peluso, G (corresponding author), CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy.	g.peluso@ibp.cnr.it	Calarco, Anna/P-2568-2019	Calarco, Anna/0000-0002-1441-7662; MARGARUCCI, SABRINA/0000-0001-5361-1241				Auboeuf D, 1997, DIABETES, V46, P1319, DOI 10.2337/diabetes.46.8.1319; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Ciacci C, 2007, DIGEST LIVER DIS, V39, P922, DOI 10.1016/j.dld.2007.06.013; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; D'Argenio G, 2006, FASEB J, V20, P2544, DOI 10.1096/fj.06-5950fje; Degenhardt T, 2006, J BIOL CHEM, V281, P39607, DOI 10.1074/jbc.M605623200; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; HAMILTON JW, 1986, GASTROENTEROLOGY, V91, P10, DOI 10.1016/0016-5085(86)90432-4; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Koch A, 2008, EXP BIOL MED, V233, P356, DOI 10.3181/0706-RM-168; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Lahjouji K, 2001, MOL GENET METAB, V73, P287, DOI 10.1006/mgme.2001.3207; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lohninger A, 2005, MONATSH CHEM, V136, P1255, DOI 10.1007/s00706-005-0339-2; Maeda T, 2008, BIOL PHARM BULL, V31, P1230, DOI 10.1248/bpb.31.1230; Mandard S, 2007, CELL MOL LIFE SCI, V64, P1145, DOI 10.1007/s00018-007-7006-1; Meier Y, 2007, DRUG METAB DISPOS, V35, P590, DOI 10.1124/dmd.106.013342; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Ohashi R, 2001, MOL PHARMACOL, V59, P358, DOI 10.1124/mol.59.2.358; Ohashi R, 1999, J PHARMACOL EXP THER, V291, P778; Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003; Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39; Ringseis R, 2007, PHARMACOL RES, V56, P175, DOI 10.1016/j.phrs.2007.06.001; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Sabatino L, 2005, J BIOL CHEM, V280, P26517, DOI 10.1074/jbc.M502716200; SAHI J, 1994, AM J PHYSIOL-GASTR L, V266, P846; Schupp M, 2009, P NATL ACAD SCI USA, V106, P1105, DOI 10.1073/pnas.0812065106; Shekhawat PS, 2007, MOL GENET METAB, V92, P315, DOI 10.1016/j.ymgme.2007.08.002; Slitt AL, 2002, DRUG METAB DISPOS, V30, P212, DOI 10.1124/dmd.30.2.212; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tein I, 2003, J INHERIT METAB DIS, V26, P147, DOI 10.1023/A:1024481016187; Wang K, 2008, EXP BIOL MED, V233, P496, DOI 10.3181/0708-MR-231; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wu X, 2000, BBA-BIOMEMBRANES, V1466, P315, DOI 10.1016/S0005-2736(00)00189-9; Wu X, 1999, J PHARMACOL EXP THER, V290, P1482; Xuan WL, 2003, BIOCHEM BIOPH RES CO, V306, P121, DOI 10.1016/S0006-291X(03)00930-6	42	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27078	27087		10.1074/jbc.M110.109678	http://dx.doi.org/10.1074/jbc.M110.109678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558736	hybrid, Green Published			2022-12-25	WOS:000281172700039
J	Navarro, G; Ferre, S; Cordomi, A; Moreno, E; Mallol, J; Casado, V; Cortes, A; Hoffmann, H; Ortiz, J; Canela, EI; Lluis, C; Pardo, L; Franco, R; Woods, AS				Navarro, Gemma; Ferre, Sergi; Cordomi, Arnau; Moreno, Estefania; Mallol, Josefa; Casado, Vicent; Cortes, Antoni; Hoffmann, Hanne; Ortiz, Jordi; Canela, Enric I.; Lluis, Carme; Pardo, Leonardo; Franco, Rafael; Woods, Amina S.			Interactions between Intracellular Domains as Key Determinants of the Quaternary Structure and Function of Receptor Heteromers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; CRYSTAL-STRUCTURE; ADENOSINE A(2A); KNOCKOUT MICE; RHODOPSIN; OLIGOMERS; DIMERS; FRET; DOPAMINE-D-2; ACTIVATION	G protein-coupled receptor (GPCR) heteromers are macromolecular complexes with unique functional properties different from those of its individual protomers. Little is known about what determines the quaternary structure of GPCR heteromers resulting in their unique functional properties. In this study, using resonance energy transfer techniques in experiments with mutated receptors, we provide for the first time clear evidence for a key role of intracellular domains in the determination of the quaternary structure of GPCR heteromers between adenosine A(2A), cannabinoid CB1, and dopamine D-2 receptors. In these interactions, arginine-rich epitopes form salt bridges with phosphorylated serine or threonine residues from CK1/2 consensus sites. Each receptor (A(2A), CB1, and D-2) was found to include two evolutionarily conserved intracellular domains to establish selective electrostatic interactions with intracellular domains of the other two receptors, indicating that these particular electrostatic interactions constitute a general mechanism for receptor heteromerization. Mutation experiments indicated that the interactions of the intracellular domains of the CB1 receptor with A(2A) and D-2 receptors are fundamental for the correct formation of the quaternary structure needed for the function (MAPK signaling) of the A(2A)-CB1-D-2 receptor heteromers. Analysis of MAPK signaling in striatal slices of CB1 receptor KO mice and wild-type littermates supported the existence of A(1)-CB1-D-2 receptor heteromer in the brain. These findings allowed us to propose the first molecular model of the quaternary structure of a receptor heteromultimer.	[Ferre, Sergi; Woods, Amina S.] Natl Inst Drug Abuse, Intramural Res Program, Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Navarro, Gemma; Moreno, Estefania; Mallol, Josefa; Casado, Vicent; Cortes, Antoni; Canela, Enric I.; Lluis, Carme; Franco, Rafael] Univ Barcelona, Ctr Invest Biomed Red Sobre Enfermedades Neurodeg, Dept Biochem & Mol Biol, Fac Biol, E-08028 Barcelona, Spain; [Cordomi, Arnau; Pardo, Leonardo] Univ Autonoma Barcelona, Lab Med Computac, Unitat Bioestadist, Bellaterra 08193, Spain; [Hoffmann, Hanne; Ortiz, Jordi] Univ Autonoma Barcelona, Inst Neurosci, Bellaterra 08193, Spain; [Hoffmann, Hanne; Ortiz, Jordi] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Facultat Medicina, Bellaterra 08193, Spain; [Franco, Rafael] Univ Navarra, Ctr Invest Med Aplicada, Pamplona 31008, Spain	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); CIBERNED; University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; University of Navarra	Woods, AS (corresponding author), Natl Inst Drug Abuse, Intramural Res Program, Dept Hlth & Human Serv, 333 Cassell Dr, Baltimore, MD 21224 USA.	awoods@intra.nida.nih.gov	Cordomí, Arnau/A-1686-2009; Casadó, Vicent/K-1660-2014; Franco, Rafael/C-3694-2015; soler, martha maricel m gomez/L-6025-2014; Ortiz, Jordi/E-9018-2011; Guillén, Estefanía Moreno/ABE-4371-2020; Navarro, Gemma/AAO-7866-2021; Canela, Enric I./M-8726-2013; Ferre, Sergi/K-6115-2014; Hoffmann, Hanne/W-6557-2019; Mallol, Josefa/I-4194-2015	Cordomí, Arnau/0000-0002-3848-2928; Casadó, Vicent/0000-0002-1764-3825; Franco, Rafael/0000-0003-2549-4919; soler, martha maricel m gomez/0000-0002-4412-8108; Ortiz, Jordi/0000-0002-9748-2290; Navarro, Gemma/0000-0003-4654-0873; Canela, Enric I./0000-0003-4992-7440; Ferre, Sergi/0000-0002-1747-1779; Mallol, Josefa/0000-0002-2479-4162; Moreno, Estefania/0000-0002-2491-5753; Pardo, Leonardo/0000-0003-1778-7420; Hoffmann, Hanne Mette/0000-0003-1555-1369	National Institutes of Health; Spanish Ministerio de Ciencia y Tecnologia [SAF2008-00146, SAF2006-05481, SAF2008-03229-E/]; Fundacio La Marato de TV3 [RD07/0067/0008, 060110]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Marato de TV3; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by a National Institutes of Health grant from intramural funds to NIDA. This work was also supported by Spanish Ministerio de Ciencia y Tecnologia Grants SAF2008-00146, SAF2006-05481, and SAF2008-03229-E/ for ERA-NET Coordination of Research Activities and Instituto de Salud Carlos III (RD07/0067/0008) Grant 060110 from Fundacio La Marato de TV3.	Aso E, 2008, J NEUROCHEM, V105, P565, DOI 10.1111/j.1471-4159.2007.05149.x; Azdad K, 2009, NEUROPSYCHOPHARMACOL, V34, P972, DOI 10.1038/npp.2008.144; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ciruela F, 2004, ANAL CHEM, V76, P5354, DOI 10.1021/ac049295f; Dalrymple MB, 2008, PHARMACOL THERAPEUT, V118, P359, DOI 10.1016/j.pharmthera.2008.03.004; Davies A, 2001, J MOL BIOL, V314, P455, DOI 10.1006/jmbi.2001.5167; Ferre S, 2007, TRENDS NEUROSCI, V30, P440, DOI 10.1016/j.tins.2007.07.001; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Ferre S, 2009, NEUROPHARMACOLOGY, V56, P226, DOI 10.1016/j.neuropharm.2008.06.076; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gandia J, 2008, FEBS LETT, V582, P2979, DOI 10.1016/j.febslet.2008.07.045; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jackson SN, 2008, J AM SOC MASS SPECTR, V19, P1535, DOI 10.1016/j.jasms.2008.06.023; Jackson SN, 2006, J PROTEOME RES, V5, P122, DOI 10.1021/pr0503578; Jackson SN, 2005, J PROTEOME RES, V4, P2360, DOI 10.1021/pr050261d; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	34	88	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27346	27359		10.1074/jbc.M110.115634	http://dx.doi.org/10.1074/jbc.M110.115634			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562103	Green Published, hybrid			2022-12-25	WOS:000281172700064
J	Kaufman, L; Potla, U; Coleman, S; Dikiy, S; Hata, Y; Kurihara, H; He, JC; D'Agati, VD; Klotman, PE				Kaufman, Lewis; Potla, Uma; Coleman, Sarah; Dikiy, Stanislav; Hata, Yutaka; Kurihara, Hidetake; He, John C.; D'Agati, Vivette D.; Klotman, Paul E.			Up-regulation of the Homophilic Adhesion Molecule Sidekick-1 in Podocytes Contributes to Glomerulosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; HIV-ASSOCIATED NEPHROPATHY; GLOMERULAR SLIT DIAPHRAGM; TIGHT JUNCTION PROTEIN; CELL-ADHESION; NEPHROTIC SYNDROME; GUANYLATE KINASE; RENAL-DISEASE; MAGI-1; MICE	Focal segmental glomerulosclerosis (FSGS) is a leading cause of nephrotic syndrome and end-stage renal disease worldwide. Although the mechanisms underlying this important disease are poorly understood, the glomerular podocyte clearly plays a central role in disease pathogenesis. In the current work, we demonstrate that the homophilic adhesion molecule sidekick-1 (sdk-1) is up-regulated in podocytes in FSGS both in rodent models and in human kidney biopsy samples. Transgenic mice that have podocyte-specific overexpression of sdk-1 develop gradually progressive heavy proteinuria and severe FSGS. We also show that sdk-1 associates with the slit diaphragm linker protein MAGI-1, which is already known to interact with several critical podocyte proteins including synaptopodin, alpha-actinin-4, nephrin, JAM4, and beta-catenin. This interaction is mediated through a direct interaction between the carboxyl terminus of sdk-1 and specific PDZ domains of MAGI-1. In vitro expression of sdk-1 enables a dramatic recruitment of MAGI-1 to the cell membrane. Furthermore, a truncated version of sdk-1 that is unable to bind to MAGI-1 does not induce podocyte dysfunction when overexpressed. We conclude that the up-regulation of sdk-1 in podocytes is an important pathogenic factor in FSGS and that the mechanism involves disruption of the actin cytoskeleton possibly via alterations in MAGI-1 function.	[Kaufman, Lewis; Klotman, Paul E.] Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA; [Kaufman, Lewis; He, John C.] James J Peters Vet Affairs Med Ctr, Div Nephrol, Bronx, NY 10468 USA; [Hata, Yutaka] Tokyo Med & Dent Univ, Grad Sch Med, Dept Med Biochem, Tokyo 1138519, Japan; [Kurihara, Hidetake] Juntendo Univ, Sch Med, Dept Anat, Tokyo 1138421, Japan; [D'Agati, Vivette D.] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Tokyo Medical & Dental University (TMDU); Juntendo University; Columbia University	Kaufman, L (corresponding author), Mt Sinai Sch Med, Div Nephrol, 1 Gustave L Levy Pl,Box 1243, New York, NY 10029 USA.	lewis.kaufman@mssm.edu	Dikiy, Stanislav/GWR-2104-2022	Dikiy, Stanislav/0000-0002-8287-6561	National Institutes of Health [K08 DK070530, R01 DK084006, P01 DK056492]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056492, K08DK070530, R01DK084006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 DK070530 (to L. K.) R01 DK084006 (to L. K.) and P01 DK056492 (to P. E. K.).	Barisoni L, 2005, J AM SOC NEPHROL, V16, P2847, DOI 10.1681/ASN.2005050494; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Hayashi K, 2005, FASEB J, V19, P614, DOI 10.1096/fj.04-2947fje; Henderson J, 2008, KIDNEY INT, V73, P741, DOI 10.1038/sj.ki.5002751; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kaufman L, 2004, J AM SOC NEPHROL, V15, P1721, DOI 10.1097/01.ASN.0000128975.28958.C2; Kaufman L, 2007, FASEB J, V21, P1367, DOI 10.1096/fj.06-7191com; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; KORBET SM, 1994, AM J KIDNEY DIS, V23, P773, DOI 10.1016/S0272-6386(12)80128-4; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Mizuhara E, 2005, J BIOL CHEM, V280, P26499, DOI 10.1074/jbc.M500375200; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nguyen DNT, 1997, DEVELOPMENT, V124, P3303; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Pollak MR, 2003, SEMIN NEPHROL, V23, P141, DOI 10.1053/snep.2003.50014; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; RYDEL JJ, 1995, AM J KIDNEY DIS, V25, P534, DOI 10.1016/0272-6386(95)90120-5; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Waters AM, 2008, J AM SOC NEPHROL, V19, P1139, DOI 10.1681/ASN.2007050596; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wright GJ, 2004, DEVELOPMENT, V131, P5659, DOI 10.1242/dev.01417; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469	39	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 13	2010	285	33					25677	25685		10.1074/jbc.M110.133959	http://dx.doi.org/10.1074/jbc.M110.133959			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	635UN	20562105	Green Published, hybrid			2022-12-25	WOS:000280682400061
J	Kurita, S; Mott, JL; Almada, LL; Bronk, SF; Werneburg, NW; Sun, SY; Roberts, LR; Fernandez-Zapico, ME; Gores, GJ				Kurita, S.; Mott, J. L.; Almada, L. L.; Bronk, S. F.; Werneburg, N. W.; Sun, S-Y; Roberts, L. R.; Fernandez-Zapico, M. E.; Gores, G. J.			GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis	ONCOGENE			English	Article						apoptosis; cholangiocarcinoma; GLI transcription factors; TRAIL	BASAL-CELL CARCINOMA; CHOLANGIOCARCINOMA CELLS; SIGNALING PATHWAY; DEATH RECEPTOR-4; SONIC HEDGEHOG; CYTOCHROME-C; EXPRESSION; RESISTANCE; CANCER; REQUIREMENT	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis through its cognate receptors death receptor 4 (DR4) and death receptor 5 (DR5), preferentially in malignant cells. However, many malignant cells remain resistant to TRAIL cytotoxicity by poorly characterized mechanisms. Here, using cholangiocarcinoma cells, as a model for TRAIL resistance, we identified a role for the oncogenic Hedgehog (Hh)-GLI pathway in the regulation of TRAIL cytotoxicity. Blockade of Hh using pharmacological and genetic tools sensitizes the cells to TRAIL cytotoxicity. Restoration of apoptosis sensitivity coincided with upregulation of DR4 expression, while expression of other death effector proteins remained unaltered. Knockdown of DR4 mimics Hh-mediated resistance to TRAIL cytotoxicity. Hh regulates the expression of DR4 by modulating the activity of its promoter. Luciferase, chromatin immunoprecipitation and expression assays show that the transcription factor GLI3 binds to the DR4 promoter and Hh requires an intact GLI3-repression activity to silence DR4 expression. Finally, small interfering RNA (siRNA)-targeted knockdown of GLI3, but not GLI1 or GLI2, restores DR4 expression and TRAIL sensitivity, indicating that the Hh effect is exclusively mediated by this transcription factor. In conclusion, these data provide evidence of a regulatory mechanism, which modulates TRAIL signaling in cancer cells and suggest new therapeutic approaches for TRAIL-resistant neoplasms. Oncogene (2010) 29, 4848-4858; doi:10.1038/onc.2010.235; published online 21 June 2010	[Kurita, S.; Mott, J. L.; Almada, L. L.; Bronk, S. F.; Werneburg, N. W.; Roberts, L. R.; Fernandez-Zapico, M. E.; Gores, G. J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Almada, L. L.; Fernandez-Zapico, M. E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA; [Sun, S-Y] Emory Univ, Sch Med, Dept Hematol, Winship Canc Inst, Atlanta, GA USA; [Sun, S-Y] Emory Univ, Sch Med, Dept Med Oncol, Winship Canc Inst, Atlanta, GA USA	Mayo Clinic; Mayo Clinic; Emory University; Emory University	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 1st St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu		Mott, Justin/0000-0002-2927-6962; Roberts, Lewis/0000-0001-7885-8574	NIH [DK59427, CA136526, CA100882, P30 DK 84567]; Mayo Foundation; Mayo Clinic [P50 CA102701]; NATIONAL CANCER INSTITUTE [P50CA102701, R01CA100882, R56CA100882, R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079875, R01DK059427, R56DK059427, P30DK084567] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Mayo Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Erin Nystuen-Bungum for her excellent secretarial assistance. This work was supported by NIH R01 Grants DK59427 (GJG), CA136526, (MEF-Z), CA100882 (LRR), the Clinical and Optical Microscopy Cores for P30 DK 84567, Mayo Clinic Pancreatic SPORE P50 CA102701 (MEF-Z), and the Mayo Foundation.	Akazawa Y, 2009, GASTROENTEROLOGY, V136, P2365, DOI 10.1053/j.gastro.2009.02.071; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; Eggert A, 2001, CANCER RES, V61, P1314; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Guan BX, 2002, ONCOGENE, V21, P3121, DOI 10.1038/sj.onc.1205430; Guan BX, 2001, J CELL PHYSIOL, V188, P98, DOI 10.1002/jcp.1101; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Isomoto H, 2007, GASTROENTEROLOGY, V132, P384, DOI 10.1053/j.gastro.2006.10.037; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; Kump E, 2008, ONCOGENE, V27, P3856, DOI 10.1038/onc.2008.5; Lees C, 2005, GASTROENTEROLOGY, V129, P1696, DOI 10.1053/j.gastro.2005.05.010; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mendoza FJ, 2008, APOPTOSIS, V13, P756, DOI 10.1007/s10495-008-0210-0; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wehbe H, 2006, J PHARMACOL EXP THER, V319, P1153, DOI 10.1124/jpet.106.109835; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	33	41	46	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG	2010	29	34					4848	4858		10.1038/onc.2010.235	http://dx.doi.org/10.1038/onc.2010.235			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	643VB	20562908	Green Accepted			2022-12-25	WOS:000281326400010
J	Chou, KC; Shen, HB				Chou, Kuo-Chen; Shen, Hong-Bin			Plant-mPLoc: A Top-Down Strategy to Augment the Power for Predicting Plant Protein Subcellular Localization	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; FUNCTIONAL DOMAIN COMPOSITION; COUPLED RECEPTOR CLASSES; LOCATION PREDICTION; APOPTOSIS PROTEINS; GENE ONTOLOGY; EVOLUTION INFORMATION; APPROXIMATE ENTROPY; STRUCTURAL CLASSES	One of the fundamental goals in proteomics and cell biology is to identify the functions of proteins in various cellular organelles and pathways. Information of subcellular locations of proteins can provide useful insights for revealing their functions and understanding how they interact with each other in cellular network systems. Most of the existing methods in predicting plant protein subcellular localization can only cover three or four location sites, and none of them can be used to deal with multiplex plant proteins that can simultaneously exist at two, or move between, two or more different location sits. Actually, such multiplex proteins might have special biological functions worthy of particular notice. The present study was devoted to improve the existing plant protein subcellular location predictors from the aforementioned two aspects. A new predictor called "Plant-mPLoc'' is developed by integrating the gene ontology information, functional domain information, and sequential evolutionary information through three different modes of pseudo amino acid composition. It can be used to identify plant proteins among the following 12 location sites: (1) cell membrane, (2) cell wall, (3) chloroplast, (4) cytoplasm, (5) endoplasmic reticulum, (6) extracellular, (7) Golgi apparatus, (8) mitochondrion, (9) nucleus, (10) peroxisome, (11) plastid, and (12) vacuole. Compared with the existing methods for predicting plant protein subcellular localization, the new predictor is much more powerful and flexible. Particularly, it also has the capacity to deal with multiple-location proteins, which is beyond the reach of any existing predictors specialized for identifying plant protein subcellular localization. As a user-friendly web-server, Plant-mPLoc is freely accessible at http://www.csbio.sjtu.edu.cn/bioinf/plant-multi/. Moreover, for the convenience of the vast majority of experimental scientists, a step-by-step guide is provided on how to use the web-server to get the desired results. It is anticipated that the Plant-mPLoc predictor as presented in this paper will become a very useful tool in plant science as well as all the relevant areas.	[Chou, Kuo-Chen; Shen, Hong-Bin] Shanghai Jiao Tong Univ, Inst Image Proc & Pattern Recognit, Shanghai 200030, Peoples R China; [Chou, Kuo-Chen; Shen, Hong-Bin] Gordon Life Sci Inst, San Diego, CA USA	Shanghai Jiao Tong University	Chou, KC (corresponding author), Shanghai Jiao Tong Univ, Inst Image Proc & Pattern Recognit, Shanghai 200030, Peoples R China.	kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60704047]; Science and Technology Commission of Shanghai Municipality [08ZR1410600, 08JC1410600]; Shanghai Pujiang Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by the National Natural Science Foundation of China (Grant No. 60704047), Science and Technology Commission of Shanghai Municipality (Grant No. 08ZR1410600, 08JC1410600) and sponsored by the Shanghai Pujiang Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V316, P636, DOI 10.1016/j.bbrc.2004.02.098; CHOU KC, 1995, FEBS LETT, V363, P123, DOI 10.1016/0014-5793(95)00240-A; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2007, J CELL BIOCHEM, V100, P665, DOI 10.1002/jcb.21096; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gerstein M, 2003, CURR OPIN STRUC BIOL, V13, P341, DOI 10.1016/S0959-440X(03)00080-0; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; JIANG Y, 2008, J COMPUT CHEM; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Millar AH, 2009, PLANT CELL, V21, P1625, DOI 10.1105/tpc.109.066019; Murvai J, 2001, NUCLEIC ACIDS RES, V29, P58, DOI 10.1093/nar/29.1.58; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shafer G., 1976, MATH THEORY EVIDENCE, VVolume 1; Shen H.-B., 2009, J BIOMED SCI ENG, V2, DOI DOI 10.4236/JBISE.2009.23024; Shen H.B., 2009, OPEN BIOINFORM J, V3, P31, DOI DOI 10.2174/1875036200903010031; Shen HB, 2005, BIOCHEM BIOPH RES CO, V334, P288, DOI 10.1016/j.bbrc.2005.06.087; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; SMITH C, 2008, SUBCELLULAR TARGETIN; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Yang JY, 2009, J THEOR BIOL, V257, P618, DOI 10.1016/j.jtbi.2008.12.027; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zouhal LM, 1998, IEEE T SYST MAN CY C, V28, P263, DOI 10.1109/5326.669565	69	554	592	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11335	10.1371/journal.pone.0011335	http://dx.doi.org/10.1371/journal.pone.0011335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596258	gold, Green Published, Green Submitted			2022-12-25	WOS:000279259900008
J	Mensch, J; Carreira, V; Lavagnino, N; Goenaga, J; Folguera, G; Hasson, E; Fanara, JJ				Mensch, Julian; Carreira, Valeria; Lavagnino, Nicolas; Goenaga, Julieta; Folguera, Guillermo; Hasson, Esteban; Jose Fanara, Juan			Stage-Specific Effects of Candidate Heterochronic Genes on Variation in Developmental Time along an Altitudinal Cline of Drosophila melanogaster	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LARVAL DEVELOPMENT; BODY-SIZE; EVOLUTION; SELECTION; POPULATIONS; MASTERMIND; RESISTANCE; VIABILITY; GENOMICS	Background: Previously, we have shown there is clinal variation for egg-to-adult developmental time along geographic gradients in Drosophila melanogaster. Further, we also have identified mutations in genes involved in metabolic and neurogenic pathways that affect development time (heterochronic genes). However, we do not know whether these loci affect variation in developmental time in natural populations. Methodology/Principal Findings: Here, we constructed second chromosome substitution lines from natural populations of Drosophila melanogaster from an altitudinal cline, and measured egg-adult development time for each line. We found not only a large amount of genetic variation for developmental time, but also positive associations of the development time with thermal amplitude and altitude. We performed genetic complementation tests using substitution lines with the longest and shortest developmental times and heterochronic mutations. We identified segregating variation for neurogenic and metabolic genes that largely affected the duration of the larval stages but had no impact on the timing of metamorphosis. Conclusions/Significance: Altitudinal clinal variation in developmental time for natural chromosome substitution lines provides a unique opportunity to dissect the response of heterochronic genes to environmental gradients. Ontogenetic stage-specific variation in invected, mastermind, cricklet and CG14591 may affect natural variation in development time and thermal evolution.	[Mensch, Julian; Carreira, Valeria; Lavagnino, Nicolas; Goenaga, Julieta; Folguera, Guillermo; Hasson, Esteban; Jose Fanara, Juan] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Lab Evoluc, Buenos Aires, DF, Argentina	University of Buenos Aires	Mensch, J (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Lab Evoluc, Buenos Aires, DF, Argentina.	jmensch@ege.fcen.uba.ar	Goenaga, Julieta/O-4643-2016; MENSCH, JULIAN/GYD-5497-2022; Carreira, Valeria/AAG-2196-2020	Goenaga, Julieta/0000-0002-2894-1166; MENSCH, JULIAN/0000-0002-2298-4309; Lavagnino, Nicolas Jose/0000-0001-9737-3820; Goenaga, Julieta/0000-0002-9822-5800	University of Buenos Aires [X099, X076]; Fondo para la Investigacion Cientifica y Tecnologica [PICT 32146]; Ministerio de Ciencia e Innovacion [PCI 2006-A7-0537]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas [PIP 112-200801-01459, PIP 112-200801-02042]	University of Buenos Aires(University of Buenos Aires); Fondo para la Investigacion Cientifica y Tecnologica; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejo Nacional de Investigaciones Cientificas y Tecnologicas	This work was supported by the University of Buenos Aires (grants X099 and X076), the Fondo para la Investigacion Cientifica y Tecnologica (grant PICT 32146), the Ministerio de Ciencia e Innovacion (grant PCI 2006-A7-0537) and the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (grants PIP 112-200801-01459 and PIP 112-200801-02042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Bettler D, 1996, GENETICS, V143, P859; Campbell PM, 2001, INSECT BIOCHEM MOLEC, V31, P513, DOI 10.1016/S0965-1748(01)00035-2; Carreira VP, 2009, HEREDITY, V102, P246, DOI 10.1038/hdy.2008.117; Chippindale Adam K., 2004, P413, DOI 10.1142/9789812567222_0034; Chippindale AK, 1997, EVOLUTION, V51, P1536, DOI [10.2307/2411206, 10.1111/j.1558-5646.1997.tb01477.x]; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Crone EJ, 2007, INSECT BIOCHEM MOLEC, V37, P540, DOI 10.1016/j.ibmb.2007.02.010; Davidowitz G, 2004, INTEGR COMP BIOL, V44, P443, DOI 10.1093/icb/44.6.443; De Jong G, 2003, J GENET, V82, P207, DOI 10.1007/BF02715819; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Edwards AC, 2009, GENETICS, V182, P889, DOI 10.1534/genetics.109.101691; Fanara JJ, 2006, J EVOLUTION BIOL, V19, P900, DOI 10.1111/j.1420-9101.2006.01084.x; Fanara JJ, 2002, GENETICS, V162, P1321; Folguera G, 2008, BIOL J LINN SOC, V95, P233, DOI 10.1111/j.1095-8312.2008.01053.x; Geiger-Thornsberry GL, 2004, MECH AGEING DEV, V125, P179, DOI 10.1016/j.mad.2003.12.008; Gotthard K, 2001, EXPTL BIOL REV, P287; Gustavson E, 1996, GENETICS, V142, P893; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Harshman LG, 1999, J EVOLUTION BIOL, V12, P370, DOI 10.1046/j.1420-9101.1999.00024.x; JAMES AC, 1995, J EVOLUTION BIOL, V8, P315, DOI 10.1046/j.1420-9101.1995.8030315.x; Jordan KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r172; MACKAY TF, 2008, PROPOSAL SEQUENCE DR; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mackay TFC, 2004, NAT GENET, V36, P1145, DOI 10.1038/ng1104-1145; Mensch J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-78; Nunney L, 1996, EVOLUTION, V50, P1193, DOI 10.2307/2410660; Nunney L, 2007, J EVOLUTION BIOL, V20, P141, DOI 10.1111/j.1420-9101.2006.01214.x; Paaby AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001987; Prasad NG, 2001, EVOLUTION, V55, P1363, DOI 10.1111/j.0014-3820.2001.tb00658.x; Schmid AT, 1996, J EXP ZOOL, V274, P207, DOI 10.1002/(SICI)1097-010X(19960301)274:4<207::AID-JEZ1>3.0.CO;2-T; Soto EM, 2008, ENTOMOL EXP APPL, V126, P18, DOI 10.1111/j.1570-7458.2007.00631.x; Stearns S.C., 1992, pi; van't Land J, 1999, J EVOLUTION BIOL, V12, P222, DOI 10.1046/j.1420-9101.1999.00029.x; VANDELDEN W, 1991, GENETICS, V127, P507; Wang P, 2007, GENETICS, V177, P1655, DOI 10.1534/genetics.107.079731	36	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11229	10.1371/journal.pone.0011229	http://dx.doi.org/10.1371/journal.pone.0011229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585460	Green Published, gold, Green Submitted			2022-12-25	WOS:000278977200020
J	Drewe, JA; Tomlinson, AJ; Walker, NJ; Delahay, RJ				Drewe, Julian A.; Tomlinson, Alexandra J.; Walker, Neil J.; Delahay, Richard J.			Diagnostic Accuracy and Optimal Use of Three Tests for Tuberculosis in Live Badgers	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; MELES-MELES; SEROLOGICAL TESTS; GOLD STANDARD; CATTLE; SENSITIVITY; SPECIFICITY; ANTIBODIES; EPIDEMIOLOGY; POPULATION	Background: Accurate diagnosis of tuberculosis (TB) due to infection with Mycobacterium bovis is notoriously difficult in live animals, yet important if we are to understand the epidemiology of TB and devise effective strategies to limit its spread. Currently available tests for diagnosing TB in live Eurasian badgers (Meles meles) remain unvalidated against a reliable gold standard. The aim of the present study was to evaluate the diagnostic accuracy and optimal use of three tests for TB in badgers in the absence of a gold standard. Methodology/Principal Findings: A Bayesian approach was used to evaluate the diagnostic accuracy and optimal use of mycobacterial culture, gamma-interferon assay and a commercially available serological test using multiple samples collected from 305 live wild badgers. Although no single test was judged to be sufficiently sensitive and specific to be used as a sole diagnostic method, selective combined use of the three tests allowed guidelines to be formulated that allow a diagnosis to be made for individual animals with an estimated overall accuracy of 93% (range: 75% to 97%). Employing this approach in the study population of badgers resulted in approximately 13 out of 14 animals having their true infection status correctly classified from samples collected on a single capture. Conclusions/Significance: This method of interpretation represents a marked improvement on the current procedure for diagnosing M. bovis infection in live badgers. The results should be of use to inform future test and intervention strategies with the aim of reducing the incidence of TB in free-living wild badger populations.	[Drewe, Julian A.] Univ London Royal Vet Coll, Ctr Emerging Endem & Exot Dis, London, England; [Drewe, Julian A.; Tomlinson, Alexandra J.; Walker, Neil J.; Delahay, Richard J.] Food & Environm Res Agcy, Woodchester Pk, Glos, England	University of London; University of London Royal Veterinary College; Food & Environment Research Agency	Drewe, JA (corresponding author), Univ London Royal Vet Coll, Ctr Emerging Endem & Exot Dis, London, England.	jdrewe@rvc.ac.uk	Delahay, Richard/J-2261-2014; Delahay, Richard/GSI-4663-2022; Drewe, Julian A/A-6562-2009		Royal Veterinary College Animal Care Trust; Department for Environment, Food and Rural Affairs (Defra)	Royal Veterinary College Animal Care Trust; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA))	Funding for the long-term badger study was provided by the Department for Environment, Food and Rural Affairs (Defra; http://www.defra.gov.uk/index.htm). JAD was funded by the Royal Veterinary College Animal Care Trust (http://www.rvc.ac.uk/ACT/Index.cfm). The manuscript was approved by both Defra and the RVC (manuscript number P/VCS/00068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYES T, 1763, MFRS PHILOS T, V53, P370; Bengis R.G., 1998, ZOO WILD ANIMAL MED, P101; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Chambers MA, 2002, VET MICROBIOL, V86, P183, DOI 10.1016/S0378-1135(02)00012-3; Chambers MA, 2008, J CLIN MICROBIOL, V46, P1498, DOI 10.1128/JCM.02117-07; Chambers MA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-42; CHEESEMAN CL, 1982, J ZOOL, V197, P289; CLIFTONHADLEY RS, 1995, VET REC, V137, P555, DOI 10.1136/vr.137.22.555; CLIFTONHADLEY RS, 1993, EPIDEMIOL INFECT, V111, P9, DOI 10.1017/S0950268800056624; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Crawshaw TR, 2008, VET REC, V163, P473, DOI 10.1136/vr.163.16.473; Dalley D, 2008, TUBERCULOSIS, V88, P235, DOI 10.1016/j.tube.2007.11.001; de Leeuw ANS, 2004, VET J, V167, P186, DOI 10.1016/S1090-0233(03)00113-8; *DEFR, 2009, MONTHL PUBL NAT STAT; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Drewe JA, 2009, J VET DIAGN INVEST, V21, P31, DOI 10.1177/104063870902100105; Enoe C, 2000, PREV VET MED, V45, P61, DOI 10.1016/S0167-5877(00)00117-3; Gavier-Widen D, 2001, VET REC, V148, P299, DOI 10.1136/vr.148.10.299; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Greenwald R, 2003, DIAGN MICR INFEC DIS, V46, P197, DOI 10.1016/S0732-8893(03)00046-4; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; HANNA J, 1992, VET MICROBIOL, V31, P243, DOI 10.1016/0378-1135(92)90082-5; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Jenkins HE, 2008, EPIDEMIOL INFECT, V136, P1350, DOI 10.1017/S0950268807009909; Johnson WO, 2001, AM J EPIDEMIOL, V153, P921, DOI 10.1093/aje/153.9.921; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Lyashchenko KP, 1998, INFECT IMMUN, V66, P5344, DOI 10.1128/IAI.66.11.5344-5349.1998; Murphy D, 2010, RES VET SCI, V88, P1, DOI 10.1016/j.rvsc.2009.05.020; NEILL SD, 1988, VET REC, V123, P340, DOI 10.1136/vr.123.13.340; RITACCO V, 1991, RES VET SCI, V50, P365, DOI 10.1016/0034-5288(91)90143-C; Smith R., 2006, VET CLIN EPIDEMIOLOG, V3rd ed.; STAINSBY K, 1989, TUBERCLE, V70, P287, DOI 10.1016/0041-3879(89)90023-8; Toft N, 2005, PREV VET MED, V68, P19, DOI 10.1016/j.prevetmed.2005.01.006; Toft N, 2007, VET MICROBIOL, V120, P77, DOI 10.1016/j.vetmic.2006.10.025; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vose D., 2008, RISK ANAL QUANTITATI; Waters WR, 2006, CLIN VACCINE IMMUNOL, V13, P648, DOI 10.1128/CVI.00061-06; WOOD PR, 1992, VET MICROBIOL, V31, P71, DOI 10.1016/0378-1135(92)90142-G	41	47	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11196	10.1371/journal.pone.0011196	http://dx.doi.org/10.1371/journal.pone.0011196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20585404	Green Submitted, Green Published, gold			2022-12-25	WOS:000278886300033
J	Ozcivici, E; Luu, YK; Rubin, CT; Judex, S				Ozcivici, Engin; Luu, Yen K.; Rubin, Clinton T.; Judex, Stefan			Low-Level Vibrations Retain Bone Marrow's Osteogenic Potential and Augment Recovery of Trabecular Bone during Reambulation	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; GROWTH-FACTOR-I; LOW-MAGNITUDE; HIGH-FREQUENCY; MECHANICAL SIGNALS; WEIGHT-BEARING; TISSUE MINERALIZATION; DAILY EXPOSURE; ENHANCE; DIFFERENTIATION	Mechanical disuse will bias bone marrow stromal cells towards adipogenesis, ultimately compromising the regenerative capacity of the stem cell pool and impeding the rapid and full recovery of bone morphology. Here, it was tested whether brief daily exposure to high-frequency, low-magnitude vibrations can preserve the marrow environment during disuse and enhance the initiation of tissue recovery upon reambulation. Male C57BL/6J mice were subjected to hindlimb unloading (HU, n = 24), HU interrupted by weight-bearing for 15 min/d (HU+SHAM, n = 24), HU interrupted by low-level whole body vibrations (0.2 g, 90 Hz) for 15 min/d (HU+VIB, n = 24), or served as age-matched controls (AC, n = 24). Following 3 w of disuse, half of the mice in each group were released for 3 w of reambulation (RA), while the others were sacrificed. RA+VIB mice continued to receive vibrations for 15 min/d while RA+SHAM continued to receive sham loading. After disuse, HU+VIB mice had a 30% greater osteogenic marrow stromal cell population, 30% smaller osteoclast surface, 76% greater osteoblast surface but similar trabecular bone volume fraction compared to HU. After 3 w of reambulation, trabecular bone of RA+VIB mice had a 30% greater bone volume fraction, 51% greater marrow osteoprogenitor population, 83% greater osteoblast surfaces, 59% greater bone formation rates, and a 235% greater ratio of bone lining osteoblasts to marrow adipocytes than RA mice. A subsequent experiment indicated that receiving the mechanical intervention only during disuse, rather than only during reambulation, was more effective in altering trabecular morphology. These data indicate that the osteogenic potential of bone marrow cells is retained by low-magnitude vibrations during disuse, an attribute which may have contributed to an enhanced recovery of bone morphology during reambulation.	[Ozcivici, Engin; Luu, Yen K.; Rubin, Clinton T.; Judex, Stefan] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Judex, S (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	stefan.judex@stonybrook.edu	Ozcivici, Engin/AAN-1313-2021	Ozcivici, Engin/0000-0003-4464-0475	NASA; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	NASA(National Aeronautics & Space Administration (NASA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was kindly funded by NASA and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdjoudj S, 2002, J BONE MINER RES, V17, P668, DOI 10.1359/jbmr.2002.17.4.668; Baldwin KM, 1996, MED SCI SPORT EXER, V28, P1247, DOI 10.1097/00005768-199610000-00007; Basso N, 2005, BONE, V37, P370, DOI 10.1016/j.bone.2005.04.033; Basso N, 2005, BONE, V36, P173, DOI 10.1016/j.bone.2004.09.016; Boudignon BM, 2007, J APPL PHYSIOL, V103, P125, DOI 10.1152/japplphysiol.00111.2007; Brouwers JEM, 2007, J ORTHOP RES, V25, P1325, DOI 10.1002/jor.20439; Burghardt AJ, 2008, CALCIFIED TISSUE INT, V83, P129, DOI 10.1007/s00223-008-9158-x; Chappard D., 2008, Morphologie, V92, P162, DOI 10.1016/j.morpho.2008.10.003; CHENG CB, 1999, INT J FUZZY SYST, V1, P14; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; Garman R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000653; Garman R, 2007, J ORTHOP RES, V25, P732, DOI 10.1002/jor.20354; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Huang RP, 1999, J GERONTOL A-BIOL, V54, pB352, DOI 10.1093/gerona/54.8.B352; Judex S, 2002, FASEB J, V16, P1280, DOI 10.1096/fj.01-0913fje; Judex S, 2000, BONE, V26, P153, DOI 10.1016/S8756-3282(99)00256-2; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; KARINKANTA S, 2008, OSTEOPOROS INT; Kazakia GJ, 2008, MED PHYS, V35, P3170, DOI 10.1118/1.2924210; KEILA S, 1994, J BONE MINER RES, V9, P321; Kim CH, 2003, J BONE MINER RES, V18, P2116, DOI 10.1359/jbmr.2003.18.12.2116; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lang TF, 2006, J BONE MINER RES, V21, P1224, DOI 10.1359/JBMR.060509; LEBLANC AD, 1990, J BONE MINER RES, V5, P843; LEBLANC AD, 2002, J MUSCULOSKEL NEURON, V2, P235; Li CY, 2005, BONE, V37, P287, DOI 10.1016/j.bone.2005.04.041; Li CY, 2005, J BONE MINER RES, V20, P117, DOI 10.1359/JBMR.041010; Lian J B, 1995, Iowa Orthop J, V15, P118; Lublinsky S, 2007, CALCIFIED TISSUE INT, V81, P285, DOI 10.1007/s00223-007-9063-8; Luu YK, 2010, INT J OBESITY, V34, P401, DOI 10.1038/ijo.2009.240; Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Maddalozzo GF, 2008, INT J OBESITY, V32, P1348, DOI 10.1038/ijo.2008.111; Marwick C, 2000, JAMA-J AM MED ASSOC, V283, P2093, DOI 10.1001/jama.283.16.2093; MERRY K, 1993, J CELL SCI, V104, P1013; Milgrom C, 2000, BRIT J SPORT MED, V34, P195, DOI 10.1136/bjsm.34.3.195; MILLER LM, 2007, J BONE MINER RES; Mirza BI, 2008, J APPL PHYS, V104, DOI 10.1063/1.2982374; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Ozcivici E, 2007, J BIOMECH, V40, P3404, DOI 10.1016/j.jbiomech.2007.05.015; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Rittweger J, 2009, BONE, V44, P214, DOI 10.1016/j.bone.2008.10.044; Rubin C, 2001, FASEB J, V15, P2225, DOI 10.1096/fj.01-0166com; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; Sakata T, 2003, BONE, V32, P669, DOI 10.1016/S8756-3282(03)00088-7; Smith SM, 2008, BONE, V42, P572, DOI 10.1016/j.bone.2007.11.015; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; VAN VP, 1994, BLOOD, V84, P753; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Yavuzer G, 2002, INT J REHABIL RES, V25, P235, DOI 10.1097/00004356-200209000-00010; Zayzafoon M, 2004, ENDOCRINOLOGY, V145, P2421, DOI 10.1210/en.2003-1156	55	87	92	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11178	10.1371/journal.pone.0011178	http://dx.doi.org/10.1371/journal.pone.0011178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567514	Green Published, gold			2022-12-25	WOS:000278886300020
J	Apicella, CL; Cesarini, D; Johannesson, M; Dawes, CT; Lichtenstein, P; Wallace, B; Beauchamp, J; Westberg, L				Apicella, Coren L.; Cesarini, David; Johannesson, Magnus; Dawes, Christopher T.; Lichtenstein, Paul; Wallace, Bjoern; Beauchamp, Jonathan; Westberg, Lars			No Association between Oxytocin Receptor (OXTR) Gene Polymorphisms and Experimentally Elicited Social Preferences	PLOS ONE			English	Article							GENOME-WIDE; AUTISM LOCI; BEHAVIOR; TRUST; REPLICATION; DEFICITS; SEARCH	Background: Oxytocin (OXT) has been implicated in a suite of complex social behaviors including observed choices in economic laboratory experiments. However, actual studies of associations between oxytocin receptor (OXTR) gene variants and experimentally elicited social preferences are rare. Methodology/Principal Findings: We test hypotheses of associations between social preferences, as measured by behavior in two economic games, and 9 single nucleotide polymorphisms (SNPs) of the OXTR gene in a sample of Swedish twins (n = 684). Two standard economic games, the dictator game and the trust game, both involving real monetary consequences, were used to elicit such preferences. After correction for multiple hypothesis testing, we found no significant associations between any of the 9 single nucleotide polymorphisms (SNPs) and behavior in either of the games. Conclusion: We were unable to replicate the most significant association reported in previous research between the amount donated in a dictator game and an OXTR genetic variant.	[Apicella, Coren L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Apicella, Coren L.] Harvard Univ, Dept Human Evolutionary Biol, Boston, MA 02115 USA; [Cesarini, David] MIT, Dept Econ, Cambridge, MA 02139 USA; [Dawes, Christopher T.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Johannesson, Magnus; Wallace, Bjoern] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [Lichtenstein, Paul] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Beauchamp, Jonathan] Harvard Univ, Dept Econ, Boston, MA 02115 USA; [Westberg, Lars] Univ Gothenburg, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Stockholm School of Economics; Karolinska Institutet; Harvard University; University of Gothenburg	Apicella, CL (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	apicella@fas.harvard.edu	Johannesson, Magnus/E-9680-2011	Johannesson, Magnus/0000-0001-8759-6393; lichtenstein, paul/0000-0003-3037-5287; Cesarini, David/0000-0002-0043-009X; Apicella, Coren/0000-0002-9661-6998	Swedish Resarch Council; Jan Wallander and Tom Hedelius Foundation; Swedish Research Council; Swedish Council; Ministry for Higher Education	Swedish Resarch Council; Jan Wallander and Tom Hedelius Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council(Swedish Research Council); Ministry for Higher Education	LW thanks Fredrik och Ingrid Thuringsstiftelse, Ake Wibergsstiftelse, Ahlen-Stiftelsen, Jeanssons-stiftelsen, Magnus Bergvalls stiftelse, Soderstrom-Konigska stiftelsen, Marta Lundqvist stiftelse and the Swedish Resarch Council for financial support. MJ thanks the Jan Wallander and Tom Hedelius Foundation, the Swedish Research Council, and the Swedish Council for Working Life and Social Research for financial support. The Swedish Twin Registry is supported by grants from the Swedish Research Council and the The Ministry for Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bales KL, 2004, DEV PSYCHOBIOL, V44, P123, DOI 10.1002/dev.10165; Benjamin D., 2007, BIOSOCIAL SURVEYS, P304; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Charness G, 2002, Q J ECON, V117, P817, DOI 10.1162/003355302760193904; Cleves M., 1999, STAT TECH B, V48, P34; Costa B, 2009, PSYCHONEUROENDOCRINO, V34, P1506, DOI 10.1016/j.psyneuen.2009.05.006; Ditzen B, 2009, BIOL PSYCHIAT, V65, P728, DOI 10.1016/j.biopsych.2008.10.011; Domes G, 2010, PSYCHONEUROENDOCRINO, V35, P83, DOI 10.1016/j.psyneuen.2009.06.016; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Eckel CC, 1996, GAME ECON BEHAV, V16, P181, DOI 10.1006/game.1996.0081; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; FISCHBACHER U, 2008, 200807 CEDEX; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Henrich J., 2005, FDN HUMAN SOCIALITY; Hertwig R, 2001, BEHAV BRAIN SCI, V24, P383, DOI 10.1017/S0140525X01004149; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; INOUE T, 1994, J BIOL CHEM, V269, P32451; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; Lauritsen MB, 2006, MOL PSYCHIATR, V11, P37, DOI 10.1038/sj.mp.4001754; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lerer E, 2008, MOL PSYCHIATR, V13, P980, DOI 10.1038/sj.mp.4002087; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; NEALE BM, 2007, STAT GENETICS; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; SUMA J, 2007, NEUROSCI LETT, V417, P6; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; TANSEY KE, 2010, NEUROSCI LE IN PRESS; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wermter AK, 2010, AM J MED GENET B, V153B, P629, DOI 10.1002/ajmg.b.31032; Winslow JT, 2002, NEUROPEPTIDES, V36, P221, DOI 10.1054/npep.2002.0909; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Ylisaukko-oja T, 2006, ANN NEUROL, V59, P145, DOI 10.1002/ana.20722; Yrigollen CM, 2008, BIOL PSYCHIAT, V63, P911, DOI 10.1016/j.biopsych.2007.11.015; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	49	77	79	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11153	10.1371/journal.pone.0011153	http://dx.doi.org/10.1371/journal.pone.0011153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585395	Green Published, gold, Green Submitted			2022-12-25	WOS:000278886100017
J	Chen, BJ; Deoliveira, D; Spasojevic, I; Sempowski, GD; Jiang, C; Owzar, K; Wang, XJ; Gesty-Palmer, D; Cline, JM; Bourland, JD; Dugan, G; Meadows, SK; Daher, P; Muramoto, G; Chute, JP; Chao, NJ				Chen, Benny J.; Deoliveira, Divino; Spasojevic, Ivan; Sempowski, Gregory D.; Jiang, Chen; Owzar, Kouros; Wang, Xiaojuan; Gesty-Palmer, Diane; Cline, J. Mark; Bourland, J. Daniel; Dugan, Greg; Meadows, Sarah K.; Daher, Pamela; Muramoto, Garrett; Chute, John P.; Chao, Nelson J.			Growth Hormone Mitigates against Lethal Irradiation and Enhances Hematologic and Immune Recovery in Mice and Nonhuman Primates	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR NECROSIS FACTOR; T-CELL DEVELOPMENT; FACTOR-I; HEMATOPOIETIC STEM; NEUROENDOCRINE HORMONES; ERYTHROPOIESIS INVITRO; IONIZING-RADIATION; PROGENITOR CELLS; BONE-MARROW	Medications that can mitigate against radiation injury are limited. In this study, we investigated the ability of recombinant human growth hormone (rhGH) to mitigate against radiation injury in mice and nonhuman primates. BALB/c mice were irradiated with 7.5 Gy and treated post-irradiation with rhGH intravenously at a once daily dose of 20 mu g/dose for 35 days. rhGH protected 17 out of 28 mice (60.7%) from lethal irradiation while only 3 out of 28 mice (10.7%) survived in the saline control group. A shorter course of 5 days of rhGH post-irradiation produced similar results. Compared with the saline control group, treatment with rhGH on irradiated BALB/c mice significantly accelerated overall hematopoietic recovery. Specifically, the recovery of total white cells, CD4 and CD8 T cell subsets, B cells, NK cells and especially platelets post radiation exposure were significantly accelerated in the rhGH-treated mice. Moreover, treatment with rhGH increased the frequency of hematopoietic stem/progenitor cells as measured by flow cytometry and colony forming unit assays in bone marrow harvested at day 14 after irradiation, suggesting the effects of rhGH are at the hematopoietic stem/progenitor level. rhGH mediated the hematopoietic effects primarily through their niches. Similar data with rhGH were also observed following 2 Gy sublethal irradiation of nonhuman primates. Our data demonstrate that rhGH promotes hematopoietic engraftment and immune recovery post the exposure of ionizing radiation and mitigates against the mortality from lethal irradiation even when administered after exposure.	[Chen, Benny J.; Deoliveira, Divino; Spasojevic, Ivan; Sempowski, Gregory D.; Wang, Xiaojuan; Gesty-Palmer, Diane; Meadows, Sarah K.; Daher, Pamela; Muramoto, Garrett; Chute, John P.; Chao, Nelson J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Sempowski, Gregory D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Owzar, Kouros] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Chao, Nelson J.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Sempowski, Gregory D.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA; [Jiang, Chen; Owzar, Kouros] Duke Univ, Med Ctr, RadCCORE Biostat Core, Durham, NC USA; [Cline, J. Mark; Dugan, Greg] Wake Forest Univ, Bowman Gray Sch Med, Comparat Med Sect, Winston Salem, NC USA; [Bourland, J. Daniel] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiat Oncol, Winston Salem, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Chen, BJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	chen0032@mc.duke.edu		Sempowski, Gregory/0000-0003-0391-6594	National Institutes of Health [U19AI067798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC6AI058607, U19AI067798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant U19AI067798. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, STAT MODELS S; BLUM JE, 1988, INT J RADIAT ONCOL, V15, P547, DOI 10.1016/0360-3016(88)90293-3; BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burgess W, 2003, J NEUROIMMUNOL, V135, P82, DOI 10.1016/S0165-5728(02)00443-5; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen BJ, 2004, BLOOD, V103, P4344, DOI 10.1182/blood-2003-07-2534; Chen BJ, 2003, EXP HEMATOL, V31, P953, DOI 10.1016/S0301-472X(03)00196-6; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; Cline JM, 2009, AM J PRIMATOL, V71, P722, DOI 10.1002/ajp.20680; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Elliott TB, 2002, ANTIMICROB AGENTS CH, V46, P3463, DOI 10.1128/AAC.46.11.3463-3471.2002; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; GOLDE DW, 1977, SCIENCE, V196, P1112, DOI 10.1126/science.870971; Gratwohl A, 1998, BLOOD, V92, P765; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; Hudak S, 1998, EXP HEMATOL, V26, P515; Joshi SS, 2003, CYTOTHERAPY, V5, P542, DOI 10.1080/14653240310003648; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lempereur L, 2003, BRIT J PHARMACOL, V138, P1411, DOI 10.1038/sj.bjp.0705173; Lutgens LCHW, 2003, INT J RADIAT ONCOL, V57, P1067, DOI 10.1016/S0360-3016(03)00781-8; MAOR G, 1989, ENDOCRINOLOGY, V125, P1239, DOI 10.1210/endo-125-3-1239; MERCHAV S, 1993, J CELL PHYSIOL, V157, P178, DOI 10.1002/jcp.1041570123; MERCHAV S, 1988, BRIT J HAEMATOL, V70, P267, DOI 10.1111/j.1365-2141.1988.tb02480.x; MERCHAV S, 1992, J CLIN ENDOCR METAB, V74, P447, DOI 10.1210/jc.74.2.447; MERCHAV S, 1988, J CLIN INVEST, V81, P791, DOI 10.1172/JCI113385; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Minshall C, 1996, J IMMUNOL, V156, P939; MURPHY WJ, 1992, J IMMUNOL, V149, P3851; MURPHY WJ, 1992, J IMMUNOL, V148, P3799; Napolitano LA, 2008, J CLIN INVEST, V118, P1085, DOI 10.1172/JCI32830; Neta, 1996, Semin Radiat Oncol, V6, P306, DOI 10.1016/S1053-4296(96)80026-9; NETA R, 1988, J IMMUNOL, V140, P108; NETA R, 1994, J IMMUNOL, V153, P4230; NETA R, 1988, LYMPHOKINE RES, V7, P403; Pinheiro J, 2001, MIXED EFFECTS MODELS; Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001; Pruijt JFM, 1999, BLOOD, V93, P107, DOI 10.1182/blood.V93.1.107.401k14_107_112; R Development Core Team, 2009, R FDN STAT COMP; Roberts R, 2008, CLIN PHARMACOL THER, V83, P918, DOI 10.1038/clpt.2008.23; RODRIGUEZTARDUCHY G, 1992, J IMMUNOL, V149, P535; TANIKAWA S, 1990, BLOOD, V76, P445; TSARFATY G, 1994, EXP HEMATOL, V22, P1273; Uckun FM, 1997, CLIN CANCER RES, V3, P325; UCKUN FM, 1990, BLOOD, V75, P638; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Welniak LA, 2002, J LEUKOCYTE BIOL, V71, P381; Welniak LA, 2000, LEUKEMIA LYMPHOMA, V38, P435, DOI 10.3109/10428190009059263; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Wood CE, 2006, CANCER RES, V66, P1241, DOI 10.1158/0008-5472.CAN-05-2067; Wyatt D, 2004, EUR J ENDOCRINOL, V151, pS55, DOI 10.1530/eje.0.151S055; Xu J, 2003, J IMMUNOL, V171, P938, DOI 10.4049/jimmunol.171.2.938; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; ZSEBO KM, 1992, P NATL ACAD SCI USA, V89, P9464, DOI 10.1073/pnas.89.20.9464	57	40	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11056	10.1371/journal.pone.0011056	http://dx.doi.org/10.1371/journal.pone.0011056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585403	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886100006
J	Rotman, E; Amado, L; Kuzminov, A				Rotman, Ella; Amado, Luciana; Kuzminov, Andrei			Unauthorized Horizontal Spread in the Laboratory Environment: The Tactics of Lula, a Temperate Lambdoid Bacteriophage of Escherichia coli	PLOS ONE			English	Article							PHAGE PHI-80; DNA-REPAIR; RECOMBINATION; AEROSOLS; INACTIVATION; EXCISION; MECHANISM; SURVIVAL; IRRADIATION; INDUCTION	We investigated the characteristics of a lambdoid prophage, nicknamed Lula, contaminating E. coli strains from several sources, that allowed it to spread horizontally in the laboratory environment. We found that new Lula infections are inconspicuous; at the same time, Lula lysogens carry unusually high titers of the phage in their cultures, making them extremely infectious. In addition, Lula prophage interferes with P1 phage development and induces its own lytic development in response to P1 infection, turning P1 transduction into an efficient vehicle of Lula spread. Thus, using Lula prophage as a model, we reveal the following principles of survival and reproduction in the laboratory environment: 1) stealth (via laboratory material commensality), 2) stability (via resistance to specific protocols), 3) infectivity (via covert yet aggressive productivity and laboratory protocol hitchhiking). Lula, which turned out to be identical to bacteriophage phi80, also provides an insight into a surprising persistence of T1-like contamination in BAC libraries.	[Rotman, Ella; Amado, Luciana; Kuzminov, Andrei] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign	Rotman, E (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL USA.	kuzminov@life.uiuc.edu			American Cancer Society [RSG-05-135-01-GMC]; National Institutes of Health [GM 073115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073115] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant # RSG-05-135-01-GMC from the American Cancer Society and by grant # GM 073115 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; ADAMS MH, 1948, J GEN PHYSIOL, V31, P417, DOI 10.1085/jgp.31.5.417; AIZAWA S, 1975, VIROLOGY, V67, P168, DOI 10.1016/0042-6822(75)90414-6; Amado L, 2006, J BIOL CHEM, V281, P22635, DOI 10.1074/jbc.M602320200; ANDERSON RE, 1952, J BACTERIOL, V64, P473, DOI 10.1002/path.1700640307; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; *BACPAC RES, 2010, STAND OP PROC T1 PHA; BARNHART BJ, 1970, J BACTERIOL, V103, P9, DOI 10.1128/JB.103.1.9-15.1970; BOGOSIAN G, 2006, BACTERIOPHAGES, P667; Bolt EL, 2002, MOL CELL, V10, P187, DOI 10.1016/S1097-2765(02)00560-9; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P321, DOI 10.1164/ajrccm.155.1.9001331; Campbell-Renton ML, 1942, J PATHOL BACTERIOL, V54, P235, DOI 10.1002/path.1700540211; CSONKA LN, 1979, GENETICS, V93, P321; DELAPPE N, 2009, MBC MICROBIOL, V9, P155; DERMODY JJ, 1979, J BACTERIOL, V139, P701, DOI 10.1128/JB.139.2.701-704.1979; *ECOLIWIKI, 2008, METH DEAL POSS T1 IN; EDLIN G, 1977, J VIROL, V21, P560, DOI 10.1128/JVI.21.2.560-564.1977; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; *EMP GEN, 2010, WHAT IS T1 PHAG; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Haynes R.H., 1981, MOL BIOL YEAST SACCH, P371; Hendrix R. W, 1983, LAMBDA, VII; HOWARDFL.P, 1973, BRIT MED BULL, V29, P226, DOI 10.1093/oxfordjournals.bmb.a071012; HOWARDFL.P, 1969, J BACTERIOL, V97, P1134, DOI 10.1128/JB.97.3.1134-1141.1969; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; JAMES HS, 2008, BUSINESS DILEMMAS RE; Jepson CD, 2004, VACCINE, V22, P2413, DOI 10.1016/j.vaccine.2003.11.065; JONES KE, 1981, APPL ENVIRON MICROB, V41, P1072, DOI 10.1128/AEM.41.4.1072-1073.1981; Katz KC, 2002, J CLIN MICROBIOL, V40, P2686, DOI 10.1128/JCM.40.7.2686-2688.2002; KENNY MT, 1968, APPL MICROBIOL, V16, P1146, DOI 10.1128/AEM.16.8.1146-1150.1968; KOZYREV DP, 1987, GENETIKA+, V23, P793; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov Andrei, 2005, P349; LLOYD RG, 1991, J BACTERIOL, V173, P1004, DOI 10.1128/jb.173.3.1004-1011.1991; MANDAL TN, 1993, J BACTERIOL, V175, P4325, DOI 10.1128/JB.175.14.4325-4334.1993; MATSUSHIRO A, 1963, VIROLOGY, V19, P475, DOI 10.1016/0042-6822(63)90041-2; MUNDY C, 2000, PHAGE CONTAMINATION; RADMAN M, 1970, J MOL BIOL, V49, P203, DOI 10.1016/0022-2836(70)90386-4; ROTTEM S, 1993, TRENDS BIOTECHNOL, V11, P143, DOI 10.1016/0167-7799(93)90089-R; RYBCHIN VN, 1984, GENE, V27, P3, DOI 10.1016/0378-1119(84)90233-6; SEGAWA T, 1973, VIROLOGY, V54, P287, DOI 10.1016/0042-6822(73)90139-6; SONGER JR, 1967, APPL MICROBIOL, V15, P35, DOI 10.1128/AEM.15.1.35-42.1967; TAKEBE H, 1967, VIROLOGY, V33, P638, DOI 10.1016/0042-6822(67)90064-5; THOMS B, 1987, J BACTERIOL, V169, P1731, DOI 10.1128/jb.169.4.1731-1736.1987; TROUWBOR.T, 1974, APPL MICROBIOL, V27, P834, DOI 10.1128/AEM.27.5.834-837.1974; TROUWBORST T, 1972, APPL MICROBIOL, V23, P938, DOI 10.1128/AEM.23.5.938-941.1972; TROUWBORST T, 1972, J GEN VIROL, V15, P235, DOI 10.1099/0022-1317-15-3-235; TROUWBORST T, 1973, APPL MICROBIOL, V26, P252, DOI 10.1128/AEM.26.3.252-257.1973; Van Valen L.M., 1991, EVOLUTIONARY THEORY, V10, P71; Vostrov AA, 1996, J BACTERIOL, V178, P1484, DOI 10.1128/jb.178.5.1484-1486.1996	50	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11106	10.1371/journal.pone.0011106	http://dx.doi.org/10.1371/journal.pone.0011106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559442	Green Published, gold, Green Submitted			2022-12-25	WOS:000278741100019
J	Swiatkowska, M; Padula, G; Michalec, L; Stasiak, M; Skurzynski, S; Cierniewski, CS				Swiatkowska, Maria; Padula, Gianluca; Michalec, Lidia; Stasiak, Marta; Skurzynski, Szymon; Cierniewski, Czeslaw S.			Ero1 alpha Is Expressed on Blood Platelets in Association with Protein-disulfide Isomerase and Contributes to Redox-controlled Remodeling of alpha(IIb)beta(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; FUNCTIONAL ASSOCIATION; INTEGRIN ACTIVATION; PLASMA-MEMBRANE; TISSUE FACTOR; SURFACE; EXCHANGE; FAMILY; LOCALIZATION; CYSTEINES	Recent evidence supports a role of protein-disulfide isomerase (PDI) in redox-controlled remodeling of the exofacial domains of alpha(IIb)beta(3) in blood platelets. The aim of this study was to explain whether Ero1 alpha can be responsible for extracellular reoxidation of the PDI active site. We showed that Ero1 alpha can be found on platelets and is rapidly recruited to the cell surface in response to platelet agonists. It is physically associated with PDI and alpha(IIb)beta(3), as suggested by colocalization analysis in confocal microscopy and confirmed by immunoprecipitation experiments. Apart from monomeric oxidized Ero1 alpha, anti-alpha(IIb)beta(3) immunoprecipitates showed the presence of several Ero1 alpha-positive bands that corresponded to the complexes alpha(IIb)beta(3)-PDI-Ero1 alpha, PDI-Ero1 alpha, and Ero1 alpha-Ero1 alpha dimers. It binds more efficiently to the activated alpha(IIb)beta(3) conformer, and its interaction is inhibited by RGD peptides. Ero1 alpha appears to be involved in the regulation of alpha(IIb)beta(3) receptor activity because of the following: (a) blocking the cell surface Ero1 alpha by antibodies leads to a decrease in platelet aggregation in response to agonists and a decrease in fibrinogen and PAC-1 binding, and (b) transfection of MEG01 with Ero1 alpha increases alpha(IIb)beta(3) receptor activity, as indicated by increased binding of fibrinogen.	[Swiatkowska, Maria; Padula, Gianluca; Michalec, Lidia; Stasiak, Marta; Skurzynski, Szymon; Cierniewski, Czeslaw S.] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Cierniewski, Czeslaw S.] Polish Acad Sci, Inst Med Biol, PL-92232 Lodz, Poland	Medical University Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	czeslaw.cierniewski@umed.lodz.pl		Stasiak, Marta/0000-0003-0969-1162	Polish Ministry of Scientific Research and Higher Education [N301 012 31/0230, 343/N-INCA/2008/0]	Polish Ministry of Scientific Research and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Projects N301 012 31/0230 and 343/N-INCA/2008/0 from Polish Ministry of Scientific Research and Higher Education.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Burgess JK, 2000, J BIOL CHEM, V275, P9758, DOI 10.1074/jbc.275.13.9758; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; CIERNIEWSKI CS, 1982, THROMB HAEMOSTASIS, V48, P33; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; Essex DW, 2001, BIOCHEMISTRY-US, V40, P6070, DOI 10.1021/bi002454e; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Holbrook LM, 2010, BRIT J HAEMATOL, V148, P627, DOI 10.1111/j.1365-2141.2009.07994.x; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; Jordan PA, 2005, BLOOD, V105, P1500, DOI 10.1182/blood-2004-02-0608; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Mor-Cohen R, 2008, J BIOL CHEM, V283, P19235, DOI 10.1074/jbc.M802399200; Mou YL, 1998, J IMMUNOL, V161, P6323; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Walkowiak B, 2000, THROMB RES, V99, P495, DOI 10.1016/S0049-3848(00)00282-6; Walsh GM, 2004, BIOCHEMISTRY-US, V43, P473, DOI 10.1021/bi0354536; Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200	36	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 24	2010	285	39					29874	29883		10.1074/jbc.M109.092486	http://dx.doi.org/10.1074/jbc.M109.092486			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	652EK	20562109	Green Published, hybrid			2022-12-25	WOS:000281984300024
J	Li, FC; Nandini, CD; Hattori, T; Bao, XF; Murayama, D; Nakamura, T; Fukushima, N; Sugahara, K				Li, Fuchuan; Nandini, Chilkunda D.; Hattori, Tomohide; Bao, Xingfeng; Murayama, Daisuke; Nakamura, Toshikazu; Fukushima, Nobuhiro; Sugahara, Kazuyuki			Structure of Pleiotrophin- and Hepatocyte Growth Factor-binding Sulfated Hexasaccharide Determined by Biochemical and Computational Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC PIG BRAIN; CHONDROITIN SULFATE; HYBRID CHAINS; NEURITE OUTGROWTH; HEPARAN-SULFATE; NEURITOGENIC ACTIVITY; DERMATAN SULFATE; FACTOR/SCATTER FACTOR; HIPPOCAMPAL-NEURONS; SHARK CARTILAGE	Endogenous pleiotrophin and hepatocyte growth factor (HGF) mediate the neurite outgrowth-promoting activity of chondroitin sulfate (CS)/dermatan sulfate (DS) hybrid chains isolated from embryonic pig brain. CS/DS hybrid chains isolated from shark skin have a different disaccharide composition, but also display these activities. In this study, pleiotrophin-and HGF-binding domains in shark skin CS/DS were investigated. A high affinity CS/DS fraction was isolated using a pleiotrophin-immobilized column. It showed marked neurite outgrowth-promoting activity and strong inhibitory activity against the binding of pleiotrophin to immobilized CS/DS chains from embryonic pig brain. The inhibitory activity was abolished by chondroitinase ABC or B, and partially reduced by chondroitinase AC-I. A pentasulfated hexasaccharide with a novel structure was isolated from the chondroitinase AC-I digest using pleiotrophin affinity and anion exchange chromatographies. It displayed a potent inhibitory effect on the binding of HGF to immobilized shark skin CS/DS chains, suggesting that the pleiotrophin-and HGF-binding domains at least partially overlap in the CS/DS chains involved in the neuritogenic activity. Computational chemistry using molecular modeling and calculations of the electrostatic potential of the hexasaccharide and two pleiotrophin-binding octasaccharides previously isolated from CS/DS hybrid chains of embryonic pig brain identified an electronegative zone potentially involved in the molecular recognition of the oligosaccharides by pleiotrophin. Homology modeling of pleiotrophin based on a related midkine protein structure predicted the binding pocket of pleiotrophin for the oligosaccharides and provided new insights into the molecular mechanism of the interactions between the oligosaccharides and pleiotrophin.	[Sugahara, Kazuyuki] Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Fac Adv Life Sci, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Li, Fuchuan; Nandini, Chilkunda D.; Bao, Xingfeng; Sugahara, Kazuyuki] Kobe Pharmaceut Univ, Dept Biochem, Kobe, Hyogo 6588558, Japan; [Hattori, Tomohide; Murayama, Daisuke; Fukushima, Nobuhiro] Sci Technol Syst Inc, Tokyo 1130033, Japan; [Nakamura, Toshikazu] Osaka Univ, Kringle Pharma Joint Res Div, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan	Hokkaido University; Kobe Pharmaceutical University; Osaka University	Sugahara, K (corresponding author), Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Fac Adv Life Sci, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [17659020, 16390026, 18390030, 20390019, 14082207]; Human Frontier Science Program [RGP18/2005]; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Exploratory Research 17659020 (to K. S.), Scientific Research B 16390026, 18390030, and 20390019 (to K. S.), Scientific Research on Priority Areas 14082207 (to K. S.), the Future Drug Discovery and Medical Care Innovation Program (to K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), and the Human Frontier Science Program RGP18/2005 (to K. S.).; Supported in part by a postdoctoral fellowship from the Japan Society for the Promotion of Science.	Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Blanchard V, 2007, BIOCHEMISTRY-US, V46, P1167, DOI 10.1021/bi061971f; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CACERES A, 1986, J NEUROSCI, V6, P714; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Deakin JA, 1999, J CELL SCI, V112, P1999; Deakin JA, 2009, J BIOL CHEM, V284, P6311, DOI 10.1074/jbc.M807671200; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Delley B, 2006, MOL SIMULAT, V32, P117, DOI 10.1080/08927020600589684; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; Eswar N, 2006, CURRENT PROTOCOLS S, P561; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fath M, 1999, FEBS LETT, V454, P105, DOI 10.1016/S0014-5793(99)00785-1; FERNANDEZ DP, 1995, J PHYS CHEM REF DATA, V24, P33, DOI 10.1063/1.555977; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; HASCALL VC, 1977, J SUPRAMOL STR CELL, V7, P101, DOI 10.1002/jss.400070110; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Iwasaki W, 1997, EMBO J, V16, P6936, DOI 10.1093/emboj/16.23.6936; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kinnunen T, 1996, J BIOL CHEM, V271, P2243, DOI 10.1074/jbc.271.4.2243; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; MAIMONE MM, 1991, J BIOL CHEM, V266, P14830; Maina F, 1999, NAT NEUROSCI, V2, P213, DOI 10.1038/6310; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MATSUMOTO K, 1993, J BIOCHEM-TOKYO, V114, P820, DOI 10.1093/oxfordjournals.jbchem.a124262; Matsumoto K, 2008, PROTEOMICS, V8, P3360, DOI 10.1002/pmic.200800156; MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; POOLE AR, 1986, BIOCHEM J, V236, P1; Pothacharoen P, 2007, J BIOL CHEM, V282, P35232, DOI 10.1074/jbc.M702255200; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Raulo E, 2005, J BIOL CHEM, V280, P41576, DOI 10.1074/jbc.M506457200; RODEN L, 1980, BIOCH GLYCOPROTEINS, P491; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; SAITO H, 1968, J BIOL CHEM, V243, P1536; Sakiyama R, 2007, J BIOCHEM, V141, P653, DOI 10.1093/jb/mvm067; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; SUGAHARA K, 1995, J BIOL CHEM, V270, P7204, DOI 10.1074/jbc.270.13.7204; SUGAHARA K, 1989, BIOCHEM BIOPH RES CO, V162, P189, DOI 10.1016/0006-291X(89)91980-3; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523	69	27	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27673	27685		10.1074/jbc.M110.118703	http://dx.doi.org/10.1074/jbc.M110.118703			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20584902	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000281404100023
J	Tseng, CN; Zhang, LL; Wu, SL; Wang, WF; Wang, ZZ; Cascio, M				Tseng, Chao-Neng; Zhang, Lili; Wu, Shey-Lin; Wang, Wen-Fu; Wang, Zuo-Zhong; Cascio, Michael			Asparagine of z8 Insert Is Critical for the Affinity, Conformation, and Acetylcholine Receptor-clustering Activity of Neural Agrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; NEUROMUSCULAR-JUNCTION; CULTURED MYOTUBES; MUSCLE-CELLS; LIPID RAFTS; BINDING; PROTEIN; DYSTROGLYCAN; AGGREGATION; RNA	Agrin isoforms with different bioactivities are synthesized by the nerve and the muscle. Neural agrin containing an 8-amino acid insert (z8) introduced by alternative splicing is the active form that induces synaptic differentiation at the neuromuscular junction. In addition to alternative splicing, extracellular calcium is also required for the activity of neural agrin. To understand better how the activity of agrin is regulated by alternative splicing, we have applied alanine substitution mutagenesis to the z8 insert and the calcium binding site in the minimally functional AgG3z8 fragment. Single alanine substitutions in the 4th through the 7th amino acid of the z8 splice insert significantly reduced the function of agrin, in terms of acetylcholine receptor clustering activity and the affinity for binding to the muscle surface. Mutation of the asparagine at the 4th position drastically reduces bioactivity such that it is equivalent to that of muscle form AgG3z0. These reduced activity mutants also show reduced magnitudes of the calcium-induced CD spectrum change from that observed in AgG3z8 fragments, indicating that cross-talk between calcium and the z8 insert is critical for the normal activity of agrin. However, removal of Ca2+ binding via mutation of both aspartic acids in the calcium binding site did not totally eliminate the activity of AgG3z8. These results suggest a model wherein the z8 insert is a Ca2+-responsive allosteric element that is essential in forming an active conformation in neuronal agrin.	[Cascio, Michael] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA; [Tseng, Chao-Neng] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan; [Tseng, Chao-Neng] Kaohsiung Med Univ, Dept Pharm, Kaohsiung 807, Taiwan; [Tseng, Chao-Neng; Zhang, Lili; Wang, Zuo-Zhong] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; [Cascio, Michael] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Wu, Shey-Lin; Wang, Wen-Fu] Changhua Christian Hosp, Dept Neurol, Changhua 500, Taiwan	Duquesne University; Kaohsiung Medical University; Kaohsiung Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Changhua Christian Hospital	Cascio, M (corresponding author), Duquesne Univ, Dept Chem & Biochem, 600 Forbes Ave, Pittsburgh, PA 15282 USA.	casciom@duq.edu	Tseng, Chao-Neng/A-3798-2014	Tseng, Chao-Neng/0000-0001-9972-7987	National Institutes of Health [NS38301]; Muscular Dystrophy Association; National Science Council in Taiwan [NSC 95-2314-B-037-108, NSC96-2320-B037-033-MY2]; Kaohsiung Medical University [Q095006, Q097007]; National Institutes of Health/National Center for Research Resources [1S10RR11998]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University; National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS38301 and the Muscular Dystrophy Association (to Z.-Z. W.), National Science Council in Taiwan Grants NSC 95-2314-B-037-108 and NSC96-2320-B037-033-MY2, and Kaohsiung Medical University Faculty Development Grants Q095006 and Q097007 (to C.-N. T.). The CD studies were supported by National Institutes of Health/National Center for Research Resources Shared Instrumentation Grant 1S10RR11998 (to M. C.).	Alexandrescu AT, 2001, J BIOMOL NMR, V20, P295, DOI 10.1023/A:1011256008944; Bhalla J, 2006, MOL CELL PROTEOMICS, V5, P1212, DOI 10.1074/mcp.M500315-MCP200; BLOCH RJ, 1983, J NEUROSCI, V3, P2670; Borges LS, 2002, J NEUROBIOL, V50, P69, DOI 10.1002/neu.10020; Bowen DC, 1996, J NEUROSCI, V16, P3791; Burgess RW, 2002, J NEUROCHEM, V83, P271, DOI 10.1046/j.1471-4159.2002.01102.x; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Deyst KA, 1998, DEV BRAIN RES, V110, P185, DOI 10.1016/S0165-3806(98)00105-9; Dobbins GC, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-18; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gautam M, 1999, DEV BRAIN RES, V114, P171, DOI 10.1016/S0165-3806(99)00013-9; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Gingras J, 2005, CELL TISSUE RES, V320, P115, DOI 10.1007/s00441-004-1045-9; Gingras J, 2007, DEV NEUROBIOL, V67, P521, DOI 10.1002/dneu.20304; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; HUNTER WM, 1964, BIOCHEM J, V91, P43, DOI 10.1042/bj0910043; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Koirala S, 2003, J NEUROCYTOL, V32, P987, DOI 10.1023/B:NEUR.0000020637.71452.3c; Nguyen QT, 2000, J NEUROSCI, V20, P6077, DOI 10.1523/JNEUROSCI.20-16-06077.2000; NITKIN RM, 1990, J CELL BIOL, V111, P1161, DOI 10.1083/jcb.111.3.1161; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; Pato C, 2008, CHEM-BIOL INTERACT, V175, P64, DOI 10.1016/j.cbi.2008.03.020; Ramseger R, 2009, J BIOL CHEM, V284, P7697, DOI 10.1074/jbc.M806719200; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200; SHADIACK AM, 1991, J NEUROBIOL, V22, P617, DOI 10.1002/neu.480220607; Sidhu SS, 2007, CURR OPIN CHEM BIOL, V11, P347, DOI 10.1016/j.cbpa.2007.05.001; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2001, ANAL BIOCHEM, V299, P271, DOI 10.1006/abio.2001.5420; Stetefeld J, 2004, STRUCTURE, V12, P503, DOI 10.1016/j.str.2004.02.001; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; THOMAS WS, 1993, DEV BIOL, V158, P523, DOI 10.1006/dbio.1993.1210; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Tseng CN, 2003, J BIOL CHEM, V278, P17236, DOI 10.1074/jbc.M300282200; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	48	2	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27641	27651		10.1074/jbc.M110.130625	http://dx.doi.org/10.1074/jbc.M110.130625			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20566625	Green Published, hybrid			2022-12-25	WOS:000281404100020
J	Takenaka, M; Verbitskiy, D; Zehrmann, A; Brennicke, A				Takenaka, Mizuki; Verbitskiy, Daniil; Zehrmann, Anja; Brennicke, Axel			Reverse Genetic Screening Identifies Five E-class PPR Proteins Involved in RNA Editing in Mitochondria of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CHLOROPLAST TRANSCRIPTS; DYW PROTEIN; PLANT-MITOCHONDRIA; SITES; RECOGNITION; SEQUENCE; ELEMENTS; REVEALS; GENOME	RNA editing in flowering plant mitochondria post-transcriptionally alters several hundred nucleotides from C to U, mostly in mRNAs. Several factors required for specific RNA-editing events in plant mitochondria and plastids have been identified, all of them PPR proteins of the PLS subclass with a C-terminal E-domain and about half also with an additional DYW domain. Based on this information, we here probe the connection between E-PPR proteins and RNA editing in plant mitochondria. We initiated a reverse genetics screen of T-DNA insertion lines in Arabidopsis thaliana and investigated 58 of the 150 E-PPR-coding genes for a function in RNA editing. Six genes were identified to be involved in mitochondrial RNA editing at specific sites. Homozygous mutants of the five genes MEF18-MEF22 display no gross disturbance in their growth or development patterns, suggesting that the editing sites affected are not crucial at least in the greenhouse. These results show that a considerable percentage of the E-PPR proteins are involved in the functional processing of site-specific RNA editing in plant mitochondria.	[Takenaka, Mizuki; Verbitskiy, Daniil; Zehrmann, Anja; Brennicke, Axel] Univ Ulm, D-89069 Ulm, Germany	Ulm University	Takenaka, M (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/B-2636-2013; Takenaka, Mizuki/AAK-9884-2020	Takenaka, Mizuki/0000-0002-3242-5092; Takenaka, Mizuki/0000-0002-3242-5092	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to M. T. and A. B.).	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Bock R, 1996, EMBO J, V15, P5052, DOI 10.1002/j.1460-2075.1996.tb00885.x; Bock R, 1997, EMBO J, V16, P3282, DOI 10.1093/emboj/16.11.3282; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; Chateigner-Boutin AL, 2002, MOL CELL BIOL, V22, P8448, DOI 10.1128/MCB.22.24.8448-8456.2002; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chaudhuri S, 1996, EMBO J, V15, P5958, DOI 10.1002/j.1460-2075.1996.tb00982.x; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Hegeman CE, 2005, PLANT J, V42, P124, DOI 10.1111/j.1365-313X.2005.02360.x; Kempken F, 2009, ENDOCYT CELL RES, V19, P1; Kim SR, 2009, PLANT J, V59, P738, DOI 10.1111/j.1365-313X.2009.03909.x; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Nakamura T, 2008, FEBS LETT, V582, P4163, DOI 10.1016/j.febslet.2008.11.017; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2008, MOL BIOL EVOL, V25, P1405, DOI 10.1093/molbev/msn084; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Sasaki T, 2006, PLANT J, V47, P802, DOI 10.1111/j.1365-313X.2006.02825.x; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn975; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tang JW, 2010, PLANT J, V61, P456, DOI 10.1111/j.1365-313X.2009.04082.x; Tillich M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-201; van der Merwe JA, 2006, FEBS LETT, V580, P268, DOI 10.1016/j.febslet.2005.12.011; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Williams-Carrier R, 2008, RNA, V14, P1930, DOI 10.1261/rna.1077708; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	52	69	76	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27122	27129		10.1074/jbc.M110.128611	http://dx.doi.org/10.1074/jbc.M110.128611			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566637	Green Published, hybrid			2022-12-25	WOS:000281172700043
J	Yang, W; Bell, SG; Wang, H; Zhou, WH; Hoskins, N; Dale, A; Bartlam, M; Wong, LL; Rao, ZH				Yang, Wen; Bell, Stephen G.; Wang, Hui; Zhou, Weihong; Hoskins, Nicola; Dale, Alison; Bartlam, Mark; Wong, Luet-Lok; Rao, Zihe			Molecular Characterization of a Class I P450 Electron Transfer System from Novosphingobium aromaticivorans DSM12444	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BACTERIAL CYTOCHROMES P450; NADH-DEPENDENT FERREDOXIN; CRYSTAL-STRUCTURE; PUTIDAREDOXIN REDUCTASE; RHODOPSEUDOMONAS-PALUSTRIS; TRANSFER COMPLEX; REDOX PARTNER; THERMOSTABLE CYP175A1; BOVINE ADRENODOXIN	Cytochrome P450 (CYP) enzymes of the CYP101 and CYP111 families from the oligotrophic bacterium Novosphingobium aromaticivorans DSM12444 are heme monooxygenases that receive electrons from NADH via Arx, a [2Fe-2S] ferredoxin, and ArR, a ferredoxin reductase. These systems show fast NADH turnovers (k(cat) = 39-91 s(-1)) that are efficiently coupled to product formation. The three-dimensional structures of ArR, Arx, and CYP101D1, which form a physiological class I P450 electron transfer chain, have been resolved by x-ray crystallography. The general structural features of these proteins are similar to their counterparts in other class I systems such as putidaredoxin reductase (PdR), putidaredoxin (Pdx), and CYP101A1 of the camphor hydroxylase system from Pseudomonas putida, and adrenodoxin (Adx) of the mitochondrial steroidogenic CYP11 and CYP24A1 systems. However, significant differences in the proposed protein-protein interaction surfaces of the ferredoxin reductase, ferredoxin, and P450 enzyme are found. There are regions of positive charge on the likely interaction face of ArR and CYP101D1 and a corresponding negatively charged area on the surface of Arx. The [2Fe-2S] cluster binding loop in Arx also has a neutral, hydrophobic patch on the surface. These surface characteristics are more in common with those of Adx than Pdx. The observed structural features are consistent with the ionic strength dependence of the activity.	[Bell, Stephen G.; Hoskins, Nicola; Dale, Alison; Wong, Luet-Lok] Univ Oxford, Inorgan Chem Lab, Dept Chem, Oxford OX1 3QR, England; [Yang, Wen; Zhou, Weihong; Bartlam, Mark; Rao, Zihe] Nankai Univ, Tianjin Key Lab Prot Sci, Coll Life Sci, Tianjin 300071, Peoples R China; [Wang, Hui; Bartlam, Mark; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China	University of Oxford; Nankai University; Tsinghua University	Bell, SG (corresponding author), Univ Oxford, Inorgan Chem Lab, Dept Chem, S Parks Rd, Oxford OX1 3QR, England.	stephen.bell@chem.ox.ac.uk; bartlam@nankai.edu.cn	WANG, HUI/AAL-7764-2020; YANG, WEN/A-1993-2014; Bell, Stephen/E-8222-2011; Rao, Zihe/HCH-6944-2022	Bell, Stephen/0000-0002-7457-9727; Bartlam, Mark/0000-0001-5173-5080; Wang, Hui/0000-0002-5745-2599	Ministry of Science and Technology of China [2007CB914301]; Tianjin Municipal Science and Technology Commission [08SYSYTC00200]; Higher Education Funding Council for England, UK	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Tianjin Municipal Science and Technology Commission; Higher Education Funding Council for England, UK(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	The work was supported by Grant 2007CB914301 from the Ministry of Science and Technology of China Project 973 (to M. B.), Tianjin Municipal Science and Technology Commission Grant 08SYSYTC00200, and a grant from the Higher Education Funding Council for England, UK (to L.-L. W.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agematu H, 2006, BIOSCI BIOTECH BIOCH, V70, P307, DOI 10.1271/bbb.70.307; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Bell SG, 2008, J MOL BIOL, V383, P561, DOI 10.1016/j.jmb.2008.08.033; Bell SG, 2007, BIOCHEM BIOPH RES CO, V360, P666, DOI 10.1016/j.bbrc.2007.06.119; Bell SG, 2010, J BIOL INORG CHEM, V15, P315, DOI 10.1007/s00775-009-0604-7; Bell SG, 2010, APPL MICROBIOL BIOT, V86, P163, DOI 10.1007/s00253-009-2234-y; Bell SG, 2010, MOL BIOSYST, V6, P206, DOI 10.1039/b913487e; Brazeau BJ, 2003, BIOCHEM BIOPH RES CO, V312, P143, DOI 10.1016/j.bbrc.2003.09.242; Churbanova IY, 2010, BIOCHEMISTRY-US, V49, P58, DOI 10.1021/bi901872s; Crowley PB, 2004, PROTEINS, V55, P603, DOI 10.1002/prot.20043; Cryle MJ, 2003, AUST J CHEM, V56, P749, DOI 10.1071/CH03040; Denisov IG, 2009, PHARMACOL THERAPEUT, V124, P151, DOI 10.1016/j.pharmthera.2009.05.011; DEPREZ E, 1994, FEBS LETT, V347, P207, DOI 10.1016/0014-5793(94)00545-1; DEPREZ E, 1994, BIOCHEMISTRY-US, V33, P14464, DOI 10.1021/bi00252a012; Deprez E, 2002, J INORG BIOCHEM, V91, P597, DOI 10.1016/S0162-0134(02)00467-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grinberg AV, 2000, PROTEINS, V40, P590, DOI 10.1002/1097-0134(20000901)40:4<590::AID-PROT50>3.0.CO;2-P; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2001, CURR DRUG METAB, V2, P93, DOI 10.2174/1389200013338694; HAMAMOTO I, 1993, J STEROID BIOCHEM, V46, P33, DOI 10.1016/0960-0760(93)90206-C; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hanukoglu I., 1996, ADV MOL CEL, V14, P29; Holden M, 1997, J BIOL CHEM, V272, P21720, DOI 10.1074/jbc.272.35.21720; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Kakuta Y, 2001, BIOCHEMISTRY-US, V40, P11007, DOI 10.1021/bi010544t; Karyakin A, 2007, BBA-GEN SUBJECTS, V1770, P420, DOI 10.1016/j.bbagen.2006.08.020; Kimmich N, 2007, J BIOL CHEM, V282, P27006, DOI 10.1074/jbc.M703790200; Koo LS, 2002, J AM CHEM SOC, V124, P5684, DOI 10.1021/ja017174g; Kuznetsov VY, 2006, BIOCHEMISTRY-US, V45, P11934, DOI 10.1021/bi0611154; Kuznetsov VY, 2005, J BIOL CHEM, V280, P16135, DOI 10.1074/jbc.M500771200; LAMBETH JD, 1979, J BIOL CHEM, V254, P7255; LAMBETH JD, 1985, J BIOL CHEM, V260, P8810; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovett JE, 2009, PHYS CHEM CHEM PHYS, V11, P6840, DOI 10.1039/b907010a; Mandai T, 2009, FEBS J, V276, P2416, DOI 10.1111/j.1742-4658.2009.06974.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mo HP, 1999, BIOCHEMISTRY-US, V38, P5666, DOI 10.1021/bi983063r; Momoi K, 2006, BIOCHEM BIOPH RES CO, V339, P331, DOI 10.1016/j.bbrc.2005.11.023; Muller A, 1998, STRUCTURE, V6, P269, DOI 10.1016/S0969-2126(98)00031-8; Muller JJ, 2001, J BIOL CHEM, V276, P2786, DOI 10.1074/jbc.M008501200; Munro AW, 2007, BBA-GEN SUBJECTS, V1770, P345, DOI 10.1016/j.bbagen.2006.08.018; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nodate M, 2006, APPL MICROBIOL BIOT, V71, P455, DOI 10.1007/s00253-005-0147-y; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pochapsky SS, 2003, BIOCHEMISTRY-US, V42, P5649, DOI 10.1021/bi034263s; Pochapsky SS, 2009, BIOCHEMISTRY-US, V48, P4254, DOI 10.1021/bi900002k; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; PROJECT TC, 1994, ACTA CRYSTALLOGR D, V50, P760; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; Roitberg AE, 1998, J AM CHEM SOC, V120, P8927, DOI 10.1021/ja9739906; Romine MF, 1999, J BACTERIOL, V181, P1585, DOI 10.1128/JB.181.5.1585-1602.1999; Romine MF, 1999, J IND MICROBIOL BIOT, V23, P303, DOI 10.1038/sj.jim.2900750; ROOME PW, 1988, ARCH BIOCHEM BIOPHYS, V266, P32, DOI 10.1016/0003-9861(88)90233-0; Sainz G, 2006, J BIOL INORG CHEM, V11, P235, DOI 10.1007/s00775-005-0069-2; Sambrook J., 2002, MOL CLONING LAB MANU; Schiffler B, 2003, BIOCHEM BIOPH RES CO, V312, P223, DOI 10.1016/j.bbrc.2003.09.214; Schiffler B, 2001, J BIOL CHEM, V276, P36225, DOI 10.1074/jbc.M102320200; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Senda M, 2007, J MOL BIOL, V373, P382, DOI 10.1016/j.jmb.2007.08.002; Senda T, 2000, J MOL BIOL, V304, P397, DOI 10.1006/jmbi.2000.4200; Sevrioukova IF, 2004, J MOL BIOL, V336, P889, DOI 10.1016/j.jmb.2003.12.067; Sevrioukova IF, 2003, J MOL BIOL, V333, P377, DOI 10.1016/j.jmb.2003.08.028; Sevrioukova IF, 2001, BIOCHEMISTRY-US, V40, P10592, DOI 10.1021/bi010874d; Sevrioukova IF, 2010, J BIOL CHEM, V285, P13616, DOI 10.1074/jbc.M110.104968; Sigel A., 2007, UBIQUITOUS ROLES CYT; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Usanov SA, 2002, BIOCHEMISTRY-US, V41, P8310, DOI 10.1021/bi0255928; WADA A, 1992, J BIOL CHEM, V267, P22877; Westlake ACG, 1999, EUR J BIOCHEM, V265, P929, DOI 10.1046/j.1432-1327.1999.00793.x; Williams J W, 1979, Methods Enzymol, V63, P437; Xu F, 2009, PROTEINS, V77, P867, DOI 10.1002/prot.22510; Zhang W, 2008, J MOL BIOL, V384, P349, DOI 10.1016/j.jmb.2008.09.037	75	66	66	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27372	27384		10.1074/jbc.M110.118349	http://dx.doi.org/10.1074/jbc.M110.118349			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576606	Green Published, hybrid			2022-12-25	WOS:000281172700066
J	Solomon, IH; Huettner, JE; Harris, DA				Solomon, Isaac H.; Huettner, James E.; Harris, David A.			Neurotoxic Mutants of the Prion Protein Induce Spontaneous Ionic Currents in Cultured Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA OLIGOMERS; TRANSMEMBRANE FORM; IN-VIVO; SCRAPIE; DISEASE; PRP; FRAGMENT; TOXICITY; CHANNELS; PERMEABILIZATION	The mechanisms by which prions kill neurons and the role of the cellular prion protein in this process are enigmatic. Insight into these questions is provided by the neurodegenerative phenotypes of transgenic mice expressing prion protein (PrP) molecules with deletions of conserved amino acids in the central region. We report here that expression in transfected cells of the most toxic of these PrP deletion mutants (Delta 105-125) induces large, spontaneous ionic currents that can be detected by patch-clamping techniques. These currents are produced by relatively non-selective, cation-permeable channels or pores in the cell membrane and can be silenced by overexpression of wild-type PrP, as well as by treatment with a sulfated glycosaminoglycan. Similar currents are induced by PrP molecules carrying several different point mutations in the central region that cause familial prion diseases in humans. The ionic currents described here are distinct from those produced in artificial lipid membranes by synthetic peptides derived from the PrP sequence because they are induced by membrane-anchored forms of PrP that are synthesized by cells and that are found in vivo. Our results indicate that the neurotoxicity of some mutant forms of PrP is attributable to enhanced ion channel activity and that wild-type PrP possesses a channel-silencing activity. Drugs that block PrP-associated channels or pores may therefore represent novel therapeutic agents for treatment of patients with prion diseases.	[Solomon, Isaac H.; Huettner, James E.; Harris, David A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Harris, DA (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,K225, Boston, MA 02118 USA.	daharris@bu.edu	Huettner, James E/C-5219-2012	Harris, David/0000-0002-6985-5790	National Institutes of Health [NS052526, NS040975, NS30888, NS063547, T32GM007200, P30 NS057105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052526, R01NS030888, P30NS057105, R01NS040975, R01NS065244, F30NS063547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS052526 and NS040975 (to D. A. H.) and NS30888 (to J. E. H.) and by National Institutes of Health Predoctoral Fellowship NS063547 and the Medical Scientist Training Program at Washington University (National Institutes of Health Grant T32GM007200) (to I. H. S.).; We thank Tim Wilding, Joe Amatrudo, and Jennifer Leubke for advice and technical assistance with patch clamping. We also acknowledge Aimin Li for help with Sf9 cells, Till Voigtlaender and Nada Husic for assistance with lentiviral preparation, and Tania Massignan for generation of several of the HEK cell lines. Lentiviral constructs were created by the Hope Center Viral Vectors Core at Washington University, which is supported by a Neuroscience Blueprint Core grant (Grant P30 NS057105) from the National Institutes of Health.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chich JF, 2010, J MOL BIOL, V397, P1017, DOI 10.1016/j.jmb.2010.02.013; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Christensen HM, 2010, AM J PATHOL, V176, P2695, DOI 10.2353/ajpath.2010.091007; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Fuhrmann M, 2006, J NEUROCHEM, V98, P1876, DOI 10.1111/j.1471-4159.2006.04011.x; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Herms JW, 2001, NEUROBIOL DIS, V8, P324, DOI 10.1006/nbdi.2000.0369; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kourie JI, 2000, AM J PHYSIOL-CELL PH, V278, pC1063, DOI 10.1152/ajpcell.2000.278.6.C1063; Kourie JI, 2000, J NEUROSCI RES, V62, P120, DOI 10.1002/1097-4547(20001001)62:1<120::AID-JNR13>3.0.CO;2-2; Larsen EH, 1996, J GEN PHYSIOL, V107, P695, DOI 10.1085/jgp.107.6.695; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lester HA, 2000, ANNU REV NEUROSCI, V23, P89, DOI 10.1146/annurev.neuro.23.1.89; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Li MJ, 2005, METH MOL B, V309, P261; Lin MX, 1997, J BIOL CHEM, V272, P44; Maglio LE, 2004, MOL BRAIN RES, V131, P58, DOI 10.1016/j.molbrainres.2004.08.004; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005; Palasz A, 2000, ACTA BIOCHIM POL, V47, P1107; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2004, PRION BIOL DIS; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Roucou X, 2004, J NEUROSCI RES, V75, P153, DOI 10.1002/jnr.10864; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Thornton G, 2005, GENES CELLS, V10, P941, DOI 10.1111/j.1365-2443.2005.00891.x; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Wilding TJ, 2005, J NEUROSCI, V25, P9470, DOI 10.1523/JNEUROSCI.2826-05.2005; Wolkowicz Roland, 2004, Methods Mol Biol, V246, P391; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	56	54	54	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26719	26726		10.1074/jbc.M110.134619	http://dx.doi.org/10.1074/jbc.M110.134619			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20573963	hybrid, Green Published			2022-12-25	WOS:000280921000086
J	Vendrov, AE; Madamanchi, NR; Niu, XL; Molnar, KC; Runge, M; Szyndralewiez, C; Page, P; Runge, MS				Vendrov, Aleksandr E.; Madamanchi, Nageswara R.; Niu, Xi-Lin; Molnar, Kimberly C.; Runge, Mason; Szyndralewiez, Cedric; Page, Patrick; Runge, Marschall S.			NADPH Oxidases Regulate CD44 and Hyaluronic Acid Expression in Thrombin-treated Vascular Smooth Muscle Cells and in Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; OXIDATIVE STRESS; TYROSINE KINASE; SOLUBLE CD44; TNF-ALPHA; MACROPHAGES; ACTIVATION	The intracellular signaling events by which NADPH oxidase-generated reactive oxygen species (ROS) modulate vascular smooth muscle cell (VSMC) function and atherogenesis are yet to be entirely elucidated. We previously demonstrated that NADPH oxidase deficiency decreased atherosclerosis in apoE(-/-) mice and identified adhesion protein CD44 as an important ROS-sensitive gene expressed in VSMC and atherosclerotic lesions. Here, we examined the molecular mechanisms by which NADPH oxidase-generated ROS regulate the expression of CD44 and its principal ligand, hyaluronan (HA), and how CD44-HA interaction affects VSMC proliferation and migration and inflammatory gene expression in apoE(-/-) mice aortas. Thrombin-induced CD44 expression is mediated by transcription factor AP-1 in a NADPH oxidase-dependent manner. NADPH oxidase-mediated ROS generation enhanced thrombin-induced HA synthesis, and hyaluronan synthase 2 expression in VSMC. Hyaluronidase, which generates low molecular weight HA (LMW-HA), is induced in VSMC in a NADPH oxidase-dependent manner and LMW-HA stimulated ROS generation and cell proliferation in wild-type but not p47(phox-/-) VSMC, effects that were enhanced by thrombin pretreatment. Haptotactic VSMC migration toward HA was increased by thrombin in a CD44dependent manner. HA expression in atherosclerotic lesions and plasma-soluble CD44 and HA levels were higher in apoE(-/-) compared with apoE(-/-)/p47(phox-/-) mice. HA-regulated pro-inflammatory gene expression was higher in apoE(-/-) than apoE(-/-)/p47(phox-/-) mouse aortas. GKT136901, a specific inhibitor of Nox1- and Nox4-containing NADPH oxidase activity, attenuated ROS generation and atherosclerosis and decreased CD44 and HA expression in atherosclerotic lesions. Together, these data suggest that increased CD44 and HA expression and CD44-HA-dependent gene regulation may play a role in atherosclerosis stimulated by NADPH oxidase activation.	[Vendrov, Aleksandr E.; Madamanchi, Nageswara R.; Niu, Xi-Lin; Molnar, Kimberly C.; Runge, Mason; Runge, Marschall S.] Univ N Carolina, McAllister Heart Inst, Dept Med, Chapel Hill, NC 27599 USA; [Szyndralewiez, Cedric; Page, Patrick] GenKyoTex SA, CH-1228 Geneva, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; Genkyotex	Runge, MS (corresponding author), Univ N Carolina, McAllister Heart Inst, Dept Med, 125 MacNider Hall, Chapel Hill, NC 27599 USA.	mrunge@med.unc.edu	Vendrov, Aleksandr/A-4115-2010; Vendrov, Aleksandr E./AHE-8649-2022; Vendrov, Aleksandr E./ABF-1266-2021	Vendrov, Aleksandr/0000-0003-4971-8040; Vendrov, Aleksandr E./0000-0003-4971-8040; Madamanchi, Nageswara/0000-0003-0590-0908; Vendrov, Kimberly/0000-0002-9131-5272	National Institutes of Health [HL-57352, AG 024282]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-57352 and AG 024282.	Ali ZA, 2008, CIRCULATION, V118, pS71, DOI 10.1161/CIRCULATIONAHA.107.753558; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927; Basoni C, 2006, BIOCHEM BIOPH RES CO, V343, P609, DOI 10.1016/j.bbrc.2006.03.003; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bennet AM, 2006, ATHEROSCLEROSIS, V187, P408, DOI 10.1016/j.atherosclerosis.2005.09.022; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Cichy J, 2005, BBA-MOL CELL RES, V1745, P59, DOI 10.1016/j.bbamcr.2005.02.006; Colao A, 2005, J ENDOCRINOL INVEST, V28, P440, DOI 10.1007/BF03347225; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Fischer JW, 2007, THROMB HAEMOSTASIS, V98, P287, DOI 10.1160/TH07-02-0155; Flannery CR, 1998, BIOCHEM BIOPH RES CO, V251, P824, DOI 10.1006/bbrc.1998.9561; Foster LC, 2000, FASEB J, V14, P368, DOI 10.1096/fasebj.14.2.368; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Hagg D, 2007, ATHEROSCLEROSIS, V190, P291, DOI 10.1016/j.atherosclerosis.2006.03.020; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hemming R, 2008, GLYCOBIOLOGY, V18, P280, DOI 10.1093/glycob/cwn006; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Inoue N, 2001, ATHEROSCLEROSIS, V155, P45, DOI 10.1016/S0021-9150(00)00530-X; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Kawachi S, 2005, ARTERIOSCL THROM VAS, V25, P617, DOI 10.1161/01.ATV.0000154486.03017.35; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Krettek A, 2004, AM J PATHOL, V165, P1571, DOI 10.1016/S0002-9440(10)63414-1; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Madamanchi NR, 2001, J BIOL CHEM, V276, P18915, DOI 10.1074/jbc.M008802200; Mayer S, 2008, J CANCER RES CLIN, V134, P1229, DOI 10.1007/s00432-008-0397-z; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; MCNEIL JD, 1985, ANN RHEUM DIS, V44, P780, DOI 10.1136/ard.44.11.780; Mine S, 2006, ENDOCR J, V53, P761, DOI 10.1507/endocrj.K05-119; Mishra JP, 2005, J BIOL CHEM, V280, P26825, DOI 10.1074/jbc.M500244200; Miyazaki T, 2001, POLYM DEGRAD STABIL, V74, P77, DOI 10.1016/S0141-3910(01)00104-5; Moon SK, 2001, AM J PHYSIOL-HEART C, V280, pH2779, DOI 10.1152/ajpheart.2001.280.6.H2779; Namiki M, 2002, ARTERIOSCL THROM VAS, V22, P115, DOI 10.1161/hq0102.102278; Nieuwdorp M, 2007, DIABETOLOGIA, V50, P1288, DOI 10.1007/s00125-007-0666-4; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; PAGE P, 2008, Patent No. 2008113856; Peng XQ, 2003, HYPERTENSION, V41, P378, DOI 10.1161/01.HYP.0000049624.99844.3D; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PHILIPSON LH, 1985, BIOCHEMISTRY-US, V24, P7899, DOI 10.1021/bi00348a008; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Sjoberg S, 2005, METABOLISM, V54, P139, DOI 10.1016/j.metabol.2004.09.001; SRINIVASAN SR, 1980, ATHEROSCLEROSIS, V36, P25, DOI 10.1016/0021-9150(80)90195-1; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stuhlmeier KM, 2005, J IMMUNOL, V174, P7376, DOI 10.4049/jimmunol.174.11.7376; Tchivilev I, 2008, J BIOL CHEM, V283, P22193, DOI 10.1074/jbc.M803452200; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tucci M, 2006, J HYPERTENS, V24, P1307, DOI 10.1097/01.hjh.0000234111.31239.c3; van den Boom M, 2006, CIRC RES, V98, P36, DOI 10.1161/01.RES.0000199263.67107.c0; Vendrov AE, 2006, CIRC RES, V98, P1254, DOI 10.1161/01.RES.0000221214.37803.79; WALTERS TK, 1994, J VASC RES, V31, P173, DOI 10.1159/000319584; Wei Y, 2007, HYPERTENSION, V50, P384, DOI 10.1161/HYPERTENSIONAHA.107.089284; Westmuckett AD, 2000, THROMB HAEMOSTASIS, V84, P904, DOI 10.1055/s-0037-1614135; Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P871, DOI 10.1161/01.ATV.0000259358.31234.37; Yoshinari C, 1999, MELANOMA RES, V9, P223, DOI 10.1097/00008390-199906000-00003; Zhao L, 2007, ARTERIOSCL THROM VAS, V27, P886, DOI 10.1161/01.ATV.0000259362.10882.c5	74	74	81	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26545	26557		10.1074/jbc.M110.143917	http://dx.doi.org/10.1074/jbc.M110.143917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20558727	Green Published, hybrid			2022-12-25	WOS:000280921000071
J	Liu, SJ; Li, ST; Du, YG				Liu, Sijin; Li, Shitao; Du, Yuguo			Polychlorinated Biphenyls (PCBs) Enhance Metastatic Properties of Breast Cancer Cells by Activating Rho-Associated Kinase (ROCK)	PLOS ONE			English	Article							REGULATED EIF2-ALPHA KINASE; ENDOCRINE DISRUPTORS; ESTROGEN-RECEPTOR; HUMAN HEALTH; RISK; EXPOSURE; INVASION; ORGANOCHLORINES; BONE; INVOLVEMENT	Background: Polychlorinated biphenyls (PCBs) are a family of structurally related chlorinated aromatic hydrocarbons. Numerous studies have documented a wide spectrum of biological effects of PCBs on human health, such as immunotoxicity, neurotoxocity, estrogenic or antiestrogenic activity, and carcinogensis. The role of PCBs as etiologic agents for breast cancer has been intensively explored in a variety of in vivo, animal and epidemiologic studies. A number of investigations indicated that higher levels of PCBs in mammary tissues or sera correlated to breast cancer risk, and PCBs might be implicated in advancing breast cancer progression. Methodology/Principal Findings: In the current study, we for the first time report that PCBs greatly promote the ROCK activity and therefore increase cell motility for both non-metastatic and metastatic human breast cancer cells in vitro. In the in vivo study, PCBs significantly advance disease progression, leading to enhanced capability of metastatic breast cancer cells to metastasize to bone, lung and liver. Additionally, PCBs robustly induce the production of intracellular reactive oxygen species (ROS) in breast cancer cells; ROS mechanistically elevate ROCK activity. Conclusions/Significance: PCBs enhance the metastatic propensity of breast cancer cells by activating the ROCK signaling, which is dependent on ROS induced by PCBs. Inhibition of ROCK may stand for a unique way to restrain metastases in breast cancer upon PCB exposure.	[Liu, Sijin; Du, Yuguo] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Chem & Ecotoxicol, Beijing, Peoples R China; [Li, Shitao] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Harvard University; Harvard Medical School	Liu, SJ (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Chem & Ecotoxicol, POB 934, Beijing, Peoples R China.	sjliu@rcees.ac.cn		Li, Shitao/0000-0002-1398-8519	Chinese Academy of Sciences; National Natural Science Foundation of China (NSFC)	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the "Hundreds Talents'' program of the Chinese Academy of Sciences (http://english.cas.cn/), and National Natural Science Foundation of China (NSFC) (http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SF, 1996, SCIENCE, V272, P1489, DOI 10.1126/science.272.5267.1489; Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Calle EE, 2002, CA-CANCER J CLIN, V52, P301, DOI 10.3322/canjclin.52.5.301; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Dada LA, 2007, J CELL SCI, V120, P2214, DOI 10.1242/jcs.003038; DeCaprio AP, 2005, ENVIRON RES, V98, P284, DOI 10.1016/j.envres.2004.09.004; Demers A, 2000, CANCER EPIDEM BIOMAR, V9, P161; FOSSI MC, 1995, ENVIRON POLLUT, V90, P15, DOI 10.1016/0269-7491(94)00098-X; Golden R, 2009, CRIT REV TOXICOL, V39, P299, DOI 10.1080/10408440802291521; Holford TR, 2000, INT J EPIDEMIOL, V29, P975, DOI 10.1093/ije/29.6.975; Humphrey HEB, 2000, ENVIRON HEALTH PERSP, V108, P167, DOI 10.2307/3454516; Imamura F, 2000, JPN J CANCER RES, V91, P811, DOI 10.1111/j.1349-7006.2000.tb01018.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KORACH KS, 1988, MOL PHARMACOL, V33, P120; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Lane J, 2008, INT J ONCOL, V33, P585, DOI 10.3892/ijo_00000044; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Liu SJ, 2008, BRIT J HAEMATOL, V143, P129, DOI 10.1111/j.1365-2141.2008.07293.x; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Millikan R, 2000, CANCER EPIDEM BIOMAR, V9, P1233; MURPHY LE, ENV HLTH PERSPECT, V118, P297; Negri E, 2003, EUR J CANCER PREV, V12, P509, DOI 10.1097/00008469-200312000-00010; Park JS, 2007, ENVIRON HEALTH PERSP, V115, P20, DOI 10.1289/ehp.8913; Potin S, 2007, FEBS LETT, V581, P118, DOI 10.1016/j.febslet.2006.12.016; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Safe S, 2004, TOXICOLOGY, V205, P3, DOI 10.1016/j.tox.2004.06.032; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P276, DOI 10.1080/10937400701875923; Shiraishi F, 2003, CHEMOSPHERE, V52, P33, DOI 10.1016/S0045-6535(03)00261-3; Snedeker SM, 2001, ENVIRON HEALTH PERSP, V109, P35, DOI [10.2307/3434845, 10.2307/3434918]; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Suva LJ, 2009, ENDOCR-RELAT CANCER, V16, P703, DOI 10.1677/ERC-09-0012; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Woolcott CG, 2001, CANCER CAUSE CONTROL, V12, P395, DOI 10.1023/A:1011289905751; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yamaguchi T, 2003, BIOL PHARM BULL, V26, P1706, DOI 10.1248/bpb.26.1706; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; ZHAO X, CHEMOSPHERE, V78, P659	40	53	57	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11272	10.1371/journal.pone.0011272	http://dx.doi.org/10.1371/journal.pone.0011272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585605	Green Submitted, gold, Green Published			2022-12-25	WOS:000279135400018
J	Jiang, H; Ren, F; Sun, JL; He, L; Li, WW; Xie, YN; Wang, Q				Jiang, Hui; Ren, Fei; Sun, Jiangling; He, Lin; Li, Weiwei; Xie, Yannan; Wang, Qun			Molecular Cloning and Gene Expression Analysis of the Leptin Receptor in the Chinese Mitten Crab Eriocheir sinensis	PLOS ONE			English	Article							TROPHOBLASTIC CELLS; JAPONICA-SINENSIS; BOVINE OOCYTES; HEPATOPANCREAS; PREGNANCY; REPRODUCTION; TRANSCRIPT; SALINITIES; SURVIVAL; STRESS	Background: Leptin is an adipocyte-derived hormone with multiple functions that regulates energy homeostasis and reproductive functions. Increased knowledge of leptin receptor function will enhance our understanding of the physiological roles of leptin in animals. Methodology/Principal Findings: In the present study, a full-length leptin receptor (lepr) cDNA, consisting of 1,353 nucleotides, was cloned from Chinese mitten crab (Eriocheir sinensis) using rapid amplification of cDNA ends (RACE) following the identification of a single expressed sequence tag (EST) clone in a cDNA library. The lepr cDNA consisted of a 22-nucleotide 5'-untranslated region (5' UTR), a 402-nucleotide open reading frame (ORF) and a 929-nucleotide 3' UTR. Multiple sequence alignments revealed that Chinese mitten crab lepr shared a conserved vacuolar protein sorting 55 (Vps55) domain with other species. Chinese mitten crab lepr expression was determined in various tissues and at three different reproductive stages using quantitative real-time RT-PCR. Lepr expression was highest in the intestine, thoracic ganglia, gonad, and accessory gonad, moderate in hepatopancreas and cranial ganglia, and low in muscle, gill, heart, haemocytes, and stomach. Furthermore, lepr expression was significantly higher in the intestine, gonad and thoracic ganglia in immature crabs relative to precocious and mature crabs. In contrast, lepr expression was significantly lower in the hepatopancreas of immature crabs relative to mature crabs. Conclusions/Significance: We are the first to identify the lepr gene and to determine its gene expression patterns in various tissues and at three different reproductive stages in Chinese mitten crab. Taken together, our results suggest that lepr may be involved in the nutritional regulation of metabolism and reproduction in Chinese mitten crabs.	[Jiang, Hui; Ren, Fei; Sun, Jiangling; He, Lin; Li, Weiwei; Xie, Yannan; Wang, Qun] E China Normal Univ, Dept Biol, Shanghai 200062, Peoples R China	East China Normal University	Wang, Q (corresponding author), E China Normal Univ, Dept Biol, Shanghai 200062, Peoples R China.	qun_300@hotmail.com	Wang, Qun/I-7778-2013; LI, WEIWEI/J-3538-2013	Wang, Qun/0000-0001-7929-7692; 	National Nature Science Foundation of China [30671607, 30972241]; Shanghai Science and Technology Project [09391911100]; ECNU [2010042]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Project; ECNU	This research was supported by grants from the National Nature Science Foundation of China (No. 30671607,30972241), Shanghai Science and Technology Project (Grant no. 09391911100), and PhD Program Scholarship Fund of ECNU (No. 2010042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assumpcao TCF, 2008, INSECT BIOCHEM MOLEC, V38, P213, DOI 10.1016/j.ibmb.2007.11.001; BABU B T, 1989, Folia Morphologica (Prague), V37, P388; CHENG SP, 2009, SURGERY; Churbanov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-261; Fang JJ, 2009, MOL BIOL REP, V36, P1521, DOI 10.1007/s11033-008-9346-9; HENAULT MA, 1995, BIOL REPROD, V52, P390, DOI 10.1095/biolreprod52.2.390; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Herborg LM, 2006, J EXP MAR BIOL ECOL, V329, P1, DOI 10.1016/j.jembe.2005.08.001; Huang Y, 2001, BBA-GENE STRUCT EXPR, V1517, P327, DOI 10.1016/S0167-4781(00)00266-9; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Jiang H, 2009, MAR BIOTECHNOL, V11, P317, DOI 10.1007/s10126-008-9146-1; Kalinina M V, 2008, Ontogenez, V39, P58; Kratzsch J, 2000, CURR OPIN OBSTET GYN, V12, P501, DOI 10.1097/00001703-200012000-00008; Kronfeld-Schor N, 2000, BIOL REPROD, V63, P274, DOI 10.1095/biolreprod63.1.274; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li EC, 2008, AQUACULTURE, V274, P80, DOI 10.1016/j.aquaculture.2007.11.001; Li XD, 2007, AQUACULTURE, V272, P361, DOI 10.1016/j.aquaculture.2007.08.029; Magarinos MP, 2007, BIOL REPROD, V76, P203, DOI 10.1095/biolreprod.106.051391; Mollineau WM, 2009, ANAT HISTOL EMBRYOL, V38, P204, DOI 10.1111/j.1439-0264.2008.00922.x; Morash BA, 2003, MOL CELL ENDOCRINOL, V210, P1, DOI 10.1016/j.mce.2003.09.003; Normant M, 2002, THERMOCHIM ACTA, V394, P233, DOI 10.1016/S0040-6031(02)00259-9; Paula-Lopes FF, 2007, BIOL REPROD, V76, P532, DOI 10.1095/biolreprod.106.054551; Paz GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003098; Perez-Perez A, 2008, ARCH BIOCHEM BIOPHYS, V477, P390, DOI 10.1016/j.abb.2008.06.015; Rudnick DA, 2003, BASIC APPL ECOL, V4, P249, DOI 10.1078/1439-1791-00152; Smith GD, 2002, THERIOGENOLOGY, V57, P73, DOI 10.1016/S0093-691X(01)00658-6; Sui L, 2007, AQUACULTURE, V273, P139, DOI 10.1016/j.aquaculture.2007.09.016; Torres G, 2007, COMP BIOCHEM PHYS A, V147, P460, DOI 10.1016/j.cbpa.2007.01.020; Wang HZ, 2006, AQUACULTURE, V255, P456, DOI 10.1016/j.aquaculture.2006.01.005; Wang YP, 1997, J BIOL CHEM, V272, P16216, DOI 10.1074/jbc.272.26.16216; Wen XB, 2002, COMP BIOCHEM PHYS A, V131, P675, DOI 10.1016/S1095-6433(01)00515-3; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Yamaguchi S, 2008, ECOTOXICOLOGY, V17, P772, DOI 10.1007/s10646-008-0228-7; Yang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001472; Yuen BSJ, 2004, BIOL REPROD, V70, P1650, DOI 10.1095/biolreprod.103.025254; Zarubin TP, 2009, MOL BIOL REP, V36, P1231, DOI 10.1007/s11033-008-9302-8; Zhao JM, 2007, MOL IMMUNOL, V44, P360, DOI 10.1016/j.molimm.2006.02.025	38	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11175	10.1371/journal.pone.0011175	http://dx.doi.org/10.1371/journal.pone.0011175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567508	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886300018
J	Catania, KC				Catania, Kenneth C.			Born Knowing: Tentacled Snakes Innately Predict Future Prey Behavior	PLOS ONE			English	Article							HUNTING ARCHER FISH; MAUTHNER CELL; RESPONSES; PREDATOR; START; EXPLOITATION; SPEED; TIME	Background: Aquatic tentacled snakes (Erpeton tentaculatus) can take advantage of their prey's escape response by startling fish with their body before striking. The feint usually startles fish toward the snake's approaching jaws. But when fish are oriented at a right angle to the jaws, the C-start escape response translates fish parallel to the snake's head. To exploit this latter response, snakes must predict the future location of the fish. Adult snakes can make this prediction. Is it learned, or are tentacled snakes born able to predict future fish behavior? Methods and Findings: Laboratory-born, naive snakes were investigated as they struck at fish. Trials were recorded at 250 or 500 frames per second. To prevent learning, snakes were placed in a water container with a clear transparency sheet or glass bottom. The chamber was placed over a channel in a separate aquarium with fish below. Thus snakes could see and strike at fish, without contact. The snake's body feint elicited C-starts in the fish below the transparency sheet, allowing strike accuracy to be quantified in relationship to the C-starts. When fish were oriented at a right angle to the jaws, naive snakes biased their strikes to the future location of the escaping fish's head, such that the snake's jaws and the fish's translating head usually converged. Several different types of predictive strikes were observed. Conclusions: The results show that some predators have adapted their nervous systems to directly compensate for the future behavior of prey in a sensory realm that usually requires learning. Instead of behavior selected during their lifetime, newborn tentacled snakes exhibit behavior that has been selected on a different scale-over many generations. Counter adaptations in fish are not expected, as tentacled snakes are rare predators exploiting fish responses that are usually adaptive.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA.	ken.catania@vanderbilt.edu			National Science Foundation [0844743]; MacArthur Award	National Science Foundation(National Science Foundation (NSF)); MacArthur Award	Funding was provided by the National Science Foundation award # 0844743 and a MacArthur Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunskill R.W, 1978, ILLUSTRATED HDB VERN; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Canfield JG, 2003, BRAIN BEHAV EVOLUT, V61, P148, DOI 10.1159/000069751; Canfield JG, 1996, BRAIN BEHAV EVOLUT, V48, P137, DOI 10.1159/000113193; Catania KC, 2010, J EXP BIOL, V213, P359, DOI 10.1242/jeb.039685; Catania KC, 2009, P NATL ACAD SCI USA, V106, P11183, DOI 10.1073/pnas.0905183106; Catania KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003472; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Dawkins R., 1982, pi; Eaton R.C., 1984, P213; EATON RC, 1977, J EXP BIOL, V66, P65; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Hale ME, 2002, EVOLUTION, V56, P993; HARTLINE PH, 1978, SCIENCE, V199, P1225, DOI 10.1126/science.628839; Hoogland R., 1957, Behaviour, V10, P205; Jablonski PG, 2001, BRAIN BEHAV EVOLUT, V58, P218, DOI 10.1159/000057565; Jablonski PG, 2001, P ROY SOC B-BIOL SCI, V268, P1017, DOI 10.1098/rspb.2001.1623; Jablonski PG, 1999, BEHAV ECOL, V10, P7, DOI 10.1093/beheco/10.1.7; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Makino CL, 2003, CURR OPIN NEUROBIOL, V13, P404, DOI 10.1016/S0959-4388(03)00091-6; McHenry MJ, 2009, BIOL LETTERS, V5, P477, DOI 10.1098/rsbl.2009.0048; Murphy J. C., 2007, HOMALOPSID SNAKES EV; Preuss T, 2006, J NEUROSCI, V26, P3454, DOI 10.1523/JNEUROSCI.5259-05.2006; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Reimchen TE, 2002, EVOLUTION, V56, P2472; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Smith TL, 2002, J ZOOL, V256, P233, DOI 10.1017/S0952836902000274; STEIN BE, 1975, SCIENCE, V189, P224, DOI 10.1126/science.1094540; Stein BE., 1993, MERGING SENSES; Stephens D.W., 1986, pi; TAYLOR EDWARD H., 1965, UNIV KANS SCI BULL, V45, P609; Weiss SA, 2008, P NATL ACAD SCI USA, V105, P18047, DOI 10.1073/pnas.0806145105; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WINOKUR R M, 1977, Herpetologica, V33, P247; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646; Wohl S, 2006, J EXP BIOL, V209, P141, DOI 10.1242/jeb.01981; Zottoli SJ, 2000, NEUROSCIENTIST, V6, P26, DOI 10.1177/107385840000600111	38	24	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e10953	10.1371/journal.pone.0010953	http://dx.doi.org/10.1371/journal.pone.0010953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585384	Green Published, gold			2022-12-25	WOS:000278886100003
J	Lyn-Kew, K; Rich, E; Zeng, XY; Wen, HT; Kunkel, SL; Newstead, MW; Bhan, U; Standiford, TJ				Lyn-Kew, Kenneth; Rich, Eric; Zeng, Xianying; Wen, Haitao; Kunkel, Steven L.; Newstead, Michael W.; Bhan, Urvashi; Standiford, Theodore J.			IRAK-M Regulates Chromatin Remodeling in Lung Macrophages during Experimental Sepsis	PLOS ONE			English	Article							UP-REGULATION; ENDOTOXIN TOLERANCE; SEPTIC PATIENTS; METHYLATION; EXPRESSION; MONOCYTES; IMMUNOSUPPRESSION; INFLAMMATION; CELLS	Sepsis results in a profound state of immunosuppression, which is temporally associated with impaired leukocyte function. The mechanism of leukocyte reprogramming in sepsis is incompletely understood. In this study, we explored mechanisms contributing to dysregulated inflammatory cytokine expression by pulmonary macrophages during experimental sepsis. Pulmonary macrophages (PM) recovered from the lungs of mice undergoing cecal ligation and puncture (CLP) display transiently reduced expression of some, but not all innate genes in response to LPS. Impaired expression of TNF-alpha and iNOS was associated with reduced acetylation and methylation of specific histones (AcH4 and H3K4me3) and reduced binding of RNA polymerase II to the promoters of these genes. Transient impairment in LPS-induced cytokine responses in septic PM temporally correlated with induction of IRAK-M mRNA and protein, which occurred in a MyD88-dependent fashion. PM isolated from IRAK-M-/- mice were largely refractory to CLP-induced impairment in cytokine expression, chromatin remodeling, recruitment of RNA polymerase II, and induction of histone deacetylase-2 observed during sepsis. Our findings indicate that systemic sepsis induces epigenetic silencing of cytokine gene expression in lung macrophages, and IRAK-M appears to be a critical mediator of this response.	[Lyn-Kew, Kenneth; Rich, Eric; Zeng, Xianying; Newstead, Michael W.; Bhan, Urvashi; Standiford, Theodore J.] Univ Michigan, Sch Med, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48104 USA; [Wen, Haitao; Kunkel, Steven L.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lyn-Kew, K (corresponding author), Univ Michigan, Sch Med, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48104 USA.	tstandif@umich.edu	Wen, Haitao/AAJ-7621-2020		NIH/NHLBI [P50 HL074024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL094762, P50HL074024, R01HL031237] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by NIH/NHLBI grant P50 HL074024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2000, AM J RESP CRIT CARE, V162, P1877, DOI 10.1164/ajrccm.162.5.2003058; Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Hall MW, 2007, PEDIATR RES, V62, P597, DOI 10.1203/PDR.0b013e3181559774; Harada K, 2006, LIVER INT, V26, P935, DOI 10.1111/j.1478-3231.2006.01325.x; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lyn-Kew K, 2008, CURR PHARM DESIGN, V14, P1870, DOI 10.2174/138161208784980545; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Nakayama K, 2004, J BIOL CHEM, V279, P6629, DOI 10.1074/jbc.M308620200; Reddy RC, 2010, CURR OPIN HEMATOL, V17, P18, DOI 10.1097/MOH.0b013e32833338f3; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rosati O, 2002, BIOCHEM BIOPH RES CO, V293, P1472, DOI 10.1016/S0006-291X(02)00411-4; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Seki M, 2010, J IMMUNOL, V184, P1410, DOI 10.4049/jimmunol.0901709; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Strickland FM, 2008, AUTOIMMUNITY, V41, P278, DOI 10.1080/08916930802024616; van der Poll T, 1999, INFECT DIS CLIN N AM, V13, P413, DOI 10.1016/S0891-5520(05)70083-0; Volk HD, 2000, CHEM IMMUNOL, V74, P162; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403	28	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11145	10.1371/journal.pone.0011145	http://dx.doi.org/10.1371/journal.pone.0011145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585389	gold, Green Published, Green Submitted			2022-12-25	WOS:000278886100013
J	Gutte, H; Oxbol, J; Kristoffersen, US; Mortensen, J; Kjaer, A				Gutte, Henrik; Oxbol, Jytte; Kristoffersen, Ulrik Sloth; Mortensen, Jann; Kjaer, Andreas			Gene Expression of ANP, BNP and ET-1 in the Heart of Rats during Pulmonary Embolism	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; RIGHT-VENTRICULAR DYSFUNCTION; ACTIVATION; FAILURE	Aims: Atrial natriuretic petide (ANP), brain natriuretic peptide (BNP) and endothelin-1 (ET-1) may reflect the severity of right ventricular dysfunction (RVD) in patients with pulmonary embolism (PE). The exact nature and source of BNP, ANP and ET-1 expression and secretion following PE has not previously been studied. Methods and Results: Polystyrene microparticles were injected to induce PE in rats. Gene expression of BNP, ANP and ET-1 were determined in the 4 cardiac chambers by quantitative real time polymerase chain reaction (QPCR). Plasma levels of ANP, BNP, ET-1 and cardiac troponin I (TNI) were measured in plasma. PE dose-dependently increased gene expression of ANP and BNP in the right ventricle (RV) and increased gene expression of ANP in the right atrium (RA). In contrast PE dose-dependently decreased BNP gene expression in both the left ventricle (LV) and the left atrium (LA). Plasma levels of BNP, TNI and ET-1 levels dose-dependently increased with the degree of PE. Conclusion: We found a close correlation between PE degree and gene-expression of ANP, and BNP in the cardiac chambers with a selective increase in the right chambers of the heart. The present data supports the idea of natriuretic peptides as valuable biomarkers of RVD in PE.	[Gutte, Henrik; Kristoffersen, Ulrik Sloth; Mortensen, Jann; Kjaer, Andreas] Copenhagen Univ Hosp, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Gutte, Henrik; Oxbol, Jytte; Kristoffersen, Ulrik Sloth; Kjaer, Andreas] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Gutte, H (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark.	henrikgb@gmail.com	; Kjaer, Andreas/E-8932-2015	Gutte, Henrik/0000-0001-5494-5323; Mortensen, Jann/0000-0002-1399-8995; Kjaer, Andreas/0000-0002-2706-5547	Novo Nordisk Foundation; Lundbeck Foundation; A.P. Moller Foundation; Danish Heart Foundation [09-04-R72-A2356-22560]; Danish Medical Research Council [959592772]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); A.P. Moller Foundation; Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The financial support from Novo Nordisk Foundation (www.novonordiskfonden.dk), Lundbeck Foundation (www.lundbeckfonden.dk), A.P. Moller Foundation (www.apmollerfonde.dk), The Danish Heart Foundation (grant no. 09-04-R72-A2356-22560; www.hjerteforeningen.dk), and Danish Medical Research Council (grant no. 959592772; www.fi.dk) is gratefully acknowledged. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Bin Yap L, 2004, CHEST, V126, P1330, DOI 10.1378/chest.126.4.1330; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; COMINI L, 1995, AM J PHYSIOL-HEART C, V268, pH391, DOI 10.1152/ajpheart.1995.268.1.H391; DAGNINO L, 1991, MOL ENDOCRINOL, V5, P1292, DOI 10.1210/mend-5-9-1292; de Bold AJ, 2001, CAN J PHYSIOL PHARM, V79, P705, DOI 10.1139/cjpp-79-8-705; GOLDHABER SZ, 1993, LANCET, V341, P507, DOI 10.1016/0140-6736(93)90274-K; Jones AE, 2003, AM J PHYSIOL-LUNG C, V284, pL1072, DOI 10.1152/ajplung.00283.2002; Kaczynska A, 2008, CLIN CHIM ACTA, V398, P1, DOI 10.1016/j.cca.2008.07.020; Kiely DG, 2005, RESP MED, V99, P1286, DOI 10.1016/j.rmed.2005.02.029; Kjaer A, 2001, CLIN PHYSIOL, V21, P661, DOI 10.1046/j.1365-2281.2001.00371.x; Koyanagi T, 2008, AM J PHYSIOL-HEART C, V295, pH220, DOI 10.1152/ajpheart.00289.2008; Kucher N, 2003, CIRCULATION, V107, P2545, DOI 10.1161/01.CIR.0000074039.45523.BE; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Lee JH, 2001, AM J RESP CRIT CARE, V164, P1282, DOI 10.1164/ajrccm.164.7.2011011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco AP, 2006, AM J PHYSIOL-HEART C, V291, pH1587, DOI 10.1152/ajpheart.01004.2005; LUALDI JC, 1995, AM HEART J, V130, P1276, DOI 10.1016/0002-8703(95)90155-8; Luchner A, 1998, AM J PHYSIOL-HEART C, V274, pH1684, DOI 10.1152/ajpheart.1998.274.5.H1684; MUKOYAMA M, 1990, LANCET, V335, P801, DOI 10.1016/0140-6736(90)90925-U; Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X; OGAWA Y, 1991, CIRC RES, V69, P491, DOI 10.1161/01.RES.69.2.491; OGAWA Y, 1990, ENDOCRINOLOGY, V126, P2225, DOI 10.1210/endo-126-4-2225; Pruszczyk P, 2003, EUR RESPIR J, V22, P649, DOI 10.1183/09031936.03.00023303; Roncon-Albuquerque R, 2006, LIFE SCI, V78, P2633, DOI 10.1016/j.lfs.2005.10.021; Sawada Y, 1997, J BIOL CHEM, V272, P20545, DOI 10.1074/jbc.272.33.20545; STELZNER TJ, 1992, AM J PHYSIOL, V262, pL614, DOI 10.1152/ajplung.1992.262.5.L614; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Watts JA, 2006, J MOL CELL CARDIOL, V41, P296, DOI 10.1016/j.yjmcc.2006.05.011	30	8	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11111	10.1371/journal.pone.0011111	http://dx.doi.org/10.1371/journal.pone.0011111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559433	gold, Green Submitted, Green Published			2022-12-25	WOS:000278741100023
J	Valle-Delgado, JJ; Alfonso-Prieto, M; de Groot, NS; Ventura, S; Samitier, J; Rovira, C; Fernandez-Busquets, X				Jose Valle-Delgado, Juan; Alfonso-Prieto, Mercedes; de Groot, Natalia S.; Ventura, Salvador; Samitier, Josep; Rovira, Carme; Fernandez-Busquets, Xavier			Modulation of A beta(42) fibrillogenesis by glycosaminoglycan structure	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid fibril structure; fibrillogenesis enhancers and inhibitors; polysaccharides	HEPARAN-SULFATE PROTEOGLYCANS; MEROZOITE SURFACE PROTEIN-2; ATOMIC-FORCE MICROSCOPY; SOLUBLE AMYLOID OLIGOMERS; X-RAY-DIFFRACTION; ALZHEIMERS-DISEASE; CHONDROITIN-SULFATE; PLASMODIUM-FALCIPARUM; A-BETA; FIBRIL FORMATION	The role of amyloid beta (A beta) peptide in the onset and progression of Alzheimer's disease is linked to the presence of soluble A beta species. Sulfated glycosaminoglycans (GAGs) promote A beta fibrillogenesis and reduce the toxicity of the peptide in neuronal cell cultures, but a satisfactory rationale to explain these effects at the molecular level has not been provided yet. We have used circular dichroism, Fourier transform infrared spectroscopy, fluorescence microscopy and spectroscopy, protease digestion, atomic force microscopy (AFM), and molecular dynamics simulations to characterize the association of the 42-residue fragment A beta(42) with sulfated GAGs, hyaluronan, chitosan, and poly(vinyl sulfate) (PVS). Our results indicate that the formation of stable A beta(42) fibrils is promoted by polymeric GAGs with negative charges placed in-frame with the 4.8-angstrom separating A beta(42) monomers within protofibrillar beta-sheets. Incubation of A beta(42) with excess sulfated GAGs and hyaluronan increased amyloid fibril content and resistance to proteolysis 2- to 5-fold, whereas in the presence of the cationic polysaccharide chitosan, A beta(42) fibrillar species were reduced by 25% and sensitivity to protease degradation increased similar to 3-fold. Fibrils of intermediate stability were obtained in the presence of PVS, an anionic polymer with more tightly packed charges than GAGs. Important structural differences between A beta(42) fibrils induced by PVS and A beta(42) fibrils obtained in the presence of GAGs and hyaluronan were observed by AFM, whereas mainly precursor protofibrillar forms were detected after incubation with chitosan. Computed binding energies per peptide from -11.2 to -13.5 kcal/mol were calculated for GAGs and PVS, whereas a significantly lower value of -7.4 kcal/mol was obtained for chitosan. Taken together, our data suggest a simple and straightforward mechanism to explain the role of GAGs as enhancers of the formation of insoluble A beta(42) fibrils trapping soluble toxic forms.-Valle-Delgado, J. J., Alfonso-Prieto, M., de Groot, N. S., Ventura, S., Samitier, J., Rovira, C., Fernandez-Busquets, X. Modulation of A beta(42) fibrillo-genesis by glycosaminoglycan structure. FASEB J. 24, 4250-4261 (2010). www.fasebj.org	[Jose Valle-Delgado, Juan; Samitier, Josep; Fernandez-Busquets, Xavier] Inst Bioengn Catalonia, Nanobioengn Grp, E-08028 Barcelona, Spain; [Jose Valle-Delgado, Juan; Fernandez-Busquets, Xavier] Univ Barcelona, Biomol Interact Team, Nanosci & Nanotechnol Inst, Barcelona, Spain; [Alfonso-Prieto, Mercedes; Rovira, Carme] Univ Barcelona, Inst Quim Teor & Computac, Barcelona, Spain; [Samitier, Josep] Univ Barcelona, Dept Elect, Barcelona, Spain; [Alfonso-Prieto, Mercedes; Rovira, Carme] CoSMo LAB, Barcelona, Spain; [de Groot, Natalia S.; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra, Spain; [de Groot, Natalia S.; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Spain; [Rovira, Carme] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; ICREA	Valle-Delgado, JJ (corresponding author), Inst Bioengn Catalonia, Nanobioengn Grp, Baldiri Reixac 10-12, E-08028 Barcelona, Spain.	jjvalle@pcb.ub.es; xfernandez_busquets@ub.edu	Fernàndez-Busquets, Xavier/K-1323-2014; de Groot, Natalia Sanchez/J-8212-2014; Ventura, Salvador/AAY-3170-2021; Valle-Delgado, Juan Jose/H-8857-2013; Ventura, Salvador/C-7021-2008; Rovira, Carme/K-5195-2014; de Groot, Natalia Sanchez/AFN-2768-2022; Alfonso-Prieto, Mercedes/M-3376-2014	Fernàndez-Busquets, Xavier/0000-0002-4622-9631; de Groot, Natalia Sanchez/0000-0002-0492-5532; Ventura, Salvador/0000-0002-9652-6351; Valle-Delgado, Juan Jose/0000-0002-4808-1730; Ventura, Salvador/0000-0002-9652-6351; Rovira, Carme/0000-0003-1477-5010; de Groot, Natalia Sanchez/0000-0002-0492-5532; Alfonso-Prieto, Mercedes/0000-0003-4509-4517	Ministerio de Ciencia e Innovacion, Spain [BIO2005-01591, BIO2007-68046, BIO2008-01184, FIS2008-03845, CSD2006-00012]; Generalitat de Catalunya (GENCAT), Spain [2009SGR-760, 2009SGR-1309]; GENCAT; ICREA ACADEMIA; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya (GENCAT), Spain(Generalitat de Catalunya); GENCAT; ICREA ACADEMIA(ICREA); ICREA(ICREA)	This work was supported by grants BIO2005-01591, BIO2007-68046, BIO2008-01184, FIS2008-03845, and CSD2006-00012 from the Ministerio de Ciencia e Innovacion, Spain, which included FEDER funds, and by grants 2009SGR-760 and 2009SGR-1309 from the Generalitat de Catalunya (GENCAT), Spain. A fellowship of the F.I. program from GENCAT (to M.A.-P) and the financial support from Juan de la Cierva Programme of the Ministerio de Ciencia e Innovacion, Spain (to J.J.V.-D.) are acknowledged. S.V. was granted an ICREA ACADEMIA award (ICREA). The computer support, technical expertise, and assistance provided by the Barcelona Supercomputing Center-Centro Nacional de Supercomputacion (BSC-CNS), the Scientific and Technical Services of the University of Barcelona, and the Proteomics Platform of the Barcelona Science Park are also acknowledged.	Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Almond A, 2000, GLYCOBIOLOGY, V10, P329, DOI 10.1093/glycob/10.3.329; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Andrews KT, 2005, INFECT IMMUN, V73, P4288, DOI 10.1128/IAI.73.7.4288-4294.2005; Antzutkin ON, 2004, MAGN RESON CHEM, V42, P231, DOI 10.1002/mrc.1341; Arimon M, 2005, FASEB J, V19, P1344, DOI 10.1096/fj.04-3137fje; Barragan A, 2000, BLOOD, V95, P3594, DOI 10.1182/blood.V95.11.3594.011k21_3594_3599; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Cooke BM, 2004, TRENDS PARASITOL, V20, P581, DOI 10.1016/j.pt.2004.09.008; DeGroot J, 2004, CURR OPIN PHARMACOL, V4, P301, DOI 10.1016/j.coph.2004.01.007; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; Fernandez-Busquets X, 2010, CURR ALZHEIMER RES, V7, P428, DOI 10.2174/156720510791383787; Fernandez-Busquets X, 2008, CURR MED CHEM, V15, P1336, DOI 10.2174/092986708784534938; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; GUPTABANSAL R, 1995, J BIOL CHEM, V270, P18666, DOI 10.1074/jbc.270.31.18666; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Haxaire K, 2000, GLYCOBIOLOGY, V10, P587, DOI 10.1093/glycob/10.6.587; Hirschfield GM, 2003, INT J BIOCHEM CELL B, V35, P1608, DOI 10.1016/S1357-2725(03)00169-9; Hu JG, 1998, BRAIN RES, V785, P195, DOI 10.1016/S0006-8993(97)01318-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Low A, 2007, BIOPOLYMERS, V87, P12, DOI 10.1002/bip.20764; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McLaurin J, 2000, EUR J BIOCHEM, V267, P6353, DOI 10.1046/j.1432-1327.2000.01725.x; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Mudher A, 2002, TRENDS NEUROSCI, V25, P22, DOI 10.1016/S0166-2236(00)02031-2; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Naito A, 2007, BBA-BIOMEMBRANES, V1768, P1900, DOI 10.1016/j.bbamem.2007.03.025; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; POLLACK SJ, 1995, NEUROSCI LETT, V184, P113, DOI 10.1016/0304-3940(94)11182-I; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rodriguez-Carvajal MA, 2003, BIOPOLYMERS, V69, P15, DOI 10.1002/bip.10304; Roher AE, 2000, BBA-MOL BASIS DIS, V1502, P31, DOI 10.1016/S0925-4439(00)00030-2; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Snow AD, 1996, EXP NEUROL, V138, P305, DOI 10.1006/exnr.1996.0069; SNOW AD, 1992, J HISTOCHEM CYTOCHEM, V40, P105, DOI 10.1177/40.1.1370306; SNOW AD, 1988, AM J PATHOL, V133, P456; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; SU JH, 1992, NEUROSCIENCE, V51, P801, DOI 10.1016/0306-4522(92)90521-3; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Timmer NM, 2010, NEUROSCI RES, V66, P380, DOI 10.1016/j.neures.2009.12.012; Valente T, 2010, NEUROBIOL DIS, V37, P67, DOI 10.1016/j.nbd.2009.09.008; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; WOODS AG, 1995, BRAIN RES, V697, P53, DOI 10.1016/0006-8993(95)00775-L; Yang X, 2007, J PEPT SCI, V13, P839, DOI 10.1002/psc.910; YUI T, 1994, MACROMOLECULES, V27, P7601, DOI 10.1021/ma00104a014	78	62	61	0	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2010	24	11					4250	4261		10.1096/fj.09-153551	http://dx.doi.org/10.1096/fj.09-153551			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20585030				2022-12-25	WOS:000283861100013
J	Ramboarina, S; Garnett, JA; Zhou, MX; Li, YB; Peng, ZX; Taylor, JD; Lee, WC; Bodey, A; Murray, JW; Alguel, Y; Bergeron, J; Bardiaux, B; Sawyer, E; Isaacson, R; Tagliaferri, C; Cota, E; Nilges, M; Simpson, P; Ruiz, T; Wu, H; Matthews, S				Ramboarina, Stephanie; Garnett, James A.; Zhou, Meixian; Li, Yuebin; Peng, Zhixiang; Taylor, Jonathan D.; Lee, Wei-chao; Bodey, Andrew; Murray, James W.; Alguel, Yilmaz; Bergeron, Julien; Bardiaux, Benjamin; Sawyer, Elizabeth; Isaacson, Rivka; Tagliaferri, Camille; Cota, Ernesto; Nilges, Michael; Simpson, Peter; Ruiz, Teresa; Wu, Hui; Matthews, Stephen			Structural Insights into Serine-rich Fimbriae from Gram-positive Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE GLYCOPROTEINS GSPB; AUTOMATED NOE ASSIGNMENT; STREPTOCOCCUS-PARASANGUIS; STAPHYLOCOCCUS-AUREUS; ACID TOLERANCE; FIBRONECTIN-BINDING; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; HIGH-RESOLUTION; CHEMICAL-SHIFT	The serine-rich repeat family of fimbriae play important roles in the pathogenesis of streptococci and staphylococci. Despite recent attention, their finer structural details and precise adhesion mechanisms have yet to be determined. Fap1 (Fimbriae-associated protein 1) is the major structural subunit of serine-rich repeat fimbriae from Streptococcus parasanguinis and plays an essential role in fimbrial biogenesis, adhesion, and the early stages of dental plaque formation. Combining multidisciplinary, high resolution structural studies with biological assays, we provide new structural insight into adhesion by Fap1. We propose a model in which the serine-rich repeats of Fap1 subunits form an extended structure that projects the N-terminal globular domains away from the bacterial surface for adhesion to the salivary pellicle. We also uncover a novel pH-dependent conformational change that modulates adhesion and likely plays a role in survival in acidic environments.	[Zhou, Meixian; Li, Yuebin; Peng, Zhixiang; Wu, Hui] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA; [Lee, Wei-chao; Bodey, Andrew; Murray, James W.; Alguel, Yilmaz; Bergeron, Julien; Matthews, Stephen] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Struct Biol Ctr, London SW7 2AZ, England; [Bergeron, Julien] Kings Coll London, Sch Med, Dept Infect Dis, London SE1 9RT, England; [Bardiaux, Benjamin] Leibniz Inst Mol Pharmacol, Struct Biol Unit, D-13125 Berlin, Germany; [Nilges, Michael] Inst Pasteur, Unite Bioinformat Struct, F-75724 Paris 15, France; [Ruiz, Teresa] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Alabama System; University of Alabama Birmingham; Imperial College London; University of London; King's College London; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Vermont	Wu, H (corresponding author), Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA.	hwu@uab.edu; s.j.matthews@imperial.ac.uk	Taylor, Jonathan/A-1416-2013; Sawyer, Elizabeth B/E-6906-2010; Bardiaux, Benjamin/A-4799-2011; Bardiaux, Benjamin/AAN-2741-2021; Sawyer, Elizabeth/J-6962-2012; Nilges, Michael/E-4803-2011; Bergeron, Julien/AGY-1707-2022	Taylor, Jonathan/0000-0003-0119-433X; Bardiaux, Benjamin/0000-0003-4014-9195; Nilges, Michael/0000-0002-1451-8092; Sawyer, Elizabeth/0000-0003-0389-2692; Simpson, Pete/0000-0002-2679-9303; Isaacson, Rivka Leah/0000-0002-9978-8904; Matthews, Steve/0000-0003-0676-0927; Taylor, Jonathan/0000-0002-9797-3989; Murray, James/0000-0002-8897-0161	National Institutes of Health [R01DE017474, R01DE011000, R01DE017954]; Wellcome Trust [079819, 085464]; E.P. Abraham Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954, R01DE017474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); E.P. Abraham Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE017474 (to T.R.) and R01DE011000 and R01DE017954 (to H.W.). This work was also supported by Wellcome Trust Program Grant 079819 and Equipment Grant 085464 (to S.M.).; We thank the beamline scientists at ID29 of the European Synchrotron Radiation Facility and X33 at the DORIS-III ring of the Deutsches Elektronen-Synchrotron. Weare also indebted to Christina Redfield at Oxford University for the provision of 950 MHz instrument time. The 950 MHz NMR facility was funded by the Wellcome Trust Joint Infrastructure Fund and the E.P. Abraham Fund.	Asakura T, 2005, MACROMOLECULES, V38, P7397, DOI 10.1021/ma050936y; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bardiaux B, 2009, PROTEINS, V75, P569, DOI 10.1002/prot.22268; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; BROOKS DE, 1983, J GEN MICROBIOL, V129, P3661; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FIVESTAYLOR PM, 1985, INFECT IMMUN, V47, P752, DOI 10.1128/IAI.47.3.752-759.1985; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; Fujitani S, 2008, CLIN INFECT DIS, V46, P1064, DOI 10.1086/529199; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Giannitsioti E, 2007, CLIN MICROBIOL INFEC, V13, P770, DOI 10.1111/j.1469-0691.2007.01753.x; Guglielmetti S, 2009, CURR MICROBIOL, V59, P167, DOI 10.1007/s00284-009-9415-x; Handley PS, 2005, ORAL MICROBIOL IMMUN, V20, P131, DOI 10.1111/j.1399-302X.2004.00190.x; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ito HO, 2003, J MICROBIOL METH, V55, P29, DOI 10.1016/S0167-7012(03)00111-8; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kajava AV, 2001, J STRUCT BIOL, V134, P132, DOI 10.1006/jsbi.2000.4328; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Kim SB, 2008, COLLOID SURFACE B, V63, P236, DOI 10.1016/j.colsurfb.2007.12.003; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Miller DJ, 2008, STRUCTURE, V16, P1036, DOI 10.1016/j.str.2008.03.019; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Paju S, 2007, ORAL DIS, V13, P508, DOI 10.1111/j.1601-0825.2007.01410a.x; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Petoukhov MV, 2003, J APPL CRYSTALLOGR, V36, P540, DOI 10.1107/S0021889803000591; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Ruiz T, 2003, J STRUCT BIOL, V143, P124, DOI 10.1016/S1047-8477(03)00140-0; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Sangappa, 2005, J BIOSCIENCES, V30, P259, DOI 10.1007/BF02703707; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Sillanpaa J, 2009, MICROBIOL-SGM, V155, P2390, DOI 10.1099/mic.0.027821-0; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; Svensater G, 1997, ORAL MICROBIOL IMMUN, V12, P266, DOI 10.1111/j.1399-302X.1997.tb00390.x; Takahashi N, 1999, ORAL MICROBIOL IMMUN, V14, P43, DOI 10.1034/j.1399-302X.1999.140105.x; TAKAI S, 1980, INFECT IMMUN, V28, P669; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Tanaka Y, 2008, STRUCTURE, V16, P488, DOI 10.1016/j.str.2007.12.018; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Welin-Neilands J, 2007, APPL ENVIRON MICROB, V73, P5633, DOI 10.1128/AEM.01049-07; Westling K, 2006, INT J ANTIMICROB AG, V28, P292, DOI 10.1016/j.ijantimicag.2006.05.032; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Zhou MX, 2008, INFECT IMMUN, V76, P5624, DOI 10.1128/IAI.00534-08; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	87	41	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32446	32457		10.1074/jbc.M110.128165	http://dx.doi.org/10.1074/jbc.M110.128165			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20584910	Green Published, hybrid			2022-12-25	WOS:000282683000058
J	He, PJ; Klein, J; Yun, CC				He, Peijian; Klein, Janet; Yun, C. Chris			Activation of Na+/H+ Exchanger NHE3 by Angiotensin II Is Mediated by Inositol 1,4,5-Triphosphate (IP3) Receptor-binding Protein Released with IP3 (IRBIT) and Ca2+/Calmodulin-dependent Protein Kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL BICARBONATE ABSORPTION; 1,4,5-TRISPHOSPHATE RECEPTOR; SIGNALING PATHWAYS; INHIBITOR PROTEIN; RAT; PHOSPHORYLATION; REQUIRES; CALCIUM; ISOFORM; KIDNEY	Angiotensin II (ANG II) stimulates renal tubular reabsorption of NaCl by targeting Na+/H+ exchanger NHE3. We have shown previously that inositol 1,4,5-triphosphate receptor-binding protein released with inositol 1,4,5-triphosphate (IRBIT) plays a critical role in stimulation of NHE3 in response to elevated intracellular Ca2+ concentration ([Ca2+](i)). In this study, we investigated the role of IRBIT in mediating NHE3 activation by ANG II. IRBIT is abundantly expressed in the proximal tubules where NHE3 is located. ANG II at physiological concentrations stimulates NHE3 transport activity in a model proximal tubule cell line. ANG II-induced activation of NHE3 was abrogated by knockdown of IRBIT, whereas overexpression of IRBIT enhanced the effect of ANG II on NHE3. ANG II transiently increased binding of IRBIT to NHE3 at 5 min but became dissociated by 45 min. In comparison, it took at least 15 min of ANG II treatment for an increase in NHE3 activity and NHE3 surface expression. The stimulation of NHE3 by ANG II was dependent on changes in [Ca2+](i) and Ca2+/calmodulin-dependent protein kinases II. Inhibition of CaMKII completely blocked the ANG II-induced binding of IRBIT to NHE3 and the increase in NHE3 surface abundance. Several serine residues of IRBIT are thought to be important for IRBIT binding. Mutations of Ser-68, Ser-71, and Ser-74 of IRBIT decreased binding of IRBIT to NHE3 and its effect on NHE3 activity. In conclusion, our current findings demonstrate that IRBIT is critically involved in mediating activation of NHE3 by ANG II via a Ca2+/calmodulin-dependent protein kinases II-dependent pathway.	[He, Peijian; Yun, C. Chris] Emory Univ, Dept Med, Div Digest Dis, Atlanta, GA 30324 USA; [Klein, Janet] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30324 USA	Emory University; Emory University	Yun, CC (corresponding author), Emory Univ, Sch Med, Div Digest Dis, Dept Med, Whitehead Bldg,Rm 201,615 Michael St, Atlanta, GA 30322 USA.	ccyun@emory.edu	He, Peijian/F-4790-2011	He, Peijian/0000-0002-9526-8004	National Institutes of Health [DK061418, DK061418S1, DK064399]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061418, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061418 and DK061418S1.; Supported by a postdoctoral fellowship from the American Heart Association.; We acknowledge the Emory Digestive Disease Research Development Center (supported by National Institutes of Health Grant DK064399) for the use of the confocal microscope. We are grateful to Dr. Tom Soderling for the CaMKIIN2 construct.	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Aronson PS, 1996, KIDNEY INT, V49, P1665, DOI 10.1038/ki.1996.243; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; Biemesderfer D, 1999, J BIOL CHEM, V274, P17518, DOI 10.1074/jbc.274.25.17518; Bobulescu IA, 2005, AM J PHYSIOL-RENAL, V289, pF685, DOI 10.1152/ajprenal.00447.2004; BROWN GP, 1982, ENDOCRINOLOGY, V111, P1830, DOI 10.1210/endo-111-6-1830; Carraro-Lacroix LR, 2006, PFLUG ARCH EUR J PHY, V452, P728, DOI 10.1007/s00424-006-0085-2; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Chu TS, 1996, J CLIN INVEST, V97, P1454, DOI 10.1172/JCI118567; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Devogelaere B, 2008, BIOESSAYS, V30, P642, DOI 10.1002/bies.20772; Devogelaere B, 2007, BIOCHEM J, V407, P303, DOI 10.1042/BJ20070361; Di Sole F, 2003, J AM SOC NEPHROL, V14, P1720, DOI 10.1097/01.ASN.0000072743.97583.DB; du Cheyron D, 2003, KIDNEY INT, V64, P939, DOI 10.1046/j.1523-1755.2003.00189.x; Feng Z, 2006, KIDNEY INT, V70, P130, DOI 10.1038/sj.ki.5000342; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; HARRIS PJ, 1977, PFLUG ARCH EUR J PHY, V367, P295, DOI 10.1007/BF00581370; He PJ, 2008, J BIOL CHEM, V283, P33544, DOI 10.1074/jbc.M805534200; Houillier P, 1996, KIDNEY INT, V50, P1496, DOI 10.1038/ki.1996.464; Kiefer H, 2009, J BIOL CHEM, V284, P10694, DOI 10.1074/jbc.M807136200; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kwon TH, 2003, AM J PHYSIOL-RENAL, V285, pF152, DOI 10.1152/ajprenal.00307.2002; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; LIU FY, 1990, AM J PHYSIOL, V258, pF927, DOI 10.1152/ajprenal.1990.258.4.F927; LIU FY, 1989, J CLIN INVEST, V84, P83, DOI 10.1172/JCI114174; LIU FY, 1988, J CLIN INVEST, V82, P601, DOI 10.1172/JCI113638; LIU FY, 1990, AM J PHYSIOL, V259, pF451, DOI 10.1152/ajprenal.1990.259.3.F451; Purkiss JR, 1996, CELL CALCIUM, V20, P21, DOI 10.1016/S0143-4160(96)90047-0; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; Riquier ADM, 2009, AM J PHYSIOL-CELL PH, V296, pC900, DOI 10.1152/ajpcell.00526.2008; Rossig L, 1996, J BIOL CHEM, V271, P22063; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; SCHUSTER VL, 1984, J CLIN INVEST, V73, P507, DOI 10.1172/JCI111237; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; Sudo T, 2001, J NEUROENDOCRINOL, V13, P942, DOI 10.1046/j.1365-2826.2001.00699.x; Tsuganezawa H, 1998, KIDNEY INT, V54, P394, DOI 10.1046/j.1523-1755.1998.00029.x; Wang DS, 2007, AM J PHYSIOL-CELL PH, V292, pC396, DOI 10.1152/ajpcell.00345.2006; Wang DS, 2006, AM J PHYSIOL-RENAL, V290, pF428, DOI 10.1152/ajprenal.00161.2005; Wang DS, 2005, AM J PHYSIOL-CELL PH, V289, pC802, DOI 10.1152/ajpcell.00597.2004; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; WELSH C, 1988, J CLIN INVEST, V81, P710, DOI 10.1172/JCI113376; Williams MR, 2001, INVEST OPHTH VIS SCI, V42, P1009; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010	47	57	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27869	27878		10.1074/jbc.M110.133066	http://dx.doi.org/10.1074/jbc.M110.133066			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20584908	Green Published, hybrid			2022-12-25	WOS:000281404100042
J	Liang, B; Duan, BY; Zhou, XP; Gong, JX; Luo, ZG				Liang, Bin; Duan, Bao-Yu; Zhou, Xiu-Ping; Gong, Jia-Xin; Luo, Zhen-Ge			Calpain Activation Promotes BACE1 Expression, Amyloid Precursor Protein Processing, and Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SECRETASE ACTIVITY; IN-VIVO; BRAIN-INJURY; WATER-MAZE; MICE; PRESENILIN-1; NEURODEGENERATION; DEPOSITION; CALCIUM; P25	Abnormal activation of calpain is implicated in synaptic dysfunction and participates in neuronal death in Alzheimer disease (AD) and other neurological disorders. Pharmacological inhibition of calpain has been shown to improve memory and synaptic transmission in the mouse model of AD. However, the role and mechanism of calpain in AD progression remain elusive. Here we demonstrate a role of calpain in the neuropathology in amyloid precursor protein (APP) and presenilin 1 (PS1) double-transgenic mice, an established mouse model of AD. We found that overexpression of endogenous calpain inhibitor calpastatin (CAST) under the control of the calcium/calmodulindependent protein kinase II promoter in APP/PS1 mice caused a remarkable decrease of amyloid plaque burdens and prevented Tau phosphorylation and the loss of synapses. Furthermore, CAST overexpression prevented the decrease in the phosphorylation of the memory-related molecules CREB and ERK in the brain of APP/PS1 mice and improved spatial learning and memory. Interestingly, treatment of cultured primary neurons with amyloid-beta (A beta) peptides caused an increase in the level of beta-site APP-cleaving enzyme 1 (BACE1), the key enzyme responsible for APP processing and A beta production. This effect was inhibited by CAST overexpression. Consistently, overexpression of calpain in heterologous APP expressing cells up-regulated the level of BACE1 and increased A beta production. Finally, CAST transgene prevented the increase of BACE1 in APP/PS1 mice. Thus, calpain activation plays an important role in APP processing and plaque formation, probably by regulating the expression of BACE1.	[Luo, Zhen-Ge] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, ZG (corresponding author), Chinese Acad Sci, Inst Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zgluo@ion.ac.cn	Luo, Zhen-Ge/GNM-7635-2022; zhou, xiuping/AAH-6334-2020; gong, jiaxin/AAL-5510-2020	Luo, Zhen-Ge/0000-0001-5037-0542; gong, jiaxin/0000-0001-5101-3109	National Natural Science Foundation of China [30721004, 30825013]; National Basic Research Program [2006CB806600, 2011CB809002]; Key State Research Program of China [2006CB943900]; Chinese Academy of Sciences [KSCX2-YW-R-102]; Program of Shanghai Subject Chief Scientist [08XD14050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Key State Research Program of China; Chinese Academy of Sciences(Chinese Academy of Sciences); Program of Shanghai Subject Chief Scientist	This work was supported by National Natural Science Foundation of China Grants 30721004 and 30825013, National Basic Research Program Grant 2006CB806600 and 2011CB809002, Key State Research Program of China Grant 2006CB943900, Chinese Academy of Sciences Grant KSCX2-YW-R-102, and Program of Shanghai Subject Chief Scientist Grant 08XD14050.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; BARTUS RT, 1995, NEUROL RES, V17, P249, DOI 10.1080/01616412.1995.11740322; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Brendza RP, 2005, J CLIN INVEST, V115, P428, DOI 10.1172/JCI200523269; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Chen M, 2004, BIOCHEM BIOPH RES CO, V316, P332, DOI 10.1016/j.bbrc.2004.02.052; Chen M, 2000, BIOCHEM BIOPH RES CO, V273, P170, DOI 10.1006/bbrc.2000.2919; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; D'Amore JD, 2003, J NEUROPATH EXP NEUR, V62, P137, DOI 10.1093/jnen/62.2.137; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Frautschy SA, 1998, J NEUROSCI, V18, P8311; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Imahori K, 1997, J BIOCHEM, V121, P179; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kurt MA, 2003, NEUROBIOL DIS, V14, P89, DOI 10.1016/S0969-9961(03)00084-6; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lombardo JA, 2003, J NEUROSCI, V23, P10879, DOI 10.1523/jneurosci.23-34-10879.2003; Ma QL, 2007, J NEUROCHEM, V103, P1594, DOI 10.1111/j.1471-4159.2007.04869.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; Nixon RA, 2000, ANN NY ACAD SCI, V924, P117; Nixon RA, 2003, AGEING RES REV, V2, P407, DOI 10.1016/S1568-1637(03)00029-1; OLIVER MW, 1989, BRAIN RES, V505, P233, DOI 10.1016/0006-8993(89)91448-0; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patzke H, 2003, J NEUROSCI, V23, P2769; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Shelton SB, 2004, J NEUROCHEM, V88, P1313, DOI 10.1111/j.1471-4159.2003.02328.x; STAUBLI U, 1988, BRAIN RES, V444, P153, DOI 10.1016/0006-8993(88)90922-5; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200	67	85	89	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27737	27744		10.1074/jbc.M110.117960	http://dx.doi.org/10.1074/jbc.M110.117960			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20595388	Green Published, hybrid			2022-12-25	WOS:000281404100029
J	Yang, JL; Tadokoro, T; Keijzers, G; Mattson, MP; Bohr, VA				Yang, Jenq-Lin; Tadokoro, Takashi; Keijzers, Guido; Mattson, Mark P.; Bohr, Vilhelm A.			Neurons Efficiently Repair Glutamate-induced Oxidative DNA Damage by a Process Involving CREB-mediated Up-regulation of Apurinic Endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; EXTRACELLULAR-SUPEROXIDE DISMUTASE; ELEMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; POLYMERASE-BETA; MITOCHONDRIAL DYSFUNCTION; PERMEABILITY TRANSITION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE	Glutamate, the major excitatory neurotransmitter in the brain, activates receptors coupled to membrane depolarization and Ca2+ influx that mediates functional responses of neurons including processes such as learning and memory. Here we show that reversible nuclear oxidative DNA damage occurs in cerebral cortical neurons in response to transient glutamate receptor activation using non-toxic physiological levels of glutamate. This DNA damage was prevented by intracellular Ca2+ chelation, the mitochondrial superoxide dismutase mimetic MnTMPyP (Mn-5,10,15,20-tetra(4-pyridyl)-21H, 23H-porphine chloride tetrakis( methochloride)), and blockade of the permeability transition pore. The repair of glutamate-induced DNA damage was associated with increased DNA repair activity and increased mRNA and protein levels of apurinic endonuclease 1 (APE1). APE1 knockdown induced accumulation of oxidative DNA damage after glutamate treatment, suggesting that APE1 is a key repair protein for glutamate-induced DNA damage. A cAMP-response element-binding protein (CREB) binding sequence is present in the Ape1 gene (encodes APE1 protein) promoter and treatment of neurons with a Ca2+/calmodulin-dependent kinase inhibitor (KN-93) blocked the ability of glutamate to induce CREB phosphorylation and APE1 expression. Selective depletion of CREB using RNA interference prevented glutamate-induced up-regulation of APE1. Thus, glutamate receptor stimulation triggers Ca2+- and mitochondrial reactive oxygen species-mediated DNA damage that is then rapidly repaired by a mechanism involving Ca2+-induced, CREB-mediated APE1 expression. Our findings reveal a previously unknown ability of neurons to efficiently repair oxidative DNA lesions after transient activation of glutamate receptors.	[Yang, Jenq-Lin; Tadokoro, Takashi; Keijzers, Guido; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Intramural Res Program, Baltimore, MD 21224 USA; [Yang, Jenq-Lin; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Bohr, VA (corresponding author), 251 Bayview Blvd,Ste 100, Baltimore, MD 21224 USA.	bohrv@grc.nia.nih.gov	Bohr, Vilhelm/AAP-5931-2020; Keijzers, Guido/M-2843-2019; Mattson, Mark P/F-6038-2012	Keijzers, Guido/0000-0001-9353-8042; Yang, Jenq-Lin/0000-0002-9897-8087	National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000312, ZIAAG000331, ZIAAG000735, ZIAAG000313, ZIAAG000727, ZIAAG000317, ZIAAG000314, ZIAAG000723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIA.	Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Balazs R, 2006, CURR TOP MED CHEM, V6, P961, DOI 10.2174/156802606777323700; Baute J, 2008, CRIT REV BIOCHEM MOL, V43, P239, DOI 10.1080/10409230802309905 ; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Bianchi M, 2007, BBA-MOL CELL RES, V1773, P774, DOI 10.1016/j.bbamcr.2007.01.014; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLISS TVP, 1993, NATURE, V31, P361, DOI DOI 10.1038/361031A0.[; Chinopoulos C, 2000, J NEUROSCI, V20, P2094; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Culmsee C, 2001, MOL BRAIN RES, V87, P257, DOI 10.1016/S0169-328X(01)00008-0; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Didier M, 1996, J NEUROSCI, V16, P2238; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Englander EW, 2008, MECH AGEING DEV, V129, P475, DOI 10.1016/j.mad.2008.02.001; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; Grosch S, 1999, BIOCHEM BIOPH RES CO, V261, P859, DOI 10.1006/bbrc.1999.1125; Grosch S, 1998, CANCER RES, V58, P4410; Gwag BJ, 1997, NEUROSCIENCE, V77, P393, DOI 10.1016/S0306-4522(96)00473-3; Hongpaisan J, 2003, MOL CELL NEUROSCI, V24, P1103, DOI 10.1016/j.mcn.2003.09.003; Hongpaisan J, 2004, J NEUROSCI, V24, P10878, DOI 10.1523/JNEUROSCI.3278-04.2004; Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002; Izumi T, 1996, BIOCHEMISTRY-US, V35, P14679, DOI 10.1021/bi961995u; Keller JN, 1998, J NEUROSCI, V18, P687; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Kulkarni A, 2008, NUCLEIC ACIDS RES, V36, P5111, DOI 10.1093/nar/gkn480; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Leutgeb JK, 2005, NEUROSCIENCE, V131, P601, DOI 10.1016/j.neuroscience.2004.12.002; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Li N, 2007, DNA REPAIR, V6, P1297, DOI 10.1016/j.dnarep.2007.02.027; Li YB, 1998, BRAIN RES, V814, P164, DOI 10.1016/S0006-8993(98)01082-8; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Maciel EN, 2001, J NEUROCHEM, V79, P1237, DOI 10.1046/j.1471-4159.2001.00670.x; Mandir AS, 2000, J NEUROSCI, V20, P8005; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; MATTSON MP, 1993, EXP NEUROL, V121, P1, DOI 10.1006/exnr.1993.1066; Miller FD, 2000, CELL DEATH DIFFER, V7, P880, DOI 10.1038/sj.cdd.4400736; Morris EJ, 1999, BIOTECHNIQUES, V26, P282, DOI 10.2144/99262st02; OKAZAKI T, 1994, J BIOL CHEM, V269, P27855; Raffoul JJ, 2004, J BIOL CHEM, V279, P18425, DOI 10.1074/jbc.M313983200; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Sengpiel B, 1998, EUR J NEUROSCI, V10, P1903, DOI 10.1046/j.1460-9568.1998.00202.x; SODERLING TR, 1994, J NEUROBIOL, V25, P304, DOI 10.1002/neu.480250310; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Thiels E, 2000, J NEUROSCI, V20, P7631; Uz T, 1996, NEUROSCIENCE, V73, P631, DOI 10.1016/0306-4522(96)00155-8; Vasko MR, 2005, DNA REPAIR, V4, P367, DOI 10.1016/j.dnarep.2004.11.006; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wei F, 2006, J NEUROSCI, V26, P851, DOI 10.1523/JNEUROSCI.3292-05.2006; Wei W, 2008, J NEUROCHEM, V107, P734, DOI 10.1111/j.1471-4159.2008.05644.x; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; Weissman L, 2009, NEUROBIOL AGING, V30, P2080, DOI 10.1016/j.neurobiolaging.2008.02.014; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yoo DG, 2008, LUNG CANCER, V60, P277, DOI 10.1016/j.lungcan.2007.10.015; Zhao JF, 2008, J BIOL CHEM, V283, P9925, DOI 10.1074/jbc.M708345200	63	77	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					28191	28199		10.1074/jbc.M109.082883	http://dx.doi.org/10.1074/jbc.M109.082883			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20573957	Green Published, hybrid			2022-12-25	WOS:000281404100062
J	Bhattacharyya, S; Rajan, RE; Swarupa, Y; Rathore, U; Verma, A; Udaykumar, R; Varadarajan, R				Bhattacharyya, Sanchari; Rajan, Roshan Elizabeth; Swarupa, Yalla; Rathore, Ujjwal; Verma, Anjali; Udaykumar, Ranga; Varadarajan, Raghavan			Design of a Non-glycosylated Outer Domain-derived HIV-1 gp120 Immunogen That Binds to CD4 and Induces Neutralizing Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECOMBINANT GLYCOPROTEIN-120 VACCINE; ENVELOPE GLYCOPROTEINS; CD4-BINDING SITE; MYCOBACTERIUM-W; FAB FRAGMENTS; ENV CLONES; EPITOPE; INFECTIONS; PROTEIN	The outer domain (OD) of the HIV-1 envelope glycoprotein gp120 is an important target for vaccine design as it contains a number of conserved epitopes, including a large fraction of the CD4 binding site. Attempts to design OD-based immunogens in the past have met with little success. We report the design and characterization of an Escherichia coli-expressed OD-based immunogen (ODEC), based on the sequence of the HxBc2 strain. The ODEC-designed immunogen lacks the variable loops V1V2 and V3 and incorporates 11 designed mutations at the interface of the inner and the outer domains of gp120. Biophysical studies showed that ODEC is folded and protease-resistant, whereas ODEC lacking the designed mutations is highly aggregation-prone. In contrast to previously characterized OD constructs, ODEC bound CD4 and the broadly neutralizing antibody b12 but not the non-neutralizing antibodies b6 and F105. Upon immunization in rabbits, ODEC was highly immunogenic, and the sera showed measurable neutralization for four subtype B and one subtype C virus including two b12-resistant viruses. In contrast, sera from rabbits immunized with gp120 did not neutralize any of the viruses. ODEC is the first example of a gp120 fragment-based immunogen that yields significant neutralizing antibodies.	[Bhattacharyya, Sanchari; Rathore, Ujjwal; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Varadarajan, Raghavan] Jawaharlal Nehru Ctr Adv Sci Res, Chem Biol Unit, Bangalore 560064, Karnataka, India; [Rajan, Roshan Elizabeth; Swarupa, Yalla; Verma, Anjali; Udaykumar, Ranga] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	varadar@mbu.iisc.ernet.in	Rathore, Ujjwal/AAD-9974-2021; Bhattacharyya, Sanchari/L-4344-2019	Rathore, Ujjwal/0000-0002-0329-7431; Bhattacharyya, Sanchari/0000-0003-3421-4755	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Biotechnology, Government of India (to R. V. and R. U.).; Recipient of a fellowship from Council of Scientific and Industrial Research, Government of India.	Banerjee K, 2009, VIROLOGY, V389, P108, DOI 10.1016/j.virol.2009.04.001; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Chen H, 2008, J GEN VIROL, V89, P2597, DOI 10.1099/vir.0.2008/003491-0; Chen HY, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-33; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; FENOUILLET E, 1994, TRENDS BIOCHEM SCI, V19, P65, DOI 10.1016/0968-0004(94)90034-5; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Graham BS, 1998, J INFECT DIS, V177, P310, DOI 10.1086/514209; GRAHAM BS, 1995, NEW ENGL J MED, V333, P1331, DOI 10.1056/NEJM199511163332007; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Grundner C, 2004, VIROLOGY, V330, P233, DOI 10.1016/j.virol.2004.08.037; Gupta A, 2009, INFECT IMMUN, V77, P223, DOI 10.1128/IAI.00526-08; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; MONTEFIORI DC, 2004, CURRENT PROTOCOLS IM, P1; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Prajapati RS, 2007, BIOCHEMISTRY-US, V46, P10339, DOI 10.1021/bi700577m; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; REDDI PP, 1994, INT J LEPROSY, V62, P229; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Sharma D, 2005, BIOCHEMISTRY-US, V44, P16192, DOI 10.1021/bi051120s; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Varadarajan R, 2005, J VIROL, V79, P1713, DOI 10.1128/JVI.79.3.1713-1723.2005; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	51	28	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27100	27110		10.1074/jbc.M110.152272	http://dx.doi.org/10.1074/jbc.M110.152272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20558728	hybrid, Green Published			2022-12-25	WOS:000281172700041
J	Foley, DA; Swartzentruber, KG; Lavie, A; Colley, KJ				Foley, Deirdre A.; Swartzentruber, Kristin G.; Lavie, Arnon; Colley, Karen J.			Structure and Mutagenesis of Neural Cell Adhesion Molecule Domains EVIDENCE FOR FLEXIBILITY IN THE PLACEMENT OF POLYSIALIC ACID ATTACHMENT SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ST8SIA II STX; N-CAM; HUMAN POLYSIALYLTRANSFERASE; NCAM; POLYSIALYLATION; EXPRESSION; TUMOR; PST; LOCALIZATION; PLASTICITY	The addition of alpha 2,8-polysialic acid to the N-glycans of the neural cell adhesion molecule, NCAM, is critical for brain development and plays roles in synaptic plasticity, learning and memory, neuronal regeneration, and the growth and invasiveness of cancer cells. Our previous work indicates that the polysialylation of two N-glycans located on the fifth immunoglobulin domain (Ig5) of NCAM requires the presence of specific sequences in the adjacent fibronectin type III repeat (FN1). To understand the relationship of these two domains, we have solved the crystal structure of the NCAM Ig5-FN1 tandem. Unexpectedly, the structure reveals that the sites of Ig5 polysialylation are on the opposite face from the FN1 residues previously found to be critical for N-glycan polysialylation, suggesting that the Ig5-FN1 domain relationship may be flexible and/or that there is flexibility in the placement of Ig5 glycosylation sites for polysialylation. To test the latter possibility, new Ig5 glycosylation sites were engineered and their polysialylation tested. We observed some flexibility in glycosylation site location for polysialylation and demonstrate that the lack of polysialylation of a glycan attached to Asn-423 may be in part related to a lack of terminal processing. The data also suggest that, although the polysialyltransferases do not require the Ig5 domain for NCAM recognition, their ability to engage with this domain is necessary for polysialylation to occur on Ig5 N-glycans.	[Foley, Deirdre A.; Swartzentruber, Kristin G.; Lavie, Arnon; Colley, Karen J.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu	Lavie, Arnon/H-4927-2012	Lavie, Arnon/0000-0001-5591-8722	National Institutes of Health [RO1 GM063843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM063843 (to K. J. C.).	Albach C, 2004, ANAL BIOANAL CHEM, V378, P1129, DOI 10.1007/s00216-003-2383-2; Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Atkins AR, 2001, J MOL BIOL, V311, P161, DOI 10.1006/jmbi.2001.4861; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; Carafoli F, 2008, J MOL BIOL, V377, P524, DOI 10.1016/j.jmb.2008.01.030; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Durbec P, 2001, MOL NEUROBIOL, V24, P53; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Gluer S, 1998, J PEDIATR SURG, V33, P1516, DOI 10.1016/S0022-3468(98)90488-2; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hildebrandt H, 1998, CANCER RES, V58, P779; Jensen PH, 1999, NAT STRUCT BIOL, V6, P486; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kasper C, 2000, NAT STRUCT BIOL, V7, P389; Kiselyov VV, 1997, J BIOL CHEM, V272, P10125; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; KOMMINOTH P, 1991, AM J PATHOL, V139, P297; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; PELKONEN S, 1989, J VIROL, V63, P4409, DOI 10.1128/JVI.63.10.4409-4416.1989; Ranheim TS, 1996, P NATL ACAD SCI USA, V93, P4071, DOI 10.1073/pnas.93.9.4071; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tanaka F, 2000, CANCER RES, V60, P3072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wuhrer M, 2003, BIOCHIMIE, V85, P207, DOI 10.1016/S0300-9084(03)00043-9; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZUBER C, 1992, J BIOL CHEM, V267, P9965	64	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27360	27371		10.1074/jbc.M110.140038	http://dx.doi.org/10.1074/jbc.M110.140038			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573953	Green Published, hybrid			2022-12-25	WOS:000281172700065
J	Liu, Y; Li, PK; Li, CL; Lin, JY				Liu, Yan; Li, Pui-Kai; Li, Chenglong; Lin, Jiayuh			Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA; TUMOR MICROENVIRONMENT; EPITHELIAL-CELLS; VEGF EXPRESSION; AUTOCRINE IL-6; MYELOMA CELLS; UP-REGULATION; IN-VIVO; INTERLEUKIN-6	Interleukin-6 (IL-6) is a multifunctional cytokine, which may block apoptosis during inflammation to protect cells under very toxic conditions. However, IL-6 also activates STAT3 in many types of human cancer. Recent studies demonstrate that high levels of IL-6 are associated with hepatocellular carcinoma, the most common type of liver cancer. Here we reported that IL-6 promoted survival of human liver cancer cells through activating STAT3 in response to doxorubicin treatment. Endogenous IL-6 levels in SNU-449 cells were higher than in Hep3B cells. Meanwhile, SNU-449 cells were more resistant to doxorubicin than Hep3B cells. Addition of IL-6 induced STAT3 activation in Hep3B cells and led to protection against doxorubicin. In contrast, neutralizing IL-6 with anti-IL-6 antibody decreased survival of SNU-449 cells in response to doxorubicin. To elucidate the mechanism of the anti-apoptotic function of IL-6, we investigated if STAT3 mediated this drug resistance. Targeting STAT3 with STAT3 siRNA reduced the protection of IL-6 against doxorubicin-induced apoptosis, indicating that STAT3 signaling contributed to the anti-apoptotic effect of IL-6. Moreover, we further explored if a STAT3 small molecule inhibitor could abolish this anti-apoptotic effect. LLL12, a STAT3 small molecule inhibitor, blocked IL-6-induced STAT3 phosphorylation, resulting in attenuation of the anti-apoptotic activity of IL-6. Finally, neutralization of endogenous IL-6 with anti-IL-6 antibody or blockade of STAT3 with LLL12 lowered the recovery in SNU-449 cells after doxorubicin treatment. Therefore, our results demonstrated that targeting STAT3 signaling could interrupt the anti-apoptotic function of IL-6 in human liver cancer cells.	[Liu, Yan; Lin, Jiayuh] Ohio State Univ, Ctr Childhood Canc, Dept Pediat, Nationwide Childrens Hosp,Res Inst, Columbus, OH 43205 USA; [Li, Pui-Kai; Li, Chenglong] Ohio State Univ, Div Med Chem & Pharmacognosy, Coll Pharm, Columbus, OH 43205 USA; [Lin, Jiayuh] Ohio State Univ, Expt Therapeut Program, Ctr Comprehens Canc, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lin, JY (corresponding author), Ohio State Univ, Ctr Childhood Canc, Dept Pediat, Coll Med, 700 Childrens Dr, Columbus, OH 43205 USA.	lin.674@osu.edu	Lin, Jiayuh/E-3515-2011; Li, Chenglong/E-7182-2010	Li, Chenglong/0000-0003-3174-8719; Li, Pui Kai/0000-0002-4831-7213	National Institutes of Health [R21CA133652-01]; Pancreatic Cancer Action Network-AACR, National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R21CA133652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pancreatic Cancer Action Network-AACR, National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health R21 Grant R21CA133652-01 (to J. L.). This work was also supported by a Pancreatic Cancer Action Network-AACR, National Foundation for Cancer Research grant.	Amin HM, 2004, ONCOGENE, V23, P5426, DOI 10.1038/sj.onc.1207703; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Choudhari SR, 2007, MOL CANCER THER, V6, P112, DOI 10.1158/1535-7163.MCT-06-0561; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Gao LF, 2005, CLIN CANCER RES, V11, P6333, DOI 10.1158/1078-0432.CCR-05-0148; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hodge DR, 2002, BIOCHEM BIOPH RES CO, V292, P287, DOI 10.1006/bbrc.2002.6652; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kudo M, 2009, J NEUROSURG, V111, P219, DOI 10.3171/2008.12.JNS081284; Leu CM, 2003, ONCOGENE, V22, P7809, DOI 10.1038/sj.onc.1207084; Li GH, 2009, J NEURO-ONCOL, V91, P165, DOI 10.1007/s11060-008-9696-0; Lin L, 2010, NEOPLASIA, V12, P39, DOI 10.1593/neo.91196; Lin MT, 2001, CARCINOGENESIS, V22, P1947, DOI 10.1093/carcin/22.12.1947; Liu SQ, 2010, EUR J HAEMATOL, V84, P137, DOI 10.1111/j.1600-0609.2009.01365.x; Lou W, 2000, PROSTATE, V42, P239, DOI 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G; Malinowska K, 2009, ENDOCR-RELAT CANCER, V16, P155, DOI 10.1677/ERC-08-0174; Meng F, 2006, J HEPATOL, V44, P1055, DOI 10.1016/j.jhep.2005.10.030; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Rabinovich A, 2007, ANTICANCER RES, V27, P267; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Santer FR, 2010, ENDOCR-RELAT CANCER, V17, P241, DOI 10.1677/ERC-09-0200; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Smith PC, 2001, PROSTATE, V48, P47; Spiotto MT, 2000, PROSTATE, V42, P88, DOI 10.1002/(SICI)1097-0045(20000201)42:2<88::AID-PROS2>3.0.CO;2-P; Spiotto MT, 2000, PROSTATE, V42, P186, DOI 10.1002/(SICI)1097-0045(20000215)42:3<186::AID-PROS4>3.0.CO;2-E; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Wei LH, 2001, ONCOGENE, V20, P5799, DOI 10.1038/sj.onc.1204733; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yu CY, 2002, ONCOGENE, V21, P3949, DOI 10.1038/sj.onc.1205499; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	54	127	135	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27429	27439		10.1074/jbc.M110.142752	http://dx.doi.org/10.1074/jbc.M110.142752			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20562100	Green Published, hybrid			2022-12-25	WOS:000281172700072
J	Hohle, TH; O'Brian, MR				Hohle, Thomas H.; O'Brian, Mark R.			Transcriptional Control of the Bradyrhizobium japonicum irr Gene Requires Repression by Fur and Antirepression by Irr	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON RESPONSE REGULATOR; RHIZOBIUM-LEGUMINOSARUM; SINORHIZOBIUM-MELILOTI; HEME-BIOSYNTHESIS; ALPHA-PROTEOBACTERIA; BINDING SITES; PROTEIN; MANGANESE; EXPRESSION; DEGRADATION	Bradyrhizobium japonicum Fur mediates manganese-responsive transcriptional control of the mntH gene independently of iron, but it also has been implicated in iron-dependent regulation of the irr gene. Thus, we sought to address the apparent discrepancy in Fur responsiveness to metals. Irr is a transcriptional regulator found in iron-limited cells. Here, we show that irr gene mRNA was regulated by both iron and manganese, and repression occurred only in the presence of both metals. Under these conditions, Fur occupied the irr promoter in vivo in the parent strain, and irr mRNA expression was derepressed in a fur mutant. Under low iron conditions, the irr promoter was occupied by Irr, but not by Fur, and control by manganese was lost. Fur occupancy of the irr promoter was dependent on manganese, but not iron, in an irr mutant, suggesting that Irr normally interferes with Fur binding. Correspondingly, regulation of irr mRNA was dependent only on manganese in the irr strain. The Irr binding site within the irr promoter partially overlaps the Fur binding site. DNase I footprinting analysis showed that Irr interfered with Fur binding in vitro. In addition, Fur repression of transcription from the irr promoter in vitro was relieved by Irr. We conclude that Fur mediates manganese-dependent repression of irr transcription and that Irr acts as an antirepressor under iron limitation by preventing Fur binding to the promoter.	[Hohle, Thomas H.; O'Brian, Mark R.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	O'Brian, MR (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY 14214 USA.	mrobrian@buffalo.edu			National Institutes of Health [R01 GM067966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM067966 to (M. R. O'B.).	Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Chao TC, 2004, J BACTERIOL, V186, P3609, DOI 10.1128/JB.186.11.3609-3620.2004; Diaz-Mireles E, 2005, MICROBIOL-SGM, V151, P4071, DOI 10.1099/mic.0.28342-0; Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Friedman YE, 2004, J BIOL CHEM, V279, P32100, DOI 10.1074/jbc.M404924200; Friedman YE, 2003, J BIOL CHEM, V278, P38395, DOI 10.1074/jbc.M306710200; FRUSTACI JM, 1991, J BACTERIOL, V173, P1145, DOI 10.1128/jb.173.3.1145-1150.1991; Hamza I, 1999, J BACTERIOL, V181, P5843, DOI 10.1128/JB.181.18.5843-5846.1999; Hamza I, 1998, J BIOL CHEM, V273, P21669, DOI 10.1074/jbc.273.34.21669; Hamza I, 2000, MICROBIOL-SGM, V146, P669, DOI 10.1099/00221287-146-3-669; Hohle TH, 2009, MOL MICROBIOL, V72, P399, DOI 10.1111/j.1365-2958.2009.06650.x; Johnston AWB, 2007, BIOMETALS, V20, P501, DOI 10.1007/s10534-007-9085-8; Martinez M, 2005, MICROBIOL-SGM, V151, P3427, DOI 10.1099/mic.0.28213-0; Platero R, 2004, APPL ENVIRON MICROB, V70, P4349, DOI 10.1128/AEM.70.7.4349-4355.2004; Platero R, 2007, APPL ENVIRON MICROB, V73, P4832, DOI 10.1128/AEM.00686-07; Puri S, 2010, P NATL ACAD SCI USA, V107, P10691, DOI 10.1073/pnas.1002342107; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Rudolph G, 2006, J BACTERIOL, V188, P733, DOI 10.1128/JB.188.2.733-744.2006; Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x; Sangwan I, 2008, J BACTERIOL, V190, P5172, DOI 10.1128/JB.00495-08; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Small SK, 2009, J BACTERIOL, V191, P1361, DOI 10.1128/JB.01571-08; Small S, 2009, BIOMETALS, V22, P89, DOI 10.1007/s10534-008-9192-1; Todd JD, 2006, MOL GENET GENOMICS, V275, P564, DOI 10.1007/s00438-006-0115-y; Yang J, 2006, MOL MICROBIOL, V60, P209, DOI 10.1111/j.1365-2958.2006.05087.x; Yang JH, 2006, MOL MICROBIOL, V60, P427, DOI 10.1111/j.1365-2958.2006.05101.x; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yang JH, 2006, MOL GENET GENOMICS, V276, P555, DOI 10.1007/s00438-006-0162-4	31	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26074	26080		10.1074/jbc.M110.145979	http://dx.doi.org/10.1074/jbc.M110.145979			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20573962	hybrid, Green Published			2022-12-25	WOS:000280921000023
J	Wiseman, B; Carpena, X; Feliz, M; Donald, LJ; Pons, M; Fita, I; Loewen, PC				Wiseman, Ben; Carpena, Xavi; Feliz, Miguel; Donald, Lynda J.; Pons, Miquel; Fita, Ignacio; Loewen, Peter C.			Isonicotinic Acid Hydrazide Conversion to Isonicotinyl-NAD by Catalase-peroxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS KATG; X-RAY ANALYSIS; ISONIAZID RESISTANCE; BURKHOLDERIA-PSEUDOMALLEI; SUPEROXIDE REACTIVITY; CRYSTAL-STRUCTURE; EPR SPECTROSCOPY; OXIDATION; BINDING; INHA	Activation of the pro-drug isoniazid (INH) as an anti-tubercular drug in Mycobacterium tuberculosis involves its conversion to isonicotinyl-NAD, a reaction that requires the catalase-peroxidase KatG. This report shows that the reaction proceeds in the absence of KatG at a slow rate in a mixture of INH, NAD(+), Mn2+, and O-2, and that the inclusion of KatG increases the rate by >7 times. Superoxide, generated by either Mn2+- or KatG-catalyzed reduction of O-2, is an essential intermediate in the reaction. Elimination of the peroxidatic process by mutation slows the rate of reaction by 60% revealing that the peroxidatic process enhances, but is not essential for isonicotinyl-NAD formation. The isonicotinyl-NAD(center dot+) radical is identified as a reaction intermediate, and its reduction by superoxide is proposed. Binding sites for INH and its co-substrate, NAD(+), are identified for the first time in crystal complexes of Burkholderia pseudomallei catalase-peroxidase with INH and NAD(+) grown by co-crystallization. The best defined INH binding sites were identified, one in each subunit, on the opposite side of the protein from the entrance to the heme cavity in a funnel-shaped channel. The NAD(+) binding site is similar to 20 angstrom from the entrance to the heme cavity and involves interactions primarily with the AMP portion of the molecule in agreement with the NMR saturation transfer difference results.	[Loewen, Peter C.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Donald, Lynda J.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Carpena, Xavi; Pons, Miquel; Fita, Ignacio] Inst Biomed Res, Barcelona 08028, Spain; [Carpena, Xavi; Fita, Ignacio] Inst Mol Biol, Barcelona 08028, Spain; [Feliz, Miguel; Pons, Miquel] Univ Barcelona, Dept Organ Chem, E-08028 Barcelona, Spain	University of Manitoba; University of Manitoba; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Barcelona	Loewen, PC (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	ploewen@ms.umanitoba.ca	pons, miquel/C-8657-2011; Fita, Ignasi/R-4515-2019; Carpena, Xavi/J-5877-2017; Feliz, Miguel/F-3792-2016	pons, miquel/0000-0002-0586-8322; Fita, Ignasi/0000-0002-7521-2679; Carpena, Xavi/0000-0002-8646-0440; Feliz, Miguel/0000-0002-7676-3309; Wiseman, Benjamin/0000-0002-2994-5839	Natural Sciences and Engineering Research Council (NSERC) of Canada [9600]; Canada Research Chair; NSERC; National Research Council; Canadian Institutes for Health Research; University of Saskatchewan; Spanish Ministry of Science and Innovation; Generalitat de Catalunya [SGR2009-1352];  [BFU2005-08686-C02-01];  [BIO2007-63458]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ; 	This work was supported by a Discovery Grant 9600 from the Natural Sciences and Engineering Research Council (NSERC) of Canada (to P. C. L.) and by the Canada Research Chair Program (to P. C. L.). The diffraction data were collected at the Canadian Light Source, which is supported by NSERC, National Research Council, Canadian Institutes for Health Research, and the University of Saskatchewan. This work was supported by Grants BFU2005-08686-C02-01 (to I. F.), BIO2007-63458 (to M. P.), both from the Spanish Ministry of Science and Innovation, and SGR2009-1352 (to M. P.) from the Generalitat de Catalunya.	Amos RIJ, 2008, CHEM COMMUN, P1695, DOI 10.1039/b719570b; AUCLAIR C, 1978, FEBS LETT, V89, P26, DOI 10.1016/0014-5793(78)80514-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Carpena X, 2005, EMBO REP, V6, P1156, DOI 10.1038/sj.embor.7400550; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; Carpena X, 2002, ACTA CRYSTALLOGR D, V58, P2184, DOI 10.1107/S0907444902017869; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Colin J, 2009, J AM CHEM SOC, V131, P8557, DOI 10.1021/ja901402v; Deemagarn T, 2005, J MOL BIOL, V345, P21, DOI 10.1016/j.jmb.2004.10.020; Deemagarn T, 2007, PROTEINS, V66, P219, DOI 10.1002/prot.21209; DUNFORD HB, 1999, HEME PEROXIDASES, P97; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARRINGTON JA, 1980, BIOCHIM BIOPHYS ACTA, V590, P273, DOI 10.1016/0005-2728(80)90031-6; Ghiladi RA, 2005, J AM CHEM SOC, V127, P13428, DOI 10.1021/ja054366t; Ghiladi RA, 2004, J AM CHEM SOC, V126, P4772, DOI 10.1021/ja031728t; Klein J, 1999, J AM CHEM SOC, V121, P5336, DOI 10.1021/ja990706x; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8; Lei BF, 2000, J BIOL CHEM, V275, P2520, DOI 10.1074/jbc.275.4.2520; Loboda AV, 2000, RAPID COMMUN MASS SP, V14, P1047, DOI 10.1002/1097-0231(20000630)14:12<1047::AID-RCM990>3.0.CO;2-E; Magliozzo RS, 1996, J AM CHEM SOC, V118, P11303, DOI 10.1021/ja962047j; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Metcalfe C, 2008, J BIOL CHEM, V283, P6193, DOI 10.1074/jbc.M707412200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pierattelli R, 2004, J BIOL CHEM, V279, P39000, DOI 10.1074/jbc.M402384200; Rawat R, 2003, P NATL ACAD SCI USA, V100, P13881, DOI 10.1073/pnas.2235848100; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHOEB HA, 1985, ANTIMICROB AGENTS CH, V27, P399, DOI 10.1128/AAC.27.3.399; SHOEB HA, 1985, ANTIMICROB AGENTS CH, V27, P404, DOI 10.1128/AAC.27.3.404; SHOEB HA, 1985, ANTIMICROB AGENTS CH, V27, P408, DOI 10.1128/AAC.27.3.408; Singh AK, 2010, J BIOL CHEM, V285, P1569, DOI 10.1074/jbc.M109.060327; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; Singh R, 2008, ARCH BIOCHEM BIOPHYS, V471, P207, DOI 10.1016/j.abb.2007.12.008; Singh R, 2007, J AM CHEM SOC, V129, P15954, DOI 10.1021/ja075108u; Todorovic S, 1999, J AM CHEM SOC, V121, P10962, DOI 10.1021/ja9918674; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Wada K, 2002, ACTA CRYSTALLOGR D, V58, P157, DOI 10.1107/S0907444901017735; Wang JY, 1998, ANTIMICROB AGENTS CH, V42, P709, DOI 10.1128/AAC.42.3.709; Wengenack NL, 1997, J INFECT DIS, V176, P722, DOI 10.1086/514096; Wengenack NL, 1999, J AM CHEM SOC, V121, P9748, DOI 10.1021/ja992590a; Wengenack NL, 2001, BIOCHEMISTRY-US, V40, P8990, DOI 10.1021/bi002614m; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Yamada Y, 2001, ACTA CRYSTALLOGR D, V57, P1157, DOI 10.1107/S0907444901008927; Zabinski RF, 1997, J AM CHEM SOC, V119, P2331, DOI 10.1021/ja9639731; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o	50	51	52	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26662	26673		10.1074/jbc.M110.139428	http://dx.doi.org/10.1074/jbc.M110.139428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20554537	hybrid, Green Published			2022-12-25	WOS:000280921000081
J	Phillips, D; Reilley, MJ; Aponte, AM; Wang, GH; Boja, E; Gucek, M; Balaban, RS				Phillips, Darci; Reilley, Matthew J.; Aponte, Angel M.; Wang, Guanghui; Boja, Emily; Gucek, Marjan; Balaban, Robert S.			Stoichiometry of STAT3 and Mitochondrial Proteins IMPLICATIONS FOR THE REGULATION OF OXIDATIVE PHOSPHORYLATION BY PROTEIN-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART; CELL; PHOSPHOPROTEOME; DYNAMICS; BIOLOGY	The signal transducer and activator of transcription 3 (STAT3) is a transcription factor and downstream product of cytokine and growth factor pathways. Among members of the STAT family, STAT3 has garnered particular interest due to its role in cancer and development. Recently, it was proposed that STAT3 regulates cardiac ATP generation in vivo through protein interaction with the mitochondrial complexes of oxidative phosphorylation, specifically Complexes I/II. For this mechanism to work effectively, the cellular ratio of Complexes I/II and STAT3 must approach one. However, using three different proteomic approaches in cardiac tissue, we determined the ratio of Complexes I/II and STAT3 to be similar to 10(5). This finding suggests that direct protein interaction between Complexes I/II and STAT3 cannot be required for optimal ATP production, nor can it dramatically modulate oxidative phosphorylation in vivo. Thus, STAT3 is likely altering mitochondrial function via transcriptional regulation or indirect signaling pathways that warrant further investigation.	[Phillips, Darci; Reilley, Matthew J.; Balaban, Robert S.] NHLBI, Cardiac Energet Lab, NIH, Bethesda, MD 20892 USA; [Aponte, Angel M.; Wang, Guanghui; Boja, Emily; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Balaban, RS (corresponding author), 9000 Rockville Pike,Bldg 10,Rm B1D 416, Bethesda, MD 20892 USA.	balabanr@nhlbi.nih.gov		Phillips, Darci/0000-0002-0804-3342	National Institutes of Health Division of Intramural Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005903, ZIAHL004601] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Division of Intramural Research.	Aponte AM, 2009, J PROTEOME RES, V8, P2679, DOI 10.1021/pr800913j; Balaban RS, 2006, ANN NY ACAD SCI, V1080, P140, DOI 10.1196/annals.1380.013; Balaban RS, 1996, ANAL BIOCHEM, V237, P274, DOI 10.1006/abio.1996.0239; Boja ES, 2009, J PROTEOME RES, V8, P4665, DOI 10.1021/pr900387b; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; GOMEZFERNANDEZ JC, 1978, BIOCHEM J, V176, P967, DOI 10.1042/bj1760967; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Hopper RK, 2006, BIOCHEMISTRY-US, V45, P2524, DOI 10.1021/bi052475e; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Mootha VK, 1997, AM J PHYSIOL-HEART C, V272, pH769, DOI 10.1152/ajpheart.1997.272.2.H769; Myers MG, 2009, SCIENCE, V323, P723, DOI 10.1126/science.1169660; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Phillips D, 2010, J MOL CELL CARDIOL, V48, P582, DOI 10.1016/j.yjmcc.2009.10.033; Phillips D, 2009, BIOCHEMISTRY-US, V48, P7140, DOI 10.1021/bi900725c; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; RIPPERGER JA, 1995, J BIOL CHEM, V270, P29998, DOI 10.1074/jbc.270.50.29998; Schagger H, 2001, J BIOL CHEM, V276, P37861; VOLPE P, 1970, EUR J BIOCHEM, V12, P195, DOI 10.1111/j.1432-1033.1970.tb00837.x; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Zeiser S, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-11	22	68	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 30	2010	285	31					23532	23536		10.1074/jbc.C110.152652	http://dx.doi.org/10.1074/jbc.C110.152652			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	630RT	20558729	Green Published, hybrid			2022-12-25	WOS:000280291400002
J	Delogu, M; De Marco, MA; Di Trani, L; Raffini, E; Cotti, C; Puzelli, S; Ostanello, F; Webster, RG; Cassone, A; Donatelli, I				Delogu, Mauro; De Marco, Maria A.; Di Trani, Livia; Raffini, Elisabetta; Cotti, Claudia; Puzelli, Simona; Ostanello, Fabio; Webster, Robert G.; Cassone, Antonio; Donatelli, Isabella			Can Preening Contribute to Influenza A Virus Infection in Wild Waterbirds?	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; THIOESTERASE GENE; UROPYGIAL GLAND; MALLARD DUCKS; H5N1; BIRDS; PERSISTENCE; WATERFOWL; FEATHERS; BEHAVIOR	Wild aquatic birds in the Orders Anseriformes and Charadriiformes are the main reservoir hosts perpetuating the genetic pool of all influenza A viruses, including pandemic viruses. High viral loads in feces of infected birds permit a fecal-oral route of transmission. Numerous studies have reported the isolation of avian influenza viruses (AIVs) from surface water at aquatic bird habitats. These isolations indicate aquatic environments have an important role in the transmission of AIV among wild aquatic birds. However, the progressive dilution of infectious feces in water could decrease the likelihood of virus/host interactions. To evaluate whether alternate mechanisms facilitate AIV transmission in aquatic bird populations, we investigated whether the preen oil gland secretions by which all aquatic birds make their feathers waterproof could support a natural mechanism that concentrates AIVs from water onto birds' bodies, thus, representing a possible source of infection by preening activity. We consistently detected both viral RNA and infectious AIVs on swabs of preened feathers of 345 wild mallards by using reverse transcription-polymerase chain reaction (RT-PCR) and virus-isolation (VI) assays. Additionally, in two laboratory experiments using a quantitative real-time (qR) RT-PCR assay, we demonstrated that feather samples (n=5) and cotton swabs (n = 24) experimentally impregnated with preen oil, when soaked in AIV-contaminated waters, attracted and concentrated AIVs on their surfaces. The data presented herein provide information that expands our understanding of AIV ecology in the wild bird reservoir system.	[Delogu, Mauro; Cotti, Claudia; Ostanello, Fabio] Univ Bologna, Fac Vet Med, Dept Vet Publ Hlth & Anim Pathol, Ozzano Dell Emilia, Italy; [De Marco, Maria A.; Puzelli, Simona; Cassone, Antonio; Donatelli, Isabella] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Di Trani, Livia] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Raffini, Elisabetta] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Lugo, Italy; [Webster, Robert G.] St Jude Childrens Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	University of Bologna; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); IZS Lombardia e Emilia; St Jude Children's Research Hospital	Delogu, M (corresponding author), Univ Bologna, Fac Vet Med, Dept Vet Publ Hlth & Anim Pathol, Ozzano Dell Emilia, Italy.	mauro.delogu@unibo.it	Ostanello, Fabio/L-7225-2015; Ostanello, Fabio/AAC-3402-2019; Cassone, Antonio/J-4666-2019; Puzelli, Simona/C-2542-2016	Ostanello, Fabio/0000-0003-1122-8628; Ostanello, Fabio/0000-0003-1122-8628; Puzelli, Simona/0000-0003-4497-9719	University of Bologna	University of Bologna	This work was supported by 2006 and 2008 RFO grants from the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Capua I, 2000, VET REC, V147, P640; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; COTGREAVE P, 1994, BEHAVIOUR, V131, P171, DOI 10.1163/156853994X00424; DAUB BC, 1989, J FIELD ORNITHOL, V60, P305; De Marco MA, 2004, VET MICROBIOL, V98, P197, DOI 10.1016/j.vetmic.2003.10.018; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; DELOGU M, 2008, AVIAN INFLUENZA RES, P91; Di Trani L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-87; DONATELLI IDE, 2008, RES SIGNPOST, V37, P1; Ellstrom P, 2008, VACCINE, V26, P4414, DOI 10.1016/j.vaccine.2008.06.027; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; Feare CJ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-96; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Henson Shandelle M., 2007, Journal of Biological Dynamics, V1, P95, DOI 10.1080/17513750601032679; JACOB J, 1978, J LIPID RES, V19, P148; Khalenkov A, 2008, J VIROL METHODS, V149, P180, DOI 10.1016/j.jviromet.2008.01.001; KOLATTUKUDY PE, 1985, J BIOL CHEM, V260, P789; KOLATTUKUDY PE, 1991, ARCH BIOCHEM BIOPHYS, V284, P201, DOI 10.1016/0003-9861(91)90284-P; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lebarbenchon C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007289; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Melville DS, 2006, LETT APPL MICROBIOL, V42, P435, DOI 10.1111/j.1472-765X.2006.01892.x; Montalti D., 2000, ORNITOL NEOTROP, V11, P297; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Puzelli S, 2004, J MED VIROL, V74, P629, DOI 10.1002/jmv.20225; Reneerkens J., 2006, ACTA ZOOLOGICA SINCA, V52, P272; Rijpstra WIC, 2007, J NAT PROD, V70, P1804, DOI 10.1021/np070254z; ROEPKE DC, 1989, AVIAN DIS, V33, P649, DOI 10.2307/1591139; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; ROSE K, 2006, FAO ANIMAL PRODUCTIO, V4; ROSE K, 2006, 4 FAO; ROWE RA, 1983, WILSON BULL, V95, P690; SIEBINGA JT, 1988, ARCH VIROL, V100, P75, DOI 10.1007/BF01310909; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; Tsiodras S, 2008, J INFECTION, V56, P83, DOI 10.1016/j.jinf.2007.11.001; UVA B, 1983, ACTA HISTOCHEM, V73, P175, DOI 10.1016/S0065-1281(83)80026-9; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Villegas P., 2006, LAB MANUAL ISOLATION, P248; Wachtmeister CA, 2001, ANIM BEHAV, V61, P861, DOI 10.1006/anbe.2001.1684; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization, 2004, WHO MAN AN INFL DIAG; Yamamoto Y, 2008, EMERG INFECT DIS, V14, P1671, DOI [10.3201/1410.080415, 10.3201/eid1410.080415]; Yamamoto Y, 2007, AVIAN DIS, V51, P744, DOI 10.1637/0005-2086(2007)51[744:PICDII]2.0.CO;2; Yamamoto Y, 2008, EMERG INFECT DIS, V14, P149, DOI 10.3201/eid1401.071036; Yamamoto Y, 2007, AVIAN DIS, V51, P52, DOI 10.1637/0005-2086(2007)051[0052:SNEWMA]2.0.CO;2	60	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11315	10.1371/journal.pone.0011315	http://dx.doi.org/10.1371/journal.pone.0011315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593026	Green Published, gold			2022-12-25	WOS:000279140800016
J	Ahmad, KF; Lim, WA				Ahmad, K. Farid; Lim, Wendell A.			The Minimal Autoinhibited Unit of the Guanine Nucleotide Exchange Factor Intersectin	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; ACTIN-DEPOLYMERIZING PROTEIN; TYROSINE KINASE HCK; RHO-GTPASES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; N-WASP; GUANOSINE TRIPHOSPHATASES; ENDOCYTIC MACHINERY; DBL FAMILY	Intersectin-1L is a member of the Dbl homology (DH) domain guanine nucleotide exchange factors (GEF) which control Rho-family GTPase signaling. Intersectin-1L is a GEF that is specific for Cdc42. It plays an important role in endocytosis, and is regulated by several partners including the actin regulator N-WASP. Intact intersectin-1L shows low Cdc42 exchange activity, although the isolated catalytic DH domain shows high activity. This finding suggests that the molecule is autoinhibited. To investigate the mechanism of autoinhibition we have constructed a series of domain deletions. We find that the five SH3 domains of intersectin are important for autoinhibition, with the fifth domain (SH3(E)) being sufficient for the bulk of the autoinhibitory effect. This SH3 domain appears to primarily interact with the DH domain. We have determined the crystal structure of the SH3(E)-DH domain construct, which shows a domain swapped arrangement in which the SH3 from one monomer interacts with the DH domain of the other monomer. Analytical ultracentrifugation and gel filtration, however, show that under biochemical concentrations, the construct is fully monomeric. Thus we propose that the actual autoinhibited structure contains the related intramolecular SH3(E)-DH interaction. We propose a model in which this intramolecular interaction may block or distort the GTPase binding region of the DH domain.	[Ahmad, K. Farid; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ahmad, KF (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	lim@cmp.ucsf.edu			National Institutes of Health (NIH) [R01-GM062583, R01-GM055040]; Howard Hughes Medical Institute (HHMI); National Cancer Institute of Canada; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, R01GM062583] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the National Institutes of Health (NIH) (R01-GM062583 and R01-GM055040) and the Howard Hughes Medical Institute (HHMI) to WAL. KFA was supported by postdoctoral fellowships from National Cancer Institute of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Baumeister MA, 2003, J BIOL CHEM, V278, P11457, DOI 10.1074/jbc.M211901200; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Guipponi M, 1998, GENOMICS, V53, P369, DOI 10.1006/geno.1998.5521; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HART MJ, 1994, J BIOL CHEM, V269, P62; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lemmon MA, 1998, CURR TOP MICROBIOL, V228, P39; Lim WA, 2002, CURR OPIN STRUC BIOL, V12, P61, DOI 10.1016/S0959-440X(02)00290-7; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McPherson PS, 2002, TRENDS CELL BIOL, V12, P312, DOI 10.1016/S0962-8924(02)02309-7; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; O'Bryan JP, 2001, ONCOGENE, V20, P6300, DOI 10.1038/sj.onc.1204773; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Pucharcos C, 2001, BBA-GENE STRUCT EXPR, V1521, P1, DOI 10.1016/S0167-4781(01)00276-7; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; RON D, 1991, NEW BIOL, V3, P372; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Rossman KL, 2000, METHOD ENZYMOL, V325, P25; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; Zhu KJ, 2001, MOL CELL BIOL, V21, P425, DOI 10.1128/MCB.21.2.425-437.2001	67	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11291	10.1371/journal.pone.0011291	http://dx.doi.org/10.1371/journal.pone.0011291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585582	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135800005
J	Gawecka, JE; Griffiths, GS; Ek-Rylander, B; Ramos, JW; Matter, ML				Gawecka, Joanna E.; Griffiths, Genevieve S.; Ek-Rylander, Barbro; Ramos, Joe W.; Matter, Michelle L.			R-Ras Regulates Migration through an Interaction with Filamin A in Melanoma Cells	PLOS ONE			English	Article							BREAST EPITHELIAL-CELLS; FIBRONECTIN MATRIX; INTEGRIN ACTIVATION; CYTOPLASMIC DOMAIN; ACTIN; BINDING; ADHESION; KINASE; EFFECTOR; IDENTIFICATION	Background: Changes in cell adhesion and migration in the tumor microenvironment are key in the initiation and progression of metastasis. R-Ras is one of several small GTPases that regulate cell adhesion and migration on the extracellular matrix, however the mechanism has not been completely elucidated. Using a yeast two-hybrid approach we sought to identify novel R-Ras binding proteins that might mediate its effects on integrins. Methods and Findings: We identified Filamin A (FLNa) as a candidate interacting protein. FLNa is an actin-binding scaffold protein that also binds to integrin beta 1, beta 2 and beta 7 tails and is associated with diverse cell processes including cell migration. Indeed, M2 melanoma cells require FLNa for motility. We further show that R-Ras and FLNa interact in co-immunoprecipitations and pull-down assays. Deletion of FLNa repeat 3 (FLNa Delta 3) abrogated this interaction. In M2 melanoma cells active R-Ras co-localized with FLNa but did not co-localize with FLNa lacking repeat 3. Thus, activated R-Ras binds repeat 3 of FLNa. The functional consequence of this interaction was that active R-Ras and FLNa coordinately increased cell migration. In contrast, co-expression of R-Ras and FLNa Delta 3 had a significantly reduced effect on migration. While there was enhancement of integrin activation and fibronectin matrix assembly, cell adhesion was not altered. Finally, siRNA knockdown of endogenous R-Ras impaired FLNa-dependent fibronectin matrix assembly. Conclusions: These data support a model in which R-Ras functionally associates with FLNa and thereby regulates integrin-dependent migration. Thus in melanoma cells R-Ras and FLNa may cooperatively promote metastasis by enhancing cell migration.	[Gawecka, Joanna E.; Ramos, Joe W.] Univ Hawaii Manoa, Canc Res Ctr Hawaii, Honolulu, HI 96822 USA; [Griffiths, Genevieve S.; Matter, Michelle L.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Ek-Rylander, Barbro] Karolinska Univ Hosp, Karolinska Inst, Div Pathol, Dept Lab Med, Huddinge, Sweden	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Karolinska Institutet; Karolinska University Hospital	Gawecka, JE (corresponding author), Univ Hawaii Manoa, Canc Res Ctr Hawaii, Honolulu, HI 96822 USA.	matter@hawaii.edu	Matter, Michelle/GSN-9703-2022; Ramos, Joe/G-4074-2010	Ramos, Joe/0000-0002-9708-2115; Matter, Michelle/0000-0002-5988-9663	National Institutes of Health NIH/NCRR [P20RR016453]; Geist Foundation [200842993]; Department of Defense [05245002]; NATIONAL CANCER INSTITUTE [R01CA093849] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER	National Institutes of Health NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Geist Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health NIH/NCRR P20RR016453 (M.L.M), the Geist Foundation 200842993 (M.L.M.) and the Department of Defense 05245002 (J.W.R.). The funders had no role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Cukier IH, 2007, FEBS LETT, V581, P1661, DOI 10.1016/j.febslet.2007.03.041; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; de Curtis I, 2001, EMBO REP, V2, P277, DOI 10.1093/embo-reports/kve072; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Green JA, 2009, J BIOL CHEM, V284, P8148, DOI 10.1074/jbc.M805934200; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Jeong HW, 2005, CANCER RES, V65, P507; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; KIM H, AM J PHYSL CELL PHYS, V298, pC221; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; MCHUGH BJ, J CELL SCI, V123, P51; Mora N, 2007, CANCER IMMUNOL IMMUN, V56, P535, DOI 10.1007/s00262-006-0205-z; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Oertli B, 2000, ONCOGENE, V19, P4961, DOI 10.1038/sj.onc.1203876; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Ramos JW, 1998, J BIOL CHEM, V273, P33897, DOI 10.1074/jbc.273.51.33897; Ramsay AG, 2007, CANCER METAST REV, V26, P567, DOI 10.1007/s10555-007-9078-7; Rincon-Arano H, 2003, CANCER, V97, P575, DOI 10.1002/cncr.11093; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sechler JL, 2000, J CELL SCI, V113, P1491; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Stossel TP, 2003, DEV CELL, V4, P444, DOI 10.1016/S1534-5807(03)00098-4; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Wu CY, 1996, CELL ADHES COMMUN, V4, P149, DOI 10.3109/15419069609014219; WU CY, 1993, J BIOL CHEM, V268, P21883; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	51	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11269	10.1371/journal.pone.0011269	http://dx.doi.org/10.1371/journal.pone.0011269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585650	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135400015
J	Almanza, G; Fernandez, A; Volinia, S; Cortez-Gonzalez, X; Croce, CM; Zanetti, M				Almanza, Gonzalo; Fernandez, Antonio; Volinia, Stefano; Cortez-Gonzalez, Xochitl; Croce, Carlo M.; Zanetti, Maurizio			Selected MicroRNAs Define Cell Fate Determination of Murine Central Memory CD8 T Cells	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; POTASSIUM CHANNEL; IL-7 RECEPTOR; EFFECTOR; DIFFERENTIATION; EXPRESSION; MIR-150; NAIVE; PROLIFERATION; REQUIREMENT	During an immune response T cells enter memory fate determination, a program that divides them into two main populations: effector memory and central memory T cells. Since in many systems protection appears to be preferentially mediated by T cells of the central memory it is important to understand when and how fate determination takes place. To date, cell intrinsic molecular events that determine their differentiation remains unclear. MicroRNAs are a class of small, evolutionarily conserved RNA molecules that negatively regulate gene expression, causing translational repression and/or messenger RNA degradation. Here, using an in vitro system where activated CD8 T cells driven by IL-2 or IL-15 become either effector memory or central memory cells, we assessed the role of microRNAs in memory T cell fate determination. We found that fate determination to central memory T cells is under the balancing effects of a discrete number of microRNAs including miR-150, miR-155 and the let-7 family. Based on miR-150 a new target, KChIP. 1 (K+ channel interacting protein 1), was uncovered, which is specifically upregulated in developing central memory CD8 T cells. Our studies indicate that cell fate determination such as surface phenotype and self-renewal may be decided at the pre-effector stage on the basis of the balancing effects of a discrete number of microRNAs. These results may have implications for the development of T cell vaccines and T cell-based adoptive therapies.	[Almanza, Gonzalo; Fernandez, Antonio; Cortez-Gonzalez, Xochitl; Zanetti, Maurizio] Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA; [Almanza, Gonzalo; Fernandez, Antonio; Cortez-Gonzalez, Xochitl; Zanetti, Maurizio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Volinia, Stefano; Croce, Carlo M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Volinia, Stefano; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Volinia, Stefano] Univ Ferrara, Dept Morphol & Embryol, Telethon Facil Data Min Anal DNA Microarrays, I-44100 Ferrara, Italy	University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Ferrara	Almanza, G (corresponding author), Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA.	mzanetti@ucsd.edu	Volinia, Stefano/A-3029-2010; Young, Richard A/F-6495-2012; Volinia, Stefano/AAA-9264-2019	Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Fernandez-Perez, Antonio/0000-0002-3781-7327	National Institutes of Health (NIH) [RO1AI062894, PO1CA76259]; NATIONAL CANCER INSTITUTE [P01CA076259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062894] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fondazione Telethon(Fondazione Telethon)	This work was supported by National Institutes of Health (NIH) grants RO1AI062894 (to M.Z.) and PO1CA76259 (to C. M. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Castiglioni P, 2004, VACCINE, V23, P699, DOI 10.1016/j.vaccine.2004.06.028; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; HOZUMI K, 1994, INT IMMUNOL, V6, P1451, DOI 10.1093/intimm/6.9.1451; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; LEWIS RS, 1988, SCIENCE, V239, P771, DOI 10.1126/science.2448877; Li M, 2000, NAT NEUROSCI, V3, P202, DOI 10.1038/72898; Lieu YK, 2004, P NATL ACAD SCI USA, V101, P14853, DOI 10.1073/pnas.0405338101; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moskophidis D, 1998, J EXP MED, V188, P223, DOI 10.1084/jem.188.2.223; Mueller YM, 2003, INT IMMUNOL, V15, P49, DOI 10.1093/intimm/dxg013; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Savignac M, 2005, EMBO J, V24, P3555, DOI 10.1038/sj.emboj.7600810; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vaccari M, 2005, J IMMUNOL, V175, P3502, DOI 10.4049/jimmunol.175.6.3502; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang M, 2008, J PATHOL, V215, P13, DOI 10.1002/path.2333; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zanetti M, 2006, TRENDS IMMUNOL, V27, P511, DOI 10.1016/j.it.2006.09.004; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	51	41	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11243	10.1371/journal.pone.0011243	http://dx.doi.org/10.1371/journal.pone.0011243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582165	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058500009
J	Jaeger, PA; Pickford, F; Sun, CH; Lucin, KM; Masliah, E; Wyss-Coray, T				Jaeger, Philipp A.; Pickford, Fiona; Sun, Chung-Huan; Lucin, Kurt M.; Masliah, Eliezer; Wyss-Coray, Tony			Regulation of Amyloid Precursor Protein Processing by the Beclin 1 Complex	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BETA; AUTOPHAGY; EXPRESSION; FORMS; PATHWAY; TARGET; MTOR; APP	Autophagy is an intracellular degradation pathway that functions in protein and organelle turnover in response to starvation and cellular stress. Autophagy is initiated by the formation of a complex containing Beclin 1 (BECN1) and its binding partner Phosphoinositide-3-kinase, class 3 (PIK3C3). Recently, BECN1 deficiency was shown to enhance the pathology of a mouse model of Alzheimer Disease (AD). However, the mechanism by which BECN1 or autophagy mediate these effects are unknown. Here, we report that the levels of Amyloid precursor protein (APP) and its metabolites can be reduced through autophagy activation, indicating that they are a substrate for autophagy. Furthermore, we find that knockdown of Becn1 in cell culture increases the levels of APP and its metabolites. Accumulation of APP and APP C-terminal fragments (APP-CTF) are accompanied by impaired autophagosomal clearance. Pharmacological inhibition of autophagosomal-lysosomal degradation causes a comparable accumulation of APP and APP-metabolites in autophagosomes. Becn1 reduction in cell culture leads to lower levels of its binding partner Pik3c3 and increased presence of Microtubule-associated protein 1, light chain 3 (LC3). Overexpression of Becn1, on the other hand, reduces cellular APP levels. In line with these observations, we detected less BECN1 and PIK3C3 but more LC3 protein in brains of AD patients. We conclude that BECN1 regulates APP processing and turnover. BECN1 is involved in autophagy initiation and autophagosome clearance. Accordingly, BECN1 deficiency disrupts cellular autophagy and autophagosomal-lysosomal degradation and alters APP metabolism. Together, our findings suggest that autophagy and the BECN1-PIK3C3 complex regulate APP processing and play an important role in AD pathology.	[Jaeger, Philipp A.; Pickford, Fiona; Sun, Chung-Huan; Lucin, Kurt M.; Wyss-Coray, Tony] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Jaeger, Philipp A.] Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci & Pathol, San Diego, CA 92103 USA; [Wyss-Coray, Tony] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA	Stanford University; Free University of Berlin; University of California System; University of California San Diego; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Jaeger, PA (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	twc@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019; Jaeger, Philipp/H-8377-2012	Wyss-Coray, Tony/0000-0001-5893-0831; Jaeger, Philipp/0000-0002-3624-0802	Biogen IDEC (TWC); National Institutes of Health (NIH) [AG030144, AG5131, AG18440, AG22074, AG10435, AG02270]; John Douglas French Alzheimer's Foundation; Veterans Administration Geriatric Research, Education, and Clinical Center (GRECC); NATIONAL INSTITUTE ON AGING [R01AG030144, P50AG005131, R37AG018440, P01AG022074, P01AG010435, R01AG018440] Funding Source: NIH RePORTER	Biogen IDEC (TWC)(Biogen); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Douglas French Alzheimer's Foundation; Veterans Administration Geriatric Research, Education, and Clinical Center (GRECC); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Biogen IDEC (TWC), the National Institutes of Health (NIH) (TWC: AG030144, EM: AG5131, AG18440, AG22074, AG10435, and AG02270), The John Douglas French Alzheimer's Foundation (TWC, FP), and the Veterans Administration Geriatric Research, Education, and Clinical Center (GRECC) (TWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang KA, 2005, J PHARMACOL SCI, V97, P461, DOI 10.1254/jphs.CR0050014; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Engidawork E, 2001, AMINO ACIDS, V21, P331, DOI 10.1007/s007260170001; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; GOODGER Z, 2009, J CELL SCI; Guyant-Marechal L, 2007, NEUROLOGY, V68, P684, DOI 10.1212/01.wnl.0000255938.33739.46; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hirayama A, 2003, BRAIN DEV-JPN, V25, P180, DOI 10.1016/S0387-7604(02)00209-7; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; HUNG S, 2009, AUTOPHAGY, V5, P441; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; KLIONSKY DJ, 2008, AUTOPHAGY, V4, P1; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Masliah E, 1996, J NEUROSCI, V16, P5795; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moir RD, 1998, J BIOL CHEM, V273, P5013, DOI 10.1074/jbc.273.9.5013; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; Schupf N, 2001, NEUROSCI LETT, V301, P199, DOI 10.1016/S0304-3940(01)01657-3; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; SMALL S, 2008, ARCH NEUROL-CHICAGO, P323; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Xu X, 1999, P NATL ACAD SCI USA, V96, P7547, DOI 10.1073/pnas.96.13.7547; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zetterberg H, 2010, EXP GERONTOL, V45, P23, DOI 10.1016/j.exger.2009.08.002; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	77	151	165	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11102	10.1371/journal.pone.0011102	http://dx.doi.org/10.1371/journal.pone.0011102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559548	Green Submitted, Green Published, gold			2022-12-25	WOS:000278775900004
J	Matoba, N; Husk, AS; Barnett, BW; Pickel, MM; Arntzen, CJ; Montefiori, DC; Takahashi, A; Tanno, K; Omura, S; Cao, HY; Mooney, JP; Hanson, CV; Tanaka, H				Matoba, Nobuyuki; Husk, Adam S.; Barnett, Brian W.; Pickel, Michelle M.; Arntzen, Charles J.; Montefiori, David C.; Takahashi, Atsushi; Tanno, Kazunobu; Omura, Satoshi; Cao, Huyen; Mooney, Jason P.; Hanson, Carl V.; Tanaka, Haruo			HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; N-LINKED GLYCOSYLATION; CYANOVIRIN-N; ENVELOPE GLYCOPROTEIN; SYNCYTIUM FORMATION; ANTIBODY 2G12; INFECTION; GP120; MICROBICIDES; TRANSMISSION	The development of a topical microbicide blocking the sexual transmission of HIV-1 is urgently needed to control the global HIV/AIDS pandemic. The actinomycete-derived lectin actinohivin (AH) is highly specific to a cluster of high-mannose-type glycans uniquely found on the viral envelope (Env). Here, we evaluated AH's candidacy toward a microbicide in terms of in vitro anti-HIV-1 activity, potential side effects, and recombinant producibility. Two validated assay systems based on human peripheral blood mononuclear cell (hPBMC) infection with primary isolates and TZM-bl cell infection with Env-pseudotyped viruses were employed to characterize AH's anti-HIV-1 activity. In hPMBCs, AH exhibited nanomolar neutralizing activity against primary viruses with diverse cellular tropisms, but did not cause mitogenicity or cytotoxicity that are often associated with other anti-HIV lectins. In the TZM-bl-based assay, AH showed broad anti-HIV-1 activity against clinically-relevant, mucosally transmitting strains of clades B and C. By contrast, clade A viruses showed strong resistance to AH. Correlation analysis suggested that HIV-19s AH susceptibility is significantly linked to the N-glycans at the Env C2 and V4 regions. For recombinant (r)AH expression, we evaluated a tobacco mosaic virus-based system in Nicotiana benthamiana plants as a means to facilitate molecular engineering and cost-effective mass production. Biochemical analysis and an Env-mediated syncytium formation assay demonstrated high-level expression of functional rAH within six days. Taken together, our study revealed AH's cross-clade anti-HIV-1 activity, apparent lack of side effects common to lectins, and robust producibility using plant biotechnology. These findings justify further efforts to develop rAH toward a candidate HIV-1 microbicide.	[Matoba, Nobuyuki; Husk, Adam S.; Barnett, Brian W.] Owensboro Canc Res Program, Owensboro, KY USA; [Matoba, Nobuyuki] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Matoba, Nobuyuki] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Pickel, Michelle M.; Arntzen, Charles J.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Takahashi, Atsushi] Iwaki Meisei Univ, Fac Pharm, Fukushima, Japan; [Takahashi, Atsushi; Tanaka, Haruo] Iwaki Meisei Univ, Coll Sci & Engn, Fukushima, Japan; [Tanno, Kazunobu; Tanaka, Haruo] KIIM Pharmaceut Labs Inc, Fukushima, Japan; [Omura, Satoshi] Kitasato Univ, Kitasato Inst Lifesci, Tokyo, Japan; [Cao, Huyen; Mooney, Jason P.; Hanson, Carl V.] Calif Dept Publ Hlth, Richmond, CA USA	University of Louisville; University of Louisville; Arizona State University; Arizona State University-Tempe; Duke University; Iwaki Meisei University; Iwaki Meisei University; Kitasato University; California Department of Public Health	Matoba, N (corresponding author), Owensboro Canc Res Program, Owensboro, KY USA.	n.matoba@louisville.edu	Mooney, Jason Paul/K-1129-2019	Mooney, Jason Paul/0000-0002-2824-124X; Matoba, Nobuyuki/0000-0001-7231-3004	Owensboro Cancer Research Program startup funds; Telemedicine and Advanced Technology Research Center (TATRC) [W81XWH-09-2-0022]; University of Louisville School of Medicine; National Institutes of Health [AI30034]	Owensboro Cancer Research Program startup funds; Telemedicine and Advanced Technology Research Center (TATRC); University of Louisville School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported in part by Owensboro Cancer Research Program startup funds (as part of a contract that was awarded and administered by the United States Army Medical Research and Materiel Command (USAMRMC) and the Telemedicine and Advanced Technology Research Center (TATRC), under contract number: W81XWH-09-2-0022 and a grant from the University of Louisville School of Medicine (to NM), and a National Institutes of Health Grant AI30034 (to DCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouf JE, 2003, INT J MED MICROBIOL, V292, P429, DOI 10.1078/1438-4221-00232; Bachrach E, 2005, VIROLOGY, V332, P418, DOI 10.1016/j.virol.2004.11.031; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini J, 2006, J VIROL, V80, P8411, DOI 10.1128/JVI.00369-06; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chiba H, 2004, BIOCHEM BIOPH RES CO, V316, P203, DOI 10.1016/j.bbrc.2004.02.036; Chiba H, 2001, BIOCHEM BIOPH RES CO, V282, P595, DOI 10.1006/bbrc.2001.4495; Chiba H, 2001, J ANTIBIOT, V54, P818, DOI 10.7164/antibiotics.54.818; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; DSOUZA MP, 1995, AIDS, V9, P867, DOI 10.1097/00002030-199508000-00006; Elrefaei M, 2004, J IMMUNOL, V173, P2184, DOI 10.4049/jimmunol.173.3.2184; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Garg Anita B, 2009, Antivir Chem Chemother, V19, P143; Gavrovic-Jankulovic M, 2008, INT J BIOCHEM CELL B, V40, P929, DOI 10.1016/j.biocel.2007.10.033; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Inokoshi J, 2001, BIOCHEM BIOPH RES CO, V281, P1261, DOI 10.1006/bbrc.2001.4496; *JOINT UN PROGR HI, 2009, AIDS EP UPD; Keller MJ, 2009, SEX TRANSM DIS, V36, pS92, DOI 10.1097/OLQ.0b013e318199417d; Lederman MM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-116; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liedtke S, 1997, GLYCOCONJUGATE J, V14, P785, DOI 10.1023/A:1018577619036; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Ma JKC, 2005, TRENDS PLANT SCI, V10, P580, DOI 10.1016/j.tplants.2005.10.009; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; MATOBA N, METHODS MOL IN PRESS; Matoba N, 2009, PLANT BIOTECHNOL J, V7, P129, DOI 10.1111/j.1467-7652.2008.00381.x; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Morris GC, 2010, CURR OPIN INFECT DIS, V23, P57, DOI 10.1097/QCO.0b013e328334de6d; OKEEFE BR, 2009, P NATL ACAD SCI US; Paranjpe S, 2002, AIDS RES HUM RETROV, V18, P1271, DOI 10.1089/088922202320886316; Peters PJ, 2006, J VIROL, V80, P6324, DOI 10.1128/JVI.02328-05; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Shenoy SR, 2002, CHEM BIOL, V9, P1109, DOI 10.1016/S1074-5521(02)00237-5; SWANSON MD, 2010, J BIOL CHEM; Takahashi A, 2005, ARCH BIOCHEM BIOPHYS, V437, P233, DOI 10.1016/j.abb.2005.03.017; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; Wang CY, 1999, P NATL ACAD SCI USA, V96, P10367, DOI 10.1073/pnas.96.18.10367; Willey RL, 1996, J VIROL, V70, P6431, DOI 10.1128/JVI.70.9.6431-6436.1996; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Zeitlin L, 2009, P NATL ACAD SCI USA, V106, P6029, DOI 10.1073/pnas.0902239106; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	58	34	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11143	10.1371/journal.pone.0011143	http://dx.doi.org/10.1371/journal.pone.0011143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559567	Green Published, gold, Green Submitted			2022-12-25	WOS:000278775900027
J	Lam, WWL; Woo, EJ; Kotaka, M; Tam, WK; Leung, YC; Ling, TKW; Au, SWN				Lam, Wendy Wai Ling; Woo, Eui Jeon; Kotaka, Masayo; Tam, Wai Kwan; Leung, Yun Chung; Ling, Thomas Kin Wah; Au, Shannon Wing Ngor			Molecular interaction of flagellar export chaperone FliS and cochaperone HP1076 in Helicobacter pylori	FASEB JOURNAL			English	Article						protein-protein interaction; type III secretion system; bacterial motility; virulence factor	III SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; SIGMA-FACTOR; GENES; COLONIZATION; PROTEINS; BACTERIA; COMPLEX; IDENTIFICATION	Flagellar export chaperone FliS prevents premature polymerization of flagellins and is critical for flagellar assembly and bacterial colonization. Previously, a yeast 2-hybrid study identified various FliS-associated proteins in Helicobacter pylori, but the implications of these interactions are not known. Here we demonstrate the biophysical interaction of FliS (HP0753) and the uncharacterized protein HP1076 from H. pylori. HP1076 possesses a cochaperone activity that promotes the folding and chaperone activity of FliS. We further determined the crystal structures of FliS, HP1076, and the binary complex at 2.7, 1.8, and 2.7 angstrom resolution, respectively. HP1076 adopts a helix-rich bundle structure and interestingly shares a similar fold with a flagellin homologue, hook-associated protein, and FliS. The FliS-HP1076 complex revealed an extensive electrostatic and hydrophobic binding interface, which is distinct from the flagellin binding pocket in FliS. The helical stacking interaction between HP1076 and FliS suggests that HP1076 stabilizes 2 alpha helices of FliS and therefore the overall structure of the bundle. Our findings provide new insights into flagellar export chaperones and may have implications for other secretion chaperones in the type III secretion system.-Lam, W. W. L., Woo, E. J., Kotaka, M., Tam, W. K., Leung, Y. C., Ling, T. K. W., Au, S. W. N. Molecular interaction of flagellar export chaperone FliS and cochaperone HP1076 in Helicobacter pylori. FASEB J. 24, 4020-4032 (2010). www.fasebj.org	[Lam, Wendy Wai Ling; Au, Shannon Wing Ngor] Chinese Univ Hong Kong, Dept Biochem, Fac Sci, Ctr Prot Sci & Crystallog, Hong Kong, Hong Kong, Peoples R China; [Tam, Wai Kwan; Ling, Thomas Kin Wah] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Woo, Eui Jeon] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon, South Korea; [Kotaka, Masayo] Univ Hong Kong, Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Leung, Yun Chung] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Hong Kong; Hong Kong Polytechnic University	Au, SWN (corresponding author), Chinese Univ Hong Kong, Dept Biochem, Fac Sci, Ctr Prot Sci & Crystallog, Hong Kong, Hong Kong, Peoples R China.	shannon-au@cuhk.edu.hk		Woo, Eui-Jeon/0000-0001-6983-0270; Leung, Yun-chung/0000-0003-3590-7027	Research Grants Council of Hong Kong [CUHK 4592/06M]; University Grants Council of the Hong Kong [SEG CUHK08]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Council of the Hong Kong	This work was supported by a Competitive Earmarked Research grant (CUHK 4592/06M) from the Research Grants Council of Hong Kong. The authors thank the University Grants Council of the Hong Kong Special Administrative Region One-Off Special Equipment Grant (SEG CUHK08) for the equipment used in this work. W.W.L. performed the molecular and biochemical experiments, crystallization, and data analysis and prepared the manuscript; E.J.W. contributed to the data collection and phase determination of HP1076; M.K. contributed to the data collection of the binary complex; Y.C.L. assisted in the ITC assay; W.K.T. assisted the molecular cloning; K.W.L. was involved in collaboration and discussion; and S.W.N.A. supervised the research and prepared the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allan E, 2000, J BACTERIOL, V182, P5274, DOI 10.1128/JB.182.18.5274-5277.2000; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597; Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Bennett JCQ, 2001, MOL MICROBIOL, V39, P781, DOI 10.1046/j.1365-2958.2001.02268.x; CHEN L, 1994, J BACTERIOL, V176, P3093, DOI 10.1128/jb.176.11.3093-3101.1994; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Douillard FP, 2009, MICROBIOL-SGM, V155, P1901, DOI 10.1099/mic.0.026062-0; EATON KA, 1992, J MED MICROBIOL, V37, P123, DOI 10.1099/00222615-37-2-123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans LDB, 2006, P NATL ACAD SCI USA, V103, P17474, DOI 10.1073/pnas.0605197103; Evans LDB, 2009, FEMS MICROBIOL LETT, V293, P292, DOI 10.1111/j.1574-6968.2009.01535.x; Evdokimov AG, 2003, NAT STRUCT BIOL, V10, P789, DOI 10.1038/nsb982; Fraser GM, 1999, MOL MICROBIOL, V32, P569, DOI 10.1046/j.1365-2958.1999.01372.x; Galkin VE, 2008, SCIENCE, V320, P382, DOI 10.1126/science.1155307; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Ibuki T, 2009, ACTA CRYSTALLOGR F, V65, P47, DOI 10.1107/S1744309108039882; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; KAWAGISHI I, 1992, J GEN MICROBIOL, V138, P1051, DOI 10.1099/00221287-138-6-1051; Kholod N, 2001, BIOTECHNIQUES, V31, P322, DOI 10.2144/01312st03; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Leslie AGW, 1992, PROTEIN CRYSTALLOGR, V26, P27; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Muskotal A, 2006, FEBS LETT, V580, P3916, DOI 10.1016/j.febslet.2006.06.024; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; Niehus E, 2002, MICROBIOL-SGM, V148, P3827, DOI 10.1099/00221287-148-12-3827; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Quinaud M, 2005, J BIOL CHEM, V280, P36293, DOI 10.1074/jbc.M508089200; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SANGER F, 1949, BIOCHEM J, V44, P126, DOI 10.1042/bj0440126; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wattiau P, 1996, MOL MICROBIOL, V20, P255, DOI 10.1111/j.1365-2958.1996.tb02614.x; Wilharm G, 2007, INT J MED MICROBIOL, V297, P27, DOI 10.1016/j.ijmm.2006.10.003; Yokoseki T, 1996, J BACTERIOL, V178, P899, DOI 10.1128/jb.178.3.899-901.1996; YOKOSEKI T, 1995, MICROBIOL-SGM, V141, P1715, DOI 10.1099/13500872-141-7-1715	48	16	19	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					4020	4032		10.1096/fj.10-155242	http://dx.doi.org/10.1096/fj.10-155242			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20581225				2022-12-25	WOS:000285005900038
J	Bruce, SJ; Butterfield, NC; Metzis, V; Town, L; McGlinn, E; Wicking, C				Bruce, Stephen J.; Butterfield, Natalie C.; Metzis, Vicki; Town, Liam; McGlinn, Edwina; Wicking, Carol			Inactivation of Patched1 in the Mouse Limb Has Novel Inhibitory Effects on the Chondrogenic Program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC HEDGEHOG; VERTEBRATE LIMB; CARTILAGE FORMATION; CHONDROCYTE DIFFERENTIATION; INDIAN-HEDGEHOG; CELL-DIFFERENTIATION; ENDOCHONDRAL BONE; DIGIT NUMBER; IN-VITRO; EXPRESSION	The bones of the vertebrate limb form by the process of endochondral ossification, whereby limb mesenchyme condenses to form an intermediate cartilage scaffold that is then replaced by bone. Although Indian hedgehog (IHH) is known to control hypertophic differentiation of chondrocytes during this process, the role of hedgehog signaling in the earlier stages of chondrogenesis is less clear. We have conditionally inactivated the hedgehog receptor Ptc1 in undifferentiated limb mesenchyme of the mouse limb using Prx1-Cre, thus inducing constitutively active ligand-independent hedgehog signaling. In addition to major patterning defects, we observed a marked disruption to the cartilage elements in the limbs of Prx1-Cre:Ptc1c/c embryos. Using an in vitro micromass culture system we show that this defect lies downstream of mesenchymal cell condensation and likely upstream of chondrocyte differentiation. Despite early increases in levels of chondrogenic genes, soon after mesenchymal condensation the stromal layer of Prx1-Cre:Ptc1c/c-derived micromass cultures is characterized by a loss of cell integrity, which is associated with increased cell death and a striking decrease in Alcian blue staining cartilage nodules. Furthermore, inhibition of the hedgehog pathway activation using cyclopamine was sufficient to essentially overcome this chondrogenic defect in both micromass and ex vivo explant assays of Prx1-Cre: Ptc1c/c limbs. These data demonstrate for the first time the inhibitory effect of cell autonomously activated hedgehog signaling on chondrogenesis, and stress the importance of PTC1 in maintaining strict control of signaling levels during this phase of skeletal development.	[Bruce, Stephen J.; Butterfield, Natalie C.; Metzis, Vicki; Town, Liam; Wicking, Carol] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [McGlinn, Edwina] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Queensland; Harvard University; Harvard Medical School		c.wicking@imb.uq.edu.au	McGlinn, Edwina/AAE-1945-2021; Metzis, Vicki/AAU-5081-2020; Butterfield, Natalie/AAV-5483-2020; Wicking, Carol/J-1814-2014	Metzis, Vicki/0000-0002-0399-1722; Butterfield, Natalie/0000-0002-5209-7508; McGlinn, Edwina/0000-0002-1829-986X; Wicking, Carol/0000-0002-7225-3803	National Health and Medical Research Council (NHMRC) of Australia [569713]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Project Grant 569713.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Bancroft G.D., 1996, THEORY PRACTICE PATH, V4th ed.; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bobick BE, 2007, J CELL PHYSIOL, V211, P233, DOI 10.1002/jcp.20923; Butterfield NC, 2009, DEVELOPMENT, V136, P3515, DOI 10.1242/dev.037507; Cash DE, 1997, J CELL BIOL, V136, P445, DOI 10.1083/jcb.136.2.445; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Enomoto-Iwamoto M, 2000, J BONE MINER RES, V15, P1659, DOI 10.1359/jbmr.2000.15.9.1659; Fernandez-Teran MA, 2006, DEV DYNAM, V235, P2521, DOI 10.1002/dvdy.20916; Fowles LF, 2003, GENESIS, V35, P73, DOI 10.1002/gene.10165; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Incardona JP, 1998, DEVELOPMENT, V125, P3553; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Karp SJ, 2000, DEVELOPMENT, V127, P543; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; LEE YS, 1998, CELLS MAT, V8, P19; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Mille F, 2009, NAT CELL BIOL, V11, P739, DOI 10.1038/ncb1880; Montero JA, 2007, DEV BIOL, V303, P325, DOI 10.1016/j.ydbio.2006.11.019; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nagy A., 2003, MANIPULATING MOUSE E; Nieuwenhuis E, 2005, CLIN GENET, V67, P193, DOI 10.1111/j.1399-0004.2004.00360.x; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Park J, 2010, DEV DYNAM, V239, P514, DOI 10.1002/dvdy.22192; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Stott NS, 1997, J CELL SCI, V110, P2691; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Tavella S, 2004, J BONE MINER RES, V19, P1678, DOI 10.1359/JBMR.040706; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WALLIN J, 1994, DEVELOPMENT, V120, P1109; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yu K, 2008, DEVELOPMENT, V135, P483, DOI 10.1242/dev.013268	58	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27967	27981		10.1074/jbc.M109.091785	http://dx.doi.org/10.1074/jbc.M109.091785			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20576618	Green Published, hybrid			2022-12-25	WOS:000281404100051
J	Pu, MM; Orr, A; Redfield, AG; Roberts, MF				Pu, Mingming; Orr, Andrew; Redfield, Alfred G.; Roberts, Mary F.			Defining Specific Lipid Binding Sites for a Peripheral Membrane Protein in Situ Using Subtesla Field-cycling NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C; ACTIVATION; DYNAMICS; SPECTROSCOPY; INHIBITION; RELAXATION; SUBSTRATE	Despite the profound physiological consequences associated with peripheral membrane protein localization, only a rudimentary understanding of the interactions of proteins with membrane surfaces exists because these questions are inaccessible by commonly used structural techniques. Here, we combine high resolution field-cycling P-31 NMR relaxation methods with spin-labeled proteins to delineate specific interactions of a bacterial phospholipase C with phospholipid vesicles. Unexpectedly, discrete binding sites for both a substrate analogue and a different phospholipid (phosphatidylcholine) known to activate the enzyme are observed. The lifetimes for the occupation of these sites (when the protein is anchored transiently to the membrane) are > 1-2 mu s (but < 1 ms), which represents the first estimate of an off-rate for a lipid dissociating from a specific site on the protein and returning to the bilayer. Furthermore, analyses of the spin-label induced NMR relaxation corroborates the presence of a discrete tyrosine-rich phosphatidylcholine binding site whose location is consistent with that suggested by modeling studies. The methodology illustrated here may	Boston Coll, Dept Chem, Chestnut Hill, MA 02465 USA; [Redfield, Alfred G.] Brandeis Univ, Dept Biochem, Waltham, MA USA	Boston College; Brandeis University	Roberts, MF (corresponding author), Merkert Chem Ctr, 2609 Beacon St, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu	Pu, Mingming/F-6760-2012		National Institutes of Health [GM60418, GM077974]; National Science Foundation [MCB-0517381]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077974, R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60418 (to M. F. R.) and GM077974 (to A. G. R.). This work was also supported by National Science Foundation Grant MCB-0517381 (to M. F. R.).	Guo S, 2008, BIOCHEMISTRY-US, V47, P4201, DOI 10.1021/bi702269u; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Hondal RJ, 1998, BIOCHEMISTRY-US, V37, P4568, DOI 10.1021/bi972646i; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pu MM, 2009, BIOCHEMISTRY-US, V48, P8282, DOI 10.1021/bi901190j; Pu MM, 2009, BIOCHEMISTRY-US, V48, P6835, DOI 10.1021/bi900633p; Pu MM, 2009, J BIOL CHEM, V284, P16099, DOI 10.1074/jbc.M809600200; Redfield AG, 2003, MAGN RESON CHEM, V41, P753, DOI 10.1002/mrc.1264; Roberts MF, 2004, P NATL ACAD SCI USA, V101, P17066, DOI 10.1073/pnas.0407565101; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; Shao CH, 2007, J BIOL CHEM, V282, P9228, DOI 10.1074/jbc.M610918200; Sivanandam VN, 2009, J AM CHEM SOC, V131, P3420, DOI 10.1021/ja808431h; Victor K, 2005, BIOPHYS J, V88, P443, DOI 10.1529/biophysj.104.046459; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o; Zhou C, 1998, BIOCHEMISTRY-US, V37, P16430, DOI 10.1021/bi980601r	17	32	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					26916	26922		10.1074/jbc.M110.123083	http://dx.doi.org/10.1074/jbc.M110.123083			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20576615	Green Published, hybrid			2022-12-25	WOS:000281172700023
J	Wegmann, S; Jung, YJ; Chinnathambi, S; Mandelkow, EM; Mandelkow, E; Muller, DJ				Wegmann, Susanne; Jung, Yu Jin; Chinnathambi, Subashchandrabose; Mandelkow, Eva-Maria; Mandelkow, Eckhard; Muller, Daniel J.			Human Tau Isoforms Assemble into Ribbon-like Fibrils That Display Polymorphic Structure and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ATOMIC-FORCE MICROSCOPY; PRION-LIKE PROPAGATION; ALZHEIMERS-DISEASE; BETA-STRUCTURE; AMYLOID FIBRILS; CORTICOBASAL DEGENERATION; ELECTRON-MICROSCOPY; SINGLE-MOLECULE; SOLID-SURFACES	Fibrous aggregates of Tau protein are characteristic features of Alzheimer disease. We applied high resolution atomic force and EM microscopy to study fibrils assembled from different human Tau isoforms and domains. All fibrils reveal structural polymorphism; the "thin twisted" and "thin smooth" fibrils resemble flat ribbons (cross-section similar to 10 x 15 nm) with diverse twist periodicities. "Thick fibrils" show periodicities of similar to 5-70 nm and thicknesses of similar to 9-18 nm such as routinely reported for "paired helical filaments" but structurally resemble heavily twisted ribbons. Therefore, thin and thick fibrils assembled from different human Tau isoforms challenge current structural models of paired helical filaments. Furthermore, all Tau fibrils reveal axial subperiodicities of similar to 17-19 nm and, upon exposure to mechanical stress or hydrophobic surfaces, disassemble into uniform fragments that remain connected by thin thread-like structures (similar to 2 nm). This hydrophobically induced disassembly is inhibited at enhanced electrolyte concentrations, indicating that the fragments resemble structural building blocks and the fibril integrity depends largely on hydrophobic and electrostatic interactions. Because full-length Tau and repeat domain constructs assemble into fibrils of similar thickness, the "fuzzy coat" of Tau protein termini surrounding the fibril axis is nearly invisible for atomic force microscopy and EM, presumably because of its high flexibility.	[Chinnathambi, Subashchandrabose; Mandelkow, Eva-Maria; Mandelkow, Eckhard] DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; [Wegmann, Susanne; Muller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Jung, Yu Jin] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Chinnathambi, Subashchandrabose; Mandelkow, Eva-Maria; Mandelkow, Eckhard] CAESAR, German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technische Universitat Dresden; Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Mandelkow, E (corresponding author), DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany.	mand@mpasmb.desy.de; daniel.mueller@bsse.ethz.ch	Chinnathambi, Subashchandrabose/T-8471-2019; Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665; Chinnathambi, Subashchandrabose/0000-0002-5468-2129	Deutsche Forschungsgemeinschaft; Max-Planck Society; VW Foundation [1/82544]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society); VW Foundation(Volkswagen)	This work was supported by the Deutsche Forschungsgemeinschaft (to D. M.), Max-Planck Society (to D. J. M. and E. M. M.), and VW Foundation Grant 1/82544 (to E. M. M.).	ALLEN MJ, 1992, ULTRAMICROSCOPY, V42, P1095, DOI 10.1016/0304-3991(92)90408-C; Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Bright JN, 2001, PROG BIOPHYS MOL BIO, V76, P131, DOI 10.1016/S0079-6107(01)00012-8; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buee L, 1999, BRAIN PATHOL, V9, P681; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Congdon EE, 2008, J ALZHEIMERS DIS, V14, P453; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; CROWTHER RA, 1990, BIOCHIM BIOPHYS ACTA, V1096, P1, DOI 10.1016/0925-4439(90)90004-9; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; DICKSON DW, 1992, ACTA NEUROPATHOL, V84, P596; Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929; Engel A, 1997, CURR OPIN STRUC BIOL, V7, P279, DOI 10.1016/S0959-440X(97)80037-1; Fandrich M, 2009, PRION, V3, P89; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Flory, 1969, STAT MECH CHAIN MOL, P432; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001; HANSMA HG, 1994, ANNU REV BIOPH BIOM, V23, P115, DOI 10.1146/annurev.bb.23.060194.000555; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; KATO S, 1990, ACTA NEUROPATHOL, V81, P125, DOI 10.1007/BF00334500; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Krammer C, 2009, PRION, V3, P206, DOI 10.4161/pri.3.4.10013; Krebs MRH, 2009, BIOCHEM SOC T, V37, P682, DOI 10.1042/BST0370682; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; LECKBAND D, 2001, Q REV BIOPHYS, V105, P267; LINS L, 1995, FASEB J, V9, P535, DOI 10.1096/fasebj.9.7.7737462; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Meyer EE, 2006, P NATL ACAD SCI USA, V103, P15739, DOI 10.1073/pnas.0606422103; Minati L, 2009, AM J ALZHEIMERS DIS, V24, P95, DOI 10.1177/1533317508328602; Moreno-Herrero F, 2004, BIOPHYS J, V86, P517, DOI 10.1016/S0006-3495(04)74130-2; Moreno-Herrero F, 2006, NUCLEIC ACIDS RES, V34, P3057, DOI 10.1093/nar/gkl397; Moreno-Herrero F, 2001, J ALZHEIMERS DIS, V3, P443, DOI 10.3233/JAD-2001-3502; Moya S, 2005, ANGEW CHEM INT EDIT, V44, P4578, DOI 10.1002/anie.200500228; Muller DJ, 2006, CURR OPIN STRUC BIOL, V16, P489, DOI 10.1016/j.sbi.2006.06.001; Mukhopadhyay R, 2001, FEBS LETT, V505, P374, DOI 10.1016/S0014-5793(01)02844-7; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Oesterhelt F, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/006; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Perez M, 1996, J NEUROCHEM, V67, P1183; POLLANEN MS, 1994, AM J PATHOL, V144, P869; Pollanen MS, 1997, J NEUROPATH EXP NEUR, V56, P79, DOI 10.1097/00005072-199701000-00008; Rivetti C, 2001, ULTRAMICROSCOPY, V87, P55, DOI 10.1016/S0304-3991(00)00064-4; Ruben GC, 2005, MICROSC RES TECHNIQ, V67, P175, DOI 10.1002/jemt.20197; Sagis LMC, 2004, LANGMUIR, V20, P924, DOI 10.1021/la035390s; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Schaap IAT, 2007, J STRUCT BIOL, V158, P282, DOI 10.1016/j.jsb.2006.11.010; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Skrabana R, 2006, CELL MOL NEUROBIOL, V26, P1085, DOI 10.1007/s10571-006-9083-3; Stromer T, 2005, MICROSC RES TECHNIQ, V67, P210, DOI 10.1002/jemt.20190; Su TX, 2009, ACTA BIOMATER, V5, P1855, DOI 10.1016/j.actbio.2009.01.038; Sydow A, 2010, NEURODEGENER DIS, V7, P28, DOI 10.1159/000283479; Vanswieten JC, 2007, J NEUROPATH EXP NEUR, V66, P17, DOI 10.1097/nen.0b013e31802c39a4; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; WISCHIK CM, 1985, J CELL BIOL, V100, P1905, DOI 10.1083/jcb.100.6.1905; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0	83	85	90	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27302	27313		10.1074/jbc.M110.145318	http://dx.doi.org/10.1074/jbc.M110.145318			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20566652	Green Published, hybrid			2022-12-25	WOS:000281172700060
J	Baudry, A; Bitard, J; Mouillet-Richard, S; Locker, M; Poliard, A; Launay, JM; Kellermann, O				Baudry, Anne; Bitard, Juliette; Mouillet-Richard, Sophie; Locker, Morgane; Poliard, Anne; Launay, Jean-Marie; Kellermann, Odile			Serotonergic 5-HT2B Receptor Controls Tissue-nonspecific Alkaline Phosphatase Activity in Osteoblasts via Eicosanoids and Phosphatidylinositol-specific Phospholipase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-FORMATION; INFANTILE HYPOPHOSPHATASIA; INHIBITION; CELL; 5-HYDROXYTRYPTAMINE; DIFFERENTIATION; MINERALIZATION; ACTIVATION; EXPRESSION; PROTEIN	In previous studies, we observed that mice knocked out for the serotonin-2B receptor (5-HT2BR) show defects in bone homeostasis. The present work focuses on the downstream targets relaying the anabolic function of this receptor in osteoblasts. A functional link between the 5-HT2BR and the activity of the tissue-nonspecific alkaline phosphatase (TNAP) is established using the C1 osteoprogenitor cell line. During C1 osteogenic differentiation, both 5-HT2BR and TNAP mRNA translations are delayed with respect to extracellular matrix deposition. Once the receptor is expressed, it constitutively controls TNAP activity at a post-translational level along the overall period of mineral deposition. Indeed, pharmacological inhibition of the 5-HT2BR intrinsic activity or shRNA-mediated 5-HT2BR knockdown prevents TNAP activation, but not its mRNA translation. In contrast, agonist stimulation of the receptor further increases TNAP activity during the initial mineralization phase. Building upon our previous observations that the 5-HT2BR couples with the phospholipase A2 pathway and prostaglandin production at the beginning of mineral deposition, we show that the 5-HT2BR controls leukotriene synthesis via phospholipase A2 at the terminal stages of C1 differentiation. These two 5-HT2BR-dependent eicosanoid productions delineate distinct time windows of TNAP regulation during the osteogenic program. Finally, prostaglandins or leukotrienes are shown to relay the post-translational activation of TNAP via stimulation of the phosphatidylinositol-specific phospholipase C. In agreement with the above findings, primary calvarial osteoblasts from 5-HT2BR-null mice exhibit defects in TNAP activity.	[Baudry, Anne; Bitard, Juliette; Mouillet-Richard, Sophie; Locker, Morgane; Poliard, Anne; Kellermann, Odile] Univ Paris 05, INSERM U747, F-75006 Paris, France; [Launay, Jean-Marie] Hop Lariboisiere, INSERM U942, Serv Biochim, AP HP, F-75009 Paris, France; [Launay, Jean-Marie] F Hoffmann La Roche & Co Ltd, Pharma Res Dept, CH-4070 Basel, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Roche Holding	Kellermann, O (corresponding author), Univ Paris 05, INSERM U747, 45 Rue St Peres, F-75006 Paris, France.	odile.kellermann@parisdescartes.fr	Mouillet, Sophie/E-4960-2017; Baudry, Anne/O-2624-2017	Mouillet, Sophie/0000-0002-8950-1949; Baudry, Anne/0000-0002-7729-1753; BITARD, Juliette/0000-0001-6626-3522	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from Centre National de la Recherche Scientifique and the Institut National de la Sante et de la Recherche Medicale.	BAXTER G, 1995, TRENDS PHARMACOL SCI, V16, P105, DOI 10.1016/S0165-6147(00)88991-9; Baxter GS, 1996, BEHAV BRAIN RES, V73, P149; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Bliziotes MM, 2001, BONE, V29, P477, DOI 10.1016/S8756-3282(01)00593-2; Ciancaglini P, 2006, BRAZ J MED BIOL RES, V39, P603, DOI 10.1590/S0100-879X2006000500006; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Haney E. M., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P133; Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053; HENTHORN PS, 1992, CLIN CHEM, V38, P2501; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hikiji H, 2008, PROG LIPID RES, V47, P107, DOI 10.1016/j.plipres.2007.12.003; Jonnakuty C, 2008, J CELL PHYSIOL, V217, P301, DOI 10.1002/jcp.21533; Kleven MS, 1997, J PHARMACOL EXP THER, V282, P747; Kozak W, 2004, FRONT BIOSCI-LANDMRK, V9, P3339, DOI 10.2741/1486; Leysen JE, 2004, CNS NEUROL DISORD-DR, V3, P11, DOI 10.2174/1568007043482598; Locker M, 2006, CELL SIGNAL, V18, P628, DOI 10.1016/j.cellsig.2005.06.006; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; Manivet P, 2000, J BIOL CHEM, V275, P9324, DOI 10.1074/jbc.275.13.9324; Masferrer JL, 1999, ANN NY ACAD SCI, V889, P84, DOI 10.1111/j.1749-6632.1999.tb08726.x; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Minamizaki T, 2009, BONE, V44, P1177, DOI 10.1016/j.bone.2009.02.010; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nakano Y, 2004, BONE, V35, P1077, DOI 10.1016/j.bone.2004.07.009; Narisawa S, 1997, DEV DYNAM, V208, P432, DOI 10.1002/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1; POLIARD A, 1995, J CELL BIOL, V130, P1461, DOI 10.1083/jcb.130.6.1461; Poliard A, 1999, EXP CELL RES, V253, P385, DOI 10.1006/excr.1999.4704; Spyridakis S, 2010, AM J RESP CELL MOL, V42, P357, DOI 10.1165/rcmb.2009-0078OC; Tesch W, 2003, J BONE MINER RES, V18, P117, DOI 10.1359/jbmr.2003.18.1.117; VANBELLE H, 1976, CLIN CHEM, V22, P972; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Warden SJ, 2008, MENOPAUSE, V15, P1176, DOI 10.1097/gme.0b013e318173566b; Warden SJ, 2010, BONE, V46, P4, DOI 10.1016/j.bone.2009.06.029; Westbroek I, 2001, J BIOL CHEM, V276, P28961, DOI 10.1074/jbc.M101824200; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059	38	23	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26066	26073		10.1074/jbc.M109.073791	http://dx.doi.org/10.1074/jbc.M109.073791			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20573958	Green Published, hybrid			2022-12-25	WOS:000280921000022
J	Schelter, F; Gerg, M; Halbgewachs, B; Schaten, S; Gorlach, A; Schrotzlmair, F; Kruger, A				Schelter, Florian; Gerg, Michael; Halbgewachs, Birgit; Schaten, Susanne; Goerlach, Agnes; Schroetzlmair, Florian; Krueger, Achim			Identification of a Survival-independent Metastasis-enhancing Role of Hypoxia-inducible Factor-1 alpha with a Hypoxia-tolerant Tumor Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR 1-ALPHA; TRANSCRIPTIONAL ACTIVATION; BREAST-CANCER; MET RECEPTOR; IN-VIVO; HIF-1-ALPHA; INVASION; EXPRESSION; INHIBITOR	During tumor progression, malignant cells must repeatedly survive microenvironmental stress. Hypoxia-inducible factor-1 (HIF-1) signaling has emerged as one major pathway allowing cellular adaptation to stress. Recent findings led to the hypothesis that HIF-1 alpha may enhance the metastatic potential of tumor cells by a survival-independent mechanism. So far it has not been shown that HIF-1 alpha also directly regulates invasive processes during metastasis in addition to conferring a survival advantage to metastasizing tumor cells. In a hypoxia-tolerant tumor cell line (L-CI.5s), which did not rely on HIF-1 signaling for viability in vitro and in vivo, knockdown of Hif-1 alpha reduced invasiveness of the tumor cells in vitro as well as extravasation and secondary infiltration in vivo. Liver metastases associated induction of proinvasive receptor tyrosine kinase Met phosphorylation as well as gelatinolytic activity were Hif-1 alpha-dependent. Indeed, promoter activity of the matrix metalloproteinase-9 (mmp-9) was shown to be Hif-1 alpha-dependent. This study uncovers a new survival-independent biological function of HIF-1 alpha contributing to the efficacy of metastases formation.	[Schelter, Florian; Gerg, Michael; Halbgewachs, Birgit; Schaten, Susanne; Schroetzlmair, Florian; Krueger, Achim] Tech Univ Munich, Inst Expt Onkol & Therapieforsch, Klinikum Rechts Isar, D-81675 Munich, Germany; [Goerlach, Agnes] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany	Technical University of Munich; German Heart Centre Munich; Technical University of Munich	Kruger, A (corresponding author), Tech Univ Munich, Inst Expt Onkol & Therapieforsch, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany.	achim.krueger@lrz.tu-muenchen.de	Gorlach, Agnes/B-3494-2013		European Union [HEALTH-2007-201279/Microenvimet, HEALTH-F2-2009-222741/Metoxia]; Deutsche Forschungsgemeinschaft [KR2047/1-1]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the European Union Research Framework Programme 7, Project HEALTH-2007-201279/Microenvimet (to A.K.) and Project HEALTH-F2-2009-222741/Metoxia (to A.G.), and Deutsche Forschungsgemeinschaft grant KR2047/1-1 (to A.K.).	Akakura Nobuaki, 2001, Hokkaido Journal of Medical Science, V76, P375; Arlt M, 2002, CANCER RES, V62, P5543; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen CG, 2009, ANTICANCER RES, V29, P1367; Dikmen ZG, 2008, J CELL BIOCHEM, V104, P985, DOI 10.1002/jcb.21681; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Esteve PO, 2002, BIOCHEM BIOPH RES CO, V296, P864, DOI 10.1016/S0006-291X(02)02008-9; Fujiwara S, 2007, INT J ONCOL, V30, P793; Furlan D, 2007, SURG ONCOL, V16, pS25, DOI 10.1016/j.suronc.2007.10.014; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerg M, 2008, MOL CANCER RES, V6, P341, DOI 10.1158/1541-7786.MCR-07-2032; Gorden DL, 2007, INT J CANCER, V121, P495, DOI 10.1002/ijc.22594; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kopitz C, 2007, CANCER RES, V67, P8615, DOI 10.1158/0008-5472.CAN-07-0232; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kruger A, 2010, BBA-MOL CELL RES, V1803, P95, DOI 10.1016/j.bbamcr.2009.09.016; Krueger A, 2009, BIOL CHEM, V390, P91, DOI 10.1515/BC.2009.015; Kruger A, 2005, CANCER RES, V65, P3523, DOI 10.1158/0008-5472.CAN-04-3570; KRUGER A, 1994, INT J CANCER, V58, P275, DOI 10.1002/ijc.2910580222; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; LERNER WA, 1983, INT J CANCER, V31, P463, DOI 10.1002/ijc.2910310411; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Nguyen MVC, 2007, J NEUROSCI RES, V85, P1119, DOI 10.1002/jnr.21202; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shyu KG, 2007, EXP CELL RES, V313, P1181, DOI 10.1016/j.yexcr.2007.01.013; Victor N, 2006, CLIN EXP METASTAS, V23, P87, DOI 10.1007/s10585-006-9024-z; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wykoff CC, 2000, CANCER RES, V60, P7075; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Zhong H, 1999, CANCER RES, V59, P5830	45	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26182	26189		10.1074/jbc.M110.140608	http://dx.doi.org/10.1074/jbc.M110.140608			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566631	hybrid, Green Published			2022-12-25	WOS:000280921000035
J	Ling, H; Sylvestre, JR; Jolicoeur, P				Ling, H.; Sylvestre, J-R; Jolicoeur, P.			Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors	ONCOGENE			English	Article						mammary tumors; stem cells; Notch1	HEMATOPOIETIC STEM-CELLS; NOTCH PROMOTES SURVIVAL; HUMAN BREAST-CANCER; SIGNALING PATHWAY; TRANSGENIC MICE; UP-REGULATION; C-MYC; D1; TRANSFORMATION; ONCOGENESIS	Members of the Notch family are involved in the development of breast cancer in animal models and in humans. In young transgenic mice, expressing intracellular activated Notch1 (N1(IC)) in mammary cells, we found that CD24(+) CD29(high) progenitor cells had enhanced survival, and were expanded through a cyclin D1-dependent pathway. This expansion positively correlated with the later cyclin D1-dependent formation of basal-like ductal tumors. This expanded population exhibited abnormal differentiation skewed toward the basal cells, showed signs of pre-malignancy (low PTEN/p53 and high c-myc) and contained stem cells with impaired self-renewal in vivo, and more numerous multipotent, ductal-restricted progenitors. Our data suggest that N1(IC) can favor transformation of progenitor cells early in life through a cyclin D1-dependent pathway. Oncogene (2010) 29, 4543-4554; doi: 10.1038/onc.2010.186; published online 21 June 2010	[Ling, H.; Sylvestre, J-R; Jolicoeur, P.] Clin Res Inst Montreal, Mol Biol Lab, Montreal, PQ H2W 1R7, Canada; [Jolicoeur, P.] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Jolicoeur, P.] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal	Jolicoeur, P (corresponding author), Clin Res Inst Montreal, Mol Biol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	paul.jolicoeur@ircm.qc.ca			Canadian Institute of Heath Research (CIHR); Canada Research Chair	Canadian Institute of Heath Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grant to PJ from the Canadian Institute of Heath Research (CIHR). PJ is a recipient of a Canada Research Chair and HL of a Postdoctoral Fellowship from CIHR Training grant in cancer. We are grateful to Annie Lavallee as well as to Eric Massicotte and Martine Dupuis for excellent assistance with tissue sections and flow cytometry, respectively, and to Dominic Filion for image analysis.	Ahmed KM, 2008, ONCOGENE, V27, P6738, DOI 10.1038/onc.2008.265; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brown JM, 1999, CANCER RES, V59, P1391; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; DEOME KB, 1959, CANCER RES, V19, P515; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Gusterson B, 2009, NAT REV CANCER, V9, P128, DOI 10.1038/nrc2571; Hanna Z, 2009, J VIROL, V83, P9743, DOI 10.1128/JVI.00125-09; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kiaris H, 2004, AM J PATHOL, V165, P695, DOI 10.1016/S0002-9440(10)63333-0; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Lee CW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2200; Martinez-Rumayor A, 2008, AM J CARDIOL, V101, p3A, DOI 10.1016/j.amjcard.2007.11.012; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Michels KB, 2004, NEW ENGL J MED, V351, P1679, DOI 10.1056/NEJMe048229; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Nair P, 2003, J VIROL, V77, P7106, DOI 10.1128/JVI.77.12.7106-7112.2003; Oishi K, 2004, DEV BIOL, V276, P172, DOI 10.1016/j.ydbio.2004.08.039; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Roue G, 2008, ONCOGENE, V27, P4909, DOI 10.1038/onc.2008.126; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Smith GH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1856; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stahl M, 2006, CANCER RES, V66, P7562, DOI 10.1158/0008-5472.CAN-06-0974; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	42	58	59	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 12	2010	29	32					4543	4554		10.1038/onc.2010.186	http://dx.doi.org/10.1038/onc.2010.186			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	638AQ	20562911				2022-12-25	WOS:000280862300005
J	Lindberg, J; Wijbrandts, CA; van Baarsen, LG; Nader, G; Klareskog, L; Catrina, A; Thurlings, R; Vervoordeldonk, M; Lundeberg, J; Tak, PP				Lindberg, Johan; Wijbrandts, Carla A.; van Baarsen, Lisa G.; Nader, Gustavo; Klareskog, Lars; Catrina, Anca; Thurlings, Rogier; Vervoordeldonk, Margriet; Lundeberg, Joakim; Tak, Paul P.			The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis	PLOS ONE			English	Article							FACTOR-ALPHA THERAPY; COLLEGE-OF-RHEUMATOLOGY; LYMPHOID NEOGENESIS; SET ENRICHMENT; BLOOD-CELLS; MICROARRAY; CANCER; TISSUE; RESPONSIVENESS; INFLAMMATION	Background: Although the use of TNF inhibitors has fundamentally changed the way rheumatoid arthritis (RA) is treated, not all patients respond well. It is desirable to facilitate the identification of responding and non-responding patients prior to treatment, not only to avoid unnecessary treatment but also for financial reasons. In this work we have investigated the transcriptional profile of synovial tissue sampled from RA patients before anti-TNF treatment with the aim to identify biomarkers predictive of response. Methodology/Principal Findings: Synovial tissue samples were obtained by arthroscopy from 62 RA patients before the initiation of infliximab treatment. RNA was extracted and gene expression profiling was performed using an in-house spotted long oligonucleotide array covering 17972 unique genes. Tissue sections were also analyzed by immunohistochemistry to evaluate cell infiltrates. Response to infliximab treatment was assessed according to the EULAR response criteria. The presence of lymphocyte aggregates dominated the expression profiles and a significant overrepresentation of lymphocyte aggregates in good responding patients confounded the analyses. A statistical model was set up to control for the effect of aggregates, but no differences could be identified between responders and non-responders. Subsequently, the patients were split into lymphocyte aggregate positive-and negative patients. No statistically significant differences could be identified except for 38 transcripts associated with differences between good- and non-responders in aggregate positive patients. A profile was identified in these genes that indicated a higher level of metabolism in good responding patients, which indirectly can be connected to increased inflammation. Conclusions/Significance: It is pivotal to account for the presence of lymphoid aggregates when studying gene expression patterns in rheumatoid synovial tissue. In spite of our original hypothesis, the data do not support the notion that microarray analysis of whole synovial biopsy specimens can be used in the context of personalized medicine to identify non-responders to anti-TNF therapy before the initiation of treatment.	[Lindberg, Johan; Lundeberg, Joakim] Royal Inst Technol, AlbaNova Univ Ctr, Sch Biotechnol, Dept Gene Technol, Stockholm, Sweden; [Wijbrandts, Carla A.; van Baarsen, Lisa G.; Thurlings, Rogier; Vervoordeldonk, Margriet; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Nader, Gustavo; Klareskog, Lars; Catrina, Anca] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Rheumatol Unit, Solna, Sweden	Royal Institute of Technology; University of Amsterdam; Academic Medical Center Amsterdam; Karolinska Institutet; Karolinska University Hospital	Lindberg, J (corresponding author), Royal Inst Technol, AlbaNova Univ Ctr, Sch Biotechnol, Dept Gene Technol, Stockholm, Sweden.	P.P.Tak@amc.uva.nl	Lindberg, Johan/F-4104-2011; Nader, Gustavo/E-9161-2013; Thurlings, R.M./L-4689-2015; van Baarsen, Lisa G/N-3646-2015	van Baarsen, Lisa G/0000-0003-3346-8921; Lindberg, Johan/0000-0003-3610-6774; Klareskog, Lars/0000-0001-9601-6186	The Netherlands Organization for Health Research and Development (ZonMw), The Netherlands Organization for Scientific Research (NWO) [945-02-029]; Center for Translational Molecular Medicine (TRACER); Dutch Arthritis Association; European Community; Swedish Knowledge Foundation	The Netherlands Organization for Health Research and Development (ZonMw), The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Center for Translational Molecular Medicine (TRACER); Dutch Arthritis Association; European Community(European Commission); Swedish Knowledge Foundation(General Electric)	This study was funded by a Health Care Efficiency Research Programme grant from The Netherlands Organization for Health Research and Development (ZonMw) in assignment of The Netherlands Organization for Scientific Research (NWO) (grant number 945-02-029), the Center for Translational Molecular Medicine (TRACER), the Dutch Arthritis Association, the European Community's FP6 funding (Autocure), and the Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics at the Centre for Medical Innovations (CMI) at the Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badot V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2678; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Braun-Moscovici Y, 2006, J RHEUMATOL, V33, P497; Cantaert T, 2008, J IMMUNOL, V181, P785, DOI 10.4049/jimmunol.181.1.785; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; Kraan MC, 2002, ARTHRITIS RHEUM-US, V46, P2034, DOI 10.1002/art.10556; Kraan TCV, 2008, ANN RHEUM DIS, V67, P563, DOI 10.1136/ard.2007.081950; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Lequerre T, 2007, RHEUMATOLOGY, V46, P446, DOI 10.1093/rheumatology/kel262; Lequerre T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1990; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2090; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1903; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Marotte H, 2005, ARTHRITIS RES THER, V7, pR149, DOI 10.1186/ar1465; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sekiguchi N, 2008, RHEUMATOLOGY, V47, P780, DOI 10.1093/rheumatology/ken083; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Thurlings RM, 2008, ARTHRITIS RHEUM, V58, P1582, DOI 10.1002/art.23505; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulfgren AK, 2000, ARTHRITIS RHEUM, V43, P2391, DOI 10.1002/1529-0131(200011)43:11<2391::AID-ANR3>3.0.CO;2-F; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P1728, DOI 10.1002/art.22716; van Vollenhoven RF, 2003, ARTHRITIS RHEUM, V48, P1500, DOI 10.1002/art.11027; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Wijbrandts CA, 2008, ANN RHEUM DIS, V67, P1139, DOI 10.1136/ard.2007.080440; Wolbink GJ, 2005, ANN RHEUM DIS, V64, P704, DOI 10.1136/ard.2004.030452; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; [No title captured]; [No title captured]	46	66	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11310	10.1371/journal.pone.0011310	http://dx.doi.org/10.1371/journal.pone.0011310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593016	Green Published, gold, Green Submitted			2022-12-25	WOS:000279140800011
J	Bousbia, S; Papazian, L; La Scola, B; Raoult, D				Bousbia, Sabri; Papazian, Laurent; La Scola, Bernard; Raoult, Didier			Detection of Plant DNA in the Bronchoalveolar Lavage of Patients with Ventilator-Associated Pneumonia	PLOS ONE			English	Article							PULMONARY ASPIRATION; CYSTIC-FIBROSIS; DIAGNOSIS; MORTALITY; POSITION	Background: Hospital-acquired infections such as nosocomial pneumonia are a serious cause of mortality for hospitalized patients, especially for those admitted to intensive care units (ICUs). Despite the number of the studies reported to date, the causative agents of pneumonia are not completely known. Herein, we found by molecular technique that vegetable and tobacco DNA may be detected in the bronchoalveolar lavage from patients with ventilator-associated pneumonia (VAP). Methodology/Principal Findings: In the present study, we studied bronchoalveolar lavage (BAL) from patients admitted to ICUs with ventilator-associated pneumonia. BAL fluids were assessed with molecular tests, culture and blood culture. We successfully identified plant DNA in six patients out of 106 (6%) with ventilator-associated pneumonia. Inhalation was confirmed in four cases and suspected in the other two cases. Inhalation was significantly frequent in patients with plant DNA (four out of six patients) than those without plant DNA (three out of 100 patients) (P < 0.001). Nicotiana tabacum chloroplast DNA was identified in three patients who were smokers (cases 2, 3 and 6). Cucurbita pepo, Morus bombycis and Triticum aestivum DNA were identified in cases 1, 4 and 5 respectively. Twenty-three different bacterial species, two viruses and five fungal species were identified from among these six patients by using molecular and culture techniques. Several of the pathogenic microorganisms identified are reported to be food-borne or tobacco plant-associated pathogens. Conclusions/Significance: Our study shows that plants DNA may be identified in the BAL fluid of pneumonia patients, especially when exploring aspiration pneumonia, but the significance of the presence of plant DNA and its role in the pathogenesis of pneumonia is unknown and remains to be investigated. However, the identification of these plants may be a potential marker of aspiration in patients with pneumonia.	[Bousbia, Sabri; La Scola, Bernard; Raoult, Didier] Fac Med Marseille, CNRS, IRD, UMR 6236 198,Unite Rech Malad Infect & Trop Emerg, F-13385 Marseille, France; [Papazian, Laurent] Hop Sud, Serv Reanimat Med, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bousbia, S (corresponding author), Fac Med Marseille, CNRS, IRD, UMR 6236 198,Unite Rech Malad Infect & Trop Emerg, F-13385 Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016	RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704	Programme Hospitalier de Recherche Clinique [2006]	Programme Hospitalier de Recherche Clinique	This work was supported by a grant from the Programme Hospitalier de Recherche Clinique 2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Artinian V, 2006, CHEST, V129, P960, DOI 10.1378/chest.129.4.960; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Berger P, 2006, EMERG INFECT DIS, V12, P248; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bousbia S, 2010, EMERG INFECT DIS, V16, P258, DOI 10.3201/eid1602.090610; CROME L, 1962, J CLIN PATHOL, V15, P21, DOI 10.1136/jcp.15.1.21; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Heyder Joachim, 2004, Proc Am Thorac Soc, V1, P315, DOI 10.1513/pats.200409-046TA; HICKLING KG, 1988, INTENS CARE MED, V14, P617; Khlif M, 2009, CLIN MICROBIOL INFEC, V15, P656, DOI 10.1111/j.1469-0691.2009.02762.x; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; MANDELL LA, 2007, B J HOPKINS HOSP S2, V44, pS27; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Mukhopadhyay S, 2007, AM J SURG PATHOL, V31, P752, DOI 10.1097/01.pas.0000213418.08009.f9; OROZCOLEVI M, 1995, AM J RESP CRIT CARE, V152, P1387, DOI 10.1164/ajrccm.152.4.7551400; TORRES A, 1992, ANN INTERN MED, V116, P540, DOI 10.7326/0003-4819-116-7-540; VALLES J, 1995, ANN INTERN MED, V122, P179, DOI 10.7326/0003-4819-122-3-199502010-00004; Vincent A, 2009, CRIT CARE MED, V37, P111, DOI 10.1097/CCM.0b013e318192fa8b; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370	24	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11298	10.1371/journal.pone.0011298	http://dx.doi.org/10.1371/journal.pone.0011298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585574	Green Published, gold, Green Submitted			2022-12-25	WOS:000279135800007
J	Peddinti, D; Memili, E; Burgess, SC				Peddinti, Divyaswetha; Memili, Erdogan; Burgess, Shane C.			Proteomics-Based Systems Biology Modeling of Bovine Germinal Vesicle Stage Oocyte and Cumulus Cell Interaction	PLOS ONE			English	Article							IN-VITRO MATURATION; COMPANION GRANULOSA-CELLS; MESSENGER-RNA EXPRESSION; TANDEM MASS-SPECTROMETRY; PROTEIN EXPRESSION; METABOLIC COOPERATIVITY; EMBRYO DEVELOPMENT; PORCINE OOCYTES; GENE-EXPRESSION; MOUSE OOCYTES	Background: Oocytes are the female gametes which establish the program of life after fertilization. Interactions between oocyte and the surrounding cumulus cells at germinal vesicle (GV) stage are considered essential for proper maturation or 'programming' of oocytes, which is crucial for normal fertilization and embryonic development. However, despite its importance, little is known about the molecular events and pathways involved in this bidirectional communication. Methodology/Principal Findings: We used differential detergent fractionation multidimensional protein identification technology (DDF-Mud PIT) on bovine GV oocyte and cumulus cells and identified 811 and 1247 proteins in GV oocyte and cumulus cells, respectively; 371 proteins were significantly differentially expressed between each cell type. Systems biology modeling, which included Gene Ontology (GO) and canonical genetic pathway analysis, showed that cumulus cells have higher expression of proteins involved in cell communication, generation of precursor metabolites and energy, as well as transport than GV oocytes. Our data also suggests a hypothesis that oocytes may depend on the presence of cumulus cells to generate specific cellular signals to coordinate their growth and maturation. Conclusions/Significance: Systems biology modeling of bovine oocytes and cumulus cells in the context of GO and protein interaction networks identified the signaling pathways associated with the proteins involved in cell-to-cell signaling biological process that may have implications in oocyte competence and maturation. This first comprehensive systems biology modeling of bovine oocytes and cumulus cell proteomes not only provides a foundation for signaling and cell physiology at the GV stage of oocyte development, but are also valuable for comparative studies of other stages of oocyte development at the molecular level.	[Peddinti, Divyaswetha; Burgess, Shane C.] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Memili, Erdogan] Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA; [Peddinti, Divyaswetha; Memili, Erdogan; Burgess, Shane C.] Mississippi State Univ, Inst Digital Biol, Mississippi State, MS 39762 USA; [Burgess, Shane C.] Mississippi State Univ, Life Sci & Biotechnol Inst, Mississippi State, MS 39762 USA; [Burgess, Shane C.] Mississippi State Univ, Mississippi Agr & Forestry Expt Stn, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University	Peddinti, D (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	dpeddinti@cvm.msstate.edu	Memili, Erdogan/AAY-8726-2020	Memili, Erdogan/0000-0002-8335-5645	Life Sciences and Biology Institute; Mississippi Agricultural and Forestry Experiment Station, Mississippi State University	Life Sciences and Biology Institute; Mississippi Agricultural and Forestry Experiment Station, Mississippi State University	This study was funded by the Life Sciences and Biology Institute and Mississippi Agricultural and Forestry Experiment Station, Mississippi State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2005, THERIOGENOLOGY, V64, P261, DOI 10.1016/j.theriogenology.2004.12.001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ASSIDI M, 2008, BIOL REPROD; BETTEGOWDA A, 2008, BIOL REPROD; Bhojwani M, 2006, CLONING STEM CELLS, V8, P259, DOI 10.1089/clo.2006.8.259; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; BRIDGES SM, 2007, BMC BIOINFORMATICS, V8; BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Coonrod SA, 2002, J REPROD IMMUNOL, V53, P55, DOI 10.1016/S0165-0378(01)00102-4; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Dalbies-Tran R, 2005, MOL REPROD DEV, V71, P414, DOI 10.1002/mrd.20298; deMatos DG, 1997, BIOL REPROD, V57, P1420, DOI 10.1095/biolreprod57.6.1420; DONAHUE RP, 1968, J REPROD FERTIL, V17, P395, DOI 10.1530/jrf.0.0170395; Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ellederova Z, 2004, BIOL REPROD, V71, P1533, DOI 10.1095/biolreprod.104.030304; EPPIG JJ, 1993, DEV BIOL, V158, P400, DOI 10.1006/dbio.1993.1198; EPPIG JJ, 1991, BIOESSAYS, V13, P569, DOI 10.1002/bies.950131105; Fair T, 2007, THERIOGENOLOGY, V68, pS91, DOI 10.1016/j.theriogenology.2007.04.018; Fatehi AN, 2002, THERIOGENOLOGY, V57, P1347, DOI 10.1016/S0093-691X(01)00717-8; Gerling IC, 2006, MOL CELL PROTEOMICS, V5, P293, DOI 10.1074/mcp.M500197-MCP200; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; GrazulBilska AT, 1997, BIOL REPROD, V57, P947, DOI 10.1095/biolreprod57.5.947; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hamamah S, 2006, REPROD BIOMED ONLINE, V13, P807, DOI 10.1016/S1472-6483(10)61028-0; Huang Y, 2006, PHYSIOL GENOMICS, V24, P144, DOI 10.1152/physiolgenomics.00258.2005; KIM H, 1991, CELL TISSUE RES, V265, P105, DOI 10.1007/BF00318144; LEESE HJ, 1985, J EXP ZOOL, V234, P231, DOI 10.1002/jez.1402340208; Leyens G, 2004, BIOL REPROD, V71, P1646, DOI 10.1095/biolreprod.104.030155; Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001; Ma MY, 2008, J PROTEOME RES, V7, P4821, DOI 10.1021/pr800392s; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; McCarthy FM, 2007, NUCLEIC ACIDS RES, V35, pD599, DOI 10.1093/nar/gkl936; McCarthy FM, 2006, PROTEOMICS, V6, P2759, DOI 10.1002/pmic.200500648; Memili E, 2007, REPRODUCTION, V133, P1107, DOI 10.1530/REP-06-0149; Memili E, 1999, BIOL REPROD, V61, P1198, DOI 10.1095/biolreprod61.5.1198; Meng Y, 2007, BBA-PROTEINS PROTEOM, V1774, P1477, DOI 10.1016/j.bbapap.2007.08.026; Monniaux D, 2006, SEMIN REPROD MED, V24, P251, DOI 10.1055/s-2006-948554; Mori T, 2000, BIOL REPROD, V62, P913, DOI 10.1095/biolreprod62.4.913; Nanduri B, 2005, PROTEOMICS, V5, P4852, DOI 10.1002/pmic.200500112; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212; Orchard S, 2007, PROTEOMICS, V7, P1006, DOI 10.1002/pmic.200700014; Park GW, 2006, PROTEOMICS, V6, P1121, DOI 10.1002/pmic.200500318; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pennetier S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-26; Pfeffer PL, 2007, THERIOGENOLOGY, V68, pS84, DOI 10.1016/j.theriogenology.2007.03.016; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Racedo SE, 2009, REPROD FERT DEVELOP, V21, P738, DOI 10.1071/RD09039; RICHTER JD, 1991, BIOESSAYS, V13, P179, DOI 10.1002/bies.950130406; Sagirkaya H, 2006, REPRODUCTION, V131, P895, DOI 10.1530/rep.1.01021; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Snow AJ, 2008, BIOL REPROD, V79, P337, DOI 10.1095/biolreprod.108.069328; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; Sugiura K, 2005, REPROD FERT DEVELOP, V17, P667, DOI 10.1071/RD05071; Sugiura K, 2005, DEV BIOL, V279, P20, DOI 10.1016/j.ydbio.2004.11.027; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; Sutton ML, 2003, REPRODUCTION, V126, P27, DOI 10.1530/rep.0.1260027; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; Thelie A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-125; VESELSKA R, 2001, SCRIPTA MED, V74, P265; Vozzi C, 2001, REPRODUCTION, V122, P619, DOI 10.1530/reprod/122.4.619; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Wongsrikeao P, 2005, REPROD DOMEST ANIM, V40, P166, DOI 10.1111/j.1439-0531.2005.00576.x; ZHANG L, 1995, MOL REPROD DEV, V40, P338, DOI 10.1002/mrd.1080400310	74	33	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11240	10.1371/journal.pone.0011240	http://dx.doi.org/10.1371/journal.pone.0011240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574525	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058300024
J	Smet, A; Van Nieuwerburgh, F; Vandekerckhove, TTM; Martel, A; Deforce, D; Butaye, P; Haesebrouck, F				Smet, Annemieke; Van Nieuwerburgh, Filip; Vandekerckhove, Tom T. M.; Martel, An; Deforce, Dieter; Butaye, Patrick; Haesebrouck, Freddy			Complete Nucleotide Sequence of CTX-M-15-Plasmids from Clinical Escherichia coli Isolates: Insertional Events of Transposons and Insertion Sequences	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; DNA-SEQUENCE; CTX-M; RESISTANCE; PLASMIDS; DISSEMINATION; SALMONELLA; ENTEROBACTERIACEAE; EMERGENCE; POULTRY	Background: CTX-M-producing Escherichia coli strains are regarded as major global pathogens. Methodology/Principal Findings: The nucleotide sequence of three plasmids (pEC_B24: 73801-bp; pEC_L8: 118525-bp and pEC_L46: 144871-bp) from Escherichia coli isolates obtained from patients with urinary tract infections and one plasmid (pEC_Bactec: 92970-bp) from an Escherichia coli strain isolated from the joint of a horse with arthritis were determined. Plasmid pEC_Bactec belongs to the Incl1 group and carries two resistance genes: bla(TEM-1) and bla(CTX-M-15). It shares more than 90% homology with a previously published bla(CTX-M)-plasmid from E. coli of human origin. Plasmid pEC_B24 belongs to the IncFII group whereas plasmids pEC_L8 and pEC_L46 represent a fusion of two replicons of type FII and FIA. On the pEC_B24 backbone, two resistance genes, blaTEM-1 and blaCTX-M-15, were found. Six resistance genes, blaTEM-1, blaCTX-M-15, bla(OXA-1), aac6'-lb-cr, tetA and catB4, were detected on the pEC_L8 backbone. The same antimicrobial drug resistance genes, with the exception of tetA, were also identified on the pEC_L46 backbone. Genome analysis of all 4 plasmids studied provides evidence of a seemingly frequent transposition event of the bla(CTX-M-15)-ISEcp1 element. This element seems to have a preferred insertion site at the tnpA gene of a bla(TEM)-carrying Tn3-like transposon, the latter itself being inserted by a transposition event. The IS26-composite transposon, which contains the blaOXA-1, aac6'-lb-cr and catB4 genes, was inserted into plasmids pEC_L8 and pEC_L46 by homologous recombination rather than a transposition event. Results obtained for pEC_L46 indicated that IS26 also plays an important role in structural rearrangements of the plasmid backbone and seems to facilitate the mobilisation of fragments from other plasmids. Conclusions: Collectively, these data suggests that IS26 together with ISEcp1 could play a critical role in the evolution of diverse multiresistant plasmids found in clinical Enterobacteriaceae.	[Smet, Annemieke; Martel, An; Butaye, Patrick; Haesebrouck, Freddy] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, NXTGNT Sequencing Facil, B-9000 Ghent, Belgium; [Vandekerckhove, Tom T. M.] Univ Ghent, Dept Mol Biotechnol, Biobix Lab Bioinformat & Computat Genom, B-9000 Ghent, Belgium; [Butaye, Patrick] CODA CERVA VAR, Dept Bacteriol & Immunol, Brussels, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Smet, A (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	Annemieke.Smet@UGent.be	Van Nieuwerburgh, Filip/H-9697-2015; Deforce, Dieter LD/J-4725-2013; Smet, Annemieke/M-9295-2017; Haesebrouck, Freddy/M-3857-2014; Martel, An/D-3713-2014; Butaye, Patrick/AAJ-8240-2020	Van Nieuwerburgh, Filip/0000-0001-8815-5485; Deforce, Dieter LD/0000-0002-0635-661X; Smet, Annemieke/0000-0002-1271-6191; Haesebrouck, Freddy/0000-0002-1709-933X; Butaye, Patrick/0000-0003-0780-6384	Federal Public Service of Health, Food Chain Safety and Environment [RT 06/3 ABRISK]; CODA-CERVA-VAR; Ghent University	Federal Public Service of Health, Food Chain Safety and Environment; CODA-CERVA-VAR; Ghent University(Ghent University)	This work was supported in part by a grant from the Federal Public Service of Health, Food Chain Safety and Environment (Grant number RT 06/3 ABRISK), by the CODA-CERVA-VAR and Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bae IK, 2006, J ANTIMICROB CHEMOTH, V58, P315, DOI 10.1093/jac/dkl252; Bae IK, 2006, J ANTIMICROB CHEMOTH, V58, P1257, DOI 10.1093/jac/dkl397; BELOGUROV AA, 1993, J BACTERIOL, V175, P4843, DOI 10.1128/JB.175.15.4843-4850.1993; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Bywater RJ, 2005, POULTRY SCI, V84, P644, DOI 10.1093/ps/84.4.644; Bywater RJ, 2004, J VET MED B, V51, P361, DOI 10.1111/j.1439-0450.2004.00791.x; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chaibi EB, 1999, J ANTIMICROB CHEMOTH, V43, P447, DOI 10.1093/jac/43.4.447; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Eckert C, 2006, J ANTIMICROB CHEMOTH, V57, P14, DOI 10.1093/jac/dki398; Fernandez AG, 2007, ANTIMICROB AGENTS CH, V51, P4177, DOI 10.1128/AAC.00603-07; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Garcia-Fernandez A, 2008, J ANTIMICROB CHEMOTH, V61, P1229, DOI 10.1093/jac/dkn131; Gootz TD, 2009, ANTIMICROB AGENTS CH, V53, P1998, DOI 10.1128/AAC.01355-08; Gupta V, 2007, INDIAN J MED RES, V126, P417; HEFFRON F, 1979, CELL, V18, P1153, DOI 10.1016/0092-8674(79)90228-9; Hopkins KL, 2006, ANTIMICROB AGENTS CH, V50, P3203, DOI 10.1128/AAC.00149-06; Horish R.E., 2002, CURR TOP MED CHEM, V2, P717; IIDA S, 1984, MOL GEN GENET, V198, P84, DOI 10.1007/BF00328705; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Komano T, 2000, MOL MICROBIOL, V35, P1348, DOI 10.1046/j.1365-2958.2000.01769.x; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; LEE KY, 1990, J BACTERIOL, V172, P3229, DOI 10.1128/jb.172.6.3229-3236.1990; MIKKONEN M, 1994, FEMS MICROBIOL LETT, V116, P315, DOI 10.1016/0378-1097(94)90053-1; Miriagou V, 2005, ANTIMICROB AGENTS CH, V49, P3541, DOI 10.1128/AAC.49.8.3541-3543.2005; Mushtaq S, 2003, J ANTIMICROB CHEMOTH, V52, P528, DOI 10.1093/jac/dkg353; Naas T, 2001, J BACTERIOL, V183, P235, DOI 10.1128/JB.183.1.235-249.2001; Partridge SR, 2005, ANTIMICROB AGENTS CH, V49, P1267, DOI 10.1128/AAC.49.3.1267-1268.2005; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Perichon B, 2008, ANTIMICROB AGENTS CH, V52, P2581, DOI 10.1128/AAC.01540-07; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rhodes G, 2000, APPL ENVIRON MICROB, V66, P3883, DOI 10.1128/AEM.66.9.3883-3890.2000; Ruppe E, 2009, EMERG INFECT DIS, V15, P741, DOI 10.3201/eid1505.071299; SCHRAMM E, 1987, J BACTERIOL, V169, P3350, DOI 10.1128/jb.169.7.3350-3357.1987; Shen P, 2008, J ANTIMICROB CHEMOTH, V62, P1252, DOI 10.1093/jac/dkn397; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Sidjabat HE, 2009, ANTIMICROB AGENTS CH, V53, P4733, DOI 10.1128/AAC.00533-09; SMET A, 2010, MICROB DRUG IN PRESS; Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07; Smet A, 2009, J ANTIMICROB CHEMOTH, V63, P1286, DOI 10.1093/jac/dkp101; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Zhu WH, 2009, ANTIMICROB AGENTS CH, V53, P5291, DOI 10.1128/AAC.00032-09	46	88	90	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11202	10.1371/journal.pone.0011202	http://dx.doi.org/10.1371/journal.pone.0011202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585456	Green Published, gold			2022-12-25	WOS:000278977200007
J	Krankel, N; Armstrong, SP; McArdle, CA; Dayan, C; Madeddu, P				Kraenkel, Nicolle; Armstrong, Stephen Paul; McArdle, Craig Alexander; Dayan, Colin; Madeddu, Paolo			Distinct Kinin-Induced Functions Are Altered in Circulating Cells of Young Type 1 Diabetic Patients	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; NADPH OXIDASE; STEM-CELLS; RECEPTOR; IMPAIRS; MOBILIZATION; RECRUITMENT; MECHANISMS; MELLITUS; STRESS	Aims/Hypothesis: We aimed to understand early alterations in kinin-mediated migration of circulating angio-supportive cells and dysfunction of kinin-sensitive cells in type-1 diabetic (T1D) patients before the onset of cardiovascular disease. Methods: Total mononuclear cells (MNC) were isolated from peripheral blood of 28 T1D patients free from cardiovascular complications except mild background retinopathy (age: 34.8+/-1.6 years, HbA(1C): 7.9+/-0.2%) and 28 age-and sex-matched non-diabetic controls (H). We tested expression of kinin receptors by flow cytometry and migratory capacity of circulating monocytes and progenitor cells towards bradykinin (BK) in transwell migration assays. MNC migrating towards BK (BKmig) were assessed for capacity to support endothelial cell function in a matrigel assay, as well as generation of nitric oxide (NO) and superoxide (O-2(-)*) by using the fluorescent probes diaminofluorescein and dihydroethidium. Results: CD14(hi)CD16(neg), CD14(hi)CD16(pos) and CD14(lo)CD16(pos) monocytes and circulating CD34(pos) progenitor cells did not differ between T1D and H subjects in their kinin receptor expression and migration towards BK. T1D BKmig failed to generate NO upon BK stimulation and supported endothelial cell network formation less efficiently than H BKmig. In contrast, O-2(-)* production was similar between groups. High glucose disturbed BK-induced NO generation by MNC-derived cultured angiogenic cells. Conclusions/Interpretation: Our data point out alterations in kinin-mediated functions of circulating MNC from T1D patients, occurring before manifest macrovascular damage or progressed microvascular disease. Functional defects of MNC recruited to the vessel wall might compromise endothelial maintenance, initially without actively promoting endothelial damage, but rather by lacking supportive contribution to endothelial regeneration and healing.	[Kraenkel, Nicolle; Armstrong, Stephen Paul; McArdle, Craig Alexander; Dayan, Colin] Univ Bristol, Labs Integrated Neurosci & Endocrinol, Bristol, Avon, England	University of Bristol	Krankel, N (corresponding author), Univ Bristol, Labs Integrated Neurosci & Endocrinol, Bristol, Avon, England.	n.kraenkel@gmx.de	McArdle, Craig/AAQ-5660-2021; Dayan, Colin/AAH-6242-2019	McArdle, Craig/0000-0003-4836-5351; Dayan, Colin/0000-0002-6557-3462; Kraenkel, Nicolle/0000-0002-9363-1770	European Foundation for the Study of Diabetes; Juvenile Diabetes Research Foundation; NovoNordisk; Wellcome Trust [083018]; U.K. Biotechnology and Biological Sciences Research Council	European Foundation for the Study of Diabetes; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NovoNordisk(Novo Nordisk); Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was supported by a grant from the European Foundation for the Study of Diabetes (www.europeandiabetesfoundation.org), co-sponsored by the Juvenile Diabetes Research Foundation and NovoNordisk. N.K. is supported by a Wellcome Trust project grant (# 083018, www.wellcome.ac.uk). S. A. is supported by a Doctoral Training Award of the U.K. Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and do not participate in intellectual property arising from this research. None of the investigators are employed by the funders. Adherence to the PLoS ONE policies on sharing data and materials is not affected.	Brandes RP, 2008, CURR OPIN LIPIDOL, V19, P513, DOI 10.1097/MOL.0b013e32830c91e3; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Costa-Neto CM, 2008, INT IMMUNOPHARMACOL, V8, P135, DOI 10.1016/j.intimp.2007.08.003; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Danielisova V, 2008, NEUROCHEM RES, V33, P1057, DOI 10.1007/s11064-007-9550-3; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Fadini GP, 2007, DIABETES CARE, V30, P1305, DOI 10.2337/dc06-2305; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fujii H, 1997, J BIOL CHEM, V272, P32773, DOI 10.1074/jbc.272.52.32773; Krankel N, 2008, CIRC RES, V103, P1335, DOI 10.1161/CIRCRESAHA.108.179952; Kubo M, 2009, J CELL PHYSIOL, V220, P508, DOI 10.1002/jcp.21803; Larsen BT, 2009, ARTERIOSCL THROM VAS, V29, P739, DOI 10.1161/ATVBAHA.108.169367; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Matsumoto T, 2008, BONE, V43, P434, DOI 10.1016/j.bone.2008.05.001; Oikawa A, 2010, ARTERIOSCL THROM VAS, V30, P498, DOI 10.1161/ATVBAHA.109.200154; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Sambuceti G, 2009, STEM CELLS, V27, P399, DOI 10.1634/stemcells.2008-0800; Seeger FH, 2009, ARTERIOSCL THROM VAS, V29, P1802, DOI 10.1161/ATVBAHA.109.194688; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Selemidis S, 2007, CARDIOVASC RES, V75, P349, DOI 10.1016/j.cardiores.2007.03.030; Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Tschope C, 2005, FASEB J, V19, P2057, DOI 10.1096/fj.05-4095fje; Voo S, 2008, EUR HEART J, V29, P241, DOI 10.1093/eurheartj/ehm542; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Yoder MC, 2009, BBA-REV CANCER, V1796, P50, DOI 10.1016/j.bbcan.2009.04.002; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2010	5	6							e11146	10.1371/journal.pone.0011146	http://dx.doi.org/10.1371/journal.pone.0011146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612HB	20567501	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886300003
J	Chatterjee, A; Adak, A; Singh, AK; Srivastava, MK; Ghosh, SK; Tiwari, S; Devara, PCS; Raha, S				Chatterjee, Abhijit; Adak, Anandamay; Singh, Ajay K.; Srivastava, Manoj K.; Ghosh, Sanjay K.; Tiwari, Suresh; Devara, Panuganti C. S.; Raha, Sibaji			Aerosol Chemistry over a High Altitude Station at Northeastern Himalayas, India	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ATMOSPHERIC AEROSOL; SIZE DISTRIBUTIONS; TIBETAN PLATEAU; NEPAL HIMALAYA; DRY DEPOSITION; BOUNDARY-LAYER; PARTICLE-SIZE; WESTERN INDIA; MINERAL DUST	Background: There is an urgent need for an improved understanding of the sources, distributions and properties of atmospheric aerosol in order to control the atmospheric pollution over northeastern Himalayas where rising anthropogenic interferences from rapid urbanization and development is becoming an increasing concern. Methodology/Principal Findings: An extensive aerosol sampling program was conducted in Darjeeling (altitude,2200 meter above sea level (masl), latitude 27 degrees 01'N and longitude 88 degrees 15'E), a high altitude station in northeastern Himalayas, during January-December 2005. Samples were collected using a respirable dust sampler and a fine dust sampler simultaneously. Ion chromatograph was used to analyze the water soluble ionic species of aerosol. The average concentrations of fine and coarse mode aerosol were found to be 29.5 +/- 20.8 mu g m(-3) and 19.6 +/- 11.1 mu g m(-3) respectively. Fine mode aerosol dominated during dry seasons and coarse mode aerosol dominated during monsoon. Nitrate existed as NH4NO3 in fine mode aerosol during winter and as NaNO3 in coarse mode aerosol during monsoon. Gas phase photochemical oxidation of SO2 during premonsoon and aqueous phase oxidation during winter and postmonsoon were the major pathways for the formation of SO42- in the atmosphere. Long range transport of dust aerosol from arid regions of western India was observed during premonsoon. The acidity of fine mode aerosol was higher in dry seasons compared to monsoon whereas the coarse mode acidity was higher in monsoon compared to dry seasons. Biomass burning, vehicular emissions and dust particles were the major types of aerosol from local and continental regions whereas sea salt particles were the major types of aerosol from marine source regions. Conclusions/Significance: The year-long data presented in this paper provide substantial improvements to the heretofore poor knowledge regarding aerosol chemistry over northeastern Himalayas, and should be useful to policy makers in making control strategies.	[Chatterjee, Abhijit; Adak, Anandamay; Raha, Sibaji] Bose Inst, Environm Sci Sect, Kolkata, India; [Singh, Ajay K.; Ghosh, Sanjay K.; Raha, Sibaji] Bose Inst, Ctr Astroparticle Phys & Space Sci, Kolkata, India; [Singh, Ajay K.; Ghosh, Sanjay K.; Raha, Sibaji] Bose Inst, Ctr Astroparticle Phys & Space Sci, Darjeeling, India; [Srivastava, Manoj K.] Banaras Hindu Univ, Dept Geophys, Varanasi 221005, Uttar Pradesh, India; [Ghosh, Sanjay K.; Raha, Sibaji] Bose Inst, Dept Phys, Kolkata, India; [Tiwari, Suresh] Indian Inst Trop Meteorol, New Delhi, India; [Devara, Panuganti C. S.] Indian Inst Trop Meteorol, Pune, Maharashtra, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; Banaras Hindu University (BHU); Department of Science & Technology (India); Bose Institute; Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM); Ministry of Earth Sciences (MoES) - India; Indian Institute of Tropical Meteorology (IITM)	Chatterjee, A (corresponding author), Bose Inst, Environm Sci Sect, Kolkata, India.	sibajiraha@bic.boseinst.ernet.in	Singh, Ajay/AAF-4414-2020	Srivastava, Manoj Kumar/0000-0002-1035-8220	Science & Engineering Research Council, Department of Science & Technology, Government of India [IR/S2/PF-01/2003]	Science & Engineering Research Council, Department of Science & Technology, Government of India(Department of Science & Technology (India))	This study was supported through a grant (No. IR/S2/PF-01/2003) of the Science & Engineering Research Council, Department of Science & Technology, Government of India under the IRHPA (Intensification of Research in High Priority Areas) scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHISH A, 2006, NATURE SCI, V4, P53; Carrico CM, 2003, ATMOS ENVIRON, V37, P2811, DOI 10.1016/S1352-2310(03)00197-3; Chatterjee A, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007144; Dasgupta PK, 2007, ATMOS ENVIRON, V41, P4242, DOI 10.1016/j.atmosenv.2006.09.054; DECESARI S, 2009, ATMOS CHEM PHYS DISC, V9, P25522; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Gajananda K, 2005, ATMOS ENVIRON, V39, P4817, DOI 10.1016/j.atmosenv.2005.01.038; Gautam R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037641; Gautam R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036967; Giuliacci M., 1988, PHYS DYNAMICAL CLIMA; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Kaupp H, 1999, ATMOS ENVIRON, V33, P85, DOI 10.1016/S1352-2310(98)00129-0; Kim HS, 2007, ATMOS ENVIRON, V41, P6762, DOI 10.1016/j.atmosenv.2007.04.060; Kulshrestha MJ, 2003, ATMOS ENVIRON, V37, P3057, DOI 10.1016/S1352-2310(03)00290-5; Kulshrestha UC, 1998, J ATMOS CHEM, V29, P109, DOI 10.1023/A:1005796400044; Kumar A, 2008, ATMOS ENVIRON, V42, P5169, DOI 10.1016/j.atmosenv.2008.03.004; Lau KM, 2006, CLIM DYNAM, V26, P855, DOI 10.1007/s00382-006-0114-2; Lippmann M, 2000, Appl Occup Environ Hyg, V15, P57; MAENHAUT W, 1987, Journal of Trace and Microprobe Techniques, V5, P135; MAYEWSKI PA, 1979, ARCTIC ALPINE RES, V11, P267, DOI 10.2307/1550417; MCINNES LM, 1994, J GEOPHYS RES-ATMOS, V99, P8257, DOI 10.1029/93JD03453; Momin GA, 1999, CURR SCI INDIA, V76, P985; MOZURKEWICH M, 1993, ATMOS ENVIRON A-GEN, V27, P261, DOI 10.1016/0960-1686(93)90356-4; OHTA S, 1990, ATMOS ENVIRON A-GEN, V24, P815, DOI 10.1016/0960-1686(90)90282-R; Pakkanen TA, 1996, ATMOS ENVIRON, V30, P2475, DOI 10.1016/1352-2310(95)00492-0; Pathak RK, 2004, ATMOS ENVIRON, V38, P2965, DOI 10.1016/j.atmosenv.2004.02.044; Ramanathan V, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008124; Rastogi N, 2007, J ATMOS CHEM, V56, P149, DOI 10.1007/s10874-006-9047-5; Rastogi N, 2005, ATMOS ENVIRON, V39, P5541, DOI 10.1016/j.atmosenv.2005.06.011; Rastogi N, 2009, ATMOS ENVIRON, V43, P3481, DOI 10.1016/j.atmosenv.2009.04.030; Rengarajan R, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008150; Safai P.D., 1995, IASTA B, pS1; Seinfeld JH, 1986, ENV POL SUS DEV, V40, P26; Shrestha AB, 1997, ATMOS ENVIRON, V31, P2815, DOI 10.1016/S1352-2310(97)00047-2; Shrestha AB, 2000, ATMOS ENVIRON, V34, P3349, DOI 10.1016/S1352-2310(99)00366-0; *SPSS INC, 2003, ADV STAT MAN SPSS PC; Venkataraman C, 2002, ATMOS ENVIRON, V36, P1979, DOI 10.1016/S1352-2310(02)00167-X; VONSTROCH, 1999, STAT ANAL CLIMATE RE; WAKE CP, 1994, ATMOS ENVIRON, V28, P695, DOI 10.1016/1352-2310(94)90046-9; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; Xiu GL, 2004, ATMOS ENVIRON, V38, P227, DOI 10.1016/j.atmosenv.2003.09.053; ZELENKA MP, 1994, ATMOS ENVIRON, V28, P1425, DOI 10.1016/1352-2310(94)90205-4; Zhuang H, 1999, ATMOS ENVIRON, V33, P843, DOI 10.1016/S1352-2310(98)00305-7	43	57	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11122	10.1371/journal.pone.0011122	http://dx.doi.org/10.1371/journal.pone.0011122			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585397	Green Submitted, Green Published, gold			2022-12-25	WOS:000278886100008
J	Gelfand, M; Piro, O; Magnasco, MO; Hudspeth, AJ				Gelfand, Michael; Piro, Oreste; Magnasco, Marcelo O.; Hudspeth, A. J.			Interactions between Hair Cells Shape Spontaneous Otoacoustic Emissions in a Model of the Tokay Gecko's Cochlea	PLOS ONE			English	Article							BASILAR PAPILLA; BOBTAIL LIZARD; ELECTRICAL-STIMULATION; RELAXATION DYNAMICS; EXTERNAL TONES; SUPPRESSION; BUNDLES; SYNCHRONIZATION; AMPLIFICATION; AMPLIFIER	Background: The hearing of tetrapods including humans is enhanced by an active process that amplifies the mechanical inputs associated with sound, sharpens frequency selectivity, and compresses the range of responsiveness. The most striking manifestation of the active process is spontaneous otoacoustic emission, the unprovoked emergence of sound from an ear. Hair cells, the sensory receptors of the inner ear, are known to provide the energy for such emissions; it is unclear, though, how ensembles of such cells collude to power observable emissions. Methodology and Principal Findings: We have measured and modeled spontaneous otoacoustic emissions from the ear of the tokay gecko, a convenient experimental subject that produces robust emissions. Using a van der Pol formulation to represent each cluster of hair cells within a tonotopic array, we have examined the factors that influence the cooperative interaction between oscillators. Conclusions and Significance: A model that includes viscous interactions between adjacent hair cells fails to produce emissions similar to those observed experimentally. In contrast, elastic coupling yields realistic results, especially if the oscillators near the ends of the array are weakened so as to minimize boundary effects. Introducing stochastic irregularity in the strength of oscillators stabilizes peaks in the spectrum of modeled emissions, further increasing the similarity to the responses of actual ears. Finally, and again in agreement with experimental findings, the inclusion of a pure-tone external stimulus repels the spectral peaks of spontaneous emissions. Our results suggest that elastic coupling between oscillators of slightly differing strength explains several properties of the spontaneous otoacoustic emissions in the gecko.	[Gelfand, Michael; Hudspeth, A. J.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Gelfand, Michael; Hudspeth, A. J.] Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10021 USA; [Piro, Oreste] Univ Illes Balears, Dept Fis, Univ Balear Isl UIB, Spanish Natl Res Council CSIC, E-07071 Palma de Mallorca, Spain; [Piro, Oreste] Univ Illes Balears, Inst Cross Disciplinary Phys & Complex Syst IFISC, Univ Balear Isl UIB, Spanish Natl Res Council CSIC, E-07071 Palma de Mallorca, Spain; [Magnasco, Marcelo O.] Rockefeller Univ, Phys Math Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Rockefeller University	Gelfand, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	hudspaj@rockefeller.edu	Piro, Oreste/B-4899-2014	Piro, Oreste/0000-0002-6966-2796; Gelfand, Michael/0000-0002-4816-8756	National Institutes of Health [DC000241, DC007294, GM07739]; Spanish Ministerio de Educacion y Ciencias; Consejo Superior de Investigaciones Cientificas (CSIC); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Educacion y Ciencias(Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This investigation was supported by grants DC000241, DC007294, and GM07739 from the National Institutes of Health, by the Spanish Ministerio de Educacion y Ciencias, and by Consejo Superior de Investigaciones Cientificas (CSIC) project HIELOCRIS. A.J.H. is an Investigator of Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranyosi AJ, 2005, J ACOUST SOC AM, V118, P1585, DOI 10.1121/1.1993147; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; AUTHIER S, 1995, HEARING RES, V82, P1, DOI 10.1016/0378-5955(94)00138-G; Basak S, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2423254; Bergevin C, 2008, J COMP PHYSIOL A, V194, P665, DOI 10.1007/s00359-008-0338-y; BIALEK W, 1984, PHYS LETT A, V104, P173, DOI 10.1016/0375-9601(84)90371-2; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chiappe ME, 2007, J NEUROSCI, V27, P11978, DOI 10.1523/JNEUROSCI.3679-07.2007; Dallos P, 2006, J PHYSIOL-LONDON, V576, P37, DOI 10.1113/jphysiol.2006.114652; EATOCK RA, 1981, J COMP PHYSIOL, V142, P203, DOI 10.1007/BF00605739; FRISHKOPF LS, 1983, HEARING RES, V12, P393, DOI 10.1016/0378-5955(83)90008-4; HOLTON T, 1983, SCIENCE, V222, P508, DOI 10.1126/science.6623089; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; HUDSPETH AJ, 2008, NEURON IN PRESS; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kern A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.128101; KOPPL C, 1994, HEARING RES, V72, P159, DOI 10.1016/0378-5955(94)90215-1; KOPPL C, 1988, HEARING RES, V35, P209, DOI 10.1016/0378-5955(88)90119-0; KOPPL C, 1995, HEARING RES, V82, P14, DOI 10.1016/0378-5955(94)00139-H; KOPPL C, 1993, HEARING RES, V71, P157, DOI 10.1016/0378-5955(93)90031-U; LONG GR, 1991, J ACOUST SOC AM, V89, P1201, DOI 10.1121/1.400651; Manley GA, 2006, HEARING RES, V212, P33, DOI 10.1016/j.heares.2005.10.007; Manley GA, 2001, J NEUROPHYSIOL, V86, P541, DOI 10.1152/jn.2001.86.2.541; Manley GA, 2001, P NATL ACAD SCI USA, V98, P2826, DOI 10.1073/pnas.041604998; Manley GA, 1999, HEARING RES, V131, P107, DOI 10.1016/S0378-5955(99)00021-0; Manley GA, 2000, P NATL ACAD SCI USA, V97, P11736, DOI 10.1073/pnas.97.22.11736; Manley GA, 1996, J ACOUST SOC AM, V99, P1588, DOI 10.1121/1.414680; Manley GA, 1997, J ACOUST SOC AM, V102, P1049, DOI 10.1121/1.419858; Martin P, 2003, J NEUROSCI, V23, P4533; MILLER MR, 1973, Z ZELLFORSCH MIK ANA, V136, P307, DOI 10.1007/BF00307037; MURPHY WJ, 1995, J ACOUST SOC AM, V97, P3711, DOI 10.1121/1.412388; Murphy WJ, 1996, J ACOUST SOC AM, V100, P3979, DOI 10.1121/1.417217; Nadrowski B, 2004, P NATL ACAD SCI USA, V101, P12195, DOI 10.1073/pnas.0403020101; Nobili R, 1998, TRENDS NEUROSCI, V21, P159, DOI 10.1016/S0166-2236(97)01192-2; Probst R, 1990, Adv Otorhinolaryngol, V44, P1; RUGGERO MA, 1984, HEARING RES, V13, P293, DOI 10.1016/0378-5955(84)90083-2; Stewart CE, 2000, P NATL ACAD SCI USA, V97, P454, DOI 10.1073/pnas.97.1.454; TALMADGE CL, 1990, LECT NOTES BIOMATH, V87, P235; VANDIJK P, 1990, J ACOUST SOC AM, V88, P850, DOI 10.1121/1.399734; vanDijk P, 1996, J ACOUST SOC AM, V100, P2220, DOI 10.1121/1.417931; vanHengel PWJ, 1996, J ACOUST SOC AM, V99, P3566, DOI 10.1121/1.414955; Vilfan A, 2008, BIOPHYS J, V95, P4622, DOI 10.1529/biophysj.108.130286; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; WIT HP, 1990, ADV AUDIOL, V7, P110	47	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11116	10.1371/journal.pone.0011116	http://dx.doi.org/10.1371/journal.pone.0011116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559557	Green Submitted, Green Published, gold			2022-12-25	WOS:000278775900007
J	Touchon, M; Rocha, EPC				Touchon, Marie; Rocha, Eduardo P. C.			The Small, Slow and Specialized CRISPR and Anti-CRISPR of Escherichia and Salmonella	PLOS ONE			English	Article							PROVIDES ACQUIRED-RESISTANCE; STREPTOCOCCUS-THERMOPHILUS; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; BACTERIAL GENOMES; COLI; REPEATS; SEQUENCES; DNA; IDENTIFICATION	Prokaryotes thrive in spite of the vast number and diversity of their viruses. This partly results from the evolution of mechanisms to inactivate or silence the action of exogenous DNA. Among these, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are unique in providing adaptive immunity against elements with high local resemblance to genomes of previously infecting agents. Here, we analyze the CRISPR loci of 51 complete genomes of Escherichia and Salmonella. CRISPR are in two pairs of loci in Escherichia, one single pair in Salmonella, each pair showing a similar turnover rate, repeat sequence and putative linkage to a common set of cas genes. Yet, phylogeny shows that CRISPR and associated cas genes have different evolutionary histories, the latter being frequently exchanged or lost. In our set, one CRISPR pair seems specialized in plasmids often matching genes coding for the replication, conjugation and antirestriction machinery. Strikingly, this pair also matches the cognate cas genes in which case these genes are absent. The unexpectedly high conservation of this anti-CRISPR suggests selection to counteract the invasion of mobile elements containing functional CRISPR/cas systems. There are few spacers in most CRISPR, which rarely match genomes of known phages. Furthermore, we found that strains divergent less than 250 thousand years ago show virtually identical CRISPR. The lack of congruence between cas, CRISPR and the species phylogeny and the slow pace of CRISPR change make CRISPR poor epidemiological markers in enterobacteria. All these observations are at odds with the expectedly abundant and dynamic repertoire of spacers in an immune system aiming at protecting bacteria from phages. Since we observe purifying selection for the maintenance of CRISPR these results suggest that alternative evolutionary roles for CRISPR remain to be uncovered.	[Touchon, Marie; Rocha, Eduardo P. C.] Inst Pasteur, Dept Genom & Genet, Paris, France; [Touchon, Marie; Rocha, Eduardo P. C.] CNRS, URA2171, Paris, France; [Touchon, Marie; Rocha, Eduardo P. C.] Univ Paris 06, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Touchon, M (corresponding author), Inst Pasteur, Dept Genom & Genet, Paris, France.	marie.touchon@pasteur.fr	Rocha, Eduardo/B-7009-2009; Rocha, Eduardo/A-4727-2008	Rocha, Eduardo/0000-0001-7704-822X; Touchon, marie/0000-0001-7389-447X				Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Balbi KJ, 2009, MOL BIOL EVOL, V26, P345, DOI 10.1093/molbev/msn252; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; DIEZVILLASENOR C, 2010, MICROBIOLOGY; Dobrindt U, 2005, INT J MED MICROBIOL, V295, P357, DOI 10.1016/j.ijmm.2005.07.009; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; KRUGER DH, 1983, MICROBIOL REV, V47, P345; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lerat E, 2004, GENOME RES, V14, P2273, DOI 10.1101/gr.2925604; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; NAKATA A, 1989, J BACTERIOL, V171, P3553, DOI 10.1128/jb.171.6.3553-3556.1989; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Price EP, 2007, APPL ENVIRON MICROB, V73, P3431, DOI 10.1128/AEM.02702-06; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Touchon M, 2007, MOL BIOL EVOL, V24, P969, DOI 10.1093/molbev/msm014; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	169	183	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11126	10.1371/journal.pone.0011126	http://dx.doi.org/10.1371/journal.pone.0011126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559554	Green Submitted, Green Published, gold			2022-12-25	WOS:000278775900016
J	Marcoux, J; Man, P; Petit-Haertlein, I; Vives, C; Forest, E; Fieschi, F				Marcoux, Julien; Man, Petr; Petit-Haertlein, Isabelle; Vives, Corinne; Forest, Eric; Fieschi, Franck			p47(phox) Molecular Activation for Assembly of the Neutrophil NADPH Oxidase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC HOMOLOGY-3 DOMAINS; PHOSPHORYLATION-INDUCED ACTIVATION; TANDEM SH3 DOMAINS; PX DOMAINS; INTRAMOLECULAR INTERACTION; RESTING STATE; NOX-FAMILY; BINDING; P40(PHOX); P67(PHOX)	The p47(phox) cytosolic factor from neutrophilic NADPH oxidase has always been resistant to crystallogenesis trials due to its modular organization leading to relative flexibility. Hydrogen/deuterium exchange coupled to mass spectrometry was used to obtain structural information on the conformational mechanism that underlies p47(phox) activation. We confirmed a relative opening of the protein with exposure of the SH3 Src loops that are known to bind p22(phox) upon activation. A new surface was shown to be unmasked after activation, representing a potential autoinhibitory surface that may block the interaction of the PX domain with the membrane in the resting state. Within this surface, we identified 2 residues involved in the interaction with the PX domain. The double mutant R162A/D166A showed a higher affinity for specific phospholipids but none for the C-terminal part of p22(phox), reflecting an intermediate conformation between the autoinhibited and activated forms.	[Fieschi, Franck] IBS, Direct Sci Vivant, CEA, Lab Prot Membranaires, F-38027 Grenoble, France; [Marcoux, Julien; Man, Petr; Forest, Eric] IBS, Direct Sci Vivant, CEA, Lab Spectrometrie Masse Prote, F-38027 Grenoble, France; [Marcoux, Julien; Man, Petr; Petit-Haertlein, Isabelle; Vives, Corinne; Forest, Eric; Fieschi, Franck] CNRS, UMR 5075, F-38027 Grenoble, France; [Marcoux, Julien; Man, Petr; Petit-Haertlein, Isabelle; Vives, Corinne; Forest, Eric; Fieschi, Franck] Univ Grenoble 1, F-38041 Grenoble, France; [Man, Petr] Acad Sci Czech Republic, Inst Microbiol, Vvi, CZ-14220 Prague 4, Czech Republic; Charles Univ Prague, Fac Sci, Dept Biochem, CZ-12840 Prague 2, Czech Republic	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Fieschi, F (corresponding author), IBS, Direct Sci Vivant, CEA, Lab Prot Membranaires, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	franck.fieschi@ibs.fr	Marcoux, Julien/I-3908-2012; Forest, Eric/E-9042-2012; Fieschi, Franck/W-2748-2019; Man, Petr/H-2451-2014	Man, Petr/0000-0002-1485-2197; Marcoux, Julien/0000-0001-7321-7436; FIESCHI, Franck/0000-0003-1194-8107	CEA; Association pour la Recherche sur le Cancer	CEA(French Atomic Energy Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by grants from the CEA and the Association pour la Recherche sur le Cancer.	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Li XJ, 2007, J LEUKOCYTE BIOL, V81, P238, DOI 10.1189/jlb.0905541; Marcoux J, 2009, FEBS LETT, V583, P835, DOI 10.1016/j.febslet.2009.01.046; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Nakamura R, 1998, EUR J BIOCHEM, V251, P583, DOI 10.1046/j.1432-1327.1998.2510583.x; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nobuhisa I, 2006, BIOCHEM J, V396, P183, DOI 10.1042/BJ20051899; Noda Y, 2003, J BIOL CHEM, V278, P43516, DOI 10.1074/jbc.M306330200; Ogura K, 2006, J BIOL CHEM, V281, P3660, DOI 10.1074/jbc.M505193200; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Segal AW, 1996, MOL MED TODAY, V2, P129, DOI 10.1016/1357-4310(96)88723-5; Shen K, 2008, BIOCHEMISTRY-US, V47, P8855, DOI 10.1021/bi8005847; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; TANG J, 1963, NATURE, V199, P1094, DOI 10.1038/1991094a0; Taura M, 2009, BIOCHEM J, V419, P329, DOI 10.1042/BJ20082028; Taylor RA, 2007, BIOCHEMISTRY-US, V46, P14291, DOI 10.1021/bi701626p; Wilson L, 1997, INFLAMM RES, V46, P265, DOI 10.1007/s000110050185; Yuzawa S, 2004, J BIOL CHEM, V279, P29752, DOI 10.1074/jbc.M401457200; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhang HM, 2008, ANAL CHEM, V80, P9034, DOI 10.1021/ac801417d; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	36	32	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 10	2010	285	37					28980	28990		10.1074/jbc.M110.139824	http://dx.doi.org/10.1074/jbc.M110.139824			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	647CR	20592030	Green Published, hybrid			2022-12-25	WOS:000281594000063
J	Li, H; Wang, W; Liu, X; Paulson, KE; Yee, AS; Zhang, X				Li, H.; Wang, W.; Liu, X.; Paulson, K. E.; Yee, A. S.; Zhang, X.			Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence	ONCOGENE			English	Article						Ras; HBP1; p16(INK4A); senescence; transformation	BREAST-CANCER CELLS; HUMAN MELANOCYTE; REPRESSOR HBP1; CYCLE ARREST; LIFE-SPAN; PROTEIN; KINASE; GENE; PATHWAY; TRANSFORMATION	Oncogene-mediated premature senescence has emerged as a potential tumor-suppressive mechanism in early cancer transitions. Many studies showed that Ras and p38 mitogen-activated protein kinase (MAPK) participate in premature senescence. Our previous work indicated that the HMG box-containing protein 1 (HBP1) transcription factor is involved in Ras- and p38 MAPK-induced premature senescence, but the mechanism of which has not yet been identified. Here, we showed that the p16(INK4A) cyclin-dependent kinase inhibitor is a novel target of HBP1 participating in Ras-induced premature senescence. The promoter of the p16(INK4A) gene contains an HBP1-binding site at position -426 to -433 bp from the transcriptional start site. HBP1 regulates the expression of the endogenous p16(INK4A) gene through direct sequence-specific binding. With HBP1 expression and the subsequent increase of p16(INK4A) gene expression, Ras induces premature senescence in primary cells. The data suggest a model in which Ras and p38 MAPK signaling engage HBP1 and p16(INK4A) to trigger premature senescence. In addition, we report that HBP1 knockdown is also required for Ras-induced transformation. All the data indicate that the mechanism of HBP1-mediated transcriptional regulation is important for not only premature senescence but also tumorigenesis. Oncogene (2010) 29, 5083-5094; doi:10.1038/onc.2010.252; published online 28 June 2010	[Li, H.; Wang, W.; Liu, X.; Zhang, X.] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Paulson, K. E.] Tufts Univ New England Med Ctr, Dept Radiat Oncol, Boston, MA USA; [Yee, A. S.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Peking University; Tufts Medical Center; Tufts University	Zhang, X (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Xueyuan Rd 38, Beijing 100191, Peoples R China.	xiaoweizhang@bjmu.edu.cn			National Natural Science Foundation of China [30770442]; National Basic Research Programs of China [2007CB507400]; NIH/NCI [CA94187, CA104236]; Susan B Komen Foundation for the Cure [BCTR0504367]; NATIONAL CANCER INSTITUTE [R01CA104236, R01CA094187] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Programs of China(National Basic Research Program of China); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan B Komen Foundation for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Natural Science Foundation of China (no. 30770442) to Xiaowei Zhang, and from the National Basic Research Programs of China (no. 2007CB507400) to Tanjun Tong; from the NIH/NCI (CA94187 and CA104236) to Amy S Yee and the Susan B Komen Foundation for the Cure (BCTR0504367) to K Eric Paulson. We thank Dr Wengong Wang for helpful discussion on the paper.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bandyopadhyay D, 2001, EXP GERONTOL, V36, P1265, DOI 10.1016/S0531-5565(01)00098-5; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bond JA, 1999, MOL CELL BIOL, V19, P3103; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Haferkamp S, 2008, AGING CELL, V7, P733, DOI 10.1111/j.1474-9726.2008.00422.x; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Haq R, 2002, CANCER RES, V62, P5076; Hornsby PJ, 2007, J CLIN ONCOL, V25, P1852, DOI 10.1200/JCO.2006.10.3101; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; Kim JE, 2008, INT J MOL MED, V22, P651, DOI 10.3892/ijmm_00000068; Kim JY, 2006, J BIOL CHEM, V281, P10865, DOI 10.1074/jbc.M513378200; Lavender P, 1997, ONCOGENE, V14, P2721, DOI 10.1038/sj.onc.1201243; Lemercier C, 2000, MOL CELL BIOL, V20, P6627, DOI 10.1128/MCB.20.18.6627-6637.2000; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Molnar A, 1997, J BIOL CHEM, V272, P13229, DOI 10.1074/jbc.272.20.13229; Muscarella P, 2008, GENE EXPRESSION, V14, P207, DOI 10.3727/105221608786883825; Nelyudova A, 2007, CELL CYCLE, V6, P2171, DOI 10.4161/cc.6.17.4610; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Paulson KE, 2007, CANCER RES, V67, P6136, DOI 10.1158/0008-5472.CAN-07-0567; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shih HH, 1998, MOL CELL BIOL, V18, P4732, DOI 10.1128/MCB.18.8.4732; Shih HH, 2001, MOL CELL BIOL, V21, P5723, DOI 10.1128/MCB.21.17.5723-5732.2001; Signer RAJ, 2008, GENE DEV, V22, P3115, DOI 10.1101/gad.1715808; Smith JM, 2004, DEV DYNAM, V230, P366, DOI 10.1002/dvdy.20053; Sokol JP, 2005, BREAST CANCER RES, V7, pR844, DOI 10.1186/bcr1312; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tevosian SG, 1997, GENE DEV, V11, P383, DOI 10.1101/gad.11.3.383; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Xiu M, 2003, MOL CELL BIOL, V23, P8890, DOI 10.1128/MCB.23.23.8890-8901.2003; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Yee AS, 2004, GENE, V336, P1, DOI 10.1016/j.gene.2004.04.004; Yee AS, 1999, PEDIATR PATHOL MOL M, V18, P275; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	48	43	49	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	36					5083	5094		10.1038/onc.2010.252	http://dx.doi.org/10.1038/onc.2010.252			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	647LN	20581871				2022-12-25	WOS:000281620100008
J	Satow, R; Shitashige, M; Jigami, T; Honda, K; Ono, M; Hirohashi, S; Yamada, T				Satow, Reiko; Shitashige, Miki; Jigami, Takafumi; Honda, Kazufumi; Ono, Masaya; Hirohashi, Setsuo; Yamada, Tesshi			Traf2-and Nck-interacting Kinase Is Essential for Canonical Wnt Signaling in Xenopus Axis Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; COLORECTAL-CANCER; TARGET GENES; EMBRYOS; EXPRESSION; PATHWAY; COMPLEX; DORSAL; CELLS; TNIK	Wnt signaling pathways play important roles in various stages of developmental events and several aspects of adult homeostasis. Aberrant activation of Wnt signaling has also been associated with several types of cancer. We have recently identified Traf2- and Nck-interacting kinase (TNIK) as a novel activator of Wnt signaling through a comprehensive proteomic approach in human colorectal cancer cell lines. TNIK is an activating kinase for T-cell factor-4 (TCF4) and essential for the beta-catenin-TCF4 transactivation and colorectal cancer growth. Here, we report the essential role of TNIK in Wnt signaling during Xenopus development. We found that Xenopus TNIK (XTNIK) was expressed maternally and that the functional knockdown of XTNIK by catalytically inactive XTNIK (K54R) or antisense morpholino oligonucleotides resulted in significant malformations with a complete loss of head and axis structures. XTNIK enhanced beta-catenin-induced axis duplication and the expression of beta-catenin-TCF target genes, whereas knockdown of XTNIK inhibited it. XTNIK was recruited to the promoter region of beta-catenin-TCF target genes in a beta-catenin-dependent manner. These results demonstrate that XTNIK is an essential factor for the transcriptional activity of the beta-catenin-TCF complex and dorsal axis determination in Xenopus embryos.	[Satow, Reiko; Shitashige, Miki; Jigami, Takafumi; Honda, Kazufumi; Ono, Masaya; Hirohashi, Setsuo; Yamada, Tesshi] Natl Canc Ctr, Div Chemotherapy, Chuo Ku, Tokyo 1040045, Japan	National Cancer Center - Japan	Satow, R (corresponding author), Natl Canc Ctr, Div Chemotherapy, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	resato@ncc.go.jp		Satow, Reiko/0000-0002-6339-4268	National Institute of Biomedical Innovation of Japan; Ministry of Health, Labor, and Welfare of Japan	National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the "Program for Promotion of Fundamental Studies in Health Sciences" conducted by the National Institute of Biomedical Innovation of Japan and the "Third-Term Comprehensive Control Research for Cancer" and "Research on Biological Markers for New Drug Development" conducted by the Ministry of Health, Labor, and Welfare of Japan.	Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Fan MJ, 1998, P NATL ACAD SCI USA, V95, P5626, DOI 10.1073/pnas.95.10.5626; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Haramoto Y, 2004, DEV BIOL, V265, P155, DOI 10.1016/j.ydbio.2003.09.015; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Houston DW, 2002, DEVELOPMENT, V129, P4015; Huang L, 2007, GASTROENTEROLOGY, V133, P1569, DOI 10.1053/j.gastro.2007.08.011; Idogawa M, 2007, CANCER RES, V67, P911, DOI 10.1158/0008-5472.CAN-06-2360; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Sato S, 2005, GASTROENTEROLOGY, V129, P1225, DOI 10.1053/j.gastro.2005.07.025; Satow R, 2002, BIOCHEM BIOPH RES CO, V295, P85, DOI 10.1016/S0006-291X(02)00641-1; Shitashige M, 2008, GASTROENTEROLOGY, V134, P1961, DOI 10.1053/j.gastro.2008.03.010; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Shitashige M, 2010, CANCER RES, V70, P5024, DOI 10.1158/0008-5472.CAN-10-0306; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Standley HJ, 2006, DEV BIOL, V289, P318, DOI 10.1016/j.ydbio.2005.10.012; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Takahashi S, 2000, DEVELOPMENT, V127, P5319; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434	27	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 20	2010	285	34					26289	26294		10.1074/jbc.M109.090597	http://dx.doi.org/10.1074/jbc.M109.090597			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638UB	20566648	Green Published, hybrid			2022-12-25	WOS:000280921000046
J	Borkow, G; Zhou, SS; Page, T; Gabbay, J				Borkow, Gadi; Zhou, Steve S.; Page, Tom; Gabbay, Jeffrey			A Novel Anti-Influenza Copper Oxide Containing Respiratory Face Mask	PLOS ONE			English	Article							VIRUS; INFLUENZA; INACTIVATION; INFECTION; IONS; INTERVENTIONS; TRANSMISSION; EMERGENCE; FILTERS; HUMANS	Background: Protective respiratory face masks protect the nose and mouth of the wearer from vapor drops carrying viruses or other infectious pathogens. However, incorrect use and disposal may actually increase the risk of pathogen transmission, rather than reduce it, especially when masks are used by non-professionals such as the lay public. Copper oxide displays potent antiviral properties. A platform technology has been developed that permanently introduces copper oxide into polymeric materials, conferring them with potent biocidal properties. Methodology/Principal Findings: We demonstrate that impregnation of copper oxide into respiratory protective face masks endows them with potent biocidal properties in addition to their inherent filtration properties. Both control and copper oxide impregnated masks filtered above 99.85% of aerosolized viruses when challenged with 5.66 +/- 0.51 and 6.17 +/- 0.37 log(10)TCID(50) of human influenza A virus (H1N1) and avian influenza virus (H9N2), respectively, under simulated breathing conditions (28.3 L/min). Importantly, no infectious human influenza A viral titers were recovered from the copper oxide containing masks within 30 minutes (<= 0.88 log(10)TCID(50)), while 4.67 +/- 1.35 log(10)TCID(50) were recovered from the control masks. Similarly, the infectious avian influenza titers recovered from the copper oxide containing masks were <= 0.97 +/- 0.01 log(10)TCID(50) and from the control masks 5.03 +/- 0.54 log(10)TCID(50). The copper oxide containing masks successfully passed Bacterial Filtration Efficacy, Differential Pressure, Latex Particle Challenge, and Resistance to Penetration by Synthetic Blood tests designed to test the filtration properties of face masks in accordance with the European EN 14683: 2005 and NIOSH N95 standards. Conclusions/Significance: Impregnation of copper oxide into respiratory protective face masks endows them with potent anti-influenza biocidal properties without altering their physical barrier properties. The use of biocidal masks may significantly reduce the risk of hand or environmental contamination, and thereby subsequent infection, due to improper handling and disposal of the masks.	[Borkow, Gadi; Page, Tom; Gabbay, Jeffrey] Cupron Sci, Modiin, Israel; [Zhou, Steve S.] Microbac Labs Inc, Microbiotest, Sterling, VA USA		Borkow, G (corresponding author), Cupron Sci, Modiin, Israel.	gadi@cupron.com	Borkow, Gadi/W-4294-2019		Cupron Scientific	Cupron Scientific	The study was funded by Cupron Scientific, a company that conducts research and development of medical devices using copper oxide as the active ingredient. Cupron Scientific developed the antiviral mask, and had a role in the study design and decision to publish and preparation of the manuscript.	Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208; [Anonymous], 2004, TOX PROF COPP; Aragon D, 2005, AACN ADV CRIT CARE, V16, P121, DOI 10.1097/00044067-200504000-00002; Borkow G, 2005, CURR MED CHEM, V12, P2163, DOI 10.2174/0929867054637617; Borkow G, 2004, FASEB J, V18, P1728, DOI 10.1096/fj.04-2029fje; Borkow G, 2009, CURR CHEM BIOL, V3, P272, DOI DOI 10.2174/187231309789054887; Borkow G, 2008, ANTIMICROB AGENTS CH, V52, P518, DOI 10.1128/AAC.00899-07; Borkow G, 2007, ANTIMICROB AGENTS CH, V51, P2605, DOI 10.1128/AAC.00125-07; *CDCP, 2006, INT GUID PROT PERS I; Chatterjee A, 2004, INFECT CONT HOSP EP, V25, P786, DOI 10.1086/502479; Cohen B, 2003, PEDIATR INFECT DIS J, V22, P494, DOI 10.1097/00006454-200306000-00003; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Edmiston CE, 2005, SURGERY, V138, P573, DOI 10.1016/j.surg.2005.06.045; Gabbay J., 2006, J IND TEXT, V35, P323, DOI [10.1177/1528083706060785, DOI 10.1177/1528083706060785]; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gorter Robert W, 2004, Am J Ther, V11, P453, DOI 10.1097/01.mjt.0000127148.83065.e5; Gould D, 1996, INT J NURS STUD, V33, P143, DOI 10.1016/0020-7489(95)00048-8; Hensley Scott E, 2009, Expert Rev Anti Infect Ther, V7, P763, DOI 10.1586/eri.09.62; Horie M, 2008, ARCH VIROL, V153, P1467, DOI 10.1007/s00705-008-0154-2; Hostynek Jurij J, 2003, Rev Environ Health, V18, P153; *INT, 2009, EDANA REIT WHO ADV F; JEFFERSON T, 2007, COCHRANE DATABASE SY, V6207; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; JORDAN FTW, 1971, VET REC, V89, P609, DOI 10.1136/vr.89.23.609; KARLSTROM AR, 1991, P NATL ACAD SCI USA, V88, P5552, DOI 10.1073/pnas.88.13.5552; Katz Jonathan D, 2004, Anesthesiol Clin North Am, V22, P457, DOI 10.1016/S0889-8537(04)00027-6; Landolt Gabriele A., 2007, Animal Health Research Reviews, V8, P1, DOI 10.1017/S1466252307001272; Noyce JO, 2007, APPL ENVIRON MICROB, V73, P2748, DOI 10.1128/AEM.01139-06; *OSHA, 2004, GUID PROT WORK AV FL; Owers KL, 2004, J HOSP INFECT, V58, P230, DOI 10.1016/j.jhin.2004.06.028; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Sagripanti JL, 1996, AIDS RES HUM RETROV, V12, P333, DOI 10.1089/aid.1996.12.333; Sagripanti JL, 1997, ANTIMICROB AGENTS CH, V41, P812, DOI 10.1128/AAC.41.4.812; SAGRIPANTI JL, 1993, APPL ENVIRON MICROB, V59, P4374, DOI 10.1128/AEM.59.12.4374-4376.1993; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SPEARMAN C, TITERBESTRIMMUNG, P37; Yahaya M. T., 2001, INACTIVATION POLIOVI; Zatcoff Richard C, 2008, Foot (Edinb), V18, P136, DOI 10.1016/j.foot.2008.03.005	39	206	209	7	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11295	10.1371/journal.pone.0011295	http://dx.doi.org/10.1371/journal.pone.0011295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20592763	gold, Green Published, Green Submitted			2022-12-25	WOS:000279140800006
J	Gigante, B; Bennet, AM; Leander, K; Vikstrom, M; de Faire, U				Gigante, Bruna; Bennet, Anna M.; Leander, Karin; Vikstrom, Max; de Faire, Ulf			The Interaction between Coagulation Factor 2 Receptor and Interleukin 6 Haplotypes Increases the Risk of Myocardial Infarction in Men	PLOS ONE			English	Article							THROMBIN; INFLAMMATION; ATHEROSCLEROSIS; ASSOCIATION; ACTIVATION; EXPRESSION; DISEASE; PREDICT; GENES; ALPHA	The aim of the study was to investigate if the interaction between the coagulation factor 2 receptor (F2R) and the interleukin 6 (IL6) haplotypes modulates the risk of myocardial infarction (MI) in the Stockholm Heart Epidemiology Program (SHEEP). Seven SNPs at the F2R locus and three SNPs at the IL6 locus were genotyped. Haplotypes and haplotype pairs (IL6*F2R) were generated. A logistic regression analysis was performed to analyze the association of the haplotypes and haplotype pairs with the MI risk. Presence of an interaction between the two haplotypes in each haplotype pair was calculated using two different methods: the statistical, on a multiplicative scale, which includes the cross product of the two factors into the logistic regression model; the biological, on an additive scale, which evaluates the relative risk associated with the joint presence of both factors. The ratio between the observed and the predicted effect of the joint exposure, the synergy index (S), indicates the presence of a synergy (S. 1) or of an antagonism (S, 1). None of the haplotypes within the two loci was associated with the risk of MI. Out of 22 different haplotype pairs, the haplotype pair 17 GGG*ADGTCCT was associated with an increased risk of MI with an OR (95%CI) of 1.58 (1.05-2.41) (p = 0.02) in the crude and an OR of 1.72 (1.11-2.67) (p = 0.01) in the adjusted analysis. We observed the presence of an interaction on a multiplicative scale with an OR (95%CI) of 2.24 (1.27-3.95) (p = 0.005) and a slight interactive effect between the two haplotypes on an additive scale with an OR (95%CI) of 1.56 (1.02-2.37) (p = 0.03) and S of 1.66 (0.89-31). In conclusion, our results support the hypothesis that the interaction between these two functionally related genes may influence the risk of MI and suggest new mechanisms involved in the genetic susceptibility to MI.	[Gigante, Bruna; Leander, Karin; Vikstrom, Max; de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Bennet, Anna M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Gigante, Bruna; de Faire, Ulf] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Gigante, B (corresponding author), Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden.	bruna.gigante@ki.se	Leander, Karin/C-7261-2017; Gigante, Bruna/I-9252-2012	Leander, Karin/0000-0002-1404-9222; Bennet-Bark, Anna/0000-0003-2704-2625; Gigante, Bruna/0000-0003-4508-7990	Swedish Research Council; Swedish Heart and Lung Foundation; Karolinska Institutet [2008]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Research Council and the Swedish Heart and Lung Foundation (to UdF), Karolinska Institutet grant (KI fonder 2008) (to BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Baessler A, 2007, HUM MOL GENET, V16, P887, DOI 10.1093/hmg/ddm033; Bennet AM, 2003, ATHEROSCLEROSIS, V171, P359, DOI 10.1016/j.atherosclerosis.2003.08.029; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Chi LQ, 2001, J INTERF CYTOK RES, V21, P231, DOI 10.1089/107999001750169871; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; de Mutsert R, 2009, KIDNEY INT, V75, P677, DOI 10.1038/ki.2008.645; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Gigante B, 2007, ARTERIOSCL THROM VAS, V27, P1213, DOI 10.1161/ATVBAHA.107.140541; Gigante B, 2009, THROMB HAEMOSTASIS, V101, P943, DOI 10.1160/TH08-09-0612; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Kaplanski G, 1997, J IMMUNOL, V158, P5435; Kranzhofer R, 1996, CIRC RES, V79, P286, DOI 10.1161/01.RES.79.2.286; Lundberg M, 1996, EPIDEMIOLOGY, V7, P655; Marin V, 2001, J IMMUNOL, V167, P3435, DOI 10.4049/jimmunol.167.6.3435; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Noto D, 2007, THROMB HAEMOSTASIS, V98, P1362, DOI 10.1160/TH07-06-0414; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Reuterwall C, 1999, J INTERN MED, V246, P161, DOI 10.1046/j.1365-2796.1999.00554.x; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; UTERMANN G, 1989, P NATL ACAD SCI USA, V86, P4171, DOI 10.1073/pnas.86.11.4171; Zhang J, 2008, HUM HERED, V66, P252, DOI 10.1159/000143407	27	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2010	5	6							e11300	10.1371/journal.pone.0011300	http://dx.doi.org/10.1371/journal.pone.0011300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615LC	20585578	Green Published, Green Submitted, gold			2022-12-25	WOS:000279135800009
J	Shin, D; Pierce, MC; Gillenwater, AM; Williams, MD; Richards-Kortum, RR				Shin, Dongsuk; Pierce, Mark C.; Gillenwater, Ann M.; Williams, Michelle D.; Richards-Kortum, Rebecca R.			A Fiber-Optic Fluorescence Microscope Using a Consumer-Grade Digital Camera for In Vivo Cellular Imaging	PLOS ONE			English	Article							REAL-TIME; CONFOCAL MICROSCOPY; PHONES; MICROENDOSCOPY; SYSTEM; TISSUE; CARE	Background: Early detection is an essential component of cancer management. Unfortunately, visual examination can often be unreliable, and many settings lack the financial capital and infrastructure to operate PET, CT, and MRI systems. Moreover, the infrastructure and expense associated with surgical biopsy and microscopy are a challenge to establishing cancer screening/early detection programs in low-resource settings. Improvements in performance and declining costs have led to the availability of optoelectronic components, which can be used to develop low-cost diagnostic imaging devices for use at the point-of-care. Here, we demonstrate a fiber-optic fluorescence microscope using a consumer-grade camera for in vivo cellular imaging. Methods: The fiber-optic fluorescence microscope includes an LED light, an objective lens, a fiber-optic bundle, and a consumer-grade digital camera. The system was used to image an oral cancer cell line labeled with 0.01% proflavine. A human tissue specimen was imaged following surgical resection, enabling dysplastic and cancerous regions to be evaluated. The oral mucosa of a healthy human subject was imaged in vivo, following topical application of 0.01% proflavine. Findings: The fiber-optic microscope resolved individual nuclei in all specimens and tissues imaged. This capability allowed qualitative and quantitative differences between normal and precancerous or cancerous tissues to be identified. The optical efficiency of the system permitted imaging of the human oral mucosa in real time. Conclusion: Our results indicate this device as a useful tool to assist in the identification of early neoplastic changes in epithelial tissues. This portable, inexpensive unit may be particularly appropriate for use at the point-of-care in low-resource settings.	[Shin, Dongsuk; Pierce, Mark C.; Richards-Kortum, Rebecca R.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Gillenwater, Ann M.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Williams, Michelle D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Rice University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shin, D (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	rkortum@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467; Pierce, Mark/0000-0003-4377-9547; Gillenwater, Ann/0000-0002-0935-0037; Williams, Michelle D./0000-0002-9133-7332	National Institutes of Health (NIH) [RO1 EB007594]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007594] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded through National Institutes of Health (NIH) grant RO1 EB007594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro L, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-S1-S19; Aslanoglu M, 2006, ANAL SCI, V22, P439, DOI 10.2116/analsci.22.439; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Carlson AL, 2006, LASER SURG MED, V38, P928, DOI 10.1002/lsm.20409; Carlson K, 2005, GYNECOL ONCOL, V99, pS84, DOI 10.1016/j.ygyno.2005.07.049; CHEN Y, 2005, ANN INT C IEEE ENG M, V7, P1442; Collier T, 2002, ACAD RADIOL, V9, P504, DOI 10.1016/S1076-6332(03)80326-4; Collier T, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717899; Dromard T, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2736346; Dubaj V, 2002, J MICROSC-OXFORD, V207, P108, DOI 10.1046/j.1365-2818.2002.01052.x; Ebner C, 2008, J TELEMED TELECARE, V14, P2, DOI 10.1258/jtt.2007.070302; Ghoghawala SY, 2007, EXP EYE RES, V84, P1031, DOI 10.1016/j.exer.2007.01.021; Guillaud M, 2004, CYTOM PART A, V60A, P81, DOI 10.1002/cyto.a.20034; Han B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2435700; Janssen PA, 2003, PEDIATRICS, V111, P15, DOI 10.1542/peds.111.1.15; Jean F, 2007, OPT EXPRESS, V15, P4008, DOI 10.1364/OE.15.004008; KAUFMAN RH, 1978, AM J OBSTET GYNECOL, V132, P861, DOI 10.1016/0002-9378(78)90713-5; Kurman RJ, 1994, BLAUSTEINS PATHOLOGY; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Lane PM, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103583; Maisels MJ, 2008, NEW ENGL J MED, V358, P920, DOI 10.1056/NEJMct0708376; MAKINEN JT, 2007, P SPIE, V6585; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Massone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000483; MCCONNELL TP, 2004, NEWBORN INFANT NURS, V4, P211; Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037; Muldoon TJ, 2008, GASTROINTEST ENDOSC, V68, P737, DOI 10.1016/j.gie.2008.05.018; Muldoon TJ, 2007, OPT EXPRESS, V15, P16413, DOI 10.1364/OE.15.016413; PEREZ MA, 2008, IEEE INT S IND EL, P939; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Roblyer D, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2904658; Rodriguez WR, 2005, PLOS MED, V2, P663, DOI 10.1371/journal.pmed.0020182; Zhong W, 2009, BRIT J CANCER, V101, P2015, DOI 10.1038/sj.bjc.6605436	33	54	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11218	10.1371/journal.pone.0011218	http://dx.doi.org/10.1371/journal.pone.0011218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585636	Green Submitted, Green Published, gold			2022-12-25	WOS:000279135400009
J	Drogemuller, C; Becker, D; Kessler, B; Kemter, E; Tetens, J; Jurina, K; Jaderlund, KH; Flagstad, A; Perloski, M; Lindblad-Toh, K; Matiasek, K				Droegemueller, Cord; Becker, Doreen; Kessler, Barbara; Kemter, Elisabeth; Tetens, Jens; Jurina, Konrad; Jaderlund, Karin Hultin; Flagstad, Annette; Perloski, Michele; Lindblad-Toh, Kerstin; Matiasek, Kaspar			A Deletion in the N-Myc Downstream Regulated Gene 1 (NDRG1) Gene in Greyhounds with Polyneuropathy	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; SENSORY NEUROPATHY; HEREDITARY MOTOR; BORDER-COLLIE; DOGS; COMPLEX	The polyneuropathy of juvenile Greyhound show dogs shows clinical similarities to the genetically heterogeneous Charcot-Marie-Tooth (CMT) disease in humans. The pedigrees containing affected dogs suggest monogenic autosomal recessive inheritance and all affected dogs trace back to a single male. Here, we studied the neuropathology of this disease and identified a candidate causative mutation. Peripheral nerve biopsies from affected dogs were examined using semi-thin histology, nerve fibre teasing and electron microscopy. A severe chronic progressive mixed polyneuropathy was observed. Seven affected and 17 related control dogs were genotyped on the 50k canine SNP chip. This allowed us to localize the causative mutation to a 19.5 Mb interval on chromosome 13 by homozygosity mapping. The NDRG1 gene is located within this interval and NDRG1 mutations have been shown to cause hereditary motor and sensory neuropathy-Lom in humans (CMT4D). Therefore, we considered NDRG1 a positional and functional candidate gene and performed mutation analysis in affected and control Greyhounds. A 10 bp deletion in canine NDRG1 exon 15 (c.1080_1089delTCGCCTGGAC) was perfectly associated with the polyneuropathy phenotype of Greyhound show dogs. The deletion causes a frame shift (p.Arg361SerfsX60) which alters several amino acids before a stop codon is encountered. A reduced level of NDRG1 transcript could be detected by RT-PCR. Western blot analysis demonstrated an absence of NDRG1 protein in peripheral nerve biopsy of an affected Greyhound. We thus have identified a candidate causative mutation for polyneuropathy in Greyhounds and identified the first genetically characterized canine CMT model which offers an opportunity to gain further insights into the pathobiology and therapy of human NDRG1 associated CMT disease. Selection against this mutation can now be used to eliminate polyneuropathy from Greyhound show dogs.	[Droegemueller, Cord; Becker, Doreen] Univ Bern, Fac Vet, Inst Genet, Bern, Switzerland; [Kessler, Barbara; Kemter, Elisabeth] Univ Munich, Gene Ctr, Lab Funct Genome Anal, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Jurina, Konrad] Tierklin Haar, Haar, Germany; [Jaderlund, Karin Hultin] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Jaderlund, Karin Hultin] Norwegian Sch Vet Sci, Dept Compan Anim Clin Sci, Oslo, Norway; [Flagstad, Annette] Univ Copenhagen, Dept Clin Sci, Fac Life Sci, Copenhagen, Denmark; [Perloski, Michele; Lindblad-Toh, Kerstin] Broad Inst Harvard & MIT, Cambridge, MA USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Matiasek, Kaspar] Anim Hlth Trust, Neuropathol Lab, Newmarket, Suffolk, England	University of Bern; University of Munich; University of Kiel; Swedish University of Agricultural Sciences; Norwegian University of Life Sciences; University of Copenhagen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University; Animal Health Trust	Drogemuller, C (corresponding author), Univ Bern, Fac Vet, Inst Genet, Bern, Switzerland.	Cord.Droegemueller@itz.unibe.ch	Jäderlund, Karin Hultin/AAL-8211-2020; Tetens, Jens/H-5344-2012; Becker, Doreen/AAF-9108-2020	Becker, Doreen/0000-0003-0425-6284; Tetens, Jens/0000-0001-5352-464X; Drogemuller, Cord/0000-0001-9773-522X; Matiasek, Kaspar/0000-0001-5021-3280; Kemter, Elisabeth/0000-0001-7785-7502	Gesellschaft fur Kynologische Forschung (GKF), Bonn, Germany; Greyhound Club of America; ESF	Gesellschaft fur Kynologische Forschung (GKF), Bonn, Germany; Greyhound Club of America; ESF(European Commission)	This study was financed by research grants of the Gesellschaft fur Kynologische Forschung (GKF), Bonn, Germany, and the Greyhound Club of America to CD. KLT is the recipient of a European Young Investigator Award from the ESF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertorini T, 2004, NEUROLOGIST, V10, P327, DOI 10.1097/01.nrl.0000145596.38640.27; BRAUND KG, 1994, AM J VET RES, V55, P534; BRAUND KG, 1994, VET PATHOL, V31, P316, DOI 10.1177/030098589403100304; Braund KG, 1997, J VET INTERN MED, V11, P243, DOI 10.1111/j.1939-1676.1997.tb00098.x; Coates JR, 2004, VET CLIN N AM-SMALL, V34, P1361, DOI 10.1016/j.cvsm.2004.05.011; DACOSTA RC, 2005, J VET INTERN MED, V19, pA459; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Gabriel A, 2006, J SMALL ANIM PRACT, V47, P144, DOI 10.1111/j.1748-5827.2006.00058.x; Harkin KR, 2005, JAVMA-J AM VET MED A, V227, P1263, DOI 10.2460/javma.2005.227.1263; HENRICKS PM, 1987, VAN VET J, V28, P165; Horste GMZ, 2006, CURR OPIN NEUROL, V19, P464, DOI 10.1097/01.wco.0000245369.44199.27; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Martyn C, 1997, J NEUROL NEUROSUR PS, V62, P310, DOI 10.1136/jnnp.62.4.310; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Pareyson D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3; PATTERSON DF, 1988, J AM VET MED ASSOC, V193, P1131; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schatzberg SJ, 2004, VET CLIN N AM-SMALL, V34, P1497, DOI 10.1016/j.cvsm.2004.06.001; Shelton GD, 2003, MUSCLE NERVE, V27, P471, DOI 10.1002/mus.10350; Vanhaesebrouck AE, 2008, J NEUROL SCI, V275, P100, DOI 10.1016/j.jns.2008.07.031; Vermeersch K, 2005, J SMALL ANIM PRACT, V46, P295, DOI 10.1111/j.1748-5827.2005.tb00324.x; 2010, HOMEPAGE INHERITED P	24	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2010	5	6							e11258	10.1371/journal.pone.0011258	http://dx.doi.org/10.1371/journal.pone.0011258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KX	20582309	Green Published, Green Submitted, gold			2022-12-25	WOS:000279058500001
J	Shi, HY; Santander, J; Brenneman, KE; Wanda, SY; Wang, SF; Senechal, P; Sun, W; Roland, KL; Curtiss, R				Shi, Huoying; Santander, Javier; Brenneman, Karen E.; Wanda, Soo-Young; Wang, Shifeng; Senechal, Patti; Sun, Wei; Roland, Kenneth L.; Curtiss, Roy, III			Live Recombinant Salmonella Typhi Vaccines Constructed to Investigate the Role of rpoS in Eliciting Immunity to a Heterologous Antigen	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SURFACE PROTEIN-A; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; SIGMA-FACTOR; VI-ANTIGEN; PNEUMOCOCCAL PSPA; REGULATORY SYSTEM; CONJUGATE VACCINE; FOREIGN ANTIGEN	We hypothesized that the immunogenicity of live Salmonella enterica serovar Typhi vaccines expressing heterologous antigens depends, at least in part, on its rpoS status. As part of our project to develop a recombinant attenuated S. Typhi vaccine (RASTyV) to prevent pneumococcal diseases in infants and children, we constructed three RASTyV strains synthesizing the Streptococcus pneumoniae surface protein PspA to test this hypothesis. Each vector strain carried ten engineered mutations designed to optimize safety and immunogenicity. Two S. Typhi vector strains (chi 9639 and chi 9640) were derived from the rpoS mutant strain Ty2 and one (chi 9633) from the RpoS(+) strain ISP1820. In chi 9640, the nonfunctional rpoS gene was replaced with the functional rpoS gene from ISP1820. Plasmid pYA4088, encoding a secreted form of PspA, was moved into the three vector strains. The resulting RASTyV strains were evaluated for safety in vitro and for immunogenicity in mice. All three RASTyV strains were similar to the live attenuated typhoid vaccine Ty21a in their ability to survive in human blood and human monocytes. They were more sensitive to complement and were less able to survive and persist in sewage and surface water than their wild-type counterparts. Adult mice intranasally immunized with any of the RASTyV strains developed immune responses against PspA and Salmonella antigens. The RpoS(+) vaccines induced a balanced Th1/Th2 immune response while the RpoS(-) strain chi 9639(pYA4088) induced a strong Th2 immune response. Immunization with any RASTyV provided protection against S. pneumoniae challenge; the RpoS(+) strain chi 9640(pYA4088) provided significantly greater protection than the ISP1820 derivative, chi 9633(pYA4088). In the pre-clinical setting, these strains exhibited a desirable balance between safety and immunogenicity and are currently being evaluated in a Phase 1 clinical trial to determine which of the three RASTyVs has the optimal safety and immunogenicity profile in human hosts.	[Shi, Huoying] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Shi, HY (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA.	rcurtiss@asu.edu	Santander, Javier/AAU-9423-2020		Bill and Melinda Gates Foundation [37863]; CONICYT, Chile; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060557] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Bill and Melinda Gates Foundation Grant #37863, and in part by CONICYT, Chile, through Gestion-Propia Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianopoulos K, 1998, J BACTERIOL, V180, P998, DOI 10.1128/JB.180.4.998-1001.1998; Angelakopoulos H, 2000, INFECT IMMUN, V68, P2135, DOI 10.1128/IAI.68.4.2135-2141.2000; Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Arulanandam BP, 2001, INFECT IMMUN, V69, P6718, DOI 10.1128/IAI.69.11.6718-6724.2001; Baek CH, 2009, J BACTERIOL, V191, P1278, DOI 10.1128/JB.01142-08; Baker SJ, 1997, MICROB PATHOGENESIS, V22, P165, DOI 10.1006/mpat.1996.0099; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bollen WS, 2008, INFECT IMMUN, V76, P3268, DOI 10.1128/IAI.00244-08; Boron WF, 2003, MED PHYSL CELLULAR M, P1300; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Briles DE, 1996, VACCINE, V14, P858, DOI 10.1016/0264-410X(96)82948-3; BROOME C, 1996, WHOVRDGEN9602, P28; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; Capozzo AVE, 2004, INFECT IMMUN, V72, P4637, DOI 10.1128/IAI.72.8.4637-4646.2004; CHATFIELD SN, 1992, VACCINE, V10, P53, DOI 10.1016/0264-410X(92)90420-O; CHEN CY, 1995, J BACTERIOL, V177, P5303, DOI 10.1128/jb.177.18.5303-5309.1995; Coligan JE., 1994, CURRENT PROTOCOLS IM; Collinson SK, 1996, J BACTERIOL, V178, P662, DOI 10.1128/jb.178.3.662-667.1996; Coynault C, 1996, MOL MICROBIOL, V22, P149, DOI 10.1111/j.1365-2958.1996.tb02664.x; Coynault C, 1999, MICROB PATHOGENESIS, V26, P299, DOI 10.1006/mpat.1999.0273; Curtiss III R, 2003, International patent, Patent No. [WO 03/096812, 03096812]; Curtiss R, 2002, J CLIN INVEST, V110, P1061, DOI 10.1172/JCI200216941; CURTISS R, 1987, INFECT IMMUN, V55, P3035, DOI 10.1128/IAI.55.12.3035-3043.1987; CURTISS R, 1965, J BACTERIOL, V89, P28, DOI 10.1128/JB.89.1.28-40.1965; Curtiss Roy III, 2007, P297; Curtiss R, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1009, DOI 10.1016/B978-012491543-5/50060-7; Curtiss R, 2009, INFECT IMMUN, V77, P1071, DOI 10.1128/IAI.00693-08; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; ELLNER PD, 1966, J INFECT DIS, V116, P238, DOI 10.1093/infdis/116.2.238; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; FELIX A, 1951, J HYG-CAMBRIDGE, V49, P92, DOI 10.1017/S0022172400015394; FRASER D, 1953, J BIOL CHEM, V205, P291; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; GERMANIER R, 1971, INFECT IMMUN, V4, P663, DOI 10.1128/IAI.4.6.663-673.1971; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; GUNN BM, 2010, CLIN VACCIN IN PRESS; Hassan JO, 1996, INFECT IMMUN, V64, P938, DOI 10.1128/IAI.64.3.938-944.1996; HENGGEARONIS R, 1992, MOL MICROBIOL, V6, P1877, DOI 10.1111/j.1365-2958.1992.tb01360.x; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hohmann EL, 1996, VACCINE, V14, P19, DOI 10.1016/0264-410X(95)00173-X; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HONE DM, 1988, INFECT IMMUN, V56, P1326, DOI 10.1128/IAI.56.5.1326-1333.1988; HONE DM, 1991, VACCINE, V9, P810, DOI 10.1016/0264-410X(91)90218-U; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kang HY, 2002, J BACTERIOL, V184, P307, DOI 10.1128/JB.184.1.307-312.2002; Kang HY, 2002, INFECT IMMUN, V70, P1739, DOI 10.1128/IAI.70.4.1739-1749.2002; Kong W, 2008, P NATL ACAD SCI USA, V105, P9361, DOI 10.1073/pnas.0803801105; Konjufca V, 2006, INFECT IMMUN, V74, P6785, DOI 10.1128/IAI.00851-06; KORHONEN TK, 1980, J BACTERIOL, V144, P800, DOI 10.1128/JB.144.2.800-805.1980; Kotton CN, 2004, INFECT IMMUN, V72, P5535, DOI 10.1128/IAI.72.10.5535-5547.2004; KOWARZ L, 1994, J BACTERIOL, V176, P6852, DOI 10.1128/JB.176.22.6852-6860.1994; Ledeboer NA, 2005, J BACTERIOL, V187, P3214, DOI 10.1128/JB.187.9.3214-3226.2005; Li YH, 2008, INFECT IMMUN, V76, P5238, DOI 10.1128/IAI.00720-08; Li YH, 2009, P NATL ACAD SCI USA, V106, P593, DOI 10.1073/pnas.0811697106; Link C, 2006, MICROBES INFECT, V8, P2262, DOI 10.1016/j.micinf.2006.04.013; LOONEY RJ, 1986, J LAB CLIN MED, V108, P506; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; MULVEY MR, 1990, J BACTERIOL, V172, P6713, DOI 10.1128/jb.172.12.6713-6720.1990; NardelliHaefliger D, 1996, INFECT IMMUN, V64, P5219, DOI 10.1128/IAI.64.12.5219-5224.1996; Nayak AR, 1998, INFECT IMMUN, V66, P3744, DOI 10.1128/IAI.66.8.3744-3751.1998; NEILANDS JB, 1994, METHOD ENZYMOL, V235, P352; Nickerson CA, 1997, INFECT IMMUN, V65, P1814, DOI 10.1128/IAI.65.5.1814-1823.1997; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; OLD DC, 1968, J GEN MICROBIOL, V51, P1; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Pasetti MF, 2003, VACCINE, V21, P401, DOI 10.1016/S0264-410X(02)00472-3; Paton JC, 2003, MED INTELL UNIT, P294; Raffatellu M, 2005, INFECT IMMUN, V73, P3367, DOI 10.1128/IAI.73.6.3367-3374.2005; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Roland K, 1999, AVIAN DIS, V43, P429, DOI 10.2307/1592640; Roland KL, 2007, VACCINE, V25, P8574, DOI 10.1016/j.vaccine.2007.09.074; ROMEO T, 1989, J BACTERIOL, V171, P2773, DOI 10.1128/jb.171.5.2773-2782.1989; Ross J, 1996, P NATL ACAD SCI USA, V93, P14314, DOI 10.1073/pnas.93.25.14314; RUBIN FA, 1990, J CLIN MICROBIOL, V28, P825, DOI 10.1128/JCM.28.4.825-827.1990; Sambrook J, 2001, MOL CLONING LAB MANU; Santander J, 2007, INFECT IMMUN, V75, P1382, DOI 10.1128/IAI.00888-06; Santander MJ, 2008, J INFECT DEV COUNTR, V2, P412; Santos RL, 2001, INFECT IMMUN, V69, P4610, DOI 10.1128/IAI.69.7.4610-4617.2001; Schwan WR, 2000, INFECT IMMUN, V68, P1005, DOI 10.1128/IAI.68.3.1005-1013.2000; SEDGWICK JD, 1983, J IMMUNOL METHODS, V57, P301, DOI 10.1016/0022-1759(83)90091-1; SHI H, 2010, CLIN VACCIN IN PRESS; Sizemore DR, 1997, INFECT IMMUN, V65, P309, DOI 10.1128/IAI.65.1.309-312.1997; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; TACKET CO, 1992, INFECT IMMUN, V60, P536, DOI 10.1128/IAI.60.2.536-541.1992; Tacket CO, 2000, INFECT IMMUN, V68, P1196, DOI 10.1128/IAI.68.3.1196-1201.2000; Tacket CO, 1997, INFECT IMMUN, V65, P3381, DOI 10.1128/IAI.65.8.3381-3385.1997; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Winter SE, 2009, MOL MICROBIOL, V74, P175, DOI 10.1111/j.1365-2958.2009.06859.x; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; Wu HY, 1997, J INFECT DIS, V175, P839, DOI 10.1086/513980; Xin W, 2008, INFECT IMMUN, V76, P3241, DOI 10.1128/IAI.01623-07; Yamamoto M, 1997, INFECT IMMUN, V65, P640, DOI 10.1128/IAI.65.2.640-644.1997	103	37	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11142	10.1371/journal.pone.0011142	http://dx.doi.org/10.1371/journal.pone.0011142			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585446	Green Published, gold, Green Submitted			2022-12-25	WOS:000278977200002
J	Tsai, PS; Garcia-Gil, N; van Haeften, T; Gadella, BM				Tsai, Pei-Shiue; Garcia-Gil, Nuria; van Haeften, Theo; Gadella, Bart M.			How Pig Sperm Prepares to Fertilize: Stable Acrosome Docking to the Plasma Membrane	PLOS ONE			English	Article							DOMAIN PROTEIN MUPP1; MAMMALIAN SPERM; LIPID RAFTS; SCAFFOLDING PROTEIN; SNARE COMPLEXES; VESICLE FUSION; EXOCYTOSIS; SPERMATOZOA; CAPACITATION; SYNTAXIN	Background: Mammalian sperms are activated in the oviduct. This process, which involves extensive sperm surface remodelling, is required for fertilization and can be mimicked under in vitro fertilization conditions (IVF). Methodology/Principal Findings: Here we demonstrate that such treatments caused stable docking and priming of the acrosome membrane to the apical sperm head surface without the emergence of exocytotic membrane fusion. The interacting membranes could be isolated as bilamellar membrane structures after cell disruption. These membrane structures as well as whole capacitated sperm contained stable ternary trans-SNARE complexes that were composed of VAMP 3 and syntaxin 1B from the plasma membrane and SNAP 23 from the acrosomal membrane. This trans-SNARE complex was not observed in control sperm. Conclusions/Significance: We propose that this capacitation driven membrane docking and stability thereof is a preparative step prior to the multipoint membrane fusions characteristic for the acrosome reaction induced by sperm-zona binding. Thus, sperm can be considered a valuable model for studying exocytosis.	[Tsai, Pei-Shiue; Garcia-Gil, Nuria; van Haeften, Theo; Gadella, Bart M.] Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Biochem & Cell Biol, Utrecht, Netherlands; [Tsai, Pei-Shiue; Gadella, Bart M.] Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Farm Anim Hlth, Utrecht, Netherlands	Utrecht University; Utrecht University	Tsai, PS (corresponding author), Univ Utrecht, Fac Vet Med, Grad Sch Anim Hlth, Dept Biochem & Cell Biol, Utrecht, Netherlands.	b.m.gadella@uu.nl	Gadella, B.M./S-8667-2019	TSAI, PEI-SHIUE/0000-0001-8217-6285	University of Utrecht, NL	University of Utrecht, NL	We thank Dr. Ian Brewis (Cardiff University, UK) for critical reading and Prof. Dr. Ben Colenbrander (University of Utrecht, NL) for his support.	Ackermann F, 2008, J CELL PHYSIOL, V214, P757, DOI 10.1002/jcp.21272; Ackermann F, 2009, J CELL SCI, V122, P4547, DOI 10.1242/jcs.058263; Arnoult C, 1996, J CELL BIOL, V134, P637, DOI 10.1083/jcb.134.3.637; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; Bos E S, 1981, J Immunoassay, V2, P187, DOI 10.1080/15321818108056977; Breden TG, 1996, J ANDROL, V17, P443; Breitbart H, 2002, J REPROD IMMUNOL, V53, P151, DOI 10.1016/S0165-0378(01)00085-7; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Flesch FM, 1998, BIOL REPROD, V59, P1530, DOI 10.1095/biolreprod59.6.1530; Florman HM, 2008, INT J DEV BIOL, V52, P503, DOI 10.1387/ijdb.082696hf; Gadella BM, 2008, INT J DEV BIOL, V52, P473, DOI 10.1387/ijdb.082583bg; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Harrison RAP, 1996, REPROD FERT DEVELOP, V8, P581, DOI 10.1071/RD9960581; Heydecke D, 2006, J ANDROL, V27, P390, DOI 10.2164/jandrol.05166; Hu C, 2007, EXP CELL RES, V313, P3198, DOI 10.1016/j.yexcr.2007.06.008; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Liu HW, 2000, MOL HUM REPROD, V6, P422, DOI 10.1093/molehr/6.5.422; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Mollinedo F, 2006, J IMMUNOL, V177, P2831, DOI 10.4049/jimmunol.177.5.2831; Ramalho-Santos J, 2000, DEV BIOL, V223, P54, DOI 10.1006/dbio.2000.9745; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Schulz JR, 1998, J BIOL CHEM, V273, P24355, DOI 10.1074/jbc.273.38.24355; SOUCEK DA, 1984, BIOL REPROD, V31, P687, DOI 10.1095/biolreprod31.4.687; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; SUSI FR, 1971, AM J ANAT, V130, P251, DOI 10.1002/aja.1001300302; Tiwari N, 2009, Inflamm Res, V58 Suppl 1, P13, DOI 10.1007/s00011-009-0645-y; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Tsai PS, 2007, MOL MEMBR BIOL, V24, P313, DOI 10.1080/09687860701228692; van Gestel RA, 2005, MOL HUM REPROD, V11, P583, DOI 10.1093/molehr/gah200; van Gestel RA, 2007, MOL HUM REPROD, V13, P445, DOI 10.1093/molehr/gam030; Verhage M, 2007, CURR OPIN CELL BIOL, V19, P402, DOI 10.1016/j.ceb.2007.05.002; Verhage M, 2009, P NATL ACAD SCI USA, V106, P19745, DOI 10.1073/pnas.0911425106; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Wit H, 2010, BIOCHEM SOC T, V38, P192; Yanagimachi R., 1994, Zygote, V2, P371; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Yang CM, 2001, MOL CELL BIOL, V21, P1573, DOI 10.1128/MCB.21.5.1573-1580.2001; ZANETTI N, 2009, BIOL REPROD; Zhao L, 2007, DEV BIOL, V309, P236, DOI 10.1016/j.ydbio.2007.07.009	49	60	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11204	10.1371/journal.pone.0011204	http://dx.doi.org/10.1371/journal.pone.0011204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585455	Green Published, Green Submitted, gold			2022-12-25	WOS:000278977200009
J	Scherzer-Attali, R; Pellarin, R; Convertino, M; Frydman-Marom, A; Egoz-Matia, N; Peled, S; Levy-Sakin, M; Shalev, DE; Caflisch, A; Gazit, E; Segal, D				Scherzer-Attali, Roni; Pellarin, Riccardo; Convertino, Marino; Frydman-Marom, Anat; Egoz-Matia, Nirit; Peled, Sivan; Levy-Sakin, Michal; Shalev, Deborah E.; Caflisch, Amedeo; Gazit, Ehud; Segal, Daniel			Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; ORBITAL ELECTRONEGATIVITY METHOD; MODIFIED PARTIAL EQUALIZATION; A-BETA; STRUCTURAL-CHARACTERIZATION; DROSOPHILA MODEL; BINDING MODES; PEPTIDE; POLYPEPTIDE; FRAGMENT	The rational design of amyloid oligomer inhibitors is yet an unmet drug development need. Previous studies have identified the role of tryptophan in amyloid recognition, association and inhibition. Furthermore, tryptophan was ranked as the residue with highest amyloidogenic propensity. Other studies have demonstrated that quinones, specifically anthraquinones, can serve as aggregation inhibitors probably due to the dipole interaction of the quinonic ring with aromatic recognition sites within the amyloidogenic proteins. Here, using in vitro, in vivo and in silico tools we describe the synthesis and functional characterization of a rationally designed inhibitor of the Alzheimer's disease-associated beta-amyloid. This compound, 1,4-naphthoquinon-2-yl-L-tryptophan (NQTrp), combines the recognition capacities of both quinone and tryptophan moieties and completely inhibited A beta oligomerization and fibrillization, as well as the cytotoxic effect of A beta oligomers towards cultured neuronal cell line. Furthermore, when fed to transgenic Alzheimer's disease Drosophila model it prolonged their life span and completely abolished their defective locomotion. Analysis of the brains of these flies showed a significant reduction in oligomeric species of A beta while immuno-staining of the 3(rd) instar larval brains showed a significant reduction in A beta accumulation. Computational studies, as well as NMR and CD spectroscopy provide mechanistic insight into the activity of the compound which is most likely mediated by clamping of the aromatic recognition interface in the central segment of A beta. Our results demonstrate that interfering with the aromatic core of amyloidogenic peptides is a promising approach for inhibiting various pathogenic species associated with amyloidogenic diseases. The compound NQTrp can serve as a lead for developing a new class of disease modifying drugs for Alzheimer's disease.	[Scherzer-Attali, Roni; Frydman-Marom, Anat; Egoz-Matia, Nirit; Peled, Sivan; Levy-Sakin, Michal; Gazit, Ehud; Segal, Daniel] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Pellarin, Riccardo; Convertino, Marino; Caflisch, Amedeo] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Shalev, Deborah E.] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Jerusalem, Israel	Tel Aviv University; University of Zurich; Hebrew University of Jerusalem	Scherzer-Attali, R (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	vpr@tauex.tau.ac.il; dsegal@post.tau.ac.il	Gazit, Ehud/M-8026-2019; Gazit, Ehud/AHE-9332-2022; Caflisch, Amedeo/I-3459-2012; Shalev, Deborah E/AAY-2873-2021; Gazit, Ehud/C-3715-2011	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Segal, Daniel/0000-0002-6777-505X	German-Israeli Project Cooperation (DIP); Swiss National Competence Center in Research (NCCR) on Neural Plasticity and Repair and the Swiss National Science Foundation	German-Israeli Project Cooperation (DIP); Swiss National Competence Center in Research (NCCR) on Neural Plasticity and Repair and the Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	The authors acknowledge the funding by the German-Israeli Project Cooperation (DIP) to UG and the Swiss National Competence Center in Research (NCCR) on Neural Plasticity and Repair and the Swiss National Science Foundation, to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cecchini M, 2006, J MOL BIOL, V357, P1306, DOI 10.1016/j.jmb.2006.01.009; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cohen T, 2006, BIOCHEMISTRY-US, V45, P4727, DOI 10.1021/bi051525c; Colombo G, 2005, PROTEINS, V59, P519, DOI 10.1002/prot.20426; Convertino M, 2009, PROTEIN SCI, V18, P792, DOI 10.1002/pro.87; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferrara P, 2002, PROTEINS, V46, P24, DOI 10.1002/prot.10001; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fraser PE, 2000, BBA-MOL BASIS DIS, V1502, P1, DOI 10.1016/S0925-4439(00)00028-4; FREW T, 1995, ANTI-CANCER DRUG DES, V10, P347; Frydman-Marom A, 2009, ANGEW CHEM INT EDIT, V48, P1981, DOI 10.1002/anie.200802123; GANETZKY B, 1978, EXP GERONTOL, V13, P189, DOI 10.1016/0531-5565(78)90012-8; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gazit E, 2004, DRUG FUTURE, V29, P613, DOI 10.1358/dof.2004.029.06.853453; Gazit E, 2002, BIOINFORMATICS, V18, P880, DOI 10.1093/bioinformatics/18.6.880; GAZIT E, 2005, DRUG DES REV, V2, P115; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HONIG B, 1993, J PHYS CHEM-US, V97, P1101, DOI 10.1021/j100108a002; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Inouye H, 2006, BIOPHYS J, V90, P1774, DOI 10.1529/biophysj.105.070136; Jarvet J, 2000, J AM CHEM SOC, V122, P4261, DOI 10.1021/ja991167z; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lieu VH, 2007, BIOTECHNOL PROGR, V23, P698, DOI 10.1021/bp060353n; MacDougall C, 2004, J ANTIMICROB CHEMOTH, V53, P899, DOI 10.1093/jac/dkh244; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; MANN DMA, 1989, NEUROBIOL AGING, V10, P397, DOI 10.1016/0197-4580(89)90073-0; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; NO KT, 1990, J PHYS CHEM-US, V94, P4740, DOI 10.1021/j100374a067; NO KT, 1990, J PHYS CHEM-US, V94, P4732, DOI 10.1021/j100374a066; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; PEARLMEN DA, 1995, COMP PHYS, V91, P6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Riviere C, 2007, BIOORGAN MED CHEM, V15, P1160, DOI 10.1016/j.bmc.2006.09.069; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; ShresthaDawadi PB, 1996, SYNTHESIS-STUTTGART, P1468; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; TERRY RD, 1994, PROG BRAIN RES, V101, P383; Tomiyama T, 1997, BIOCHEM J, V322, P859, DOI 10.1042/bj3220859; van Leuven F, 2000, PROG NEUROBIOL, V61, P305, DOI 10.1016/S0301-0082(99)00055-6; Wagner R, 1996, J MAGN RESON SER A, V123, P119, DOI 10.1006/jmra.1996.0222; Wu C, 2005, BIOPHYS J, V88, P2897, DOI 10.1529/biophysj.104.055574; Wu C, 2007, J AM CHEM SOC, V129, P1225, DOI 10.1021/ja0662772; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Wuthrich K, 1986, NMR PROTEINS NUCL AC; XURONG Q, 2002, BIOCHEM BIOPH RES CO, V297, P1011; Zanuy D, 2004, STRUCTURE, V12, P439, DOI 10.1016/j.str.2004.02.002	65	116	117	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11101	10.1371/journal.pone.0011101	http://dx.doi.org/10.1371/journal.pone.0011101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559435	Green Published, Green Submitted, gold			2022-12-25	WOS:000278741100015
J	Tessema, M; Klinge, DM; Yingling, CM; Do, K; Van Neste, L; Belinsky, SA				Tessema, M.; Klinge, D. M.; Yingling, C. M.; Do, K.; Van Neste, L.; Belinsky, S. A.			Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis	ONCOGENE			English	Article						CXCL14; chemokines; lung cancer; DNA methylation; CXCL5; CXCL12	SQUAMOUS-CELL CARCINOMA; PROMOTER HYPERMETHYLATION; DNA METHYLATION; SUPPRESSOR GENES; CHEMOKINE CXCL14; DENDRITIC CELLS; DOWN-REGULATION; MULTIPLE GENES; IN-VIVO; EXPRESSION	Chemokines are important regulators of directional cell migration and tumor metastasis. A genome-wide transcriptome array designed to uncover novel genes silenced by methylation in lung cancer identified the CXCsubfamily of chemokines. Expression of 11 of the 16 known human CXC-chemokines was increased in lung adenocarcinoma cell lines after treatment with 5-aza-2'-deoxycytidine (DAC). Tumor-specific methylation leading to silencing of CXCL5, 12 and 14 was found in over 75% of primary lung adenocarcinomas and DAC treatment restored the expression of each of the silenced gene. Forced expression of CXCL14 in H23 cells, where this gene is silenced by methylation, increased cell death in vitro and dramatically reduced the in vivo growth of lung tumor xenografts through necrosis of up to 90% of the tumor mass. CXCL14 re-expression had a profound effect on the genome altering the transcription of over 1000 genes, including increased expression of 30 cell-cycle inhibitor and pro-apoptosis genes. In addition, CXCL14 methylation in sputum from asymptomatic early-stage lung cancer cases was associated with a 2.9-fold elevated risk for this disease compared with controls, substantiating its potential as a biomarker for early detection of lung cancer. Together, these findings identify CXCL14 as an important tumor suppressor gene epigenetically silenced during lung carcinogenesis. Oncogene (2010) 29, 5159-5170; doi:10.1038/onc.2010.255; published online 21 June 2010	[Tessema, M.; Klinge, D. M.; Yingling, C. M.; Do, K.; Belinsky, S. A.] Lovelace Resp Res Inst, Lung Canc Program, Albuquerque, NM 87108 USA; [Van Neste, L.] Univ Ghent, Dept Mol Biotechnol, Fac Biosci Engn, B-9000 Ghent, Belgium	Lovelace Respiratory Research Institute; Ghent University	Belinsky, SA (corresponding author), Lovelace Resp Res Inst, Lung Canc Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	sbelinsk@LRRI.org			NIH [R01 ES008801, P50 CA58184]; NATIONAL CANCER INSTITUTE [P50CA058184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008801] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grant support: supported largely by NIH Grant R01 ES008801 and in part by P50 CA58184.	Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belinsky SA, 2006, CANCER RES, V66, P3338, DOI 10.1158/0008-5472.CAN-05-3408; Belinsky SA, 2003, CANCER RES, V63, P7089; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Cirincione R, 2006, INT J CANCER, V118, P1248, DOI 10.1002/ijc.21473; Darash-Yahana M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006695; Deng T, 2009, BIOCHEM BIOPH RES CO, V387, P611, DOI 10.1016/j.bbrc.2009.07.093; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Hsu HS, 2007, J PATHOL, V213, P412, DOI 10.1002/path.2246; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Kim TY, 2006, CANCER RES, V66, P7490, DOI 10.1158/0008-5472.CAN-05-4552; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; McKinnon CM, 2008, ONCOGENE, V27, P6856, DOI 10.1038/onc.2008.317; Meissner A, 2006, NATURE, V439, P212, DOI 10.1038/nature04257; Miyazaki H, 2006, CANCER RES, V66, P4279, DOI 10.1158/0008-5472.CAN-05-4398; Morris MR, 2008, BRIT J CANCER, V98, P496, DOI 10.1038/sj.bjc.6604180; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Mu X, 2009, ACTA BIOCH BIOPH SIN, V41, P631, DOI 10.1093/abbs/gmp051; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ozawa S, 2006, BIOCHEM BIOPH RES CO, V348, P406, DOI 10.1016/j.bbrc.2006.07.070; Ozawa S, 2009, CANCER SCI, V100, P2202, DOI 10.1111/j.1349-7006.2009.01281.x; Palmisano WA, 2003, CANCER RES, V63, P4620; Parsanejad R, 2008, J INTERF CYTOK RES, V28, P703, DOI 10.1089/jir.2008.0139; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Schwarze SR, 2005, PROSTATE, V64, P67, DOI 10.1002/pros.20215; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Speetjens FM, 2008, CLIN CANCER RES, V14, P2276, DOI 10.1158/1078-0432.CCR-07-4045; Strieter RM, 2004, ANN NY ACAD SCI, V1028, P351, DOI 10.1196/annals.1322.041; Tessema M, 2008, CANCER RES, V68, P1707, DOI 10.1158/0008-5472.CAN-07-6325; Tessema M, 2009, CARCINOGENESIS, V30, P1132, DOI 10.1093/carcin/bgp114; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Yoshino M, 2009, INT J ONCOL, V35, P1201, DOI 10.3892/ijo_00000437; Yuvaraj S, 2009, MOL CANCER RES, V7, P1399, DOI 10.1158/1541-7786.MCR-08-0589; Zhou W, 2008, J NEUROSCI RES, V86, P3002, DOI 10.1002/jnr.21746	45	86	92	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2010	29	37					5159	5170		10.1038/onc.2010.255	http://dx.doi.org/10.1038/onc.2010.255			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	650QZ	20562917	Green Accepted			2022-12-25	WOS:000281867200005
J	Basu, B; Sarkar, C; Chakroborty, D; Ganguly, S; Shome, S; Dasgupta, PS; Basu, S				Basu, Biswarup; Sarkar, Chandrani; Chakroborty, Debanjan; Ganguly, Subhalakshmi; Shome, Saurav; Dasgupta, Partha Sarathi; Basu, Sujit			D-1 and D-2 Dopamine Receptor-mediated Inhibition of Activated Normal T Cell Proliferation Is Lost in Jurkat T Leukemic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; MESSENGER-RNA EXPRESSION; ENDOGENOUS CATECHOLAMINES; STRUCTURAL POLYMORPHISM; TYROSINE-HYDROXYLASE; D2 RECEPTOR; GENE; SCHIZOPHRENIA; CANCER; NEUROTRANSMITTER	Dopamine is a catecholamine neurotransmitter, which plays an important role in the regulation of T cell functions. In activated T cells from normal volunteers, stimulation of D-1 and D-2 dopamine receptors inhibit cell proliferation and cytokine secretion. However, there is no report yet regarding the regulatory role of D-1 and D-2 dopamine receptors in abnormally proliferating T cells. The present study investigates the expression and effect of activation of these dopamine receptors in Jurkat cells, a leukemic T cell line showing uncontrolled proliferation. Like normal human T cells, in Jurkat cells, D-1 and D-2 dopamine receptors are also expressed; however, unlike activated normal T cells, stimulation of these dopamine receptors in Jurkat cells fails to inhibit their T cell receptor-induced proliferation. This alteration is due to failure of D-1 dopamine receptor-mediated activation of cyclic AMP signaling and a missense mutation at the third cytoplasmic loop of D-2 dopamine receptors affecting inhibition of phosphorylation of ZAP-70, an important downstream protein transducing signal from the T cell receptor. These results help to understand the biology of abnormal proliferation of T cells in pathophysiological conditions where dopamine plays an important role.	[Sarkar, Chandrani; Chakroborty, Debanjan; Basu, Sujit] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Basu, Sujit] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Basu, Biswarup; Ganguly, Subhalakshmi; Shome, Saurav; Dasgupta, Partha Sarathi] Chittaranjan Natl Canc Inst, Dept Signal Transduct & Biogen Amines, Kolkata 700026, India	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Basu, S (corresponding author), Ohio State Univ, Dept Pathol, 166 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	sujit.basu@osumc.edu	Basu, Biswarup/ABD-3331-2020	Basu, Biswarup/0000-0002-5417-2735	National Institutes of Health [CA118265, CA124763]; Council of Scientific and Industrial Research Government of India [9/30(43)/2005-EMR-1, 9/30(54)/2009-EMR-1]; Department of Defense [W81XWH-07-1-0051]; NATIONAL CANCER INSTITUTE [R01CA124763, R21CA118265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Council of Scientific and Industrial Research Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA118265 (to S. B.) and CA124763 (to S. B.). This work was also supported by Council of Scientific and Industrial Research Government of India Fellowships 9/30(43)/2005-EMR-1 (to B. B.) and 9/30(54)/2009-EMR-1 (to S. S.) and Department of Defense Grant W81XWH-07-1-0051 (to S. B.).	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; ARINAMI T, 1994, LANCET, V343, P703, DOI 10.1016/S0140-6736(94)91581-4; Barbanti P, 1996, NEUROSCI LETT, V207, P73, DOI 10.1016/0304-3940(96)12491-5; Barbanti P, 2000, MECH AGEING DEV, V120, P65, DOI 10.1016/S0047-6374(00)00183-4; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Bergquist J, 1997, ELECTROPHORESIS, V18, P1760, DOI 10.1002/elps.1150181009; Campa D, 2007, LUNG CANCER, V56, P17, DOI 10.1016/j.lungcan.2006.11.007; Carr L, 2003, J NEUROIMMUNOL, V137, P87, DOI 10.1016/S0165-5728(03)00047-X; Cianfarani F, 2010, J INVEST DERMATOL, V130, P93, DOI 10.1038/jid.2009.180; Cioca DP, 2000, JPN HEART J, V41, P385; CLARK BJ, 1985, DOPAMINERGIC SYSTEM, P27; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Cravchik A, 1996, J BIOL CHEM, V271, P26013, DOI 10.1074/jbc.271.42.26013; DiMaio S, 2003, J PSYCHIATR NEUROSCI, V28, P27; Ekholm D, 1999, BIOCHEM PHARMACOL, V58, P935, DOI 10.1016/S0006-2952(99)00188-4; EPSTEIN PM, 1977, CANCER RES, V37, P4016; Ferrari M, 2004, BIOCHEM PHARMACOL, V67, P865, DOI 10.1016/j.bcp.2003.10.004; Ferrari M, 2008, J PSYCHIATR RES, V43, P24, DOI 10.1016/j.jpsychires.2008.01.014; FLEMSTROM G, 1993, GASTROENTEROLOGY, V104, P825, DOI 10.1016/0016-5085(93)91019-E; Gemignani F, 2005, CANCER EPIDEM BIOMAR, V14, P1633, DOI 10.1158/1055-9965.EPI-05-0057; Ghosh MC, 2003, INT IMMUNOPHARMACOL, V3, P1019, DOI 10.1016/S1567-5769(03)00100-0; Giorelli M, 2005, J INTERF CYTOK RES, V25, P395, DOI 10.1089/jir.2005.25.395; GRANDY DK, 1990, AM J HUM GENET, V47, P828; GRANDY DK, 1989, AM J HUM GENET, V45, P778; HASKEL Y, 1994, DIGEST DIS SCI, V39, P2364, DOI 10.1007/BF02087652; HIGUCHI S, 1994, BIOCHEM BIOPH RES CO, V204, P1199, DOI 10.1006/bbrc.1994.2590; Ilani T, 2001, P NATL ACAD SCI USA, V98, P625, DOI 10.1073/pnas.021535398; ITOKAWA M, 1993, BIOCHEM BIOPH RES CO, V196, P1369, DOI 10.1006/bbrc.1993.2404; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kaiser R, 2002, MOL PSYCHIATR, V7, P695, DOI 10.1038/sj.mp.4001054; Kirillova GP, 2008, J NEUROSCI METH, V174, P272, DOI 10.1016/j.jneumeth.2008.07.018; Lemmer K, 2002, LIFE SCI, V71, P667, DOI 10.1016/S0024-3205(02)01703-4; Levite M, 2008, CURR OPIN PHARMACOL, V8, P460, DOI 10.1016/j.coph.2008.05.001; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Nagai Y, 1996, NEUROLOGY, V46, P791, DOI 10.1212/WNL.46.3.791; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; RIEDERER P, 1985, ROLE BRAIN DOPAMINE, P1; Saha B, 2001, NEUROIMMUNOMODULAT, V9, P23, DOI 10.1159/000049004; Sarkar C, 2006, J IMMUNOL, V177, P7525, DOI 10.4049/jimmunol.177.11.7525; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Seybold J, 1998, J BIOL CHEM, V273, P20575, DOI 10.1074/jbc.273.32.20575; Stockinger B, 2004, IMMUNOLOGY, V111, P241, DOI 10.1111/j.1365-2567.2004.01831.x; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; WEISS A, 1984, J IMMUNOL, V133, P123	48	34	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27026	27032		10.1074/jbc.M110.144022	http://dx.doi.org/10.1074/jbc.M110.144022			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20592018	Green Published, hybrid			2022-12-25	WOS:000281172700034
J	Pelissier, MC; Lesley, SA; Kuhn, P; Bourne, Y				Pelissier, Marie-Cecile; Lesley, Scott A.; Kuhn, Peter; Bourne, Yves			Structural Insights into the Catalytic Mechanism of Bacterial Guanosine-diphospho-D-mannose Pyrophosphorylase and Its Regulation by Divalent Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALGINATE BIOSYNTHETIC-PATHWAY; GDP-MANNOSE; PHOSPHOMANNOSE ISOMERASE; BIFUNCTIONAL ENZYME; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; IDENTIFICATION; PURIFICATION; URIDYLTRANSFERASE	GMP catalyzes the formation of GDP-Man, a fundamental precursor for protein glycosylation and bacterial cell wall and capsular polysaccharide biosynthesis. Crystal structures of GMP from the thermophilic bacterium Thermotoga maritima in the apo form, in complex with the substrates mannose-1-phosphate or GTP and bound with the end product GDP-Man in the presence of the essential divalent cation Mg2+, were solved in the 2.1-2.8 angstrom resolution range. The T. maritima GMP molecule is organized in two separate domains: a N-terminal Rossman fold-like domain and a C-terminal left-handed beta-helix domain. Two molecules associate into a dimer through a tail-to-tail arrangement of the C-terminal domains. Comparative analysis of the structures along with characterization of enzymatic parameters reveals the bases of substrate specificity of this class of sugar nucleotidyltransferases. In particular, substrate and product binding are associated with significant changes in the conformation of loop regions lining the active center and in the relative orientation of the two domains. Involvement of both the N- and C-terminal domains, coupled to the catalytic role of a bivalent metal ion, highlights the catalytic features of bacterial GMPs compared with other members of the pyrophosphorylase superfamily.	[Pelissier, Marie-Cecile; Bourne, Yves] Univ Aix Marseille, UMR6098, AFMB, CNRS, F-13288 Marseille 09, France; [Lesley, Scott A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Kuhn, Peter] Scripps Res Inst, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Novartis; Scripps Research Institute	Bourne, Y (corresponding author), Univ Aix Marseille, UMR6098, AFMB, CNRS, Case 932,163 Ave Luminy, F-13288 Marseille 09, France.	yves.bourne@afmb.univ-mrs.fr	Bourne, Yves/AAC-4635-2022	Bourne, Yves/0000-0003-3850-0548	CNRS; Fondation de la Recherche Medicale; National Institutes of Health [U54GM074961]; French Ministry of Research; Attache Temporaire d'Enseignement et de Recherche position at the Universite de la Mediterranee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Attache Temporaire d'Enseignement et de Recherche position at the Universite de la Mediterranee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds from the CNRS and the Fondation de la Recherche Medicale (to Y.B.) and Grant U54GM074961 from the National Institutes of Health (to P.K.).; Recipient of a fellowship from the French Ministry of Research and an Attache Temporaire d'Enseignement et de Recherche position at the Universite de la Mediterranee. Present address: EMBL, c/o DESY, Bldg. 25A, Not-kestrasse 85, 22603 Hamburg, Germany.	Abergel Chantal, 2003, Journal of Structural and Functional Genomics, V4, P141, DOI 10.1023/A:1026177202925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blankenfeldt W, 2000, EMBO J, V19, P6652, DOI 10.1093/emboj/19.24.6652; Cupp-Vickery JR, 2008, BIOCHEMISTRY-US, V47, P4439, DOI 10.1021/bi701933q; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diez MDA, 2010, ARCH MICROBIOL, V192, P103, DOI 10.1007/s00203-009-0534-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fey S, 1997, CARBOHYD RES, V305, P475, DOI 10.1016/S0008-6215(97)10095-7; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jensen SO, 1998, BBA-PROTEIN STRUCT M, V1382, P5, DOI 10.1016/S0167-4838(97)00122-2; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee HJ, 2008, FEBS LETT, V582, P3479, DOI 10.1016/j.febslet.2008.09.013; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; LINDQUIST L, 1993, EUR J BIOCHEM, V211, P763, DOI 10.1111/j.1432-1033.1993.tb17607.x; MAY TB, 1994, J BIOL CHEM, V269, P4872; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; Mizanur RM, 2009, ORG BIOMOL CHEM, V7, P2135, DOI 10.1039/b822794b; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ning B, 1999, ARCH BIOCHEM BIOPHYS, V362, P339, DOI 10.1006/abbi.1998.1053; Ning BT, 2000, EUR J BIOCHEM, V267, P6866, DOI 10.1046/j.1432-1033.2000.01781.x; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PAULE MR, 1971, J BIOL CHEM, V246, P4602; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; PREISS J, 1964, J BIOL CHEM, V239, P3119; SHINABARGER D, 1991, J BIOL CHEM, V266, P2080; Sousa SA, 2008, APPL MICROBIOL BIOT, V80, P1015, DOI 10.1007/s00253-008-1612-1; Sulzenbacher G, 2001, J BIOL CHEM, V276, P11844, DOI 10.1074/jbc.M011225200; Thoden JB, 2007, PROTEIN SCI, V16, P1379, DOI 10.1110/ps.072864707; Thoden JB, 2007, PROTEIN SCI, V16, P432, DOI 10.1110/ps.062626007; VanFossen AL, 2008, ANN NY ACAD SCI, V1125, P322, DOI 10.1196/annals.1419.017; Wu BY, 2002, FEBS LETT, V519, P87, DOI 10.1016/S0014-5793(02)02717-5; Yang J, 2004, BIOORGAN MED CHEM, V12, P1577, DOI 10.1016/j.bmc.2003.12.046; Yang YH, 2005, J MOL CATAL B-ENZYM, V37, P1, DOI 10.1016/j.molcatb.2005.08.002; Zuccotti S, 2001, J MOL BIOL, V313, P831, DOI 10.1006/jmbi.2001.5073	41	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 27	2010	285	35					27468	27476		10.1074/jbc.M109.095182	http://dx.doi.org/10.1074/jbc.M109.095182			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	641ZQ	20573954	hybrid, Green Published			2022-12-25	WOS:000281172700076
J	de Meijer, VE; Sverdlov, DY; Popov, Y; Le, HD; Meisel, JA; Nose, V; Schuppan, D; Puder, M				de Meijer, Vincent E.; Sverdlov, Deanna Y.; Popov, Yury; Le, Hau D.; Meisel, Jonathan A.; Nose, Vania; Schuppan, Detlef; Puder, Mark			Broad-Spectrum Matrix Metalloproteinase Inhibition Curbs Inflammation and Liver Injury but Aggravates Experimental Liver Fibrosis in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEPATIC STELLATE CELLS/; CARBON-TETRACHLORIDE; FACTOR-ALPHA; TRANSGENIC MOUSE; ANTIFIBROTIC THERAPIES; CONVERTING-ENZYME; TISSUE INHIBITOR; FACTOR RECEPTOR; EXPRESSION	Background: Liver fibrosis is characterized by excessive synthesis of extracellular matrix proteins, which prevails over their enzymatic degradation, primarily by matrix metalloproteinases (MMPs). The effect of pharmacological MMP inhibition on fibrogenesis, however, is largely unexplored. Inflammation is considered a prerequisite and important co-contributor to fibrosis and is, in part, mediated by tumor necrosis factor (TNF)-alpha-converting enzyme (TACE). We hypothesized that treatment with a broad-spectrum MMP and TACE-inhibitor (Marimastat) would ameliorate injury and inflammation, leading to decreased fibrogenesis during repeated hepatotoxin-induced liver injury. Methodology/Principal Findings: Liver fibrosis was induced in mice by repeated carbon tetrachloride (CCl4) administration, during which the mice received either Marimastat or vehicle twice daily. A single dose of CCl(4) was administered to investigate acute liver injury in mice pretreated with Marimastat, mice deficient in Mmp9, or mice deficient in both TNF-alpha receptors. Liver injury was quantified by alanine aminotransferase (ALT) levels and confirmed by histology. Hepatic collagen was determined as hydroxyproline, and expression of fibrogenesis and fibrolysis-related transcripts was determined by quantitative reverse-transcription polymerase chain reaction. Marimastat-treated animals demonstrated significantly attenuated liver injury and inflammation but a 25% increase in collagen deposition. Transcripts related to fibrogenesis were significantly less upregulated compared to vehicle-treated animals, while MMP expression and activity analysis revealed efficient pharmacologic MMP-inhibition and decreased fibrolysis following Marimastat treatment. Marimastat pre-treatment significantly attenuated liver injury following acute CCl(4)-administration, whereas Mmp9 deficient animals demonstrated no protection. Mice deficient in both TNF-alpha receptors exhibited an 80% reduction of serum ALT, confirming the hepatoprotective effects of Marimastat via the TNF-signaling pathway. Conclusions/Significance: Inhibition of MMP and TACE activity with Marimastat during chronic CCl(4) administration counterbalanced any beneficial anti-inflammatory effect, resulting in a positive balance of collagen deposition. Since effective inhibition of MMPs accelerates fibrosis progression, MMP inhibitors should be used with caution in patients with chronic liver diseases.	[de Meijer, Vincent E.; Le, Hau D.; Meisel, Jonathan A.; Puder, Mark] Harvard Univ, Sch Med, Dept Surg, Childrens Hosp Boston, Boston, MA 02115 USA; [de Meijer, Vincent E.; Le, Hau D.; Meisel, Jonathan A.; Puder, Mark] Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program, Boston, MA USA; [de Meijer, Vincent E.] Univ Med Ctr Rotterdam, Erasmus Med Ctr MC, Dept Surg, Rotterdam, Netherlands; [Sverdlov, Deanna Y.; Popov, Yury; Schuppan, Detlef] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol & Hepatol, Boston, MA 02215 USA; [Nose, Vania] Univ Miami, Miller Sch Med, Dept Anat Pathol, Miami, FL 33136 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Miami	de Meijer, VE (corresponding author), Harvard Univ, Sch Med, Dept Surg, Childrens Hosp Boston, Boston, MA 02115 USA.	mark.puder@childrens.harvard.edu	de Meijer, Vincent Erwin/H-6610-2019; Popov, Yury V./A-7781-2008	de Meijer, Vincent Erwin/0000-0002-7900-5917; Popov, Yury V./0000-0001-7973-942X; Le, Hau/0000-0003-0514-3513	Children's Hospital Surgical Foundation (Boston, MA); Prof. Michael-van Vloten Fonds (Venray, The Netherlands); VSBfonds (Utrecht, The Netherlands); Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands); Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands); Dr Saal van Zwanenberg Stichting (Oss, The Netherlands)	Children's Hospital Surgical Foundation (Boston, MA); Prof. Michael-van Vloten Fonds (Venray, The Netherlands)(Netherlands Government); VSBfonds (Utrecht, The Netherlands)(Netherlands Government); Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands)(Netherlands Government); Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands)(Netherlands Government); Dr Saal van Zwanenberg Stichting (Oss, The Netherlands)(Netherlands Government)	Dr. de Meijer was recipient of fellowships from the foundations Stichting Prof. Michael-van Vloten Fonds (Venray, The Netherlands), VSBfonds (Utrecht, The Netherlands), Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands), Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands), and Dr Saal van Zwanenberg Stichting (Oss, The Netherlands). Dr. Puder was supported by the Children's Hospital Surgical Foundation (Boston, MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2009, SEMIN LIVER DIS, V29, P3, DOI 10.1055/s-0029-1192052; Albanis E, 2006, AM J TRANSPLANT, V6, P12, DOI 10.1111/j.1600-6143.2005.01143.x; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; ARTHUR MJP, 1989, J CLIN INVEST, V84, P1076, DOI 10.1172/JCI114270; Bahcecioglu IH, 2008, INFLAMMATION, V31, P215, DOI 10.1007/s10753-008-9067-1; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bramhall SR, 2002, BRIT J CANCER, V86, P1864, DOI 10.1038/sj.bjc.6600310; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Clements JM, 1997, J NEUROIMMUNOL, V74, P85, DOI 10.1016/S0165-5728(96)00210-X; *CLINICALTRIALS GO, 2010, NCT01051921 CLINICAL; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; CZAJA MJ, 1995, GASTROENTEROLOGY, V108, P1849, DOI 10.1016/0016-5085(95)90149-3; Doggrell SA, 2002, EXPERT OPIN INV DRUG, V11, P1003, DOI 10.1517/13543784.11.7.1003; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Hamada T, 2008, HEPATOLOGY, V47, P186, DOI 10.1002/hep.21922; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Kahraman A, 2009, HEPATOL RES, V39, P805, DOI 10.1111/j.1872-034X.2009.00541.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Knittel T, 2000, HISTOCHEM CELL BIOL, V113, P443; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Mohammed FF, 2005, HEPATOLOGY, V41, P857, DOI 10.1002/hep.20618; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Moses MA, 2006, NEW ENGL J MED, V354, P2621, DOI 10.1056/NEJMc053410; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Olle EW, 2006, HEPATOLOGY, V44, P540, DOI 10.1002/hep.21314; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Popov Y, 2006, J BIOL CHEM, V281, P15090, DOI 10.1074/jbc.M600030200; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Rasmussen HS, 1997, PHARMACOL THERAPEUT, V75, P69, DOI 10.1016/S0163-7258(97)00023-5; Rosenbaum E, 2005, CLIN CANCER RES, V11, P4437, DOI 10.1158/1078-0432.CCR-04-2252; SCHNEIDER BS, 1992, BIOCHEM BIOPH RES CO, V188, P767, DOI 10.1016/0006-291X(92)91122-7; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Sudo K, 2005, CYTOKINE, V29, P236, DOI 10.1016/j.cyto.2004.11.001; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wells RG, 2000, AM J PHYSIOL-GASTR L, V279, pG845, DOI 10.1152/ajpgi.2000.279.5.G845; Wielockx B, 2001, NAT MED, V7, P1202, DOI 10.1038/nm1101-1202; WINWOOD PJ, 1995, HEPATOLOGY, V22, P304; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625	59	46	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11256	10.1371/journal.pone.0011256	http://dx.doi.org/10.1371/journal.pone.0011256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593020	Green Published, Green Submitted, gold			2022-12-25	WOS:000279140800002
J	Haggarty, P; Hoad, G; Harris, SE; Starr, JM; Fox, HC; Deary, IJ; Whalley, LJ				Haggarty, Paul; Hoad, Gwen; Harris, Sarah E.; Starr, John M.; Fox, Helen C.; Deary, Ian J.; Whalley, Lawrence J.			Human Intelligence and Polymorphisms in the DNA Methyltransferase Genes Involved in Epigenetic Marking	PLOS ONE			English	Article							DE-NOVO METHYLATION; IMPRINTED GENES; BRAIN-DEVELOPMENT; DNMT3L; DISORDERS; HOMOCYSTEINE; INHERITANCE; EXPRESSION; CHILDHOOD; MUTATIONS	Epigenetic mechanisms have been implicated in syndromes associated with mental impairment but little is known about the role of epigenetics in determining the normal variation in human intelligence. We measured polymorphisms in four DNA methyltransferases (DNMT1, DNMT3A, DNMT3B and DNMT3L) involved in epigenetic marking and related these to childhood and adult general intelligence in a population (n = 1542) consisting of two Scottish cohorts born in 1936 and residing in Lothian (n = 1075) or Aberdeen (n = 467). All subjects had taken the same test of intelligence at age 11yrs. The Lothian cohort took the test again at age 70yrs. The minor T allele of DNMT3L SNP 11330C>T (rs7354779) allele was associated with a higher standardised childhood intelligence score; greatest effect in the dominant analysis but also significant in the additive model (coefficient = 1.40(additive); 95%CI 0.22,2.59; p = 0.020 and 1.99(dominant); 95%CI 0.55,3.43; p = 0.007). The DNMT3L C allele was associated with an increased risk of being below average intelligence (OR 1.25(additive); 95%CI 1.05,1.51; p = 0.011 and OR 1.37(dominant); 95%CI 1.11,1.68; p = 0.003), and being in the lowest 40(th) (p(additive) = 0.009; p(dominant) = 0.002) and lowest 30(th) (p(additive) = 0.004; p(dominant) = 0.002) centiles for intelligence. After Bonferroni correction for the number variants tested the link between DNMT3L 11330C>T and childhood intelligence remained significant by linear regression and centile analysis; only the additive regression model was borderline significant. Adult intelligence was similarly linked to the DNMT3L variant but this analysis was limited by the numbers studied and nature of the test and the association was not significant after Bonferroni correction. We believe that the role of epigenetics in the normal variation in human intelligence merits further study and that this novel finding should be tested in other cohorts.	[Haggarty, Paul; Hoad, Gwen] Univ Aberdeen, Rowett Inst Nutr & Hlth, Nutr & Epigenet Grp, Aberdeen, Scotland; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Royal Victoria Hosp, Ctr Cognit Ageing & Cognit Epidemiol, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Fox, Helen C.; Whalley, Lawrence J.] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Aberdeen; University of Edinburgh; University of Edinburgh; University of Aberdeen; University of Edinburgh	Haggarty, P (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Nutr & Epigenet Grp, Aberdeen, Scotland.	p.haggarty@abdn.ac.uk	Haggarty, Paul/C-1696-2009; whalley, lawrence j/E-9019-2011; Deary, Ian J/C-6297-2009	Deary, Ian J/0000-0002-1733-263X	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Alzheimer's Research Trust; BBSRC; EPSRC; ESRC; MRC; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0700704] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0700704] Funding Source: researchfish	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Alzheimer's Research Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The genotype measurements were funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD) and the Alzheimer's Research Trust. PH and GH acknowledge the support of RERAD. The Aberdeen data and sample collection was funded by BBSRC. The Lothian work was undertaken within The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative, with funding from BBSRC, EPSRC, ESRC and MRC. The Lothian data collection was supported by a programme grant from Research Into Ageing, which continues as the Disconnected Mind project funded by Help the Aged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapola U, 2002, NUCLEIC ACIDS RES, V30, P3602, DOI 10.1093/nar/gkf474; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Arnaud P, 2006, HUM MOL GENET, V15, P589, DOI 10.1093/hmg/ddi475; Ausio J, 2003, CLIN GENET, V64, P83, DOI 10.1034/j.1399-0004.2003.00124.x; Badcock C, 2006, J EVOLUTION BIOL, V19, P1007, DOI 10.1111/j.1420-9101.2006.01091.x; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; Bouchard TJ, 1998, HUM BIOL, V70, P257; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Buiting K, 2003, AM J HUM GENET, V72, P571, DOI 10.1086/367926; Butcher LM, 2005, HUM MOL GENET, V14, P1315, DOI 10.1093/hmg/ddi142; Catchpoole D, 1997, J MED GENET, V34, P353, DOI 10.1136/jmg.34.5.353; Cebrian A, 2006, CARCINOGENESIS, V27, P1661, DOI 10.1093/carcin/bgi375; Chamary JV, 2009, SCI AM, V300, P46, DOI 10.1038/scientificamerican0609-46; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Cooney CA, 2002, J NUTR, V132, p2393S; Cunningham MD, 2010, DEV CELL, V18, P169, DOI 10.1016/j.devcel.2010.01.012; Davies W, 2001, ANN MED, V33, P428, DOI 10.3109/07853890108995956; Davies W, 2008, FRONT NEUROENDOCRIN, V29, P413, DOI 10.1016/j.yfrne.2007.12.001; Davies W, 2008, ADV EXP MED BIOL, V626, P62; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; El-Maarri O, 2009, HUM MOL GENET, V18, P1755, DOI 10.1093/hmg/ddp088; Flynn J R, 2000, Novartis Found Symp, V233, P202, DOI 10.1002/0470870850.ch13; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Goos LM, 2008, ADV EXP MED BIOL, V626, P71; Goos LM, 2006, J NEUROGENET, V20, P19, DOI 10.1080/01677060600685840; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; LIU Z, 2008, CANC LETT; LYNN R, 1987, NATURE, V328, P797, DOI 10.1038/328797a0; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Sandovici I, 2003, HUM MOL GENET, V12, P1569, DOI 10.1093/hmg/ddg167; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Scottish Council for Research in Education, 1949, TREND SCOTT INT COMP; Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Trasler JM, 2006, REPROD FERT DEVELOP, V18, P63, DOI 10.1071/RD05118; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; Whittington J, 2004, J INTELL DISABIL RES, V48, P172, DOI 10.1111/j.1365-2788.2004.00556.x; Whittington J, 2009, J INTELL DISABIL RES, V53, P411, DOI 10.1111/j.1365-2788.2009.01157.x; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Xie ZH, 2006, HUM MOL GENET, V15, P1375, DOI 10.1093/hmg/ddl059; Zhao XY, 2007, EPIGENETICS-US, V2, P126, DOI 10.4161/epi.2.2.4236	56	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11329	10.1371/journal.pone.0011329	http://dx.doi.org/10.1371/journal.pone.0011329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593030	Green Submitted, Green Published, gold			2022-12-25	WOS:000279140800026
J	Romano, CM; de Carvalho-Mello, IMVG; Jamal, LF; de Melo, FL; Iamarino, A; Motoki, M; Pinho, JRR; Holmes, EC; Zanotto, PMD				Romano, Camila Malta; Guedes de Carvalho-Mello, Isabel M. V.; Jamal, Leda F.; de Melo, Fernando Lucas; Iamarino, Atila; Motoki, Marco; Rebello Pinho, Joao Renato; Holmes, Edward C.; de Andrade Zanotto, Paolo Marinho		VGDN Consortium	Social Networks Shape the Transmission Dynamics of Hepatitis C Virus	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; RISK-FACTOR; INFECTION; SEQUENCES; HISTORY; SEROPREVALENCE; EVOLUTION; VIREMIA; MODELS	Hepatitis C virus (HCV) infects 170 million people worldwide, and is a major public health problem in Brazil, where over 1% of the population may be infected and where multiple viral genotypes co-circulate. Chronically infected individuals are both the source of transmission to others and are at risk for HCV-related diseases, such as liver cancer and cirrhosis. Before the adoption of anti-HCV control measures in blood banks, this virus was mainly transmitted via blood transfusion. Today, needle sharing among injecting drug users is the most common form of HCV transmission. Of particular importance is that HCV prevalence is growing in non-risk groups. Since there is no vaccine against HCV, it is important to determine the factors that control viral transmission in order to develop more efficient control measures. However, despite the health costs associated with HCV, the factors that determine the spread of virus at the epidemiological scale are often poorly understood. Here, we sequenced partial NS5b gene sequences sampled from blood samples collected from 591 patients in Sao Paulo state, Brazil. We show that different viral genotypes entered Sao Paulo at different times, grew at different rates, and are associated with different age groups and risk behaviors. In particular, subtype 1b is older and grew more slowly than subtypes 1a and 3a, and is associated with multiple age classes. In contrast, subtypes 1a and 3b are associated with younger people infected more recently, possibly with higher rates of sexual transmission. The transmission dynamics of HCV in Sao Paulo therefore vary by subtype and are determined by a combination of age, risk exposure and underlying social network. We conclude that social factors may play a key role in determining the rate and pattern of HCV spread, and should influence future intervention policies.	[Romano, Camila Malta; de Melo, Fernando Lucas; Iamarino, Atila; Motoki, Marco; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Lab Mol Evolut & Bioinformat,ICBII, Sao Paulo, Brazil; [Guedes de Carvalho-Mello, Isabel M. V.] Butantan Inst, Viral Immunol Lab, Sao Paulo, Brazil; [Guedes de Carvalho-Mello, Isabel M. V.; Rebello Pinho, Joao Renato] Univ Sao Paulo, Sch Med, Lab Trop Gastroenterol & Hepatol, Dept Gastroenterol,Inst Trop Med, Sao Paulo, Brazil; [Jamal, Leda F.] Ctr Dis Control, Training & Reference Ctr DST AIDS, Sao Paulo, Brazil; [Holmes, Edward C.] Penn State Univ, Dept Biol, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo; Coordenadoria de Controle de Doencas da Secretaria de Estado; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Romano, CM (corresponding author), Univ Sao Paulo, Dept Microbiol, Inst Biomed Sci, Lab Mol Evolut & Bioinformat,ICBII, Sao Paulo, Brazil.	pzanotto@usp.br	Romano, Camila/ABC-2883-2020; Botosso, Viviane/I-5591-2014; Romano, Camila M/C-8185-2013; de A. Zanotto, Paolo M./B-9286-2019; Holmes, Edward/GVR-9499-2022; Pinho, Joao R. R./G-2850-2012; Melo, Fernando Lucas/U-6535-2017; Holmes, Edward/Y-2789-2019; de carvalho-Mello, Isabel Maria V G/D-3641-2012; Richtzenhain, Leonardo J/U-1026-2017	Romano, Camila/0000-0003-4550-1987; Botosso, Viviane/0000-0002-7876-3687; de A. Zanotto, Paolo M./0000-0002-8167-0625; Pinho, Joao R. R./0000-0003-3999-0489; Melo, Fernando Lucas/0000-0002-9591-0239; Holmes, Edward/0000-0001-9596-3552; de carvalho-Mello, Isabel Maria V G/0000-0002-4448-1972; Richtzenhain, Leonardo J/0000-0002-1419-3515; Iamarino, Atila/0000-0003-3904-0248; Rezende, Rosamar/0000-0003-3895-0864; Durigon, Edison/0000-0003-4898-6553	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [00/04205-6]; Conselho Nacional de Pesquisa (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was made possible by the Viral Genetic Diversity (VGDN) program funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (www.fapesp.br) project number 00/04205-6 and by the Conselho Nacional de Pesquisa (CNPq) (www.cnpq.br), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; ANDERSON RM, 1992, FRAMEWORK POPULATION, P665; Andrade AFB, 2006, MEM I OSWALDO CRUZ, V101, P673, DOI 10.1590/S0074-02762006000600016; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Brown KA, 2005, CURR OPIN GASTROEN, V21, P331, DOI 10.1097/01.mog.0000159830.36793.2b; Chevaliez S, 2007, WORLD J GASTROENTERO, V13, P2461, DOI 10.3748/wjg.v13.i17.2461; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Pardini MI, 2008, PLOS BIOL, V6, P428, DOI 10.1371/journal.pbio.0060057; de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubois F, 1997, HEPATOLOGY, V25, P1490, DOI 10.1002/hep.510250630; Friedman SR, 2001, J URBAN HEALTH, V78, P411, DOI 10.1093/jurban/78.3.411; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Karmochkine M, 2006, J VIRAL HEPATITIS, V13, P775, DOI 10.1111/j.1365-2893.2006.00742.x; Kiss IZ, 2005, P ROY SOC B-BIOL SCI, V272, P1407, DOI 10.1098/rspb.2005.3092; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Lopes Carmen L R, 2009, Rev. Saúde Pública, V43, P43, DOI 10.1590/S0034-89102009000800008; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Martinez A, 2008, LIVER INT, V28, P757, DOI 10.1111/j.1478-3231.2008.01765.x; Mathei C, 2008, J VIRAL HEPATITIS, V15, P399, DOI 10.1111/j.1365-2893.2007.00950.x; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MILLER LH, 1956, J AM STAT ASSOC, V51, P111, DOI 10.2307/2280807; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Olsson GE, 2002, EMERG INFECT DIS, V8, P924, DOI 10.3201/eid0809.020037; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395; Shannon K, 2010, ARCH PEDIAT ADOL MED, V164, P61, DOI 10.1001/archpediatrics.2009.241; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; SHERLOCK S, 1993, LANCET, V342, P1127, DOI 10.1016/0140-6736(93)92117-C; SILINI E, 1995, J HEPATOL, V22, P691, DOI 10.1016/0168-8278(95)80225-8; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Simmonds P, 1996, J GEN VIROL, V77, P3013, DOI 10.1099/0022-1317-77-12-3013; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trepo C, 1999, J HEPATOL, V31, P80, DOI 10.1016/S0168-8278(99)80379-1; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Reiche EMV, 2008, INT J MOL MED, V21, P387; Zwickl D.J., 2006, THESIS U TEXAS AUSTI	46	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11170	10.1371/journal.pone.0011170	http://dx.doi.org/10.1371/journal.pone.0011170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585651	Green Published, gold, Green Submitted			2022-12-25	WOS:000279135400004
J	Vala, IS; Martins, LR; Imaizumi, N; Nunes, RJ; Rino, J; Kuonen, F; Carvalho, LM; Ruegg, C; Grillo, IM; Barata, JT; Mareel, M; Santos, SCR				Vala, Ines Sofia; Martins, Leila R.; Imaizumi, Natsuko; Nunes, Raquel J.; Rino, Jose; Kuonen, Francois; Carvalho, Lara M.; Rueegg, Curzio; Grillo, Isabel Monteiro; Barata, Joao Taborda; Mareel, Marc; Rosa Santos, Susana Constantino			Low Doses of Ionizing Radiation Promote Tumor Growth and Metastasis by Enhancing Angiogenesis	PLOS ONE			English	Article							SURVIVAL; THERAPY; RADIOTHERAPY; RECURRENCE; APOPTOSIS; VEGFR-2; CELLS	Radiotherapy is a widely used treatment option in cancer. However, recent evidence suggests that doses of ionizing radiation (IR) delivered inside the tumor target volume, during fractionated radiotherapy, can promote tumor invasion and metastasis. Furthermore, the tissues that surround the tumor area are also exposed to low doses of IR that are lower than those delivered inside the tumor mass, because external radiotherapy is delivered to the tumor through multiple radiation beams, in order to prevent damage of organs at risk. The biological effects of these low doses of IR on the healthy tissue surrounding the tumor area, and in particular on the vasculature remain largely to be determined. We found that doses of IR lower or equal to 0.8 Gy enhance endothelial cell migration without impinging on cell proliferation or survival. Moreover, we show that low-dose IR induces a rapid phosphorylation of several endothelial cell proteins, including the Vascular Endothelial Growth Factor (VEGF) Receptor-2 and induces VEGF production in hypoxia mimicking conditions. By activating the VEGF Receptor-2, low-dose IR enhances endothelial cell migration and prevents endothelial cell death promoted by an anti-angiogenic drug, bevacizumab. In addition, we observed that low-dose IR accelerates embryonic angiogenic sprouting during zebrafish development and promotes adult angiogenesis during zebrafish fin regeneration and in the murine Matrigel assay. Using murine experimental models of leukemia and orthotopic breast cancer, we show that low-dose IR promotes tumor growth and metastasis and that these effects were prevented by the administration of a VEGF receptor-tyrosine kinase inhibitor immediately before IR exposure. These findings demonstrate a new mechanism to the understanding of the potential pro-metastatic effect of IR and may provide a new rationale basis to the improvement of current radiotherapy protocols.	[Vala, Ines Sofia; Nunes, Raquel J.; Rosa Santos, Susana Constantino] Univ Lisbon, Fac Med, Inst Mol Med, Angiogenesis Unit, P-1699 Lisbon, Portugal; [Martins, Leila R.; Barata, Joao Taborda] Univ Lisbon, Fac Med, Inst Mol Med, Canc Biol Unit, P-1699 Lisbon, Portugal; [Imaizumi, Natsuko; Kuonen, Francois; Rueegg, Curzio] Univ Lausanne, Fac Biol & Med, Div Expt Oncol, Ctr Pluridisciplinaire Oncol, CH-1066 Epalinges, Switzerland; [Imaizumi, Natsuko; Kuonen, Francois; Rueegg, Curzio] EPFL, NCCR Mol Oncol ISREC, Epalinges, Switzerland; [Rino, Jose] Univ Lisbon, Fac Med, Inst Mol Med, Bioimaging Unit, P-1699 Lisbon, Portugal; [Carvalho, Lara M.] Univ Lisbon, Fac Med, Inst Mol Med, Zebrafish Unit, P-1699 Lisbon, Portugal; [Grillo, Isabel Monteiro] Hosp Santa Maria, Serv Radioterapia, Lisbon, Portugal; [Mareel, Marc] Univ Ghent, Dept Radiotherapy, B-9000 Ghent, Belgium	Universidade de Lisboa; Universidade de Lisboa; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Ghent University	Vala, IS (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Angiogenesis Unit, P-1699 Lisbon, Portugal.	sconstantino@fm.ul.pt	Barata, João T./D-9181-2015; Rino, José/I-2990-2013; Santos, Susana/AAM-8902-2021	Barata, João T./0000-0002-4826-8976; Rino, José/0000-0002-0637-4527; monteiro grillo, isabel/0000-0002-2481-5576; Martins, Leila/0000-0002-5887-4734; Kuonen, Francois/0000-0001-6137-7483; Constantino Rosa Santos, Susana/0000-0002-5711-1292; Batista Vala Silva de Oliveira, Ines Sofia/0000-0003-0497-6804	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/27541/2006, SFRH/BD/41415/2007, SFRH/BPD/43482/2008, PPCDT/SAU-OBS/58913, PTDC/SAU-OBD/69974]; National Centre for Competence in Research (NCCR); Swiss National Science Foundation; TUMIC FP7; Children with Leukaemia Charity, U.K.	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); National Centre for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TUMIC FP7; Children with Leukaemia Charity, U.K.	I. S. V., L. R. M. and R.J.N. were supported by Fundacao para a Ciencia e Tecnologia (FCT) fellowships (SFRH/BD/27541/2006 and SFRH/BD/41415/2007, SFRH/BPD/43482/2008 respectively). Work in C. R. lab was supported by grants from the Molecular Oncology Program of the National Centre for Competence in Research (NCCR), the Swiss National Science Foundation and TUMIC FP7. Work in J.T.B. lab was supported by FCT (PPCDT/SAU-OBS/58913 and PTDC/SAU-OBD/69974) and by Children with Leukaemia Charity, U.K. (IVIS Lumina support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, CLIN CANCER RES, V11, P6270, DOI 10.1158/1078-0432.CCR-04-1223; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Constantino S, 2001, ONCOGENE, V20, P2080, DOI 10.1038/sj.onc.1204308; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Gorski DH, 1999, CANCER RES, V59, P3374; Lee CG, 2000, CANCER RES, V60, P5565; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; Nozue M, 2001, ONCOL REP, V8, P1247; OBRIEN CJ, 1986, AM J SURG, V152, P456, DOI 10.1016/0002-9610(86)90324-7; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; PASSANITI A, 1992, LAB INVEST, V67, P519; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; SUIT HD, 1992, INT J RADIAT ONCOL, V23, P653, DOI 10.1016/0360-3016(92)90025-D; Sung HK, 2006, BIOCHEM BIOPH RES CO, V345, P545, DOI 10.1016/j.bbrc.2006.04.121; Teicher BA, 1994, RADIAT ONCOL INVEST, V2, P269, DOI DOI 10.1002/ROI.2970020604; Vicini FA, 2003, CANCER, V97, P910, DOI 10.1002/cncr.11143; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zoula S, 2003, BRIT J CANCER, V88, P1439, DOI 10.1038/sj.bjc.6600837	27	136	136	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2010	5	6							e11222	10.1371/journal.pone.0011222	http://dx.doi.org/10.1371/journal.pone.0011222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KV	20574535	Green Submitted, Green Published, gold			2022-12-25	WOS:000279058300014
J	Faure, A; Richard, JM; Berridge, KC				Faure, Alexis; Richard, Jocelyn M.; Berridge, Kent C.			Desire and Dread from the Nucleus Accumbens: Cortical Glutamate and Subcortical GABA Differentially Generate Motivation and Hedonic Impact in the Rat	PLOS ONE			English	Article							VENTRAL PALLIDUM; MESOLIMBIC DOPAMINE; DEFENSIVE BEHAVIOR; INCENTIVE SALIENCE; NEURONS; REWARD; SHELL; RECEPTORS; ACTIVATION; MODULATION	Background: GABAergic signals to the nucleus accumbens (NAc) shell arise from predominantly subcortical sources whereas glutamatergic signals arise mainly from cortical-related sources. Here we contrasted GABAergic and glutamatergic generation of hedonics versus motivation processes, as a proxy for comparing subcortical and cortical controls of emotion. Local disruptions of either signals in medial shell of NAc generate intense motivated behaviors corresponding to desire and/or dread, along a rostrocaudal gradient. GABA or glutamate disruptions in rostral shell generate appetitive motivation whereas disruptions in caudal shell elicit fearful motivation. However, GABA and glutamate signals in NAc differ in important ways, despite the similarity of their rostrocaudal motivation gradients. Methodology/Principal Findings: Microinjections of a GABA(A) agonist (muscimol), or of a glutamate AMPA antagonist (DNQX) in medial shell of rats were assessed for generation of hedonic "liking'' or "disliking'' by measuring orofacial affective reactions to sucrose-quinine taste. Motivation generation was independently assessed measuring effects on eating versus natural defensive behaviors. For GABAergic microinjections, we found that the desire-dread motivation gradient was mirrored by an equivalent hedonic gradient that amplified affective taste "liking'' (at rostral sites) versus "disliking'' (at caudal sites). However, manipulation of glutamatergic signals completely failed to alter pleasure-displeasure reactions to sensory hedonic impact, despite producing a strong rostrocaudal gradient of motivation. Conclusions/Significance: We conclude that the nucleus accumbens contains two functional affective keyboards for amino-acid signals: a motivation-generating keyboard and a hedonic-generating keyboard. Corticolimbic glutamate signals and subcortical GABA signals equivalently engage the motivation keyboard to generate desire and-or dread. Only subcortical GABA signals additionally engage the hedonic keyboard to amplify affective "liking'' and "disliking'' reactions. We thus suggest that top-down cortical glutamate signals powerfully regulate motivation components, but are relatively unable to penetrate core hedonic components of emotion. That may carry implications of limits to therapeutic regulation of pathological emotions.	[Faure, Alexis; Richard, Jocelyn M.; Berridge, Kent C.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Faure, A (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	afaure@umich.edu	Carroll, Joseph/D-1158-2011; Richard, Jocelyn/G-1980-2011; Richard, Jocelyn/I-4327-2019; Berridge, Kent C/C-1525-2009	Carroll, Joseph/0000-0003-2656-1378; Richard, Jocelyn/0000-0001-5750-0418; Berridge, Kent C/0000-0002-6031-2626; FAURE, alexis/0000-0002-2033-3879	NIH [DA015188, MH63649]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research described here was supported by grants from the NIH (DA015188, and MH63649). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo BA, 2005, BEHAV NEUROSCI, V119, P1195, DOI 10.1037/0735-7044.119.5.1195; Barch DM, 2005, SCHIZOPHRENIA BULL, V31, P875, DOI 10.1093/schbul/sbi040; Barrett LF, 2006, CURR DIR PSYCHOL SCI, V15, P79, DOI 10.1111/j.0963-7214.2006.00411.x; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Behrends JC, 2002, PFLUG ARCH EUR J PHY, V443, P707, DOI 10.1007/s00424-001-0740-6; Belujon P, 2008, J NEUROSCI, V28, P9797, DOI 10.1523/JNEUROSCI.2200-08.2008; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Berthoud HR, 2008, ANNU REV PSYCHOL, V59, P55, DOI 10.1146/annurev.psych.59.103006.093551; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chen Q, 1998, NEUROSCIENCE, V83, P749, DOI 10.1016/S0306-4522(97)00452-1; CHURCHILL L, 1994, J COMP NEUROL, V345, P579, DOI 10.1002/cne.903450408; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; CROMWELL HC, 1993, BRAIN RES, V624, P1, DOI 10.1016/0006-8993(93)90053-P; Damasio A. R., 2004, FEELINGS EMOTIONS, P49, DOI DOI 10.1017/CBO9780511806582.004; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; Faure A, 2008, J NEUROSCI, V28, P7184, DOI 10.1523/JNEUROSCI.4961-07.2008; Gable P, 2008, PSYCHOPHYSIOLOGY, V45, P275, DOI 10.1111/j.1469-8986.2007.00627.x; Goetz T, 2007, PROG BRAIN RES, V160, P21, DOI 10.1016/S0079-6123(06)60003-4; Groenewegen HJ, 1999, PSYCHOBIOLOGY, V27, P149; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Jeun SH, 2009, KOREAN J PHYSIOL PHA, V13, P209, DOI 10.4196/kjpp.2009.13.3.209; JOHNSON LR, 1994, BASAL GANGLIA, V4, P109; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; KALIVAS PW, 2009, NAT REV NEUROSCI; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kiyatkin EA, 1999, BRAIN RES, V822, P88, DOI 10.1016/S0006-8993(99)01093-8; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; KRINGELBACH ML, 2009, PLEASURE CTR; Kringelbach ML, 2010, PLEASURES BRAIN, P202; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Mahler SV, 2009, J NEUROSCI, V29, P6500, DOI 10.1523/JNEUROSCI.3875-08.2009; MEREDITH GE, 1990, BRAIN RES, V513, P329, DOI 10.1016/0006-8993(90)90476-R; MEREDITH GE, 1993, PROG BRAIN RES, V99, P3; Meredith GE, 1999, ANN NY ACAD SCI, V877, P140, DOI 10.1111/j.1749-6632.1999.tb09266.x; Meredith GE, 2008, BRAIN STRUCT FUNCT, V213, P17, DOI 10.1007/s00429-008-0175-3; Moore H, 2001, BIOL PSYCHIAT, V49, p10S; O'Donnell P, 1999, PSYCHOBIOLOGY, V27, P187; Owings D. H., 1998, ANIMAL VOCAL COMMUNI; Paxinos G., 1996, RAT BRAIN STEREOTAXI; PAXINOS G, 2007, RAT BRAIN COORDINATE; Pecina S, 2005, J NEUROSCI, V25, P11777, DOI 10.1523/JNEUROSCI.2329-05.2005; Pecina S, 1997, PHARMACOL BIOCHEM BE, V58, P801, DOI 10.1016/S0091-3057(97)00044-0; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Reynolds SM, 2008, NAT NEUROSCI, V11, P423, DOI 10.1038/nn2061; Reynolds SM, 2003, EUR J NEUROSCI, V17, P2187, DOI 10.1046/j.1460-9568.2003.02642.x; Reynolds SM, 2002, J NEUROSCI, V22, P7308; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Salomons TV, 2007, J COGNITIVE NEUROSCI, V19, P993, DOI 10.1162/jocn.2007.19.6.993; Schoepp DD, 2001, J PHARMACOL EXP THER, V299, P12; SESACK SR, 1992, J COMP NEUROL, V320, P145, DOI 10.1002/cne.903200202; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shimura T, 2006, EUR J NEUROSCI, V23, P1596, DOI 10.1111/j.1460-9568.2006.04689.x; Smith K.S., 2010, PLEASURES BRAIN, P27; Smith KS, 2005, J NEUROSCI, V25, P8637, DOI 10.1523/JNEUROSCI.1902-05.2005; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; Spooren W, 2003, BEHAV PHARMACOL, V14, P257, DOI 10.1097/01.fbp.0000081783.35927.8f; Stratford TR, 1999, J NEUROSCI, V19, P11040, DOI 10.1523/JNEUROSCI.19-24-11040.1999; Stratford TR, 1998, BEHAV BRAIN RES, V93, P43, DOI 10.1016/S0166-4328(97)00140-X; SUN N, 1993, J COMP NEUROL, V330, P381, DOI 10.1002/cne.903300308; Suwabe T, 2008, J NEUROPHYSIOL, V99, P1267, DOI 10.1152/jn.01115.2007; Swanson LW, 2005, J COMP NEUROL, V493, P122, DOI 10.1002/cne.20733; Taylor SF, 2005, NEUROPSYCHOPHARMACOL, V30, P984, DOI 10.1038/sj.npp.1300679; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; WILKIE DM, 1979, J EXP ANAL BEHAV, V31, P299, DOI 10.1901/jeab.1979.31-299; Wolf JA, 2005, J NEUROSCI, V25, P9080, DOI 10.1523/JNEUROSCI.2220-05.2005; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Zahm DS, 2006, NEUROSCI BIOBEHAV R, V30, P148, DOI 10.1016/j.neubiorev.2005.06.003; Zhang M, 2003, BEHAV NEUROSCI, V117, P202, DOI 10.1037/0735-7044.117.2.202	76	80	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e11223	10.1371/journal.pone.0011223	http://dx.doi.org/10.1371/journal.pone.0011223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585461	Green Submitted, Green Published, gold			2022-12-25	WOS:000278977200018
J	Conteh, L; Sicuri, E; Manzi, F; Hutton, G; Obonyo, B; Tediosi, F; Biao, P; Masika, P; Matovu, F; Otieno, P; Gosling, RD; Hamel, M; Odhiambo, FO; Grobusch, MP; Kremsner, PG; Chandramohan, D; Aponte, JJ; Egan, A; Schellenberg, D; Macete, E; Slutsker, L; Newman, RD; Alonso, P; Menendez, C; Tanner, M				Conteh, Lesong; Sicuri, Elisa; Manzi, Fatuma; Hutton, Guy; Obonyo, Benson; Tediosi, Fabrizio; Biao, Prosper; Masika, Paul; Matovu, Fred; Otieno, Peter; Gosling, Roly D.; Hamel, Mary; Odhiambo, Frank O.; Grobusch, Martin P.; Kremsner, Peter G.; Chandramohan, Daniel; Aponte, John J.; Egan, Andrea; Schellenberg, David; Macete, Eusebio; Slutsker, Laurence; Newman, Robert D.; Alonso, Pedro; Menendez, Clara; Tanner, Marcel			The Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants in Sub-Saharan Africa	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; ROUTINE VACCINATIONS; TANZANIAN INFANTS; EXPANDED PROGRAM; DELIVERY-SYSTEM; VECTOR CONTROL; ANEMIA CONTROL; DOUBLE-BLIND; HEALTH; IPTI	Background: Intermittent preventive treatment in infants (IPTi) has been shown to decrease clinical malaria by approximately 30% in the first year of life and is a promising malaria control strategy for Sub-Saharan Africa which can be delivered alongside the Expanded Programme on Immunisation (EPI). To date, there have been limited data on the cost-effectiveness of this strategy using sulfadoxine pyrimethamine (SP) and no published data on cost-effectiveness using other antimalarials. Methods: We analysed data from 5 countries in sub-Saharan Africa using a total of 5 different IPTi drug regimens; SP, mefloquine (MQ), 3 days of chlorproguanil-dapsone (CD), SP plus 3 days of artesunate (SP-AS3) and 3 days of amodiaquine-artesunate (AQ3-AS3). The cost per malaria episode averted and cost per Disability-Adjusted Life-Year (DALY) averted were modeled using both trial specific protective efficacy (PE) for all IPTi drugs and a pooled PE for IPTi with SP, malaria incidence, an estimated malaria case fatality rate of 1.57%, IPTi delivery costs and country specific provider and household malaria treatment costs. Findings: In sites where IPTi had a significant effect on reducing malaria, the cost per episode averted for IPTi-SP was very low, USD 1.36-4.03 based on trial specific data and USD 0.68-2.27 based on the pooled analysis. For IPTi using alternative antimalarials, the lowest cost per case averted was for AQ3-AS3 in western Kenya (USD 4.62) and the highest was for MQ in Korowge, Tanzania (USD 18.56). Where efficacious, based only on intervention costs, IPTi was shown to be cost effective in all the sites and highly cost-effective in all but one of the sites, ranging from USD 2.90 (Ifakara, Tanzania with SP) to USD 39.63 (Korogwe, Tanzania with MQ) per DALY averted. In addition, IPTi reduced health system costs and showed significant savings to households from malaria cases averted. A threshold analysis showed that there is room for the IPTi-efficacy to fall and still remain highly cost effective in all sites where IPTi had a statistically significant effect on clinical malaria. Conclusions: IPTi delivered alongside the EPI is a highly cost effective intervention against clinical malaria with a range of drugs in a range of malaria transmission settings. Where IPTi did not have a statistically significant impact on malaria, generally in low transmission sites, it was not cost effective.	[Conteh, Lesong; Hutton, Guy; Tediosi, Fabrizio; Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Sicuri, Elisa; Aponte, John J.; Egan, Andrea; Alonso, Pedro; Menendez, Clara] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Sicuri, Elisa; Alonso, Pedro; Menendez, Clara] CIBERESP, Barcelona, Spain; [Manzi, Fatuma] IHI, Dar Es Salaam, Tanzania; [Obonyo, Benson; Otieno, Peter; Hamel, Mary; Odhiambo, Frank O.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Tediosi, Fabrizio] Univ Boconni, Milan, Italy; [Masika, Paul] Natl Inst Med Res, Tanga, Tanzania; [Matovu, Fred] Makerere Univ, Fac Econ & Management, Kampala, Uganda; [Conteh, Lesong; Gosling, Roly D.; Chandramohan, Daniel; Schellenberg, David; Slutsker, Laurence; Newman, Robert D.] London Sch Hyg & Trop Med, London WC1, England; [Hamel, Mary] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis, Atlanta, GA USA; [Grobusch, Martin P.] Albert Schweitzer Hosp, Resp Med Unit, Lambarene, Gabon; [Grobusch, Martin P.; Kremsner, Peter G.] Univ Witwatersrand, Sch Med, Fac Hlth Sci, Div Infect Dis, Johannesburg, South Africa; [Grobusch, Martin P.; Kremsner, Peter G.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Macete, Eusebio; Alonso, Pedro; Menendez, Clara] Manhica Hlth Res Ctr, Manhica, Mozambique	University of Basel; Swiss Tropical & Public Health Institute; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Kenya Medical Research Institute; Makerere University; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; University of Witwatersrand; Eberhard Karls University of Tubingen; Centro de Investigacao em Saude de Manhica	Conteh, L (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	lesong.conteh@lshtm.ac.uk	Sicuri, Elisa/L-8012-2014; Tediosi, Fabrizio/ABC-7880-2020; Conteh, Lesong/ABE-9550-2020; Menéndez, Clara/Q-3446-2016; Tediosi, Fabrizio/AAD-4805-2022; Alonso, Pedro L/AAZ-3645-2020; Agyemang, Samuel/H-8377-2014	Sicuri, Elisa/0000-0002-2499-2732; Conteh, Lesong/0000-0002-0719-3672; Menéndez, Clara/0000-0002-2641-6907; Tediosi, Fabrizio/0000-0001-8671-9400; Alonso, Pedro L/0000-0003-3292-3443; Schellenberg, David/0000-0001-8222-0186; MATOVU, FRED/0000-0003-1562-2374	Bill and Melinda Gates Global Health Foundation [38479]	Bill and Melinda Gates Global Health Foundation	The work was funded by the Bill and Melinda Gates Global Health Foundation, Grant Number 38479. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; ANAND S, 1997, J HLTH EC, V6; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], 1996, GLOBAL BURDEN DIS CO; APONTE JJ, 2009, POOLED ANAL 6 IPTI T; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Barbieri M, 2005, VALUE HEALTH, V8, P10, DOI 10.1111/j.1524-4733.2005.03070.x; Bognar G, 2008, ECON PHILOS, V24, P167, DOI 10.1017/S026626710800179X; Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO;2-F; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Brooker S, 2008, HEALTH POLICY PLANN, V23, P24, DOI 10.1093/heapol/czm041; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Chandramohan D, 2007, TROP MED INT HEALTH, V12, P743, DOI 10.1111/j.1365-3156.2007.01844.x; Conteh L, 2004, TROP MED INT HEALTH, V9, P125, DOI 10.1046/j.1365-3156.2003.01150.x; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Egan A, 2005, TROP MED INT HEALTH, V10, P815, DOI 10.1111/j.1365-3156.2005.01474.x; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Grobusch MP, 2007, CURR OPIN INFECT DIS, V20, P613, DOI 10.1097/QCO.0b013e3282f1ae3b; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Hutton G, 2005, HEALTH POLICY PLANN, V20, P252, DOI 10.1093/heapol/czi025; Hutton Guy, 2004, Appl Health Econ Health Policy, V3, P161, DOI 10.2165/00148365-200403030-00007; Hutton G, 2009, B WORLD HEALTH ORGAN, V87, P123, DOI 10.2471/BLT.08.051961; Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036; Johns Benjamin, 2003, Cost Eff Resour Alloc, V1, P1, DOI 10.1186/1478-7547-1-1; *JOINT WHO RBM UNI, 2004, SOUR PRIC SEL PROD P; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Kolaczinski J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-37; Kruger C, 2004, LANCET, V363, P2000, DOI 10.1016/S0140-6736(04)16424-6; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Lord J, 1999, HEALTH ECON, V8, P323, DOI 10.1002/(SICI)1099-1050(199906)8:4<323::AID-HEC431>3.0.CO;2-0; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Manzi F, 2009, T ROY SOC TROP MED H, V103, P79, DOI 10.1016/j.trstmh.2008.08.014; Manzi F, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-165; Mbonye AK, 2008, T ROY SOC TROP MED H, V102, P685, DOI 10.1016/j.trstmh.2008.04.016; Menendez C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-132; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Mushi AK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-191; Odhiambo FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010016; Phillips M, 1996, PHARMACOECONOMICS, V10, P225, DOI 10.2165/00019053-199610030-00004; Pool R, 2006, TROP MED INT HEALTH, V11, P1670, DOI 10.1111/j.1365-3156.2006.01725.x; Pool R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-213; Ross A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002661; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Sachs JD, 2001, MACR HLTH INV HLTH E; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Sculpher MJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; TAN-TORRES TE, 2003, MAKING CHOICES HLTH; TANTORRES, 2005, BMJ, V331; Temperley M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-196; WHO, 1996, INV HLTH RES DEV; *WHO, 2008, LIF TABL WHO MEMB ST; *WORLD BANK, 1993, WORLD DEV REP; Yeung S, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.179; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258; 2007, INT DRUG PRICE INDIC	59	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e10313	10.1371/journal.pone.0010313	http://dx.doi.org/10.1371/journal.pone.0010313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	610YF	20559558	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000278775900001
J	Lund, JP; Sadeghi, S; Athanassiadis, T; Salas, NC; Auclair, F; Thivierge, B; Arsenault, I; Rompre, P; Westberg, KG; Kolta, A				Lund, James P.; Sadeghi, Somayeh; Athanassiadis, Tuija; Salas, Nadia Caram; Auclair, Francois; Thivierge, Benoit; Arsenault, Isabel; Rompre, Pierre; Westberg, Karl-Gunnar; Kolta, Arlette			Assessment of the Potential Role of Muscle Spindle Mechanoreceptor Afferents in Chronic Muscle Pain in the Rat Masseter Muscle	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; METABOTROPIC GLUTAMATE RECEPTORS; PRIMARY SENSORY NEURONS; MESENCEPHALIC-V NEURONS; C-FOS; MECHANICAL ALLODYNIA; TRIGEMINAL NEURONS; NEUROPATHIC PAIN; JAW-MUSCLE; GROUP-I	Background: The phenotype of large diameter sensory afferent neurons changes in several models of neuropathic pain. We asked if similar changes also occur in "functional'' pain syndromes. Methodology/Principal Findings: Acidic saline (AS, pH 4.0) injections into the masseter muscle were used to induce persistent myalgia. Controls received saline at pH 7.2. Nocifensive responses of Experimental rats to applications of Von Frey Filaments to the masseters were above control levels 1-38 days post-injection. This effect was bilateral. Expression of c-Fos in the Trigeminal Mesencephalic Nucleus (NVmes), which contains the somata of masseter muscle spindle afferents (MSA), was above baseline levels 1 and 4 days after AS. The resting membrane potentials of neurons exposed to AS (n = 167) were hyperpolarized when compared to their control counterparts (n = 141), as were their thresholds for firing, high frequency membrane oscillations (HFMO), bursting, inward and outward rectification. The amplitude of HFMO was increased and spontaneous ectopic firing occurred in 10% of acid-exposed neurons, but never in Controls. These changes appeared within the same time frame as the observed nocifensive behaviour. Ectopic action potentials can travel centrally, but also antidromically to the peripheral terminals of MSA where they could cause neurotransmitter release and activation of adjacent fibre terminals. Using immunohistochemistry, we confirmed that annulospiral endings of masseter MSA express the glutamate vesicular transporter VGLUT1, indicating that they can release glutamate. Many capsules also contained fine fibers that were labelled by markers associated with nociceptors (calcitonin gene-related peptide, Substance P, P2X3 receptors and TRPV1 receptors) and that expressed the metabotropic glutamate receptor, mGluR5. Antagonists of glutamatergic receptors given together with the 2(nd) injection of AS prevented the hypersensitivity observed bilaterally but were ineffective if given contralaterally. Conclusions/Significance: Low pH leads to changes in several electrical properties of MSA, including initiation of ectopic action potentials which could propagate centrally but could also invade the peripheral endings causing glutamate release and activation of nearby nociceptors within the spindle capsule. This peripheral drive could contribute both to the transition to, and maintenance of, persistent muscle pain as seen in some "functional'' pain syndromes.	[Lund, James P.; Auclair, Francois; Arsenault, Isabel; Kolta, Arlette] Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent Fonds Rech Sante Quebe, Montreal, PQ H3C 3J7, Canada; [Thivierge, Benoit; Rompre, Pierre; Kolta, Arlette] Univ Montreal, Dept Stomatol, Montreal, PQ, Canada; [Lund, James P.; Sadeghi, Somayeh; Salas, Nadia Caram; Kolta, Arlette] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Athanassiadis, Tuija; Westberg, Karl-Gunnar] Umea Univ, Physiol Sect, Dept Integrat Med Biol, Umea, Sweden	Universite de Montreal; Universite de Montreal; McGill University; Umea University		arlette.kolta@umontreal.ca	Caram-Salas, Nadia L/F-1977-2019; Salas, Nadia Lizeth Caram/AAG-4767-2020	Salas, Nadia Lizeth Caram/0000-0002-1894-9498; Auclair, Francois/0000-0001-7617-4056	Canadian Institute of Health Research [15176]; Fonds de la Recherche en Sante du Quebec [5249]; Louise and Alan Edwards Foundation [217171]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Louise and Alan Edwards Foundation	Canadian Institute of Health Research, grant number 15176, Fonds de la Recherche en Sante du Quebec, grant number 5249, and The Louise and Alan Edwards Foundation, grant number 217171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOEV GN, 1988, MECHANORECEPTORS THE, P198; Ambalavanar R, 2007, NEUROSCIENCE, V149, P650, DOI 10.1016/j.neuroscience.2007.07.058; Ambalavanar R, 2005, PAIN, V117, P280, DOI 10.1016/j.pain.2005.06.029; Ambalavanar R, 2003, J COMP NEUROL, V460, P167, DOI 10.1002/cne.10655; Amir R, 2005, J NEUROSCI, V25, P2576, DOI 10.1523/JNEUROSCI.4118-04.2005; Amir R, 1999, J NEUROSCI, V19, P8589; Amir R, 2002, J NEUROSCI, V22, P1187, DOI 10.1523/JNEUROSCI.22-03-01187.2002; Amir R, 1997, J PHYSIOL-LONDON, V501, P183, DOI 10.1111/j.1469-7793.1997.183bo.x; Barbe MF, 2006, BRAIN BEHAV IMMUN, V20, P423, DOI 10.1016/j.bbi.2006.03.001; Barden JA, 2000, NEUROSCI LETT, V287, P183, DOI 10.1016/S0304-3940(00)01150-2; Barlas P, 2000, PAIN, V87, P221, DOI 10.1016/S0304-3959(00)00287-6; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bewick GS, 2005, J PHYSIOL-LONDON, V562, P381, DOI 10.1113/jphysiol.2004.074799; Bhave G, 2001, NAT NEUROSCI, V4, P417, DOI 10.1038/86075; Bombardi C, 2006, TISSUE CELL, V38, P121, DOI 10.1016/j.tice.2005.12.003; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Carlton S M, 2001, Curr Opin Pharmacol, V1, P52, DOI 10.1016/S1471-4892(01)00002-9; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chizh BA, 2001, PHARMACOL REV, V53, P553; Connor M, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-31; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Corbin KB, 1940, J NEUROPHYSIOL, V3, P423, DOI 10.1152/jn.1940.3.5.423; DECAMILLI P, 1988, J NEUROSCI, V8, P1625; DelNegro CA, 1997, J NEUROPHYSIOL, V77, P537; Devor M, 2005, WALL MELZACKS TXB PA, P905; Devor M, 2009, EXP BRAIN RES, V196, P115, DOI 10.1007/s00221-009-1724-6; Dogrul A, 2000, NEUROSCI LETT, V292, P115, DOI 10.1016/S0304-3940(00)01458-0; Dong XD, 2006, NEUROSCIENCE, V141, P939, DOI 10.1016/j.neuroscience.2006.04.024; Dong XD, 2007, NEUROSCIENCE, V146, P822, DOI 10.1016/j.neuroscience.2007.01.051; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; DRAISCI G, 1989, MOL BRAIN RES, V6, P31, DOI 10.1016/0169-328X(89)90025-9; Fields RD, 1997, J NEUROSCI, V17, P7252; Gerke MB, 2001, BRAIN RES, V911, P101, DOI 10.1016/S0006-8993(01)02750-0; Gossard JP, 1999, BRAIN RES, V825, P132, DOI 10.1016/S0006-8993(99)01236-6; GRACELY RH, 1992, PAIN, V51, P175, DOI 10.1016/0304-3959(92)90259-E; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; HOHEISEL U, 1994, ANAT EMBRYOL, V189, P41; HOOD VL, 1988, AM J PHYSIOL, V255, P479; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; Jin YH, 2009, J PHARMACOL SCI, V109, P233, DOI 10.1254/jphs.08262FP; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kellgren JH, 1938, CLIN SCI, V3, P175; Khakh BS, 1998, J PHYSIOL-LONDON, V510, P695, DOI 10.1111/j.1469-7793.1998.00695.x; Kim YS, 2008, J COMP NEUROL, V506, P627, DOI 10.1002/cne.21544; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; Klis SFL, 2000, NEUROREPORT, V11, P623, DOI 10.1097/00001756-200002280-00037; KOPIN IJ, 1972, PHARMACOL REV, V24, P245; KRUGER L, 1989, J COMP NEUROL, V280, P291, DOI 10.1002/cne.902800210; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Lee HJ, 2006, BRAIN RES BULL, V70, P378, DOI 10.1016/j.brainresbull.2005.09.021; Lee J, 2007, NEUROSCI LETT, V421, P91, DOI 10.1016/j.neulet.2007.05.031; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; LUO PF, 1995, J COMP NEUROL, V358, P63, DOI 10.1002/cne.903580104; Matthews PBC, 1972, MAMMALIAN MUSCLE REC, P630; Mayer E.A., 2009, FUNCTIONAL PAIN SYND; MCCARTHY PW, 1990, NEUROSCIENCE, V34, P623, DOI 10.1016/0306-4522(90)90169-5; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Munoz A, 1999, J COMP NEUROL, V409, P549; NORDIN M, 1984, PAIN, V20, P231, DOI 10.1016/0304-3959(84)90013-7; Pang YW, 2006, J COMP NEUROL, V498, P129, DOI 10.1002/cne.21047; Pare M, 2001, J NEUROSCI, V21, P7236, DOI 10.1523/JNEUROSCI.21-18-07236.2001; Pedroarena CM, 1999, J NEUROPHYSIOL, V82, P1465, DOI 10.1152/jn.1999.82.3.1465; PUIL E, 1988, NEUROSCIENCE, V24, P635, DOI 10.1016/0306-4522(88)90357-0; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Ren K, 1999, PHYSIOL BEHAV, V67, P711, DOI 10.1016/S0031-9384(99)00136-5; Ro JY, 2007, EUR J PAIN, V11, P398, DOI 10.1016/j.ejpain.2006.05.008; Rosendal L, 2004, PAIN, V112, P324, DOI 10.1016/j.pain.2004.09.017; RUSSELL LC, 1988, SOMATOSENS MOT RES, V6, P163, DOI 10.3109/08990228809144672; SANTINI M, 1971, BRAIN RES, V33, P289, DOI 10.1016/0006-8993(71)90104-1; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sluka KA, 2002, J PHARMACOL EXP THER, V302, P1146, DOI 10.1124/jpet.102.033167; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; Sohn MK, 2000, MUSCLE NERVE, V23, P1219, DOI 10.1002/1097-4598(200008)23:8<1219::AID-MUS10>3.0.CO;2-A; Staikopoulos V, 2007, NEUROSCIENCE, V144, P208, DOI 10.1016/j.neuroscience.2006.09.035; Stohler CS, 1992, BIOL MECH TOOTH MOVE, P503; Sukhotinsky I, 2004, EUR J PAIN, V8, P135, DOI 10.1016/S1090-3801(03)00086-7; Svensson P, 1998, J OROFAC PAIN, V12, P7; Svensson P, 2003, PAIN, V101, P221, DOI 10.1016/S0304-3959(02)00079-9; SZENTAGOTHAI J, 1948, J NEUROPHYSIOL, V11, P445, DOI 10.1152/jn.1948.11.5.445; Taguchi T, 2005, J PHYSIOL-LONDON, V564, P259, DOI 10.1113/jphysiol.2004.079483; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tanaka S, 2003, J NEUROPHYSIOL, V89, P1288, DOI 10.1152/jn.00850.2002; Tegeder I, 2002, INFLAMM RES, V51, P393, DOI 10.1007/PL00000320; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; Tsuboi Y, 2004, PAIN, V111, P323, DOI 10.1016/j.pain.2004.07.014; Turman JE, 2001, DEV NEUROSCI-BASEL, V23, P41, DOI 10.1159/000048695; Verdier D, 2004, J NEUROPHYSIOL, V92, P2444, DOI 10.1152/jn.00279.2004; Walker R E, 2001, Semin Musculoskelet Radiol, V5, P5; WALL PD, 1983, PAIN, V17, P321, DOI 10.1016/0304-3959(83)90164-1; Weerakkody NS, 2001, J PAIN, V2, P209, DOI 10.1054/jpai.2001.22496; Westberg KG, 1997, PAIN, V73, P295, DOI 10.1016/S0304-3959(97)00103-6; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; WILSON POG, 1988, BRIT J EXP PATHOL, V69, P91; Winarakwong L, 2004, ARCH HISTOL CYTOL, V67, P227, DOI 10.1679/aohc.67.227; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Wu NP, 2001, J NEUROSCI, V21, P3729, DOI 10.1523/JNEUROSCI.21-11-03729.2001; Wu SX, 2004, BRAIN RES, V1011, P247, DOI 10.1016/brainres.2004.03.047; XIE YK, 1995, J NEUROPHYSIOL, V73, P1811, DOI 10.1152/jn.1995.73.5.1811; Zhu CZ, 2005, PAIN, V114, P195, DOI 10.1016/j.pain.2004.12.016	102	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11131	10.1371/journal.pone.0011131	http://dx.doi.org/10.1371/journal.pone.0011131			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559566	Green Published, Green Submitted, gold			2022-12-25	WOS:000278775900020
J	Rehle, TM; Hallett, TB; Shisana, O; Pillay-van Wyk, V; Zuma, K; Carrara, H; Jooste, S				Rehle, Thomas M.; Hallett, Timothy B.; Shisana, Olive; Pillay-van Wyk, Victoria; Zuma, Khangelani; Carrara, Henri; Jooste, Sean			A Decline in New HIV Infections in South Africa: Estimating HIV Incidence from Three National HIV Surveys in 2002, 2005 and 2008	PLOS ONE			English	Article							PREVALENCE; INCOME	Background: Three national HIV household surveys were conducted in South Africa, in 2002, 2005 and 2008. A novelty of the 2008 survey was the addition of serological testing to ascertain antiretroviral treatment (ART) use. Methods and Principal Findings: We used a validated mathematical method to estimate the rate of new HIV infections (HIV incidence) in South Africa using nationally representative HIV prevalence data collected in 2002, 2005 and 2008. The observed HIV prevalence levels in 2008 were adjusted for the effect of antiretroviral treatment on survival. The estimated "excess'' HIV prevalence due to ART in 2008 was highest among women 25 years and older and among men 30 years and older. In the period 2002-2005, the HIV incidence rate among men and women aged 15-49 years was estimated to be 2.0 new infections each year per 100 susceptible individuals (/100pyar) (uncertainty range: 1.2-3.0/100pyar). The highest incidence rate was among 15-24 year-old women, at 5.5/100pyar (4.5-6.5). In the period 2005-2008, incidence among men and women aged 15-49 was estimated to be 1.3/100 (0.6-2.5/100pyar), although the change from 2002-2005 was not statistically significant. However, the incidence rate among young women aged 15-24 declined by 60% in the same period, to 2.2/100pyar, and this change was statistically significant. There is evidence from the surveys of significant increases in condom use and awareness of HIV status, especially among youth. Conclusions: Our analysis demonstrates how serial measures of HIV prevalence obtained in population-based surveys can be used to estimate national HIV incidence rates. We also show the need to determine the impact of ART on observed HIV prevalence levels. The estimation of HIV incidence and ART exposure is crucial to disentangle the concurrent impact of prevention and treatment programs on HIV prevalence.	[Rehle, Thomas M.; Shisana, Olive; Pillay-van Wyk, Victoria; Zuma, Khangelani; Carrara, Henri; Jooste, Sean] Human Sci Res Council, Cape Town, South Africa; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, London, England	Human Sciences Research Council-South Africa; Imperial College London	Rehle, TM (corresponding author), Human Sci Res Council, Cape Town, South Africa.	TRehle@hsrc.ac.za	Hallett, Timothy/A-2390-2011; Pillay-van Wyk, Victoria/D-3567-2018	Pillay-van Wyk, Victoria/0000-0001-8772-7197; Hallett, Timothy/0000-0002-9681-0424; Zuma, Khangelani/0000-0003-4492-5083	Nelson Mandela Foundation; Nelson Mandela Children's Fund; Swiss Agency for Development and Cooperation; United States Centers for Disease Control and Prevention (CDC) [CDC-RFA-PS06-614]; United Nations Children's Fund; Wellcome Trust	Nelson Mandela Foundation; Nelson Mandela Children's Fund; Swiss Agency for Development and Cooperation; United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United Nations Children's Fund; Wellcome Trust(Wellcome TrustEuropean Commission)	The 2002 survey was funded by the Nelson Mandela Foundation and the Nelson Mandela Children's Fund, with additional financial support from the Swiss Agency for Development and Cooperation. The 2005 survey was commissioned by the Nelson Mandela Foundation, with additional financial support from the Swiss Agency for Development and Cooperation and the United States Centers for Disease Control and Prevention (CDC). The 2008 survey was funded by the CDC through Funding Opportunity Announcement Number CDC-RFA-PS06-614 of the President's Emergency Plan for AIDS Relief (PEPFAR), with additional financial support from the United Nations Children's Fund. TBH thanks the Wellcome Trust for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; *DEP HLTH S AFR, 2007, NAT STRAT PLAN HIV A; Department of Health (South Africa), 2009, NAT ANT SENT HIV SYP; DODD P, 2009, AIDS IN PRESS; Egger M, 2007, 14 C RETR OPP INF LO; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; GRANICH RM, 2008, LANCET; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI50, DOI 10.1136/sti.2006.023606; Hallett T, 2009, AIDS, V23, P131, DOI 10.1097/QAD.0b013e3283177f59; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kirkwood BR, 2003, ESSENTIAL MED STAT; Koal T, 2005, RAPID COMMUN MASS SP, V19, P2995, DOI 10.1002/rcm.2158; Lewis JJC, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200406002-00005; MARSH KA, 2009, SEX TRANSM INF UNPUB; Marston M, 2008, SEX TRANSM INFECT, V84, pI71, DOI 10.1136/sti.2008.030353; Michelo C, 2008, TROP MED INT HEALTH, V13, P171, DOI 10.1111/j.1365-3156.2007.01987.x; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; REHLE T, 2007, 3 S AFR AIDS C JUN 5; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Shisana O, 2009, S AFRICAN NATL PREVA; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; *UNAIDS, 2005, EV HIV DECL ZIMB COM; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	32	108	112	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11094	10.1371/journal.pone.0011094	http://dx.doi.org/10.1371/journal.pone.0011094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559425	Green Submitted, Green Published, gold			2022-12-25	WOS:000278741100010
J	Li, X; Shridas, P; Forrest, K; Bailey, W; Webb, NR				Li, Xia; Shridas, Preetha; Forrest, Kathy; Bailey, William; Webb, Nancy R.			Group X secretory phospholipase A(2) negatively regulates adipogenesis in murine models	FASEB JOURNAL			English	Article						obesity; arachidonic acid; nuclear receptor	ACTIVATED-RECEPTOR-GAMMA; ELEMENT-BINDING PROTEIN-1; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; IN-VIVO; DENSITY-LIPOPROTEIN; PROMOTER ACTIVITY; CELL FUNCTION; PPAR-GAMMA	Studies in vitro indicate that group X secretory phospholipase A(2) (GX sPLA(2)) potently releases arachidonic acid (AA) and lysophosphatidylcholine from mammalian cell membranes. To define the function of GX sPLA(2) in vivo, our laboratory recently generated C57BL/6 mice with targeted deletion of GX sPLA(2) (GX(-/-) mice). When fed a normal rodent diet, GX(-/-) mice gained significantly more weight and had increased adiposity compared to GX(+/+) mice, which was not attributable to alterations in food consumption or energy expenditure. When treated with adipogenic stimuli ex vivo, stromal vascular cells isolated from adipose tissue of GX(-/-) mice accumulated significantly more (20%) triglyceride compared to cells from GX(+/+) mice. Conversely, overexpression of GX sPLA(2), but not catalytically inactive GX sPLA(2), resulted in a significant 50% reduction in triglyceride accumulation in OP9 adipocytes. The induction of genes encoding adipogenic proteins (PPAR gamma, SREBP-1c, SCD1, and FAS) was also significantly blunted by 50-80% in OP9 cells overexpressing GX sPLA(2). Activation of the liver X receptor (LXR), a nuclear receptor known to up-regulate adipogenic gene expression, was suppressed in 3T3-L1 and OP9 cells when GX sPLA(2) was overexpressed. Thus, hydrolytic products generated by GX sPLA(2) negatively regulate adipogenesis, possibly by suppressing LXR activation.-Li, X., Shridas, P., Forrest, K., Bailey, W., Webb, N. R. Group X secretory phospholipase A(2) negatively regulates adipogenesis in murine models. FASEB J. 24, 4313-4324 (2010). www.fasebj.org	[Li, Xia; Webb, Nancy R.] Univ Kentucky, Grad Ctr Nutr Sci, Med Ctr, Lexington, KY 40536 USA; [Shridas, Preetha; Forrest, Kathy; Bailey, William; Webb, Nancy R.] Univ Kentucky, Dept Internal Med, Div Endocrinol, Med Ctr, Lexington, KY 40536 USA; [Shridas, Preetha; Forrest, Kathy; Bailey, William; Webb, Nancy R.] Univ Kentucky, Med Ctr, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Webb, Nancy R.] Dept Vet Affairs Med Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Webb, NR (corresponding author), Univ Kentucky, Grad Ctr Nutr Sci, Med Ctr, Rm 535,CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA.	nrwebb1@uky.edu	Webb, Nancy/AAL-7030-2021		U.S. National Institutes of Health [RO1 DK082419]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082419] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this study was supported by U.S. National Institutes of Health grant RO1 DK082419 (to N.R.W.). This article is the result of work supported with resources and the use of facilities at the Lexington Veterans Affairs Medical Center.	Boyanovsky BB, 2009, CARDIOVASC DRUG THER, V23, P61, DOI 10.1007/s10557-008-6134-7; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Darimont C, 2006, BIOCHIMIE, V88, P309, DOI 10.1016/j.biochi.2005.08.010; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Elberg G, 2000, J BIOL CHEM, V275, P27815; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Gerin I, 2005, J BIOL CHEM, V280, P23024, DOI 10.1074/jbc.M412564200; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; Hauner H, 2004, PHYSIOL BEHAV, V83, P653, DOI 10.1016/j.physbeh.2004.09.016; Hui DY, 2009, BRIT J PHARMACOL, V157, P1263, DOI 10.1111/j.1476-5381.2009.00308.x; Hummasti S, 2004, J LIPID RES, V45, P616, DOI 10.1194/jlr.M300312-JLR200; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Karabina SA, 2006, FASEB J, V20, P2547, DOI 10.1096/fj.06-6018fje; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; Labonte ED, 2010, FASEB J, V24, P2516, DOI 10.1096/fj.09-144436; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lawson MA, 2009, J ADOLESCENT HEALTH, V44, P94, DOI 10.1016/j.jadohealth.2008.06.007; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Shridas P, 2010, J BIOL CHEM, V285, P20031, DOI 10.1074/jbc.M109.090423; Simon MF, 2005, J BIOL CHEM, V280, P14656, DOI 10.1074/jbc.M412585200; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Steffensen KR, 2003, BIOCHEM BIOPH RES CO, V310, P589, DOI 10.1016/j.bbrc.2003.08.139; Takeuchi Y, 2010, J BIOL CHEM, V285, P11681, DOI 10.1074/jbc.M109.096107; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Triggiani M, 2006, BBA-MOL CELL BIOL L, V1761, P1289, DOI 10.1016/j.bbalip.2006.07.003; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	55	26	26	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2010	24	11					4313	4324		10.1096/fj.10-154716	http://dx.doi.org/10.1096/fj.10-154716			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	675UA	20585029	Green Published			2022-12-25	WOS:000283861100019
J	Lu, XL; Shi, Y; Lu, QL; Ma, Y; Luo, J; Wang, QS; Ji, JG; Jiang, Q; Zhang, CM				Lu, Xuelong; Shi, Yang; Lu, Quanlong; Ma, Yan; Luo, Jia; Wang, Qingsong; Ji, Jianguo; Jiang, Qing; Zhang, Chuanmao			Requirement for Lamin B Receptor and Its Regulation by Importin beta and Phosphorylation in Nuclear Envelope Assembly during Mitotic Exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN LBR; RAN GTPASE; BINDING-PROTEIN; CHROMODOMAIN PROTEINS; LOCALIZATION SIGNAL; INTEGRAL PROTEIN; IN-VIVO; CHROMATIN; MUTATIONS; MITOSIS	Lamin B receptor (LBR), a chromatin and lamin B-binding protein in the inner nuclear membrane, has been proposed to target the membrane precursor vesicles to chromatin mediated by importin beta during the nuclear envelope (NE) assembly. However, the mechanisms for the binding of LBR with importin beta and the membrane targeting by LBR in NE assembly remain largely unknown. In this report, we show that the amino acids (aa) 69-90 of LBR sequences are required to bind with importin beta at aa 45-462, and the binding is essential for the NE membrane precursor vesicle targeting to the chromatin during the NE assembly at the end of mitosis. We also show that this binding is cell cycle-regulated and dependent on the phosphorylation of LBR Ser-71 by p34(cdc2) kinase. RNAi knockdown of LBR causes the NE assembly failure and abnormal chromatin decondensation of the daughter cell nuclei, leading to the daughter cell death at early G(1) phase by apoptosis. Perturbation of the interaction of LBR with importin beta by deleting the LBR N-terminal spanning region or aa 69-73 also induces the NE assembly failure, the abnormal chromatin decondensation, and the daughter cell death. The first transmembrane domain of LBR promotes the NE production and expansion, because overexpressing this domain is sufficient to induce membrane overproduction of the NE. Thus, these results demonstrate that LBR targets the membrane precursor vesicles to chromatin by interacting with importin beta in a LBR phosphorylation-dependent manner during the NE assembly at the end of mitosis and that the first transmembrane domain of LBR promotes the LBR-bearing membrane production and the NE expansion in interphase.	[Lu, Xuelong; Shi, Yang; Lu, Quanlong; Ma, Yan; Luo, Jia; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Lu, Xuelong; Shi, Yang; Lu, Quanlong; Ma, Yan; Luo, Jia; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Bioengn, Beijing 100871, Peoples R China; [Wang, Qingsong; Ji, Jianguo] Peking Univ, Coll Life Sci, State Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Zhang, CM (corresponding author), Peking Univ, Coll Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.	zhangcm@pku.edu.cn	Lu, Quanlong/M-4436-2015	Lu, Quanlong/0000-0002-4261-5121	National Natural Science Foundation of China [30721064, 31030044, 31971188, 30900726, 90913021, 90919023]; State Key Basic Research and Development Plan [2010CB833705, 2007CB914502, 2006CB910101, 2010CB912203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research and Development Plan	This work was supported by the National Natural Science Foundation of China (Grants 30721064, 31030044, 31971188, 30900726, 90913021, and 90919023) and by the State Key Basic Research and Development Plan (Grants 2010CB833705, 2007CB914502, 2006CB910101, and 2010CB912203).	APPELBAUM J, 1990, J BIOL CHEM, V265, P4181; Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Best S, 2003, BRIT J HAEMATOL, V123, P542, DOI 10.1046/j.1365-2141.2003.04621.x; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Cohen TV, 2008, BIOCHEM SOC T, V36, P1329, DOI 10.1042/BST0361329; Collas P, 1996, J CELL BIOL, V135, P1715, DOI 10.1083/jcb.135.6.1715; COURVALIN JC, 1992, J BIOL CHEM, V267, P19035; Delmar VA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-14; DREGER M, 2004, S SOC EXP BIOL, V9; Duband-Goulet I, 1998, J CELL SCI, V111, P1441; Duband-Goulet I, 2000, BIOCHEMISTRY-US, V39, P6483, DOI 10.1021/bi992908b; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; Foisner Roland, 2003, ScientificWorldJournal, V3, P1; Forwood JK, 2001, BIOCHEMISTRY-US, V40, P5208, DOI 10.1021/bi002732+; Gaines P, 2008, EXP HEMATOL, V36, P965, DOI 10.1016/j.exphem.2008.04.006; Gajewski A, 1999, J CELL SCI, V112, P2583; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; GOLDBERG M, 2004, S SOC EXP BIOL, V115; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guarda A, 2009, EXP CELL RES, V315, P1895, DOI 10.1016/j.yexcr.2009.01.019; Haraguchi T, 2000, J CELL SCI, V113, P779; Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; HARTL P, 1994, J CELL BIOL, V124, P235, DOI 10.1083/jcb.124.3.235; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Hoffmann K, 2007, CHROMOSOMA, V116, P227, DOI 10.1007/s00412-007-0094-8; Hughes M, 1998, J CELL SCI, V111, P3017; Irons SL, 2003, J EXP BOT, V54, P943, DOI 10.1093/jxb/erg102; Ito H, 2007, EXP CELL RES, V313, P1897, DOI 10.1016/j.yexcr.2007.03.015; Kabuta T, 2008, BIOCHEM BIOPH RES CO, V377, P741, DOI 10.1016/j.bbrc.2008.09.106; Kawahire S, 1997, J BIOCHEM-TOKYO, V121, P881, DOI 10.1093/oxfordjournals.jbchem.a021669; Kushibiki S, 2001, J DAIRY RES, V68, P579, DOI 10.1017/S0022029901005040; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; MEIER J, 1994, EMBO J, V13, P1888, DOI 10.1002/j.1460-2075.1994.tb06458.x; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Mylonis I, 2004, J BIOL CHEM, V279, P11626, DOI 10.1074/jbc.M311949200; Nikolakaki E, 1997, J BIOL CHEM, V272, P6208, DOI 10.1074/jbc.272.10.6208; Nikolakaki E, 1996, J BIOL CHEM, V271, P8365, DOI 10.1074/jbc.271.14.8365; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Polioudaki H, 2001, EMBO REP, V2, P920, DOI 10.1093/embo-reports/kve199; Pyrpasopoulou A, 1996, EMBO J, V15, P7108, DOI 10.1002/j.1460-2075.1996.tb01102.x; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Sambrook J, 2001, MOL CLONING LAB MANU; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Shultz LD, 2003, HUM MOL GENET, V12, P61, DOI 10.1093/hmg/ddg003; SIMOS G, 1992, EMBO J, V11, P4027, DOI 10.1002/j.1460-2075.1992.tb05496.x; SMITH S, 1993, J CELL BIOL, V120, P631, DOI 10.1083/jcb.120.3.631; SMITH S, 1994, P NATL ACAD SCI USA, V91, P10124, DOI 10.1073/pnas.91.21.10124; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; Takano M, 2004, J BIOL CHEM, V279, P13265, DOI 10.1074/jbc.M308854200; Takano M, 2002, EUR J BIOCHEM, V269, P943, DOI 10.1046/j.0014-2956.2001.02730.x; Takizawa CG, 1999, P NATL ACAD SCI USA, V96, P7938, DOI 10.1073/pnas.96.14.7938; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; WORMAN HJ, 1990, J CELL BIOL, V111, P1535, DOI 10.1083/jcb.111.4.1535; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; YE Q, 1994, J BIOL CHEM, V269, P11306; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 1996, J CELL SCI, V109, P2275; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288; Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5; Zhang CM, 2001, CURR BIOL, V11, P208, DOI 10.1016/S0960-9822(01)00053-7; Zwerger M, 2008, EXP HEMATOL, V36, P977, DOI 10.1016/j.exphem.2008.03.003	76	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33281	33293		10.1074/jbc.M110.102368	http://dx.doi.org/10.1074/jbc.M110.102368			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20576617	Green Published, hybrid			2022-12-25	WOS:000283048200064
J	Canning, BJ; Mori, N				Canning, Brendan J.; Mori, Nanako			An essential component to brainstem cough gating identified in anesthetized guinea pigs	FASEB JOURNAL			English	Article						solitary tract; capsaicin; respiration; C fiber; bradykinin	NUCLEUS-TRACTUS-SOLITARIUS; AFFERENT NERVE SUBTYPES; EXCITATORY AMINO-ACIDS; RECEPTOR RELAY NEURONS; AXONAL HORSERADISH-PEROXIDASE; RAPIDLY ADAPTING RECEPTORS; SYNERGISTIC INTERACTIONS; CONVERGENCE PROPERTIES; MEDULLARY PROJECTIONS; SENSORY GANGLIA	Coughing protects and clears the airways and lungs of inhaled irritants, particulates, pathogens, and accumulated secretions. An initial urge to cough, and an almost binary output suggests gating mechanisms that encode and modulate this defensive reflex. Whether this "gate" has a physical location for the physiological barrier it poses to cough is unknown. Here we describe a critical component to cough gating, the central terminations of the cough receptors. A novel microinjection strategy defined coordinates for microinjection of glutamate receptor antagonists that nearly abolished cough evoked from the trachea and larynx in anesthetized guinea pigs while having no effect on basal respiratory rate and little or no effect on reflexes attributed to activating other afferent nerve subtypes. Comparable microinjections in adjacent brainstem locations (0.5-2 mm distal) were without effect on coughing. Subsequent transganglionic and dual tracing studies confirmed that the central terminations of the cough receptors and their primary relay neurons are found bilaterally within nucleus tractus solitarius (nTS), lateral to the commissural subnucleus and perhaps in the medial subnuclei. These synapses possess the physiological characteristics of a cough gate. Their localization should facilitate more mechanistic studies of the encoding and gating of cough.-Canning, B. J., Nanako Mori. An essential component to brainstem cough gating identified in anesthetized guinea pigs. FASEB J. 24, 3916-3926 (2010). www.fasebj.org	[Canning, Brendan J.; Mori, Nanako] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Canning, BJ (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	bjc@jhmi.edu	Canning, Brendan/AAM-9404-2021; Canning, Brendan/ABE-5261-2020	Canning, Brendan/0000-0003-4197-5560; 	National Institutes of Health (Bethesda, MD, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083192] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research described in this manuscript was funded by a grant (HL083192) from the National Institutes of Health (Bethesda, MD, USA).	Allen WF, 1923, J COMP NEUROL, V35, P171, DOI 10.1002/cne.900350204; Allen WF, 1923, J COMP NEUROL, V35, P275, DOI 10.1002/cne.900350403; ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; Aylwin ML, 1997, J NEUROPHYSIOL, V77, P2539, DOI 10.1152/jn.1997.77.5.2539; Bolser DC, 2006, RESP PHYSIOL NEUROBI, V152, P255, DOI 10.1016/j.resp.2006.01.008; BONHAM AC, 1993, J PHYSIOL-LONDON, V464, P725, DOI 10.1113/jphysiol.1993.sp019660; BONHAM AC, 1991, J PHYSIOL-LONDON, V441, P95, DOI 10.1113/jphysiol.1991.sp018740; BONHAM AC, 1990, J PHYSIOL-LONDON, V427, P261, DOI 10.1113/jphysiol.1990.sp018171; Canning BJ, 2004, J PHYSIOL-LONDON, V557, P543, DOI 10.1113/jphysiol.2003.057885; Canning BJ, 2008, LUNG, V186, pS23, DOI 10.1007/s00408-007-9054-6; Canning BJ, 2006, RESP PHYSIOL NEUROBI, V152, P223, DOI 10.1016/j.resp.2006.03.001; Canning BJ, 2006, AM J PHYSIOL-REG I, V291, pR454, DOI 10.1152/ajpregu.00862.2005; Canning BJ, 2009, PULM PHARMACOL THER, V22, P75, DOI 10.1016/j.pupt.2009.01.003; Canning BJ, 2008, PULM PHARMACOL THER, V21, P702, DOI 10.1016/j.pupt.2008.01.004; Chianca DA, 1996, BRAIN RES, V718, P185, DOI 10.1016/0006-8993(96)00010-8; Chou YL, 2008, AM J PHYSIOL-REG I, V295, pR1572, DOI 10.1152/ajpregu.90382.2008; CHRISTIAN EP, 1993, J NEUROSCI METH, V47, P147, DOI 10.1016/0165-0270(93)90031-L; DAVIES A, 1981, J PHYSIOL-LONDON, V318, P17; DAVIES RO, 1986, J PHYSIOL-LONDON, V373, P63, DOI 10.1113/jphysiol.1986.sp016035; DAVIES RO, 1987, J PHYSIOL-LONDON, V383, P571; DEKIN MS, 1987, J NEUROPHYSIOL, V58, P195, DOI 10.1152/jn.1987.58.1.195; Doyle MW, 2004, J NEUROSCI METH, V137, P37, DOI 10.1016/j.jneumeth.2004.02.007; EZURE K, 1991, BRAIN RES, V564, P268, DOI 10.1016/0006-8993(91)91463-B; Ezure K, 1999, EXP BRAIN RES, V128, P471, DOI 10.1007/s002210050870; Gestreau C, 1997, J NEUROSCI, V17, P9340; GREEN JF, 1990, J APPL PHYSIOL, V68, P2186, DOI 10.1152/jappl.1990.68.5.2186; Haxhiu MA, 2000, J AUTONOM NERV SYST, V80, P22, DOI 10.1016/S0165-1838(99)00088-0; Irwin RS, 2006, CHEST, V129, p1S, DOI 10.1378/chest.129.1_suppl.1S; Jakus J, 2008, RESP PHYSIOL NEUROBI, V160, P289, DOI 10.1016/j.resp.2007.10.014; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; KALIA M, 1988, J COMP NEUROL, V274, P560, DOI 10.1002/cne.902740406; KALIA M, 1985, J COMP NEUROL, V241, P521, DOI 10.1002/cne.902410410; KALIA M, 1988, J COMP NEUROL, V274, P574, DOI 10.1002/cne.902740407; KALIA M, 1985, J COMP NEUROL, V241, P503, DOI 10.1002/cne.902410409; KARIUS DR, 1994, J APPL PHYSIOL, V76, P1293, DOI 10.1152/jappl.1994.76.3.1293; Kollarik M, 2002, J PHYSIOL-LONDON, V543, P591, DOI 10.1113/jphysiol.2002.022848; KUBIN L, 1991, J PHYSIOL-LONDON, V435, P207, DOI 10.1113/jphysiol.1991.sp018506; Kubin L, 2006, J APPL PHYSIOL, V101, P618, DOI 10.1152/japplphysiol.00252.2006; LIPSKI J, 1991, J PHYSIOL-LONDON, V443, P55, DOI 10.1113/jphysiol.1991.sp018822; Lu WY, 1998, AM J PHYSIOL-REG I, V274, pR1436; Mazzone SB, 2005, J PHYSIOL-LONDON, V569, P559, DOI 10.1113/jphysiol.2005.093153; Mazzone SB, 2002, AM J PHYSIOL-REG I, V283, pR86, DOI 10.1152/ajpregu.00007.2002; Mazzone SB, 2009, J NEUROSCI, V29, P13662, DOI 10.1523/JNEUROSCI.4354-08.2009; Mazzone Stuart B, 2008, Cough, V4, P9, DOI 10.1186/1745-9974-4-9; MIFFLIN SW, 1988, J PHYSIOL-LONDON, V399, P349; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Mutolo D, 2008, AM J PHYSIOL-REG I, V295, pR243, DOI 10.1152/ajpregu.00184.2008; Mutolo D, 2007, BRAIN RES BULL, V74, P284, DOI 10.1016/j.brainresbull.2007.07.001; Mutolo D, 2009, BRAIN RES BULL, V80, P22, DOI 10.1016/j.brainresbull.2009.05.022; Ohi Y, 2007, NEUROSCIENCE, V146, P1425, DOI 10.1016/j.neuroscience.2007.02.052; Ohi Y, 2005, NEUROSCI RES, V53, P201, DOI 10.1016/j.neures.2005.06.016; OTAKE K, 1992, J COMP NEUROL, V324, P365, DOI 10.1002/cne.903240307; Paton JFR, 1998, J PHYSIOL-LONDON, V508, P237, DOI 10.1111/j.1469-7793.1998.237br.x; PISARRI TE, 1986, RESP PHYSIOL, V64, P29, DOI 10.1016/0034-5687(86)90058-7; Riccio MM, 1996, J PHYSIOL-LONDON, V496, P521, DOI 10.1113/jphysiol.1996.sp021703; Seagard JL, 1999, J PHYSIOL-LONDON, V520, P243, DOI 10.1111/j.1469-7793.1999.00243.x; Sekizawa SI, 2008, EUR J NEUROSCI, V28, P771, DOI 10.1111/j.1460-9568.2008.06378.x; Silva-Carvalho L, 1998, J NEUROPHYSIOL, V79, P2374, DOI 10.1152/jn.1998.79.5.2374; VARDHAN A, 1993, BRAIN RES, V618, P23, DOI 10.1016/0006-8993(93)90424-L; Wank M, 2001, J COMP NEUROL, V435, P41, DOI 10.1002/cne.1192; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P55, DOI 10.1113/jphysiol.1954.sp005033; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P71, DOI 10.1113/jphysiol.1954.sp005034; Wilson CG, 1996, J PHYSIOL-LONDON, V496, P773, DOI 10.1113/jphysiol.1996.sp021726	63	52	54	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2010	24	10					3916	3926		10.1096/fj.09-151068	http://dx.doi.org/10.1096/fj.09-151068			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20581226	Green Published			2022-12-25	WOS:000285005900029
J	Cruse, G; Kaur, D; Leyland, M; Bradding, P				Cruse, Glenn; Kaur, Davinder; Leyland, Mark; Bradding, Peter			A novel Fc epsilon RI beta-chain truncation regulates human mast cell proliferation and survival	FASEB JOURNAL			English	Article						MS4A2; IgE receptor; cell cycle; G2 phase; cell membrane	CD20; ACTIVATION; RECEPTOR; IGE; IDENTIFICATION; EXPRESSION; HTM4; PROGRESSION; TRYPTASE; CHANNELS	Mast cells contribute to allergy through IgE-dependent activation via the high-affinity IgE receptor Fc epsilon RI. The role of the Fc epsilon RI beta chain (MS4A2) in mast cell function is not understood fully, although it serves to amplify Fc epsilon RI-dependent signaling. We demonstrate the expression of a novel MS4A2 truncation lacking exon 3 in human mast cells termed MS4A2(trunc). MS4A2(trunc) gene expression was regulated negatively by the mast cell growth factor stem cell factor (SCF), and its expression was not detected in the SCF receptor gain-of-function human mast cell line HMC-1. Unlike MS4A2, MS4A2(trunc) did not traffic to the cytoplasmic membrane but instead was associated with the nuclear membrane. Overexpression of MS4A2(trunc) induced human lung mast cell death and profoundly inhibited HMC-1 cell proliferation by inducing G(2)-phase cell cycle arrest and apoptosis. Thus, we have identified a novel splice variant of MS4A2 that might be important in the regulation of human mast cell proliferation and survival. This finding demonstrates that the MS4A2 gene has multiple roles, extending beyond the regulation of acute allergic responses. By understanding the mechanisms regulating its function, it might be possible to induce its expression in mast cells in vivo, which could lead to better treatments for diseases such as mastocytosis and asthma.-Cruse, G., Kaur, D., Leyland, M., Bradding, P. A novel Fc epsilon RI beta-chain truncation regulates human mast cell proliferation and survival. FASEB J. 24, 4047-4057 (2010). www.fasebj.org	[Leyland, Mark] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Cruse, Glenn; Kaur, Davinder; Bradding, Peter] Glenfield Gen Hosp, Inst Lung Hlth, Dept Infect Immun & Inflammat, Glenfield, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Cruse, G (corresponding author), NIAID, Lab Allerg Dis, NIH, Bldg 10,Rm 11C205,10 Ctr Dr,MSC 1881, Bethesda, MD 20892 USA.	glenncruse@hotmail.com	Cruse, Glenn/B-4597-2012; Cruse, Glenn/AAZ-1093-2021	Bradding, Peter/0000-0001-8403-0319; Cruse, Glenn/0000-0002-7511-0082	Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	This study was funded in part by an unrestricted Ph.D. studentship (G.C.) from Novartis Pharmaceuticals. The authors are grateful to the Midlands Lung Tissue Consortium for the coordination of human lung tissue retrieval. The authors also thank Ryan Murray-Slater and Michelle Powell for assistance with the mast cell isolation and the Wolfson Foundation Light Microscopy Facility (Department of Biochemistry, University of Leicester) for the use of the scanning confocal microscope.	ALBER G, 1991, J BIOL CHEM, V266, P22613; ANDERSON KC, 1984, BLOOD, V63, P1424, DOI 10.1182/blood.V63.6.1424.1424; Bangur CS, 2004, INT J ONCOL, V25, P1583; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Bradding P., 2008, ALLERGY ALLERGIC DIS, P217; Brown JM, 2008, CLIN EXP ALLERGY, V38, P4, DOI 10.1111/j.1365-2222.2007.02886.x; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; BUTTERFIELD JH, 1990, J LEUKOCYTE BIOL, V47, P409, DOI 10.1002/jlb.47.5.409; Chinami M, 2005, J BIOL CHEM, V280, P17235, DOI 10.1074/jbc.M413437200; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Cruse G, 2005, EUR RESPIR J, V25, P858, DOI 10.1183/09031936.05.00091704; Cruse G, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-2; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Donato JL, 2002, J CLIN INVEST, V109, P51, DOI 10.1172/JCI14025; Donnadieu E, 2003, IMMUNITY, V18, P665, DOI 10.1016/S1074-7613(03)00115-8; Duffy SM, 2003, J ALLERGY CLIN IMMUN, V112, P965, DOI 10.1016/j.jaci.2003.07.004; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Ishibashi K, 2001, GENE, V264, P87, DOI 10.1016/S0378-1119(00)00598-9; KANZAKI M, 1995, J BIOL CHEM, V270, P13099, DOI 10.1074/jbc.270.22.13099; Kaur D, 2005, CLIN EXP ALLERGY, V35, P226, DOI 10.1111/j.1365-2222.2005.02161.x; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Koslowski M, 2008, CANCER RES, V68, P3458, DOI 10.1158/0008-5472.CAN-07-5768; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li HD, 2003, J BIOL CHEM, V278, P42427, DOI 10.1074/jbc.M308802200; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; RA C, 1989, J BIOL CHEM, V264, P15323; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Sanmugalingam D, 2000, J LEUKOCYTE BIOL, V68, P38; Singleton TE, 2009, MOL IMMUNOL, V46, P2333, DOI 10.1016/j.molimm.2009.03.023; Sorek R, 2001, NAT BIOTECHNOL, V19, P196, DOI 10.1038/85613; TEDDER TE, 1994, IMMUNOL TODAY, V15, P450, DOI 10.1016/0167-5699(94)90276-3; TETLOW LC, 1995, ANN RHEUM DIS, V54, P549, DOI 10.1136/ard.54.7.549; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wu YC, 2005, HUM EXP TOXICOL, V24, P41, DOI 10.1191/0960327105ht502oa; Wykes RCE, 2007, J IMMUNOL, V179, P4045, DOI 10.4049/jimmunol.179.6.4045	42	28	30	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2010	24	10					4047	4057		10.1096/fj.10-158378	http://dx.doi.org/10.1096/fj.10-158378			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	690LI	20554927	Green Published			2022-12-25	WOS:000285005900040
J	To, C; Shilton, BH; Di Guglielmo, GM				To, Ciric; Shilton, Brian H.; Di Guglielmo, Gianni M.			Synthetic Triterpenoids Target the Arp2/3 Complex and Inhibit Branched Actin Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; CDDO INDUCES APOPTOSIS; NITRIC-OXIDE PRODUCTION; NF-KAPPA-B; 2-CYANO-3,12-DIOXOOLEANA-1,9-DIEN-28-OIC ACID CDDO; INDUCED INFLAMMATORY RESPONSE; TUMOR-NECROSIS-FACTOR; 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID; DOWN-REGULATION; GROWTH ARREST	Synthetic triterpenoids are anti-tumor agents that affect numerous cellular functions including apoptosis and growth inhibition. Here, we used mass spectrometric and protein array approaches and uncovered that triterpenoids associate with proteins of the actin cytoskeleton, including actin-related protein 3 (Arp3). Arp3, a subunit of the Arp2/3 complex, is involved in branched actin polymerization and the formation of lamellipodia. 2-cyano-3,12-dioxooleana-1,9-dien- 28-oic acid (CDDO)-Im and CDDO-Me were observed to 1) inhibit the localization of Arp3 and actin at the leading edge of cells, 2) abrogate cell polarity, and 3) inhibit Arp2/3-dependent branched actin polymerization. We confirmed our drug effects with siRNA targeting of Arp3 and observed a decrease in Rat2 cell migration. Taken together, our data suggest that synthetic triterpenoids target Arp3 and branched actin polymerization to inhibit cell migration.	[To, Ciric; Di Guglielmo, Gianni M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Shilton, Brian H.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Di Guglielmo, GM (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Med Sci Bldg, London, ON N6A 5C1, Canada.	john.diguglielmo@schulich.uwo.ca	Shilton, Brian H/A-6667-2011; To, Ciric/AAE-7406-2019		National Cancer Institute of Canada [17189]; Canadian Institutes of Health [MOP-93625]	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by National Cancer Institute of Canada Grant 17189 and Canadian Institutes of Health Research Grant MOP-93625.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Bore L, 2002, ACTA CRYSTALLOGR C, V58, po199, DOI 10.1107/S010827010102176X; Brookes PS, 2007, CANCER RES, V67, P1793, DOI 10.1158/0008-5472.CAN-06-2678; Chintharlapalli S, 2005, MOL PHARMACOL, V68, P119, DOI 10.1124/mol.105.011437; Couch RD, 2006, MOL PHARMACOL, V69, P1158, DOI 10.1124/mol.105.018572; Deeb D, 2007, ANTICANCER RES, V27, P3035; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gao XH, 2008, IMMUNOPHARM IMMUNOT, V30, P581, DOI 10.1080/08923970802135559; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; Han SS, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-22; Honda T, 2004, J MED CHEM, V47, P4923, DOI 10.1021/jm049727e; Honda T, 1998, BIOORG MED CHEM LETT, V8, P2711, DOI 10.1016/S0960-894X(98)00479-X; Honda T, 1999, BIOORG MED CHEM LETT, V9, P3429, DOI 10.1016/S0960-894X(99)00623-X; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Ikeda T, 2004, MOL CANCER THER, V3, P39, DOI 10.2463/mrms.3.39; Ikeda T, 2003, CANCER RES, V63, P5551; Inoue S, 2004, LEUKEMIA, V18, P948, DOI 10.1038/sj.leu.2403328; Ito Y, 2001, MOL PHARMACOL, V59, P1094, DOI 10.1124/mol.59.5.1094; Ito Y, 2000, CELL GROWTH DIFFER, V11, P261; Kim KB, 2002, MOL CANCER THER, V1, P177; Konopleva M, 2006, MOL CANCER THER, V5, P317, DOI 10.1158/1535-7163.MCT-05-0350; Konopleva M, 2005, LEUKEMIA, V19, P1350, DOI 10.1038/sj.leu.2403828; Konopleva M, 2004, CANCER RES, V64, P7927, DOI 10.1158/0008-5472.CAN-03-2402; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Kress CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000559; Lapillonne H, 2003, CANCER RES, V63, P5926; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby K, 2006, CLIN CANCER RES, V12, P4288, DOI 10.1158/1078-0432.CCR-06-0215; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Ling XY, 2007, CANCER RES, V67, P4210, DOI 10.1158/0008-5472.CAN-06-3629; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Melichar B, 2004, GYNECOL ONCOL, V93, P149, DOI 10.1016/j.ygyno.2004.01.008; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pedersen IM, 2002, BLOOD, V100, P2965, DOI 10.1182/blood-2002-04-1174; Ray DM, 2006, EXP HEMATOL, V34, P1202, DOI 10.1016/j.exphem.2006.04.026; Samudio I, 2005, J BIOL CHEM, V280, P36273, DOI 10.1074/jbc.M507518200; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Sogno I, 2009, RECENT RESULTS CANC, V181, P209; Stadheim TA, 2002, J BIOL CHEM, V277, P16448, DOI 10.1074/jbc.M108974200; Suh NJ, 1999, CANCER RES, V59, P336; Suh WS, 2003, LEUKEMIA, V17, P2122, DOI 10.1038/sj.leu.2403112; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; Thimmulappa RK, 2006, BIOCHEM BIOPH RES CO, V351, P883, DOI 10.1016/j.bbrc.2006.10.102; To C, 2008, J BIOL CHEM, V283, P11700, DOI 10.1074/jbc.M704064200; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	56	35	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 3	2010	285	36					27944	27957		10.1074/jbc.M110.103036	http://dx.doi.org/10.1074/jbc.M110.103036			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644TL	20566646	Green Published, hybrid			2022-12-25	WOS:000281404100049
J	Tromp, JM; Tonino, SH; Elias, JA; Jaspers, A; Luijks, DM; Kater, AP; van Lier, RAW; van Oers, MHJ; Eldering, E				Tromp, J. M.; Tonino, S. H.; Elias, J. A.; Jaspers, A.; Luijks, D. M.; Kater, A. P.; van Lier, R. A. W.; van Oers, M. H. J.; Eldering, E.			Dichotomy in NF-kappa B signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering	ONCOGENE			English	Article						CLL; CD40; TLR9; NF-kappa B; Bcl-X-L; IgVH mutation status	CHRONIC LYMPHOCYTIC-LEUKEMIA; IMMUNOSTIMULATORY CPG-OLIGONUCLEOTIDES; CD40 STIMULATION; SURVIVAL; EXPRESSION; PHENOTYPE; APOPTOSIS; RECEPTOR; GENE; PROLIFERATION	Chronic lymphocytic leukemia (CLL) cells circulating in peripheral blood (PB) differ from the leukemic fraction in lymph nodes (LNs) with respect to cell division and drug sensitivity. CD40 stimulation of PB CLL cells in vitro results in chemoresistance and provides a partial model for the LN microenvironment. The TLR9 ligand CpG induces proliferation in immunoglobulin variable heavy-chain- unmutated CLL, but apoptosis in immunoglobulin variable heavy-chain-mutated CLL. To juxtapose proliferative with antiapoptotic signals, we investigated the effects of CpG in the context of CD40 ligation in mutated versus unmutated CLL cells in this study. Prolonged CD40 ligation induced classical, followed by alternative nuclear factor-kappa B (NF-kappa B), activity in both subgroups, correlating with enhanced Bfl-1 and Bcl-X-L levels, respectively. A dichotomy in NF-kappa B signaling occurred on combined CD40/TLR9 triggering. This induced declining p52 and Bcl-X-L levels, and reversed chemoresistance only in mutated cells, whereas unmutated cells proliferated, maintained p52 and Bcl-X-L and remained chemoresistant. The pivotal contribution of Bcl-X-L to chemoresistance was shown by the BH3 mimetic ABT-737 and RNA interference. Finally, in ex vivo LN samples, p52, p65 and Bcl-X-L levels were highly expressed, corroborating the in vitro findings. Thus, a distinction in NF-kappa B activation and drug susceptibility in mutated versus unmutated (LN-like) CLL cells was uncovered, which was causally linked to Bcl-X-L levels. Oncogene (2010) 29, 5071-5082; doi:10.1038/onc.2010.248; published online 28 June 2010	[Tromp, J. M.; Tonino, S. H.; Elias, J. A.; Jaspers, A.; van Lier, R. A. W.; Eldering, E.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Noord Holland, Netherlands; [Tromp, J. M.; Tonino, S. H.; Elias, J. A.; Luijks, D. M.; Kater, A. P.; van Oers, M. H. J.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Noord Holland, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Tromp, JM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Noord Holland, Netherlands.	j.m.tromp@amc.uva.nl		van Lier, Rene/0000-0002-3201-7144	Dutch Cancer Society (KWF) [UvA 2007-3856]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	We thank professor Carel JM van Noessel and Dr Richard Bende (department of pathology, AMC) for obtaining lymph node material of CLL patients. We are very grateful to the patients for donating blood samples. ABT-737, a BH3 mimetic, was obtained under MTA from Abbott (Abbott Park, courtesy Dr S Rosenberg). This work was supported by the Dutch Cancer Society (KWF), Grant no. UvA 2007-3856.	Caligaris-Cappio F, 2003, BRIT J HAEMATOL, V123, P380, DOI 10.1046/j.1365-2141.2003.04679.x; Caligaris-Cappio F, 2008, J CLIN ONCOL, V26, P4497, DOI 10.1200/JCO.2007.15.4393; Chen LG, 2005, BLOOD, V105, P2036, DOI 10.1182/blood-2004-05-1715; Chiorazzi N, 2007, BEST PRACT RES CL HA, V20, P399, DOI 10.1016/j.beha.2007.03.007; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Damle RN, 2002, BLOOD, V99, P4087, DOI 10.1182/blood.V99.11.4087; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Decker T, 2000, BLOOD, V95, P999, DOI 10.1182/blood.V95.3.999.003k10_999_1006; Decker T, 2001, LEUKEMIA LYMPHOMA, V42, P301, DOI 10.3109/10428190109064586; Endo T, 2007, BLOOD, V109, P703, DOI 10.1182/blood-2006-06-027755; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Fakler M, 2008, BLOOD, V112, P317; Furman RR, 2000, J IMMUNOL, V164, P2200, DOI 10.4049/jimmunol.164.4.2200; Ghia P, 2005, CURR TOP MICROBIOL, V294, P135, DOI 10.1007/3-540-29933-5_8; Granziero L, 2001, BLOOD, V97, P2777, DOI 10.1182/blood.V97.9.2777; Hallaert DYH, 2008, BLOOD, V112, P5141, DOI 10.1182/blood-2008-03-146704; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Homig-Holzel C, 2008, J EXP MED, V205, P1317, DOI 10.1084/jem.20080238; Kater AP, 2004, BRIT J HAEMATOL, V127, P404, DOI 10.1111/j.1365-2141.2004.05225.x; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; KEATING MJ, 2003, HEMATOL-AM SOC HEMAT, V5, P153; Kipps TJ, 2007, BEST PRACT RES CL HA, V20, P415, DOI 10.1016/j.beha.2007.04.001; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; LANKESTER AC, 1995, BLOOD, V86, P1090; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Longo PG, 2007, LEUKEMIA, V21, P110, DOI 10.1038/sj.leu.2404417; Lopez-Guerra M, 2009, CLIN CANCER RES, V15, P2767, DOI 10.1158/1078-0432.CCR-08-2382; Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI23409; Nedellec S, 2005, J IMMUNOL, V174, P3749, DOI 10.4049/jimmunol.174.6.3749; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Pedersen IM, 2004, LEUKEMIA LYMPHOMA, V45, P2365, DOI 10.1080/10428190412331272703; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Rodriguez A, 2004, CLIN CANCER RES, V10, P6796, DOI 10.1158/1078-0432.CCR-04-0753; Romano MF, 1998, BLOOD, V92, P990; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Smit LA, 2007, BLOOD, V109, P1660, DOI 10.1182/blood-2006-05-021683; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Tas SW, 2007, BLOOD, V110, P1540, DOI 10.1182/blood-2006-11-056010; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; van Gent R, 2008, CANCER RES, V68, P10137, DOI 10.1158/0008-5472.CAN-08-2325; Wierda WG, 2003, BRIT J HAEMATOL, V120, P452, DOI 10.1046/j.1365-2141.2003.04118.x; Willimott S, 2007, BRIT J HAEMATOL, V138, P721, DOI 10.1111/j.1365-2141.2007.06717.x; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	54	61	62	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	36					5071	5082		10.1038/onc.2010.248	http://dx.doi.org/10.1038/onc.2010.248			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	647LN	20581863				2022-12-25	WOS:000281620100007
J	Zeng, X; Shaikh, FY; Harrison, MK; Adon, AM; Trimboli, AJ; Carroll, KA; Sharma, N; Timmers, C; Chodosh, LA; Leone, G; Saavedra, HI				Zeng, X.; Shaikh, F. Y.; Harrison, M. K.; Adon, A. M.; Trimboli, A. J.; Carroll, K. A.; Sharma, N.; Timmers, C.; Chodosh, L. A.; Leone, G.; Saavedra, H. I.			The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2	ONCOGENE			English	Article						Ras; centrosome amplification; mammary cancers; cyclin D1; Cdk4; Nek2	IN-SITU HYBRIDIZATION; BREAST-CANCER; C-MYC; CHROMOSOME INSTABILITY; GENETIC INSTABILITY; TRANSGENIC MICE; MMTV-RAS; P21(WAF1/CIP1) DEFICIENCY; GENOMIC INSTABILITY; PROTEIN-KINASE	Centrosome amplification (CA) contributes to carcinogenesis by generating aneuploidy. Elevated frequencies of CA in most benign breast lesions and primary tumors suggest a causative role for CA in breast cancers. Clearly, identifying which and how altered signal transduction pathways contribute to CA is crucial to breast cancer control. Although a causative and cooperative role for c-Myc and Ras in mammary tumorigenesis is well documented, their ability to generate CA during mammary tumor initiation remains unexplored. To answer that question, K-Ras(G12D) and c-Myc were induced in mouse mammary glands. Although CA was observed in mammary tumors initiated by c-Myc or K-Ras(G12D), it was detected only in premalignant mammary lesions expressing K-Ras(G12D). CA, both in vivo and in vitro, was associated with increased expression of the centrosome-regulatory proteins, cyclin D1 and Nek2. Abolishing the expression of cyclin D1, Cdk4 or Nek2 in MCF10A human mammary epithelial cells expressing H-Ras(G12V) abrogated Ras-induced CA, whereas silencing cyclin E1 or B2 had no effect. Thus, we conclude that CA precedes mammary tumorigenesis, and interfering with centrosome-regulatory targets suppresses CA. Oncogene (2010) 29, 5103-5112; doi:10.1038/onc.2010.253; published online 28 June 2010	[Zeng, X.; Harrison, M. K.; Adon, A. M.; Saavedra, H. I.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Zeng, X.; Harrison, M. K.; Adon, A. M.; Saavedra, H. I.] Emory Winship Canc Inst, Atlanta, GA USA; [Shaikh, F. Y.; Trimboli, A. J.; Sharma, N.; Timmers, C.; Leone, G.] Program Human Canc Genet, Dept Mol Virol Immunol & Med Genet, Columbus, OH USA; [Carroll, K. A.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Chodosh, L. A.] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Chodosh, L. A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Emory University; Emory University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Saavedra, HI (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, 1365C Clifton Rd,Room C3084, Atlanta, GA 30322 USA.	hsaaved@emory.edu			Georgia Cancer Coalition Distinguished Scholar Award;  [NIH R01CA98371];  [DOD BCRP W81XWH-05-1-0405];  [NIH U01 CA105490];  [R01CA85619];  [R01HD042619];  [R01CA121275];  [R01HD047470];  [P01CA097189];  [K01CA104079]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042619, R01HD047470] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA085619, K01CA104079, R01CA098371, R01CA121275, U01CA105490, P01CA097189, R01CA151521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER	Georgia Cancer Coalition Distinguished Scholar Award; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs Rene Opavsky, Paul W Doetsch, Ya Wang and Hui Wang for manuscript discussions. We also thank Ms Carla G Saavedra and Meredith Roberts for editing; Dr Harold Varmus for providing tetO-K-Ras<SUP>G12D</SUP> mice; Dr J Brugge for nontransformed MCF10A cells; and Jana Opavska, Joi Carmichael and Stacy Sannem for technical assistance. We thank Dr Adam Marcus (from the Emory Imaging Core) and Mr Alan Bakaletz, for imaging advice. Lewis A Chodosh was funded by NIH R01CA98371, DOD BCRP W81XWH-05-1-0405 and NIH U01 CA105490, Gustavo Leone by R01CA85619, R01HD042619, R01CA121275, R01HD047470 and P01CA097189, Harold Saavedra by K01CA104079, and a Georgia Cancer Coalition Distinguished Scholar Award.	Adon AM, 2010, MOL CELL BIOL, V30, P694, DOI 10.1128/MCB.00253-09; BAILLY E, 1992, J CELL SCI, V101, P529; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bearss DJ, 2002, CANCER RES, V62, P2077; Berman H, 2005, COLD SH Q B, V70, P317, DOI 10.1101/sqb.2005.70.051; BERNS EMJJ, 1992, J STEROID BIOCHEM, V43, P13, DOI 10.1016/0960-0760(92)90182-I; Blakely CM, 2005, DEVELOPMENT, V132, P1147, DOI 10.1242/dev.01655; Blancato J, 2004, BRIT J CANCER, V90, P1612, DOI 10.1038/sj.bjc.6601703; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Chrzan P, 2001, CLIN BIOCHEM, V34, P557, DOI 10.1016/S0009-9120(01)00260-0; CLAIR T, 1987, CANCER RES, V47, P5290; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Doxsey S, 2002, MOL CELL, V10, P439, DOI 10.1016/S1097-2765(02)00654-8; Duensing A, 2006, CELL CYCLE, V5, P2899, DOI 10.4161/cc.5.24.3567; Duesberg P, 2000, CELL MOTIL CYTOSKEL, V47, P81; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Fleisch MC, 2006, MICROSC RES TECHNIQ, V69, P964, DOI 10.1002/jemt.20372; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Goepfert TM, 2000, FASEB J, V14, P2221, DOI 10.1096/fj.00-0165com; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Guo HQ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1752; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hanashiro K, 2008, ONCOGENE, V27, P5288, DOI 10.1038/onc.2008.161; Hayward DG, 2004, CANCER RES, V64, P7370, DOI 10.1158/0008-5472.CAN-04-0960; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Hundley JE, 1997, MOL CELL BIOL, V17, P723, DOI 10.1128/MCB.17.2.723; Hundley JE, 1997, CANCER RES, V57, P600; Iovino F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-38; JANES PW, 1994, ONCOGENE, V9, P3601; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; MANGUES R, 1990, ONCOGENE, V5, P1491; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Miyakis S, 1998, BIOCHEM BIOPH RES CO, V251, P609, DOI 10.1006/bbrc.1998.9527; Nelsen CJ, 2005, J BIOL CHEM, V280, P768, DOI 10.1074/jbc.M407105200; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oikawa T, 2005, MOL CELL BIOL, V25, P4046, DOI 10.1128/MCB.25.10.4046-4061.2005; Omer CA, 2000, CANCER RES, V60, P2680; Pihan GA, 1998, CANCER RES, V58, P3974; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Reddy HKDL, 2005, CANCER RES, V65, P10174, DOI 10.1158/0008-5472.CAN-05-2639; Rummukainen JK, 2001, MODERN PATHOL, V14, P1030, DOI 10.1038/modpathol.3880431; Saavedra HI, 2003, CANCER CELL, V3, P333, DOI 10.1016/S1535-6108(03)00083-7; Saavedra HI, 1999, J BIOL CHEM, V274, P38083, DOI 10.1074/jbc.274.53.38083; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schliekelman M, 2009, CANCER RES, V69, P45, DOI 10.1158/0008-5472.CAN-07-6330; Schneeweiss A, 2003, INT J CANCER, V107, P346, DOI 10.1002/ijc.11408; Shackney SE, 2004, CLIN CANCER RES, V10, P3042, DOI 10.1158/1078-0432.CCR-0401-3; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Weaver ZA, 1999, GENE CHROMOSOME CANC, V25, P251, DOI 10.1002/(SICI)1098-2264(199907)25:3<251::AID-GCC7>3.0.CO;2-3; Wu GK, 2008, CANCER RES, V68, P8393, DOI 10.1158/0008-5472.CAN-08-1915; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	70	62	67	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2010	29	36					5103	5112		10.1038/onc.2010.253	http://dx.doi.org/10.1038/onc.2010.253			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	647LN	20581865	Green Accepted			2022-12-25	WOS:000281620100010
J	Dickson, RJ; Wahl, LM; Fernandes, AD; Gloor, GB				Dickson, Russell J.; Wahl, Lindi M.; Fernandes, Andrew D.; Gloor, Gregory B.			Identifying and Seeing beyond Multiple Sequence Alignment Errors Using Intra-Molecular Protein Covariation	PLOS ONE			English	Article							COEVOLVING RESIDUES; COEVOLUTION; INFORMATION; IDENTIFICATION; PHYLOGENY; ACCURACY; SYSTEM	Background: There is currently no way to verify the quality of a multiple sequence alignment that is independent of the assumptions used to build it. Sequence alignments are typically evaluated by a number of established criteria: sequence conservation, the number of aligned residues, the frequency of gaps, and the probable correct gap placement. Covariation analysis is used to find putatively important residue pairs in a sequence alignment. Different alignments of the same protein family give different results demonstrating that covariation depends on the quality of the sequence alignment. We thus hypothesized that current criteria are insufficient to build alignments for use with covariation analyses. Methodology/Principal Findings: We show that current criteria are insufficient to build alignments for use with covariation analyses as systematic sequence alignment errors are present even in hand-curated structure-based alignment datasets like those from the Conserved Domain Database. We show that current non-parametric covariation statistics are sensitive to sequence misalignments and that this sensitivity can be used to identify systematic alignment errors. We demonstrate that removing alignment errors due to 1) improper structure alignment, 2) the presence of paralogous sequences, and 3) partial or otherwise erroneous sequences, improves contact prediction by covariation analysis. Finally we describe two non-parametric covariation statistics that are less sensitive to sequence alignment errors than those described previously in the literature. Conclusions/Significance: Protein alignments with errors lead to false positive and false negative conclusions ( incorrect assignment of covariation and conservation, respectively). Covariation analysis can provide a verification step, independent of traditional criteria, to identify systematic misalignments in protein alignments. Two non-parametric statistics are shown to be somewhat insensitive to misalignment errors, providing increased confidence in contact prediction when analyzing alignments with erroneous regions because of an emphasis on they emphasize pairwise covariation over group covariation.	[Dickson, Russell J.; Fernandes, Andrew D.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Wahl, Lindi M.; Fernandes, Andrew D.] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Dickson, RJ (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	ggloor@uwo.ca	Gloor, Greg B/D-1671-2013	Gloor, Gregory/0000-0001-5803-3380	National Sciences and Engineering Council of Canada; Canada Research Chair	National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	LMW is supported by grants from the National Sciences and Engineering Council of Canada and the Canada Research Chair Program. RJD is supported by a National Sciences and Engineering Council of Canada CGS scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Edgar RC, 2006, CURR OPIN STRUC BIOL, V16, P368, DOI 10.1016/j.sbi.2006.04.004; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Floudas CA, 2006, CHEM ENG SCI, V61, P966, DOI 10.1016/j.ces.2005.04.009; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; GLOOR GB, 2010, MOL BIOL EVOL; Gotoh O, 1996, J MOL BIOL, V264, P823, DOI 10.1006/jmbi.1996.0679; Hogue CWV, 1997, TRENDS BIOCHEM SCI, V22, P314, DOI 10.1016/S0968-0004(97)01093-1; Kim CH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-355; KLEINSTIVER BP, 2010, NUCL ACIDS RES; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; OLIVEIRA R, 2007, FINDING COEVOLVING A; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; SHACKELFORD G, 2007, PROTEINS; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Travers SAA, 2007, MOL BIOL EVOL, V24, P1032, DOI 10.1093/molbev/msm022; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593; Yip KY, 2008, BIOINFORMATICS, V24, P290, DOI 10.1093/bioinformatics/btm584	31	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11082	10.1371/journal.pone.0011082	http://dx.doi.org/10.1371/journal.pone.0011082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596526	Green Published, gold, Green Submitted			2022-12-25	WOS:000279259900001
J	Hurt, CB; Torrone, E; Green, K; Foust, E; Leone, P; Hightow-Weidman, L				Hurt, Christopher B.; Torrone, Elizabeth; Green, Kelly; Foust, Evelyn; Leone, Peter; Hightow-Weidman, Lisa			Methamphetamine Use among Newly Diagnosed HIVPositive Young Men in North Carolina, United States, from 2000 to 2005	PLOS ONE			English	Article							SEXUAL RISK BEHAVIORS; EARLY SYPHILIS; SAN-FRANCISCO; BISEXUAL MEN; DRUG-USE; HIV-INFECTION; GAY; TRANSMISSION; EPIDEMIC	Background: Methamphetamine (MA) is a new arrival to the Southeastern United States (US). Incidence of HIV is also increasing regionally, but data are limited regarding any association between this trend and MA use. We examined behavioral data from North Carolina (NC) residents newly diagnosed with HIV, collected by the Department of Health between 2000-2005. Principal Findings: Among 1,460 newly diagnosed HIV-positive young men, an increasing trend was seen from 2000-2005 in MA use (p = 0.01, total n = 20). In bivariate analyses, users of MA had significantly greater odds of reporting other substance use, including alcohol, powder or crack cocaine, marijuana, and methylenedioxymethamphetamine (MDMA, "ecstasy''). They were also more likely to have reported sexual activity while traveling outside NC; sex with anonymous partners; and previous HIV testing. In a predictive model, MA use had a negative association with nonwhite race, and strong positive associations with powder cocaine, "ecstasy,'' or intravenous drug use and being a university student. Conclusions: Similar to trends seen in more urban parts of the US, MA use among newly diagnosed, HIV-positive young men is increasing in NC. These data are among the first to demonstrate this relationship in a region with a burgeoning epidemic of MA use. Opportunities exist for MA-related HIV risk-reduction interventions whenever young men intersect the healthcare system.	[Hurt, Christopher B.; Leone, Peter; Hightow-Weidman, Lisa] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA; [Torrone, Elizabeth] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Green, Kelly] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA; [Foust, Evelyn] N Carolina Dept Hlth & Human Serv, HIV STD Prevent & Care Branch, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hurt, CB (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA.	churt@med.unc.edu			National Institute of Allergy and Infectious Diseases (NIAID) [5T32AI07001-32]; Health Resources and Services Administration Special Projects of National Significance (HRSA SPNS) [1H97HA03789-01-00]; National Institute of Mental Health (NIMH) [5K23MH075718-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH075718] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Health Resources and Services Administration Special Projects of National Significance (HRSA SPNS); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr. Hurt was supported by a National Institute of Allergy and Infectious Diseases (NIAID) T32 training grant, #5T32AI07001-32. Dr. Hightow-Weidman received funding through a Health Resources and Services Administration Special Projects of National Significance (HRSA SPNS) grant, #1H97HA03789-01-00; and a National Institute of Mental Health (NIMH) K23 award, #5K23MH075718-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EP PROF HIV STD PREV; Buchacz K, 2005, AIDS, V19, P1423, DOI 10.1097/01.aids.0000180794.27896.fb; Centers for Disease Control and Prevention, 2008, HIV AIDS SURV REP 20; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P273; Clatts MC, 2005, J URBAN HLTH S1, V82, P9; COLFAX G, 2005, J URBAN HLTH S1, V82, P62; Colfax GN, 2001, J ACQ IMMUN DEF SYND, V28, P373, DOI 10.1097/00126334-200112010-00011; Cook RL, 2006, MED CARE, V44, pS31, DOI 10.1097/01.mlr.0000223710.35008.d9; Fendrich M, 2003, ADDICTION, V98, P1693, DOI 10.1111/j.1360-0443.2003.00577.x; Gerbert B, 1997, J GEN INTERN MED, V12, P698, DOI 10.1046/j.1525-1497.1997.07143.x; Halkitis PN, 2001, J HOMOSEXUAL, V41, P17, DOI 10.1300/J082v41n02_02; Hightow LB, 2005, JAIDS-J ACQ IMM DEF, V38, P531, DOI 10.1097/01.qai.0000155037.10628.cb; IRWIN TW, 2005, J URBAN HLTH; Kalichman SC, 1997, AIDS EDUC PREV, V9, P41; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Lambert E, 2005, J URBAN HEALTH, V82, pI1, DOI 10.1093/jurban/jti018; Mansergh G, 2006, PUBLIC HEALTH REP, V121, P127, DOI 10.1177/003335490612100205; *NC DEP HLTH HUM S, 2004, 2004 HIV STD SURV RE; *NC DEP HLTH HUM S, 2007, 2007 HIV STD SURV RE; Patinkin N, 2007, SOC WORK HEALTH CARE, V44, P73, DOI 10.1300/J010v44n01_07; Plankey MW, 2007, JAIDS-J ACQ IMM DEF, V45, P85, DOI 10.1097/QAI.0b013e3180417c99; PLANT MA, 1990, ALCOHOL ALCOHOLISM, V25, P293, DOI 10.1093/oxfordjournals.alcalc.a045003; Reback CJ, 2004, AIDS BEHAV, V8, P87, DOI 10.1023/B:AIBE.0000017528.39338.75; SEMPLE SJ, 2008, ARCH SEX BEHAV; Sena AC, 2008, AIDS PATIENT CARE ST, V22, P955, DOI 10.1089/apc.2008.0077; Sexton Rocky L, 2005, J Ethn Subst Abuse, V4, P77, DOI 10.1300/J233v04n01_06; Taylor MM, 2007, INT J STD AIDS, V18, P93, DOI 10.1258/095646207779949709; *US DEP HHS, 2004, SAMPL EL HOSP; *US DRUG ENF ADM, 2009, DEA BRIEFS BACKGR DR; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Waldo CR, 2000, J ACQ IMMUN DEF SYND, V24, P168; Wong W, 2005, SEX TRANSM DIS, V32, P458, DOI 10.1097/01.olq.0000168280.34424.58; Zule WA, 2007, J RURAL HEALTH, V23, P73, DOI 10.1111/j.1748-0361.2007.00127.x	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11314	10.1371/journal.pone.0011314	http://dx.doi.org/10.1371/journal.pone.0011314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615NA	20593025	gold, Green Submitted, Green Published			2022-12-25	WOS:000279140800015
J	Singhal, H; Ren, YZR; Kern, SE				Singhal, Hari; Ren, Yunzhao R.; Kern, Scott E.			Improved DNA Electrophoresis in Conditions Favoring Polyborates and Lewis Acid Complexation	PLOS ONE			English	Article							CONDUCTIVE MEDIA; BUFFERS	Spatial compression among the longer DNA fragments occurs during DNA electrophoresis in agarose and non-agarose gels when using certain ions in the conductive buffer, impairing the range of fragment sizes resolved well in a single gel. Substitutions using various polyhydroxyl anions supported the underlying phenomenon as the complexation of Lewis acids to DNA. We saw significant improvements using conditions (lithium borate 10 mM cations, pH 6.5) favoring the formation of borate polyanions and having lower conductance and Joule heating, delayed electrolyte exhaustion, faster electrophoretic run-speed, and sharper separation of DNA bands from 100bp to 12 kb in a single run.	[Singhal, Hari] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Singhal, Hari; Ren, Yunzhao R.; Kern, Scott E.] Johns Hopkins, Sidney Kimmel Comprehens Ctr, Baltimore, MD USA; [Singhal, Hari; Ren, Yunzhao R.; Kern, Scott E.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Singhal, H (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	sk@jhmi.edu			National Institutes of Health [CA62924]; Marjorie Kovler Research Fellowship; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marjorie Kovler Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant CA62924 and the Marjorie Kovler Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody JR, 2004, BIOTECHNIQUES, V37, P598, DOI 10.2144/04374ST04; Brody JR, 2004, ANAL BIOCHEM, V333, P1, DOI 10.1016/j.ab.2004.05.054; HASHIMOTO Y, 1952, NATURE, V170, P975, DOI 10.1038/170975b0; INGRI N, 1963, ACTA CHEM SCAND, V17, P581, DOI 10.3891/acta.chem.scand.17-0581; Maeda M, 1978, INORG NUCL CHEM, V41, P1217; SMITH SS, 1983, ANAL BIOCHEM, V128, P138, DOI 10.1016/0003-2697(83)90354-8; Stellwagen NC, 2000, BIOPOLYMERS, V54, P137, DOI 10.1002/1097-0282(200008)54:2<137::AID-BIP6>3.0.CO;2-I; Stellwagen NC, 2000, ANAL BIOCHEM, V287, P167, DOI 10.1006/abio.2000.4848	8	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11318	10.1371/journal.pone.0011318	http://dx.doi.org/10.1371/journal.pone.0011318			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593002	gold, Green Published, Green Submitted			2022-12-25	WOS:000279140800018
J	De Luca, M; Klimentidis, YC; Casazza, K; Chambers, MM; Cho, R; Harbison, ST; Jumbo-Lucioni, P; Zhang, SY; Leips, J; Fernandez, JR				De Luca, Maria; Klimentidis, Yann C.; Casazza, Krista; Chambers, Michelle Moses; Cho, Ruth; Harbison, Susan T.; Jumbo-Lucioni, Patricia; Zhang, Shaoyan; Leips, Jeff; Fernandez, Jose R.			A Conserved Role for Syndecan Family Members in the Regulation of Whole-Body Energy Metabolism	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INSULIN-LIKE PEPTIDES; HEPARAN-SULFATE PROTEOGLYCAN; GENE DISRUPTION PROJECT; DROSOPHILA-MELANOGASTER; LIFE-SPAN; SKELETAL-MUSCLE; SUSCEPTIBILITY LOCUS; AFFECTING LONGEVITY; STRESS RESISTANCE	Syndecans are a family of type-I transmembrane proteins that are involved in cell-matrix adhesion, migration, neuronal development, and inflammation. Previous quantitative genetic studies pinpointed Drosophila Syndecan (dSdc) as a positional candidate gene affecting variation in fat storage between two Drosophila melanogaster strains. Here, we first used quantitative complementation tests with dSdc mutants to confirm that natural variation in this gene affects variability in Drosophila fat storage. Next, we examined the effects of a viable dSdc mutant on Drosophila whole-body energy metabolism and associated traits. We observed that young flies homozygous for the dSdc mutation had reduced fat storage and slept longer than homozygous wild-type flies. They also displayed significantly reduced metabolic rate, lower expression of spargel (the Drosophila homologue of PGC-1), and reduced mitochondrial respiration. Compared to control flies, dSdc mutants had lower expression of brain insulin-like peptides, were less fecund, more sensitive to starvation, and had reduced life span. Finally, we tested for association between single nucleotide polymorphisms (SNPs) in the human SDC4 gene and variation in body composition, metabolism, glucose homeostasis, and sleep traits in a cohort of healthy early pubertal children. We found that SNP rs4599 was significantly associated with resting energy expenditure (P = 0.001 after Bonferroni correction) and nominally associated with fasting glucose levels (P = 0.01) and sleep duration (P = 0.044). On average, children homozygous for the minor allele had lower levels of glucose, higher resting energy expenditure, and slept shorter than children homozygous for the common allele. We also observed that SNP rs1981429 was nominally associated with lean tissue mass (P = 0.035) and intra-abdominal fat (P = 0.049), and SNP rs2267871 with insulin sensitivity (P = 0.037). Collectively, our results in Drosophila and humans argue that syndecan family members play a key role in the regulation of body metabolism.	[De Luca, Maria; Casazza, Krista; Chambers, Michelle Moses; Jumbo-Lucioni, Patricia; Zhang, Shaoyan; Fernandez, Jose R.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [De Luca, Maria; Fernandez, Jose R.] Univ Alabama Birmingham, Nutr & Obes Res Ctr, Birmingham, AL 35294 USA; [De Luca, Maria; Fernandez, Jose R.] Univ Alabama Birmingham, Diabet Res Training Ctr, Birmingham, AL 35294 USA; [Klimentidis, Yann C.] Univ Alabama Birmingham, Sect Stat Genet, Dept Biostat, Birmingham, AL 35294 USA; [Cho, Ruth; Leips, Jeff] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA; [Harbison, Susan T.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Maryland; University of Maryland Baltimore County; University of North Carolina; North Carolina State University	De Luca, M (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA.	mdeluca2@uab.edu	Harbison, Susan T/P-2577-2016; Klimentidis, Yann/B-2348-2015; Leips, Jeff/AAK-6676-2021	Harbison, Susan T/0000-0001-7233-0947; Klimentidis, Yann/0000-0002-6065-4044; Leips, Jeff/0000-0001-8999-6630; De Luca, Maria/0000-0001-6345-7508; Jumbo-Lucioni, Patricia/0000-0003-0266-5498	U.S. National Institutes of Health [P30-DK56336, P60-DK0797626, R01HL80812, R01DK084219, R01DK067426]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067426, R01DK084219, P30DK056336] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health Grants P30-DK56336 (Nutrition Obesity Research Center), P60-DK0797626 (Diabetes Research and Training Center's Bioanalytical Redox Biology Core), R01HL80812 (to MD and JL), R01DK084219 (to MD and JL), and R01DK067426 (to JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Bisht B, 2007, DIABETOLOGIA, V50, P1058, DOI 10.1007/s00125-007-0591-6; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Bray MS, 2009, OBES REV, V10, P6, DOI 10.1111/j.1467-789X.2009.00684.x; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Carskadon MA, 2002, SLEEP, V25, P606, DOI 10.1093/sleep/25.6.606; CASAZZA K, 2009, OBESITY  SILVER SPRI, V17, P1313; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; CHO I, 2010, DNA CELL BIOL   0522; Cirelli C, 2005, J NEUROCHEM, V94, P1411, DOI 10.1111/j.1471-4159.2005.03291.x; CLARK AG, 1988, GENETICS, V119, P595; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Couchman JR, 2001, INT REV CYTOL, V207, P113; Cox D. R., 1984, ANAL SURVIVAL DATA; De Luca M, 2005, OBES RES, V13, P1596, DOI 10.1038/oby.2005.196; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; De Luca M, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-52; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Divers J, 2007, GENETICS, V176, P1823, DOI 10.1534/genetics.107.075408; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; FLEGAL KM, 2010, JAMA-J AM MED ASSOC, V235, P1999; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P2198, DOI 10.1073/pnas.96.5.2198; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; HANIS CL, 1986, TEXAS AM J PHYS ANTH, V70, P433; Harbison ST, 2008, GENETICS, V178, P2341, DOI 10.1534/genetics.107.081232; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Hunter GR, 2000, AM J CLIN NUTR, V71, P500; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ji LN, 1997, DIABETES, V46, P876, DOI 10.2337/diabetes.46.5.876; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; KOJIMA T, 1993, BIOCHEM BIOPH RES CO, V190, P814, DOI 10.1006/bbrc.1993.1122; Kolset SO, 1999, CELL MOL LIFE SCI, V56, P857, DOI 10.1007/s000180050031; Korner J, 2009, AM J MED, V122, pS12, DOI 10.1016/j.amjmed.2009.01.003; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leips J, 2006, GENETICS, V172, P1595, DOI 10.1534/genetics.105.048520; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; MATTHEWS DR, 1990, DIABETIC MED, V7, P246, DOI 10.1111/j.1464-5491.1990.tb01379.x; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Nuzhdin SV, 1997, P NATL ACAD SCI USA, V94, P9734, DOI 10.1073/pnas.94.18.9734; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Pasyukova EG, 2000, GENETICS, V156, P1129; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rostand KS, 1997, INFECT IMMUN, V65, P1; Roy JLP, 2006, AM J HUM BIOL, V18, P454, DOI 10.1002/ajhb.20509; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Spradling AC, 1999, GENETICS, V153, P135; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Ten S, 2008, J PEDIATR ENDOCR MET, V21, P359; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Tiefenbock SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Van Voorhies WA, 2004, J APPL PHYSIOL, V97, P1915, DOI 10.1152/japplphysiol.00505.2004; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Weinsier RL, 2000, AM J CLIN NUTR, V71, P1138; Weinsier RL, 2002, AM J CLIN NUTR, V75, P499, DOI 10.1093/ajcn/75.3.499; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; Woods A, 2001, J CLIN INVEST, V107, P935, DOI 10.1172/JCI12802; Zepelin H, 1994, PRINCIPLES PRACTICE, P69; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106; Zouali H, 1997, HUM MOL GENET, V6, P1401, DOI 10.1093/hmg/6.9.1401; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	91	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11286	10.1371/journal.pone.0011286	http://dx.doi.org/10.1371/journal.pone.0011286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585652	gold, Green Published, Green Submitted			2022-12-25	WOS:000279135400028
J	Tang, SY; Xiao, YN; Yang, YP; Zhou, YC; Wu, JH; Ma, ZE				Tang, Sanyi; Xiao, Yanni; Yang, Youping; Zhou, Yicang; Wu, Jianhong; Ma, Zhien			Community-Based Measures for Mitigating the 2009 H1N1 Pandemic in China	PLOS ONE			English	Article							INFLUENZA; INTERVENTIONS; MODELS; VIRUS	Since the emergence of influenza A/H1N1 pandemic virus in March-April 2009, very stringent interventions including Fengxiao were implemented to prevent importation of infected cases and decelerate the disease spread in mainland China. The extent to which these measures have been effective remains elusive. We sought to investigate the effectiveness of Fengxiao that may inform policy decisions on improving community-based interventions for management of on-going outbreaks in China, in particular during the Spring Festival in mid-February 2010 when nationwide traveling will be substantially increased. We obtained data on initial laboratory-confirmed cases of H1N1 in the province of Shaanxi and used Markov-chain Monte-Carlo (MCMC) simulations to estimate the reproduction number. Given the estimates for the exposed and infectious periods of the novel H1N1 virus, we estimated a mean reproduction number of 1.68 (95% CI 1.45-1.92) and other A/H1N1 epidemiological parameters. Our results based on a spatially stratified population dynamical model show that the early implementation of Fengxiao can delay the epidemic peak significantly and prevent the disease spread to the general population but may also, if not implemented appropriately, cause more severe outbreak within universities/ colleges, while late implementation of Fengxiao can achieve nothing more than no implementation. Strengthening local control strategies (quarantine and hygiene precaution) is much more effective in mitigating outbreaks and inhibiting the successive waves than implementing Fengxiao. Either strong mobility or high transport-related transmission rate during the Spring Festival holiday will not reverse the ongoing outbreak, but both will result in a large new wave. The findings suggest that Fengxiao and travel precautions should not be relaxed unless strict measures of quarantine, isolation, and hygiene precaution practices are put in place. Integration and prompt implementation of these interventions can significantly reduce the overall attack rate of pandemic outbreaks.	[Tang, Sanyi] Shaanxi Normal Univ, Coll Math & Informat Sci, Xian, Peoples R China; [Xiao, Yanni; Yang, Youping; Zhou, Yicang; Ma, Zhien] Xi An Jiao Tong Univ, Dept Appl Math, Xian 710049, Peoples R China; [Wu, Jianhong] York Univ, Ctr Dis Modeling, Toronto, ON M3J 2R7, Canada	Shaanxi Normal University; Xi'an Jiaotong University; York University - Canada	Tang, SY (corresponding author), Shaanxi Normal Univ, Coll Math & Informat Sci, Xian, Peoples R China.	zhma@mail.xjtu.edu.cn	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China (NSFC) [10871122, 10701062]; Program for New Century Excellent Talents in University [NCET-08-0430]; Mathematics of Information Technology and Complex Systems (MITACS); Communications Research Centre Canada; Natural Sciences and Engineering Research Council of Canada (NSERC); GEOmatics for Informed DEcisions (GEOIDE); Communications Research Centre Canada-International Development Research Centre (CRC-IDRC)	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Mathematics of Information Technology and Complex Systems (MITACS); Communications Research Centre Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); GEOmatics for Informed DEcisions (GEOIDE); Communications Research Centre Canada-International Development Research Centre (CRC-IDRC)	This work was partially supported by the National Natural Science Foundation of China (NSFC), 10871122 (ST) and 10701062 (YX), and by the Program for New Century Excellent Talents in University (NCET-08-0430, YX). This work was also partially supported by Mathematics of Information Technology and Complex Systems (MITACS), Communications Research Centre Canada, Natural Sciences and Engineering Research Council of Canada (NSERC), and GEOmatics for Informed DEcisions (GEOIDE) (JWU) and by the Canada-China collaboration on disease modeling, as well as funded by the Communications Research Centre Canada-International Development Research Centre (CRC-IDRC) International Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Day T, 2006, AM J EPIDEMIOL, V163, P479, DOI 10.1093/aje/kwj056; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; NISHIURA H, 2009, NZ MED J, V122; PEREZTRALLERO E, 2009, EURO SURVEILL, V14; TUITE AR, 2009, CMAJ, DOI DOI 10.1503/CMAJ091807; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; 2010, NATIONWIDE TRAVEL SP; 2009, REPORT POLICY; 2009, FENGXIAO STRATEGY	21	58	61	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2010	5	6							e10911	10.1371/journal.pone.0010911	http://dx.doi.org/10.1371/journal.pone.0010911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	613KE	20585565	Green Published, Green Submitted, gold			2022-12-25	WOS:000278977200001
J	Mehla, R; Bivalkar-Mehla, S; Zhang, RN; Handy, I; Albrecht, H; Giri, S; Nagarkatti, P; Nagarkatti, M; Chauhan, A				Mehla, Rajeev; Bivalkar-Mehla, Shalmali; Zhang, Ruonan; Handy, Indhira; Albrecht, Helmut; Giri, Shailendra; Nagarkatti, Prakash; Nagarkatti, Mitzi; Chauhan, Ashok			Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; KINASE-C-ZETA; T-CELLS; IN-VIVO; VALPROIC ACID; UP-REGULATION; VIRAL LOAD; EXPRESSION; RESERVOIR	HIV's ability to establish long-lived latent infection is mainly due to transcriptional silencing in resting memory T lymphocytes and other non dividing cells including monocytes. Despite an undetectable viral load in patients treated with potent antiretrovirals, current therapy is unable to purge the virus from these latent reservoirs. In order to broaden the inhibitory range and effectiveness of current antiretrovirals, the potential of bryostatin was investigated as an HIV inhibitor and latent activator. Bryostatin revealed antiviral activity against R5- and X4-tropic viruses in receptor independent and partly via transient decrease in CD4/CXCR4 expression. Further, bryostatin at low nanomolar concentrations robustly reactivated latent viral infection in monocytic and lymphocytic cells via activation of Protein Kinase C (PKC) -alpha and -delta, because PKC inhibitors rottlerin and GF109203X abrogated the bryostatin effect. Bryostatin specifically modulated novel PKC (nPKC) involving stress induced AMP Kinase (AMPK) inasmuch as an inhibitor of AMPK, compound C partially ablated the viral reactivation effect. Above all, bryostatin was non-toxic in vitro and was unable to provoke T-cell activation. The dual role of bryostatin on HIV life cycle may be a beneficial adjunct to the treatment of HIV especially by purging latent virus from different cellular reservoirs such as brain and lymphoid organs.	[Mehla, Rajeev; Bivalkar-Mehla, Shalmali; Zhang, Ruonan; Handy, Indhira; Nagarkatti, Prakash; Nagarkatti, Mitzi; Chauhan, Ashok] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Albrecht, Helmut] Univ S Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA; [Giri, Shailendra] Mayo Clin, Dept Expt Pathol, Rochester, MN USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Mayo Clinic	Mehla, R (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Ashok.Chauhan@uscmed.sc.edu	Albrecht, Helmut/D-5319-2011	Nagarkatti, Prakash/0000-0003-2663-0759	National Institutes of Health [RO1 NS 050064, PO1AT003961]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported with federal funds from National Institutes of Health grant RO1 NS 050064 (AC) and PO1AT003961 (PN and MN).	Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; ASIEDU C, 1995, CANCER RES, V55, P3716; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Banda N K, 1999, Biol Blood Marrow Transplant, V5, P162, DOI 10.1053/bbmt.1999.v5.pm10392962; Bedoya LM, 2009, BIOCHEM PHARMACOL, V77, P965, DOI 10.1016/j.bcp.2008.11.025; BOTO WMO, 1991, CELL REGUL, V2, P95, DOI 10.1091/mbc.2.2.95; Brown A, 2006, J LEUKOCYTE BIOL, V80, P1127, DOI 10.1189/jlb.0206126; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chauhan A, 2003, J BIOL CHEM, V278, P13512, DOI 10.1074/jbc.M209381200; Chauhan A, 2007, FASEB J, V21, P777, DOI 10.1096/fj.06-7054com; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Das SR, 2005, INDIAN J MED RES, V121, P315; Davidson SK, 2001, APPL ENVIRON MICROB, V67, P4531, DOI 10.1128/AEM.67.10.4531-4537.2001; Do Y, 2004, CANCER RES, V64, P6756, DOI 10.1158/0008-5472.CAN-03-4002; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; ESA AH, 1990, INT J IMMUNOPHARMACO, V12, P481, DOI 10.1016/0192-0561(90)90110-9; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Folgueira L, 1996, J VIROL, V70, P223, DOI 10.1128/JVI.70.1.223-231.1996; Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; He X, 2008, CANCER RES, V68, P8678, DOI 10.1158/0008-5472.CAN-08-0294; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Jones J, 2005, VIROLOGY, V331, P106, DOI 10.1016/j.virol.2004.10.013; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; LINT CV, 1996, EMBO J, V15, P1112; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; MANN DL, 1990, J IMMUNOL, V144, P2152; Margolis David M., 2006, Infectious Disorders - Drug Targets, V6, P369, DOI 10.2174/187152606779025824; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Martelli AM, 2003, HISTOL HISTOPATHOL, V18, P1301, DOI 10.14670/HH-18.1301; MATTHES E, 1990, ANTIVIR RES, V13, P273, DOI 10.1016/0166-3542(90)90012-V; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nekhai S, 2002, BIOCHEM J, V364, P649, DOI 10.1042/BJ20011191; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; PETTIT GR, 1984, J AM CHEM SOC, V106, P6768, DOI 10.1021/ja00334a050; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; REUSE S, 2009, PLOS, V4, P1; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; SAJAN MP, 2009, AM J PHYSIOL-ENDOC M, DOI DOI 10.1152/AJPENDO.00392; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Smith L, 2000, J BIOL CHEM, V275, P40620, DOI 10.1074/jbc.M908517199; STANLEY SK, 1992, J IMMUNOL, V149, P689; Steel A, 2006, AIDS, V20, P1681, DOI 10.1097/01.aids.0000238421.36313.fa; Sundstrom JB, 2007, BLOOD, V109, P5293, DOI 10.1182/blood-2006-11-058438; THEOPHILUS SV, 2008, VIROLOGY, V381, P1; Thiebot H, 2001, J VIROL, V75, P11594, DOI 10.1128/JVI.75.23.11594-11602.2001; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	69	174	180	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2010	5	6							e11160	10.1371/journal.pone.0011160	http://dx.doi.org/10.1371/journal.pone.0011160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	612GZ	20585398	Green Published, Green Submitted, gold			2022-12-25	WOS:000278886100021
J	von Kraus, LM; Sacktor, TC; Francis, JT				von Kraus, Lee Michael; Sacktor, Todd Charlton; Francis, Joseph Thachil			Erasing Sensorimotor Memories via PKM zeta Inhibition	PLOS ONE			English	Article							PROTEIN-KINASE-C; MOTOR CORTEX; MOVEMENT REPRESENTATIONS; SKILL; RAT; CONSOLIDATION; REORGANIZATION; SYNAPTOGENESIS; MAINTENANCE; EXPRESSION	Sensorimotor cortex has a role in procedural learning. Previous studies suggested that this learning is subserved by long-term potentiation (LTP), which is in turn maintained by the persistently active kinase, protein kinase Mzeta (PKM zeta). Whereas the role of PKMf in animal models of declarative knowledge is established, its effect on procedural knowledge is not well understood. Here we show that PKMf inhibition, via injection of zeta inhibitory peptide (ZIP) into the rat sensorimotor cortex, disrupts sensorimotor memories for a skilled reaching task even after several weeks of training. The rate of relearning the task after the memory disruption by ZIP was indistinguishable from the rate of initial learning, suggesting no significant savings after the memory loss. These results indicate a shared molecular mechanism of storage for declarative and procedural forms of memory.	[von Kraus, Lee Michael] SUNY Hlth Sci Ctr, Grad Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton; Francis, Joseph Thachil] SUNY Hlth Sci Ctr, Robert Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton; Francis, Joseph Thachil] SUNY Hlth Sci Ctr, Dept Physiol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton; Francis, Joseph Thachil] SUNY Hlth Sci Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton] SUNY Hlth Sci Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Francis, Joseph Thachil] SUNY Hlth Sci Ctr, Grad Program Biomed Engn, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	von Kraus, LM (corresponding author), SUNY Hlth Sci Ctr, Grad Program Neural & Behav Sci, Brooklyn, NY 11203 USA.	Joe.francis@downstate.edu	Francis, Joseph T/I-4984-2012		New York State Spinal Cord Injury Research Board [C022048, C023682]; National Academies Keck Futures Initiative [N66001-10-C-2008]; Downstate Medical Center; NIH [R01 MH53576, MH57068]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057068, R37MH057068, R01MH053576] Funding Source: NIH RePORTER	New York State Spinal Cord Injury Research Board; National Academies Keck Futures Initiative; Downstate Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the New York State Spinal Cord Injury Research Board (www.health.state.ny.us) Grants C022048, C023682, National Academies Keck Futures Initiative (www.keckfutures.org) Grant NAKFI SP09, DARPA (www.darpa.mil) Contract #N66001-10-C-2008, Downstate Medical Center (www.downstate.edu) Dean's Initiative Research Grant (J.T.F.), and NIH (www.nih.gov) R01 MH53576 and MH57068 (T.C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Byl NN, 1997, PHYS THER, V77, P269, DOI 10.1093/ptj/77.3.269; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Crary JF, 2006, J NEUROPATH EXP NEUR, V65, P319, DOI 10.1097/01.jnen.0000218442.07664.04; Criscimagna-Hemminger SE, 2008, J NEUROSCI, V28, P9610, DOI 10.1523/JNEUROSCI.3071-08.2008; Kleim JA, 2003, NEURON, V40, P167, DOI 10.1016/S0896-6273(03)00592-0; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Kleim JA, 1996, J NEUROSCI, V16, P4529; Lenz FA, 1999, J NEUROPHYSIOL, V82, P3204, DOI 10.1152/jn.1999.82.6.3204; Monfils MH, 2004, CEREB CORTEX, V14, P586, DOI 10.1093/cercor/bhh020; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Oster H, 2004, MOL BRAIN RES, V127, P79, DOI 10.1016/j.molbrainres.2004.05.009; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PETERSON GM, 1932, COMP PSYCHOL MONOGRA, V9; Remple MS, 2001, BEHAV BRAIN RES, V123, P133, DOI 10.1016/S0166-4328(01)00199-1; Rioult-Pedotti MS, 2007, J NEUROPHYSIOL, V98, P3688, DOI 10.1152/jn.00164.2007; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; SHAO CY, 2009, SOC NEUR ANN M CHIC; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Wang Y, 1998, BRAIN RES, V781, P137, DOI 10.1016/S0006-8993(97)01223-7; WHISHAW IQ, 1989, BEHAV BRAIN RES, V32, P11, DOI 10.1016/S0166-4328(89)80067-1; WHISHAW IQ, 1986, BRAIN, V109, P805, DOI 10.1093/brain/109.5.805	29	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2010	5	6							e11125	10.1371/journal.pone.0011125	http://dx.doi.org/10.1371/journal.pone.0011125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610YF	20559553	Green Published, Green Submitted, gold			2022-12-25	WOS:000278775900015
J	Ryan, GJ; Hoff, DR; Driver, ER; Voskuil, MI; Gonzalez-Juarrero, M; Basaraba, RJ; Crick, DC; Spencer, JS; Lenaerts, AJ				Ryan, Gavin J.; Hoff, Donald R.; Driver, Emily R.; Voskuil, Martin I.; Gonzalez-Juarrero, Mercedes; Basaraba, Randall J.; Crick, Dean C.; Spencer, John S.; Lenaerts, Anne J.			Multiple M. tuberculosis Phenotypes in Mouse and Guinea Pig Lung Tissue Revealed by a Dual-Staining Approach	PLOS ONE			English	Article							MYCOBACTERIAL ACID-FASTNESS; DORMANT TUBERCLE-BACILLI; INTERFERON-GAMMA; ALPHA-CRYSTALLIN; GENE-EXPRESSION; IN-VITRO; NONREPLICATING PERSISTENCE; LATENT TUBERCULOSIS; STATIONARY-PHASE; BOVIS BCG	A unique hallmark of tuberculosis is the granulomatous lesions formed in the lung. Granulomas can be heterogeneous in nature and can develop a necrotic, hypoxic core which is surrounded by an acellular, fibrotic rim. Studying bacilli in this in vivo microenvironment is problematic as Mycobacterium tuberculosis can change its phenotype and also become acid-fast negative. Under in vitro models of differing environments, M. tuberculosis alters its metabolism, transcriptional profile and rate of replication. In this study, we investigated whether these phenotypic adaptations of M. tuberculosis are unique for certain environmental conditions and if they could therefore be used as differential markers. Bacilli were studied using fluorescent acid-fast auramine-rhodamine targeting the mycolic acid containing cell wall, and immunofluorescence targeting bacterial proteins using an anti-M. tuberculosis whole cell lysate polyclonal antibody. These techniques were combined and simultaneously applied to M. tuberculosis in vitro culture samples and to lung sections of M. tuberculosis infected mice and guinea pigs. Two phenotypically different subpopulations of M. tuberculosis were found in stationary culture whilst three subpopulations were found in hypoxic culture and in lung sections. Bacilli were either exclusively acid-fast positive, exclusively immunofluorescent positive or acid-fast and immunofluorescent positive. These results suggest that M. tuberculosis exists as multiple populations in most conditions, even within seemingly a single microenvironment. This is relevant information for approaches that study bacillary characteristics in pooled samples (using lipidomics and proteomics) as well as in M. tuberculosis drug development.	[Ryan, Gavin J.; Hoff, Donald R.; Driver, Emily R.; Gonzalez-Juarrero, Mercedes; Basaraba, Randall J.; Crick, Dean C.; Spencer, John S.; Lenaerts, Anne J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Voskuil, Martin I.] Univ Colorado, Sch Med, Denver, CO USA	Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ryan, GJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	lenaerts@colostate.edu	Crick, Dean/H-8251-2017; Lenaerts, Anne/F-1353-2017; Spencer, John S/G-6968-2017	Crick, Dean/0000-0001-9281-7058; Spencer, John S/0000-0002-8051-3038; gonzalez-juarrero, mercedes/0000-0002-4045-2365	National Institutes of Health (NIH) [RO-1 AI061505, NO1 AI-95385]; NIH, at CSU [NO1 AI-95385]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095385, R01AI061505] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, at CSU(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institutes of Health (NIH) grant RO-1 AI061505 and the NIH Contract NO1 AI-95385 at CSU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amand ALS, 2005, J CLIN MICROBIOL, V43, P5369, DOI 10.1128/JCM.43.10.5369-5371.2005; Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Desjardin LE, 2001, J BACTERIOL, V183, P5311, DOI 10.1128/JB.183.18.5311-5316.2001; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dick T, 2001, J ANTIMICROB CHEMOTH, V47, P117, DOI 10.1093/jac/47.1.117; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GOREN MB, 1978, AM REV RESPIR DIS, V118, P151; Hanscheid T, 2007, LANCET INFECT DIS, V7, P236, DOI 10.1016/S1473-3099(07)70058-0; HARADA K, 1976, STAIN TECHNOL, V51, P255, DOI 10.3109/10520297609116714; Hoff DR, 2008, ANTIMICROB AGENTS CH, V52, P4137, DOI 10.1128/AAC.00196-08; Johnson CM, 2005, ANTIMICROB AGENTS CH, V49, P4335, DOI 10.1128/AAC.49.10.4335-4338.2005; Kelly BP, 1996, ANTIMICROB AGENTS CH, V40, P2809, DOI 10.1128/AAC.40.12.2809; KOJIMA K, 1989, AM J CLIN PATHOL, V92, P57, DOI 10.1093/ajcp/92.1.57; Kraft SL, 2004, INFECT IMMUN, V72, P5963, DOI 10.1128/IAI.72.10.5963-5971.2004; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lenaerts AJ, 2008, TRENDS MICROBIOL, V16, P48, DOI 10.1016/j.tim.2007.12.002; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Murugasu-Oei B, 2000, J ANTIMICROB CHEMOTH, V46, P917, DOI 10.1093/jac/46.6.917; ORTALOMAGNE A, 1995, MICROBIOL-UK, V141, P1609, DOI 10.1099/13500872-141-7-1609; OSTER G, 1951, CR HEBD ACAD SCI, V232, P1708; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pearl JE, 2001, CELL IMMUNOL, V211, P43, DOI 10.1006/cimm.2001.1819; Purohit MR, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-36; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; RICHARDS OSCAR W., 1941, SCIENCE, V93, P190, DOI 10.1126/science.93.2408.190; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Shapiro HM, 2008, J MICROBIOL METH, V74, P119, DOI 10.1016/j.mimet.2008.04.005; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; SMITH DW, 1991, TUBERCLE, V72, P223, DOI 10.1016/0041-3879(91)90013-I; Turner OC, 2003, GRANULOMATOUS INFECTIONS AND INFLAMMATIONS: CELLULAR AND MOLECULAR MECHANISMS, P65; Ulrichs T, 2005, J PATHOL, V205, P633, DOI 10.1002/path.1728; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2004, TUBERCULOSIS, V84, P138, DOI 10.1016/j.tube.2003.12.008; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; *WHO, 2009, WHO REP 2009 GLOB TU; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	58	59	60	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11108	10.1371/journal.pone.0011108	http://dx.doi.org/10.1371/journal.pone.0011108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559431	Green Published, gold, Green Submitted			2022-12-25	WOS:000278741100021
J	Todeschini, AL; Teysset, L; Delmarre, V; Ronsseray, S				Todeschini, Anne-Laure; Teysset, Laure; Delmarre, Valerie; Ronsseray, Stephane			The Epigenetic Trans-Silencing Effect in Drosophila Involves Maternally-Transmitted Small RNAs Whose Production Depends on the piRNA Pathway and HP1	PLOS ONE			English	Article							SMALL INTERFERING RNA; TELOMERIC P-ELEMENTS; DISTINCT CHROMATIN DOMAINS; HYBRID DYSGENESIS; CYTOTYPE REGULATION; SUBTELOMERIC HETEROCHROMATIN; ENDOGENOUS RETROVIRUS; TRANSPOSABLE ELEMENTS; TISSUE-SPECIFICITY; MELANOGASTER	Background: The study of P transposable element repression in Drosophila melanogaster led to the discovery of the Trans-Silencing Effect (TSE), a homology-dependent repression mechanism by which a P-transgene inserted in subtelomeric heterochromatin (Telomeric Associated Sequences, "TAS'') has the capacity to repress in trans, in the female germline, a homologous P-lacZ transgene located in euchromatin. Phenotypic and genetic analysis have shown that TSE exhibits variegation in ovaries, displays a maternal effect as well as epigenetic transmission through meiosis and involves heterochromatin (including HP1) and RNA silencing. Principal Findings: Here, we show that mutations in squash and zucchini, which are involved in the piwi-interacting RNA (piRNA) silencing pathway, strongly affect TSE. In addition, we carried out a molecular analysis of TSE and show that silencing is correlated to the accumulation of lacZ small RNAs in ovaries. Finally, we show that the production of these small RNAs is sensitive to mutations affecting squash and zucchini, as well as to the dose of HP1. Conclusions and Significance: Thus, our results indicate that the TSE represents a bona fide piRNA-based repression. In addition, the sensitivity of TSE to HP1 dose suggests that in Drosophila, as previously shown in Schizosaccharomyces pombe, a RNA silencing pathway can depend on heterochromatin components.	[Todeschini, Anne-Laure; Teysset, Laure; Delmarre, Valerie; Ronsseray, Stephane] Univ Paris 06, CNRS, Lab Biol Dev, UMR7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Todeschini, AL (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR7592, Paris, France.	stephane.ronsseray@snv.jussieu.fr	Ronsseray, Stephane/AAD-6378-2021	Teysset, Laure/0000-0002-7413-1850	Centre National de la Recherche Scientifique (Laboratoire de Biologie du Developpement - Unite Mixte de Recherche, Institut Jacques Monod - Unite Mixte de Recherche ) [7622, 7592]; Universite Pierre & Marie Curie - Paris; Universite Paris-Diderot - Paris; Action Concertee Incitative - Biologie Moleculaire et Structurale programme; Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique (Laboratoire de Biologie du Developpement - Unite Mixte de Recherche, Institut Jacques Monod - Unite Mixte de Recherche )(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre & Marie Curie - Paris; Universite Paris-Diderot - Paris; Action Concertee Incitative - Biologie Moleculaire et Structurale programme; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique (Laboratoire de Biologie du Developpement - Unite Mixte de Recherche 7622 and Institut Jacques Monod - Unite Mixte de Recherche 7592), Universite Pierre & Marie Curie - Paris 6, Universite Paris-Diderot - Paris 7, Action Concertee Incitative - Biologie Moleculaire et Structurale programme and the Association pour la Recherche sur le Cancer. A. L. T. was supported by a post-doctoral fellowship from the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva EN, 2005, J CELL SCI, V118, P5465, DOI 10.1242/jcs.02654; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Biessmann H, 2005, GENETICS, V171, P1767, DOI 10.1534/genetics.105.048827; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; Brasset E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-25; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; Chalvet F, 1999, EMBO J, V18, P2659, DOI 10.1093/emboj/18.9.2659; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; COEN D, 1994, GENETICA, V93, P61, DOI 10.1007/BF01435240; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Desset S, 2003, GENETICS, V164, P501; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Dramard X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000304; EISSENBERG JC, 1992, GENETICS, V131, P345; ENGELS WR, 1979, GENET RES, V33, P219, DOI 10.1017/S001667230001836X; ENGELS WR, 1979, P NATL ACAD SCI USA, V76, P4011, DOI 10.1073/pnas.76.8.4011; ENGELS WR, 1989, P ELEMENTS DROSOPHIL, P437; FAGEGALTIER D, 2009, P NATL ACAD SCI US; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Frydrychova RC, 2008, GENETICS, V180, P121, DOI 10.1534/genetics.108.090647; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Haley KJ, 2005, GENETICS, V171, P583, DOI 10.1534/genetics.102.001594; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Josse T, 2007, PLOS GENET, V3, P1633, DOI 10.1371/journal.pgen.0030158; Josse T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003249; KARPEN GH, 1992, GENETICS, V132, P737; KIDWELL MG, 1977, GENETICS, V86, P813; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; LASKI FA, 1986, CELL, V44, P7, DOI 10.1016/0092-8674(86)90480-0; LEMAITRE B, 1993, GENETICS, V135, P149; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Marin L, 2000, GENETICS, V155, P1841; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; PICARD G, 1978, GENET RES, V32, P275, DOI 10.1017/S0016672300018772; Reiss D, 2004, MOL GENET GENOMICS, V272, P336, DOI 10.1007/s00438-004-1061-1; Rio Donald C., 2002, P484; Roche SE, 1998, GENETICS, V149, P1839; Ronsseray S, 1996, GENETICS, V143, P1663; RONSSERAY S, 1993, MOL GEN GENET, V241, P115, DOI 10.1007/BF00280208; RONSSERAY S, 1991, GENETICS, V129, P501; Ronsseray S, 2003, GENETICA, V117, P327, DOI 10.1023/A:1022929121828; Ronsseray S, 2001, GENETICS, V159, P1631; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; SCHUPBACH T, 1991, GENETICS, V129, P1119; Simmons MJ, 2007, GENETICS, V176, P1945, DOI 10.1534/genetics.106.066746; Simmons MJ, 2004, GENETICS, V166, P243, DOI 10.1534/genetics.166.1.243; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Stuart JR, 2002, GENETICS, V162, P1641; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Tushir JS, 2009, CELL, V139, P634, DOI 10.1016/j.cell.2009.10.021; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	73	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2010	5	6							e11032	10.1371/journal.pone.0011032	http://dx.doi.org/10.1371/journal.pone.0011032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	610NX	20559422	Green Published, gold, Green Submitted			2022-12-25	WOS:000278741100002
